PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cerofolini, L; Fields, GB; Fragai, M; Geraldes, CFGC; Luchinat, C; Parigi, G; Ravera, E; Svergun, DI; Teixeira, JMC				Cerofolini, Linda; Fields, Gregg B.; Fragai, Marco; Geraldes, Carlos F. G. C.; Luchinat, Claudio; Parigi, Giacomo; Ravera, Enrico; Svergun, Dmitri I.; Teixeira, Joao M. C.			Examination of Matrix Metalloproteinase-1 in Solution A PREFERENCE FOR THE PRE-COLLAGENOLYSIS STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Collagen; Matrix Metalloproteinase (MMP); Metalloprotease; Structural Biology; Collagenolysis; Maximum Occurrence	PARAMAGNETIC RELAXATION ENHANCEMENT; BIOLOGICAL MACROMOLECULES; SUBSTRATE-SPECIFICITY; CONFORMATIONAL SPACE; SOLUTION SCATTERING; CATALYTIC DOMAIN; STRUCTURAL BASIS; CYTOCHROME-C; METAL-IONS; BINDING	Catalysis of collagen degradation by matrix metalloproteinase 1 (MMP-1) has been proposed to critically rely on flexibility between the catalytic (CAT) and hemopexin-like (HPX) domains. A rigorous assessment of the most readily accessed conformations in solution is required to explain the onset of substrate recognition and collagenolysis. The present study utilized paramagnetic NMR spectroscopy and small angle x-ray scattering (SAXS) to calculate the maximum occurrence (MO) of MMP-1 conformations. The MMP-1 conformations with large MO values (up to 47%) are restricted into a relatively small conformational region. All conformations with high MO values differ largely from the closed MMP-1 structures obtained by x-ray crystallography. The MO of the latter is approximate to 20%, which represents the upper limit for the presence of this conformation in the ensemble sampled by the protein in solution. In all the high MO conformations, the CAT and HPX domains are not in tight contact, and the residues of the HPX domain reported to be responsible for the binding to the collagen triple-helix are solvent exposed. Thus, overall analysis of the highest MO conformations indicated that MMP-1 in solution was poised to interact with collagen and then could readily proceed along the steps of collagenolysis.	[Cerofolini, Linda; Fragai, Marco; Luchinat, Claudio; Parigi, Giacomo; Ravera, Enrico; Teixeira, Joao M. C.] Univ Florence, CERM, I-50019 Sesto Fiorentino, FI, Italy; [Fragai, Marco; Luchinat, Claudio; Parigi, Giacomo; Ravera, Enrico] Univ Florence, Dept Chem U Schiff, I-50019 Sesto Fiorentino, FI, Italy; [Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Geraldes, Carlos F. G. C.; Teixeira, Joao M. C.] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3001401 Coimbra, Portugal; [Geraldes, Carlos F. G. C.; Teixeira, Joao M. C.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3001401 Coimbra, Portugal; [Svergun, Dmitri I.] DESY, EMBL, D-22603 Hamburg, Germany	University of Florence; University of Florence; Torrey Pines Institute for Molecular Studies, Florida; Universidade de Coimbra; Universidade de Coimbra; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org; claudioluchinat@cerm.unifi.it	Cerofolini, Linda/AAQ-2914-2020; Ravera, Enrico/E-9361-2012; Fragai, Marco/K-4732-2015; Parigi, Giacomo/A-4329-2018; Ravera, Enrico/N-1251-2019; Teixeira, João Miguel Correia/ABD-1037-2020; Parigi, Giacomo/ABF-5321-2020	Ravera, Enrico/0000-0001-7708-9208; Fragai, Marco/0000-0002-8440-1690; Parigi, Giacomo/0000-0002-1989-4644; Ravera, Enrico/0000-0001-7708-9208; Teixeira, João Miguel Correia/0000-0002-9113-0622; Parigi, Giacomo/0000-0002-1989-4644; Cerofolini, Linda/0000-0002-0795-9594; Geraldes, Carlos/0000-0002-0837-8329; Luchinat, Claudio/0000-0003-2271-8921; Svergun, Dmitri/0000-0003-0830-5696	National Institutes of Health [CA98799]; MIUR-FIRB [RBLA032ZM7, RBRN07BMCT]; European Commission [228461, 261572, 261863]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/45928/2008]; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); Ente Cassa di Risparmio; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); Ente Cassa di Risparmio; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98799, Ente Cassa di Risparmio, MIUR-FIRB contracts RBLA032ZM7 and RBRN07BMCT, European Commission contracts East-NMR number 228461, WeNMR number 261572, and Bio-NMR number 261863, and Fundacao para a Ciencia e Tecnologia (FCT), Portugal, Grant SFRH/BD/45928/2008 (to J. M. C. T.), and Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions.	Anthis NJ, 2011, J AM CHEM SOC, V133, P18966, DOI 10.1021/ja2082813; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Bashir Q, 2010, J AM CHEM SOC, V132, P241, DOI 10.1021/ja9064574; Berlin K, 2009, J MAGN RESON, V201, P25, DOI 10.1016/j.jmr.2009.07.028; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101; Bertini I, 2003, BIOCHEMISTRY-US, V42, P8011, DOI 10.1021/bi034494z; Bertini I, 2002, PROG NUCL MAG RES SP, V40, P249, DOI 10.1016/S0079-6565(02)00002-X; Bertini I, 2005, J MED CHEM, V48, P7544, DOI 10.1021/jm050574k; Bertini I, 2004, ANGEW CHEM INT EDIT, V43, P2254, DOI 10.1002/anie.200353453; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2007, J AM CHEM SOC, V129, P12786, DOI 10.1021/ja0726613; Bertini I, 2012, J BIOMOL NMR, V53, P271, DOI 10.1007/s10858-012-9638-1; Bertini I, 2012, PHYS CHEM CHEM PHYS, V14, P9149, DOI 10.1039/c2cp40139h; Bertini I, 2012, FEBS LETT, V586, P557, DOI 10.1016/j.febslet.2011.09.020; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2011, COORDIN CHEM REV, V255, P649, DOI 10.1016/j.ccr.2010.09.001; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bertini I, 2010, J AM CHEM SOC, V132, P13553, DOI 10.1021/ja1063923; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bode W, 2003, BIOCHEM SOC SYMP, V70, P1; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Dasgupta S, 2011, J BIOMOL NMR, V51, P253, DOI 10.1007/s10858-011-9532-2; Fasciglione GF, 2012, J BIOL INORG CHEM, V17, P663, DOI 10.1007/s00775-012-0886-z; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fragai M, 2013, COORDIN CHEM REV, V257, P2652, DOI 10.1016/j.ccr.2013.02.009; Ikegami T, 2004, J BIOMOL NMR, V29, P339, DOI 10.1023/B:JNMR.0000032611.72827.de; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Keizers PHJ, 2008, J AM CHEM SOC, V130, P14802, DOI 10.1021/ja8054832; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuffner JJ, 2004, IEEE INT CONF ROBOT, P3993, DOI 10.1109/ROBOT.2004.1308895; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Longinetti M, 2002, J PHYS A-MATH GEN, V35, P8153, DOI 10.1088/0305-4470/35/39/302; Longinetti M, 2006, INVERSE PROBL, V22, P1485, DOI 10.1088/0266-5611/22/4/019; Lu KG, 2013, J MOL BIOL, V425, P1815, DOI 10.1016/j.jmb.2013.02.002; Luchinat C, 2012, J MAGN RESON, V215, P85, DOI 10.1016/j.jmr.2011.12.016; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Nagulapalli M, 2012, STRUCTURE, V20, P522, DOI 10.1016/j.str.2012.01.021; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Ryabov YE, 2007, J AM CHEM SOC, V129, P3315, DOI 10.1021/ja067667r; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Shealy P, 2010, J MAGN RESON, V207, P8, DOI 10.1016/j.jmr.2010.07.016; Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tolman JR, 2001, J AM CHEM SOC, V123, P1416, DOI 10.1021/ja002500y; Tsukada H, 2002, J BIOL CHEM, V277, P27378, DOI 10.1074/jbc.M201367200; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Weiss DR, 2009, J MOL BIOL, V385, P665, DOI 10.1016/j.jmb.2008.10.064; Wohnert J, 2003, J AM CHEM SOC, V125, P13338, DOI 10.1021/ja036022d; Xu XF, 2008, J AM CHEM SOC, V130, P6395, DOI 10.1021/ja7101357; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yuwen T, 2011, J BIOMOL NMR, V51, P131, DOI 10.1007/s10858-011-9548-7	69	59	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30659	30671		10.1074/jbc.M113.477240	http://dx.doi.org/10.1074/jbc.M113.477240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025334	Green Published, hybrid			2022-12-25	WOS:000329868100066
J	Gil, E; Bosch, A; Lampe, D; Lizcano, JM; Perales, JC; Danos, O; Chillon, M				Gil, Estel; Bosch, Assumpcio; Lampe, David; Lizcano, Jose M.; Perales, Jose C.; Danos, Olivier; Chillon, Miguel			Functional Characterization of the Human Mariner Transposon Hsmar2	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; SLEEPING-BEAUTY; MAMMALIAN-CELLS; HUMAN GENOME; SETMAR PROTEIN; ELEMENTS; GENE; RECOMBINATION; LOCALIZATION; NEUROPATHIES	DNA transposons are mobile elements with the ability to mobilize and transport genetic information between different chromosomal loci. Unfortunately, most transposons copies are currently inactivated, little is known about mariner elements in humans despite their role in the evolution of the human genome, even though the Hsmar2 transposon is associated to hotspots for homologous recombination involved in human genetic disorders as Charcot-Marie-Tooth, Prader-Willi/Angelman, and Williams syndromes. This manuscript describes the functional characterization of the human HSMAR2 transposase generated from fossil sequences and shows that the native HSMAR2 is active in human cells, but also in bacteria, with an efficiency similar to other mariner elements. We observe that the subcellular localization of HSMAR2 is dependent on the host cell type, and is cytotoxic when overexpressed in HeLa cells. Finally, we also demonstrate that the binding of HSMAR2 to its own ITRs is specific, and that the excision reaction leaves non-canonical footprints both in bacteria and eukaryotic cells.	[Gil, Estel; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Ctr Anim Biotechnol & Gene Therapy CBATEG, Bellaterra, Spain; [Lampe, David] Duquesne Univ, Dept Biol Sci, Bayer Sch Nat & Environm Sci, Pittsburgh, PA 15219 USA; [Lizcano, Jose M.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Inst Neurociences, Bellaterra, Spain; [Perales, Jose C.] Univ Barcelona, IDIBELL, Dept Physiol Sci 2, Barcelona, Spain; [Danos, Olivier] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U845, Paris, France; [Chillon, Miguel] Inst Catala Recerca & Estudis Avancats ICREA, Barcelona, Spain	Autonomous University of Barcelona; Duquesne University; Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; ICREA	Chillon, M (corresponding author), Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Ctr Anim Biotechnol & Gene Therapy CBATEG, Edifici H, Bellaterra, Spain.	miguel.chillon@uab.es	PERALES, JOSE C. C/D-5586-2012; PERALES, JOSE C./AAC-3156-2019; PERALES, JOSE C/J-7457-2017; Gil, Estel/B-9786-2015; Lizcano, Jose M/E-6080-2010; lizcano, jose m/AAK-3577-2020; Bosch, Assumpcio/C-7593-2015; Chillon, Miguel/A-2466-2009	PERALES, JOSE C. C/0000-0001-7363-2226; PERALES, JOSE C./0000-0001-7363-2226; PERALES, JOSE C/0000-0001-7363-2226; Lizcano, Jose M/0000-0002-3154-5383; lizcano, jose m/0000-0002-3154-5383; Bosch, Assumpcio/0000-0002-7205-2796; Chillon, Miguel/0000-0003-0840-2111; Gil, Estel/0000-0003-4502-4623	Institute of Health Carlos III [ISCIII-PI10-00561, ISC-III-PS09/00720, SGR2009-1300]; ICREA Funding Source: Custom	Institute of Health Carlos III(Instituto de Salud Carlos III); ICREA(ICREA)	This work was supported by ISCIII-PI10-00561, ISC-III-PS09/00720 and SGR2009-1300 (The Institute of Health Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MG, 2006, GENETICA, V127, P351, DOI 10.1007/s10709-006-6250-x; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chillon M, 2011, METHODS MOL BIOL, V737, P117, DOI 10.1007/978-1-61779-095-9_5; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Delauriere L, 2009, GENETICA, V137, P9, DOI 10.1007/s10709-009-9370-2; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Feng XF, 2010, NUCLEIC ACIDS RES, V38, P1204, DOI 10.1093/nar/gkp1068; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Ivics Z, 2004, METH MOL B, V260, P255, DOI 10.1385/1-59259-755-6:255; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2004, MOL CELL, V13, P279, DOI 10.1016/S1097-2765(03)00524-0; JOHNSON RC, 1984, GENETICS, V107, P9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keravala A, 2006, HUM GENE THER, V17, P1006, DOI 10.1089/hum.2006.17.1006; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; King RD, 1997, COMPUT APPL BIOSCI, V13, P473; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Miskey C, 2003, NUCLEIC ACIDS RES, V31, P6873, DOI 10.1093/nar/gkg910; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1999, GENOME RES, V9, P839, DOI 10.1101/gr.9.9.839; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Robertson HM, 1997, GENE, V205, P219, DOI 10.1016/S0378-1119(97)00471-X; Robertson HM, 1996, NAT GENET, V12, P360, DOI 10.1038/ng0496-360; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; Urban Z, 1996, AM J HUM GENET, V59, P958; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yant SR, 2003, MOL CELL BIOL, V23, P8505, DOI 10.1128/MCB.23.23.8505-8518.2003; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	47	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73227	10.1371/journal.pone.0073227	http://dx.doi.org/10.1371/journal.pone.0073227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039890	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500029
J	Martin, FPJ; Montoliu, I; Collino, S; Scherer, M; Guy, P; Tavazzi, I; Thorimbert, A; Moco, S; Rothney, MP; Ergun, DL; Beaumont, M; Ginty, F; Qanadli, SD; Favre, L; Giusti, V; Rezzi, S				Martin, Francois-Pierre J.; Montoliu, Ivan; Collino, Sebastiano; Scherer, Max; Guy, Philippe; Tavazzi, Isabelle; Thorimbert, Anita; Moco, Sofia; Rothney, Megan P.; Ergun, David L.; Beaumont, Maurice; Ginty, Fiona; Qanadli, Salah D.; Favre, Lucie; Giusti, Vittorio; Rezzi, Serge			Topographical Body Fat Distribution Links to Amino Acid and Lipid Metabolism in Healthy Non-Obese Women	PLOS ONE			English	Article							ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; PLATELET ACTIVATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; CENTRAL OBESITY; ABDOMINAL FAT; PLASMALOGENS; POPULATION	Visceral adiposity is increasingly recognized as a key condition for the development of obesity related disorders, with the ratio between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reported as the best correlate of cardiometabolic risk. In this study, using a cohort of 40 obese females (age: 25-45 y, BMI: 28-40 kg/m(2)) under healthy clinical conditions and monitored over a 2 weeks period we examined the relationships between different body composition parameters, estimates of visceral adiposity and blood/urine metabolic profiles. Metabonomics and lipidomics analysis of blood plasma and urine were employed in combination with in vivo quantitation of body composition and abdominal fat distribution using iDXA and computerized tomography. Of the various visceral fat estimates, VAT/SAT and VAT/total abdominal fat ratios exhibited significant associations with regio-specific body lean and fat composition. The integration of these visceral fat estimates with metabolic profiles of blood and urine described a distinct amino acid, diacyl and ether phospholipid phenotype in women with higher visceral fat. Metabolites important in predicting visceral fat adiposity as assessed by Random forest analysis highlighted 7 most robust markers, including tyrosine, glutamine, PC-O 44: 6, PC-O 44: 4, PC-O 42: 4, PC-O 40: 4, and PC-O 40: 3 lipid species. Unexpectedly, the visceral fat associated inflammatory profiles were shown to be highly influenced by inter-days and between-subject variations. Nevertheless, the visceral fat associated amino acid and lipid signature is proposed to be further validated for future patient stratification and cardiometabolic health diagnostics.	[Martin, Francois-Pierre J.; Collino, Sebastiano; Scherer, Max; Guy, Philippe; Tavazzi, Isabelle; Thorimbert, Anita; Moco, Sofia; Rezzi, Serge] Nestec Ltd, Nestle Res Ctr, Metabol & Biomarkers, CH-1000 Lausanne, Switzerland; [Montoliu, Ivan] Nestec Ltd, Nestle Res Ctr, Appl Math, CH-1000 Lausanne, Switzerland; [Rothney, Megan P.] GE Global Res Ctr, Diagnost & Biomed Technol Org, Niskayuna, NY USA; [Ergun, David L.; Ginty, Fiona] GE Healthcare, Madison, WI USA; [Beaumont, Maurice] Nestec Ltd, Nestle Res Ctr, Clin Dev Unit, CH-1000 Lausanne, Switzerland; [Qanadli, Salah D.] Univ Lausanne Hosp, Dept Radiol, Cardiothorac & Vasc Unit, Lausanne, Switzerland; [Favre, Lucie; Giusti, Vittorio] Univ Lausanne Hosp, Dept Med, Serv Endocrinol Diabetol & Metab, Lausanne, Switzerland	Nestle SA; Nestle SA; General Electric; General Electric; Nestle SA; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Martin, FPJ (corresponding author), Nestle Inst Hlth Sci SA, Mol Biomarkers, Lausanne, Switzerland.	francois-pierre.martin@rd.nestle.com; serge.rezzi@rd.nestle.com	Moco, Sofia/AAN-7187-2021	Moco, Sofia/0000-0001-8170-8876; Ginty, Fiona/0000-0001-6638-683X; Guy, philippe/0000-0002-2968-8625; QANADLI, Salah Dine/0000-0003-1330-660X; Martin, Francois-Pierre/0000-0003-1373-5367				Basili S, 2006, J AM COLL CARDIOL, V48, P2531, DOI 10.1016/j.jacc.2006.08.040; Batra A, 2012, DIGEST DIS, V30, P70, DOI 10.1159/000335722; Baur P, 2011, J PROTEOME RES, V10, P5523, DOI 10.1021/pr2007973; Borruel S, 2013, J CLIN ENDOCR METAB, V98, P1254, DOI 10.1210/jc.2012-3698; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chiolero A, 2007, Rev Med Suisse, V3, P1262; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Davi G, 2002, JAMA-J AM MED ASSOC, V288, P2008, DOI 10.1001/jama.288.16.2008; DESPRES JP, 1988, PREV MED, V17, P423, DOI 10.1016/0091-7435(88)90041-2; DONAHUE RP, 1987, LANCET, V2, P1215; Dulloo AG, 2010, INT J OBESITY, V34, pS1, DOI 10.1038/ijo.2010.233; Ezeh U, 2013, J CLIN ENDOCR METAB, V98, P1541, DOI 10.1210/jc.2012-2937; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; KALKHOFF RK, 1983, J LAB CLIN MED, V102, P621; Kang SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027694; Klannemark M, 1998, DIABETOLOGIA, V41, P1516, DOI 10.1007/s001250051099; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Lasserre AM, 2007, SWISS MED WKLY, V137, P157; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Leitinger N, 1997, THROMB RES, V86, P337, DOI 10.1016/S0049-3848(97)00077-7; LEMIEUX S, 1994, DIABETOLOGIA, V37, P757, DOI 10.1007/BF00404332; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.40; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Park SH, 2007, J AM COLL NUTR, V26, P321, DOI 10.1080/07315724.2007.10719618; Peairs AD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-122; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rothney MP, 2012, J CLIN DENSITOM; Samaras K, 1999, ANN INTERN MED, V130, P873, DOI 10.7326/0003-4819-130-11-199906010-00002; SCHRAKAMP G, 1985, BIOCHIM BIOPHYS ACTA, V833, P170, DOI 10.1016/0005-2760(85)90266-8; Smith SC, 2007, CURR MED RES OPIN, V23, P29, DOI 10.1185/030079906X159489; SNYDER F, 1995, BBA-LIPID LIPID MET, V1254, P231, DOI 10.1016/0005-2760(94)00192-2; Sorensen TIA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010012; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Szuldrzynski K, 2010, POL ARCH MED WEWN, V120, P19; Szymanska E, 2012, OMICS, V16, P652, DOI 10.1089/omi.2012.0062; Teran-Garcia M, 2007, APPL PHYSIOL NUTR ME, V32, P89, DOI [10.1139/H06-102, 10.1139/h06-102]; Trygg J, 2003, J CHEMOMETR, V17, P53, DOI 10.1002/cem.775; Viguerie N, 2005, DIABETOLOGIA, V48, P123, DOI 10.1007/s00125-004-1618-x; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S., 1987, PLS M FRANKF; Wu B, 2009, ENDOCR J, V56, P773, DOI 10.1507/endocrj.K08E-332; Yamakado M, 2012, CLIN OBES, V2, P29, DOI 10.1111/j.1758-8111.2012.00039.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769	63	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73445	10.1371/journal.pone.0073445	http://dx.doi.org/10.1371/journal.pone.0073445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039943	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500032
J	da Silva, EF; Freiria-Oliveira, AH; Custodio, CHX; Ghedini, PC; Bataus, LAM; Colombari, E; de Castro, CH; Colugnati, DB; Rosa, DA; Cravo, SLD; Pedrino, GR				da Silva, Elaine Fernanda; Freiria-Oliveira, Andre Henrique; Xavier Custodio, Carlos Henrique; Ghedini, Paulo Cesar; Mendes Bataus, Luiz Artur; Colombari, Eduardo; de Castro, Carlos Henrique; Colugnati, Diego Basile; Rosa, Daniel Alves; Cravo, Sergio L. D.; Pedrino, Gustavo Rodrigues			A1 Noradrenergic Neurons Lesions Reduce Natriuresis and Hypertensive Responses to Hypernatremia in Rats	PLOS ONE			English	Article							SOLITARY NUCLEUS EXCITATION; CENTRAL-NERVOUS-SYSTEM; VOLUME-EXPANSION; CATECHOLAMINERGIC NEURONS; VENTROLATERAL MEDULLA; CARDIOVASCULAR-RESPONSES; BARORECEPTOR INFLUENCES; SODIUM-EXCRETION; PEPTIDE RELEASE; PREOPTIC AREA	Noradrenergic neurons in the caudal ventrolateral medulla (CVLM; A1 group) contribute to cardiovascular regulation. The present study assessed whether specific lesions in the A1 group altered the cardiovascular responses that were evoked by hypertonic saline (HS) infusion in non-anesthetized rats. Male Wistar rats (280-340 g) received nanoinjections of antidopamine-beta-hydroxylase-saporin (A1 lesion, 0.105 ng.nL(-1)) or free saporin (sham, 0.021 ng.nL(-1)) into their CVLMs. Two weeks later, the rats were anesthetized (2% halothane in O-2) and their femoral artery and vein were catheterized and led to exit subcutaneously between the scapulae. On the following day, the animals were submitted to HS infusion (3 M NaCl, 1.8 ml . kg(-1), b.wt., for longer than 1 min). In the sham-group (n = 8), HS induced a sustained pressor response (Delta MAP: 35 +/- 3.6 and 11 +/- 1.8 mmHg, for 10 and 90 min after HS infusion, respectively; P<0.05 vs. baseline). Ten min after HS infusion, the pressor responses of the anti-D beta H-saporin-treated rats (n = 11) were significantly smaller(Delta MAP: 18 +/- 1.4 mmHg; P<0.05 vs. baseline and vs. sham group), and at 90 min, their blood pressures reached baseline values (2 +/- 1.6 mmHg). Compared to the sham group, the natriuresis that was induced by HS was reduced in the lesioned group 60 min after the challenge (19 +/- 65.5 mM vs. 262 +/- 7.6 mM, respectively; P<0.05). In addition, A1-lesioned rats excreted only 47% of their sodium 90 min after HS infusion, while sham animals excreted 80% of their sodium. Immunohistochemical analysis confirmed a substantial destruction of the A1 cell group in the CVLM of rats that had been nanoinjected withanti-D beta H-saporin. These results suggest that medullary noradrenergic A1 neurons are involved in the excitatory neural pathway that regulates hypertensive and natriuretic responses to acute changes in the composition of body fluid.	[da Silva, Elaine Fernanda; Freiria-Oliveira, Andre Henrique; Xavier Custodio, Carlos Henrique; Ghedini, Paulo Cesar; Mendes Bataus, Luiz Artur] Univ Fed Goias, Inst Biol Sci, Dept Physiol Sci, Goiania, Go, Brazil; [Colombari, Eduardo] Sao Paulo State Univ, Sch Dent, Dept Physiol & Pathol, Araraquara, SP, Brazil; [Cravo, Sergio L. D.] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Pedrino, GR (corresponding author), Univ Fed Goias, Inst Biol Sci, Dept Physiol Sci, Goiania, Go, Brazil.	pedrino@pq.cnpq.br	Castro, Carlos/H-2139-2013; Freiria-Oliveira, Andre/F-2756-2012; Rosa, Daniel A/E-5429-2018; Bataus, Luiz Artur/H-8869-2013; Pedrino, Gustavo R/I-5614-2015; Colombari, Eduardo/C-3044-2012; Silva, Elaine Fernanda/U-9322-2019; Colugnati, Diego/AAD-2977-2019	Castro, Carlos/0000-0002-9510-1124; Rosa, Daniel A/0000-0002-7036-0840; Bataus, Luiz Artur/0000-0002-5437-6762; Pedrino, Gustavo R/0000-0003-0488-5400; Colombari, Eduardo/0000-0002-1395-4036; Colugnati, Diego/0000-0002-6565-0042; Ghedini, Paulo/0000-0003-2104-4064; Freiria-Oliveira, Andre Henrique/0000-0002-7511-5035	Coordenadoria de Aperfeic, oamento em Pesquisa (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477832/2010-5, 483411/2012-4]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG) [200910267000352]	Coordenadoria de Aperfeic, oamento em Pesquisa (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by Coordenadoria de Aperfeic, oamento em Pesquisa (CAPES; www.capes.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; #477832/2010-5; 483411/2012-4; www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG; #200910267000352; www.fapeg.go.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombari DSA, 2008, BRAIN RES BULL, V76, P572, DOI 10.1016/j.brainresbull.2008.04.001; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ANTUNESRODRIGUES J, 1991, P NATL ACAD SCI USA, V88, P2956, DOI 10.1073/pnas.88.7.2956; ANTUNESRODRIGUES J, 1992, P NATL ACAD SCI USA, V89, P6828, DOI 10.1073/pnas.89.15.6828; Badoer E, 2003, AM J PHYSIOL-RENAL, V285, pF640, DOI 10.1152/ajprenal.00372.2002; BEALER SL, 1983, AM J PHYSIOL, V244, pR815, DOI 10.1152/ajpregu.1983.244.6.R815; BEALER SL, 1988, AM J PHYSIOL, V254, pR84, DOI 10.1152/ajpregu.1988.254.1.R84; BEALER SL, 1983, AM J PHYSIOL, V244, pR51, DOI 10.1152/ajpregu.1983.244.1.R51; BIE P, 1980, PHYSIOL REV, V60, P961, DOI 10.1152/physrev.1980.60.4.961; BLESSING WW, 1982, BRAIN RES BULL, V9, P279, DOI 10.1016/0361-9230(82)90141-1; BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN LA, 1971, AM J PHYSIOL, V221, P273; Buller KM, 1999, BRAIN RES, V834, P42, DOI 10.1016/S0006-8993(99)01539-5; CHIBA T, 1985, BRAIN RES BULL, V14, P261, DOI 10.1016/0361-9230(85)90091-7; CIRIELLO J, 1984, AM J PHYSIOL, V246, pR968, DOI 10.1152/ajpregu.1984.246.6.R968; Colombari BSA, 2000, AM J PHYSIOL-REG I, V279, pR884, DOI 10.1152/ajpregu.2000.279.3.R884; Colombari DSA, 1999, HYPERTENSION, V34, P762, DOI 10.1161/01.HYP.34.4.762; CONRAD KP, 1986, AM J PHYSIOL, V251, pF290, DOI 10.1152/ajprenal.1986.251.2.F290; CROFTON JT, 1989, AM J PHYSIOL, V257, pR738, DOI 10.1152/ajpregu.1989.257.4.R738; DAY TA, 1990, NEUROSCI LETT, V113, P156, DOI 10.1016/0304-3940(90)90296-L; DAY TA, 1989, AM J PHYSIOL, V257, pR1020, DOI 10.1152/ajpregu.1989.257.5.R1020; DAY TA, 1984, J PHYSIOL-LONDON, V355, P237, DOI 10.1113/jphysiol.1984.sp015416; DAY TA, 1988, AM J PHYSIOL, V254, pR711, DOI 10.1152/ajpregu.1988.254.4.R711; DAY TA, 1992, BRAIN RES, V594, P244, DOI 10.1016/0006-8993(92)91131-W; FERNANDEZGALAZ C, 1994, BRAIN RES, V636, P227, DOI 10.1016/0006-8993(94)91021-9; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Frithiof R, 2009, AM J PHYSIOL-REG I, V297, pR185, DOI 10.1152/ajpregu.00058.2008; FUJITA T, 1991, JPN J PHYSIOL, V41, P653, DOI 10.2170/jjphysiol.41.653; Godino A, 2005, NEUROSCIENCE, V133, P493, DOI 10.1016/j.neuroscience.2005.02.035; HAANWINCKEL MA, 1995, P NATL ACAD SCI USA, V92, P7902, DOI 10.1073/pnas.92.17.7902; HATZINIKOLAOU P, 1981, AM J PHYSIOL, V240, pH827; Hochstenbach SL, 1996, BRAIN RES, V713, P17, DOI 10.1016/0006-8993(95)01425-X; HOCHSTENBACH SL, 1995, BRAIN RES, V674, P46, DOI 10.1016/0006-8993(94)01434-J; Howe BM, 2004, EXP NEUROL, V187, P190, DOI 10.1016/j.expneurol.2004.01.020; HUANG W, 1995, AM J PHYSIOL-REG I, V268, pR634, DOI 10.1152/ajpregu.1995.268.3.R634; KANNAN H, 1984, NEUROSCI LETT, V51, P183, DOI 10.1016/0304-3940(84)90548-2; Kapoor JR, 2000, J NEUROSCI, V20, P8868; MORITA H, 1985, AM J PHYSIOL, V249, pF680, DOI 10.1152/ajprenal.1985.249.5.F680; MORRIS M, 1989, HYPERTENSION, V13, P110, DOI 10.1161/01.HYP.13.2.110; MORRIS M, 1988, ENDOCRINOLOGY, V122, P373, DOI 10.1210/endo-122-1-373; Nishida Y, 1998, AM J PHYSIOL-REG I, V274, pR97, DOI 10.1152/ajpregu.1998.274.1.R97; Pedrino GR, 2005, AUTON NEUROSCI-BASIC, V117, P9, DOI 10.1016/j.autneu.2004.09.005; Pedrino GR, 2009, CLIN EXP PHARM PHYSL, V36, P383; Pedrino GR, 2011, AUTON NEUROSCI-BASIC, V160, P37, DOI 10.1016/j.autneu.2010.11.009; Pedrino GR, 2008, AUTON NEUROSCI-BASIC, V142, P55, DOI 10.1016/j.autneu.2008.06.006; Pedrino GR, 2006, EXP PHYSIOL, V91, P995, DOI 10.1113/expphysiol.2006.034611; Pedrino GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037587; PETTERSSON A, 1986, LIFE SCI, V38, P1127, DOI 10.1016/0024-3205(86)90249-3; RAUCH AL, 1990, AM J PHYSIOL, V258, pR531, DOI 10.1152/ajpregu.1990.258.2.R531; SAPER CB, 1983, NEUROSCI LETT, V42, P285, DOI 10.1016/0304-3940(83)90276-8; SAPHIER D, 1993, AM J PHYSIOL, V264, pR891, DOI 10.1152/ajpregu.1993.264.5.R891; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; Schreihofer AM, 2000, AM J PHYSIOL-REG I, V279, pR729, DOI 10.1152/ajpregu.2000.279.2.R729; Sera CTN, 1999, HYPERTENSION, V33, P1315; Spyer K M, 1981, Rev Physiol Biochem Pharmacol, V88, P24, DOI 10.1007/BFb0034536; Strange K, 1993, CELLULAR MOL PHYSL C; TANAKA J, 1992, NEUROREPORT, V3, P946, DOI 10.1097/00001756-199210000-00033; Tanaka J, 1997, NEUROREPORT, V8, P3147, DOI 10.1097/00001756-199709290-00028; TUCKER DC, 1987, J COMP NEUROL, V259, P591, DOI 10.1002/cne.902590408; Weiss ML, 1996, J AUTONOM NERV SYST, V57, P109, DOI 10.1016/0165-1838(95)00108-5; Wrenn CC, 1996, BRAIN RES, V740, P175, DOI 10.1016/S0006-8993(96)00855-4	62	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73187	10.1371/journal.pone.0073187	http://dx.doi.org/10.1371/journal.pone.0073187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039883	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600019
J	Al-Ahmad, A; Laird, D; Zou, P; Tomakidi, P; Steinberg, T; Lienkamp, K				Al-Ahmad, Ali; Laird, Dougal; Zou, Peng; Tomakidi, Pascal; Steinberg, Thorsten; Lienkamp, Karen			Nature-Inspired Antimicrobial Polymers - Assessment of Their Potential for Biomedical Applications	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SYNTHETIC MIMICS; CHARGE-DENSITY; PEPTIDES; CYTOTOXICITY; ANTIBACTERIAL; PLATFORM	We explored the potential of poly(oxonorbornene)-based synthetic mimics of antimicrobial peptides (SMAMPs), a promising new class of antimicrobial polymers with cell-selectivity and low resistance development potential, for clinical applications. We evaluated their antimicrobial activity against a panel of seven clinical and regulatory relevant bacteria strains, and tested their toxicity with two different kinds of primary human cells. For the antimicrobial activity, we performed the minimum inhibitory concentration (MIC) assay and determined the minimum bactericidal concentration (MBC) according to the NCCLS guidelines. The results revealed specific problems that may occur when testing the antimicrobial activity of amphiphilic cationic polymers, and confirmed the working hypothesis that the more hydrophilic SMAMP polymers in our portfolio were 'doubly selective', i.e. they are not only selective for bacteria over mammalian cells, but also for Gram-positive over Gram-negative bacteria. The data also showed that we could improve the broad-band activity of one SMAMP, and in combination with the results from the cell toxicity experiments, identified this polymer as a promising candidate for further in-vitro and in-vivo testing. Transmission electron studies revealed that the cellular envelopes of both E. coli and S. aureus were severely damaged due to SMAMP action on the bacterial membrane, which strengthened the argument that SMAMPs closely resemble antimicrobial peptides. To test cell toxicity, we used the traditional hemolysis assay with human red blood cells, and the novel xCelligence assay with primary human fibroblasts. The data reported here is the first example in which a hemolysis assay is benchmarked against the xCelligence assay. It revealed that the same trends were obtained using these complementary methods. This establishes the xCelligence assay with primary human cells as a useful tool for SMAMP characterization.	[Al-Ahmad, Ali; Laird, Dougal; Tomakidi, Pascal; Steinberg, Thorsten] Univ Freiburg, Univ Med Ctr, D-79106 Freiburg, Germany; [Laird, Dougal; Zou, Peng; Lienkamp, Karen] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Zou, Peng; Lienkamp, Karen] Univ Freiburg, Dept Microsyst Engn, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Lienkamp, K (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies, Hugstetter Str 55, D-79106 Freiburg, Germany.	lienkamp@imtek.uni-freiburg.de	Lienkamp, Karen/F-2558-2010	Lienkamp, Karen/0000-0001-6868-3707; Steinberg, Thorsten/0000-0003-1924-2694	Emmy-Noether-Program of the German Research Foundation (DFG) [LI1714/5-1]; Freiburg Institute for Advanced Studies; Albert Ludwigs University Freiburg	Emmy-Noether-Program of the German Research Foundation (DFG)(German Research Foundation (DFG)); Freiburg Institute for Advanced Studies; Albert Ludwigs University Freiburg	Funding from the Emmy-Noether-Program of the German Research Foundation (DFG, LI1714/5-1, K.L.) and the Freiburg Institute for Advanced Studies (Junior Fellowship, K. L.) is gratefully acknowledged. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Badri ZM, 2008, BIOMACROMOLECULES, V9, P2805, DOI 10.1021/bm800569x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Clinical and Laboratory Standards Institute, 1999, METHODS DETERMINING; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; Gabriel GJ, 2008, LANGMUIR, V24, P12489, DOI 10.1021/la802232p; Gabriel GJ, 2008, BIOMACROMOLECULES, V9, P2980, DOI 10.1021/bm800855t; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kuroda K, 2013, WIRES NANOMED NANOBI, V5, P49, DOI 10.1002/wnan.1199; Kuroda K, 2009, CHEM-EUR J, V15, P1123, DOI 10.1002/chem.200801523; Lienkamp K, 2008, J AM CHEM SOC, V130, P9836, DOI 10.1021/ja801662y; Lienkamp K, 2009, CHEM-EUR J, V15, P11784, DOI 10.1002/chem.200900049; Lienkamp K, 2009, CHEM-EUR J, V15, P11715, DOI 10.1002/chem.200900606; Lienkamp K, 2009, CHEM-EUR J, V15, P11710, DOI 10.1002/chem.200802558; Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005; Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d; Mowery BP, 2009, J AM CHEM SOC, V131, P9735, DOI 10.1021/ja901613g; NCCLS, 2003, M7A6 NCCLS; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Palermo EF, 2009, BIOMACROMOLECULES, V10, P1416, DOI 10.1021/bm900044x; Schulz S, 2012, TISSUE ENG PART C-ME, V18, P785, DOI 10.1089/ten.tec.2012.0027; Schulz SD, 2012, DENT MATER, V28, pE135, DOI 10.1016/j.dental.2012.04.018; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Som A, 2008, J PHYS CHEM B, V112, P3495, DOI 10.1021/jp077487j; Song AR, 2011, ACS CHEM BIOL, V6, P590, DOI 10.1021/cb100413w; Thennarasu S, 2005, BBA-BIOMEMBRANES, V1711, P49, DOI 10.1016/j.bbamem.2005.02.010; Tomakidi P, 2000, J Orofac Orthop, V61, P2; Tomakidi P, 2000, BIOMATERIALS, V21, P1549, DOI 10.1016/S0142-9612(00)00037-5; Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007; Xiao C, 2005, TOXICOL APPL PHARM, V206, P102, DOI 10.1016/j.taap.2004.10.025; Xing JZ, 2006, TOXICOL IN VITRO, V20, P995, DOI 10.1016/j.tiv.2005.12.008; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou P, 2012, J MATER CHEM, V22, P19579, DOI 10.1039/c2jm31695a	33	48	49	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73812	10.1371/journal.pone.0073812	http://dx.doi.org/10.1371/journal.pone.0073812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040079	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300131
J	Gibbs, SL; Xie, Y; Goodwill, HL; Nasr, KA; Ashitate, Y; Madigan, VJ; Siclovan, TM; Zavodszky, M; Hehir, CAT; Frangioni, JV				Gibbs, Summer L.; Xie, Yang; Goodwill, Haley L.; Nasr, Khaled A.; Ashitate, Yoshitomo; Madigan, Victoria J.; Siclovan, Tiberiu M.; Zavodszky, Maria; Hehir, Cristina A. Tan; Frangioni, John V.			Structure-Activity Relationship of Nerve-Highlighting Fluorophores	PLOS ONE			English	Article							INTRAMOLECULAR WITTIG; MYELIN; SURGERY; HORNER; AGENTS; LIGHT	Nerve damage is a major morbidity associated with numerous surgical interventions. Yet, nerve visualization continues to challenge even the most experienced surgeons. A nerve-specific fluorescent contrast agent, especially one with near-infrared (NIR) absorption and emission, would be of immediate benefit to patients and surgeons. Currently, there are only three classes of small molecule organic fluorophores that penetrate the blood nerve barrier and bind to nerve tissue when administered systemically. Of these three classes, the distyrylbenzenes (DSBs) are particularly attractive for further study. Although not presently in the NIR range, DSB fluorophores highlight all nerve tissue in mice, rats, and pigs after intravenous administration. The purpose of the current study was to define the pharmacophore responsible for nerve-specific uptake and retention, which would enable future molecules to be optimized for NIR optical properties. Structural analogs of the DSB class of small molecules were synthesized using combinatorial solid phase synthesis and commercially available building blocks, which yielded more than 200 unique DSB fluorophores. The nerve-specific properties of all DSB analogs were quantified using an ex vivo nerve-specific fluorescence assay on pig and human sciatic nerve. Results were used to perform quantitative structure-activity relationship (QSAR) modeling and to define the nerve-specific pharmacophore. All DSB analogs with positive ex vivo fluorescence were tested for in vivo nerve specificity in mice to assess the effect of biodistribution and clearance on nerve fluorescence signal. Two new DSB fluorophores with the highest nerve to muscle ratio were tested in pigs to confirm scalability.	[Gibbs, Summer L.; Xie, Yang; Goodwill, Haley L.; Ashitate, Yoshitomo; Madigan, Victoria J.; Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Nasr, Khaled A.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Siclovan, Tiberiu M.; Zavodszky, Maria; Hehir, Cristina A. Tan] GE Global Res, Diagnost & Biomed Technol, New York, NY USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; General Electric; Harvard University; Beth Israel Deaconess Medical Center	Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Biomed Engn, Portland, OR 97201 USA.	gibbss@ohsu.edu		Madigan, Victoria/0000-0001-8781-4274	National Institute of Health [R01-EB-022872, R01-CA-115296, K01-EB-010201]; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022872, R01EB011872, K01EB010201] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by grants from the National Institute of Health, including R01-EB-022872 (CTH), R01-CA-115296 (JVF), and K01-EB-010201 (SLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER KB, 1980, TETRAHEDRON, V36, P1717, DOI 10.1016/0040-4020(80)80068-8; Cotero VE, 2012, MOL IMAGING BIOL, V14, P708, DOI 10.1007/s11307-012-0555-1; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Grand AM, 2003, TECHNOL CANCER RES T, V2, P553, DOI 10.1177/153303460300200607; Gibbs-Strauss SL, 2011, MOL IMAGING, V10, P91, DOI 10.2310/7290.2010.00026; Gibbs-Strauss SL, 2010, MOL IMAGING, V9, P128, DOI 10.2310/7290.2010.00009; Gioux S, 2009, MOL IMAGING, V8, P156, DOI 10.2310/7290.2009.00009; HERON BM, 1995, HETEROCYCLES, V41, P2357; Inglese J, 2007, NAT CHEM BIOL, V3, P438, DOI 10.1038/nchembio0807-438; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Littke AF, 2005, ORG SYNTH, V81, P63; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michaelson MD, 2008, CA-CANCER J CLIN, V58, P196, DOI 10.3322/CA.2008.0002; Nakayama Akira, 2002, Mol Imaging, V1, P365, DOI 10.1162/153535002321093972; Pleijhuis RG, 2011, EJSO-EUR J SURG ONC, V37, P32, DOI 10.1016/j.ejso.2010.10.006; Popa A, 2006, POLYM BULL, V57, P189, DOI 10.1007/s00289-006-0553-z; Schmued L, 1999, BRAIN RES, V837, P289, DOI 10.1016/S0006-8993(99)01624-8; Singhal S, 2010, ANNU REV MED, V61, P359, DOI 10.1146/annurev.med.60.052907.094936; Stankoff B, 2006, P NATL ACAD SCI USA, V103, P9304, DOI 10.1073/pnas.0600769103; STILWELL DL, 1957, STAIN TECHNOL, V32, P19, DOI 10.3109/10520295709111391; Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6; Unangst PC, 1997, J MED CHEM, V40, P4026, DOI 10.1021/jm970422s; Wagenaar MM, 2008, MOLECULES, V13, P1406, DOI 10.3390/molecules13061406; Walz J, 2007, WORLD J UROL, V25, P31, DOI 10.1007/s00345-007-0159-6; Whitney MA, 2011, NAT BIOTECHNOL, V29, P352, DOI 10.1038/nbt.1764; Wu CY, 2006, J HISTOCHEM CYTOCHEM, V54, P997, DOI 10.1369/jhc.5A6901.2006; Wu CY, 2008, J MED CHEM, V51, P6682, DOI 10.1021/jm8003637; Xiang ZM, 2005, J HISTOCHEM CYTOCHEM, V53, P1511, DOI 10.1369/jhc.5A6704.2005	31	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73493	10.1371/journal.pone.0073493	http://dx.doi.org/10.1371/journal.pone.0073493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039960	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300081
J	Lancioni, H; Di Lorenzo, P; Ceccobelli, S; Perego, UA; Miglio, A; Landi, V; Antognoni, MT; Sarti, FM; Lasagna, E; Achilli, A				Lancioni, Hovirag; Di Lorenzo, Piera; Ceccobelli, Simone; Perego, Ugo A.; Miglio, Arianna; Landi, Vincenzo; Antognoni, Maria T.; Sarti, Francesca M.; Lasagna, Emiliano; Achilli, Alessandro			Phylogenetic Relationships of Three Italian Merino-Derived Sheep Breeds Evaluated through a Complete Mitogenome Analysis	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; GENTILE-DI-PUGLIA; GENETIC DIVERSITY; DOMESTIC SHEEP; POPULATION-STRUCTURE; MOUNTAIN SHEEP; OVIS-ARIES; ORIGIN; REVEALS; CATTLE	In Italy, the crisis of the wool industry triggered the necessity to reconvert the two traditional Merino-derived breeds, Gentile di Puglia and Sopravissana, to meat production, by creating the Merinizzata Italiana. The aim of the present study was to assess the genetic diversity of these three Italian Merino-derived (IMd) breeds by examining the molecular information encoded in the maternally-inherited mitochondrial DNA (mtDNA). A parallel molecular investigation was performed on the putative paternal and maternal breeds, the Merino from Spain and the Appenninica from Italy, respectively, as well as on three unrelated dairy breeds (Sarda and Comisana from Italy, and Lacaune from France). Firstly, the mtDNA control region of 291 samples was analyzed. When comparing the overall genetic distances among the eight stocks, the three IMd breeds clustered together close to the Appenninica, thus confirming its parental role. Among the 90 IMd samples, 82 different haplotypes were observed, almost all belonging to haplogroup B, and only one to A. For 23 mtDNAs, including nine IMd, the analysis was then brought to the level of entire mitogenomes. Three distinct sub-haplogroups within B were found to encompass the IMd samples, with one clade (B1a2a1) apparently restricted to those sheep. Thus, despite experiencing a drastic reduction in number (mainly due to changes in breeding practices driven by the economy), the IMd breeds still represent a reservoir of distinctive mitochondrial variants, which could potentially contribute to the development of conservation and management programs of Italian sheep breeds.	[Lancioni, Hovirag; Perego, Ugo A.; Achilli, Alessandro] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy; [Di Lorenzo, Piera; Ceccobelli, Simone; Sarti, Francesca M.; Lasagna, Emiliano] Univ Perugia, Dipartimento Biol Applicata, I-06100 Perugia, Italy; [Ceccobelli, Simone] Univ Padua, Dipartimento Agron Anim Alimenti Risorse Nat & Am, Padua, Italy; [Miglio, Arianna; Antognoni, Maria T.] Univ Perugia, Dipartimento Patol Diagnost Clin & Vet, I-06100 Perugia, Italy; [Landi, Vincenzo] Univ Cordoba, Dept Genet, Cordoba, Spain	University of Perugia; University of Perugia; University of Padua; University of Perugia; Universidad de Cordoba	Lasagna, E (corresponding author), Univ Perugia, Dipartimento Biol Applicata, I-06100 Perugia, Italy.	elasagna@unipg.it; alessandro.achilli@unipg.it	Sarti, Francesca Maria FMS/Y-4993-2018; Perego, Ugo/AAG-9327-2019; Miglio, Arianna/D-5913-2014; Miglio, Arianna/AAP-7602-2020; Landi, Vincenzo/T-7484-2017; Achilli, Alessandro/I-9236-2012; Lancioni, Hovirag/F-9067-2014; Emiliano, Lasagna/I-9304-2019; Ceccobelli, Simone/AAZ-9332-2020	Miglio, Arianna/0000-0002-5459-6298; Miglio, Arianna/0000-0002-5459-6298; Landi, Vincenzo/0000-0003-1385-8439; Achilli, Alessandro/0000-0001-6871-3451; Lancioni, Hovirag/0000-0001-5514-1853; Ceccobelli, Simone/0000-0002-0416-5748; Lasagna, Emiliano/0000-0003-2725-2921; SARTI, Francesca Maria/0000-0001-9366-0400; ANTOGNONI, Maria Teresa/0000-0002-5469-7996	Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca (Italian Ministry of the University)	Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca (Italian Ministry of the University)	This research received support from the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2009 (to AA) and FIRB-Futuro in Ricerca 2008 and 2012 (Italian Ministry of the University) (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Bruford MW, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P306; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Casasus I, 2011, ANIMAL FARMING ENV I; CHEN H, 1995, COMP BIOCHEM PHYS B, V111, P643, DOI 10.1016/0305-0491(95)00023-2; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Ciani E, 2013, SMALL RUMINANT RES, V112, P21, DOI 10.1016/j.smallrumres.2012.12.013; Cinkulov M, 2008, J ANIM BREED GENET, V125, P417, DOI 10.1111/j.1439-0388.2008.00742.x; Dalvit C, 2009, J ANIM SCI, V87, P3837, DOI 10.2527/jas.2008-1682; de Rancourt M, 2006, SMALL RUMINANT RES, V62, P167, DOI 10.1016/j.smallrumres.2005.08.012; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferencakovic M, 2013, ANIM GENET, V44, P184, DOI 10.1111/j.1365-2052.2012.02393.x; Goncalves J, 2012, J AGR FOOD CHEM, V60, P10480, DOI 10.1021/jf3029896; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kusza S, 2008, SMALL RUMINANT RES, V78, P13, DOI 10.1016/j.smallrumres.2008.04.002; Lasagna E, 2011, SMALL RUMINANT RES, V96, P111, DOI 10.1016/j.smallrumres.2010.11.014; Lavery S, 1996, MOL BIOL EVOL, V13, P1106, DOI 10.1093/oxfordjournals.molbev.a025672; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loehr J, 2006, J EVOLUTION BIOL, V19, P419, DOI 10.1111/j.1420-9101.2005.01027.x; Luo Yu-Zhu, 2005, Acta Genetica Sinica, V32, P1256; Meadows JRS, 2006, ANIM GENET, V37, P444, DOI 10.1111/j.1365-2052.2006.01496.x; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Mendelsohn R, 2003, ECOL ECON, V45, P501, DOI 10.1016/S0921-8009(03)00100-9; Moioli B, 2006, ITAL J ANIM SCI, V5, P73; Nergadze SG, 2010, ANIM GENET, V41, P176, DOI 10.1111/j.1365-2052.2010.02130.x; Niemi M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-2; Olivieri C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033792; Panella F., 2006, P247; Pardeshi VC, 2007, ANIM GENET, V38, P460, DOI 10.1111/j.1365-2052.2007.01636.x; Pariset L, 2011, THESCIENTIFICWORLDJO, V11, P1641, DOI 10.1100/2011/186342; Passero A, 2012, REPROD DOMEST ANIM, V47, P509; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pedrosa S, 2007, GENET SEL EVOL, V39, P91, DOI 10.1051/gse:2006034; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Pieramati C, 2011, ITAL J ANIM SCI, V10, P51, DOI 10.4081/ijas.2011.e11; RAMEY RR, 1995, MOL ECOL, V4, P429; Rege JEO, 2003, ECOL ECON, V45, P319, DOI 10.1016/S0921-8009(03)00087-9; Sarti DM, 1996, ALLEVATORE OVINI CAP, V7, P1; Sarti FM, 2006, ITAL J ANIM SCI, V5, P371; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Tapio M, 2005, MOL ECOL, V14, P3951, DOI 10.1111/j.1365-294X.2005.02727.x; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Tserenbataa T, 2004, MOL ECOL, V13, P1333, DOI 10.1111/j.1365-294X.2004.02123.x; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Zhao X, 2004, HEREDITY, V93, P399, DOI 10.1038/sj.hdy.6800516; Zhao YJ, 2011, TROP ANIM HEALTH PRO, V43, P1405, DOI 10.1007/s11250-011-9869-2	61	42	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73712	10.1371/journal.pone.0073712	http://dx.doi.org/10.1371/journal.pone.0073712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040036	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300114
J	Li, XZ; Johansson, C; Palacios, CC; Mossberg, A; Dhanjal, S; Bergvall, M; Schwartz, S				Li, Xiaoze; Johansson, Cecilia; Palacios, Carlos Cardoso; Mossberg, Anki; Dhanjal, Soniya; Bergvall, Monika; Schwartz, Stefan			Eight Nucleotide Substitutions Inhibit Splicing to HPV-16 3' -Splice Site SA3358 and Reduce the Efficiency by which HPV-16 Increases the Life Span of Primary Human Keratinocytes	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; LATE GENE-EXPRESSION; MESSENGER-RNAS; POLYADENYLATION ELEMENT; CERVICAL-CANCER; CODING REGION; CELL-LINE; TRANSCRIPTION; IDENTIFICATION; E2	The most commonly used 3'-splice site on the human papillomavirus type 16 (HPV-16) genome named SA3358 is used to produce HPV-16 early mRNAs encoding E4, E5, E6 and E7, and late mRNAs encoding L1 and L2. We have previously shown that SA3358 is suboptimal and is totally dependent on a downstream splicing enhancer containingmultiple potential ASF/SF2 binding sites. Here weshow that only one of the predicted ASF/SF2 sites accounts for the majority of the enhancer activity. We demonstrate that single nucleotide substitutions in this predicted ASF/SF2 site impair enhancer function and that this correlates with less efficient binding to ASF/SF2 in vitro. We provide evidence that HPV-16 mRNAs that arespliced to SA3358 interact with ASF/SF2 in living cells. In addition, mutational inactivation of the ASF/SF2 site weakened the enhancer at SA3358 in episomal forms of the HPV-16 genome, indicating that the enhancer is active in the context of the full HPV-16 genome. This resulted in induction of HPV-16 late gene expression as a result of competition from late splice site SA5639. Furthermore, inactivation of the ASF/SF2 site of the SA3358 splicing enhancer reduced the ability of E6- and E7-encoding HPV-16 plasmids to increase the life span of primary keratinocytes in vitro, demonstrating arequirement for an intact splicing enhancer of SA3358 forefficient production of the E6 and E7 mRNAs. These results link the strength of the HPV-16 SA3358 splicing enhancer to expression of E6 and E7 and to the pathogenic properties of HPV-16.	[Li, Xiaoze; Johansson, Cecilia; Palacios, Carlos Cardoso; Mossberg, Anki; Dhanjal, Soniya; Bergvall, Monika; Schwartz, Stefan] Lund Univ, Dept Lab Med, Lund, Sweden	Lund University	Schwartz, S (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	Stefan.Schwartz@med.lu.se	Johansson, Cecilia/B-4751-2019; Johansson, Cecilia/O-9433-2019	Johansson, Cecilia/0000-0001-5965-2853; Cardoso Palacios, Carlos/0000-0003-4185-1568	Swedish Research Council; Swedish Cancer Society (Cancerfonden)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	Research funded by the Swedish Research Council and the Swedish Cancer Society (Cancerfonden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker C., 1997, HUMAN PAPILLOMAVIRUS; BELAGULI NS, 1992, J VIROL, V66, P2724, DOI 10.1128/JVI.66.5.2724-2730.1992; Bernard HU, 2002, ANTIVIR THER, V7, P219; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; CHOW LT, 1987, J VIROL, V61, P2581, DOI 10.1128/JVI.61.8.2581-2588.1987; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; DOORBAR J, 1990, VIROLOGY, V178, P254, DOI 10.1016/0042-6822(90)90401-C; Fay J, 2009, J MED VIROL, V81, P897, DOI 10.1002/jmv.21406; Graham SV, 2008, FRONT BIOSCI-LANDMRK, V13, P5646; Grassmann K, 1996, J VIROL, V70, P2339, DOI 10.1128/JVI.70.4.2339-2349.1996; Howley P. M., 2006, VIROLOGY, V2, P2299; HUMMEL M, 1995, J VIROL, V69, P3381, DOI 10.1128/JVI.69.6.3381-3388.1995; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; Johansson C., 2010, CURR TOP VIROL, V8, P17; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Klumpp DJ, 1997, J VIROL, V71, P8186, DOI 10.1128/JVI.71.11.8186-8194.1997; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Mole S, 2009, J VIROL, V83, P357, DOI 10.1128/JVI.01414-08; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NASSERI M, 1987, VIROLOGY, V159, P433, DOI 10.1016/0042-6822(87)90482-X; Oberg D, 2005, J VIROL, V79, P9254, DOI 10.1128/JVI.79.14.9254-9269.2005; Orru B, 2012, J VIROL METHODS, V183, P106, DOI 10.1016/j.jviromet.2012.03.023; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; ROTENBERG MO, 1989, VIROLOGY, V172, P489, DOI 10.1016/0042-6822(89)90191-8; Rush M, 2005, J VIROL, V79, P12002, DOI 10.1128/JVI.79.18.12002-12015.2005; Schmitt M, 2010, CANCER RES, V70, P249, DOI 10.1158/0008-5472.CAN-09-2514; Schwartz S, 2008, FRONT BIOSCI-LANDMRK, V13, P5880, DOI 10.2741/3123; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Somberg M, 2011, J GEN VIROL, V92, P2411, DOI 10.1099/vir.0.033183-0; Somberg M, 2010, J VIROL, V84, P8219, DOI 10.1128/JVI.00462-10; Terhune SS, 2001, J VIROL, V75, P8147, DOI 10.1128/JVI.75.17.8147-8157.2001; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789; Zhao X, 2008, VIRUS GENES, V36, P45, DOI 10.1007/s11262-007-0174-0; Zhao XM, 2005, J VIROL, V79, P4270, DOI 10.1128/JVI.79.7.4270-4288.2005; Zhao XM, 2004, J VIROL, V78, P10888, DOI 10.1128/JVI.78.20.10888-10905.2004; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	49	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72776	10.1371/journal.pone.0072776	http://dx.doi.org/10.1371/journal.pone.0072776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039800	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300026
J	Beltran-Pardo, E; Jonsson, KI; Wojcik, A; Haghdoost, S; Harms-Ringdahl, M; Bermudez-Cruz, RM; Villegas, JEB				Beltran-Pardo, Eliana; Jonsson, K. Ingemar; Wojcik, Andrzej; Haghdoost, Siamak; Harms-Ringdahl, Mats; Bermudez-Cruz, Rosa M.; Villegas, Jaime E. Bernal			Effects of Ionizing Radiation on Embryos of the Tardigrade Milnesium cf. tardigradum at Different Stages of Development	PLOS ONE			English	Article							HYPSIBIUS-DUJARDINI; DNA-DAMAGE; HEAT-SHOCK; TOLERANCE; RESISTANCE; STRESS; DESICCATION; SPACE; HSP70	Tardigrades represent one of the most desiccation and radiation tolerant animals on Earth, and several studies have documented their tolerance in the adult stage. Studies on tolerance during embryological stages are rare, but differential effects of desiccation and freezing on different developmental stages have been reported, as well as dose-dependent effect of gamma irradiation on tardigrade embryos. Here, we report a study evaluating the tolerance of eggs from the eutardigrade Milnesium cf. tardigradum to three doses of gamma radiation (50, 200 and 500 Gy) at the early, middle, and late stage of development. We found that embryos of the middle and late developmental stages were tolerant to all doses, while eggs in the early developmental stage were tolerant only to a dose of 50 Gy, and showed a declining survival with higher dose. We also observed a delay in development of irradiated eggs, suggesting that periods of DNA repair might have taken place after irradiation induced damage. The delay was independent of dose for eggs irradiated in the middle and late stage, possibly indicating a fixed developmental schedule for repair after induced damage. These results show that the tolerance to radiation in tardigrade eggs changes in the course of their development. The mechanisms behind this pattern are unknown, but may relate to changes in mitotic activities over the embryogenesis and/or to activation of response mechanisms to damaged DNA in the course of development.	[Beltran-Pardo, Eliana; Villegas, Jaime E. Bernal] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Beltran-Pardo, Eliana; Jonsson, K. Ingemar; Wojcik, Andrzej; Haghdoost, Siamak; Harms-Ringdahl, Mats] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Bermudez-Cruz, Rosa M.] CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Genet & Biol Mol, Mexico City 14000, DF, Mexico	Pontificia Universidad Javeriana; Stockholm University; Kristianstad University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Jonsson, KI (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	ingemar.jonsson@hkr.se	Jönsson, Ingemar K/K-6047-2013	Jönsson, Ingemar K/0000-0002-1732-0372; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143; Bermudez-Cruz, Rosa Maria/0000-0002-5980-0454; Bermudez-Cruz, Rosa Maria/0000-0003-0463-9357; Levine, Eliana/0000-0002-0609-3944	Magnus Bergwall Foundation; Swedish Space Agency; Department of Genetics, Microbiology & Toxicology, Stockholm University, Sweden	Magnus Bergwall Foundation; Swedish Space Agency; Department of Genetics, Microbiology & Toxicology, Stockholm University, Sweden	The study was financially supported by the Magnus Bergwall Foundation, the Swedish Space Agency, and Department of Genetics, Microbiology & Toxicology, Stockholm University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga SK, 2007, REPRODUCTION, V133, P415, DOI 10.1530/REP-06-0048; Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; Beltran-Pardo EA, 2013, J LIMNOL, V72, P80, DOI 10.4081/jlimnol.2013.s1.e10; Bergonie J, 1906, CR HEBD ACAD SCI, V143, P983; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Epel D, 2003, EVOL DEV, V5, P83, DOI 10.1046/j.1525-142X.2003.03013.x; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; Hengherr S, 2010, COMP BIOCHEM PHYS A, V156, P151, DOI 10.1016/j.cbpa.2010.01.015; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horikawa DD, 2012, ASTROBIOLOGY, V12, P283, DOI 10.1089/ast.2011.0669; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2003, PHYSIOL BIOCHEM ZOOL, V76, P429; MAY RAOUL-MICHEL, 1964, BULL BIOL FRANCE BELG, V98, P349; Michalczyk L, 2012, ZOOTAXA, P1; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Parashar V, 2008, RADIAT RES, V169, P707, DOI 10.1667/RR1225.1; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Purdy A, 2005, J CELL SCI, V118, P3305, DOI 10.1242/jcs.02454; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Schill RO, 2008, J ZOOL, V276, P103, DOI 10.1111/j.1469-7998.2008.00474.x; Schill RO, 2004, J EXP BIOL, V207, P1607, DOI 10.1242/jeb.00935; Schokraie E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045682; Schokraie E, 2011, J ZOOL SYST EVOL RES, V49, P111, DOI 10.1111/j.1439-0469.2010.00608.x; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Suzuki AC, 2003, ZOOL SCI, V20, P49, DOI 10.2108/zsj.20.49; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019	35	17	17	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72098	10.1371/journal.pone.0072098	http://dx.doi.org/10.1371/journal.pone.0072098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039737	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500012
J	Hsieh, CH; Chen, GC; Chen, PH; Wu, TF; Chao, PM				Hsieh, Cheng-Hsien; Chen, Gou-Chun; Chen, Pei-Hsuan; Wu, Ting-Feng; Chao, Pei-Min			Altered White Adipose Tissue Protein Profile in C57BL/6J Mice Displaying Delipidative, Inflammatory, and Browning Characteristics after Bitter Melon Seed Oil Treatment	PLOS ONE			English	Article							REDUCES ADIPOSITY; GENE-EXPRESSION; COENZYME-Q; FAT; ADIPOCYTES; CAVEOLIN-1; ACTIN; MOUSE; ADIPOGENESIS; MAINTENANCE	Objective: We have previously shown that bitter melon seed oil (BMSO), which is rich in cis-9, trans-11, trans-13 conjugated linolenic acid, is more potent than soybean oil in attenuating body fat deposition in high-fat diet-induced obese C57BL/6J mice. The aim of this study was to obtain a comprehensive insight into how white adipose tissue (WAT) is affected by BMSO administration and to explore the underlying mechanisms of the anti-adiposity effect of BMSO. Methods and Results: A proteomic approach was used to identify proteins differentially expressed in the WAT of mice fed diets with or without BMSO for 11 wks. The WAT was also analyzed histologically for morphological changes. Two-dimensional gel electrophoresis (pH 4-7) revealed 32 spots showing a statistically significant difference (P<0.05) in intensity in BMSO-treated mice and 30 of these were shown to code for 23 proteins (15 increased and 8 decreased expression; >2-fold change). Combined with histological evidence of macrophage infiltration and brown adipocyte recruitment, the proteomic and immunoblotting data showed that the WAT in mice subjected to long-term high dose BMSO administration was characterized by reduced caveolae formation, increased ROS insult, tissue remodeling/repair, mitochondria uncoupling, and stabilization of the actin cytoskeleton, this last change being putatively related to an increased inflammatory response. Conclusion: The anti-adiposity effect of BMSO is associated with WAT delipidation, inflammation, and browning. Some novel proteins participating in these processes were identified. In addition, the BMSO-mediated WAT browning may account for the increased inflammation without causing adverse metabolic effects.	[Hsieh, Cheng-Hsien; Chen, Gou-Chun; Chen, Pei-Hsuan; Chao, Pei-Min] China Med Univ, Inst Nutr, Taichung, Taiwan; [Wu, Ting-Feng] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan	China Medical University Taiwan; Southern Taiwan University of Science & Technology	Wu, TF (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	wutingfe@mail.stut.edu.tw; pmchao@mail.cmu.edu.tw	WU, TING-FENG/ABH-9009-2020; chao, P/GSD-8001-2022; Chao, Pei-Min/L-8157-2013	Chao, Pei-Min/0000-0002-4846-3245	National Science Council of Taiwan [NSC101-2320-B039-053-MY3, NSC99-2313-B218-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work is funded by the National Science Council of Taiwan [grant numbers NSC101-2320-B039-053-MY3 and NSC99-2313-B218-001-MY3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Carbone R, 1997, CANCER RES, V57, P5498; Chan LLY, 2005, J NUTR, V135, P2517, DOI 10.1093/jn/135.11.2517; Chen J, 2007, CHEM PHYS LIPIDS, V150, P136, DOI 10.1016/j.chemphyslip.2007.06.223; Chen PH, 2012, J NUTR, V142, P1197, DOI 10.3945/jn.112.159939; Chen QX, 2003, J NUTR, V133, P1088, DOI 10.1093/jn/133.4.1088; Chou YC, 2012, NUTRITION, V28, P803, DOI 10.1016/j.nut.2011.11.019; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; Hontecillas R, 2008, CLIN NUTR, V27, P764, DOI 10.1016/j.clnu.2008.07.007; House RL, 2005, PHYSIOL GENOMICS, V21, P351, DOI 10.1152/physiolgenomics.00244.2004; Huang HL, 2008, BRIT J NUTR, V99, P230, DOI 10.1017/S0007114507793947; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Koba K, 2007, J AGR FOOD CHEM, V55, P3741, DOI 10.1021/jf063264z; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Le Lay S, 2010, AUTOPHAGY, V6, P754, DOI 10.4161/auto.6.6.12574; Lee ST, 2012, PROTEOMICS, V12, P3251, DOI 10.1002/pmic.201200084; Lieber JG, 1996, J CELL SCI, V109, P3047; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Lu KN, 2013, J FUNCT FOODS, V5, P668, DOI 10.1016/j.jff.2013.01.010; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; Ramesh T P, 2009, Immune Netw, V9, P274, DOI 10.4110/in.2009.9.6.274; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Takenouchi T, 2004, CELL BIOL INT, V28, P615, DOI 10.1016/j.cellbi.2004.05.003; Tsuzuki T, 2004, J NUTR, V134, P2634, DOI 10.1093/jn/134.10.2634; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu LL, 2012, INT J BIOCHEM CELL B, V44, P612, DOI 10.1016/j.biocel.2011.12.018; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	51	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72917	10.1371/journal.pone.0072917	http://dx.doi.org/10.1371/journal.pone.0072917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039822	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500028
J	Li, H; Huang, XX; Cai, Y; Xiao, HJ; Zhang, QF; Kong, DM				Li, Hui; Huang, Xiao-Xi; Cai, Yang; Xiao, Hao-Jie; Zhang, Qiu-Fen; Kong, De-Ming			Label-Free Detection of Cu2+ and Hg2+ Ions Using Reconstructed Cu2+-Specific DNAzyme and G-quadruplex DNAzyme	PLOS ONE			English	Article							FLUORESCENT SENSOR; MOLECULAR BEACONS; HIGH-SENSITIVITY; AQUEOUS-SOLUTION; DNA; PB2+; AG+; TEMPERATURE; BIOSENSOR; MERCURY	Label-free metal ion detection methods were developed. To achieve these, a reconstructed Cu2+-specific DNA-cleaving DNAzyme (Cu2+-specific DNAzyme) with an intramolecular stem-loop structure was used. G-quadruplex-forming G-rich sequence(s), linked at the ends of double-helix stem of an intramolecular stem-loop structure, was partly caged in an intramolecular duplex or formed a split G-quadruplex. Cu2+-triggered DNA cleavage at a specific site decreased the stability of the double-helix stem, resulting in the formation or destruction of G-quadruplex DNAzyme that can effectively catalyze the 2,2'-azinobis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS)-H2O2 reaction. Based on these, two label-free, cost-effective and simple Cu2+ sensors were designed. These two sensors followed different detection modes: 'turn-on' and 'turn-off'. As for the 'turn-on' sensor, the intramolecular stem-loop structure ensured a low background signal, and the co-amplification of detection signal by dual DNAzymes (Cu2+-specific DNAzyme and G-quadruplex DNAzyme) provided a high sensitivity. This sensor enabled the selective detection of aqueous Cu2+ with a detection limit of 3.9 nM. Visual detection was possible. Although the 'turn-off' sensor gave lower detection sensitivity than the 'turn-on' one, the characteristics of cost-effectiveness and ease of operation made it an important implement to reduce the possibility of pseudo-positive or pseudo-negative results. Combining the ability of Hg2+ ion to stabilize T-T base mismatch, above dual DNAzymes-based strategy was further used for Hg2+ sensor design. The proposed sensor allowed the specific detection of Hg2+ ion with a detection of 4.8 nM. Visual detection was also possible.	[Li, Hui; Huang, Xiao-Xi; Cai, Yang; Xiao, Hao-Jie; Zhang, Qiu-Fen; Kong, De-Ming] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Kong, De-Ming] Synerget Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China	Nankai University	Kong, DM (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	kongdem@nankai.edu.cn			Natural Science Foundation of China [21175072]; National Natural Science Foundation of Tianjin [12JCYBJC13300]; National Basic Research Program of China [2011CB707703]; Fundamental Research Funds for the Central Universities; Program for New Century Excellent Talents in University, Chinese Ministry of Education [NCET-10-0504]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin; National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University, Chinese Ministry of Education(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China)	This work was supported by The Natural Science Foundation of China (No. 21175072); The National Natural Science Foundation of Tianjin (No. 12JCYBJC13300); The National Basic Research Program of China (No. 2011CB707703); The Fundamental Research Funds for the Central Universities and the Program for New Century Excellent Talents in University (NCET-10-0504), Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravo-Sanchez LR, 2001, TALANTA, V55, P1071, DOI 10.1016/S0039-9140(01)00523-9; Carmi N, 1998, P NATL ACAD SCI USA, V95, P2233, DOI 10.1073/pnas.95.5.2233; Carmi N, 2001, BIOORGAN MED CHEM, V9, P2589, DOI 10.1016/S0968-0896(01)00035-9; Chang LF, 2007, J CHROMATOGR A, V1176, P143, DOI 10.1016/j.chroma.2007.10.072; Clever GH, 2007, ANGEW CHEM INT EDIT, V46, P6226, DOI 10.1002/anie.200701185; Fang ZY, 2010, CHEM COMMUN, V46, P9043, DOI 10.1039/c0cc02782k; Hollenstein M, 2008, ANGEW CHEM INT EDIT, V47, P4346, DOI 10.1002/anie.200800960; KATZ S, 1963, BIOCHIM BIOPHYS ACTA, V68, P240; Kolpashchikov DM, 2008, J AM CHEM SOC, V130, P2934, DOI 10.1021/ja711192e; Kong DM, 2009, TALANTA, V80, P459, DOI 10.1016/j.talanta.2009.07.010; Kong DM, 2011, PROG CHEM, V23, P2119; Kosman J, 2011, ANAL CHIM ACTA, V707, P7, DOI 10.1016/j.aca.2011.08.050; Kuklenyik Z, 1996, INORG CHEM, V35, P5654, DOI 10.1021/ic960260a; Lan T, 2010, CHEM COMMUN, V46, P3896, DOI 10.1039/b926910j; Li H, 2013, BIOSENS BIOELECTRON, V42, P225, DOI 10.1016/j.bios.2012.10.070; Li H, 2012, BIOSENS BIOELECTRON, V34, P159, DOI 10.1016/j.bios.2012.01.037; Li J, 2000, J AM CHEM SOC, V122, P10466, DOI 10.1021/ja0021316; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Lin YW, 2011, ANALYST, V136, P863, DOI 10.1039/c0an00652a; Lin ZZ, 2011, ANAL CHEM, V83, P6896, DOI 10.1021/ac2014096; Liu J, 2007, CHEM COMMUN, P4872, DOI 10.1039/b712421j; Liu J, 2007, ANGEW CHEM INT EDIT, V46, P7587, DOI 10.1002/anie.200702006; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Liu JW, 2004, J AM CHEM SOC, V126, P12298, DOI 10.1021/ja046628h; Peracchi A, 2000, J BIOL CHEM, V275, P11693, DOI 10.1074/jbc.275.16.11693; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Wang Y, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205502; Wen ZC, 2006, CHEM COMMUN, P106, DOI 10.1039/b510546c; Xiang Y, 2009, J AM CHEM SOC, V131, P15352, DOI 10.1021/ja905854a; Xu J, 2012, CHINESE J ANAL CHEM, V40, P347, DOI 10.1016/S1872-2040(11)60536-7; Yang X, 2011, ANAL CHEM, V83, P5005, DOI 10.1021/ac2008465; Yin BC, 2009, J AM CHEM SOC, V131, P14624, DOI 10.1021/ja9062426; Zhang XB, 2010, ANAL CHEM, V82, P5005, DOI 10.1021/ac1009047; Zhou XH, 2010, ANAL CHEM, V82, P789, DOI 10.1021/ac902421u	35	10	12	3	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73012	10.1371/journal.pone.0073012	http://dx.doi.org/10.1371/journal.pone.0073012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039849	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500033
J	Singhal, A; Monaco, S; Kaufman, LD; Culham, JC				Singhal, Anthony; Monaco, Simona; Kaufman, Liam D.; Culham, Jody C.			Human fMRI Reveals That Delayed Action Re-Recruits Visual Perception	PLOS ONE			English	Article							ANTERIOR INTRAPARIETAL AREA; TRANSCRANIAL MAGNETIC STIMULATION; PARIETAL CORTEX; WORKING-MEMORY; 3-DIMENSIONAL SHAPE; BRAIN; REACTIVATION; ACTIVATION; HAND; RECOGNITION	Behavioral and neuropsychological research suggests that delayed actions rely on different neural substrates than immediate actions; however, the specific brain areas implicated in the two types of actions remain unknown. We used functional magnetic resonance imaging (fMRI) to measure human brain activation during delayed grasping and reaching. Specifically, we examined activation during visual stimulation and action execution separated by a 18-s delay interval in which subjects had to remember an intended action toward the remembered object. The long delay interval enabled us to unambiguously distinguish visual, memory-related, and action responses. Most strikingly, we observed reactivation of the lateral occipital complex (LOC), a ventral-stream area implicated in visual object recognition, and early visual cortex (EVC) at the time of action. Importantly this reactivation was observed even though participants remained in complete darkness with no visual stimulation at the time of the action. Moreover, within EVC, higher activation was observed for grasping than reaching during both vision and action execution. Areas in the dorsal visual stream were activated during action execution as expected and, for some, also during vision. Several areas, including the anterior intraparietal sulcus (aIPS), dorsal premotor cortex (PMd), primary motor cortex (M1) and the supplementary motor area (SMA), showed sustained activation during the delay phase. We propose that during delayed actions, dorsal-stream areas plan and maintain coarse action goals; however, at the time of execution, motor programming requires re-recruitment of detailed visual information about the object through reactivation of (1) ventral-stream areas involved in object perception and (2) early visual areas that contain richly detailed visual representations, particularly for grasping.	[Singhal, Anthony] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Singhal, Anthony] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Monaco, Simona] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Kaufman, Liam D.; Culham, Jody C.] Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada	University of Alberta; University of Alberta; York University - Canada; Western University (University of Western Ontario)	Culham, JC (corresponding author), Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada.	jculham@uwo.ca	Monaco, Simona/AAD-9493-2019; Culham, Jody C./A-9863-2013	Culham, Jody C./0000-0003-0754-2999; Monaco, Simona/0000-0002-5806-5961	Canadian Institutes of Health Research [MOP 62986, MOP 84293]; Premier's Research Excellence Award (Ontario Ministry of Enterprise, Opportunity & Innovation, Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Premier's Research Excellence Award (Ontario Ministry of Enterprise, Opportunity & Innovation, Canada)	This research was funded by grants from the Canadian Institutes of Health Research (Grant Numbers: MOP 62986 and MOP 84293) and the Premier's Research Excellence Award (Ontario Ministry of Enterprise, Opportunity & Innovation, Canada) to JCC. (http://www.cihr-irsc.gc.ca/) (http://www.mri.gov.on.ca/english/programs/era/program.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Cruikshank LC, 2012, J VISION, V12, DOI 10.1167/12.6.29; Culham J.C., 2004, ATTENTION PERFORM, P417; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; De Weerd P, 2012, J NEUROSCI, V32, P1981, DOI 10.1523/JNEUROSCI.3712-11.2011; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Fiehler K, 2011, NEUROIMAGE, V54, P2401, DOI 10.1016/j.neuroimage.2010.09.080; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Franz VH, 2009, NEUROPSYCHOLOGIA, V47, P1518, DOI 10.1016/j.neuropsychologia.2008.08.029; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; Gallivan JP, 2013, EUR J NEUROSCI, V38, P2408, DOI 10.1111/ejn.12215; Gallivan JP, 2013, J NEUROSCI, V33, P1991, DOI 10.1523/JNEUROSCI.0541-12.2013; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P230, DOI 10.1162/jocn.2008.21025; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hesse C, 2009, NEUROPSYCHOLOGIA, V47, P1532, DOI 10.1016/j.neuropsychologia.2008.08.012; Himmelbach M, 2005, J COGNITIVE NEUROSCI, V17, P632, DOI 10.1162/0898929053467514; Himmelbach M, 2009, NEUROPSYCHOLOGIA, V47, P1508, DOI 10.1016/j.neuropsychologia.2009.01.033; Hu Y, 1999, EXP BRAIN RES, V126, P109, DOI 10.1007/s002210050720; Hu Y, 2000, J COGNITIVE NEUROSCI, V12, P856, DOI 10.1162/089892900562462; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; James W., 1890, PRINCIPLES PSYCHOL; Johnson MR, 2007, NEUROIMAGE, V37, P290, DOI 10.1016/j.neuroimage.2007.05.017; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Kuhl BA, 2012, J NEUROSCI, V32, P3453, DOI 10.1523/JNEUROSCI.5846-11.2012; Kuhl BA, 2011, P NATL ACAD SCI USA, V108, P5903, DOI 10.1073/pnas.1016939108; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Lewis-Peacock JA, 2008, J NEUROSCI, V28, P8765, DOI 10.1523/JNEUROSCI.1953-08.2008; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Milner AD, 2001, CURR BIOL, V11, P1896, DOI 10.1016/S0960-9822(01)00591-7; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Nelissen K, 2011, J NEUROSCI, V31, P8220, DOI 10.1523/JNEUROSCI.0623-11.2011; Nilsson LG, 2000, NEUROREPORT, V11, P2199, DOI 10.1097/00001756-200007140-00027; Nyberg L, 2001, NEUROIMAGE, V14, P521, DOI 10.1006/nimg.2001.0801; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Prabhu G, 2007, J NEUROSCI, V27, P12651, DOI 10.1523/JNEUROSCI.4308-07.2007; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Romero MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055340; Romero MC, 2012, EUR J NEUROSCI, V36, P2324, DOI 10.1111/j.1460-9568.2012.08135.x; Rossetti Y, 2005, NEUROPSYCHOLOGIA, V43, P162, DOI 10.1016/j.neuropsychologia.2004.11.004; Rossit S, 2011, NEUROPSYCHOLOGIA, V49, P2498, DOI 10.1016/j.neuropsychologia.2011.04.030; Rossit S, 2010, EXP BRAIN RES, V200, P109, DOI 10.1007/s00221-009-2074-0; Rossit S, 2009, NEUROPSYCHOLOGIA, V47, P1563, DOI 10.1016/j.neuropsychologia.2008.08.008; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Shulman GL, 2002, CEREB CORTEX, V12, P590, DOI 10.1093/cercor/12.6.590; Skinner EI, 2010, NEUROPSYCHOLOGIA, V48, P156, DOI 10.1016/j.neuropsychologia.2009.08.023; Slotnick SD, 2009, BRAIN RES, V1268, P97, DOI 10.1016/j.brainres.2009.02.056; Smyrnis N, 2003, J NEUROPHYSIOL, V89, P3344, DOI 10.1152/jn.00810.2002; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; Tal N, 2009, EXP BRAIN RES, V198, P165, DOI 10.1007/s00221-009-1949-4; Talairach J, 1988, ATLAS HUMAN BRAIN; Theys T, 2013, J COGNITIVE NEUROSCI, V25, P352, DOI 10.1162/jocn_a_00332; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; van de Ven V, 2012, J NEUROSCI, V32, P4, DOI 10.1523/JNEUROSCI.3261-11.2012; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; Wernicke C., 1874, WERNICKES WORKS APHA, P91; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518; Wheeler ME, 2006, CEREB CORTEX, V16, P949, DOI 10.1093/cercor/bhj037; Whitwell RL, 2011, VISION RES, V51, P908, DOI 10.1016/j.visres.2011.02.005; Wohlschlager AM, 2005, NEUROIMAGE, V26, P73, DOI 10.1016/j.neuroimage.2005.01.021; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	82	80	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73629	10.1371/journal.pone.0073629	http://dx.doi.org/10.1371/journal.pone.0073629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040007	Green Submitted, gold, Green Published			2022-12-25	WOS:000324856500053
J	Charron, MVP; Balenghien, T; Seegers, H; Langlais, M; Ezanno, P				Charron, Maud V. P.; Balenghien, Thomas; Seegers, Henri; Langlais, Michel; Ezanno, Pauline			How Much Can Diptera-Borne Viruses Persist over Unfavourable Seasons?	PLOS ONE			English	Article							WEST-NILE-VIRUS; EQUINE ENCEPHALOMYELITIS VIRUS; CULICOIDES BITING MIDGES; CULEX-PIPIENS DIPTERA; BLUETONGUE-VIRUS; SOUTHERN CALIFORNIA; ENCEPHALITIS-VIRUS; INFECTED CATTLE; TRANSMISSION; MOSQUITOS	Diptera are vectors of major human and animal pathogens worldwide, such as dengue, West-Nile or bluetongue viruses. In seasonal environments, vector-borne disease occurrence varies with the seasonal variations of vector abundance. We aimed at understanding how diptera-borne viruses can persist for years under seasonal climates while vectors overwinter, which should stop pathogen transmission during winter. Modeling is a relevant integrative approach for investigating the large panel of persistence mechanisms evidenced through experimental and observational studies on specific biological systems. Inter-seasonal persistence of virus may occur in hosts due to viremia duration, chronic infection, or vertical transmission, in vector resistance stages, and due to a low continuous transmission in winter. Using a generic stochastic modeling framework, we determine the parameter ranges under which virus persistence could occur via these different mechanisms. The parameter ranges vary according to the host demographic regime: for a high host population turnover, persistence increases with the mechanism parameter, whereas for a low turnover, persistence is maximal for an optimal range of parameter. Persistence in hosts due to long viremia duration in a few hosts or due to vertical transmission is an effective strategy for the virus to overwinter. Unexpectedly, a low continuous transmission during winter does not give rise to certain persistence, persistence barely occurring for a low turnover of the susceptible population. We propose a generic framework adaptable to most diptera-borne diseases. This framework allows ones to assess the plausibility of each persistence mechanism in real epidemiological situations and to compare the range of parameter values theoretically allowing persistence with the range of values determined experimentally.	[Charron, Maud V. P.; Seegers, Henri; Ezanno, Pauline] LUNAM Univ, Biol Epidemiol & Anal Risques Sante Anim UMR1300, INRA, Oniris,Ecole Natl Vet Agroalimentaire & Alimentat, Nantes, France; [Charron, Maud V. P.; Langlais, Michel] Univ Bordeaux, UMR 5251, IMB, Bordeaux, France; [Charron, Maud V. P.; Langlais, Michel] CNRS, UMR 5251, IMB, Talence, France; [Balenghien, Thomas] CIRAD, INRA, CMAEE, UMR1309, Montpellier, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite de Bordeaux; CIRAD; INRAE	Charron, MVP (corresponding author), LUNAM Univ, Biol Epidemiol & Anal Risques Sante Anim UMR1300, INRA, Oniris,Ecole Natl Vet Agroalimentaire & Alimentat, Nantes, France.	maud_charron@hotmail.com	Ezanno, Pauline/A-4699-2009	Ezanno, Pauline/0000-0002-0034-8950	INRA; IRSTEA; Basse-Normandie, Bretagne; Pays de la Loire; Poitou-Charentes Regional Councils under SANCRE project	INRA; IRSTEA; Basse-Normandie, Bretagne; Pays de la Loire; Poitou-Charentes Regional Councils under SANCRE project(Region Nouvelle-Aquitaine)	Financial support for this research was provided by INRA, IRSTEA and Basse-Normandie, Bretagne, Pays de la Loire and Poitou-Charentes Regional Councils under SANCRE project, in the framework of "For and About Regional Development" programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001; Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; BAILEY CL, 1978, SCIENCE, V199, P1346, DOI 10.1126/science.628843; Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2; Baylis M, 2008, MED VET ENTOMOL, V22, P228, DOI 10.1111/j.1365-2915.2008.00732.x; Bonneau KR, 2002, VET MICROBIOL, V88, P115, DOI 10.1016/S0378-1135(02)00106-2; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Charron MVP, 2011, J THEOR BIOL, V291, P1, DOI 10.1016/j.jtbi.2011.08.041; Clements A., 2012, BIOL MOSQUITOES, V3; Clements AN., 1999, SENSORY RECEPTION BE; Cruz-Pacheco G, 2005, B MATH BIOL, V67, P1157, DOI 10.1016/j.bulm.2004.11.008; Dajoz R, 2006, MESOCLIMATS MICROCLI, P57; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P352, DOI 10.1111/j.1865-1682.2008.01044.x; De Clercq K, 2008, VET REC, V162, P564, DOI 10.1136/vr.162.17.564; DEFOLIART GR, 1987, ANNU REV ENTOMOL, V32, P479, DOI 10.1146/annurev.en.32.010187.002403; Desmecht D, 2008, VET REC, V163, P50, DOI 10.1136/vr.163.2.50; Dohm DJ, 2001, J MED ENTOMOL, V38, P462, DOI 10.1603/0022-2585-38.3.462; Farajollahi A, 2005, J MED ENTOMOL, V42, P490, DOI 10.1603/0022-2585(2005)042[0490:DOWNVR]2.0.CO;2; Gerry AC, 2001, J MED ENTOMOL, V38, P197, DOI 10.1603/0022-2585-38.2.197; Glass K, 2005, T ROY SOC TROP MED H, V99, P252, DOI 10.1016/j.trstmh.2004.08.004; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Jetten TH., 1994, ANOPHELISM MALARIA E; Lopez G, 2008, VECTOR-BORNE ZOONOT, V8, P615, DOI 10.1089/vbz.2007.0200; Lord CC, 2010, ISR J ECOL EVOL, V56, P371, DOI 10.1560/IJEE.55.3-4.371; Losson B, 2007, VET REC, V160, P451, DOI 10.1136/vr.160.13.451-b; LUEDKE AJ, 1977, AM J TROP MED HYG, V26, P313, DOI 10.4269/ajtmh.1977.26.313; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2008, VET REC, V162, P490, DOI 10.1136/vr.162.15.490-b; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Mitchell C.J, 1988, ARBOVIRUSES EPIDEMIO, V1, P191; MITCHELL CJ, 1989, J MED ENTOMOL, V26, P318, DOI 10.1093/jmedent/26.4.318; Mullens BA, 2004, VETER ITAL SER, V40, P160; MURRAY J O, 1970, Journal of Wildlife Diseases, V6, P144; Nasci RS, 2001, EMERG INFECT DIS, V7, P742; REEVES WC, 1958, P SOC EXP BIOL MED, V97, P733, DOI 10.3181/00379727-97-23862; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Robich RM, 2005, P NATL ACAD SCI USA, V102, P15912, DOI 10.1073/pnas.0507958102; ROSEN L, 1987, AM J TROP MED HYG, V37, pS69, DOI 10.4269/ajtmh.1987.37.69S; ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Santman-Berends IMGA, 2010, VET MICROBIOL, V141, P31, DOI 10.1016/j.vetmic.2009.08.010; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; TAUBER CA, 1981, ANNU REV ECOL SYST, V12, P281, DOI 10.1146/annurev.es.12.110181.001433; THOMAS LA, 1962, P SOC EXP BIOL MED, V109, P421, DOI 10.3181/00379727-109-27225; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210	48	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74213	10.1371/journal.pone.0074213	http://dx.doi.org/10.1371/journal.pone.0074213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023929	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600132
J	Guleria, P; Yadav, SK				Guleria, Praveen; Yadav, Sudesh Kumar			Agrobacterium Mediated Transient Gene Silencing (AMTS) in Stevia rebaudiana: Insights into Steviol Glycoside Biosynthesis Pathway	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; GIBBERELLIC-ACID; GLYCOSYLTRANSFERASES; ENZYMES	Background: Steviol glycoside biosynthesis pathway has emerged as bifurcation from ent-kaurenoic acid, substrate of methyl erythritol phosphate pathway that also leads to gibberellin biosynthesis. However, the genetic regulation of steviol glycoside biosynthesis has not been studied. So, in present study RNA interference (RNAi) based Agrobacterium mediated transient gene silencing (AMTS) approach was followed. SrKA13H and three SrUGTs (SrUGT85C2, SrUGT74G1 and SrUGT76G1) genes encoding ent-kaurenoic acid-13 hydroxylase and three UDP glycosyltransferases of steviol glycoside biosynthesis pathway were silenced in Stevia rebaudiana to understand its molecular mechanism and association with gibberellins. Methodology/Principal Findings: RNAi mediated AMTS of SrKA13H and three SrUGTs has significantly reduced the expression of targeted endogenous genes as well as total steviol glycoside accumulation. While gibberellins (GA(3)) content was significantly enhanced on AMTS of SrUGT85C2 and SrKA13H. Silencing of SrKA13H and SrUGT85C2 was found to block the metabolite flux of steviol glycoside pathway and shifted it towards GA(3) biosynthesis. Further, molecular docking of three SrUGT proteins has documented highest affinity of SrUGT76G1 for the substrates of alternate pathways synthesizing steviol glycosides. This could be a plausible reason for maximum reduction in steviol glycoside content on silencing of SrUGT76G1 than other genes. Conclusions: SrKA13H and SrUGT85C2 were identified as regulatory genes influencing carbon flux between steviol glycoside and gibberellin biosynthesis. This study has also documented the existence of alternate steviol glycoside biosynthesis route.	[Guleria, Praveen; Yadav, Sudesh Kumar] CSIR Inst Himalayan Bioresource Technol, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Yadav, SK (corresponding author), CSIR Inst Himalayan Bioresource Technol, Palampur, Himachal Prades, India.	sudeshkumar@ihbt.res.in	Guleria, Praveen/F-3025-2015	Guleria, Praveen/0000-0001-5235-4829	Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to the Director, IHBT for his continuous encouragement and support. PG is thankful to the Council of Scientific and Industrial Research (CSIR), Government of India for giving a fellowship in the form of SRF.	ALVES LM, 1979, PLANT CELL PHYSIOL, V20, P123; BARENDSE GWM, 1980, J CHROMATOGR, V198, P449, DOI 10.1016/S0021-9673(00)80514-2; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Bondarev NI, 2003, BIOL PLANTARUM, V47, P261, DOI 10.1023/B:BIOP.0000022261.35259.4f; Brandle JE, 2007, PHYTOCHEMISTRY, V68, P1855, DOI 10.1016/j.phytochem.2007.02.010; Brandle JE, 1998, CAN J PLANT SCI, V78, P527, DOI 10.4141/P97-114; BRANDLE JE, 1992, CAN J PLANT SCI, V72, P1263, DOI 10.4141/cjps92-159; Deng XB, 2012, PLANT BIOTECHNOL J, V10, P970, DOI 10.1111/j.1467-7652.2012.00726.x; Di Stilio VS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012064; Geuns JMC, 2003, PHYTOCHEMISTRY, V64, P913, DOI 10.1016/S0031-9422(03)00426-6; Guleria P, 2013, J BIOTECH MOLE SCI, V3, P1, DOI 10.3923/ajbmb.2013.1.19; Guo ShuQiao, 2010, Genomics and Applied Biology, V29, P911; Helm JM, 2011, METHODS MOL BIOL, V744, P97, DOI 10.1007/978-1-61779-123-9_7; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Humphrey TV, 2006, PLANT MOL BIOL, V61, P47, DOI 10.1007/s11103-005-5966-9; Jaitak V, 2009, PHYTOCHEM ANALYSIS, V20, P240, DOI 10.1002/pca.1120; Kelen M, 2004, TURK J CHEM, V28, P603; Kinghorn AD, 2002, MED AROMATIC PLANTS, P1; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Mohamed AAA, 2011, J PLANT PHYSIOL, V168, P1136, DOI 10.1016/j.jplph.2011.01.030; Mohanpuria P, 2011, PLANT MOL BIOL, V76, P523, DOI 10.1007/s11103-011-9785-x; Nagamatsu A, 2007, PLANT BIOTECHNOL J, V5, P778, DOI 10.1111/j.1467-7652.2007.00288.x; Nakamura S., 1985, Japanese Journal of Tropical Agriculture, V29, P109; Patil R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012029; Richman A, 2005, PLANT J, V41, P56, DOI 10.1111/j.1365-313X.2004.02275.x; Richman AS, 1999, PLANT J, V19, P411, DOI 10.1046/j.1365-313X.1999.00531.x; Rotunno T, 1999, ITAL J FOOD SCI, V11, P131; Shafii B, 2012, ANAL BIOANAL CHEM, V403, P2683, DOI 10.1007/s00216-012-6071-y; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Stephanopoulos G, 2012, US patent, Patent No. [20120164678A1 US, 20120164678A1]; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Wan HD, 2012, J MOL CATAL B-ENZYM, V82, P12, DOI 10.1016/j.molcatb.2012.05.018; Wang CC, 2006, FUNCT PLANT BIOL, V33, P347, DOI 10.1071/FP05096; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Yadav SK, 2012, CRIT REV FOOD SCI, V52, P988, DOI 10.1080/10408398.2010.519447; Ye J, 2009, PLANT BIOTECHNOL J, V7, P964, DOI 10.1111/j.1467-7652.2009.00457.x; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	37	26	34	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74731	10.1371/journal.pone.0074731	http://dx.doi.org/10.1371/journal.pone.0074731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023961	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600155
J	Liu, LS; Li, C; Su, BF; Beck, BH; Peatman, E				Liu, Lisa; Li, Chao; Su, Baofeng; Beck, Benjamin H.; Peatman, Eric			Short-Term Feed Deprivation Alters Immune Status of Surface Mucosa in Channel Catfish (Ictalurus punctatus)	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; RAINBOW-TROUT; DIFFERENTIAL EXPRESSION; TRANSPORTER PEPT1; GENE-EXPRESSION; SUSCEPTIBILITY; RESISTANCE; STARVATION; RESPONSES; GROWTH	Short-term feed deprivation (or fasting) is a common occurrence in aquacultured fish species whether due to season, production strategies, or disease. In channel catfish (Ictalurus punctatus) fasting impacts susceptibility to several bacterial pathogens including Flavobacterium columnare, the causative agent of columnaris disease. As columnaris gains entry through the gills and skin of fish, we examined here changes in transcriptional regulation induced in these surface mucosal tissues due to short-term (7 day) fasting. RNA-seq expression analysis revealed a total of 1,545 genes perturbed by fasting. Fasting significantly altered expression of critical innate immune factors in a manner consistent with lower immune fitness as well as dysregulating key genes involved in energy metabolism and cell cycling/proliferation. Downregulation of innate immune actors such as iNOS2b, Lysozyme C, and peptidoglycan recognition protein 6 is predicted to impact the delicate recognition/tolerance balance for commensal and pathogenic bacteria on the skin and gill. The highlighted expression profiles reveal potential mechanistic similarities between gut and surface mucosa and underscore the complex interrelationships between nutrition, mucosal integrity, and immunity in teleost fish.	[Li, Chao; Su, Baofeng; Peatman, Eric] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA; [Beck, Benjamin H.] ARS, USDA, Stuttgart Natl Aquaculture Res Ctr, Stuttgart, AR USA; [Liu, Lisa] Cornell Univ, Coll Arts & Sci, Dept Chem & Chem Biol, Ithaca, NY USA	Auburn University System; Auburn University; United States Department of Agriculture (USDA); Cornell University	Peatman, E (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA.	peatmer@auburn.edu	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Beck, Benjamin/0000-0002-9611-826X; Liu, Lisa/0000-0003-1506-2370; Li, Chao/0000-0002-1950-0190				Agar C, 2011, BLOOD, V117, P6939, DOI 10.1182/blood-2010-12-325951; Angeles Esteban M, 2012, ISRN IMMUNOLOGY; Arias CR, 2012, DIS AQUAT ORGAN, V100, P77, DOI 10.3354/dao02492; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Baumgarner BL, 2013, COMP BIOCHEM PHYS D, V8, P58, DOI 10.1016/j.cbd.2012.11.001; Beck BH, 2012, FISH SHELLFISH IMMUN, V33, P1008, DOI 10.1016/j.fsi.2012.08.018; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; BROWN HO, 1963, AM J PHYSIOL, V205, P868, DOI 10.1152/ajplegacy.1963.205.5.868; Bucking C, 2012, COMP BIOCHEM PHYS A, V161, P379, DOI 10.1016/j.cbpa.2011.12.008; Chang MX, 2008, VET IMMUNOL IMMUNOP, V124, P295, DOI 10.1016/j.vetimm.2008.04.003; Cleveland BM, 2009, AM J PHYSIOL-REG I, V297, pR1332, DOI 10.1152/ajpregu.00272.2009; Costas B, 2011, FISH PHYSIOL BIOCHEM, V37, P495, DOI 10.1007/s10695-010-9451-2; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Florbela V, 2011, SPARUS AURATUS; Gendrin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000694; Gisbert E, 2011, J FISH BIOL, V78, P580, DOI 10.1111/j.1095-8649.2010.02879.x; Glover CN, 2011, P ROY SOC B-BIOL SCI, V278, P3096, DOI 10.1098/rspb.2010.2784; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Goldman DL, 2012, MBIO, P3; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ingersoll SA, 2012, AM J PHYSIOL-GASTR L, V302, pG484, DOI 10.1152/ajpgi.00477.2011; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Klasing KC, 1998, POULTRY SCI, V77, P1119, DOI 10.1093/ps/77.8.1119; Knight Darryl A, 2010, Expert Rev Respir Med, V4, P747, DOI 10.1586/ers.10.72; Krogdahl A, 1999, AQUACULT NUTR, V5, P121; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; Lai YYY, 2009, MAR GENOM, V2, P193, DOI 10.1016/j.margen.2009.10.003; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Landeira-Dabarca A, 2013, J FISH BIOL, V82, P893, DOI 10.1111/jfb.12025; LARSSON A, 1973, COMP BIOCHEM PHYSIOL, V44, P367, DOI 10.1016/0300-9629(73)90489-1; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Li C, 2013, DEV COMP IMMUNOL, V39, P447, DOI 10.1016/j.dci.2012.11.009; Li C, 2013, FISH SHELLFISH IMMUN, V34, P920, DOI 10.1016/j.fsi.2013.01.002; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Liu George E, 2011, Recent Pat Food Nutr Agric, V3, P187; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Navarro Isabel, 1995, Biochemistry and Molecular Biology of Fishes, V4, P393; Peatman E, 2013, MOL IMMUNOL, V56, P317, DOI 10.1016/j.molimm.2013.04.014; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Pottinger TG, 2003, COMP BIOCHEM PHYS B, V136, P403, DOI 10.1016/S1096-4959(03)00212-4; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Savendahl L, 1999, J NUTR, V129, P2005, DOI 10.1093/jn/129.11.2005; Shoemaker CA, 2003, J FISH DIS, V26, P553, DOI 10.1046/j.1365-2761.2003.00489.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith J, 2011, J VIROL, V85, P11146, DOI 10.1128/JVI.05499-11; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Tacchi L, 2012, MAR BIOTECHNOL, V14, P35, DOI 10.1007/s10126-011-9385-4; Terova G, 2009, AQUACULTURE, V294, P288, DOI 10.1016/j.aquaculture.2009.06.014; Terova G, 2009, COMP BIOCHEM PHYS B, V153, P372, DOI 10.1016/j.cbpb.2009.04.008; Verri T, 2003, FEBS LETT, V549, P115, DOI 10.1016/S0014-5793(03)00759-2; Verri T, 2011, BIOL LETTERS, V7, P597, DOI 10.1098/rsbl.2010.1164; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Wang JN, 2011, COMP BIOCHEM PHYS B, V158, P208, DOI 10.1016/j.cbpb.2010.11.010; Wise DJ, 2008, J AQUAT ANIM HEALTH, V20, P39, DOI 10.1577/H07-008.1; Wong WM, 1999, J CLIN PATHOL, V52, P321, DOI 10.1136/jcp.52.5.321; Yazawa R, 2006, TRANSGENIC RES, V15, P385, DOI 10.1007/s11248-006-0009-0; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	68	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74581	10.1371/journal.pone.0074581	http://dx.doi.org/10.1371/journal.pone.0074581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023952	gold, Green Published			2022-12-25	WOS:000324515600147
J	Scortegagna, M; Ruller, C; Feng, Y; Lazova, R; Kluger, H; Li, JL; De, SK; Rickert, R; Pellecchia, M; Bosenberg, M; Ronai, ZA				Scortegagna, M.; Ruller, C.; Feng, Y.; Lazova, R.; Kluger, H.; Li, J-L; De, S. K.; Rickert, R.; Pellecchia, M.; Bosenberg, M.; Ronai, Z. A.			Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma	ONCOGENE			English	Article						PDK1; FOXO3a; melanoma; Braf; Pten; GSK2334470	AKT; DOWNSTREAM; MECHANISMS; RESISTANCE; MUTATIONS; SIZE; JNK	Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including AKT and protein kinase C (PKC), and is implicated in important cellular processes including survival, metabolism and tumorigenesis. In large cohorts of nevi and melanoma samples, PDK1 expression was significantly higher in primary melanoma, compared with nevi, and was further increased in metastatic melanoma. PDK1 expression suffices for its activity, owing to auto-activation, or elevated phosphorylation by phosphoinositide 3'-OH-kinase (PI3K). Selective inactivation of Pdk1 in the melanocytes of Braf(V600E)::Pten(-/-) or Braf(V600E)::Cdkn2a(-/-)::Pten(-/-) mice delayed the development of pigmented lesions and melanoma induced by systemic or local administration of 4-hydroxytamoxifen. Melanoma invasion and metastasis were significantly reduced or completely prevented by Pdk1 deletion. Administration of the PDK1 inhibitor GSK2334470 (PDKi) effectively delayed melanomagenesis and metastasis in Braf(V600E)::Pten(-/-) mice. Pdk1(-/-) melanomas exhibit a marked decrease in the activity of AKT, P70S6K and PKC. Notably, PDKi was as effective in inhibiting AGC kinases and colony forming efficiency of melanoma with Pten wild-type (WT) genotypes. Gene expression analyses identified Pdk1-dependent changes in FOXO3a-regulated genes, and inhibition of FOXO3a restored proliferation and colony formation of Pdk1(-/-) melanoma cells. Our studies provide direct genetic evidence for the importance of PDK1, in part through FOXO3a-dependent pathway, in melanoma development and progression.	[Scortegagna, M.; Ruller, C.; Feng, Y.; Li, J-L; De, S. K.; Rickert, R.; Pellecchia, M.; Ronai, Z. A.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA; [Lazova, R.; Kluger, H.; Bosenberg, M.] Yale Univ, Dept Dermatol Med & Pathol, New Haven, CT USA	Sanford Burnham Prebys Medical Discovery Institute; Yale University	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ronai@sbmri.org	Li, Jian-Liang/AAE-9315-2019; Li, J L/E-6100-2018; Pellecchia, Maurizio/Y-7072-2018	Li, Jian-Liang/0000-0002-6487-081X; Li, J L/0000-0002-6487-081X; RONAI, ZEEV/0000-0002-3859-0400; De, SURYA/0000-0001-5014-0798	NIH [CA099961, CA128814]; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [R01CA099961, R01CA179170, P30CA030199, P01CA128814] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This manuscript is dedicated in fond memory to Victor Fung, Ph.D., a former Program Officer at NCI and a former Scientific Review Officer of the Cancer Etiology study section of CSR, NIH, for his wisdom, compassion, integrity, his love of the sciences and the arts and his contributions to the career development of so many investigators during his own distinguished career. We thank Dario Alessi for providing the conditional Pdk1<SUP>-/-</SUP> mice, Vincent Hearing for the Tyrp1 antibody and Pedro Aza-Blanc for small interfering RNA library work. Support by NIH grants CA099961 (to ZR) and CA128814 (to ZR and MP) and a Melanoma Research Alliance grant (to ZR) is gratefully acknowledged.	Axten JM, 2011, CHEM COMPOUNDS; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Bagrodia S, 2012, PIGM CELL MELANOMA R, V25, P819, DOI 10.1111/pcmr.12007; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Choucair KA, 2012, TRANSL ONCOL, V5, P453, DOI 10.1593/tlo.12286; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Ellwood-Yen K, 2011, CANCER RES, V71, P3052, DOI 10.1158/0008-5472.CAN-10-2282; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Gagliardi PA, 2012, NEOPLASIA, V14, P719, DOI 10.1593/neo.12856; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Medina JR, 2011, J MED CHEM, V54, P1871, DOI 10.1021/jm101527u; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nagashima K, 2011, J BIOL CHEM, V286, P6433, DOI 10.1074/jbc.M110.156463; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Bayascas JR, 2010, CURR TOP MICROBIOL, V346, P9, DOI 10.1007/82_2010_43; Shen H, 2008, CANCER GENET CYTOGEN, V181, P100, DOI 10.1016/j.cancergencyto.2007.11.012; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vultur A, 2009, PIGM CELL MELANOMA R, V22, P4, DOI 10.1111/j.1755-148X.2008.00527.x; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101	35	34	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4330	4339		10.1038/onc.2013.383	http://dx.doi.org/10.1038/onc.2013.383			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24037523	Green Accepted			2022-12-25	WOS:000341156900006
J	Filant, J; Lydon, JP; Spencer, TE				Filant, Justyna; Lydon, John P.; Spencer, Thomas E.			Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus	FASEB JOURNAL			English	Article						ChIP-Seq; development; function; transcription factor	LEUKEMIA INHIBITORY FACTOR; BETA-CATENIN; TRANSCRIPTION FACTORS; ENDOMETRIAL GLANDS; RECEPTOR-ALPHA; PROGESTERONE; IMPLANTATION; EXPRESSION; BINDING; MORPHOGENESIS	Uterine glands and their secretions are indispensable for endometrial function and fertility; however, the mechanisms regulating their development and function are not well understood. Forkhead transcription factor box A2 (FOXA2) is uniquely expressed in the glandular epithelial (GE) cells of the uterus, and conditional deletion of Foxa2 after birth impedes uterine gland development. An integrative approach was used here to define the FOXA2 cistrome in the murine uterus. Genome-wide mapping of FOXA2 binding sites was combined with transcriptomic analyses of isolated GE and Foxa2-deleted uteri. ChIP-Seq analyses found the number of FOXA2 target genes was substantially greater in the adult (8893) than neonatal uterus (1101). In the neonatal uterus, FOXA2-bound and GE-expressed genes (469) were enriched for developmentally related processes, including cell cycle, cell junction, focal adhesion, and WNT signaling. In the adult uterus, FOXA2-bound and GE-expressed genes (3730) were enriched for functional processes, including metabolic pathways, focal adhesion, bacterial invasion of epithelial cells, and WNT signaling. Analysis of the uterine FOXA2 cistrome provides novel insights into mechanisms governing endometrial gland development and function, which are important to understand fundamental aspects of uterine differentiation, regeneration and disease. Filant, J., Lydon, J. P., Spencer, T. E. Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus.	[Filant, Justyna; Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 83843 USA; [Filant, Justyna; Spencer, Thomas E.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 83843 USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Washington State University; Washington State University; Baylor College of Medicine	Spencer, TE (corresponding author), Washington State Univ, Dept Anim Sci, 1815 Ferdinands Lane,VMRB 175, Pullman, WA 83843 USA.	thomas.spencer@wsu.edu	Spencer, Thomas/AAD-6434-2020	Spencer, Thomas/0000-0003-2815-766X	NICHD NIH HHS [R21 HD076347] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bazer FW, 2012, J REPROD DEVELOP, V58, P180, DOI 10.1262/jrd.2011-019; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burton GJ, 2011, J REPROD IMMUNOL, V89, P118, DOI 10.1016/j.jri.2011.02.005; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen W, 2010, CELL TISSUE RES, V341, P441, DOI 10.1007/s00441-010-1013-5; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; Cooke PS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097188; Cummings M, 2011, ANAL BIOCHEM, V416, P123, DOI 10.1016/j.ab.2011.05.009; Diao HL, 2010, FERTIL STERIL, V94, P2808, DOI 10.1016/j.fertnstert.2010.06.034; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Dunlap KA, 2011, BIOL REPROD, V85, P386, DOI 10.1095/biolreprod.111.091769; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; Filant J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097089; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gonzalez IM, 2012, DEV BIOL, V361, P286, DOI 10.1016/j.ydbio.2011.10.021; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong JW, 2006, J ENDOCRINOL, V189, P473, DOI 10.1677/joe.1.06747; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; K Deb, 2005, PLACENTA TROPHOBLAST, V121; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LUDWIG H, 1991, ANN NY ACAD SCI, V622, P28, DOI 10.1111/j.1749-6632.1991.tb37848.x; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Niklaus AL, 2006, ENDOCRINOLOGY, V147, P3375, DOI 10.1210/en.2005-1665; O'Sullivan CM, 2002, MOL REPROD DEV, V62, P328, DOI 10.1002/mrd.10142; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Shelton DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040312; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spencer TE, 2012, MOL CELL ENDOCRINOL, V354, P34, DOI 10.1016/j.mce.2011.09.035; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Tan YF, 2006, REPROD NUTR DEV, V46, P641, DOI 10.1051/rnd:2006037; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Villacorte M, 2013, ONCOGENE, V32, P3477, DOI 10.1038/onc.2012.376; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	31	33	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					230	243		10.1096/fj.13-237446	http://dx.doi.org/10.1096/fj.13-237446			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24025729	Green Published			2022-12-25	WOS:000333526100023
J	Dong, X; Feng, H; Xu, M; Lee, J; Kim, YK; Lim, YP; Piao, ZY; Park, YD; Ma, H; Hur, Y				Dong, Xiangshu; Feng, Hui; Xu, Ming; Lee, Jeongyeo; Kim, Yeon Ki; Lim, Yong Pyo; Piao, Zhongyun; Park, Young Doo; Ma, Hong; Hur, Yoonkang			Comprehensive Analysis of Genic Male Sterility-Related Genes in Brassica rapa Using a Newly Developed Br300K Oligomeric Chip	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ANTHER-SPECIFIC GENES; ARABIDOPSIS-THALIANA; TAPETUM DEVELOPMENT; REPRODUCTIVE DEVELOPMENT; TRANSCRIPTION FACTOR; POLLEN COAT; EXPRESSION; PROTEIN; IDENTIFICATION	To identify genes associated with genic male sterility (GMS) that could be useful for hybrid breeding in Chinese cabbage (Brassica rapa ssp. pekinensis), floral bud transcriptome analysis was carried out using a B. rapa microarray with 300,000 probes (Br300K). Among 47,548 clones deposited on a Br300K microarray with seven probes of 60 nt length within the 3' 150 bp region, a total of 10,622 genes were differentially expressed between fertile and sterile floral buds; 4,774 and 5,848 genes were up-regulated over 2-fold in fertile and sterile buds, respectively. However, the expression of 1,413 and 199 genes showed fertile and sterile bud-specific features, respectively. Genes expressed specifically in fertile buds, possibly GMS-related genes, included homologs of several Arabidopsis male sterility-related genes, genes associated with the cell wall and synthesis of its surface proteins, pollen wall and coat components, signaling components, and nutrient supplies. However, most early genes for pollen development, genes for primexine and callose formation, and genes for pollen maturation and anther dehiscence showed no difference in expression between fertile and sterile buds. Some of the known genes associated with Arabidopsis pollen development showed similar expression patterns to those seen in this study, while others did not. BrbHLH89 and BrMYP99 are putative GMS genes. Additionally, 17 novel genes identified only in B. rapa were specifically and highly expressed only in fertile buds, implying the possible involvement in male fertility. All data suggest that Chinese cabbage GMS might be controlled by genes acting in post-meiotic tapetal development that are different from those known to be associated with Arabidopsis male sterility.	[Dong, Xiangshu; Lee, Jeongyeo; Hur, Yoonkang] Chungnam Natl Univ, Dept Biol Sci, Taejon, South Korea; [Feng, Hui; Xu, Ming; Piao, Zhongyun] Shenyang Agr Univ, Dept Hort, Shenyang, Peoples R China; [Kim, Yeon Ki] GreenGene Biotech Inc, Genom & Genet Inst, Yongin, South Korea; [Lim, Yong Pyo] Chungnam Natl Univ, Dept Hort, Taejon, South Korea; [Park, Young Doo] Kyung Hee Univ, Dept Hort Biotechnol, Yongin, South Korea; [Ma, Hong] Fudan Univ, Sch Life Sci, Ctr Evolutionary Biol, Inst Plant Biol,State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Chungnam National University; Shenyang Agricultural University; Chungnam National University; Kyung Hee University; Fudan University	Hur, Y (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Taejon, South Korea.	ykhur@cnu.ac.kr	FENG, HUI/R-8503-2019; Park, Young-Doo/AAJ-3826-2020; Ma, Hong/W-5251-2018	Ma, Hong/0000-0001-8717-4422; Hur, Yoonkang/0000-0002-2325-2249; Park, Young-Doo/0000-0001-8221-814X; Dong, Xiangshu/0000-0002-6640-0731	Next-Generation BioGreen 21 Program (Next-Generation Genomics Center), Rural Development Administration, Republic of Korea [PJ008118]	Next-Generation BioGreen 21 Program (Next-Generation Genomics Center), Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (the Next-Generation Genomics Center No. PJ008118), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Alves-Ferreira M, 2007, PLANT PHYSIOL, V145, P747, DOI 10.1104/pp.107.104422; Amagai M, 2003, SEX PLANT REPROD, V15, P213, DOI 10.1007/s00497-002-0159-z; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Balasubramanian S, 2000, DEVELOPMENT, V127, P4227; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chang F, 2011, CURR OPIN PLANT BIOL, V14, P66, DOI 10.1016/j.pbi.2010.11.001; Chen YN, 2009, PLANT CELL REP, V28, P1363, DOI 10.1007/s00299-009-0736-9; Coimbra S, 2010, SEX PLANT REPROD, V23, P199, DOI 10.1007/s00497-010-0136-x; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; De Storme N, 2011, PLANT PHYSIOL, V155, P1403, DOI 10.1104/pp.110.170415; DEOLIVEIRA DE, 1993, PLANT J, V3, P495, DOI 10.1046/j.1365-313X.1993.03040495.x; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Dong X, 2013, PLANT SCI, V199, P7, DOI 10.1016/j.plantsci.2012.11.001; Engelke T, 2010, J EXP BOT, V61, P2693, DOI 10.1093/jxb/erq105; Feng H., 1996, ACTA HORTIC, V467, P133; Feng Hui, 1995, Acta Horticulturae, P133; Ge XC, 2010, CURR BIOL, V20, pR988, DOI 10.1016/j.cub.2010.09.040; Glover J, 1998, PLANT J, V15, P345, DOI 10.1046/j.1365-313X.1998.00216.x; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Huang MD, 2011, PLANT CELL PHYSIOL, V52, P1459, DOI 10.1093/pcp/pcr088; Huang MD, 2009, PLANT PHYSIOL, V149, P694, DOI 10.1104/pp.108.131128; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito T, 2002, PLANT CELL PHYSIOL, V43, P1285, DOI 10.1093/pcp/pcf154; Ito T, 2007, PLANT CELL, V19, P3549, DOI 10.1105/tpc.107.054536; Jia GX, 2008, P NATL ACAD SCI USA, V105, P2220, DOI 10.1073/pnas.0708795105; Jiang PL, 2007, PLANT CELL PHYSIOL, V48, P812, DOI 10.1093/pcp/pcm051; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kaida R, 2009, PLANT PHYSIOL, V150, P1822, DOI 10.1104/pp.109.139287; Kang JG, 2008, PLANT MOL BIOL, V66, P177, DOI 10.1007/s11103-007-9261-9; Konagaya K, 2008, PLANT CELL REP, V27, P1741, DOI 10.1007/s00299-008-0598-6; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Levitin B, 2008, PLANT J, V56, P351, DOI 10.1111/j.1365-313X.2008.03607.x; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Liu XD, 2009, PLANT PHYSIOL, V151, P1401, DOI 10.1104/pp.109.145896; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Minami A, 1995, PLANT CELL PHYSIOL, V36, P1599; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Murphy DJ, 2006, PROTOPLASMA, V228, P31, DOI 10.1007/s00709-006-0163-5; Murphy D. J., 2005, PLANT LIPIDS BIOL UT; Ohnishi T, 2009, PHYTOCHEMISTRY, V70, P1918, DOI 10.1016/j.phytochem.2009.09.015; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Rieder B, 2011, PLANT CELL, V23, P1932, DOI 10.1105/tpc.111.084574; Ringli C, 2010, PLANT PHYSIOL, V153, P1445, DOI 10.1104/pp.110.154518; Rubinelli P, 1998, PLANT MOL BIOL, V37, P607, DOI 10.1023/A:1005964431302; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Tran HT, 2010, PLANT SCI, V179, P14, DOI 10.1016/j.plantsci.2010.04.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; VANDERMEER QP, 1987, EUPHYTICA, V36, P927, DOI 10.1007/BF00051877; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang YX, 2006, PLANTA, V223, P613, DOI 10.1007/s00425-005-0154-3; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Wijeratne AJ, 2007, PLANT J, V52, P14, DOI 10.1111/j.1365-313X.2007.03217.x; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; WORKMAN C, 2002, GENOME BIOL, V0003; Xu FX, 1999, PLANT J, V17, P321, DOI 10.1046/j.1365-313X.1999.00370.x; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; Ye QQ, 2010, P NATL ACAD SCI USA, V107, P6100, DOI 10.1073/pnas.0912333107; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang ZB, 2007, PLANT J, V52, P528, DOI 10.1111/j.1365-313X.2007.03254.x; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu Y, 2010, PLANT MOL BIOL, V72, P111, DOI 10.1007/s11103-009-9556-0; Zik M, 2003, PLANT CELL, V15, P207, DOI 10.1105/tpc.006353	89	42	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72178	10.1371/journal.pone.0072178	http://dx.doi.org/10.1371/journal.pone.0072178			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039743	gold, Green Submitted, Green Published			2022-12-25	WOS:000326734500009
J	Raine, LB; Lee, HK; Saliba, BJ; Chaddock-Heyman, L; Hillman, CH; Kramer, AF				Raine, Lauren B.; Lee, Hyun Kyu; Saliba, Brian J.; Chaddock-Heyman, Laura; Hillman, Charles H.; Kramer, Arthur F.			The Influence of Childhood Aerobic Fitness on Learning and Memory	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACADEMIC-ACHIEVEMENT; EXERCISE; HIPPOCAMPAL; BRAIN; PERFORMANCE; NEUROGENESIS; ENHANCE; NOVELTY; TESTS	Introduction: There is a growing trend of inactivity among children, which may not only result in poorer physical health, but also poorer cognitive health. Previous research has shown that lower fitness has been related to decreased cognitive function for tasks requiring perception, memory, and cognitive control as well as lower academic achievement. Purpose: To investigate the relationship between aerobic fitness, learning, and memory on a task that involved remembering names and locations on a fictitious map. Different learning strategies and recall procedures were employed to better understand fitness effects on learning novel material. Methods: Forty-eight 9-10 year old children (n = 24 high fit; HF and n = 24 low fit; LF) performed a task requiring them to learn the names of specific regions on a map, under two learning conditions in which they only studied (SO) versus a condition in which they were tested during study (TS). The retention day occurred one day after initial learning and involved two different recall conditions: free recall and cued recall. Results: There were no differences in performance at initial learning between higher fit and lower fit participants. However, during the retention session higher fit children outperformed lower fit children, particularly when the initial learning strategy involved relatively poor recall performance (i.e., study only versus test-study strategy). Conclusions: We interpret these novel data to suggest that fitness can boost learning and memory of children and that these fitness-associated performance benefits are largest in conditions in which initial learning is the most challenging. Such data have important implications for both educational practice and policy.	[Raine, Lauren B.; Saliba, Brian J.; Hillman, Charles H.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Lee, Hyun Kyu; Chaddock-Heyman, Laura; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Hillman, CH (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	chhillma@illinois.edu	Meijer, Anna/K-5118-2016; Kramer, Arthur/AAB-2937-2019; Hillman, Charles/AAD-4828-2019	Hillman, Charles/0000-0002-3722-5612; Kramer, Arthur/0000-0001-5870-2724				American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bar-Or O., 1983, PEDIAT SPORTS MED PR; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Birnbaum AS, 2002, AM J HEALTH BEHAV, V26, P284, DOI 10.5993/AJHB.26.4.5; Carpenter SK, 2006, MEM COGNITION, V34, P268, DOI 10.3758/BF03193405; Carpenter SK, 2007, PSYCHON B REV, V14, P474, DOI 10.3758/BF03194092; CARRIER M, 1992, MEM COGNITION, V20, P633, DOI 10.3758/BF03202713; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Department of Health and Human Services [DHHS] and Department of Education [DOE], 2000, PROM BETT HLTH YOUNG; DuPaul G. J., 1998, ADHD RATING SCALE 4; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; FORDYCE DE, 1991, BEHAV BRAIN RES, V43, P115, DOI 10.1016/S0166-4328(05)80061-0; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; FREEDSON PS, 1993, PEDIATRIC LABORATORY EXERCISE TESTING, P91; Gluck MA, 1997, ANNU REV PSYCHOL, V48, P481, DOI 10.1146/annurev.psych.48.1.481; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Healthy Active Living and Obesity (HALO) Research Group, 2010, PREP HLTH SCREEN CHI; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2009, DEV PSYCHOL, V45, P114, DOI 10.1037/a0014437; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; KAMIJO K, 2012, OBESITY; Kamijo K, 2012, PSYCHOPHYSIOLOGY; Karpicke JD, 2011, SCIENCE, V331, P772, DOI 10.1126/science.1199327; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; MCDANIEL MA, 1985, J EXP PSYCHOL LEARN, V11, P371, DOI 10.1037/0278-7393.11.2.371; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; POLSTER MR, 1991, J COGNITIVE NEUROSCI, V3, P95, DOI 10.1162/jocn.1991.3.2.95; Roediger HL, 2006, PERSPECT PSYCHOL SCI, V1, P181, DOI 10.1111/j.1745-6916.2006.00012.x; Rohrer D, 2010, J EXP PSYCHOL LEARN, V36, P233, DOI 10.1037/a0017678; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Tulving E, 1983, ELEMENTS EPISODIC ME, VClarendon Press, P56; Utter AC, 2002, MED SCI SPORT EXER, V34, P139, DOI 10.1097/00005768-200201000-00021; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x	51	50	51	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72666	10.1371/journal.pone.0072666	http://dx.doi.org/10.1371/journal.pone.0072666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	248VW	24039791	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500016
J	Zhao, G; Zhang, JG; Shi, Y; Qin, Q; Liu, Y; Wang, B; Tian, K; Deng, SC; Li, X; Zhu, S; Gong, Q; Niu, Y; Wang, CY				Zhao, Gang; Zhang, Jun-gang; Shi, Ying; Qin, Qi; Liu, Yang; Wang, Bo; Tian, Kui; Deng, Shi-chang; Li, Xiang; Zhu, Shuai; Gong, Qiong; Niu, Yi; Wang, Chun-you			MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3	PLOS ONE			English	Article							MICRORNA; EXPRESSION; IDENTIFICATION; METASTASIS; CARCINOMA; PROFILES; PROMOTES; GROWTH	Accumulating evidence indicates that microRNAs (miRNAs) are aberrantly expressed in human cancer and contribute to the tumorigenesis, but their roles in pancreatic cancer are still largely unknown. In this study, our data showed that miR-130b was significantly downregulated in 52 pairs of pancreatic cancer tissues and five cell lines. Furthermore, the deregulated miR-130b was correlated with worse prognosis, increased tumor size, late TNM stage, lymphatic invasion and distant metastasis. Multivariate analysis showed that miR-130b expression was a significant and independent prognostic predictor for pancreatic cancer patients. Functional studies indicated that the overexpression of miR-130b dramatically suppressed the proliferation of pancreatic cancer cells both in vitro and in vivo, which could be attributed to the induction of apoptosis and cell cycle arrest at S phase. Meanwhile, an overexpressed miR-130b remarkably inhibited the invasive ability of pancreatic cancer cells. Moreover, the dual luciferase assay revealed that STAT3 was directly targeted by miR-130b, which was further confirmed by the inverse expression of miR-130b and STAT3 in pancreatic cancer samples. Our findings suggested that miR-130b might have a considerable potential in prognosis identification and application of therapy for pancreatic cancer.	[Zhao, Gang; Zhang, Jun-gang; Qin, Qi; Liu, Yang; Wang, Bo; Tian, Kui; Deng, Shi-chang; Li, Xiang; Zhu, Shuai; Gong, Qiong; Niu, Yi; Wang, Chun-you] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan 430074, Peoples R China; [Zhang, Jun-gang] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China; [Shi, Ying] Zhejiang Prov Peoples Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China	Huazhong University of Science & Technology; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Zhao, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan 430074, Peoples R China.	gangzhao@aliyun.com; chunyouwang52@163.com		Li, Xiang/0000-0002-5942-7282	National Science Foundation Committee (NSFC) of China [30972900, 30600594]	National Science Foundation Committee (NSFC) of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Science Foundation Committee (NSFC) of China (grant numbers 30972900 and 30600594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Byers LA, 2009, CLIN CANCER RES, V15, P6852, DOI 10.1158/1078-0432.CCR-09-0767; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Li HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025941; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yan HJ, 2010, HUM GENE THER, V21, P1723, DOI 10.1089/hum.2010.061; Yang C, 2012, GYNECOL ONCOL, V124, P325, DOI 10.1016/j.ygyno.2011.10.013; Yang G, 2009, WORLD J GASTROENTERO, V15, P3757, DOI 10.3748/wjg.15.3757; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81; Zhao G, 2012, MOL CANC THER; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123	39	98	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73803	10.1371/journal.pone.0073803	http://dx.doi.org/10.1371/journal.pone.0073803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040078	gold, Green Submitted, Green Published			2022-12-25	WOS:000327538600046
J	Delgado, L; Carrion, O; Martinez, G; Lopez-Iglesias, C; Mercade, E				Delgado, Lidia; Carrion, Ornella; Martinez, Gema; Lopez-Iglesias, Carmen; Mercade, Elena			The Stack: A New Bacterial Structure Analyzed in the Antarctic Bacterium Pseudomonas deceptionensis M1(T) by Transmission Electron Microscopy and Tomography	PLOS ONE			English	Article							PRESSURE FROZEN SAMPLES; CRYOELECTRON TOMOGRAPHY; FREEZE-SUBSTITUTION; SYNCHRONIZATION; MESOSOMES; SECTIONS; DNA	In recent years, improvements in transmission electron microscopy (TEM) techniques and the use of tomography have provided a more accurate view of the complexity of the ultrastructure of prokaryotic cells. Cryoimmobilization of specimens by rapid cooling followed by freeze substitution (FS) and sectioning, freeze fracture (FF) and observation of replica, or cryoelectron microscopy of vitreous sections (CEMOVIS) now allow visualization of biological samples close to their native state, enabling us to refine our knowledge of already known bacterial structures and to discover new ones. Application of these techniques to the new Antarctic cold-adapted bacterium Pseudomonas deceptionensis M1(T) has demonstrated the existence of a previously undescribed cytoplasmic structure that does not correspond to known bacterial inclusion bodies or membranous formations. This structure, which we term a "stack", was mainly visualized in slow growing cultures of P. deceptionensis M1(T) and can be described as a set of stacked membranous discs usually arranged perpendicularly to the cell membrane, but not continuous with it, and found in variable number in different locations within the cell. Regardless of their position, stacks were mostly observed very close to DNA fibers. Stacks are not exclusive to P. deceptionensis M1(T) and were also visualized in slow-growing cultures of other bacteria. This new structure deserves further study using cryoelectron tomography to refine its configuration and to establish whether its function could be related to chromosome dynamics.	[Delgado, Lidia; Martinez, Gema; Lopez-Iglesias, Carmen] Univ Barcelona, Ctr Cient, Barcelona, Spain; [Delgado, Lidia; Martinez, Gema; Lopez-Iglesias, Carmen] Univ Barcelona, Ctr Tecnol, Barcelona, Spain; [Delgado, Lidia; Carrion, Ornella; Mercade, Elena] Univ Barcelona, Fac Farm, Microbiol Lab, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona	Lopez-Iglesias, C (corresponding author), Univ Barcelona, Ctr Cient, Barcelona, Spain.	carmenli@ccit.ub.edu; mmercade@ub.edu	Mercade, Elena/L-5218-2014; Carrion, Ornella/AAS-5142-2021; DELGADO, LIDIA/H-7939-2015	Mercade, Elena/0000-0001-7828-2210; Carrion, Ornella/0000-0002-9959-7905; DELGADO, LIDIA/0000-0001-7351-6188	Government of Spain (CICYT) [CTQ 2010-21183-C02-01/PPQ]; Autonomous Government of Catalonia [2009SGR1212]	Government of Spain (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Autonomous Government of Catalonia(Generalitat de Catalunya)	This study was supported by the Government of Spain (CICYT project CTQ 2010-21183-C02-01/PPQ) and by the Autonomous Government of Catalonia (grant 2009SGR1212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Agulleiro JI, 2010, J STRUCT BIOL, V170, P570, DOI 10.1016/j.jsb.2010.01.008; Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x; BOHRMANN B, 1994, J HISTOCHEM CYTOCHEM, V42, P635, DOI 10.1177/42.5.7512586; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Carrion O, 2011, INT J SYST EVOL MICR, V61, P2401, DOI 10.1099/ijs.0.024919-0; DOWNING KH, 2004, MICROSC MICROANAL, V10, P1184, DOI DOI 10.1017/S1431927604882953; DREWS G, 1992, PROKARYOTIC STRUCTUR, P249; EBERSOLD HR, 1981, ARCH MICROBIOL, V130, P19, DOI 10.1007/BF00527066; Eltsov M, 2006, J STRUCT BIOL, V156, P246, DOI 10.1016/j.jsb.2006.07.007; Fernandez JJ, 2012, MICRON, V43, P1010, DOI 10.1016/j.micron.2012.05.003; Fernandez JJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-178; Ferullo DJ, 2009, METHODS, V48, P8, DOI 10.1016/j.ymeth.2009.02.010; Fontana J, 2010, VIROLOGY, V405, P579, DOI 10.1016/j.virol.2010.06.043; Frias A, 2010, MICROB ECOL, V59, P476, DOI 10.1007/s00248-009-9622-9; Fridman K, 2012, NAT REV MOL CELL BIO, V13, P736, DOI 10.1038/nrm3453; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; GRAHAM LL, 1990, J BACTERIOL, V172, P2141, DOI 10.1128/jb.172.4.2141-2149.1990; HELMSTETTER CE, 1963, P NATL ACAD SCI USA, V50, P767, DOI 10.1073/pnas.50.4.767; HELMSTETTER CE, 1992, J BACTERIOL, V174, P3445, DOI 10.1128/JB.174.11.3445-3449.1992; Heuser JE, 2011, J ELECTRON MICROSC, V60, pS3, DOI 10.1093/jmicro/dfr044; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Jensen GJ, 2007, CURR OPIN STRUC BIOL, V17, P260, DOI 10.1016/j.sbi.2007.03.002; Jimenez N, 2009, J STRUCT BIOL, V166, P103, DOI 10.1016/j.jsb.2008.12.009; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lovett ST, 2004, EMBO REP, V5, P860, DOI 10.1038/sj.embor.7400232; MCDOWALL AW, 1983, J MICROSC-OXFORD, V131, P1, DOI 10.1111/j.1365-2818.1983.tb04225.x; Milne JLS, 2009, NAT REV MICROBIOL, V7, P666, DOI 10.1038/nrmicro2183; Moissl C, 2005, MOL MICROBIOL, V56, P361, DOI 10.1111/j.1365-2958.2005.04294.x; NIEDERMAN RA, 2006, MICROBIOLOGY MONOGRA, P193; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Pierson J, 2011, J ELECTRON MICROSC, V60, pS93, DOI 10.1093/jmicro/dfr014; Pierson J, 2010, J STRUCT BIOL, V169, P219, DOI 10.1016/j.jsb.2009.10.001; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; Shetty A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020725; SHIVELY JM, 1974, ANNU REV MICROBIOL, V28, P167, DOI 10.1146/annurev.mi.28.100174.001123; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; SILVA MT, 1976, BIOCHIM BIOPHYS ACTA, V443, P92, DOI 10.1016/0005-2736(76)90493-4; STEINBRECHT RA, 1987, CRYOTECHNIQUES BIOL, P328; Studer D., 1988, SCANNING MICROSCOPY, V3, P253, DOI DOI 10.1080/02827588809382513; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x	47	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73297	10.1371/journal.pone.0073297	http://dx.doi.org/10.1371/journal.pone.0073297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039905	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300063
J	Dong, CX; Ge, PF; Ren, XL; Wang, J; Fan, HQ; Yan, X; Yin, SA				Dong, Caixia; Ge, Pengfei; Ren, Xiaolan; Wang, Jie; Fan, Haoqiang; Yan, Xiang; Yin, Shi-an			Prospective Study on the Effectiveness of Complementary Food Supplements on Improving Status of Elder Infants and Young Children in the Areas Affected by Wenchuan Earthquake	PLOS ONE			English	Article							IRON-DEFICIENCY; VITAMIN-A; GROWTH; FORTIFICATION; INTERVENTION; MORTALITY; ANEMIA; HEALTH; RISK	Objective: To prospectively evaluate the efficiency of daily providing complementary food supplements decreasing malnutrition and anemia prevalence in elder infants and young children living in areas affected by Wenchuan Earthquake. Design: Using promotional probability sampling method, 250 to 300 children from six- randomized townships ( 30 to 50 children in each township) in Kang County affected by the Earthquake were randomly chosen for follow up to evaluate intervention effectiveness using anthropometric measurement and hemoglobin level at six, twelve and eighteen months after start of intervention. Setting and Subjects: All children from 6 to 18 months of age in Kang County ( in North Western China) were daily provided with complementary food supplements containing multiple vitamins and minerals for up to 24 months of age. The intervention period lasted for one and half year. Results: At beginning of intervention, malnutrition prevalence, including underweight, stunting and wasting were respectively 4.5%, 8.9% and 3.5%; anemia prevalence was 74.3%. After one and half year intervention, the growth and anemia status were significantly improved; the percentages of wasting, stunting underweight prevalence were decreased from 3.5%, 8.9% and 4.5% to 1.7%, 5.0% and 3.3% respectively, and the anemia rates were significantly decreased. Conclusions: Our results indicated that an intervention using complementary food supplements could improve nutritional status and elevate hemoglobin level in elder infants and young children, which would significantly decrease the prevalence of malnutrition and anemia.	[Dong, Caixia; Ge, Pengfei; Ren, Xiaolan; Fan, Haoqiang] Gansu Ctr Dis Control & Prevent, Dept Chron Dis, Lanzhou, Gansu, Peoples R China; [Wang, Jie; Yin, Shi-an] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Dept Maternal & Child Nutr, Beijing, Peoples R China; [Yan, Xiang] Lanzhou Univ, Hosp 1, Dept Geriatr, Lanzhou 730000, Gansu, Peoples R China	Chinese Center for Disease Control & Prevention; Lanzhou University	Yin, SA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Dept Maternal & Child Nutr, Beijing, Peoples R China.	shianyin@126.com			UNICEF in China	UNICEF in China	This survey was partly supported by UNICEF in China, however, the funding sources had no direct influence on the design, collection, and analyses of the data or the decision to submit this manuscript for publication. The authors have no commercial associations or sources of support. No additional external funding received for this study.	Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Carter RC, 2010, PEDIATRICS, V126, pE427, DOI 10.1542/peds.2009-2097; Chen K, 2008, J NUTR SCI VITAMINOL, V54, P440, DOI 10.3177/jnsv.54.440; Corapci F, 2010, J PEDIATR PSYCHOL, V35, P296, DOI 10.1093/jpepsy/jsp065; DALLMAN PR, 1980, AM J CLIN NUTR, V33, P86, DOI 10.1093/ajcn/33.1.86; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Huang C, 2010, J NUTR, V140, P1874, DOI 10.3945/jn.110.121293; Kanade A, 2011, J AM COLL NUTR, V30, P216, DOI 10.1080/07315724.2011.10719963; Krebs NF, 2007, J NUTR, V137, p511S, DOI 10.1093/jn/137.2.511S; Mason JB, 2010, FOOD NUTR BULL, V31, pS234, DOI 10.1177/15648265100313S303; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Nishikiori N, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-73; Remans R, 2011, AM J CLIN NUTR, V94, P1632, DOI 10.3945/ajcn.111.020099; Rim H, 2008, ASIA PAC J CLIN NUTR, V17, P264; Rivera JA, 2001, AM J CLIN NUTR, V74, P657; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012167; Seal AJ, 2005, J NUTR, V135, P808, DOI 10.1093/jn/135.4.808; Semba RD, 2010, AM J CLIN NUTR, V92, P170, DOI 10.3945/ajcn.2010.29254; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; United Nations Standing Committee on Nutrition, 1993, NUTR INF CRIS SIT FO; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang Li-juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P696; Wang Yuying, 2004, Wei Sheng Yan Jiu, V33, P334; Yang ZY, 2011, MATERN CHILD NUTR, V7, P123, DOI 10.1111/j.1740-8709.2011.00355.x; Zeng G., 2008, CHIN J PREV MED, V42, P786; Zhao Li-yun, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P701; Zhao Xian-feng, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P691; [No title captured]	31	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72711	10.1371/journal.pone.0072711	http://dx.doi.org/10.1371/journal.pone.0072711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039797	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300023
J	Kullmann, FA; Wells, GI; Langdale, CL; Zheng, JH; Thor, KB				Kullmann, F. Aura; Wells, Grace I.; Langdale, Christopher L.; Zheng, Jihong; Thor, Karl B.			Stability of the Acetic Acid-Induced Bladder Irritation Model in Alpha Chloralose-Anesthetized Female Cats	PLOS ONE			English	Article							LOWER URINARY-TRACT; NEURAL-CONTROL; SPINAL-CORD; POSTNATAL-DEVELOPMENT; PUDENDAL AFFERENTS; MICTURITION; STIMULATION; RECEPTORS; REFLEX; SEROTONIN	Time- and vehicle-related variability of bladder and urethral rhabdosphincter (URS) activity as well as cardiorespiratory and blood chemistry values were examined in the acetic acid-induced bladder irritation model in alpha-chloralose-anesthetized female cats. Additionally, bladder and urethra were evaluated histologically using Mason trichrome and toluidine blue staining. Urodynamic, cardiovascular and respiratory parameters were collected during intravesical saline infusion followed by acetic acid (0.5%) to irritate the bladder. One hour after starting acetic acid infusion, a protocol consisting of a cystometrogram, continuous infusion-induced rhythmic voiding contractions, and a 5 min "quiet period" (bladder emptied without infusion) was precisely repeated every 30 minutes. Administration of vehicle (saline i.v.) occurred 15 minutes after starting each of the first 7 cystometrograms and duloxetine (1mg/kg i.v.) after the 8th. Acetic acid infusion into the bladder increased URS-EMG activity, bladder contraction frequency, and decreased contraction amplitude and capacity, compared to saline. Bladder activity and URS activity stabilized within 1 and 2 hours, respectively. Duloxetine administration significantly decreased bladder contraction frequency and increased URS-EMG activity to levels similar to previous reports. Cardiorespiratory parameters and blood gas levels remained consistent throughout the experiment. The epithelium of the bladder and urethra were greatly damaged and edema and infiltration of neutrophils in the lamina propria of urethra were observed. These data provide an ample evaluation of the health of the animals, stability of voiding function and appropriateness of the model for testing drugs designed to evaluate lower urinary tract as well as cardiovascular and respiratory systems function.	[Kullmann, F. Aura; Wells, Grace I.; Langdale, Christopher L.; Zheng, Jihong; Thor, Karl B.] Urogenix Inc Astellas, Durham, NC USA		Kullmann, FA (corresponding author), Urogenix Inc Astellas, Durham, NC USA.	Aura.Kullmann@gmail.com	Langdale, Christopher/R-7209-2019	Kullmann, F. Aura/0000-0001-6625-2946; Langdale, Christopher/0000-0002-6704-2665	Astellas Pharma	Astellas Pharma(Astellas Pharmaceuticals)	This study was supported by Astellas Pharma. The funders had no role in study design, data collection and analysis or preparation of the manuscript. The funders approved the manuscript for publication.	ANGEL MJ, 1994, J PHYSIOL-LONDON, V479, P451, DOI 10.1113/jphysiol.1994.sp020309; ARFORS KE, 1971, ACTA PHYSIOL SCAND, V81, P47, DOI 10.1111/j.1748-1716.1971.tb04876.x; Birder LA, 2010, AUTON NEUROSCI-BASIC, V153, P33, DOI 10.1016/j.autneu.2009.07.005; Boggs JW, 2006, J PHYSIOL-LONDON, V577, P115, DOI 10.1113/jphysiol.2006.111815; Chang HY, 2008, AM J PHYSIOL-RENAL, V295, pF1248, DOI 10.1152/ajprenal.90259.2008; Chen Z, 2001, J UROLOGY, V166, P1539, DOI 10.1016/S0022-5347(05)65827-2; CIRIELLO J, 1980, AM J PHYSIOL, V239, pR137, DOI 10.1152/ajpregu.1980.239.1.R137; COVERT RF, 1988, AM J PHYSIOL, V255, pH419, DOI 10.1152/ajpheart.1988.255.3.H419; COVERT RF, 1994, BIOL NEONATE, V66, P316; COX RH, 1972, AM J PHYSIOL, V223, P660, DOI 10.1152/ajplegacy.1972.223.3.660; Dass N, 2001, J UROLOGY, V165, P1294, DOI 10.1016/S0022-5347(01)69887-2; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; DEGROAT WC, 1990, J AUTONOM NERV SYST, V30, pS71, DOI 10.1016/0165-1838(90)90105-R; DEGROAT WC, 1969, J PHYSIOL-LONDON, V200, P87, DOI 10.1113/jphysiol.1969.sp008683; DOWNIE JW, 1991, EUR J PHARMACOL, V195, P301, DOI 10.1016/0014-2999(91)90551-Z; Espey MJ, 1995, EUR J PHARMACOL, V287, P173, DOI 10.1016/0014-2999(95)00614-1; FELDBERG W, 1965, J PHYSIOL-LONDON, V179, P509, DOI 10.1113/jphysiol.1965.sp007677; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Gabella G, 1998, J NEUROCYTOL, V27, P141, DOI 10.1023/A:1006903507321; Garrett KM, 1998, J PHARMACOL EXP THER, V285, P680; GILLIS RA, 1988, J PHARMACOL EXP THER, V247, P765; Habler HJ, 1997, J AUTONOM NERV SYST, V66, P97, DOI 10.1016/S0165-1838(97)00073-8; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Karicheti V, 2006, 2006 AUA ANN M ATL G; Karicheti V, 2010, AM J PHYSIOL-REG I, V298, pR1198, DOI 10.1152/ajpregu.00599.2009; Katofiasc MA, 2002, LIFE SCI, V71, P1227, DOI 10.1016/S0024-3205(02)01848-9; Kirby M, 2008, NAT CLIN PRACT UROL, V5, P188, DOI 10.1038/ncpuro1077; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Larson JA, 2011, J PHYSIOL-LONDON, V589, P5833, DOI 10.1113/jphysiol.2011.215657; Lee JA, 2003, J VET EMERG CRIT CAR, V13, P227, DOI 10.1111/j.1534-6935.2003.00100.x; LEES P, 1972, VET REC, V91, P330, DOI 10.1136/vr.91.14.330; MACKEL R, 1979, J PHYSIOL-LONDON, V294, P105, DOI 10.1113/jphysiol.1979.sp012918; Matsuura S, 2000, NEUROUROL URODYNAM, V19, P87, DOI 10.1002/(SICI)1520-6777(2000)19:1<87::AID-NAU9>3.0.CO;2-O; Mitobe Manabu, 2008, Journal of Pharmacological and Toxicological Methods, V57, P188, DOI 10.1016/j.vascn.2007.12.001; MORTON CR, 1989, NEUROSCIENCE, V31, P807; Radziszewski P, 1996, SCAND J UROL NEPHROL, V30, P81; RAMAGE AG, 1984, NEUROPHARMACOLOGY, V23, P43, DOI 10.1016/0028-3908(84)90215-6; Roppolo JR, 2005, J UROLOGY, V173, P1011, DOI 10.1097/01.ju.0000145591.35569.9e; RUDY DC, 1991, AM J PHYSIOL, V261, pR1560, DOI 10.1152/ajpregu.1991.261.6.R1560; Sadananda P, 2009, BRIT J PHARMACOL, V158, P1655, DOI 10.1111/j.1476-5381.2009.00431.x; Sadananda P, 2012, EUR J PHARMACOL, V683, P252, DOI 10.1016/j.ejphar.2012.02.041; Smith PP, 2012, NEUROUROL URODYNAM, V31, P30, DOI 10.1002/nau.21223; Snellings AE, 2012, NEUROSCI LETT, V516, P34, DOI 10.1016/j.neulet.2012.03.045; Stone EA, 2005, LONG TERM REAL TIME; Tai CF, 2011, J UROLOGY, V186, P326, DOI 10.1016/j.juro.2011.04.023; TANG PC, 1956, J COMP NEUROL, V106, P213, DOI 10.1002/cne.901060108; TAYLOR DEM, 1965, Q J EXP PHYSIOL CMS, V50, P263, DOI 10.1113/expphysiol.1965.sp001791; Thor KB, 2010, AM J PHYSIOL-REG I, V299, pR416, DOI 10.1152/ajpregu.00111.2010; THOR KB, 1994, NEUROREPORT, V5, P1673, DOI 10.1097/00001756-199408150-00033; Thor KB, 1999, AM J PHYSIOL-REG I, V277, pR1002, DOI 10.1152/ajpregu.1999.277.4.R1002; Thor KB, 2003, UROLOGY, V62, P3, DOI 10.1016/S0090-4295(03)00754-4; THOR KB, 1990, DEV BRAIN RES, V57, P255, DOI 10.1016/0165-3806(90)90051-Y; THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014; THOR KB, 1983, J UROLOGY, V129, P202, DOI 10.1016/S0022-5347(17)51984-9; THOR KB, 1989, DEV BRAIN RES, V46, P137, DOI 10.1016/0165-3806(89)90151-X; Wang JC, 2009, BJU INT, V103, P530, DOI 10.1111/j.1464-410X.2008.08029.x; Westropp JL, 2007, AM J VET RES, V68, P203, DOI 10.2460/ajvr.68.2.203; Wibberley A, 2006, BRIT J PHARMACOL, V148, P154, DOI 10.1038/sj.bjp.0706715; Woock JP, 2009, J UROLOGY, V182, P366, DOI 10.1016/j.juro.2009.02.110; Wu CH, 2011, AM J VET RES, V72, P578, DOI 10.2460/ajvr.72.4.578; Yoo PB, 2008, EXP NEUROL, V212, P218, DOI 10.1016/j.expneurol.2008.04.010	61	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73771	10.1371/journal.pone.0073771	http://dx.doi.org/10.1371/journal.pone.0073771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040064	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300127
J	Narayanan, G; Bharathidevi, SR; Vuyyuru, H; Muthuvel, B; Natrajan, SK				Narayanan, Gomathy; Bharathidevi, S. R.; Vuyyuru, Harish; Muthuvel, Bharathselvi; Natrajan, Sulochana Konerirajapuram			CTR1 Silencing Inhibits Angiogenesis by Limiting Copper Entry into Endothelial Cells	PLOS ONE			English	Article							GROWTH; PROLIFERATION; TRANSPORTER; SIRNA; RNAI; MECHANISMS; EXPRESSION; THERAPY; ASSAY	Increased levels of intracellular copper stimulate angiogenesis in human umbilical vein endothelial cells (HUVECs). Copper transporter 1 (CTR1) is a copper importer present in the cell membrane and plays a major role in copper transport. In this study, three siRNAs targeting CTR1 mRNA were designed and screened for gene silencing. HUVECs when exposed to 100 mu M copper showed 3 fold increased proliferation, migration by 1.8 - fold and tube formation by 1.8 - fold. One of the designed CTR1 siRNA (si 1) at 10 nM concentration decreased proliferation by 2.5 - fold, migration by 4 - fold and tube formation by 2.8 - fold. Rabbit corneal packet assay also showed considerable decrease in matrigel induced blood vessel formation by si 1 when compared to untreated control. The designed si 1 when topically applied inhibited angiogenesis. This can be further developed for therapeutic application.	[Narayanan, Gomathy; Bharathidevi, S. R.; Vuyyuru, Harish; Muthuvel, Bharathselvi; Natrajan, Sulochana Konerirajapuram] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Madras, Tamil Nadu, India; [Narayanan, Gomathy; Muthuvel, Bharathselvi] Birla Inst Technol & Sci, Pilani, Rajasthan, India	Birla Institute of Technology & Science Pilani (BITS Pilani)	Natrajan, SK (corresponding author), Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Madras, Tamil Nadu, India.	drkns@snmail.org			Department of Biotechnology under the Ministry of Science and Technology [DBT-BT/PR12285/AGR/36/620/2009]	Department of Biotechnology under the Ministry of Science and Technology	This work was supported by the Department of Biotechnology under the Ministry of Science and Technology (DBT-BT/PR12285/AGR/36/620/2009, http://dbtindia.nic.in/index.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Brem S, 2005, NEURO-ONCOLOGY, V7, P246, DOI 10.1215/S1152851704000869; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Eisen T, 2012, JNCI-J NATL CANCER I, V104, P93, DOI 10.1093/jnci/djr511; el Filali M, 2012, MOL VIS, V18, P2454; Elice F, 2012, THROMB RES, V129, pS50, DOI 10.1016/S0049-3848(12)70016-6; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Harris ED, 2004, NUTR REV, V62, P60, DOI 10.1301/nr.2004.feb.60-64; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A; Jiang YC, 2007, J EXP MED, V204, P657, DOI 10.1084/jem.20061943; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Kaiser PK, 2010, AM J OPHTHALMOL, V150, P33, DOI 10.1016/j.ajo.2010.02.006; Krupanidhi S, 2008, INDIAN J MED RES, V128, P448; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou JR, 2010, ANTICANCER RES, V30, P3249; Lowndes SA, 2005, J MAMMARY GLAND BIOL, V10, P299, DOI 10.1007/s10911-006-9003-7; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; MCAUSLAN BR, 1980, T OPHTHAL SOC UK, V100, P354; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Qiu LY, 2012, J PHARMACOL EXP THER, V342, P561, DOI 10.1124/jpet.112.194662; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Riely G, 2007, CLIN CANCER RES, V13, p4623S, DOI 10.1158/1078-0432.CCR-07-0544; Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Sharp PA, 2003, INT J BIOCHEM CELL B, V35, P288, DOI 10.1016/S1357-2725(02)00134-6; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; van Hinsbergh VWM, 2008, CARDIOVASC RES, V78, P203, DOI 10.1093/cvr/cvm102; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644	42	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e71982	10.1371/journal.pone.0071982	http://dx.doi.org/10.1371/journal.pone.0071982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039729	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300005
J	Chen, CJ; Unger, C; Hoffmann, W; Lindsay, JA; Huang, YC; Gotz, F				Chen, Chih-Jung; Unger, Clemens; Hoffmann, Wolfgang; Lindsay, Jodi A.; Huang, Yhu-Chering; Goetz, Friedrich			Characterization and Comparison of 2 Distinct Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus Clones of ST59 Lineage	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; CHEMOTAXIS INHIBITORY PROTEIN; NASAL COLONIZATION; NECROTIZING PNEUMONIA; CONVERGENT EVOLUTION; COMPLEMENT INHIBITOR; TAIWANESE CHILDREN; LEUCOCIDIN GENES; NORTHERN TAIWAN; VIRULENCE	Sequence type (ST) 59 is an epidemic lineage of community-associated (CA) methicillin-resistant Staphylococcus aureus (MRSA) isolates. Taiwanese CA-MRSA isolates belong to ST59 and can be grouped into 2 distinct clones, a virulent Taiwan clone and a commensal Asian-Pacific clone. The Taiwan clone carries the Panton-Valentine leukocidin (PVL) genes and the staphylococcal chromosomal cassette mec (SCCmec) VT, and is frequently isolated from patients with severe disease. The Asian-Pacific clone is PVL-negative, carries SCCmec IV, and a frequent colonizer of healthy children. Isolates of both clones were characterized by their ability to adhere to respiratory A549 cells, cytotoxicity to human neutrophils, and nasal colonization of a murine and murine sepsis models. Genome variation was determined by polymerase chain reaction of selected virulence factors and by multi-strain whole genome microarray. Additionally, the expression of selected factors was compared between the 2 clones. The Taiwan clone showed a much higher cytotoxicity to the human neutrophils and caused more severe septic infections with a high mortality rate in the murine model. The clones were indistinguishable in their adhesion to A549 cells and persistence of murine nasal colonization. The microarray data revealed that the Taiwan clone had lost the empty set3-prophage that integrates into the beta-hemolysin gene and includes staphylokinase-and enterotoxin P-encoding genes, but had retained the genes for human immune evasion, scn and chps. Production of the virulence factors did not differ significantly in the 2 clonal groups, although more alpha-toxin was expressed in Taiwan clone isolates from pneumonia patients. In conclusion, the Taiwan CA-MRSA clone was distinguished by enhanced virulence in both humans and an animal infection model. The evolutionary acquisition of PVL, the higher expression of alpha-toxin, and possibly the loss of a large portion of the beta-hemolysin-converting prophage likely contribute to its higher pathogenic potential than the Asian-Pacific clone.	[Chen, Chih-Jung; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chen, Chih-Jung; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Unger, Clemens; Hoffmann, Wolfgang] Inst Tropenmed, Tubingen, Germany; [Lindsay, Jodi A.] Univ London, Dept Cellular & Mol Med, London, England; [Goetz, Friedrich] Univ Tubingen, Fac Biol, Dept Microbial Genet, Tubingen, Germany	Chang Gung Memorial Hospital; Chang Gung University; University of London; Eberhard Karls University of Tubingen	Chen, CJ (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	chinjung@adm.cgmh.org.tw	Hoffmann, Wolfgang H/C-9696-2010; Lindsay, Jodi/B-9565-2008; Lindsay, Jodi/ABH-8205-2020	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625	National Science Council [NMRPG476011, NMRPG476012, NMRPG476013]; Chang Gung Memorial Hospital [CMRPG450121, CMRPG450122, CMRPG450123]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The financial support to this study included the funding from National Science Council (NMRPG476011, NMRPG476012, NMRPG476013) and Chang Gung Memorial Hospital (CMRPG450121, CMRPG450122, CMRPG450123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014431; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chen FJ, 2005, EMERG INFECT DIS, V11, P1761, DOI 10.3201/eid1111.050367; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Fossum AE, 2006, CLIN MICROBIOL INFEC, V12, P627, DOI 10.1111/j.1469-0691.2006.01467.x; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Georgiades K, 2012, CLIN MICROBIOL INFEC, V18, P213, DOI 10.1111/j.1469-0691.2012.03781.x; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Ho PL, 2007, DIAGN MICR INFEC DIS, V57, P145, DOI 10.1016/j.diagmicrobio.2006.08.003; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Hsu LY, 2006, J CLIN MICROBIOL, V44, P1090, DOI 10.1128/JCM.44.3.1090-1093.2006; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2005, PEDIATR INFECT DIS J, V24, P276, DOI 10.1097/01.inf.0000154333.46032.0f; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Jin T, 2003, J MED MICROBIOL, V52, P919, DOI 10.1099/jmm.0.05145-0; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Milstone AM, 2011, CLIN INFECT DIS, V53, P853, DOI 10.1093/cid/cir547; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Mulvey MR, 2005, EMERG INFECT DIS, V11, P844, DOI 10.3201/eid1106.041146; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wannet WJB, 2005, J CLIN MICROBIOL, V43, P3341, DOI 10.1128/JCM.43.7.3341-3345.2005; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	48	40	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e63210	10.1371/journal.pone.0063210	http://dx.doi.org/10.1371/journal.pone.0063210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039691	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600001
J	Choi, HW; Navia, JA; Kassab, GS				Choi, Hyo Won; Navia, Jose A.; Kassab, Ghassan S.			Stroke Propensity Is Increased under Atrial Fibrillation Hemodynamics: A Simulation Study	PLOS ONE			English	Article							AORTIC-ARCH; RISK-FACTOR; FLOW; THROMBOEMBOLISM; PREVENTION; EMBOLISM; BRANCHES; REGISTRY; LENGTH	Atrial fibrillation (AF) is the most common sustained dysfunction in heart rhythm clinically and has been identified as an independent risk factor for stroke through formation and embolization of thrombi. AF is associated with reduced cardiac output and short and irregular cardiac cycle length. Although the effect of AF on cardiac hemodynamic parameters has been reported, it remains unclear how the hemodynamic perturbations affect the potential embolization of blood clots to the brain that can cause stroke. To understand stroke propensity in AF, we performed computer simulations to describe trajectories of blood clots subject to the aortic flow conditions that represent normal heart rhythm and AF. Quantitative assessment of stroke propensity by blood clot embolism was carried out for a range of clot properties (e. g., 2-6 mm in diameter and 0-0.8 m/s ejection speed) under normal and AF flow conditions. The simulations demonstrate that the trajectory of clot is significantly affected by clot properties as well as hemodynamic waveforms which lead to significant variations in stroke propensity. The predicted maximum difference in stroke propensity in the left common carotid artery was shown to be about 60% between the normal and AF flow conditions examined. The results suggest that the reduced cardiac output and cycle length induced by AF can significantly increase the incidence of carotid embolism. The present simulations motivate further studies on patient-specific risk assessment of stroke in AF.	[Choi, Hyo Won; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Navia, Jose A.] Austral Univ, Dept Surg, Buenos Aires, DF, Argentina	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Austral University	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu			3DT Holdings, Inc. (Indianapolis, IN)	3DT Holdings, Inc. (Indianapolis, IN)	This research was funded by 3DT Holdings, Inc. (Indianapolis, IN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOGOUSSLAVSKY J, 1990, NEUROLOGY, V40, P1046, DOI 10.1212/WNL.40.7.1046; BOGOUSSLAVSKY J, 1991, NEUROLOGY, V41, P855, DOI 10.1212/WNL.41.6.855; BRITTON M, 1985, STROKE, V16, P182, DOI 10.1161/01.STR.16.2.182; Casteleyn C, 2010, J ANAT, V216, P563, DOI 10.1111/j.1469-7580.2010.01220.x; Cheng Z, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000964; Clark DM, 1997, J AM COLL CARDIOL, V30, P1039, DOI 10.1016/S0735-1097(97)00254-4; Gallo D, 2012, ANN BIOMED ENG, V40, P729, DOI 10.1007/s10439-011-0431-1; GREENFIELD JC, 1968, J CLIN INVEST, V47, P2411, DOI 10.1172/JCI105924; Hart RG, 1999, ANN INTERN MED, V131, P688, DOI 10.7326/0003-4819-131-9-199911020-00010; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; HINTON RC, 1977, AM J CARDIOL, V40, P509, DOI 10.1016/0002-9149(77)90064-9; Huo YL, 2008, ANN BIOMED ENG, V36, P685, DOI 10.1007/s10439-008-9473-4; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Lantz J, 2012, MED ENG PHYS, V34, P1139, DOI 10.1016/j.medengphy.2011.12.002; MANNING WJ, 1995, ARCH INTERN MED, V155, P2193, DOI 10.1001/archinte.155.20.2193; Meyer JS, 1971, STROKE, V2, P541, DOI 10.1161/01.STR.2.6.541; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Nahirnyak VM, 2006, J ACOUST SOC AM, V119, P3766, DOI 10.1121/1.2201251; Nanthakumar K, 2002, EUR HEART J, V23, P695, DOI 10.1053/euhj.2001.3024; Niu YY, 2009, COMMUN COMPUT PHYS, V5, P142; Osorio A. F., 2011, COMPUT METHOD BIOMEC, V16, P622; Popovic ZB, 2002, AM J PHYSIOL-HEART C, V283, pH2706, DOI 10.1152/ajpheart.00571.2002; Richard Dodel J.-P.R.M.B.a.W.H.O., 2008, REP TOUCH BRIEF; Shin IY, 2008, J KOREAN NEUROSURG S, V44, P78, DOI 10.3340/jkns.2008.44.2.78; Tan FPP, 2009, COMPUT STRUCT, V87, P680, DOI 10.1016/j.compstruc.2008.09.007; Vukovic-Cvetkovic V, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/382361; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73485	10.1371/journal.pone.0073485	http://dx.doi.org/10.1371/journal.pone.0073485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039957	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600082
J	Hamdan, L; Arrar, Z; Al Muataz, Y; Suleiman, L; Negrier, C; Mulengi, JK; Boukerche, H				Hamdan, Lamia; Arrar, Zoheir; Al Muataz, Yacoub; Suleiman, Lutfi; Negrier, Claude; Mulengi, Joseph Kajima; Boukerche, Habib			Alpha Cyano-4-Hydroxy-3-Methoxycinnamic Acid Inhibits Proliferation and Induces Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							TRANSPORTER INHIBITION; IN-VITRO; LACTATE; METABOLISM; RESPIRATION; MECHANISMS; PROTEIN; TUMORS; P53	This study investigated the underlying mechanism of 4-hydroxy-3-methoxycinnamic acid (ACCA), on the growth of breast cancer cells and normal immortal epithelial cells, and compared their cytotoxic effects responses. Treatment of breast cancer cells (MCF-7, T47D, and MDA-231) with ACCA resulted in dose-and time-dependent decrease of cell proliferation, viability in colony formation assay, and programmed cell death (apoptosis) with minimal effects on non-tumoral cells. The ability of ACCA to suppress growth in cancer cells not expressing or containing defects in p53 gene indicates a lack of involvement of this critical tumor suppressor element in mediating ACCA-induced growth inhibition. Induction of apoptosis correlated with an increase in Bax protein, an established inducer of programmed cell death, and the ratio of Bax to Bcl-2, an established inhibitor of apoptosis. We also documented the ability of ACCA to inhibit the migration and invasion of MDA-231 cells with ACCA in vitro. Additionally, tumor growth of MDA-231 breast cancer cells in vivo was dramatically affected with ACCA. On the basis of its selective anticancer inhibitory activity on tumor cells, ACCA may represent a promising therapeutic drug that should be further evaluated as a chemotherapeutic agent for human breast cancer.	[Hamdan, Lamia; Al Muataz, Yacoub; Suleiman, Lutfi; Negrier, Claude; Boukerche, Habib] Univ Lyon 1, INSERM, Unite Rech Mixte EA4174, F-69365 Lyon, France; [Hamdan, Lamia; Arrar, Zoheir; Mulengi, Joseph Kajima] Univ Tlemcen, Dept Chim Organ Subst Nat & Anal, Tilimsen, Algeria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Abou Bekr Belkaid	Boukerche, H (corresponding author), Univ Lyon 1, INSERM, Unite Rech Mixte EA4174, F-69365 Lyon, France.	Habib.boukerche@sante.univ-lyon1.fr	Mulengi, Joseph Kajima/R-8067-2019	Negrier, Claude/0000-0003-3569-0366; Chamouard, Valerie/0000-0002-4443-1609; Kajima Mulengi, Joseph/0000-0002-2662-4271	General Directorate for Scientific Research and Technological Development (GDSR Ministry of Higher Education and Scientific Research/Algeria); Ligue nationale contre le Cancer; GSDR	General Directorate for Scientific Research and Technological Development (GDSR Ministry of Higher Education and Scientific Research/Algeria); Ligue nationale contre le Cancer(Ligue nationale contre le cancer); GSDR	This was supported by grants from the General Directorate for Scientific Research and Technological Development (GDSR Ministry of Higher Education and Scientific Research/Algeria), and the Ligue nationale contre le Cancer. LH was supported by a salary support from GSDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe RD, 2001, CARCINOGENESIS, V22, P1607, DOI 10.1093/carcin/22.10.1607; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; Banje J, 2003, NAT MED, V7, P548; Boukerche H, 2000, CANCER RES, V60, P5848; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Colen CB, 2011, NEOPLASIA, V13, P620, DOI 10.1593/neo.11134; Colen CB, 2006, NEUROSURGERY, V59, P1313, DOI 10.1227/01.NEU.0000249218.65332.BF; Cross RA, 2003, MOL CANCER, V2, P383; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; Del Prete E, 2004, PHYSIOL BEHAV, V80, P489, DOI 10.1016/j.physbeh.2003.10.007; Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Frenzel J, 2005, GLIA, V52, P276, DOI 10.1002/glia.20244; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Kim HS, 2012, BJU INT, V110, P1062, DOI 10.1111/j.1464-410X.2012.10971.x; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Marchini S, 1999, APOPTOSIS, V4, P39, DOI 10.1023/A:1009630132087; Petit T, 2003, MOL CANCER THER, V2, P165; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tanaka M, 2004, NEUROSCI RES, V48, P13, DOI 10.1016/j.neures.2003.09.001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong HL, 2007, ADV DRUG DELIVER REV, V59, P491, DOI 10.1016/j.addr.2007.04.008; WOSIKOWSKI K, 1995, CELL GROWTH DIFFER, V6, P1395; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zhang XD, 2006, ANTICANCER RES, V26, P3561	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72953	10.1371/journal.pone.0072953	http://dx.doi.org/10.1371/journal.pone.0072953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039831	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600046
J	Lohmann, D; Spandl, J; Stevanovic, A; Schoene, M; Philippou-Massier, J; Thiele, C				Lohmann, Daniel; Spandl, Johanna; Stevanovic, Ana; Schoene, Mario; Philippou-Massier, Julia; Thiele, Christoph			Monoubiquitination of Ancient Ubiquitous Protein 1 Promotes Lipid Droplet Clustering	PLOS ONE			English	Article							TRIACYLGLYCEROL SYNTHESIS; DROSOPHILA EMBRYOS; BINDING DOMAINS; CUE DOMAIN; TRANSPORT; FAT; PERILIPIN; STORAGE; SEIPIN; ADIPOCYTES	Lipid droplets, the intracellular storage organelles for neutral lipids, exist in a wide range of sizes and of morphologically distinct organization, from loosely dispersed lipid droplets to tightly packed lipid droplet clusters. We show that the lipid droplet protein AUP1 induces cluster formation. A fraction of AUP1 is monoubiquitinated at various lysine residues. This process depends on its internal CUE domain, which is a known ubiquitin-binding domain. AUP1 with a deleted or point mutagenized CUE domain, as well as a lysine-free mutant, are not ubiquitinated and do not induce lipid droplet clustering. When such ubiquitination deficient mutants are fused to ubiquitin, clustering is restored. AUP1 mutants with defective droplet targeting fail to induce clustering. Also, another lipid droplet protein, NSDHL, with a fused ubiquitin does not induce clustering. The data indicate that monoubiquitinated AUP1 on the lipid droplet surface specifically induces clustering, and suggest a homophilic interaction with a second AUP1 molecule or a heterophilic interaction with another ubiquitin-binding protein.	[Lohmann, Daniel; Spandl, Johanna; Stevanovic, Ana; Schoene, Mario; Philippou-Massier, Julia; Thiele, Christoph] Univ Bonn, LIMES Life & Med Sci Inst, Bonn, Germany	University of Bonn	Thiele, C (corresponding author), Univ Bonn, LIMES Life & Med Sci Inst, Bonn, Germany.	cthiele@uni-bonn.de			Deutsche Forschungsgemeinschaft [SFB645 TPB10, TRR83 TP12]; Federal Ministry of Education and Research, Germany (BMBF) (The Virtual Liver); Max Planck Institute of Molecular Cell Biology and Genetics, Dresden (MPI-CGB)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research, Germany (BMBF) (The Virtual Liver); Max Planck Institute of Molecular Cell Biology and Genetics, Dresden (MPI-CGB)	The authors acknowledge financial support from the Deutsche Forschungsgemeinschaft (SFB645 TPB10, TRR83 TP12) and the Federal Ministry of Education and Research, Germany (BMBF) (The Virtual Liver). The authors thank the Max Planck Institute of Molecular Cell Biology and Genetics, Dresden (MPI-CGB) for support during the early phase of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ohashi M, 2003, J BIOL CHEM, V278, P36819, DOI 10.1074/jbc.M301408200; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Orlicky DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066837; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Ta MT, 2012, FEBS J; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Thiel K, 2013, J CELL SCI, V126, P2198, DOI 10.1242/jcs.120493; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang CW, 2012, J CELL SCI, V125, P2930, DOI 10.1242/jcs.100230; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yu YXV, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-9; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	63	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72453	10.1371/journal.pone.0072453	http://dx.doi.org/10.1371/journal.pone.0072453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039768	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600029
J	Peter, KH; Sommer, U				Peter, Kalista Higini; Sommer, Ulrich			Phytoplankton Cell Size Reduction in Response to Warming Mediated by Nutrient Limitation	PLOS ONE			English	Article							TEMPERATURE	Shrinking of body size has been proposed as one of the universal responses of organisms to global climate warming. Using phytoplankton as an experimental model system has supported the negative effect of warming on body-size, but it remains controversial whether the size reduction under increasing temperatures is a direct temperature effect or an indirect effect mediated over changes in size selective grazing or enhanced nutrient limitation which should favor smaller cell-sizes. Here we present an experiment with a factorial combination of temperature and nutrient stress which shows that most of the temperature effects on phytoplankton cell size are mediated via nutrient stress. This was found both for community mean cell size and for the cell sizes of most species analyzed. At the highest level of nutrient stress, community mean cell size decreased by 46% per degrees C, while it decreased only by 4.7% at the lowest level of nutrient stress. Individual species showed qualitatively the same trend, but shrinkage per degrees C was smaller. Overall, our results support the hypothesis that temperature effects on cell size are to a great extent mediated by nutrient limitation. This effect is expected to be exacerbated under field conditions, where higher temperatures of the surface waters reduce the vertical nutrient transport.	[Peter, Kalista Higini; Sommer, Ulrich] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Sommer, U (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	usommer@geomar.de			DAAD (Deutscher Akademischer Austauschdienst = German Academic Exchange Service); Tanzania Ministry of Education and Vocational Training	DAAD (Deutscher Akademischer Austauschdienst = German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Tanzania Ministry of Education and Vocational Training	The authors acknowledge support by DAAD (Deutscher Akademischer Austauschdienst = German Academic Exchange Service) and Tanzania Ministry of Education and Vocational Training which supported this research by a PhD-fellowship for Kalista H. Peter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Bergmann C., 1847, GOTTINGER STUDIEN, V3, P538; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DROOP MR, 1973, J PHYCOL, V9, P264; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; KAMYKOWSKI D, 1986, DEEP-SEA RES, V33, P89, DOI 10.1016/0198-0149(86)90109-3; KIORBOE T, 1993, ADV MAR BIOL, V29, P1, DOI 10.1016/S0065-2881(08)60129-7; Maranon E, 2012, LIMNOL OCEANOGR, V57, P1266, DOI 10.4319/lo.2012.57.5.1266; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Peter KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049632; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Sommer U, 2005, OECOLOGIA, V142, P274, DOI 10.1007/s00442-004-1708-y; Sommer U, 2012, MAR BIOL, V159, P1; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Utermohl H., 1958, MITT INT VER THEOR, V9, P263; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	27	47	51	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71528	10.1371/journal.pone.0071528	http://dx.doi.org/10.1371/journal.pone.0071528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039717	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324481600011
J	Al-Mahdawi, S; Sandi, C; Pinto, RM; Pook, MA				Al-Mahdawi, Sahar; Sandi, Chiranjeevi; Pinto, Ricardo Mouro; Pook, Mark A.			Friedreich Ataxia Patient Tissues Exhibit Increased 5-Hydroxymethylcytosine Modification and Decreased CTCF Binding at the FXN Locus	PLOS ONE			English	Article							GAA REPEAT LENGTH; TRIPLET-REPEAT; EPIGENETIC CHANGES; DNA METHYLATION; FRATAXIN GENE; TRANSCRIPTION; BRAIN; 5-METHYLCYTOSINE; HYPEREXPANSION; EXPRESSION	Background: Friedreich ataxia (FRDA) is caused by a homozygous GAA repeat expansion mutation within intron 1 of the FXN gene, which induces epigenetic changes and FXN gene silencing. Bisulfite sequencing studies have identified 5-methylcytosine (5mC) DNA methylation as one of the epigenetic changes that may be involved in this process. However, analysis of samples by bisulfite sequencing is a time-consuming procedure. In addition, it has recently been shown that 5-hydroxymethylcytosine (5hmC) is also present in mammalian DNA, and bisulfite sequencing cannot distinguish between 5hmC and 5mC. Methodology/Principal Findings: We have developed specific MethylScreen restriction enzyme digestion and qPCR-based protocols to more rapidly quantify DNA methylation at four CpG sites in the FXN upstream GAA region. Increased DNA methylation was confirmed at all four CpG sites in both FRDA cerebellum and heart tissues. We have also analysed the DNA methylation status in FRDA cerebellum and heart tissues using an approach that enables distinction between 5hmC and 5mC. Our analysis reveals that the majority of DNA methylation in both FRDA and unaffected tissues actually comprises 5hmC rather than 5mC. We have also identified decreased occupancy of the chromatin insulator protein CTCF (CCCTC-binding factor) at the FXN 5' UTR region in the same FRDA cerebellum tissues. Conclusions/Significance: Increased DNA methylation at the FXN upstream GAA region, primarily 5hmC rather than 5mC, and decreased CTCF occupancy at the FXN 5' UTR are associated with FRDA disease-relevant human tissues. The role of such molecular mechanisms in FRDA pathogenesis has now to be determined.	[Al-Mahdawi, Sahar; Sandi, Chiranjeevi; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Ataxia Res Grp, Uxbridge UB8 3PH, Middx, England; [Pinto, Ricardo Mouro] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA	Brunel University; Harvard University; Massachusetts General Hospital	Pook, MA (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Ataxia Res Grp, Uxbridge UB8 3PH, Middx, England.	Mark.Pook@brunel.ac.uk	Pinto, Ricardo Mouro/AAD-1048-2021	Pinto, Ricardo Mouro/0000-0001-6744-2805	European Union [242193/EFACTS]; Wellcome Trust [089757]; Ataxia UK	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Ataxia UK	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 242193/EFACTS (CS), the Wellcome Trust [089757] (SA) and Ataxia UK (RMP) to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Chan PK, 2013, HUM MOL GENET, V22, P2662, DOI 10.1093/hmg/ddt115; Chen H, 2012, RESTOR NEUROL NEUROS, V30, P237, DOI 10.3233/RNN-2012-110223; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Filla A, 1996, AM J HUM GENET, V59, P554; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Haffner MC, 2013, CELL CYCLE, V12, P1835, DOI 10.4161/cc.25010; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Robertson J, 2011, BIOCHEM BIOPH RES CO, V411, P40, DOI 10.1016/j.bbrc.2011.06.077; Sandi C, 2013, GENET RES INT, V2013, DOI 10.1155/2013/852080; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Sharma R, 2004, ANN NEUROL, V56, P898, DOI 10.1002/ana.20333; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang T, 2012, HUM MOL GENET, V21, P5500, DOI 10.1093/hmg/dds394; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425	37	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74956	10.1371/journal.pone.0074956	http://dx.doi.org/10.1371/journal.pone.0074956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023969	gold, Green Published, Green Submitted			2022-12-25	WOS:000324515600163
J	Gassman, A; Hao, LT; Bhoite, L; Bradford, CL; Chien, CB; Beattie, CE; Manfredi, JP				Gassman, Andrew; Hao, Le T.; Bhoite, Leena; Bradford, Chad L.; Chien, Chi-Bin; Beattie, Christine E.; Manfredi, John P.			Small Molecule Suppressors of Drosophila Kinesin Deficiency Rescue Motor Axon Development in a Zebrafish Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; GAMMA-SECRETASE INHIBITORS; NEURON SMN PROTEIN; MOUSE MODEL; NEUROMUSCULAR-JUNCTION; MESSENGER-RNA; BETA-PROTEIN; HEAVY-CHAIN; SOMITE SEGMENTATION	Proximal spinal muscular atrophy (SMA) is the most common inherited motor neuropathy and the leading hereditary cause of infant mortality. Currently there is no effective treatment for the disease, reflecting a need for pharmacologic interventions that restore performance of dysfunctional motor neurons or suppress the consequences of their dysfunction. In a series of assays relevant to motor neuron biology, we explored the activities of a collection of tetrahydroindoles that were reported to alter the metabolism of amyloid precursor protein (APP). In Drosophila larvae the compounds suppressed aberrant larval locomotion due to mutations in the Khc and Klc genes, which respectively encode the heavy and light chains of kinesin-1. A representative compound of this class also suppressed the appearance of axonal swellings (alternatively termed axonal spheroids or neuritic beads) in the segmental nerves of the kinesin-deficient Drosophila larvae. Given the importance of kinesin-dependent transport for extension and maintenance of axons and their growth cones, three members of the class were tested for neurotrophic effects on isolated rat spinal motor neurons. Each compound stimulated neurite outgrowth. In addition, consistent with SMA being an axonopathy of motor neurons, the three axonotrophic compounds rescued motor axon development in a zebrafish model of SMA. The results introduce a collection of small molecules as pharmacologic suppressors of SMA-associated phenotypes and nominate specific members of the collection for development as candidate SMA therapeutics. More generally, the results reinforce the perception of SMA as an axonopathy and suggest novel approaches to treating the disease.	[Gassman, Andrew; Bradford, Chad L.] Sera Prognost Inc, Salt Lake City, UT USA; [Hao, Le T.; Beattie, Christine E.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Bhoite, Leena] Univ Utah, Technol Commercializat Off, Salt Lake City, UT USA; [Chien, Chi-Bin] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Manfredi, John P.] Sfida BioLog Inc, Salt Lake City, UT USA	University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Manfredi, JP (corresponding author), Sfida BioLog Inc, Salt Lake City, UT USA.	john.manfredi@sfidabiologic.com			Myriad Pharmaceuticals, Inc.; Muscular Dystrophy Association (MDA) [171550]; NIH/NINDS [P30 NS045758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R01NS050414] Funding Source: NIH RePORTER	Myriad Pharmaceuticals, Inc.; Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Experiments with Drosophila, GSK-3beta, and cultured spinal motor neurons were funded by Myriad Pharmaceuticals, Inc. while four of the authors (AG, CLB, LB, and JPM) were employees of the company. Beyond the contributions of these four individuals, Myriad had no role is the design of the study, collection of data, analysis of the data, decision to publish, or preparation of the manuscript. The zebrafish studies were funded by a grant from the Muscular Dystrophy Association (MDA Award 171550) to JPM and CEB with additional support from NIH/NINDS P30 NS045758. Neither the MDA nor the NIH had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Beattie CE, 2007, J CHILD NEUROL, V22, P995, DOI 10.1177/0883073807305671; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Blair MA, 2006, NEUROGENETICS, V7, P47, DOI 10.1007/s10048-005-0027-8; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Bowerman M, 2007, J MOL NEUROSCI, V32, P120, DOI 10.1007/s12031-007-0024-5; Bowerman M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-24; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Bowerman M, 2009, MOL CELL NEUROSCI, V42, P66, DOI 10.1016/j.mcn.2009.05.009; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bulic B, 2011, CURR NEUROPHARMACOL, V9, P598, DOI 10.2174/157015911798376352; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chen PC, 2012, ACS CHEM NEUROSCI, V3, P5, DOI 10.1021/cn200085z; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Cherry JJ, 2012, FUTURE MED CHEM, V4, P1733, DOI [10.4155/FMC.12.107, 10.4155/fmc.12.107]; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dale JM, 2011, ACTA NEUROPATHOL, V122, P331, DOI 10.1007/s00401-011-0848-5; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Du J, 2010, P NATL ACAD SCI USA, V107, P11573, DOI 10.1073/pnas.0913138107; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GHO M, 1992, SCIENCE, V258, P313, DOI 10.1126/science.1384131; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hao LT, 2012, J NEUROSCI, V32, P5074, DOI 10.1523/JNEUROSCI.5808-11.2012; Hilario JD, 2009, DEV BIOL, V326, P190, DOI 10.1016/j.ydbio.2008.11.007; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; HOLM S, 1979, SCAND J STAT, V6, P65; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hurd DD, 1996, GENETICS, V142, P195; Hurd DD, 1996, GENETICS, V144, P1075; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kabashi E, 2010, HUM MOL GENET, V19, P3102, DOI 10.1093/hmg/ddq203; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Kim YS, 2001, J NEUROBIOL, V47, P26, DOI 10.1002/neu.1013; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee AJH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046353; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Lorson MA, 2012, FUTURE MED CHEM, V4, P2067, DOI [10.4155/FMC.12.131, 10.4155/fmc.12.131]; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Martinez-Hernandez R, 2013, J PATHOL, V229, P49, DOI 10.1002/path.4080; Mattila PM, 1999, ACTA NEUROPATHOL, V98, P157, DOI 10.1007/s004010051064; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Mochida S, 2011, NEUROSCI RES, V70, P16, DOI 10.1016/j.neures.2011.03.005; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Morel M, 2010, NEUROSCIENCE, V167, P1044, DOI 10.1016/j.neuroscience.2010.02.077; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2013, NEUROBIOL DIS, V49, P57, DOI 10.1016/j.nbd.2012.08.019; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pendleton RG, 2002, J PHARMACOL EXP THER, V300, P91, DOI 10.1124/jpet.300.1.91; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pigino G, 2003, J NEUROSCI, V23, P4499; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rodino-Klapac LR, 2004, DEV BIOL, V273, P308, DOI 10.1016/j.ydbio.2004.06.007; RODINOKLAPAC LR, 2005, THESIS OHIO STATE U; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; SLADE R, 2010, Patent No. 7678823; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tang BL, 2003, NEUROCHEM INT, V42, P189, DOI 10.1016/S0197-0186(02)00094-3; Tang BL, 2009, CELL ADHES MIGR, V3, P118, DOI 10.4161/cam.3.1.7254; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; TATE BA, 2006, SCI AGING KNOWLEDGE, pRE2; WEAVER C, 2012, TRAFFIC; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108	119	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74325	10.1371/journal.pone.0074325	http://dx.doi.org/10.1371/journal.pone.0074325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023935	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600134
J	Potenza, L; Vallerini, D; Barozzi, P; Riva, G; Forghieri, F; Beauvais, A; Beau, R; Candoni, A; Maertens, J; Rossi, G; Morselli, M; Zanetti, E; Quadrelli, C; Codeluppi, M; Guaraldi, G; Pagano, L; Caira, M; Del Giovane, C; Maccaferri, M; Stefani, A; Morandi, U; Tazzioli, G; Girardis, M; Delia, M; Specchia, G; Longo, G; Marasca, R; Narni, F; Merli, F; Imovilli, A; Apolone, G; Carvalho, A; Comoli, P; Romani, L; Latge, JP; Luppi, M				Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Forghieri, Fabio; Beauvais, Anne; Beau, Remi; Candoni, Anna; Maertens, Johan; Rossi, Giulio; Morselli, Monica; Zanetti, Eleonora; Quadrelli, Chiara; Codeluppi, Mauro; Guaraldi, Giovanni; Pagano, Livio; Caira, Morena; Del Giovane, Cinzia; Maccaferri, Monica; Stefani, Alessandro; Morandi, Uliano; Tazzioli, Giovanni; Girardis, Massimo; Delia, Mario; Specchia, Giorgina; Longo, Giuseppe; Marasca, Roberto; Narni, Franco; Merli, Francesco; Imovilli, Annalisa; Apolone, Giovanni; Carvalho, Agostinho; Comoli, Patrizia; Romani, Luigina; Latge, Jean Paul; Luppi, Mario			Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients	PLOS ONE			English	Article							T-CELL RESPONSES; ACUTE LYMPHOBLASTIC-LEUKEMIA; PULMONARY ASPERGILLOSIS; FUMIGATUS; GENERATION; TH1	Several studies in mouse model of invasive aspergillosis (IA) and in healthy donors have shown that different Aspergillus antigens may stimulate different adaptive immune responses. However, the occurrence of Aspergillus-specific T cells have not yet been reported in patients with the disease. In patients with IA, we have investigated during the infection: a) whether and how specific T-cell responses to different Aspergillus antigens occur and develop; b) which antigens elicit the highest frequencies of protective immune responses and, c) whether such protective T cells could be expanded ex-vivo. Forty hematologic patients have been studied, including 22 patients with IA and 18 controls. Specific T cells producing IL-10, IFN-gamma, IL-4 and IL-17A have been characterized through enzyme linked immunospot and cytokine secretion assays on 88 peripheral blood (PB) samples, by using the following recombinant antigens: GEL1p, CRF1p, PEP1p, SOD1p, alpha 1-3glucan, beta 1-3glucan, galactomannan. Specific T cells were expanded through short term culture. Aspergillus-specific T cells producing non-protective interleukin-10 (IL-10) and protective interferon-gamma (IFN-gamma) have been detected to all the antigens only in IA patients. Lower numbers of specific T cells producing IL-4 and IL-17A have also been shown. Protective T cells targeted predominantly Aspergillus cell wall antigens, tended to increase during the IA course and to be associated with a better clinical outcome. Aspergillus-specific T cells could be successfully generated from the PB of 8 out of 8 patients with IA and included cytotoxic subsets able to lyse Aspergillus hyphae. Aspergillus specific T-cell responses contribute to the clearance of the pathogen in immunosuppressed patients with IA and Aspergillus cell wall antigens are those mainly targeted by protective immune responses. Cytotoxic specific T cells can be expanded from immunosuppressed patients even during the infection by using the above mentioned antigens. These findings may be exploited for immunotherapeutic purposes in patients with IA.	[Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Forghieri, Fabio; Morselli, Monica; Zanetti, Eleonora; Quadrelli, Chiara; Del Giovane, Cinzia; Maccaferri, Monica; Longo, Giuseppe; Marasca, Roberto; Narni, Franco; Luppi, Mario] Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Surg & Med Sci, Sect Hematol, Modena, Italy; [Beauvais, Anne; Beau, Remi; Latge, Jean Paul] Inst Pasteur, Unite Aspergillus, Paris, France; [Maertens, Johan] Univ Ziekenhuizen Leuven, Dept Hematol, Louvain, Belgium; [Rossi, Giulio] IRCCS Arcispedale S Maria Nuova Reggio, Sect Histopathol, Emilia, Italy; [Pagano, Livio; Caira, Morena] Univ Cattolica Sacro Cuore, Dept Hematol, Rome, Italy; [Codeluppi, Mauro; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Surg & Med Sci, Infect Dis Clin, Modena, Italy; [Stefani, Alessandro; Morandi, Uliano] Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Surg & Med Sci, Div Thorac Surg, Modena, Italy; [Tazzioli, Giovanni] Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Surg & Med Sci, Div Gen Surg, Modena, Italy; [Girardis, Massimo] Univ Modena & Reggio Emilia, Azienda Osped Policlin, Div Anaesthesiol & Intens Care, Modena, Italy; [Delia, Mario; Specchia, Giorgina] Univ Bari, Dept Hematol, DAP, Bari, Italy; [Merli, Francesco; Imovilli, Annalisa; Apolone, Giovanni] IRCCS Arcispedale S Maria Nuova Reggio, Div Hematol, Emilia, Italy; [Carvalho, Agostinho; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Romani, Luigina] IRCCS S Matteo Hosp, Pavia, Italy	Universita di Modena e Reggio Emilia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; KU Leuven; University Hospital Leuven; IRCCS Arcispedale S. Maria Nuova; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita degli Studi di Bari Aldo Moro; IRCCS Arcispedale S. Maria Nuova; University of Perugia; IRCCS Fondazione San Matteo	Potenza, L (corresponding author), Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Surg & Med Sci, Sect Hematol, Modena, Italy.	leonardo.potenza@unimore.it	Zanetti, Eleonora/J-6078-2016; Luppi, Mario/J-3668-2016; Imovilli, Annalisa/AAF-9172-2021; pagano, livio/A-2024-2008; Rossi, Giulio/K-6217-2016; Guaraldi, Giovanni/J-9467-2018; Romani, Luigina/O-9987-2018; Marasca, Roberto/I-8072-2013; Candoni, Anna/AAU-6289-2020; Carvalho, Agostinho/D-2667-2009; Rossi, Antonio/K-7054-2016; Candoni, Anna/ABE-1708-2021; Latge, Jean Paul/C-9846-2014; Potenza, Leonardo/P-9579-2016; pagano, livio/J-3020-2018; Beauvais, Anne/A-6358-2012; Comoli, Patrizia/K-2732-2018; Stefani, Alessandro/I-8199-2014; Tazzioli, Giovanni/C-5654-2017; Girardis, Massimo/K-8974-2016; Barozzi, Patrizia/Q-2638-2016; Merli, Francesco/K-8041-2016; Maccaferri, Monica/J-1737-2018; Apolone, Giovanni/R-9799-2016; Morandi, Uliano/C-9451-2017; Specchia, Giorgina/K-3084-2016	Zanetti, Eleonora/0000-0002-3483-130X; Luppi, Mario/0000-0002-0373-1154; Imovilli, Annalisa/0000-0002-2696-7389; Rossi, Giulio/0000-0001-8855-1218; Marasca, Roberto/0000-0002-6431-6878; Candoni, Anna/0000-0003-4436-1310; Carvalho, Agostinho/0000-0001-8935-8030; Rossi, Antonio/0000-0003-3295-0345; Potenza, Leonardo/0000-0002-2738-6105; pagano, livio/0000-0001-8287-928X; Comoli, Patrizia/0000-0001-5964-0553; Stefani, Alessandro/0000-0003-4547-6232; Tazzioli, Giovanni/0000-0002-1102-7431; Girardis, Massimo/0000-0002-2453-0829; Barozzi, Patrizia/0000-0002-8936-1114; Merli, Francesco/0000-0002-0979-7883; Maccaferri, Monica/0000-0003-2818-6516; Apolone, Giovanni/0000-0001-5179-104X; Morandi, Uliano/0000-0002-4039-7626; Guaraldi, Giovanni/0000-0002-5724-3914; Specchia, Giorgina/0000-0002-2479-9529; Del Giovane, Cinzia/0000-0002-5028-932X; Maccaferri, Monica/0000-0002-1413-825X; NARNI, Franco/0000-0003-3994-9101; Romani, Luigina/0000-0002-1356-525X; Delia, Mario/0000-0002-6486-8912	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy [AIRC IG-10811]; European Commission [LSHC-CT-2005-018704]; Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS; Programma di ricerca Regione-Universita, Regione Emilia Romagna; Gilead Fellowship Program; Societa Italiana di Ematologia Sperimentale (SIES); Merck Sharp Dohme; Gilead Sciences	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro); European Commission(European CommissionEuropean Commission Joint Research Centre); Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS; Programma di ricerca Regione-Universita, Regione Emilia Romagna(Regione Emilia Romagna); Gilead Fellowship Program(Gilead Sciences); Societa Italiana di Ematologia Sperimentale (SIES); Merck Sharp Dohme(Merck & Company); Gilead Sciences(Gilead Sciences)	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC IG-10811), Milan, Italy (ML); the European Commission's FP6 Life-Science-Health Programme (INCA project, LSHC-CT-2005-018704) (ML); the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP, FF); the Programma di ricerca Regione-Universita 2007-2009, Regione Emilia Romagna (ML, FN); Gilead Fellowship Program 2012-2014 (ML); the Societa Italiana di Ematologia Sperimentale (SIES, "Piero Martino'' award to LP); research funds by Merck Sharp & Dohme and Gilead Sciences to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2007, YEAST, V24, P289, DOI 10.1002/yea.1480; Beck O, 2006, BLOOD, V107, P2562, DOI 10.1182/blood-2005-04-1660; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Brodoefel H, 2006, AM J ROENTGENOL, V187, P404, DOI 10.2214/AJR.05.0513; Caillot D, 2001, J CLIN ONCOL, V19, P253, DOI 10.1200/JCO.2001.19.1.253; Carvalho A, 2012, BLOOD, V119, P967, DOI 10.1182/blood-2011-06-362582; Chai LYA, 2010, IMMUNOLOGY, V130, P46, DOI 10.1111/j.1365-2567.2009.03211.x; Chaudhary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009036; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Perruccio K, 2005, BLOOD, V106, P4397, DOI 10.1182/blood-2005-05-1775; Potenza L, 2007, LEUKEMIA, V21, P578, DOI 10.1038/sj.leu.2404504; Potenza L, 2011, BLOOD, V118, P5416, DOI 10.1182/blood-2011-07-366526; Ramadan G, 2005, CLIN EXP IMMUNOL, V139, P257, DOI 10.1111/j.1365-2249.2005.02699.x; Ramadan G, 2005, CLIN EXP IMMUNOL, V140, P81, DOI 10.1111/j.1365-2249.2005.02738.x; Rezvani K, 2009, BLOOD, V113, P2245, DOI 10.1182/blood-2008-03-144071; Riva G, 2010, BLOOD, V115, P1512, DOI 10.1182/blood-2009-06-230391; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Ryan SO, 2011, J EXP MED, V208, P1041, DOI 10.1084/jem.20100508; Sarfati J, 2006, DIAGN MICR INFEC DIS, V55, P279, DOI 10.1016/j.diagmicrobio.2006.02.002; Stuehler C, 2011, BLOOD, V117, P5881, DOI 10.1182/blood-2010-12-325084	23	49	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74326	10.1371/journal.pone.0074326	http://dx.doi.org/10.1371/journal.pone.0074326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023936	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600135
J	Soler, MA; Faisca, PFN				Soler, Miguel A.; Faisca, Patricia F. N.			Effects of Knots on Protein Folding Properties	PLOS ONE			English	Article							NONNATIVE INTERACTIONS; LANDSCAPE; PATHWAYS; STATE	This work explores the impact of knots, knot depth and motif of the threading terminus in protein folding properties (kinetics, thermodynamics and mechanism) via extensive Monte Carlo simulations of lattice models. A knotted backbone has no effect on protein thermodynamic stability but it may affect key aspects of folding kinetics. In this regard, we found clear evidence for a functional advantage of knots: knots enhance kinetic stability because a knotted protein unfolds at a distinctively slower rate than its unknotted counterpart. However, an increase in knot deepness does not necessarily lead to more effective changes in folding properties. In this regard, a terminus with a non-trivial conformation (e. g. hairpin) can have a more dramatic effect in enhancing kinetic stability than knot depth. Nevertheless, our results suggest that the probability of the denatured ensemble to keep knotted is higher for proteins with deeper knots, indicating that knot depth plays a role in determining the topology of the denatured state. Refolding simulations starting from denatured knotted conformations show that not every knot is able to nucleate folding and further indicate that the formation of the knotting loop is a key event in the folding of knotted trefoils. They also show that there are specific native contacts within the knotted core that are crucial to keep a native knotting loop in denatured conformations which otherwise have no detectable structure. The study of the knotting mechanism reveals that the threading of the knotting loop generally occurs towards late folding in conformations that exhibit a significant degree of structural consolidation.	[Soler, Miguel A.; Faisca, Patricia F. N.] Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal; [Soler, Miguel A.; Faisca, Patricia F. N.] Univ Lisbon, Dept Fis, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Faisca, PFN (corresponding author), Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal.	patricia.fn.faisca@gmail.com	SOLER, MIGUEL/J-2389-2013; Faisca, Patricia/E-9758-2010	SOLER, MIGUEL/0000-0002-5780-9949; Faisca, Patricia/0000-0002-2493-2748	Fundacao para a Ciencia e a Tecnologia [PTDC/QUI-QUI/112358/2009]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	PFNF & MAS thank the Fundacao para a Ciencia e a Tecnologia for financial support through grant PTDC/QUI-QUI/112358/2009 (to PFNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Alam MT, 2002, FEBS LETT, V519, P35, DOI 10.1016/S0014-5793(02)02693-5; Andersson FI, 2009, FEBS J, V276, P2625, DOI 10.1111/j.1742-4658.2009.06990.x; Bhattacherjee A, 2012, BIOPHYS J, V102, P569, DOI 10.1016/j.bpj.2011.12.008; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Faisca PFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035599; Faisca PFN, 2010, PROTEIN SCI, V19, P2196, DOI 10.1002/pro.498; Faisca PFN, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016009; Faisca PFN, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/37/373102; Faisca PFN, 2005, BIOPHYS CHEM, V115, P169, DOI 10.1016/j.bpc.2004.12.022; Faisca PFN, 2002, J CHEM PHYS, V116, P7231, DOI 10.1063/1.1466833; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Gin BC, 2009, J MOL BIOL, V392, P1303, DOI 10.1016/j.jmb.2009.06.058; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Krobath H, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/016002; Kwiecinska JI, 2005, J PHYS-CONDENS MAT, V17, pS1565, DOI 10.1088/0953-8984/17/18/013; Lai YL, 2012, NUCLEIC ACIDS RES, V40, pW228, DOI 10.1093/nar/gks592; Li L, 2000, NAT STRUCT BIOL, V7, P336; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Li MS, 2002, J PHYS CHEM B, V106, P8302, DOI 10.1021/jp025837q; Li YW, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012706; Mallam AL, 2008, MOL CELL, V30, P642, DOI 10.1016/j.molcel.2008.03.019; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mallam AL, 2009, FEBS J, V276, P365, DOI 10.1111/j.1742-4658.2008.06801.x; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; QUAKE SR, 1995, PHYS REV E, V52, P1176, DOI 10.1103/PhysRevE.52.1176; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Sayre TC, 2011, PROTEIN ENG DES SEL, V24, P627, DOI 10.1093/protein/gzr024; Skrbic T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002504; Soler MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052343; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Yeates T, 2007, CURR OPIN CHEM BIOL, V11, P595, DOI 10.1016/j.cbpa.2007.10.002	49	35	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74755	10.1371/journal.pone.0074755	http://dx.doi.org/10.1371/journal.pone.0074755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023962	gold, Green Published, Green Submitted			2022-12-25	WOS:000324515600156
J	Sana, B; Johnson, E; Le Magueres, P; Criswell, A; Cascio, D; Lim, S				Sana, Barindra; Johnson, Eric; Le Magueres, Pierre; Criswell, Angela; Cascio, Duilio; Lim, Sierin			The Role of Nonconserved Residues of Archaeoglobus fulgidus Ferritin on Its Unique Structure and Biophysical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Enzyme Kinetics; Ferritin; Mutant; Protein Engineering; Archaeoglobus fulgidus; Protein Nanocage	HYPERTHERMOPHILIC ARCHAEON; PROTEIN NANOCAGES; H-CHAIN; IRON; PORES; MECHANISM; CHANNELS; SYSTEM; SITE	Background:Archaeoglobus fulgidus ferritin (AfFtn) assembles with unique tetrahedral symmetry and four large pores. Results: The AfFtn K150A/R151A double mutant forms a closed octahedral assembly with reduced iron release rates relative to the tetrahedral assembly. Conclusion: The K150A/R151A substitution alters the symmetry type of the ferritin cage. Significance: The AfFtn can be modulated for tuning molecular release from the cavity. Archaeoglobus fulgidus ferritin (AfFtn) is the only tetracosameric ferritin known to form a tetrahedral cage, a structure that remains unique in structural biology. As a result of the tetrahedral (2-3) symmetry, four openings (approximate to 45 in diameter) are formed in the cage. This open tetrahedral assembly contradicts the paradigm of a typical ferritin cage: a closed assembly having octahedral (4-3-2) symmetry. To investigate the molecular mechanism affecting this atypical assembly, amino acid residues Lys-150 and Arg-151 were replaced by alanine. The data presented here shed light on the role that these residues play in shaping the unique structural features and biophysical properties of the AfFtn. The x-ray crystal structure of the K150A/R151A mutant, solved at 2.1 resolution, indicates that replacement of these key residues flips a symmetry switch. The engineered molecule no longer assembles with tetrahedral symmetry but forms a typical closed octahedral ferritin cage. Small angle x-ray scattering reveals that the overall shape and size of AfFtn and AfFtn-AA in solution are consistent with those observed in their respective crystal structures. Iron binding and release kinetics of the AfFtn and AfFtn-AA were investigated to assess the contribution of cage openings to the kinetics of iron oxidation, mineralization, or reductive iron release. Identical iron binding kinetics for AfFtn and AfFtn-AA suggest that Fe2+ ions do not utilize the triangular pores for access to the catalytic site. In contrast, relatively slow reductive iron release was observed for the closed AfFtn-AA, demonstrating involvement of the large pores in the pathway for iron release.	[Sana, Barindra; Lim, Sierin] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 637457, Singapore; [Johnson, Eric] CALTECH, Div Chem & Chem Engn, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Le Magueres, Pierre; Criswell, Angela] Rigaku Amer, The Woodlands, TX 77381 USA; [Cascio, Duilio] UCLA DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; California Institute of Technology; Howard Hughes Medical Institute; Rigaku Corporation; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Cascio, D (corresponding author), UCLA DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA.	cascio@mbi.ucla.edu; slim@ntu.sg	Lim, Sierin/G-6109-2010	Lim, Sierin/0000-0001-7455-6771; Johnson, Eric/0000-0002-2909-865X	DOE [DE-FC02-02ER63421]; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103403-10]; Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Imke Schroeder (UCLA) and Prof. Wilfred R. Hagen (Delft University of Technology) for the generous gifts of AfFtn, AfFtn-AA, and PfFtn plasmids, respectively. We thank M. Sawaya and the UCLA-DOE X-ray Crystallography Core Facility, which is supported by DOE Grant DE-FC02-02ER63421. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy (Northeastern Collaborative Access Team Beamline 24-ID at Advanced Photon Source, which is supported by National Center for Research Resources Grant 5P41RR015301-10 and National Institute of General Medical Sciences Grant 8 P41 GM103403-10 from the National Institutes of Health). Use of the Advanced Photon Source is supported by the Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPHICS S; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; BONOMI F, 1986, EUR J BIOCHEM, V155, P295, DOI 10.1111/j.1432-1033.1986.tb09489.x; Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matias PM, 2005, ACTA CRYSTALLOGR F, V61, P503, DOI 10.1107/S1744309105011516; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Swift J, 2009, LANGMUIR, V25, P5219, DOI 10.1021/la8040743; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Tosha T, 2012, J BIOL CHEM, V287, P13016, DOI 10.1074/jbc.M111.332734; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; WESSON L, 1992, PROTEIN SCI, V1, P227	37	33	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32663	32672		10.1074/jbc.M113.491191	http://dx.doi.org/10.1074/jbc.M113.491191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24030827	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000328681700051
J	Schweiger, R; Soll, J; Jung, K; Heermann, R; Schwenkert, S				Schweiger, Regina; Soll, Juergen; Jung, Kirsten; Heermann, Ralf; Schwenkert, Serena			Quantification of Interaction Strengths between Chaperones and Tetratricopeptide Repeat Domain-containing Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Chloroplast; Endoplasmic Reticulum(ER); Mitochondria; Surface Plasmon Resonance (SPR); Interaction Map Analysis; Microscale Thermophoresis	OUTER-MEMBRANE; SIGNAL PEPTIDES; TPR DOMAIN; MITOCHONDRIAL; IMPORT; HSP90; RECEPTOR; TRANSLOCATION; COMPLEX; RECOGNITION	The three tetratricopeptide repeat domain-containing docking proteins Toc64, OM64, and AtTPR7 reside in the chloroplast, mitochondrion, and endoplasmic reticulum of Arabidopsis thaliana, respectively. They are suggested to act during post-translational protein import by association with chaperone-bound preprotein complexes. Here, we performed a detailed biochemical, biophysical, and computational analysis of the interaction between Toc64, OM64, and AtTPR7 and the five cytosolic chaperones HSP70.1, HSP90.1, HSP90.2, HSP90.3, and HSP90.4. We used surface plasmon resonance spectroscopy in combination with Interaction Map (R) analysis to distinguish between chaperone oligomerization and docking protein-chaperone interactions and to calculate binding affinities for all tested interactions. Complementary to this, we applied pulldown assays as well as microscale thermophoresis as surface immobilization independent techniques. The data revealed that OM64 prefers HSP70 over HSP90, whereas Toc64 binds all chaperones with comparable affinities. We could further show that AtTPR7 is able to bind HSP90 in addition to HSP70. Moreover, differences between the HSP90 isoforms were detected and revealed a weaker binding for HSP90.1 to AtTPR7 and OM64, showing that slight differences in the amino acid composition or structure of the chaperones influence binding to the tetratricopeptide repeat domain. The combinatory approach of several methods provided a powerful toolkit to determine binding affinities of similar interaction partners in a highly quantitative manner.	[Schweiger, Regina; Soll, Juergen; Jung, Kirsten; Heermann, Ralf; Schwenkert, Serena] Univ Munich, Munich Ctr Integrated Prot Sci, Dept Biol 1, D-82152 Planegg Martinsried, Germany	University of Munich	Heermann, R (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, Dept Biol 1, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	heermann@lmu.de; serena.schwenkert@lmu.de	Heermann, Ralf/CAF-8609-2022; Schwenkert, Serena/F-8564-2012; Heermann, Ralf/E-1793-2013	Heermann, Ralf/0000-0003-0631-6156	Deutsche Forschungsgemeinschaft [SFB 1035]; Fonds der Chemischen Industrie [Do 187/22];  [Exc114/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); 	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 1035, Project A04 (to J. S. and S. S.), Fonds der Chemischen Industrie Grant Do 187/22 (to R. S.), and the Exc114/1.	Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Barta P, 2011, NUCL MED COMMUN, V32, P863, DOI 10.1097/MNM.0b013e3283483e1c; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Carrie C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-249; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Faou P, 2012, BBA-MOL CELL RES, V1823, P348, DOI 10.1016/j.bbamcr.2011.12.001; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Fellerer C, 2011, MOL PLANT, V4, P1133, DOI 10.1093/mp/ssr037; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Kriechbaumer V, 2011, BIOPHYS J, V101, P504, DOI 10.1016/j.bpj.2011.06.011; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Lamberti G, 2011, PLANT PHYSIOL, V157, P70, DOI 10.1104/pp.111.182774; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Qbadou S, 2007, J MOL BIOL, V367, P1330, DOI 10.1016/j.jmb.2007.01.047; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schweiger R, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25286; Schweiger R, 2012, J CELL SCI, V125, P5196, DOI 10.1242/jcs.111054; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Sohrt K, 2000, J CELL BIOL, V148, P1213, DOI 10.1083/jcb.148.6.1213; Sommer M, 2013, PLANT CELL ENVIRON, V36, P970, DOI 10.1111/pce.12030; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; von Loeffelholz O, 2011, BIOCHEM J, V438, P143, DOI 10.1042/BJ20110448; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	37	27	31	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30614	30625		10.1074/jbc.M113.493015	http://dx.doi.org/10.1074/jbc.M113.493015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24036116	Green Published, hybrid			2022-12-25	WOS:000329868100062
J	Roehlecke, C; Schumann, U; Ader, M; Brunssen, C; Bramke, S; Morawietz, H; Funk, RHW				Roehlecke, Cora; Schumann, Ulrike; Ader, Marius; Brunssen, Coy; Bramke, Silvia; Morawietz, Henning; Funk, Richard H. W.			Stress Reaction in Outer Segments of Photoreceptors after Blue Light Irradiation	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; MITOCHONDRIAL-DNA DAMAGE; RETINAL EXPLANT SYSTEM; MACULAR DEGENERATION; OXIDATIVE STRESS; RETINITIS-PIGMENTOSA; OXYGEN; DEATH; ROD; APOPTOSIS	The retina is prone to oxidative stress from many factors which are also involved in the pathogenesis of degenerative diseases. In this study, we used the application of blue light as a physiological stress factor. The aim of this study was to identify the major source of intracellular ROS that mediates blue light-induced detrimental effects on cells which may lead to cytotoxicity. We hypothesized that outer segments are the major source of blue light induced ROS generation. In photoreceptors, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) enzymes and the recently found respiratory chain complexes may represent a major source for reactive oxygen species (ROS), beside mitochondria and chromophores. Therefore, we investigated this hypothesis and analysed the exact localization of the ROS source in photoreceptors in an organotypic culture system for mouse retinas. Whole eyeball cultures were irradiated with visible blue light (405 nm) with an output power of 1 mW/cm(2). Blue light impingement lead to an increase of ROS production (detected by H(2)DCFDA in live retinal explants), which was particularly strong in the photoreceptor outer segments. Nox-2 and Nox-4 proteins are sources of ROS in blue light irradiated photoreceptors; the Nox inhibitor apocynin decreased ROS stimulated by blue light. Concomitantly, enzyme SOD-1, a member of the antioxidant defense system, indicator molecules of protein oxidation (CML) and lipid oxidation (MDA and 4-HNE) were also increased in the outer segments. Interestingly, outer segments showed a mitochondrial-like membrane potential which was demonstrated using two dyes (JC-1 and TMRE) normally exclusively associated with mitochondria. As in mitochondria, these dyes indicated a decrease of the membrane potential in hypoxic states or cell stress situations. The present study demonstrates that ROS generation and oxidative stress occurs directly in the outer segments of photoreceptors after blue light irradiation.	[Roehlecke, Cora; Schumann, Ulrike; Bramke, Silvia; Funk, Richard H. W.] Tech Univ Dresden, Inst Anat, D-01062 Dresden, Germany; [Ader, Marius; Morawietz, Henning; Funk, Richard H. W.] Ctr Biotechnol, DFG Cluster Excellence, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Brunssen, Coy; Morawietz, Henning] Tech Univ Dresden, Dept Med 3, Div Vasc Endothelium & Microcirculat, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Roehlecke, C (corresponding author), Tech Univ Dresden, Inst Anat, D-01062 Dresden, Germany.	cora.roehlecke@tu-dresden.de	Ader, Marius/E-7535-2010	Ader, Marius/0000-0001-9467-7677; Schumann, Ulrike/0000-0003-3406-4849				ALDER VA, 1990, INVEST OPHTH VIS SCI, V31, P1029; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bhatt L, 2010, MOL VIS, V16, P283; Bianchini P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982528; Burns ME, 2006, J NEUROSCI, V26, P1036, DOI 10.1523/JNEUROSCI.3301-05.2006; Demontis GC, 2002, INVEST OPHTH VIS SCI, V43, P2421; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Engelmann K, 2009, KLIN MONATSBL AUGENH, V226, P829, DOI 10.1055/s-0028-1109529; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; ISOGAI Y, 1995, J BIOL CHEM, V270, P7853, DOI 10.1074/jbc.270.14.7853; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039739; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Muller G, 2009, ANTIOXID REDOX SIGN, V11, P1711, DOI 10.1089/ARS.2008.2403; Nack M, 2012, FEBS LETT, V586, P1344, DOI 10.1016/j.febslet.2012.03.047; Nuydens R, 1999, J NEUROSCI METH, V92, P153, DOI 10.1016/S0165-0270(99)00107-7; Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x; Panfoli I, 2012, MED HYPOTHESES, V78, P423, DOI 10.1016/j.mehy.2011.12.012; Panfoli I, 2008, J PROTEOME RES, V7, P2654, DOI 10.1021/pr7006939; Panfoli I, 2009, INT J BIOCHEM CELL B, V41, P2555, DOI 10.1016/j.biocel.2009.08.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Roehlecke C, 2011, MOL VIS, V17, P876; Roehlecke C, 2009, MOL VIS, V15, P1929; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Stefansson E, 2006, SURV OPHTHALMOL, V51, P364, DOI 10.1016/j.survophthal.2006.04.005; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; UHL R, 1989, J PHOTOCH PHOTOBIO B, V3, P549, DOI 10.1016/1011-1344(89)80079-X; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285; Wolin Michael S, 2013, Biochem J, V452, pe1, DOI 10.1042/BJ20130484; Wood JPM, 2008, MOL VIS, V14, P334; Wu JM, 2006, SURV OPHTHALMOL, V51, P461, DOI 10.1016/j.survophthal.2006.06.009; Yang JH, 2003, INVEST OPHTH VIS SCI, V44, P1312, DOI 10.1167/iovs.02-0768	45	67	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e71570	10.1371/journal.pone.0071570	http://dx.doi.org/10.1371/journal.pone.0071570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039718	Green Published, gold			2022-12-25	WOS:000326734500006
J	Delatorre, E; Bello, G				Delatorre, Edson; Bello, Gonzalo			Phylodynamics of the HIV-1 Epidemic in Cuba	PLOS ONE			English	Article							CIRCULATING RECOMBINANT FORMS; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; ANTIRETROVIRAL DRUGS; POPULATION-DYNAMICS; MAXIMUM-LIKELIHOOD; HIV/AIDS EPIDEMIC; SUBTYPE-B; TYPE-1	Previous studies have shown that the HIV-1 epidemic in Cuba displayed a complex molecular epidemiologic profile with circulation of several subtypes and circulating recombinant forms (CRF); but the evolutionary and population history of those viral variants remains unknown. HIV-1 pol sequences of the most prevalent Cuban lineages (subtypes B, C and G, CRF18_cpx, CRF19_cpx, and CRFs20/23/24_BG) isolated between 1999 and 2011 were analyzed. Maximum-likelihood analyses revealed multiple introductions of subtype B (n >= 66), subtype C (n >= 10), subtype G (n >= 8) and CRF18_cpx (n >= 2) viruses in Cuba. The bulk of HIV-1 infections in this country, however, was caused by dissemination of a few founder strains probably introduced from North America/Europe (clades BCU-I and BCU-II), east Africa (clade CCU-I) and central Africa (clades G(CU), CRF18(CU) and CRF19(CU)), or locally generated (clades CRFs20/23/24_BG). Bayesian-coalescent analyses show that the major HIV-1 founder strains were introduced into Cuba during 1985-1995; whereas the CRFs_BG strains emerged in the second half of the 1990s. Most HIV-1 Cuban clades appear to have experienced an initial period of fast exponential spread during the 1990s and early 2000s, followed by a more recent decline in growth rate. The median initial growth rate of HIV-1 Cuban clades ranged from 0.4 year(-1) to 1.6 year(-1). Thus, the HIV-1 epidemic in Cuba has been a result of the successful introduction of a few viral strains that began to circulate at a rather late time of the AIDS pandemic, but then were rapidly disseminated through local transmission networks.	[Delatorre, Edson; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Bentancor, Gonzalo Jose Bello/N-7377-2019; Delatorre, Edson/J-8330-2015; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Delatorre, Edson/0000-0002-5746-0820; 	Public Health Service from the FAPERJ [E-26/111.758/2012]; CNPq [472896/2012-1]	Public Health Service from the FAPERJ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Public Health Service grants E-26/111.758/2012 from the FAPERJ and 472896/2012-1 from the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; Anderson T, 2009, REV PANAM SALUD PUBL, V26, P78, DOI 10.1590/S1020-49892009000700012; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bello G, 2009, AIDS RES HUM RETROV, V25, P1065, DOI 10.1089/aid.2009.0106; Carr JK, 2001, VIROLOGY, V286, P168, DOI 10.1006/viro.2001.0976; Casado G, 2005, JAIDS-J ACQ IMM DEF, V40, P532, DOI 10.1097/01.qai.0000186363.27587.c0; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; de Arazoza H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-130; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delatorre E, 2013, AIDS; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Figueras MA, 2001, LAT AM STUD ASS LASA; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hansen H, 2001, Med Anthropol, V19, P259; Hsieh YH, 2001, AIDS, V15, P426, DOI 10.1097/00002030-200102160-00023; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; Kalish ML, 2004, EMERG INFECT DIS, V10, P1227; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Machado LY, 2013, AIDS RES HUM RETROV, V29, P411, DOI [10.1089/AID.2012.0183, 10.1089/aid.2012.0183]; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Marechal V, 2006, AIDS RES HUM RETROV, V22, P1036, DOI 10.1089/aid.2006.22.1036; Niama FR, 2006, INFECT GENET EVOL; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; PEREZSTABLE EJ, 1991, AM J PUBLIC HEALTH, V81, P563, DOI 10.2105/AJPH.81.5.563; Pircher M, 2012, AIDS RES HUM RETROV, V28, P1798, DOI [10.1089/aid.2012.0083, 10.1089/AID.2012.0083]; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell R, 2010, VIRUSES-BASEL, V2, P639, DOI 10.3390/v2020639; Rambaut A, 2014, TRACER V1 6; Rambaut A, 2009, FIGTREE V1 4 0 TREE; Ray SC, 1999, SIMPLOT V2 5 0; Ristic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017485; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sierra M, 2007, JAIDS-J ACQ IMM DEF, V45, P151, DOI 10.1097/QAI.0b013e318046ea47; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d; Thomson MM, 2005, AIDS REV, V7, P210; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1; UNAIDS, 2012, COUNTR PROGR REP; UNAIDS, 2013, AIDS INFO DATABASE; Vergne L, 2003, VIROLOGY, V310, P254, DOI 10.1016/S0042-6822(03)00167-3; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	59	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72448	10.1371/journal.pone.0072448	http://dx.doi.org/10.1371/journal.pone.0072448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039765	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300011
J	Duan, L; Chen, BY; Sun, XL; Luo, ZJ; Rao, ZR; Wang, JJ; Chen, LW				Duan, Li; Chen, Bei-Yu; Sun, Xiao-Long; Luo, Zhuo-Jing; Rao, Zhi-Ren; Wang, Jing-Jie; Chen, Liang-Wei			LPS-Induced proNGF Synthesis and Release in the N9 and BV2 Microglial Cells: A New Pathway Underling Microglial Toxicity in Neuroinflammation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MOUSE MODEL; PARKINSONS-DISEASE; NGF MATURATION; SPINAL-CORD; SORTILIN	Purpose: While aberrant activation of microglial cells was evidently involved in neuroinflammation and neurotoxicity in the neurodegenerative diseases such as Alzheimer's and Parkinson's disease, objective of study was to address if activated microglias deliver their effect by releasing pro-neurotrophins. Materials and methods: By in vitro culture of N9 and BV2 cell lines and lipopolysaccharide (LPS) stimulation model, generation and release of proNGF, proBDNF and MMP-9 was studied in the activated microglial cells by immunocytochemistry, western blotting and bioassay methods. Results: Activation of microglial cells was observed with obvious increasing iba1-immunoreactivity following LPS stimulation in cell culture. Synthesis and up-regulation of proNGF protein significantly occurred in N9 and BV2 cells 12h-48h after LPS exposure, whereas no significant changes of proBDNF and MMP9 were observed in these microglial cell lines with LPS insult. More interestingly, extracellular release or secretion of proNGF molecule was also detected in culture medium of N9 cells after LPS stimulation. Finally, bioassay using MTT, Hoechst/PI and TUNEL staining in SH-SY5Y cells further confirmed that proNGF treatment could result in apoptotic cell death but it did not significantly influence cell viability of SH-SY5Y cells. Conclusions: This in vitro study revealed LPS-stimulated proNGF synthesis and release in activated N9/BV2 microglial cell lines, also suggesting that proNGF may appeal a new pathway or possible mechanism underlying microglial toxicity in the neuroinflammation and a potential target for therapeutic manipulation of the neurodegenerative diseases.	[Duan, Li; Sun, Xiao-Long; Rao, Zhi-Ren; Chen, Liang-Wei] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; [Chen, Bei-Yu; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China; [Sun, Xiao-Long] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Wang, Jing-Jie] Fourth Mil Med Univ, Dept Gastroenterol, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, JJ (corresponding author), Fourth Mil Med Univ, Dept Gastroenterol, Tangdu Hosp, Xian 710032, Peoples R China.	jjwang@fmmu.edu.cn; lwchen@fmmu.edu.cn			Basic Research Program of China [2011CB504103, 2012CB525002]; National Natural Science Foundation of China [81071609, 81272346, 30970862]	Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by Basic Research Program of China (2011CB504103, 2012CB525002) and National Natural Science Foundation of China (81071609, 81272346, 30970862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2007, ANN NY ACAD SCI, V1119, P208, DOI 10.1196/annals.1404.024; Ali TK, 2011, DIABETOLOGIA, V54, P657, DOI 10.1007/s00125-010-1935-1; Armugam A, 2012, NEUROCHEM INT, V60, P852, DOI 10.1016/j.neuint.2012.03.006; Arnett MG, 2007, BRAIN RES, V1183, P32, DOI 10.1016/j.brainres.2007.09.051; BIEDLER JL, 1973, CANCER RES, V33, P2643; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P1309, DOI 10.1097/NEN.0b013e3181c22569; Capsoni S, 2011, CNS NEUROL DISORD-DR, V10, P635, DOI 10.2174/187152711796235032; Chen LW, 2008, CNS NEUROL DISORD-DR, V7, P512, DOI 10.2174/187152708787122923; Cuello AC, 2007, NEUROCHEM RES, V32, P1041, DOI 10.1007/s11064-006-9270-0; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Di Maria E, 2012, J ALZHEIMERS DIS, V29, P699, DOI 10.3233/JAD-2012-112006; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fang LB, 2010, J NEUROL SCI, V294, P51, DOI 10.1016/j.jns.2010.04.005; Ferretti MT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-62; Girard S, 2010, J NEUROPATH EXP NEUR, V69, P1116, DOI 10.1097/NEN.0b013e3181f971e4; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Le AP, 2012, J NEUROSCI, V32, P703, DOI 10.1523/JNEUROSCI.4128-11.2012; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; Nakayama K, 2013, J BIOL CHEM; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Rogers ML, 2010, J NEUROIMMUNOL, V226, P93, DOI 10.1016/j.jneuroim.2010.05.040; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Shin SM, 2010, NEUROCHEM RES, V35, P976, DOI 10.1007/s11064-010-0141-3; Sobottka B, 2008, J NEUROCHEM, V107, P1294, DOI 10.1111/j.1471-4159.2008.05690.x; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Stoica G, 2008, BRAIN RES, V1208, P204, DOI 10.1016/j.brainres.2008.02.085; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tiveron C, 2013, CELL DEATH DIFFER, V20; Turner BJ, 2004, J NEUROSCI RES, V78, P193, DOI 10.1002/jnr.20256; Urban D, 2013, J BIOCHEM, V153, P197, DOI 10.1093/jb/mvs137; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Wang YJ, 2010, NEUROTOX RES, V17, P257, DOI 10.1007/s12640-009-9098-x; Xiao QZ, 2013, CIRC RES, V112, P35, DOI 10.1161/CIRCRESAHA.112.274019; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	45	26	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73768	10.1371/journal.pone.0073768	http://dx.doi.org/10.1371/journal.pone.0073768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040063	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300126
J	Filkor, K; Hegedus, Z; Szasz, A; Tubak, V; Kemeny, L; Kondorosi, E; Nagy, I				Filkor, Kata; Hegedues, Zoltan; Szasz, Andras; Tubak, Vilmos; Kemeny, Lajos; Kondorosi, Eva; Nagy, Istvan			Genome Wide Transcriptome Analysis of Dendritic Cells Identifies Genes with Altered Expression in Psoriasis	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTOXIN TOLERANCE; NEGATIVE REGULATION; TAM RECEPTORS; SKIN; INDUCTION; INNATE; KERATINOCYTES; INFLAMMATION; MACROPHAGES	Activation of dendritic cells by different pathogens induces the secretion of proinflammatory mediators resulting in local inflammation. Importantly, innate immunity must be properly controlled, as its continuous activation leads to the development of chronic inflammatory diseases such as psoriasis. Lipopolysaccharide (LPS) or peptidoglycan (PGN) induced tolerance, a phenomenon of transient unresponsiveness of cells to repeated or prolonged stimulation, proved valuable model for the study of chronic inflammation. Thus, the aim of this study was the identification of the transcriptional diversity of primary human immature dendritic cells (iDCs) upon PGN induced tolerance. Using SAGE-Seq approach, a tag-based transcriptome sequencing method, we investigated gene expression changes of primary human iDCs upon stimulation or restimulation with Staphylococcus aureus derived PGN, a widely used TLR2 ligand. Based on the expression pattern of the altered genes, we identified non-tolerizeable and tolerizeable genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (Kegg) analysis showed marked enrichment of immune-, cell cycle- and apoptosis related genes. In parallel to the marked induction of proinflammatory mediators, negative feedback regulators of innate immunity, such as TNFAIP3, TNFAIP8, Tyro3 and Mer are markedly downregulated in tolerant cells. We also demonstrate, that the expression pattern of TNFAIP3 and TNFAIP8 is altered in both lesional, and non-lesional skin of psoriatic patients. Finally, we show that pretreatment of immature dendritic cells with anti-TNF-alpha inhibits the expression of IL-6 and CCL1 in tolerant iDCs and partially releases the suppression of TNFAIP8. Our findings suggest that after PGN stimulation/restimulation the host cell utilizes different mechanisms in order to maintain critical balance between inflammation and tolerance. Importantly, the transcriptome sequencing of stimulated/restimulated iDCs identified numerous genes with altered expression to date not associated with role in chronic inflammation, underlying the relevance of our in vitro model for further characterization of IFN-primed iDCs.	[Filkor, Kata; Szasz, Andras; Kondorosi, Eva; Nagy, Istvan] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Hegedues, Zoltan] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Hegedues, Zoltan] Zenon Bio Ltd, Szeged, Hungary; [Tubak, Vilmos] Creat Lab Ltd, Szeged, Hungary; [Kemeny, Lajos] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary; [Kemeny, Lajos] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary; [Kemeny, Lajos] Univ Szeged, Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Hungarian Academy of Sciences; Szeged University	Nagy, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	nagyi@baygen.hu	Hegedus, Zoltan/D-1066-2013; Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501; Kondorosi, Eva/0000-0002-4065-8515	French-Hungarian Associated European Laboratory (LEA) SkinChroma [OMFB-00272/2009]; ERC Grant of the European Research Council [269067]	French-Hungarian Associated European Laboratory (LEA) SkinChroma(French National Research Agency (ANR)); ERC Grant of the European Research Council	Work in our laboratories has been supported by the French-Hungarian Associated European Laboratory (LEA) SkinChroma (grant number OMFB-00272/2009 to IN) and the ERC Grant of the European Research Council (grant number 269067 to EK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Belso N, 2008, J INVEST DERMATOL, V128, P634, DOI 10.1038/sj.jid.5701059; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen HX, 1998, J EXP MED, V188, P1657, DOI 10.1084/jem.188.9.1657; Chen M, 2010, IMMUNOL REV, V236, P11, DOI 10.1111/j.1600-065X.2010.00916.x; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foti M, 2006, J LEUKOCYTE BIOL, V79, P913, DOI 10.1189/jlb.1005547; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hueber AJ, 2007, IMMUNOL LETT, V114, P59, DOI 10.1016/j.imlet.2007.08.009; Jiang XB, 2012, CLIN VACCINE IMMUNOL, V19, P1938, DOI 10.1128/CVI.00500-12; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kim HO, 2012, CLIN EXP DERMATOL, V37, P521, DOI 10.1111/j.1365-2230.2011.04295.x; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Musacchio E, 2009, J RHEUMATOL, V36, P1575, DOI 10.3899/jrheum.081321; N'Diaye M, 2009, LIFE SCI, V84, P451, DOI 10.1016/j.lfs.2009.01.012; Nagy I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-122; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; SCHULZ BS, 1993, J IMMUNOL, V151, P4399; Siebert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022953; Sockolov ME, 2009, J DERMATOL TREAT, V20, P319, DOI 10.3109/09546630902936778; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Szasz A, 2013, J DERMATOL SCI, V71, P215, DOI 10.1016/j.jdermsci.2013.04.018; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Van Parijs L, 1998, SCIENCE, V280, P243; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Williams SCP, 2012, NAT MED, V18, P638, DOI 10.1038/nm0512-638; Woodward MJ, 2010, CELL DEATH DIFFER, V17, P316, DOI 10.1038/cdd.2009.125; Zhang GZ, 2010, MOL IMMUNOL, V47, P2435, DOI 10.1016/j.molimm.2010.06.016; Zhang L, 2011, MOL IMMUNOL, V48, P1209, DOI 10.1016/j.molimm.2011.03.001	50	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73435	10.1371/journal.pone.0073435	http://dx.doi.org/10.1371/journal.pone.0073435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039940	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300074
J	Niu, L; Ma, Y; Mannakkara, A; Zhao, Y; Ma, WH; Lei, CL; Chen, LZ				Niu, Lin; Ma, Yan; Mannakkara, Amani; Zhao, Yao; Ma, Weihua; Lei, Chaoliang; Chen, Lizhen			Impact of Single and Stacked Insect-Resistant Bt-Cotton on the Honey Bee and Silkworm	PLOS ONE			English	Article							APIS-MELLIFERA; BACILLUS-THURINGIENSIS; CORN POLLEN; TRANSGENIC CROPS; LEPIDOPTERA; TOXIN; IMMUNOCOMPETENCE; AGROECOSYSTEMS; HYMENOPTERA; ARTHROPODS	Transgenic insect-resistant cotton (Bt cotton) has been extensively planted in China, but its effects on non-targeted insect species such as the economically important honey bee (Apis mellifera) and silkworm (Bombyx mori) currently are unknown. In this study, pollen from two Bt cotton cultivars, one expressing Cry1Ac/EPSPS and the other expressing Cry1Ac/Cry2Ab, were used to evaluate the effects of Bt cotton on adult honey bees and silkworm larvae. Laboratory feeding studies showed no adverse effects on the survival, cumulative consumption, and total hemocyte count (THC) of A. mellifera fed with Bt pollen for 7 days. No effects on the survival or development of B. mori larvae were observed either. A marginally significant difference between Cry1Ac/Cry2Ab cotton and the conventional cotton on the THC of the 3(rd) day of 5(th) B. mori instar larvae was observed only at the two highest pollen densities (approximately 900 and 8000 grains/cm(2)), which are much higher than the pollen deposition that occurs under normal field conditions. The results of this study show that pollen of the tested Bt cotton varieties carried no lethal or sublethal risk for A. mellifera, and the risk for B. mori was negligible.	[Niu, Lin; Mannakkara, Amani; Zhao, Yao; Ma, Weihua; Lei, Chaoliang; Chen, Lizhen] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China; [Ma, Yan] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Henan, Peoples R China; [Mannakkara, Amani] Univ Ruhuna, Fac Agr, Dept Agr Biol, Kamburupitiya, Sri Lanka; [Niu, Lin; Chen, Lizhen] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; University Ruhuna; Huazhong Agricultural University	Lei, CL (corresponding author), Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China.	ioir@mail.hzau.edu.cn; lzchen@mail.hzau.edu.cn		Zhao, Yao/0000-0003-2199-0210; MA, WEIHUA/0000-0001-9521-2038; Ma, Yan/0000-0001-6897-5064	National Special Transgenic Project from the Chinese Ministry of Agriculture [2013ZX08011-002]	National Special Transgenic Project from the Chinese Ministry of Agriculture	This work was supported by the National Special Transgenic Project from the Chinese Ministry of Agriculture (grant No. 2013ZX08011-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; [Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Babendreier D, 2005, APIDOLOGIE, V36, P585, DOI 10.1051/apido:2005049; Babu RM, 2003, CROP PROT, V22, P1071, DOI 10.1016/S0261-2194(03)00142-X; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Chen LZ, 2011, J PEST SCI, V84, P9, DOI 10.1007/s10340-010-0319-0; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Dai PL, 2012, ECOTOX ENVIRON SAFE, V79, P232, DOI 10.1016/j.ecoenv.2012.01.005; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Dankocsik C, 2006, MOL MICROBIOL, V4, P2087; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Duan JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001415; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Hendriksma HP, 2012, APIDOLOGIE, V43, P549, DOI 10.1007/s13592-012-0123-3; Hendriksma HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028174; HOFTE H, 1989, MICROBIOL REV, V53, P242; James Clive, 2010, GM Crops, V1, P8, DOI 10.4161/gmcr.1.1.9756; Jesse LCH, 2000, OECOLOGIA, V125, P241, DOI 10.1007/s004420000502; Jesse LCH, 2003, AGR ECOSYST ENVIRON, V97, P225, DOI 10.1016/S0167-8809(03)00124-5; Kim Young Ho, 2008, Journal of Asia-Pacific Entomology, V11, P107, DOI 10.1016/j.aspen.2008.05.004; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Li WD, 2005, ENVIRON ENTOMOL, V34, P922, DOI 10.1603/0046-225X-34.4.922; [李文东 Li Wendong], 2002, [中国农业科学, Scientia Agricultura Sinica], V35, P1543; Li WenDong, 2003, Journal of Agricultural Biotechnology, V11, P488; Liu Baio, 2003, Acta Ecologica Sinica, V23, P946; Liu BA, 2009, ECOTOX ENVIRON SAFE, V72, P1163, DOI 10.1016/j.ecoenv.2009.02.002; Liu PengFei, 2011, Scientia Agricultura Sinica, V44, P5117; Liu XiJuan, 2007, Journal of Agricultural Biotechnology, V15, P958; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luo Jun-Yu, 2012, Chinese Journal of Applied Entomology, V49, P906; Malone LA, 2009, ENVIRONMENTAL IMPACT OF GENETICALLY MODIFIED CROPS, P199, DOI 10.1079/9781845934095.0199; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Schmid-Hempel R, 2002, FUNCTIONAL ECOLOGY, V12, P22; Shimizu M, 1972, HDB SILKWORM REARING, V1; Shinkawa A, 1999, CURR MICROBIOL, V39, P14, DOI 10.1007/PL00006820; Tu Zhen-Li, 1999, Journal of Sericultural Science of Japan, V68, P491; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Wolt JD, 2003, ENVIRON ENTOMOL, V32, P237, DOI 10.1603/0046-225X-32.2.237; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yao HW, 2006, APPL ENTOMOL ZOOL, V41, P339, DOI 10.1303/aez.2006.339; Zhang XingHua, 2012, Acta Agriculturae Jiangxi, V24, P12	56	29	33	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72988	10.1371/journal.pone.0072988	http://dx.doi.org/10.1371/journal.pone.0072988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039838	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300040
J	Ruhaak, LR; Koeleman, CAM; Uh, HW; Stam, JC; van Heemst, D; Maier, AB; Houwing-Duistermaat, JJ; Hensbergen, PJ; Slagboom, PE; Deelder, AM; Wuhrer, M				Ruhaak, L. Renee; Koeleman, Carolien A. M.; Uh, Hae-Won; Stam, Jord C.; van Heemst, Diana; Maier, Andrea B.; Houwing-Duistermaat, Jeanine J.; Hensbergen, Paul J.; Slagboom, P. Eline; Deelder, Andre M.; Wuhrer, Manfred			Targeted Biomarker Discovery by High Throughput Glycosylation Profiling of Human Plasma Alpha1-Antitrypsin and Immunoglobulin A	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; N-GLYCANS; STRUCTURAL-CHANGES; SAMPLE PREPARATION; OLIGOSACCHARIDES; PROTEIN; IGA1; ALPHA(1)-ANTITRYPSIN; GALACTOSYLATION; ERYTHROPOIETIN	Protein N-glycosylation patterns are known to show vast genetic as well as physiological and pathological variation and represent a large pool of potential biomarkers. Large-scale studies are needed for the identification and validation of biomarkers, and the analytical techniques required have recently been developed. Such methods have up to now mainly been applied to complex mixtures of glycoproteins in biofluids (e.g. plasma). Here, we analyzed N-glycosylation profiles of alpha1-antitrypsin (AAT) and immunoglobulin A (IgA) enriched fractions by 96-well microtitration plate based high-throughput immuno-affinity capturing and N-glycan analysis using multiplexed capillary gel electrophoresis with laser-induced fluorescence detection (CGE-LIF). Human plasma samples were from the Leiden Longevity Study comprising 2415 participants of different chronological and biological ages. Glycosylation patterns of AAT enriched fractions were found to be associated with chronological (calendar) age and they differed between females and males. Moreover, several glycans in the AAT enriched fraction were associated with physiological parameters marking cardiovascular and metabolic diseases. Pronounced differences were found between males and females in the glycosylation profiles of IgA enriched fractions. Our results demonstrate that large-scale immuno-affinity capturing of proteins from human plasma using a bead-based method combined with high-throughput N-glycan analysis is a powerful tool for the discovery of glycosylation-based biomarker candidates.	[Ruhaak, L. Renee; Koeleman, Carolien A. M.; Hensbergen, Paul J.; Deelder, Andre M.; Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands; [Uh, Hae-Won; Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Med Stat, Leiden, Netherlands; [Stam, Jord C.] Univ Utrecht, Dept Biol, Sect Biomol Imaging, Utrecht, Netherlands; [van Heemst, Diana; Maier, Andrea B.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Slagboom, P. Eline] Netherlands Consortium Hlth Aging, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ruhaak, LR (corresponding author), Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands.	lrruhaak@gmail.com	Maier, Andrea/W-7060-2019; Slagboom, P. Eline/R-4790-2016; Wuhrer, Manfred/ABE-9168-2020; Maier, Andrea B./Q-5548-2019; Houwing-Duistermaat, Jeanne/V-9048-2018; Ruhaak, Renee/AAE-7668-2019	Maier, Andrea/0000-0001-7206-1724; Slagboom, P. Eline/0000-0002-2875-4723; Wuhrer, Manfred/0000-0002-0814-4995; Ruhaak, Renee/0000-0003-3737-3807; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Uh, Hae-Won/0000-0003-4195-7872; Hensbergen, Paul/0000-0002-3193-5445	IOP (innovation oriented programs, The Netherlands) [IGE05007]; European Union (Seventh Framework Programme HighGlycan project, [278535]	IOP (innovation oriented programs, The Netherlands)(Netherlands Government); European Union (Seventh Framework Programme HighGlycan project,	This work was funded by IOP (innovation oriented programs, The Netherlands) grant IGE05007, and by the European Union (Seventh Framework Programme HighGlycan project, grant number: 278535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Deshpande N, 2010, J PROTEOME RES, V9, P1063, DOI 10.1021/pr900956x; Ferrarotti I., 2012, THORAX; FIELD MC, 1994, BIOCHEM J, V299, P261, DOI 10.1042/bj2990261; FUKUDA MN, 1989, BLOOD, V73, P84; Gomes MM, 2008, BIOCHEMISTRY-US, V47, P11285, DOI 10.1021/bi801185b; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Heijmans BT, 2006, PLOS MED, V3, P2317, DOI 10.1371/journal.pmed.0030495; Huhn C, 2012, J PROTEOMICS, V75, P1515, DOI 10.1016/j.jprot.2011.11.028; Janciauskiene SM, 2011, RESP MED, V105, P1129, DOI 10.1016/j.rmed.2011.02.002; Karnaukhova E, 2006, AMINO ACIDS, V30, P317, DOI 10.1007/s00726-005-0324-4; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Kolarich D, 2006, PROTEOMICS, V6, P3369, DOI 10.1002/pmic.200500751; Kronewitter SR, 2010, J PROTEOME RES, V9, P4952, DOI 10.1021/pr100202a; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Mills K, 2001, CLIN CHEM, V47, P2012; Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Poland DCW, 2001, GLYCOCONJUGATE J, V18, P261, DOI 10.1023/A:1012412908983; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Rozing MP, 2009, AGING-US, V1, P714, DOI 10.18632/aging.100071; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Ruhaak LR, 2008, ANAL CHEM, V80, P6119, DOI 10.1021/ac800630x; Ruhaak LR, 2011, J PROTEOME RES, V10, P1667, DOI 10.1021/pr1009959; Ruhaak LR, 2010, J PROTEOME RES, V9, P6655, DOI 10.1021/pr100802f; Ruhaak LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012566; Ruhaak LR, 2010, PROTEOMICS, V10, P2330, DOI 10.1002/pmic.200900804; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shikata K, 1998, GLYCOCONJUGATE J, V15, P683, DOI 10.1023/A:1006936431276; Skov T, 2006, J CHEMOMETR, V20, P484, DOI 10.1002/cem.1031; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Su DM, 2010, INT J HEMATOL, V91, P238, DOI 10.1007/s12185-010-0496-x; Takahashi K, 2011, J PROTEOME RES; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Takimori S, 2011, FEBS J, V278, P3769, DOI 10.1111/j.1742-4658.2011.08299.x; TORANO A, 1977, P NATL ACAD SCI USA, V74, P2301, DOI 10.1073/pnas.74.6.2301; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; VANZEBEN D, 1994, BRIT J RHEUMATOL, V33, P36; Wada Y, 2010, J PROTEOME RES, V9, P1367, DOI 10.1021/pr900913k; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Yamada E, 1997, GLYCOCONJUGATE J, V14, P401, DOI 10.1023/A:1018582930906; Yang ZP, 2004, J CHROMATOGR A, V1053, P79, DOI 10.1016/j.chroma.2004.08.150; Yoo EM, 2005, CLIN IMMUNOL, V116, P3, DOI 10.1016/j.clim.2005.03.010	57	40	40	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73082	10.1371/journal.pone.0073082	http://dx.doi.org/10.1371/journal.pone.0073082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039863	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300048
J	Artigao-Rodenas, LM; Carbayo-Herencia, JA; Divison-Garrote, JA; Gil-Guillen, VF; Masso-Orozco, J; Simarro-Rueda, M; Molina-Escribano, F; Sanchis, C; Carrion-Valero, L; de Coca, EL; Caldevilla, D; Lopez-Abril, J; Carratala-Munuera, C; Lopez-Pineda, A				Artigao-Rodenas, Luis M.; Carbayo-Herencia, Julio A.; Divison-Garrote, Juan A.; Gil-Guillen, Vicente F.; Masso-Orozco, Javier; Simarro-Rueda, Marta; Molina-Escribano, Francisca; Sanchis, Carlos; Carrion-Valero, Lucinio; Lopez de Coca, Enrique; Caldevilla, David; Lopez-Abril, Juan; Carratala-Munuera, Concepcion; Lopez-Pineda, Adriana		Grp Enfermedades Vasc Albacete	Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SECONDARY PREVENTION PROGRAMS; PREVALENCE; ADAPTATION; PROFILE	Background: The question about what risk function should be used in primary prevention remains unanswered. The Framingham Study proposed a new algorithm based on three key ideas: use of the four risk factors with the most weight (cholesterol, blood pressure, diabetes and smoking), prediction of overall cardiovascular diseases and incorporating the concept of vascular age. The objective of this study was to apply this new function in a cohort of the general non Anglo-Saxon population, with a 10-year follow-up to determine its validity. Methods: The cohort was studied in 1992-94 and again in 2004-06. The sample comprised 959 randomly-selected persons, aged 30-74 years, who were representative of the population of Albacete, Spain. At the first examination cycle, needed data for the new function were collected and at the second examination, data on all events were recorded during the follow-up period. Discrimination was studied with ROC curves. Comparisons of prediction models and reality in tertiles (Hosmer-Lemeshow) were performed, and the individual survival functions were calculated. Results: The mean risks for women and men, respectively, were 11.3% and 19.7% and the areas under the ROC curve were 0.789 (95% CI, 0.716-0.863) and 0.780 (95% CI, 0.713-0.847) (P<0.001, both). Cardiovascular disease events occurred in the top risk tertiles. Of note were the negative predictive values in both sexes, and a good specificity in women (85.6%) and sensitivity in men (79.1%) when their risk for cardiovascular disease was high. This model overestimates the risk in older women and in middle-aged men. The cumulative probability of individual survival by tertiles was significant in both sexes (P<0.001). Conclusions: The results support the proposal for "reclassification" of Framingham. This study, with a few exceptions, passed the test of discrimination and calibration in a random sample of the general population from southern Europe.	[Artigao-Rodenas, Luis M.; Lopez-Abril, Juan] Zone 3 Primary Hlth Care Ctr, Albacete, Spain; [Carbayo-Herencia, Julio A.] Acad Gen Aire, Murcia, Spain; [Carbayo-Herencia, Julio A.] Univ Castilla La Mancha, Sch Med, Albacete, Spain; [Divison-Garrote, Juan A.; Carrion-Valero, Lucinio] Zone 2 Primary Hlth Care Ctr, Albacete, Spain; [Gil-Guillen, Vicente F.; Carratala-Munuera, Concepcion; Lopez-Pineda, Adriana] Univ Miguel Hernandez, Chair Family, Dept Clin Med, Alacant, Spain; [Gil-Guillen, Vicente F.] Elda Hosp, Res Unit, Elda, Spain; [Masso-Orozco, Javier] Casas de Juan Nunez Primary Hlth Care Ctr, Albacete, Spain; [Simarro-Rueda, Marta] Zone 4 Primary Hlth Care Ctr, Albacete, Spain; [Molina-Escribano, Francisca] Casas Ibanez Primary Hlth Care Ctr, Albacete, Spain; [Sanchis, Carlos] Primary Hlth Care Ctr, Valencia, Spain; [Lopez de Coca, Enrique] Primary Hlth Care Ctr, Albacete, Spain; [Caldevilla, David] Univ Hospitalary Complex, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad Miguel Hernandez de Elche	Gil-Guillen, VF (corresponding author), Univ Miguel Hernandez, Chair Family, Dept Clin Med, Alacant, Spain.	vte.gil@gmail.com	Carratala-Munuera, Concepcion/ABH-1205-2020; Guillén, Vicente Francisco Gil/AAE-8201-2019	Carratala-Munuera, Concepcion/0000-0002-1303-6294; Molina-Escribano, Francisca/0000-0003-2865-6768; Lopez-Pineda, Adriana/0000-0002-2117-0178; Gil-Guillen, Vicente F/0000-0003-3793-9786; DIVISON GARROTE, JUAN ANTONIO/0000-0001-9947-8423; Carbayo-Herencia, Julio Antonio/0000-0001-7818-7176	Junta de Comunidades Castilla-La Mancha, Consejeria de Sanidad, Spain; FISCAM Project of Junta de Comunidades de Castilla-La Mancha, Spain [03069-00]	Junta de Comunidades Castilla-La Mancha, Consejeria de Sanidad, Spain; FISCAM Project of Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This study was supported by two grants from Junta de Comunidades Castilla-La Mancha, Consejeria de Sanidad, Spain (Orden 3 July 1992 del DOCM and Orden 14 September 1993 del DOCM), and funding from FISCAM Project 2003-2006 (03069-00) of Junta de Comunidades de Castilla-La Mancha, Spain (ALM, MD PhD, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Aranceta J, 2004, MED CLIN-BARCELONA, V123, P686, DOI 10.1016/S0025-7753(04)75331-2; ARTIGAO M, 1991, ATENCION PACIENTE VA, P53; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Banegas JR, 2003, EUR J CLIN NUTR, V57, pS18, DOI 10.1038/sj.ejcn.1601804; BANEGAS JR, 2006, REV ESP CARDIOL S, V6, pC4, DOI DOI 10.1157/13092028; Berry JD, 2009, CIRCULATION, V119, P382, DOI 10.1161/CIRCULATIONAHA.108.800235; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Divison J A, 1998, Aten Primaria, V21, P205; Essink-Bot ML, 2007, EUR J PUBLIC HEALTH, V17, P314, DOI 10.1093/eurpub/ckl238; Fuster V, 2002, REV ESP CARDIOL, V55, P327, DOI 10.1016/S0300-8932(02)76609-8; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marma AK, 2009, CIRCULATION, V120, P384, DOI 10.1161/CIRCULATIONAHA.108.835470; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; O'Donnel CJ, 2008, REV ESP CARDIOL, V61, P299, DOI 10.1016/S1885-5857(08)60118-8; PANOS BR, 2000, ATEN PRIM, V25, P84; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Puras A, 1998, EUR J EPIDEMIOL, V14, P31, DOI 10.1023/A:1007483916158; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006; WARNICK GR, 1985, CLIN CHEM, V31, P217; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	35	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73529	10.1371/journal.pone.0073529	http://dx.doi.org/10.1371/journal.pone.0073529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039972	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600084
J	Schlacher, TA; Weston, MA; Lynn, D; Connolly, RM				Schlacher, Thomas A.; Weston, Michael A.; Lynn, David; Connolly, Rod M.			Setback Distances as a Conservation Tool in Wildlife-Human Interactions: Testing Their Efficacy for Birds Affected by Vehicles on Open-Coast Sandy Beaches	PLOS ONE			English	Article							OFF-ROAD VEHICLES; RECREATIONAL DISTURBANCE; WANDERING ALBATROSSES; BEHAVIORAL-RESPONSES; BURROW ARCHITECTURE; PRIMARY-SCHOOL; GHOST CRABS; IMPACTS; ORVS; DENSITY	In some wilderness areas, wildlife encounter vehicles disrupt their behaviour and habitat use. Changing driver behaviour has been proposed where bans on vehicle use are politically unpalatable, but the efficacy of vehicle setbacks and reduced speeds remains largely untested. We characterised bird-vehicle encounters in terms of driver behaviour and the disturbance caused to birds, and tested whether spatial buffers or lower speeds reduced bird escape responses on open beaches. Focal observations showed that: i) most drivers did not create sizeable buffers between their vehicles and birds; ii) bird disturbance was frequent; and iii) predictors of probability of flushing (escape) were setback distance and vehicle type (buses flushed birds at higher rates than cars). Experiments demonstrated that substantial reductions in bird escape responses required buffers to be wide (> 25 m) and vehicle speeds to be slow (< 30 km h(-1)). Setback distances can reduce impacts on wildlife, provided that they are carefully designed and derived from empirical evidence. No speed or distance combination we tested, however, eliminated bird responses. Thus, while buffers reduce response rates, they are likely to be much less effective than vehicle-free zones (i.e. beach closures), and rely on changes to current driver behaviour.	[Schlacher, Thomas A.; Lynn, David] Univ Sunshine Coast, Fac Sci, Brisbane, Qld, Australia; [Connolly, Rod M.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Gold Coast, Qld, Australia	University of the Sunshine Coast; Griffith University	Schlacher, TA (corresponding author), Univ Sunshine Coast, Fac Sci, Brisbane, Qld, Australia.	tschlach@usc.edu.au	Connolly, Rod M/C-4094-2008; Schlacher, Thomas/J-4614-2016	Connolly, Rod M/0000-0001-6223-1291; Schlacher, Thomas/0000-0003-2184-9217	Queensland Wader Study Group	Queensland Wader Study Group	Partial funding for the work was received from the Queensland Wader Study Group. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Anderson D.R., 2008, MODEL BASED INFERENC; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Boves TJ, 2012, J WILDLIFE MANAGE, V76, P1381, DOI 10.1002/jwmg.378; Braby J, 2009, OSTRICH, V80, P71, DOI 10.2989/OSTRICH.2009.80.2.1.828; Braby R. J., 2001, Marine Ornithology, V29, P81; Buckley R, 2012, ANN TOURISM RES, V39, P528, DOI 10.1016/j.annals.2012.02.003; Buckley R, 2009, J SUSTAIN TOUR, V17, P643, DOI 10.1080/09669580902999188; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; BUICK AM, 1989, EMU, V89, P159, DOI 10.1071/MU9890159; Burger J, 2012, URBAN ECOSYST, P1; Burger J, 2007, POLAR BIOL, V30, P1303, DOI 10.1007/s00300-007-0291-1; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Celliers L, 2004, OCEAN COAST MANAGE, V47, P123, DOI 10.1016/j.ocecoaman.2004.02.001; Fanini L, 2007, OCEANOLOGIA, V49, P145; Farmer RG, 2012, J WILDLIFE MANAGE, V76, P1215, DOI 10.1002/jwmg.358; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fisher Fiona, 1998, Sunbird, V28, P1; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Foster CR, 2009, ESTUAR COAST, V32, P1079, DOI 10.1007/s12237-009-9224-2; Frid A, 2002, CONSERV ECOL, V6; Glover HK, 2011, LANDSCAPE URBAN PLAN, V103, P326, DOI 10.1016/j.landurbplan.2011.08.006; Groom JD, 2007, BIOL CONSERV, V135, P119, DOI 10.1016/j.biocon.2006.10.005; Higgins P. J., 1996, HDB AUSTR NZ ANTARCT, V3; HOLMES TL, 1993, WILDLIFE SOC B, V21, P461; HOSIER PE, 1981, ENVIRON CONSERV, V8, P158, DOI 10.1017/S0376892900027284; Houser C, 2013, OCEAN COAST MANAGE, V71, P33, DOI 10.1016/j.ocecoaman.2012.09.012; IAATO, 2007, AATO MAR WILDL WAT 2; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Jimenez G, 2013, BIOL CONSERV, V159, P477, DOI 10.1016/j.biocon.2012.10.030; Kaiser FG, 1999, J ENVIRON PSYCHOL, V19, P1, DOI 10.1006/jevp.1998.0107; Lafferty KD, 2006, BIODIVERS CONSERV, V15, P2217, DOI 10.1007/s10531-004-7180-5; LONSDALE WM, 1994, BIOL CONSERV, V69, P277, DOI 10.1016/0006-3207(94)90427-8; Lucrezi S, 2010, ENVIRON MANAGE, V45, P1352, DOI 10.1007/s00267-010-9491-5; Marchant S., 1993, HDB AUSTR NZ ANTARCT, V2; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; McFarland David, 1993, Sunbird, V23, P109; Meager JJ, 2012, DIVERS DISTRIB, V18, P294, DOI 10.1111/j.1472-4642.2011.00873.x; Monroe M.C., 2003, HUM ECOL REV, V10, P113; Moss D, 2006, COAST MANAGE, V34, P133, DOI 10.1080/08920750500379383; Petel TV, 2012, COAST MANAGE, V40, P501, DOI 10.1080/08920753.2012.709464; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quiros AL, 2007, FISH RES, V84, P102, DOI 10.1016/j.fishres.2006.11.017; Randler C, 2006, EUR J WILDLIFE RES, V52, P265, DOI 10.1007/s10344-006-0049-z; Rodgers JA, 1997, WILDLIFE SOC B, V25, P139; Rodriguez-Prieto I, 2008, BEHAVIOUR, V145, P1125, DOI 10.1163/156853908784474489; Schlacher TA, 2010, VIE MILIEU, V60, P313; Schlacher TA, 2013, MAR ECOL, V2013, P1; Schlacher TA, 2008, MAR POLLUT BULL, V56, P1646, DOI 10.1016/j.marpolbul.2008.06.008; Schlacher TA, 2008, HYDROBIOLOGIA, V610, P345, DOI 10.1007/s10750-008-9426-9; Schlacher TA, 2008, ENVIRON MANAGE, V41, P878, DOI 10.1007/s00267-008-9071-0; Schlacher TA, 2008, J COASTAL RES, V24, P234, DOI 10.2112/06-0691.1; Schlacher TA, 2007, MAR ECOL-EVOL PERSP, V28, P354, DOI 10.1111/j.1439-0485.2007.00156.x; Schlacher TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068221; Schlacher TA, 2013, ACTA OECOL, V48, P7, DOI 10.1016/j.actao.2013.01.007; Schlacher TA, 2013, ESTUAR COAST SHELF S, V118, P31, DOI 10.1016/j.ecss.2012.12.016; Sheppard N, 2009, J EXP MAR BIOL ECOL, V380, P113, DOI 10.1016/j.jembe.2009.09.009; Shilling F, 2012, ENVIRON MANAGE, V50, P381, DOI 10.1007/s00267-012-9906-6; Skorka P, 2013, BIOL CONSERV, V159, P148, DOI 10.1016/j.biocon.2012.12.028; Stolen ED, 2003, WATERBIRDS, V26, P429, DOI 10.1675/1524-4695(2003)026[0429:TEOVPO]2.0.CO;2; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tarr NM, 2010, J WILDLIFE MANAGE, V74, P1776, DOI 10.2193/2009-105; Taylor EC, 2007, IBIS, V149, P37, DOI 10.1111/j.1474-919X.2007.00645.x; Thompson Luke M. C., 2008, Journal of Coastal Conservation, V12, P67, DOI 10.1007/s11852-008-0032-9; Vaske JJ, 2007, J LEISURE RES, V39, P182, DOI 10.1080/00222216.2007.11950103; Villiers M, 2005, POLAR BIOL, V28, P255, DOI 10.1007/s00300-004-0682-5; Walker BG, 2006, CONSERV BIOL, V20, P146, DOI 10.1111/j.1523-1739.2005.00271.x; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Weston MA, 2007, J COASTAL RES, V23, P569, DOI 10.2112/04-0151.1; Weston Michael A., 2012, Pacific Conservation Biology, V18, P47; Weston Michael A., 2006, Ecological Management & Restoration, V7, P223, DOI 10.1111/j.1442-8903.2006.312_2.x; Wheeler M, 2009, POLAR BIOL, V32, P197, DOI 10.1007/s00300-008-0520-2; Williams A.J., 2004, Wader Study Group Bulletin, V104, P79; WOLCOTT TG, 1984, BIOL CONSERV, V29, P217, DOI 10.1016/0006-3207(84)90100-9; Wright R. G., 1996, NATL PARKS PROTECTED; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	78	40	41	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71200	10.1371/journal.pone.0071200	http://dx.doi.org/10.1371/journal.pone.0071200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039711	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600009
J	Sun, HY; Wu, YH; Yu, D; Zhou, J				Sun, Hongyang; Wu, Yanhong; Yu, Dong; Zhou, Jun			Altitudinal Gradient of Microbial Biomass Phosphorus and Its Relationship with Microbial Biomass Carbon, Nitrogen, and Rhizosphere Soil Phosphorus on the Eastern Slope of Gongga Mountain, SW China	PLOS ONE			English	Article							FILLED PORE-SPACE; PHOSPHATE SOLUBILIZATION; HEDLEY FRACTIONATION; NORTHEASTERN BRAZIL; ORGANIC PHOSPHORUS; EXTRACTION METHOD; GROWTH PROMOTION; GRASSLAND SOIL; CLEAR-CUT; LAND-USE	Microbial biomass phosphorus (MBP) is one of the most active forms of phosphorus (P) in soils. MBP plays an important role in the biogeochemical P cycle. To explore MBP distribution and its relationship with other factors, the MBP and rhizosphere soil P concentrations and fractions in six vegetation zones on the eastern slope of Gongga Mountain in SW China were investigated. The MBP distribution followed a parabolic pattern with altitude and the concentration was highest in the subalpine dark coniferous forest (SDC) zone, which was approximately 3500 m above sea level (asl). Below 3500 m asl, the MBP distribution was controlled by precipitation and vegetation type. In addition, temperature, precipitation and vegetation type controlled the MBP distribution at elevations above 3500 m asl. No specific distribution pattern was determined regarding rhizosphere soil P fractions. However, MBP was significantly correlated with the unavailable P fraction in the rhizosphere rather than with the available P fraction. This result suggests that the relationships between the rhizosphere soil P fractions and the MBP depend on time. The microbial biomass element ratios were relatively consistent on the eastern slope of Gongga Mountain. However, variations in the microbial biomass element rations were observed in six of the vegetation zones. The mean C:N:P ratio was 9.0:1.3:1. Overall, vegetation type resulted in the observed fluctuations of the microbial biomass element ratio.	[Sun, Hongyang; Wu, Yanhong; Yu, Dong; Zhou, Jun] Chinese Acad Sci, Chengdu Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Peoples R China; [Sun, Hongyang] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, YH (corresponding author), Chinese Acad Sci, Chengdu Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Peoples R China.	yhwu@imde.ac.cn	, 周俊/J-6152-2012	, 周俊/0000-0001-7315-6645	Chinese Academy of Sciences [KZCX2-YW-BR-21]; Chinese Nature Science Foundation [41272200]	Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Nature Science Foundation	This study was supported by the Chinese Academy of Sciences (Grant no. KZCX2-YW-BR-21) and the Chinese Nature Science Foundation (41272200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenin JO, 1998, SOIL USE MANAGE, V14, P59, DOI 10.1111/j.1475-2743.1998.tb00614.x; AGBENIN JO, 1994, GEODERMA, V62, P345, DOI 10.1016/0016-7061(94)90098-1; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Araujo MSB, 2004, GEODERMA, V119, P309, DOI 10.1016/j.geoderma.2003.07.002; AUSMUS BS, 1976, ROLE TERRESTRIAL AQU, P397; BOTTNER P, 1985, SOIL BIOL BIOCHEM, V17, P329, DOI 10.1016/0038-0717(85)90070-7; BOWMAN RA, 1978, SOIL SCI, V125, P49, DOI 10.1097/00010694-197801000-00008; BROOKES PC, 1984, SOIL BIOL BIOCHEM, V16, P169, DOI 10.1016/0038-0717(84)90108-1; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Cassagne N, 2000, GEODERMA, V95, P161, DOI 10.1016/S0016-7061(99)00093-2; CHAUHAN BS, 1981, CAN J SOIL SCI, V61, P373, DOI 10.4141/cjss81-041; Chen CR, 2000, PLANT SOIL, V220, P151, DOI 10.1023/A:1004712401721; Chen GC, 2000, COMMUN SOIL SCI PLAN, V31, P655, DOI 10.1080/00103620009370467; Chen GC, 2002, COMMUN SOIL SCI PLAN, V33, P2101, DOI 10.1081/CSS-120005751; Cheng G.W., 1996, MOUNTAIN RES, V14, P177; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Cross AF, 2001, BIOGEOCHEMISTRY, V52, P155, DOI 10.1023/A:1006437504494; Encyclopedia of Chinese Agriculture, 1996, ENC CHIN AGR SOIL VO; Esberg C, 2010, PLANT SOIL, V329, P209, DOI 10.1007/s11104-009-0146-3; Feng XJ, 2007, SOIL BIOL BIOCHEM, V39, P2027, DOI 10.1016/j.soilbio.2007.03.003; Franzluebbers AJ, 1999, APPL SOIL ECOL, V11, P91, DOI 10.1016/S0929-1393(98)00128-0; Gardner AS, 2009, J CLIMATE, V22, P4281, DOI 10.1175/2009JCLI2845.1; George TS, 2006, EUR J SOIL SCI, V57, P47, DOI 10.1111/j.1365-2389.2006.00767.x; Gerke J, 2010, SOIL SCI, V175, P417, DOI 10.1097/SS.0b013e3181f1b4dd; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Hashimoto S, 2004, J FOREST RES-JPN, V9, P125, DOI 10.1007/s10310-003-0063-x; He ZL, 1997, BIOL FERT SOILS, V24, P421, DOI 10.1007/s003740050267; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Henri F, 2008, AFR J MICROBIOL RES, V2, P171; HUE NV, 1984, SOIL SCI, V137, P324, DOI 10.1097/00010694-198405000-00005; Iyamuremye F, 1996, ADV AGRON, V56, P139, DOI 10.1016/S0065-2113(08)60181-9; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; JOERGENSEN RG, 1995, BIOL FERT SOILS, V19, P215, DOI 10.1007/BF00336162; Ju ZQ, 2011, SOIL SCI SOC AM J, V75, P26, DOI 10.2136/sssaj2010.0050N; KILLHAM K, 1990, PLANT SOIL, V128, P31, DOI 10.1007/BF00009394; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KUCEY RMN, 1989, ADV AGRON, V42, P199; Lindo Z, 2003, CAN J FOREST RES, V33, P1610, DOI [10.1139/x03-080, 10.1139/X03-080]; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Liu XZ, 2010, RAPID COMMUN MASS SP, V24, P3063, DOI 10.1002/rcm.4735; Lukito HP, 1998, SOIL BIOL BIOCHEM, V30, P865, DOI 10.1016/S0038-0717(98)00011-X; MJ T, 1971, STANDARD METHODS EXA; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; Paredes C, 2011, SOIL SCI, V176, P245, DOI 10.1097/SS.0b013e3182147fd3; REDFIELD AC, 1958, AM SCI, V46, P205; REINERS WA, 1986, AM NAT, V127, P59, DOI 10.1086/284467; Richter DD, 2006, OECOLOGIA, V150, P259, DOI 10.1007/s00442-006-0510-4; Rodriguez H, 2004, NATURWISSENSCHAFTEN, V91, P552, DOI 10.1007/s00114-004-0566-0; Ross DJ, 1999, SOIL BIOL BIOCHEM, V31, P803, DOI 10.1016/S0038-0717(98)00180-1; SARATHCHANDRA SU, 1989, SOIL BIOL BIOCHEM, V21, P987, DOI 10.1016/0038-0717(89)90034-5; SCHNURER J, 1986, MICROBIAL ECOL, V12, P217, DOI 10.1007/BF02011206; Sharma S, 2006, APPL ENVIRON MICROB, V72, P2148, DOI 10.1128/AEM.72.3.2148-2154.2006; Sharma V, 2005, CAN J MICROBIOL, V51, P477, DOI 10.1139/W05-032; SPARLING GP, 1985, AUST J SOIL RES, V23, P613, DOI 10.1071/SR9850613; Stres B, 2008, FEMS MICROBIOL ECOL, V66, P110, DOI 10.1111/j.1574-6941.2008.00555.x; Sun B, 2007, PROTOCOLS STANDARD S, P345; Sun SQ, 2011, ENVIRON TOXICOL CHEM, V30, P2608, DOI 10.1002/etc.661; Tiessen Holm, 2008, V7, P1; Whitelaw MA, 2000, ADV AGRON, V69, P99; WILHELMI V, 1990, PLANT SOIL, V121, P197, DOI 10.1007/BF00012312; Wu J, 2000, BIOL FERT SOILS, V32, P500, DOI 10.1007/s003740000284; Wu YH, 2011, J SOIL SEDIMENT, V11, P940, DOI 10.1007/s11368-011-0387-7; Yang X, 2011, BIOGEOSCIENCES, V8, P2907, DOI 10.5194/bg-8-2907-2011; Yeates GW, 1998, J ROY SOC NEW ZEAL, V28, P523, DOI 10.1080/03014223.1998.9517574; Zhou J, 2013, GEODERMA, V195, P251, DOI [10.1016/j.geoderma.2012.12.010, 10.1016/j.geoderma2012.12.010]	70	12	18	12	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72952	10.1371/journal.pone.0072952	http://dx.doi.org/10.1371/journal.pone.0072952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039830	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600045
J	Dong, T; Qu, ZY; Zhang, LJ				Dong, Tuo; Qu, Zhangyi; Zhang, Lijuan			Detection of A. phagocytophilum and E. chaffeensis in Patient and Mouse Blood and Ticks by a Duplex Real-Time PCR Assay	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; EHRLICHIA-CHAFFEENSIS; PERIPHERAL-BLOOD; CHINA; INFECTION; RICKETTSIOSES; PATHOGENS; MARGINALE; DISEASES; RODENTS	Human granulocytic anaplasmosis (HGA) and human monocytic ehrlichiosis (HME) are emerging, tick-borne, zoonotic infectious diseases caused by Anaplasma phagocytophilum and Ehrlichia chaffeensis, respectively. Early diagnosis is essential for rapid clinical treatment to avoid misdiagnosis and severe patient outcomes. Simple, sensitive and reliable diagnostic methods are urgently needed. In this study, we developed a duplex real-time PCR assay targeting the A. phagocytophilum ankA gene and the E. chaffeensis TRP120 gene, respectively. The lowest limit of detection of the duplex real-time PCR assay was 100 copies of the targeted A. phagocytophilum ankA gene and the E. chaffeensis TRP120 gene per reaction, and the specificity was 100%. Detection in blood DNA samples from the acute stage of illness for 22 HGA cases and 8 HME cases indicated that the duplex real-time PCR assay was more sensitive than the nested PCR assay. The infection of Citellus undulatus Pallas with A. phagocytophilum and E. chaffeensis was first confirmed in Xinjiang Province and the positive rate was 3.1% for A. phagocytophilum, 6.3% for E. chaffeensis and 3.1% for co-infection with both pathogens. The rates of A. phagocytophilum and E. chaffeensis infection of D. silvarum ticks collected from Shanxi Province were 8.2% and 14.8%, respectively, and the co-infection rate was 3.3%. The rates of A. phagocytophilum and E. chaffeensis infection in H. longicornis ticks collected from Shandong Province were 1.6% and 6.3%, respectively, and the co-infection rate was 1.6%.	[Dong, Tuo; Qu, Zhangyi] Harbin Med Univ, Sch Publ Hlth, Harbin, Heilongjiang Pr, Peoples R China; [Dong, Tuo; Zhang, Lijuan] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Anaplasma, Beijing, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Qu, ZY (corresponding author), Harbin Med Univ, Sch Publ Hlth, Harbin, Heilongjiang Pr, Peoples R China.	qirainbow@126.com; zhanglijuan@icdc.cn			China Mega-Project for Infectious Disease [2011ZX10004-001]; National Basic Research Program of China (973 Program) [2010CB530206]; National Key Science and Technology Projects of China [2008ZX10004-008, 2012ZX10004215]	China Mega-Project for Infectious Disease; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Science and Technology Projects of China	This study was supported by the China Mega-Project for Infectious Disease (2011ZX10004-001), the National Basic Research Program of China (973 Program- 2010CB530206) and the National Key Science and Technology Projects of China (2008ZX10004-008 and 2012ZX10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bakken JS, 1998, CLIN INFECT DIS, V27, P1491, DOI 10.1086/515048; Brennan RE, 2003, J CLIN MICROBIOL, V41, P1869, DOI 10.1128/JCM.41.5.1869-1874.2003; Cao WC, 2006, AM J TROP MED HYG, V75, P664, DOI 10.4269/ajtmh.2006.75.664; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; EREMEEVA ME, 1994, CLIN DIAGN LAB IMMUN, V1, P318, DOI 10.1128/CDLI.1.3.318-324.1994; FAN MY, 1988, AM J TROP MED HYG, V39, P497, DOI 10.4269/ajtmh.1988.39.497; Guero-Rosenfeld M. E., 2003, MANUAL CLIN MICROBIO, P1015; Jiang JF, 2011, EMERG INFECT DIS, V17, P932, DOI 10.3201/eid1705.101630; Kim CM, 2006, APPL ENVIRON MICROB, V72, P5766, DOI 10.1128/AEM.00431-06; Lee M, 2009, J VET MED SCI, V71, P101, DOI 10.1292/jvms.71.101; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Reinbold JB, 2010, J CLIN MICROBIOL, V48, P2424, DOI 10.1128/JCM.02405-09; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Sirigireddy KR, 2005, J MOL DIAGN, V7, P308, DOI 10.1016/S1525-1578(10)60559-4; Takano A, 2009, MICROBIOL IMMUNOL, V53, P101, DOI 10.1111/j.1348-0421.2008.00093.x; Thomas RJ, 2009, EXPERT REV ANTI-INFE, V7, P709, DOI [10.1586/eri.09.44, 10.1586/ERI.09.44]; Wakeel A, 2011, 111 GEN M AM SOC WAS; Wakeel A, 2010, MICROBES INFECT, V12, P337, DOI 10.1016/j.micinf.2010.01.009; Walker David H, 2004, Trans Am Clin Climatol Assoc, V115, P375; WALKER DH, 1994, NEW ENGL J MED, V331, P1651, DOI 10.1056/NEJM199412153312410; Wang S, 2012, DIS SURVEIL, V27, P242; Wen BH, 2002, J CLIN MICROBIOL, V40, P3286, DOI 10.1128/JCM.40.9.3286-3290.2002; Yoshimoto K, 2010, VET PARASITOL, V168, P170, DOI 10.1016/j.vetpar.2009.10.008; Yu XJ, 1996, J CLIN MICROBIOL, V34, P2853, DOI 10.1128/JCM.34.11.2853-2855.1996; Zhan L, 2010, VET MICROBIOL, V144, P405, DOI 10.1016/j.vetmic.2010.02.018; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057155; Zhang LJ, 2012, AM J TROP MED HYG, V87, P185, DOI 10.4269/ajtmh.2012.12-0005; Zhang LJ, 2010, ASIAN PAC J TROP MED, V3, P851, DOI 10.1016/S1995-7645(10)60205-2; Zhang XC, 2012, VECTOR-BORNE ZOONOT, V12, P932, DOI 10.1089/vbz.2012.0961	36	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74796	10.1371/journal.pone.0074796	http://dx.doi.org/10.1371/journal.pone.0074796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023963	Green Submitted, gold, Green Published			2022-12-25	WOS:000324515600157
J	Mishra, S; Deng, JJ; Gowda, PS; Rao, MK; Lin, CL; Chen, CL; Huang, T; Sun, LZ				Mishra, S.; Deng, J. J.; Gowda, P. S.; Rao, M. K.; Lin, C-L; Chen, C. L.; Huang, T.; Sun, L-Z			Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer	ONCOGENE			English	Article						microRNA; androgen receptor; tumor suppressor; prostate cancer	CROSS-TALK; MIR-21; PTEN; CELLS; METHYLATION; ACTIVATION; APOPTOSIS; PROTEIN	Prostate cancer cells escape growth inhibition from transforming growth factor beta (TGF beta) by downregulating TGF beta receptors. However, the mechanism by which cancer cells downregulate TGF beta receptors in prostate is not clear. Here, we showed that coordinated action of miR-21 and androgen receptor (AR) signaling had a critical role in inhibiting TGF beta receptor II (TGFBR2) expression in prostate cancer cells. Our results revealed that miR-21 suppresses TGFBR2 levels by binding to its 3'-UTR and AR signaling further potentiates this effect in both untransformed and transformed human prostate epithelial cells as well as in human prostate cancers. Analysis of primary prostate cancers showed that increased miR-21/AR expression parallel a significantly reduced expression of TGFBR2. Manipulation of androgen signaling or the expression levels of AR or miR-21 negatively altered TGFBR2 expression in untransformed and transformed human prostate epithelial cells, human prostate cancer xenografts and mouse prostate glands. Importantly, we demonstrated that miR-21 and AR regulated each other's expression resulting in a positive feedback loop. Our results indicated that miR-21/AR mediate its tumor-promoting function by attenuating TGF beta-mediated Smad2/3 activation, cell growth inhibition, cell migration and apoptosis. Together, these results suggest that the AR and miR-21 axis exerts its oncogenic effects in prostate tumors by downregulating TGFBR2, hence inhibiting the tumor-suppressive activity of TGF beta pathway. Targeting miR-21 alone or in combination with AR may restore the tumor inhibitory activity of TGF beta in prostate cancer.	[Mishra, S.; Deng, J. J.; Gowda, P. S.; Rao, M. K.; Sun, L-Z] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Lin, C-L; Chen, C. L.; Huang, T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Huang, T.; Sun, L-Z] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Sun, LZ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,Mail Code 7762, San Antonio, TX 78229 USA.	SUNL@UTHSCSA.EDU	, LuZhe/AAW-4095-2021	Chen, Chun-Liang/0000-0002-6774-9003	NIH [R01CA75253, R01CA79683]; William and Ella Owens Foundation; Thrive Well foundation [U54 CA113001]; Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio through the NCI Cancer Center [2P30CA054174-17]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA075253, R01CA079683, U54CA113001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Ella Owens Foundation; Thrive Well foundation; Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio through the NCI Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funding from NIH Grants R01CA75253 and R01CA79683 to LuZhe Sun, William and Ella Owens Foundation and Thrive Well foundation to Manjeet Rao, U54 CA113001 (Integrative Cancer Biology Program) to Tim Huang and the Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant 2P30CA054174-17 to the optical imaging core facility. We thank Dr Clifford G Tepper and Dr Paramita Ghosh at UC Davis Cancer Center for the CWR22 xenograft tissue and PSA-luciferase plasmid, respectively, and Dr Scott Lucia at University of Colorado Health Science Center for providing us with BPH-1 cells.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brattain Michael G., 1996, Current Opinion in Oncology, V8, P49, DOI 10.1097/00001622-199601000-00009; Brodin G, 1999, CANCER RES, V59, P2731; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chowdhury Sanjib, 2009, Mol Cell Pharmacol, V1, P57; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Hayes SA, 2001, CANCER RES, V61, P2112; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Kim IY, 1996, MOL ENDOCRINOL, V10, P107, DOI 10.1210/me.10.1.107; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Leite KR, 2011, UROL ONCOL, V31, P796; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li T, 2012, J UROLOGY, V187, P1466, DOI 10.1016/j.juro.2011.11.082; Lin HK, 2004, MOL ENDOCRINOL, V18, P2409, DOI 10.1210/me.2004-0117; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lucia MS, 1998, J CELL PHYSIOL, V175, P184, DOI 10.1002/(SICI)1097-4652(199805)175:2<184::AID-JCP8>3.0.CO;2-K; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mishra S, 2011, PROSTATE, V71, P1441, DOI 10.1002/pros.21361; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nagabhushan M, 1996, CANCER RES, V56, P3042; Osada H, 2001, CANCER RES, V61, P8331; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Song K, 2008, CANCER RES, V68, P8173, DOI 10.1158/0008-5472.CAN-08-2290; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012; Williams RH, 1996, CLIN CANCER RES, V2, P635; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Yamashita S, 2008, CANCER RES, V68, P2112, DOI 10.1158/0008-5472.CAN-07-5282; Zeng L, 2004, HUM PATHOL, V35, P290, DOI 10.1016/j.humpath.2003.11.001; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096; Zhu ML, 2008, PROSTATE, V68, P287, DOI 10.1002/pros.20698; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	45	102	106	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4097	4106		10.1038/onc.2013.374	http://dx.doi.org/10.1038/onc.2013.374			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24037531	Green Accepted			2022-12-25	WOS:000340595300009
J	Huang, GC; He, QY; Guo, JH; Cha, J; Liu, Y				Huang, Guocun; He, Qiyang; Guo, Jinhu; Cha, Joonseok; Liu, Yi			The Ccr4-Not Protein Complex Regulates the Phase of the Neurospora Circadian Clock by Controlling WHITE COLLAR Protein Stability and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK LOOP; MESSENGER-RNA DEADENYLASE; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; DIFFERENTIALLY AFFECTS; PHOSPHORYLATION; FREQUENCY; LIGHT; GENE; FRQ	In the Neurospora circadian negative feedback loop, WHITE COLLAR 1 (WC-1) and WC-2 form the WC complex that activates frequency (frq) transcription. Here we show that Not1 is a WC-interacting protein and is important for maintaining WC levels. The not1 transcript displays a circadian oscillation with a similar phase as frq. Down-regulation of not1 leads to low levels of WC-1 and WC-2 and a delayed circadian phase as a result of increased protein degradation and increased WC activity. Protein purification of Not1 shows that it is part of the Neurospora Ccr4-Not complex. ccr4 is a clock-controlled gene and is regulated directly by the WC complex. Down-regulation of ccr4 results in a phase delay and period lengthening of the clock. Together, our findings suggest that the Ccr4-Not complex participates in the Neurospora clock function by interacting with and regulating the WC complex.	[Huang, Guocun] Soochow Univ, Ctr Circadian Clocks, Coll Med, Suzhou 215123, Peoples R China; [Huang, Guocun; He, Qiyang; Guo, Jinhu; Cha, Joonseok; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Huang, Guocun] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [He, Qiyang] Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China; [He, Qiyang] Chinese Acad Med Sci, Beijing 100050, Peoples R China; [Guo, Jinhu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China	Soochow University - China; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Sun Yat Sen University	Huang, GC (corresponding author), Soochow Univ, Ctr Circadian Clocks, Coll Med, Suzhou 215123, Peoples R China.	gchuang@suda.edu.cn; Yi.Liu@UTsouthwestern.edu	He, qiyang/GQA-4070-2022; He, qiyang/AAT-5826-2021; Cha, Joonseok/AAE-9918-2020		National Institutes of Health [GM068496, GM062591]; Welch Foundation [I-1560]; National Natural Science Foundation of China [31271281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496, R01GM062591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068496 and GM062591 (to Y. L.). This work was also supported by Welch Foundation Grant I-1560 (to Y. L.) and National Natural Science Foundation of China Grant 31271281 (to G. H.).	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Guo JH, 2010, J BIOL CHEM, V285, P11508, DOI 10.1074/jbc.M109.071688; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hong CI, 2008, GENE DEV, V22, P3196, DOI 10.1101/gad.1706908; Hunt SM, 2010, P NATL ACAD SCI USA, V107, P16709, DOI 10.1073/pnas.1009474107; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lenssen E, 2002, MOL MICROBIOL, V43, P1023, DOI 10.1046/j.1365-2958.2002.02799.x; Li R, 2008, MAR GEOD, V31, P1, DOI 10.1080/01490410701860856; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Shi M, 2010, GENETICS, V184, P351, DOI 10.1534/genetics.109.111393; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	49	6	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31002	31009		10.1074/jbc.M113.494120	http://dx.doi.org/10.1074/jbc.M113.494120			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030828	Green Published, hybrid			2022-12-25	WOS:000330778900019
J	Mangialavori, IC; Ferreira-Gomes, MS; Saffioti, NA; Gonzalez-Lebrero, RM; Rossi, RC; Rossi, JPFC				Mangialavori, Irene C.; Ferreira-Gomes, Mariela S.; Saffioti, Nicolas A.; Gonzalez-Lebrero, Rodolfo M.; Rossi, Rolando C.; Rossi, Juan Pablo F. C.			Conformational Changes Produced by ATP Binding to the Plasma Membrane Calcium Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM ATPASE; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATASE; STRUCTURAL BASIS; ENERGY-TRANSFER; STEADY-STATE; CA2+; CA2+-ATPASE; MECHANISM	The aim of this work was to study the plasma membrane calcium pump (PMCA) reaction cycle by characterizing conformational changes associated with calcium, ATP, and vanadate binding to purified PMCA. This was accomplished by studying the exposure of PMCA to surrounding phospholipids by measuring the incorporation of the photoactivatable phosphatidylcholine analog 1-O-hexadecanoyl-2-O-[9-[[[2-[I-125] iodo-4-(trifluoromethyl-3H-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn-glycero-3-phosphocholine to the protein. ATP could bind to the different vanadate-bound states of the enzyme either in the presence or in the absence of Ca2+ with high apparent affinity. Conformational movements of the ATP binding domain were determined using the fluorescent analog 2'(3')-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate. To assess the conformational behavior of the Ca2+ binding domain, we also studied the occlusion of Ca2+, both in the presence and in the absence of ATP and with or without vanadate. Results show the existence of occluded species in the presence of vanadate and/or ATP. This allowed the development of a model that describes the transport of Ca2+ and its relation with ATP hydrolysis. This is the first approach that uses a conformational study to describe the PMCA P-type ATPase reaction cycle, adding important features to the classical E-1-E-2 model devised using kinetics methodology only.	[Mangialavori, Irene C.; Ferreira-Gomes, Mariela S.; Saffioti, Nicolas A.; Gonzalez-Lebrero, Rodolfo M.; Rossi, Rolando C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Consejo Nacl Invest Cient & Tecn, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rossi, RC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Consejo Nacl Invest Cient & Tecn, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	rcr@retina.ar; jprossi@qb.ffyb.uba.ar	Mangialavori, Irene/GLU-8182-2022	Rossi, Juan Pablo/0000-0001-7087-844X; Mangialavori, Irene/0000-0003-3187-3130; Saffioti, Nicolas Andres/0000-0002-5722-182X; Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica (UBACYT; Argentina)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica (UBACYT; Argentina)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica (UBACYT; Argentina).	ADAMO HP, 1990, J BIOL CHEM, V265, P3789; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; Burnham K.P., 2002, MODEL SELECTION MULT, P60; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2011, J BIOL CHEM, V286, P11792, DOI 10.1074/jbc.M110.206094; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Ferreira-Gomes MS, 2011, J BIOL CHEM, V286, P32018, DOI 10.1074/jbc.M111.266650; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Forbush B., 1988, NA PLUS K PLUS PUM A, P229; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KREBS J, 1987, BIOCHEMISTRY-US, V26, P3921, DOI 10.1021/bi00387a027; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lin SH, 1996, BIOCHEMISTRY-US, V35, P8419, DOI 10.1021/bi960407+; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori I, 2011, FEBS LETT, V585, P1153, DOI 10.1016/j.febslet.2011.03.024; Mangialavori I, 2010, J BIOL CHEM, V285, P123, DOI 10.1074/jbc.M109.076679; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Mangialavori IC, 2012, BIOCHEM J, V443, P125, DOI 10.1042/BJ20111035; MARKUS S, 1989, BIOCHEMISTRY-US, V28, P793, DOI 10.1021/bi00428a057; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147; NAKAMURA J, 1987, J BIOL CHEM, V262, P14492; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; PICK U, 1982, J BIOL CHEM, V257, P6111; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Rega A., 1986, CA2 PUMP PLASMA MEMB, P115; REYNOLDS JA, 1985, P NATL ACAD SCI USA, V82, P3658, DOI 10.1073/pnas.82.11.3658; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Scarborough GA, 2003, TRENDS BIOCHEM SCI, V28, P581, DOI 10.1016/j.tibs.2003.08.010; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vanagas L, 2013, CELL BIOCHEM BIOPHYS, V66, P187, DOI 10.1007/s12013-012-9467-6; VAS M, 1994, BIOCHEM J, V301, P885, DOI 10.1042/bj3010885; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	73	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31030	31041		10.1074/jbc.M113.494633	http://dx.doi.org/10.1074/jbc.M113.494633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025327	hybrid, Green Published			2022-12-25	WOS:000330778900022
J	Okano, Y; Nezu, U; Enokida, Y; Lee, MTM; Kinoshita, H; Lezhava, A; Hayashizaki, Y; Morita, S; Taguri, M; Ichikawa, Y; Kaneko, T; Natsumeda, Y; Yokose, T; Nakayama, H; Miyagi, Y; Ishikawa, T				Okano, Yasuko; Nezu, Uru; Enokida, Yasuaki; Lee, Ming Ta Michael; Kinoshita, Hiroko; Lezhava, Alexander; Hayashizaki, Yoshihide; Morita, Satoshi; Taguri, Masataka; Ichikawa, Yasushi; Kaneko, Takeshi; Natsumeda, Yutaka; Yokose, Tomoyuki; Nakayama, Haruhiko; Miyagi, Yohei; Ishikawa, Toshihisa			SNP (-617C > A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; GROWTH-FACTOR RECEPTOR; MOLECULAR-MECHANISMS; CELL-PROLIFERATION; STRESS-RESPONSE; PHASE-III; CANCER; MUTATIONS; EXPRESSION; GEFITINIB	Purpose: The transcription factor NRF2 plays a pivotal role in protecting normal cells from external toxic challenges and oxidative stress, whereas it can also endow cancer cells resistance to anticancer drugs. At present little information is available about the genetic polymorphisms of the NRF2 gene and their clinical relevance. We aimed to investigate the single nucleotide polymorphisms in the NRF2 gene as a prognostic biomarker in lung cancer. Experimental Design: We prepared genomic DNA samples from 387 Japanese patients with primary lung cancer and detected SNP (c.-617C>A; rs6721961) in the ARE-like loci of the human NRF2 gene by the rapid genetic testing method we developed in this study. We then analyzed the association between the SNP in the NRF2 gene and patients' overall survival. Results: Patients harboring wild-type (WT) homozygous (c.-617C/C), SNP heterozygous (c.-617C/A), and SNP homozygous (c.-617A/A) alleles numbered 216 (55.8%), 147 (38.0%), and 24 (6.2%), respectively. Multivariate logistic regression models revealed that SNP homozygote (c.-617A/A) was significantly related to gender. Its frequency was four-fold higher in female patients than in males (10.8% female vs 2.7% male) and was associated with female non-smokers with adenocarcinoma. Interestingly, lung cancer patients carrying NRF2 SNP homozygous alleles (c.-617A/A) and the 309T (WT) allele in the MDM2 gene exhibited remarkable survival over 1,700 days after surgical operation (log-rank p = 0.021). Conclusion: SNP homozygous (c.-617A/A) alleles in the NRF2 gene are associated with female non-smokers with adenocarcinoma and regarded as a prognostic biomarker for assessing overall survival of patients with lung adenocarcinoma.	[Okano, Yasuko; Nezu, Uru; Enokida, Yasuaki; Kinoshita, Hiroko; Lezhava, Alexander; Hayashizaki, Yoshihide; Kaneko, Takeshi; Ishikawa, Toshihisa] RIKEN, Yokohama Inst, Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Okano, Yasuko; Ichikawa, Yasushi] Yokohama City Univ, Grad Sch Med, Dept Clin Oncol, Yokohama, Kanagawa 232, Japan; [Nezu, Uru] Univ Ryukyus, Dept Clin Pharmacol & Therapeut, Grad Sch Med, Nishihara, Okinawa 90301, Japan; [Enokida, Yasuaki] Gunma Univ, Grad Sch Med, Div Thorac & Visceral Organ Surg, Maehashi, Japan; [Lee, Ming Ta Michael] RIKEN, Ctr Integrat Med Sci, Lab Int Alliance Genom Res, Yokohama, Kanagawa, Japan; [Lee, Ming Ta Michael; Morita, Satoshi] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Taguri, Masataka] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Kaneko, Takeshi] Yokohama City Univ, Med Ctr, Resp Dis Ctr, Yokohama, Kanagawa 232, Japan; [Natsumeda, Yutaka] Yokohama City Univ, Dept Clin Res, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Yokose, Tomoyuki] Kanagawa Canc Ctr, Res Inst, Dept Pathol, Yokohama, Kanagawa 2410815, Japan; [Nakayama, Haruhiko] Kanagawa Canc Ctr, Res Inst, Dept Thorac Surg, Yokohama, Kanagawa 2410815, Japan; [Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Yokohama, Kanagawa 2410815, Japan	RIKEN; Yokohama City University; University of the Ryukyus; RIKEN; Academia Sinica - Taiwan; Yokohama City University; Yokohama City University; Yokohama City University; Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center	Ishikawa, T (corresponding author), RIKEN, Yokohama Inst, Omics Sci Ctr, Yokohama, Kanagawa, Japan.	toshihisa.ishikawa.r@gmail.com	Hayashizaki, Yoshihide/N-6590-2015		a Japan Science and Technology Agency (JST); RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology	a Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology	This study was supported by a Japan Science and Technology Agency (JST) research project named "Development of the world's fastest SNP detection system" (to TI) and Research This study was supported by a grant for RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology (to YH). The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2007, J EXP THER ONCOL, V6, P335; Azuma K, 2011, CLIN CHIM ACTA, V412, P1249, DOI 10.1016/j.cca.2011.03.017; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Enokida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060151; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Han JY, 2008, CANCER-AM CANCER SOC, V113, P799, DOI 10.1002/cncr.23668; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Hosgood HD, 2012, HUM GENET, V131, P1197, DOI 10.1007/s00439-012-1144-8; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishikawa Toshihisa, 2013, Methods Mol Biol, V1015, P55, DOI 10.1007/978-1-62703-435-7_3; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matsukuma S, 2006, J MOL DIAGN, V8, P504, DOI 10.2353/jmoldx.2006.060030; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Okinaga S, 1996, BLOOD, V87, P5074, DOI 10.1182/blood.V87.12.5074.bloodjournal87125074; Oshita F, 2006, BRIT J CANCER, V95, P1070, DOI 10.1038/sj.bjc.6603396; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rotblat B, 2012, ONCOTARGET, V3, P1272; Saito H, 2006, J PHARMACOL EXP THER, V317, P1114, DOI 10.1124/jpet.105.099036; Schwabedissen HEMZ, 2006, DRUG METAB DISPOS, V34, P524, DOI 10.1124/dmd.105.007591; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; SHIBAHARA S, 1989, EUR J BIOCHEM, V179, P557, DOI 10.1111/j.1432-1033.1989.tb14583.x; Singh A, 2010, MOL CANCER THER, V9, P2365, DOI 10.1158/1535-7163.MCT-10-0108; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Toyooka S, 2007, CLIN CANCER RES, V13, P5622; Travis WD., 2004, TRAVIS WB WHO CLASSI; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Yamamoto T, 2004, BIOCHEM BIOPH RES CO, V321, P72, DOI 10.1016/j.bbrc.2004.06.112; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; You A, 2011, ARCH BIOCHEM BIOPHYS, V507, P356, DOI 10.1016/j.abb.2010.12.034	55	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73794	10.1371/journal.pone.0073794	http://dx.doi.org/10.1371/journal.pone.0073794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040073	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500051
J	Onody, P; Stangl, R; Fulop, A; Rosero, O; Garbaisz, D; Turoczi, Z; Lotz, G; Rakonczay, Z; Balla, Z; Hegedus, V; Harsanyi, L; Szijarto, A				Onody, Peter; Stangl, Rita; Fulop, Andras; Rosero, Oliver; Garbaisz, David; Turoczi, Zsolt; Lotz, Gabor; Rakonczay, Zoltan, Jr.; Balla, Zsolt; Hegedus, Viktor; Harsanyi, Laszlo; Szijarto, Attila			Levosimendan: A Cardiovascular Drug to Prevent Liver Ischemia-Reperfusion Injury?	PLOS ONE			English	Article							K-ATP CHANNEL; HEAT-SHOCK PROTEINS; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ACTIVATION; MODEL; RATS; MICROCIRCULATION; MECHANISMS	Introduction: Temporary occlusion of the hepatoduodenal ligament leads to an ischemic-reperfusion (IR) injury in the liver. Levosimendan is a new positive inotropic drug, which induces preconditioning-like adaptive mechanisms due to opening of mitochondrial K-ATP channels. The aim of this study was to examine possible protective effects of levosimendan in a rat model of hepatic IR injury. Material and Methods: Levosimendan was administered to male Wistar rats 1 hour (early pretreatment) or 24 hours (late pretreatment) before induction of 60-minute segmental liver ischemia. Microcirculation of the liver was monitored by laser Doppler flowmeter. After 24 hours of reperfusion, liver and blood samples were taken for histology, immuno-and enzyme-histochemistry (TUNEL; PARP; NADH-TR) as well as for laboratory tests. Furthermore, liver antioxidant status was assessed and HSP72 expression was measured. Results: In both groups pretreated with levosimendan, significantly better hepatic microcirculation was observed compared to respective IR control groups. Similarly, histological damage was also reduced after levosimendan administration. This observation was supported by significantly lower activities of serum ALT (p(early) = 0.02; p(late) = 0.005), AST (p(early) = 0.02; p(late) = 0.004) and less DNA damage by TUNEL test (p(early) = 0.05; p(late) = 0.034) and PAR positivity (p(early) = 0.02; p(late) = 0.04). Levosimendan pretreatment resulted in significant improvement of liver redox homeostasis. Further, significantly better mitochondrial function was detected in animals receiving late pretreatment. Finally, HSP72 expression was increased by IR injury, but it was not affected by levosimendan pretreatment. Conclusion: Levosimendan pretreatment can be hepatoprotective and it could be useful before extensive liver resection.	[Onody, Peter; Stangl, Rita; Fulop, Andras; Rosero, Oliver; Garbaisz, David; Turoczi, Zsolt; Hegedus, Viktor; Harsanyi, Laszlo; Szijarto, Attila] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Lotz, Gabor] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Rakonczay, Zoltan, Jr.; Balla, Zsolt] Univ Szeged, Dept Med 1, Szeged, Hungary	Semmelweis University; Semmelweis University; Szeged University	Onody, P (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	peter.onody@gmail.com	David, Garbaisz/C-8022-2014; Lotz, Gábor/K-5734-2017	David, Garbaisz/0000-0001-8047-3665; Rosero, Oliver/0000-0002-9006-7238; Rakonczay Jr., Zoltan/0000-0002-1499-3416	Orion Pharma	Orion Pharma	The authors thank Orion Pharma for covering the publication fee. Orion Pharma had no influence on this study and publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008154; Blazovics A, 1999, CLIN CHEM, V45, P895; BLOIS S, 1955, BIOCHIM BIOPHYS ACTA, V18, P165, DOI 10.1016/0006-3002(55)90038-X; Das B, 2007, VASC PHARMACOL, V47, P248, DOI 10.1016/j.vph.2007.06.008; De Luca L, 2006, J AM SOC ECHOCARDIOG, V19, P172, DOI 10.1016/j.echo.2005.08.016; du Toit EF, 2008, BRIT J PHARMACOL, V154, P41, DOI 10.1038/bjp.2008.52; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Garcia-Septien J, 2010, SHOCK, V34, P275, DOI 10.1097/SHK.0b013e3181cd8c5b; Grossini E, 2009, BRIT J PHARMACOL, V156, P250, DOI 10.1111/j.1476-5381.2008.00024.x; Grossini E, 2012, J PHARMACOL EXP THER, V342, P376, DOI 10.1124/jpet.112.193961; Gurusamy KS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006315.pub2; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007629; HATANO T, 1988, CHEM PHARM BULL, V36, P2090; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Ito H, 2006, NAT CLIN PRACT CARD, V3, P499, DOI 10.1038/ncpcardio0632; Jaeschke H, 1998, J Hepatobiliary Pancreat Surg, V5, P402; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Karakus E, 2012, BASIC CLIN PHARM TOX; Kopustinskiene DM, 2001, EUR J PHARMACOL, V428, P311, DOI 10.1016/S0014-2999(01)01350-4; Kume M, 1996, J LAB CLIN MED, V128, P251, DOI 10.1016/S0022-2143(96)90026-8; KUPCSULIK P, 1977, RES EXP MED, V170, P259, DOI 10.1007/BF01851436; KUZUYA T, 1993, CIRC RES, V72, P1293, DOI 10.1161/01.RES.72.6.1293; Liaudet L, 2003, CORONARY ARTERY DIS, V14, P115, DOI 10.1097/00019501-200304000-00004; Lilleberg J, 2007, EUR J HEART FAIL, V9, P75, DOI 10.1016/j.ejheart.2006.04.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Massip-Salcedo M, 2006, AM J PATHOL, V168, P1474, DOI 10.2353/ajpath.2006.050645; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pagel PS, 1996, BRIT J PHARMACOL, V119, P609, DOI 10.1111/j.1476-5381.1996.tb15716.x; Pollesello Piero, 2004, Curr Opin Crit Care, V10, P436, DOI 10.1097/01.ccx.0000145099.20822.19; Pollesello P, 2007, J CARDIOVASC PHARM, V50, P257, DOI 10.1097/FJC.0b013e3180986230; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Radovits T, 2007, EXP BIOL MED, V232, P1204, DOI 10.3181/0701-RM-16; Rakonczay Z, 2003, J GASTROEN HEPATOL, V18, P858, DOI 10.1046/j.1440-1746.2003.03076.x; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Soeding PF, 2011, EUR J PHARMACOL, V655, P59, DOI 10.1016/j.ejphar.2010.12.035; Stangl R, 2011, J SURG RES, V166, P95, DOI 10.1016/j.jss.2009.09.047; Szijarto A, 2006, J SURG RES, V131, P150, DOI 10.1016/j.jss.2005.09.002; Szijarto A, 2007, CLIN NUTR, V26, P640, DOI 10.1016/j.clnu.2007.06.011; Tapuria N, 2009, HPB, V11, P108, DOI 10.1111/j.1477-2574.2009.00006.x; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Theruvath TP, 2008, TRANSPLANTATION, V85, P1500, DOI 10.1097/TP.0b013e31816fefb5; Tsukamoto O, 2005, BIOCHEM BIOPH RES CO, V338, P1460, DOI 10.1016/j.bbrc.2005.10.109; VANWINKLE DM, 1991, CORONARY ARTERY DIS, V2, P613; Woolsey CA, 2006, CURR OPIN CRIT CARE, V12, P155, DOI 10.1097/01.ccx.0000216584.72427.e4; Zager RA, 2006, AM J PHYSIOL-RENAL, V290, pF1453, DOI 10.1152/ajprenal.00485.2005	47	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73758	10.1371/journal.pone.0073758	http://dx.doi.org/10.1371/journal.pone.0073758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040056	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500046
J	Bai, H; Cao, YH; Quan, JZ; Dong, L; Li, ZY; Zhu, YB; Zhu, LH; Dong, ZP; Li, DY				Bai, Hui; Cao, Yinghao; Quan, Jianzhang; Dong, Li; Li, Zhiyong; Zhu, Yanbin; Zhu, Lihuang; Dong, Zhiping; Li, Dayong			Identifying the Genome-Wide Sequence Variations and Developing New Molecular Markers for Genetics Research by Re-Sequencing a Landrace Cultivar of Foxtail Millet	PLOS ONE			English	Article							SETARIA-ITALICA; AGRONOMIC TRAITS; RICE; POLYMORPHISMS; DIVERSITY; PATTERNS; MAP; DNA; IDENTIFICATION; ASSOCIATION	Foxtail millet (Setaria italica) is a drought-resistant, barren-tolerant grain crop and forage. Currently, it has become a new model plant for cereal crops and biofuel grasses. Although two reference genome sequences were released recently, comparative genomics research on foxtail millet is still in its infancy. Using the Solexa sequencing technology, we performed genome re-sequencing on one important foxtail millet Landrace, Shi-Li-Xiang (SLX). Compared with the two reference genome sequences, the following genetic variation patterns were identified: 762,082 SNPs, 26,802 insertion/deletion polymorphisms of 1 to 5 bp in length (indels), and 10,109 structural variations (SVs) between SLX and Yugu1 genomes; 915,434 SNPs, 28,546 indels and 12,968 SVs between SLX and Zhang gu genomes. Furthermore, based on the Yugu1 genome annotation, we found out that similar to 40% SNPs resided in genes containing NB-ARC domain, protein kinase or leucine-rich repeats, which had higher non-synonymous to synonymous SNPs ratios than average, suggesting that the diversification of plant disease resistance proteins might be caused by pathogen pressure. In addition, out of the polymorphisms identified between SLX and Yugu1, 465 SNPs and 146 SVs were validated with more than 90% accuracy, which could be used as DNA markers for whole-genome genotyping and marker-assisted breeding. Here, we also represented an example of fine mapping and identifying a waxy locus in SLX using these newly developed DNA markers. This work provided important information that will allow a deeper understanding of the foxtail millet genome and will be helpful for dissecting the genetic basis of important traits in foxtail millet.	[Bai, Hui; Quan, Jianzhang; Dong, Li; Li, Zhiyong; Zhu, Yanbin; Dong, Zhiping] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Hebei, Peoples R China; [Bai, Hui; Quan, Jianzhang; Dong, Li; Li, Zhiyong; Zhu, Yanbin; Dong, Zhiping] Natl Foxtail Millet Improvement Ctr, Shijiazhuang, Hebei, Peoples R China; [Bai, Hui; Cao, Yinghao; Zhu, Lihuang; Li, Dayong] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Bai, Hui; Cao, Yinghao; Zhu, Lihuang; Li, Dayong] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Zhu, Yanbin] Agr Univ Hebei, Coll Life Sci, Baoding, Hebei, Peoples R China; [Bai, Hui; Quan, Jianzhang; Dong, Li; Li, Zhiyong; Zhu, Yanbin; Dong, Zhiping] Minor Cereal Crops Lab Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Hebei Agricultural University	Dong, ZP (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Hebei, Peoples R China.	dzping001@163.com; dyli@genetics.ac.cn			National Natural Science Foundation of China [31101163, 31271787]; Twelfth Five-Year Plan of Science and Technology in Rural Areas [2011BAD06B01-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Five-Year Plan of Science and Technology in Rural Areas	This work was supported by the National Natural Science Foundation of China (31101163 and 31271787, http://www.nsfc.gov.cn) and the Twelfth Five-Year Plan of Science and Technology in Rural Areas (2011BAD06B01-1, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Arai-Kichise Y, 2011, PLANT CELL PHYSIOL, V52, P274, DOI 10.1093/pcp/pcr003; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cheng RH, 2010, J HEBEI AGR SCI, V14, P8; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Daniel Z., 2000, DOMESTICATION PLANTS; Dekker J, 2003, EVOLUTIONARY BIOL FO, P65; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Diao X, 2011, INDUSTRIAL PRODUCTIO, P20; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Falconer D. S, 1996, INTRO QUANTITATIVE G; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Kawase M, 2005, MOL GENET GENOMICS, V274, P131, DOI 10.1007/s00438-005-0013-8; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030952; Liu Ying-Hui, 2007, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V23, P531; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Mokry M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-256; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Quan J., 2010, J HEBEI AGR SCI, V14, P127; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; [袁隆平 YUAN Longping], 2011, [杂交水稻, Hybrid Rice], V26, P72; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhao LQ, 2010, SCI AGR SINICA, V43, P3705; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zidani S, 2005, AFR J BIOTECHNOL, V4, P862	50	41	52	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73514	10.1371/journal.pone.0073514	http://dx.doi.org/10.1371/journal.pone.0073514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039970	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600030
J	Chen, X; Wang, WK; Han, LZ; Liu, Y; Zhang, H; Tang, J; Liu, QZ; Huangfu, YC; Ni, YX				Chen, Xu; Wang, Wen-Kui; Han, Li-Zhong; Liu, Ying; Zhang, Hong; Tang, Jin; Liu, Qing-Zhong; Huangfu, Yu-Chan; Ni, Yu-Xing			Epidemiological and Genetic Diversity of Staphylococcus aureus Causing Bloodstream Infection in Shanghai, 2009-2011	PLOS ONE			English	Article							METHICILLIN; RESISTANCE; CFR; SUSCEPTIBILITY; IDENTIFICATION	Objectives: Staphylococcus aureus or methicillin-resistant Staphylococcus aureus (MRSA) has been an important pathogen causing bloodstream infections. Our study aimed to investigate the epidemiological and genetic diversity of clinical S. aureus isolates from patients with bloodstream infection in four hospitals of Shanghai from 2009 to 2011. Methods: A collection of S. aureus isolates causing bloodstream infection from four hospitals in the central part of Shanghai was carried out. Antimicrobial susceptibility testings of collected isolates were performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines, and spa-type, multi-locus sequence typing, agr type and toxin gene profiling were performed to explore the molecular diversity. Moreover, MRSA strains were also characterized by Staphylococcal cassette chromosome mec (SCCmec) typing. Results: The drugs such as linezolid, teicoplanin and vancomycin were efficacious for treating S. aureus including MRSA bloodstream infection. Methicillin-sensitive Staphylococcus aureus (MSSA) strains displayed distinct diversity in molecular characterization and toxin genes, and three virulent MSSA strains encoding at least five toxins were detected. Five community-associated MRSA (CA-MRSA) strains were found, but the majority (88.7%) of MRSA strains belonged to two epidemic clones (ST239-MRSA-III and ST5-MRSA-II) with different toxin gene profiles among patients with bloodstream infection. Conclusions: Healthcare-associated MRSA (HA-MRSA) strains were still the main pathogen causing bloodstream infections in spite of the emergence of CA-MRSA strains in hospital setting.	[Chen, Xu; Han, Li-Zhong; Ni, Yu-Xing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Wang, Wen-Kui] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burns, Shanghai 200030, Peoples R China; [Liu, Ying; Huangfu, Yu-Chan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Zhang, Hong] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Tang, Jin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Clin Lab, Shanghai 200030, Peoples R China; [Liu, Qing-Zhong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China.	13916291150@163.com			public welfare industry of health [201002021]; Pfizer	public welfare industry of health; Pfizer(Pfizer)	This study was supported by the research special fund for public welfare industry of health (No.201002021) and a grant of investigator-initiated research from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albur MS, 2012, EUR J CLIN MICROBIOL, V31, P295, DOI 10.1007/s10096-011-1310-2; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Chen R, 2012, CHINESE MED J-PEKING, V125, P226, DOI 10.3760/cma.j.issn.0366-6999.2012.02.012; Chen X, 2012, BURNS, V38, P738, DOI 10.1016/j.burns.2011.12.023; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Han LZ, 2010, EMERG INFECT DIS, V16, P731, DOI 10.3201/eid1604.081324; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kim JS, 2011, AM J INFECT CONTROL, V39, P640, DOI 10.1016/j.ajic.2010.11.005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuo SC, 2012, INT J ANTIMICROB AG, V39, P22, DOI 10.1016/j.ijantimicag.2011.08.014; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062, DOI 10.1128/AAC.43.5.1062; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Locke JB, 2010, ANTIMICROB AGENTS CH, V54, P5352, DOI 10.1128/AAC.00714-10; Mehndiratta PL, 2012, INDIAN J MED MICROBI, V30, P16, DOI 10.4103/0255-0857.93015; Morell Emily A., 2010, Yale Journal of Biology and Medicine, V83, P223; Otter JA, 2012, J HOSP INFECT, V81, P143, DOI 10.1016/j.jhin.2012.04.009; Perez-Roth E, 2001, J CLIN MICROBIOL, V39, P4037, DOI 10.1128/JCM.39.11.4037-4041.2001; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; [宋燕 SONG Yan], 2011, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V34, P705; Wang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030394; Wang Y, 2012, ANTIMICROB AGENTS CH, V56, P1485, DOI 10.1128/AAC.05827-11; Yamada K, 2011, TOHOKU J EXP MED, V224, P61, DOI 10.1620/tjem.224.61; Zurita J, 2010, BRAZ J INFECT DIS, V14, pS97, DOI 10.1590/S1413-86702010000800005	28	25	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72811	10.1371/journal.pone.0072811	http://dx.doi.org/10.1371/journal.pone.0072811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039803	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300029
J	Chowdhury, AA; Chaudhuri, J; Biswas, N; Manna, A; Chatterjee, S; Mahato, SK; Chaudhuri, U; Jaisankar, P; Bandyopadhyay, S				Chowdhury, Avik Acharya; Chaudhuri, Jaydeep; Biswas, Nabendu; Manna, Anirban; Chatterjee, Saurav; Mahato, Sanjit K.; Chaudhuri, Utpal; Jaisankar, Parasuraman; Bandyopadhyay, Santu			Synergistic Apoptosis of CML Cells by Buthionine Sulfoximine and Hydroxychavicol Correlates with Activation of AIF and GSH-ROS-JNK-ERK-iNOS Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRIOXIDE-INDUCED APOPTOSIS; SIGNAL-REGULATED KINASE; ARSENIC-TRIOXIDE; CANCER CELLS; GLUTATHIONE DEPLETION; BETEL LEAF; CELLULAR GLUTATHIONE; HYDROGEN-PEROXIDE; PROTEIN-KINASES	Background: Hydroxychavicol (HCH), a constituent of Piper betle leaf has been reported to exert anti-leukemic activity through induction of reactive oxygen species (ROS). The aim of the study is to optimize the oxidative stress -induced chronic myeloid leukemic (CML) cell death by combining glutathione synthesis inhibitor, buthionine sulfoximine (BSO) with HCH and studying the underlying mechanism. Materials and Methods: Anti-proliferative activity of BSO and HCH alone or in combination against a number of leukemic (K562, KCL22, KU812, U937, Molt4), non-leukemic (A549, MIA-PaCa2, PC-3, HepG2) cancer cell lines and normal cell lines (NIH3T3, Vero) was measured by MTT assay. Apoptotic activity in CML cell line K562 was detected by flow cytometry (FCM) after staining with annexinV-FITC/propidium iodide (PI), detection of reduced mitochondrial membrane potential after staining with JC-1, cleavage of caspase-3 and poly (ADP)-ribose polymerase proteins by western blot analysis and translocation of apoptosis inducing factor (AIF) by confocal microscopy. Intracellular reduced glutathione (GSH) was measured by colorimetric assay using GSH assay kit. 2',7'-dichlorodihydrofluorescein diacetate (DCF-DA) and 4-amino-5-methylamino-2',7'-difluorofluorescein (DAF-FM) were used as probes to measure intracellular increase in ROS and nitric oxide (NO) levels respectively. Multiple techniques like siRNA transfection and pharmacological inhibition were used to understand the mechanisms of action. Results: Non-apoptotic concentrations of BSO significantly potentiated HCH-induced apoptosis in K562 cells. BSO potentiated apoptosis-inducing activity of HCH in CML cells by caspase-dependent as well as caspase-independent but apoptosis inducing factor (AIF)-dependent manner. Enhanced depletion of intracellular GSH induced by combined treatment correlated with induction of ROS. Activation of ROS- dependent JNK played a crucial role in ERK1/2 activation which subsequently induced the expression of inducible nitric oxide synthase (iNOS). iNOS- mediated production of NO was identified as an effector molecule causing apoptosis of CML cells. Conclusion/Significance: BSO synergizes with HCH in inducing apoptosis of CML cells through the GSH-ROS-JNK-ERK-iNOS pathway.	[Chowdhury, Avik Acharya; Chaudhuri, Jaydeep; Biswas, Nabendu; Manna, Anirban; Bandyopadhyay, Santu] IICB, CSIR, Div Canc Biol & Inflammatory Disorder, Kolkata, India; [Chatterjee, Saurav; Mahato, Sanjit K.; Jaisankar, Parasuraman] IICB, CSIR, Div Chem, Kolkata, India; [Chaudhuri, Utpal] Coll Med, Inst Hematol & Transfus Med, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, S (corresponding author), IICB, CSIR, Div Canc Biol & Inflammatory Disorder, Kolkata, India.	santu2@iicb.res.in	Chatterjee, Sourav/W-9051-2019; MAHATO, SANJIT KUMAR/AAR-4279-2021; Jaisankar, Parasuraman/C-1553-2009	MAHATO, SANJIT KUMAR/0000-0003-4178-6583; Jaisankar, Parasuraman/0000-0003-0583-4920; Acharya Chowdhury, Avik/0000-0003-0331-0314	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Funding was provided by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMONKAR AJ, 1986, FOOD CHEM TOXICOL, V24, P1321, DOI 10.1016/0278-6915(86)90065-7; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Arai S, 2008, ACTA OTO-LARYNGOL, V128, P78, DOI 10.1080/00016480701361962; Biswas N, 2012, APOPTOSIS, V17, P612, DOI 10.1007/s10495-011-0695-9; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Chakraborty JB, 2012, CANCER SCI, V103, P88, DOI 10.1111/j.1349-7006.2011.02107.x; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Chen M, 2004, J INFECT DIS, V190, P127, DOI 10.1086/421243; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Dong Zigang, 2003, Mol Interv, V3, P306, DOI 10.1124/mi.3.6.306; Fernandez C, 2004, J BIOL CHEM, V279, P3877, DOI 10.1074/jbc.M310665200; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gao FH, 2012, INT J MOL MED, V29, P649, DOI 10.3892/ijmm.2012.895; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Harada K, 2004, IN VIVO, V18, P449; Ho SY, 2011, CHEM-BIOL INTERACT, V193, P162, DOI 10.1016/j.cbi.2011.06.007; Hwang CK, 2012, BIOSCI BIOTECH BIOCH, V76, P536, DOI 10.1271/bbb.110842; Ivanov VN, 2004, J BIOL CHEM, V279, P22747, DOI 10.1074/jbc.M314131200; Iwai-Kanai E, 2002, J CELL PHYSIOL, V190, P54, DOI 10.1002/jcp.10036; Iwama K, 2001, INT J CANCER, V92, P518, DOI 10.1002/ijc.1220; Iwashina M, 1998, CIRCULATION, V98, P1212, DOI 10.1161/01.CIR.98.12.1212; Jeng JH, 2004, CELL MOL LIFE SCI, V61, P83, DOI 10.1007/s00018-003-3272-8; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kim J, 2002, CANCER RES, V62, P1549; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Lewis-Wambi JS, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2208; Lewis-Wambi JS, 2009, J STEROID BIOCHEM, V114, P33, DOI 10.1016/j.jsbmb.2008.12.016; Losler S, 2009, ANN HEMATOL, V88, P1047, DOI 10.1007/s00277-009-0736-4; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Milella M, 2005, CURR PHARM DESIGN, V11, P2779, DOI 10.2174/1381612054546842; NAGABHUSHAN M, 1989, MUTAGENESIS, V4, P200, DOI 10.1093/mutage/4.3.200; O'Hara KA, 2007, FREE RADICAL BIO MED, V43, P1132, DOI 10.1016/j.freeradbiomed.2007.07.005; Paranjpe R, 2013, CARCINOGENESIS, V34, P1558, DOI 10.1093/carcin/bgt066; Park S, 2004, INT J BIOCHEM CELL B, V36, P2180, DOI 10.1016/j.biocel.2004.04.005; Rudin CM, 2003, CANCER RES, V63, P312; Schnelldorfer T, 2000, CANCER-AM CANCER SOC, V89, P1440, DOI 10.1002/1097-0142(20001001)89:7<1440::AID-CNCR5>3.3.CO;2-S; Sharma S, 2009, ANTIMICROB AGENTS CH, V53, P216, DOI 10.1128/AAC.00045-08; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Vanhoefer U, 1997, BIOCHEM PHARMACOL, V53, P801, DOI 10.1016/S0006-2952(97)00010-5; Vargas F, 2012, AM J HYPERTENS, V25, P629, DOI 10.1038/ajh.2011.240; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Xu K, 2001, BIOCHEM PHARMACOL, V61, P165, DOI 10.1016/S0006-2952(00)00526-8; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	51	31	34	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73672	10.1371/journal.pone.0073672	http://dx.doi.org/10.1371/journal.pone.0073672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040019	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300107
J	Fiser, B; Jojart, B; Csizmadia, IG; Viskolcz, B				Fiser, Bela; Jojart, Balazs; Csizmadia, Imre G.; Viskolcz, Bela			Glutathione - Hydroxyl Radical Interaction: A Theoretical Study on Radical Recognition Process	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; AQUEOUS-SOLUTION; HYDROGEN-BONDS; REDOX STATE; SOLVATION; ATOMS	Non-reactive, comparative (2 x 1.2 mu s) molecular dynamics simulations were carried out to characterize the interactions between glutathione (GSH, host molecule) and hydroxyl radical (OH center dot, guest molecule). From this analysis, two distinct steps were identified in the recognition process of hydroxyl radical by glutathione: catching and steering, based on the interactions between the host-guest molecules. Over 78% of all interactions are related to the catching mechanism via complex formation between anionic carboxyl groups and the OH radical, hence both terminal residues of GSH serve as recognition sites. The glycine residue has an additional role in the recognition of OH radical, namely the steering. The flexibility of the Gly residue enables the formation of further interactions of other parts of glutathione (e. g. thiol, alpha-and beta-carbons) with the lone electron pair of the hydroxyl radical. Moreover, quantum chemical calculations were carried out on selected GSH/OH center dot complexes and on appropriate GSH conformers to describe the energy profile of the recognition process. The relative enthalpy and the free energy changes of the radical recognition of the strongest complexes varied from -42.4 to -27.8 kJ/ mol and from -21.3 to 9.8 kJ/mol, respectively. These complexes, containing two or more intermolecular interactions, would be the starting configurations for the hydrogen atom migration to quench the hydroxyl radical via different reaction channels.	[Fiser, Bela; Jojart, Balazs; Csizmadia, Imre G.; Viskolcz, Bela] Univ Szeged, Dept Chem Informat, Fac Educ, Szeged, Hungary; [Csizmadia, Imre G.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada	Szeged University; University of Toronto	Jojart, B (corresponding author), Univ Szeged, Dept Chem Informat, Fac Educ, Szeged, Hungary.	jojartb@jgypk.u-szeged.hu	Viskolcz, Bela/R-3927-2017; Viskolcz, Béla/Q-6225-2019	Viskolcz, Bela/0000-0002-0777-9569; Viskolcz, Béla/0000-0002-0777-9569; Fiser, Bela/0000-0003-0603-4626	Supercomputer as a national virtual laboratory [TAMOP-4.2.2.C-11/1/KONV-2012-0010]; New functional material and their biological and environmental answers [TAMOP-4.2.2.A-11/1/KONV-2012-0047]; University of Szeged	Supercomputer as a national virtual laboratory; New functional material and their biological and environmental answers; University of Szeged(European Commission)	This work was supported by the following grants: "Supercomputer as a national virtual laboratory" (project ID: TAMOP-4.2.2.C-11/1/KONV-2012-0010) and "New functional material and their biological and environmental answers" (project ID: TAMOP-4.2.2.A-11/1/KONV-2012-0047). The publication fee was supported by "University of Szeged Talent Publishing Support". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo AP, 1999, FREE RADICAL BIO MED, V27, P936, DOI 10.1016/S0891-5849(99)00175-6; BADER RFW, 1991, CHEM REV, V91, P893, DOI 10.1021/cr00005a013; BADER RFW, 1985, ACCOUNTS CHEM RES, V18, P9, DOI 10.1021/ar00109a003; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biegler-Konig F, 2001, J COMPUT CHEM, V22, P545, DOI 10.1002/1096-987X(20010415)22:5<545::AID-JCC1027>3.0.CO;2-Y; Bowers K.J., 2006, P 2006 ACM IEEE C SU, V06, P84; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser B, 2011, J PHYS CHEM B, V115, P11269, DOI 10.1021/jp2049525; Frisch M. J., 2009, GAUSSIAN 09 REVISION; FUJIWARA S, 1977, B CHEM SOC JPN, V50, P3131, DOI 10.1246/bcsj.50.3131; Galano A, 2011, RSC ADV, V1, P1763, DOI 10.1039/c1ra00474c; Ghosh SK, 1996, J BIOSCIENCES, V21, P35, DOI 10.1007/BF02716811; GILBOA H, 1984, BIOCHIM BIOPHYS ACTA, V800, P251, DOI 10.1016/0304-4165(84)90403-3; Han Y, 2007, SCI CHINA SER B, V50, P660, DOI 10.1007/S11426-007-0080-2; Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jojart B, 2011, J MOL MODEL, V17, P2639, DOI 10.1007/s00894-011-0958-y; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lampela O, 2003, J PHYS CHEM A, V107, P9208, DOI 10.1021/jp030556j; Lipinski B, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/809696; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mayne CG, 2012, UNPUB; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mezyk SP, 1996, J PHYS CHEM-US, V100, P8861, DOI 10.1021/jp9535553; Owen MC, 2011, J PHYS CHEM B, V115, P8014, DOI 10.1021/jp202345p; PRUTZ WA, 1994, BIOPHYS CHEM, V49, P101, DOI 10.1016/0301-4622(93)E0057-C; Sampson NS, 2001, P NATL ACAD SCI USA, V98, P12870, DOI 10.1073/pnas.231391398; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SCHNEIDER HJ, 1991, ANGEW CHEM INT EDIT, V30, P1417, DOI 10.1002/anie.199114171; SJOBERG L, 1982, RADIAT RES, V89, P255, DOI 10.2307/3575771; Soriano-Correa C, 2010, J PHYS CHEM B, V114, P8961, DOI 10.1021/jp1035162; Vacha R, 2004, J PHYS CHEM A, V108, P11573, DOI 10.1021/jp046268k; Vila-Vicosa D, 2013, J PHYS CHEM B, V117, P7507, DOI 10.1021/jp401066v; Voehringer DW, 1999, FREE RADICAL BIO MED, V27, P945, DOI 10.1016/S0891-5849(99)00174-4; YORK MJ, 1987, INT J PEPT PROT RES, V29, P638; Zhang R, 2011, J MOL LIQ, V162, P20, DOI 10.1016/j.molliq.2011.05.010	40	17	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73652	10.1371/journal.pone.0073652	http://dx.doi.org/10.1371/journal.pone.0073652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040010	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300102
J	Nagano, J; Shimizu, M; Hara, T; Shirakami, Y; Kochi, T; Nakamura, N; Ohtaki, H; Ito, H; Tanaka, T; Tsurumi, H; Saito, K; Seishima, M; Moriwaki, H				Nagano, Junji; Shimizu, Masahito; Hara, Takeshi; Shirakami, Yohei; Kochi, Takahiro; Nakamura, Nobuhiko; Ohtaki, Hirofumi; Ito, Hiroyasu; Tanaka, Takuji; Tsurumi, Hisashi; Saito, Kuniaki; Seishima, Mitsuru; Moriwaki, Hisataka			Effects of Indoleamine 2,3-Dioxygenase Deficiency on High-Fat Diet-Induced Hepatic Inflammation	PLOS ONE			English	Article							REGULATORY T-CELLS; NONALCOHOLIC STEATOHEPATITIS; CRYPTOGENIC CIRRHOSIS; TRYPTOPHAN-METABOLISM; PRENEOPLASTIC LESIONS; ADIPOSE-TISSUE; LIVER-DISEASE; UP-REGULATION; OBESITY; SUSCEPTIBILITY	Hepatic immune regulation is associated with the progression from simple steatosis to non-alcoholic steatohepatitis, a severe condition of inflamed fatty liver. Indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme that mediates the catabolism of L-tryptophan to L-kynurenine, plays an important role in hepatic immune regulation. In the present study, we examined the effects of IDO gene silencing on high-fat diet (HFD)-induced liver inflammation and fibrosis in mice. After being fed a HFD for 26 weeks, the IDO-knockout (KO) mice showed a marked infiltration of inflammatory cells, especially macrophages and T lymphocytes, in the liver. The expression levels of F4/80, IFN gamma, IL-1 beta, and IL-6 mRNA in the liver and the expression levels of F4/80 and TNF-alpha mRNA in the white adipose tissue were significantly increased in IDO-KO mice, although hepatic steatosis, the accumulation of intrahepatic triglycerides, and the amount of oxidative stress were lower than those in IDO-wild-type mice. IDO-KO mice also developed marked pericellular fibrosis in the liver, accumulated hepatic hydroxyproline, and exhibited increased expression levels of hepatic TGF-beta 1 mRNA. These findings suggest that IDO-KO renders the mice more susceptible to HFD-induced hepatic inflammation and fibrosis. Therefore, IDO may have a protective effect against hepatic fibrosis, at least in this HFD-induced liver injury model.	[Nagano, Junji; Shimizu, Masahito; Hara, Takeshi; Kochi, Takahiro; Nakamura, Nobuhiko; Tsurumi, Hisashi; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Internal Med, Gifu, Japan; [Shirakami, Yohei; Ohtaki, Hirofumi; Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Dept Informat Clin Med, Sch Med, Gifu, Japan; [Tanaka, Takuji] Gifu Univ, Dept Tumor Pathol, Grad Sch Med, Gifu, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto, Japan	Gifu University; Gifu University; Gifu University; Kyoto University; Kyoto University	Shimizu, M (corresponding author), Gifu Univ, Grad Sch Med, Dept Internal Med, Gifu, Japan.	shimim-gif@umin.ac.jp						Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Brandacher G, 2006, OBES SURG, V16, P541, DOI 10.1381/096089206776945066; Caldwell SH, 2009, ANN HEPATOL, V8, P346, DOI 10.1016/S1665-2681(19)31748-X; Chang KM, 2005, HEPATOLOGY, V41, P700, DOI 10.1002/hep.20678; Chatzigeorgiou A, 2012, DIABETOLOGIA, V55, P2583, DOI 10.1007/s00125-012-2607-0; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dienes HP, 2010, DIGEST DIS, V28, P57, DOI 10.1159/000282065; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Higashitani K, 2013, J GASTROENTEROL, V48, P660, DOI 10.1007/s00535-012-0667-z; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Iwamoto N, 2009, LIVER INT, V29, P277, DOI 10.1111/j.1478-3231.2008.01748.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Li D, 2012, CELL BIOCHEM FUNCT, V30, P309, DOI 10.1002/cbf.2803; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Machado MV, 2011, EXPERT REV GASTROENT, V5, P213, DOI [10.1586/egh.11.16, 10.1586/EGH.11.16]; Maheshwari A, 2006, AM J GASTROENTEROL, V101, P664, DOI 10.1111/j.1572-0241.2006.00478.x; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Munn DH, 2011, CURR MED CHEM, V18, P2240, DOI 0929-8673/11 $58.00+.00; Ogawa K, 2012, CANCER SCI, V103, P951, DOI 10.1111/j.1349-7006.2012.02237.x; Osawa Y, 2011, J BIOL CHEM, V286, P34800, DOI 10.1074/jbc.M111.235473; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Terakura D, 2012, CARCINOGENESIS, V33, P2499, DOI 10.1093/carcin/bgs303; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolowczuk I., 2012, AM J PHYSIOL-REG I, V303, pR135, DOI DOI 10.1152/ajpregu.00373.2011; Yasuda Y, 2009, CHEM-BIOL INTERACT, V182, P159, DOI 10.1016/j.cbi.2009.07.015; Zhan YT, 2010, WORLD J GASTROENTERO, V16, P4652, DOI 10.3748/wjg.v16.i37.4652	32	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73404	10.1371/journal.pone.0073404	http://dx.doi.org/10.1371/journal.pone.0073404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039933	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300071
J	Restrepo, CM; De La Guardia, C; Sousa, OE; Calzada, JE; Fernandez, PL; Lleonart, R				Restrepo, Carlos M.; De La Guardia, Carolina; Sousa, Octavio E.; Calzada, Jose E.; Fernandez, Patricia L.; Lleonart, Ricardo			AFLP Polymorphisms Allow High Resolution Genetic Analysis of American Tegumentary Leishmaniasis Agents Circulating in Panama and Other Members of the Leishmania Genus	PLOS ONE			English	Article							ENZOOTIC CUTANEOUS LEISHMANIASIS; MOLECULAR EPIDEMIOLOGY; EASTERN PANAMA; SP-N; EVOLUTION; VIANNIA; CHROMOSOMES; PHYLOGENY; BRAZILIENSIS; TRYPANOSOMA	American Tegumentary Leishmaniasis is caused by parasites of the genus Leishmania, and causes significant health problems throughout the Americas. In Panama, Leishmania parasites are endemic, causing thousands of new cases every year, mostly of the cutaneous form. In the last years, the burden of the disease has increased, coincident with increasing disturbances in its natural sylvatic environments. The study of genetic variation in parasites is important for a better understanding of the biology, population genetics, and ultimately the evolution and epidemiology of these organisms. Very few attempts have been made to characterize genetic polymorphisms of parasites isolated from Panamanian patients of cutaneous leishmaniasis. Here we present data on the genetic variability of local isolates of Leishmania, as well as specimens from several other species, by means of Amplified Fragment Length Polymorphisms (AFLP), a technique seldom used to study genetic makeup of parasites. We demonstrate that this technique allows detection of very high levels of genetic variability in local isolates of Leishmania panamensis in a highly reproducible manner. The analysis of AFLP fingerprints generated by unique selective primer combinations in L. panamensis suggests a predominant clonal mode of reproduction. Using fluorescently labeled primers, many taxon-specific fragments were identified which may show potential as species diagnostic fragments. The AFLP permitted a high resolution genetic analysis of the Leishmania genus, clearly separating certain groups among L. panamensis specimens and highly related species such as L. panamensis and L. guyanensis. The phylogenetic networks reconstructed from our AFLP data are congruent with established taxonomy for the genus Leishmania, even when using single selective primer combinations. Results of this study demonstrate that AFLP polymorphisms can be informative for genetic characterization in Leishmania parasites, at both intra and inter-specific levels.	[Restrepo, Carlos M.; De La Guardia, Carolina; Fernandez, Patricia L.; Lleonart, Ricardo] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ciudad De Panama, Panama; [Sousa, Octavio E.] Univ Panama, Fac Med, CIDEP, Ciudad De Panama, Panama; [Calzada, Jose E.] Inst Conmemorat Gorgas Estudios Salud, Ciudad De Panama, Panama; [Restrepo, Carlos M.; De La Guardia, Carolina] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidad de Panama; Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University	Lleonart, R (corresponding author), Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ciudad De Panama, Panama.	rlleonart@indicasat.org.pa	Lleonart, Ricardo/Q-5372-2019	Lleonart, Ricardo/0000-0002-5830-6315; De La Guardia, Carolina/0000-0002-9505-0873; Llanes Fernandez, Patricia/0000-0002-0762-0566	Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama) [FID08-104]	Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama)	This work was partially supported by funds from grant FID08-104 from Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Banuls AL, 1999, AM J TROP MED HYG, V61, P838, DOI 10.4269/ajtmh.1999.61.838; Banuls AL, 1998, THESIS U SCI TECHNIQ; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Boite MC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001888; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; CHRISTENSEN HA, 1972, ANN TROP MED PARASIT, V66, P55, DOI 10.1080/00034983.1972.11686797; Christensen HA, 1999, AM J TROP MED HYG, V60, P54, DOI 10.4269/ajtmh.1999.60.54; CHRISTENSEN HA, 1983, J MED ENTOMOL, V20, P463, DOI 10.1093/jmedent/20.5.463; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; Cupolillo E, 2003, J CLIN MICROBIOL, V41, P3126, DOI 10.1128/JCM.41.7.3126-3132.2003; CUPOLILLO E, 1995, MOL BIOCHEM PARASIT, V73, P145, DOI 10.1016/0166-6851(95)00108-D; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DEVASQUEZ AM, 1990, AM J TROP MED HYG, V43, P619, DOI 10.4269/ajtmh.1990.43.619; Dujardin JC, 2007, PARASITOLOGY, V134, P33, DOI 10.1017/S0031182006001156; Evans D.A., 1987, P52; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; Fraga J, 2010, INFECT GENET EVOL, V10, P238, DOI 10.1016/j.meegid.2009.11.007; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GIANNINI SH, 1990, MOL BIOCHEM PARASIT, V39, P9, DOI 10.1016/0166-6851(90)90003-5; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HERRER A, 1971, J PARASITOL, V57, P626, DOI 10.2307/3277928; HERRER A, 1971, ANN TROP MED PARASIT, V65, P349, DOI 10.1080/00034983.1971.11686764; Holland BR, 2008, SYST BIOL, V57, P347, DOI 10.1080/10635150802044037; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [DOI 10.1111/J.1469-8137.1912.TB05611.X, 10.1111/j.1469-8137.1912.tb05611.x]; Kebede A, 1999, INT J PARASITOL, V29, P549, DOI 10.1016/S0020-7519(99)00010-7; KREUTZER RD, 1991, AM J TROP MED HYG, V44, P662, DOI 10.4269/ajtmh.1991.44.662; Kumar A, 2010, ACTA TROP, V113, P202, DOI 10.1016/j.actatropica.2009.10.006; Kumar A, 2009, ACTA TROP, V110, P80, DOI 10.1016/j.actatropica.2009.01.005; LANZER M, 1994, PARASITOL TODAY, V10, P114, DOI 10.1016/0169-4758(94)90012-4; LEON W, 1978, NUCLEIC ACIDS RES, V5, P491, DOI 10.1093/nar/5.2.491; MANTEL N, 1967, CANCER RES, V27, P209; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Miranda A, 2009, AM J TROP MED HYG, V81, P565, DOI 10.4269/ajtmh.2009.08-0265; Montalvo AM, 2010, PARASITOLOGY, V137, P1159, DOI 10.1017/S0031182010000089; Odiwuor S, 2012, INFECT GENET EVOL, V12, P1994, DOI 10.1016/j.meegid.2012.03.028; Odiwuor S, 2011, INFECT GENET EVOL, V11, P960, DOI 10.1016/j.meegid.2011.03.008; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Petersen J, 1987, Rev Med Panama, V12, P158; Restrepo C. M., 2011, Current Trends in Biotechnology and Pharmacy, V5, P1183; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Romero LI, 2004, J MICROBIOL METH, V57, P391, DOI 10.1016/j.mimet.2004.02.008; Saravia NG, 1998, AM J TROP MED HYG, V59, P86, DOI 10.4269/ajtmh.1998.59.86; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; TAKAFUJI ET, 1980, AM J TROP MED HYG, V29, P516, DOI 10.4269/ajtmh.1980.29.516; Telleria J, 2004, MOL BIOCHEM PARASIT, V137, P133, DOI 10.1016/j.molbiopara.2004.05.006; Tibayrenc M, 1999, MICROBES INFECT, V1, P465, DOI 10.1016/S1286-4579(99)80050-1; Vasquez A, 1998, INFORM FINAL ESTUDIO; Victoir K, 1998, PARASITOLOGY, V117, P1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73177	10.1371/journal.pone.0073177	http://dx.doi.org/10.1371/journal.pone.0073177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039881	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300055
J	Szittner, Z; Papp, K; Sandor, N; Bajtay, Z; Prechl, J				Szittner, Zoltan; Papp, Krisztian; Sandor, Noemi; Bajtay, Zsuzsa; Prechl, Jozsef			Application of Fluorescent Monocytes for Probing Immune Complexes on Antigen Microarrays	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN BLOOD MONOCYTES; COMPLEMENT ACTIVATION; STAPHYLOCOCCUS-AUREUS; FC-RECEPTORS; HUMAN-IGG; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ANTIBODY PROFILES; U937 CELLS; DOMAIN	Microarrayed antigens are used for identifying serum antibodies with given specificities and for generating binding profiles. Antibodies bind to these arrayed antigens forming immune complexes and are conventionally identified by secondary labelled antibodies. In the body immune complexes are identified by bone marrow derived phagocytic cells, such as monocytes. In our work we were looking into the possibility of replacing secondary antibodies with monocytoid cells for the generation of antibody profiles. Using the human monocytoid cell line U937, which expresses cell surface receptors for immune complex components, we show that cell adhesion is completely dependent on the interaction of IgG heavy chains and Fc gamma receptors, and this recognition is susceptible to differences between heavy chain structures and their glycosylation. We also report data on a possible application of this system in autoimmune diagnostics. Compared to secondary antibodies, fluorescent monocytesas biosensors are superior in reflecting biological functions of microarray-bound antibodies and represent an easy and robust alternative for profiling interactions between serum proteins and antigens.	[Szittner, Zoltan; Bajtay, Zsuzsa] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Papp, Krisztian; Sandor, Noemi; Prechl, Jozsef] Eotvos Lorand Univ, Hungarian Acad Sci, Immunol Res Grp, Budapest, Hungary; [Szittner, Zoltan; Papp, Krisztian; Prechl, Jozsef] Diagnosticum Ltd, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences	Prechl, J (corresponding author), Eotvos Lorand Univ, Hungarian Acad Sci, Immunol Res Grp, Budapest, Hungary.	jprechl@gmail.com	Prechl, József/B-2094-2009; Sándor, Noémi/AAG-1715-2021; Papp, Krisztián/B-2251-2009; bajtay, zsuzsa/AAI-1267-2020	Prechl, József/0000-0003-3859-4353; Papp, Krisztián/0000-0003-0619-8233; Sandor, Noemi/0000-0002-2461-1389	National Development Agency [KMOP 1.1.1-08/1-2008-028]; OTKA [PD104779, K104838]; Hungarian Academy of Sciences; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	National Development Agency; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by KMOP 1.1.1-08/1-2008-028 grant from the National Development Agency, OTKA PD104779 and K104838 grants and by the Hungarian Academy of Sciences. KP is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhorn M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001413; Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Belov L, 2001, CANCER RES, V61, P4483; Binstadt BA, 2003, J ALLERGY CLIN IMMUN, V111, P697, DOI 10.1067/mai.2003.1380; BOLTZNITULESCU G, 1995, J LEUKOCYTE BIOL, V58, P256, DOI 10.1002/jlb.58.2.256; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Cohen-Solal J, 2011, MOL IMMUNOL, V48, P1328, DOI 10.1016/j.molimm.2010.12.003; Defendenti C, 2011, AUTOIMMUN REV, V10, P150, DOI 10.1016/j.autrev.2010.09.005; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Katsumata Y, 2011, ARTHRITIS RHEUM-US, V63, P2436, DOI 10.1002/art.30401; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Nilsson K, 1981, Haematol Blood Transfus, V26, P215; Nimrichter L, 2004, GLYCOBIOLOGY, V14, P197, DOI 10.1093/glycob/cwh022; Okochi M, 2008, BIOCHEM BIOPH RES CO, V371, P85, DOI 10.1016/j.bbrc.2008.04.019; Pankhurst T, 2011, CLIN EXP IMMUNOL, V164, P218, DOI 10.1111/j.1365-2249.2011.04367.x; Papp K, 2012, CELL MOL LIFE SCI; Papp K, 2008, PROTEOMICS, V8, P2840, DOI 10.1002/pmic.200800014; Papp K, 2007, MOL CELL PROTEOMICS, V6, P133, DOI 10.1074/mcp.T600036-MCP200; Papp K, 2008, J IMMUNOL, V181, P8162, DOI 10.4049/jimmunol.181.11.8162; Prechl J, 2012, IMMUNOL LETT, V143, P101, DOI 10.1016/j.imlet.2012.01.011; Prechl J, 2010, TRENDS IMMUNOL, V31, P133, DOI 10.1016/j.it.2010.01.004; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Spittler A, 1997, IMMUNOLOGY, V90, P286, DOI 10.1046/j.1365-2567.1997.00148.x; SPITTLER A, 1995, IMMUNOLOGY, V85, P311; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; TAO MH, 1991, J EXP MED, V173, P1025, DOI 10.1084/jem.173.4.1025; Tetteh-Quarcoo PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034820; VERBRUGH HA, 1979, IMMUNOLOGY, V37, P615; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; WILKINSON BJ, 1978, INFECT IMMUN, V20, P388, DOI 10.1128/IAI.20.2.388-392.1978	43	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72401	10.1371/journal.pone.0072401	http://dx.doi.org/10.1371/journal.pone.0072401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039758	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600025
J	Tajiri, N; Kaneko, Y; Shinozuka, K; Ishikawa, H; Yankee, E; McGrogan, M; Case, C; Borlongan, CV				Tajiri, Naoki; Kaneko, Yuji; Shinozuka, Kazutaka; Ishikawa, Hiroto; Yankee, Ernest; McGrogan, Michael; Case, Casey; Borlongan, Cesar V.			Stem Cell Recruitment of Newly Formed Host Cells via a Successful Seduction? Filling the Gap between Neurogenic Niche and Injured Brain Site	PLOS ONE			English	Article							MARROW STROMAL CELLS; PROGENITOR CELLS; SB623 CELLS; MODEL; ISCHEMIA; NEUROPROTECTION; DIFFERENTIATION; PLASTICITY; NEURONS; STROKE	Here, we report that a unique mechanism of action exerted by stem cells in the repair of the traumatically injured brain involves their ability to harness a biobridge between neurogenic niche and injured brain site. This biobridge, visualized immunohistochemically and laser captured, corresponded to an area between the neurogenic subventricular zone and the injured cortex. That the biobridge expressed high levels of extracellular matrix metalloproteinases characterized initially by a stream of transplanted stem cells, but subsequently contained only few to non-detectable grafts and overgrown by newly formed host cells, implicates a novel property of stem cells. The transplanted stem cells manifest themselves as pathways for trafficking the migration of host neurogenic cells, but once this biobridge is formed between the neurogenic site and the injured brain site, the grafted cells disappear and relinquish their task to the host neurogenic cells. Our findings reveal that long-distance migration of host cells from the neurogenic niche to the injured brain site can be achieved through transplanted stem cells serving as biobridges for initiation of endogenous repair mechanisms. This is the first report of a stem cell-paved "biobridge". Indeed, to date the two major schools of discipline in stem cell repair mechanism primarily support the concept of "cell replacement" and bystander effects of "trophic factor secretion". The present novel observations of a stem cell seducing a host cell to engage in brain repair advances basic science concepts on stem cell biology and extracellular matrix, as well as provokes translational research on propagating this stem cell-paved biobridge beyond cell replacement and trophic factor secretion for the treatment of traumatic brain injury and other neurological disorders.	[Tajiri, Naoki; Kaneko, Yuji; Shinozuka, Kazutaka; Ishikawa, Hiroto; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Yankee, Ernest; McGrogan, Michael; Case, Casey] Sanbio Inc, Mountain View, CA USA	State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Kaneko, Yuji/J-6447-2012; Tajiri, Naoki/K-1230-2012	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X; Ishikawa, Hiroto/0000-0003-0760-7203; Shinozuka, Kazutaka/0000-0002-6435-4460	Sanbio Inc.; James and Esther King Biomedical Research Foundation [1KG01-33966]; NIH [5U01NS055914-04, 1R01NS071956-01A1]; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956, U01NS055914] Funding Source: NIH RePORTER	Sanbio Inc.; James and Esther King Biomedical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was through Sanbio Inc. CVB is additionally funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04 and NIH 1R01NS071956-01A1, Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Dao M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-81; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Ducruet AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038664; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hassani Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050444; Hawkes SP, 2010, METHODS MOL BIOL, V622, P257, DOI 10.1007/978-1-60327-299-5_16; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lin CH, 2013, NEUROBIOL DIS, V58, P76, DOI 10.1016/j.nbd.2013.05.006; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Mazzocchi-Jones D, 2009, EUR J NEUROSCI, V30, P2134, DOI 10.1111/j.1460-9568.2009.07006.x; Mezey E, 2011, J CELL BIOCHEM, V112, P2683, DOI 10.1002/jcb.23216; Park KP, 2009, STROKE, V40, P2836, DOI 10.1161/STROKEAHA.109.554824; Pastori C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002754; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Seol HJ, 2011, CANCER LETT, V311, P152, DOI 10.1016/j.canlet.2011.07.001; Sobrino T, 2012, J NEUROSCI RES, V90, P1788, DOI 10.1002/jnr.23068; Tate CC, 2010, CELL TRANSPLANT, V19, P973, DOI 10.3727/096368910X494885; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Trueman R C, 2013, Curr Top Behav Neurosci, V15, P357, DOI 10.1007/7854_2012_223; Wang L, 2011, J CEREBR BLOOD F MET, V31, P640, DOI 10.1038/jcbfm.2010.138; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	48	63	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74857	10.1371/journal.pone.0074857	http://dx.doi.org/10.1371/journal.pone.0074857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023965	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600159
J	Alhazzaa, R; Sinclair, AJ; Turchini, GM				Alhazzaa, Ramez; Sinclair, Andrew J.; Turchini, Giovanni M.			Bioconversion of alpha-Linolenic Acid into n-3 Long-Chain Polyunsaturated Fatty Acid in Hepatocytes and Ad Hoc Cell Culture Optimisation	PLOS ONE			English	Article							SELECTIVE INCORPORATION; DOCOSAHEXAENOIC ACID; ECHIUM OIL; IN-VITRO; METABOLISM; LIVER; ACCUMULATION; DESATURASE; ELONGATION; EXPRESSION	This study aimed to establish optimal conditions for a cell culture system that would allow the measurement of 18:3n-3 (ALA) bioconversion into n-3 long-chain polyunsaturated fatty acid (n-3 LC-PUFA), and to determine the overall pathway kinetics. Using rat hepatocytes (FaO) as model cells, it was established that a maximum 20:5n-3 (EPA) production from 50 mu M ALA initial concentration was achieved after 3 days of incubation. Next, it was established that a gradual increase in the ALA concentration from 0 up to 125 mu M lead to a proportional increase in EPA, without concomitant increase in further elongated or desaturated products, such as 22: 5n-3 (DPA) and 22:6n-3 (DHA) in 3 day incubations. Of interest, ALA bioconversion products were observed in the culture medium. Therefore, in vitro experiments disregarding the medium fatty acid content are underestimating the metabolism efficiency. The novel application of the fatty acid mass balance (FAMB) method on cell culture system (cells with medium) enabled quantifying the apparent enzymatic activities for the biosynthesis of n-3 LC-PUFA. The activity of the key enzymes was estimated and showed that, under these conditions, 50% (Km) of the theoretical maximal (V-max = 3654 mu mol.g(-1) of cell protein.hour(-1)) Fads2 activity on ALA can be achieved with 81 mu M initial ALA. Interestingly, the apparent activity of Elovl2 (20: 5n-3 elongation) was the slowest amongst other biosynthesis steps. Therefore, the possible improvement of Elovl2 activity is suggested toward a more efficient DHA production from ALA. The present study proposed and described an ad hoc optimised cell culture conditions and methodology towards achieving a reliable experimental platform, using FAMB, to assist in studying the efficiency of ALA bioconversion into n-3 LC-PUFA in vitro. The FAMB proved to be a powerful and inexpensive method to generate a detailed description of the kinetics of n-3 LC-PUFA biosynthesis enzymes activities in vitro.	[Alhazzaa, Ramez; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia; [Sinclair, Andrew J.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Deakin University; Deakin University	Alhazzaa, R (corresponding author), Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia.	ramez.alhazzaa@deakin.edu.au	Alhazzaa, Ramez/C-2307-2008	Alhazzaa, Ramez/0000-0001-9762-0377; Turchini, Giovanni/0000-0003-0694-4283	Australian Research Council [DP1093570]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council's Discovery Projects funding scheme (Project DP1093570). The views expressed herein are those of the authors and are not necessarily those of the Australian Research Council. R. Alhazzaa is an Alfred Deakin Post-doctoral Research Fellow at the School of Life and Environmental Sciences and the Centre for Chemistry and Biotechnology of Deakin University. G. Turchini's contribution to this study was made whilst holding an Australian Research Fellowship (ARF) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESSON B, 1970, BIOCHIM BIOPHYS ACTA, V210, P15, DOI 10.1016/0005-2760(70)90057-3; Alhazzaa R, 2013, J FUNCT FOODS, V5, P829, DOI 10.1016/j.jff.2013.01.030; Alhazzaa R, 2013, FOOD CHEM, V141, P1424, DOI 10.1016/j.foodchem.2013.04.052; Alhazzaa R, 2013, COMP BIOCHEM PHYS A, V165, P243, DOI 10.1016/j.cbpa.2013.03.019; Alhazzaa R, 2011, J AGR FOOD CHEM, V59, P8423, DOI 10.1021/jf201871w; Alhazzaa R, 2011, AQUACULTURE, V312, P162, DOI 10.1016/j.aquaculture.2010.12.023; ANGELETTI C, 1995, MOL CELL BIOCHEM, V143, P99, DOI 10.1007/BF01816942; Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; BOURRE JM, 1993, J NUTR, V123, P1313, DOI 10.1093/jn/123.7.1313; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; BRENNER RR, 1966, J BIOL CHEM, V241, P5213; Brown JE, 2005, EUR J LIPID SCI TECH, V107, P119, DOI 10.1002/ejlt.200401098; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; Christie W.W, 2003, LIPID ANAL ISOLATION, V3rd; Cleveland BJ, 2012, J NUTR, V142, P1449, DOI 10.3945/jn.112.161497; Cunnane SC, 1997, J NUTR, V127, P146, DOI 10.1093/jn/127.1.146; Cunnane SC, 2001, LIPIDS, V36, P975, DOI 10.1007/s11745-001-0808-3; Dhurandhar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047813; DIAS VC, 1995, J LIPID RES, V36, P552; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Emery JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057463; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gibson RA, 2013, PROSTAG LEUKOTR ESS, V88, P139, DOI 10.1016/j.plefa.2012.04.003; Goyens PLL, 2005, J LIPID RES, V46, P1474, DOI 10.1194/jlr.M400514-JLR200; Gregory MK, 2013, J NUTR, V143, P12, DOI 10.3945/jn.112.170290; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Gstraunthaler G, 2002, CELL CULTURE MODELS OF BIOLOGICAL BARRIERS, P112, DOI 10.1201/9780203219935.ch7; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; Harper CR, 2006, J NUTR, V136, P83, DOI 10.1093/jn/136.1.83; HILL EE, 1968, J BIOL CHEM, V243, P4440; HOLMAN RT, 1986, J AM COLL NUTR, V5, P183; Holman RT, 1998, J NUTR, V128, p427S, DOI 10.1093/jn/128.2.427S; Huang MC, 1996, J NUTR, V126, P2199, DOI 10.1093/jn/126.9.2199; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kaur G, 2011, PROSTAG LEUKOTR ESS, V85, P155, DOI 10.1016/j.plefa.2011.06.002; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; LEVINE L, 1984, J ALLERGY CLIN IMMUN, V74, P430, DOI 10.1016/0091-6749(84)90143-X; MANTZIORIS E, 1995, AM J CLIN NUTR, V61, P320, DOI 10.1093/ajcn/61.2.320; MARRA CA, 1992, MOL CELL BIOCHEM, V117, P107, DOI 10.1007/BF00230749; MARTIN LJ, 1991, LIPIDS, V26, P374, DOI 10.1007/BF02537202; MOHRHAUER H, 1963, J LIPID RES, V4, P151; NEILL AR, 1972, BIOCHEM J, V127, P375, DOI 10.1042/bj1270375; Palmeri G, 2007, FOOD CHEM, V102, P796, DOI 10.1016/j.foodchem.2006.06.018; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Portolesi R, 2007, J LIPID RES, V48, P1592, DOI 10.1194/jlr.M700081-JLR200; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Su HM, 1999, PEDIATR RES, V45, P87, DOI 10.1203/00006450-199901000-00015; Su HM, 2001, J LIPID RES, V42, P581; TINOCO J, 1983, PROG LIPID RES, V21, P1, DOI 10.1016/0163-7827(82)90015-7; Tu WC, 2013, PROSTAG LEUKOTR ESS, V88, P53, DOI 10.1016/j.plefa.2012.04.005; Turchini G, 2011, REC ADV AN NUTR AUST, P69; Turchini GM, 2008, LIPIDS, V43, P977, DOI 10.1007/s11745-008-3213-2; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Yin FQ, 1999, BBA-MOL CELL BIOL L, V1438, P63, DOI 10.1016/S1388-1981(99)00039-6	63	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73719	10.1371/journal.pone.0073719	http://dx.doi.org/10.1371/journal.pone.0073719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040040	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500044
J	Raschke, S; Elsen, M; Gassenhuber, H; Sommerfeld, M; Schwahn, U; Brockmann, B; Jung, R; Wisloff, U; Tjonna, AE; Raastad, T; Hallen, J; Norheim, F; Drevon, CA; Romacho, T; Eckardt, K; Eckel, J				Raschke, Silja; Elsen, Manuela; Gassenhuber, Hans; Sommerfeld, Mark; Schwahn, Uwe; Brockmann, Barbara; Jung, Raphael; Wisloff, Ulrik; Tjonna, Arnt E.; Raastad, Truls; Hallen, Jostein; Norheim, Frode; Drevon, Christian A.; Romacho, Tania; Eckardt, Kristin; Eckel, Juergen			Evidence against a Beneficial Effect of Irisin in Humans	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; CIRCULATING LEVELS; MUSCLE; EXPRESSION; EXERCISE; MOUSE; WHITE; CELL; FAT; IDENTIFICATION	Brown adipose tissue has gained interest as a potential target to treat obesity and metabolic diseases. Irisin is a newly identified hormone secreted from skeletal muscle enhancing browning of white fat cells, which improves systemic metabolism by increasing energy expenditure in mice. The discovery of irisin raised expectations of its therapeutic potential to treat metabolic diseases. However, the effect of irisin in humans is unclear. Analyses of genomic DNA, mRNA and expressed sequence tags revealed that FNDC5, the gene encoding the precursor of irisin, is present in rodents and most primates, but shows in humans a mutation in the conserved start codon ATG to ATA. HEK293 cells transfected with a human FNDC5 construct with ATA as start codon resulted in only 1% full-length protein compared to human FNDC5 with ATG. Additionally, in vitro contraction of primary human myotubes by electrical pulse stimulation induced a significant increase in PGC1 alpha mRNA expression. However, FNDC5 mRNA level was not altered. FNDC5 mRNA expression in muscle biopsies from two different human exercise studies was not changed by endurance or strength training. Preadipocytes isolated from human subcutaneous adipose tissue exhibited differentiation to brite human adipocytes when incubated with bone morphogenetic protein (BMP) 7, but neither recombinant FNDC5 nor irisin were effective. In conclusion, our findings suggest that it is rather unlikely that the beneficial effect of irisin observed in mice can be translated to humans.	[Raschke, Silja; Elsen, Manuela; Jung, Raphael; Romacho, Tania; Eckardt, Kristin; Eckel, Juergen] German Diabet Ctr, Paul Langerhans Grp, Dusseldorf, Germany; [Gassenhuber, Hans; Sommerfeld, Mark; Schwahn, Uwe; Brockmann, Barbara] Sanofi Aventis Deutschland GmbH, R&D Diabet Div, Frankfurt, Germany; [Wisloff, Ulrik; Tjonna, Arnt E.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Raastad, Truls; Hallen, Jostein] Norwegian Sch Sport Sci, Oslo, Norway; [Norheim, Frode; Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway	Deutsches Diabetes-Zentrum (DDZ); Sanofi-Aventis; Norwegian University of Science & Technology (NTNU); Norwegian School of Sport Sciences; University of Oslo	Eckel, J (corresponding author), German Diabet Ctr, Paul Langerhans Grp, Dusseldorf, Germany.	eckel@uni-duesseldorf.de	Romacho, Tania/AAB-3306-2021	Romacho, Tania/0000-0002-0962-7163; Norheim, Frode/0000-0002-5319-5679; Eckel, Juergen/0000-0003-3645-5288; Gassenhuber, johann/0000-0001-5338-8238	Ministerium fur Wissenschaft und Forschung des Landes Nordrhein-Westfalen (Ministry of Science and Research of the State of North Rhine-Westphalia); Bundesministerium fur Gesundheit (Federal Ministry of Health); Deutsche Forschungsgemeinschaft [EC 440/1-1]; Caja Madrid Foundation; German Federal Ministry of Education and Research (BMBF); K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; University of Oslo; Johan Throne Holst Foundation; Freia Medical Foundation; Anders Jahres Medical Research Foundation	Ministerium fur Wissenschaft und Forschung des Landes Nordrhein-Westfalen (Ministry of Science and Research of the State of North Rhine-Westphalia); Bundesministerium fur Gesundheit (Federal Ministry of Health); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Caja Madrid Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; University of Oslo; Johan Throne Holst Foundation; Freia Medical Foundation; Anders Jahres Medical Research Foundation	This work was supported by the Ministerium fur Wissenschaft und Forschung des Landes Nordrhein-Westfalen (Ministry of Science and Research of the State of North Rhine-Westphalia), the Bundesministerium fur Gesundheit (Federal Ministry of Health), and the Deutsche Forschungsgemeinschaft (EC 440/1-1). T. Romacho is the recipient of a fellowship from Caja Madrid Foundation. This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V.). Additionally, this study was funded by K.G. Jebsen Foundation, The Norwegian Council on Cardiovascular Disease, University of Oslo, The Johan Throne Holst Foundation, Freia Medical Foundation, and Anders Jahres Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, NATURE, V488, P286, DOI 10.1038/488286a; Choi YK, 2013, DIABETES RES CLIN PR; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Gauthier ER, 1997, PFLUG ARCH EUR J PHY, V433, P664, DOI 10.1007/s004240050328; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; JAMES W, 2003, COMP QUANTIFICATION, P497; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Lambernd S, 2012, DIABETOLOGIA, V55, P1128, DOI 10.1007/s00125-012-2454-z; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Lee DV, 2013, DIABETES, V62, pA25; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ronnestad BR, 2007, J STRENGTH COND RES, V21, P157, DOI 10.1519/00124278-200702000-00028; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Velho G, 2002, HORM RES, V57, P29, DOI 10.1159/000053309; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	51	234	251	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73680	10.1371/journal.pone.0073680	http://dx.doi.org/10.1371/journal.pone.0073680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040023	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500041
J	Rudolf, M; Czajka, C; Borstler, J; Melaun, C; Jost, H; von Thien, H; Badusche, M; Becker, N; Schmidt-Chanasit, J; Kruger, A; Tannich, E; Becker, S				Rudolf, Martin; Czajka, Christina; Boerstler, Jessica; Melaun, Christian; Joest, Hanna; von Thien, Heidrun; Badusche, Marlis; Becker, Norbert; Schmidt-Chanasit, Jonas; Krueger, Andreas; Tannich, Egbert; Becker, Stefanie			First Nationwide Surveillance of Culex pipiens Complex and Culex torrentium Mosquitoes Demonstrated the Presence of Culex pipiens Biotype pipiens/molestus Hybrids in Germany	PLOS ONE			English	Article							VALLEY FEVER VIRUS; DIPTERA-CULICIDAE; MOLESTUS; IDENTIFICATION; EPIDEMIOLOGY; REGION; FORMS	Mosquitoes and other arthropods may transmit medically important pathogens, in particular viruses such as West Nile virus. The presence of suitable hosts and competent vectors for those zoonotic viruses is essential for an enzootic transmission, which is a prerequisite for epidemics. To establish reliable risk projections, it is an urgent need for an exact identification of mosquito species, which is especially challenging in the case of sibling species, such as Culex. pipiens pipiens biotypes pipiens and molestus. To facilitate detection of different Culex pipiens forms and their hybrids we established a multiplex real-time PCR. Culex pipiens samples were obtained by egg raft collection and rearing until imago stage or adult sampling using CO2 baited traps and gravid traps. In total, we tested more than 16,500 samples collected all over Germany in the years 2011 and 2012. The predominant species in Germany are Culex pipiens pipiens biotype pipiens and Culex. torrentium, but we also detected Culex pipiens pipiens biotype molestus and hybrids of the two pipiens biotypes at sites where both species occur sympatrically. This report of a potentially important bridge vector for West Nile virus might have major impact in the risk projections for West Nile virus in Germany.	[Rudolf, Martin; Boerstler, Jessica; Badusche, Marlis; Becker, Stefanie] Bernhard Nocht Inst Trop Med, Mol Entomol Grp, D-20359 Hamburg, Germany; [Czajka, Christina; von Thien, Heidrun; Tannich, Egbert] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; [Joest, Hanna; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, D-20359 Hamburg, Germany; [Melaun, Christian] Biodivers & Climate Res Ctr Med Biodivers & Paras, Frankfurt, Germany; [Czajka, Christina; Joest, Hanna; Becker, Norbert] KABS eV, Waldsee, Germany; [Krueger, Andreas] Bundeswehr Hosp Hamburg, Dept Trop Med, Entomol Grp, Hamburg, Germany; [Joest, Hanna; Schmidt-Chanasit, Jonas; Tannich, Egbert] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research	Becker, S (corresponding author), Bernhard Nocht Inst Trop Med, Mol Entomol Grp, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	stefanie.mueller@bni-hamburg.de	Becker, Stefanie/AEM-2050-2022	Jost, Hanna/0000-0001-6947-8334	Leibniz Association [SAW-2011-BNI-3-29]; German Centre for Infection Research (DZIF)	Leibniz Association; German Centre for Infection Research (DZIF)	This work was financially supported by the Leibniz Association, grant number SAW-2011-BNI-3-29, and the German Centre for Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amraoui F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036757; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Danabalan R, 2012, J AM MOSQUITO CONTR, V28, P68, DOI 10.2987/8756-971X-28.0.68; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Harbach RE, 2011, ACTA TROP, V120, P1, DOI 10.1016/j.actatropica.2011.06.005; HARBACH RE, 1985, P ENTOMOL SOC WASH, V87, P1; HARBACH RE, 1984, P ENTOMOL SOC WASH, V86, P521; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Huang SM, 2009, VECTOR-BORNE ZOONOT, V9, P637, DOI 10.1089/vbz.2008.0146; MATTINGLY PF, 1951, NATURE, V168, P172, DOI 10.1038/168172a0; MEEGAN JM, 1980, AM J TROP MED HYG, V29, P1405, DOI 10.4269/ajtmh.1980.29.1405; Mohrig W, 1969, PARASITOLOG SCHRREIH, V18; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Reusken CBEM, 2010, J VECTOR ECOL, V35, P210, DOI 10.1111/j.1948-7134.2010.00050.x; SERVICE MW, 1968, J ZOOL, V156, P313; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; STRUPPE T, 1989, Zeitschrift fuer Angewandte Zoologie, V76, P257	21	84	85	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e71832	10.1371/journal.pone.0071832	http://dx.doi.org/10.1371/journal.pone.0071832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039724	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500007
J	Malloy-Diniz, LF; Lage, GM; Campos, SB; de Paula, JJ; Costa, DD; Romano-Silva, MA; de Miranda, DM; Correa, H				Malloy-Diniz, Leandro Fernandes; Lage, Guilherme Menezes; Campos, Simone Becho; de Paula, Jonas Jardim; Costa, Danielle de Souza; Romano-Silva, Marco Aurelio; de Miranda, Debora Marques; Correa, Humberto			Association between the Catechol O-Methyltransferase (COMT) Val158met Polymorphism and Different Dimensions of Impulsivity	PLOS ONE			English	Article							ATTENTION DEFICIT/HYPERACTIVITY DISORDER; DECISION-MAKING; EXECUTIVE FUNCTION; TRAIT IMPULSIVITY; NO EVIDENCE; GENOTYPE; DOPAMINE; 5-HTTLPR; BEHAVIOR; CORTEX	Background: Impulsivity is a multidimensional construct which has been associated with dopaminergic neurotransmission. Nonetheless, until this moment, few studies addressed the relationship between different types of impulsivity and the single nucleotide polymorphism caused by a substitution of valine (val) with methionine (met) in the 158 codon of the Catechol-o-Methyltransferase gene (COMT-val158met). The present study aimed to investigate the association between val158met COMT polymorphism and impulsive behavior measured by two neuropsychological tests. Methodology/Principal Findings: We administered two neuropsychological tests, a Continuous Performance Task and the Iowa Gambling Task were applied to 195 healthy participants to characterize their levels of motor, attentional and non-planning impulsivity. Then, subjects were grouped by genotype, and their scores on impulsivity measures were compared. There were no significant differences between group scores on attentional and motor impulsivity. Those participants who were homozygous for the met allele performed worse in the Iowa Gambling Task than val/val and val/met subjects. Conclusions/Significance: Our results suggest that met allele of val158met COMT polymorphism is associated with poor performance in decision-making/cognitive impulsivity task. The results reinforce the hypothesis that val and met alleles of the val158met polymorphism show functional dissociation and are related to different prefrontal processes.	[Malloy-Diniz, Leandro Fernandes; Lage, Guilherme Menezes; de Paula, Jonas Jardim; Costa, Danielle de Souza; Romano-Silva, Marco Aurelio; de Miranda, Debora Marques; Correa, Humberto] Univ Fed Minas Gerais, LIN, Belo Horizonte, MG, Brazil; [Malloy-Diniz, Leandro Fernandes; Lage, Guilherme Menezes; Campos, Simone Becho; de Paula, Jonas Jardim; Costa, Danielle de Souza; Romano-Silva, Marco Aurelio; de Miranda, Debora Marques; Correa, Humberto] Univ Fed Minas Gerais, Fac Med, INCT Med Mol, Belo Horizonte, MG, Brazil; [Malloy-Diniz, Leandro Fernandes; Romano-Silva, Marco Aurelio; Correa, Humberto] Univ Fed Minas Gerais, Fac Med, Dept Saude Mental, Belo Horizonte, MG, Brazil; [de Miranda, Debora Marques] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Malloy-Diniz, LF (corresponding author), Univ Fed Minas Gerais, LIN, Belo Horizonte, MG, Brazil.	malloy.diniz@gmail.com	Miranda, Debora/AAQ-1952-2020; Malloy-Diniz, Leandro/D-7829-2013; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021; Romano-Silva, Marco Aurelio/A-1790-2008; Correa, Humberto/B-6497-2009; Romano-Silva, Marco Aurelio/T-8321-2019; Lage, Guilherme/F-4355-2011; de Paula, Jonas J/I-8066-2012	Miranda, Debora/0000-0002-7081-8401; Malloy-Diniz, Leandro/0000-0002-6606-1354; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Correa, Humberto/0000-0003-4327-6413; Lage, Guilherme/0000-0001-8296-3676; de Paula, Jonas/0000-0001-5530-2346	INCT-MM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) [FAPEMIG: CBB-APQ-00075-09/CNPq 573646/2008-2]	INCT-MM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by INCT-MM that is financed by the Brazilian agencies for research development: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) (FAPEMIG: CBB-APQ-00075-09/CNPq 573646/2008-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, IBM SPSS STAT WIND V; ARAUJO P, 2012, DEMENT GERIATR COGN, V34, P90, DOI DOI 10.1159/000341578.PUBMED:22922787; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Bishara AJ, 2009, J BEHAV DECIS MAKING, V22, P435, DOI 10.1002/bdm.641; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Congdon E, 2008, J PERS, V76, P1447, DOI 10.1111/j.1467-6494.2008.00528.x; CONNERS CK, 2007, CONNERS CONTINUOUS P, pR2; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; COSTA A, 2012, PSYCHIAT RES, P58972; da Rocha FF, 2008, BEHAV BRAIN RES, V195, P159, DOI 10.1016/j.bbr.2008.05.015; Dalley JW, 2012, NEUROSCIENCE, V215, P42, DOI 10.1016/j.neuroscience.2012.03.065; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Glaser B, 2006, AM J PSYCHIAT, V163, P537, DOI 10.1176/appi.ajp.163.3.537; IRA E, 2013, J PSYCHIATR NEUROSCI, V26, P20178; Kang JI, 2010, NEUROPHARMACOLOGY, V58, P1109, DOI 10.1016/j.neuropharm.2010.02.001; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Lage GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016927; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LANCASTER TM, 2012, GENES BRAIN BEHAV, P954; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Liu B, 2010, NEUROIMAGE, V50, P243, DOI 10.1016/j.neuroimage.2009.12.020; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; LUIJTEN M, 2012, EUR NEUROPSYCHOPHARM, P94834; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Malloy-Diniz LF, 2008, REV BRAS PSIQUIATR, V30, P144, DOI 10.1590/S1516-44462008005000009; Malloy-Diniz LF, 2011, J AFFECT DISORDERS, V133, P221, DOI 10.1016/j.jad.2011.03.051; Marazziti D, 2010, NEUROPSYCH DIS TREAT, V6, P9; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Mills S, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-15; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Paloyelis Y, 2010, NEUROPSYCHOPHARMACOL, V35, P2414, DOI 10.1038/npp.2010.124; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Roussos P, 2008, NEUROPSYCHOLOGIA, V46, P757, DOI 10.1016/j.neuropsychologia.2007.10.009; Sevy S, 2006, PSYCHOPHARMACOLOGY, V188, P228, DOI 10.1007/s00213-006-0450-z; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Soeiro-De-Souza MG, 2013, MOL MED REP, V7, P1067, DOI 10.3892/mmr.2013.1336; Stoltenberg SF, 2008, ADDICT BEHAV, V33, P252, DOI 10.1016/j.addbeh.2007.09.004; Thomason ME, 2010, NEUROIMAGE, V53, P926, DOI 10.1016/j.neuroimage.2010.01.033; Toplak ME, 2010, CLIN PSYCHOL REV, V30, P562, DOI 10.1016/j.cpr.2010.04.002; van den Bos R, 2009, NEUROPHARMACOLOGY, V56, P493, DOI 10.1016/j.neuropharm.2008.10.002; Verdejo-Garcia A, 2013, NEUROPSYCHOPHARMACOL, V38, P1598, DOI 10.1038/npp.2013.59; Wishart HA, 2011, J INT NEUROPSYCH SOC, V17, P174, DOI 10.1017/S1355617710001402	47	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73509	10.1371/journal.pone.0073509	http://dx.doi.org/10.1371/journal.pone.0073509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039968	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600029
J	Yuan, YF; Shen, YX; Xue, L; Fan, H				Yuan, Yunfeng; Shen, Yaxing; Xue, Liang; Fan, Hong			miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor	PLOS ONE			English	Article							MICRORNAS; PATHWAY; MECHANISM; CARCINOMA	MicroRNAs (miRNAs) are a class of small noncoding RNA molecules that play important roles in carcinogenesis and tumor progression. In this study, we investigated the roles and mechanisms of miR-140 in human non-small cell lung cancer (NSCLC). We found that miR-140 is significantly downregulated in NSCLC tissues and cell lines. Both gain-of-function and loss-of-function studies demonstrated that miR-140 suppresses NSCLC cell proliferation, migration, and invasion in vitro. Importantly, overexpression of miR-140 effectively repressed tumor growth and metastasis in nude mouse models. Integrated analysis identified IGF1R as a direct and functional target of miR-140. Knockdown of IGF1R inhibited cell proliferation and invasion resembling that of miR-140 overexpression, while overexpression of IGF1R attenuated the function of miR-140 in NSCLC cells. Together, our results highlight the significance of miR-140 and IGF1R in the development and progression of NSCLC.	[Yuan, Yunfeng; Shen, Yaxing; Xue, Liang; Fan, Hong] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200433, Peoples R China	Fudan University	Fan, H (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200433, Peoples R China.	fanhong6000@126.com						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060317; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Jusufovic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045577; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Li Y, 2012, MOL BIOL CELL, V23, P1423, DOI 10.1091/mbc.E11-09-0777; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Scagliotti GV, 2012, CANCER TREAT REV, V38, P292, DOI 10.1016/j.ctrv.2011.07.008; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Wang J, 2013, ONCOGENE; Yang H, 2013, HEPATOLOGY; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	28	100	109	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73604	10.1371/journal.pone.0073604	http://dx.doi.org/10.1371/journal.pone.0073604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039995	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600032
J	Ahmed, S; Luis, AS; Bras, JLA; Ghosh, A; Gautam, S; Gupta, MN; Fontes, CMGA; Goyal, A				Ahmed, Shadab; Luis, Ana Sofia; Bras, Joana L. A.; Ghosh, Arabinda; Gautam, Saurabh; Gupta, Munishwar N.; Fontes, Carlos M. G. A.; Goyal, Arun			A Novel alpha-L-Arabinofuranosidase of Family 43 Glycoside Hydrolase (Ct43Araf) from Clostridium thermocellum	PLOS ONE			English	Article							DIVALENT METAL; WHEAT-FLOUR; BINDING; ARABINOXYLANS; ACTIVATION; PROTEINS; MODULE; ENZYME	The study describes a comparative analysis of biochemical, structural and functional properties of two recombinant derivatives from Clostridium thermocellum ATCC 27405 belonging to family 43 glycoside hydrolase. The family 43 glycoside hydrolase encoding alpha-L-arabinofuranosidase (Ct43Araf) displayed an N-terminal catalytic module CtGH43 (903 bp) followed by two carbohydrate binding modules CtCBM6A (405 bp) and CtCBM6B (402 bp) towards the C-terminal. Ct43Araf and its truncated derivative CtGH43 were cloned in pET-vectors, expressed in Escherichia coli and functionally characterized. The recombinant proteins displayed molecular sizes of 63 kDa (Ct43Araf) and 34 kDa (CtGH43) on SDS-PAGE analysis. Ct43Araf and CtGH43 showed optimal enzyme activities at pH 5.7 and 5.4 and the optimal temperature for both was 50 degrees C. Ct43Araf and CtGH43 showed maximum activity with rye arabinoxylan 4.7 Umg(-1) and 5.0 Umg(-1), respectively, which increased by more than 2-fold in presence of Ca2+ and Mg2+ salts. This indicated that the presence of CBMs (CtCBM6A and CtCBM6B) did not have any effect on the enzyme activity. The thin layer chromatography and high pressure anion exchange chromatography analysis of Ct43Araf hydrolysed arabinoxylans (rye and wheat) and oat spelt xylan confirmed the release of L-arabinose. This is the first report of alpha-L-arabinofuranosidase from C. thermocellum having the capacity to degrade both p-nitrophenol-alpha-L-arabinofuranoside and p-nitrophenol-alpha-L-arabinopyranoside. The protein melting curves of Ct43Araf and CtGH43 demonstrated that CtGH43 and CBMs melt independently. The presence of Ca2+ ions imparted thermal stability to both the enzymes. The circular dichroism analysis of CtGH43 showed 48% beta-sheets, 49% random coils but only 3% alpha-helices.	[Ahmed, Shadab; Ghosh, Arabinda; Goyal, Arun] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Gautam, Saurabh; Gupta, Munishwar N.] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Luis, Ana Sofia; Bras, Joana L. A.; Fontes, Carlos M. G. A.] CIISA Fac Med Vet, Lisbon, Portugal	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Universidade de Lisboa	Goyal, A (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	arungoyl@iitg.ernet.in	Luis, Ana/ABE-5158-2020; Gautam, Dr. Saurabh/X-6871-2019; Ghosh, Arabinda/AAS-3900-2020; Ahmed, Shadab/Y-5245-2019	Luis, Ana/0000-0002-5086-7353; Gautam, Dr. Saurabh/0000-0003-0366-6169; Ahmed, Shadab/0000-0002-9092-7963; Fontes, Carlos/0000-0002-1219-9753; Ghosh, Arabinda/0000-0002-3891-5949; Bras, Joana/0000-0002-1141-5530	Department of Biotechnology, Ministry of Science and Technology, New Delhi, Govt. of India [BT/23/NE/TBP/2010]; IIT Guwahati; Moulana Azad National Fellowship (UGC-MANF); University Grants Commission (UGC-JRF)	Department of Biotechnology, Ministry of Science and Technology, New Delhi, Govt. of India; IIT Guwahati; Moulana Azad National Fellowship (UGC-MANF); University Grants Commission (UGC-JRF)(University Grants Commission, India)	The research work was supported by a project grant (Grant No: BT/23/NE/TBP/2010) from Department of Biotechnology, Ministry of Science and Technology, New Delhi, Govt. of India to Arun Goyal. Scholarships from IIT Guwahati and Moulana Azad National Fellowship (UGC-MANF) to Shadab Ahmed and from University Grants Commission (UGC-JRF) to Arabinda Ghosh are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; Adelsberger H, 2004, MICROBIOL-SGM, V150, P2257, DOI 10.1099/mic.0.27066-0; Ahmed S, 2012, J PROTEINS PROTEOMIC, V3, P31; Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; BENGTSSON S, 1992, CARBOHYD POLYM, V17, P277, DOI 10.1016/0144-8617(92)90170-U; Bharali Sangeeta, 2005, Indian Journal of Microbiology, V45, P317; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bourgois TM, 2007, APPL MICROBIOL BIOT, V75, P1309, DOI 10.1007/s00253-007-0956-2; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; Cote GL, 2005, J IND MICROBIOL BIOT, V32, P53, DOI 10.1007/s10295-004-0194-x; Das SP, 2012, APPL BIOCHEM BIOTECH, V167, P1475, DOI 10.1007/s12010-012-9618-7; de Sanctis D, 2013, FEBS, V277, P4562; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Finkelstein AV, 2004, PHYS LIFE REV, V1, P23, DOI 10.1016/j.plrev.2004.03.001; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; GILEAD S, 1995, APPL ENVIRON MICROB, V61, P170, DOI 10.1128/AEM.61.1.170-174.1995; GRUPPEN H, 1992, J CEREAL SCI, V16, P53, DOI 10.1016/S0733-5210(09)80079-9; Guais O, 2010, APPL MICROBIOL BIOT, V87, P1007, DOI 10.1007/s00253-010-2532-4; Harris P.J., 2009, BIOMASS RECALCITRANC, P61, DOI DOI 10.1002/9781444305418.CH4; Hashimoto K, 2011, BIOSCI BIOTECH BIOCH, V75, P342, DOI 10.1271/bbb.100434; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Jordan DB, 2013, ARCH BIOCHEM BIOPHYS, V533, P79, DOI 10.1016/j.abb.2013.02.020; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CC, 2013, ENZYME MICROB TECH, V52, P84, DOI 10.1016/j.enzmictec.2012.10.010; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morais S, 2012, J BIOL CHEM, V287, P9213, DOI 10.1074/jbc.M111.314286; MORRIS PC, 2000, CEREAL BIOTECHNOLOGY; Nelson N, 1944, J BIOL CHEM, V153, P375; Numan MT, 2006, J IND MICROBIOL BIOT, V33, P247, DOI 10.1007/s10295-005-0072-1; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; Ordaz-Ortiz JJ, 2005, J CEREAL SCI, V42, P119, DOI 10.1016/j.jcs.2005.02.004; Osaki S, 2001, J NUTR, V131, P796, DOI 10.1093/jn/131.3.796; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pason P, 2010, APPL MICROBIOL BIOT, V85, P573, DOI 10.1007/s00253-009-2117-2; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Saha BC, 2000, BIOTECHNOL ADV, V18, P403, DOI 10.1016/S0734-9750(00)00044-6; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P137, DOI 10.1007/s00253-010-2988-2; SOMOGYI M, 1945, J BIOL CHEM, V160, P61; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; Taylor EJ, 2006, BIOCHEM J, V395, P31, DOI 10.1042/BJ20051780; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Zhou JG, 2012, J IND MICROBIOL BIOT, V39, P143, DOI 10.1007/s10295-011-1009-5	45	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73575	10.1371/journal.pone.0073575	http://dx.doi.org/10.1371/journal.pone.0073575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039988	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300095
J	Bandopadhyay, L; Basu, D; Sikdar, SR				Bandopadhyay, Lekha; Basu, Debabrata; Sikdar, Samir Ranjan			Identification of Genes Involved in Wild Crucifer Rorippa indica Resistance Response on Mustard Aphid Lipaphis erysimi Challenge	PLOS ONE			English	Article							MYZUS-PERSICAE; ARABIDOPSIS; DEFENSE; PROTEIN; EXPRESSION; JASMONATE; INTERACTS; TOMATO; PERFORMANCE; ACTIVATION	Mustard aphid, Lipaphis erysimi (L.) Kaltenbach is a perpetual annual threat in the cultivation of rapeseed-mustard (Brassica spp.) crop in tropical and sub-tropical climate. Cultivated Brassica germplasm has failed so far to provide any source of resistance. Wild germplasm is a potential source of resistance against many threatening herbivores. On wild germplasm screening, we noted that the wild crucifer Rorippa indica (L.) Hiern confers resistance against L. erysimi. In the present study L. erysimi challenged transcriptome of R. indica was compared to un-infested R. indica sample to get a molecular insight about the aphid resistance mechanism and identify the candidate defense response genes. Cloning, sequencing and in silico sequence analysis of complimentary DNA amplified fragment length polymorphism identified 116 differentially expressed transcript derived fragments revealed thirty candidates which are from different functional categories including redox regulation, signalling, photosynthesis, structure, metabolism, defense response as well as a few of unknown function. Twenty four identifications were then studied by quantitative real time RT PCR analysis at 6, 12, 24 and 48 hour time point post infestation to understand the early-to-late defense response through their relative gene expression profiles. Seventeen fragments showed significant up or down regulation at p<0.05 level. The response was influenced by different phytohormonal signalling pathways simultaneously. The candidate defense response expressed sequence tags specifically for the resistance genes identified in this study have implication in building desired mustard aphid resistance in susceptible rapeseed-mustard plants in future. This is the first molecular report on crucifer defense response against mustard aphid L. erysimi.	[Bandopadhyay, Lekha; Basu, Debabrata; Sikdar, Samir Ranjan] Bose Inst, Div Plant Biol, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sikdar, SR (corresponding author), Bose Inst, Div Plant Biol, Centenary Campus, Kolkata, India.	samir@jcbose.ac.in			Council of Scientific and Industrial Research, New Delhi, India [38(1244)/10/EMR-II]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This research work was supported by Council of Scientific and Industrial Research, New Delhi, India; Sanction No: 38(1244)/10/EMR-II dated 17.05.2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakhetia DR, 1987, PLANT PROTECTION FIE, P249; Bhatia V, 2011, BIOTECHNOL ADV, V29, P879, DOI 10.1016/j.biotechadv.2011.07.005; Bridges M, 2002, P ROY SOC B-BIOL SCI, V269, P187, DOI 10.1098/rspb.2001.1861; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chen H, 2005, PLANT J, V44, P396, DOI 10.1111/j.1365-313X.2005.02538.x; Cherqui A, 2003, J INSECT PHYSIOL, V49, P1199, DOI 10.1016/j.jinsphys.2003.09.004; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; Densiow SA, 2007, PLANT PHYSIOL BIOCH, V45, P152, DOI 10.1016/j.plaphy.2007.01.007; Deraison C, 2004, INSECT MOL BIOL, V13, P165, DOI 10.1111/j.0962-1075.2004.00474.x; Dutta I, 2005, PLANT SCI, V169, P996, DOI 10.1016/j.plantsci.2005.05.016; Dutta I, 2005, PLANT BIOTECHNOL J, V3, P601, DOI 10.1111/j.1467-7652.2005.00151.x; Dutta S, 2007, THESIS JADAVPUR U; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Ellis C, 2002, MOL PLANT MICROBE IN, V15, P1025, DOI 10.1094/MPMI.2002.15.10.1025; Eulgem T, 2007, PLANT J, V49, P829, DOI 10.1111/j.1365-313X.2006.02999.x; Frost M R, 1999, Nucleic Acids Res, V27, pe6, DOI 10.1093/nar/27.15.e6; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Ghanashyam C, 2009, PLANT SIGNAL BEHAV, V4, P846, DOI 10.4161/psb.4.9.9376; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hossain MA, 2006, CROP SCI, V46, P2022, DOI 10.2135/cropsci2005.11.0418; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Kanrar S, 2002, PLANT CELL REP, V20, P976, DOI 10.1007/s00299-001-0422-z; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kumar S, 2011, EUPHYTICA, V179, P461, DOI 10.1007/s10681-011-0351-z; Lawo NC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004804; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; LIN YL, 1995, PHYTOCHEMISTRY, V39, P919, DOI 10.1016/0031-9422(95)00005-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal P, 2003, CURR SCI INDIA, V85, P1451; Mandal P, 2003, THESIS JADAVPUR U KO; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Oh K, 2006, PLANTA, V224, P133, DOI 10.1007/s00425-005-0202-z; Okinaka Y, 2002, MOL PLANT MICROBE IN, V15, P1213, DOI 10.1094/MPMI.2002.15.12.1213; Patel S. R., 2004, Applied Ecology and Environmental Research, V2, P1; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Qubbaj T, 2005, ENTOMOL EXP APPL, V115, P145, DOI 10.1111/j.1570-7458.2005.00255.x; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; Shekhawat K, 2012, INT J AGRON, V2012, DOI 10.1155/2012/408284; Shiojiri K, 2005, J INSECT BEHAV, V18, P567, DOI 10.1007/s10905-005-5613-y; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Terra W. R., 1996, P206; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Tsuchiya T, 2011, MOL PLANT MICROBE IN, V24, P1573, DOI 10.1094/MPMI-05-11-0123; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; YAMANE A, 1992, J CHEM ECOL, V18, P1941, DOI 10.1007/BF00981918; YANO S, 1993, RES POPUL ECOL, V35, P349, DOI 10.1007/BF02513606; YANO S, 1994, RES POPUL ECOL, V36, P63, DOI 10.1007/BF02515086; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	62	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73632	10.1371/journal.pone.0073632	http://dx.doi.org/10.1371/journal.pone.0073632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040008	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300101
J	Conti, F; Ceccarelli, F; Massaro, L; Pacucci, VA; Miranda, F; Truglia, S; Cipriano, E; Martinelli, F; Leccese, I; Spinelli, FR; Alessandri, C; Perricone, C; Valesini, G				Conti, Fabrizio; Ceccarelli, Fulvia; Massaro, Laura; Pacucci, Viviana A.; Miranda, Francesca; Truglia, Simona; Cipriano, Enrica; Martinelli, Francesco; Leccese, Ilaria; Spinelli, Francesca Romana; Alessandri, Cristiano; Perricone, Carlo; Valesini, Guido			Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; REPORTED OUTCOMES; OSTEOARTHRITIS; MULTICENTER; VALIDATION; ARTHRITIS; PROFILE; FLARE; KNEE; TIME	Objectives: The aim of this study was to evaluate the discriminant capability of the patient acceptable symptom state (PASS) according to disease activity, in a cohort of Italian patients affected by systemic Lupus erythematosus (SLE). Methods: Consecutive SLE patients were enrolled. At each visit, the patients underwent a complete physical examination and the clinical/laboratory data were collected in a standardized, computerized, and electronically-filled form. The evaluation of serum complement C3 and C4 levels and determination of autoantibodies was obtained. Disease activity was assessed with the SLEDAI-2K and ECLAM, while chronic damage was measured with the SLICC. Finally, PASS was assessed in all patients by asking to answer yes or no to a single question. Results: One hundred sixty-five patients were enrolled (M/F 12/153; mean age 40.4+/-11.8 years, mean disease duration 109.1+/-96.2 months). No patients refused to answer, suggesting the acceptability of PASS. A total of 80% of patients rated their state as acceptable. The patients with an acceptable status had significantly lower mean SLEDAI-2K and ECLAM scores than the others [1.8+/-2.7 versus 3.4+/-2.3(P=0.004); 0.7+/-0.9 versus 1.4+/-1.1(P=0.0027)]. No significant differences were observed when considering chronic damage, evaluated with SLICC. Conclusions: In the clinical practice, SLE patients assessment performed by using complex disease activity indices such as SLEDAI-2K and ECLAM, could be time consuming. In our study, for the first time, we used PASS, a quick and easily comprehensible tool, to evaluate the patients' status, this single question seems to be able to discriminate patients with different disease activity, especially when this is determined by musculoskeletal involvement.	[Conti, Fabrizio; Ceccarelli, Fulvia; Massaro, Laura; Pacucci, Viviana A.; Miranda, Francesca; Truglia, Simona; Cipriano, Enrica; Martinelli, Francesco; Leccese, Ilaria; Spinelli, Francesca Romana; Alessandri, Cristiano; Perricone, Carlo; Valesini, Guido] Univ Roma La Sapienza, Lupus Clin, Dipartimento Med Interna & Specialita Med, I-00185 Rome, Italy	Sapienza University Rome	Perricone, C (corresponding author), Univ Roma La Sapienza, Lupus Clin, Dipartimento Med Interna & Specialita Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	carlo.perricone@gmail.com	Spinelli, Francesca Romana/AAM-7061-2020; Spinelli, Francesca Romana/F-1475-2013	Spinelli, Francesca Romana/0000-0003-1969-2097; Perricone, Carlo/0000-0003-4771-6981; , simona/0000-0001-9515-2135; Alessandri, Cristiano/0000-0003-4149-5321; Valesini, Guido/0000-0002-7757-8092				Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Ball EMA, 2012, RHEUMATOLOGY, V51, P771, DOI 10.1093/rheumatology/ker381; Colasanti T, 2012, ARTHRITIS RHEUM-US, V64, P778, DOI 10.1002/art.33400; Conti F, 2004, ARTHRITIS RES THER, V6, pR366, DOI 10.1186/ar1198; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045934; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033824; Conti F, 2011, CLIN REV ALLERG IMMU, V40, P192, DOI 10.1007/s12016-010-8208-0; Conti F, 2010, ARTHRIT CARE RES, V62, P899, DOI 10.1002/acr.20145; Dougados M, 2008, ARTHRIT RHEUM-ARTHR, V59, P553, DOI 10.1002/art.23527; Dougados M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2118; Dougados M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3859; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gladman DD, 2000, J RHEUMATOL, V27, P377; Govoni M, 2012, RHEUMATOLOGY, V51, P157, DOI 10.1093/rheumatology/ker310; Heiberg T, 2008, ANN RHEUM DIS, V67, P967, DOI 10.1136/ard.2007.077503; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kvamme MK, 2010, J RHEUMATOL, V37, P26, DOI 10.3899/jrheum.090449; Maksymowych WP, 2007, ARTHRIT RHEUM-ARTHR, V57, P133, DOI 10.1002/art.22469; Maksymowych WP, 2010, ARTHRIT CARE RES, V62, P826, DOI 10.1002/acr.20131; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Margutti P, 2005, ARTHRITIS RES THER, V7, pR896, DOI 10.1186/ar1759; McElhone K, 2007, ARTHRIT RHEUM-ARTHR, V57, P972, DOI 10.1002/art.22881; Mosca M, 2000, LUPUS, V9, P445, DOI 10.1191/096120300678828640; Mosca M, 2010, ANN RHEUM DIS, V69, P1269, DOI 10.1136/ard.2009.117200; Nikpour M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1152, DOI 10.1002/art.24741; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Priori R, 2003, LUPUS, V12, P735, DOI 10.1191/0961203303lu457oa; Rodriguez-Lozano C, 2012, J RHEUMATOL, V39, P1424, DOI 10.3899/jrheum.111481; Saag KG, 2003, J RHEUMATOL, V30, P639; Tang XH, 2010, MEDICINE, V89, P62, DOI 10.1097/MD.0b013e3181cb449c; Tubach F, 2005, ANN RHEUM DIS, V64, P34, DOI 10.1136/ard.2004.023028; Tubach F, 2012, ARTHRIT CARE RES, V64, P1699, DOI 10.1002/acr.21747; Tubach F, 2006, ARTHRIT RHEUM-ARTHR, V55, P526, DOI 10.1002/art.22110; Valesini G, 2006, ANN NY ACAD SCI, V1069, P118, DOI 10.1196/annals.1351.010; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wariaghli G, 2012, CLIN EXP RHEUMATOL, V30, P106	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73517	10.1371/journal.pone.0073517	http://dx.doi.org/10.1371/journal.pone.0073517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039971	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300087
J	Dou, Y; Zhao, Y; Zhang, ZY; Mao, HW; Tu, WW; Zhao, XD				Dou, Ying; Zhao, Yao; Zhang, Zhi-yong; Mao, Hua-wei; Tu, Wen-wei; Zhao, Xiao-dong			Respiratory Syncytial Virus Infection Induces Higher Toll-Like Receptor-3 Expression and TNF-alpha Production Than Human Metapneumovirus Infection	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; INNATE IMMUNITY; SIGNALING PATHWAY; YOUNG-CHILDREN; TRACT DISEASE; BRONCHIOLITIS; RECOGNITION; INDUCTION	Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are common causes of respiratory infections in children. Diseases caused by hMPV are generally considered to be less severe than those caused by RSV; the underlying mechanisms, however, remain unknown. In the present study, the expressions of TLRs in airway epithelial cells and lungs of BALB/c mice infected by hMPV or RSV were measured in an attempt to explore the differences in the airway inflammation caused by the two viruses. Our results demonstrate that both hMPV and RSV infection upregulated the expressions of TLRs and inflammatory cytokines. Specifically, the TLR3 expression was revealed to be elevated in vitro and in mouse lungs. IFN-alpha produced by A549 cells after RSV or hMPV infection remained undistinguishable, whereas production of TNF-alpha was significantly higher after RSV infection than hMPV infection either in the presence or absence of Poly I: C. This study provides a clue that more severe clinical syndrome of RSV infection may be due to the greater magnitude of induction of airway inflammation by RSV involving TLR3 activation and production of TNF-alpha.	[Dou, Ying] Chongqing Med Univ, Childrens Hosp, Inst Pediat, Lab Biosafety 2, Chongqing, Peoples R China; [Zhao, Xiao-dong] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Zhao, Yao] Chongqing Med Univ, Childrens Hosp, Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Zhang, Zhi-yong] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Mao, Hua-wei; Tu, Wen-wei] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Hong Kong	Zhao, XD (corresponding author), Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.	zhaoxd530@aliyun.com		Tripp, Ralph/0000-0002-2924-9956	National Natural Science Foundation of China [30730098]; Excellent Youth Foundation of Chongqing Scientific Committee (CSTC) [2008BA5040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Chongqing Scientific Committee (CSTC)	This work was supported by National Natural Science Foundation of China (30730098) and Excellent Youth Foundation of Chongqing Scientific Committee (CSTC, 2008BA5040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baron S, 2000, ANTIVIR RES, V48, P71, DOI 10.1016/S0166-3542(00)00126-1; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Garofalo R, 1996, J IMMUNOL, V157, P2506; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gern JE, 2003, AM J RESP CELL MOL, V28, P731, DOI 10.1165/rcmb.2002-0055OC; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Holtzman Michael J, 2004, Pediatr Infect Dis J, V23, pS235, DOI 10.1097/01.inf.0000144674.24802.c1; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Noah TL, 2002, CLIN IMMUNOL, V104, P86, DOI 10.1006/clim.2002.5248; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Viazov S, 2003, J CLIN MICROBIOL, V41, P3043, DOI 10.1128/JCM.41.7.3043-3045.2003; Von Linstow ML, 2004, SCAND J INFECT DIS, V36, P578, DOI 10.1080/00365540410018166; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Xie XH, 2009, PEDIATR RES, V65, P156, DOI 10.1203/PDR.0b013e318191f5c6; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Zhao MQ, 2000, J CLIN INVEST, V106, pR49, DOI 10.1172/JCI9786	47	25	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73488	10.1371/journal.pone.0073488	http://dx.doi.org/10.1371/journal.pone.0073488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039959	Green Published, gold			2022-12-25	WOS:000326405300080
J	Han, XY; Wei, B; Fang, JF; Zhang, S; Zhang, FC; Zhang, HB; Lan, TY; Lu, HQ; Wei, HB				Han, Xiao-Yan; Wei, Bo; Fang, Jia-Feng; Zhang, Shi; Zhang, Fu-Cheng; Zhang, Hai-Bo; Lan, Tian-Yun; Lu, Hui-Qiong; Wei, Hong-Bo			Epithelial-Mesenchymal Transition Associates with Maintenance of Stemness in Spheroid-Derived Stem-Like Colon Cancer Cells	PLOS ONE			English	Article							SIDE-POPULATION CELLS; TUMOR PROGRESSION; MALIGNANT-TUMOR; BETA-CATENIN; IDENTIFICATION; METASTASIS; SURVIVAL; INVASION; PATHWAY; TARGET	Despite earlier studies demonstrating characteristics of colon cancer stem cells (CCSCs) and the role of epithelial-mesenchymal transition (EMT) in tumor development, it remains controversial as to the relationship between CCSCs and EMT. In this study, in order to present an insight into this relationship in colon cancer, we developed HCT116 and HT29 sphere models, which are known to be the cells enriching cancer stem cells. Compared to their parental counterparts, spheroid cells displayed lower homotypic/heterotypic adhesion but higher in vitro migratory/invasive capacity, as well as higher tumorigenic and metastatic potential in vivo. The spheroid cells also demonstrated down-regulated E-cadherin and up-regulated alpha-SMA and Vimentin expression, which is the typical phenotype of EMT. In order to explore whether this phenomenon is associated to activation of Wnt/beta-catenin pathway, we detected several key signaling molecules. Compared with their parental cells, HCT116 and HT29 spheroid cells demonstrated down-regulated expression of GSK3 beta, but up-regulated expression of Slug and Snail. And also, the up-regulation of nucleus beta-catenin in spheroid cells indicated that the free beta-catenin transferred from cytoplasm to cell nucleus. Our findings indicate that spheroid cells have the characteristics of colon cancer stem cells, and EMT may account for their stemness and malignancy. And persistent activation of Wnt/beta-catenin pathway may play an important role in the EMT of CCSCs.	[Han, Xiao-Yan; Zhang, Fu-Cheng; Zhang, Hai-Bo; Lan, Tian-Yun; Lu, Hui-Qiong] Sun Yat Sen Univ, Affiliated Hosp 3, Cent Lab, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Bo; Fang, Jia-Feng; Zhang, Shi; Wei, Hong-Bo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wei, HB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China.	drweihb@126.com	han, xiao/HDN-9782-2022	Wei, Bo/0000-0002-1058-5888	National Science Foundation of China [81000960]; Science Foundation of Guangdong Province [10251008901000011]; Fundamental Research Funds for the Central Universities [12ykpy42]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Science Foundation of China (No. 81000960), Key Project of Science Foundation of Guangdong Province (No. 10251008901000011) and the Fundamental Research Funds for the Central Universities (No. 12ykpy42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Blavier L, 2010, CANCER BIOL THER, V10, P198, DOI 10.4161/cbt.10.2.12193; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Buda A, 2004, INT J BIOCHEM CELL B, V36, P759, DOI 10.1016/j.biocel.2003.09.004; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	35	33	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73341	10.1371/journal.pone.0073341	http://dx.doi.org/10.1371/journal.pone.0073341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039918	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300068
J	He, ZY; Wu, SG; Li, Q; Lin, Q; Xu, JJ				He, Zhenyu; Wu, Sangang; Li, Qun; Lin, Qin; Xu, Junjie			Use of the Metastatic Lymph Node Ratio to Evaluate the Prognosis of Esophageal Cancer Patients with Node Metastasis Following Radical Esophagectomy	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; STAGING SYSTEM; NUMBER; LYMPHADENECTOMY; SURVIVAL; IMPACT	Objectives: The objective of this study was to investigate the number of metastatic lymph nodes (pN) and the metastatic lymph node ratio (MLR) on the post-surgical prognosis of Chinese patients with esophageal cancer (EC) and lymph node metastasis. Methods: We enrolled 353 patients who received primary curative resection for EC from 1990 to 2003. The association of pN and MLR with 5-year overall survival (OS) was examined by receiver operating characteristic (ROC) and area under the curve (AUC) analysis. The Kaplan-Meier method was used to calculate survival rates, and survival curves were compared with the log-rank test. The Cox model was employed for univariate and multivariate analyses of factors associated with 5-year OS. Results: The median follow-up time was 41 months, and the 1-, 3- and 5-year OS rates were 71.2%, 30.4%, and 19.5%, respectively. Univariate analysis showed that age, pN stage, and the MLR were prognostic factors for OS. Patients with MLRs less than 0.15, MLRs of 0.15-0.30, and MLRs greater than 0.30 had 5-year OS rates of 30.1%, 17.8%, and 9.5%, respectively (p < 0.001). Patients classified as pN1, pN2, and pN3 had 5-year OS rates of 23.7%, 11.4%, and 9.9%, respectively (p < 0.001). Multivariate analysis indicated that a high MLR and advanced age were significant and independent risk factors for poor OS. Patients classified as pN2 had significantly worse OS than those classified as pN1 (p = 0.022), but those classified as pN3 had similar OS as those classified as pN1 (p = 0.166). ROC analysis indicated that MLR (AUC = 0.585, p = 0.016) had better predictive value than pN (AUC = 0.565, p = 0.068). Conclusions: The integrated use of MLR and pN may be suitable for evaluation of OS in Chinese patients with EC and positive nodal metastasis after curative resection.	[He, Zhenyu; Li, Qun; Xu, Junjie] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [He, Zhenyu; Li, Qun; Xu, Junjie] Guangdong Esophageal Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Sangang; Lin, Qin] Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen Canc Ctr, Xiamen, Fujian, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Xiamen University	Li, Q (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	liqun0799@126.com	Wu, San-Gang/AAA-8959-2022		Science and Technology Plan of Guangdong Province [2007B031516005]; Youth Research Development Fund of the First Affiliated Hospital of Xiamen University [XYY2012005]	Science and Technology Plan of Guangdong Province; Youth Research Development Fund of the First Affiliated Hospital of Xiamen University	The paper is supported by a grant from the Science and Technology Plan of Guangdong Province(No.2007B031516005), and the Youth Research Development Fund of the First Affiliated Hospital of Xiamen University, (No.XYY2012005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Barbour AP, 2007, ANN SURG ONCOL, V14, P306, DOI 10.1245/s10434-006-9166-x; Bogoevski D, 2008, ANN SURG, V247, P633, DOI 10.1097/SLA.0b013e3181656d07; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; Esophageal Carcinoma Cooperative Group of Radiation Oncology Society of Chinese Medical Association, 2010, Chin J Cancer, V29, P855; Hsu PK, 2010, ANN THORAC SURG, V89, P1024, DOI 10.1016/j.athoracsur.2010.01.017; Hsu WH, 2009, J GASTROINTEST SURG, V13, P1913, DOI 10.1007/s11605-009-0982-8; Kelty CJ, 2010, J THORAC ONCOL, V5, P1467, DOI 10.1097/JTO.0b013e3181e8f6b1; Kuwano H, 2008, ESOPHAGUS, V5, P117, DOI DOI 10.1007/s10388-008-0158-8; Kuwano H, 2008, ESOPHAGUS, V5, P61, DOI [10.1007/s10388-008-0151-2, DOI 10.1007/s10388-008-0151-2]; Liu YP, 2010, EJSO-EUR J SURG ONC, V36, P155, DOI 10.1016/j.ejso.2009.09.005; Mariette C, 2008, ANN SURG, V247, P365, DOI 10.1097/SLA.0b013e31815aaadf; Peyre CG, 2008, ANN SURG, V248, P549, DOI 10.1097/SLA.0b013e318188c474; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Siewert JR, 2007, SEMIN RADIAT ONCOL, V17, P38, DOI 10.1016/j.semradonc.2006.09.007; Sobin, 2009, UICC TNM CLASSIFICAT; Stahl M, 2009, ANN ONCOL, V20, P32, DOI 10.1093/annonc/mdp121; Thota R, 2011, J CLIN ONCOL S4, V29; Udagawa H, 2001, DIS ESOPHAGUS, V14, P110, DOI 10.1046/j.1442-2050.2001.00166.x; Wilson M, 2008, J SURG RES, V146, P11, DOI 10.1016/j.jss.2007.07.028; Yang HX, 2011, ANN THORAC SURG, V92, P216, DOI 10.1016/j.athoracsur.2011.03.032; Yang HX, 2010, ANN SURG ONCOL, V17, P1901, DOI 10.1245/s10434-010-0948-9	21	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73446	10.1371/journal.pone.0073446	http://dx.doi.org/10.1371/journal.pone.0073446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039944	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300075
J	Lavelin, I; Wolfenson, H; Patla, I; Henis, YI; Medalia, O; Volberg, T; Livne, A; Kam, Z; Geiger, B				Lavelin, Irena; Wolfenson, Haguy; Patla, Israel; Henis, Yoav I.; Medalia, Ohad; Volberg, Tova; Livne, Ariel; Kam, Zvi; Geiger, Benjamin			Differential Effect of Actomyosin Relaxation on the Dynamic Properties of Focal Adhesion Proteins	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; CELL-ADHESION; EXTRACELLULAR-MATRIX; PAXILLIN; CYTOSKELETON; SUFFICIENT; KINETICS; VINCULIN; TENSION; ZYXIN	Treatment of cultured cells with inhibitors of actomyosin contractility induces rapid deterioration of stress fibers, and disassembly of the associated focal adhesions (FAs). In this study, we show that treatment with the Rho kinase inhibitor Y-27632, which blocks actomyosin contractility, induces disarray in the FA-associated actin bundles, followed by the differential dissociation of eight FA components from the adhesion sites. Live-cell microscopy indicated that the drug triggers rapid dissociation of VASP and zyxin from FAs (tau values of 7-8 min), followed by talin, paxillin and ILK (tau similar to 16 min), and then by FAK, vinculin and kindlin-2 (tau = 25-28 min). Examination of the molecular kinetics of the various FA constituents, using Fluorescence Recovery After Photobleaching (FRAP), in the absence of or following short-term treatment with the drug, revealed major changes in the k(on) and k(off) values of the different proteins tested, which are in close agreement with their differential dissociation rates from the adhesion sites. These findings indicate that mechanical, actomyosin-generated forces differentially regulate the molecular kinetics of individual FA-associated molecules, and thereby modulate FA composition and stability.	[Lavelin, Irena; Volberg, Tova; Livne, Ariel; Kam, Zvi; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Wolfenson, Haguy; Henis, Yoav I.] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Patla, Israel; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Patla, Israel; Medalia, Ohad] Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel; [Medalia, Ohad] Univ Zurich, Dept Biochem, Zurich, Switzerland	Weizmann Institute of Science; Tel Aviv University; Ben Gurion University; Ben Gurion University; University of Zurich	Geiger, B (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il	Wolfenson, Haguy/AAC-7601-2020	Henis, Yoav/0000-0002-1408-3877; Medalia, Ohad/0000-0003-0994-2937	National Institutes of Health (NIH) Common Fund Nanomedicine Program [PN2 EY016586]; NoE Systems Microscopy Grant [258068]; European Union; ERC [243047 INCEL]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Common Fund Nanomedicine Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NoE Systems Microscopy Grant; European Union(European Commission); ERC(European Research Council (ERC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health (NIH) Common Fund Nanomedicine Program (PN2 EY016586), an NoE Systems Microscopy Grant no. 258068, funded through the European Union's Seventh Framework Programme (to BG), and an ERC Starting Grant 243047 INCEL (to OM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Berkovich R, 2011, TRAFFIC, V12, P1648, DOI 10.1111/j.1600-0854.2011.01264.x; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Case LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026631; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Dubash AD, 2009, INT REV CEL MOL BIO, V277, P1, DOI 10.1016/S1937-6448(09)77001-7; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; GARRELS JI, 1989, J BIOL CHEM, V264, P5283; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Grosheva I, 2006, EXP EYE RES, V82, P945, DOI 10.1016/j.exer.2006.01.006; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pasquet JM, 2002, THROMB HAEMOSTASIS, V88, P115; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; Uemura A, 2011, BIOPHYS J, V101, P1069, DOI 10.1016/j.bpj.2011.08.001; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577; Zamir E, 1999, J CELL SCI, V112, P1655; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901	53	40	40	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73549	10.1371/journal.pone.0073549	http://dx.doi.org/10.1371/journal.pone.0073549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039980	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326405300091
J	Nykyri, J; Mattinen, L; Niemi, O; Adhikari, S; Koiv, V; Somervuo, P; Fang, X; Auvinen, P; Mae, A; Palva, ET; Pirhonen, M				Nykyri, Johanna; Mattinen, Laura; Niemi, Outi; Adhikari, Satish; Koiv, Viia; Somervuo, Panu; Fang, Xin; Auvinen, Petri; Mae, Andres; Palva, E. Tapio; Pirhonen, Minna			Role and Regulation of the Flp/Tad Pilus in the Virulence of Pectobacterium atrosepticum SCRI1043 and Pectobacterium wasabiae SCC3193	PLOS ONE			English	Article							WIDESPREAD COLONIZATION ISLAND; CAROTOVORA SUBSP ATROSEPTICA; PATHOGEN ERWINIA-CAROTOVORA; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; TAD LOCUS; NONSPECIFIC ADHERENCE; BIOFILM FORMATION; GENE-EXPRESSION; PROTEIN	In this study, we characterized a putative Flp/Tad pilus-encoding gene cluster, and we examined its regulation at the transcriptional level and its role in the virulence of potato pathogenic enterobacteria of the genus Pectobacterium. The Flp/Tad pilus-encoding gene clusters in Pectobacterium atrosepticum, Pectobacterium wasabiae and Pectobacterium aroidearum were compared to previously characterized flp/tad gene clusters, including that of the well-studied Flp/Tad pilus model organism Aggregatibacter actinomycetemcomitans, in which this pilus is a major virulence determinant. Comparative analyses revealed substantial protein sequence similarity and open reading frame synteny between the previously characterized flp/tad gene clusters and the cluster in Pectobacterium, suggesting that the predicted flp/tad gene cluster in Pectobacterium encodes a Flp/Tad pilus-like structure. We detected genes for a novel two-component system adjacent to the flp/tad gene cluster in Pectobacterium, and mutant analysis demonstrated that this system has a positive effect on the transcription of selected Flp/Tad pilus biogenesis genes, suggesting that this response regulator regulate the flp/tad gene cluster. Mutagenesis of either the predicted regulator gene or selected Flp/Tad pilus biogenesis genes had a significant impact on the maceration ability of the bacterial strains in potato tubers, indicating that the Flp/Tad pilus-encoding gene cluster represents a novel virulence determinant in Pectobacterium. Soft-rot enterobacteria in the genera Pectobacterium and Dickeya are of great agricultural importance, and an investigation of the virulence of these pathogens could facilitate improvements in agricultural practices, thus benefiting farmers, the potato industry and consumers.	[Nykyri, Johanna; Mattinen, Laura; Adhikari, Satish; Fang, Xin; Pirhonen, Minna] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Niemi, Outi; Palva, E. Tapio] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Koiv, Viia; Mae, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Somervuo, Panu; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Tartu; University of Helsinki	Pirhonen, M (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	minna.pirhonen@helsinki.fi	Mäe, Andres/AAE-8876-2021; Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021	Auvinen, Petri/0000-0002-3947-4778; Nykyri, Johanna/0000-0001-5065-2830; Pirhonen, Minna/0000-0001-5249-563X; Niemi, Outi/0000-0002-4277-6259	Academy of Finland [128566]; University of Helsinki; Finnish Doctoral Program in Plant Science; Viikki Doctoral Programme in Molecular Biosciences; Niemi Foundation (Koisjarvi, Finland); Finnish Cultural Foundation; Olvi Foundation (Iisalmi, Finland); Future Fund (University of Helsinki); Department of Agricultural Sciences, the Estonian Science Foundation [SF0180088s08]	Academy of Finland(Academy of Finland); University of Helsinki; Finnish Doctoral Program in Plant Science; Viikki Doctoral Programme in Molecular Biosciences; Niemi Foundation (Koisjarvi, Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Olvi Foundation (Iisalmi, Finland); Future Fund (University of Helsinki); Department of Agricultural Sciences, the Estonian Science Foundation	The authors gratefully acknowledge the support of Academy of Finland grant no. 128566, University of Helsinki, The Finnish Doctoral Program in Plant Science, The Viikki Doctoral Programme in Molecular Biosciences, The Niemi Foundation (Koisjarvi, Finland), The Finnish Cultural Foundation, The Olvi Foundation (Iisalmi, Finland), The Future Fund (University of Helsinki) and Department of Agricultural Sciences, the Estonian Science Foundation Grant SF0180088s08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; Bernard CS, 2009, J BACTERIOL, V191, P1961, DOI 10.1128/JB.01330-08; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Czajkowski R, 2011, PLANT PATHOL, DOI DOI 10.1111/J.1365-3059.2011.02470.X/ABSTRACT.ACCESSED; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evans TJ, 2010, J APPL MICROBIOL, V109, P505, DOI 10.1111/j.1365-2672.2010.04669.x; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; HINTON JCD, 1985, J BACTERIOL, V161, P786, DOI 10.1128/JB.161.2.786-788.1985; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kitaoka M, 2011, J BACTERIOL, V193, P6471, DOI 10.1128/JB.05414-11; Koiv V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054248; Kram KE, 2008, J BACTERIOL, V190, P3859, DOI 10.1128/JB.00128-08; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Nika JR, 2002, INFECT IMMUN, V70, P2965, DOI 10.1128/IAI.70.6.2965-2975.2002; Nykyri J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003013; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Perez BA, 2006, J BACTERIOL, V188, P6361, DOI 10.1128/JB.00496-06; Perez-Cheeks BA, 2012, MOL MICROBIOL, V83, P694, DOI 10.1111/j.1365-2958.2011.07955.x; Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0; PIRHONEN M, 1988, MICROB PATHOGENESIS, V4, P359, DOI 10.1016/0882-4010(88)90063-0; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Pitman AR, 2010, EUR J PLANT PATHOL, V126, P423, DOI 10.1007/s10658-009-9551-y; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Pollumaa L, 2012, SENSORS-BASEL, V12, P3327, DOI 10.3390/s120303327; Schilling J, 2010, J BACTERIOL, V192, P3809, DOI 10.1128/JB.01672-09; SUMMERS WC, 1970, ANAL BIOCHEM, V33, P459; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tomich M, 2006, J BACTERIOL, V188, P6899, DOI 10.1128/JB.00690-06; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Wairuri CK, 2012, MOL PLANT MICROBE IN, V25, P546, DOI 10.1094/MPMI-06-11-0166	43	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73718	10.1371/journal.pone.0073718	http://dx.doi.org/10.1371/journal.pone.0073718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040039	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300116
J	Singh, M; Gadepalli, R; Dhawan, B; Mukhopadhyay, K				Singh, Madhuri; Gadepalli, Ravisekhar; Dhawan, Benu; Mukhopadhyay, Kasturi			Combination of Alpha-Melanocyte Stimulating Hormone with Conventional Antibiotics against Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL PEPTIDES; INVITRO ACTIVITY; TIME-KILL; RIFAMPIN; GENTAMICIN; DAPTOMYCIN; VANCOMYCIN; MECHANISM; SUSCEPTIBILITY	Our previous studies revealed that alpha-melanocyte stimulating hormone (alpha-MSH) is strongly active against Staphylococcus aureus (S. aureus) including methicillin resistant S. aureus (MRSA). Killing due to alpha-MSH occurred by perturbation of the bacterial membrane. In the present study, we investigated the in vitro synergistic potential of alpha-MSH with five selected conventional antibiotics viz., oxacillin (OX), ciprofloxacin (CF), tetracycline (TC), gentamicin (GM) and rifampicin (RF) against a clinical MRSA strain which carried a type III staphylococcal cassette chromosome mec (SCCmec) element and belonged to the sequence type (ST) 239. The strain was found to be highly resistant to OX (minimum inhibitory concentration (MIC) = 1024 mg/ml) as well as to other selected antimicrobial agents including alpha-MSH. The possibility of the existence of intracellular target sites of alpha-MSH was evaluated by examining the DNA, RNA and protein synthesis pathways. We observed a synergistic potential of alpha-MSH with GM, CF and TC. Remarkably, the supplementation of alpha-MSH with GM, CF and TC resulted in >= 64-, 8- and 4-fold reductions in their minimum bactericidal concentrations (MBCs), respectively. Apart from membrane perturbation, in this study we found that alpha-MSH inhibited similar to 53% and similar to 47% DNA and protein synthesis, respectively, but not RNA synthesis. Thus, the mechanistic analogy between alpha-MSH and CF or GM or TC appears to be the reason for the observed synergy between them. In contrast, alpha-MSH did not act synergistically with RF which may be due to its inability to inhibit RNA synthesis (<10%). Nevertheless, the combination of alpha-MSH with RF and OX showed an enhanced killing by similar to 45% and similar to 70%, respectively, perhaps due to the membrane disrupting properties of alpha-MSH. The synergistic activity of alpha-MSH with antibiotics is encouraging, and promises to restore the lost potency of discarded antibiotics.	[Singh, Madhuri; Mukhopadhyay, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Gadepalli, Ravisekhar; Dhawan, Benu] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mukhopadhyay, K (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	kasturim@mail.jnu.ac.in	Gadepalli, Ravisekhar/AAU-2636-2020	Singh, Madhuri/0000-0001-8569-8599	Indian Council of Medical Research, India and Department of Biotechnology, India	Indian Council of Medical Research, India and Department of Biotechnology, India	This work is supported by the grants from Indian Council of Medical Research, India and Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakere G, 2009, FEMS MICROBIOL LETT, V292, P141, DOI 10.1111/j.1574-6968.2008.01482.x; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Cohen MA, 1998, J ANTIMICROB CHEMOTH, V41, P605, DOI 10.1093/jac/41.6.605; Credito K, 2007, ANTIMICROB AGENTS CH, V51, P1504, DOI 10.1128/AAC.01455-06; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Entenza JM, 2011, ANTIMICROB AGENTS CH, V55, P3977, DOI 10.1128/AAC.00402-11; Fry DE, 2011, SURG INFECT, V12, P191, DOI 10.1089/sur.2011.068; Gadepalli R, 2009, J HOSP INFECT, V73, P253, DOI 10.1016/j.jhin.2009.07.021; Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; JAWETZ E, 1968, ANNU REV PHARMACOLOG, V8, P151, DOI 10.1146/annurev.pa.08.040168.001055; Khanavi M, 2010, BIOL RES, V43, P31, DOI [10.4067/S0716-97602010000100005, /S0716-97602010000100005]; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krogstad DJ, 1980, ANTIBIOTICS LABORATO, P300; Kronvall G, 2006, J ANTIMICROB CHEMOTH, V57, P498, DOI 10.1093/jac/dki489; Leszczynska K, 2010, APMIS, V118, P830, DOI 10.1111/j.1600-0463.2010.02667.x; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Madhuri, 2009, PEPTIDES, V30, P1627, DOI 10.1016/j.peptides.2009.06.020; Menzel TM, 2011, ANTIMICROB AGENTS CH, V55, P311, DOI 10.1128/AAC.00586-10; MINUTH JN, 1974, ANTIMICROB AGENTS CH, V6, P411, DOI 10.1128/AAC.6.4.411; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Nadrah Kristina, 2011, Chemother Res Pract, V2011, P619321, DOI 10.1155/2011/619321; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otter JA, 2008, CLIN MICROBIOL INFEC, V14, P670, DOI 10.1111/j.1469-0691.2008.02017.x; Pankey GA, 2011, DIAGN MICR INFEC DIS, V70, P561, DOI 10.1016/j.diagmicrobio.2011.05.003; Park Y, 2006, BBA-PROTEINS PROTEOM, V1764, P24, DOI 10.1016/j.bbapap.2005.10.019; POGWIZD SM, 1976, ANTIMICROB AGENTS CH, V10, P878, DOI 10.1128/AAC.10.6.878; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rishi P, 2011, ANTIMICROB AGENTS CH, V55, P4176, DOI 10.1128/AAC.00273-11; Sakoulas G, 2012, ANTIMICROB AGENTS CH, V56, P838, DOI 10.1128/AAC.05551-11; Sanfilippo CM, 2011, CHEMOTHERAPY, V57, P363, DOI 10.1159/000330858; Schafer JA, 2006, J ANTIMICROB CHEMOTH, V58, P108, DOI 10.1093/jac/dkl216; Shireen T, 2012, PEPTIDES, V37, P334, DOI 10.1016/j.peptides.2012.05.025; Singh M, 2011, ANTIMICROB AGENTS CH, V55, P1920, DOI 10.1128/AAC.00957-10; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Tiwari Hare Krishna, 2008, Infect Drug Resist, V1, P57; TRACZEWSKI MM, 1983, ANTIMICROB AGENTS CH, V23, P571, DOI 10.1128/AAC.23.4.571; TUAZON CU, 1978, ANTIMICROB AGENTS CH, V13, P759, DOI 10.1128/AAC.13.5.759; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; van der Linden DS, 2009, BIOTECHNOL LETT, V31, P1265, DOI 10.1007/s10529-009-0010-9; Wong A, 2010, ANTIMICROB AGENTS CH, V54, P742, DOI 10.1128/AAC.00621-09; Wu K, 2013, EUR J CLIN MICROBIOL, V32, P33, DOI 10.1007/s10096-012-1711-x; Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1111, DOI 10.1128/AAC.43.5.1111; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Yenugu S, 2004, ENDOCRINOLOGY, V145, P3165, DOI 10.1210/en.2003-1698; Yenugu S, 2010, J PEPT SCI, V16, P337, DOI 10.1002/psc.1246; Yount NY, 2012, ANNU REV PHARMACOL, V52, P337, DOI 10.1146/annurev-pharmtox-010611-134535; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	57	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73815	10.1371/journal.pone.0073815	http://dx.doi.org/10.1371/journal.pone.0073815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040081	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300132
J	De Jong, AM; Van Gelder, IC; Vreeswijk-Baudoin, I; Cannon, MV; Van Gilst, WH; Maass, AH				De Jong, Anne Margreet; Van Gelder, Isabelle C.; Vreeswijk-Baudoin, Inge; Cannon, Megan V.; Van Gilst, Wiek H.; Maass, Alexander H.			Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload	PLOS ONE			English	Article							MITRAL-VALVE DISEASE; STRUCTURAL-CHANGES; HEART-FAILURE; MATRIX METALLOPROTEINASES; CARDIAC-HYPERTROPHY; OVINE MODEL; RAT HEARTS; FIBRILLATION; MICE; FIBROSIS	Background: Atrial fibrillation (AF) is often preceded by underlying cardiac diseases causing ventricular pressure overload. Objective: It was our aim to investigate the progression of atrial remodeling in a small animal model of ventricular pressure overload and its association with induction of AF. Methods: Male mice were subjected to transverse aortic constriction (TAC) or sham operation. After four or eight weeks, echocardiographic measurements and hemodynamic measurements were made and AF induction was tested. The hearts were either fixed in formalin or ventricles and atria were separated, weighed and snap-frozen for RNA analysis. Results: Four weeks of pressure overload induced ventricular hypertrophy and minor changes in the atria. After eight weeks a significant reduction in left ventricular function occurred, associated with significant atrial remodeling including increased atrial weight, a trend towards an increased left atrial cell diameter, atrial dilatation and increased expression of markers of hypertrophy and inflammation. Histologically, no fibrosis was found in the left atrium. But atrial gene expression related to fibrosis was increased. Minor changes related to electrical remodeling were observed. AF inducibility was not different between the groups. Left ventricular end diastolic pressures were increased and correlated with the severity of atrial remodeling but not with AF induction. Conclusion: Permanent ventricular pressure overload by TAC induced atrial remodeling, including hypertrophy, dilatation and inflammation. The extent of atrial remodeling was directly related to LVEDP and not duration of TAC per se.	[De Jong, Anne Margreet; Van Gelder, Isabelle C.; Vreeswijk-Baudoin, Inge; Cannon, Megan V.; Van Gilst, Wiek H.; Maass, Alexander H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 AB Groningen, Netherlands; [De Jong, Anne Margreet] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Groningen; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Maass, AH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 AB Groningen, Netherlands.	a.h.maass@umcg.nl	van Gilst, Wiek/R-1806-2019; Maass, Alexander/B-8534-2008	van Gilst, Wiek/0000-0003-2968-8585; Maass, Alexander/0000-0002-7936-360X	Medtronic; Biotronik	Medtronic(Medtronic); Biotronik	This work was supported by Medtronic and Biotronik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016; Boixel C, 2003, J AM COLL CARDIOL, V42, P336, DOI 10.1016/S0735-1097(03)00578-3; Boldt A, 2003, J AM COLL CARDIOL, V42, P1785, DOI 10.1016/j.jacc.2003.07.014; Brundel BJJM, 2001, CIRCULATION, V103, P684; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Choisy SCM, 2007, HYPERTENSION, V49, P498, DOI 10.1161/01.HYP.0000257123.95372.ab; Corradi D, 2012, J CARDIOVASC ELECTR, V23, P271, DOI 10.1111/j.1540-8167.2011.02187.x; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Everett TH, 2000, CIRCULATION, V102, P1454, DOI 10.1161/01.CIR.102.12.1454; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kim SJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P761, DOI 10.1161/CIRCEP.111.964783; Kimura S, 2011, HYPERTENS RES, V34, P584, DOI 10.1038/hr.2010.277; Kistler PM, 2006, EUR HEART J, V27, P3045, DOI 10.1093/eurheartj/ehl360; Kume O, 2011, HEART RHYTHM, V8, P278, DOI 10.1016/j.hrthm.2010.10.029; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Levy S, 1999, CIRCULATION, V99, P3028, DOI 10.1161/01.CIR.99.23.3028; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942; Maass AH, 2004, CIRCULATION, V110, P2102, DOI 10.1161/01.CIR.0000144460.84795.E3; Maesen B, 2012, EUROPACE, V14, P159, DOI 10.1093/europace/eur208; Medi C, 2011, J CARDIOVASC ELECTR, V22, P1317, DOI 10.1111/j.1540-8167.2011.02125.x; Nishida K, 2010, EUROPACE, V12, P160, DOI 10.1093/europace/eup328; Olgin JE, 2002, CARDIOVASC RES, V54, P280, DOI 10.1016/S0008-6363(02)00225-0; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; van Deel ED, 2011, J MOL CELL CARDIOL, V50, P1017, DOI 10.1016/j.yjmcc.2011.01.016; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wang XJ, 1999, J MOL CELL CARDIOL, V31, P307, DOI 10.1006/jmcc.1998.0884; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Zhang DL, 2011, J MOL CELL CARDIOL, V51, P381, DOI 10.1016/j.yjmcc.2011.06.008; Zile MR, 2012, AM J PHYSIOL-HEART C, V302, pH1429, DOI 10.1152/ajpheart.00580.2011	34	32	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72651	10.1371/journal.pone.0072651	http://dx.doi.org/10.1371/journal.pone.0072651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039788	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500024
J	de Mello, RA; Ferreira, M; Soares-Pires, F; Costa, S; Cunha, J; Oliveira, JCP; Hespanhol, V; Reis, RM				de Mello, Ramon Andrade; Ferreira, Monica; Soares-Pires, Filipa; Costa, Sandra; Cunha, Joao; Oliveira, Pedro; Hespanhol, Venceslau; Reis, Rui Manuel			The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; PHASE-III TRIAL; 1ST-LINE THERAPY; FACTOR RECEPTOR; SURVIVAL; SUSCEPTIBILITY; BEVACIZUMAB; GENE; GEMCITABINE	Introduction: Polymorphic variants in the 5p15, 6p12, 6p21, and 15q25 loci were demonstrated to potentially contribute to lung cancer carcinogenesis. Therefore, this study was performed to assess the role of those variants in non-small cell lung cancer (NSCLC) risk and prognosis in a Portuguese population. Materials and Methods: Blood from patients with NSCLC was prospectively collected. To perform an association study, DNA from these patients and healthy controls were genotyped for a panel of 19 SNPs using a Sequenom (R) MassARRAY platform. Kaplan-Meier curves were used to assess the overall survival (OS) and progression-free survival (PFS). Results: One hundred and forty-four patients with NSCLC were successfully consecutively genotyped for the 19 SNPs. One SNP was associated with NSCLC risk: rs9295740 G/A. Two SNPs were associated with non-squamous histology: rs3024994 (VEGF intron 2) T/C and rs401681 C/T. Three SNPs were associated with response rate: rs3025035 (VEGF intron 7) C/T, rs833061 (VEGF -460) C/T and rs9295740 G/A. One SNP demonstrated an influence on PFS: rs401681 C/T at 5p15, p = 0.021. Four SNPs demonstrated an influence on OS: rs2010963 (VEGF +405 G/C), p = 0.042; rs3025010 (VEGF intron 5 C/T), p = 0.047; rs401681 C/T at 5p15, p = 0.046; and rs31489 C/A at 5p15, p = 0.029. Conclusions: Our study suggests that SNPs in the 6p12, 6p21, and 5p15 loci may serve as risk, predictive and prognostic NSCLC biomarkers. In the future, SNPs identified in the genomes of patients may improve NSCLC screening strategies and therapeutic management as well.	[de Mello, Ramon Andrade; Hespanhol, Venceslau] Univ Porto FMUP, Fac Med, Dept Med, Oporto, Portugal; [de Mello, Ramon Andrade] Inst Portugues Oncol Francisco Gentil IPO PORTO, Dept Med Oncol, Oporto, Portugal; [Ferreira, Monica; Costa, Sandra; Reis, Rui Manuel] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Ferreira, Monica; Costa, Sandra; Reis, Rui Manuel] PT Govt Associate Lab, 3Bs, Braga, Portugal; [Soares-Pires, Filipa; Hespanhol, Venceslau] Univ Porto, Fac Med, Ctr Hosp Sao Joao, Dept Pneumol, P-4100 Oporto, Portugal; [Oliveira, Pedro] Hosp Sao Marcos, Dept Pneumol, Braga, Portugal; [Oliveira, Pedro] Univ Porto, Abel Salazar Biomed Sci Inst ICBAS, Dept Populat Studies, P-4100 Oporto, Portugal; [Reis, Rui Manuel] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, SP, Brazil	Universidade do Porto; Universidade do Minho; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Hospital de Cancer de Barretos	de Mello, RA (corresponding author), Univ Porto FMUP, Fac Med, Dept Med, Oporto, Portugal.	ramondemello@gmail.com; rreis@ecsaude.uminho.pt	Reis, Rui M/C-2859-2009; Reis, Rui Manuel/B-1744-2018; De+Mello, Ramon Andrade/ABG-4463-2020; Costa, Sandra/B-4253-2011; Costa, Sandra/AAV-7175-2020; Reis, Rui Manuel/AAD-6470-2020; Oliveira, Pedro/B-2224-2010	Reis, Rui M/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; De+Mello, Ramon Andrade/0000-0002-9640-4573; Costa, Sandra/0000-0001-6795-4245; Costa, Sandra/0000-0001-6795-4245; Reis, Rui Manuel/0000-0002-9639-7940; Oliveira, Pedro/0000-0002-2470-0795; Guimaraes, Filipa/0000-0002-8603-9357; Hespanhol, Venceslau/0000-0001-6577-0063	Programa Doutoral em Medicina e Oncologia Molecular, University of Porto, Porto, Portugal; University of Minho, Braga, Portugal	Programa Doutoral em Medicina e Oncologia Molecular, University of Porto, Porto, Portugal; University of Minho, Braga, Portugal	This project was supported by Programa Doutoral em Medicina e Oncologia Molecular, University of Porto, Porto, Portugal and University of Minho, Braga, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Araujo A, 2012, REV PORT PNEUMOL, V18, P244, DOI 10.1016/j.rppneu.2012.04.011; Bae EY, 2012, RESPIROLOGY, V17, P699, DOI 10.1111/j.1440-1843.2012.02165.x; Bieniasz M, 2009, LUNG CANCER, V66, P319, DOI 10.1016/j.lungcan.2009.02.020; Saad IAB, 2007, SAO PAULO MED J, V125, P46, DOI 10.1590/S1516-31802007000100009; Carvalho L, 2009, REV PORT PNEUMOL, V15, P67; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Dahlberg SE, 2010, J CLIN ONCOL, V28, P949, DOI 10.1200/JCO.2009.25.4482; Dajczman E, 2008, J THORAC ONCOL, V3, P1133, DOI 10.1097/JTO.0b013e318186a272; de Mello RA, 2013, BIOCH BASIS THERAPEU; De Mello RA, 2012, CLINICS, V67, P1349, DOI 10.6061/clinics/2012(11)22; de Mello RA, 2012, TUMOR BIOL, V33, P2061, DOI 10.1007/s13277-012-0465-5; de Mello RA, 2012, TUMOR BIOL, V33, P1341, DOI 10.1007/s13277-012-0382-7; de Mello RA, 2012, RECENT PAT ANTI-CANC, V7, P118; de Mello RA, 2011, WORLD J CLIN ONCOL, V2, P367, DOI 10.5306/wjco.v2.i11.367; Dias Olívia Meira, 2006, Sao Paulo Med. J., V124, P125, DOI 10.1590/S1516-31802006000300003; Dong J, 2010, CARCINOGENESIS, V31, P1080, DOI 10.1093/carcin/bgq079; Dong Qianggang, 2002, Zhonghua Zhongliu Zazhi, V24, P142; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Heist RS, 2008, J CLIN ONCOL, V26, P856, DOI 10.1200/JCO.2007.13.5947; Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lee SJ, 2005, CANCER EPIDEM BIOMAR, V14, P571, DOI 10.1158/1055-9965.EPI-04-0472; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Masago K, 2009, CANCER SCI, V100, P1917, DOI 10.1111/j.1349-7006.2009.01253.x; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Naik NA, 2012, TUMOR BIOL, V33, P833, DOI 10.1007/s13277-011-0306-y; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wünsch-Filho Victor, 2002, Sao Paulo Med. J., V120, P38, DOI 10.1590/S1516-31802002000200003; Zhai RH, 2008, CLIN CANCER RES, V14, P612, DOI 10.1158/1078-0432.CCR-07-1655	39	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72373	10.1371/journal.pone.0072373	http://dx.doi.org/10.1371/journal.pone.0072373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039754	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500016
J	Diaz-Ruiz, A; Rabanal-Ruiz, Y; Travez, A; Gracia-Navarro, F; Cruz-Garcia, D; Montero-Hadjadje, M; Anouar, Y; Gasman, S; Vitale, N; Vazquez-Martinez, R; Malagon, MM				Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Travez, Andres; Gracia-Navarro, Francisco; Cruz-Garcia, David; Montero-Hadjadje, Maite; Anouar, Youssef; Gasman, Stephane; Vitale, Nicolas; Vazquez-Martinez, Rafael; Malagon, Maria M.			The Long Coiled-Coil Protein NECC2 Is Associated to Caveolae and MODULATES NGF/TrkA Signaling IN PC12 CELLS	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PRESYNAPTIC ACTIVE ZONE; CHOLESTEROL-RICH DOMAINS; LIPID RAFTS; RNA INTERFERENCE; PLASMA-MEMBRANE; TRKA; RECEPTOR; GOLGI; PHOSPHORYLATION	TrkA-mediated NGF signaling in PC12 cells has been shown to be compartimentalized in specialized microdomains of the plasma membrane, the caveolae, which are organized by scaffold proteins including the member of the caveolin family of proteins, caveolin-1. Here, we characterize the intracellular distribution as well as the biochemical and functional properties of the neuroendocrine long coiled-coil protein 2 (NECC2), a novel long coiled-coil protein selectively expressed in neuroendocrine tissues that contains a predicted caveolin-binding domain and displays structural characteristics of a scaffolding factor. NECC2 distributes in caveolae, wherein it colocalizes with the TrkA receptor, and behaves as a caveolae-associated protein in neuroendocrine PC12 cells. In addition, stimulation of PC12 cells with nerve growth factor (NGF) increased the expression and regulated the distribution of NECC2. Interestingly, knockdown as well as overexpression of NECC2 resulted in a reduction of NGF-induced phosphorylation of the TrkA downstream effector extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) but not of Akt. Altogether, our results identify NECC2 as a novel component of caveolae in PC12 cells and support the contribution of this protein in the maintenance of TrkA-mediated NGF signaling.	[Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Travez, Andres; Gracia-Navarro, Francisco; Cruz-Garcia, David; Vazquez-Martinez, Rafael; Malagon, Maria M.] Univ Cordoba, Inst Maimonides Invest Biomed IMIBIC, Dept Cell Biol Physiol & Immunol, Reina Sofia Univ Hosp, Cordoba, Spain; [Montero-Hadjadje, Maite; Anouar, Youssef] Univ Rouen, Inst Res & Innovat Biomed, INSERM U982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Mont St Aignan, France; [Gasman, Stephane; Vitale, Nicolas] CNRS, INCI, UPR 3212, Strasbourg, France; [Gasman, Stephane; Vitale, Nicolas] Univ Strasbourg, Strasbourg, France	Universidad de Cordoba; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Malagon, MM (corresponding author), Univ Cordoba, Inst Maimonides Invest Biomed IMIBIC, Dept Cell Biol Physiol & Immunol, Reina Sofia Univ Hosp, Cordoba, Spain.	bc1mapom@uco.es	Gasman, Stephane/D-5113-2017; Anouar, Youssef/F-9683-2017; stéphane, gasman/Q-1145-2019; Malagon, Maria M/L-5386-2014; Vazquez-Martinez, Rafael/G-1243-2016; Montero-Hadjadje, Maite/AAC-5692-2019; Cruz-Garcia, David/R-4705-2018; Rabanal, Yoana/R-9471-2019; Vitale, Nicolas/G-5967-2014	Gasman, Stephane/0000-0001-8415-1276; stéphane, gasman/0000-0001-8415-1276; Malagon, Maria M/0000-0002-2419-2727; Montero-Hadjadje, Maite/0000-0001-8859-893X; Cruz-Garcia, David/0000-0001-5808-8488; Rabanal, Yoana/0000-0003-1904-8218; Vitale, Nicolas/0000-0002-4752-4907; Diaz-Ruiz, Alberto/0000-0002-0488-4216; Gracia Navarro, Francisco/0000-0003-2128-4228	MINECO/FEDER [BFU2010-17116]; J. Andalucia/FEDER [CTS-6606]; CIBERobn (Instituto de Salud Carlos III), Spain; Agence Nationale de la Recherche [ANR-09-BLAN-0326-01]	MINECO/FEDER(Spanish Government); J. Andalucia/FEDER; CIBERobn (Instituto de Salud Carlos III), Spain; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by MINECO/FEDER (BFU2010-17116), J. Andalucia/FEDER (CTS-6606), CIBERobn (Instituto de Salud Carlos III), Spain, and by Agence Nationale de la Recherche Grant ANR-09-BLAN-0326-01 (to NV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Begle A, 2009, J BIOL CHEM, V284, P4836, DOI 10.1074/jbc.M806894200; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Braun JEA, 2000, J NEUROSCI, V20, P5997, DOI 10.1523/JNEUROSCI.20-16-05997.2000; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Bronfman FC, 2007, DEV NEUROBIOL, V67, P1183, DOI 10.1002/dneu.20513; Bu J, 2003, J NEUROSCI RES, V72, P185, DOI 10.1002/jnr.10556; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Cruz-Garcia D, 2007, FEBS LETT, V581, P3149, DOI 10.1016/j.febslet.2007.06.002; Cruz-Garcia D, 2012, BIOCHEM J, V443, P387, DOI 10.1042/BJ20110554; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Gaudreault SB, 2005, J NEUROCHEM, V92, P831, DOI 10.1111/j.1471-4159.2004.02917.x; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Gordon DE, 2009, EMBO REP, V10, P851, DOI 10.1038/embor.2009.96; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hanson CA, 2013, TRAFFIC; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Jung EJ, 2010, BIOCHEM BIOPH RES CO, V402, P736, DOI 10.1016/j.bbrc.2010.10.097; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Peiro S, 2000, J BIOL CHEM, V275, P37846, DOI 10.1074/jbc.M000487200; Pryor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035163; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodriguez-Pacheco F, 2009, ENDOCRINOLOGY, V150, P4643, DOI 10.1210/en.2009-0116; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Schmitz M, 2010, J NEUROSCI RES, V88, P572, DOI 10.1002/jnr.22235; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Steindler C, 2004, J BIOL CHEM, V279, P43168, DOI 10.1074/jbc.M401915200; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Stralfors P, 2012, ADV EXP MED BIOL, V729, P111, DOI 10.1007/978-1-4614-1222-9_8; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Vidal RL, 2007, MOL CELL NEUROSCI, V35, P501, DOI 10.1016/j.mcn.2007.04.008; Vidal RL, 2012, MOL CELL NEUROSCI, V51, P1, DOI 10.1016/j.mcn.2012.07.007; Vidal RL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-37; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Yu T, 2011, TRAFFIC, V12, P521, DOI 10.1111/j.1600-0854.2010.01156.x; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	60	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73668	10.1371/journal.pone.0073668	http://dx.doi.org/10.1371/journal.pone.0073668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040018	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500054
J	Yonezawa, H; Osaki, T; Hanawa, T; Kurata, S; Ochiai, K; Kamiya, S				Yonezawa, Hideo; Osaki, Takako; Hanawa, Tomoko; Kurata, Satoshi; Ochiai, Kuniyasu; Kamiya, Shigeru			Impact of Helicobacter pylori Biofilm Formation on Clarithromycin Susceptibility and Generation of Resistance Mutations	PLOS ONE			English	Article							HUMAN GASTRIC-MUCOSA; 23S RIBOSOMAL-RNA; BACTERIAL BIOFILMS; CONSENSUS REPORT; INFECTION; MANAGEMENT; SEQUENCE; JAPAN; GENE; METRONIDAZOLE	The human gastric pathogen Helicobacter pylori forms biofilms in vitro and in vivo. The purpose of this study was to evaluate the effects of H. pylori biofilm formation in vitro on clarithromycin (CLR) susceptibility. CLR susceptibility of H. pylori intermediate (2-day) and mature (3-day) biofilms on glass coverslips was determined at concentrations from 0.03 to 0.5 mu g/ml. H. pylori biofilm biomass was increased after treatment with CLR at minimum inhibitory concentration levels by up to 4-fold (2-day biofilm) and 16-fold (3-day biofilm). Minimum bactericidal concentrations of CLR against cells in a biofilm were higher (1.0 mu g/ml) than that for planktonic cells (0.25 mu g/ml). It was shown that the expression of efflux pump genes was significantly increased in biofilm cells. In addition, exposure of biofilms to CLR resulted in high level resistance generation compared to planktonic cells with increased resistance associated with the presence of a point mutation at either position 2142 or 2143 in the domain V loop of the 23S rRNA gene. These results demonstrate that H. pylori biofilm formation decreases the susceptibility to CLR and that H. pylori CLR resistance mutations are more frequently generated in biofilms than in planktonic cells.	[Yonezawa, Hideo; Osaki, Takako; Hanawa, Tomoko; Kurata, Satoshi; Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Tokyo, Japan; [Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 101, Japan	Kyorin University; Nihon University	Yonezawa, H (corresponding author), Kyorin Univ, Sch Med, Dept Infect Dis, Tokyo, Japan.	yonezawa@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology [23590518, 24593166]; Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1001024]; Asahi Glass Foundation and Health and Labour Sciences Research; Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research [23590518] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation and Health and Labour Sciences Research; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants for Scientific Research 23590518 and 24593166 from the Ministry of Education, Culture, Sport, Science and Technology, and a grant for Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024). This work was also partially supported by the Asahi Glass Foundation and Health and Labour Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek RJ, 1998, AM J GASTROENTEROL, V93, P386, DOI 10.1016/S0002-9270(97)00110-X; Adams JL, 1999, APPL ENVIRON MICROB, V65, P4285; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; BODE G, 1993, EPIDEMIOL INFECT, V111, P483, DOI 10.1017/S0950268800057216; Cammarota G, 2012, ALIMENT PHARM THER, V36, P222, DOI 10.1111/j.1365-2036.2012.05165.x; Carron MA, 2006, J GASTROINTEST SURG, V10, P712, DOI 10.1016/j.gassur.2005.10.019; Cellini L, 2008, J APPL MICROBIOL, V105, P761, DOI 10.1111/j.1365-2672.2008.03808.x; Cellini L, 2008, SCAND J GASTROENTERO, V43, P178, DOI 10.1080/00365520701675965; Cole SP, 2004, J BACTERIOL, V186, P3124, DOI 10.1128/JB.186.10.3124-3132.2004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Coticchia JM, 2006, J GASTROINTEST SURG, V10, P883, DOI 10.1016/j.gassur.2005.12.009; Desai M, 1998, J ANTIMICROB CHEMOTH, V42, P153, DOI 10.1093/jac/42.2.153; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522; Fujimura Shigeru, 2004, Journal of Infection and Chemotherapy, V10, P128, DOI 10.1007/s10156-004-0300-z; Garcia-Arata MI, 1999, ANTIMICROB AGENTS CH, V43, P374, DOI 10.1128/AAC.43.2.374; Graham DY, 1996, AM J GASTROENTEROL, V91, P1072; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Hirata K, 2010, J GASTROEN HEPATOL, V25, pS75, DOI 10.1111/j.1440-1746.2009.06220.x; Horiki N, 2009, HELICOBACTER, V14, P86, DOI 10.1111/j.1523-5378.2009.00714.x; Kobayashi I, 2007, J CLIN MICROBIOL, V45, P4006, DOI 10.1128/JCM.00740-07; Lind T, 1999, GASTROENTEROLOGY, V116, P248, DOI 10.1016/S0016-5085(99)70119-8; Liu ZQ, 2008, WORLD J GASTROENTERO, V14, P5217, DOI 10.3748/wjg.14.5217; Macia MD, 2011, ANTIMICROB AGENTS CH, V55, P5230, DOI 10.1128/AAC.00617-11; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MARSHALL BJ, 1984, LANCET, V1, P1311; Megraud F, 1998, GUT, V43, pS61, DOI 10.1136/gut.43.2008.S61; Mulet X, 2009, ANTIMICROB AGENTS CH, V53, P1552, DOI 10.1128/AAC.01264-08; Nakagawa S, 2005, CLIN DIAGN LAB IMMUN, V12, P347, DOI 10.1128/CDLI.12.2.347-353.2005; Nakamura M, 2003, HELICOBACTER, V8, P294, DOI 10.1046/j.1523-5378.2003.00156.x; Noguchi N, 2007, J MED MICROBIOL, V56, P1174, DOI 10.1099/jmm.0.47302-0; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Stark RM, 1999, LETT APPL MICROBIOL, V28, P121, DOI 10.1046/j.1365-2672.1999.00481.x; Taylor DE, 1997, ANTIMICROB AGENTS CH, V41, P2621, DOI 10.1128/AAC.41.12.2621; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Amsterdam K, 2005, ANTIMICROB AGENTS CH, V49, P1477, DOI 10.1128/AAC.49.4.1477-1482.2005; Versalovic J, 1997, J ANTIMICROB CHEMOTH, V40, P283, DOI 10.1093/jac/40.2.283; Wang GE, 2001, ANTIMICROB AGENTS CH, V45, P727, DOI 10.1128/AAC.45.3.727-733.2001; Yang FL, 2011, HELICOBACTER, V16, P89, DOI 10.1111/j.1523-5378.2010.00815.x; Yonezawa H, 2011, ANAEROBE, V17, P388, DOI 10.1016/j.anaerobe.2011.03.020; Yonezawa H, 2010, J GASTROEN HEPATOL, V25, pS90, DOI 10.1111/j.1440-1746.2009.06213.x; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197	48	50	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73301	10.1371/journal.pone.0073301	http://dx.doi.org/10.1371/journal.pone.0073301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039906	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500037
J	Yu, XK; Jin, L; Jih, J; Shih, CH; Zhou, ZH				Yu, Xuekui; Jin, Lei; Jih, Jonathan; Shih, Chiaho; Zhou, Z. Hong			3.5 angstrom cryoEM Structure of Hepatitis B Virus Core Assembled from Full-Length Core Protein	PLOS ONE			English	Article							ARGININE-RICH DOMAIN; E-ANTIGEN; CAPSID PROTEIN; ESCHERICHIA-COLI; PARTICLES; MODEL; VISUALIZATION; ENCAPSIDATION; DETERMINANTS; STABILITY	The capsid shell of infectious hepatitis B virus (HBV) is composed of 240 copies of a single protein called HBV core antigen (HBc). An atomic model of a core assembled from truncated HBc was determined previously by X-ray crystallography. In an attempt to obtain atomic structural information of HBV core in a near native, non-crystalline environment, we reconstructed a 3.5 angstrom-resolution structure of a recombinant core assembled from full-length HBc by cryo electron microscopy (cryoEM) and derived an atomic model. The structure shows that the 240 molecules of full-length HBc form a core with two layers. The outer layer, composed of the N-terminal assembly domain, is similar to the crystal structure of the truncated HBc, but has three differences. First, unlike the crystal structure, our cryoEM structure shows no disulfide bond between the Cys61 residues of the two subunits within the dimer building block, indicating such bond is not required for core formation. Second, our cryoEM structure reveals up to four more residues in the linker region (amino acids 140-149). Third, the loops in the cryoEM structures containing this linker region in subunits B and C are oriented differently (similar to 30 degrees and similar to 90 degrees) from their counterparts in the crystal structure. The inner layer, composed of the C-terminal arginine-rich domain (ARD) and the ARD-bound RNAs, is partially-ordered and connected with the outer layer through linkers positioned around the two-fold axes. Weak densities emanate from the rims of positively charged channels through the icosahedral three-fold and local three-fold axes. We attribute these densities to the exposed portions of some ARDs, thus explaining ARD's accessibility by proteases and antibodies. Our data supports a role of ARD in mediating communication between inside and outside of the core during HBV maturation and envelopment.	[Yu, Xuekui; Jin, Lei; Jih, Jonathan; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Yu, Xuekui; Jin, Lei; Jih, Jonathan; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Shih, Chiaho] Acad Sinica, Inst Biomed Sci IBMS, Taipei, Taiwan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Academia Sinica - Taiwan	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	Hong.Zhou@ucla.edu	Shih, Chiaho/S-7017-2018; Zhou, Z Hong/HDN-0747-2022	Jih, Jonathan/0000-0001-5169-0919	National Institute of Health [GM071940]; NIH [1S10RR23057]; CNSI at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNSI at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported in part by a grant from the National Institute of Health (GM071940 to Z.H.Z). We acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by NIH (1S10RR23057 to ZHZ) and CNSI at UCLA. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; COHEN BJ, 1982, NATURE, V296, P677, DOI 10.1038/296677a0; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; DERMAN AI, 1991, J BACTERIOL, V173, P7719, DOI 10.1128/jb.173.23.7719-7722.1991; DiMattia MA, 2013, STRUCTURE, V21, P133, DOI 10.1016/j.str.2012.10.017; Dryden KA, 2006, MOL CELL, V22, P843, DOI 10.1016/j.molcel.2006.04.025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALLINA A, 1989, J VIROL, V63, P4645, DOI 10.1128/JVI.63.11.4645-4652.1989; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; IMAI M, 1982, J IMMUNOL, V128, P69; JENG KS, 1991, J VIROL, V65, P3924, DOI 10.1128/JVI.65.7.3924-3927.1991; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; Ladenstein R, 2006, FEBS J, V273, P4170, DOI 10.1111/j.1742-4658.2006.05421.x; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Liu SY, 2010, VIRUS RES, V149, P241, DOI 10.1016/j.virusres.2010.01.020; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NASSAL M, 1992, VIROLOGY, V190, P499, DOI 10.1016/0042-6822(92)91242-M; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 1993, Trends Microbiol, V1, P221, DOI 10.1016/0966-842X(93)90136-F; Newman M, 2009, J VIROL, V83, P10616, DOI 10.1128/JVI.00749-09; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; PETIT MA, 1985, J VIROL, V53, P543, DOI 10.1128/JVI.53.2.543-551.1985; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; SCHODEL F, 1993, J BIOL CHEM, V268, P1332; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SEIFER M, 1994, J VIROL, V68, P5548, DOI 10.1128/JVI.68.9.5548-5555.1994; STANDRING DN, 1988, P NATL ACAD SCI USA, V85, P8405, DOI 10.1073/pnas.85.22.8405; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; Uetrecht C, 2008, ANGEW CHEM INT EDIT, V47, P6247, DOI 10.1002/anie.200802410; Uetrecht C, 2008, P NATL ACAD SCI USA, V105, P9216, DOI 10.1073/pnas.0800406105; Watts NR, 2011, J MOL BIOL, V409, P202, DOI 10.1016/j.jmb.2011.03.049; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zhang XK, 2010, J STRUCT BIOL, V172, P400, DOI 10.1016/j.jsb.2010.05.006; ZHENG J, 1992, J BIOL CHEM, V267, P9422; ZHOU SL, 1992, J VIROL, V66, P5393, DOI 10.1128/JVI.66.9.5393-5398.1992; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556	52	58	60	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e69729	10.1371/journal.pone.0069729	http://dx.doi.org/10.1371/journal.pone.0069729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039702	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500003
J	Frensing, T; Heldt, FS; Pflugmacher, A; Behrendt, I; Jordan, I; Flockerzi, D; Genzel, Y; Reichl, U				Frensing, Timo; Heldt, Frank Stefan; Pflugmacher, Antje; Behrendt, Ilona; Jordan, Ingo; Flockerzi, Dietrich; Genzel, Yvonne; Reichl, Udo			Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles	PLOS ONE			English	Article							CONTINUOUS-FLOW CULTURES; RUBELLA-VIRUS; GROWTH; REPLICATION; GENERATION; DYNAMICS; SYSTEM; MODEL; LINES	Influenza viruses are a major public health burden during seasonal epidemics and a continuous threat due to their potential to cause pandemics. Annual vaccination provides the best protection against the contagious respiratory illness caused by influenza viruses. However, the current production capacities for influenza vaccines are insufficient to meet the increasing demands. We explored the possibility to establish a continuous production process for influenza viruses using the duck-derived suspension cell line AGE1. CR. A two-stage bioreactor setup was designed in which cells were cultivated in a first stirred tank reactor where an almost constant cell concentration was maintained. Cells were then constantly fed to a second bioreactor where virus infection and replication took place. Using this two-stage reactor system, it was possible to continuously produce influenza viruses. Surprisingly, virus titers showed a periodic increase and decrease during the run-time of 17 days. These titer fluctuations were caused by the presence of defective interfering particles (DIPs), which we detected by PCR. Mathematical modeling confirmed this observation showing that constant virus titers can only emerge in the absence of DIPs. Even with very low amounts of DIPs in the seed virus and very low rates for de novo DIP generation, defective viruses rapidly accumulate and, therefore, represent a serious challenge for continuous vaccine production. Yet, the continuous replication of influenza virus using a two-stage bioreactor setup is a novel tool to study aspects of viral evolution and the impact of DIPs.	[Frensing, Timo; Heldt, Frank Stefan; Pflugmacher, Antje; Behrendt, Ilona; Flockerzi, Dietrich; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Jordan, Ingo] ProBioGen AG, Berlin, Germany; [Reichl, Udo] Otto Von Guericke Univ, Chair Bioproc Engn, Magdeburg, Germany	Max Planck Society; Otto von Guericke University	Frensing, T (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	frensing@mpi-magdeburg.mpg.de	Heldt, Frank Stefan/J-2675-2017	Heldt, Frank Stefan/0000-0002-9276-5013; Genzel, Yvonne/0000-0002-2652-5943; Jordan, Ingo/0000-0003-2711-7252				Audsley JM, 2008, DRUGS, V68, P1483, DOI 10.2165/00003495-200868110-00002; BANGHAM CRM, 1990, VIROLOGY, V179, P821, DOI 10.1016/0042-6822(90)90150-P; Cohen S. D., 1996, Computers in Physics, V10, P138; DAVIS AR, 1979, P NATL ACAD SCI USA, V76, P3092, DOI 10.1073/pnas.76.7.3092; DEGOOIJER CD, 1992, BIOTECHNOL BIOENG, V40, P537, DOI 10.1002/bit.260400413; FREY TK, 1988, VIROLOGY, V164, P22, DOI 10.1016/0042-6822(88)90615-0; Genzel Y., 2007, ANIMAL CELL BIOTECHN, P457, DOI [DOI 10.1007/978-1-59745-399-8_21, 10.1007/978-1-59745-399-8_21]; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Heldt FS, 2012, J VIROL, V86, P7806, DOI 10.1128/JVI.00080-12; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOLMSTROM B, 1968, BIOTECHNOL BIOENG, V10, P373, DOI 10.1002/bit.260100310; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jordan I, 2009, VACCINE, V27, P748, DOI 10.1016/j.vaccine.2008.11.066; Jordan I, 2011, BIOLOGICALS, V39, P50, DOI 10.1016/j.biologicals.2010.11.005; Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002; KANG CY, 1978, J VIROL, V25, P202, DOI 10.1128/JVI.25.1.202-206.1978; KILBURN DG, 1970, J GEN VIROL, V9, P1, DOI 10.1099/0022-1317-9-1-1; KIRKWOOD TBL, 1994, P NATL ACAD SCI USA, V91, P8685, DOI 10.1073/pnas.91.18.8685; KOMPIER R, 1988, BIOTECHNOL LETT, V10, P849, DOI 10.1007/BF01026994; KOOL M, 1991, VIROLOGY, V183, P739, DOI 10.1016/0042-6822(91)91003-Y; Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083; Lohr V, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-79; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; NAYAK DP, 1985, CURR TOP MICROBIOL, V114, P103; Rouzine IM, 2013, J VIROL, V87, P2081, DOI 10.1128/JVI.02741-12; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; STARK C, 1978, VIROLOGY, V89, P285, DOI 10.1016/0042-6822(78)90060-0; Stauffer KA, 2009, J GEN VIROL, V90, P888, DOI 10.1099/vir.0.005249-0; Thompson KAS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-257; VANLIER FLJ, 1992, J BIOTECHNOL, V22, P291, DOI 10.1016/0168-1656(92)90147-2; VONMAGNUS P, 1951, ACTA PATHOL MIC SC, V28, P278; Zhang XM, 2008, P NATL ACAD SCI USA, V105, P16749, DOI 10.1073/pnas.0807225105; Zuccotti GV, 2011, EXPERT OPIN BIOL TH, V11, P1, DOI 10.1517/14712598.2010.539047	35	54	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72288	10.1371/journal.pone.0072288	http://dx.doi.org/10.1371/journal.pone.0072288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039749	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600021
J	Lapadula, WJ; Puerta, MVS; Ayub, MJ				Lapadula, Walter J.; Sanchez Puerta, Maria Virginia; Juri Ayub, Maximiliano			Revising the Taxonomic Distribution, Origin and Evolution of Ribosome Inactivating Protein Genes	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; FRUITING BODIES; WEB SERVER; MECHANISM; RICIN; ANTIFUNGAL; INFERENCE; BINDING; TYPE-1; PLANTS	Ribosome inactivating proteins are enzymes that depurinate a specific adenine residue in the alpha-sarcin-ricin loop of the large ribosomal RNA, being ricin and Shiga toxins the most renowned examples. They are widely distributed in plants and their presence has also been confirmed in a few bacterial species. According to this taxonomic distribution, the current model about the origin and evolution of RIP genes postulates that an ancestral RIP domain was originated in flowering plants, and later acquired by some bacteria via horizontal gene transfer. Here, we unequivocally detected the presence of RIP genes in fungi and metazoa. These findings, along with sequence and phylogenetic analyses, led us to propose an alternative, more parsimonious, hypothesis about the origin and evolutionary history of the RIP domain, where several paralogous RIP genes were already present before the three domains of life evolved. This model is in agreement with the current idea of the Last Universal Common Ancestor (LUCA) as a complex, genetically redundant organism. Differential loss of paralogous genes in descendants of LUCA, rather than multiple horizontal gene transfer events, could account for the complex pattern of RIP genes across extant species, as it has been observed for other genes.	[Lapadula, Walter J.; Juri Ayub, Maximiliano] UNSL, Area Biol Mol, Dept Bioquim & Ciencias Biol, San Luis, Argentina; [Lapadula, Walter J.; Juri Ayub, Maximiliano] Inst Multidisciplinario Invest Biol San Luis IMIB, San Luis, Argentina; [Sanchez Puerta, Maria Virginia] Univ Nacl Cuyo, Inst Ciencias Basicas, IBAM CONICET, RA-5500 Mendoza, Argentina; [Sanchez Puerta, Maria Virginia] Univ Nacl Cuyo, Fac Ciencias Agr, RA-5500 Mendoza, Argentina	Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza	Ayub, MJ (corresponding author), UNSL, Area Biol Mol, Dept Bioquim & Ciencias Biol, San Luis, Argentina.	mayub@unsl.edu.ar		Juri Ayub, Maximiliano/0000-0002-5787-0993; Lapadula, Walter/0000-0003-4180-9490; Sanchez-Puerta, Maria Virginia/0000-0003-2511-5093	CONICET; CONICET [PIP 0021]; FONCyT [PICT 2010-1468]; Fundacion Bunge y Born	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT); Fundacion Bunge y Born	MJA and MVSP are members of the scientific career of the National Council for Research (CONICET). WJL has a CONICET fellowship. Grants from CONICET (PIP 0021), FONCyT (PICT 2010-1468) and Fundacion Bunge y Born to M.J.A. are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Arias FJ, 2003, INT J BIOCHEM CELL B, V35, P61, DOI 10.1016/S1357-2725(02)00093-6; Barbieri L, 2001, FEBS LETT, V505, P196, DOI 10.1016/S0014-5793(01)02789-2; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Girbes T, 2004, MINI-REV MED CHEM, V4, P461, DOI 10.2174/1389557043403891; Glansdorff N, 2009, J MOL EVOL, V69, P470, DOI 10.1007/s00239-009-9277-7; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Hao Q, 2001, PLANT PHYSIOL, V125, P866, DOI 10.1104/pp.125.2.866; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hudak KA, 1999, J BIOL CHEM, V274, P3859, DOI 10.1074/jbc.274.6.3859; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Labedan B, 2004, MOL BIOL EVOL, V21, P364, DOI 10.1093/molbev/msh024; Lam SK, 2001, ARCH BIOCHEM BIOPHYS, V393, P271, DOI 10.1006/abbi.2001.2506; Lam SK, 2001, BIOCHEM BIOPH RES CO, V285, P1071, DOI 10.1006/bbrc.2001.5279; Lapadula WJ, 2012, TOXICON, V59, P427, DOI 10.1016/j.toxicon.2011.12.014; Lewis PO, 1998, MOL BIOL EVOL, V15, P277, DOI 10.1093/oxfordjournals.molbev.a025924; Ng TB, 2004, PEPTIDES, V25, P929, DOI 10.1016/j.peptides.2004.03.007; NILSSON L, 1986, EUR J BIOCHEM, V161, P111, DOI 10.1111/j.1432-1033.1986.tb10130.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Peumans WJ, 2010, EVOLUTION PLANT RIBO; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rajamohan F, 2001, BIOCHEMISTRY-US, V40, P9104, DOI 10.1021/bi002851p; Reyes AG, 2010, MICROBIOL-SGM, V156, P3021, DOI 10.1099/mic.0.039073-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; SPERTI S, 1973, BIOCHEM J, V136, P813, DOI 10.1042/bj1360813; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; WALSH TA, 1991, J BIOL CHEM, V266, P23422; Wang HX, 2001, LIFE SCI, V68, P2151, DOI 10.1016/S0024-3205(01)01023-2; Yao QZ, 1998, J AGR FOOD CHEM, V46, P788, DOI 10.1021/jf970551h	41	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72825	10.1371/journal.pone.0072825	http://dx.doi.org/10.1371/journal.pone.0072825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039805	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600035
J	Santos, A; Anta, AF; Fernandez, LL				Santos, Agustin; Fernandez Anta, Antonio; Lopez Fernandez, Luis			Quid Pro Quo: A Mechanism for Fair Collaboration in Networked Systems	PLOS ONE			English	Article							GAME-THEORY; TRANSFORM	Collaboration may be understood as the execution of coordinated tasks (in the most general sense) by groups of users, who cooperate for achieving a common goal. Collaboration is a fundamental assumption and requirement for the correct operation of many communication systems. The main challenge when creating collaborative systems in a decentralized manner is dealing with the fact that users may behave in selfish ways, trying to obtain the benefits of the tasks but without participating in their execution. In this context, Game Theory has been instrumental to model collaborative systems and the task allocation problem, and to design mechanisms for optimal allocation of tasks. In this paper, we revise the classical assumptions of these models and propose a new approach to this problem. First, we establish a system model based on heterogenous nodes (users, players), and propose a basic distributed mechanism so that, when a new task appears, it is assigned to the most suitable node. The classical technique for compensating a node that executes a task is the use of payments (which in most networks are hard or impossible to implement). Instead, we propose a distributed mechanism for the optimal allocation of tasks without payments. We prove this mechanism to be robust evenevent in the presence of independent selfish or rationally limited players. Additionally, our model is based on very weak assumptions, which makes the proposed mechanisms susceptible to be implemented in networked systems (e.g., the Internet).	[Santos, Agustin; Fernandez Anta, Antonio] Inst IMDEA Networks, Madrid, Spain; [Lopez Fernandez, Luis] Univ Rey Juan Carlos, FUN LAB, Madrid, Spain	Universidad Rey Juan Carlos	Santos, A (corresponding author), Inst IMDEA Networks, Madrid, Spain.	agustin.santos@imdea.org	Anta, Antonio Fernández/B-4176-2009	Anta, Antonio Fernández/0000-0001-6501-2377	Comunidad de Madrid [S-2009/TIC-1692]; Spanish MICINN [TEC2011-29688-C02]; National Natural Science Foundation of China [61020106002]	Comunidad de Madrid(Comunidad de Madrid); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by the Comunidad de Madrid grant S-2009/TIC-1692, the Spanish MICINN grant TEC2011-29688-C02, and the National Natural Science Foundation of China grant 61020106002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg L., 2003, MOBICOM, P245; ANGUS JE, 1994, SIAM REV, V36, P652, DOI 10.1137/1036146; Aumann R.J., 1995, REPEATED GAMES INCOM; Bell MGH, 2000, TRANSPORT RES B-METH, V34, P533, DOI 10.1016/S0191-2615(99)00042-9; Beverly R, 2006, EC NETWORKED SYSTEMS; BIRNBAUM ZW, 1951, ANN MATH STAT, V22, P592, DOI 10.1214/aoms/1177729550; Burgert C, 2006, STATIST RISK MODEL, V24, P153, DOI 10.1524/stnd.2006.24.1.153; Czumaj A, 2004, P 23 ANN ACM S PRINC, P98; DEHARDT J, 1971, ANN MATH STAT, V42, P2050, DOI 10.1214/aoms/1177693073; Evans M., 1993, STAT DISTRIBUTIONS; Feigenbaum J, 2002, P 21 ACM S PRINC DIS, P173; Feigenbaum J, 2002, DIALM 02, P1; Ferguson TS, 1967, MATH STAT DECISION T; Anta AF, 2012, PARALLEL PROCESS LET, V22, DOI 10.1142/S0129626412500028; Georgiou C, 2010, 24 IEEE INT S PAR DI, P1; Jackson M. O., 2003, ENCY LIFE SUPPORT SY; Jackson MO, 2007, ECONOMETRICA, V75, P241, DOI 10.1111/j.1468-0262.2007.00737.x; Jackson MO, 2003, ECONWPA MICROECONOMI; Jackson MO, 1999, WORKING PAPERS CALTE, V1076; Kolmogorov AN., 1933, GIORN I ITAL DEGLI A, V4, P83; Koutsoupias E, 2009, COMPUT SCI REV, V3, P65, DOI 10.1016/j.cosrev.2009.04.003; Murray D. G., 2010, PROC 2TH ACM SIGCOMM, P39, DOI DOI 10.1145/1851322.1851334; Procaccia AD, 2009, 10TH ACM CONFERENCE ON ELECTRONIC COMMERCE - EC 2009, P177; Ravindra MP, 2011, GAMES ALGORITHMS INT, P5; Rosenschein J. S., 1994, RULES ENCOUNTER DESI; Roughgarden T, 2005, SELFISH ROUTING PRIC; Ruschendorf L, 2009, J STAT PLAN INFER, V139, P3921, DOI 10.1016/j.jspi.2009.05.030; Smirnov N., 1939, B MOSCOW U, V2, P3; Srivastava V, 2005, IEEE COMMUN SURV TUT, V7, P46, DOI 10.1109/COMST.2005.1593279; Veszteg RF, 2005, FACULTY WORKING PAPE, V10/05; Zhu H., 2012, GAME THEORY WIRELESS	31	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e66575	10.1371/journal.pone.0066575	http://dx.doi.org/10.1371/journal.pone.0066575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039696	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600003
J	Turgeon, N; Blais, M; Gagne, JM; Tardif, V; Boudreau, F; Perreault, N; Asselin, C				Turgeon, Naomie; Blais, Mylene; Gagne, Julie-Moore; Tardif, Veronique; Boudreau, Francois; Perreault, Nathalie; Asselin, Claude			HDAC1 and HDAC2 Restrain the Intestinal Inflammatory Response by Regulating Intestinal Epithelial Cell Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE DEACETYLASES; LYSINE DEACETYLASES; PROGENITOR CELLS; GUT MICROBIOTA; CLASS-I; NOTCH; HOST; PROLIFERATION; DEFENSE	Acetylation and deacetylation of histones and other proteins depends on histone acetyltransferases and histone deacetylases (HDACs) activities, leading to either positive or negative gene expression. HDAC inhibitors have uncovered a role for HDACs in proliferation, apoptosis and inflammation. However, little is known of the roles of specific HDACs in intestinal epithelial cells (IEC). We investigated the consequences of ablating both HDAC1 and HDAC2 in murine IECs. Floxed Hdac1 and Hdac2 homozygous mice were crossed with villin-Cre mice. Mice deficient in both IEC HDAC1 and HDAC2 weighed less and survived more than a year. Colon and small intestinal sections were stained with hematoxylin and eosin, or with Alcian blue and Periodic Acid Schiff for goblet cell identification. Tissue sections from mice injected with BrdU for 2 h, 14 h and 48 h were stained with anti-BrdU. To determine intestinal permeability, 4-kDa FITC-labeled dextran was given by gavage for 3 h. Microarray analysis was performed on total colon RNAs. Inflammatory and IEC-specific gene expression was assessed by Western blot or semi-quantitative RT-PCR and qPCR with respectively total colon protein and total colon RNAs. HDAC1 and HDAC2-deficient mice displayed: 1) increased migration and proliferation, with elevated cyclin D1 expression and phosphorylated S6 ribosomal protein, a downstream mTOR target; 2) tissue architecture defects with cell differentiation alterations, correlating with reduction of secretory Paneth and goblet cells in jejunum and goblet cells in colon, increased expression of enterocytic markers such as sucrase-isomaltase in the colon, increased expression of cleaved Notch1 and augmented intestinal permeability; 3) loss of tissue homeostasis, as evidenced by modifications of claudin 3 expression, caspase-3 cleavage and Stat3 phosphorylation; 4) chronic inflammation, as determined by inflammatory molecular expression signatures and altered inflammatory gene expression. Thus, epithelial HDAC1 and HDAC2 restrain the intestinal inflammatory response, by regulating intestinal epithelial cell proliferation and differentiation.	[Turgeon, Naomie; Blais, Mylene; Gagne, Julie-Moore; Tardif, Veronique; Boudreau, Francois; Perreault, Nathalie; Asselin, Claude] Univ Sherbrooke, Pavillon Rech Appl Canc, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Asselin, C (corresponding author), Univ Sherbrooke, Pavillon Rech Appl Canc, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1K 2R1, Canada.	Claude.Asselin@USherbrooke.ca			Crohn's and Colitis Foundation of Canada	Crohn's and Colitis Foundation of Canada	This work has been supported by a grant from the Crohn's and Colitis Foundation of Canada (www.ccfc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; COOPER HS, 1993, LAB INVEST, V69, P238; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duerr CU, 2012, SEMIN IMMUNOL, V24, P25, DOI 10.1016/j.smim.2011.11.002; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hruz P, 2010, CURR OPIN GASTROEN, V26, P109, DOI 10.1097/MOG.0b013e3283365279; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Johnson ES, 2012, CURR OPIN CELL BIOL, V24, P876, DOI 10.1016/j.ceb.2012.10.002; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koch S, 2012, ANNU REV PATHOL-MECH, V7, P35, DOI 10.1146/annurev-pathol-011811-120905; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lin YY, 2012, NATURE, V482, P251, DOI 10.1038/nature10804; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Mihaylova MM, 2013, TRENDS ENDOCRIN MET, V24, P48, DOI 10.1016/j.tem.2012.09.003; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Ose T, 2007, ONCOGENE, V26, P349, DOI 10.1038/sj.onc.1209799; Parikh Abhirath, 2012, Biomol Concepts, V3, P57; Perdigoto CN, 2013, BBA-GEN SUBJECTS, V1830, P2307, DOI 10.1016/j.bbagen.2012.08.009; Rathmell JC, 2009, SCIENCE, V324, P1021, DOI 10.1126/science.1174665; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sassone-Corsi P, 2013, SCIENCE, V339, P148, DOI 10.1126/science.1233423; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Turgeon N, 2013, J CELL BIOCHEM, V114, P1203, DOI 10.1002/jcb.24463; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vooijs M, 2011, GASTROENTEROLOGY, V141, P448, DOI 10.1053/j.gastro.2011.06.003; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	66	62	64	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73785	10.1371/journal.pone.0073785	http://dx.doi.org/10.1371/journal.pone.0073785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040068	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600099
J	Getzmann, S; Falkenstein, M; Gajewski, PD				Getzmann, Stephan; Falkenstein, Michael; Gajewski, Patrick D.			Long-Term Cardiovascular Fitness Is Associated with Auditory Attentional Control in Old Adults: Neuro-Behavioral Evidence	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED POTENTIALS; INVOLUNTARY ATTENTION; PHYSICAL-ACTIVITY; RESPONSE SELECTION; BRAIN POTENTIALS; EVOKED-RESPONSES; AGE; P3A; DISTRACTION	It has been shown that healthy aging affects the ability to focus attention on a given task and to ignore distractors. Here, we asked whether long-term physical activity is associated with lower susceptibility to distraction of auditory attention, and how physically active and inactive seniors may differ regarding subcomponents of auditory attention. An auditory duration discrimination task was employed, and involuntary attentional shifts to task-irrelevant rare frequency deviations and subsequent reorientation were studied by analysis of behavioral data and event-related potential measures. The frequency deviations impaired performance more in physically inactive than active seniors. This was accompanied by a stronger frontal positivity (P3a) and increased activation of anterior cingulate cortex, suggesting a stronger involuntary shift of attention towards task-irrelevant stimulus features in inactive compared to active seniors. These results indicate a positive relationship between physical fitness and attentional control in elderly, presumably due to more focused attentional resources and enhanced inhibition of irrelevant stimulus features.	[Getzmann, Stephan; Falkenstein, Michael; Gajewski, Patrick D.] Tech Univ Dortmund IfADo, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Getzmann, S (corresponding author), Tech Univ Dortmund IfADo, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	stephan.getzmann@rub.de	Gajewski, Patrick/AFP-1227-2022; Falkenstein, Michael/ABA-7497-2020; Gajewski, Patrick/AAI-9014-2020	Getzmann, Stephan/0000-0002-6382-0183; Gajewski, Patrick/0000-0001-8240-1702	German Insurance Association (GDV, Gesamtverband der Deutschen Versicherungswirtschaft); Deutsche Forschungsgemeinschaft [DFG GE 1920/3-1]	German Insurance Association (GDV, Gesamtverband der Deutschen Versicherungswirtschaft); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the German Insurance Association (GDV, Gesamtverband der Deutschen Versicherungswirtschaft to P. G. and M. F.) and the Deutsche Forschungsgemeinschaft (DFG GE 1920/3-1 to S. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2004, PSYCHOL AGING, V19, P125, DOI 10.1037/0882-7974.19.1.125; Alain C, 2010, J COGNITIVE NEUROSCI, V22, P392, DOI 10.1162/jocn.2009.21279; Anderer P, 1996, ELECTROEN CLIN NEURO, V99, P458, DOI 10.1016/S0013-4694(96)96518-9; Berti S, 2013, BRAIN RES, V1491, P156, DOI 10.1016/j.brainres.2012.11.009; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Campbell PT, 2001, AM J HUM BIOL, V13, P190, DOI 10.1002/1520-6300(200102/03)13:2<190::AID-AJHB1028>3.0.CO;2-N; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cooper RJ, 2006, NEUROBIOL AGING, V27, P752, DOI 10.1016/j.neurobiolaging.2005.03.012; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; CZIGLER I, 1992, BIOL PSYCHOL, V33, P195, DOI 10.1016/0301-0511(92)90031-O; Czigler I, 2006, INT J PSYCHOPHYSIOL, V62, P290, DOI 10.1016/j.ijpsycho.2006.05.008; DUSTMAN RE, 1990, NEUROBIOL AGING, V11, P193, DOI 10.1016/0197-4580(90)90545-B; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gaeta H, 2001, PSYCHOL AGING, V16, P55, DOI 10.1037//0882-7974.16.1.55; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; Gajewski PD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00130; Getzmann S, 2013, NEUROBIOL AGING, V34, P1952, DOI 10.1016/j.neurobiolaging.2013.02.014; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Hillman CH, 2004, RES Q EXERCISE SPORT, V75, P176, DOI 10.1080/02701367.2004.10609149; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holig C, 2010, BRAIN RES, V1345, P164, DOI 10.1016/j.brainres.2010.05.047; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Horvath J, 2009, NEUROBIOL AGING, V30, P1157, DOI 10.1016/j.neurobiolaging.2007.10.003; IRAGUI VJ, 1993, PSYCHOPHYSIOLOGY, V30, P10, DOI 10.1111/j.1469-8986.1993.tb03200.x; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kramer A. F., 2008, HDB AGING COGNITION, V3, P189, DOI DOI 10.1080/01924780903295796; Kramer AF, 2006, PSYCHOBIOLOGY PHYS A, P45; Mager R, 2005, J NEURAL TRANSM, V112, P1165, DOI 10.1007/s00702-004-0258-0; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Polich J, 1997, ELECTROEN CLIN NEURO, V103, P493, DOI 10.1016/S0013-4694(97)96033-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Ruzzoli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.021; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Schroger E, 2000, CLIN NEUROPHYSIOL, V111, P1450, DOI 10.1016/S1388-2457(00)00337-0; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Snyder JS, 2009, PSYCHOPHYSIOLOGY, V46, P1208, DOI 10.1111/j.1469-8986.2009.00870.x; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Talairach J., 1988, COPLANAR STEREOTAXIC; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; Townsend J. T., 1983, STOCHASTIC MODELING; Van der Linden M, 1999, AGING NEUROPSYCHOL C, V6, P32, DOI 10.1076/anec.6.1.32.791; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Weintraub DM, 2012, PSYCHOPHYSIOLOGY, V49, P1372, DOI 10.1111/j.1469-8986.2012.01457.x	61	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74539	10.1371/journal.pone.0074539	http://dx.doi.org/10.1371/journal.pone.0074539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023949	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600145
J	Wang, ZC; Cai, F; Chen, XY; Luo, MH; Hu, LL; Lu, Y				Wang, Zhicheng; Cai, Feng; Chen, Xiaoyu; Luo, Meihong; Hu, Lingling; Lu, Yuan			The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; OVARIAN-CANCER; CYTOCHROME-C; HEAT-STRESS; CELL-DEATH; SUPEROXIDE; ROS; CARDIOLIPIN; DYSFUNCTION	A combination of hyperthermia with radiotherapy and chemotherapy for various solid tumors has been practiced clinically. However, hyperthermic therapy has side effects, such as thrombocytopenia. Up to now, the pathogenesis of hyperthermia-induced thrombocytopenia remains unclear. Previous studies have shown that hyperthermia induces platelet apoptosis. However, the signaling pathways and molecular mechanisms involved in hyperthermia-induced platelet apoptosis have not been determined. Here we show that hyperthermia induced intracellular reactive oxygen species (ROS) production and mitochondrial ROS generation in a time-dependent manner in platelets. The mitochondria-targeted ROS scavenger Mito-TEMPO blocked intracellular ROS and mitochondrial ROS generation. By contrast, inhibitors of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, nitric oxide synthase, cyclooxygenase and lipoxygenase did not. Furthermore, Mito-TEMPO inhibited hyperthermia-induced malonyldialdehyde production and cardiolipin peroxidation. We also showed that hyperthermia-triggered platelet apoptosis was inhibited by Mito-TEMPO. Furthermore, Mito-TEMPO ameliorated hyperthermia-impaired platelet aggregation and adhesion function. Lastly, hyperthermia decreased platelet manganese superoxide dismutase (MnSOD) protein levels and enzyme activity. These data indicate that mitochondrial ROS play a pivotal role in hyperthermia-induced platelet apoptosis, and decreased of MnSOD activity might, at least partially account for the enhanced ROS levels in hyperthermia-treated platelets. Therefore, determining the role of mitochondrial ROS as contributory factors in platelet apoptosis, is critical in providing a rational design of novel drugs aimed at targeting mitochondrial ROS. Such therapeutic approaches would have potential clinical utility in platelet-associated disorders involving oxidative damage.	[Wang, Zhicheng; Lu, Yuan] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Wang, Zhicheng; Cai, Feng; Luo, Meihong; Hu, Lingling] Shanghai Univ Tradit Chinese Med, Shanghai Hosp Tradit Chinese Med, Dept Lab Med, Shanghai, Peoples R China; [Chen, Xiaoyu] Anhui Med Univ, Dept Histol & Embryol, Hefei, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine; Anhui Medical University	Lu, Y (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China.	yuanlu@hsh.stn.sh.cn	hu, ling/GWC-1104-2022		National Natural Science Foundation of China [NSFC 81270650]; Innovation Program of Shanghai Municipal Education Commission [12YZ068]; Natural Science Foundation of Shanghai [12ZR1429900]; Postdoctoral Science Foundation of Shanghai [12R21411700]; China Postdoctoral Science Foundation [2012M511043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Postdoctoral Science Foundation of Shanghai(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (NSFC 81270650), the Innovation Program of Shanghai Municipal Education Commission (12YZ068), the Natural Science Foundation of Shanghai (12ZR1429900), the Postdoctoral Science Foundation of Shanghai (12R21411700), the China Postdoctoral Science Foundation (2012M511043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca A, 2009, GYNECOL ONCOL, V112, P384, DOI 10.1016/j.ygyno.2008.11.001; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bolisetty S, 2013, INT J MOL SCI, V14, P6306, DOI 10.3390/ijms14036306; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18; Celotto AM, 2012, BRAIN BEHAV, V2, P424, DOI 10.1002/brb3.73; Dai KS, 2009, THROMB RES, V124, P101, DOI 10.1016/j.thromres.2008.12.044; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Ferlini C, 2007, NAT PROTOC, V2, P3111, DOI 10.1038/nprot.2007.397; Fotopoulou C, 2010, INT J HYPERTHER, V26, P118, DOI 10.3109/02656730903369200; Kagan VE, 2009, MOL NUTR FOOD RES, V53, P104, DOI 10.1002/mnfr.200700402; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kalvegren H, 2005, THROMB HAEMOSTASIS, V94, P327, DOI 10.1160/TH04-06-0360; Kanter M, 2013, TOXICOL IND HEALTH, V29, P99, DOI 10.1177/0748233711425082; Katschinski DM, 2000, J BIOL CHEM, V275, P21094, DOI 10.1074/jbc.M001629200; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lim S, 2011, CELL PHYSIOL BIOCHEM, V28, P873, DOI 10.1159/000335802; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Luanpitpong S, 2013, MOL BIOL CELL, V24, P858, DOI 10.1091/mbc.E12-10-0747; Luanpitpong S, 2012, BIOCHEM PHARMACOL, V83, P1643, DOI 10.1016/j.bcp.2012.03.010; Luchetti F, 2003, HISTOL HISTOPATHOL, V18, P1041, DOI 10.14670/HH-18.1041; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Marjanovic JA, 2008, J BIOL CHEM, V283, P28827, DOI 10.1074/jbc.M801646200; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Pajonk F, 2005, CANCER RES, V65, P4836, DOI 10.1158/0008-5472.CAN-03-2749; Pandey KB, 2010, OXID MED CELL LONGEV, V3, P2, DOI 10.4161/oxim.3.1.10476; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; SCHULZ E, 2012, ANTIOXID REDOX SIGN, P57349; Sciancalepore M, 2012, FREE RADICAL BIO MED, V53, P1392, DOI 10.1016/j.freeradbiomed.2012.08.002; Shen Garry X., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P106; Souslova T, 2004, INT J RADIAT ONCOL, V60, P1538, DOI 10.1016/j.ijrobp.2004.07.686; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Swerdlow RH, 2007, ANTIOXID REDOX SIGN, V9, P1591, DOI 10.1089/ars.2007.1676; Tissier R, 2013, RESUSCITATION, V84, P249, DOI 10.1016/j.resuscitation.2012.06.030; Tyurina YY, 2010, AM J PHYSIOL-LUNG C, V299, pL73, DOI 10.1152/ajplung.00035.2010; Vela L, 2011, J INORG BIOCHEM, V105, P1306, DOI 10.1016/j.jinorgbio.2011.06.004; Venkataraman S, 2004, FREE RADICAL RES, V38, P1119, DOI 10.1080/10715760400010470; Wang ZC, 2010, PLATELETS, V21, P229, DOI 10.3109/09537100903443949; Wang ZC, 2010, THROMB RES, V125, P340, DOI 10.1016/j.thromres.2010.02.001; Wang ZC, 2010, ARCH BIOCHEM BIOPHYS, V495, P136, DOI 10.1016/j.abb.2010.01.003; Wartenberg M, 2005, INT J CANCER, V113, P229, DOI 10.1002/ijc.20596; White MG, 2012, J NEUROPHYSIOL, V108, P2203, DOI 10.1152/jn.00638.2011; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Yuki H, 2003, FREE RADICAL RES, V37, P631, DOI 10.1080/1071576031000088292; Zhang S, 2013, J THROMB HAEMOST, V11, P149, DOI 10.1111/jth.12063; Zhang WL, 2012, THROMB RES, V130, P81, DOI 10.1016/j.thromres.2012.02.013; Zhao QL, 2006, FREE RADICAL BIO MED, V40, P1131, DOI 10.1016/j.freeradbiomed.2005.10.064; Zhou MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032349	54	39	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e75044	10.1371/journal.pone.0075044	http://dx.doi.org/10.1371/journal.pone.0075044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023970	Green Submitted, Green Published, gold			2022-12-25	WOS:000324515600164
J	Ozbek, P; Soner, S; Haliloglu, T				Ozbek, Pemra; Soner, Seren; Haliloglu, Turkan			Hot Spots in a Network of Functional Sites	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; LIGAND-BINDING; CONSERVED RESIDUES; STRUCTURAL BASIS; PROTON CHANNEL; FREE-ENERGY; IDENTIFICATION; RECOGNITION; PREDICTION; INTERFACES	It is of significant interest to understand how proteins interact, which holds the key phenomenon in biological functions. Using dynamic fluctuations in high frequency modes, we show that the Gaussian Network Model (GNM) predicts hot spot residues with success rates ranging between S 8-58%, C 84-95%, P 5-19% and A 81-92% on unbound structures and S 8-51%, C 97-99%, P 14-50%, A 94-97% on complex structures for sensitivity, specificity, precision and accuracy, respectively. High specificity and accuracy rates with a single property on unbound protein structures suggest that hot spots are predefined in the dynamics of unbound structures and forming the binding core of interfaces, whereas the prediction of other functional residues with similar dynamic behavior explains the lower precision values. The latter is demonstrated with the case studies; ubiquitin, hen egg-white lysozyme and M2 proton channel. The dynamic fluctuations suggest a pseudo network of residues with high frequency fluctuations, which could be plausible for the mechanism of biological interactions and allosteric regulation.	[Ozbek, Pemra] Marmara Univ, Dept Bioengn, Istanbul, Turkey; [Soner, Seren; Haliloglu, Turkan] Bogazici Univ, Dept Chem Engn, TR-80815 Bebek, Turkey; [Soner, Seren; Haliloglu, Turkan] Bogazici Univ, Polymer Res Ctr, TR-80815 Bebek, Turkey	Marmara University; Bogazici University; Bogazici University	Haliloglu, T (corresponding author), Bogazici Univ, Dept Chem Engn, TR-80815 Bebek, Turkey.	turkan@prc.boun.edu.tr	Ozbek, Pemra/A-3594-2016	Ozbek, Pemra/0000-0002-3043-0015	TUBITAK project [110T088]; Marmara University Commission of Scientific Research Project [FEN-A-130612-0219]	TUBITAK project(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Marmara University Commission of Scientific Research Project(Marmara University)	The authors acknowledge TUBITAK project no: 110T088 and Betil Fund. PO acknowledges Marmara University Commission of Scientific Research Project, FEN-A-130612-0219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; [Anonymous], J MOL BIOL, V244, P522; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Camacho CJ, 2006, PROTEINS, V63, P868, DOI 10.1002/prot.20932; Campbell SJ, 2003, CURR OPIN STRUC BIOL, V13, P389, DOI 10.1016/S0959-440X(03)00075-7; Castillo V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000476; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Erman B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/056003; Ertekin A, 2006, PROTEIN SCI, V15, P2265, DOI 10.1110/ps.051815006; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Fernandez-Recio J, 2011, WIRES COMPUT MOL SCI, V1, P680, DOI 10.1002/wcms.45; Fischer TB, 2003, BIOINFORMATICS, V19, P1453, DOI 10.1093/bioinformatics/btg163; Gao M, 2012, P NATL ACAD SCI USA, V109, P3784, DOI 10.1073/pnas.1117768109; Gonzalez-Ruiz D, 2006, CURR MED CHEM, V13, P2607, DOI 10.2174/092986706778201530; Grosdidier S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-447; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Guney E, 2008, NUCLEIC ACIDS RES, V36, pD662, DOI 10.1093/nar/gkm813; Haliloglu T, 2005, BIOPHYS J, V88, P1552, DOI 10.1529/biophysj.104.051342; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haliloglu T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000845; Haliloglu T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088103; Haliloglu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228102; Hall DH, 2011, J AM CHEM SOC, V133, P20668, DOI 10.1021/ja207914y; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Hubbard SJT, 1993, NUCLEIC ACIDS RES; Juanico B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238104; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; Koes DR, 2012, BIOINFORMATICS, V28, P784, DOI 10.1093/bioinformatics/btr717; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Kozakov D, 2010, TRENDS BIOCHEM SCI, V35, P471, DOI 10.1016/j.tibs.2010.03.006; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; KUNDROT CE, 1987, J MOL BIOL, V193, P157, DOI 10.1016/0022-2836(87)90634-6; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Laskowski RA, 2007, BIOINFORMATICS, V23, P1824, DOI 10.1093/bioinformatics/btm085; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; LEHMANN MS, 1989, BIOCHEMISTRY-US, V28, P7028, DOI 10.1021/bi00443a037; Li L, 2006, BIOINFORMATION, V1, P121, DOI 10.6026/97320630001121; Li X, 2004, J MOL BIOL, V344, P781, DOI 10.1016/j.jmb.2004.09.051; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liepinsh E, 1997, NAT BIOTECHNOL, V15, P264, DOI 10.1038/nbt0397-264; Lise S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016774; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Morange M, 2012, J BIOSCIENCES, V37, P13, DOI 10.1007/s12038-012-9186-6; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nussinov R, 2012, MOL BIOSYST, V8, P22, DOI 10.1039/c1mb05205e; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Ose T, 2009, J BIOCHEM, V146, P651, DOI 10.1093/jb/mvp110; Ozbabacan SEA, 2010, CURR OPIN DRUG DISC, V13, P527; Ozbek P, 2010, NUCLEIC ACIDS RES, V38, pW417, DOI 10.1093/nar/gkq396; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; PIKE ACW, 1994, PROTEIN SCI, V3, P706; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rosenberg MR, 2010, P NATL ACAD SCI USA, V107, P13866, DOI 10.1073/pnas.1002051107; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vajda S, 2006, CURR OPIN DRUG DISC, V9, P354; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang ZM, 1998, BBA-PROTEIN STRUCT M, V1384, P335, DOI 10.1016/S0167-4838(98)00027-2; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Yogurtcu ON, 2008, BIOPHYS J, V94, P3475, DOI 10.1529/biophysj.107.114835; YONATH A, 1978, BIOPHYS STRUCT MECH, V4, P27, DOI 10.1007/BF00538838	99	26	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74320	10.1371/journal.pone.0074320	http://dx.doi.org/10.1371/journal.pone.0074320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023934	Green Published, Green Submitted, gold			2022-12-25	WOS:000324238400095
J	Xu, XH; Hu, H; Dailey, AB; Kearney, G; Talbott, EO; Cook, RL				Xu, Xiaohui; Hu, Hui; Dailey, Amy B.; Kearney, Greg; Talbott, Evelyn O.; Cook, Robert L.			Potential Health Impacts of Heavy Metals on HIV-Infected Population in USA	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUTRITION EXAMINATION SURVEY; ACTIVE ANTIRETROVIRAL THERAPY; EXAMINATION SURVEY KNHANES; KOREA NATIONAL-HEALTH; CARDIOVASCULAR COMPLICATIONS; SOCIOECONOMIC-STATUS; CADMIUM EXPOSURE; LIFE EXPECTANCY; AIR-POLLUTION	Purpose: Noninfectious comorbidities such as cardiovascular diseases have become increasingly prevalent and occur earlier in life in persons with HIV infection. Despite the emerging body of literature linking environmental exposures to chronic disease outcomes in the general population, the impacts of environmental exposures have received little attention in HIV-infected population. The aim of this study is to investigate whether individuals living with HIV have elevated prevalence of heavy metals compared to non-HIV infected individuals in United States. Methods: We used the National Health and Nutrition Examination Survey (NHANES) 2003-2010 to compare exposures to heavy metals including cadmium, lead, and total mercury in HIV infected and non-HIV infected subjects. Results: In this cross-sectional study, we found that HIV-infected individuals had higher concentrations of all heavy metals than the non-HIV infected group. In a multivariate linear regression model, HIV status was significantly associated with increased blood cadmium (p=0.03) after adjusting for age, sex, race, education, poverty income ratio, and smoking. However, HIV status was not statistically associated with lead or mercury levels after adjusting for the same covariates. Conclusions: Our findings suggest that HIV-infected patients might be significantly more exposed to cadmium compared to non-HIV infected individuals which could contribute to higher prevalence of chronic diseases among HIV-infected subjects. Further research is warranted to identify sources of exposure and to understand more about specific health outcomes.	[Xu, Xiaohui; Hu, Hui; Cook, Robert L.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32610 USA; [Xu, Xiaohui; Hu, Hui; Cook, Robert L.] Univ Florida, Dept Epidemiol, Coll Med, Gainesville, FL USA; [Dailey, Amy B.] Gettysburg Coll, Dept Hlth Sci, Gettysburg, PA 17325 USA; [Kearney, Greg] E Carolina Univ, Dept Publ Hlth, Brody Sch Med, Greenville, NC USA; [Talbott, Evelyn O.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Gettysburg College; University of North Carolina; East Carolina University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xu, XH (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32610 USA.	xhxu@phhp.ufl.edu	Xu, Xiaohui/H-5397-2019	Xu, Xiaohui/0000-0001-7269-4089; Kearney, Greg/0000-0001-9684-9516; Talbott, Evelyn/0000-0002-5198-7939; Hu, Hui/0000-0002-7482-9060				Afridi HI, 2011, CLIN LAB, V57, P867; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; [Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P689; Barbaro G, 2003, CURR PHARM DESIGN, V9, P1475, DOI 10.2174/1381612033454711; Barregard L, 2011, TOXICOL SCI, V120, P499, DOI 10.1093/toxsci/kfr009; Brito G, 2004, J FOOD PROTECT, V67, P1927, DOI 10.4315/0362-028X-67.9.1927; BROWN P, 1995, ENVIRON RES, V69, P15, DOI 10.1006/enrs.1995.1021; *BUREAU USC, 2003, CURR POP SURV CPS DE; Calderon-Garciduenas L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00217; CAMUS F, 1993, AIDS, V7, P1075, DOI 10.1097/00002030-199308000-00008; CDC, 2013, QUEST DAT REL DOC; *CDC, 2004, PROC MAN AN LEAD CAD; *CDC, 2007, PROC MAN AN HIV ANT; Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), 2006, NATL HLTH NUTR EXAMI; CHAISEMARTIN RA, 1976, CR SOC BIOL, V170, P886; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Fox MA, 2002, ENVIRON HEALTH PERSP, V110, P203, DOI 10.1289/ehp.02110s2203; Gandhi RT, 2012, J INFECT DIS, V205, pS353, DOI 10.1093/infdis/jis202; Garg Himanshu, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P58; Griffin T B, 1975, Environ Qual Saf Suppl, V2, P221; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Ibrahim D, 2006, CLIN LAB MED, V26, P67, DOI 10.1016/j.cll.2006.02.003; JARUP L, 1983, SCAND J WORK ENV HEA, V9, P327, DOI 10.5271/sjweh.2404; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; Jones M, 2012, SEMIN LIVER DIS, V32, P167, DOI 10.1055/s-0032-1316472; Kim Dae-Seon, 2005, J Prev Med Public Health, V38, P401; KYEREMATEN GA, 1990, CLIN PHARMACOL THER, V48, P641, DOI 10.1038/clpt.1990.208; Laurent O, 2007, J EPIDEMIOL COMMUN H, V61, P665, DOI 10.1136/jech.2006.053611; Lee MG, 2005, J AM COLL NUTR, V24, P1; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Losina E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6015; Mahaffey KR, 2004, ENVIRON HEALTH PERSP, V112, P562, DOI 10.1289/ehp.6587; Marth E, 2001, Int J Occup Med Environ Health, V14, P375; Messner B, 2010, BIOMETALS, V23, P811, DOI 10.1007/s10534-010-9314-4; Mijal RS, 2010, ENVIRON RES, V110, P505, DOI 10.1016/j.envres.2010.02.007; Miro JM, 2012, CURR HIV-AIDS REP, V9, P187, DOI 10.1007/s11904-012-0125-9; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; *NCHS, 2011, NHANES RESP RAT CPS; Ozturk IM, 2009, TOXICOL MECH METHOD, V19, P308, DOI 10.1080/15376510802662751; PERKINS KA, 1990, PHARMACOL BIOCHEM BE, V37, P11, DOI 10.1016/0091-3057(90)90035-G; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Poirier CD, 2001, AM J RESP CRIT CARE, V164, P542, DOI 10.1164/ajrccm.164.4.2010019; RABINOWITZ MB, 1976, J CLIN INVEST, V58, P260, DOI 10.1172/JCI108467; *REG AFTSAD, 2005, ERCLA PRIOR LIST HAZ; Rhee SY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-9; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Samet JM, 2001, ENVIRON HEALTH PERSP, V109, P357; SHAW RJ, 1988, THORAX, V43, P436, DOI 10.1136/thx.43.6.436; Sorvari J, 2007, ENVIRON POLLUT, V145, P324, DOI 10.1016/j.envpol.2006.03.004; Stepanova N. V., 2003, Gigiena i Sanitariya, P42; Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008; Tchashin V. P., 2010, Meditsina Truda i Promyshlennaya Ekologiya, P1; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P1017, DOI 10.1289/ehp.1104352; *UNAIDS JOINT UN P, 2010, AIDS EP UPD; Vallet-Pichard A, 2012, SEMIN LIVER DIS, V32, P158, DOI 10.1055/s-0032-1316471; van Ooik T, 2008, CHEMOSPHERE, V71, P1840, DOI 10.1016/j.chemosphere.2008.02.014; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; VIGNESHKUMAR B, 2011, ENVIRON TOXICOL, V28, P313; Young GS, 2012, INT J ENV RES PUB HE, V9, P2204, DOI 10.3390/ijerph9062204	64	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74288	10.1371/journal.pone.0074288	http://dx.doi.org/10.1371/journal.pone.0074288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023932	Green Accepted, Green Published, gold			2022-12-25	WOS:000324238400094
J	Lim, SP; Koh, JHK; Seh, CC; Liew, CW; Davidson, AD; Chua, LS; Chandrasekaran, R; Cornvik, TC; Shi, PY; Lescar, J				Lim, Siew Pheng; Koh, Jolene Hong Kiew; Seh, Cheah Chen; Liew, Chong Wai; Davidson, Andrew D.; Chua, Leng Shiew; Chandrasekaran, Ramya; Cornvik, Tobias C.; Shi, Pei-Yong; Lescar, Julien			A Crystal Structure of the Dengue Virus Non-structural Protein 5 (NS5) Polymerase Delineates Interdomain Amino Acid Residues That Enhance Its Thermostability and de Novo Initiation Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; OLIGOMERIZATION; FLEXIBILITY; MUTAGENESIS; DOMAIN; TYPE-2	The dengue virus (DENV) non-structural protein 5 (NS5) comprises an N-terminal methyltransferase and a C-terminal RNA-dependent RNA polymerase (RdRp) domain. Both enzymatic activities form attractive targets for antiviral development. Available crystal structures of NS5 fragments indicate that residues 263-271 (using the DENV serotype 3 numbering) located between the two globular domains of NS5 could be flexible. We observed that the addition of linker residues to the N-terminal end of the DENV RdRp core domain stabilizes DENV1-4 proteins and improves their de novo polymerase initiation activities by enhancing the turnover of the RNA and NTP substrates. Mutation studies of linker residues also indicate their importance for viral replication. We report the structure at 2.6-angstrom resolution of an RdRp fragment from DENV3 spanning residues 265-900 that has enhanced catalytic properties compared with the RdRp fragment (residues 272-900) reported previously. This new orthorhombic crystal form (space group P2(1)2(1)2) comprises two polymerases molecules arranged as a dimer around a non-crystallographic dyad. The enzyme adopts a closed "preinitiation" conformation similar to the one that was captured previously in space group C222(1) with one molecule per asymmetric unit. The structure reveals that residues 269-271 interact with the RdRp domain and suggests that residues 263-268 of the NS5 protein from DENV3 are the major contributors to the flexibility between its methyltransferase and RdRp domains. Together, these results should inform the screening and development of antiviral inhibitors directed against the DENV RdRp.	[Lim, Siew Pheng; Seh, Cheah Chen; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Koh, Jolene Hong Kiew; Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Liew, Chong Wai; Chua, Leng Shiew; Chandrasekaran, Ramya; Cornvik, Tobias C.; Lescar, Julien] Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 138673, Singapore; [Lescar, Julien] CHU Pitie Salpetriere, Fac Med, INSERM UMRS 945 Immunite & Infect, F-75013 Paris, France; [Lescar, Julien] Univ Paris 06, F-75013 Paris, France	Novartis; University of Bristol; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Lim, SP (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.	siew_pheng.lim@novartis.com; julien@ntu.edu.sg	Lim, Siew Pheng/P-8528-2016; Pheng, Lim Siew/AAG-4368-2021	Pheng, Lim Siew/0000-0002-7377-5662; Chandrasekaran, Ramya/0000-0002-3468-2092	Biomedical Research Council Grant [0912219/599]; National Research Foundation [CRP2008]; MRC [G0801973] Funding Source: UKRI; Medical Research Council [G0801973] Funding Source: researchfish	Biomedical Research Council Grant(Agency for Science Technology & Research (A*STAR)); National Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biomedical Research Council Grant 0912219/599 and in part by Competitive Research Programme Grant CRP2008 from the National Research Foundation (to the J. L. laboratory).	Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; PATA JD, 1995, RNA, V1, P466; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Tellez AB, 2011, J MOL BIOL, V412, P737, DOI 10.1016/j.jmb.2011.07.053; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yap TL, 2007, ACTA CRYSTALLOGR F, V63, P78, DOI 10.1107/S1744309106055084; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189	28	64	67	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31105	31114		10.1074/jbc.M113.508606	http://dx.doi.org/10.1074/jbc.M113.508606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025331	hybrid, Green Published			2022-12-25	WOS:000330778900029
J	Quintero, IB; Herrala, AM; Araujo, CL; Pulkka, AE; Hautaniemi, S; Ovaska, K; Pryazhnikov, E; Kulesskiy, E; Ruuth, MK; Soini, Y; Sormunen, RT; Khirug, L; Vihko, PT				Quintero, Ileana B.; Herrala, Annakaisa M.; Araujo, Cesar L.; Pulkka, Anitta E.; Hautaniemi, Sampsa; Ovaska, Kristian; Pryazhnikov, Evgeny; Kulesskiy, Evgeny; Ruuth, Maija K.; Soini, Ylermi; Sormunen, Raija T.; Khirug, Leonard; Vihko, Pirkko T.			Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma	PLOS ONE			English	Article							MOUSE MODELS; PROTEIN; EXPRESSION; PTEN; PROSTASOMES; CARCINOMA; PHOSPHORYLATION; IDENTIFICATION; PROGRESSION; TRANSPORT	The molecular mechanisms underlying prostate carcinogenesis are poorly understood. Prostatic acid phosphatase (PAP), a prostatic epithelial secretion marker, has been linked to prostate cancer since the 1930's. However, the contribution of PAP to the disease remains controversial. We have previously cloned and described two isoforms of this protein, a secretory (sPAP) and a transmembrane type-I (TMPAP). The goal in this work was to understand the physiological function of TMPAP in the prostate. We conducted histological, ultra-structural and genome-wide analyses of the prostate of our PAP-deficient mouse model (PAP(-/-)) with C57BL/6J background. The PAP(-/-) mouse prostate showed the development of slow-growing non-metastatic prostate adenocarcinoma. In order to find out the mechanism behind, we identified PAP-interacting proteins byyeast two-hybrid assays and a clear result was obtained for the interaction of PAP with snapin, a SNARE-associated protein which binds Snap25 facilitating the vesicular membrane fusion process. We confirmed this interaction by co-localization studies in TMPAP-transfected LNCaP cells (TMPAP/LNCaP cells) and in vivo FRET analyses in transient transfected LNCaP cells. The differential gene expression analyses revealed the dysregulation of the same genes known to be related to synaptic vesicular traffic. Both TMPAP and snapin were detected in isolated exosomes. Our results suggest that TMPAP is involved in endo-/exocytosis and disturbed vesicular traffic is a hallmark of prostate adenocarcinoma.	[Quintero, Ileana B.; Herrala, Annakaisa M.; Araujo, Cesar L.; Pulkka, Anitta E.; Ruuth, Maija K.; Vihko, Pirkko T.] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; [Quintero, Ileana B.; Herrala, Annakaisa M.; Araujo, Cesar L.; Pulkka, Anitta E.; Ruuth, Maija K.; Vihko, Pirkko T.] Helsinki Univ Hosp Lab, Helsinki, Finland; [Hautaniemi, Sampsa; Ovaska, Kristian] Univ Helsinki, Res Programs Unit, SF-00100 Helsinki, Finland; [Hautaniemi, Sampsa; Ovaska, Kristian] Univ Helsinki, Inst Biomed, SF-00100 Helsinki, Finland; [Pryazhnikov, Evgeny; Kulesskiy, Evgeny; Khirug, Leonard] Univ Helsinki, Ctr Neurosci, SF-00100 Helsinki, Finland; [Soini, Ylermi] Univ Eastern Finland, Sch Med, Dept Pathol & Forens Med, Inst Clin Med,Canc Ctr Eastern Finland, Kuopio, Finland; [Sormunen, Raija T.] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Sormunen, Raija T.] Univ Oulu, Dept Pathol, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Eastern Finland; University of Oulu; University of Oulu	Vihko, PT (corresponding author), Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland.	pirkko.vihko@helsinki.fi	Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022; Ruuth, Maija/P-6767-2019	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Ruuth, Maija/0000-0001-8903-0617; Quintero, Ileana/0000-0001-7040-1289; Kulesskiy, Evgeny/0000-0001-5965-2917	Academy of Finland [132201]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Academy of Finland to P.V. (grant no. 132201) and to Center of Excellence in Cancer Genetics (S.H., K.O.); and The Sigrid Juselius Foundation grants to P. V., and to S. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; DZIEMBORGRYSZKIEWICZ E, 1978, B ACAD POL SCI BIOL, V26, P815; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Golembiowska K, 2004, NEUROPHARMACOLOGY, V47, P414, DOI 10.1016/j.neuropharm.2004.04.018; Gutman AB, 1938, J CLIN INVEST, V17, P473, DOI 10.1172/JCI100974; HAKALAHTI L, 1993, INT J CANCER, V55, P590, DOI 10.1002/ijc.2910550413; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; LI HC, 1984, EUR J BIOCHEM, V138, P45, DOI 10.1111/j.1432-1033.1984.tb07879.x; LIN MF, 1992, CANCER RES, V52, P4600; LINDQVIST Y, 1993, J BIOL CHEM, V268, P20744; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Ronquist G, 2012, J INTERN MED, V271, P400, DOI 10.1111/j.1365-2796.2011.02487.x; Ronquist G, 2004, PROSTATE CANCER P D, V7, P21, DOI 10.1038/sj.pcan.4500684; Roy-Burman P, 2004, ENDOCR-RELAT CANCER, V11, P225, DOI 10.1677/erc.0.0110225; Ruder C, 2005, MOL BIOL CELL, V16, P1245, DOI 10.1091/mbc.E04-09-0817; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sahlen G, 2010, UPSALA J MED SCI, V115, P107, DOI 10.3109/03009730903366067; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Sharma P, 1999, ONCOGENE, V18, P5349, DOI 10.1038/sj.onc.1203037; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Svensson RU, 2011, AM J PATHOL, V179, P502, DOI 10.1016/j.ajpath.2011.03.014; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; Uustare A, 2006, NEUROSCI LETT, V406, P169, DOI 10.1016/j.neulet.2006.07.051; Veeramani S, 2012, FREE RADICAL BIO MED, V53, P95, DOI 10.1016/j.freeradbiomed.2012.03.024; VIHKO P, 1978, CLIN CHEM, V24, P1783; VIHKO PT, 2005, P AACR 96 ANN M AN C, P5239; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wei SH, 2010, MOL CELL NEUROSCI, V45, P418, DOI 10.1016/j.mcn.2010.07.014; Xue LX, 1997, CARCINOGENESIS, V18, P995, DOI 10.1093/carcin/18.5.995; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	51	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73072	10.1371/journal.pone.0073072	http://dx.doi.org/10.1371/journal.pone.0073072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039861	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600016
J	Woodall, CW; Domke, GM; Riley, KL; Oswalt, CM; Crocker, SJ; Yohe, GW				Woodall, Christopher W.; Domke, Grant M.; Riley, Karin L.; Oswalt, Christopher M.; Crocker, Susan J.; Yohe, Gary W.			A Framework for Assessing Global Change Risks to Forest Carbon Stocks in the United States	PLOS ONE			English	Article							CLIMATE-CHANGE; DISTURBANCE; UNCERTAINTY	Among terrestrial environments, forests are not only the largest long-term sink of atmospheric carbon (C), but are also susceptible to global change themselves, with potential consequences including alterations of C cycles and potential C emission. To inform global change risk assessment of forest C across large spatial/temporal scales, this study constructed and evaluated a basic risk framework which combined the magnitude of C stocks and their associated probability of stock change in the context of global change across the US. For the purposes of this analysis, forest C was divided into five pools, two live (aboveground and belowground biomass) and three dead (dead wood, soil organic matter, and forest floor) with a risk framework parameterized using the US's national greenhouse gas inventory and associated forest inventory data across current and projected future Koppen-Geiger climate zones (A1F1 scenario). Results suggest that an initial forest C risk matrix may be constructed to focus attention on short-and long-term risks to forest C stocks (as opposed to implementation in decision making) using inventory-based estimates of total stocks and associated estimates of variability (i.e., coefficient of variation) among climate zones. The empirical parameterization of such a risk matrix highlighted numerous knowledge gaps: 1) robust measures of the likelihood of forest C stock change under climate change scenarios, 2) projections of forest C stocks given unforeseen socioeconomic conditions (i.e., land-use change), and 3) appropriate social responses to global change events for which there is no contemporary climate/disturbance analog (e. g., severe droughts in the Lake States). Coupling these current technical/social limits of developing a risk matrix to the biological processes of forest ecosystems (i.e., disturbance events and interaction among diverse forest C pools, potential positive feedbacks, and forest resiliency/recovery) suggests an operational forest C risk matrix remains elusive.	[Woodall, Christopher W.; Domke, Grant M.; Crocker, Susan J.] US Forest Serv, USDA, No Res Stn, St Paul, MN USA; [Riley, Karin L.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Oswalt, Christopher M.] US Forest Serv, USDA, Southern Res Stn, Knoxville, TN USA; [Yohe, Gary W.] Wesleyan Univ, Middletown, CT USA	United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; Wesleyan University	Woodall, CW (corresponding author), US Forest Serv, USDA, No Res Stn, St Paul, MN USA.	cwoodall@fs.fed.us		Domke, Grant/0000-0003-0485-0355; Woodall, Christopher/0000-0001-8076-6214				Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; [Anonymous], 2011, NRS88 USDA FOR SERV; Bechtold WA, 2005, USDA GEN TECH REP, DOI 10.1371/journal.pone.0044795; Birdsey R, 2006, J ENVIRON QUAL, V35, P1461, DOI 10.2134/jeq2005.0162; BRIEF RP, 1969, J FINANC, V24, P901, DOI 10.2307/2325684; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Eisner JB, 2006, J GEOPHYS RES, V33; EPA, 2011, INV US GREENH GAS EM; ESRL, 2012, TRENDS ATM CARB DIOX; Etheridge D. M., 1998, TRENDS COMPENDIUM DA, P351; Grosse G., 2011, J GEOPHYS RES, V116; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Hurteau Matthew D, 2009, Carbon Balance Manag, V4, P1, DOI 10.1186/1750-0680-4-1; Iverson LR, 2012, CLIMATIC CHANGE, V114, P231, DOI 10.1007/s10584-012-0412-x; Jonas M, 2010, CLIMATIC CHANGE, V103, P3, DOI 10.1007/s10584-010-9922-6; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; O'Halloran TL, 2012, GLOBAL CHANGE BIOL, V18, P555, DOI 10.1111/j.1365-2486.2011.02577.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Raiffa H., 2000, APPL STAT DECISION T; Reich PB, 2011, NAT CLIM CHANGE, V1, P346; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Seidl R, 2011, GLOBAL CHANGE BIOL, V17, P2842, DOI 10.1111/j.1365-2486.2011.02452.x; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; U.S. Department of Agriculture Forest Service, 2012, WO87 USDA FORS SERV; Walker G, 2006, NATURE, V441, P802, DOI 10.1038/441802a; Weitzman ML, 2011, REV ENV ECON POLICY, V5, P275, DOI 10.1093/reep/rer006; Woodall CW, 2011, FOREST PROD J, V61, P595, DOI 10.13073/0015-7473-61.8.595; Woodall C. W., 2011, NATL REPORT SUSTAINA, pII59; Woodall CW, 2012, FORESTRY, V85, P125, DOI 10.1093/forestry/cpr065; Yohe G., 2010, BRIDGE, V40, P14; Yohe G, 2010, ANN NY ACAD SCI, V1196, P29, DOI 10.1111/j.1749-6632.2009.05310.x; Zeng HC, 2009, P NATL ACAD SCI USA, V106, P7888, DOI 10.1073/pnas.0808914106; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	40	8	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73222	10.1371/journal.pone.0073222	http://dx.doi.org/10.1371/journal.pone.0073222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039889	gold, Green Submitted, Green Published			2022-12-25	WOS:000327538600021
J	Bubendorfer, S; Ishihara, M; Dohlich, K; Heiss, C; Vogel, J; Sastre, F; Panico, M; Hitchen, P; Dell, A; Azadi, P; Thormann, KM				Bubendorfer, Sebastian; Ishihara, Mayumi; Dohlich, Kim; Heiss, Christian; Vogel, Jan; Sastre, Federico; Panico, Maria; Hitchen, Paul; Dell, Anne; Azadi, Parastoo; Thormann, Kai M.			Analyzing the Modification of the Shewanella oneidensis MR-1 Flagellar Filament	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI FLAGELLIN; HELICOBACTER-PYLORI; POSTTRANSLATIONAL MODIFICATION; FUNCTIONAL-CHARACTERIZATION; PROTEIN GLYCOSYLATION; AEROMONAS-HYDROPHILA; N-ACETYLGLUCOSAMINE; BACTERIAL FLAGELLA; ESCHERICHIA-COLI; GENUS SHEWANELLA	The unsheathed flagellar filament of Shewanella oneidensis MR-1 is composed of two highly homologous flagellins, FlaA, and the major structural unit, FlaB. We identified a gene cluster, SO_3261-SO_3265 (now sfmABCDE), that is required for the formation of a fully functional filament and for motility. The predicted function of the corresponding gene products strongly indicated a role in flagellin modification. Accordingly, loss of sfmABCDE results in a significant mass shift of both FlaA and FlaB. Mass spectroscopy analysis and single residue substitutions identified five serine residues in both flagellins that are modified via O-linkage. Modeling of the flagellin structures strongly suggests that at least four of the modified residues are exposed to the filament's surface. However, none of the five serine residues solely is crucial for function and assembly. Structural analysis of the flagellin modification revealed that it likely contains a nonulosonic acid (274 Da) linked to each glycosylated serine. The putative nonulosonic acid is further substituted with a 236 Da moiety which can carry additional methyl groups (250 Da, 264 Da). In addition, at least 5 lysine residues in FlaB and one in FlaA were found to be methylated. Based on homology comparisons we suggest that smfABCDE is required for species-specific flagellin modification in S. oneidensis MR-1.	[Bubendorfer, Sebastian; Vogel, Jan; Thormann, Kai M.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Ishihara, Mayumi; Heiss, Christian; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Sastre, Federico; Panico, Maria; Hitchen, Paul; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England; [Dohlich, Kim] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Sastre, Federico] Pontificia Univ Catolica Chile, Dept Ingn Quim & Bioproc, Santiago, Chile	Max Planck Society; University System of Georgia; University of Georgia; Imperial College London; Max Planck Society; Pontificia Universidad Catolica de Chile	Azadi, P (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	azadi@ccrc.uga.edu; thormann@mpi-marburg.mpg.de	Heiss, Christian/GPX-7678-2022	Heiss, Christian/0000-0003-1118-8953; Dell, Anne/0000-0003-1380-2347; Aoki, Mayumi/0000-0002-8368-8546	Max-Planck-Gesellschaft (MPG); U. S. Department of Energy [DE-FG02-93ER-20097]; National Institutes of Health Center for Functional Glycomics [8P41GM103490]; Biotechnology and Biological Sciences Research Council [BBF0083091, BBC5196701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	Max-Planck-Gesellschaft (MPG)(Max Planck Society); U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health Center for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors from the Max Planck Institute for Terrestrial Microbiology thank the Max-Planck-Gesellschaft (MPG) for financial support. Work at the Complex Carbohydrate Research Center was funded by the U. S. Department of Energy (DE-FG02-93ER-20097) and by the National Institutes of Health Center for Functional Glycomics (8P41GM103490). The Imperial College authors thank the Biotechnology and Biological Sciences Research Council for financial support (BBF0083091 and BBC5196701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, J BIOL CHEM, V256, P1905; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Bencharit S, 2005, J BACTERIOL, V187, P5049, DOI 10.1128/JB.187.14.5049-5053.2005; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Bubendorfer S, 2012, MOL MICROBIOL, V83, P335, DOI 10.1111/j.1365-2958.2011.07934.x; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; FOLLETT EAC, 1963, J GEN MICROBIOL, V32, P235, DOI 10.1099/00221287-32-2-235; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; HEIMBROOK ME, 1989, J CLIN MICROBIOL, V27, P2612, DOI 10.1128/JCM.27.11.2612-2615.1989; Hitchen P, 2010, MICROBIOL-SGM, V156, P1953, DOI 10.1099/mic.0.038091-0; Iida Y, 2009, J MOL BIOL, V394, P1011, DOI 10.1016/j.jmb.2009.10.003; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Jedrychowski MP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009910; Johnson CN, 2013, MICROB ECOL, V65, P826, DOI 10.1007/s00248-012-0168-x; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Logan SM, 2009, FEBS J, V276, P1014, DOI 10.1111/j.1742-4658.2008.06840.x; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MCCARTER L, 1988, CELL, V54, P345, DOI 10.1016/0092-8674(88)90197-3; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; McNally DJ, 2006, J BIOL CHEM, V281, P18489, DOI 10.1074/jbc.M603777200; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MINNICH SA, 1988, J BACTERIOL, V170, P3953, DOI 10.1128/jb.170.9.3953-3960.1988; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; NEALSON KH, 2003, PROKARYOTES EVOLVING, P1133; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Sambrook KJ, 1989, MOL CLONING LAB MANU; Schirm M, 2005, ANAL CHEM, V77, P7774, DOI 10.1021/ac051316y; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Song W, 2008, FEMS MICROBIOL LETT, V283, P223, DOI 10.1111/j.1574-6968.2008.01175.x; Sun LL, 2013, J BACTERIOL, V195, P2550, DOI 10.1128/JB.00015-13; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Tsai MS, 2008, INT J INFECT DIS, V12, pE119, DOI 10.1016/j.ijid.2008.03.020; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wilhelms M, 2012, J BIOL CHEM, V287, P27851, DOI 10.1074/jbc.M112.376525; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	65	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73444	10.1371/journal.pone.0073444	http://dx.doi.org/10.1371/journal.pone.0073444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039942	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500042
J	Gandia, M; del Castillo, FJ; Rodriguez-Alvarez, FJ; Garrido, G; Villamar, M; Calderon, M; Moreno-Pelayo, MA; Moreno, F; del Castillo, I				Gandia, Marta; del Castillo, Francisco J.; Rodriguez-Alvarez, Francisco J.; Garrido, Gema; Villamar, Manuela; Calderon, Manuela; Moreno-Pelayo, Miguel A.; Moreno, Felipe; del Castillo, Ignacio			A Novel Splice-Site Mutation in the GJB2 Gene Causing Mild Postlingual Hearing Impairment	PLOS ONE			English	Article							CONNEXIN-30 GENE; HIGH PREVALENCE; HIGH-FREQUENCY; CODING REGION; DEAFNESS; DFNB1; DELETION; FOUNDER; POPULATION; MULTICENTER	The DFNB1 subtype of autosomal recessive, nonsyndromic hearing impairment, caused by mutations affecting the GJB2 (connection-26) gene, is highly prevalent in most populations worldwide. DFNB1 hearing impairment is mostly severe or profound and usually appears before the acquisition of speech (prelingual onset), though a small number of hypomorphic missense mutations result in mild or moderate deafness of postlingual onset. We identified a novel GJB2 splice-site mutation, c. -22-2A>C, in three siblings with mild postlingual hearing impairment that were compound heterozygous for c. -22-2A>C and c.35delG. Reverse transcriptase-PCR experiments performed on total RNA extracted from saliva samples from one of these siblings confirmed that c. -22-2A>C abolished the acceptor splice site of the single GJB2 intron, resulting in the absence of normally processed transcripts from this allele. However, we did isolate transcripts from the c. -22-2A>C allele that keep an intact GJB2 coding region and that were generated by use of an alternative acceptor splice site previously unknown. The residual expression of wild-type connection-26 encoded by these transcripts probably underlies the mild severity and late onset of the hearing impairment of these subjects.	[Gandia, Marta; del Castillo, Francisco J.; Rodriguez-Alvarez, Francisco J.; Garrido, Gema; Villamar, Manuela; Moreno-Pelayo, Miguel A.; Moreno, Felipe; del Castillo, Ignacio] Hosp Univ Ramon y Cajal, IRYCIS, Unidad Genet Mol, Madrid, Spain; [Gandia, Marta; del Castillo, Francisco J.; Rodriguez-Alvarez, Francisco J.; Garrido, Gema; Villamar, Manuela; Moreno-Pelayo, Miguel A.; Moreno, Felipe; del Castillo, Ignacio] CIBERER, Madrid, Spain; [Calderon, Manuela] Hosp Univ Ramon y Cajal, Serv Otorrinolaringol, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Ramon y Cajal	del Castillo, I (corresponding author), Hosp Univ Ramon y Cajal, IRYCIS, Unidad Genet Mol, Madrid, Spain.	ignacio.castillo@salud.madrid.org	del Castillo, Francisco J./A-6467-2013; Garrido, Gema/ABF-5941-2021; Villamar, Manuela/AAD-3842-2020; del Castillo, Ignacio/B-4314-2013	del Castillo, Francisco J./0000-0003-0467-4320; Villamar, Manuela/0000-0002-5115-4937; del Castillo, Ignacio/0000-0003-1188-3665; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098	Ministerio de Educacion y Ciencia; Instituto de Salud Carlos III [FIS CP06/00050, FIS PI11/00612]; Ministerio de Ciencia e Innovacion [SAF 2008-03216]; Fundacion Ramon Areces	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces	M.G. was a recipient of a Formacion de Personal Investigador fellowship from Ministerio de Educacion y Ciencia. This work was supported by grants from Instituto de Salud Carlos III FIS CP06/00050 (to F.J.d.C.) and FIS PI11/00612 (to I.d.C.), from Ministerio de Ciencia e Innovacion SAF 2008-03216 (to F. M.), and from Fundacion Ramon Areces (to I.d.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Alvarez A, 2005, AM J MED GENET A, V137A, P255, DOI 10.1002/ajmg.a.30884; Ballana E, 2013, CONNEXINS DEAFNESS H; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo FJ, 2011, FRONT BIOSCI-LANDMRK, V16, P3252, DOI 10.2741/3910; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Feldmann D, 2009, EUR J MED GENET, V52, P195, DOI 10.1016/j.ejmg.2008.11.006; Janecke AR, 2002, HUM GENET, V111, P145, DOI 10.1007/s00439-002-0762-y; Kiang DT, 1997, GENE, V199, P165, DOI 10.1016/S0378-1119(97)00365-X; Mahdieh N, 2004, CLIN GENET, V65, P506, DOI 10.1111/j.1399-0004.2004.00262.x; Marlin S, 2001, ARCH OTOLARYNGOL, V127, P927, DOI 10.1001/archotol.127.8.927; Matos TD, 2007, J MED GENET, V44, P721, DOI 10.1136/jmg.2007.050682; Minarik G, 2003, GEN PHYSIOL BIOPHYS, V22, P549; Nhlbi GO, EXOME SEQUENCING PRO; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; RamShankar M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e68; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Seeman P, 2006, CLIN GENET, V69, P410, DOI 10.1111/j.1399-0004.2006.00602.x; Shahin H, 2002, HUM GENET, V110, P284, DOI 10.1007/s00439-001-0674-2; Sirmaci A, 2006, J GENET, V85, P213, DOI 10.1007/BF02935334; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Sobe T, 1999, AM J MED GENET, V86, P499, DOI 10.1002/(SICI)1096-8628(19991029)86:5<499::AID-AJMG19>3.3.CO;2-F; Tekin M, 2010, ANN HUM GENET, V74, P155, DOI 10.1111/j.1469-1809.2010.00564.x; Van Camp G., 2012, HEREDITARY HEARING L; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Wilch E, 2010, CLIN GENET, V78, P267, DOI 10.1111/j.1399-0004.2010.01387.x; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yuan YY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-127	33	14	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73566	10.1371/journal.pone.0073566	http://dx.doi.org/10.1371/journal.pone.0073566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039984	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500046
J	Mejean, CO; Schaefer, AW; Buck, KB; Kress, H; Shundrovsky, A; Merrill, JW; Dufresne, ER; Forscher, P				Mejean, Cecile O.; Schaefer, Andrew W.; Buck, Kenneth B.; Kress, Holger; Shundrovsky, Alla; Merrill, Jason W.; Dufresne, Eric R.; Forscher, Paul			Elastic Coupling of Nascent apCAM Adhesions to Flowing Actin Networks	PLOS ONE			English	Article							CYTOSKELETAL DYNAMICS; MICROTUBULE DYNAMICS; LEADING-EDGE; GROWTH CONES; FORCE; MOLECULE; TRANSMISSION; FILOPODIA; TRANSPORT; FILAMENT	Adhesions are multi-molecular complexes that transmit forces generated by a cell's acto-myosin networks to external substrates. While the physical properties of some of the individual components of adhesions have been carefully characterized, the mechanics of the coupling between the cytoskeleton and the adhesion site as a whole are just beginning to be revealed. We characterized the mechanics of nascent adhesions mediated by the immunoglobulin-family cell adhesion molecule apCAM, which is known to interact with actin filaments. Using simultaneous visualization of actin flow and quantification of forces transmitted to apCAM-coated beads restrained with an optical trap, we found that adhesions are dynamic structures capable of transmitting a wide range of forces. For forces in the picoNewton scale, the nascent adhesions' mechanical properties are dominated by an elastic structure which can be reversibly deformed by up to 1 mu m. Large reversible deformations rule out an interface between substrate and cytoskeleton that is dominated by a number of stiff molecular springs in parallel, and favor a compliant cross-linked network. Such a compliant structure may increase the lifetime of a nascent adhesion, facilitating signaling and reinforcement.	[Mejean, Cecile O.; Kress, Holger; Shundrovsky, Alla; Dufresne, Eric R.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Schaefer, Andrew W.; Buck, Kenneth B.; Shundrovsky, Alla; Forscher, Paul] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Merrill, Jason W.; Dufresne, Eric R.] Yale Univ, Dept Phys, New Haven, CT USA; [Dufresne, Eric R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA; [Dufresne, Eric R.] Yale Univ, Dept Cell Biol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Forscher, P (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	paul.forscher@yale.edu	Dufresne, Eric R/A-7760-2009	Forscher, Paul/0000-0003-1988-5155; Dufresne, Eric Robert/0000-0002-3091-5039	National Science Foundation [DBI-0619674]; National Institutes of Health [1U54-RR022232, R01 NS28695, R01 NS051786]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695, R01NS051786] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge financial support from the National Science Foundation (DBI-0619674) and the National Institutes of Health (1U54-RR022232, R01 NS28695, R01 NS051786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen B, 2010, BIOPHYS J, V98, P2154, DOI 10.1016/j.bpj.2010.02.007; Chen H, 2011, BIOPHYS J, V101, P1231, DOI 10.1016/j.bpj.2011.07.028; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; EVANS EA, 1974, BIOPHYS J, V14, P923, DOI 10.1016/S0006-3495(74)85959-X; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; FORSCHER P, 1987, J NEUROSCI, V7, P3600; Gao HJ, 2011, J R SOC INTERFACE, V8, P1217, DOI 10.1098/rsif.2011.0157; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mejean CO, 2009, OPT EXPRESS, V17, P6209, DOI 10.1364/OE.17.006209; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Qian J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012342; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Sabass B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194112; Safran S. A., 1994, STAT THERMODYNAMICS; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schmidt S, 2010, BIOPHYS J, V98, P2246, DOI 10.1016/j.bpj.2010.01.055; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Thompson C, 1996, J CELL SCI, V109, P2843; Xiong Y, 2009, BIOPHYS J, V96, P5060, DOI 10.1016/j.bpj.2009.03.032; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	47	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73389	10.1371/journal.pone.0073389	http://dx.doi.org/10.1371/journal.pone.0073389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039928	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500041
J	Joly, P; Duda, GN; Schone, M; Welzel, PB; Freudenberg, U; Werner, C; Petersen, A				Joly, Pascal; Duda, Georg N.; Schoene, Martin; Welzel, Petra B.; Freudenberg, Uwe; Werner, Carsten; Petersen, Ansgar			Geometry-Driven Cell Organization Determines Tissue Growths in Scaffold Pores: Consequences for Fibronectin Organization	PLOS ONE			English	Article							ASCORBIC-ACID; COLLAGEN; MATRIX; FIBROBLASTS; MODEL; STIFFNESS; DYNAMICS; PATTERNS; REPAIR; SIZE	To heal tissue defects, cells have to bridge gaps and generate new extracellular matrix (ECM). Macroporous scaffolds are frequently used to support the process of defect filling and thus foster tissue regeneration. Such biomaterials contain micro-voids (pores) that the cells fill with their own ECM over time. There is only limited knowledge on how pore geometry influences cell organization and matrix production, even though it is highly relevant for scaffold design. This study hypothesized that 1) a simple geometric description predicts cellular organization during pore filling at the cell level and that 2) pore closure results in a reorganization of ECM. Scaffolds with a broad distribution of pore sizes (macroporous starPEG-heparin cryogel) were used as a model system and seeded with primary fibroblasts. The strategies of cells to fill pores could be explained by a simple geometrical model considering cells as tensioned chords. The model matched qualitatively as well as quantitatively by means of cell number vs. open cross-sectional area for all pore sizes. The correlation between ECM location and cell position was higher when the pores were not filled with tissue (Pearson's coefficient rho = 0.45 +/- 0.01) and reduced once the pores were closed (rho = 0.26 +/- 0.04) indicating a reorganization of the cell/ECM network. Scaffold pore size directed the time required for pore closure and furthermore impacted the organization of the fibronectin matrix. Understanding how cells fill micro-voids will help to design biomaterial scaffolds that support the endogenous healing process and thus allow a fast filling of tissue defects.	[Joly, Pascal; Duda, Georg N.; Schoene, Martin; Petersen, Ansgar] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Joly, Pascal; Duda, Georg N.; Schoene, Martin] Charite, Berlin Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany; [Duda, Georg N.; Petersen, Ansgar] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Joly, Pascal; Duda, Georg N.; Schoene, Martin; Petersen, Ansgar] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Welzel, Petra B.; Freudenberg, Uwe; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, Dresden, Germany; [Welzel, Petra B.; Freudenberg, Uwe; Werner, Carsten] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Joly, P (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	pascal.joly@charite.de	Freudenberg, Uwe/C-3009-2019; Duda, Georg N/H-2085-2016; Petersen, Ansgar/O-1945-2015; Werner, Carsten/AAF-1510-2019; Werner, Carsten/F-8127-2010	Freudenberg, Uwe/0000-0002-1359-1095; Duda, Georg N/0000-0001-7605-3908; Werner, Carsten/0000-0003-0189-3448	Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Berlin-Brandenburg School for Regenerative Therapies (BSRT)	Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Berlin-Brandenburg School for Regenerative Therapies (BSRT)	This work has been funded by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and the Berlin-Brandenburg School for Regenerative Therapies (BSRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cheng G, 2009, BIOPHYS J, V97, P401, DOI 10.1016/j.bpj.2009.03.067; Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5; Edwards SL, 2011, TISSUE ENG PART C-ME, V17, P123, DOI [10.1089/ten.tec.2010.0182, 10.1089/ten.TEC.2010.0182]; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Freudenberg U, 2012, ADV FUNCT MATER, V22, P1391, DOI 10.1002/adfm.201101868; Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002; Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Jeon YK, 2010, WOUND REPAIR REGEN, V18, P655, DOI 10.1111/j.1524-475X.2010.00636.x; Knychala J, 2013, ANN BIOMED ENG, V41, P917, DOI 10.1007/s10439-013-0748-z; Kollmannsberger P, 2011, SOFT MATTER, V7, P9549, DOI 10.1039/c1sm05588g; Lozinsky VI, 2002, USP KHIM+, V71, P559; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; O'Dea RD, 2012, J MATH BIOL; Petersen A, 2012, TISSUE ENG PT A, V18, P1804, DOI [10.1089/ten.tea.2011.0514, 10.1089/ten.TEA.2011.0514]; Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195; Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Shimizu M, 1997, BBA-PROTEIN STRUCT M, V1339, P53, DOI 10.1016/S0167-4838(96)00214-2; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Vidal G, 2011, CARBON, V49, P2318, DOI 10.1016/j.carbon.2011.01.064; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Welzel PB, 2012, BIOMACROMOLECULES, V13, P2349, DOI 10.1021/bm300605s; Welzel PB, 2011, POLYMERS-BASEL, V3, P602, DOI 10.3390/polym3010602; Zhou LL, 1998, CURR EYE RES, V17, P211, DOI 10.1076/ceyr.17.2.211.5608	46	59	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73545	10.1371/journal.pone.0073545	http://dx.doi.org/10.1371/journal.pone.0073545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039979	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600086
J	Del Rio, M; Mollevi, C; Vezzio-Vie, N; Bibeau, F; Ychou, M; Martineau, P				Del Rio, Maguy; Mollevi, Caroline; Vezzio-Vie, Nadia; Bibeau, Frederic; Ychou, Marc; Martineau, Pierre			Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases	PLOS ONE			English	Article							COLORECTAL-CANCER PROGRESSION; LARGE GENE LISTS; ENDOTHELIAL-CELLS; LIVER METASTASIS; TUMOR-METASTASIS; EXPRESSION; BIOINFORMATICS; MICROARRAY; SURVIVAL; FLUOROURACIL	To identify genes implicated in metastatic colonization of the liver in colorectal cancer, we collected pairs of primary tumors and hepatic metastases before chemotherapy in 13 patients. We compared mRNA expression in the pairs of patients to identify genes deregulated during metastatic evolution. We then validated the identified genes using data obtained by different groups. The 33-gene signature was able to classify 87% of hepatic metastases, 98% of primary tumors, 97% of normal colon mucosa, and 95% of normal liver tissues in six datasets obtained using five different microarray platforms. The identified genes are specific to colon cancer and hepatic metastases since other metastatic locations and hepatic metastases originating from breast cancer were not classified by the signature. Gene Ontology term analysis showed that 50% of the genes are implicated in extracellular matrix remodeling, and more precisely in cell adhesion, extracellular matrix organization and angiogenesis. Because of the high efficiency of the signature to classify colon hepatic metastases, the identified genes represent promising targets to develop new therapies that will specifically affect hepatic metastasis microenvironment.	[Del Rio, Maguy; Vezzio-Vie, Nadia; Ychou, Marc; Martineau, Pierre] IRCM, Montpellier, France; [Del Rio, Maguy; Vezzio-Vie, Nadia; Ychou, Marc; Martineau, Pierre] INSERM, U896, Montpellier, France; [Del Rio, Maguy; Vezzio-Vie, Nadia; Ychou, Marc; Martineau, Pierre] Univ Montpellier I, Montpellier, France; [Del Rio, Maguy; Mollevi, Caroline; Vezzio-Vie, Nadia; Bibeau, Frederic; Ychou, Marc; Martineau, Pierre] Inst Reg Canc Montpellier, ICM, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Martineau, P (corresponding author), IRCM, Montpellier, France.	pierre.martineau@inserm.fr	Martineau, Pierre/N-4386-2017; Mollevi, Caroline/AAA-6839-2019	Martineau, Pierre/0000-0002-7993-7183; Mollevi, Caroline/0000-0003-4827-3684; Ychou, Marc/0000-0001-7378-9469	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	This work was supported by a grant from Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEHREND EI, 1994, CANCER RES, V54, P832; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bonebakker L, 2012, GPLOTS VARIOUS R PRO; Copur S, 2001, Clin Colorectal Cancer, V1, P55, DOI 10.3816/CCC.2001.n.006; Del Rio M, 2007, J CLIN ONCOL, V25, P773, DOI 10.1200/JCO.2006.07.4187; Du R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-189; Ferlay J, 2012, IARC CANCERBASE; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iii JAS, 2011, NATURE, V474, P511, DOI [10.1038/nature10085, DOI 10.1038/NATURE10085]; Jeon JW, 2006, INT J ONCOL, V29, P209; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kleivi K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-2; Koehler A, 2004, J PATHOL, V204, P65, DOI 10.1002/path.1606; Koh KH, 2008, ONCOLOGY-BASEL, V75, P92, DOI 10.1159/000155211; Lin AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016636; Lucas A., 2011, AMAP MULTIDIMENSIONA; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; McFadyen Morag C E, 2005, Future Oncol, V1, P259, DOI 10.1517/14796694.1.2.259; Miyaki M, 1995, ONCOGENE, V11, P2547; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Nissan A, 2009, J SURG ONCOL, V100, P335, DOI 10.1002/jso.21323; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Pawlik TM, 2007, J GASTROINTEST SURG, V11, P1057, DOI 10.1007/s11605-006-0061-3; Provenzani A, 2006, CARCINOGENESIS, V27, P1323, DOI 10.1093/carcin/bgi377; Saini S, 2009, CANCER RES, V69, P7038, DOI 10.1158/0008-5472.CAN-09-1691; Schellerer VS, 2007, LAB INVEST, V87, P1159, DOI 10.1038/labinvest.3700671; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Taminau J, 2012, INSILICOMERGING COLL; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; TARIN D, 1984, CANCER RES, V44, P3584; Team RC, 2012, R LANG ENV STAT COMP; Terraube V, 2007, THROMB RES, V120, pS64, DOI 10.1016/S0049-3848(07)70132-9; Tibshirani R., 2011, SAMR SAM SIGNIFICANC; Yamasaki M, 2007, INT J ONCOL, V30, P129; Yanagawa R, 2001, NEOPLASIA, V3, P395, DOI 10.1038/sj.neo.7900185; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	53	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74599	10.1371/journal.pone.0074599	http://dx.doi.org/10.1371/journal.pone.0074599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023955	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600150
J	Menard, L; McKey, D; Muhlen, GS; Clair, B; Rowe, NP				Menard, Lea; McKey, Doyle; Muehlen, Gilda S.; Clair, Bruno; Rowe, Nick P.			The Evolutionary Fate of Phenotypic Plasticity and Functional Traits under Domestication in Manioc: Changes in Stem Biomechanics and the Appearance of Stem Brittleness	PLOS ONE			English	Article							CASSAVA MANIHOT-ESCULENTA; MICROFIBRIL ANGLE; TRADITIONAL AGROECOSYSTEMS; GENETIC DIVERSITY; PROPAGATED CROP; CELL-WALL; PLANT; WOOD; EUPHORBIACEAE; DYNAMICS	Domestication can influence many functional traits in plants, from overall life-history and growth form to wood density and cell wall ultrastructure. Such changes can increase fitness of the domesticate in agricultural environments but may negatively affect survival in the wild. We studied effects of domestication on stem biomechanics in manioc by comparing domesticated and ancestral wild taxa from two different regions of greater Amazonia. We compared mechanical properties, tissue organisation and wood characteristics including microfibril angles in both wild and domesticated plants, each growing in two different habitats (forest or savannah) and varying in growth form (shrub or liana). Wild taxa grew as shrubs in open savannah but as lianas in overgrown and forested habitats. Growth form plasticity was retained in domesticated manioc. However, stems of the domesticate showed brittle failure. Wild plants differed in mechanical architecture between shrub and liana phenotypes, a difference that diminished between shrubs and lianas of the domesticate. Stems of wild plants were generally stiffer, failed at higher bending stresses and were less prone to brittle fracture compared with shrub and liana phenotypes of the domesticate. Biomechanical differences between stems of wild and domesticated plants were mainly due to changes in wood density and cellulose microfibril angle rather than changes in secondary growth or tissue geometry. Domestication did not significantly modify "large-scale" trait development or growth form plasticity, since both wild and domesticated manioc can develop as shrubs or lianas. However, "finer-scale" developmental traits crucial to mechanical stability and thus ecological success of the plant were significantly modified. This profoundly influenced the likelihood of brittle failure, particularly in long climbing stems, thereby also influencing the survival of the domesticate in natural situations vulnerable to mechanical perturbation. We discuss the different selective pressures that could explain evolutionary modifications of stem biomechanical properties under domestication in manioc.	[Menard, Lea; Rowe, Nick P.] Univ Montpellier 2, UMR AMAP, Montpellier, France; [Menard, Lea; Rowe, Nick P.] CNRS, UMR AMAP, Montpellier, France; [McKey, Doyle] Univ Montpellier 2, CNRS, UMR 5175, CEFE, Montpellier, France; [McKey, Doyle] Inst Univ France, Paris, France; [Muehlen, Gilda S.] Fed Univ Rondonia, Dept Agron, Rolim De Moura, Rondonia, Brazil; [Clair, Bruno] Univ Montpellier 2, CNRS, LMGC, Montpellier, France; [Clair, Bruno] CNRS, UMR Ecol Forets Guyane EcoFoG, Kourou, French Guiana	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Institut Universitaire de France; Universidade Federal de Rondonia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Rowe, NP (corresponding author), Univ Montpellier 2, UMR AMAP, Montpellier, France.	nrowe@cirad.fr	Clair, Bruno/B-7503-2013	Clair, Bruno/0000-0002-4093-9034	Contrats Projets Etat Region (CPER) Guyane; Programme 'Ecosystemes Tropicaux' from the French Ministry of Ecology and Sustainable Development; Programme of the French National Research Agency [ANR-05-BDIV-012-04]; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	Contrats Projets Etat Region (CPER) Guyane; Programme 'Ecosystemes Tropicaux' from the French Ministry of Ecology and Sustainable Development; Programme of the French National Research Agency(French National Research Agency (ANR)); Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This research was funded by the following grants: 1) Contrats Projets Etat Region (CPER) Guyane to DM. www.datar.gouv.fr/contrats-etat-regions. 2) Programme 'Ecosystemes Tropicaux' from the French Ministry of Ecology and Sustainable Development, to study the diversity of Manihot in French Guiana to DM. http://www.agropolis.fr/actualites/retour-seminaire-ecosystemes-tropicaux-ecofor-2010.php. 3) Programme of the French National Research Agency (ANR-05-BDIV-012-04) to N. Rowe and B. Clair. www.agence-nationale-recherche.fr. 4) This work also benefited from an "Investissement d'Avenir" grant managed by the Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). www.labex-ceba.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allem A. C., 1987, Plant Genetic Resources Newsletter, P22; Allem Antonio C., 1994, Genetic Resources and Crop Evolution, V41, P133, DOI 10.1007/BF00051630; Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; [Anonymous], 1973, MANIHOT MANIHOTOIDES; [Anonymous], 1995, EVOLUTION CROP PLANT; Arroyo-Kalin M., 2010, Diversity, V2, P473; Barnett JR, 2004, BIOL REV, V79, P461, DOI 10.1017/S1464793103006377; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Bodig J., 1982, MECH WOOD WOOD COMPO; Boster J., 1984, ADV EC BOT, V1, P34; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Burgert L, 2001, TREES-STRUCT FUNCT, V15, P168; Caballe G, 1998, CAN J BOT, V76, P1703, DOI 10.1139/b98-127; CAVE I. D., 1966, FOREST PRODJ, V16, P37; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Cury R, 1993, THESIS U SAO PAULO S; D'Ennequin ML, 1999, J EVOLUTION BIOL, V12, P1138, DOI 10.1046/j.1420-9101.1999.00115.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Donaldson LA, 1996, IAWA J, V17, P421, DOI 10.1163/22941932-90000639; Doust A, 2007, ANN BOT-LONDON, V100, P941, DOI 10.1093/aob/mcm040; Duputie A, 2007, MOL ECOL, V16, P3025, DOI 10.1111/j.1365-294X.2007.03340.x; Duputie A, 2011, J BIOGEOGR, V38, P1033, DOI 10.1111/j.1365-2699.2011.02474.x; Elias M, 2000, HEREDITY, V85, P219, DOI 10.1046/j.1365-2540.2000.00749.x; Elias M, 2000, ACTA OECOL, V21, P223, DOI 10.1016/S1146-609X(00)00053-9; Elias M, 2001, EUPHYTICA, V120, P143, DOI 10.1023/A:1017501017031; Elias M, 2001, MOL ECOL, V10, P1895, DOI 10.1046/j.0962-1083.2001.01331.x; Elias M, 2007, GENET RESOUR CROP EV, V54, P99, DOI 10.1007/s10722-005-2022-1; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; Ennos AR, 2010, P ROY SOC B-BIOL SCI, V277, P1253, DOI 10.1098/rspb.2009.2093; FAO STAT, 2010, AGR PROD DAT; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Gallenmuller F, 2001, PLANT BIOLOGY, V3, P50, DOI 10.1055/s-2001-11750; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gillespie LJ, 2002, GUIDE VASCULAR PLA 2, P266; Gordon J.E., 2006, NEW SCI STRONG MAT W; Gordon J.E., 1978, STRUCTURES WHY THING; Hancock JF, 2005, ANN BOT-LONDON, V96, P953, DOI 10.1093/aob/mci259; Hershey C, 1994, 1 M INT NETW CASS GE; Isnard S, 2003, NEW PHYTOL, V158, P543, DOI 10.1046/j.1469-8137.2003.00771.x; JACKSON AP, 1992, BIOMECHANICS MAT PRA, P33; JERONIMIDIS G, 1980, PROC R SOC SER B-BIO, V208, P447, DOI 10.1098/rspb.1980.0062; Kohler L, 2000, PLANTA, V210, P691, DOI 10.1007/s004250050669; Lahaye R, 2005, AM J BOT, V92, P1381, DOI 10.3732/ajb.92.8.1381; Leotard G, 2009, MOL PHYLOGENET EVOL, V53, P329, DOI 10.1016/j.ympev.2009.05.003; Lichtenegger H, 1999, J STRUCT BIOL, V128, P257, DOI 10.1006/jsbi.1999.4194; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Lucas PW, 1997, PHILOS T R SOC B, V352, P341, DOI 10.1098/rstb.1997.0025; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; MCKEY D, 1993, MAN BIOSPH, V13, P83; McKey D, 2001, GENET SEL EVOL, V33, pS465, DOI 10.1186/BF03500895; McKey DB, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P377; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; McLean JP, 2011, ANN FOREST SCI, V68, P681, DOI 10.1007/s13595-011-0085-z; Menard L, 2009, ANN BOT-LONDON, V103, P1249, DOI 10.1093/aob/mcp078; Niklas KJ, 2003, AM J BOT, V90, P663, DOI 10.3732/ajb.90.5.663; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Olsen KM, 2004, PLANT MOL BIOL, V56, P517, DOI 10.1007/s11103-004-5043-9; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Olsen KM, 2002, MOL ECOL, V11, P901, DOI 10.1046/j.1365-294X.2002.01493.x; Paterson AH, 2005, GENOME RES, V15, P1643, DOI 10.1101/gr.3725905; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Pujol B, 2005, NEW PHYTOL, V166, P305, DOI 10.1111/j.1469-8137.2004.01295.x; Pujol B, 2002, ECON BOT, V56, P366, DOI [10.1663/0013-0001(2002)056[0366:GEOCME]2.0.CO;2, 10.1111/j.1461-0248.2004.00708.x]; Ross-Ibarra J, 2004, AM NAT, V163, P105, DOI 10.1086/380606; Rowe N, 2004, J PLANT GROWTH REGUL, V23, P108, DOI 10.1007/s00344-004-0044-0; Rowe NP, 2006, ECOLOGY AND BIOMECHANICS, P35; Rowe NP, 1996, INT J PLANT SCI, V157, P406, DOI 10.1086/297357; Ruelle J, 2006, IAWA J, V27, P341, DOI 10.1163/22941932-90000159; Sambatti JBM, 2001, ECON BOT, V55, P93, DOI 10.1007/BF02864549; Speck T, 2003, REGNUM VEG, V141, P241; Speck T., 1991, NATURAL STRUCTURES 1, P89; Speck T., 1999, EVOLUTION PLANT ARCH, P447; Speck Thomas, 1994, Biomimetics, V2, P109; van Casteren A, 2012, TREES-STRUCT FUNCT, V26, P789, DOI 10.1007/s00468-011-0650-y; Vincent J, 1990, STRUCTURAL BIOMATERI; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; YAMAMOTO H, 1993, MOKUZAI GAKKAISHI, V39, P375; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2	81	22	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74727	10.1371/journal.pone.0074727	http://dx.doi.org/10.1371/journal.pone.0074727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023960	Green Submitted, Green Published, gold			2022-12-25	WOS:000324515600154
J	Carland, JE; Cooper, MA; Livesey, MR; Hales, TG; Peters, JA; Lambert, JJ				Carland, Jane E.; Cooper, Michelle A.; Livesey, Matthew R.; Hales, Tim G.; Peters, John A.; Lambert, Jeremy J.			Mutagenic Analysis of the Intracellular Portals of the Human 5-HT(3)A Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; GATED ION CHANNELS; LARGE CYTOPLASMIC LOOP; CHARGED AMINO-ACIDS; 5-HT3 RECEPTOR; 5-HYDROXYTRYPTAMINE TYPE-3; STRUCTURAL DETERMINANTS; PROTEIN-PHOSPHORYLATION; SEROTONIN-RECEPTOR	Structural models of Cys-loop receptors based on homology with the Torpedo marmorata nicotinic acetylcholine receptor infer the existence of cytoplasmic portals within the conduction pathway framed by helical amphipathic regions (termed membrane-associated (MA) helices) of adjacent intracellular M3-M4 loops. Consistent with these models, two arginine residues (Arg(436) and Arg(440)) within the MA helix of 5-hydroxytryptamine type 3A (5-HT(3)A) receptors act singularly as rate-limiting determinants of single-channel conductance (gamma). However, there is little conservation in primary amino acid sequences across the cytoplasmic loops of Cys-loop receptors, limiting confidence in the fidelity of this particular aspect of the 5-HT(3)A receptor model. We probed the majority of residues within the MA helix of the human 5-HT(3)A subunit using alanine-and arginine-scanning mutagenesis and the substituted cysteine accessibility method to determine their relative influences upon gamma. Numerous residues, prominently those at the 435, 436, 439, and 440 positions, were found to markedly influence gamma. This approach yielded a functional map of the 5-HT(3)A receptor portals, which agrees well with the homology model.	[Lambert, Jeremy J.] Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Res Inst, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Educ Inst, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Lambert, JJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Res Inst, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk; j.j.lambert@dundee.ac.uk		Carland, Jane/0000-0002-1456-876X; Livesey, Matthew/0000-0002-3441-7977	Wellcome Trust; Tenovus Scotland; Anonymous Trust; Biotechnology and Biological Sciences Research Council; Lilly; National Science Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Tenovus Scotland; Anonymous Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lilly(Eli Lilly); National Science Foundation(National Science Foundation (NSF))	The work was supported by the Wellcome Trust, Tenovus Scotland, the Anonymous Trust (to J. A. P. and J. J. L.), the Biotechnology and Biological Sciences Research Council in conjunction with Lilly (to M. R. L.), and the National Science Foundation (to T. G. H.).	Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; Baptista-Hon DT, 2012, BRIT J PHARMACOL, V165, P693, DOI 10.1111/j.1476-5381.2011.01582.x; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Criado M, 2011, FEBS LETT, V585, P2477, DOI 10.1016/j.febslet.2011.06.028; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V522, P187, DOI 10.1111/j.1469-7793.2000.00187.x; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kottwitz D, 2004, PROTEIN EXPRES PURIF, V38, P237, DOI 10.1016/j.pep.2004.07.017; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mochizuki S, 1999, AMINO ACIDS, V17, P243, DOI 10.1007/BF01366923; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Valor LM, 2002, BIOCHEMISTRY-US, V41, P7931, DOI 10.1021/bi025831r; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	53	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31592	31601		10.1074/jbc.M113.503300	http://dx.doi.org/10.1074/jbc.M113.503300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24030822	Green Published, hybrid			2022-12-25	WOS:000330596200018
J	Xuan, Z; Barthet, G; Shioi, J; Xu, JD; Georgakopoulos, A; Bruban, J; Robakis, NK				Xuan, Zhao; Barthet, Gael; Shioi, Junichi; Xu, Jindong; Georgakopoulos, Anastasios; Bruban, Julien; Robakis, Nikolaos K.			Presenilin-1/gamma-Secretase Controls Glutamate Release, Tyrosine Phosphorylation, and Surface Expression of N-Methyl-D-aspartate Receptor (NMDAR) Subunit GluN2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Glutamate; Glutamate Receptor Ionotropic (AMPA; NMDA); Presenilin; Secretases	AMYLOID PRECURSOR PROTEIN; CALPAIN-I ACTIVATION; HIPPOCAMPAL-NEURONS; NA+/CA2+ EXCHANGER; MECHANISMS; CLEAVAGE; BINDING; BETA; NEURODEGENERATION; PRESENILINS	Abnormally high concentrations of extracellular glutamate in the brain may cause neuronal damage via excitotoxicity. Thus, tight regulation of glutamate release is critical to neuronal function and survival. Excitotoxicity is caused mainly by overactivation of the extrasynaptic NMDA receptor (NMDAR) and results in specific cellular changes, including calcium-induced activation of calpain proteases. Here, we report that presenilin-1 (PS1) null mouse cortical neuronal cultures have increased amounts of calpain-dependent spectrin breakdown products (SBDPs) compared with WT cultures. NMDAR antagonists blocked accumulation of SBDPs, suggesting abnormal activation of this receptor in PS1 null cultures. Importantly, an increase in SBDPs was detected in cultures of at least 7 days in vitro but not in younger cultures. Conditioned medium from PS1 null neuronal cultures at 8 days in vitro contained higher levels of glutamate than medium from WT cultures and stimulated production of SBDPs when added to WT cultures. Use of glutamate reuptake inhibitors indicated that accumulation of this neurotransmitter in the media of PS1 null cultures was due to increased rates of release. PS1 null neurons showed decreased cell surface expression and phosphorylation of the GluN2B subunit of NMDAR, indicating decreased amounts of extrasynaptic NMDAR in the absence of PS1. Inhibition of -secretase activity in WT neurons caused changes similar to those observed in PS1 null neurons. Together, these data indicate that the PS1/-secretase system regulates release of glutamate, tyrosine phosphorylation, and surface expression of GluN2B-containing NMDARs.	Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, Grad Sch Biomed Sci, New York, NY 10029 USA; Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Robakis, Nikolaos/AAA-1838-2021	Barthet, Gael/0000-0003-4025-1616; Georgakopoulos, Anastasios/0000-0001-8241-6306; Xuan, Zhao/0000-0002-8254-2887	National Institutes of Health [AG-17926, NS047229, AG-05138]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG017926, P50AG005138, R01AG017926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-17926, NS047229, and AG-05138.	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Pratt KG, 2011, J NEUROSCI, V31, P899, DOI 10.1523/JNEUROSCI.4625-10.2011; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIMAN R, 1989, J NEUROSCI, V9, P1579; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wahl AS, 2009, NEUROSCIENCE, V158, P344, DOI 10.1016/j.neuroscience.2008.06.018; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yang Y, 2004, NEUROSCIENCE, V124, P501, DOI 10.1016/j.neuroscience.2003.11.029; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	47	2	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30495	30501		10.1074/jbc.M113.499004	http://dx.doi.org/10.1074/jbc.M113.499004			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025330	hybrid, Green Published			2022-12-25	WOS:000329868100045
J	Faust, AME; Wong, CCL; Yates, JR; Drubin, DG; Barnes, G				Faust, Ann Marie E.; Wong, Catherine C. L.; Yates, John R., III; Drubin, David G.; Barnes, Georjana			The FEAR Protein Slk19 Restricts Cdc14 Phosphatase to the Nucleus until the End of Anaphase, Regulating Its Participation in Mitotic Exit in Saccharomyces cerevisiae	PLOS ONE			English	Article							BUDDING-YEAST; KINASE; NETWORK; SEPARASE; MITOSIS; CDK; PHOSPHORYLATION; LOCALIZATION; COMPLEX; RELEASE	In Saccharomyces cerevisiae mitosis, the protein Slk19 plays an important role in the initial release of Cdc14 phosphatase from the nucleolus to the nucleus in early anaphase, an event that is critical for proper anaphase progression. A role for Slk19 in later mitotic stages of Cdc14 regulation, however, has not been demonstrated. While investigating the role of Slk19 post-translational modification on Cdc14 regulation, we found that a triple point mutant of SLK19, slk19(3R) (three lysine-to-arginine mutations), strongly affects Cdc14 localization during late anaphase and mitotic exit. Using fluorescence live-cell microscopy, we found that, similar to slk19 Delta cells, slk19(3R) cells exhibit no defect in spindle stability and only a mild defect in spindle elongation dynamics. Unlike slk19 Delta cells, however, slk19(3R) cells exhibit no defect in Cdc14 release from the nucleolus to the nucleus. Instead, slk19(3R) cells are defective in the timing of Cdc14 movement from the nucleus to the cytoplasm at the end of anaphase. This mutant has a novel phenotype: slk19(3R) causes premature Cdc14 movement to the cytoplasm prior to, rather than concomitant with, spindle disassembly. One consequence of this premature Cdc14 movement is the inappropriate activation of the mitotic exit network, made evident by the fact that slk19(3R) partially rescues a mutant of the mitotic exit network kinase Cdc15. In conclusion, in addition to its role in regulating Cdc14 release from the nucleolus to the nucleus, we found that Slk19 is also important for regulating Cdc14 movement from the nucleus to the cytoplasm at the end of anaphase.	[Faust, Ann Marie E.; Drubin, David G.; Barnes, Georjana] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wong, Catherine C. L.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Scripps Research Institute	Barnes, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	gbarnes@berkeley.edu		Wong, Catherine CL/0000-0001-7270-980X	National Science Foundation (NSF) Graduate Research Fellowship; UC Berkeley Fellowship; National Institutes of Health (NIH) [GM 47842, P41 RR011823]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM047842, R55GM047842] Funding Source: NIH RePORTER	National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); UC Berkeley Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation (NSF) Graduate Research Fellowship (http://www.nsfgrfp.org/) and UC Berkeley Fellowship (http://grad.berkeley.edu/financial/deadlines.shtml#entering) to AF and by National Institutes of Health (NIH) grants GM 47842 to GB and P41 RR011823 to JY (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; Hancioglu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030810; Havens KA, 2010, GENETICS, V186, P1247, DOI 10.1534/genetics.110.123257; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jin FZ, 2008, P NATL ACAD SCI USA, V105, P16177, DOI 10.1073/pnas.0808719105; KAHANA JA, 1995, P NATL ACAD SCI USA, V92, P9707, DOI 10.1073/pnas.92.21.9707; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Manzoni R, 2010, J CELL BIOL, V190, P209, DOI 10.1083/jcb.201002026; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Rahal R, 2008, CELL CYCLE, V7, P3262, DOI 10.4161/cc.7.20.6852; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; SCHWEITZER B, 1991, YEAST, V7, P265, DOI 10.1002/yea.320070308; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Xu SC, 2000, CURR BIOL, V10, P329, DOI 10.1016/S0960-9822(00)00382-1; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	33	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73194	10.1371/journal.pone.0073194	http://dx.doi.org/10.1371/journal.pone.0073194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039885	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600020
J	Mondloch, CJ; Nelson, NL; Horner, M				Mondloch, Catherine J.; Nelson, Nicole L.; Horner, Matthew			Asymmetries of Influence: Differential Effects of Body Postures on Perceptions of Emotional Facial Expressions	PLOS ONE			English	Article							POSITIVE EMOTIONS; CIRCUMPLEX MODEL; RECOGNITION; FACES; ATTENTION; MOVEMENT; PRESCHOOLERS; INTEGRATION; MODULATION; DISPLAYS	The accuracy and speed with which emotional facial expressions are identified is influenced by body postures. Two influential models predict that these congruency effects will be largest when the emotion displayed in the face is similar to that displayed in the body: the emotional seed model and the dimensional model. These models differ in whether similarity is based on physical characteristics or underlying dimensions of valence and arousal. Using a 3-alternative forced-choice task in which stimuli were presented briefly (Exp 1a) or for an unlimited time (Exp 1b) we provide evidence that congruency effects are more complex than either model predicts; the effects are asymmetrical and cannot be accounted for by similarity alone. Fearful postures are especially influential when paired with facial expressions, but not when presented in a flanker task (Exp 2). We suggest refinements to each model that may account for our results and suggest that additional studies be conducted prior to drawing strong theoretical conclusions.	[Mondloch, Catherine J.; Nelson, Nicole L.; Horner, Matthew] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada	Brock University	Mondloch, CJ (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada.	cmondloch@brocku.ca	Nelson, Nicole/P-1078-2014	Nelson, Nicole/0000-0001-8299-4798	SSHRC Insight Grant; International Research Fellowship (NSF); Joseph-Armand Bombardier Master's Scholarship (SSHRC)	SSHRC Insight Grant; International Research Fellowship (NSF); Joseph-Armand Bombardier Master's Scholarship (SSHRC)	This research was supported by a SSHRC Insight Grant awarded to CJM, an International Research Fellowship (NSF) awarded to NLN, and a Joseph-Armand Bombardier Master's Scholarship (SSHRC) Awarded to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON RP, 1962, J EXP PSYCHOL, V63, P546, DOI 10.1037/h0042280; App B, 2012, COGNITION EMOTION, V26, P690, DOI 10.1080/02699931.2011.588688; Aviezer H., 2008, 1 IMPRESSIONS, P255; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Aviezer H, 2012, J PERS SOC PSYCHOL, V103, P20, DOI 10.1037/a0027411; Aviezer H, 2011, EMOTION, V11, P1406, DOI 10.1037/a0023578; BULLOCK M, 1984, INT J BEHAV DEV, V7, P193, DOI 10.1177/016502548400700207; Carroll JM, 1996, J PERS SOC PSYCHOL, V70, P205, DOI 10.1037/0022-3514.70.2.205; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2000, COGNITION EMOTION, V14, P321, DOI 10.1080/026999300378842; de Gelder B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00181; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Derryberry D., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Ekman P, 1978, FACIAL ACTION CODING; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; Gagnon M, 2010, J NONVERBAL BEHAV, V34, P27, DOI 10.1007/s10919-009-0076-z; Gao XQ, 2010, J EXP CHILD PSYCHOL, V105, P98, DOI 10.1016/j.jecp.2009.09.001; Gao XQ, 2009, J EXP CHILD PSYCHOL, V102, P503, DOI 10.1016/j.jecp.2008.11.002; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; HARMS L, 1983, PERCEPT PSYCHOPHYS, V33, P11, DOI 10.3758/BF03205861; Hassin RR, 2013, EMOT REV, V5, P60, DOI 10.1177/1754073912451331; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hietanen JK, 2008, SCAND J PSYCHOL, V49, P221, DOI 10.1111/j.1467-9450.2008.00644.x; Horstmann G, 2006, EMOTION, V6, P28, DOI 10.1037/1528-3542.6.1.28; HUNTSINGER JR, J EXP PSYCH IN PRESS; Izard C.E., 1971, FACE EMOTION; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Kanske P, 2010, NEUROPSYCHOLOGIA, V48, P3661, DOI 10.1016/j.neuropsychologia.2010.07.021; Kret ME, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00028; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; KRET ME, EXP BRAIN RES IN PRE; Lorenz K., 1970, STUDIES ANIMAL HUMAN, V1; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; MATSUMOTO D, 1992, J CROSS CULT PSYCHOL, V23, P72, DOI 10.1177/0022022192231005; Matsumoto D, 2010, SOC PERSONAL PSYCHOL, V4, P393, DOI 10.1111/j.1751-9004.2010.00271.x; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; MILLER J, 1991, PERCEPT PSYCHOPHYS, V49, P270, DOI 10.3758/BF03214311; Mondloch CJ, 2013, J EXP CHILD PSYCHOL, V114, P203, DOI 10.1016/j.jecp.2012.06.003; Mondloch CJ, 2012, J EXP CHILD PSYCHOL, V111, P180, DOI 10.1016/j.jecp.2011.08.003; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Nelson NL, 2011, J EXP CHILD PSYCHOL, V110, P52, DOI 10.1016/j.jecp.2011.03.014; Paquet L, 1997, MEM COGNITION, V25, P182, DOI 10.3758/BF03201111; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Righart R, 2008, COGN AFFECT BEHAV NE, V8, P264, DOI 10.3758/CABN.8.3.264; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Sauter DA, 2007, MOTIV EMOTION, V31, P192, DOI 10.1007/s11031-007-9065-x; Schindler K, 2008, NEURAL NETWORKS, V21, P1238, DOI 10.1016/j.neunet.2008.05.003; SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570; Sinke CBA, 2012, SCI PSYCH S, P335; Susskind JM, 2007, NEUROPSYCHOLOGIA, V45, P152, DOI 10.1016/j.neuropsychologia.2006.05.001; Thelen E, 1994, STUDY INSTINCT; TINBERGEN N, 1950, BEHAVIOUR, V3, P1, DOI 10.1163/156853951X00197; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Van den Stock J, 2009, BRAIN TOPOGR, V21, P216, DOI 10.1007/s10548-009-0099-0; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Widen SC, 2008, COGNITIVE DEV, V23, P291, DOI 10.1016/j.cogdev.2008.01.002; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P812, DOI 10.1037/0096-1523.16.4.812	72	23	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73605	10.1371/journal.pone.0073605	http://dx.doi.org/10.1371/journal.pone.0073605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PK	24039996	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600033
J	Baran-Gale, J; Fannin, EE; Kurtz, CL; Sethupathy, P				Baran-Gale, Jeanette; Fannin, Emily E.; Kurtz, C. Lisa; Sethupathy, Praveen			Beta Cell 5 '-Shifted isomiRs Are Candidate Regulatory Hubs in Type 2 Diabetes	PLOS ONE			English	Article							SMALL RNAS; MIRNA VARIANTS; MICRORNAS; REVEALS; IDENTIFICATION; ASSOCIATION; BIOGENESIS; EXPRESSION; GENERATION; GLUCOSE	Next-generation deep sequencing of small RNAs has unveiled the complexity of the microRNA (miRNA) transcriptome, which is in large part due to the diversity of miRNA sequence variants ("isomiRs"). Changes to a miRNA's seed sequence (nucleotides 2-8), including shifted start positions, can redirect targeting to a dramatically different set of RNAs and alter biological function. We performed deep sequencing of small RNA from mouse insulinoma (MIN6) cells (widely used as a surrogate for the study of pancreatic beta cells) and developed a bioinformatic analysis pipeline to profile isomiR diversity. Additionally, we applied the pipeline to recently published small RNA-seq data from primary human beta cells and whole islets and compared the miRNA profiles with that of MIN6. We found that: (1) the miRNA expression profile in MIN6 cells is highly correlated with those of primary human beta cells and whole islets; (2) miRNA loci can generate multiple highly expressed isomiRs with different 5'-start positions (5'-isomiRs); (3) isomiRs with shifted start positions (5'-shifted isomiRs) are highly expressed, and can be as abundant as their unshifted counterparts (5'-reference miRNAs). Finally, we identified 10 beta cell miRNA families as candidate regulatory hubs in a type 2 diabetes (T2D) gene network. The most significant candidate hub was miR-29, which we demonstrated regulates the mRNA levels of several genes critical to beta cell function and implicated in T2D. Three of the candidate miRNA hubs were novel 5'-shifted isomiRs: miR-375+1, miR-375-1 and miR-183-5p+1. We showed by in silico target prediction and in vitro transfection studies that both miR-375+1 and miR-375-1 are likely to target an overlapping, but distinct suite of beta cell genes compared to canonical miR-375. In summary, this study characterizes the isomiR profile in beta cells for the first time, and also highlights the potential functional relevance of 5'-shifted isomiRs to T2D.	[Baran-Gale, Jeanette; Fannin, Emily E.; Kurtz, C. Lisa; Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Baran-Gale, Jeanette] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Sethupathy, Praveen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sethupathy, P (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	praveen_sethupathy@med.unc.edu		Kurtz, C. Lisa/0000-0002-7407-7655; Baran-Gale, Jeanette/0000-0002-8779-328X	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH) [DK091318-02]; NIH [5T32GM067553]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK091318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an R00 grant (DK091318-02) from the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH) awarded to PS. Also, JBG was supported in part by an NIH training grant (5T32GM067553) awarded to the University of North Carolina Bioinformatics and Computational Biology graduate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bagge A, 2012, BIOCHEM BIOPH RES CO, V426, P266, DOI 10.1016/j.bbrc.2012.08.082; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burroughs AM, 2012, NUCLEIC ACIDS RES, V40, P1424, DOI 10.1093/nar/gkr903; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gunaratne Preethi H, 2012, Methods Mol Biol, V822, P273, DOI 10.1007/978-1-61779-427-8_19; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hudder A, 2008, TOXICOL SCI, V103, P228, DOI 10.1093/toxsci/kfn033; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Martin M., 2011, EMBNET J, V17, p[10, 12]; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Sdassi N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-149; Szklarczyk D, STRING DATABASE 2011; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Westholm JO, 2012, RNA, V18, P177, DOI 10.1261/rna.030627.111; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	50	61	64	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73240	10.1371/journal.pone.0073240	http://dx.doi.org/10.1371/journal.pone.0073240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039891	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300058
J	Dennis, C; Zanni, V; Brasset, E; Eymery, A; Zhang, L; Mteirek, R; Jensen, S; Rong, YKS; Vaury, C				Dennis, Cynthia; Zanni, Vanessa; Brasset, Emilie; Eymery, Angeline; Zhang, Liang; Mteirek, Rana; Jensen, Silke; Rong, Yikang S.; Vaury, Chantal			"Dot COM'', a Nuclear Transit Center for the Primary piRNA Pathway in Drosophila	PLOS ONE			English	Article							SMALL RNAS; BIOGENESIS; MELANOGASTER; RETROVIRUSES; PROTEIN; GYPSY; ZAM; YB	The piRNA pathway protects genomes by silencing mobile elements. Despite advances in understanding the processing events that generate piRNAs for silencing, little is known about how primary transcripts are transported from their genomic clusters to their processing centers. Using a model of the Drosophila COM/flamenco locus in ovarian somatic cells, we identified a prominent nuclear structure called Dot COM, which is enriched in long transcripts from piRNA clusters but located far from their transcription sites. Remarkably, transcripts from multiple clusters accumulate at Dot COM, which is often juxtaposed with Yb-bodies, the cytoplasmic processing centers for cluster transcripts. Genetic evidence suggests that the accumulation of precursor transcripts at Dot COM represents one of the most upstream events in the piRNA pathway. Our results provide new insights into the initial steps of the piRNA pathway, and open up a new research area important for a complete understanding of this conserved pathway.	[Dennis, Cynthia; Zanni, Vanessa; Brasset, Emilie; Eymery, Angeline; Mteirek, Rana; Jensen, Silke; Vaury, Chantal] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Dennis, Cynthia; Zanni, Vanessa; Brasset, Emilie; Eymery, Angeline; Mteirek, Rana; Jensen, Silke; Vaury, Chantal] INSERM, U1103, Clermont Ferrand, France; [Dennis, Cynthia; Zanni, Vanessa; Brasset, Emilie; Eymery, Angeline; Mteirek, Rana; Jensen, Silke; Vaury, Chantal] CNRS, UMR 6293, Clermont Ferrand, France; [Zhang, Liang; Rong, Yikang S.] NCI, LBMB, NIH, Bethesda, MD 20892 USA; [Zanni, Vanessa] INRA AgroParisTech, UMR 1318, Versailles, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Vaury, C (corresponding author), Univ Auvergne, Clermont Univ, Clermont Ferrand, France.	rongy@mail.nih.gov; chantal.vaury@udamail.fr	Brasset, Emilie/J-6684-2015; Vaury, Chantal/I-4658-2015	Vaury, Chantal/0000-0002-7725-5760; Jensen, Silke/0000-0002-1858-8792; Brasset, Emilie/0000-0003-2479-7969; Dennis, Cynthia/0000-0002-7317-2124	Association pour la Recherche contre le Cancer [ARC 1139]; Ligue contre le Cancer; Region Auvergne and European Union (EU); Intramural Research Program of the National Cancer Institute, USA	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer(Ligue nationale contre le cancer); Region Auvergne and European Union (EU)(Region Auvergne-Rhone-Alpes); Intramural Research Program of the National Cancer Institute, USA	This work was supported by grants from the Association pour la Recherche contre le Cancer (ARC 1139) and Ligue contre le Cancer. CD, VZ and EB received a grant from the Region Auvergne and European Union (EU). Research in YSR's laboratory is supported by the Intramural Research Program of the National Cancer Institute, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Handler D, 2013, MOL CELL; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Leblanc P, 1997, EMBO J, V16, P7521, DOI 10.1093/emboj/16.24.7521; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Muerdter F, 2013, MOL CELL; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Qi H, 2010, J BIOL CHEM; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040	23	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72752	10.1371/journal.pone.0072752	http://dx.doi.org/10.1371/journal.pone.0072752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039799	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300025
J	Li, R; He, L; Hao, LL; Wang, Q; Zhou, Y; Jiang, HC				Li, Rui; He, Liang; Hao, Lili; Wang, Qi; Zhou, Yu; Jiang, Hongchen			Genotypic and Phenotypic Characterization of Antimicrobial-Resistant Escherichia coli from Farm-Raised Diarrheic Sika Deer in Northeastern China	PLOS ONE			English	Article							VIRULENCE GENES; ANTIBIOTIC-RESISTANCE; POSTWEANING DIARRHEA; FECAL SAMPLES; PIGS; PREVALENCE; ANIMALS; O157-H7; DETERMINANTS; SEROGROUPS	In China, overuse and/or abuse of antimicrobials are common in stockbreeding, which possess high risks of antimicrobial-resistant contaminations. The serogroups, major virulence genes, and antimicrobial resistant patterns of the antimicrobial-resistant Escherichia coli (E. coli) were investigated in the feces of diarrheic farm-raised sika deer from 50 farms in three Northeastern provinces of China. A total of 220 E. coli isolates were obtained and characterized. Twenty-eight O serogroups were identified from the obtained E. coli isolates with O2, O26, O128, O142 and O154 being dominant. Nearly all the isolates were resistant to at least four of the tested antimicrobials. More than 90% of the E. coli isolates carried at least one of the tested virulence genes. About 85% of the E. coli isolates carried one or more antimicrobial-resistant genes responsible for resistant phenotypes of sulfonamides, streptomycin/spectionomycin or tetracycline. The antimicrobial resistant level and pathogenic group occurrences of the obtained E. coli isolates were higher than that of livestock and wild animals reported in some developed countries. Thus, the fecal-carrying antimicrobial-resistant E. coli from the farm-raised sika deer is potentially a significant contamination source for freshwater systems and food chain, and may pose great health risks for human and animals in Northeastern China.	[Li, Rui; Zhou, Yu] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, Agr Minist,Key Lab Pesticide Residue Detect, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [He, Liang] Natl Shanghai Ctr New Drug Safety Evaluat & Res, Shanghai Inst Pharmaceut Ind, Shanghai, Peoples R China; [Hao, Lili] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China; [Wang, Qi] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Jiang, Hongchen] China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Hubei, Peoples R China	Zhejiang Academy of Agricultural Sciences; Southwest Minzu University; University of Guelph; China University of Geosciences	Zhou, Y (corresponding author), Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, Agr Minist,Key Lab Pesticide Residue Detect, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	microbesyu@yahoo.com	Jiang, Hongchen/Y-9471-2018; Jiang, Hongchen/I-5838-2016; Zhou, Yu/AAV-6584-2021	Jiang, Hongchen/0000-0003-1271-7028; Zhou, Yu/0000-0003-2604-1161	Zhejiang provincial project for science and technology development [2011C12024]; National Natural Science Foundation of China [31000001]	Zhejiang provincial project for science and technology development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Zhejiang provincial project for science and technology development (2011C12024) and the National Natural Science Foundation of China (31000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2005, JPN J INFECT DIS, V58, P369; Asakura H, 1998, MICROBIOL IMMUNOL, V42, P815, DOI 10.1111/j.1348-0421.1998.tb02356.x; Bardiau M, 2010, J APPL MICROBIOL, V109, P2214, DOI 10.1111/j.1365-2672.2010.04855.x; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Bosworth BT CT, 1997, GEN MET AM SOC MIC B, V509; Chen B, 2011, APPL ENVIRON MICROB, V77, P148, DOI 10.1128/AEM.01676-10; Chen X, 2004, VET MICROBIOL, V103, P13, DOI 10.1016/j.vetmic.2004.06.014; Dai L, 2008, FEMS MICROBIOL LETT, V286, P178, DOI 10.1111/j.1574-6968.2008.01272.x; Dale R, 2009, BIOL MANAGEMENT NATI, P521; Dunn JR, 2004, J WILDLIFE DIS, V40, P361, DOI 10.7589/0090-3558-40.2.361; Enne VI, 2008, FEMS MICROBIOL LETT, V278, P193, DOI 10.1111/j.1574-6968.2007.00991.x; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Fukuyama M, 1999, Kansenshogaku Zasshi, V73, P1140; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; Hammerum AM, 2006, INT J FOOD MICROBIOL, V106, P235, DOI 10.1016/j.ijfoodmicro.2005.06.023; Ho PL, 2009, LETT APPL MICROBIOL, V49, P627, DOI 10.1111/j.1472-765X.2009.02717.x; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lei T, 2010, VET MICROBIOL, V146, P85, DOI 10.1016/j.vetmic.2010.04.025; Lillehaug A, 2005, ACTA VET SCAND, V46, P23, DOI 10.1186/1751-0147-46-23; Lim SK, 2007, INT J FOOD MICROBIOL, V116, P283, DOI 10.1016/j.ijfoodmicro.2006.12.014; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Mackintosh C, 2002, REV SCI TECH OIE, V21, P249, DOI 10.20506/rst.21.2.1341; Madsen L, 2000, VET MICROBIOL, V75, P73, DOI 10.1016/S0378-1135(00)00207-8; MYERS LL, 1976, INFECT IMMUN, V13, P1117, DOI 10.1128/IAI.13.4.1117-1119.1976; Nagano H, 2004, J MED MICROBIOL, V53, P1037, DOI 10.1099/jmm.0.05381-0; Ngeleka M, 2003, J VET DIAGN INVEST, V15, P242, DOI 10.1177/104063870301500305; Ojeniyi B., 1994, Journal of Veterinary Medicine Series B, V41, P49, DOI 10.1111/j.1439-0450.1994.tb00205.x; Osek J, 2003, VET MICROBIOL, V91, P65, DOI 10.1016/S0378-1135(02)00262-6; Pedersen K, 2007, J ANTIMICROB CHEMOTH, V60, P775, DOI 10.1093/jac/dkm269; Perreten V, 2003, ANTIMICROB AGENTS CH, V47, P1169, DOI 10.1128/AAC.47.3.1169-1172.2003; Rabatsky-Ehr T, 2002, EMERG INFECT DIS, V8, P525, DOI 10.3201/eid0805.010373; Renter DG, 2001, J WILDLIFE DIS, V37, P755, DOI 10.7589/0090-3558-37.4.755; Sanchez S, 2009, APPL ENVIRON MICROB, V75, P1769, DOI 10.1128/AEM.02043-08; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schets FA, 2008, APPL ENVIRON MICROB, V74, P2069, DOI 10.1128/AEM.01609-07; Tang XB, 2011, MICROB PATHOGENESIS, V50, P207, DOI 10.1016/j.micpath.2011.01.004; Tuckman M, 2007, ANTIMICROB AGENTS CH, V51, P3205, DOI 10.1128/AAC.00625-07; Vagh AA, 2010, VET WORLD, V3, P458; Vu Khac Hung, 2006, BMC Vet Res, V2, P10, DOI 10.1186/1746-6148-2-10; Xiao YH, 2008, EUR J CLIN MICROBIOL, V27, P697, DOI 10.1007/s10096-008-0494-6; Yamamoto T, 1997, J CLIN MICROBIOL, V35, P223, DOI 10.1128/JCM.35.1.223-227.1997; Yang HC, 2004, J CLIN MICROBIOL, V42, P3483, DOI 10.1128/JCM.42.8.3483-3489.2004; Zhang T, 2012, POULTRY SCI, V91, P884, DOI 10.3382/ps.2011-01960	44	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73342	10.1371/journal.pone.0073342	http://dx.doi.org/10.1371/journal.pone.0073342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039919	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300069
J	Moron, B; Spalinger, M; Kasper, S; Atrott, K; Frey-Wagner, I; Fried, M; McCole, DF; Rogler, G; Scharl, M				Moron, Belen; Spalinger, Marianne; Kasper, Stephanie; Atrott, Kirstin; Frey-Wagner, Isabelle; Fried, Michael; McCole, Declan F.; Rogler, Gerhard; Scharl, Michael			Activation of Protein Tyrosine Phosphatase Non-Receptor Type 2 by Spermidine Exerts Anti-Inflammatory Effects in Human THP-1 Monocytes and in a Mouse Model of Acute Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; ULCERATIVE-COLITIS; DIETARY POLYAMINES; TC-PTP; RECEPTOR; MACROPHAGES; DEPHOSPHORYLATION; EXPRESSION	Background: Spermidine is a dietary polyamine that is able to activate protein tyrosine phosphatase non-receptor type 2 (PTPN2). As PTPN2 is known to be a negative regulator of interferon-gamma (IFN-gamma)-induced responses, and IFN-gamma stimulation of immune cells is a critical process in the immunopathology of inflammatory bowel disease (IBD), we wished to explore the potential of spermidine for reducing pro-inflammatory effects in vitro and in vivo. Methods: Human THP-1 monocytes were treated with IFN-gamma and/or spermidine. Protein expression and phosphorylation were analyzed by Western blot, cytokine expression by quantitative-PCR, and cytokine secretion by ELISA. Colitis was induced in mice by dextran sodium sulfate (DSS) administration. Disease severity was assessed by recording body weight, colonoscopy and histology. Results: Spermidine increased expression and activity of PTPN2 in THP-1 monocytes and reduced IFN-gamma-induced phosphorylation of signal transducer and activator of transcription (STAT) 1 and 3, as well as p38 mitogen-activated protein kinase (MAPK) in a PTPN2 dependent manner. Subsequently, IFN-gamma-induced expression/secretion of intracellular cell adhesion molecule (ICAM)-1 mRNA, monocyte chemoattractant protein (MCP)-1, and interleukin (IL)-6 was reduced in spermidine-treated cells. The latter effects were absent in PTPN2-knockdown cells. In mice with DSS-induced colitis, spermidine treatment resulted in ameliorated weight loss and decreased mucosal damage indicating reduced disease severity. Conclusions: Activation of PTPN2 by spermidine ameliorates IFN-gamma-induced inflammatory responses in THP-1 cells. Furthermore, spermidine treatment significantly reduces disease severity in mice with DSS-induced colitis; hence, spermidine supplementation and subsequent PTPN2 activation may be helpful in the treatment of chronic intestinal inflammation such as IBD.	[Moron, Belen; Spalinger, Marianne; Kasper, Stephanie; Atrott, Kirstin; Frey-Wagner, Isabelle; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [McCole, Declan F.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of California System; University of California Riverside; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	michael.scharl@usz.ch	McCole, Declan/AAL-2454-2020; Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Moron, Belen/0000-0003-4815-7536; Kasper, Stephanie/0000-0003-2698-0206; Scharl, Michael/0000-0002-6729-1469	Fonds zur Forderung des akademischen Nachwuchses (FAN) of the Zurcher Universitatsverein (ZUNIV); Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation (SNF) [314730-146204, 310030-120312]; Swiss IBD Cohort [3347CO-108792]; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich; Holcim Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091281] Funding Source: NIH RePORTER	Fonds zur Forderung des akademischen Nachwuchses (FAN) of the Zurcher Universitatsverein (ZUNIV); Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss IBD Cohort; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich; Holcim Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a grant from Fonds zur Forderung des akademischen Nachwuchses (FAN) of the Zurcher Universitatsverein (ZUNIV) to MS, a research grant from the Swiss Philanthropy Foundation to MS and GR, a research credit from the University of Zurich to MS, research grants from the Swiss National Science Foundation (SNF) to MS (Grant No. 314730-146204), GR (Grant No. 310030-120312) and the Swiss IBD Cohort (Grant No. 3347CO-108792), by the Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich and by a research grant from the Holcim Foundation to BM. Funding was given for costs of consumbales and salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Deloyer P, 2001, EUR J GASTROEN HEPAT, V13, P1027, DOI 10.1097/00042737-200109000-00005; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Grimm MC, 1996, J LEUKOCYTE BIOL, V59, P804, DOI 10.1002/jlb.59.6.804; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KVALE D, 1992, SCAND J IMMUNOL, V35, P669, DOI 10.1111/j.1365-3083.1992.tb02973.x; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; MAHIDA YR, 1989, GUT, V30, P826, DOI 10.1136/gut.30.6.826; Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21, DOI 10.1097/00054725-200002000-00004; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Mattila E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-7; McCole DF, 2012, ANN NY ACAD SCI, V1257, P108, DOI 10.1111/j.1749-6632.2012.06522.x; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Nielsen OH, 2011, J INTERN MED, V270, P15, DOI 10.1111/j.1365-2796.2011.02344.x; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Plevy SE, 2011, GASTROENTEROLOGY, V140, P1838, DOI 10.1053/j.gastro.2011.02.014; Ricci G, 1999, EUR J GASTROEN HEPAT, V11, P903, DOI 10.1097/00042737-199908000-00016; Rogler G, 1997, EUR J GASTROEN HEPAT, V9, P893, DOI 10.1097/00042737-199709000-00013; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Scharl M, 2011, GUT, V60, P189, DOI 10.1136/gut.2010.216606; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Siegmund B, 2011, WORLD J GASTROENTERO, V17, P3178, DOI 10.3748/wjg.v17.i27.3178; Taylor KM, 2011, NAT REV GASTRO HEPAT, V8, P646, DOI 10.1038/nrgastro.2011.172; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Weiss TS, 2004, INFLAMM BOWEL DIS, V10, P529, DOI 10.1097/00054725-200409000-00006; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zhu W, 2002, J BIOL CHEM, V277, P35787, DOI 10.1074/jbc.C200346200	42	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73703	10.1371/journal.pone.0073703	http://dx.doi.org/10.1371/journal.pone.0073703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040033	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000326405300112
J	Robles-Escajeda, E; Lerma, D; Nyakeriga, AM; Ross, JA; Kirken, RA; Aguilera, RJ; Varela-Ramirez, A				Robles-Escajeda, Elisa; Lerma, Dennise; Nyakeriga, Alice M.; Ross, Jeremy A.; Kirken, Robert A.; Aguilera, Renato J.; Varela-Ramirez, Armando			Searching in Mother Nature for Anti-Cancer Activity: Anti-Proliferative and Pro-Apoptotic Effect Elicited by Green Barley on Leukemia/Lymphoma Cells	PLOS ONE			English	Article							HUMAN LEUKEMIA-CELLS; TYROSINE KINASE LCK; POLY(ADP-RIBOSE) POLYMERASE-1; INHIBITS PROLIFERATION; ICE/CED-3 PROTEASE; CRANBERRY EXTRACT; MICE LACKING; DNA-CONTENT; DEATH; LINE	Green barley extract (GB) was investigated for possible anti-cancer activity by examining its anti-proliferative and pro-apoptotic properties on human leukemia/lymphoma cell lines. Our results indicate that GB exhibits selective anti-proliferative activity on a panel of leukemia/lymphoma cells in comparison to non-cancerous cells. Specifically, GB disrupted the cell-cycle progression within BJAB cells, as manifested by G2/M phase arrest and DNA fragmentation, and induced apoptosis, as evidenced by phosphatidylserine (PS) translocation to the outer cytoplasmic membrane in two B-lineage leukemia/lymphoma cell lines. The pro-apoptotic effect of GB was found to be independent of mitochondrial depolarization, thus implicating extrinsic cell death pathways to exert its cytotoxicity. Indeed, GB elicited an increase of TNF-alpha production, caspase-8 and caspase-3 activation, and PARP-1 cleavage within pre-B acute lymphoblastic leukemia Nalm-6 cells. Moreover, caspase-8 and caspase-3 activation and PARP-1 cleavage were strongly inhibited/blocked by the addition of the specific caspase inhibitors Z-VAD-FMK and Ac-DEVD-CHO. Furthermore, intracellular signaling analyses determined that GB treatment enhanced constitutive activation of Lck and Src tyrosine kinases in Nalm-6 cells. Taken together, these findings indicate that GB induced preferential anti-proliferative and pro-apoptotic signals within B-lineage leukemia/lymphoma cells, as determined by the following biochemical hallmarks of apoptosis: PS externalization, enhanced release of TNF-alpha, caspase-8 and caspase-3 activation, PARP-1 cleavage and DNA fragmentation Our observations reveal that GB has potential as an antileukemia/lymphoma agent alone or in combination with standard cancer therapies and thus warrants further evaluation in vivo to support these findings.	[Robles-Escajeda, Elisa; Ross, Jeremy A.; Kirken, Robert A.; Aguilera, Renato J.; Varela-Ramirez, Armando] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Robles-Escajeda, Elisa; Ross, Jeremy A.; Kirken, Robert A.; Aguilera, Renato J.; Varela-Ramirez, Armando] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Lerma, Dennise] St Marys Univ, Sch Sci Engn & Technol, San Antonio, TX USA; [Nyakeriga, Alice M.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, El Paso, TX USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Texas Tech University System; Texas Tech University	Varela-Ramirez, A (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	avarela2@utep.edu	Varela-Ramirez, Armando/ABI-4315-2020	Varela-Ramirez, Armando/0000-0002-2071-4874	NIGMS SCORE Grant [1SC3GM103713-01]; Edward N. and Margaret G. Marsh Foundation; Lizanell, and Colbert Coldwell Foundation; National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH) [8G12MD007592, P20MD002287-06]; RISE Scholars Program at UTEP through NIGMS [R25GM069621-08]; REU-NSF [DBI-0851881]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069621, SC3GM103713] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592, P20MD002287] Funding Source: NIH RePORTER	NIGMS SCORE Grant; Edward N. and Margaret G. Marsh Foundation; Lizanell, and Colbert Coldwell Foundation; National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH); RISE Scholars Program at UTEP through NIGMS; REU-NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for this work was provided by NIGMS SCORE Grant 1SC3GM103713-01 to RJA; the Edward N. and Margaret G. Marsh Foundation, Lizanell, and Colbert Coldwell Foundation to RAK; Grants 8G12MD007592 to the Border Biomedical Research Center (BBRC) and P20MD002287-06 to the Hispanic Health Disparities Research Center (HHDRC) from the National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH). ER-E and DL were supported by the RISE Scholars Program at UTEP through NIGMS Grant No. R25GM069621-08 and REU-NSF Grant No. DBI-0851881, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013552; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; *AUSTR GOV DEP HLT, 2008, BIOL HORD VULG L; BARNUN S, 1983, BIOCHIM BIOPHYS ACTA, V741, P123, DOI 10.1016/0167-4781(83)90018-0; Belcredi NB, 2010, J AGR FOOD CHEM, V58, P11755, DOI 10.1021/jf1014389; Belka C, 1999, ONCOGENE, V18, P4983, DOI 10.1038/sj.onc.1202878; Benedet JA, 2007, J AGR FOOD CHEM, V55, P5499, DOI 10.1021/jf070543t; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Billard C, 2003, LEUKEMIA, V17, P2435, DOI 10.1038/sj.leu.2403139; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Burkle A, 2005, INT J BIOCHEM CELL B, V37, P1043, DOI 10.1016/j.biocel.2004.10.006; Cremer L, 1996, Roum Arch Microbiol Immunol, V55, P285; Cremer L, 1998, Roum Arch Microbiol Immunol, V57, P231; Diaz-Hernandez JI, 2007, CELL DEATH DIFFER, V14, P1211, DOI 10.1038/sj.cdd.4402117; Dirsch VM, 2002, LEUKEMIA, V16, P74, DOI 10.1038/sj.leu.2402337; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; Ehrenbergerova J, 2009, PLANT FOOD HUM NUTR, V64, P122, DOI 10.1007/s11130-009-0113-4; Ekert PG, 1997, BRIT MED BULL, V53, P591; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Ferguson PJ, 2004, J NUTR, V134, P1529, DOI 10.1093/jn/134.6.1529; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hamblin T, 2006, LEUKEMIA RES, V30, P649, DOI 10.1016/j.leukres.2005.10.023; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lahouel M, 2006, THERAPIE, V61, P347, DOI 10.2515/therapie:2006025; Lema Carolina, 2011, Curr Cell Biochem, V1, P1; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu LF, 1996, ANN NY ACAD SCI, V803, P44, DOI 10.1111/j.1749-6632.1996.tb26375.x; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Looi CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056643; Lund T, 2005, BRIT J CANCER, V92, P1773, DOI 10.1038/sj.bjc.6602537; Madhujith T, 2007, J AGR FOOD CHEM, V55, P5018, DOI 10.1021/jf070072a; Markham KR, 2003, Z NATURFORSCH C, V58, P53; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; OSAWA T, 1992, J AGR FOOD CHEM, V40, P1135, DOI 10.1021/jf00019a009; Ovadje P, 2011, J ETHNOPHARMACOL, V133, P86, DOI 10.1016/j.jep.2010.09.005; Padget K, 2000, LEUKEMIA, V14, P1997, DOI 10.1038/sj.leu.2401928; Quiney C, 2006, LEUKEMIA, V20, P491, DOI 10.1038/sj.leu.2404098; RICCARDI A, 1982, CYTOMETRY, V3, P104, DOI 10.1002/cyto.990030207; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; Sauerwald TM, 2003, BIOTECHNOL BIOENG, V81, P329, DOI 10.1002/bit.10473; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; Shaik N, 2009, INORG CHEM, V48, P1577, DOI 10.1021/ic801925k; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Solary E, 2000, LEUKEMIA, V14, P1833, DOI 10.1038/sj.leu.2401902; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249; Tumanov AV, 2010, BLOOD, V116, P3456, DOI 10.1182/blood-2009-10-249177; Varela-Ramirez A, 2011, CELL BIOL TOXICOL, V27, P159, DOI 10.1007/s10565-010-9178-y; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wang TS, 2011, AFR J PHARM PHARMACO, V5, P1046; Wieder T, 2001, LEUKEMIA, V15, P1735, DOI 10.1038/sj.leu.2402284; YODOI J, 1985, J IMMUNOL, V134, P1623; Yu YM, 2002, DIABETES METAB, V28, P107; ZOHARY D, 2000, DOMESTICATION PLANTS, V6	70	74	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73508	10.1371/journal.pone.0073508	http://dx.doi.org/10.1371/journal.pone.0073508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039967	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300085
J	Muise, ES; Souza, S; Chi, A; Tan, YJ; Zhao, XM; Liu, F; Dallas-yang, Q; Wu, M; Sarr, T; Zhu, L; Guo, HB; Li, ZH; Li, WY; Hu, WW; Jiang, GQ; Paweletz, CP; Hendrickson, RC; Thompson, JR; Mu, J; Berger, JP; Mehmet, H				Muise, Eric S.; Souza, Sandra; Chi, An; Tan, Yejun; Zhao, Xuemei; Liu, Franklin; Dallas-yang, Qing; Wu, Margaret; Sarr, Tim; Zhu, Lan; Guo, Hongbo; Li, Zhihua; Li, Wenyu; Hu, Weiwen; Jiang, Guoqiang; Paweletz, Cloud P.; Hendrickson, Ronald C.; Thompson, John R.; Mu, James; Berger, Joel P.; Mehmet, Huseyin			Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN SENSITIVITY; BETA-KLOTHO; PPAR-ALPHA; EXPRESSION; FGF21; FIBROBLAST-GROWTH-FACTOR-21; GLUCOSE; PROTEIN; OBESITY	FGF21 is a novel secreted protein with robust anti-diabetic, anti-obesity, and anti-atherogenic activities in preclinical species. In the current study, we investigated the signal transduction pathways downstream of FGF21 following acute administration of the growth factor to mice. Focusing on adipose tissues, we identified FGF21-mediated downstream signaling events and target engagement biomarkers. Specifically, RNA profiling of adipose tissues and phosphoproteomic profiling of adipocytes, following FGF21 treatment revealed several specific changes in gene expression and post-translational modifications, specifically phosphorylation, in several relevant proteins. Affymetrix microarray analysis of white adipose tissues isolated from both C57BL/6 (fed either regular chow or HFD) and db/db mice identified over 150 robust potential RNA transcripts and over 50 potential secreted proteins that were changed greater than 1.5 fold by FGF21 acutely. Phosphoprofiling analysis identified over 130 phosphoproteins that were modulated greater than 1.5 fold by FGF21 in 3T3-L1 adipocytes. Bioinformatic analysis of the combined gene and phosphoprotein profiling data identified a number of known metabolic pathways such as glucose uptake, insulin receptor signaling, Erk/Mapk signaling cascades, and lipid metabolism. Moreover, a number of novel events with hitherto unknown links to FGF21 signaling were observed at both the transcription and protein phosphorylation levels following treatment. We conclude that such a combined "omics" approach can be used not only to identify robust biomarkers for novel therapeutics but can also enhance our understanding of downstream signaling pathways; in the example presented here, novel FGF21-mediated signaling events in adipose tissue have been revealed that warrant further investigation.	[Muise, Eric S.; Souza, Sandra; Chi, An; Tan, Yejun; Zhao, Xuemei; Liu, Franklin; Dallas-yang, Qing; Wu, Margaret; Sarr, Tim; Zhu, Lan; Guo, Hongbo; Li, Zhihua; Li, Wenyu; Hu, Weiwen; Jiang, Guoqiang; Paweletz, Cloud P.; Hendrickson, Ronald C.; Thompson, John R.; Mu, James; Berger, Joel P.; Mehmet, Huseyin] Merck Sharp & Dohme Corp, Discovery & Preclin Sci, Merck Res Labs, Whitehouse Stn, NJ USA	Merck & Company	Muise, ES (corresponding author), Merck Sharp & Dohme Corp, Discovery & Preclin Sci, Merck Res Labs, Whitehouse Stn, NJ USA.	eric_muise@merck.com		Mu, James/0000-0001-8081-2401; Muise, Eric/0000-0002-1238-5118	Merck	Merck(Merck & Company)	Merck provided all funds for this work. All authors are current or former employees of Merck and may own stock or hold stock options in Merck. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Camacho RC, 2013, EUR J PHARMACOL; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Ehrlund A, 2013, J CLIN ENDOCR METAB, V98, pE503, DOI 10.1210/jc.2012-3416; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Warner A, 2012, J NEUROENDOCRINOL; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457; Zhao WQ, 2010, MOL PHARMACOL, V78, P350, DOI 10.1124/mol.110.064980	37	43	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73011	10.1371/journal.pone.0073011	http://dx.doi.org/10.1371/journal.pone.0073011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039848	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500032
J	Balint, J; Nagy, BV; Fail, J				Balint, Janos; Nagy, Balazs Vince; Fail, Jozsef			Correlations between Colonization of Onion Thrips and Leaf Reflectance Measures across Six Cabbage Varieties	PLOS ONE			English	Article							TABACI THYSANOPTERA; WHITE CABBAGE; RESISTANCE; RADIATION; MANAGEMENT; PERCEPTION; INSECTS; DAMAGE; PEST	The main purpose of this study was to reveal if the UV-A, and visible light reflection of leaves of white cabbage varieties is correlated to resistance against onion thrips. The antixenotic resistance (AR) against onion thrips and thrips damage differed between varieties Balashi, Bloktor, Riana - considered resistant - and Green Gem, Hurricane, Quisor - considered susceptible. The solar UV-A (340-400 nm) and visible (401-650 nm) light reflection of white cabbage leaves were recorded. Correlation between AR against onion thrips and reflection of leaves in UV-A and visible range of the studied white cabbage varieties were computed. According to the AR evaluation onion thrips density was always higher on susceptible than on resistant varieties. The UV-A light reflection of head forming leaves and the contrast between head and exterior leaves (H/E) was negatively correlated with onion thrips host preference at an early stage of cabbage head formation. The visible light reflection of both head forming and exterior leaves was also negatively correlated with onion thrips host preference. Susceptible varieties had greater damage ratings at harvest than resistant ones and positive correlations were observed between AR and damage. AR against onion thrips may be affected by differences in reflection of cabbage leaves at an early growth stage. It is suggested that more intensive reflection of leaves and/or higher contrast values between the reflectance intensity of head versus outer leaves made the resistant varieties less attractive to onion thrips. Our results reported here provide the first evidence of negative correlation between UV-A and visible reflection of leaves and AR of white cabbage against a dangerous insect pest, opening new perspectives for understanding the role of reflection by plant leaves in pest management.	[Balint, Janos; Fail, Jozsef] Corvinus Univ Budapest, Fac Hort Sci, Dept Entomol, Budapest, Hungary; [Balint, Janos] Sapientia Univ, Fac Tech & Human Sci, Dept Hort, Targu Mures, Romania; [Nagy, Balazs Vince] Budapest Univ Technol & Econ, Dept Mechatron Opt & Engn Informat, Budapest, Hungary; [Nagy, Balazs Vince] Univ Sao Paulo, Inst Psychol, Sao Paulo, Brazil	Corvinus University Budapest; Sapientia Hungarian University of Transylvania; Budapest University of Technology & Economics; Universidade de Sao Paulo	Fail, J (corresponding author), Corvinus Univ Budapest, Fac Hort Sci, Dept Entomol, Budapest, Hungary.	jozsef.fail@uni-corvinus.hu	Nagy, Balazs Vince/H-8565-2012; Fail, Jozsef/A-5429-2011; NAGY, Balazs Vince/K-6546-2015; Bálint, János/B-8200-2013	Fail, Jozsef/0000-0001-8049-5776; NAGY, Balazs Vince/0000-0002-8489-7200; Bálint, János/0000-0002-0351-888X	Balassi Institute - Hungarian Scholarship Board Office; Institute for Ethnic and National Minority Studies of the Hungarian Academy of Sciences; FAPESP [09/54292-7]	Balassi Institute - Hungarian Scholarship Board Office; Institute for Ethnic and National Minority Studies of the Hungarian Academy of Sciences; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financially supported by the Balassi Institute - Hungarian Scholarship Board Office and Institute for Ethnic and National Minority Studies of the Hungarian Academy of Sciences. Bakker Brothers, Bejo Zaden B.V., Daehnfeldt A/S and Syngenta Seeds Inc. are acknowledged for providing seeds for this study. Author BVN was supported by FAPESP (09/54292-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDALORO JT, 1983, J ECON ENTOMOL, V76, P1121, DOI 10.1093/jee/76.5.1121; BOTHWELL ML, 1994, SCIENCE, V265, P97, DOI 10.1126/science.265.5168.97; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Fail J., 2008, Acta Phytopathologica et Entomologica Hungarica, V43, P267, DOI 10.1556/APhyt.43.2008.2.8; Fail J, 2005, THESIS CORVINUS U BU; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HOY CW, 1991, ENTOMOPHAGA, V36, P561, DOI 10.1007/BF02374439; KIRK WDJ, 1984, ECOL ENTOMOL, V9, P35, DOI 10.1111/j.1365-2311.1984.tb00696.x; KOGAN M, 1978, Bulletin of the Entomological Society of America, V24, P175; MATTESON N, 1992, J INSECT PHYSIOL, V38, P453, DOI 10.1016/0022-1910(92)90122-T; Mazza CA, 2000, PLANT PHYSIOL, V122, P117, DOI 10.1104/pp.122.1.117; Mazza CA, 2002, ECOL LETT, V5, P722, DOI 10.1046/j.1461-0248.2002.00379.x; Mazza CA, 1999, P NATL ACAD SCI USA, V96, P980, DOI 10.1073/pnas.96.3.980; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Momol MT, 2002, THRIPS TOSP P 7 INT, P111; R Core Team, 2012, R LANG ENV STAT COMP; SHELTON AM, 1987, J ECON ENTOMOL, V80, P1051, DOI 10.1093/jee/80.5.1051; Shelton AM, 1998, J ECON ENTOMOL, V91, P329, DOI 10.1093/jee/91.1.329; STONER KA, 1988, J ECON ENTOMOL, V81, P1062, DOI 10.1093/jee/81.4.1062; STONER KA, 1988, J ECON ENTOMOL, V81, P1190, DOI 10.1093/jee/81.4.1190; STONER KA, 1988, J ECON ENTOMOL, V81, P1186, DOI 10.1093/jee/81.4.1186; Terry L. Irene, 1997, P65; Trdan S, 2008, INT J PEST MANAGE, V54, P309, DOI 10.1080/09670870802220596; Trdan S, 2007, J PEST SCI, V80, P217, DOI 10.1007/s10340-007-0174-9; VERNON RS, 1990, ENVIRON ENTOMOL, V19, P1229, DOI 10.1093/ee/19.5.1229; Yan J, 2012, R NEWS, P5	27	8	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73848	10.1371/journal.pone.0073848	http://dx.doi.org/10.1371/journal.pone.0073848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040093	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000324481600104
J	Cam, A; Sivaguru, M; de Mejia, EG				Cam, Anthony; Sivaguru, Mayandi; de Mejia, Elvira Gonzalez			Endocytic Mechanism of Internalization of Dietary Peptide Lunasin into Macrophages in Inflammatory Condition Associated with Cardiovascular Disease	PLOS ONE			English	Article							INTEGRIN; MEMBRANE; ACTIVATION; PLASMA; BINDS	Cardiovascular disease (CVD) is the leading cause of death in the United States. Diet influences risk factors associated with CVD and atherosclerosis, a major vascular disease that arises from inflammation. Lunasin, a peptide derived from plant foods such as soybeans, contains a unique Arg-Gly-Asp cell-adhesion motif and inhibits the pathways involved in the inflammatory cascade. The objective was to determine the mechanism by which lunasin is internalized into human THP-1 macrophages, investigate the expression of endocytic membrane proteins in inflammatory conditions and to identify the pathways involved. While lipopolysaccharide (10 nM), vitronectin (130 nM) and a combination of these two molecules enhanced lunasin uptake and increased basal alpha V beta 3 integrin expression, lunasin reduced aVb3 expression by 25.5, 26.8 and 49.2%, respectively. The pretreatment of cells with brefeldin A (71 mu M), an inhibitor of protein trafficking, inhibited lunasin internalization by up to 99.8%. Lunasin increased caveolin-1 expression by up to 204.8%, but did not modulate clathrin. The pretreatment of macrophages with nystatin (54 mu M), an inhibitor of caveolae-dependent endocytosis, reduced lunasin internalization. The presence of amantadine (1 mM) and amiloride (1 mM), inhibitors of clathrin-mediated endocytosis and macropinocytosis, abolished lunasin cell entry. Lunasin elicited a transient reduction in intracellular levels of Ca2+ in LPS-induced macrophages. The results suggest that internalization of lunasin into macrophages is amplified in inflammatory conditions and is primarily mediated by endocytic mechanisms that involve integrin signaling, clathrin-coated structures and macropinosomes. Lunasin may be responsible for attenuation of CVD risk factors by interacting with pathways involved in endocytosis and inflammation.	[Cam, Anthony; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Sivaguru, Mayandi] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	de Mejia, EG (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA.	edemejia@illinois.edu	Sivaguru, Mayandi/M-3393-2019; Sivaguru, Mayandi/L-7845-2019	Sivaguru, Mayandi/0000-0001-5532-4393; DE MEJIA, ELVIRA/0000-0001-7426-9035	U.S. Department of Agriculture [CREES 698 AG 2010-34644-20970 EGdM]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work is supported by U.S. Department of Agriculture grant number: CREES 698 AG 2010-34644-20970 EGdM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Cavazos A, 2012, J FOOD SCI, V77, pC539, DOI 10.1111/j.1750-3841.2012.02676.x; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Dia VP, 2009, J AGR FOOD CHEM, V57, P1260, DOI 10.1021/jf803303k; Divita G, 2010, CHEM BIOL, V17, P679, DOI 10.1016/j.chembiol.2010.07.002; Galvez AF, 2001, CANCER RES, V61, P7473; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gianni T, 2012, P NATL ACAD SCI USA, V109, P19792, DOI 10.1073/pnas.1212597109; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Jeong HJ, 2010, NUTR CANCER, V62, P1113, DOI 10.1080/01635581.2010.515529; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Maile LA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000476; Mickler FM, 2011, J CONTROL RELEASE, V156, P364, DOI 10.1016/j.jconrel.2011.08.003; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nichols TC, 1999, CIRC RES, V85, P1040; Raborn J, 2012, J CELL BIOCHEM, V113, P1190, DOI 10.1002/jcb.23448; Saltoh SI, 2009, IMMUNOBIOLOGY, V214, P594, DOI 10.1016/j.imbio.2008.11.012; Sancey L, 2009, MOL THER, V17, P837, DOI 10.1038/mt.2009.29; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SHANKAR G, 1995, EXP CELL RES, V219, P364, DOI 10.1006/excr.1995.1240; Tiwari S, 2011, J CELL SCI, V124, P1672, DOI 10.1242/jcs.084483; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007	29	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72115	10.1371/journal.pone.0072115	http://dx.doi.org/10.1371/journal.pone.0072115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039740	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600018
J	Takacs, VT; Freund, TF; Nyiri, G				Takacs, Virag T.; Freund, Tamas F.; Nyiri, Gabor			Neuroligin 2 Is Expressed in Synapses Established by Cholinergic Cells in the Mouse Brain	PLOS ONE			English	Article							NEURONAL NICOTINIC SYNAPSES; INHIBITORY SYNAPSES; ACETYLCHOLINE INNERVATION; PYRAMIDAL CELLS; IN-VIVO; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; ADHESION MOLECULES; GABAERGIC SYNAPSES; DORSAL HIPPOCAMPUS	Neuroligin 2 is a postsynaptic protein that plays a critical role in the maturation and proper function of GABAergic synapses. Previous studies demonstrated that deletion of neuroligin 2 impaired GABAergic synaptic transmission, whereas its overexpression caused increased inhibition, which suggest that its presence strongly influences synaptic function. Interestingly, the overexpressing transgenic mouse line showed increased anxiety-like behavior and other behavioral phenotypes, not easily explained by an otherwise strengthened GABAergic transmission. This suggested that other, non-GABAergic synapses may also express neuroligin 2. Here, we tested the presence of neuroligin 2 at synapses established by cholinergic neurons in the mouse brain using serial electron microscopic sections double labeled for neuroligin 2 and choline acetyltransferase. We found that besides GABAergic synapses, neuroligin 2 is also present in the postsynaptic membrane of cholinergic synapses in all investigated brain areas (including dorsal hippocampus, somatosensory and medial prefrontal cortices, caudate putamen, basolateral amygdala, centrolateral thalamic nucleus, medial septum, vertical-and horizontal limbs of the diagonal band of Broca, substantia innominata and ventral pallidum). In the hippocampus, the density of neuroligin 2 labeling was similar in GABAergic and cholinergic synapses. Moreover, several cholinergic contact sites that were strongly labeled with neuroligin 2 did not resemble typical synapses, suggesting that cholinergic axons form more synaptic connections than it was recognized previously. We showed that cholinergic cells themselves also express neuroligin 2 in a subset of their input synapses. These data indicate that mutations in human neuroligin 2 gene and genetic manipulations of neuroligin 2 levels in rodents will potentially cause alterations in the cholinergic system as well, which may also have a profound effect on the functional properties of brain circuits and behavior.	[Takacs, Virag T.; Freund, Tamas F.; Nyiri, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Lab Cerebral Cortex Res, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Nyiri, G (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Lab Cerebral Cortex Res, Budapest, Hungary.	nyiri.gabor@koki.mta.hu		Takacs, Virag/0000-0002-3276-4131	National Institutes of Health [NS030549]; National Office for Research and Technology - Hungarian Scientific Research Fund [CNK77793]; European Research Council (SERRACO) [ERC-2011-ADG-294313]; Janos Bolyai Research Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Office for Research and Technology - Hungarian Scientific Research Fund; European Research Council (SERRACO); Janos Bolyai Research Scholarship(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NS030549, www.nih.gov); National Office for Research and Technology - Hungarian Scientific Research Fund (CNK77793, www.nih.gov.hu, www.otka.hu); European Research Council (ERC-2011-ADG-294313, SERRACO, erc.europa.eu). GN was supported by Janos Bolyai Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznavour N, 2005, J COMP NEUROL, V486, P61, DOI 10.1002/cne.20501; Aznavour N, 2002, HIPPOCAMPUS, V12, P206, DOI 10.1002/hipo.1108; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Conroy WG, 2007, DEV BIOL, V307, P79, DOI 10.1016/j.ydbio.2007.04.017; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; COZZARI C, 1990, Society for Neuroscience Abstracts, V16, P200; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalvi A, 1996, PSYCHOPHARMACOLOGY, V128, P380, DOI 10.1007/s002130050148; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; HOOVER DB, 1978, BRAIN RES, V153, P295, DOI 10.1016/0006-8993(78)90408-0; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Irvine EE, 2001, PHARMACOL BIOCHEM BE, V68, P319, DOI 10.1016/S0091-3057(00)00449-4; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Kohl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056871; MCGEER PL, 1971, BRAIN RES, V35, P308, DOI 10.1016/0006-8993(71)90625-1; Mechawar N, 2002, J COMP NEUROL, V443, P250, DOI 10.1002/cne.10114; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Mineur YS, 2013, P NATL ACAD SCI USA, V110, P3573, DOI 10.1073/pnas.1219731110; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Picciotto MR, 2002, NEUROREPORT, V13, P1097, DOI 10.1097/00001756-200207020-00006; Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; REESE NB, 1995, PROG NEUROBIOL, V47, P105, DOI 10.1016/0301-0082(95)00023-O; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Rosenberg MM, 2010, J NEUROSCI, V30, P11073, DOI 10.1523/JNEUROSCI.0983-10.2010; Ross BS, 2008, DEV NEUROBIOL, V68, P409, DOI 10.1002/dneu.20598; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi L, 2004, J COMP NEUROL, V478, P282, DOI 10.1002/cne.20303; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siok CJ, 2006, EUR J NEUROSCI, V23, P570, DOI 10.1111/j.1460-9568.2005.04560.x; Smiley JF, 1997, EXP NEUROL, V144, P361, DOI 10.1006/exnr.1997.6413; Song CZ, 2005, NEUROPHARMACOLOGY, V48, P869, DOI 10.1016/j.neuropharm.2005.01.003; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Takacs VT, 2012, HIPPOCAMPUS, V22, P1379, DOI 10.1002/hipo.20974; Tallafuss A, 2010, EUR J NEUROSCI, V32, P198, DOI 10.1111/j.1460-9568.2010.07340.x; Temburni MK, 2004, J NEUROSCI, V24, P6776, DOI 10.1523/JNEUROSCI.1826-04.2004; Turrini P, 2001, NEUROSCIENCE, V105, P277, DOI 10.1016/S0306-4522(01)00172-5; Umbriaco D, 1995, HIPPOCAMPUS, V5, P605, DOI 10.1002/hipo.450050611; UMBRIACO D, 1994, J COMP NEUROL, V348, P351, DOI 10.1002/cne.903480304; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vizi ES, 2004, NEUROCHEM INT, V45, P443, DOI 10.1016/j.neuint.2003.11.016; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Wohr M, 2012, BEHAV BRAIN RES; Yarnall A, 2011, MOVEMENT DISORD, V26, P2496, DOI 10.1002/mds.23932; Zarrindast MR, 2001, PHARMACOL BIOCHEM BE, V69, P9, DOI 10.1016/S0091-3057(01)00518-4; Zarrindast MR, 2000, EUR J PHARMACOL, V407, P145, DOI 10.1016/S0014-2999(00)00628-2; Zeidan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042314; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	76	33	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72450	10.1371/journal.pone.0072450	http://dx.doi.org/10.1371/journal.pone.0072450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039767	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000324481600028
J	Verplanken, B; Roy, D				Verplanken, Bas; Roy, Deborah			"My Worries Are Rational, Climate Change Is Not": Habitual Ecological Worrying Is an Adaptive Response	PLOS ONE			English	Article							ENVIRONMENTAL CONCERN; PLANNED BEHAVIOR; ANXIETY; WILLINGNESS; INTENTIONS; ACTIVATION; IDENTITY; IMPACTS; ENGAGE; VALUES	Qualifications such as "global warming hysteria" and "energy policy schizophrenia" put forward by some climate change skeptics, usually outside the academic arena, may suggest that people who seriously worry about the environment suffer from psychological imbalance. The present study aimed to refute this thesis. While habitual worrying in general is strongly associated with psychopathological symptoms, in a survey a near-zero correlation was found between habitual ecological worrying and pathological worry. Instead, habitual ecological worrying was associated with pro-environmental attitudes and behaviors, and with a personality structure characterized by imagination and an appreciation for new ideas. The study had sufficient statistical power and measures were valid and reliable. The results confirm that those who habitually worry about the ecology are not only lacking in any psychopathology, but demonstrate a constructive and adaptive response to a serious problem. In the public domain, these findings may contribute to a more rational and less emotional debate on climate change and to the prevention of stigmatization of people who are genuinely concerned about our habitat and are prepared to do something about it ("habitual worriers are not crazy"). In the academic arena this study may contribute to environmental psychology ("habitual worrying is part of a green identity"), as well as to the literature on worry and anxiety ("habitual worrying can be a constructive response").	[Verplanken, Bas; Roy, Deborah] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England	University of Bath	Verplanken, B (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.	b.verplanken@bath.ac.uk	Roy, Deborah/HGT-8786-2022	Roy, Deborah/0000-0003-4401-5426; Verplanken, Bas/0000-0001-7217-0293	Department for Environment, Food, and Rural Affairs (Defra), UK [RMP 5687]	Department for Environment, Food, and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA))	This research was supported by a grant from the Department for Environment, Food, and Rural Affairs (Defra), UK, grant number RMP 5687. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht G, 2011, INT CULT PSYCHOL, P43, DOI 10.1007/978-1-4419-9742-5_3; [Anonymous], 2008, CLIMATE CONFUSION GL; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Besthorn F. H., 2002, J PROGR HUMAN SERVIC, V13, P53, DOI [DOI 10.1300/J059V13N01_04, 10.1300/j059v13n01_04]; Black IR, 2010, J CONSUM BEHAV, V9, P437, DOI 10.1002/cb.337; Bord RJ, 1998, CLIMATE RES, V11, P75, DOI 10.3354/cr011075; BORKOVEC TD, 1995, J BEHAV THER EXP PSY, V26, P25, DOI 10.1016/0005-7916(94)00064-S; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Dahlstrand U, 1997, J APPL SOC PSYCHOL, V27, P588, DOI 10.1111/j.1559-1816.1997.tb00650.x; DAVEY GCL, 1992, PERS INDIV DIFFER, V13, P133, DOI 10.1016/0191-8869(92)90036-O; Doherty TJ, 2011, AM PSYCHOL, V66, P265, DOI 10.1037/a0023141; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Ferguson MA, 2010, J ENVIRON PSYCHOL, V30, P135, DOI 10.1016/j.jenvp.2009.11.010; Few R, 2009, GLOB ENV CHANG, V17, P281; Fielding KS, 2008, J ENVIRON PSYCHOL, V28, P318, DOI 10.1016/j.jenvp.2008.03.003; Fransson N, 1999, J ENVIRON PSYCHOL, V19, P369, DOI 10.1006/jevp.1999.0141; Fritze Jessica G, 2008, Int J Ment Health Syst, V2, P13, DOI 10.1186/1752-4458-2-13; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hansla A, 2008, J ENVIRON PSYCHOL, V28, P1, DOI 10.1016/j.jenvp.2007.08.004; Harland P, 1999, J APPL SOC PSYCHOL, V29, P2505, DOI 10.1111/j.1559-1816.1999.tb00123.x; Hirsch ML, 2011, PSYCH TODAY, V44, P29; Homburg A, 2006, J ENVIRON PSYCHOL, V26, P1, DOI 10.1016/j.jenvp.2006.03.003; Mahoney AEJ, 2012, J ANXIETY DISORD, V26, P359, DOI 10.1016/j.janxdis.2011.12.003; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Milfont TL, 2010, J ENVIRON PSYCHOL, V30, P80, DOI 10.1016/j.jenvp.2009.09.001; Murray L, 2009, PSYCHOL MED, V39, P1413, DOI 10.1017/S0033291709005157; Nilsson A, 2004, J ENVIRON PSYCHOL, V24, P267, DOI 10.1016/j.jenvp.2004.06.002; Page LA, 2010, PSYCHOL MED, V40, P177, DOI 10.1017/S0033291709992169; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Reser JP, 2011, AM PSYCHOL, V66, P277, DOI 10.1037/a0023412; Sjoberg L, 1998, RISK ANAL, V18, P85, DOI 10.1111/j.1539-6924.1998.tb00918.x; Steg L, 2005, J ENVIRON PSYCHOL, V25, P415, DOI 10.1016/j.jenvp.2005.08.003; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; Terry DJ, 1999, BRIT J SOC PSYCHOL, V38, P225, DOI 10.1348/014466699164149; van der Heiden C, 2010, J ANXIETY DISORD, V24, P284, DOI 10.1016/j.janxdis.2009.12.005; Verplanken B, 2002, J PERS SOC PSYCHOL, V82, P434, DOI 10.1037/0022-3514.82.3.434; Verplanken B, 2008, J ENVIRON PSYCHOL, V28, P121, DOI 10.1016/j.jenvp.2007.10.005; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; Verplanken B, 2014, MINDFULNESS, V5, P566, DOI 10.1007/s12671-013-0211-0; Verplanken B, 2012, EUR J SOC PSYCHOL, V42, P285, DOI 10.1002/ejsp.1852; WARWICK HMC, 1990, BEHAV RES THER, V28, P105, DOI 10.1016/0005-7967(90)90023-C; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Whitmarsh L, 2009, J ENVIRON PSYCHOL, V29, P13, DOI 10.1016/j.jenvp.2008.05.003; Zaalberg R, 2009, RISK ANAL, V29, P1759, DOI 10.1111/j.1539-6924.2009.01316.x	49	57	57	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74708	10.1371/journal.pone.0074708	http://dx.doi.org/10.1371/journal.pone.0074708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023958	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600152
J	Nordemann, U; Wifling, D; Schnell, D; Bernhardt, G; Stark, H; Seifert, R; Buschauer, A				Nordemann, Uwe; Wifling, David; Schnell, David; Bernhardt, Guenther; Stark, Holger; Seifert, Roland; Buschauer, Armin			Luciferase Reporter Gene Assay on Human, Murine and Rat Histamine H-4 Receptor Orthologs: Correlations and Discrepancies between Distal and Proximal Readouts	PLOS ONE			English	Article							PHARMACOLOGICAL CHARACTERIZATION; ADENYLYL-CYCLASE; ADRENERGIC-RECEPTOR; POTENT; INHIBITION; CLONING; CAMP; INFLAMMATION; ACTIVATION; ANTAGONISTS	The investigation of the (patho) physiological role of the histamine H-4 receptor (H4R) and its validation as a possible drug target in translational animal models are compromised by distinct species-dependent discrepancies regarding potencies and receptor subtype selectivities of the pharmacological tools. Such differences were extremely pronounced in case of proximal readouts, e. g. [P-32]GTPase or [S-35]GTP gamma S binding assays. To improve the predictability of in vitro investigations, the aim of this study was to establish a reporter gene assay for human, murine and rat H(4)Rs, using bioluminescence as a more distal readout. For this purpose a cAMP responsive element (CRE) controlled luciferase reporter gene assay was established in HEK293T cells, stably expressing the human (h), the mouse (m) or the rat (r) H4R. The potencies and efficacies of 23 selected ligands (agonists, inverse agonists and antagonists) were determined and compared with the results obtained from proximal readouts. The potencies of the examined ligands at the human H4R were consistent with reported data from [P-32]GTPase or [S-35]GTP gamma S binding assays, despite a tendency toward increased intrinsic efficacies of partial agonists. The differences in potencies of individual agonists at the three H4R orthologs were generally less pronounced compared to more proximal readouts. In conclusion, the established reporter gene assay is highly sensitive and reliable. Regarding discrepancies compared to data from functional assays such as [P-32]GTPase and [S-35]GTP gamma S binding, the readout may reflect multifactorial causes downstream from G-protein activation, e. g. activation/amplification of or cross-talk between different signaling pathways.	[Nordemann, Uwe; Wifling, David; Schnell, David; Bernhardt, Guenther; Buschauer, Armin] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany; [Stark, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany; [Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany	University of Regensburg; Heinrich Heine University Dusseldorf; Hannover Medical School	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de	Wifling, David/AAB-8213-2020; Stark, Holger/A-4235-2009; Seifert, Roland/G-3189-2013	Wifling, David/0000-0002-1370-2138; Stark, Holger/0000-0003-3336-1710; 	German Research Foundation (DFG) [GRK760]; European Cooperation in Science and Technology, COST Action [BM0806]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Cooperation in Science and Technology, COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Graduate Training Program (Graduiertenkolleg) GRK760, "Medicinal Chemistry: Molecular Recognition - Ligand-Receptor Interactions" of the German Research Foundation (DFG), by the European Cooperation in Science and Technology, COST Action BM0806, 'Recent advances in histamine receptor H4R research' and by the DFG within the DFG funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appl H, 2011, N-S ARCH PHARMACOL, V385, P145; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Beermann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030285; Brunskole I, 2011, N-S ARCH PHARMACOL, V384, P301, DOI 10.1007/s00210-011-0673-3; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coruzzi G, 2007, EUR J PHARMACOL, V563, P240, DOI 10.1016/j.ejphar.2007.02.026; Cowart MD, 2008, J MED CHEM, V51, P6547, DOI 10.1021/jm800670r; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Deml KF, 2009, MOL PHARMACOL, V76, P1019, DOI 10.1124/mol.109.058651; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; George SE, 1997, J BIOMOL SCREEN, V2, P235, DOI 10.1177/108705719700200408; GETHER U, 1995, J BIOL CHEM, V270, P28268; Guillou JL, 1999, J BIOL CHEM, V274, P35539, DOI 10.1074/jbc.274.50.35539; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Hornigold DC, 2003, BRIT J PHARMACOL, V138, P1340, DOI 10.1038/sj.bjp.0705178; Igel P, 2009, J MED CHEM, V52, P6297, DOI 10.1021/jm900526h; Igel P, 2009, J MED CHEM, V52, P2623, DOI 10.1021/jm9000693; Kemp DM, 2002, J BIOMOL SCREEN, V7, P141, DOI 10.1089/10870570252906602; Kitbunnadaj R, 2003, J MED CHEM, V46, P5445, DOI 10.1021/jm030905y; Leurs R, 2011, TRENDS PHARMACOL SCI, V32, P250, DOI 10.1016/j.tips.2011.02.004; Leurs R, 2009, BRIT J PHARMACOL, V157, P14, DOI 10.1111/j.1476-5381.2009.00250.x; Lim HD, 2005, J PHARMACOL EXP THER, V314, P1310, DOI 10.1124/jpet.105.087965; Lim HD, 2006, J MED CHEM, V49, P6650, DOI 10.1021/jm060880d; Lim HD, 2010, MOL PHARMACOL, V77, P734, DOI 10.1124/mol.109.063040; Liu CL, 2001, J PHARMACOL EXP THER, V299, P121; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Ma YS, 1998, J BIOL CHEM, V273, P8727, DOI 10.1074/jbc.273.15.8727; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058; Mou TC, 2009, BIOCHEMISTRY-US, V48, P3387, DOI 10.1021/bi802122k; Neumann D, 2010, PHARMACOLOGY, V85, P217, DOI 10.1159/000285088; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; Nijmeijer S, 2012, MOL PHARMACOL, V82, P1174, DOI 10.1124/mol.112.080911; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Reher TM, 2012, BIOCHEM PHARMACOL, V84, P192, DOI 10.1016/j.bcp.2012.04.004; Rodrigues DJ, 2009, METHODS MOL BIOL, V552, P319, DOI 10.1007/978-1-60327-317-6_23; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sander K, 2009, BIOORGAN MED CHEM, V17, P7186, DOI 10.1016/j.bmc.2009.08.059; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Schnell D, 2011, N-S ARCH PHARMACOL, V383, P457, DOI 10.1007/s00210-011-0612-3; Seifert R, 2011, MOL PHARMACOL, V79, P631, DOI 10.1124/mol.111.071266; Strakhova MI, 2009, BRIT J PHARMACOL, V157, P44, DOI 10.1111/j.1476-5381.2009.00236.x; Strasser A, 2013, TRENDS PHARMACOL SCI, V34, P13, DOI 10.1016/j.tips.2012.10.004; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Williams C, 2004, NAT REV DRUG DISCOV, V3, P125, DOI 10.1038/nrd1306; Wong MPM, 2000, BRIT J PHARMACOL, V130, P1021, DOI 10.1038/sj.bjp.0703411; Yu FQ, 2010, J RECEPT LIGAND CH R, V3, P37; Zampeli E, 2009, INFLAMM RES, V58, P285, DOI 10.1007/s00011-009-8245-4; Zhang M, 2007, PHARMACOL THERAPEUT, V113, P594, DOI 10.1016/j.pharmthera.2006.11.008; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434	56	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73961	10.1371/journal.pone.0073961	http://dx.doi.org/10.1371/journal.pone.0073961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023919	Green Published, Green Submitted, gold			2022-12-25	WOS:000324238400088
J	Giovannelli, D; Molari, M; d'Errico, G; Baldrighi, E; Pala, C; Manini, E				Giovannelli, Donato; Molari, Massimiliano; d'Errico, Giuseppe; Baldrighi, Elisa; Pala, Claudia; Manini, Elena			Large-Scale Distribution and Activity of Prokaryotes in Deep-Sea Surface Sediments of the Mediterranean Sea and the Adjacent Atlantic Ocean	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TARGETED OLIGONUCLEOTIDE PROBES; CATALYZED REPORTER DEPOSITION; COMMUNITY STRUCTURE; ORGANIC-MATTER; BACTERIAL ABUNDANCE; MICROBIAL COMMUNITY; CONTINENTAL-MARGIN; PACIFIC-OCEAN; WATER MASSES	The deep-sea represents a substantial portion of the biosphere and has a major influence on carbon cycling and global biogeochemistry. Benthic deep-sea prokaryotes have crucial roles in this ecosystem, with their recycling of organic matter from the photic zone. Despite this, little is known about the large-scale distribution of prokaryotes in the surface deep-sea sediments. To assess the influence of environmental and trophic variables on the large-scale distribution of prokaryotes, we investigated the prokaryotic assemblage composition (Bacteria to Archaea and Euryarchaeota to Crenarchaeota ratio) and activity in the surface deep-sea sediments of the Mediterranean Sea and the adjacent North Atlantic Ocean. Prokaryotic abundance and biomass did not vary significantly across the Mediterranean Sea; however, there were depth-related trends in all areas. The abundance of prokaryotes was positively correlated with the sedimentary concentration of protein, an indicator of the quality and bioavailability of organic matter. Moving eastwards, the Bacteria contribution to the total prokaryotes decreased, which appears to be linked to the more oligotrophic conditions of the Eastern Mediterranean basins. Despite the increased importance of Archaea, the contributions of Crenarchaeota Marine Group I to the total pool was relatively constant across the investigated stations, with the exception of Matapan-Vavilov Deep, in which Euryarchaeota Marine Group II dominated. Overall, our data suggest that deeper areas of the Mediterranean Sea share more similar communities with each other than with shallower sites. Freshness and quality of sedimentary organic matter were identified through Generalized Additive Model analysis as the major factors for describing the variation in the prokaryotic community structure and activity in the surface deep-sea sediments. Longitude was also important in explaining the observed variability, which suggests that the overlying water masses might have a critical role in shaping the benthic communities.	[Giovannelli, Donato; Molari, Massimiliano; d'Errico, Giuseppe; Baldrighi, Elisa; Pala, Claudia; Manini, Elena] Natl Res Council Italy CNR, Inst Marine Sci ISMAR, Ancona, Italy; [Giovannelli, Donato] Rutgers State Univ, Inst Marine & Coastal Sci IMCS, New Brunswick, NJ 08903 USA; [Molari, Massimiliano] Max Planck Inst Marine Microbiol, Bremen, Germany; [Pala, Claudia] Univ Parma, Dept Biosci, I-43100 Parma, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Rutgers State University New Brunswick; Max Planck Society; University of Parma	Manini, E (corresponding author), Natl Res Council Italy CNR, Inst Marine Sci ISMAR, Ancona, Italy.	e.manini@ismar.cnr.it	Giovannelli, Donato/A-4812-2011; Baldrighi, Elisa/AAP-1826-2020; Manini, Elena/C-2032-2015; CNR, Ismar/P-1247-2014	Giovannelli, Donato/0000-0001-7182-8233; Manini, Elena/0000-0002-8990-2929; d'Errico, Giuseppe/0000-0003-1667-8038; Pala, Claudia/0000-0003-2501-4647; Molari, Massimiliano/0000-0003-4995-7818; CNR, Ismar/0000-0001-5351-1486	European Science Foundation	European Science Foundation(European Science Foundation (ESF)European Commission)	This study is part of ESF-EuroDEEP project BIOFUN (Biodiversity and Ecosystem functioning in contrasting southern European deep-sea environment) funded by the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMANN RI, 1995, MOL ECOL, V4, P543, DOI 10.1111/j.1365-294X.1995.tb00255.x; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2010, R LANG ENV STAT COMP; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Biddanda B, 2001, LIMNOL OCEANOGR, V46, P730, DOI 10.4319/lo.2001.46.3.0730; Boetius A, 2000, DEEP-SEA RES PT II, V47, P2835, DOI 10.1016/S0967-0645(00)00051-5; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Clarke K., 2001, PRIMER V5 USER MANUA; Corinaldesi C, 2012, ISME J, V6, P1250, DOI 10.1038/ismej.2011.185; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Danovaro R, 2002, APPL ENVIRON MICROB, V68, P1468, DOI 10.1128/AEM.68.3.1468-1472.2002; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; De Corte D, 2012, ISME J, V6, P1566, DOI 10.1038/ismej.2011.214; De Corte D, 2009, ISME J, V3, P147, DOI 10.1038/ismej.2008.94; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Deming JW, 2008, DEEP-SEA RES PT II, V55, P2597, DOI 10.1016/j.dsr2.2008.07.009; Dixon JL, 2001, MICROB ECOL, V42, P549, DOI 10.1007/s00248-001-0022-z; Duineveld GCA, 2004, MAR ECOL PROG SER, V277, P13, DOI 10.3354/meps277013; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Durbin AM, 2010, ENV MICROBIOL REP, V2, P693, DOI 10.1111/j.1758-2229.2010.00163.x; FABIANO M, 1995, CONT SHELF RES, V15, P1453, DOI 10.1016/0278-4343(94)00088-5; Flach E, 2002, PROG OCEANOGR, V52, P433, DOI 10.1016/S0079-6611(02)00018-6; FUHRMAN J, 1992, ENVIR SCI R, V43, P361; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; La Ferla R., 2010, ADV OCEANOGR LIMNOL, V1, P143, DOI [DOI 10.4081/AI0L.2010.5298, 10.4081/aiol.2010.5298, DOI 10.4081/AIOL.2010.5298]; LEGENDRE L, 1995, AQUAT MICROB ECOL, V9, P69, DOI 10.3354/ame009069; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Luna GM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004168; Manini E, 2006, FEMS MICROBIOL ECOL, V55, P416, DOI 10.1111/j.1574-6941.2005.00042.x; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Moeseneder MM, 2001, LIMNOL OCEANOGR, V46, P95, DOI 10.4319/lo.2001.46.1.0095; Molari M, 2012, ESTUAR COAST SHELF S, V97, P141, DOI 10.1016/j.ecss.2011.11.036; Molari M, 2012, CURR MICROBIOL, V64, P242, DOI 10.1007/s00284-011-0056-5; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pearson A, 2008, NATURE, V454, P952, DOI 10.1038/454952a; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pfannkuche O, 1998, PROG OCEANOGR, V42, P189, DOI 10.1016/S0079-6611(98)00034-2; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, MAR ECOL PROG SER, V375, P41, DOI 10.3354/meps07735; Queric NV, 2004, J MICROBIOL METH, V57, P351, DOI 10.1016/j.mimet.2004.02.005; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Sahm K, 1998, MAR ECOL PROG SER, V165, P71, DOI 10.3354/meps165071; Santinelli C, 2010, DEEP-SEA RES PT II, V57, P1446, DOI 10.1016/j.dsr2.2010.02.014; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Schlitzer R, 2014, OCEAN DATA VIEW; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Stoica E, 2007, J PLANKTON RES, V29, P699, DOI 10.1093/plankt/fbm051; Tamburini C, 2009, DEEP-SEA RES PT II, V56, P700, DOI 10.1016/j.dsr2.2008.07.021; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; THIEL H, 1988, Biological Oceanography, V6, P203; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; Turley CM, 2000, LIMNOL OCEANOGR, V45, P419, DOI 10.4319/lo.2000.45.2.0419; Turley CM, 2002, DEEP-SEA RES PT I, V49, P815, DOI 10.1016/S0967-0637(01)00080-2; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yakimov MM, 2011, ISME J, V5, P945, DOI 10.1038/ismej.2010.197; Yokokawa T, 2010, AQUAT MICROB ECOL, V59, P185, DOI 10.3354/ame01393; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1128/AEM.69.1.24-32.2003.PUBMED:12513973; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	102	20	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72996	10.1371/journal.pone.0072996	http://dx.doi.org/10.1371/journal.pone.0072996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24039667	Green Submitted, gold, Green Published			2022-12-25	WOS:000323733800088
J	Hwang, JW; Sundar, IK; Yao, HW; Sellix, MT; Rahman, I				Hwang, Jae-Woong; Sundar, Isaac K.; Yao, Hongwei; Sellix, Michael T.; Rahman, Irfan			Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway	FASEB JOURNAL			English	Article						oxidative stress; cytokines; chronic obstructive pulmonary disease; locomotor activity; emphysema; mouse	OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; GENE-EXPRESSION; SIRT1; DEPRESSION; PROTEIN; EMPHYSEMA; DEACETYLASE; BMAL1; SUSCEPTIBILITY	Patients with obstructive lung diseases display abnormal circadian rhythms in lung function. We determined the mechanism whereby environmental tobacco/cigarette smoke (CS) modulates expression of the core clock gene BMAL1, through Sirtuin1 (SIRT1) deacetylase during lung inflammatory and injurious responses. Adult C57BL6/J and various mice mutant for SIRT1 and BMAL1 were exposed to both chronic (6 mo) and acute (3 and 10 d) CS, and we measured the rhythmic expression of clock genes, circadian rhythms of locomotor activity, lung function, and inflammatory and emphysematous responses in the lungs. CS exposure (100-300 mg/m(3) particulates) altered clock gene expression and reduced locomotor activity by disrupting the central and peripheral clocks and increased lung inflammation, causing emphysema in mice. BMAL1 was acetylated and degraded in the lungs of mice exposed to CS and in patients with chronic obstructive pulmonary disease (COPD), compared with lungs of the nonsmoking controls, linking it mechanistically to CS-induced reduction of SIRT1. Targeted deletion of Bmal1 in lung epithelium augmented inflammation in response to CS, which was not attenuated by the selective SIRT1 activator SRT1720 (EC50=0.16 M) in these mice. Thus, the circadian clock, specifically the enhancer BMAL1 in epithelium, plays a pivotal role, mediated by SIRT1-dependent BMAL1, in the regulation of CS-induced lung inflammatory and injurious responses. Hwang, J.-W., Sundar, I. K., Yao, H., Sellix, M. T., Rahman, I. Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway.	[Hwang, Jae-Woong; Sundar, Isaac K.; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Sellix, Michael T.] Univ Rochester, Med Ctr, Dept Med, Div Endocrinol & Metab, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460	U.S. National Institutes of Health [1R01HL097751, 1R01HL092842]; National Institute of Environmental Health Sciences (NIEHS) Environmental Health Science Center [P30-ES01247]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097751, R01HL092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS) Environmental Health Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Thomas J. Mariani (University of Rochester, Rochester, NY) for providing the Cre recombinase transgenic mice with CC10 promoter, Dr. Michael McBurney (University of Ottawa, Ottawa, ON, Canada) for providing SIRT1-knockout mice (SIRT1-deficient mice), Dr. Leonard Guarente (Massachusetts Institutes of Technology, Cambridge, MA, USA) and Dr. Wei Gu (Columbia University, New York, NY, USA) for providing Tg mice overexpressing Sirt1 (SIRT1 Tg mice), and Dr. Sangwoon Chung, Katherine Bachmann, Lindsay Marchetti, Zachary Murphy, Drew Phillips, Suzanne Bellanca, and Stephanie Uhrinek (University of Rochester, Rochester, NY, USA) for technical assistance. This study was supported by grants from the U.S. National Institutes of Health (1R01HL097751, 1R01HL092842) to I. R. and a grant from the National Institute of Environmental Health Sciences (NIEHS) Environmental Health Science Center (P30-ES01247). The authors declare no conflicts of interest. Author contributions: J.H. performed mouse studies, cell counts, immunoblotting, real-time PCR analysis, ELISA, and manuscript writing; I. S. K. performed cell counts, real-time PCR analysis, ELISA, mean linear intercept (Lm) analysis, immunoblotting, immunoprecipitation, and overall data collection and analysis; J.H. and I. S. K. performed: data analysis for circadian experiments and cell counts; H.Y., I. S. K., M. T. S., and I. R. performed: interpretation of results and manuscript editing; M. T. S. performed wheel running activity assay and, PER2:: luciferase assays; I. R. performed study design and manuscript writing.	Agusti A, 2011, EUR RESPIR REV, V20, P183, DOI 10.1183/09059180.00004311; Antoniu SA, 2011, EXPERT REV RESP MED, V5, P333, DOI [10.1586/ers.11.30, 10.1586/ERS.11.30]; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; BOYSEN PG, 1979, CHEST, V76, P536, DOI 10.1378/chest.76.5.536; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Casale R, 1997, RESPIRATION, V64, P251, DOI 10.1159/000196682; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen CY, 2008, AM J PHYSIOL-HEART C, V295, pH632, DOI 10.1152/ajpheart.91535.2007; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Foronjy RF, 2005, EXP LUNG RES, V31, P547, DOI 10.1080/019021490951522; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gebel S, 2006, TOXICOL SCI, V93, P422, DOI 10.1093/toxsci/kfl071; Gentner NJ, 2012, AM J PHYSIOL-HEART C, V302, pH818, DOI 10.1152/ajpheart.00852.2011; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gierisch JM, 2012, J GEN INTERN MED, V27, P351, DOI 10.1007/s11606-011-1915-2; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012; Hanania NA, 2011, AM J RESP CRIT CARE, V183, P604, DOI 10.1164/rccm.201003-0472OC; Hida A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-7; Hoegh SV, 2010, IMMUNOBIOLOGY, V215, P314, DOI 10.1016/j.imbio.2009.05.001; Hwang JW, 2011, J IMMUNOL, V187, P987, DOI 10.4049/jimmunol.1001861; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Leone MJ, 2012, CHRONOBIOL INT, V29, P715, DOI 10.3109/07420528.2012.682681; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Laurin C, 2012, AM J RESP CRIT CARE, V185, P918, DOI 10.1164/rccm.201105-0939PP; Lewis D A, 2001, Curr Opin Pulm Med, V7, P105, DOI 10.1097/00063198-200103000-00008; Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mortola JP, 2002, RESP PHYSIOL NEUROBI, V131, P91, DOI 10.1016/S1569-9048(02)00040-X; Murphy JM, 2003, AM J PSYCHIAT, V160, P1663, DOI 10.1176/appi.ajp.160.9.1663; Mykletun A, 2008, EUR PSYCHIAT, V23, P77, DOI 10.1016/j.eurpsy.2007.10.005; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; PETTY TL, 1988, AM J MED, V85, P21, DOI 10.1016/0002-9343(88)90237-9; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Thomas A, 1993, Pneumologie, V47, P526; Tsai CL, 2007, CHRONOBIOL INT, V24, P699, DOI 10.1080/07420520701535753; Vasu VT, 2009, INTEGR CANCER THER, V8, P321, DOI 10.1177/1534735409352027; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoon JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044053; Zheng X, 2007, P NATL ACAD SCI USA, V104, P15899, DOI 10.1073/pnas.0701599104	70	97	100	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					176	194		10.1096/fj.13-232629	http://dx.doi.org/10.1096/fj.13-232629			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24025728	Green Published			2022-12-25	WOS:000333526100019
J	Muller, S; Faulhaber, A; Sieber, C; Pfeifer, D; Hochberg, T; Gansz, M; Deshmukh, SD; Dauth, S; Brix, K; Saftig, P; Peters, C; Henneke, P; Reinheckel, T				Mueller, Sabrina; Faulhaber, Anja; Sieber, Carolin; Pfeifer, Dietmar; Hochberg, Tanja; Gansz, Martina; Deshmukh, Sachin D.; Dauth, Stephanie; Brix, Klaudia; Saftig, Paul; Peters, Christoph; Henneke, Philipp; Reinheckel, Thomas			The endolysosomal cysteine cathepsins L and K are involved in macrophage-mediated clearance of Staphylococcus aureus and the concomitant cytokine induction	FASEB JOURNAL			English	Article						proteases; lysosome; innate immune system; phagocyte; nonoxidative killing	TOLL-LIKE RECEPTORS; ACTIVATION; PROTEASES; RECOGNITION; TRANSCRIPTION; PHAGOCYTOSIS; PROTEOLYSIS; INFECTION; CLEAVAGE	Cysteine cathepsins are endolysosomal cysteine proteases highly expressed in macrophages; however, their individual contributions to the elimination of bacteria and bacteria-induced cytokine production by macrophages are unknown. We assessed the contribution of cysteine cathepsins to macrophage defense pathways against Staphylococcus aureus by using chemical inhibitors and by infecting primary bone marrow-derived macrophages deficient in 1 of 7 major macrophage-expressed endolysosomal cysteine proteases. We show that cysteine cathepsins are involved in the phagocytosis and killing of S. aureus. Cathepsin L was identified as an executor of nonoxidative killing. Moreover, microarray data revealed cysteine cathepsins to be important for the maximal induction of certain proinflammatory genes, such as IL6, in response to S. aureus. Cysteine cathepsin's contribution to IL6 production was dependent on phagocytosis, and cathepsin K was identified to be a critical protease in this process. Analysis of macrophages with impaired trafficking of endolysosomal Toll-like receptors (TLRs) to the acidic compartment revealed that they were not involved in cathepsin-dependent IL6 induction. Because IL6 production was completely dependent on the TLR-adaptor protein myeloid differentiation primary response gene 88 (MyD88), it appears that other TLRs are involved. In summary, lysosomal cysteine proteases are functionally linked to the complex bactericidal and inflammatory activities of macrophages. Muller, S., Faulhaber, A., Sieber, C., Pfeifer, D., Hochberg, T., Gansz, M., Deshmukh, S. D., Dauth, S., Brix, K., Saftig, P., Peters, C., Henneke, P., Reinheckel, T. The endolysosomal cysteine cathepsins L and K are involved in macrophage-mediated clearance of Staphylococcus aureus and the concomitant cytokine induction.	[Mueller, Sabrina; Faulhaber, Anja; Sieber, Carolin; Hochberg, Tanja; Gansz, Martina; Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Mueller, Sabrina; Deshmukh, Sachin D.; Henneke, Philipp; Reinheckel, Thomas] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Internal Med 1, Core Facil Genom, Freiburg, Germany; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Paediat & Adolescent Med, Div Pediat Infect Dis & Rheumatol, Freiburg, Germany; [Mueller, Sabrina; Gansz, Martina] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Dauth, Stephanie; Brix, Klaudia] Jacobs Univ Bremen, Res Ctr Mol Life Sci, Sch Sci & Engn, D-28759 Bremen, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, Kiel, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Jacobs University; University of Kiel	Reinheckel, T (corresponding author), Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Saftig, Paul/A-7966-2010; Reinheckel, Thomas/AAL-9761-2021; Brix, Klaudia/F-5072-2013	Reinheckel, Thomas/0000-0001-9866-9105; Brix, Klaudia/0000-0002-4476-0357	Excellence Initiative of the German Federal and State Governments [EXC 294]; CAU Kiel; Deutsche Forschungsgemeinschaft [SFB 850, B7, SFB 877, SPP 1580]; Centre of Chronic Immunodeficiency (CCI) Freiburg [TP8]	Excellence Initiative of the German Federal and State Governments; CAU Kiel; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Chronic Immunodeficiency (CCI) Freiburg	The authors thank H. A. Chapman (University of California, San Francisco, CA, USA) and J. Joyce (Memorial Sloan-Kettering Cancer Center, New York, NY, USA) for kindly providing cathepsin S-deficient mice, M. A. Freudenberg (Max-Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany) for kindly providing TLR9- and Unc93B1-deficient mice, J. Potempa (Jagiellonian University, Krakow, Poland) for the S. aureus Newman strain, M. Bogyo (Stanford University, Stanford, CA, USA) for the JPM-OEt protease inhibitor, and Susanne Dollwet-Mack, Lars Ellenrieder, and Ulrike Reif (Albert Ludwigs University, Freiburg, Germany) and Bernhard Kremer (University Medical Center, Freiburg, Germany) for outstanding technical assistance. This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294), Inflammation at Interfaces, CAU Kiel, the Deutsche Forschungsgemeinschaft SFB 850 Project B7, SFB 877, and SPP 1580, and the Centre of Chronic Immunodeficiency (CCI) Freiburg grant TP8.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Avalos AM, 2013, J IMMUNOL, V190, P695, DOI 10.4049/jimmunol.1202342; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Deshmukh SD, 2012, J IMMUNOL, V188, P774, DOI 10.4049/jimmunol.1101383; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Grimm S, 2012, FREE RADICAL BIO MED, V52, P1011, DOI 10.1016/j.freeradbiomed.2011.12.021; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaplan A, 2012, J IMMUNOL, V189, P4537, DOI 10.4049/jimmunol.1201111; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rivera-Marrero CA, 2004, INFECT IMMUN, V72, P5712, DOI 10.1128/IAI.72.10.5712-5721.2004; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232	57	34	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					162	175		10.1096/fj.13-232272	http://dx.doi.org/10.1096/fj.13-232272			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24036885				2022-12-25	WOS:000333526100018
J	Wang, YG; Shek, FH; Wong, KF; Liu, LX; Zhang, XQ; Yuan, Y; Khin, E; Hu, MY; Wang, JH; Poon, RTP; Hong, WJ; Lee, NP; Luk, JM				Wang, Yonggang; Shek, Felix H.; Wong, Kwong F.; Liu, Ling Xiao; Zhang, Xiao Qian; Yuan, Yi; Khin, Ester; Hu, Mei-yu; Wang, Jian Hua; Poon, Ronnie T. P.; Hong, Wanjin; Lee, Nikki P.; Luk, John M.			Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-INTESTINE-CADHERIN; GROWTH-FACTOR RECEPTOR; CELL-ADHESION MOLECULES; MONOCLONAL-ANTIBODIES; POOR-PROGNOSIS; GENE STRUCTURE; EXPRESSION; CANCER; IDENTIFICATION; ASSOCIATION	Cadherin-17 (CDH17) is an oncofetal molecule associated with poor prognostic outcomes of hepatocellular carcinoma (HCC), for which the treatment options are very limited. The present study investigates the therapeutic potential of a monoclonal antibody (Lic5) that targets the CDH17 antigen in HCC. In vitro experiments showed Lic5 could markedly reduce CDH17 expression in a dose-dependent manner, suppress beta-catenin signaling, and induce cleavages of apoptotic enzymes caspase-8 and -9 in HCC cells. Treatment of animals in subcutaneous HCC xenograft model similarly demonstrated significant tumor growth inhibition (TGI) using Lic5 antibody alone (5 mg/kg, i.p., t.i.w.; ca. 60-65% TGI vs. vehicle at day 28), or in combination with conventional chemotherapy regimen (cisplatin 1 mg/kg; ca. 85-90% TGI). Strikingly, lung metastasis was markedly suppressed by Lic5 treatments. Immunohistochemical and western blot analyses of xenograft explants revealed inactivation of the Wnt pathway and suppression of Wnt signaling components in HCC tissues. Collectively, anti-CDH17 antibody promises as an effective biologic agent for treating malignant HCC.	[Wang, Yonggang; Hu, Mei-yu] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China; [Wang, Yonggang; Shek, Felix H.; Poon, Ronnie T. P.; Lee, Nikki P.; Luk, John M.] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Wong, Kwong F.; Yuan, Yi; Khin, Ester; Luk, John M.] Natl Univ Hlth Syst, Dept Pharmacol, Singapore, Singapore; [Wong, Kwong F.; Yuan, Yi; Khin, Ester; Luk, John M.] Natl Univ Hlth Syst, Dept Surg, Singapore, Singapore; [Wang, Yonggang; Liu, Ling Xiao; Wang, Jian Hua] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Zhang, Xiao Qian; Hong, Wanjin; Luk, John M.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Shanghai Jiao Tong University; University of Hong Kong; National University of Singapore; National University of Singapore; Fudan University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lee, NP (corresponding author), Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China.	nikkilee@hku.hk; dr.johnluk@gmail.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940	National Research Foundation Proof-of-Concept Fund [NRF2009NRF-POC002-97]; Hong Kong Research Grants Council General Research Fund	National Research Foundation Proof-of-Concept Fund; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council)	The study was supported in part by grant the National Research Foundation Proof-of-Concept Fund (NRF2009NRF-POC002-97) and the Hong Kong Research Grants Council General Research Fund (J.M.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belda-Iniesta C, 2011, CLIN TRANSL ONCOL, V13, P84, DOI 10.1007/s12094-011-0623-z; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Callahan R, 2011, CURR OPIN OBSTET GYN, V23, P37, DOI 10.1097/GCO.0b013e3283414e87; Caponigro F, 2005, CURR OPIN ONCOL, V17, P212, DOI 10.1097/01.cco.0000159623.68506.cf; Damasceno M, 2011, CURR OPIN ONCOL, V23, pS3, DOI 10.1097/01.cco.0000397417.75245.9c; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; De Vita F, 2010, CANCER TREAT REV, V36, pS11, DOI 10.1016/S0305-7372(10)70014-1; Ding ZB, 2009, CANCER-AM CANCER SOC, V115, P4753, DOI 10.1002/cncr.24513; Driscoll JJ, 2010, TARGET ONCOL, V5, P281, DOI 10.1007/s11523-010-0165-2; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Fatima S, 2011, WORLD J CLIN ONCOL, V2, P311, DOI 10.5306/wjco.v2.i8.311; Gessner R, 2000, ANN NY ACAD SCI, V915, P136; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung R, 2004, CELL MOL LIFE SCI, V61, P1157, DOI 10.1007/s00018-004-3470-z; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Koutras AK, 2011, CURR MED CHEM, V18, P1599, DOI 10.2174/092986711795471338; Lee NP, 2010, BBA-REV CANCER, V1806, P138, DOI 10.1016/j.bbcan.2010.05.002; Lee NP, 2010, INT J CANCER, V127, P968, DOI 10.1002/ijc.25100; Lee NP, 2009, J PROTEOME RES, V8, P1293, DOI 10.1021/pr800637z; Lee NPY, 2008, PROTEOMICS, V8, P2136, DOI 10.1002/pmic.200700590; Lee NPY, 2006, APOPTOSIS, V11, P1215, DOI 10.1007/s10495-006-6981-2; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Luk JM, 2006, CLIN EXP PHARMACOL P, V33, P482, DOI 10.1111/j.1440-1681.2006.04396.x; Luk JM, 2005, PROTEOMICS, V5, P1980, DOI 10.1002/pmic.200401084; Majidi Jafar, 2009, Human Antibodies, V18, P81, DOI 10.3233/HAB-2009-0204; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Paredes J, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1774; Qiu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056959; Spratlin J, 2011, CURR ONCOL REP, V13, P97, DOI 10.1007/s11912-010-0149-5; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wang XQ, 2006, CLIN CANCER RES, V12, P5248, DOI 10.1158/1078-0432.CCR-06-0558; Wang XQ, 2005, CLIN CANCER RES, V11, P483; Wendeler MW, 2006, CELL MOL LIFE SCI, V63, P1564, DOI 10.1007/s00018-006-6014-x; Wong BW, 2003, BIOCHEM BIOPH RES CO, V311, P618, DOI 10.1016/j.bbrc.2003.10.032; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Zhang CH, 2012, J SURG RES, V174, P120, DOI 10.1016/j.jss.2010.10.030; Zhu R, 2010, J CELL BIOCHEM, V111, P618, DOI 10.1002/jcb.22742	43	11	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72386	10.1371/journal.pone.0072386	http://dx.doi.org/10.1371/journal.pone.0072386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039755	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500012
J	Akimoto, Y; Yugi, K; Uda, S; Kudo, T; Komori, Y; Kubota, H; Kuroda, S				Akimoto, Yuki; Yugi, Katsuyuki; Uda, Shinsuke; Kudo, Takamasa; Komori, Yasunori; Kubota, Hiroyuki; Kuroda, Shinya			The Extraction of Simple Relationships in Growth Factor-Specific Multiple-Input and Multiple-Output Systems in Cell-Fate Decisions by Backward Elimination PLS Regression	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; PC12 PHEOCHROMOCYTOMA CELLS; RECEPTOR TYROSINE KINASE; LEAST-SQUARES REGRESSION; NEURONAL DIFFERENTIATION; MAP KINASE; NEURITE OUTGROWTH; INDUCED APOPTOSIS; ACTIVATION; PROTEIN	Cells use common signaling molecules for the selective control of downstream gene expression and cell-fate decisions. The relationship between signaling molecules and downstream gene expression and cellular phenotypes is a multiple-input and multiple-output (MIMO) system and is difficult to understand due to its complexity. For example, it has been reported that, in PC12 cells, different types of growth factors activate MAP kinases (MAPKs) including ERK, JNK, and p38, and CREB, for selective protein expression of immediate early genes (IEGs) such as c-FOS, c-JUN, EGR1, JUNB, and FOSB, leading to cell differentiation, proliferation and cell death; however, how multiple-inputs such as MAPKs and CREB regulate multipleoutputs such as expression of the IEGs and cellular phenotypes remains unclear. To address this issue, we employed a statistical method called partial least squares (PLS) regression, which involves a reduction of the dimensionality of the inputs and outputs into latent variables and a linear regression between these latent variables. We measured 1,200 data points for MAPKs and CREB as the inputs and 1,900 data points for IEGs and cellular phenotypes as the outputs, and we constructed the PLS model from these data. The PLS model highlighted the complexity of the MIMO system and growth factor-specific input-output relationships of cell-fate decisions in PC12 cells. Furthermore, to reduce the complexity, we applied a backward elimination method to the PLS regression, in which 60 input variables were reduced to 5 variables, including the phosphorylation of ERK at 10 min, CREB at 5 min and 60 min, AKT at 5 min and JNK at 30 min. The simple PLS model with only 5 input variables demonstrated a predictive ability comparable to that of the full PLS model. The 5 input variables effectively extracted the growth factor-specific simple relationships within the MIMO system in cell-fate decisions in PC12 cells.	[Akimoto, Yuki; Yugi, Katsuyuki; Uda, Shinsuke; Kudo, Takamasa; Komori, Yasunori; Kubota, Hiroyuki; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Shinya] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	skuroda@bi.s.u-tokyo.ac.jp			Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics CREST, of the Japan Science and Technology (JST); KAKENHI Scientific Research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21240025]; Human Frontier Science Project (HFSP) [RGP0061/2011]	Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics CREST, of the Japan Science and Technology (JST); KAKENHI Scientific Research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Human Frontier Science Project (HFSP)(Human Frontier Science Program)	This work was funded by The Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, of the Japan Science and Technology (JST); a KAKENHI Scientific Research grant (A) (#21240025) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (http://www.jst.go.jp/kisoken/crest/en/index.html), and by a Human Frontier Science Project (HFSP) grant (RGP0061/2011; http://www.hfsp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Amato SF, 1996, J IMMUNOL, V157, P146; Bianco MR, 2011, J NEUROSCI RES, V89, P1302, DOI 10.1002/jnr.22665; BURSTEIN DE, 1982, BRAIN RES, V247, P115, DOI 10.1016/0006-8993(82)91033-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; Efroymson M., 1966, STEPWISE REGRESSION; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; FERRARI G, 1994, EMBO J, V13, P5922, DOI 10.1002/j.1460-2075.1994.tb06937.x; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Hanafusa H, 2009, NAT CELL BIOL, V11, P106, DOI 10.1038/ncb1820; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; LAZO PS, 1992, NUCLEIC ACIDS RES, V20, P343, DOI 10.1093/nar/20.2.343; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ozaki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009955; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; Saito TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057037; Samson LD, 2012, MOL SYST BIOL, V31, P1; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Torocsik B, 2000, BIOCHEM BIOPH RES CO, V278, P550, DOI 10.1006/bbrc.2000.3836; Torocsik B, 2000, EUR J NEUROSCI, V12, P527, DOI 10.1046/j.1460-9568.2000.00933.x; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Watanabe K, 2012, J CELL SCI, V125, P2198, DOI 10.1242/jcs.097709; Wold S., 1994, CHEMOMETRIC METHODS; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72780	10.1371/journal.pone.0072780	http://dx.doi.org/10.1371/journal.pone.0072780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039801	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300027
J	Brandner, J; Cerwenka, AF; Schliewen, UK; Geist, J				Brandner, Joerg; Cerwenka, Alexander F.; Schliewen, Ulrich K.; Geist, Juergen			Bigger Is Better: Characteristics of Round Gobies Forming an Invasion Front in the Danube River	PLOS ONE			English	Article							GOBY NEOGOBIUS-MELANOSTOMUS; LIFE-HISTORY TRAITS; EASTERN LAKE-ERIE; RANGE EXPANSION; FOOD-WEB; FISH; POPULATION; BIODIVERSITY; ABUNDANCE; ECOLOGY	Few studies have systematically investigated differences in performance, morphology and parasitic load of invaders at different stages of an invasion. This study analyzed phenotype-environment correlations in a fish invasion from initial absence until establishment in the headwater reach of the second largest European river, the Danube. Here, the round goby (Neogobius melanostomus) formed 73% of the fish abundance and 58% of the fish biomass in rip-rap bank habitats after establishment. The time from invasion until establishment was only about two years, indicating rapid expansion. Founder populations from the invasion front were different from longer established round goby populations in demography, morphology, feeding behaviour, sex ratio and parasitic load, indicating that plasticity in these traits determines invasion success. Competitive ability was mostly dependent on growth/size-related traits rather than on fecundity. As revealed by stable isotope analyses, specimens at the invasion front had a higher trophic position in the food web and seem to benefit from lower food competition. Somatic performance seems to be more important than investment in reproduction during the early stages of the invasion process and upstream-directed range expansion is not caused by out-migrating weak or juvenile individuals that were forced to leave high density areas due to high competition. This mechanism might be true for downstream introductions via drift. Greater abundance and densities of acanthocephalan endoparasites were observed at the invasion front, which contradicts the expectation that invasion success is determined by lower parasitic pressure in newly invaded areas. Overall, the pronounced changes in fish and invertebrate communities with a dominance of alien species suggest invasional meltdown and a shift of the upper Danube River towards a novel ecosystem with species that have greater resistance to goby predation. This seems to contribute to overcoming biological resistance and improve rapidity of dispersal.	[Brandner, Joerg; Cerwenka, Alexander F.; Geist, Juergen] Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, Freising Weihenstephan, Germany; [Cerwenka, Alexander F.; Schliewen, Ulrich K.] Bavarian State Collect Zool ZSM, Dept Ichthyol, Munich, Germany	Technical University of Munich	Geist, J (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, Freising Weihenstephan, Germany.	geist@wzw.tum.de	Cerwenka, Alexander/ABF-3106-2020; Geist, Juergen/C-4933-2008	Cerwenka, Alexander/0000-0002-9393-0885; Geist, Juergen/0000-0001-7698-3443	Deutsche Forschungsgemeinschaft (DFG) [DFG GE2169/1-1 (AOBJ:569812), DFG SCHL567/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding for the study was provided by Deutsche Forschungsgemeinschaft (DFG), project numbers DFG GE2169/1-1 (AOBJ:569812) and DFG SCHL567/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; Bergstrom MA, 2008, J GREAT LAKES RES, V34, P535, DOI 10.3394/0380-1330(2008)34[535:DAAROT]2.0.CO;2; Bergstrom MA, 2009, T AM FISH SOC, V138, P1009, DOI 10.1577/T08-095.1; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Borcherding J, 2011, J APPL ICHTHYOL, V27, P153, DOI 10.1111/j.1439-0426.2010.01662.x; Brandner J, 2013, J FISH BIOL, V82, P2063, DOI 10.1111/jfb.12137; Brandner J, 2013, HYDROBIOLOGIA, V703, P113, DOI 10.1007/s10750-012-1349-9; Bronnenhuber JE, 2011, MOL ECOL, V20, P1845, DOI 10.1111/j.1365-294X.2011.05030.x; Brownscombe JW, 2013, HYDROBIOLOGIA, V707, P199, DOI 10.1007/s10750-012-1427-z; Brownscombe JW, 2012, AQUAT INVASIONS, V7, P537, DOI 10.3391/ai.2012.7.4.010; Brownscombe JW, 2012, AQUAT ECOL, V46, P175, DOI 10.1007/s10452-012-9390-3; Campbell LM, 2009, J GREAT LAKES RES, V35, P224, DOI 10.1016/j.jglr.2009.02.002; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Emde S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053218; Feiner ZS, 2012, BIOL INVASIONS, V14, P2315, DOI 10.1007/s10530-012-0231-z; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Froese R, 2013, FISHBASE; Geist J, 2011, ECOL INDIC, V11, P1507, DOI 10.1016/j.ecolind.2011.04.002; Groen M, 2012, BEHAVIOUR, V149, P685, DOI 10.1163/1568539X-00002998; Gros A, 2009, THEOR POPUL BIOL, V76, P13, DOI 10.1016/j.tpb.2009.03.002; Gutowsky LFG, 2012, FISHERIES MANAG ECOL, V19, P78, DOI 10.1111/j.1365-2400.2011.00831.x; Gutowsky LFG, 2011, HYDROBIOLOGIA, V671, P27, DOI 10.1007/s10750-011-0701-9; Gutowsky LFG, 2011, FISH RES, V108, P228, DOI 10.1016/j.fishres.2010.12.014; Haertl M, 2012, SPIXIANA, V35, P155; Harka Akos, 2007, Electronic Journal of Ichthyology, V3, P1; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Janssen J, 2001, J GREAT LAKES RES, V27, P319, DOI 10.1016/S0380-1330(01)70647-8; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; Jurajda P, 2005, J APPL ICHTHYOL, V21, P319, DOI 10.1111/j.1439-0426.2005.00688.x; Karatayev AY, 2009, BIOL INVASIONS, V11, P2009, DOI 10.1007/s10530-009-9498-0; Karlson AML, 2007, ICES J MAR SCI, V64, P479, DOI 10.1093/icesjms/fsl049; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Keller Reuben P., 2011, Environmental Sciences Europe, V23, P23, DOI 10.1186/2190-4715-23-23; Kipp R, 2012, CAN J FISH AQUAT SCI, V69, P469, DOI 10.1139/F2011-139; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kornis MS, 2010, CAN J FISH AQUAT SCI, V67, P553, DOI 10.1139/F10-002; Kovac V, 2009, J APPL ICHTHYOL, V25, P33, DOI 10.1111/j.1439-0426.2009.01189.x; KOVTUN I F, 1974, Zoologicheskii Zhurnal, V53, P728; Krakowiak PJ, 2008, J GREAT LAKES RES, V34, P675, DOI 10.3394/0380-1330-34.4.675; Marentette JR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2239, DOI 10.1007/s00265-011-1233-z; Marentette JR, 2009, J GREAT LAKES RES, V35, P302, DOI 10.1016/j.jglr.2009.01.009; Miller P.J., 1984, P119; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Moyle PB, 2007, P NATL ACAD SCI USA, V104, P5711, DOI 10.1073/pnas.0701457104; NELVA A, 1979, CR ACAD SCI D NAT, V289, P1295; Ojaveer Henn, 2006, Aquatic Invasions, V1, P44, DOI 10.3391/ai.2006.1.1.11; Olden JD, 2006, ECOL MONOGR, V76, P25, DOI 10.1890/05-0330; Ondrackova M, 2005, J APPL ICHTHYOL, V21, P345, DOI 10.1111/j.1439-0426.2005.00682.x; Ondrackova M, 2010, ECOL RES, V25, P857, DOI 10.1007/s11284-010-0716-0; Paintner Stephan, 2006, Lauterbornia, V58, P101; Panov Vadim E., 2009, Integrated Environmental Assessment and Management, V5, P110, DOI 10.1897/IEAM_2008-034.1; Pennuto CM, 2010, ECOL FRESHW FISH, V19, P206, DOI 10.1111/j.1600-0633.2010.00405.x; Persat H., 1990, P197; Piria M, 2011, AQUAT INVASIONS, V6, pS153, DOI 10.3391/ai.2011.6.S1.034; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Polacik M, 2009, ECOL FRESHW FISH, V18, P640, DOI 10.1111/j.1600-0633.2009.00383.x; Polacik M., 2008, Archiv fuer Hydrobiologie Supplement, V166, P193; Polacik M, 2012, FOLIA ZOOL, V61, P1; de Leon JLP, 2011, ECOL FRESHW FISH, V20, P243, DOI 10.1111/j.1600-0633.2011.00489.x; Poos M, 2010, BIOL INVASIONS, V12, P1269, DOI 10.1007/s10530-009-9545-x; Ray WJ, 2001, J GREAT LAKES RES, V27, P329, DOI 10.1016/S0380-1330(01)70648-X; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sapota MR, 2005, BIOL INVASIONS, V7, P157, DOI 10.1007/s10530-004-9035-0; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sindilariu PD, 2006, HYDROBIOLOGIA, V571, P51, DOI 10.1007/s10750-006-0216-y; Sokolowska E, 2011, J FISH BIOL, V78, P1993, DOI 10.1111/j.1095-8649.2011.02986.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strayer DL, 2009, FRONT ECOL ENVIRON, V7, P135, DOI 10.1890/080020; Taraborelli AC, 2010, J GREAT LAKES RES, V36, P625, DOI 10.1016/j.jglr.2010.07.011; Tarkan AS, 2006, J APPL ICHTHYOL, V22, P271, DOI 10.1111/j.1439-0426.2006.00711.x; van Riel MC, 2006, HYDROBIOLOGIA, V565, P39, DOI 10.1007/s10750-005-1904-8; Velez-Espino LA, 2010, BIOL INVASIONS, V12, P3861, DOI 10.1007/s10530-010-9777-9; Wolfe RK, 1998, J GREAT LAKES RES, V24, P731; Yamaguti S., 1963, P1; Young JAM, 2010, J GREAT LAKES RES, V36, P115, DOI 10.1016/j.jglr.2009.11.001; Zahorska E, 2013, J APPL ICHTHYOL, V29, P218, DOI 10.1111/jai.12039	84	99	99	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73036	10.1371/journal.pone.0073036	http://dx.doi.org/10.1371/journal.pone.0073036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039854	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300044
J	Enomoto, Y; Takemura, T; Hagiwara, E; Iwasawa, T; Fukuda, Y; Yanagawa, N; Sakai, F; Baba, T; Nagaoka, S; Ogura, T				Enomoto, Yasunori; Takemura, Tamiko; Hagiwara, Eri; Iwasawa, Tae; Fukuda, Yuh; Yanagawa, Noriyo; Sakai, Fumikazu; Baba, Tomohisa; Nagaoka, Shouhei; Ogura, Takashi			Prognostic Factors in Interstitial Lung Disease Associated with Primary Sjogren's Syndrome: A Retrospective Analysis of 33 Pathologically-Proven Cases	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; COLLAGEN VASCULAR-DISEASE; FIBROBLASTIC FOCI; PNEUMONIA; MORTALITY; CT; CLASSIFICATION; INVOLVEMENT; PROGRESSION; PREVALENCE	Introduction: Interstitial lung disease associated with primary Sjogren's syndrome (pSS-ILD) shows several patterns such as nonspecific interstitial pneumonia (NSIP) and usual interstitial pneumonia (UIP). Although UIP is a well-recognized prognostic determinant in idiopathic interstitial pneumonias, whether this is also the case in pSS-ILD is unclear. The objectives of this study were to evaluate the prognostic effect of UIP, and to identify the prognostic factors in pSS-ILD. Methods: A retrospective review of medical records identified 33 consecutive patients with pathologically-proven pSS-ILD. Each patient was classified into each ILD pattern by multidisciplinary analysis. Baseline clinical-radiologic-pathologic characteristics and survival rates were compared between the ILD patterns. Finally, the prognostic factors in pSS-ILD were assessed by univariate and subsequent multivariate analyses using Cox's proportional hazards regression model. Results: pSS-ILD patients were diagnosed with NSIP (n = 22) or UIP (n = 11). The median follow-up period was 110 months, and five-year survival rate was 87.3% in the total patient population. The prognosis of the UIP patients was not significantly different from that of the NSIP patients (NSIP to UIP, hazard ratio [HR]: 0.77, 95% confidence interval [CI]: 0.18-3.36, P = 0.73). Multivariate analysis identified PaCO2 (HR: 1.68 per 1 Torr increase, 95% CI: 1.24-2.28, P < 0.01), extent of reticular abnormality on high-resolution CT (HR: 4.17 per 1-grade increment, 95% CI: 1.18-14.73, P = 0.03), and severity of fibroblastic foci (HR: 9.26 per 1-grade increment, 95% CI: 1.74-49.35, P < 0.01) as prognostic factors in pSS-ILD. Conclusions: UIP in pSS-ILD was not related to poorer prognosis than NSIP. Assessment of detailed clinical-radiologic-pathologic findings is more important than distinguishing UIP to evaluate prognosis in this disease.	[Enomoto, Yasunori; Hagiwara, Eri; Baba, Tomohisa; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Takemura, Tamiko] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; [Iwasawa, Tae] Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Yokohama, Kanagawa, Japan; [Fukuda, Yuh] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan; [Yanagawa, Noriyo] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Radiol, Tokyo, Japan; [Sakai, Fumikazu] Saitama Med Univ, Saitama Int Med Ctr, Dept Diagnost Radiol, Saitama, Japan; [Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan	Kanagawa Cardiovascular & Respiratory Center; Japanese Red Cross Medical Center; University of Tokyo; Kanagawa Cardiovascular & Respiratory Center; Nippon Medical School; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Saitama Medical University	Ogura, T (corresponding author), Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan.	ogura@kanagawa-junko.jp						American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; CHERNIACK RM, 1991, AM REV RESPIR DIS, V144, P892, DOI 10.1164/ajrccm/144.4.892; Enomoto N, 2006, CHEST, V130, P22, DOI 10.1378/chest.130.1.22; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Harada T, 2013, RESPIROLOGY, V18, P278, DOI 10.1111/j.1440-1843.2012.02272.x; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; JAVAHERI S, 1992, THORAX, V47, P93, DOI 10.1136/thx.47.2.93; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kocheril SV, 2005, ARTHRIT RHEUM-ARTHR, V53, P549, DOI 10.1002/art.21322; Kokosi M, 2010, CLIN CHEST MED, V31, P489, DOI 10.1016/j.ccm.2010.05.007; Kondoh Y, 2006, RESP MED, V100, P1753, DOI 10.1016/j.rmed.2006.02.002; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Palm O, 2013, RHEUMATOLOGY, V52, P173, DOI 10.1093/rheumatology/kes311; Parambil JG, 2006, CHEST, V130, P1489, DOI 10.1378/chest.130.5.1489; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shi JH, 2009, RESPIRATION, V78, P377, DOI 10.1159/000214841; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Uffmann M, 2001, J THORAC IMAG, V16, P282, DOI 10.1097/00005382-200110000-00009; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	28	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73774	10.1371/journal.pone.0073774	http://dx.doi.org/10.1371/journal.pone.0073774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040065	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300128
J	Klink, M; Brzezinska, M; Szulc, I; Brzostek, A; Kielbik, M; Sulowska, Z; Dziadek, J				Klink, Magdalena; Brzezinska, Marta; Szulc, Izabela; Brzostek, Anna; Kielbik, Michal; Sulowska, Zofia; Dziadek, Jaroslaw			Cholesterol Oxidase Is Indispensable in the Pathogenesis of Mycobacterium tuberculosis	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; TUMOR-NECROSIS-FACTOR; NADPH OXIDASE; NITRIC-OXIDE; RECEPTOR 2; MACROPHAGE PHAGOSOMES; MONOCYTES; INFECTION; INDUCTION; PHAGOCYTOSIS	Despite considerable research effort, the molecular mechanisms of Mycobacterium tuberculosis (Mtb) virulence remain unclear. Cholesterol oxidase (ChoD), an extracellular enzyme capable of converting cholesterol to its 3-keto-4-ene derivative, cholestenone, has been proposed to play a role in the virulence of Mtb. Here, we verified the hypothesis that ChoD is capable of modifying the bactericidal and pro-inflammatory activity of human macrophages. We also sought to determine the contribution of complement receptor 3 (CR3)- and Toll-like receptor 2 (TLR2)-mediated signaling pathways in the development of macrophage responses to Mtb. We found that intracellular replication of an Mtb mutant lacking a functional choD gene (Delta choD) was less efficient in macrophages than that of the wild-type strain. Blocking CR3 and TLR2 with monoclonal antibodies enhanced survival of Delta choD inside macrophages. We also showed that, in contrast to wild-type Mtb, the Delta choD strain induced nitric oxide production in macrophages, an action that depended on the TLR2, but not the CR3, signaling pathway. Both wild-type and mutant strains inhibited the production of reactive oxygen species (ROS), but the Delta choD strain did so to a significantly lesser extent. Blocking TLR2-mediated signaling abolished the inhibitory effect of wild-type Mtb on ROS production by macrophages. Wild-type Mtb, but not the Delta choD strain, decreased phorbol myristate acetate-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), which are involved in both TLR2- and CR3-mediated signaling pathways. Our finding also revealed that the production of interleukin 10 by macrophages was significantly lower in Delta choD-infected macrophages than in wild-type Mtb-infected macrophages. However, tumor necrosis factor-alpha production by macrophages was the same after infection with mutant or wild-type strains. In summary, we demonstrate here that ChoD is required for Mtb interference with the TLR2-mediated signaling pathway and subsequent intracellular growth and survival of the pathogen in human macrophages.	[Klink, Magdalena; Brzezinska, Marta; Szulc, Izabela; Brzostek, Anna; Kielbik, Michal; Sulowska, Zofia; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Klink, Magdalena/U-1953-2019	Kielbik, Michal/0000-0002-6211-8288; Szulc-Kielbik, Izabela/0000-0003-1290-697X; Dziadek, Jaroslaw/0000-0003-1427-884X; Klink, Magdalena/0000-0002-9870-7391	European Regional Development Fund under the Operational Programme Innovative Economy [POIG.01.01.02-10-107/09]	European Regional Development Fund under the Operational Programme Innovative Economy	The research was financed by a grant from the European Regional Development Fund (POIG.01.01.02-10-107/09) under the Operational Programme Innovative Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bonar A, 2005, ARCH IMMUNOL THER EX, V53, P437; Brzezinska M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-43; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Brzostek A, 2013, J STEROID BIOCHEM, V134, P1, DOI 10.1016/j.jsbmb.2012.09.028; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 2003, BIOCHEMISTRY-US, V42, P4520, DOI 10.1021/bi0205754; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Gan L, 2010, MOL IMMUNOL, V47, P1278, DOI 10.1016/j.molimm.2009.12.004; Gorudko IV, 2011, ARCH BIOCHEM BIOPHYS, V516, P173, DOI 10.1016/j.abb.2011.10.013; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Jacobs M, 2007, MICROBES INFECT, V9, P623, DOI 10.1016/j.micinf.2007.02.002; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jo EK, 2008, CURR OPIN INFECT DIS, V21, P279, DOI 10.1097/QCO.0b013e3282f88b5d; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kreit J, 2009, FEBS J, V276, P6844, DOI 10.1111/j.1742-4658.2009.07378.x; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; Lee Ji-Sook, 2009, Immune Netw, V9, P192, DOI 10.4110/in.2009.9.5.192; Madan-Lala R, 2011, INFECT IMMUN, V79, P4828, DOI 10.1128/IAI.05574-11; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Nguyen DH, 2003, EXP CELL RES, V291, P36, DOI 10.1016/S0014-4827(03)00345-8; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Raja A, 2004, INDIAN J MED RES, V120, P213; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Rivero-Lezcano OM, 2010, CLIN EXP IMMUNOL, V162, P289, DOI 10.1111/j.1365-2249.2010.04168.x; Rooyakkers AWJ, 2005, MICROB PATHOGENESIS, V39, P57, DOI 10.1016/j.micpath.2005.05.001; Schafer G, 2009, J INNATE IMMUN, V1, P231, DOI 10.1159/000173703; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Surewicz K, 2004, CELL IMMUNOL, V228, P34, DOI 10.1016/j.cellimm.2004.03.007; Thomas ST, 2011, J BIOL CHEM, V286, P43668, DOI 10.1074/jbc.M111.313643; Tiwari RL, 2011, J IMMUNOL, V187, P2632, DOI 10.4049/jimmunol.1002526; Uhia I, 2011, ENVIRON MICROBIOL, V13, P943, DOI 10.1111/j.1462-2920.2010.02398.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8; Vrielink A, 2010, SUBCELL BIOCHEM, V51, P137, DOI 10.1007/978-90-481-8622-8_5; Welin A, 2012, TUBERCULOSIS, V92, P113, DOI 10.1016/j.tube.2011.09.009; Xiong Y, 2005, J PROTEOME RES, V4, P855, DOI 10.1021/pr0500049; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yang XX, 2011, J BACTERIOL, V193, P1473, DOI 10.1128/JB.01210-10; Yoshida A, 2009, ANTICANCER RES, V29, P907	54	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73333	10.1371/journal.pone.0073333	http://dx.doi.org/10.1371/journal.pone.0073333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039915	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300065
J	Niogret, J; Epsky, ND; Schnell, RJ; Boza, EJ; Kendra, PE; Heath, RR				Niogret, Jerome; Epsky, Nancy D.; Schnell, Raymond J.; Boza, Edward J.; Kendra, Paul E.; Heath, Robert R.			Terpenoid Variations within and among Half-Sibling Avocado Trees, Persea americana Mill. (Lauraceae)	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE SCOLYTINAE; REDBAY AMBROSIA BEETLE; XYLEBORUS-GLABRATUS; BARK BEETLE; OIL CELLS; MICROSATELLITE MARKERS; PITYOGENES-BIDENTATUS; PATERNITY INFERENCE; VOLATILE EMISSIONS; PHOEBE OIL	Chemical analyses were conducted to determine the qualitative and quantitative differences in monoterpenes and sesquiterpenes in plant material from avocado trees, Persea americana Mill. (Lauraceae). The initial study analyzed plant material sampled from the trunk to the leaves through different branch diameters to quantify proximo-distal spatial differences within a tree. All trees were seedlings initiated from a single maternal tree. Two-way analysis of variance was conducted on 34 chemicals that comprised at least 3% of the total chemical content of at least one tree and/or location within a tree. There were significant interactions between genotype and location sampled for most chemicals. Parentage analysis using microsatellite molecular markers (SSR's) determined that the four trees had three fathers and that they represented two full-siblings and two half-sibling trees. Descriptive discriminant analysis found that both genotype and location within a tree could be separated based on chemical content, and that the chemical content from full-siblings tended to be more similar than chemical content from half-siblings. To further explore the relationship between genetic background and chemical content, samples were analyzed from leaf material from 20 trees that included two sets of full-sibling seedling trees, the maternal tree and the surviving paternal tree. Descriptive discriminant analysis found good separation between the two full-sibling groups, and that the separation was associated with chemistry of the parental trees. Six groups of chemicals were identified that explained the variation among the trees. We discuss the results in relation to the discrimination process used by wood-boring insects for site-selection on host trees, for tree selection among potential host trees, and the potential use of terpenoid chemical content in chemotaxonomy of avocado trees.	[Niogret, Jerome; Epsky, Nancy D.; Schnell, Raymond J.; Boza, Edward J.; Kendra, Paul E.; Heath, Robert R.] ARS, USDA, Subtrop Hort Res Stn, Miami, FL USA	United States Department of Agriculture (USDA)	Epsky, ND (corresponding author), ARS, USDA, Subtrop Hort Res Stn, Miami, FL USA.	Nancy.Epsky@ars.usda.gov			USDA	USDA(United States Department of Agriculture (USDA))	Funding was provided by USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-106; Agrell J, 2000, OIKOS, V88, P259, DOI 10.1034/j.1600-0706.2000.880204.x; BAAS P, 1985, ISRAEL J BOT, V34, P167; BEJER AB, 1979, UGESKR JORDBR, V16, P395; Berenbaum May R., 1992, P415; Borrone JW, 2008, J AM SOC HORTIC SCI, V133, P255, DOI 10.21273/JASHS.133.2.255; Bowers MD, 1993, ECOLOGY, V74, P1178; Brenes-Arguedas T, 2005, OIKOS, V108, P410, DOI 10.1111/j.0030-1299.2005.13473.x; Byers JA, 2004, NATURWISSENSCHAFTEN, V91, P215, DOI 10.1007/s00114-004-0520-1; Byers JA, 2000, NATURWISSENSCHAFTEN, V87, P503, DOI 10.1007/s001140050768; Byers John A., 1995, P154; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; Chu QingGang, 1999, Acta Phytotaxonomica Sinica, V37, P529; Crook DJ, 2008, ENVIRON ENTOMOL, V37, P356, DOI 10.1603/0046-225X(2008)37[356:DOAHSL]2.0.CO;2; Dekle GW, 1968, FLORIDA DEP AGR DIVI, V8, P1; Delphia CM, 2009, INT J PLANT SCI, V170, P12, DOI 10.1086/593039; DICKENS JC, 1984, J CHEM ECOL, V10, P1759, DOI 10.1007/BF00987360; Dunlop PJ, 1997, AUST J BOT, V45, P1, DOI 10.1071/BT96061; Geng SL, 2012, PLANT PROD SCI, V15, P1, DOI 10.1626/pps.15.1; Gershenzon J., 1992, HERBIVORES THEIR INT, VVolume 1, P165; Hanula JL, 2008, ENVIRON ENTOMOL, V37, P1403, DOI 10.1603/0046-225X-37.6.1403; HUBERTY CJ, 1984, PSYCHOL BULL, V95, P156, DOI 10.1037/0033-2909.95.1.156; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kariyat RR, 2012, ECOL LETT, V15, P301, DOI 10.1111/j.1461-0248.2011.01738.x; Kendra PE, 2012, J ECON ENTOMOL, V105, P659, DOI 10.1603/EC11398; Kendra PE, 2011, J CHEM ECOL, V37, P932, DOI 10.1007/s10886-011-9998-0; Kendra PE, 2013, FUTURE FORESTS AM J, V4, P727; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; LANGENHEIM JH, 1983, BIOCHEM SYST ECOL, V11, P97, DOI 10.1016/0305-1978(83)90006-6; Lou YG, 2006, J CHEM ECOL, V32, P2375, DOI 10.1007/s10886-006-9151-7; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1217, DOI 10.1007/BF02228321; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McCaskill D, 1997, Adv Biochem Eng Biotechnol, V55, P107; McClanahan HS, 1951, FLORIDA STATE PLANT, V18, P41; METCALFE CR, 1983, ANATOMY DICOTYLEDONS, V2, P64; Miller J.R., 1984, P127; MORTON JF, 1987, FRUITS WARM CLIMATES, P91; Niogret J, 2011, FLA ENTOMOL, V94, P1010, DOI 10.1653/024.094.0439; Niogret J, 2011, J CHEM ECOL, V37, P483, DOI 10.1007/s10886-011-9953-0; PHILLIPS P. A., 2010, UC ANR PUBLICATION, V3436; PLATT KA, 1992, INT J PLANT SCI, V153, P301, DOI 10.1086/297033; Poland T. M., 1998, Journal of the Entomological Society of British Columbia, V95, P17; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Schnell RJ, 2003, J AM SOC HORTIC SCI, V128, P881, DOI 10.21273/JASHS.128.6.0881; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Scora RW, 1992, P 2 WORLD AV C, V2, P505; Sharon D, 1997, THEOR APPL GENET, V95, P911, DOI 10.1007/s001220050642; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Thoss V, 2006, CHEMOECOLOGY, V16, P51, DOI 10.1007/s00049-005-0331-7; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Weaver DH, 2009, J ECON ENTOMOL, V102, P1009, DOI 10.1603/029.102.0320; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500; Zhang QH, 1999, J CHEM ECOL, V25, P1923, DOI 10.1023/A:1020994119019; 初庆刚, 1998, 西北植物学报, V18, P356	56	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73601	10.1371/journal.pone.0073601	http://dx.doi.org/10.1371/journal.pone.0073601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039994	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300097
J	Li, LF; Zeng, H; Hou, XW; He, XC; Chen, JX				Li, Lanfang; Zeng, Heng; Hou, Xuwei; He, Xiaochen; Chen, Jian-Xiong			Myocardial Injection of Apelin-Overexpressing Bone Marrow Cells Improves Cardiac Repair via Upregulation of Sirt3 after Myocardial Infarction	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; TOPCARE-AMI; HEART; GENE; NEOVASCULARIZATION; ANGIOGENESIS; INJURY; TRANSPLANTATION; DEACETYLATION; EXPRESSION	Our previous study shows that treatment with apelin increases bone marrow cells (BMCs) recruitment and promotes cardiac repair after myocardial infarction (MI). The objective of this study was to investigate whether overexpression of apelin in BMCs improved cell therapy and accelerated cardiac repair and functional recovery in post-MI mice. Mouse myocardial infarction was achieved by coronary artery ligation and BMCs overexpressing apelin (apelin-BMCs) or GFP (GFP-BMCs) were injected into ischemic area immediately after surgery. In vitro, exposure of cultured BMCs to apelin led to a gradual increase in SDF-1a and CXCR4 expression. Intramyocardial delivery of apelin-BMCs in post-MI mice resulted in a significant increase number of APJ(+)/c-kit(+)/Sca1(+) cells in the injected area compared to GFP-BMCs treated post-MI mice. Treatment with apelin-BMCs increased expression of VEGF, Ang-1 and Tie-2 in post-MI mice. Apelin-BMCs treatment also significantly increased angiogenesis and attenuated cardiac fibrosis formation in post-MI mice. Most importantly, treatment with apelin-BMCs significantly improved left ventricular (LV) systolic function in post-MI mice. Mechanistically, Apelin-BMCs treatment led to a significant increase in Sirtuin3 (Sirt3) expression and reduction of reactive oxygen species (ROS) formation. Treatment of cultured BMCs with apelin also increased Notch3 expression and Akt phosphorylation. Apelin treatment further attenuated stress-induced apoptosis whereas knockout of Sirt3 abolished anti-apoptotic effect of apelin in cultured BMCs. Moreover, knockout of Sirt3 significantly attenuated apelin-BMCs-induced VEGF expression and angiogenesis in post-MI mice. Knockout of Sirt3 further blunted apelin-BMCs-mediated improvement of cardiac repair and systolic functional recovery in post-MI mice. These data suggest that apelin improves BMCs therapy on cardiac repair and systolic function in post-MI mice. Upregulation of Sirt3 may contribute to the protective effect of apelin-BMCs therapy.	[Li, Lanfang; Zeng, Heng; Hou, Xuwei; He, Xiaochen; Chen, Jian-Xiong] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Chen, JX (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	JChen3@umc.edu	He, Xiaochen/ABA-9590-2021; He, Xiaochen/ABA-8102-2021	He, Xiaochen/0000-0002-8266-5895	National Institutes of Health [HL102042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health, grant HL102042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2012, EUR HEART J, V33, P1911, DOI 10.1093/eurheartj/ehr388; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Gao LAR, 2010, CELL TRANSPLANT, V19, P949, DOI 10.3727/096368910X504450; Gao LR, 2009, CELL TRANSPLANT, V18, P1311, DOI 10.3727/096368909X474843; Hu CH, 2010, CLIN EXP PHARMACOL P, V37, P551, DOI 10.1111/j.1440-1681.2010.05347.x; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Kleinz MJ, 2008, REGUL PEPTIDES, V146, P271, DOI 10.1016/j.regpep.2007.10.002; Li LF, 2012, AM J PHYSIOL-HEART C, V303, pH605, DOI 10.1152/ajpheart.00366.2012; Li LX, 2002, ARTERIOSCL THROM VAS, V22, P249, DOI 10.1161/hq0202.104124; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Przyklenk K, 2011, AUTOPHAGY, V7, P432, DOI 10.4161/auto.7.4.14395; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sack MN, 2012, J MOL CELL CARDIOL, V52, P520, DOI 10.1016/j.yjmcc.2011.11.004; Sack MN, 2011, AM J PHYSIOL-HEART C, V301, pH2191, DOI 10.1152/ajpheart.00199.2011; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Simpkin JC, 2007, BASIC RES CARDIOL, V102, P518, DOI 10.1007/s00395-007-0671-2; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0273-5; Tempel D, 2012, CIRC RES, V111, P585, DOI 10.1161/CIRCRESAHA.111.262097; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Wojakowski W, 2005, FOLIA HISTOCHEM CYTO, V43, P229; Yoon YS, 2004, MOL CELL BIOCHEM, V264, P63, DOI 10.1023/B:MCBI.0000044375.33928.62; Zeng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035905; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010; Zeng XJ, 2012, STEM CELL RES, V8, P357, DOI 10.1016/j.scr.2011.12.004	37	50	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e71041	10.1371/journal.pone.0071041	http://dx.doi.org/10.1371/journal.pone.0071041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039710	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500004
J	Pocanschi, CL; Ehsani, S; Mehrabian, M; Wille, H; Reginold, W; Trimble, WS; Wang, HS; Yee, A; Arrowsmith, CH; Bozoky, Z; Kay, LE; Forman-Kay, JD; Rini, JM; Schmitt-Ulms, G				Pocanschi, Cosmin L.; Ehsani, Sepehr; Mehrabian, Mohadeseh; Wille, Holger; Reginold, William; Trimble, William S.; Wang, Hansen; Yee, Adelinda; Arrowsmith, Cheryl H.; Bozoky, Zoltan; Kay, Lewis E.; Forman-Kay, Julie D.; Rini, James M.; Schmitt-Ulms, Gerold			The ZIP5 Ectodomain Co-Localizes with PrP and May Acquire a PrP-Like Fold That Assembles into a Dimer	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; ZINC-TRANSPORTER; ESCHERICHIA-COLI; EXPRESSION; SYSTEM; LOCALIZATION; TRAFFICKING; TRANSITION; ZEBRAFISH; SCRAPIE	The cellular prion protein (PrPC) was recently observed to co-purify with members of the LIV-1 subfamily of ZIP zinc transporters (LZTs), precipitating the surprising discovery that the prion gene family descended from an ancestral LZT gene. Here, we compared the subcellular distribution and biophysical characteristics of LZTs and their PrP-like ectodomains. When expressed in neuroblastoma cells, the ZIP5 member of the LZT subfamily was observed to be largely directed to the same subcellular locations as PrPC and both proteins were seen to be endocytosed through vesicles decorated with the Rab5 marker protein. When recombinantly expressed, the PrP-like domain of ZIP5 could be obtained with yields and levels of purity sufficient for structural analyses but it tended to aggregate, thereby precluding attempts to study its structure. These obstacles were overcome by moving to a mammalian cell expression system. The subsequent biophysical characterization of a homogeneous preparation of the ZIP5 PrP-like ectodomain shows that this protein acquires a dimeric, largely globular fold with an alpha-helical content similar to that of mammalian PrPC. The use of a mammalian cell expression system also allowed for the expression and purification of stable preparations of Takifugu rubripes PrP-1, thereby overcoming a key hindrance to high-resolution work on a fish PrPC.	[Pocanschi, Cosmin L.; Ehsani, Sepehr; Mehrabian, Mohadeseh; Reginold, William; Wang, Hansen; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ehsani, Sepehr; Mehrabian, Mohadeseh; Reginold, William; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Wille, Holger] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Wille, Holger] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Trimble, William S.; Bozoky, Zoltan; Kay, Lewis E.; Forman-Kay, Julie D.; Rini, James M.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Yee, Adelinda; Arrowsmith, Cheryl H.] Struct Genom Consortium, Toronto, ON, Canada; [Bozoky, Zoltan; Kay, Lewis E.; Forman-Kay, Julie D.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Kay, Lewis E.; Rini, James M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	wang, hansen/I-2510-2019; Ehsani, Sepehr/E-9257-2010; Wille, Holger/C-2280-2008	wang, hansen/0000-0003-4414-3372; Ehsani, Sepehr/0000-0002-9613-6898; Wille, Holger/0000-0001-5102-8706; Forman-Kay, Julie/0000-0001-8265-972X; Arrowsmith, Cheryl/0000-0002-4971-3250	PrioNet Canada High Impact operating grant; Canadian Institutes of Health Research; Alberta Prion Research Institute; Natural Sciences and Engineering Research Council of Canada; W. Garfield Weston Foundation	PrioNet Canada High Impact operating grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); W. Garfield Weston Foundation	Work on this project was supported by a PrioNet Canada High Impact operating grant (GS) and the Canadian Institutes of Health Research (GS/JMR). HW acknowledges generous support from an Alberta Prion Research Institute start-up award. CHA was supported by the Natural Sciences and Engineering Research Council of Canada. GS received generous support from the W. Garfield Weston Foundation. Note that funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Caputo A, 2010, BIOCHEM J, V425, P341, DOI 10.1042/BJ20091050; Christen B, 2008, FEBS J, V275, P263, DOI 10.1111/j.1742-4658.2007.06196.x; Davies P, 2008, BIOCHEM J, V410, P237, DOI 10.1042/BJ20071477; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Ehsani S, 2012, J MOL BIOL, V422, P556, DOI 10.1016/j.jmb.2012.06.003; Ehsani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026800; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Fujita K, 2000, BIOCHEM BIOPH RES CO, V267, P134, DOI 10.1006/bbrc.1999.1963; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Lichten LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021526; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu H, 1999, BIOCHEMISTRY-US, V38, P5362, DOI 10.1021/bi982878x; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Pawan K, 2007, BBA-GENE STRUCT EXPR, V1769, P117, DOI 10.1016/j.bbaexp.2006.12.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prusiner SB, 1998, P NATL ACAD SCI USA, V117, P421; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Roberts RL, 1999, J CELL SCI, V112, P3667; Salta E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006175; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Syed M, 2011, PRION, V5, P88, DOI 10.4161/pri.5.2.16093; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Wan JY, 2010, MOL BIOL REP, V37, P2295, DOI 10.1007/s11033-009-9722-0; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Weaver BP, 2012, BIOMETALS, V25, P319, DOI 10.1007/s10534-011-9508-4; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	44	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72446	10.1371/journal.pone.0072446	http://dx.doi.org/10.1371/journal.pone.0072446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039764	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500018
J	Van Opzeeland, I; Van Parijs, S; Kindermann, L; Burkhardt, E; Boebel, O				Van Opzeeland, Ilse; Van Parijs, Sofie; Kindermann, Lars; Burkhardt, Elke; Boebel, Olaf			Calling in the Cold: Pervasive Acoustic Presence of Humpback Whales (Megaptera novaeangliae) in Antarctic Coastal Waters	PLOS ONE			English	Article							SEASONAL VARIABILITY; BALEEN WHALES; WESTERN; ICE; MIGRATION; BEHAVIOR; SONGS; GULF; BLUE	Humpback whales migrate between relatively unproductive tropical or temperate breeding grounds and productive high latitude feeding areas. However, not all individuals of a population undertake the annual migration to the breeding grounds; instead some are thought to remain on the feeding grounds year-round, presumably to avoid the energetic demands of migration. In the Southern Hemisphere, ice and inclement weather conditions restrict investigations of humpback whale presence on feeding grounds as well as the extent of their southern range. Two years of near-continuous recordings from the PerenniAL Acoustic Observatory in the Antarctic Ocean (PALAOA, Ekstrom Iceshelf, 70 degrees 31'S, 8 degrees 13'W) are used to explore the acoustic presence of humpback whales in an Antarctic coastal area. Humpback whale calls were present during nine and eleven months of 2008 and 2009, respectively. In 2008, calls were present in January through April, June through August, November and December, whereas in 2009, calls were present throughout the year, except in September. Calls occurred in un-patterned sequences, representing non-song sound production. Typically, calls occurred in bouts, ranging from 2 to 42 consecutive days with February, March and April having the highest daily occurrence of calls in 2008. In 2009, February, March, April and May had the highest daily occurrence of calls. Whales were estimated to be within a 100 km radius off PALAOA. Calls were also present during austral winter when ice cover within this radius was >90%. These results demonstrate that coastal areas near the Antarctic continent are likely of greater importance to humpback whales than previously assumed, presumably providing food resources year-round and open water in winter where animals can breathe.	[Van Opzeeland, Ilse; Kindermann, Lars; Burkhardt, Elke; Boebel, Olaf] Alfred Wegener Inst Polar & Marine Res, Ocean Acoust Lab, Bremerhaven, Germany; [Van Parijs, Sofie] Northeast Fisheries Sci Ctr, Woods Hole, MA USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Van Opzeeland, I (corresponding author), Alfred Wegener Inst Polar & Marine Res, Ocean Acoust Lab, Bremerhaven, Germany.	ilse.van.opzeeland@awi.de			Bremerhavener Gesellschaft fur Innovationsforderung und Stadtentwicklung (BIS)	Bremerhavener Gesellschaft fur Innovationsforderung und Stadtentwicklung (BIS)	Design and implementation of the PALAOA observatory was partly funded by the Bremerhavener Gesellschaft fur Innovationsforderung und Stadtentwicklung (BIS). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Best PB, 2007, WHALES AOLPHINS SO A; Boebel O., 2006, EOS T AGU, V87, P361, DOI [10.1029/2006EO360002., DOI 10.1029/2006EO360002]; BROWN MR, 1995, P ROY SOC B-BIOL SCI, V259, P229, DOI 10.1098/rspb.1995.0034; CLAPHAM PJ, 1993, CAN J ZOOL, V71, P440, DOI 10.1139/z93-063; Clapham PJ, 2002, MAMMAL REV, V29, P37; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; D'Vincent C.G., 1985, SCI REP WHALES RES I, V36, P41; D'Vincent CG, 1985, PLOS ONE, V36, P41; Dalla Rosa L, 2008, POLAR BIOL, V31, P771, DOI 10.1007/s00300-008-0415-2; Darling JD, 2005, MAR MAMMAL SCI, V21, P557, DOI 10.1111/j.1748-7692.2005.tb01249.x; Dawbin W. H., 1997, Memoirs of the Queensland Museum, V42, P105; Dunlop RA, 2008, MAR MAMMAL SCI, V24, P613, DOI 10.1111/j.1748-7692.2008.00208.x; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; Figueroa H, 2012, XBAT EXTENSIBLE BIOA; FREEMAN M M R, 1968, Canadian Field-Naturalist, V82, P276; GEBCO, 2003, PLOS ONE; GEBCO, 2003, GEBCO DIG ATL PUBL B; Gill PC, 1997, POLAR BIOL, V17, P401, DOI 10.1007/s003000050134; Ingebrigtsen A, 1929, ICES REP, V56, P3; International Whaling Commission (IWC), 1998, REP INT WHAL COMMN, V48, P170; KELLOGG REMINGTON, 1929, SMITHSONIAN INST ANN REPT BOARD OF REGENTS, V1928, P467; Kindermann L, 2012, ACOUSTIC RECORDS UND, DOI [10.1594/PANGAEA.774290, DOI 10.1594/PANGAEA.774290]; Lockyer C., 1984, REP INT WHAL COMMN S, V6, P27; Mackintosh N. A., 1956, Norsk Hvalfangsttidende Sandefjord, V45, P469; MARSCHALL HP, 1988, POLAR BIOL, V9, P129, DOI 10.1007/BF00442041; Massom RA, 2001, ANN GLACIOL, V33, P391, DOI 10.3189/172756401781818518; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; PIATT JF, 1989, CAN J ZOOL, V67, P1523, DOI 10.1139/z89-217; Porsild MP, 1918, GEOGR REV, V6, P215, DOI 10.2307/207815; Rayner G. W., 1940, Discovery Reports Cambridge, V19, P245; RIBIC CA, 1991, ANTARCT SCI, V3, P181, DOI 10.1017/S0954102091000214; Rosenbaum HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007318; Scheidat M, 2008, ANN SCI C HAL CAN 22; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; Stafforda KM, 2007, J ACOUST SOC AM, V122, P3378, DOI 10.1121/1.2799905; Stevick PT, 2003, J ZOOL, V259, P231, DOI 10.1017/S0952836902003151; Straley J.M., 1990, Reports of the International Whaling Commission Special Issue, P319; SWINGLE WM, 1993, MAR MAMMAL SCI, V9, P309, DOI 10.1111/j.1748-7692.1993.tb00458.x; TAYLOR R. J. F., 1957, PROC ZOOL SOC LONDON, V129, P325; Thiele D, 2004, DEEP-SEA RES PT II, V51, P2311, DOI 10.1016/j.dsr2.2004.07.007; THOMPSON PO, 1986, J ACOUST SOC AM, V80, P735, DOI 10.1121/1.393947; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Valsecchi E, 2010, MAR ECOL PROG SER, V398, P275, DOI 10.3354/meps08280; Van Opzeeland, 2010, REPORTS POLAR MARINE; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Wendler G, 1997, ATMOS RES, V45, P55, DOI 10.1016/S0169-8095(97)00024-0; Williamson G. R., 1961, Norsk Hvalfangsttidende Sandefjord, V50, P335	52	40	46	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73007	10.1371/journal.pone.0073007	http://dx.doi.org/10.1371/journal.pone.0073007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039844	Green Submitted, gold, Green Published			2022-12-25	WOS:000324856500031
J	Almirall, J; Bolibar, I; Serra-Prat, M; Palomera, E; Roig, J; Hospital, I; Carandell, E; Agusti, M; Ayuso, P; Estela, A; Torres, A				Almirall, Jordi; Bolibar, Ignasi; Serra-Prat, Mateu; Palomera, Elisabet; Roig, Jordi; Hospital, Imma; Carandell, Eugenia; Agusti, Merce; Ayuso, Pilar; Estela, Andreu; Torres, Antoni		Community-Acquired Pneumonia Catal	Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RISK-FACTORS; SALMETEROL/FLUTICASONE PROPIONATE; CORTICOSTEROID USE; EXACERBATIONS; FLUTICASONE; POPULATION; SALMETEROL; COPD	Background: The role of inhaled steroids in patients with chronic respiratory diseases is a matter of debate due to the potential effect on the development and prognosis of community-acquired pneumonia (CAP). We assessed whether treatment with inhaled steroids in patients with chronic bronchitis, COPD or asthma and CAP may affect early outcome of the acute pneumonic episode. Methods: Over 1-year period, all population-based cases of CAP in patients with chronic bronchitis, COPD or asthma were registered. Use of inhaled steroids were registered and patients were followed up to 30 days after diagnosis to assess severity of CAP and clinical course (hospital admission, ICU admission and mortality). Results: Of 473 patients who fulfilled the selection criteria, inhaled steroids were regularly used by 109 (23%). In the overall sample, inhaled steroids were associated with a higher risk of hospitalization (OR=1.96, p = 0.002) in the bivariate analysis, but this effect disappeared after adjusting by other severity-related factors (adjusted OR=1.08, p=0.787). This effect on hospitalization also disappeared when considering only patients with asthma (OR=1.38, p=0.542), with COPD alone (OR=4.68, p=0.194), but a protective effect was observed in CB patients (OR=0.15, p=0.027). Inhaled steroids showed no association with ICU admission, days to clinical recovery and mortality in the overall sample and in any disease subgroup. Conclusions: Treatment with inhaled steroids is not a prognostic factor in COPD and asthmatic patients with CAP, but could prevent hospitalization for CAP in patients with clinical criteria of chronic bronchitis.	[Almirall, Jordi] Univ Autonoma Barcelona, CIBERES, Crit Care Unit, E-08193 Barcelona, Spain; [Bolibar, Ignasi] Univ Autonoma Barcelona, Ciber Epidemiol & Salud Publ, Inst Biomed Res IIB St Pau Barcelona, Dept Clin Epidemiol & Publ Hlth, E-08193 Barcelona, Spain; [Serra-Prat, Mateu; Palomera, Elisabet] Hosp Mataro, CIBEREHD, Res Unit, Barcelona, Spain; [Roig, Jordi] Hosp Nostra Senyora Meritxell, Principat Dandorra, Spain; [Hospital, Imma; Agusti, Merce] Inst Catala Salut, Basrcelona, Spain; [Carandell, Eugenia; Estela, Andreu] IB SALUT Balears, Palma de Mallorca, Spain; [Ayuso, Pilar] INSALUD, Valencia, Spain; [Torres, Antoni] Univ Autonoma Barcelona, CIBERES, Hosp Clin Barcelona, IDIBAPS,Inst Clin Torax,Serv Pneumol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Almirall, J (corresponding author), Univ Autonoma Barcelona, CIBERES, Crit Care Unit, E-08193 Barcelona, Spain.	jalmirall@csdm.cat	Torres, Antoni/H-6128-2017; Roig, Jordi/W-4773-2019; Almirall, Jordi/H-6850-2013	Torres, Antoni/0000-0002-8643-2167; Roig, Jordi/0000-0002-5593-7090; Almirall, Jordi/0000-0002-3821-4341; Carandell, Eugenia/0000-0001-7210-2776; PALOMERA FANEGAS, ELISABET/0000-0002-4384-5746; Serra-Prat, Mateu/0000-0002-6554-9913; Arranz, Javier/0000-0003-0728-9751	Fondo de Investigaciones Sanitarias [99/0002-01]; CIBER de Respiratorio, Madrid, Spain [06/06/0028]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBER de Respiratorio, Madrid, Spain	This work was supported by a grant (99/0002-01) from Fondo de Investigaciones Sanitarias and CIBER de Respiratorio (06/06/0028), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; ALMIRALL J, 1991, MED CLIN-BARCELONA, V97, P250; Almirall J, 2010, EUR RESPIR J, V36, P1080, DOI 10.1183/09031936.00022909; ANTO JM, 1995, MED CLIN-BARCELONA, V104, P487; AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; de Molina RM, 2010, EUR RESPIR J, V36, P751, DOI 10.1183/09031936.00077509; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Farr BM, 2000, RESP MED, V94, P422, DOI 10.1053/rmed.1999.0743; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Nannini LJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829; OSEASOHN R, 1978, AM REV RESPIR DIS, V117, P1003; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Singanayagam A, 2010, QJM-INT J MED, V103, P379, DOI 10.1093/qjmed/hcq023; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; van Overveld FJ, 2003, EUR J PHARMACOL, V477, P261, DOI 10.1016/S0014-2999(03)02153-8; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; WOODHEAD MA, 1987, LANCET, V1, P671	22	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73271	10.1371/journal.pone.0073271	http://dx.doi.org/10.1371/journal.pone.0073271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039899	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600061
J	Ghasemi, M; Rahgozar, M; Bidkhori, G; Masoudi-Nejad, A				Ghasemi, Mahdieh; Rahgozar, Maseud; Bidkhori, Gholamreza; Masoudi-Nejad, Ali			C-element: A New Clustering Algorithm to Find High Quality Functional Modules in PPI Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PROTEIN COMPLEXES	Graph clustering algorithms are widely used in the analysis of biological networks. Extracting functional modules in protein-protein interaction (PPI) networks is one such use. Most clustering algorithms whose focuses are on finding functional modules try either to find a clique like sub networks or to grow clusters starting from vertices with high degrees as seeds. These algorithms do not make any difference between a biological network and any other networks. In the current research, we present a new procedure to find functional modules in PPI networks. Our main idea is to model a biological concept and to use this concept for finding good functional modules in PPI networks. In order to evaluate the quality of the obtained clusters, we compared the results of our algorithm with those of some other widely used clustering algorithms on three high throughput PPI networks from Sacchromyces Cerevisiae, Homo sapiens and Caenorhabditis elegans as well as on some tissue specific networks. Gene Ontology (GO) analyses were used to compare the results of different algorithms. Each algorithm's result was then compared with GO-term derived functional modules. We also analyzed the effect of using tissue specific networks on the quality of the obtained clusters. The experimental results indicate that the new algorithm outperforms most of the others, and this improvement is more significant when tissue specific networks are used.	[Ghasemi, Mahdieh; Bidkhori, Gholamreza; Masoudi-Nejad, Ali] Univ Tehran, Lab Syst Biol & Bioinformat LBB, Inst Biochem & Biophys, Tehran, Iran; [Ghasemi, Mahdieh; Rahgozar, Maseud] Univ Tehran, Coll Engn, Sch Elect & Comp Engn, Database Res Grp DBRG,CIPCE, Tehran, Iran	University of Tehran; University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Lab Syst Biol & Bioinformat LBB, Inst Biochem & Biophys, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Rahgozar, Maseud/L-1441-2018; Masoudi-Nejad, Ali/ABH-2078-2021	Rahgozar, Maseud/0000-0002-0836-2642; 				Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Altaf-Ul-Amin M, 2012, PARTITIONING PPI NET; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashwini P, 2005, BMC BIOINFORMATICS, P6; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Blondel VD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036114; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Corban R, 2010, BMC BIOINFORMATICS, P11; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; HAGE P, 1995, SOC NETWORKS, V17, P57, DOI 10.1016/0378-8733(94)00248-9; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Jiang P, 2010, BIOINFORMATICS, V26, P1105, DOI 10.1093/bioinformatics/btq078; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Li M, 2008, INT CONF BIOMED, P3, DOI 10.1109/BMEI.2008.121; Magger O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002690; MOSTELLE.F, 1968, J AM STAT ASSOC, V63, P1, DOI 10.2307/2283825; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Patil A, 2011, NUCLEIC ACIDS RES, V39, pD744, DOI 10.1093/nar/gkq897; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Rhrissorrakrai K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-192; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Song X., 2007, P 16 ACM C C INF KNO, P971, DOI DOI 10.1145/1321440.1321588; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Valente TW, 1998, SOC NETWORKS, V20, P89, DOI 10.1016/S0378-8733(97)00007-5; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang A, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, P1, DOI 10.1017/CBO9780511626593	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72366	10.1371/journal.pone.0072366	http://dx.doi.org/10.1371/journal.pone.0072366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039752	Green Published, gold			2022-12-25	WOS:000324481600023
J	Rocha, MC; Pousinha, PA; Correia, AM; Sebastiao, AM; Ribeiro, JA				Rocha, Mariana C.; Pousinha, Paula A.; Correia, Alexandra M.; Sebastiao, Ana M.; Ribeiro, Joaquim A.			Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; MUTANT SOD1; NEUROTRANSMITTER RELEASE; ACETYLCHOLINE-RELEASE; NERVE-TERMINALS; BOTULINUM TOXIN; SKELETAL-MUSCLE; UNIT LOSS; WILD-TYPE	Amyotrophic lateral sclerosis is characterized by a progressive degeneration of the corticospinal tract motor neurons. Growing evidence suggests that degeneration may begin at the distal axon proceeding in a dying-back pattern. It seemed therefore of interest to investigate synaptic transmission at the neuromuscular junction (NMJ) in pre- and symptomatic phases of the disease. Endplate potentials (EPPs), miniatures endplate potentials (MEPPs) and giant MEPPs (GMEPPs) were recorded from innervated diaphragm muscle fibers from 4-6 and 12-15 weeks-old SOD1(G93A) mice and non-transgenic aged-matched littermates (WT). In the pre-symptomatic phase, SOD1(G93A) mice exhibited a significant increase in the mean amplitude of EPPs together with an increase in the mean quantal content of EPPs, suggesting that more acetylcholine is being released into the synaptic cleft. SOD1(G93A) mice presented a higher frequency of GMEPPs, suggestive of intracellular Ca2+ deregulation in nerve terminals. The increase in the mean amplitude of MEPPs and the decreased mean rise-time of MEPPs in SOD1(G93A) mice point to post-synaptic related changes. In the symptomatic phase, electrophysiological data showed evidence for two NMJ groups in SOD1(G93A) mice: SOD1a and SOD1b. SOD1a group presented reduced mean amplitude of both EPPs and MEPPs. The mean rise-time of MEPPs was increased, when compared to WT and to SOD1b group, indicating impairments in the neuromuscular transmission. In contrast, the neuromuscular transmission of SOD1b group was not different from age-matched WT nor pre-symptomatic SOD1(G93A) mice, being somehow in between both groups. Altogether these results show that the neuromuscular transmission of SOD1(G93A) mice is enhanced in the pre-symptomatic phase. In the symptomatic phase our results are consistent with the hypothesis that the diaphragm of SOD1(G93A) mice is undergoing cycles of denervation/re-innervation supported by mixed neuromuscular junction populations. These early changes in the neuromuscular transmission of SOD1(G93A) mice suggest that the ALS associated events start long before symptoms onset.	[Rocha, Mariana C.; Pousinha, Paula A.; Correia, Alexandra M.; Sebastiao, Ana M.; Ribeiro, Joaquim A.] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Rocha, Mariana C.; Pousinha, Paula A.; Correia, Alexandra M.; Sebastiao, Ana M.; Ribeiro, Joaquim A.] Univ Lisbon, Inst Mol Med, Unit Neurosci, P-1699 Lisbon, Portugal; [Correia, Alexandra M.] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Ribeiro, JA (corresponding author), Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal.	jaribeiro@fm.ul.pt	Rocha, Mariana/O-4313-2017; Correia, Alexandra Marcal/W-8107-2018	Rocha, Mariana/0000-0002-0056-9315; Correia, Alexandra Marcal/0000-0002-4999-0477; Sebastiao, Ana M/0000-0001-9030-6115; Pousinha, Paula/0000-0002-5992-9418; Ribeiro, Joaquim/0000-0002-9330-3507	Fundacao do Ministerio da Ciencia e Tecnologia de Portugal [PTCD/SAU-NEU/101752/2008]; European Union; Fundacao do Ministerio de Ciencia e Tecnologia de Portugal [SFRH/BD/28073/2006]	Fundacao do Ministerio da Ciencia e Tecnologia de Portugal; European Union(European Commission); Fundacao do Ministerio de Ciencia e Tecnologia de Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao do Ministerio da Ciencia e Tecnologia de Portugal [Grant PTCD/SAU-NEU/101752/2008] and European Union [Grant NEREPLAS, COST B30]. P.A.P. received a fellowship from Fundacao do Ministerio de Ciencia e Tecnologia de Portugal [Grant SFRH/BD/28073/2006]. M.C.R. was a research fellow from Fundacao do Ministerio de Ciencia e Tecnologia de Portugal [Grant PTCD/SAU-NEU/101752/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; BIRKS R, 1960, J PHYSIOL-LONDON, V150, P145, DOI 10.1113/jphysiol.1960.sp006379; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; COLMEUS C, 1982, PROC R SOC SER B-BIO, V215, P63, DOI 10.1098/rspb.1982.0028; COURTNEY J, 1981, J PHYSIOL-LONDON, V320, P435, DOI 10.1113/jphysiol.1981.sp013960; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; de Carvalho M, 2000, AMYOTROPH LATERAL SC, V1, pS43, DOI 10.1080/14660820050515539; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Gillingwater TH, 2002, J PHYSIOL-LONDON, V543, P739, DOI 10.1113/jphysiol.2002.022343; GUNDERSEN K, 1990, J PHYSIOL-LONDON, V430, P399, DOI 10.1113/jphysiol.1990.sp018298; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Jaiswal MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-64; KELLY SS, 1978, J PHYSIOL-LONDON, V274, P51, DOI 10.1113/jphysiol.1978.sp012133; Kim YI, 1996, P 18 ANN INT C IEEE, P173; Kong JM, 1998, J NEUROSCI, V18, P3241; Kretschmannova K, 2004, PHYSIOL RES, V53, P541; Marcuzzo S, 2011, EXP NEUROL, V231, P30, DOI 10.1016/j.expneurol.2011.05.007; MILEDI R, 1960, J PHYSIOL-LONDON, V154, P190, DOI 10.1113/jphysiol.1960.sp006573; Narai H, 2009, NEUROL INT, V1, P57, DOI 10.4081/ni.2009.e16; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Pagani MR, 2006, J NEUROSCI, V26, P2661, DOI 10.1523/JNEUROSCI.4394-05.2006; Pardo NE, 2006, J PHARMACOL EXP THER, V319, P1009, DOI 10.1124/jpet.106.108670; Personius KE, 2006, NEUROMUSCULAR DISORD, V16, P168, DOI 10.1016/j.nmd.2006.01.002; Pousinha PA, 2012, NEUROBIOL AGING, V33, P2869, DOI 10.1016/j.neurobiolaging.2012.01.008; RIBEIRO JA, 1975, BRIT J PHARMACOL, V54, P213, DOI 10.1111/j.1476-5381.1975.tb06931.x; RIBEIRO JA, 1987, J PHYSIOL-LONDON, V384, P571, DOI 10.1113/jphysiol.1987.sp016470; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROWE RWD, 1969, J ANAT, V104, P519; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Rozas JL, 2011, J NEUROSCI, V31, P1106, DOI 10.1523/JNEUROSCI.2011-10.2011; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; Sons MS, 2006, BRAIN RES, V1089, P126, DOI 10.1016/j.brainres.2006.03.055; Souayah N, 2012, STEM CELL REV REP, V8, P224, DOI 10.1007/s12015-011-9281-3; Tateno M, 2009, HUM MOL GENET, V18, P942, DOI 10.1093/hmg/ddn422; THESLEFF S, 1983, BRAIN RES, V264, P89, DOI 10.1016/0006-8993(83)91123-X; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Vila L, 2003, J PHYSIOL-LONDON, V549, P719, DOI 10.1113/jphysiol.2003.041905; WEINSTEIN SP, 1980, J PHYSIOL-LONDON, V307, P453, DOI 10.1113/jphysiol.1980.sp013446; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; Zhang WH, 2003, ANN NEUROL, V53, P267, DOI 10.1002/ana.10476; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319	50	96	97	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73846	10.1371/journal.pone.0073846	http://dx.doi.org/10.1371/journal.pone.0073846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040091	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600103
J	Zhu, GH; Yu, XJ; Xie, LX; Luo, H; Wang, D; Lv, JY; Xu, XH				Zhu, Guang-Hui; Yu, Xiao-Jun; Xie, Liang-Xing; Luo, Hao; Wang, Dian; Lv, Jun-Yao; Xu, Xiao-Hu			Time of Death Revealed by Hydrocarbons of Empty Puparia of Chrysomya megacephala (Fabricius) (Diptera: Calliphoridae): A Field Experiment	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; VITREOUS-HUMOR; CHEMISTRY; PROFILES; PATTERNS	Determination of the postmortem interval (PMI) is crucial for investigating homicide. However, there are currently only limited methods available. Especially, once the PMI exceeds the duration of pre-adult development of the flies with the adult emergence, its determination is very approximate. Herein, we report the regular changes in hydrocarbon composition during the weathering process of the puparia in the field in Chrysomya megacephala (Fabricius) (Diptera: Calliphoridae), one of the common species of necrophagous flies. Correlation analysis showed that the relative abundance of nearly all of the branched alkanes and alkenes decreased significantly with the weathering time. Especially, for 9 of the peaks, over 88% of the variance in their abundance was explained by weathering time. Further analysis indicated that the regular changes caused mainly by the different weathering rates of various hydrocarbons. Additionally, the weathering rates were found to depend on the chemical structure and molecular weight of the hydrocarbons. These results indicate strongly that hydrocarbon analysis is a powerful tool for determining the weathering time of the necrophagous fly puparia, and is expected to markedly improve the determination of the late PMI.	[Zhu, Guang-Hui; Yu, Xiao-Jun; Xie, Liang-Xing; Luo, Hao; Wang, Dian; Lv, Jun-Yao; Xu, Xiao-Hu] Shantou Univ, Coll Med, Dept Forens Med, Shantou, Guangdong, Peoples R China	Shantou University	Zhu, GH (corresponding author), Shantou Univ, Coll Med, Dept Forens Med, Shantou, Guangdong, Peoples R China.	ghzhu@stu.edu.cn; xhxu@stu.edu.cn			National Natural Science Foundation of China [0700967]; Natural Science Foundation of Guangdong Province, China [06301086]; Post-doctor Foundation of China [2004035616]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Post-doctor Foundation of China(China Postdoctoral Science Foundation)	This study was funded by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (0700967), the Natural Science Foundation of Guangdong Province, China (http://gdsf.gdstc.gov.cn/) (06301086) and Post-doctor Foundation of China (http://res.chinapostdoctor.org.cn/Program/Main.html) (2004035616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt J, 2004, NATURWISSENSCHAFTEN, V91, P51, DOI 10.1007/s00114-003-0493-5; Amendt J, 2007, INT J LEGAL MED, V121, P90, DOI 10.1007/s00414-006-0086-x; Anderson G.S., 2010, FORENSIC ENTOMOLOGY, P201; Archer MS, 2003, FORENSIC SCI INT, V132, P173, DOI 10.1016/S0379-0738(03)00034-3; Bernier UR, 1998, J AM SOC MASS SPECTR, V9, P320, DOI 10.1016/S1044-0305(97)00288-2; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; Calderon-Fernandez GM, 2011, J MED ENTOMOL, V48, P262, DOI 10.1603/ME10141; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; COE JI, 1989, FORENSIC SCI INT, V42, P201, DOI 10.1016/0379-0738(89)90087-X; Dapporto L, 2004, J CHEM ECOL, V30, P2139, DOI 10.1023/B:JOEC.0000048779.47821.38; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Gibbs AG, 1998, AM ZOOL, V38, P471; GILBY AR, 1970, J INSECT PHYSIOL, V16, P1517, DOI 10.1016/0022-1910(70)90250-7; Henssge C, 2004, FORENSIC SCI INT, V144, P167, DOI 10.1016/j.forsciint.2004.04.051; Henssge C, 2007, FORENSIC SCI INT, V165, P182, DOI 10.1016/j.forsciint.2006.05.017; Jashnani KD, 2010, J FORENSIC SCI, V55, P1523, DOI 10.1111/j.1556-4029.2010.01501.x; Kasper J, 2012, FORENSIC SCI INT, V223, P64, DOI 10.1016/j.forsciint.2012.08.001; LOCKEY KH, 1991, INSECT BIOCHEM, V21, P91, DOI 10.1016/0020-1790(91)90068-P; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Madea B, 2006, FORENSIC SCI INT, V164, P87, DOI 10.1016/j.forsciint.2005.12.002; Savarit F, 2002, J EXP BIOL, V205, P3241; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Vass AA, 2002, J FORENSIC SCI, V47, P542; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Wells J. D., 2010, FORENSIC ENTOMOLOGY, P367; Ye GY, 2007, J MED ENTOMOL, V44, P450, DOI 10.1603/0022-2585(2007)44[450:CHCIPE]2.0.CO;2; Zhu GH, 2007, FORENSIC SCI INT, V169, P1, DOI 10.1016/j.forsciint.2006.06.078	29	17	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73043	10.1371/journal.pone.0073043	http://dx.doi.org/10.1371/journal.pone.0073043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039855	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600051
J	Beazley, KE; Reckard, S; Nurminsky, D; Lima, F; Nurminskaya, M				Beazley, Kelly E.; Reckard, Steven; Nurminsky, Dmitry; Lima, Florence; Nurminskaya, Maria			Two Sides of MGP Null Arterial Disease CHONDROGENIC LESIONS DEPENDENT ON TRANSGLUTAMINASE 2 AND ELASTIN FRAGMENTATION ASSOCIATED WITH INDUCTION OF ADIPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX GLA PROTEIN; VASCULAR SMOOTH-MUSCLE; COMPLEMENT FACTOR-D; ADIPOSE-TISSUE; TRANSFORMING GROWTH-FACTOR-BETA-1; ELASTIN DEGRADATION; DEFICIENT MICE; MOUSE MODEL; CALCIFICATION; CELLS	Mutations in matrix Gla protein (MGP) have been correlated with vascular calcification. In the mouse model, MGP null vascular disease presents as calcifying cartilaginous lesions and mineral deposition along elastin lamellae (elastocalcinosis). Here we examined the mechanisms underlying both of these manifestations. Genetic ablation of enzyme transglutaminase 2 (TG2) in Mgp(-/-) mice dramatically reduced the size of cartilaginous lesions in the aortic media, attenuated calcium accrual more than 2-fold, and doubled longevity as compared with control Mgp(-/-) animals. Nonetheless, the Mgp(-/-); Tgm2(-/-) mice still died prematurely as compared with wild-type and retained the elastocalcinosis phenotype. This pathology in Mgp(-/-) animals was developmentally preceded by extensive fragmentation of elastic lamellae and associated with elevated serine elastase activity in aortic tissue and vascular smooth muscle cells. Systematic gene expression analysis followed by an immunoprecipitation study identified adipsin as the major elastase that is induced in the Mgp(-/-) vascular smooth muscle even in the TG2 null background. These results reveal a central role for TG2 in chondrogenic transformation of vascular smooth muscle and implicate adipsin in elastin fragmentation and ensuing elastocalcinosis. The importance of elastin calcification in MGP null vascular disease is highlighted by significant residual vascular calcification and mortality in Mgp(-/-);Tgm2(-/-) mice with reduced cartilaginous lesions. Our studies identify two potential therapeutic targets in vascular calcification associated with MGP dysfunction and emphasize the need for a comprehensive approach to this multifaceted disorder.	[Beazley, Kelly E.; Reckard, Steven; Nurminsky, Dmitry; Lima, Florence; Nurminskaya, Maria] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Nurminskaya, M (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St,Rm 329, Baltimore, MD 21201 USA.	mnurminskaya@som.umaryland.edu	Nurminskaya, Maria/GQH-4607-2022		National Institutes of Health [R01HL099305, T32AR007592]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL099305 (to M.N.) and T32AR007592 (to K.B.).	Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Al-Jallad HF, 2006, MATRIX BIOL, V25, P135, DOI 10.1016/j.matbio.2005.11.001; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Beazley KE, 2013, J BIOL CHEM, V288, P2632, DOI 10.1074/jbc.M112.368639; Beazley KE, 2013, ARTERIOSCL THROM VAS, V33, P43, DOI 10.1161/ATVBAHA.112.300260; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Chatrou MLL, 2011, HAMOSTASEOLOGIE, V31, P251, DOI 10.5482/ha-1157; CHOY LN, 1992, J BIOL CHEM, V267, P12736; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P59, DOI 10.3177/jnsv.55.59; Dao HH, 2002, J HYPERTENS, V20, P1597, DOI 10.1097/00004872-200208000-00023; El-Maadawy S, 2003, CONNECT TISSUE RES, V44, P272, DOI 10.1080/03008200390181762; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Hosaka N, 2009, CALCIFIED TISSUE INT, V85, P523, DOI 10.1007/s00223-009-9297-8; Ishizeki K, 1999, J ANAT, V194, P265, DOI 10.1046/j.1469-7580.1999.19420265.x; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Johnson KA, 2003, J BIOL CHEM, V278, P18824, DOI 10.1074/jbc.M301055200; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Lomashvili KA, 2011, J BIOL CHEM, V286, P28715, DOI 10.1074/jbc.M111.251462; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mikhaylova L, 2007, CALCIFIED TISSUE INT, V81, P372, DOI 10.1007/s00223-007-9073-6; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7; Nurminsky D, 2011, MECH DEVELOP, V128, P234, DOI 10.1016/j.mod.2010.11.007; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Qin X, 2006, ARTERIOSCL THROM VAS, V26, P1510, DOI 10.1161/01.ATV.0000225807.76419.a7; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Ruan CC, 2010, ARTERIOSCL THROM VAS, V30, P2568, DOI 10.1161/ATVBAHA.110.215525; RUCKER RB, 1974, CALC TISS RES, V14, P317, DOI 10.1007/BF02060306; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Sharma B, 2013, MICROVASC RES, V85, P24, DOI 10.1016/j.mvr.2012.10.005; Shields KJ, 2011, CTS-CLIN TRANSL SCI, V4, P146, DOI 10.1111/j.1752-8062.2011.00304.x; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yao YC, 2008, CIRC RES, V102, P1065, DOI 10.1161/CIRCRESAHA.107.166124; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2011, J CLIN INVEST, V121, P2993, DOI 10.1172/JCI57567; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; ZHU L, 1994, J CLIN INVEST, V94, P1163, DOI 10.1172/JCI117432	58	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31400	31408		10.1074/jbc.M113.495556	http://dx.doi.org/10.1074/jbc.M113.495556			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036114	hybrid, Green Published			2022-12-25	WOS:000330778900056
J	Witas, HW; Tomczyk, J; Jedrychowska-Danska, K; Chaubey, G; Ploszaj, T				Witas, Henryk W.; Tomczyk, Jacek; Jedrychowska-Danska, Krystyna; Chaubey, Gyaneshwer; Ploszaj, Tomasz			mtDNA from the Early Bronze Age to the Roman Period Suggests a Genetic Link between the Indian Subcontinent and Mesopotamian Cradle of Civilization	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; TIBETAN PLATEAU; PATTERNS; VALLEY; WEAR	Ancient DNA methodology was applied to analyse sequences extracted from freshly unearthed remains (teeth) of 4 individuals deeply deposited in slightly alkaline soil of the Tell Ashara (ancient Terqa) and Tell Masaikh (ancient Kar-Assurnasirpal) Syrian archaeological sites, both in the middle Euphrates valley. Dated to the period between 2.5 Kyrs BC and 0.5 Kyrs AD the studied individuals carried mtDNA haplotypes corresponding to the M4b1, M49 and/or M61 haplogroups, which are believed to have arisen in the area of the Indian subcontinent during the Upper Paleolithic and are absent in people living today in Syria. However, they are present in people inhabiting today's Tibet, Himalayas, India and Pakistan. We anticipate that the analysed remains from Mesopotamia belonged to people with genetic affinity to the Indian subcontinent since the distribution of identified ancient haplotypes indicates solid link with populations from the region of South Asia-Tibet (Trans-Himalaya). They may have been descendants of migrants from much earlier times, spreading the clades of the macrohaplogroup M throughout Eurasia and founding regional Mesopotamian groups like that of Terqa or just merchants moving along trade routes passing near or through the region. None of the successfully identified nuclear alleles turned out to be Delta F508 CFTR, LCT-13910T or Delta 32 CCR5.	[Witas, Henryk W.; Jedrychowska-Danska, Krystyna; Ploszaj, Tomasz] Med Univ Lodz, Dept Mol Biol, Lodz, Poland; [Tomczyk, Jacek] Cardinal Stefan Wyszynski Univ, Dept Anthropol, Warsaw, Poland; [Chaubey, Gyaneshwer] Estonian Bioctr, Tartu, Estonia	Medical University Lodz; Cardinal Stefan Wyszynski University in Warsaw; Estonian Biocentre	Witas, HW (corresponding author), Med Univ Lodz, Dept Mol Biol, Lodz, Poland.	henryk.witas@umed.lodz.pl	Ploszaj, Tomasz/S-9849-2016; Chaubey, Gyaneshwer/H-2753-2012; Witas, Henryk Wlodzimierz/S-9450-2016; Chaubey, Gyaneshwer/AAC-6409-2019	Ploszaj, Tomasz/0000-0002-9503-278X; Chaubey, Gyaneshwer/0000-0003-2899-3852; Witas, Henryk Wlodzimierz/0000-0002-8402-2084; Chaubey, Gyaneshwer/0000-0003-2899-3852; Tomczyk, Jacek/0000-0002-0605-665X; Jedrychowska-Danska, Krystyna/0000-0001-9262-4010	Polish Ministry of Science and Higher Education [N N109 286737]; Centre of Excellence of the Estonian Biocentre	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Centre of Excellence of the Estonian Biocentre	The work was funded by the scientific project no. N N109 286737 from the Polish Ministry of Science and Higher Education. Gyaneshwer Chaubey Ph.D. was supported by the Centre of Excellence of the Estonian Biocentre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2011, MOL VIS, V17, P543; Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bass W. M., 2005, HUMAN OSTEOLOGY LAB, V5th; Braun Jan, 2004, SUMERIAN TIBETO BURM; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Buikstra J. E., 1994, STANDARDS DATA COLLE; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chatty D., 1990, NOMADS CHANGING WORL, P123; Collins MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2971, DOI 10.1098/rspb.2009.0563; Crawford Harriet, 2004, SUMER SUMERIANS; Dastidar R, 2007, ANTHR TODAY TRENDS S, P349; Fernandez E, 2008, FORENS SCI INT-GEN S, V1, P271, DOI 10.1016/j.fsigss.2007.10.009; Geyer B., 1987, MARI, V5, P293; Kenoyer JM, 2013, J ARCHAEOL SCI, V40, P2286, DOI 10.1016/j.jas.2012.12.040; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Kozlowski T, 2012, METABOLIC ENDOCRINE, P401; Lagia A, 2007, INT J OSTEOARCHAEOL, V17, P269, DOI 10.1002/oa.881; Lee EJ, 2012, AM J PHYS ANTHROPOL, V148, P571, DOI 10.1002/ajpa.22074; Lewis ME, 2010, INT J OSTEOARCHAEOL, DOI [10.1002/oa.1229, DOI 10.1002/0A.1229]; Lyonnet B., 2009, NOMADS TRIBES STATE, P179; Massetti-Rouault MG, 2008, ATHENAEUM, V96, P914; Molleson T, 2003, HUMAN REMAINS WOOLLE, P91; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Ploszaj T, 2011, CENT EUR J BIOL, V6, P176, DOI 10.2478/s11535-010-0114-1; Rakha A, 2011, INT J LEGAL MED, V125, P841, DOI 10.1007/s00414-010-0540-7; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Sharma V, 2010, PHYLOGENOMIC STUDY C; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Tomczyk J, 2011, INT J OSTEOARCHAEOL, V21, P435, DOI 10.1002/oa.1150; Velud C., 2000, TRANSFORMATION NOMAD, P63; White T.D., 2000, HUMAN OSTEOLOGY; Wiercinski A, 1971, ANTROPOLOGIA STAROZY, P42; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	39	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73682	10.1371/journal.pone.0073682	http://dx.doi.org/10.1371/journal.pone.0073682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040024	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500042
J	Granziera, C; Daducci, A; Simioni, S; Cavassini, M; Roche, A; Meskaldji, D; Kober, T; Metral, M; Calmy, A; Helms, G; Hirschel, B; Lazeyras, F; Meuli, R; Krueger, G; Du Pasquier, RA				Granziera, Cristina; Daducci, Alessandro; Simioni, Samanta; Cavassini, Matthias; Roche, Alexis; Meskaldji, Djalel; Kober, Tobias; Metral, Melanie; Calmy, Alexandra; Helms, Gunther; Hirschel, Bernard; Lazeyras, Francois; Meuli, Reto; Krueger, Gunnar; Du Pasquier, Renaud A.			Micro-Structural Brain Alterations in Aviremic HIV plus Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MAGNETIZATION-TRANSFER; POSITIVE PATIENTS; INFECTION; DISEASE; UPDATE; INJURY; HAART; SCALE	Objective: Mild neurocognitive disorders (MND) affect a subset of HIV+ patients under effective combination antiretroviral therapy (cART). In this study, we used an innovative multi-contrast magnetic resonance imaging (MRI) approach at high-field to assess the presence of micro-structural brain alterations in MND+ patients. Methods: We enrolled 17 MND+ and 19 MND- patients with undetectable HIV-1 RNA and 19 healthy controls (HC). MRI acquisitions at 3T included: MP2RAGE for T1 relaxation times, Magnetization Transfer (MT), T2* and Susceptibility Weighted Imaging (SWI) to probe micro-structural integrity and iron deposition in the brain. Statistical analysis used permutation-based tests and correction for family-wise error rate. Multiple regression analysis was performed between MRI data and (i) neuropsychological results (ii) HIV infection characteristics. A linear discriminant analysis (LDA) based on MRI data was performed between MND+ and MND- patients and cross-validated with a leave-one-out test. Results: Our data revealed loss of structural integrity and micro-oedema in MND+ compared to HC in the global white and cortical gray matter, as well as in the thalamus and basal ganglia. Multiple regression analysis showed a significant influence of sub-cortical nuclei alterations on the executive index of MND+ patients (p = 0.04 he and R-2 = 95.2). The LDA distinguished MND+ and MND- patients with a classification quality of 73% after cross-validation. Conclusion: Our study shows micro-structural brain tissue alterations in MND+ patients under effective therapy and suggests that multi-contrast MRI at high field is a powerful approach to discriminate between HIV+ patients on cART with and without mild neurocognitive deficits.	[Granziera, Cristina; Simioni, Samanta; Du Pasquier, Renaud A.] CHU Vaudois, Neuroimmunol Unit, Dept Clin Neurosci, CH-1011 Lausanne, Vaud, Switzerland; [Granziera, Cristina; Simioni, Samanta; Cavassini, Matthias; Meuli, Reto; Du Pasquier, Renaud A.] Univ Lausanne, Lausanne, Vaud, Switzerland; [Granziera, Cristina] CHU Vaudois, LREN, Dept Clin Neurosci, CH-1011 Lausanne, Vaud, Switzerland; [Granziera, Cristina; Daducci, Alessandro; Roche, Alexis; Kober, Tobias; Krueger, Gunnar] Ecole Polytech Fed Lausanne, Ctr Imagerie Biomed, Lausanne, Vaud, Switzerland; [Daducci, Alessandro; Meskaldji, Djalel] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Vaud, Switzerland; [Cavassini, Matthias] CHU Vaudois, Dept Infect Dis, CH-1011 Lausanne, Vaud, Switzerland; [Metral, Melanie] Hop Univ Geneve, Neuropsychol Unit, Dept Clin Neurosci, Geneva, Switzerland; [Calmy, Alexandra; Hirschel, Bernard] Hop Univ Geneve, Dept Infect Dis, Geneva, Switzerland; [Helms, Gunther] Univ Gottingen, MR Forsch Neurol & Psychiatrie, D-37073 Gottingen, Germany; [Lazeyras, Francois] Hop Univ Geneve, Dept Radiol, Geneva, Switzerland; [Meuli, Reto] CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Vaud, Switzerland; [Krueger, Gunnar] Healthcare Siemens Schweiz AG, Renens, Vaud, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Gottingen; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Siemens AG	Granziera, C (corresponding author), CHU Vaudois, Neuroimmunol Unit, Dept Clin Neurosci, CH-1011 Lausanne, Vaud, Switzerland.	cristina.granziera@chuv.ch	Du Pasquier, Renaud/O-8588-2016; Helms, Gunther/A-9114-2010; cavassini, matthias/F-8987-2017	Du Pasquier, Renaud/0000-0002-2786-3434; Helms, Gunther/0000-0002-1371-5123; Granziera, Cristina/0000-0002-4917-8761; cavassini, matthias/0000-0003-0933-7833	Centre d'Imagerie BioMedicale of the University of Lausanne; Swiss Federal Institute of Technology Lausanne; University of Geneve; Centre Hospitalier Universitaire Vaudois; Hopitaux Universitaires de Geneve; Leenaards foundation; Jeantet foundation; Stoicescu foundation; Swiss National Science Foundation [PZ00P3_131914/11, FNS 320030_138411]; Swiss HIV Cohort Study; Abbott; ViiV	Centre d'Imagerie BioMedicale of the University of Lausanne; Swiss Federal Institute of Technology Lausanne; University of Geneve; Centre Hospitalier Universitaire Vaudois; Hopitaux Universitaires de Geneve; Leenaards foundation; Jeantet foundation; Stoicescu foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss HIV Cohort Study; Abbott(Abbott Laboratories); ViiV	Funding provided by Centre d'Imagerie BioMedicale of the University of Lausanne, the Swiss Federal Institute of Technology Lausanne, the University of Geneve, the Centre Hospitalier Universitaire Vaudois, the Hopitaux Universitaires de Geneve, the Leenaards, the Jeantet and the Stoicescu foundations, the Swiss National Science Foundation Grant PZ00P3_131914/11 and FNS 320030_138411, the Swiss HIV Cohort Study, and unrestricted grants from Abbott and ViiV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, DISCRIMINANT CORRES, P270; Amariglio RE, 2011, J AM GERIATR SOC, V59, P1612, DOI 10.1111/j.1532-5415.2011.03543.x; [Anonymous], 2008, SPIN DYNAMICS BASICS; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bell JE, 2004, HISTOPATHOLOGY, V45, P549, DOI 10.1111/j.1365-2559.2004.02004.x; Bhatia R, 2011, J NEUROVIROL; Cardenas VA, 2009, J NEUROVIROL, V15, P324, DOI 10.1080/13550280902973960; Chang L, 2008, J NEUROIMMUNE PHARM, V3, P95, DOI 10.1007/s11481-007-9092-0; Ciccarelli N, 2011, NEUROLOGY, V76, P1403, DOI 10.1212/WNL.0b013e31821670fb; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Helms G, 2008, MAGN RESON MED, V60, P1396, DOI 10.1002/mrm.21732; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; Hermosillo G, 2002, INT J COMPUT VISION, V50, P329, DOI 10.1023/A:1020830525823; Holt JL, 2012, J NEUROVIROL, V18, P291, DOI 10.1007/s13365-012-0114-1; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Kallianpur KJ, 2011, CEREB CORTEX; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kreis R, 1993, J MAGN RESON, P9; Kumar AM, 2007, J NEUROVIROL, V13, P210, DOI 10.1080/13550280701327038; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; POWER C, 1995, J ACQ IMMUN DEF SYND, V8, P273, DOI 10.1097/00042560-199503010-00008; Power C, 2002, CAN J NEUROL SCI, V29, P19, DOI 10.1017/S0317167100001682; Reitan RM, 1993, HASTEAD REITAN NEURO; Robertson KR, 2010, NEUROLOGY, V74, P1260, DOI 10.1212/WNL.0b013e3181d9ed09; Roche A, 2011, MED IMAGE ANAL, V15, P830, DOI 10.1016/j.media.2011.05.002; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Simioni S, 2012, NEUROLOGY IN PRESS; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72547	10.1371/journal.pone.0072547	http://dx.doi.org/10.1371/journal.pone.0072547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039777	Green Published, gold			2022-12-25	WOS:000327538600008
J	Loc, NH; MacRae, TH; Musa, N; Bin Abdullah, MDD; Wahid, MEA; Sung, YY				Nguyen Hong Loc; MacRae, Thomas H.; Musa, Najiah; Bin Abdullah, Muhd Danish Daniel; Wahid, Mohd. Effendy Abdul; Sung, Yeong Yik			Non-Lethal Heat Shock Increased Hsp70 and Immune Protein Transcripts but Not Vibrio Tolerance in the White-Leg Shrimp	PLOS ONE			English	Article							ARTEMIA-FRANCISCANA LARVAE; ANTIMICROBIAL PEPTIDES; TIGER SHRIMP; PROPHENOLOXIDASE SYSTEM; RECOMBINANT EXPRESSION; HEMOCYANIN; PEROXINECTIN; PENAEIDINS; VANNAMEI; CLONING	Non-lethal heat shock boosts bacterial and viral disease tolerance in shrimp, possibly due to increases in endogenous heat shock protein 70 (Hsp70) and/or immune proteins. To further understand the mechanisms protecting shrimp against infection, Hsp70 and the mRNAs encoding the immune-related proteins prophenoloxidase (proPO), peroxinectin, penaeidin, crustin and hemocyanin were studied in post-larvae of the white-leg shrimp Litopenaeus vannamei, following a non-lethal heat shock. As indicated by RT-qPCR, a 30 min abrupt heat shock increased Hsp70 mRNA in comparison to non-heated animals. Immunoprobing of western blots and quantification by ELISA revealed that Hsp70 production after heat shock was correlated with enhanced Hsp70 mRNA. proPO and hemocyanin mRNA levels were augmented, whereas peroxinectin and crustin mRNA levels were unchanged following non-lethal heat shock. Penaeidin mRNA was decreased by all heat shock treatments. Thirty min abrupt heat shock failed to improve survival of post-larvae in a standardized challenge test with Vibrio harveyi, indicating that under the conditions of this study, L. vannamei tolerance to Vibrio infection was influenced neither by Hsp70 accumulation nor the changes in the immune-related proteins, observations dissimilar to other shrimp species examined.	[Nguyen Hong Loc; Musa, Najiah; Sung, Yeong Yik] Univ Malaysia Terengganu, Fac Fisheries & Aquaind, Dept Aquaculture Sci, Kuala Terengganu, Malaysia; [MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Bin Abdullah, Muhd Danish Daniel] Univ Malaysia Terengganu, Fac Fisheries & Aquaind, Dept Fisheries Sci, Kuala Terengganu, Malaysia; [Wahid, Mohd. Effendy Abdul; Sung, Yeong Yik] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu, Malaysia	Universiti Malaysia Terengganu; Dalhousie University; Universiti Malaysia Terengganu; Universiti Malaysia Terengganu	Sung, YY (corresponding author), Univ Malaysia Terengganu, Fac Fisheries & Aquaind, Dept Aquaculture Sci, Kuala Terengganu, Malaysia.	yeong@umt.edu.my	Wahid, Mohd Effendy Abd/M-9901-2018; Musa, Najiah/AAA-6027-2021; Sung, Yeong Yik/AAA-2654-2020; Danish-Daniel, Muhd/H-8245-2018	Wahid, Mohd Effendy Abd/0000-0002-4685-7048; Sung, Yeong Yik/0000-0001-5897-9037; Danish-Daniel, Muhd/0000-0001-9438-0128; musa, najiah/0000-0003-1666-3186	Ministry of Agriculture (MOA), Malaysia [05-01-12-SF1006, 05-01-12-SF1020]	Ministry of Agriculture (MOA), Malaysia	This work was supported by the E-Science Fund Project No. 05-01-12-SF1006 and 05-01-12-SF1020 from the Ministry of Agriculture (MOA), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2001, J FOOD SCI, V66, P1130; Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Bachere E, 2000, AQUACULTURE, V191, P71, DOI 10.1016/S0044-8486(00)00419-1; Baruah K, 2011, FISH SHELLFISH IMMUN, V31, P134, DOI 10.1016/j.fsi.2011.04.008; Brockton V, 2008, DEV COMP IMMUNOL, V32, P1027, DOI 10.1016/j.dci.2008.02.002; Burge EJ, 2009, FISH SHELLFISH IMMUN, V27, P603, DOI 10.1016/j.fsi.2009.05.012; Chen JY, 2004, FISH SHELLFISH IMMUN, V16, P659, DOI 10.1016/j.fsi.2003.10.006; Chiou TT, 2007, DEV COMP IMMUNOL, V31, P132, DOI 10.1016/j.dci.2006.05.007; Clegg JS, 2000, J EXP MAR BIOL ECOL, V252, P85, DOI 10.1016/S0022-0981(00)00239-2; Cuthbertson BJ, 2002, IMMUNOGENETICS, V54, P442, DOI 10.1007/s00251-002-0487-z; de la Vega E, 2006, AQUACULTURE, V253, P82, DOI 10.1016/j.aquaculture.2005.07.041; de la Vega E, 2007, FISH SHELLFISH IMMUN, V23, P1072, DOI 10.1016/j.fsi.2007.05.001; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Destoumieux D, 1999, EUR J BIOCHEM, V266, P335, DOI 10.1046/j.1432-1327.1999.00855.x; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Holmblad T, 1999, AQUACULTURE, V172, P111, DOI 10.1016/S0044-8486(98)00446-3; Jaenicke E, 1999, J BIOL CHEM, V274, P34267, DOI 10.1074/jbc.274.48.34267; Jiravanichpaisal P, 2007, FISH SHELLFISH IMMUN, V23, P815, DOI 10.1016/j.fsi.2007.03.003; JOHANSSON MW, 1995, BIOCHEM BIOPH RES CO, V216, P1079, DOI 10.1006/bbrc.1995.2731; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lee SY, 2002, FISH SHELLFISH IMMUN, V12, P421, DOI 10.1006/fsim.2002.0420; Li CY, 2010, FISH SHELLFISH IMMUN, V29, P1044, DOI 10.1016/j.fsi.2010.08.020; Liu CH, 2005, FISH SHELLFISH IMMUN, V18, P431, DOI 10.1016/j.fsi.2004.10.005; Liu CH, 2004, FISH SHELLFISH IMMUN, V17, P13, DOI 10.1016/j.fsi.2003.11.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pan LQ, 2008, FISH SHELLFISH IMMUN, V25, P137, DOI 10.1016/j.fsi.2008.03.016; Paul R., 1998, J ZOOL, V100, P319; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Robertson PAW, 1998, DIS AQUAT ORGAN, V32, P151, DOI 10.3354/dao032151; Rungrassamee W, 2010, DEV COMP IMMUNOL, V34, P1082, DOI 10.1016/j.dci.2010.05.012; Ryckaert J, 2010, FISH SHELLFISH IMMUN, V28, P228, DOI 10.1016/j.fsi.2009.09.005; Saulnier D, 2000, AQUACULTURE, V191, P133, DOI 10.1016/S0044-8486(00)00423-3; Smith VJ, 2008, DEV COMP IMMUNOL, V32, P758, DOI 10.1016/j.dci.2007.12.002; Sricharoen S, 2005, DEV COMP IMMUNOL, V29, P1017, DOI 10.1016/j.dci.2005.03.010; Sung YY, 2012, J FISH DIS, V35, P563, DOI 10.1111/j.1365-2761.2012.01397.x; Sung YY, 2009, J FISH DIS, V32, P675, DOI 10.1111/j.1365-2761.2009.01046.x; Sung Y.Y., 2011, J AQUAC RES DEV, V3, P1, DOI 10.4172/2155-9546.S2-006; Sung YY, 2008, CELL STRESS CHAPERON, V13, P59, DOI 10.1007/s12192-008-0011-y; Sung YY, 2007, FISH SHELLFISH IMMUN, V22, P318, DOI 10.1016/j.fsi.2006.05.008; Sung YY, 2011, REV AQUACULT, V3, P120, DOI 10.1111/j.1753-5131.2011.01049.x; Sung YY, 2009, CELL STRESS CHAPERON, V14, P603, DOI 10.1007/s12192-009-0112-2; Supungul P, 2008, DEV COMP IMMUNOL, V32, P61, DOI 10.1016/j.dci.2007.04.004; Tassanakajon A, 2011, DIS ASIAN AQUACULTUR, P229; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tassanakajon Anchalee, 2008, P221; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; UNESTAM T, 1977, NATURE, V267, P45, DOI 10.1038/267045a0; Vatanavicharn T, 2009, COMP BIOCHEM PHYS B, V153, P244, DOI 10.1016/j.cbpb.2009.03.004; Wang YC, 2007, FISH SHELLFISH IMMUN, V23, P1161, DOI 10.1016/j.fsi.2007.04.004; Zhang JQ, 2007, J BIOTECHNOL, V127, P605, DOI 10.1016/j.jbiotec.2006.08.013; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhou J, 2010, J THERM BIOL, V35, P284, DOI 10.1016/j.jtherbio.2010.06.004	53	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73199	10.1371/journal.pone.0073199	http://dx.doi.org/10.1371/journal.pone.0073199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039886	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300057
J	Overman, AR; Scholtz, RV				Overman, Allen R.; Scholtz, Richard V.			Accumulation of Biomass and Mineral Elements with Calendar Time by Cotton: Application of the Expanded Growth Model	PLOS ONE			English	Article							DRY-MATTER; NITROGEN	Accumulation of plant biomass (Mg ha(-1)) with calendar time (wk) occurs as a result of photosynthesis for green land-based plants. A corresponding accumulation of mineral elements (kg ha(-1)) such as nitrogen, phosphorus, and potassium occurs from the soil through plant roots. Field data from literature for the warm-season annual cotton (Gossypium hirsutum L.) are used in this analysis. The expanded growth model is used to describe accumulation of biomass and mineral elements with calendar time. The growth model predicts a simple linear relationship between biomass yield and the growth quantifier, which is confirmed with the data. The growth quantifier incorporates the unit processes of distribution of solar energy which drives biomass accumulation by photosynthesis, partitioning of biomass between light-gathering and structural components of the plants, and an aging function. A hyperbolic relationship between plant nutrient uptake and biomass yield is assumed, and is confirmed for the mineral elements nitrogen, phosphorus, and potassium. It is concluded that the rate limiting process in the system is biomass accumulation by photosynthesis and that nutrient accumulation occurs in virtual equilibrium with biomass accumulation. The expanded growth model describes field data from California and Alabama rather well. Furthermore, all model parameters were common for the two sites with the exception of the yield factor A which accounts for differences in soil types, environmental conditions, fertilizer levels, and plant population.	[Overman, Allen R.; Scholtz, Richard V.] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Scholtz, RV (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA.	rscholtz@ufl.edu	Scholtz, Richard/F-9513-2011	Scholtz, Richard/0000-0001-8989-0131	Florida Experiment Station; University of Florida Library Open-Access Publishing Grant	Florida Experiment Station; University of Florida Library Open-Access Publishing Grant	The funding of this analysis was provided by the Florida Experiment Station. The authors express appreciation to Amy G. Buhler, George A. Smather's Library and staff, for assistance with funding for the publishing costs of this article as part of the commitment of the University of Florida Library Open-Access Publishing Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Fritschi FB, 2003, AGRON J, V95, P133, DOI 10.2134/agronj2003.0133; Lederman L. M., 2008, SYMMETRY BEAUTIFUL U; Moore Jason, 2014, EATING SUN PLANTS PO; MULLINS GL, 1990, AGRON J, V82, P729, DOI 10.2134/agronj1990.00021962008200040017x; Overman A.R., 2002, MATH MODELS CROP GRO; Overman A. R., 2010, MEMOIR SIMPLIFIED TH; Overman AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028515; Overman AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016117	9	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72810	10.1371/journal.pone.0072810	http://dx.doi.org/10.1371/journal.pone.0072810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039802	Green Published, gold			2022-12-25	WOS:000326405300028
J	Meeren, HKM; de Gelder, B; Ahlfors, SP; Hamalainen, MS; Hadjikhani, N				Meeren, Hanneke K. M.; de Gelder, Beatrice; Ahlfors, Seppo P.; Hamalainen, Matti S.; Hadjikhani, Nouchine			Different Cortical Dynamics in Face and Body Perception: An MEG study	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; SURFACE-BASED ANALYSIS; BRAIN-AREAS; SOURCE LOCALIZATION; SELECTIVE CORTEX; INVERSION; BODIES; RECOGNITION; RESPONSES; FMRI	Evidence from functional neuroimaging indicates that visual perception of human faces and bodies is carried out by distributed networks of face and body-sensitive areas in the occipito-temporal cortex. However, the dynamics of activity in these areas, needed to understand their respective functional roles, are still largely unknown. We monitored brain activity with millisecond time resolution by recording magnetoencephalographic (MEG) responses while participants viewed photographs of faces, bodies, and control stimuli. The cortical activity underlying the evoked responses was estimated with anatomically-constrained noise-normalised minimum-norm estimate and statistically analysed with spatiotemporal cluster analysis. Our findings point to distinct spatiotemporal organization of the neural systems for face and body perception. Face-selective cortical currents were found at early latencies (120-200 ms) in a widespread occipito-temporal network including the ventral temporal cortex (VTC). In contrast, early body-related responses were confined to the lateral occipito-temporal cortex (LOTC). These were followed by strong sustained body-selective responses in the orbitofrontal cortex from 200-700 ms, and in the lateral temporal cortex and VTC after 500 ms latency. Our data suggest that the VTC region has a key role in the early processing of faces, but not of bodies. Instead, the LOTC, which includes the extra-striate body area (EBA), appears the dominant area for early body perception, whereas the VTC contributes to late and post-perceptual processing.	[Meeren, Hanneke K. M.; de Gelder, Beatrice] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Ahlfors, Seppo P.; Hamalainen, Matti S.; Hadjikhani, Nouchine] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Tilburg University; Harvard University; Massachusetts General Hospital	de Gelder, B (corresponding author), Tilburg Univ, NL-5000 LE Tilburg, Netherlands.	b.degelder@uvt.nl	Hamalainen, Matti S/C-8507-2013; Hadjikhani, Nouchine/C-2018-2008; Ahlfors, Seppo/P-3644-2016	Hadjikhani, Nouchine/0000-0003-4075-3106; Ahlfors, Seppo/0000-0001-7674-6931	National Institute of Health (NIH) [RO1NS44824, 5R01EB009048, 5R01NS037462, R01NS57500]; Netherlands Organization for Scientific Research (NWO) [R 95-403, 451-05-014]; MIND institute; Center for Functional Neuroimaging Technologies (NIH) [P41 RR14075]; Swiss National Foundation [PPOOP3_130191]; Human Frontier Science Program [RGP0054/2004-C]; EU [FDP6-NEST-043403]; TANGO (FP7 FET-Open); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044824, R01NS057500, R01NS037462] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); MIND institute; Center for Functional Neuroimaging Technologies (NIH); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Human Frontier Science Program(Human Frontier Science Program); EU(European Commission); TANGO (FP7 FET-Open); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health (NIH) (grant number RO1NS44824 to NH) and the Netherlands Organization for Scientific Research (NWO grants number R 95-403 and number 451-05-014 to HKMM). MSH, SPA and BdG were supported by the MIND institute, MSH by the Center for Functional Neuroimaging Technologies (NIH grant number P41 RR14075) as well as NIH grants 5R01EB009048 and 5R01NS037462, SPA by NIH grant R01NS57500 and NH by the Swiss National Foundation (PPOOP3_130191). Partial support was also provided by the Human Frontier Science Program (grant number RGP0054/2004-C) and the EU project grants COBOL (FDP6-NEST-043403) and TANGO (FP7 FET-Open) to BdG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, HUM BRAIN MAPP, V31, P140, DOI 10.1002/hbm.20851; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Barbeau EJ, 2008, CEREB CORTEX, V18, P997, DOI 10.1093/cercor/bhm140; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Corrigan NM, 2009, BRAIN TOPOGR, V22, P83, DOI 10.1007/s10548-009-0086-5; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Downing PE, 2004, COGNITION, V93, pB27, DOI 10.1016/j.cognition.2003.10.010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Ekman P., 1975, UNMASKING FACE; Ekman P., 1976, PICTURES FACIAL AFFE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gliga T, 2005, J COGNITIVE NEUROSCI, V17, P1328, DOI 10.1162/0898929055002481; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Henson RN, 2007, NEUROIMAGE, V38, P422, DOI 10.1016/j.neuroimage.2007.07.026; Henson RN, 2009, NEUROIMAGE, V47, P581, DOI 10.1016/j.neuroimage.2009.04.063; Hietanen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024408; Ishizu T, 2010, NEUROSCI LETT, V481, P36, DOI 10.1016/j.neulet.2010.06.047; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Itier RJ, 2006, BRAIN RES, V1115, P108, DOI 10.1016/j.brainres.2006.07.072; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lewis S, 2003, NEUROREPORT, V14, P1841, DOI 10.1097/00001756-200310060-00017; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Meeren HKM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003503; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Minnebusch DA, 2010, NEUROIMAGE, V49, P2746, DOI 10.1016/j.neuroimage.2009.10.046; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Mnatsakanian EV, 2004, CLIN NEUROPHYSIOL, V115, P880, DOI 10.1016/j.clinph.2003.11.027; Okazaki Y, 2008, NEUROSCIENCE, V152, P1130, DOI 10.1016/j.neuroscience.2008.01.056; Ono M, 1990, ATLAS CEREBRAL SULCI; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Pitcher D, 2012, J NEUROSCI, V32, P15877, DOI 10.1523/JNEUROSCI.2624-12.2012; Puce A, 1996, J NEUROSCI, V16, P5205; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Rolls ET, 2006, EXP BRAIN RES, V170, P74, DOI 10.1007/s00221-005-0191-y; Sadeh B, 2011, CURR BIOL, V21, P1894, DOI 10.1016/j.cub.2011.09.030; Sadeh B, 2010, HUM BRAIN MAPP, V31, P1490, DOI 10.1002/hbm.20952; Sakreida K, 2005, J NEUROSCI, V25, P1335, DOI 10.1523/JNEUROSCI.4170-04.2005; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Sato N, 1999, NEUROREPORT, V10, P3633, DOI 10.1097/00001756-199911260-00031; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; Tanskanen T, 2005, CEREB CORTEX, V15, P526, DOI 10.1093/cercor/bhh152; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Taylor JC, 2010, BRAIN COGNITION, V73, P153, DOI 10.1016/j.bandc.2010.04.001; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Van den Stock J, 2014, HUM BRAIN MAPP, V35, P492, DOI 10.1002/hbm.22195; van Heijnsbergen CCRJ, 2007, BRAIN RES, V1186, P233, DOI 10.1016/j.brainres.2007.09.093; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Watanabe S, 1999, COGNITIVE BRAIN RES, V8, P125, DOI 10.1016/S0926-6410(99)00013-0	90	32	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e71408	10.1371/journal.pone.0071408	http://dx.doi.org/10.1371/journal.pone.0071408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039712	Green Published, gold			2022-12-25	WOS:000324856500005
J	Berg-Larsen, A; Landsverk, OJB; Progida, C; Gregers, TF; Bakke, O				Berg-Larsen, Axel; Landsverk, Ole J. B.; Progida, Cinzia; Gregers, Tone F.; Bakke, Oddmund			Differential Regulation of Rab GTPase Expression in Monocyte-Derived Dendritic Cells upon Lipopolysaccharide Activation: A Correlation to Maturation-Dependent Functional Properties	PLOS ONE			English	Article							CLASS-II TRANSPORT; EXCHANGE FACTOR; MEMBRANE TRAFFICKING; NUCLEOTIDE EXCHANGE; SCREEN REVEALS; ARF6; MACROPHAGES; PROTEINS; EFFECTOR; RECRUITMENT	The regulation of Rab expression to modulate cellular function has recently been proposed. Dendritic cells are a prototypic example of cells that drastically alter their function in response to environmental cues by reducing endocytosis, secreting cytokines, changing surface protein repertoires and altering morphology and migration. This is not a binary event, but is subject to fluctuations through the activation process, termed maturation. Consequently, DCs transiently increase endocytosis and production of major histocompatibility complex class II molecules, and secrete inflammatory cytokines in infected tissues before migrating to secondary lymph nodes and releasing T cell polarizing factors. All these cellular processes rely on intracellular membrane transport, which is regulated by Rab family GTPases and their diverse effectors. Here we examine how the Rabs likely to be involved in these functions are regulated throughout DC maturation. We find that Rab expression is altered upon lipopolysaccharide-induced activation, and discuss how this correlates to the reported functions of these cells during maturation.	[Berg-Larsen, Axel; Landsverk, Ole J. B.; Progida, Cinzia; Gregers, Tone F.; Bakke, Oddmund] Univ Oslo, Dept Biosci, Ctr Immune Regulat, Oslo, Norway	University of Oslo	Landsverk, OJB (corresponding author), Univ Oslo, Dept Biosci, Ctr Immune Regulat, Oslo, Norway.	o.j.b.landsverk@ibv.uio.no	Progida, Cinzia/AAA-1411-2019; Landsverk, Ole Jørgen Bjarnason/J-1975-2019	Progida, Cinzia/0000-0002-9254-0690; Landsverk, Ole Jørgen Bjarnason/0000-0002-1367-2397; Bakke, Oddmund/0000-0003-4843-7626	University of Oslo; Norwegian Research council; Norwegian Cancer Society	University of Oslo; Norwegian Research council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	Funding provided by University of Oslo, Norwegian Research council and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire PD, 2012, J CELL SCI; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barois N, 2002, TRAFFIC, V3, P894, DOI 10.1034/j.1600-0854.2002.31205.x; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cardoso CMP, 2010, TRAFFIC, V11, P221, DOI 10.1111/j.1600-0854.2009.01013.x; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Catz SD, 2013, J LEUKOC BIOL; Chabrillat ML, 2005, MOL BIOL CELL, V16, P1640, DOI 10.1091/mbc.e04-09-0770; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Egami Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006689; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hooper S, 2010, BRIT J CANCER, V102, P392, DOI 10.1038/sj.bjc.6605469; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Krawczyk M, 2007, NUCLEIC ACIDS RES, V35, P595, DOI 10.1093/nar/gkl980; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Landsverk OJB, 2012, J LEUKOCYTE BIOL, V91, P729, DOI 10.1189/jlb.0311150; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li GP, 1997, J BIOL CHEM, V272, P10337; Linford A, 2012, DEV CELL, V22, P952, DOI 10.1016/j.devcel.2012.04.010; LLEDO PM, 1993, NATURE, V364, P540, DOI 10.1038/364540a0; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Mori R, 2011, EUR J IMMUNOL, V41, P3230, DOI 10.1002/eji.201141640; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ohbayashi N, 2012, MOL BIOL CELL, V23, P669, DOI 10.1091/mbc.E11-04-0324; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Pei G, 2012, J LEUKOCYTE BIOL, V92, P41, DOI 10.1189/jlb.0212076; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Progida C, 2012, TRAFFIC, V13, P1273, DOI 10.1111/j.1600-0854.2012.01388.x; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Yang MJ, 2004, BIOCHEM BIOPH RES CO, V318, P792, DOI 10.1016/j.bbrc.2004.04.115; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zhang Q, 1999, MOL CELL BIOL, V19, P8158; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	89	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73538	10.1371/journal.pone.0073538	http://dx.doi.org/10.1371/journal.pone.0073538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039975	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600085
J	Moore, M; Berejikian, BA; Tezak, EP				Moore, Megan; Berejikian, Barry A.; Tezak, Eugene P.			A Floating Bridge Disrupts Seaward Migration and Increases Mortality of Steelhead Smolts in Hood Canal, Washington State	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; TROUT ONCORHYNCHUS-MYKISS; HARBOR SEALS; MARINE MORTALITY; PHOCA-VITULINA; RIVER; PREDATION; SURVIVAL; MOVEMENTS; CONSUMPTION	Background: Habitat modifications resulting from human transportation and power-generation infrastructure (e.g., roads, dams, bridges) can impede movement and alter natural migration patterns of aquatic animal populations, which may negatively affect survival and population viability. Full or partial barriers are especially problematic for migratory species whose life histories hinge on habitat connectivity. Methodology/Principal Findings: The Hood Canal Bridge, a floating structure spanning the northern outlet of Hood Canal in Puget Sound, Washington, extends 3.6 meters underwater and forms a partial barrier for steelhead migrating from Hood Canal to the Pacific Ocean. We used acoustic telemetry to monitor migration behavior and mortality of steelhead smolts passing four receiver arrays and several single receivers within the Hood Canal, Puget Sound, and Strait of Juan de Fuca. Twenty-seven mortality events were detected within the vicinity of the Hood Canal Bridge, while only one mortality was recorded on the other 325 receivers deployed throughout the study area. Migrating steelhead smolts were detected at the Hood Canal Bridge array with greater frequency, on more receivers, and for longer durations than smolts migrating past three comparably configured arrays. Longer migration times and paths are likely to result in a higher density of smolts near the bridge in relation to other sites along the migration route, possibly inducing an aggregative predator response to steelhead smolts. Conclusions/Significance: This study provides strong evidence of substantial migration interference and increased mortality risk associated with the Hood Canal Bridge, and may partially explain low early marine survival rates observed in Hood Canal steelhead populations. Understanding where habitat modifications indirectly increase predation pressures on threatened populations helps inform potential approaches to mitigation.	[Moore, Megan; Berejikian, Barry A.; Tezak, Eugene P.] Natl Ocean & Atmospher Adm Fisheries, NW Fisheries Sci Ctr, Manchester Res Lab, Manchester, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Moore, M (corresponding author), Natl Ocean & Atmospher Adm Fisheries, NW Fisheries Sci Ctr, Manchester Res Lab, Manchester, WA USA.	megan.moore@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	National Oceanic and Atmospheric Administration Fisheries	National Oceanic and Atmospheric Administration Fisheries	This study was funded through National Oceanic and Atmospheric Administration Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAX NJ, 1983, CAN J FISH AQUAT SCI, V40, P426, DOI 10.1139/f83-061; BEAMESDERFER RC, 1991, T AM FISH SOC, V120, P439, DOI 10.1577/1548-8659(1991)120<0439:AADONS>2.3.CO;2; Beamesderfer RCP, 1997, ENVIRON BIOL FISH, V48, P407, DOI 10.1023/A:1007310916515; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Beeman JW, 2006, T AM FISH SOC, V135, P584, DOI 10.1577/T05-193.1; BROWN JR, 1992, CAN J FISH AQUAT SCI, V49, P358, DOI 10.1139/f92-041; BROWN RF, 1983, FISH B-NOAA, V81, P291; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Emmett RL, 2004, FISH OCEANOGR, V13, P392, DOI 10.1111/j.1365-2419.2004.00294.x; HASSELL MP, 1966, J ANIM ECOL, V35, P65, DOI 10.2307/2690; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries Steven J., 1997, P107; Keefer ML, 2012, T AM FISH SOC, V141, P1236, DOI 10.1080/00028487.2012.688918; Keefer ML, 2004, T AM FISH SOC, V133, P1413, DOI 10.1577/T03-223.1; Laake JL, 2002, FISH B-NOAA, V100, P434; Lacroix GL, 2004, T AM FISH SOC, V133, P1455, DOI 10.1577/T03-032.1; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Melnychuk MC, 2013, ENVIRON BIOL FISH, V96, P325, DOI 10.1007/s10641-012-9976-6; Middlemas SJ, 2006, P ROY SOC B-BIOL SCI, V273, P193, DOI 10.1098/rspb.2005.3215; Moore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049645; Moore ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012881; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; National Marine Fisheries Service, 1997, NMFSNWFSC28; ( National Research Council) NRC, 1996, UPSTR SALM SOC PAC N; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; PARKER RR, 1968, J FISH RES BOARD CAN, V25, P757, DOI 10.1139/f68-068; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Porter AD, 2012, MARINE FRESHWATER ME; Price B.E., 2008, MOVEMENT HABITAT USE; Prime JH, 1979, OBSERVATIONS DIGESTI; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; RAYMOND HL, 1979, T AM FISH SOC, V108, P505, DOI 10.1577/1548-8659(1979)108<505:EODAIO>2.0.CO;2; RAYMOND HL, 1969, T AM FISH SOC, V98, P513, DOI 10.1577/1548-8659(1969)98[513:EOJDRO]2.0.CO;2; RUGGERONE GT, 1990, CAN J FISH AQUAT SCI, V47, P1963, DOI 10.1139/f90-221; RUGGERONE GT, 1986, T AM FISH SOC, V115, P736, DOI 10.1577/1548-8659(1986)115<736:COMJSB>2.0.CO;2; Sandstrom P, 2013, ENVIRON BIOL FISH, V96, P145, DOI 10.1007/s10641-012-0051-0; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111&lt;255:PIBLBA&gt;2.0.CO;2; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Van Winkle, 2000, ENV SCI POLICY S1, V3, P483, DOI [10.1016/S1462-9011(00)00063-0, DOI 10.1016/S1462-9011(00)00063-0]; Venditti David A., 2000, North American Journal of Fisheries Management, V20, P41, DOI 10.1577/1548-8675(2000)020<0041:MBAFDO>2.0.CO;2; Ward EJ, 2012, CONSERV LETT, V5, P37, DOI 10.1111/j.1755-263X.2011.00210.x; Wargo-Rub AM, 2012, SURVIVAL ADULT SPRIN; Welch DW, 2011, P NATL ACAD SCI USA, V108, P8708, DOI 10.1073/pnas.1014044108; Wright BE, 2007, ECOL APPL, V17, P338, DOI 10.1890/05-1941	49	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73427	10.1371/journal.pone.0073427	http://dx.doi.org/10.1371/journal.pone.0073427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039937	Green Published, gold			2022-12-25	WOS:000324481600075
J	Bracewell, SA; Robinson, LA; Firth, LB; Knights, AM				Bracewell, Sally A.; Robinson, Leonie A.; Firth, Louise B.; Knights, Antony M.			Predicting Free-Space Occupancy on Novel Artificial Structures by an Invasive Intertidal Barnacle Using a Removal Experiment	PLOS ONE			English	Article							COASTAL DEFENSE STRUCTURES; POPULATION-DYNAMICS; PROPAGULE PRESSURE; URBAN STRUCTURES; SETTLEMENT RATE; DISTURBANCE; RECRUITMENT; DIVERSITY; DENSITY; PERSISTENCE	Artificial structures can create novel habitat in the marine environment that has been associated with the spread of invasive species. They are often located in areas of high disturbance and can vary significantly in the area of free space provided for settlement of marine organisms. Whilst correlation between the amount of free space available and recruitment success has been shown in populations of several marine benthic organisms, there has been relatively little focus on invasive species, a group with the potential to reproduce in vast numbers and colonise habitats rapidly. Invasion success following different scales of disturbance was examined in the invasive acorn barnacle, Austrominius modestus, on a unique art installation located in Liverpool Bay. Population growth and recruitment success were examined by comparing recruitment rates within disturbance clearings of 4 different sizes and by contrasting population development with early recruitment rates over a 10 week period. Disturbed areas were rapidly recolonised and monocultures of A. modestus formed within 6 weeks. The size of patch created during disturbance had no effect on the rate of recruitment, while a linear relationship between recruit density and patch size was observed. Density-dependent processes mediated initial high recruitment resulting in population stability after 8-10 weeks, but densities continued to greatly exceed those reported in natural habitats. Given that artificial structures are likely to continue to proliferate in light of climate change projections, free-space is likely to become more available more frequently in the future supporting the expansion of fast-colonising species.	[Bracewell, Sally A.; Robinson, Leonie A.; Knights, Antony M.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Firth, Louise B.] Natl Univ Ireland Galway, Ryan Inst, Galway, Ireland	University of Liverpool; Ollscoil na Gaillimhe-University of Galway	Bracewell, SA (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	s.bracewell@student.unsw.edu.au		Knights, Antony/0000-0002-0916-3469	Esmee Fairbairn Foundation grant via the URBANE project (Urban Research on Biodiversity on Artificial and Natural coastal Environments)	Esmee Fairbairn Foundation grant via the URBANE project (Urban Research on Biodiversity on Artificial and Natural coastal Environments)	The completion of MRes by Sally Bracewell was supported by an Esmee Fairbairn Foundation grant via the URBANE project (Urban Research on Biodiversity on Artificial and Natural coastal Environments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Alexander SE, 1996, ECOL MONOGR, V66, P259, DOI 10.2307/2963518; Bando KJ, 2006, BIOL INVASIONS, V8, P755, DOI 10.1007/s10530-005-3543-4; BISHOP MWH, 1947, NATURE, V159, P501, DOI 10.1038/159501a0; BLACKBURN TM, 1990, J ANIM ECOL, V59, P335, DOI 10.2307/5176; Bracewell SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048863; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burgess SC, 2011, J ANIM ECOL, V80, P681, DOI 10.1111/j.1365-2656.2010.01802.x; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Clark GF, 2011, ECOL LETT, V14, P52, DOI 10.1111/j.1461-0248.2010.01550.x; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; Crawley M.J., 1989, BIOL INVASIONS GLOBA, P407; CRISP DJ, 1961, LIMNOL OCEANOGR, V6, P105, DOI 10.4319/lo.1961.6.2.0105; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P483, DOI 10.1017/S0025315400023833; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Dumont CP, 2011, BIOL INVASIONS, V13, P2023, DOI 10.1007/s10530-011-0018-7; Dumont CP, 2011, MAR ECOL PROG SER, V427, P95, DOI 10.3354/meps09040; Ehrlich P.R., 1989, BIOL INVASIONS GLOBA, P315; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; Findlay HS, 2010, ECOLOGY, V91, P2931, DOI 10.1890/09-1987.1; Firth LB, 2013, DIVERS DISTRIB, V19, P1275, DOI 10.1111/ddi.12079; Firth LB, 2011, J EXP MAR BIOL ECOL, V400, P1, DOI 10.1016/j.jembe.2011.02.001; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Glasby TM, 1999, AMBIO, V28, P595; Gotelli NJ, 2001, PRIMER ECOLOGY; Herbert RJH, 2007, J MAR BIOL ASSOC UK, V87, P487, DOI 10.1017/S0025315407052745; Jarrett JN, 2008, J CRUSTACEAN BIOL, V28, P16, DOI 10.1651/07-2851R.1; Jenkins SR, 2008, J ANIM ECOL, V77, P573, DOI 10.1111/j.1365-2656.2008.01366.x; KNIGHTJONES EW, 1950, J MAR BIOL ASSOC UK, V29, P281, DOI 10.1017/S0025315400055375; Knights AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035096; Knights AM, 2010, MAR ECOL PROG SER, V404, P79, DOI 10.3354/meps08480; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Martin D, 2005, COAST ENG, V52, P1027, DOI 10.1016/j.coastaleng.2005.09.006; MENGE BA, 1991, J EXP MAR BIOL ECOL, V146, P69, DOI 10.1016/0022-0981(91)90255-U; MINCHINTON TE, 1993, MAR ECOL PROG SER, V95, P233, DOI 10.3354/meps095233; Moschella PS, 2005, COAST ENG, V52, P1053, DOI 10.1016/j.coastaleng.2005.09.014; Muxagata E, 2004, ICES J MAR SCI, V61, P585, DOI 10.1016/j.icesjms.2004.03.015; PINEDA J, 1994, MAR ECOL PROG SER, V107, P125, DOI 10.3354/meps107125; Sams MA, 2007, MAR ECOL PROG SER, V348, P85, DOI 10.3354/meps07012; Sams MA, 2013, OECOLOGIA, V173, P259, DOI 10.1007/s00442-013-2597-8; Shanks AL, 2009, BIOL BULL-US, V216, P373; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; THOMAS CD, 1990, CONSERV BIOL, V4, P324, DOI 10.1111/j.1523-1739.1990.tb00295.x; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; WETHEY DS, 1984, J MAR BIOL ASSOC UK, V64, P687, DOI 10.1017/S0025315400030356; Wilson JC, 2009, WIND ENERGY, V12, P203, DOI 10.1002/we.324; Zuur Alain F., 2009, P1	53	25	25	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74457	10.1371/journal.pone.0074457	http://dx.doi.org/10.1371/journal.pone.0074457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023944	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600141
J	Heyndrickx, L; Stewart-Jones, G; Jansson, M; Schuitemaker, H; Bowles, E; Buonaguro, L; Grevstad, B; Vinner, L; Vereecken, K; Parker, J; Ramaswamy, M; Biswas, P; Vanham, G; Scarlatti, G; Fomsgaard, A				Heyndrickx, Leo; Stewart-Jones, Guillaume; Jansson, Marianne; Schuitemaker, Hanneke; Bowles, Emma; Buonaguro, Luigi; Grevstad, Berit; Vinner, Lasse; Vereecken, Katleen; Parker, Joe; Ramaswamy, Meghna; Biswas, Priscilla; Vanham, Guido; Scarlatti, Gabriella; Fomsgaard, Anders		NGIN Consortium	Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING HUMORAL IMMUNITY; ENVELOPE GLYCOPROTEIN; DISEASE PROGRESSION; ANTIBODY-RESPONSES; MACAQUE MONKEYS; MONOMERIC GP120; CHIMERIC VIRUS; ADJUVANT CAF01; IN-VITRO	Background: Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) during chronic infection. We hypothesized that immunizing rabbits with viral envelope glycoproteins (Envs) from these patients may induce bNAbs, when formulated as a trimeric protein and in the presence of an adjuvant. Methods: Based on in vitro neutralizing activity in serum, patients with bNAbs were selected for cloning of their HIV-1 Env. Seven stable soluble trimeric gp140 proteins were generated from sequences derived from four adults and two children infected with either clade A or B HIV-1. From one of the clade A Envs both the monomeric and trimeric Env were produced for comparison. Rabbits were immunized with soluble gp120 or trimeric gp140 proteins in combination with the adjuvant dimethyl dioctadecyl ammonium/trehalose dibehenate (CAF01). Env binding in rabbit immune serum was determined using ELISAs based on gp120-IIIB protein. Neutralizing activity of IgG purified from rabbit immune sera was measured with the pseudovirus-TZMbl assay and a PBMC-based neutralization assay for selected experiments. Results: It was initially established that gp140 trimers induce better antibody responses over gp120 monomers and that the adjuvant CAF01 was necessary for such strong responses. Gp140 trimers, based on HIV-1 variants from patients with bNAbs, were able to elicit both gp120(IIIB) specific IgG and NAbs to Tier 1 viruses of different subtypes. Potency of NAbs closely correlated with titers, and an gp120-binding IgG titer above a threshold of 100,000 was predictive of neutralization capability. Finally, peptide inhibition experiments showed that a large fraction of the neutralizing IgG was directed against the gp120 V3 region. Conclusions: Our results indicate that the strategy of reverse immunology based on selected Env sequences is promising when immunogens are delivered as stabilized trimers in CAF01 adjuvant and that the rabbit is a valuable model for HIV vaccine studies.	[Heyndrickx, Leo; Vereecken, Katleen; Vanham, Guido] Inst Trop Med, Biomed Dept, Virol Unit, B-2000 Antwerp, Belgium; [Stewart-Jones, Guillaume; Bowles, Emma; Parker, Joe] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England; [Jansson, Marianne] Lund Univ, Dept Lab Med, Lund, Sweden; [Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Buonaguro, Luigi] Ist Nazl Tumori, Mol Biol & Viral Oncogenesis Unit, Naples, Italy; [Grevstad, Berit; Vinner, Lasse; Fomsgaard, Anders] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Ramaswamy, Meghna] Natl Inst Biol Stand & Controls, Hertford, England; [Biswas, Priscilla; Scarlatti, Gabriella] Ist Sci San Raffaele, Transplantat & Infect Dis, Div Immunol, Viral Evolut & Transmiss Unit, I-20132 Milan, Italy; [Vanham, Guido] Univ Antwerp, Biomed Dept, B-2020 Antwerp, Belgium; [Fomsgaard, Anders] Univ Southern Denmark, Inst Clin, Odense, Denmark	Institute of Tropical Medicine (ITM); University of Oxford; Lund University; University of Amsterdam; Academic Medical Center Amsterdam; Fondazione IRCCS Istituto Nazionale Tumori Milan; Statens Serum Institut; National Institute for Biological Standards & Control; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Antwerp; University of Southern Denmark	Heyndrickx, L (corresponding author), Inst Trop Med, Biomed Dept, Virol Unit, B-2000 Antwerp, Belgium.	lheyndrickx@itg.be	Buonaguro, Luigi/AAV-5655-2020; scarlatti, gabriella/H-1482-2018	scarlatti, gabriella/0000-0003-2316-2689; Ramaswamy, Meghna/0000-0003-0333-8544; Fomsgaard, Anders/0000-0003-4304-0603; Parker, Joe/0000-0003-3777-2269; Vinner, Lasse/0000-0002-3081-3702; Buonaguro, Luigi/0000-0002-6380-7114	European Community [201433]	European Community(European Commission)	The project "Next Generation HIV-1 Immunogens inducing broadly reactive neutralizing antibodies" (NGIN) was funded by the European Community under grant number 201433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Buonaguro L, 2005, J VIROL, V79, P7059, DOI 10.1128/JVI.79.11.7059-7067.2005; BUONAGURO L, 1995, J VIROL, V69, P7971, DOI 10.1128/JVI.69.12.7971-7981.1995; Buonaguro L, 1998, AIDS RES HUM RETROV, V14, P1287, DOI 10.1089/aid.1998.14.1287; Corbet S, 2000, AIDS RES HUM RETROV, V16, P1997, DOI 10.1089/088922200750054738; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dieltjens T, 2010, J VIROL METHODS, V169, P95, DOI 10.1016/j.jviromet.2010.07.004; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Fomsgaard A, 2011, VACCINE, V29, P7067, DOI 10.1016/j.vaccine.2011.07.025; Gram GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006950; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Heyndrickx L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036438; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Lai RPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035083; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moog C, 1997, AIDS RES HUM RETROV, V13, P19, DOI 10.1089/aid.1997.13.19; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Ripamonti C, 2007, AIDS RES HUM RETROV, V23, P1531, DOI 10.1089/aid.2006.0215; Roman VRG, 2010, J IMMUNOL METHODS, V363, P29, DOI 10.1016/j.jim.2010.09.030; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; van Gils MJ, 2010, J VIROL, V84, P3576, DOI 10.1128/JVI.02622-09; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	44	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74552	10.1371/journal.pone.0074552	http://dx.doi.org/10.1371/journal.pone.0074552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023951	Green Published, Green Submitted, gold			2022-12-25	WOS:000324238400099
J	Huang, TH; Chu, TY				Huang, T-H; Chu, T-Y			Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer	ONCOGENE			English	Article							GROWTH-FACTOR EXPRESSION; VASCULAR INTEGRITY; CARCINOMA CELLS; TUMOR; MICRORNA-126; NEOPLASIA; LYMPHANGIOGENESIS; ACTIVATION; ISCHEMIA	miR-126 is an endothelial-specific microRNA essential for maintaining vessel integrity during development. Its role of tumor angiogenesis in cancer stroma is unclear. This study investigated the temporal and spatial expression and the role of miR-126 in the course of cervical carcinogenesis. miR-126 was found to be mainly expressed in the stromal endothelium of the uterine cervix. This downregulation was recapitulated in a cell coculture model, wherein cross talk of cervical cancer cells and fibroblasts induced a downregulation of miR-126 in human umbilical vein endothelial cells, with consequent increase of tube formation. Coinjection of cancer-associated fibroblasts of human cervix enhanced tumorigenesis of cervical cancer cells, with an increase of microvessel density and dye retention in the tumor vasculature. In association with angiogenesis, host-originated miR-126 in these xenograft tumors was progressively downregulated, whereas supplement of the miR-126 precursor in the coinjection suppressed angiogenesis and tumor growth. A proangiogenic gene adrenomedullin (ADM), which was found to be upregulated in the stroma of cervical cancer and which localized mainly in the blood and lymphatic vessels, was identified as a target of inhibition by miR-126 at the carcinoma in situ-to-invasion stage. The study suggests a cancer stroma cross talk induced repression of miR-126 and upregulation of ADM, and probably other proangiogenic factors, to facilitate angiogenesis and invasion growth of cervical cancer.	[Huang, T-H; Chu, T-Y] Tzu Chi Gen Hosp, Dept Res, Ctr Cerv Canc Prevent, Hualien 970, Taiwan; [Huang, T-H; Chu, T-Y] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chu, T-Y] Tzu Chi Univ, Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chu, TY (corresponding author), Tzu Chi Gen Hosp, Dept Obstet & Gynecol, 707,Sect 3,Chung Yang Rd, Hualien 970, Taiwan.	hidrchu@gmail.com		Chu, Tang-Yuan/0000-0003-2717-2681	National Science Council of the Republic of China, Taiwan [NSC 97-2314-B-303-008-MY3]; Buddhist Tzu Chi General Hospital, Hualien, Taiwan [TCRD100-54-01]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Buddhist Tzu Chi General Hospital, Hualien, Taiwan	We thank Ms Yen-Jen Shih for the technical assistance. We also thank Dr Lu-Hai Wang for his comments during the preparation of this manuscript. Ted Knoy is appreciated for his editorial assistance. This study was supported by the National Science Council of the Republic of China, Taiwan (contract number NSC 97-2314-B-303-008-MY3) and by the Buddhist Tzu Chi General Hospital, Hualien, Taiwan (contract number TCRD100-54-01).	Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Botting SK, 2010, TRANSL ONCOL, V3, P170, DOI 10.1593/tlo.09292; CINTORINO M, 1991, INT J CANCER, V47, P843, DOI 10.1002/ijc.2910470609; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Dellas A, 1997, GYNECOL ONCOL, V67, P27, DOI 10.1006/gyno.1997.4835; Dobbs SP, 1997, BRIT J CANCER, V76, P1410, DOI 10.1038/bjc.1997.571; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Frede S, 2005, CANCER RES, V65, P4690, DOI 10.1158/0008-5472.CAN-04-3877; GUIDI AJ, 1995, J NATL CANCER I, V87, P1237, DOI 10.1093/jnci/87.16.1237; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Iwase T, 2005, CIRCULATION, V111, P356, DOI 10.1161/01.CIR.0000153352.29335.B9; Karpinich NO, 2011, CURR HYPERTENS REV, V7, P228, DOI 10.2174/157340211799304761; Karpinich NO, 2013, FASEB J, V27, P590, DOI 10.1096/fj.12-214080; Kato H, 1997, ENDOCRINOLOGY, V138, P2615, DOI 10.1210/en.138.6.2615; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang KH, 2009, CANCER SCI, V100, P2175, DOI 10.1111/j.1349-7006.2009.01285.x; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang L, 2003, CANCER RES, V63, P3403; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7	36	55	58	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3636	3647		10.1038/onc.2013.335	http://dx.doi.org/10.1038/onc.2013.335			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	24037526				2022-12-25	WOS:000338942900003
J	Bailey, K; Kirk, A; Naik, S; Nace, R; Steele, MB; Suksanpaisan, L; Li, X; Federspiel, MJ; Peng, KW; Kirk, D; Russell, SJ				Bailey, Kent; Kirk, Amber; Naik, Shruthi; Nace, Rebecca; Steele, Michael B.; Suksanpaisan, Lukkana; Li, Xing; Federspiel, Mark J.; Peng, Kah-Whye; Kirk, David; Russell, Stephen J.			Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters	PLOS ONE			English	Article							MULTIPLE-MYELOMA; DEFINING CONDITIONS; TUMOR-THERAPY; GENE-THERAPY; SOLID TUMORS; VIRUS; CANCER; DYNAMICS; THERAPEUTICS; VALIDATION	Simple, inductive mathematical models of oncolytic virotherapy are needed to guide protocol design and improve treatment outcomes. Analysis of plasmacytomas regressing after a single intravenous dose of oncolytic vesicular stomatitis virus in myeloma animal models revealed that intratumoral virus spread was spatially constrained, occurring almost exclusively through radial expansion of randomly distributed infectious centers. From these experimental observations we developed a simple model to calculate the probability of survival for any cell within a treated tumor. The model predicted that small changes to the density of initially infected cells or to the average maximum radius of infected centers would have a major impact on treatment outcome, and this was confirmed experimentally. The new model provides a useful and flexible tool for virotherapy protocol optimization.	[Bailey, Kent; Li, Xing] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Kirk, Amber; Naik, Shruthi; Nace, Rebecca; Steele, Michael B.; Suksanpaisan, Lukkana; Federspiel, Mark J.; Peng, Kah-Whye; Russell, Stephen J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Kirk, Amber] Mayo Clin, Ctr Translat Sci Act, Rochester, MN USA; [Kirk, David] Consulpack Inc, Minneapolis, MN USA; [Russell, Stephen J.] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Russell, SJ (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	sjr@mayo.edu		Russell, Stephen/0000-0002-0799-6432; Federspiel, Mark/0000-0002-3713-186X; Naik, Shruthi/0000-0002-8593-9193	Al and Mary Agnes McQuinn; National Institute on Health [R01 CA1006364, RO1 CA129966]; Mayo Clinic Gary and Anita Klesch Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA129966] Funding Source: NIH RePORTER	Al and Mary Agnes McQuinn; National Institute on Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Gary and Anita Klesch Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Al and Mary Agnes McQuinn and the National Institute on Health grant R01 CA1006364 and RO1 CA129966. A. K. is funded by the Mayo Clinic Gary and Anita Klesch Predoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajzer Z, 2008, J THEOR BIOL, V252, P109, DOI 10.1016/j.jtbi.2008.01.016; Biesecker M, 2010, B MATH BIOL, V72, P469, DOI 10.1007/s11538-009-9456-0; Breitbach CJ, 2010, CYTOKINE GROWTH F R, V21, P85, DOI 10.1016/j.cytogfr.2010.02.001; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dingli D, 2006, MATH BIOSCI, V199, P55, DOI 10.1016/j.mbs.2005.11.001; Dingli D, 2009, CANCER GENE THER, V16, P873, DOI 10.1038/cgt.2009.40; Eftimie R, 2011, B MATH BIOL, V73, P2932, DOI 10.1007/s11538-011-9653-5; Greish K, 2003, CLIN PHARMACOKINET, V42, P1089, DOI 10.2165/00003088-200342130-00002; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jordan BF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00094; Komarova NL, 2010, J THEOR BIOL, V263, P530, DOI 10.1016/j.jtbi.2010.01.009; Melcher A, 1999, J MOL MED-JMM, V77, P824, DOI 10.1007/s001099900066; Mok W, 2009, CLIN CANCER RES, V15, P2352, DOI 10.1158/1078-0432.CCR-08-2082; Naik JD, 2011, CLIN CANCER RES, V17, P4214, DOI 10.1158/1078-0432.CCR-10-2848; Naik S, 2012, LEUKEMIA, V26, P1870, DOI 10.1038/leu.2012.70; Naik S, 2012, CANCER GENE THER, V19, P443, DOI 10.1038/cgt.2012.14; Paiva LR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041918; Paiva LR, 2009, CANCER RES, V69, P1205, DOI 10.1158/0008-5472.CAN-08-2173; RADL J, 1988, AM J PATHOL, V132, P593; Rommelfanger DM, 2012, GENE THER, V19, P543, DOI 10.1038/gt.2011.132; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Tian JP, 2011, MATH BIOSCI ENG, V8, P841, DOI 10.3934/mbe.2011.8.841; Wein LM, 2003, CANCER RES, V63, P1317; Westendorf JJ, 1996, LEUKEMIA, V10, P866; Wodarz D, 2003, HUM GENE THER, V14, P153, DOI 10.1089/104303403321070847; Wodarz D, 2001, CANCER RES, V61, P3501; Wodarz D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002547; Wodarz D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004271; Wongthida P, 2011, HUM GENE THER, V22, P1343, DOI 10.1089/hum.2010.216; Wu JT, 2004, B MATH BIOL, V66, P605, DOI 10.1016/j.bulm.2003.08.016; Wu JT, 2001, B MATH BIOL, V63, P731, DOI 10.1006/bulm.2001.0245	31	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73759	10.1371/journal.pone.0073759	http://dx.doi.org/10.1371/journal.pone.0073759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040057	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500047
J	Elsasser, J; Janssen, MW; Becker, F; Suttmann, H; Schmitt, K; Sester, U; Stockle, M; Sester, M				Elsaesser, Julia; Janssen, Martin W.; Becker, Frank; Suttmann, Henrik; Schmitt, Kai; Sester, Urban; Stoeckle, Michael; Sester, Martina			Antigen-Specific CD4 T Cells Are Induced after Intravesical BCG-Instillation Therapy in Patients with Bladder Cancer and Show Similar Cytokine Profiles as in Active Tuberculosis	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; LATENT TUBERCULOSIS; IMMUNE-RESPONSES; M. TUBERCULOSIS; IMMUNOTHERAPY; INFECTION; CARCINOMA; SKIN; VACCINATION; TESTS	Specific T cell immunity in patients with active tuberculosis is associated with a decrease in multifunctionality. However, it is unknown whether cytokine profiles differ in patients with primary infection and those with prior contact. We therefore used intravesical immunotherapy with attenuated live Bacille Calmette-Guerin (BCG) in patients with urothelial carcinoma as a model to characterise the induction of systemic immunity towards purified protein derivate (PPD) and to study whether cytokine profiles differ depending on pre-existing immunity. Eighteen patients with non-muscle invasive bladder cancer were recruited during the BCG-induction course. Fifty-four healthy individuals served as controls. Interferon (IFN)-gamma and interleukin (IL)-2 producing PPD-specific CD4 T cells were analysed longitudinally before each instillation using a rapid flow-cytometric whole blood immunoassay. Baseline levels of IFN-gamma producing PPD-specific T cells were comparable to controls. T cells showed a 5-fold increase to 0.23% by week 2/3, and further increased 8-fold by week 4/5 (to 0.42%, p=0.0007). Systemic immunity was induced in all patients, although the increase was less pronounced in patients with pre-existing immunity. As in active TB, cytokine profiling during therapy revealed a lower percentage of multifunctional IFN-gamma/IL-2 double-positive T cells compared to controls (60.2% vs. 71.9%, p=0.0003). Of note, when comparing patients with and without pre-existing immunity, cytokine profiles in patients with primary immunity were shifted towards IL-2 single producing T cells (p=0.02), whereas those in patients with pre-existing immunity were shifted towards IFN-gamma single-positivity (p=0.01). In conclusion, systemic T cell responses were induced after BCG-therapy, and their kinetics and cytokine profile depended on pre-existing immunity. Decreased functionality is a typical feature of specific immunity in both patients with active tuberculosis and BCG-therapy. Among patients with active infection, a shift towards IL-2 or IFN-gamma single-positive cells may allow distinction between patients with primary infection and cases with boosted immunity after prior contact, respectively.	[Elsaesser, Julia; Janssen, Martin W.; Stoeckle, Michael] Univ Saarland, Dept Urol, Homburg, Germany; [Elsaesser, Julia; Janssen, Martin W.; Sester, Martina] Univ Saarland, Inst Virol, Dept Transplant & Infect Immunol, Homburg, Germany; [Becker, Frank] Boxberg Ctr, Urol Grp & Clin Derout Ponicke Becker, Neunkirchen, Germany; [Suttmann, Henrik] Urologicum Hamburg, Hamburg, Germany; [Schmitt, Kai] Univ Saarland, Dept Pathol, Homburg, Germany; [Sester, Urban] Univ Saarland, Dept Internal Med 4, Homburg, Germany	Saarland University; Saarland University; Saarland University; Saarland University	Sester, M (corresponding author), Univ Saarland, Inst Virol, Dept Transplant & Infect Immunol, Homburg, Germany.	martina.sester@uks.eu	Sester, Martina/AAA-3383-2022	Sester, Urban/0000-0003-4007-5595; Sester, Martina/0000-0001-5482-0002	medac GmbH	medac GmbH	The study was supported in part by independent research support by medac GmbH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Bilen CY, 2003, J UROLOGY, V169, P1702, DOI 10.1097/01.ju.0000059681.67567.12; Biot C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003586; Bohle A, 2003, J UROLOGY, V170, P964, DOI 10.1097/01.ju.0000073852.24341.4a; Brandau S, 2007, BIOMED PHARMACOTHER, V61, P299, DOI 10.1016/j.biopha.2007.05.004; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; de Boer EC, 2005, EUR UROL, V48, P333, DOI 10.1016/j.eururo.2005.05.004; Dinser R, 2008, RHEUMATOLOGY, V47, P212, DOI 10.1093/rheumatology/kem351; Gontero P, 2010, EUR UROL, V57, P410, DOI 10.1016/j.eururo.2009.11.023; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Herr HW, 2011, EUR UROL, V60, P32, DOI 10.1016/j.eururo.2011.03.051; Higuchi T, 2009, CANCER IMMUNOL IMMUN, V58, P1245, DOI 10.1007/s00262-008-0643-x; KELLEY DR, 1986, J UROLOGY, V135, P268, DOI 10.1016/S0022-5347(17)45605-9; Luftenegger W, 1996, J UROLOGY, V155, P483, DOI 10.1016/S0022-5347(01)66427-9; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Messing EM, 2012, EUR UROL, V62, P935, DOI 10.1016/j.eururo.2012.08.043; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Oddens J, 2013, EUR UROL, V63, P462, DOI 10.1016/j.eururo.2012.10.039; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Pieraerts C, 2012, ONCOIMMUNOLOGY, V1, P694, DOI 10.4161/onci.20526; Ponticiello A, 2004, RESP MED, V98, P509, DOI 10.1016/j.rmed.2003.12.003; PRESCOTT S, 1992, J UROLOGY, V147, P1636, DOI 10.1016/S0022-5347(17)37668-1; Richeldi L, 2009, CHEST, V136, P198, DOI 10.1378/chest.08-2575; Saint F, 2003, EUR UROL, V43, P351, DOI 10.1016/S0302-2838(03)00048-4; Saint F, 2001, J UROLOGY, V166, P2142, DOI 10.1016/S0022-5347(05)65522-X; Schmidt T, 2012, EUR J IMMUNOL, V42, P1755, DOI 10.1002/eji.201242393; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x; Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x; Sester U, 2006, NEPHROL DIAL TRANSPL, V21, P3258, DOI 10.1093/ndt/gfl416; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Vukmanovic-Stejic M, 2011, CURR OPIN IMMUNOL, V23, P525, DOI 10.1016/j.coi.2011.05.008; Watanabe E, 2003, CANCER IMMUNOL IMMUN, V52, P481, DOI 10.1007/s00262-003-0384-9; Zlotta AR, 2000, INT J CANCER, V87, P844, DOI 10.1002/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5; Zlotta AR, 2000, EUR UROL, V37, P470, DOI 10.1159/000020170	42	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e69892	10.1371/journal.pone.0069892	http://dx.doi.org/10.1371/journal.pone.0069892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039703	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500004
J	Xiao, CX; Wang, HH; Shi, Y; Li, P; Liu, YP; Ren, JL; Guleng, B				Xiao, Chuan-Xing; Wang, Huan-Huan; Shi, Ying; Li, Ping; Liu, Yun-Peng; Ren, Jian-Lin; Guleng, Bayasi			Distribution of Bone-Marrow-Derived Endothelial and Immune Cells in a Murine Colitis-Associated Colorectal Cancer Model	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; TUMOR ANGIOGENESIS; PROGENITOR CELLS; DENDRITIC CELLS; MYELOID CELLS; STEM-CELL; T-CELLS; TOLERANCE; GROWTH	Inflammatory bowel disease (IBD) can lead to an increased risk of developing colorectal cancer (CRC). The aim of this study was to establish a model for combined bone marrow transplantation (BMT) and colitis-associated colorectal cancer (CAC) and to define the contribution of BM-derived cells during the inflammation associated with carcinogenesis. We established a model for BMT using green fluorescent protein (GFP) transgenic mice, followed by AOM/DSS-induced CAC, and performed confocal microscopy analysis on in vivo living tissue and frozen tumor sections. Our imaging analyses showed that GFP-positive cells extensively infiltrated the tumor stroma and that some WGA and GFP or CD31 and GFP double-positive cells were observed in the lining of tumor vessels. Flow cytometry analysis of the tumor-infiltrating cells showed that the GFP-positive CD11c+ DCs cells were one-third of the GFP+/CD11C-cells, and that half of these DCs (0.96% vs 1.02%) were GFP-positive BM-derived cells. The majority of CD4(+) T cells were GFP-negative (12.02% vs 1.9%), and we discovered a novel CD4(+) CD11c(+) DC subset (0.34% vs 1.64%). In conclusion, we defined the distribution of BM-derived endothelial cells, CD11c(+) DCs and CD4(+) T cells in tumors. This model might be useful for elucidating the diverse BM-derived cell types and functions during the progression of colitis-associated colorectal cancer.	[Xiao, Chuan-Xing; Wang, Huan-Huan; Shi, Ying; Li, Ping; Liu, Yun-Peng; Ren, Jian-Lin; Guleng, Bayasi] Xiamen Univ, Dept Gastroenterol, Zhongshan Hosp, Xiamen, Fujian Province, Peoples R China; [Guleng, Bayasi] Xiamen Univ, Fac Clin Med, Coll Med, Xiamen, Fujian Province, Peoples R China	Xiamen University; Xiamen University	Ren, JL (corresponding author), Xiamen Univ, Dept Gastroenterol, Zhongshan Hosp, Xiamen, Fujian Province, Peoples R China.	renjianl@xmu.edu.cn; bayasi8@gmail.com			National Natural Science Foundation of China [81072013, 91229201]; Fundamental Research Funds for the Central Universities in China [2010111082]; Foundations of Health Bureau of Xiamen in China [3502Z200940010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; Foundations of Health Bureau of Xiamen in China	This work was supported by the National Natural Science Foundation of China (No. 81072013 and 91229201), Fundamental Research Funds for the Central Universities in China (No. 2010111082) and Foundations of Health Bureau of Xiamen in China (No. 3502Z200940010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyot F, 2005, IEE P SYST BIOL, V152, P61, DOI 10.1049/ip-syb:20045036; Audollent R, 2011, INT J CANCER, V129, P2304, DOI 10.1002/ijc.25882; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Brinster C, 2005, J IMMUNOL, V175, P7332, DOI 10.4049/jimmunol.175.11.7332; Chen GY, 2011, GASTROENTEROLOGY, V141, P1986, DOI 10.1053/j.gastro.2011.10.002; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; Cuenca A, 2003, CANCER RES, V63, P9007; Ding YP, 2012, CANCER MICROENVIRON, V5, P225, DOI 10.1007/s12307-012-0106-y; Direkze NC, 2006, CANCER RES, V66, P1265, DOI 10.1158/0008-5472.CAN-05-3202; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Khoo CP, 2008, REGEN MED, V3, P863, DOI 10.2217/17460751.3.6.863; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Kwah J, 2013, INFLAMM BOWEL DIS, V19, pE44, DOI 10.1002/ibd.22984; Laurent J, 2011, INT J DEV BIOL, V55, P527, DOI 10.1387/ijdb.103228jl; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marguti I, 2009, IMMUNOLOGY, V127, P50, DOI 10.1111/j.1365-2567.2008.02927.x; Melin C, 2012, ANAL CHEM, V84, P1549, DOI 10.1021/ac202797z; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Ricciardi A, 2008, MOL CANCER RES, V6, P175, DOI 10.1158/1541-7786.MCR-07-0391; SACHAR DB, 1994, GUT, V35, P1507, DOI 10.1136/gut.35.11.1507; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thaker AI, 2012, JOVE-J VIS EXP, DOI 10.3791/4100; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47	41	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73666	10.1371/journal.pone.0073666	http://dx.doi.org/10.1371/journal.pone.0073666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040017	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600037
J	Burke, MR; Barnes, GR				Burke, Melanie R.; Barnes, Graham R.			In Pursuit of Delay-Related Brain Activity for Anticipatory Eye Movements	PLOS ONE			English	Article							SHORT-TERM-MEMORY; POSTERIOR PARIETAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL-TRACKING NEURONS; CORTICAL AREA MT; SMOOTH-PURSUIT; WORKING-MEMORY; TRANSIENT DISAPPEARANCE; FUNCTIONAL NEUROANATOMY; TEMPORAL CORTEX	How the brain stores motion information and subsequently uses it to follow a moving target is largely unknown. This is mainly due to previous fMRI studies using paradigms in which the eye movements cannot be segregated from the storage of this motion information. To avoid this problem we used a novel paradigm designed in our lab in which we interlaced a delay (2, 4 or 6 seconds) between the 1st and 2nd presentation of a moving stimulus. Using this design we could examine brain activity during a delay period using fMRI and have subsequently found a number of brain areas that reveal sustained activity during predictive pursuit. These areas include, the V5 complex and superior parietal lobe. This study provides new evidence for the network involved in the storage of visual information to generate early motor responses in pursuit.	[Burke, Melanie R.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Barnes, Graham R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Leeds; University of Manchester	Burke, MR (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	m.r.burke@leeds.ac.uk		Burke, Melanie/0000-0002-2561-053X	Medical Research Council; Translational Imaging Group at Manchester University; Medical Research Council [G0601572] Funding Source: researchfish; MRC [G0601572] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Translational Imaging Group at Manchester University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was sponsored by the Medical Research Council and Translational Imaging Group at Manchester University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Barnes GR, 1999, EXP BRAIN RES, V129, P57, DOI 10.1007/s002210050936; BARNES GR, 1991, J PHYSIOL-LONDON, V439, P439, DOI 10.1113/jphysiol.1991.sp018675; Barnes GR, 2002, EXP BRAIN RES, V144, P322, DOI 10.1007/s00221-002-1050-8; BECKER W, 1985, EXP BRAIN RES, V57, P562; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; BOMAN DK, 1992, VISION RES, V32, P675, DOI 10.1016/0042-6989(92)90184-K; Brandt SA, 1998, EXP BRAIN RES, V118, P197, DOI 10.1007/s002210050272; Brascamp JW, 2010, J NEUROSCI, V30, P760, DOI 10.1523/JNEUROSCI.4171-09.2010; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; BRITTEN KH, 1992, EXP BRAIN RES, V88, P292, DOI 10.1007/BF02259104; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Burke MR, 2008, BRAIN RES, V1245, P74, DOI 10.1016/j.brainres.2008.09.073; Burke MR, 2011, J COGNITIVE NEUROSCI, V23, P3294, DOI 10.1162/jocn_a_00025; Campana G, 2002, CEREB CORTEX, V12, P663, DOI 10.1093/cercor/12.6.663; Chakraborti SR, 2002, EXP BRAIN RES, V144, P152, DOI 10.1007/s00221-002-1008-x; Dicke PW, 1999, BIOL CYBERN, V80, P71, DOI 10.1007/s004220050505; Ding JH, 2009, HUM BRAIN MAPP, V30, P3541, DOI 10.1002/hbm.20777; Ferrera VP, 1997, J NEUROPHYSIOL, V78, P1433, DOI 10.1152/jn.1997.78.3.1433; Fukushima J, 2011, CEREB CORTEX, V21, P1910, DOI 10.1093/cercor/bhq261; Fukushima K, 2008, PROG BRAIN RES, V171, P433, DOI 10.1016/S0079-6123(08)00664-X; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; GREENLEE MW, 1995, J NEUROSCI, V15, P2287, DOI 10.1523/JNEUROSCI.15-03-02287.1995; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Heinen SJ, 2006, J NEUROSCI, V26, P13515, DOI 10.1523/JNEUROSCI.4243-06.2006; Ilg UJ, 2003, NEUROREPORT, V14, P2219, DOI 10.1097/00001756-200312020-00017; Kawasaki M, 2008, BRAIN RES, V1213, P91, DOI 10.1016/j.brainres.2008.03.037; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Kurkin S, 2011, EXP BRAIN RES, V214, P293, DOI 10.1007/s00221-011-2825-6; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Lui LL, 2011, J NEUROPHYSIOL, V106, P1260, DOI 10.1152/jn.00016.2011; Magen H, 2009, NEUROPSYCHOLOGIA, V47, P1790, DOI 10.1016/j.neuropsychologia.2009.02.015; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Mazaika P, 2009, PERCENT SIGNAL CHANG; MCDANIEL WF, 1994, NEUROREPORT, V5, P1713, DOI 10.1097/00001756-199409080-00006; Missal M, 2004, J NEUROPHYSIOL, V92, P1257, DOI 10.1152/jn.01255.2003; Missal M, 2001, J NEUROPHYSIOL, V86, P2413, DOI 10.1152/jn.2001.86.5.2413; Mitchell DJ, 2008, CEREB CORTEX, V18, P1788, DOI 10.1093/cercor/bhm205; Murthy A, 2007, J NEUROPHYSIOL, V97, P1457, DOI 10.1152/jn.00433.2006; Mustari MJ, 2009, ANN NY ACAD SCI, V1164, P147, DOI 10.1111/j.1749-6632.2009.03859.x; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Nagel M, 2008, NEUROIMAGE, V41, P483, DOI 10.1016/j.neuroimage.2008.02.058; O'Driscoll GA, 2000, NEUROREPORT, V11, P1335, DOI 10.1097/00001756-200004270-00037; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Pierrot-Deseilligny C, 2002, ANN NEUROL, V52, P10, DOI 10.1002/ana.10273; Poliakoff E, 2005, COGNITIVE BRAIN RES, V25, P688, DOI 10.1016/j.cogbrainres.2005.08.016; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Schluppeck D, 2006, J NEUROSCI, V26, P5098, DOI 10.1523/JNEUROSCI.5330-05.2006; Schmid A, 2001, NEUROREPORT, V12, P1409, DOI 10.1097/00001756-200105250-00023; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Shichinohe N, 2009, NEURON, V62, P717, DOI 10.1016/j.neuron.2009.05.010; Silvanto J, 2010, NEUROIMAGE, V50, P1683, DOI 10.1016/j.neuroimage.2010.01.021; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Thier P, 2006, PROG BRAIN RES, V151, P293, DOI 10.1016/S0079-6123(05)51010-0; THIER P, 1992, ANN NY ACAD SCI, V656, P960, DOI 10.1111/j.1749-6632.1992.tb25307.x; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Yang SN, 2010, J NEUROPHYSIOL, V103, P2458, DOI 10.1152/jn.00215.2009	65	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73326	10.1371/journal.pone.0073326	http://dx.doi.org/10.1371/journal.pone.0073326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039911	Green Published, Green Accepted, gold			2022-12-25	WOS:000326405300064
J	Murakami, R; Denda-Nagai, K; Hashimoto, S; Nagai, S; Hattori, M; Irimura, T				Murakami, Ryuichi; Denda-Nagai, Kaori; Hashimoto, Shin-ichi; Nagai, Shigenori; Hattori, Masahira; Irimura, Tatsuro			A Unique Dermal Dendritic Cell Subset That Skews the Immune Response toward Th2	PLOS ONE			English	Article							C-TYPE LECTIN; DRAINING LYMPH-NODES; CD4(+) T-CELLS; LANGERHANS CELLS; CONTACT HYPERSENSITIVITY; MOLECULAR-CLONING; FLUORESCEIN ISOTHIOCYANATE; HOST-DEFENSE; OX40 LIGAND; IN-VIVO	Dendritic cell (DC) subsets in the skin and draining lymph nodes (LNs) are likely to elicit distinct immune response types. In skin and skin-draining LNs, a dermal DC subset expressing macrophage galactose-type C-type lectin 2 (MGL2/CD301b) was found distinct from migratory Langerhans cells (LCs) or CD103(+) dermal DCs (dDCs). Lower expression levels of Th1-promoting and/or cross-presentation-related molecules were suggested by the transcriptome analysis and verified by the quantitative real-time PCR analysis in MGL2(+) dDCs than in CD103(+) dDCs. Transfer of MGL2(+) dDCs but not CD103(+) dDCs from FITC-sensitized mice induced a Th2-type immune response in vivo in a model of contact hypersensitivity. Targeting MGL2(+) dDCs with a rat monoclonal antibody against MGL2 efficiently induced a humoral immune response with Th2-type properties, as determined by the antibody subclass. We propose that the properties of MGL2(+) dDCs, are complementary to those of CD103(+) dDCs and skew the immune response toward a Th2-type response.	[Murakami, Ryuichi; Denda-Nagai, Kaori; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan; [Hashimoto, Shin-ichi; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan; [Nagai, Shigenori] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	University of Tokyo; University of Tokyo; Keio University	Denda-Nagai, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan.	denda@mol.f.u-tokyo.ac.jp; irimura@mol.f.u-tokyo.ac.jp	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019	Hattori, Masahira/0000-0001-9467-0344; Nagai, Shigenori/0000-0002-5018-5942; Murakami, Ryuichi/0000-0001-8257-585X; Denda-Nagai, Kaori/0000-0001-8325-3289	Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Medical Glycomics Project of New Energy Development Organization	Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Medical Glycomics Project of New Energy Development Organization	The study was supported in part by a grants from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI) and Medical Glycomics Project of New Energy Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2007, J IMMUNOL, V179, P6830, DOI 10.4049/jimmunol.179.10.6830; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bialecki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026919; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Feili-Hariri M, 2005, J LEUKOCYTE BIOL, V78, P656, DOI 10.1189/jlb.1104631; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Suzuki N, 1996, J IMMUNOL, V156, P128; Takeshita K, 2004, INT IMMUNOL, V16, P685, DOI 10.1093/intimm/dxh073; TOEWS GB, 1980, J IMMUNOL, V124, P445; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van de Ven R, 2011, BLOOD, V118, P2502, DOI 10.1182/blood-2011-03-344838; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Wang BH, 2003, CYTOKINE GROWTH F R, V14, P381, DOI 10.1016/S1359-6101(03)00050-9; Wick DA, 2011, VACCINE, V29, P984, DOI 10.1016/j.vaccine.2010.11.036; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	80	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73270	10.1371/journal.pone.0073270	http://dx.doi.org/10.1371/journal.pone.0073270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039898	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300061
J	Ni, Y; Sinnett-Smith, J; Young, SH; Rozengurt, E				Ni, Yang; Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique			PKD1 Mediates Negative Feedback of PI3K/Akt Activation in Response to G Protein-Coupled Receptors	PLOS ONE			English	Article							KINASE-D ACTIVATION; INTESTINAL EPITHELIAL-CELLS; POTENTIATES DNA-SYNTHESIS; IN-VIVO; LOOP SER(744); PHOSPHOINOSITIDE 3-KINASE; G(Q)-COUPLED RECEPTORS; ALPHA-SUBUNITS; LYSOPHOSPHATIDIC ACID; REGULATORY SUBUNIT	We examined whether protein kinase D1 (PKD1) mediates negative feeback of PI3K/Akt signaling in intestinal epithelial cells stimulated with G protein-coupled receptor (GPCR) agonists. Exposure of intestinal epithelial IEC-18 cells to increasing concentrations of the PKD family inhibitor kb NB 142-70, at concentrations that inhibited PKD1 activation, strikingly potentiated Akt phosphorylation at Thr(308) and Ser(473) in response to the mitogenic GPCR agonist angiotensin II (ANG II). Enhancement of Akt activation by kb NB 142-70 was also evident in cells with other GPCR agonists, including vasopressin and lysophosphatidic acid. Cell treatment rovincial Hospital Affiliated to Shandong University, Jinan, China with the structurally unrelated PKD family inhibitor CRT0066101 increased Akt phosphorylation as potently as kb NB 142-70. Knockdown of PKD1 with two different siRNAs strikingly enhanced Akt phosphorylation in response to ANG II stimulation in IEC-18 cells. To determine whether treatment with kb NB 142-70 enhances accumulation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in the plasma membrane, we monitored the redistribution of Akt-pleckstrin homology domain-green fluorescent protein (Akt-PH-GFP) in single IEC-18 cells. Exposure to kb NB 142-70 strikingly increased membrane accumulation of Akt-PH-GFP in response to ANG II. The translocation of the PIP3 sensor to the plasma membrane and the phosphorylation of Akt was completed prevented by prior exposure to the class I p110 alpha specific inhibitor A66. ANG II markedly increased the phosphorylation of p85 alpha detected by a PKD motif-specific antibody and enhanced the association of p85 alpha with PTEN. Transgenic mice overexpressing PKD1 showed a reduced phosphorylation of Akt at Ser(473) in intestinal epithelial cells compared to wild type littermates. Collectively these results indicate that PKD1 activation mediates feedback inhibition of PI3K/Akt signaling in intestinal epithelial cells in vitro and in vivo.	[Ni, Yang; Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis,CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Ni, Yang; Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Ni, Yang] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Shandong University	Rozengurt, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis,CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [R01DK55003, P30DK41301, P01CA163200]; Department of Veterans Affair [1I01BX001473]; VA Greater Los Angeles Healthcare System; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100405, R01DK055003, P30DK041301] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair(US Department of Veterans Affairs); VA Greater Los Angeles Healthcare System(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01DK55003, P30DK41301 and P01CA163200 and supported in part by the Department of Veterans Affair Grant 1I01BX001473, VA Greater Los Angeles Healthcare System (to ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty IH, 2004, BIOCHEM J, V379, P641, DOI 10.1042/BJ20031700; Ben-Ami I, 2011, J BIOL CHEM, V286, P31022, DOI 10.1074/jbc.M111.247726; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng J, 2011, J BIOL CHEM, V286, P36076, DOI 10.1074/jbc.M111.259549; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Foukas LC, 2004, MOL CELL BIOL, V24, P966, DOI 10.1128/MCB.24.3.966-975.2004; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ittner A, 2012, J EXP MED, V209, P2229, DOI 10.1084/jem.20120677; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Jiang XH, 2009, BIOCHEM BIOPH RES CO, V387, P521, DOI 10.1016/j.bbrc.2009.07.060; Kajiya M, 2012, MOL PHARMACOL, V82, P115, DOI 10.1124/mol.111.077354; Kisfalvi K, 2010, J CELL PHYSIOL, V223, P309, DOI 10.1002/jcp.22036; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JY, 2011, P NATL ACAD SCI USA, V108, P14157, DOI 10.1073/pnas.1107747108; Luckhart S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003180; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Napoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042504; Nishi JI, 2008, CIRC RES, V103, P261, DOI 10.1161/CIRCRESAHA.108.174128; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Rosso A, 2006, J BIOL CHEM, V281, P4339, DOI 10.1074/jbc.M509293200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sinnett-Smith J, 2011, J BIOL CHEM, V286, P511, DOI 10.1074/jbc.M110.167528; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Taboubi S, 2010, MOL BIOL CELL, V21, P946, DOI 10.1091/mbc.E09-06-0497; Ueda H, 2004, EXP CELL RES, V298, P207, DOI 10.1016/j.yexcr.2004.04.015; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Waldron RT, 2012, CELL SIGNAL, V24, P914, DOI 10.1016/j.cellsig.2011.12.014; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143; Wu EHT, 2006, FEBS J, V273, P2388, DOI 10.1111/j.1742-4658.2006.05245.x; Young SH, 2012, AM J PHYSIOL-GASTR L, V303, pG356, DOI 10.1152/ajpgi.00025.2012; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200	63	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73149	10.1371/journal.pone.0073149	http://dx.doi.org/10.1371/journal.pone.0073149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039875	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300052
J	Nielsen, N; Nielsen, JG; Horsley, AR				Nielsen, Niklas; Nielsen, Jorgen G.; Horsley, Alex R.			Evaluation of the Impact of Alveolar Nitrogen Excretion on Indices Derived from Multiple Breath Nitrogen Washout	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; INERT-GAS WASHOUT; CYSTIC-FIBROSIS; AIRWAYS DISEASE; VENTILATION; CHILDREN; ELIMINATION; EFFICIENCY; EXERCISE; VOLUMES	Background: A large body of evidence has now accumulated describing the advantages of multiple breath washout tests over conventional spirometry in cystic fibrosis (CF). Although the majority of studies have used exogenous sulphur hexafluoride (SF6) as the tracer gas this has also led to an increased interest in nitrogen washout tests, despite the differences between these methods. The impact of body nitrogen excreted across the alveoli has previously been ignored. Methods: A two-compartment lung model was developed that included ventilation heterogeneity and dead space (DS) effects, but also incorporated experimental data on nitrogen excretion. The model was used to assess the impact of nitrogen excretion on washout progress and accuracy of functional residual capacity (FRC) and lung clearance index (LCI) measurements. Results: Excreted nitrogen had a small effect on accuracy of FRC (1.8%) in the healthy adult model. The error in LCI calculated with true FRC was greater (6.3%), and excreted nitrogen contributed 21% of the total nitrogen concentration at the end of the washout. Increasing DS and ventilation heterogeneity both caused further increase in measurement error. LCI was increased by 6-13% in a CF child model, and excreted nitrogen increased the end of washout nitrogen concentration by 24-49%. Conclusions: Excreted nitrogen appears to have complex but clinically significant effects on washout progress, particularly in the presence of abnormal gas mixing. This may explain much of the previously described differences in washout outcomes between SF6 and nitrogen.	[Nielsen, Niklas] Univ Southern Denmark, Inst Math & Comp Sci, Odense, Denmark; [Nielsen, Jorgen G.] Innovision Ltd, Odense, Denmark; [Horsley, Alex R.] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England; [Horsley, Alex R.] Univ S Manchester Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester M20 8LR, Lancs, England	University of Southern Denmark; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Horsley, AR (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England.	Alexander.horsley@manchester.ac.uk		Horsley, Alex/0000-0003-1828-0058	National Institute for Health Research Clinician Scientist award [NIHR-CS_012-013]; National Institute for Health Research (NIHR); National Institute for Health Research [NIHR-CS-012-013] Funding Source: researchfish	National Institute for Health Research Clinician Scientist award; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Horsley is funded by a National Institute for Health Research Clinician Scientist award (NIHR-CS_012-013). This report presents independent research funded by the National Institute for Health Research (NIHR, www.nihr.ac.uk). The views expressed are those of the author and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2011, EUR RESPIR J, V37, P806, DOI 10.1183/09031936.00072510; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; Aurora P, 2005, RESP PHYSIOL NEUROBI, V148, P125, DOI 10.1016/j.resp.2005.05.027; Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; BATTINO R, 1984, J PHYS CHEM REF DATA, V13, P563, DOI 10.1063/1.555713; Darling RC, 1940, J CLIN INVEST, V19, P591, DOI 10.1172/JCI101161; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; GODFREY S, 1971, ARCH DIS CHILD, V46, P144, DOI 10.1136/adc.46.246.144; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2003, EUR RESPIR J, V21, P1033, DOI 10.1183/09031936.03.00049302; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Horsley A, 2009, RESP MED, V103, P793, DOI 10.1016/j.rmed.2009.01.025; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; KERR AA, 1976, THORAX, V31, P63, DOI 10.1136/thx.31.1.63; KJELLMAN B, 1969, SCAND J CLIN LAB INV, V23, P19, DOI 10.3109/00365516909078082; LUNDIN G, 1953, Acta Physiol Scand Suppl, V111, P130; Pendergast DR, 2012, UNDERSEA HYPERBAR M, V39, P595; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Subbarao P, 2013, AM J RESP CRIT CARE, V188, P456, DOI 10.1164/rccm.201302-0219OC; Verbanck S, 2012, J APPL PHYSIOL, V112, P782, DOI 10.1152/japplphysiol.01221.2011; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Williams L. R., 1994, REFERENCE VALUES TOT	25	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73335	10.1371/journal.pone.0073335	http://dx.doi.org/10.1371/journal.pone.0073335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039916	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300066
J	Paul, P; Qiao, J; Kim, KW; Romain, C; Lee, S; Volny, N; Mobley, B; Correa, H; Chung, DH				Paul, Pritha; Qiao, Jingbo; Kim, Kwang Woon; Romain, Carmelle; Lee, Sora; Volny, Natasha; Mobley, Bret; Correa, Hernan; Chung, Dai H.			Targeting Gastrin-Releasing Peptide Suppresses Neuroblastoma Progression via Upregulation of PTEN Signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; ANOIKIS RESISTANCE; CANCER; MIGRATION; GROWTH; CELLS; PATHOGENESIS; METASTASIS; INHIBITION; ACTIVATION	We have previously demonstrated the role of gastrin-releasing peptide (GRP) as an autocrine growth factor for neuroblastoma. Here, we report that GRP silencing regulates cell signaling involved in the invasion-metastasis cascade. Using a doxycycline inducible system, we demonstrate that GRP silencing decreased anchorage-independent growth, inhibited migration and neuroblastoma cell-mediated angiogenesis in vitro, and suppressed metastasis in vivo. Targeted inhibition of GRP decreased the mRNA levels of oncogenes responsible for neuroblastoma progression. We also identified PTEN/AKT signaling as a key mediator of the tumorigenic properties of GRP in neuroblastoma cells. Interestingly, PTEN overexpression decreased GRP-mediated migration and angiogenesis; a novel role for this, otherwise, understated tumor suppressor in neuroblastoma. Furthermore, activation of AKT (pAKT) positively correlated with neuroblastoma progression in an in vivo tumor-metastasis model. PTEN expression was slightly decreased in metastatic lesions. A similar phenomenon was observed in human neuroblastoma sections, where, early-stage localized tumors had a higher PTEN expression relative to pAKT; however, an inverse expression pattern was observed in liver lesions. Taken together, our results argue for a dual purpose of targeting GRP in neuroblastoma -1) decreasing expression of critical oncogenes involved in tumor progression, and 2) enhancing activation of tumor suppressor genes to treat aggressive, advanced-stage disease.	[Paul, Pritha; Qiao, Jingbo; Kim, Kwang Woon; Romain, Carmelle; Lee, Sora; Volny, Natasha; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37203 USA; [Paul, Pritha; Lee, Sora; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Mobley, Bret; Correa, Hernan] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chung, DH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37203 USA.	dai.chung@vanderbilt.edu			National Institutes of Health [RO1 DK61470]; Rally Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rally Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (RO1 DK61470) and Rally Foundation for Cancer Research (http://rallyfoundation.org/rally/ home).	Cotterill SJ, 2000, EUR J CANCER, V36, P901, DOI 10.1016/S0959-8049(00)00058-7; Davies MA, 1998, CANCER RES, V58, P5285; DAVIS S, 1987, AM J EPIDEMIOL, V126, P1063, DOI 10.1093/oxfordjournals.aje.a114745; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gustafson WC, 2005, WORLD J SURG, V29, P281, DOI 10.1007/s00268-004-7815-4; Ishola TA, 2007, BBA-GEN SUBJECTS, V1770, P927, DOI 10.1016/j.bbagen.2007.02.002; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; Kim S, 2002, ANN SURG, V235, P621, DOI 10.1097/00000658-200205000-00003; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Lee S, 2012, ONCOTARGET; Modak S, 2010, CANCER TREAT REV, V36, P307, DOI 10.1016/j.ctrv.2010.02.006; Moritake H, 2001, CANCER GENET CYTOGEN, V125, P151, DOI 10.1016/S0165-4608(00)00378-2; Munoz J, 2004, INT J CANCER, V109, P673, DOI 10.1002/ijc.20055; Nagakawa O, 1998, CANCER LETT, V133, P27, DOI 10.1016/S0304-3835(98)00186-4; Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Paul P, 2011, SURGERY, V149, P425, DOI 10.1016/j.surg.2010.08.011; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Qiao JB, 2005, ANN SURG, V241, P684, DOI 10.1097/01.sla.0000161173.47717.71; Qiao JB, 2008, P NATL ACAD SCI USA, V105, P12891, DOI 10.1073/pnas.0711861105; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72570	10.1371/journal.pone.0072570	http://dx.doi.org/10.1371/journal.pone.0072570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039782	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300013
J	Racoma, IO; Meisen, WH; Wang, QE; Kaur, B; Wani, AA				Racoma, Ira O.; Meisen, Walter Hans; Wang, Qi-En; Kaur, Balveen; Wani, Altaf A.			Thymoquinone Inhibits Autophagy and Induces Cathepsin-Mediated, Caspase-Independent Cell Death in Glioblastoma Cells	PLOS ONE			English	Article							CANCER-CELLS; GLIOMA-CELLS; GROWTH; RADIATION; CHLOROQUINE; LYSOSOMES; APOPTOSIS; INDUCTION; HYDROXYCHLOROQUINE; VACUOLIZATION	Glioblastoma is the most aggressive and common type of malignant brain tumor in humans, with a median survival of 15 months. There is a great need for more therapies for the treatment of glioblastoma. Naturally occurring phytochemicals have received much scientific attention because many exhibit potent tumor killing action. Thymoquinone (TQ) is the bioactive compound of the Nigella sativa seed oil. TQ has anti-oxidant, anti-inflammatory and anti-neoplastic actions with selective cytotoxicity for human cancer cells compared to normal cells. Here, we show that TQ selectively inhibits the clonogenicity of glioblastoma cells as compared to normal human astrocytes. Also, glioblastoma cell proliferation could be impaired by chloroquine, an autophagy inhibitor, suggesting that glioblastoma cells may be dependent on the autophagic pathway for survival. Exposure to TQ caused an increase in the recruitment and accumulation of the microtubule-associated protein light chain 3-II (LC3-II). TQ also caused an accumulation of the LC3-associated protein p62, confirming the inhibition of autophagy. Furthermore, the levels of Beclin-1 protein expression were unchanged, indicating that TQ interferes with a later stage of autophagy. Finally, treatment with TQ induces lysosome membrane permeabilization, as determined by a specific loss of red acridine orange staining. Lysosome membrane permeabilization resulted in a leakage of cathepsin B into the cytosol, which mediates caspase-independent cell death that can be prevented by pre-treatment with a cathepsin B inhibitor. TQ induced apoptosis, as determined by an increase in PI and Annexin V positive cells. However, apoptosis appears to be caspase-independent due to failure of the caspase inhibitor z-VAD-FMK to prevent cell death and absence of the typical apoptosis related signature DNA fragmentation. Inhibition of autophagy is an exciting and emerging strategy in cancer therapy. In this vein, our results describe a novel mechanism of action for TQ as an autophagy inhibitor selectively targeting glioblastoma cells.	[Racoma, Ira O.; Wang, Qi-En; Wani, Altaf A.] Ohio State Univ, Wexner Med Ctr, Dept Radiol, Columbus, OH 43210 USA; [Meisen, Walter Hans; Kaur, Balveen] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wani, AA (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Radiol, Columbus, OH 43210 USA.	wani.2@osu.edu	kaur, Balveen/E-3355-2011		National Institutes of Health (NIH) [CA93413, ES2388]; NATIONAL CANCER INSTITUTE [R01CA093413, P01CA163205, R01CA150153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064607] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants CA93413 and ES2388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, CANCER GENE THER, V9, P228, DOI 10.1038/sj.cgt.7700437; Aki T, 2012, CELL BIOL TOXICOL, V28, P125, DOI 10.1007/s10565-012-9212-3; Al-Majed AA, 2006, EUR J PHARMACOL, V543, P40, DOI 10.1016/j.ejphar.2006.05.046; Alhosin M, 2012, INVEST NEW DRUG, V30, P1813, DOI 10.1007/s10637-011-9734-1; Alinari L, 2011, BLOOD, V118, P6893, DOI 10.1182/blood-2011-06-363879; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Arafa ESA, 2011, MUTAT RES-FUND MOL M, V706, P28, DOI 10.1016/j.mrfmmm.2010.10.007; Arafa ESA, 2009, CANCER RES, V69, P8910, DOI 10.1158/0008-5472.CAN-09-1543; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bristol ML, 2012, AUTOPHAGY, V8, P739, DOI 10.4161/auto.19313; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Chakravarti A, 2006, CLIN CANCER RES, V12, P4738, DOI 10.1158/1078-0432.CCR-06-0596; Chazotte B, 2008, CSH PROTOC, V2008; Cho CW, 2006, CELL BIOL TOXICOL, V22, P393, DOI 10.1007/s10565-006-0104-2; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Di Piazza M, 2007, J VIROL, V81, P4186, DOI 10.1128/JVI.02601-06; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; El-Najjar Nahed, 2011, J Chem Biol, V4, P97, DOI 10.1007/s12154-010-0052-4; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Fan CD, 2006, BIOORGAN MED CHEM, V14, P3218, DOI 10.1016/j.bmc.2005.12.035; Fischer A. H., 2008, CSH PROTOC, V2008; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gali-Muhtasib H, 2006, INT J BIOCHEM CELL B, V38, P1249, DOI 10.1016/j.biocel.2005.10.009; Goldberg SB, 2012, J THORAC ONCOL, V7, P1602, DOI 10.1097/JTO.0b013e318262de4a; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Gurung RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012124; Hosseinzadeh H, 2004, PHYTOMEDICINE, V11, P56, DOI 10.1078/0944-7113-00376; Kanzawa T, 2003, J NEUROSURG, V99, P1047, DOI 10.3171/jns.2003.99.6.1047; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Khader M, 2009, FOOD CHEM TOXICOL, V47, P129, DOI 10.1016/j.fct.2008.10.019; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koka PS, 2010, EXP BIOL MED, V235, P751, DOI 10.1258/ebm.2010.009369; Kondo E, 2008, MOL CANCER THER, V7, P1461, DOI 10.1158/1535-7163.MCT-07-2010; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Michaelides M, 2011, ARCH OPHTHALMOL-CHIC, V129, P30, DOI 10.1001/archophthalmol.2010.321; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mohanam S, 2001, ONCOGENE, V20, P3665, DOI 10.1038/sj.onc.1204480; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Perry J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/428565; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Shoieb AM, 2003, INT J ONCOL, V22, P107; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Temme A, 2005, HUM GENE THER, V16, P209, DOI 10.1089/hum.2005.16.209; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ziegler DS, 2008, J CLIN ONCOL, V26, P493, DOI 10.1200/JCO.2007.13.9717	64	91	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72882	10.1371/journal.pone.0072882	http://dx.doi.org/10.1371/journal.pone.0072882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039814	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300033
J	Abecassis, M; Senina, I; Lehodey, P; Gaspar, P; Parker, D; Balazs, G; Polovina, J				Abecassis, Melanie; Senina, Inna; Lehodey, Patrick; Gaspar, Philippe; Parker, Denise; Balazs, George; Polovina, Jeffrey			A Model of Loggerhead Sea Turtle (Caretta caretta) Habitat and Movement in the Oceanic North Pacific	PLOS ONE			English	Article							ANIMAL BEHAVIOR; BODY-SIZE; JUVENILE; BYCATCH; TEMPERATURE; FISHERIES; ECOSYSTEM; CATCH; TUNA; POPULATIONS	Habitat preferences for juvenile loggerhead turtles in the North Pacific were investigated with data from two several-year long tagging programs, using 224 satellite transmitters deployed on wild and captive-reared turtles. Animals ranged between 23 and 81 cm in straight carapace length. Tracks were used to investigate changes in temperature preferences and speed of the animals with size. Average sea surface temperatures along the tracks ranged from 18 to 23 degrees C. Bigger turtles generally experienced larger temperature ranges and were encountered in warmer surface waters. Seasonal differences between small and big turtles suggest that the larger ones dive deeper than the mixed layer and subsequently target warmer surface waters to rewarm. Average swimming speeds were under 1 km/h and increased with size for turtles bigger than 30 cm. However, when expressed in body lengths per second (bl s(-1)), smaller turtles showed much higher swimming speeds (>1 bl s(-1)) than bigger ones (0.5 bl s(-1)). Temperature and speed values at size estimated from the tracks were used to parameterize a habitat- based Eulerian model to predict areas of highest probability of presence in the North Pacific. The model-generated habitat index generally matched the tracks closely, capturing the north-south movements of tracked animals, but the model failed to replicate observed east-west movements, suggesting temperature and foraging preferences are not the only factors driving large-scale loggerhead movements. Model outputs could inform potential bycatch reduction strategies.	[Abecassis, Melanie; Parker, Denise] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Senina, Inna; Lehodey, Patrick; Gaspar, Philippe] Collecte Localisat Satellite, Ramonville St Agne, France; [Balazs, George; Polovina, Jeffrey] NOAA, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA	University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA	Abecassis, M (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	melanie.abecassis@noaa.gov		Senina, Inna/0000-0002-6614-9401; Lehodey, Patrick/0000-0002-2753-4796				Abecassis M, 2012, MAR ECOL PROG SER, V452, P219, DOI 10.3354/meps09583; Avens L, 2003, MAR BIOL, V143, P211, DOI 10.1007/s00227-003-1085-9; Balazs G.H., 1996, P 15 ANN S SEA TURTL, P21; Baldwin R, 2003, LOGGERHEAD SEA TURTL, P218; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benson S, 2009, SWORDFISH LEATHERBAC; Beverly S, 2004, 17 M STAND COMM TUN, P9; Beverly S, 2009, FISH RES, V96, P281, DOI 10.1016/j.fishres.2008.12.010; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bolten Alan B., 1995, P579; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Gilman E, 2007, BIOL CONSERV, V139, P19, DOI 10.1016/j.biocon.2007.06.002; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hatase H, 2002, MAR BIOL, V141, P299, DOI 10.1007/s00227-002-0819-4; Hobday AJ, 2010, FISH OCEANOGR, V19, P243, DOI 10.1111/j.1365-2419.2010.00540.x; Hochscheid S, 2010, J EXP BIOL, V213, P1328, DOI 10.1242/jeb.037184; Howell EA, 2010, MAR BIOL, V157, P1011, DOI 10.1007/s00227-009-1381-0; Howell Evan A., 2008, Endangered Species Research, V5, P267, DOI 10.3354/esr00096; Peckham SH, 2011, MAR ECOL PROG SER, V425, P269, DOI 10.3354/meps08995; Hughes George R., 2010, Indian Ocean Turtle Newsletter, V11, P24; ISHIHARA T, 2007, N PAC LOGG SEA TURTL, P21; Ishihara Takashi, 2011, Current Herpetology, V30, P63; KAMEZAKI N., 2003, LOGGERHEAD SEA TURTL, P210; Kobayashi DR, 2008, J EXP MAR BIOL ECOL, V356, P96, DOI 10.1016/j.jembe.2007.12.019; Kobayashi DR, 2011, ICES J MAR SCI, V68, P707, DOI 10.1093/icesjms/fsq185; Lehodey P, 2003, FISH OCEANOGR, V12, P483, DOI 10.1046/j.1365-2419.2003.00244.x; Lehodey P, 2001, PROG OCEANOGR, V49, P439, DOI 10.1016/S0079-6611(01)00035-0; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Limpus C.J., 2003, BIOL CONSERVATION LO, P199; Lohmann KJ, 2008, J EXP MAR BIOL ECOL, V356, P83, DOI 10.1016/j.jembe.2007.12.017; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Nichols WJ, 2000, B MAR SCI, V67, P937; Okazaki Y, 2003, MAR ECOL PROG SER, V248, P237, DOI 10.3354/meps248237; Okuyama J, 2011, MAR BIOL, V158, P2055, DOI 10.1007/s00227-011-1712-9; Parker DM, 2005, FISH B-NOAA, V103, P142; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Peckham S. Hoyt, 2008, Endangered Species Research, V5, P171, DOI 10.3354/esr00123; Pham DT, 1998, J MARINE SYST, V16, P323; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Polovina JJ, 2003, FISH B-NOAA, V101, P189; R Core Team, 2022, R LANG ENV STAT COMP; Resendiz Antonio, 1998, Pacific Science, V52, P151; Revelles M, 2007, J EXP MAR BIOL ECOL, V349, P261, DOI 10.1016/j.jembe.2007.05.018; Revelles M, 2007, J EXP MAR BIOL ECOL, V347, P41, DOI 10.1016/j.jembe.2007.03.013; Revelles M, 2007, MAR BIOL, V151, P1501, DOI 10.1007/s00227-006-0602-z; Rio MH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006505; Sato Katsufumi, 1997, Chelonian Conservation and Biology, V2, P600; Scott R, 2012, FUNCT ECOL, V26, P227, DOI 10.1111/j.1365-2435.2011.01915.x; Seifert B, 1998, ENCY STAT SCI, V2, P367; Senina I, 2008, PROG OCEANOGR, V78, P319, DOI 10.1016/j.pocean.2008.06.003; STEVENSON RD, 1985, AM NAT, V125, P102, DOI 10.1086/284330; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Swimmer Y, 2006, SEA TURTLE PELAGIC F; Tranchant B, 2008, REMOTE SENS ENVIRON, V112, P1476, DOI 10.1016/j.rse.2007.06.023; WITHERINGTON BE, 2003, LOGGERHEAD SEA TURTL, P295; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007; ZUG GR, 1995, COPEIA, P484; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	72	53	55	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73274	10.1371/journal.pone.0073274	http://dx.doi.org/10.1371/journal.pone.0073274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039901	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600062
J	Albrecht, SS; Gordon-Larsen, P				Albrecht, Sandra S.; Gordon-Larsen, Penny			Ethnic Differences in Body Mass Index Trajectories from Adolescence to Adulthood: A Focus on Hispanic and Asian Subgroups in the United States	PLOS ONE			English	Article							BMI Z-SCORE; HEALTH DISPARITIES; PHYSICAL-ACTIVITY; RISK-FACTORS; OBESITY; CHILDREN; US; ADIPOSITY; AMERICANS; WEIGHT	Background: Compared to whites, U. S. Hispanics have higher obesity rates; U. S. Asians have lower rates. However Hispanics and Asians are each comprised of several ethnic subgroups that differ with respect to country of origin, immigration history, and geographic distribution across the U. S. Among adolescents, ethnic differences in obesity have been previously reported, but no studies have examined longitudinal change in body mass index (BMI) by Hispanic and Asian subgroup category to understand when and why these disparities emerge, especially during the critical transition between adolescence and adulthood. Methods: Using nationally-representative, longitudinal data from 1355 Hispanics (Mexican, Puerto Rican, Cuban, Central/South American, Other Hispanic), 520 Asians (Chinese, Filipino, Other Asian), and 5061whites from the National Longitudinal Study of Adolescent Health (Waves II-IV: 1996-2009), we used linear mixed spline models to examine whether Hispanic and Asian adolescent subgroups shared the same BMI trajectories as whites as they aged into adulthood. We also investigated the role of social and behavioral factors in explaining race/ethnic differences. Results: Among Hispanics, Mexican and Puerto Rican-origin individuals exhibited faster increases in BMI both in adolescence and in adulthood and these patterns were not attributable to the measured social and behavioral factors. There was also evidence of emerging disparities in Cuban males, and in Central/South Americans relative to whites. In contrast, Chinese, Filipino, and Other Asian adolescents had significantly lower BMI and slower BMI increases in adulthood compared to whites. In models adjusted for social and behavioral factors, Chinese-white and Other Asian-white differentials remained unexplained. Conclusions: Aggregate estimates of Hispanics and Asians mask important heterogeneity in BMI. A better understanding of weight dynamics early in the life course can inform how and when disparities emerge to better target prevention efforts.	[Albrecht, Sandra S.; Gordon-Larsen, Penny] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Gordon-Larsen, Penny] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Albrecht, SS (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA.	ssalb@unc.edu			National Institutes of Health, NICHD [R01-HD057194]; Postdoctoral Ruth L. Kirschstein National Research Service Award through the Carolina Population Center (CPC), University of North Carolina at Chapel Hill [T32 HD07168-33]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R01HD057194, T32HD007168, P01HD031921] Funding Source: NIH RePORTER	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Postdoctoral Ruth L. Kirschstein National Research Service Award through the Carolina Population Center (CPC), University of North Carolina at Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the National Institutes of Health, NICHD: R01-HD057194 and the Postdoctoral Ruth L. Kirschstein National Research Service Award (T32 HD07168-33) through the Carolina Population Center (CPC), University of North Carolina at Chapel Hill. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations, although no direct funding was received from P01-HD31921. We are grateful to the Carolina Population Center (R24 HD050924) for general support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; Aponte J, 2009, PUBLIC HEALTH NURS, V26, P23, DOI 10.1111/j.1525-1446.2008.00741.x; Berkey CS, 2007, ANN EPIDEMIOL, V17, P44, DOI 10.1016/j.annepidem.2006.07.014; Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Brownstein Naomi., NONRESPONSE WAVE 4 N; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Crawford PB, 2001, PEDIATR CLIN N AM, V48, P855, DOI 10.1016/S0031-3955(05)70345-X; Datar A, 2011, PEDIATRICS, V128, pE1411, DOI 10.1542/peds.2011-0114; Diez Roux AV, ANN REV PUBLIC HLTH, V33, P41; Dockterman D, 2010, STAT PORTRAIT HISPAN; Esperat MC, 2004, ANNU REV NURS RES, V22, P135, DOI 10.1891/0739-6686.22.1.135; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Harris KM, NATL LONGITUDINAL ST; Himmelgreen DA, 2004, AM J PHYS ANTHROPOL, V125, P90, DOI 10.1002/ajpa.10367; Killion L, 2006, INT J PEDIATR OBES, V1, P96, DOI 10.1080/17477160600684286; Klatsky AL, 1996, PUBLIC HEALTH REP, V111, P62; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; MacKay AP, 2000, ADOLESCENT HLTH CHAR; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; PAWSON IG, 1991, AM J CLIN NUTR, V53, pS1522, DOI 10.1093/ajcn/53.6.1522S; Pew Research Center, 2012, RIS AS AM; Popkin BM, 1998, J NUTR, V128, P701, DOI 10.1093/jn/128.4.701; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Sonneville KR, 2012, INT J OBESITY, V36, P944, DOI 10.1038/ijo.2012.68; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang YF, 2011, ADV NUTR, V2, P23, DOI 10.3945/an.110.000083; Xanthopoulos MS, 2011, BODY IMAGE, V8, P385, DOI 10.1016/j.bodyim.2011.04.011; Zambrana RE, 2001, J HEALTH CARE POOR U, V12, P20	33	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72983	10.1371/journal.pone.0072983	http://dx.doi.org/10.1371/journal.pone.0072983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24039835	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600047
J	Bridges, CC; Joshee, L; van den Heuvel, JJMW; Russel, FGM; Zalups, RK				Bridges, Christy C.; Joshee, Lucy; van den Heuvel, Jeroen J. M. W.; Russel, Frans G. M.; Zalups, Rudolfs K.			Glutathione Status and the Renal Elimination of Inorganic Mercury in the Mrp2(-/-) Mouse	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN; SYNTHETASE MESSENGER-RNA; ORGANIC ANION TRANSPORTER-5; KIDNEY PROXIMAL TUBULES; RAT-KIDNEY; METHYLMERCURY TREATMENT; CONJUGATE TRANSPORT; METHYL MERCURY; MRP2; LOCALIZATION	Multidrug resistance-associated proteins (MRP) 2 and 4 are localized in proximal tubular epithelial cells and participate in the renal elimination of xenobiotics. MRP2 has also been implicated in the renal and hepatic elimination of mercury. The current study tested the hypothesis that MRP2 and MRP4 are involved in renal and hepatic handling of inorganic mercury (Hg2+). We examined the disposition of Hg2+ in Mrp2(-/-) mice and assessed the transport of mercuric conjugates in inside-out membrane vesicles containing human MRP4. Since MRP2 has been shown to utilize glutathione (GSH) for transport of select substrates, we examined renal concentrations of GSH and cysteine and the expression of glutamate cysteine ligase (GCL) in Mrp2(-/-) and FVB mice. The effect of Hg2+ exposure on renal GSH levels was also assessed in these mice. Our data suggest that MRP2, but not MRP4, is involved in proximal tubular export of Hg2+. In addition, GSH levels are greater in Mrp2(-/-) mice and exposure to Hg2+ reduced renal levels of GSH. Expression of GCL was also altered in Mrp2(-/-) mice under normal conditions and following exposure to HgCl2. This study provides important novel data regarding the transport of Hg2+ and the effect of Hg2+ exposure on GSH levels.	[Bridges, Christy C.; Joshee, Lucy; Zalups, Rudolfs K.] Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA; [van den Heuvel, Jeroen J. M. W.; Russel, Frans G. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands	Mercer University; Radboud University Nijmegen	Bridges, CC (corresponding author), Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA.	bridges_cc@mercer.edu	Russel, Frans G.M./B-3184-2014; van den Heuvel, Jeroen JMW/W-1793-2018	Russel, Frans G.M./0000-0002-7959-2314; Bridges, Christy/0000-0003-1603-1445	National Institutes of Health (National Institute of Environmental Health Sciences) [ES015511]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES015511, R15ES019991] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Institutes of Health (National Institute of Environmental Health Sciences) grant (ES015511) awarded to Dr. Bridges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2005, J PHARMACOL EXP THER, V315, P534, DOI 10.1124/jpet.105.088583; Belanger M, 2001, HEALTH PHYS, V80, pS28; Bridges CC, 2004, J AM SOC NEPHROL, V15, P663, DOI 10.1097/01.ASN.0000113553.62380.F5; Bridges CC, 2008, TOXICOL SCI, V105, P211, DOI 10.1093/toxsci/kfn107; Bridges CC, 2008, J PHARMACOL EXP THER, V324, P383, DOI 10.1124/jpet.107.130708; Bridges CC, 2011, TOXICOL APPL PHARM, V251, P50, DOI 10.1016/j.taap.2010.11.015; Bridges CC, 2010, J TOXICOL ENV HEAL B, V13, P385, DOI 10.1080/10937401003673750; Carriere P, 2011, BIOMETALS, V24, P857, DOI 10.1007/s10534-011-9440-7; Chu XY, 2006, J PHARMACOL EXP THER, V317, P579, DOI 10.1124/jpet.105.098665; Cui YH, 1999, MOL PHARMACOL, V55, P929; Dijkstra M, 1996, LIFE SCI, V59, P1237, DOI 10.1016/0024-3205(96)00447-X; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Kwak JO, 2005, J STEROID BIOCHEM, V97, P369, DOI 10.1016/j.jsbmb.2005.06.028; Lash LH, 2009, BIOFACTORS, V35, P500, DOI 10.1002/biof.65; LEE HB, 1985, J NUCL MED, V26, P72; Leslie EM, 2012, J INORG BIOCHEM, V108, P141, DOI 10.1016/j.jinorgbio.2011.11.009; Li SN, 1996, TOXICOL APPL PHARM, V140, P180, DOI 10.1006/taap.1996.0211; Li SN, 1996, TOXICOL APPL PHARM, V141, P59; Schaub TP, 1999, J AM SOC NEPHROL, V10, P1159; Sugawara N, 1998, TOXICOLOGY, V126, P23, DOI 10.1016/S0300-483X(97)00170-4; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Van Aubel RAMH, 1999, MOL PHARMACOL, V56, P714; WOODS JS, 1995, BIOCHEM PHARMACOL, V50, P1719, DOI 10.1016/0006-2952(95)02075-6; WOODS JS, 1992, ARCH BIOCHEM BIOPHYS, V296, P350, DOI 10.1016/0003-9861(92)90583-I; Wortelboer HM, 2008, ENVIRON TOXICOL PHAR, V26, P102, DOI 10.1016/j.etap.2008.02.006; Zalups RK, 2000, PHARMACOL REV, V52, P113; ZALUPS RK, 1990, J PHARMACOL EXP THER, V254, P962; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	31	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73559	10.1371/journal.pone.0073559	http://dx.doi.org/10.1371/journal.pone.0073559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039982	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600087
J	Camoez, M; Sierra, JM; Pujol, M; Hornero, A; Martin, R; Dominguez, MA				Camoez, Mariana; Sierra, Josep M.; Pujol, Miquel; Hornero, Ana; Martin, Rogelio; Angeles Dominguez, M.			Prevalence and Molecular Characterization of Methicillin-Resistant Staphylococcus aureus ST398 Resistant to Tetracycline at a Spanish Hospital over 12 Years	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; GENES; SPA; COLONIZATION; ASSIGNMENT; DIVERSITY; INFECTION; STRAINS; HUMANS; ORIGIN	Methicillin-resistant Staphylococcus aureus (MRSA) ST398, associated with livestock animals, was described in 2003 as a new lineage infecting or colonizing humans. We evaluated the prevalence and molecular characteristics of MRSA ST398 isolated in the Hospital Universitari de Bellvitge from January 2000 to June 2011. Tetracycline resistant (Tet-R) MRSA isolates from single patients (pts) were screened by SmaI-pulsed field gel electrophoresis (PFGE). Nontypable MRSA strains by SmaI (NTSmaI)-MRSA were further analysed by ApaI-PFGE, spa, SCCmec, agr, MLST typing, and by DNA microarray hybridization. Among 164 pts harboring Tet-R MRSA, NTSmaI-MRSA ST398-agrI was found in 33 pts (20%). Although the first pt was detected in 2003, 22/33 pts (67%) were registered in the 2010-2011 period. Ten pts (30%) were infected and cancer was the most frequent underlying disease. In one case, death was due to MRSA-ST398-related infection. Five pulsotypes (A-E) were detected using ApaI-PFGE, with type A accounting for 76% of the strains. The majority of the studied isolates presented spa type t011 (70%) and SCCmec type V (88%). One strain was spa negative both by PCR and microarray analysis. Forty-nine percent of the studied isolates showed resistance to 3 or more antibiotic classes, in addition to beta-lactams. Ciprofloxacin resistance was 67%. Tet-R was mediated by tet(M) and tet(K) in 26 isolates. All isolates lacked Panton-Valentine Leukocidin production, as well as other significant toxins. This study displays the molecular features of MRSA-ST398 clone and shows the increase in tetracycline resistance together with arise in MRSA-ST398 isolates infecting or colonizing patients in our clinical setting.	[Camoez, Mariana; Sierra, Josep M.; Martin, Rogelio; Angeles Dominguez, M.] Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Pujol, Miquel; Hornero, Ana] Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [Camoez, Mariana; Sierra, Josep M.; Pujol, Miquel; Martin, Rogelio; Angeles Dominguez, M.] IDIBELL, Epidemiol Bacterial Infect Grp, Barcelona, Spain; [Camoez, Mariana; Martin, Rogelio; Angeles Dominguez, M.] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Camoez, Mariana; Sierra, Josep M.; Pujol, Miquel; Martin, Rogelio; Angeles Dominguez, M.] Inst Salud Carlos III, Spanish Network Res Infect Dis REIPI RD06 0008, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; Instituto de Salud Carlos III	Dominguez, MA (corresponding author), Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain.	adominguez@bellvitgehospital.cat	Rojo, Miquel Pujol/AAF-5681-2021; Camoez, Mariana/ACK-3178-2022; Sierra, Josep M/O-3429-2014	Rojo, Miquel Pujol/0000-0002-6475-6208; Sierra, Josep M/0000-0002-0997-5619; Camoez, Mariana/0000-0002-7517-6874; Dominguez, M. Angeles/0000-0003-3107-9586	Fondo de Investigacion Sanitaria [10/01783]; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases	This work was supported by a grant from Fondo de Investigacion Sanitaria (grant number 10/01783) and by Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III co-financed by European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases (grant number REIPI RD06/0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, APPL ENVIRON MICROB, V76, P652, DOI 10.1128/AEM.01721-09; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Aspiroz C, 2010, EMERG INFECT DIS, V16, P157, DOI 10.3201/eid1601.090694; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; CLSI, 2018, PERFORMANCE STANDARD; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Kadlec K, 2012, CLIN MICROBIOL INFEC, V18, P745, DOI 10.1111/j.1469-0691.2012.03842.x; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lo YP, 2012, COMP IMMUNOL MICROB, V35, P513, DOI 10.1016/j.cimid.2012.05.001; Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P2804, DOI 10.1093/jac/dks320; Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P330, DOI 10.1093/jac/dkr497; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Smith Tara C, 2009, PLoS One, V4, pe4258, DOI 10.1371/journal.pone.0004258; Stegger M, 2010, CLIN MICROBIOL INFEC, V16, P1018, DOI 10.1111/j.1469-0691.2009.03003.x; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Welinder-Olsson C, 2008, EMERG INFECT DIS, V14, P1271, DOI 10.3201/eid1408.071427; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x	34	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72828	10.1371/journal.pone.0072828	http://dx.doi.org/10.1371/journal.pone.0072828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039806	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600036
J	Dickman, CTD; Moehring, AJ				Dickman, Christopher T. D.; Moehring, Amanda J.			A Novel Approach Identifying Hybrid Sterility QTL on the Autosomes of Drosophila simulans and D. mauritiana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; IN-HOUSE MICE; REPRODUCTIVE ISOLATION; GENETIC ARCHITECTURE; SEXUAL ISOLATION; HALDANE RULE; SEGREGATION DISTORTION; CHROMOSOME; EVOLUTION; CLADE	When species interbreed, the hybrid offspring that are produced are often sterile. If only one hybrid sex is sterile, it is almost always the heterogametic (XY or ZW) sex. Taking this trend into account, the predominant model used to explain the genetic basis of F-1 sterility involves a deleterious interaction between recessive sex-linked loci from one species and dominant autosomal loci from the other species. This model is difficult to evaluate, however, as only a handful of loci influencing interspecies hybrid sterility have been identified, and their autosomal genetic interactors have remained elusive. One hindrance to their identification has been the overwhelming effect of the sex chromosome in mapping studies, which could 'mask' the ability to accurately map autosomal factors. Here, we use a novel approach employing attached-X chromosomes to create reciprocal backcross interspecies hybrid males that have a non-recombinant sex chromosome and recombinant autosomes. The heritable variation in phenotype is thus solely caused by differences in the autosomes, thereby allowing us to accurately identify the number and location of autosomal sterility loci. In one direction of backcross, all males were sterile, indicating that sterility could be entirely induced by the sex chromosome complement in these males. In the other direction, we identified nine quantitative trait loci that account for a surprisingly large amount (56%) of the autosome-induced phenotypic variance in sterility, with a large contribution of autosome-autosome epistatic interactions. These loci are capable of acting dominantly, and thus could contribute to F-1 hybrid sterility.	[Dickman, Christopher T. D.; Moehring, Amanda J.] Western Univ, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Moehring, AJ (corresponding author), Western Univ, Dept Biol, London, ON, Canada.	amoehrin@uwo.ca	Moehring, Amanda/AAD-6437-2020	Moehring, Amanda/0000-0002-8088-4007	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) to A.J.M. (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; Beadle GW, 1937, P NATL ACAD SCI USA, V23, P356, DOI 10.1073/pnas.23.7.356; Chang AS, 2007, GENETICS, V176, P343, DOI 10.1534/genetics.106.067314; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; CHURCHILL GA, 1994, GENETICS, V138, P963; COBB M, 1988, BEHAV GENET, V18, P211, DOI 10.1007/BF01067843; Coyne J.A., 1989, P180; COYNE JA, 1986, HEREDITY, V57, P243, DOI 10.1038/hdy.1986.114; COYNE JA, 1984, P NATL ACAD SCI-BIOL, V81, P4444, DOI 10.1073/pnas.81.14.4444; COYNE JA, 1985, NATURE, V314, P736, DOI 10.1038/314736a0; COYNE JA, 1989, HEREDITY, V62, P97, DOI 10.1038/hdy.1989.13; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; COYNE JA, 1989, P NATL ACAD SCI USA, V86, P5464, DOI 10.1073/pnas.86.14.5464; Davis AW, 1996, GENETICS, V143, P1287; Dobzhansky T, 1928, P NATL ACAD SCI USA, V14, P671, DOI 10.1073/pnas.14.8.671; Dobzhansky T, 1934, Z ZELLFORSCH MIKROSK, V21, P161; Dzur-Gejdosova M, 2012, EVOLUTION, V66, P3321, DOI 10.1111/j.1558-5646.2012.01684.x; FOREJT J, 1991, MAMM GENOME, V1, P84, DOI 10.1007/BF02443783; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hollocher H, 1996, GENETICS, V143, P1243; JOHNSON NA, 1993, GENETICS, V135, P443; Marin I, 1996, GENETICS, V142, P1169; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Moehring AJ, 2006, GENETICS, V173, P225, DOI 10.1534/genetics.105.052985; Moehring AJ, 2004, GENETICS, V167, P1265, DOI 10.1534/genetics.103.024364; Morgan T. H., 1925, Bibliographia Genetica The Hague, V2, P1; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; PEREZ DE, 1993, GENETICS, V134, P261; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Phadnis N, 2011, GENETICS, V189, P1001, DOI 10.1534/genetics.111.132324; Reed LK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003076; Silva LDCE, 2012, METHODS MOL BIOL, V871; Silva LDE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-67; Tao Y, 2003, GENETICS, V164, P1399; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; True JR, 1996, GENETICS, V142, P819; TURELLI M, 1995, GENETICS, V140, P389; White MA, 2012, GENETICS, V191, P917, DOI 10.1534/genetics.112.140251; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; ZENG LW, 1993, GENETICS, V134, P251; ZENG ZB, 1994, GENETICS, V136, P1457; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73325	10.1371/journal.pone.0073325	http://dx.doi.org/10.1371/journal.pone.0073325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039910	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600065
J	Gilbert, HTJ; Nagra, NS; Freemont, AJ; Millward-Sadler, SJ; Hoyland, JA				Gilbert, Hamish T. J.; Nagra, Navraj S.; Freemont, Anthony J.; Millward-Sadler, Sarah J.; Hoyland, Judith A.			Integrin - Dependent Mechanotransduction in Mechanically Stimulated Human Annulus Fibrosus Cells: Evidence for an Alternative Mechanotransduction Pathway Operating with Degeneration	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; HUMAN ARTICULAR CHONDROCYTES; DYNAMIC HYDROSTATIC-PRESSURE; CYCLIC TENSILE STRAIN; FOCAL ADHESION KINASE; GENE-EXPRESSION; IN-VITRO; ELECTROPHYSIOLOGICAL RESPONSES; TYROSINE PHOSPHORYLATION; ALPHA-5-BETA-1 INTEGRIN	Intervertebral disc (IVD) cells derived from degenerate tissue respond aberrantly to mechanical stimuli, potentially due to altered mechanotransduction pathways. Elucidation of the altered, or alternative, mechanotransduction pathways operating with degeneration could yield novel targets for the treatment of IVD disease. Our aim here was to investigate the involvement of RGD-recognising integrins and associated signalling molecules in the response to cyclic tensile strain (CTS) of human annulus fibrosus (AF) cells derived from non-degenerate and degenerate IVDs. AF cells from non-degenerate and degenerate human IVDs were cyclically strained with and without function blocking RGD - peptides with 10% strain, 1.0 Hz for 20 minutes using a Flexercell (R) strain device. QRT-PCR and Western blotting were performed to analyse gene expression of type I collagen and ADAMTS -4, and phosphorylation of focal adhesion kinase (FAK), respectively. The response to 1.0 Hz CTS differed between the two groups of AF cells, with decreased ADAMTS -4 gene expression and decreased type I collagen gene expression post load in AF cells derived from non-degenerate and degenerate IVDs, respectively. Pre-treatment of non-degenerate AF cells with RGD peptides prevented the CTS-induced decrease in ADAMTS -4 gene expression, but caused an increase in expression at 24 hours, a response not observed in degenerate AF cells where RGD pre-treatment failed to inhibit the mechano-response. In addition, FAK phosphorylation increased in CTS stimulated AF cells derived from non-degenerate, but not degenerate IVDs, with RGD pre-treatment inhibiting the CTS - dependent increase in phosphorylated FAK. Our findings suggest that RGD - integrins are involved in the 1.0 Hz CTS - induced mechano-response observed in AF cells derived from non-degenerate, but not degenerate IVDs. This data supports our previous work, suggesting an alternative mechanotransduction pathway may be operating in degenerate AF cells.	[Gilbert, Hamish T. J.; Nagra, Navraj S.; Freemont, Anthony J.; Millward-Sadler, Sarah J.; Hoyland, Judith A.] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Regenerat Med, Manchester, Lancs, England	University of Manchester	Hoyland, JA (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Regenerat Med, Manchester, Lancs, England.	Judith.Hoyland@manchester.ac.uk	Freemont, Tony J/A-9000-2015; Gilbert, Hamish TJ/AAW-9066-2021; Hoyland, Judith A/P-5168-2014	Freemont, Tony J/0000-0002-9780-208X; Hoyland, Judith A/0000-0003-4876-5208; Nagra, Navraj/0000-0002-6899-4465; Gilbert, Hamish T J/0000-0003-2571-765X	Arthritis Research UK [17850]	Arthritis Research UK(Versus Arthritis)	Funding provided by Arthritis Research UK, grant 17850 (www.arthritisresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287; Ali MH, 2006, AM J PHYSIOL-LUNG C, V291, pL38, DOI 10.1152/ajplung.00287.2004; Bellin R, 2002, GLYCOCONJUGATE J, V19, P295, DOI 10.1023/A:1025352501148; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilbert HTJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3229; Gilbert HTJ, 2010, ARTHRITIS RHEUM-US, V62, P3385, DOI 10.1002/art.27643; Holledge MM, 2008, BIORHEOLOGY, V45, P275, DOI 10.3233/BIR-2008-0476; Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002; Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishihara H, 1996, J APPL PHYSIOL, V80, P839, DOI 10.1152/jappl.1996.80.3.839; Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5; Kasra M, 2006, J ORTHOP RES, V24, P1967, DOI 10.1002/jor.20253; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kock LM, 2009, J BIOMECH, V42, P2177, DOI 10.1016/j.jbiomech.2009.05.039; Korecki CL, 2009, J ORTHOP RES, V27, P800, DOI 10.1002/jor.20814; Le Maitre CL, 2008, BIORHEOLOGY, V45, P563, DOI 10.3233/BIR-2008-0498; Le Maitre CL, 2009, ARTHRITIS RHEUM-US, V60, P460, DOI 10.1002/art.24248; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Li SY, 2011, EUR CELLS MATER, V21, P508, DOI 10.22203/eCM.v021a38; Liu SC, 2000, J CELL SCI, V113, P3563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; MacLean JJ, 2008, J ORTHOP RES, V26, P579, DOI 10.1002/jor.20560; MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020; MacLean JJ, 2003, SPINE, V28, P973, DOI 10.1097/00007632-200305150-00004; MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004; Matsumoto T, 1999, SPINE, V24, P315, DOI 10.1097/00007632-199902150-00002; McGill G, 1997, J CELL BIOL, V138, P901, DOI 10.1083/jcb.138.4.901; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301; Neidlinger-Wilke C, 2006, EUR SPINE J, V15, pS372, DOI 10.1007/s00586-006-0112-1; Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133; SHIRAZIADL SA, 1984, SPINE, V9, P120, DOI 10.1097/00007632-198403000-00003; Terahara K, 2003, DEV COMP IMMUNOL, V27, P521, DOI 10.1016/S0145-305X(02)00159-3; Wang DL, 2007, SPINE, V32, P2521, DOI 10.1097/BRS.0b013e318158cb61; Wenger KH, 2005, SPINE, V30, P1122, DOI 10.1097/01.brs.0000162395.56424.53; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517; WUERTZ K, 2009, J ORTHOP RES; Xia MS, 2008, CONNECT TISSUE RES, V49, P464, DOI 10.1080/03008200802325425; Yano Y, 1996, AM J PHYSIOL-CELL PH, V271, pC635, DOI 10.1152/ajpcell.1996.271.2.C635; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	48	21	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72994	10.1371/journal.pone.0072994	http://dx.doi.org/10.1371/journal.pone.0072994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039840	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600048
J	Hawco, C; Berlim, MT; Lepage, M				Hawco, Colin; Berlim, Marcelo T.; Lepage, Martin			The Dorsolateral Prefrontal Cortex Plays a Role in Self-Initiated Elaborative Cognitive Processing during Episodic Memory Encoding: rTMS Evidence	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM-MEMORY; FRONTAL LOBES; INDIVIDUAL-DIFFERENCES; STRATEGY PRODUCTION; ASSOCIATIVE MEMORY; DAMAGED PATIENTS; MOTOR THRESHOLD; VERBAL MEMORY; RECALL	During episodic memory encoding, elaborative cognitive processing can improve later recall or recognition. While multiple studies examined the neural correlates of encoding strategies, few studies have explicitly focused on the self-initiation of elaborative encoding. Repetitive transcranial magnetic stimulation (rTMS), a method which can transiently disrupt neural activity, was administered during an associative encoding task. rTMS was either applied to the left dorsolateral prefrontal cortex (DLPFC) or to the vertex (a control region not involved in memory encoding) during presentation of pairs of words. Pairs could be semantically related or not related. Two encoding instructions were given, either cueing participants to analyze semantic relationships (cued condition), or to memorize the pair without any specific strategy cues (the self-initiated condition). Participants filled out a questionnaire regarding their use of memory strategies and performed a cued-recall task. We hypothesized that if the DLPFC plays a role in the self-initiation of elaborative encoding we would observe a reduction in memory performance in the self-initiated condition, particularly for related. We found a significant correlation between the effects of rTMS and strategy use, only in the self-initiated condition with related pairs. High strategy users showed reduced performance following DLPFC stimulation, while low strategy users tended to show increased recall following DLPFC stimulation during encoding. These results suggest the left DLPFC may be involved in the self-initiation of memory strategy use, and individuals may utilize different neural networks depending on their use of encoding strategies.	[Hawco, Colin] McGill Univ, Dept Neurol & Neurosurg, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Berlim, Marcelo T.; Lepage, Martin] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Lepage, M (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	martin.lepage@mcgill.ca			Natural Science and Engineering Research Council of Canada [238617]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Science and Engineering Research Council of Canada, grant number 238617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2011, J COGNITIVE NEUROSCI, V23, P257, DOI 10.1162/jocn.2010.21459; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; CAMP CJ, 1983, J GERONTOL, V38, P3, DOI 10.1093/geronj/38.1.3; DELLAROCCHETTA AI, 1995, NEUROLOGY, V45, P797; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; Dimitrov M, 1999, BRAIN COGNITION, V41, P213, DOI 10.1006/brcg.1999.1121; Dunlosky J, 2001, MEM COGNITION, V29, P247, DOI 10.3758/BF03194918; Dunlosky J, 1998, PSYCHOL AGING, V13, P597, DOI 10.1037/0882-7974.13.4.597; Gagnon G, 2011, NEUROSCI LETT, V488, P138, DOI 10.1016/j.neulet.2010.11.016; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; GRAFMAN J, 1994, NEUROREPORT, V5, P1157, DOI 10.1097/00001756-199405000-00034; Hawco C, 2013, NEUROIMAGE, V67, P273, DOI 10.1016/j.neuroimage.2012.11.004; Hertzog C, 2004, PSYCHOL LEARN MOTIV, V45, P215, DOI 10.1016/S0079-7421(03)45006-8; Hertzog C, 2010, INT J AGING HUM DEV, V70, P61, DOI 10.2190/AG.70.1.c; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Herwig U, 2003, J PSYCHIATR RES, V37, P267, DOI 10.1016/S0022-3956(03)00042-6; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; Innocenti I, 2010, NEUROIMAGE, V53, P325, DOI 10.1016/j.neuroimage.2010.06.011; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; Kirchhoff BA, 2006, NEURON, V51, P263, DOI 10.1016/j.neuron.2006.06.006; Kohler S, 2004, J COGNITIVE NEUROSCI, V16, P178, DOI 10.1162/089892904322984490; Manenti R, 2010, NEUROSCIENCE, V166, P501, DOI 10.1016/j.neuroscience.2009.12.037; Manenti R, 2011, BEHAV BRAIN RES, V216, P153, DOI 10.1016/j.bbr.2010.07.027; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; Miller MB, 2012, NEUROIMAGE, V59, P83, DOI 10.1016/j.neuroimage.2011.05.060; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pridmore S, 1998, J ECT, V14, P25; Rossi S, 2006, EUR J NEUROSCI, V23, P793, DOI 10.1111/j.1460-9568.2006.04600.x; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossi S, 2011, CEREB CORTEX, V21, P368, DOI 10.1093/cercor/bhq103; Sandrini M, 2003, J COGNITIVE NEUROSCI, V15, P855, DOI 10.1162/089892903322370771; SHAUGHNESSY JJ, 1981, J VERB LEARN VERB BE, V20, P216, DOI 10.1016/S0022-5371(81)90389-3; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355, https://doi.org/10.1037/0894-4105.8.3.355]; VOGEL CC, 1987, INT J NEUROSCI, V33, P237, DOI 10.3109/00207458708987408; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; WHEELER MA, 1995, J INT NEUROPSYCH SOC, V1, P526	44	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73789	10.1371/journal.pone.0073789	http://dx.doi.org/10.1371/journal.pone.0073789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040072	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600100
J	Zhang, BY				Zhang, Boyu			Social Learning in the Ultimatum Game	PLOS ONE			English	Article							STATISTICAL-MECHANICS; FAIRNESS; EVOLUTION; BEHAVIOR; PUNISHMENT; MODELS	In the ultimatum game, two players divide a sum of money. The proposer suggests how to split and the responder can accept or reject. If the suggestion is rejected, both players get nothing. The rational solution is that the responder accepts even the smallest offer but humans prefer fair share. In this paper, we study the ultimatum game by a learning-mutation process based on quantal response equilibrium, where players are assumed boundedly rational and make mistakes when estimating the payoffs of strategies. Social learning is never stabilized at the fair outcome or the rational outcome, but leads to oscillations from offering 40 percent to 50 percent. To be precise, there is a clear tendency to increase the mean offer if it is lower than 40 percent, but will decrease when it reaches the fair offer. If mutations occur rarely, fair behavior is favored in the limit of local mutation. If mutation rate is sufficiently high, fairness can evolve for both local mutation and global mutation.	Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, BY (corresponding author), Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China.	zhangboyu5507@gmail.com			Chinese Scholarship Council (CSC)	Chinese Scholarship Council (CSC)(China Scholarship Council)	The author is thankful for the support of the Chinese Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink K, 2001, GAME ECON BEHAV, V37, P1, DOI 10.1006/game.2000.0837; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; BLUME LE, 1995, GAME ECON BEHAV, V11, P111, DOI 10.1006/game.1995.1046; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Brenner T, 2006, J ECON BEHAV ORGAN, V61, P617, DOI 10.1016/j.jebo.2004.07.014; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cooper DJ, 2010, EXPT EC, V14, P519; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fischbacher U, 2009, J ECON BEHAV ORGAN, V72, P527, DOI 10.1016/j.jebo.2009.05.021; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Kagel JH, 1995, HDB EXPT EC; Kirman AP, 2001, J ECON DYN CONTROL, V25, P459, DOI 10.1016/S0165-1889(00)00033-6; Levine DK, 1998, REV ECON DYNAM, V1, P593; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2001, J THEOR BIOL, V209, P173, DOI 10.1006/jtbi.2000.2251; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; ROTH AE, 1991, AM ECON REV, V81, P1068; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SELTEN R, 1986, J ECON BEHAV ORGAN, V7, P47, DOI 10.1016/0167-2681(86)90021-1; Sigmund, 2010, CALC SELF; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sinatra R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09012; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; Stirling WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056751; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Turocy TL, 2005, GAME ECON BEHAV, V51, P243, DOI 10.1016/j.geb.2004.04.003; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; Yi KO, 2005, GAME ECON BEHAV, V51, P324, DOI 10.1016/S0899-8256(03)00051-4	43	4	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74540	10.1371/journal.pone.0074540	http://dx.doi.org/10.1371/journal.pone.0074540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023950	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600146
J	Leblond, M; Dussault, C; Ouellet, JP				Leblond, Mathieu; Dussault, Christian; Ouellet, Jean-Pierre			Impacts of Human Disturbance on Large Prey Species: Do Behavioral Reactions Translate to Fitness Consequences?	PLOS ONE			English	Article							CARIBOU RANGIFER-TARANDUS; FOREST-DWELLING CARIBOU; WOODLAND CARIBOU; HOME-RANGE; HABITAT SELECTION; ROE DEER; LARGE HERBIVORES; BOREAL FOREST; CALF SURVIVAL; ROADS	Anthropogenic disturbances have been demonstrated to affect animal behavior, distribution, and abundance, but assessment of their impacts on fitness-related traits has received little attention. We hypothesized that human activities and infrastructure cause a decrease in the individual performance of preys because of anthropogenically enhanced predation risk. We evaluated the impacts of commercial logging and road networks on the fitness of a large herbivore known to be sensitive to human disturbance: the forest-dwelling woodland caribou (Rangifer tarandus caribou). For 8 consecutive years (2004-2011) we monitored 59 individuals using GPS telemetry in the Charlevoix region of Quebec, Canada. We also used Very High Frequency telemetry locations collected on 28 individuals from 1999-2000. We related habitat selection of adult caribou at various spatio-temporal scales to their probability of dying from predation, and to indices of their reproductive success and energy expenditure. The probability that adult caribou died from predation increased with the proportion of recent disturbances (including cutblocks <= 5 years old) in their annual home range. The respective effects of increasing paved and forestry road densities depended upon the overall road density within the home range of caribou. At a finer scale of 10 to 15 days before their death, caribou that were killed by a predator selected for recent disturbances more than individuals that survived, and avoided old mature conifer stands. The home range area of caribou increased with road density. Finally, the composition of the home range of females had no effect on their reproductive success. We show that human activities and infrastructure may influence the individual performance of large prey species in highly managed regions. We outline the need to consider the full set of impacts that human development may have on threatened animal populations, with particular emphasis on predator-prey relationships and population dynamics.	[Leblond, Mathieu; Ouellet, Jean-Pierre] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Leblond, Mathieu; Ouellet, Jean-Pierre] Ctr Etud Nord, Rimouski, PQ, Canada; [Dussault, Christian] Minist Dev Durable Environm Faune & Parc Quebec, Direct Faune Terrestre & Avifaune, Quebec City, PQ, Canada	University of Quebec	Leblond, M (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	mathieu_leblond@uqar.ca	Leblond, Mathieu/J-9646-2019	Leblond, Mathieu/0000-0002-2833-6265	Ministere des Transports du Quebec; Endangered Species Recovery Fund; Fondation de la faune du Quebec; Natural Sciences and Engineering Research Council of Canada	Ministere des Transports du Quebec; Endangered Species Recovery Fund; Fondation de la faune du Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Ministere des Transports du Quebec (www.mtq.gouv.qc.ca), the Endangered Species Recovery Fund (wwf.panda.org), the Fondation de la faune du Quebec (www.fondationdelafaune.qc.ca), and the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; BERGERUD AT, 1996, RANGIFER, V9, P95, DOI DOI 10.7557/2.16.4.1225; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Brommer JE, 2004, AM NAT, V163, P505, DOI 10.1086/382547; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHUBBS TE, 1993, CAN J ZOOL, V71, P487, DOI 10.1139/z93-070; CLUTTONBROCK TH, 1989, NATURE, V337, P260, DOI 10.1038/337260a0; COURTOIS R, 2003, THESIS U QUEBEC RIMO; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Desautels R, 2009, ORDRE INGENIEURS FOR, P1187; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Dyer SJ, 2002, CAN J ZOOL, V80, P839, DOI [10.1139/z02-060, 10.1139/Z02-060]; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Fahrig L, 2009, ECOL SOC, V14; Faille G, 2010, BIOL CONSERV, V143, P2840, DOI 10.1016/j.biocon.2010.08.001; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Frid A, 2002, CONSERV ECOL, V6; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Heisey DM, 2006, J WILDLIFE MANAGE, V70, P1544, DOI 10.2193/0022-541X(2006)70[1544:AROMTE]2.0.CO;2; Hewison AJM, 1999, CAN J ZOOL, V77, P58, DOI 10.1139/cjz-77-1-58; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Johnson CJ, 2002, ECOL APPL, V12, P1840, DOI 10.1890/1051-0761(2002)012[1840:AMBATU]2.0.CO;2; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Leblond M, 2013, J ZOOL, V289, P32, DOI 10.1111/j.1469-7998.2012.00959.x; Leblond M, 2011, LANDSCAPE ECOL, V26, P1433, DOI 10.1007/s10980-011-9647-6; Lesmerises F, 2012, FOREST ECOL MANAG, V276, P125, DOI 10.1016/j.foreco.2012.03.025; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Lopez RR, 2003, J WILDLIFE MANAGE, V67, P34, DOI 10.2307/3803059; Manly B.F.J., 2002, RESOURCE SELECTION A; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; MURPHY SM, 1987, CAN J ZOOL, V65, P2483, DOI 10.1139/z87-375; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Pinard V, 2012, J WILDLIFE MANAGE, V76, P189, DOI 10.1002/jwmg.217; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rytwinski T, 2011, ECOL APPL, V21, P589, DOI 10.1890/10-0968.1; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Smith KG, 2000, CAN J ZOOL, V78, P1433, DOI 10.1139/cjz-78-8-1433; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; White G.C., 1990, ANAL WILDLIFE RADIO; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y	57	36	37	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73695	10.1371/journal.pone.0073695	http://dx.doi.org/10.1371/journal.pone.0073695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040029	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500043
J	Mack, N; Ramirez, CB; Friedland, B; Nnko, S				Mack, Natasha; Ramirez, Catalina B.; Friedland, Barbara; Nnko, Soori			Lost in Translation: Assessing Effectiveness of Focus Group Questioning Techniques to Develop Improved Translation of Terminology Used in HIV Prevention Clinical Trials	PLOS ONE			English	Article							ENHANCE INFORMED-CONSENT; INFECTION; FORMS; MODEL	Introduction: Achieving participant comprehension has proven to be one of the most difficult, practical, and ethical challenges of HIV prevention clinical trials. It becomes even more challenging when local languages do not have equivalent scientific and technical vocabularies, rendering communication of scientific concepts in translated documents extremely difficult. Even when bilingual lexicons are developed, there is no guarantee that participants understand the terminology as translated. Methods: We conducted twelve focus groups with women of reproductive age in Mwanza, Tanzania to explore the effectiveness of four questioning techniques for: (1) assessing participants' familiarity with existing technical terms and concepts, (2) generating a list of acceptable technical and non-technical terms, (3) testing our definitions of technical terms, and (4) verifying participants' preferences for terms. Focus groups were transcribed, translated, and qualitatively analyzed. Results and Discussion: A translation process that uses all four questioning techniques in a step-wise approach is an effective way to establish a baseline understanding of participants' familiarity with research terms, to develop and test translatable definitions, and to identify participants' preferred terminology for international HIV clinical research. This may help to ensure that important concepts are not "lost in translation.'' The results emphasize the importance of using a variety of techniques depending on the level of participant familiarity with research concepts, the existence of colloquial or technical terms in the target language, and the inherent complexity of the terms.	[Mack, Natasha] FHI 360, Durham, NC USA; [Ramirez, Catalina B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Friedland, Barbara] Populat Council, HIV & AIDS Program, New York, NY 10021 USA; [Nnko, Soori] Natl Inst Med Res, Mwanza, Tanzania	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Population Council; National Institute of Medical Research	Mack, N (corresponding author), FHI 360, Durham, NC USA.	nmack@fhi360.org			USAID [GHO-A-00-09-00016-00]	USAID(United States Agency for International Development (USAID))	This study was funded by USAID (www.usaid.gov) under Cooperative Agreement GHO-A-00-09-00016-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 2004, B WORLD HEALTH ORGAN, V82, P771; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Elbourne D, 1997, BRIT MED J, V315, P248; Jhanwar Venu Gopal, 2010, Indian J Psychol Med, V32, P7, DOI 10.4103/0253-7176.70517; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS TERM GUID; Jones PS, 2001, NURS RES, V50, P300, DOI 10.1097/00006199-200109000-00008; Kass NE, 2001, ATTITUDES EXPERIENCE; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Kula NC, 2008, CENTRAL E SO AFRICAN; Lawson Sara L, 1995, IRB, V17, P16, DOI 10.2307/3564569; LOVERDE ME, 1989, J GEN INTERN MED, V4, P410, DOI 10.1007/BF02599693; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Marshall PA, 2006, J EMPIR RES HUM RES, V1, P25, DOI 10.1525/jer.2006.1.1.25; Meade C D, 1992, Oncol Nurs Forum, V19, P1523; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Penn C, 2010, PATIENT EDUC COUNS, V80, P191, DOI 10.1016/j.pec.2009.10.019; Penn C, 2009, AJAR-AFR J AIDS RES, V8, P285, DOI 10.2989/AJAR.2009.8.3.5.926; QSR International, 1999, NVIVO QUAL DAT AN SO; Ridpath JR, 2009, AM J HEALTH PROMOT, V23, P371, DOI 10.4278/ajhp.080613-CIT-94; Shore S, 2006, 10 INT C AUSTR LING; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Waggoner William C, 1995, IRB, V17, P6, DOI 10.2307/3563639; Weeks A, 2007, EVALUATION REV, V31, P153, DOI 10.1177/0193841X06294184; Woodsong C, 2005, AM J PUBLIC HEALTH, V95, P412, DOI 10.2105/AJPH.2004.041624	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73799	10.1371/journal.pone.0073799	http://dx.doi.org/10.1371/journal.pone.0073799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PK	24040075	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600044
J	Yokoyama, A; Ficara, F; Murphy, MJ; Meisel, C; Hatanaka, C; Kitabayashi, I; Cleary, ML				Yokoyama, Akihiko; Ficara, Francesca; Murphy, Mark J.; Meisel, Christian; Hatanaka, Chikako; Kitabayashi, Issay; Cleary, Michael L.			MLL Becomes Functional through Intra-Molecular Interaction Not by Proteolytic Processing	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MYELOID-LEUKEMIA; BITHORAX COMPLEX; SELF-RENEWAL; MUTANT MICE; GENE; EXPRESSION; TRANSFORMATION; DROSOPHILA; PROTEIN	The mixed lineage leukemia (MLL) protein is an epigenetic transcriptional regulator that controls proliferative expansion of immature hematopoietic progenitors, whose aberrant activation triggers leukemogenesis. A mature MLL protein is produced by formation of an intra-molecular complex and proteolytic cleavage. However the biological significance of these two post-transcriptional events remains unclear. To address their in vivo roles, mouse mutant alleles were created that exclusively express either a variant protein incapable of intra-molecular interaction (designated de) or an uncleavable mutant protein (designated uc). The de homozygous mice died during midgestation and manifested devastating failure in embryonic development and reduced numbers of hematopoietic progenitors, whereas uc homozygous mice displayed no apparent defects. Expression of MLL target genes was severely impaired in de homozygous fibroblasts but unaffected in uc homozygous fibroblasts. These results unequivocally demonstrate that intra-molecular complex formation is a crucial maturation step whereas proteolytic cleavage is dispensable for MLL-dependent gene activation and proliferation in vivo.	[Yokoyama, Akihiko] Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Kyoto, Japan; [Ficara, Francesca] CNR, Milan Unit, Ist Ric Genet & Biomed, I-20133 Milan, Italy; [Ficara, Francesca] Humanitas Clin & Res Ctr, Rozzano, Italy; [Murphy, Mark J.; Cleary, Michael L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Meisel, Christian] Univ Clin Carl Gustav Craus, Dept Neurol, Dresden, Germany; [Hatanaka, Chikako; Kitabayashi, Issay] Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo 104, Japan	Kyoto University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital; Stanford University; National Cancer Center - Japan	Yokoyama, A (corresponding author), Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Kyoto, Japan.	yokoyama@dsk.med.kyoto-u.ac.jp; mcleary@stanford.edu	Kitabayashi, Issay/G-2204-2017; Ficara, Francesca/M-4624-2016	Ficara, Francesca/0000-0003-1873-1189; Kitabayashi, Issay/0000-0002-8409-0407; Meisel, Christian/0000-0003-2984-5480; Yokoyama, Akihiko/0000-0002-5639-8068	Japan Society for the promotion of Science [23689050, 22118003]; National Institutes of Health [CA116606]; American Society of Hematology; Grants-in-Aid for Scientific Research [23689050, 25118511] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA116606] Funding Source: NIH RePORTER	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by a Grant-in-aid for Young Scientists (A)(23689050) and a Grant-in-aid for Scientific Research on Innovative Areas from Japan Society for the promotion of Science (22118003) to A.Y., and a grant from the National Institutes of Health to M. L. C. (CA116606). F. F, was supported by a Scholar Award from the American Society of Hematology (http://www.hematology.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Caslini C, 2009, MOL CELL BIOL, V29, P4519, DOI 10.1128/MCB.00195-09; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lochner K, 1996, CANCER RES, V56, P2171; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Yokoyama A, 2011, J CELL SCI, V124, P2208, DOI 10.1242/jcs.080523; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	34	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73649	10.1371/journal.pone.0073649	http://dx.doi.org/10.1371/journal.pone.0073649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040009	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600035
J	Birkenkamp-Demtroder, K; Hahn, SA; Mansilla, F; Thorsen, K; Maghnouj, A; Christensen, R; Oster, B; Orntoft, TF				Birkenkamp-Demtroder, Karin; Hahn, Stephan A.; Mansilla, Francisco; Thorsen, Kasper; Maghnouj, Abdelouahid; Christensen, Rikke; Oster, Bodil; Orntoft, Torben Falck			Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells	PLOS ONE			English	Article							MICROSATELLITE-INSTABILITY; DIFFERENTIATION; GENES; MODEL; IDENTIFICATION; EXPRESSION; MECHANISM; E2F; P53	Keratin 23 (KRT23) is strongly expressed in colon adenocarcinomas but absent in normal colon mucosa. Array based methylation profiling of 40 colon samples showed that the promoter of KRT23 was methylated in normal colon mucosa, while hypomethylated in most adenocarcinomas. Promoter methylation correlated with absent expression, while increased KRT23 expression in tumor samples correlated with promoter hypomethylation, as confirmed by bisulfite sequencing. Demethylation induced KRT23 expression in vitro. Expression profiling of shRNA mediated stable KRT23 knockdown in colon cancer cell lines showed that KRT23 depletion affected molecules of the cell cycle and DNA replication, recombination and repair. In vitro analyses confirmed that KRT23 depletion significantly decreased the cellular proliferation of SW948 and LS1034 cells and markedly decreased the expression of genes involved in DNA damage response, mainly molecules of the double strand break repair homologous recombination pathway. KRT23 knockdown decreased the transcript and protein expression of key molecules as e. g. MRE11A, E2F1, RAD51 and BRCA1. Knockdown of KRT23 rendered colon cancer cells more sensitive to irradiation and reduced proliferation of the KRT23 depleted cells compared to irradiated control cells.	[Birkenkamp-Demtroder, Karin; Mansilla, Francisco; Thorsen, Kasper; Oster, Bodil; Orntoft, Torben Falck] Aarhus Univ Hosp, Dept Mol Med MOMA, DK-8000 Aarhus N, Denmark; [Hahn, Stephan A.; Maghnouj, Abdelouahid] Ruhr Univ Bochum, Clin Res Ctr, Dept Mol GI Oncol, Bochum, Germany; [Christensen, Rikke] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus N, Denmark	Aarhus University; Ruhr University Bochum; Aarhus University	Birkenkamp-Demtroder, K (corresponding author), Aarhus Univ Hosp, Dept Mol Med MOMA, DK-8000 Aarhus N, Denmark.	kbdr@ki.au.dk	Hahn, Stephan/E-3880-2010; Birkenkamp-Demtröder, Karin/C-1981-2017; Birkenkamp-Demtröder, Karin/AAN-1764-2021; Hahn, Stephan A./AAV-6062-2021	Hahn, Stephan/0000-0003-0855-9741; Birkenkamp-Demtröder, Karin/0000-0001-8057-6277; Hahn, Stephan A./0000-0003-0855-9741	John and Birthe Meyer Foundation; Lundbeck Foundation; NOVO Nordisk Foundation; Danish Research Council	John and Birthe Meyer Foundation; Lundbeck Foundation(Lundbeckfonden); NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council(Det Frie Forskningsrad (DFF))	The work was supported by grants from the John and Birthe Meyer Foundation, the Lundbeck Foundation, the NOVO Nordisk Foundation and the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Benatti P, 2005, CLIN CANCER RES, V11, P8332, DOI 10.1158/1078-0432.CCR-05-1030; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Birkenkamp-Demtroder K, 2007, MOL ONCOL, V1, P181, DOI 10.1016/j.molonc.2007.05.005; Boyle P, 2008, WORLD CANC REPORT; Chen J, 2011, CELL CYCLE, V10, P1287, DOI 10.4161/cc.10.8.15341; Christensen R, 2008, REGEN MED, V3, P849, DOI 10.2217/17460751.3.6.849; Clark A J, 2004, Fam Cancer, V3, P85; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fukutomi S, 2007, SCAND J GASTROENTERO, V42, P1486, DOI 10.1080/00365520701491173; Halter M, 2011, CYTOM PART A, V79A, P192, DOI 10.1002/cyto.a.21028; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Karantza V, 2010, ONCOGENE; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Moll R, 1998, Subcell Biochem, V31, P205; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Oster B, 2011, INT J CANCER, DOI [10.1002/ijc.25951, DOI 10.1002/IJC.25951.EPUB]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Schmutte C, 1999, CANCER RES, V59, P4564; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Starmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046584; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Xu M, 2004, INT J HYPERTHER, V20, P157, DOI 10.1080/02656730310001625986; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Zhang JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022176; Zhang JS, 2001, GENE CHROMOSOME CANC, V30, P123, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1070>3.0.CO;2-W	33	33	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73593	10.1371/journal.pone.0073593	http://dx.doi.org/10.1371/journal.pone.0073593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039993	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300096
J	Mora, CV; Bingman, VP				Mora, Cordula V.; Bingman, Verner P.			Detection of Magnetic Field Intensity Gradient by Homing Pigeons (Columba livia) in a Novel "Virtual Magnetic Map'' Conditioning Paradigm	PLOS ONE			English	Article							POSITION DETERMINATION; INITIAL ORIENTATION; SEA-TURTLES; UPPER BEAK; NAVIGATION; MAGNETORECEPTION; COMPASS; NERVE; SENSE; DISCRIMINATION	It has long been thought that birds may use the Earth's magnetic field not only as a compass for direction finding, but that it could also provide spatial information for position determination analogous to a map during navigation. Since magnetic field intensity varies systematically with latitude and theoretically could also provide longitudinal information during position determination, birds using a magnetic map should be able to discriminate magnetic field intensity cues in the laboratory. Here we demonstrate a novel behavioural paradigm requiring homing pigeons to identify the direction of a magnetic field intensity gradient in a "virtual magnetic map'' during a spatial conditioning task. Not only were the pigeons able to detect the direction of the intensity gradient, but they were even able to discriminate upward versus downward movement on the gradient by differentiating between increasing and decreasing intensity values. Furthermore, the pigeons typically spent more than half of the 15 second sampling period in front of the feeder associated with the rewarded gradient direction indicating that they required only several seconds to make the correct choice. Our results therefore demonstrate for the first time that pigeons not only can detect the presence and absence of magnetic anomalies, as previous studies had shown, but are even able to detect and respond to changes in magnetic field intensity alone, including the directionality of such changes, in the context of spatial orientation within an experimental arena. This opens up the possibility for systematic and detailed studies of how pigeons could use magnetic intensity cues during position determination as well as how intensity is perceived and where it is processed in the brain.	[Mora, Cordula V.] Bowling Green State Univ, Dept Psychol, Bowling Green, OH 43403 USA; Bowling Green State Univ, JP Scott Ctr Neurosci Mind & Behav, Bowling Green, OH 43403 USA	Bowling Green State University; Bowling Green State University	Mora, CV (corresponding author), Bowling Green State Univ, Dept Psychol, Bowling Green, OH 43403 USA.	cmora@bgsu.edu			National Science Foundation [IOS-0922508]; Faculty Research Committee at Bowling Green State University	National Science Foundation(National Science Foundation (NSF)); Faculty Research Committee at Bowling Green State University	This work was supported by a grant from The National Science Foundation [IOS-0922508 to VPB and CVM] as well as a Research Incentive Grant provided by the Faculty Research Committee at Bowling Green State University to VPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beason RC, 1996, J EXP BIOL, V199, P1241; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Fischer JH, 2003, AVIAN MIGRATION, P423; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Frei U., 1976, REV SUISSE ZOOL, V83, P891; Freire R, 2005, CURR BIOL, V15, pR620, DOI 10.1016/j.cub.2005.08.017; Freire R, 2012, J EXP BIOL, V215, P2399, DOI 10.1242/jeb.068312; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; HASLER AD, 1958, LIMNOL OCEANOGR, V3, P353, DOI 10.4319/lo.1958.3.4.0353; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; KEETON WT, 1974, J COMP PHYSIOL, V95, P95, DOI 10.1007/BF00610108; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Kirschvink JL, 1997, J EXP BIOL, V200, P1363; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Kishkinev D, 2012, J ORNITHOL, V153, P1165, DOI 10.1007/s10336-012-0847-x; Kramer G., 1952, Ibis, V94, P265, DOI 10.1111/j.1474-919X.1952.tb01817.x; LOHMANN KJ, 1991, J EXP BIOL, V155, P37; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; MERRITT R, 1983, REV SCI INSTRUM, V54, P879, DOI 10.1063/1.1137480; Mora CV, 2012, ANIM BEHAV, V84, P377, DOI 10.1016/j.anbehav.2012.05.005; Mora CV, 2009, J NAVIGATION, V62, P571, DOI 10.1017/S0373463309990063; Mora CV, 2009, P R SOC B, V276, P3295, DOI 10.1098/rspb.2009.0872; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Mouritsen H, 2012, NATURE, V484, P320, DOI 10.1038/484320a; Phillips JB, 2002, J COMP PHYSIOL A, V188, P157, DOI 10.1007/s00359-002-0286-x; Postlethwaite CM, 2011, J THEOR BIOL, V269, P273, DOI 10.1016/j.jtbi.2010.10.036; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; SCHMIDTKOENIG K, 1978, ANIM BEHAV, V26, P480, DOI 10.1016/0003-3472(78)90065-9; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Vargas JP, 2006, BRAIN RES BULL, V70, P158, DOI 10.1016/j.brainresbull.2006.03.018; Voss J, 2007, NEUROREPORT, V18, P1053, DOI 10.1097/WNR.0b013e32818b2a21; Wagner G., 1976, REV SUISSE ZOOL, V83, P883; Walcott C., 1978, ANIMAL MIGRATION NAV, P143, DOI 10.1007/978-3-662-11147-5_13; Walker MM, 1999, J THEOR BIOL, V197, P271, DOI 10.1006/jtbi.1998.0875; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Walker MM, 1998, J THEOR BIOL, V192, P341, DOI 10.1006/jtbi.1998.0653; WALKER MM, 1985, J COMP PHYSIOL A, V157, P67, DOI 10.1007/BF00611096; Wiltschko R, 2013, J COMP PHYSIOL A, V199, P89, DOI 10.1007/s00359-012-0769-3; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 2011, PROCEDIA CHEM, V3, DOI 10.1016/j.proche.2011.08.035; Wilzeck C, 2010, J R SOC INTERFACE, V7, pS235, DOI 10.1098/rsif.2009.0436.focus; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Zar JH, 1999, BIOSTATISTICAL ANAL	53	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72869	10.1371/journal.pone.0072869	http://dx.doi.org/10.1371/journal.pone.0072869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039812	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300032
J	Pino-Yanes, M; Corrales, A; Cumplido, J; Poza, P; Sanchez-Machin, I; Sanchez-Palacios, A; Figueroa, J; Acosta-Fernandez, O; Buset, N; Garcia-Robaina, JC; Hernandez, M; Villar, J; Carrillo, T; Flores, C				Pino-Yanes, Maria; Corrales, Almudena; Cumplido, Jose; Poza, Paloma; Sanchez-Machin, Inmaculada; Sanchez-Palacios, Anselmo; Figueroa, Javier; Acosta-Fernandez, Orlando; Buset, Nisa; Carlos Garcia-Robaina, Jose; Hernandez, Mariano; Villar, Jesus; Carrillo, Teresa; Flores, Carlos			Assessing the Validity of Asthma Associations for Eight Candidate Genes and Age at Diagnosis Effects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HARDY-WEINBERG EQUILIBRIUM; POPULATION; VARIANTS; METAANALYSIS; REPLICATION; PHENOTYPES; CHILDREN; RISK; LOCI	Background: Before the advent of genome-wide association studies (GWAS), ADAM33, ADRB2, CD14, MS4A2 (alias FCER1B), IL13, IL4, IL4R, and TNF constituted the most replicated non-HLA candidate genes with asthma and related traits. However, except for the IL13-IL4 region, none of these genes have been found in close proximity of genome-wide significant hits among GWAS for asthma or related traits. Here we aimed to assess the reproducibility of these asthma associations and to test if associations were more evident considering the effect of age at diagnosis. Methodology/Principal Findings: We systematically evaluated 286 common single nucleotide polymorphisms (SNPs) of these 8 genes in a sample of 1,865 unrelated Spanish individuals (606 asthmatics and 1,259 controls). We found that variants at MS4A2, IL4R and ADAM33 genes demonstrated varying association effects with the age at diagnosis of asthma, with 10 SNPs showing study-wise significance after the multiple comparison adjustment. In addition, in silico replication with GWAS data supported the association of IL4R. Conclusions/Significance: Our results support the important role of MS4A2, IL4R and ADAM33 genes in asthma and/or atopy susceptibility. However, additional studies in larger samples sets are needed to firmly implicate these genes in asthma susceptibility, and also to identify the causal variation underlying the associations found.	[Pino-Yanes, Maria; Corrales, Almudena; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBERES, Madrid, Spain; [Pino-Yanes, Maria; Corrales, Almudena; Flores, Carlos] Hosp Univ Nuestra Senora Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Cumplido, Jose; Carrillo, Teresa] Hosp Univ Dr Negrin, Allergy Unit, Las Palmas Gran Canaria, Spain; [Poza, Paloma; Sanchez-Machin, Inmaculada] Hosp Torax Ofra, Allergy Management Unit, Santa Cruz De Tenerife, Spain; [Sanchez-Palacios, Anselmo; Figueroa, Javier] Hosp Univ Insular Gran Canaria, Allergy Unit, Las Palmas Gran Canaria, Spain; [Acosta-Fernandez, Orlando] Hosp Univ Canarias, Neumol Unit, San Cristobal Lagu, Spain; [Buset, Nisa; Villar, Jesus] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain; [Carlos Garcia-Robaina, Jose] Hosp Univ Nuestra Senora Candelaria, Allergy Unit, Santa Cruz De Tenerife, Spain; [Hernandez, Mariano; Flores, Carlos] Univ La Laguna, Appl Genom Grp, Genet Lab, Inst Univ Enfermedades Trop & Salud Publ Canarias, San Cristobal Lagu, Spain; [Villar, Jesus] St Michael Hosp, Keenan Res Ctr, Toronto, ON, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; Universidad de la Laguna; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Flores, C (corresponding author), Inst Salud Carlos III, CIBERES, Madrid, Spain.	cflores@ull.edu.es	Corrales, Almudena/G-5391-2017; Machín, María Inmaculada Sánchez/ABF-6003-2020; Villar, Jesús/R-4526-2019; Hernandez, Mariano/AAK-3143-2020; Hernandez, Mariano/K-6679-2015; Poza-Guedes, Paloma/AAE-6848-2022; Flores, Carlos/R-1159-2019; Pino-Yanes, Maria/C-8498-2017	Corrales, Almudena/0000-0002-2207-5463; Villar, Jesús/0000-0001-5687-3562; Hernandez, Mariano/0000-0003-1219-0246; Hernandez, Mariano/0000-0003-1219-0246; Poza-Guedes, Paloma/0000-0001-8516-6648; Pino-Yanes, Maria/0000-0003-0332-437X; Sanchez-Machin, Inmaculada/0000-0003-0109-8735; Flores, Carlos/0000-0001-5352-069X	Carlos III Health Institute; European Regional Development Fund (FEDER) [PI081383, EMER07/001]; Fundacion Canaria de Investigacion y Salud FUNCIS [27/07]; Fundacion Ramon Areces	Carlos III Health Institute(Instituto de Salud Carlos III); European Regional Development Fund (FEDER)(European Commission); Fundacion Canaria de Investigacion y Salud FUNCIS; Fundacion Ramon Areces	Funded by grants from the Carlos III Health Institute (http://www.isciii.es) and cofounded by the European Regional Development Fund (FEDER) "A way of making Europe": PI081383 and EMER07/001, and by a grant from Fundacion Canaria de Investigacion y Salud FUNCIS 27/07 (http://www.funcis.org) to CF. MPY was funded by a postdoctoral fellowship from Fundacion Ramon Areces (http://www.fundacionareces.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P16, DOI 10.1016/S0091-6749(87)80010-6; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Belfer I, 2004, GENES IMMUN, V5, P505, DOI 10.1038/sj.gene.6364118; Botigue LR, 2013, P NATL ACAD SCI US; Boulet LP, 1997, CLIN EXP ALLERGY, V27, P52, DOI 10.1111/j.1365-2222.1997.tb00672.x; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Bouzigon E, 2010, EUR J HUM GENET, V18, P700, DOI 10.1038/ejhg.2009.224; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Castro-Giner F, 2010, THORAX, V65, P124, DOI 10.1136/thx.2009.119628; CHAKRABORTY R, 1994, HUM HERED, V44, P1, DOI 10.1159/000154181; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Finkelstein Y, 2009, J ASTHMA, V46, P900, DOI 10.3109/02770900903199961; Galanter JM, 2011, J ALLERGY CLIN IMMUN, V128, P37, DOI 10.1016/j.jaci.2011.03.050; Gelfand EW, 2008, ALLERGY ASTHMA PROC, V29, P99, DOI 10.2500/aap.2008.29.3090; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Henderson J, 2009, ARCH DIS CHILD, V94, P333, DOI 10.1136/adc.2008.143636; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Holberg CJ, 1999, AM J RESP CRIT CARE, V160, P1604, DOI 10.1164/ajrccm.160.5.9807043; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Macgregor S, 2006, EUR J HUM GENET, V14, P529, DOI 10.1038/sj.ejhg.5201604; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nicolae DL, 2009, AM J RESP CRIT CARE, V179, P1078, DOI 10.1164/rccm.200903-0456ED; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Ober C, 2005, J ALLERGY CLIN IMMUN, V116, P274, DOI 10.1016/j.jaci.2005.04.039; Pino-Yanes M, 2012, J ALLERGY CLIN IMMUN, V129, P573, DOI 10.1016/j.jaci.2011.10.001; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; R Core Team, 2022, R LANG ENV STAT COMP; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun XG, 2010, J ALLERGY CLIN IMMUN, V126, P241, DOI 10.1016/j.jaci.2010.04.036; Swarr DT, 2010, CURR OPIN ALLERGY CL, V10, P434, DOI 10.1097/ACI.0b013e32833da71d; Thomsen SF, 2010, CLIN EXP ALLERGY, V40, P1054, DOI 10.1111/j.1365-2222.2010.03525.x; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007	63	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73157	10.1371/journal.pone.0073157	http://dx.doi.org/10.1371/journal.pone.0073157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039878	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300053
J	Saenz, VL; Maggi, RG; Breitschwerdt, EB; Kim, J; Vargo, EL; Schal, C				Saenz, Virna L.; Maggi, Ricardo G.; Breitschwerdt, Edward B.; Kim, Jung; Vargo, Edward L.; Schal, Coby			Survey of Bartonella spp. in US Bed Bugs Detects Burkholderia multivorans but Not Bartonella	PLOS ONE			English	Article							CANDIDATUS-MIDICHLORIA-MITOCHONDRII; INFECTIOUS-DISEASES; MOLECULAR EVIDENCE; CIMICIDAE; HEMIPTERA; BEDBUGS	Bed bugs (Cimex lectularius L.) have resurged in the United States and globally. Bed bugs are hematophagous ectoparasites of humans and other animals, including domestic pets, chickens, and bats, and their blood feeding habits contribute to their potential as disease vectors. Several species of Bartonella are re-emergent bacterial pathogens that also affect humans, domestic pets, bats and a number of other wildlife species. Because reports of both bed bugs and Bartonella have been increasing in the U. S., and because their host ranges can overlap, we investigated whether the resurgences of these medically important pathogens and their potential vector might be linked, by screening for Bartonella spp. in bed bugs collected from geographic areas where these pathogens are prevalent and from bed bugs that have been in culture in the laboratory for several years. We screened a total of 331 bed bugs: 316 bed bugs from 36 unique collections in 29 geographic locations in 13 states, 10 bed bugs from two colonies maintained in the laboratory for 3 yr, and 5 bed bugs from a colony that has been in culture since before the recent resurgence of bed bugs. Bartonella spp. DNA was screened using a polymerase chain reaction assay targeting the 16S-23S rRNA intergenic transcribed spacer region. Bartonella DNA was not amplified from any bed bug, but five bed bugs from four different apartments of an elderly housing building in North Carolina contained DNA sequences that corresponded to Burkholderia multivorans, an important pathogen in nosocomial infections that was not previously linked to an arthropod vector.	[Saenz, Virna L.; Vargo, Edward L.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Saenz, Virna L.; Vargo, Edward L.; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Maggi, Ricardo G.; Breitschwerdt, Edward B.] N Carolina State Univ, Intracellular Pathogens Res Lab, Ctr Translat Med, Raleigh, NC 27695 USA; [Kim, Jung] North Carolina Dept Agr & Consumer Serv, Struct Pest Control & Pesticide Div, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Maggi, Ricardo/0000-0001-7428-0138; Breitschwerdt, Edward/0000-0002-3506-0279	Agriculture and Food Research Initiative Competitive Grant from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2008-35302-04565]; Pest Management Foundation; Blanton J. Whitmire endowment at North Carolina State University; North Carolina Pest Management Association; Structural Pest Management Training and Research Facility at North Carolina State University	Agriculture and Food Research Initiative Competitive Grant from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture; Pest Management Foundation; Blanton J. Whitmire endowment at North Carolina State University; North Carolina Pest Management Association; Structural Pest Management Training and Research Facility at North Carolina State University	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2008-35302-04565 from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (to ELV and CS), a grant from the Pest Management Foundation (to ELV and CS), the Blanton J. Whitmire endowment at North Carolina State University, and scholarships to VLS from the North Carolina Pest Management Association and the Structural Pest Management Training and Research Facility at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvin O, 2012, PARASITOL RES, V111, P457, DOI 10.1007/s00436-012-2862-5; Beard AW, 2011, EMERG INFECT DIS, V17, P893, DOI 10.3201/eid1705.100141; Billeter SA, 2008, J MED ENTOMOL, V45, P176, DOI 10.1603/0022-2585(2008)45[176:DOTBTS]2.0.CO;2; Blow JA, 2001, J MED ENTOMOL, V38, P694, DOI 10.1603/0022-2585-38.5.694; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Brouqui P, 2011, ANNU REV ENTOMOL, V56, P357, DOI 10.1146/annurev-ento-120709-144739; Clark S, 2002, VET REC, V151, P336; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; Goddard J, 2012, J MED ENTOMOL, V49, P922, DOI 10.1603/ME11282; JAMESON P, 1995, J INFECT DIS, V172, P1145, DOI 10.1093/infdis/172.4.1145; Klempner MS, 2007, NEW ENGL J MED, V356, P2567, DOI 10.1056/NEJMp078081; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lowe CF, 2011, EMERG INFECT DIS, V17, P1132, DOI [10.3201/eid1706.101978, 10.3201/eid/1706.101978]; Potter M. F., 2011, PEST WORLD, P4; Reeves WK, 2007, J VECTOR ECOL, V32, P118, DOI 10.3376/1081-1710(2007)32[118:AOBWTF]2.0.CO;2; Reeves WK, 2005, J VECTOR ECOL, V30, P339; Richard S, 2009, CLIN MICROBIOL INFEC, V15, P84, DOI 10.1111/j.1469-0691.2008.02244.x; Sakamoto JM, 2006, J MED ENTOMOL, V43, P696, DOI 10.1603/0022-2585(2006)43[696:GDOWII]2.0.CO;2; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; Usinger RL, 1966, MONOGRAPH CIMICIDAE	24	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73661	10.1371/journal.pone.0073661	http://dx.doi.org/10.1371/journal.pone.0073661			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040015	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300106
J	Tagore, S; De, RK				Tagore, Somnath; De, Rajat K.			Simulating an Infection Growth Model in Certain Healthy Metabolic Pathways of Homo sapiens for Highlighting Their Role in Type I Diabetes mellitus Using Fire-Spread Strategy, Feedbacks and Sensitivities	PLOS ONE			English	Article							MATHEMATICAL-MODELS; GENE-EXPRESSION; FOREST-FIRE; MALONYL-COA; INSULIN; NETWORK; SYSTEMS; CYSTEINE; TAURINE	Disease Systems Biology is an area of life sciences, which is not very well understood to date. Analyzing infections and their spread in healthy metabolite networks can be one of the focussed areas in this regard. We have proposed a theory based on the classical forest fire model for analyzing the path of infection spread in healthy metabolic pathways. The theory suggests that when fire erupts in a forest, it spreads, and the surrounding trees also catch fire. Similarly, when we consider a metabolic network, the infection caused in the metabolites of the network spreads like a fire. We have constructed a simulation model which is used to study the infection caused in the metabolic networks from the start of infection, to spread and ultimately combating it. For implementation, we have used two approaches, first, based on quantitative strategies using ordinary differential equations and second, using graph-theory based properties. Furthermore, we are using certain probabilistic scores to complete this task and for interpreting the harm caused in the network, given by a 'critical value' to check whether the infection can be cured or not. We have tested our simulation model on metabolic pathways involved in Type I Diabetes mellitus in Homo sapiens. For validating our results biologically, we have used sensitivity analysis, both local and global, as well as for identifying the role of feedbacks in spreading infection in metabolic pathways. Moreover, information in literature has also been used to validate the results. The metabolic network datasets have been collected from the Kyoto Encyclopedia of Genes and Genomes (KEGG).	[Tagore, Somnath] Padmashree Dr DY Patil Univ, Dept Biotechnol & Bioinformat, Navi Mumbai, India; [De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	De, RK (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, India.	rajat@isical.ac.in	Tagore, Somnath/HCI-5816-2022					Abbasi A, 2012, EUR J CLIN INVEST, V42, P974, DOI 10.1111/j.1365-2362.2012.02685.x; Akkanen MJ, 2009, RISK MANAG HEALTHC P, V2, P55, DOI 10.2147/RMHP.S5262; Alvarez-Vasquez F, 2011, PLOS ONE S12; ANDERSON R M, 1991; Apgar JF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040030; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Bailey NTJ, 1975, MATH THEORY INFECT D; BAK P, 1990, PHYS LETT A, V147, P297, DOI 10.1016/0375-9601(90)90451-S; Baldzizhar R, 2013, J BIOL CHEM, V288, P1612, DOI 10.1074/jbc.M112.409664; Bell JA, 2006, DIABETOLOGIA, V49, P2144, DOI 10.1007/s00125-006-0362-9; BURTON FR, 1992, TRANSPLANTATION, V54, P988, DOI 10.1097/00007890-199212000-00009; Cammisotto PG, 2005, AM J PHYSIOL-ENDOC M, V289, pE166, DOI 10.1152/ajpendo.00602.2004; Casals M, 2009, REV ESP SALUD PUBLIC, V83, P689, DOI [10.1590/S1135-57272009000500010, 10.1590/s1135-57272009000500010]; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Chitour Y, 2006, NETW HETEROG MEDIA, V1, P219, DOI 10.3934/nhm.2006.1.219; Choisy M., 2007, ENCY INFECT DIS MODE, V379, DOI [10.1002/9780470114209.ch22, DOI 10.1002/9780470114209.CH22]; Coburn S P, 1996, Adv Food Nutr Res, V40, P107, DOI 10.1016/S1043-4526(08)60023-6; Everaert I, 2012, AM J PHYSIOL-RENAL, V302, pF1537, DOI 10.1152/ajprenal.00084.2012; Funahashi A., 2004, 8 ANN INT C RES COMP; Gylvin T, 2004, DIABETOLOGIA, V47, P1273, DOI 10.1007/s00125-004-1440-5; Hanan FA, 2007, KUWAIT MED J, V39, P107; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Imae M, 2000, J ENDOCRINOL, V167, pR1, DOI 10.1677/joe.0.167R001; Jain SK, 2012, CAN J PHYSIOL PHARM, V90, P1061, DOI [10.1139/y2012-087, 10.1139/Y2012-087]; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kenah E, 2007, J THEOR BIOL, V249, P706, DOI 10.1016/j.jtbi.2007.09.011; Koshiyama H, 2006, MED HYPOTHESES, V67, P307, DOI 10.1016/j.mehy.2006.02.033; Kot M, 2001, ELEMENTS MATH ECOLOG, DOI 10.1017/CBO9780511608520; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061919; Lorenzo MP, 2013, J PHARMACEUT BIOMED, V73, P116, DOI 10.1016/j.jpba.2012.03.017; Ludvigsson J, 2012, PANMINERVA MED, V54, P257; MOLBAK AG, 1994, DIABETIC MED, V11, P650, DOI 10.1111/j.1464-5491.1994.tb00327.x; Murray J.D., 2002, MATH BIOL; Nestorov IA, 1999, J PHARMACOKINET BIOP, V27, P577, DOI 10.1023/A:1020926525495; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Nicholson JK, 2008, NATURE, V456, P7221; NOKES DJ, 1988, EPIDEMIOL INFECT, V101, P1, DOI 10.1017/S0950268800029186; RABITZ H, 1983, ANNU REV PHYS CHEM, V34, P419, DOI 10.1146/annurev.pc.34.100183.002223; Ray S, 2012, Med J Malaysia, V67, P116; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rhodes CJ, 1998, J FRANKLIN I, V335B, P199, DOI 10.1016/S0016-0032(96)00096-8; Ripps H, 2012, MOL VIS, V18, P2673; Graciano MFR, 2011, ISLETS, V3, P213, DOI 10.4161/isl.3.5.15935; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Samokhvalov V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1459, DOI 10.1152/ajpendo.00018.2012; Skyler JS, 2013, DIABETIC MED, V30, P161, DOI 10.1111/dme.12100; Sobol I., 1993, MATH MODELING COM S4, V1, P577; Tappia PS, 2013, PHYSIOL RES, V62, P171, DOI 10.33549/physiolres.932388; Tomovi R, 1963, SENSITIVITY ANAL DYN; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; Trapman P, 2007, THEOR POPUL BIOL, V71, P160, DOI 10.1016/j.tpb.2006.11.002; Tsiani E, 1997, AM J PHYSIOL-CELL PH, V272, pC156, DOI 10.1152/ajpcell.1997.272.1.C156; Turchin P, 2001, ECOL LETT, V4, P267, DOI 10.1046/j.1461-0248.2001.00204.x; Verrotti A, 2012, EUR J ENDOCRINOL, V167, P749, DOI 10.1530/EJE-12-0699; Walker M, 1997, DIABETIC MED, V14, P1007, DOI 10.1002/(SICI)1096-9136(199712)14:12<1007::AID-DIA541>3.0.CO;2-R; Wang JH, 2010, SEMIN NEPHROL, V30, P500, DOI 10.1016/j.semnephrol.2010.07.007; Zinck RD, 2009, AM NAT, V174, pE170, DOI 10.1086/605959	60	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e69724	10.1371/journal.pone.0069724	http://dx.doi.org/10.1371/journal.pone.0069724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039701	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300001
J	Yew, KH; Crow, J; Hirst, J; Pressetto, Z; Godwin, AK				Yew, Kok-Hooi; Crow, Jennifer; Hirst, Jeff; Pressetto, Ziyan; Godwin, Andrew K.			Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; MORPHOGENIC PROTEIN; SURFACE EPITHELIUM; C/EBP-BETA; ANNEXIN-V; NF-KB; DIFFERENTIATION; EXPRESSION; PROLIFERATION	Distinctive genotypic and phenotypic features of ovarian cancer via epithelial-mesenchymal transition (EMT) have been correlated with drug resistance and disease recurrence. We investigated whether therapeutic reversal of EMT could resensitize ovarian cancer cells (OCCs) to existing chemotherapy. We report that epimorphin, a morphogenic protein, has pivotal control over mesenchymal versus epithelial cell lineage decision of the putative OCCs. Exposure to epimorphin induced morphological changes reminiscent of mesenchymal-to-epithelial transition (MET), but in a dose dependent manner, i. e., at 10 mu g/mL of epimorphin cells obtain a more mesenchymal-like morphology while at 20 mu g/mL of epimorphin cells display an epithelial morphology. The latter changes were accompanied by suppression of mesenchymal markers, such as vimentin (similar to 8-fold down arrow, p<,0.02), Twist1 (similar to 7-fold, p< 0.03), dystroglycan (similar to 4-fold down arrow, p< 0.01) and palladin (similar to 3-fold, p< 0.01). Conversely, significant elevations of KLF4 (similar to 28-foldq up arrow p< 0.002), beta-catenin (similar to 6-fold down arrow, p< 0.004), EpCAM (similar to 6-foldq up arrow, p< 0.0002) and occludin (similar to 15-fold up arrow, p< 0.004) mRNAs as part of the commitment to the epithelial cell lineage were detected in response to 20 mg/mL of exogenous epimorphin. Changes in occludin mRNA levels were accompanied by a parallel, albeit weaker expression at the protein level (similar to 5-fold up arrow, p< 0.001). Likewise, acquisition of epithelial-like properties, including mucin1, CK19, and beta-catenin gene expression, was also obtained following epimorphin treatment. Further, MMP3 production was found to be reduced whereas laminin secretion was strongly amplified upon epimorphin-induced MET. These results suggest there is a dosage window for actions of epimorphin on cellular differentiation, wherein it can either suppress or enhance epithelial differentiation of OCCs. Importantly, induction of epithelial-like phenotypes by epimorphin led to an enhanced sensitivity to carboplatin. Overall, we demonstrate that epimorphin can revert OCCs away from their mesenchymal phenotype and toward an epithelial phenotype, thereby enhancing their sensitivity to a front-line chemotherapeutic agent.	[Yew, Kok-Hooi; Crow, Jennifer; Hirst, Jeff; Pressetto, Ziyan; Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Godwin, Andrew K.] Univ Kansas, Ctr Canc, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center; University of Kansas	Godwin, AK (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	agodwin@kumc.edu			Ovarian Cancer Research Fund; Kansas Bioscience Authority Eminent Scholar Program; NCI [R01CA140323]; University of Kansas Cancer Centers (KUCC) [P30 CA168524]; University of Kansas Endowment Association; NATIONAL CANCER INSTITUTE [R01CA140323, P30CA168524] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; Kansas Bioscience Authority Eminent Scholar Program; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Kansas Cancer Centers (KUCC); University of Kansas Endowment Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by a program project grant from Ovarian Cancer Research Fund (http://www.ocrf.org), a grant from the Kansas Bioscience Authority Eminent Scholar Program, and a grant from the NCI (R01CA140323) to A.K.G. The authors would also like to acknowledge support from the University of Kansas Cancer Centers (KUCC) P30 CA168524) shared resources and the University of Kansas Endowment Association. A.K.G is the Chancellors Distinguished Chair in Biomedical Sciences at KUCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Chen CS, 2009, J BIOL CHEM, V284, P6877, DOI 10.1074/jbc.M805908200; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Fritsch C, 2002, J CLIN INVEST, V110, P1629, DOI 10.1172/200213588; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Iizuka M, 2007, AM J PHYSIOL-GASTR L, V292, pG39, DOI 10.1152/ajpgi.00181.2006; Johnson SW, 1997, CANCER RES, V57, P850; Koshida S, 1997, BIOCHEM BIOPH RES CO, V234, P522, DOI 10.1006/bbrc.1997.6673; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Marchini S, 2013, EUR J CANCER, V49, P520, DOI 10.1016/j.ejca.2012.06.026; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Okugawa Y, 2008, J INVEST DERMATOL, V128, P1884, DOI 10.1038/jid.2008.22; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; Simian M, 2001, DEVELOPMENT, V128, P3117; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tulachan SS, 2006, DEV GROWTH DIFFER, V48, P65, DOI 10.1111/j.1440-169x.2006.00846.x; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; VANHEERDE WL, 1995, THROMB HAEMOSTASIS, V73, P172; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Von Schalburg KR, 2006, MOL REPROD DEV, V73, P142, DOI 10.1002/mrd.20359; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546	37	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72637	10.1371/journal.pone.0072637	http://dx.doi.org/10.1371/journal.pone.0072637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039787	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300017
J	Kropatsch, R; Dekomien, G; Akkad, DA; Gerding, WM; Petrasch-Parwez, E; Young, ND; Altmuller, J; Nurnberg, P; Gasser, RB; Epplen, JT				Kropatsch, Regina; Dekomien, Gabriele; Akkad, Denis A.; Gerding, Wanda M.; Petrasch-Parwez, Elisabeth; Young, Neil D.; Altmueller, Janine; Nuernberg, Peter; Gasser, Robin B.; Epplen, Joerg T.			SOX9 Duplication Linked to Intersex in Deer	PLOS ONE			English	Article							XX SEX-REVERSAL; TESTIS DIFFERENTIATION; CAMPOMELIC DYSPLASIA; PCR AMPLIFICATION; SRY; GENE; EXPRESSION; MOUSE; UPSTREAM; MAMMALS	A complex network of genes determines sex in mammals. Here, we studied a European roe deer with an intersex phenotype that was consistent with a XY genotype with incomplete male-determination. Whole genome sequencing and quantitative real-time PCR analyses revealed a triple dose of the SOX9 gene, allowing insights into a new genetic defect in a wild animal.	[Kropatsch, Regina; Dekomien, Gabriele; Akkad, Denis A.; Gerding, Wanda M.; Petrasch-Parwez, Elisabeth; Epplen, Joerg T.] Ruhr Univ Bochum, Bochum, Germany; [Young, Neil D.; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	Ruhr University Bochum; University of Melbourne; University of Cologne	Kropatsch, R (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	regina.kropatsch@rub.de	Gasser, Robin/ABH-6185-2020; Young, Neil David/AAU-4572-2020	Gasser, Robin/0000-0002-4423-1690; Young, Neil David/0000-0001-8756-229X; Altmuller, Janine/0000-0003-4372-1521; Epplen, Joerg T./0000-0002-6087-3327	Australian Research Council (ARC) [LP110100018]; National Health and Medical Research Council (NHMRC) [APP1044022]; Melbourne Water Corporation; Alexander von Humboldt Foundation	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Water Corporation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	RBG's research is funded by the Australian Research Council (ARC, LP110100018, http://www.arc.gov.au/), the National Health and Medical Research Council (NHMRC, APP1044022, http://www.nhmrc.gov.au/), Melbourne Water Corporation (http://www.melbournewater.com.au/), and the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannasch D, 2007, VET J, V173, P437, DOI 10.1016/j.tvjl.2005.11.008; Benko S, 2011, J MED GENET, V48, P825, DOI 10.1136/jmedgenet-2011-100255; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Braunschweig A, 1970, Z JAGDWISS, V16, P116; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; DELACHAPELLE A, 1990, REPROD NUTR DEV, pS39; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; Fleming A, 2005, CLIN GENET, V67, P15, DOI 10.1111/j.1399-0004.2004.00376.x; Godde R, 2004, ELECTROPHORESIS, V25, P2212, DOI 10.1002/elps.200405929; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Kuiper H, 2005, VET J, V169, P116, DOI 10.1016/j.tvjl.2003.11.004; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOORE SS, 1991, GENOMICS, V10, P654, DOI 10.1016/0888-7543(91)90448-N; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Pajares G, 2009, ANIM REPROD SCI, V112, P190, DOI 10.1016/j.anireprosci.2008.04.018; Pajares G, 2007, ARCH TIERZUCHT, V50, P442, DOI 10.5194/aab-50-442-2007; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Takahashi M, 1998, J VET MED SCI, V60, P713, DOI 10.1292/jvms.60.713; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033; Vor Torsten, 2010, Experimental and Applied Acarology, V51, P405, DOI 10.1007/s10493-010-9337-0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8	27	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73734	10.1371/journal.pone.0073734	http://dx.doi.org/10.1371/journal.pone.0073734			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040047	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500058
J	Meyer, A; Focks, A; Radl, V; Keil, D; Welzl, G; Schoning, I; Boch, S; Marhan, S; Kandeler, E; Schloter, M				Meyer, Annabel; Focks, Andreas; Radl, Viviane; Keil, Daniel; Welzl, Gerhard; Schoening, Ingo; Boch, Steffen; Marhan, Sven; Kandeler, Ellen; Schloter, Michael			Different Land Use Intensities in Grassland Ecosystems Drive Ecology of Microbial Communities Involved in Nitrogen Turnover in Soil	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; DENITRIFYING BACTERIA; SPECIES COMPOSITION; NOSZ GENES; NITRIFICATION; MANAGEMENT; ABUNDANCE; NIRK; DIVERSITY; DENITRIFICATION	Understanding factors driving the ecology of N cycling microbial communities is of central importance for sustainable land use. In this study we report changes of abundance of denitrifiers, nitrifiers and nitrogen-fixing microorganisms (based on qPCR data for selected functional genes) in response to different land use intensity levels and the consequences for potential turnover rates. We investigated selected grassland sites being comparable with respect to soil type and climatic conditions, which have been continuously treated for many years as intensely used meadows (IM), intensely used mown pastures (IP) and extensively used pastures (EP), respectively. The obtained data were linked to above ground biodiversity pattern as well as water extractable fractions of nitrogen and carbon in soil. Shifts in land use intensity changed plant community composition from systems dominated by s-strategists in extensive managed grasslands to c-strategist dominated communities in intensive managed grasslands. Along the different types of land use intensity, the availability of inorganic nitrogen regulated the abundance of bacterial and archaeal ammonia oxidizers. In contrast, the amount of dissolved organic nitrogen determined the abundance of denitrifiers (nirS and nirK). The high abundance of nifH carrying bacteria at intensive managed sites gave evidence that the amounts of substrates as energy source outcompete the high availability of inorganic nitrogen in these sites. Overall, we revealed that abundance and function of microorganisms involved in key processes of inorganic N cycling (nitrification, denitrification and N fixation) might be independently regulated by different abiotic and biotic factors in response to land use intensity.	[Meyer, Annabel] Tech Univ Munich, Neuherberg, Germany; [Focks, Andreas] Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Radl, Viviane; Welzl, Gerhard; Schloter, Michael] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Keil, Daniel; Marhan, Sven; Kandeler, Ellen] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Sect, Stuttgart, Germany; [Schoening, Ingo] Univ Jena, Inst Ecol, Jena, Germany; [Boch, Steffen] Univ Bern, Inst Plant Sci, Bern, Switzerland	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University Hohenheim; Friedrich Schiller University of Jena; University of Bern	Schloter, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Neuherberg, Germany.	schloter@helmholtz-muenchen.de	Schöning, Ingo/D-3341-2009; Boch, Steffen/L-5436-2016; Focks, Andreas/GQZ-0508-2022; Focks, Andreas/O-1186-2015; Schloter, 1Michael/H-9151-2013	Schöning, Ingo/0000-0002-9830-5026; Focks, Andreas/0000-0002-9031-0808; Kandeler, Ellen/0000-0002-2854-0012	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard E, 2010, ENVIRON MICROBIOL, V12, P315, DOI 10.1111/j.1462-2920.2009.02070.x; Babic KH, 2008, ENVIRON MICROBIOL, V10, P2922, DOI 10.1111/j.1462-2920.2008.01762.x; Berthrong ST, 2009, APPL ENVIRON MICROB, V75, P6240, DOI 10.1128/AEM.01126-09; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Bremer C, 2007, APPL ENVIRON MICROB, V73, P6876, DOI 10.1128/AEM.01536-07; Cheneby D, 2009, APPL ENVIRON MICROB, V75, P3180, DOI 10.1128/AEM.02338-08; Cookson WR, 2007, SOIL BIOL BIOCHEM, V39, P744, DOI 10.1016/j.soilbio.2006.09.022; Dandie CE, 2008, APPL ENVIRON MICROB, V74, P5997, DOI 10.1128/AEM.00441-08; Di HJ, 2009, SOIL USE MANAGE, V25, P454, DOI 10.1111/j.1475-2743.2009.00241.x; Dilly O, 2003, CHEMOSPHERE, V52, P557, DOI 10.1016/S0045-6535(03)00237-6; DREW MC, 1980, ANN REV PHYTOPATHOLO, V18; Ellenberg H, 2001, ZEIGERWERTE PFLANZEN, V3rd ed; Enwall K, 2005, APPL ENVIRON MICROB, V71, P8335, DOI 10.1128/AEM.71.12.8335-8343.2005; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Gil SV, 2009, WORLD J MICROB BIOT, V25, P439, DOI 10.1007/s11274-008-9908-y; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; HAI B, 2009, APPL ENVIRON MICROB, V75, P1034; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hoffmann H, 2007, BIOL FERT SOILS, V44, P411, DOI 10.1007/s00374-007-0227-5; Hou Fujiang, 2002, Yingyong Shengtai Xuebao, V13, P915; HOUBA VJG, 1986, PLANT SOIL, V96, P433, DOI 10.1007/BF02375149; Jacquemyn H, 2003, BIOL CONSERV, V111, P137, DOI 10.1016/S0006-3207(02)00256-2; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P1, DOI 10.1016/j.soilbio.2009.08.020; Kirkham FW, 1996, J APPL ECOL, V33, P1013, DOI 10.2307/2404682; Klimek S, 2007, BIOL CONSERV, V134, P559, DOI 10.1016/j.biocon.2006.09.007; Le Roux X, 2003, OECOLOGIA, V137, P417, DOI 10.1007/s00442-003-1367-4; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lillis L, 2009, J APPL MICROBIOL, V107, P1883, DOI 10.1111/j.1365-2672.2009.04369.x; Maurer K, 2006, BIOL CONSERV, V130, P438, DOI 10.1016/j.biocon.2006.01.005; Mertens J, 2009, ISME J, V3, P916, DOI 10.1038/ismej.2009.39; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Mills A, 2006, CAN J PLANT SCI, V86, P1339, DOI 10.4141/P06-114; Mounier E, 2004, ENVIRON MICROBIOL, V6, P301, DOI 10.1111/j.1462-2920.2004.00571.x; MYROLD DD, 2007, BIOL N INPUTS, P365; O'Neill KM, 2010, ENVIRON ENTOMOL, V39, P775, DOI 10.1603/EN09173; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Ollivier J, 2011, FEMS MICROBIOL ECOL, V78, P3, DOI 10.1111/j.1574-6941.2011.01165.x; Parfitt RL, 2010, APPL SOIL ECOL, V45, P175, DOI 10.1016/j.apsoil.2010.03.010; Patra AK, 2005, ECOL MONOGR, V75, P65, DOI 10.1890/03-0837; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; Robson TM, 2007, SOIL BIOL BIOCHEM, V39, P930, DOI 10.1016/j.soilbio.2006.11.004; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; SCOTT D, 1990, ECOLOGY, V71, P1959; Sharma S, 2006, APPL ENVIRON MICROB, V72, P2148, DOI 10.1128/AEM.72.3.2148-2154.2006; Sharma S, 2005, APPL ENVIRON MICROB, V71, P2001, DOI 10.1128/AEM.71.4.2001-2007.2005; Simek M, 1999, BIOL FERT SOILS, V30, P41; Singh DK, 2008, INDIAN J MICROBIOL, V48, P35, DOI 10.1007/s12088-008-0004-7; Sinha S, 2009, AFR J BIOTECHNOL, V8, P6016; Subbarao GV, 2009, P NATL ACAD SCI USA, V106, P17302, DOI 10.1073/pnas.0903694106; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Thurston J.M., 1969, ECOLOGICAL ASPECTS M, P3; Tiedje J. M., 1988, ECOLOGY DENITRIFICAT; TILMAN, 1987, ECOL MONOGR, V57, P1898; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Vinther FP, 1999, SOIL BIOL BIOCHEM, V31, P603, DOI 10.1016/S0038-0717(98)00165-5; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; ZAUSIG J, 1993, SOIL SCI SOC AM J, V57, P908, DOI 10.2136/sssaj1993.03615995005700040005x	68	37	39	5	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73536	10.1371/journal.pone.0073536	http://dx.doi.org/10.1371/journal.pone.0073536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039974	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500045
J	Chaput, JP; McNeil, J; Despres, JP; Bouchard, C; Tremblay, A				Chaput, Jean-Philippe; McNeil, Jessica; Despres, Jean-Pierre; Bouchard, Claude; Tremblay, Angelo			Seven to Eight Hours of Sleep a Night Is Associated with a Lower Prevalence of the Metabolic Syndrome and Reduced Overall Cardiometabolic Risk in Adults	PLOS ONE			English	Article							WEIGHT-GAIN; PHYSICAL-ACTIVITY; DURATION; OBESITY; CHILDREN; HEALTH; METAANALYSIS; MORTALITY	Background: Previous studies looking at the relationship between sleep duration and the metabolic syndrome have only used a dichotomous approach (presence/absence) and failed to adjust for important confounding factors. The objective of the present study was to examine the association between self-reported sleep duration and features of the metabolic syndrome in adults. Methods: A cross-sectional analysis from the Quebec Family Study (Canada) was conducted on 810 participants aged 18 to 65 years. Participants were categorized as short (<= 6 h), adequate (7-8 h) or long (>= 9 h) sleepers. The metabolic syndrome was defined according to the American Heart Association/National Heart, Lung, and Blood Institute's criteria. Results: Overall, 24.6% of the sample had the metabolic syndrome. A U-shaped relationship between sleep duration and the prevalence of metabolic syndrome (33.3%, 22.0% and 28.8% in short, adequate and long sleepers, respectively) was observed (P<0.01). Only short sleepers had a significant increase in the odds of having the metabolic syndrome (OR = 1.76, 95% CI = 1.08-2.84) compared to adequate sleepers after adjustment for age, sex, smoking habits, highest education level, total annual family income, alcohol consumption, coffee intake, menopausal status, daily caloric intake, and moderate-to-vigorous physical activity. Likewise, the clustered cardiometabolic risk score (i.e. continuous risk score based on the metabolic syndrome components) was significantly higher in short sleepers compared to adequate sleepers after adjustment for covariates (P<0.05). Conclusion: Sleeping <= 6 h per night is associated with an elevated cardiometabolic risk score and an increase in the odds of having the metabolic syndrome after adjusting for possible confounders. These results strongly suggest that short sleep duration is a risk factor for the metabolic syndrome.	[Chaput, Jean-Philippe] Eastern Ontario Res Inst, Childrens Hosp, Healthy Act Living & Obes Res Grp, Ottawa, ON, Canada; [McNeil, Jessica] Univ Ottawa, Sch Human Kinet, Behav & Metab Res Unit, Ottawa, ON, Canada; [Despres, Jean-Pierre] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Cardiol, Quebec City, PQ, Canada; [Despres, Jean-Pierre; Tremblay, Angelo] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ G1K 7P4, Canada; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Laval University; Laval University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Chaput, JP (corresponding author), Eastern Ontario Res Inst, Childrens Hosp, Healthy Act Living & Obes Res Grp, Ottawa, ON, Canada.	jpchaput@cheo.on.ca	Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019; Chaput, Jean-Philippe/ABE-6307-2020	Bouchard, Claude/0000-0002-0048-491X; Chaput, Jean-Philippe/0000-0002-5607-5736	Medical Research Council of Canada; Canadian Institutes of Health Research [PG-11811, MT-13960, GR-15187]; government of Quebec; government of Canada; John W. Barton Sr. Chair in Genetics and Nutrition; Canada Research Chair in Environment and Energy Balance	Medical Research Council of Canada(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); government of Quebec; government of Canada(CGIAR); John W. Barton Sr. Chair in Genetics and Nutrition; Canada Research Chair in Environment and Energy Balance(Canada Research Chairs)	The Quebec Family Study was supported over the years by multiple grants from the Medical Research Council of Canada and the Canadian Institutes of Health Research (www.cihr.ca) (PG-11811, MT-13960 and GR-15187), as well as other agencies from the governments of Quebec and Canada. JPC holds a Junior Research Chair in Healthy Active Living and Obesity Research. JPD is scientific director of the International Chair on Cardiometabolic Risk held at Universite Laval. CB is partially supported by the John W. Barton Sr. Chair in Genetics and Nutrition. AT is partly funded by the Canada Research Chair in Environment and Energy Balance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2011, DIABETES CARE, V34, P2317, DOI 10.2337/dc11-0647; Bin YS, 2012, SLEEP MED REV, V16, P223, DOI 10.1016/j.smrv.2011.07.003; Bixler E, 2009, SLEEP MED, V10, pS3, DOI 10.1016/j.sleep.2009.07.005; Bouchard C, 1996, PENN CTR N, V5, P470; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chaput JP, 2007, DIABETOLOGIA, V50, P2298, DOI 10.1007/s00125-007-0786-x; Chaput JP, 2008, SLEEP, V31, P517, DOI 10.1093/sleep/31.4.517; Chaput JP, 2012, CURR OBES REP, V1, P245, DOI 10.1007/s13679-012-0026-7; Chaput JP, 2009, OBESITY, V17, P1964, DOI 10.1038/oby.2009.116; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; Choi JK, 2011, TOHOKU J EXP MED, V225, P187, DOI 10.1620/tjem.225.187; Choi KM, 2008, INT J OBESITY, V32, P1091, DOI 10.1038/ijo.2008.62; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Hall MH, 2012, SLEEP, V35, P783, DOI 10.5665/sleep.1874; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Knutson KL, 2006, SLEEP, V29, P878, DOI 10.1093/sleep/29.7.878; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Kobayashi D, 2011, INTERNAL MED, V50, P103, DOI 10.2169/internalmedicine.50.4317; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; TREMBLAY A, 1983, NUTR RES, V3, P819, DOI 10.1016/S0271-5317(83)80035-9	37	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72832	10.1371/journal.pone.0072832	http://dx.doi.org/10.1371/journal.pone.0072832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039808	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600037
J	Hein-Kristensen, L; Franzyk, H; Holch, A; Gram, L				Hein-Kristensen, Line; Franzyk, Henrik; Holch, Anne; Gram, Lone			Adaptive Evolution of Escherichia coli to an alpha-Peptide/beta-Peptoid Peptidomimetic Induces Stable Resistance	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; QUORUM SENSING INHIBITORS; HOST-DEFENSE PEPTIDES; POLYMYXIN-B; CELLULAR UPTAKE; OUTER-MEMBRANE; ANTIBIOTICS; DESIGN; MODE; MECHANISM	Antimicrobial peptides (AMPs) and synthetic analogues thereof target conserved structures of bacterial cell envelopes and hence, development of resistance has been considered an unlikely event. However, recently bacterial resistance to AMPs has been observed, and the aim of the present study was to determine whether bacterial resistance may also evolve against synthetic AMP analogues, e. g. alpha-peptide/beta-peptoid peptidomimetics. E. coli ATCC 25922 was exposed to increasing concentrations of a peptidomimetic (10 lineages), polymyxin B (10 lineages), or MilliQ water (4 lineages) in a re-inoculation culturing setup covering approx. 500 generations. All 10 lineages exposed to the peptidomimetic adapted to 32xMIC while this occurred for 8 out of 10 of the polymyxin B-exposed lineages. All lineages exposed to 32xMIC of either the peptidomimetic or polymyxin B had a significantly increased MIC (16-326) to the selection agent. Five transfers (similar to 35 generations) in unsupplemented media did not abolish resistance indicating that resistance was heritable. Single isolates from peptidomimetic-exposed lineage populations displayed MICs against the peptidomimetic from wild-type MIC to 32xMIC revealing heterogeneous populations. Resistant isolates showed no cross-resistance against a panel of membrane-active AMPs. These isolates were highly susceptible to blood plasma antibacterial activity and were killed when plasma concentrations exceeded similar to 30%. Notably, MIC of the peptidomimetic against resistant isolates returned to wild-type level upon addition of 25% plasma. Whole-genome sequencing of twenty isolates from four resistant lineages revealed mutations, in murein transglycosylase D (mltD) and outer-membrane proteins, which were conserved within and between lineages. However, no common resistance-conferring mutation was identified. We hypothesise that alterations in cell envelope structure result in peptidomimetic resistance, and that this may occur via several distinct mechanisms. Interestingly, this type of resistance result in a concomitant high susceptibility towards plasma, and therefore the present study does not infer additional concern for peptidomimetics as future therapeutics.	[Hein-Kristensen, Line; Holch, Anne] Tech Univ Denmark, Natl Food Inst, Div Ind Food Res, DK-2800 Lyngby, Denmark; [Franzyk, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen O, Denmark; [Gram, Lone] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Gram, L (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	gram@bio.dtu.dk		Gram, Lone/0000-0002-1076-5723; Franzyk, Henrik/0000-0002-2822-1927	Danish Research Council for Technology and Production	Danish Research Council for Technology and Production	The funder was the Danish Research Council for Technology and Production. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-52; [Anonymous], 2006, GUID M7 A7 METH DIL; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Bjarnsholt T, 2010, NAT PROTOC, V5, P282, DOI 10.1038/nprot.2009.205; Bonke G, 2008, SYNTHESIS-STUTTGART, P2381, DOI 10.1055/s-2008-1067171; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Cheng HY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-60; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Falagas ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/j.drup.2010.05.002; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Foged C, 2008, BBA-BIOMEMBRANES, V1778, P2487, DOI 10.1016/j.bbamem.2008.06.020; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; Gallo RL, 2003, CURR ALLERGY ASTHM R, V3, P402, DOI 10.1007/s11882-003-0074-x; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hazen EL, 1943, J IMMUNOL, V46, P341; Hein-Kristensen L, 2013, SELECTIVITY IN PRESS; Hein-Kristensen L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-144; Jing XN, 2012, BBA-BIOMEMBRANES, V1818, P2660, DOI 10.1016/j.bbamem.2012.05.003; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lim SS, 2005, BIOCHEM BIOPH RES CO, V334, P1329, DOI 10.1016/j.bbrc.2005.07.029; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; ODIO C, 1984, ANTIMICROB AGENTS CH, V25, P427, DOI 10.1128/AAC.25.4.427; Olsen CA, 2007, ORG LETT, V9, P1549, DOI 10.1021/ol070316c; Olsen CA, 2010, CHEMBIOCHEM, V11, P1356, DOI 10.1002/cbic.201000232; Park SC, 2011, BBA-BIOMEMBRANES, V1808, P171, DOI 10.1016/j.bbamem.2010.08.023; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Porsby CH, 2011, ANTIMICROB AGENTS CH, V55, P1332, DOI 10.1128/AAC.01222-10; Quave CL, 2011, PLANTA MED, V77, P188, DOI 10.1055/s-0030-1250145; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rahaman SO, 1998, FEMS MICROBIOL LETT, V161, P249, DOI 10.1111/j.1574-6968.1998.tb12955.x; Sallum UW, 2008, ANTIMICROB AGENTS CH, V52, P3006, DOI 10.1128/AAC.00023-08; Skiada A, 2011, INT J ANTIMICROB AG, V37, P187, DOI 10.1016/j.ijantimicag.2010.11.019; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Xu ZN, 2011, RES MICROBIOL, V162, P144, DOI 10.1016/j.resmic.2010.08.003; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zaknoon F, 2009, ANTIMICROB AGENTS CH, V53, P3422, DOI 10.1128/AAC.00010-09; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhu WL, 2006, BIOCHEM BIOPH RES CO, V349, P769, DOI 10.1016/j.bbrc.2006.08.094; Zinsser H, 1911, J EXP MED, V13, P31, DOI 10.1084/jem.13.1.31	58	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73620	10.1371/journal.pone.0073620	http://dx.doi.org/10.1371/journal.pone.0073620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040003	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600091
J	Saldana, SM; Lee, HH; Lowery, FJ; Khotskaya, YB; Xia, WY; Zhang, CY; Chang, SS; Chou, CK; Steeg, PS; Yu, DH; Hung, MC				Saldana, Sandra M.; Lee, Heng-Huan; Lowery, Frank J.; Khotskaya, Yekaterina B.; Xia, Weiya; Zhang, Chenyu; Chang, Shih-Shin; Chou, Chao-Kai; Steeg, Patricia S.; Yu, Dihua; Hung, Mien-Chie			Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis	PLOS ONE			English	Article							FACTOR BINDING PROTEIN-3; CYCLOLIGNAN PPP; IGF-I; TRASTUZUMAB RESISTANCE; TYROSINE KINASE; CELLS; ACTIVATION; EXPRESSION; LOCALIZATION; STIMULATION	Brain metastasis is a common cause of mortality in cancer patients, yet potential therapeutic targets remain largely unknown. The type I insulin-like growth factor receptor (IGF-IR) is known to play a role in the progression of breast cancer and is currently being investigated in the clinical setting for various types of cancer. The present study demonstrates that IGF-IR is constitutively autophosphorylated in brain-seeking breast cancer sublines. Knockdown of IGF-IR results in a decrease of phospho-AKT and phospho-p70s6k, as well as decreased migration and invasion of MDA-MB-231Br brain-seeking cells. In addition, transient ablation of IGFBP3, which is overexpressed in brain-seeking cells, blocks IGF-IR activation. Using an in vivo experimental brain metastasis model, we show that IGF-IR knockdown brain-seeking cells have reduced potential to establish brain metastases. Finally, we demonstrate that the malignancy of brain-seeking cells is attenuated by pharmacological inhibition with picropodophyllin, an IGF-IR-specific tyrosine kinase inhibitor. Together, our data suggest that the IGF-IR is an important mediator of brain metastasis and its ablation delays the onset of brain metastases in our model system.	[Saldana, Sandra M.; Lee, Heng-Huan; Lowery, Frank J.; Khotskaya, Yekaterina B.; Xia, Weiya; Zhang, Chenyu; Chang, Shih-Shin; Chou, Chao-Kai; Yu, Dihua; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Saldana, Sandra M.; Lee, Heng-Huan; Lowery, Frank J.; Chang, Shih-Shin; Chou, Chao-Kai; Yu, Dihua; Hung, Mien-Chie] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Steeg, Patricia S.] NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Chou, Chao-Kai; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Lowery, Frank/0000-0002-4620-5293; CHOU, CHAO-KAI/0000-0001-5231-5264; Yu, Dihua/0000-0001-6231-9381	U.S. Department of Defense (DOD) Breast Cancer Research Program, Center of Excellence (COE) [W81 XWH-062-0033]; National Institutes of Health [CA109311, CA099031, CCSG CA16672]; Susan G. Komen for the Cure; University of Texas MD Anderson-China Medical University; Hospital Sister Institution Fund; Cancer Research Center of Excellence (Taiwan) [DOH102-TD-C-111-005]; Program for Stem Cell and Regenerative Medicine Frontier Research (Taiwan) [NSC101-2321-B-039-001]; International Research-Intensive Centers of Excellence in Taiwan (Taiwan) [NSC102-2911-I-002-303]; Center for Biological Pathways; Patel Memorial Breast Cancer Endowment Fund; GSBS; DOD CDMR-BCRP [W81XWH-10-1-0749]; DOD [W81XWH-10-BCRP-POSTDOC]; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA099031, R01CA109311, ZIABC010538] Funding Source: NIH RePORTER	U.S. Department of Defense (DOD) Breast Cancer Research Program, Center of Excellence (COE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); University of Texas MD Anderson-China Medical University(China Medical University); Hospital Sister Institution Fund; Cancer Research Center of Excellence (Taiwan); Program for Stem Cell and Regenerative Medicine Frontier Research (Taiwan); International Research-Intensive Centers of Excellence in Taiwan (Taiwan); Center for Biological Pathways; Patel Memorial Breast Cancer Endowment Fund; GSBS; DOD CDMR-BCRP; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by the U.S. Department of Defense (DOD) Breast Cancer Research Program, Center of Excellence (COE) grant W81 XWH-062-0033 (P.S., D.Y, M-C.H), National Institutes of Health (CA109311, CA099031, and CCSG CA16672), Susan G. Komen for the Cure, The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund (to M.-C. Hung), Cancer Research Center of Excellence (DOH102-TD-C-111-005, Taiwan), Program for Stem Cell and Regenerative Medicine Frontier Research (NSC101-2321-B-039-001, Taiwan), International Research-Intensive Centers of Excellence in Taiwan (NSC102-2911-I-002-303, Taiwan), Center for Biological Pathways, and Patel Memorial Breast Cancer Endowment Fund. FJL was supported by the Isaiah J. Fidler Graduate Fellowship in Cancer Metastasis from GSBS. YBK was supported by DOD CDMR-BCRP Postdoctoral Fellowship (W81XWH-10-1-0749). CZ was supported by DOD Postdoctoral Fellowship (W81XWH-10-BCRP-POSTDOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; CONOVER CA, 1991, ENDOCRINOLOGY, V129, P710, DOI 10.1210/endo-129-2-710; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; Duchnowska R, 2012, ONCOLOGIST, V17, P26, DOI 10.1634/theoncologist.2011-0212; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Firth SM, 1998, BIOCHEM BIOPH RES CO, V246, P325, DOI 10.1006/bbrc.1998.8615; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1999, J ENDOCRINOL, V160, P379, DOI 10.1677/joe.0.1600379; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Hiraga T, 2012, CANCER RES, V72, P4238, DOI 10.1158/0008-5472.CAN-11-3061; Improta G, 2011, J PROTEOME RES, V10, P3089, DOI 10.1021/pr200065t; Iqbal J, 2012, HISTOPATHOLOGY, V61, P652, DOI 10.1111/j.1365-2559.2012.04255.x; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; KATO H, 1994, MOL ENDOCRINOL, V8, P40, DOI 10.1210/me.8.1.40; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Litzenburger BC, 2011, CLIN CANCER RES, V17, P2314, DOI 10.1158/1078-0432.CCR-10-1903; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Martin JL, 2011, GROWTH FACTORS, V29, P235, DOI 10.3109/08977194.2011.614237; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 1999, J BIOL CHEM, V274, P16407, DOI 10.1074/jbc.274.23.16407; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; O'Han MK, 2009, GROWTH FACTORS, V27, P394, DOI 10.3109/08977190903185032; Paharkova-Vatchkova V, 2010, ENDOCR-RELAT CANCER, V17, P293, DOI 10.1677/ERC-09-0106; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Saunus JM, 2011, GENET RES INT, V2011, DOI 10.4061/2011/219189; Schedlich LJ, 2002, MICROSC RES TECHNIQ, V59, P12, DOI 10.1002/jemt.10173; Sierra A, 1997, LAB INVEST, V77, P357; Sivaprasad U, 2004, ENDOCRINOLOGY, V145, P4213, DOI 10.1210/en.2003-1377; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; Vashisth H, 2010, J MOL BIOL, V400, P645, DOI 10.1016/j.jmb.2010.05.025; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Xi YG, 2006, MOL CANCER THER, V5, P3078, DOI 10.1158/1535-7163.MCT-06-0424; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Yin SC, 2010, NEURO-ONCOLOGY, V12, P19, DOI 10.1093/neuonc/nop008; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; YOSHIMINE T, 1985, J NEUROSURG, V62, P414, DOI 10.3171/jns.1985.62.3.0414; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	52	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73406	10.1371/journal.pone.0073406	http://dx.doi.org/10.1371/journal.pone.0073406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039934	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600073
J	Visagie, M; Theron, A; Mqoco, T; Vieira, W; Prudent, R; Martinez, A; Lafanechere, L; Joubert, A				Visagie, Michelle; Theron, Anne; Mqoco, Thandi; Vieira, Warren; Prudent, Renaud; Martinez, Anne; Lafanechere, Laurence; Joubert, Annie			Sulphamoylated 2-Methoxyestradiol Analogues Induce Apoptosis in Adenocarcinoma Cell Lines	PLOS ONE			English	Article							BREAST-CANCER CELLS; STEROID SULFATASE INHIBITORS; ESOPHAGEAL-CARCINOMA CELLS; IN-VITRO; MICROTUBULE DYNAMICS; CYCLE PROGRESSION; TUBULIN VARIANT; VIVO; PROLIFERATION; MORPHOLOGY	2-Methoxyestradiol (2ME2) is a naturally occurring estradiol metabolite which possesses antiproliferative, antiangiogenic and antitumor properties. However, due to its limited biological accessibility, synthetic analogues have been synthesized and tested in attempt to develop drugs with improved oral bioavailability and efficacy. The aim of this study was to evaluate the antiproliferative effects of three novel in silico-designed sulphamoylated 2ME2 analogues on the HeLa cervical adenocarcinoma cell line and estrogen receptor-negative breast adenocarcinoma MDA-MB-231 cells. A dose-dependent study (0.1-25 mu M) was conducted with an exposure time of 24 hours. Results obtained from crystal violet staining indicated that 0.5 mu M of all 3 compounds reduced the number of cells to 50%. Lactate dehydrogenase assay was used to assess cytotoxicity, while the mitotracker mitochondrial assay and caspase-6 and -8 activity assays were used to investigate the possible occurrence of apoptosis. Tubulin polymerization assays were conducted to evaluate the influence of these sulphamoylated 2ME2 analogues on tubulin dynamics. Double immunofluorescence microscopy using labeled antibodies specific to tyrosinate and detyrosinated tubulin was conducted to assess the effect of the 2ME2 analogues on tubulin dynamics. An insignificant increase in the level of lactate dehydrogenase release was observed in the compounds-treated cells. These sulphamoylated compounds caused a reduction in mitochondrial membrane potential, cytochrome c release and caspase 3 activation indicating apoptosis induction by means of the intrinsic pathway in HeLa and MDA-MB-231 cells. Microtubule depolymerization was observed after exposure to these three sulphamoylated analogues.	[Visagie, Michelle; Theron, Anne; Mqoco, Thandi; Vieira, Warren; Joubert, Annie] Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, South Africa; [Prudent, Renaud; Martinez, Anne; Lafanechere, Laurence] CRI INSERM UJF, Inst Albert Bonniot, U823, Team Polar Dev & Canc 3, La Tronche, France	University of Pretoria; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Joubert, A (corresponding author), Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, South Africa.	annie.joubert@up.ac.za	Visagie, Michelle/W-3068-2019; Mercier, Anne/ADU-0486-2022; Visagie, Michelle/AAV-5541-2020; Joubert, Annie/AAU-4562-2021; Lafanechère, Laurence MP/N-7474-2013	Visagie, Michelle/0000-0002-6820-7265; Mercier, Anne/0000-0002-2030-9879; Joubert, Annie/0000-0002-6931-7554; Lafanechère, Laurence MP/0000-0002-7902-7630; Mqoco, Thandi/0000-0002-5363-6630; Vieira, Warren Antonio/0000-0002-9417-7530	Cancer Association of South Africa [AK246]; Medical Research Council [AG374, AK076]; National Research Foundation, RESCOM (UP); Struwig Germeshuysen Trust [AJ038]	Cancer Association of South Africa; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation, RESCOM (UP); Struwig Germeshuysen Trust	Research was supported by grants from the Cancer Association of South Africa (AK246), the Medical Research Council (AG374, AK076), National Research Foundation, RESCOM (UP) and Struwig Germeshuysen Trust (AJ038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SK, 2000, ANTICANCER RES, V20, P2641; Bhati R, 2007, CANCER RES, V67, P702, DOI 10.1158/0008-5472.CAN-06-3406; BONNE D, 1985, J BIOL CHEM, V260, P2819; Chua YS, 2010, MOL CANCER THER, V9, P224, DOI 10.1158/1535-7163.MCT-09-1003; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; Day JM, 2009, BRIT J CANCER, V100, P476, DOI 10.1038/sj.bjc.6604873; Elger W, 1995, J STEROID BIOCHEM, V55, P395, DOI 10.1016/0960-0760(95)00214-6; Foster PA, 2008, BREAST CANCER RES TR, V111, P251, DOI 10.1007/s10549-007-9791-5; Foster PA, 2008, ANTICANCER RES, V28, P1483; Foster PA, 2008, ANTICANCER RES, V28, P577; Funakoshi T, 2006, EXP EYE RES, V83, P1102, DOI 10.1016/j.exer.2006.05.016; Geisler J, 2011, J STEROID BIOCHEM, V125, P39, DOI 10.1016/j.jsbmb.2011.02.002; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Joubert A, 2009, BIOCELL, V33, P67; Kachadourian R, 2001, ARCH BIOCHEM BIOPHYS, V392, P349, DOI 10.1006/abbi.2001.2455; Lafanechere L, 2008, COMB CHEM HIGH T SCR, V11, P617, DOI 10.2174/138620708785739943; Lakhani NJ, 2005, RAPID COMMUN MASS SP, V19, P1176, DOI 10.1002/rcm.1902; Lakka Sajani S, 2008, Expert Rev Neurother, V8, P1457, DOI 10.1586/14737175.8.10.1457; LaVallee TM, 2002, CANCER RES, V62, P3691; Lippert TH, 2003, J STEROID BIOCHEM, V84, P51, DOI 10.1016/S0960-0760(02)00268-6; Matei D, 2009, GYNECOL ONCOL, V115, P90, DOI 10.1016/j.ygyno.2009.05.042; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Mqoco T, 2010, BIOCELL, V34, P113; Newman SP, 2007, BRIT J CANCER, V97, P1673, DOI 10.1038/sj.bjc.6604100; Newman SP, 2008, CLIN CANCER RES, V14, P597, DOI 10.1158/1078-0432.CCR-07-1717; Newman SP, 2004, INT J CANCER, V109, P533, DOI 10.1002/ijc.20045; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Pribluda VS, 2000, CANCER METAST REV, V19, P173, DOI 10.1023/A:1026543018478; Prudent R, 2013, BRIT J PHARMACOL, V168, P673, DOI 10.1111/j.1476-5381.2012.02230.x; Purohit A, 2003, J STEROID BIOCHEM, V86, P423, DOI 10.1016/S0960-0760(03)00353-4; Raobaikady B, 2005, INT J CANCER, V117, P150, DOI 10.1002/ijc.21066; Raobaikady B, 2003, J STEROID BIOCHEM, V84, P351, DOI 10.1016/S0960-0760(03)00049-9; Stander A, 2011, CHEM BIOL DRUG DES, V77, P173, DOI 10.1111/j.1747-0285.2010.01064.x; Stanway SJ, 2007, ONCOLOGIST, V12, P370, DOI 10.1634/theoncologist.12-4-370; Sutherland TE, 2007, DRUG DISCOV TODAY, V12, P577, DOI 10.1016/j.drudis.2007.05.005; Tagg SLC, 2008, BRIT J CANCER, V99, P1842, DOI 10.1038/sj.bjc.6604752; Thaver V, 2009, CELL BIOCHEM FUNCT, V27, P205, DOI 10.1002/cbf.1557; Utsumi T, 2005, J STEROID BIOCHEM, V94, P219, DOI 10.1016/j.jsbmb.2005.01.022; Visagie MH, 2010, CELL MOL BIOL LETT, V15, P564, DOI 10.2478/s11658-010-0030-4; Vorster C, 2010, BIOCELL, V34, P71; Vorster CJJ, 2010, CELL BIOCHEM FUNCT, V28, P412, DOI 10.1002/cbf.1671; Wood L, 2004, APOPTOSIS, V9, P323, DOI 10.1023/B:APPT.0000025809.80684.bd; Xia Guo-Hua, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P296	46	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71935	10.1371/journal.pone.0071935	http://dx.doi.org/10.1371/journal.pone.0071935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039728	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600015
J	Balczon, R; Prasain, N; Ochoa, C; Prater, J; Zhu, B; Alexeyev, M; Sayner, S; Frank, DW; Stevens, T				Balczon, Ron; Prasain, Nutan; Ochoa, Cristhiaan; Prater, Jason; Zhu, Bing; Alexeyev, Mikhail; Sayner, Sarah; Frank, Dara W.; Stevens, Troy			Pseudomonas aeruginosa Exotoxin Y-Mediated Tau Hyperphosphorylation Impairs Microtubule Assembly in Pulmonary Microvascular Endothelial Cells	PLOS ONE			English	Article							CA2+-INHIBITABLE ADENYLYL-CYCLASE; NUCLEOTIDE-GATED CHANNELS; PROTEIN-KINASE-A; BARRIER DYSFUNCTION; GAP FORMATION; EDEMA FACTOR; CAMP; PERMEABILITY; PHOSPHORYLATION; INCREASES	Pseudomonas aeruginosa uses a type III secretion system to introduce the adenylyl and guanylyl cyclase exotoxin Y (ExoY) into the cytoplasm of endothelial cells. ExoY induces Tau hyperphosphorylation and insolubility, microtubule breakdown, barrier disruption and edema, although the mechanism(s) responsible for microtubule breakdown remain poorly understood. Here we investigated both microtubule behavior and centrosome activity to test the hypothesis that ExoY disrupts microtubule dynamics. Fluorescence microscopy determined that infected pulmonary microvascular endothelial cells contained fewer microtubules than control cells, and further studies demonstrated that the microtubule-associated protein Tau was hyperphosphorylated following infection and dissociated from microtubules. Disassembly/reassembly studies determined that microtubule assembly was disrupted in infected cells, with no detectable effects on either microtubule disassembly or microtubule nucleation by centrosomes. This effect of ExoY on microtubules was abolished when the cAMP-dependent kinase phosphorylation site (Ser-214) on Tau was mutated to a non-phosphorylatable form. These studies identify Tau in microvascular endothelial cells as the target of ExoY in control of microtubule architecture following pulmonary infection by Pseudomonas aeruginosa and demonstrate that phosphorylation of tau following infection decreases microtubule assembly.	[Balczon, Ron; Alexeyev, Mikhail; Sayner, Sarah] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Balczon, Ron; Ochoa, Cristhiaan; Prater, Jason; Zhu, Bing; Alexeyev, Mikhail; Sayner, Sarah; Stevens, Troy] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Prasain, Nutan] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ochoa, Cristhiaan; Zhu, Bing; Stevens, Troy] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA; [Prater, Jason; Stevens, Troy] Univ S Alabama, Dept Med, Mobile, AL 36688 USA; [Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	University of South Alabama; University of South Alabama; Indiana University System; Indiana University Bloomington; University of South Alabama; University of South Alabama; Medical College of Wisconsin	Balczon, R (corresponding author), Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA.	rbalczon@southalabama.edu		Ochoa, Cristhiaan/0000-0001-9113-2137	National Institutes of Health [HL-60024, HL-66299, HL-76125, HL-107122, 1R01RR031286]; American Heart Association [0715456B]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299, F31HL107122, T32HL076125, R01HL060024, R37HL060024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (www.nih.gov) grants HL-60024 and HL-66299 (T. Stevens and R. Balczon), HL-76125 and HL-107122 (C. Ochoa), and 1R01RR031286 (M. Alexeyev), and by the American Heart Association (www.aha.org) Predoctoral Fellowship 0715456B (N. Prasain). The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; BALCZON R, 1983, CELL MOTIL CYTOSKEL, V3, P213, DOI 10.1002/cm.970030303; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Bouchard M, 2011, CAN J NEUROL SCI, V38, P547, DOI 10.1017/S0317167100012087; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Chetham PM, 1997, AM J PHYSIOL-LUNG C, V273, pL22, DOI 10.1152/ajplung.1997.273.1.L22; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; CLEVELAND DW, 1979, J BIOL CHEM, V254, P2670; Creighton J, 2008, J CELL SCI, V121, P110, DOI 10.1242/jcs.011692; CROSS D, 1993, J CELL SCI, V105, P51; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Feinstein WP, 2012, AM J PHYSIOL-CELL PH, V302, pC839, DOI 10.1152/ajpcell.00361.2011; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Goedert M, 2001, CURR OPIN GENET DEV, V11, P343, DOI 10.1016/S0959-437X(00)00200-8; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; HENRIQUEZ JP, 1995, CELL BIOCHEM FUNCT, V13, P239, DOI 10.1002/cbf.290130404; Karpen JW, 2001, SCIENCE, V293, P2204, DOI 10.1126/science.293.5538.2204; Kuebler WM, 2011, AM J PHYSIOL-LUNG C, V301, pL157, DOI 10.1152/ajplung.00192.2011; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu QQ, 2001, J CELL SCI, V114, P797; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Ochoa CD, 2012, AM J PHYSIOL-LUNG C, V302, pL275, DOI [10.1152/ajplung.00215.2011., 10.1152/ajplung.00215.2011]; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; PHILLIPS PG, 1989, AM J PHYSIOL, V257, pC562, DOI 10.1152/ajpcell.1989.257.3.C562; Prasain N, 2009, AM J PHYSIOL-LUNG C, V297, pL73, DOI 10.1152/ajplung.90577.2008; PRYER NK, 1992, J CELL SCI, V103, P965; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V301, pL117, DOI 10.1152/ajplung.00417.2009; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; STEVENS T, 1995, P NATL ACAD SCI USA, V92, P2696, DOI 10.1073/pnas.92.7.2696; Stevens T, 1999, AM J PHYSIOL-LUNG C, V277, pL119, DOI 10.1152/ajplung.1999.277.1.L119; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Wilson R, 1998, THORAX, V53, P213, DOI 10.1136/thx.53.3.213; Wu SW, 2007, J BIOL CHEM, V282, P34801, DOI 10.1074/jbc.M704522200; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x; Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009	58	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74343	10.1371/journal.pone.0074343	http://dx.doi.org/10.1371/journal.pone.0074343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023939	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600138
J	Peters, J; Miedl, SF; Buchel, C				Peters, Jan; Miedl, Stephan Franz; Buechel, Christian			Elevated Functional Connectivity in a Striatal-Amygdala Circuit in Pathological Gamblers	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; DECISION-MAKING; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; DELAYED REWARDS; NEURAL SYSTEMS; SELF-CONTROL; ADDICTION; CHOICE; BEHAVIOR	Both substance-based addiction and behavioural impulse control disorders (ICDs) have been associated with dysfunctions of the ventral striatum. Recent studies using functional connectivity techniques have revealed increased coupling of the ventral striatum with other limbic regions such as amygdala and orbitofrontal cortex in patients with substance abuse disorders and attention-deficit hyperactivity disorder. In the present study, we re-analyzed previously published functional magnetic resonance imaging data acquired in pathological gamblers and controls during value-based decision-making to investigate whether PG is associated with similar functional connectivity effects. In line with previous studies in other ICDs, we observed reliable increases in functional coupling between striatum and bilateral amygdala in gamblers vs. controls. Implications of these findings for neural models of self-control and addiction are discussed.	[Peters, Jan; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Peters, Jan] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Miedl, Stephan Franz] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California Berkeley; Salzburg University	Peters, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	j.peters@uke.de	Peters, Jan/GWC-6713-2022; Peters, Jan/V-2910-2019	Peters, Jan/0000-0002-0195-5357; Peters, Jan/0000-0002-0195-5357; Miedl, Stephan/0000-0002-1977-5637	German Research Foundation DFG [PE 1627/3-1, PE 1627/4-1]; ERC [ERC-2010-AdG_20100407]; DFG [TR SFB 58]	German Research Foundation DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG))	JP was funded by the German Research Foundation DFG (PE 1627/3-1, PE 1627/4-1). CB was funded by the ERC (ERC-2010-AdG_20100407) and the DFG (TR SFB 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Balodis IM, 2012, BIOL PSYCHIAT, V72, pE25, DOI 10.1016/j.biopsych.2012.06.016; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Beck AT., 1996, BECK DEPRESSION INVE; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045938; Cohen MX, 2008, NEUROIMAGE, V39, P1396, DOI 10.1016/j.neuroimage.2007.10.004; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Jimenez-Murcia S, 2010, J GAMBL STUD, V26, P235, DOI 10.1007/s10899-009-9175-3; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Leeman RF, 2012, PSYCHOPHARMACOLOGY, V219, P469, DOI 10.1007/s00213-011-2550-7; Leyton M, 2013, NEUROSCI BIOBEHAV RE, DOI 10.1016/j.neubiorev.2013.01.018; Leyton M, 2012, BIOL PSYCHIAT, V72, pE21, DOI 10.1016/j.biopsych.2012.04.036; Ligneul R, 2013, PSYCHOL MED, V43, P1059, DOI 10.1017/S0033291712001900; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Lorenz RC, 2013, ADDICT BIOL, V18, P134, DOI 10.1111/j.1369-1600.2012.00491.x; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Miedl SF, 2012, ARCH GEN PSYCHIAT, V69, P177, DOI 10.1001/archgenpsychiatry.2011.1552; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Oberg SAK, 2011, NEUROPSYCHOLOGIA, V49, P3768, DOI 10.1016/j.neuropsychologia.2011.09.037; Ousdal OT, 2012, NEUROIMAGE, V62, P95, DOI 10.1016/j.neuroimage.2012.04.035; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petry J, 1996, PSYCHOTHERAPIE GLUCK; Petry NM, 1999, DRUG ALCOHOL DEPEN, V56, P25, DOI 10.1016/S0376-8716(99)00010-1; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Popescu AT, 2009, NAT NEUROSCI, V12, P801, DOI 10.1038/nn.2305; Potenza MN, 2013, CURR OPIN NEUROBIOL; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; Salimpoor VN, 2013, SCIENCE, V340, P216, DOI 10.1126/science.1231059; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Sescousse G, 2013, BRAIN, V136, P2527, DOI 10.1093/brain/awt126; Shin YC, 2009, J GAMBL STUD, V25, P447, DOI 10.1007/s10899-009-9125-0; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; van Holst RJ, 2013, PLOS ONE, V7; van Holst RJ, 2012, BIOL PSYCHIAT, V72, pE23, DOI 10.1016/j.biopsych.2012.06.017; van Holst RJ, 2012, BIOL PSYCHIAT, V71, P741, DOI 10.1016/j.biopsych.2011.12.030	57	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74353	10.1371/journal.pone.0074353	http://dx.doi.org/10.1371/journal.pone.0074353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023940	Green Submitted, gold, Green Published			2022-12-25	WOS:000324238400096
J	Toussirot, E; Abbas, W; Khan, KA; Tissot, M; Jeudy, A; Baud, L; Bertolini, E; Wendling, D; Herbein, G				Toussirot, Eric; Abbas, Wasim; Khan, Kashif Aziz; Tissot, Marion; Jeudy, Alicia; Baud, Lucile; Bertolini, Ewa; Wendling, Daniel; Herbein, Georges			Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha Production	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; GENE-EXPRESSION; MOUSE MODEL; IN-VIVO; TRANSCRIPTION; INFLAMMATION; MACROPHAGES; ACTIVATION; APOPTOSIS	Objective: Acetylation or deacetylation of histone proteins may modulate cytokine gene transcription such as TNF alpha (TNF). We evaluated the balance between histone deacetytlase (HDAC) and histone acetyltransferase (HAT) in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) compared to healthy controls (HC) and determined the influence of HDAC inhibitors (trichostatin A -TSA-or Sirtinol -Sirt-) on these enzymatic activities and on the PBMC production of TNF. Methods: 52 patients with RA, 21 with AS and 38 HC were evaluated. HAT and HDAC activities were measured on nuclear extracts from PBMC using colorimetric assays. Enzymatic activities were determined prior to and after ex vivo treatment of PBMC by TSA or Sirt. TNF levels were evaluated in PBMC culture supernatants in the absence or presence of TSA or Sirt. Results: HAT and HDAC activities were significantly reduced in AS, while these activities reached similar levels in RA and HC. Ex vivo treatment of PBMC by HDACi tended to decrease HDAC expression in HC, but Sirt significantly reduced HAT in RA. TNF production by PBMC was significantly down-regulated by Sirt in HC and AS patients. Conclusion: HAT and HDAC were disturbed in AS while no major changes were found in RA. HDACi may modulate HDAC and HAT PBMC expression, especially Sirt in RA. Sirtinol was able to down regulate TNF production by PBMC in HC and AS. An imbalance between HAT and HDAC activities might provide the rationale for the development of HDACi in the therapeutic approach to inflammatory rheumatic diseases.	[Toussirot, Eric] Univ Hosp Besancon, Clin Invest Ctr Biotherapy CBT 506, Besancon, France; [Toussirot, Eric; Bertolini, Ewa; Wendling, Daniel] Univ Hosp Besancon, Dept Rheumatol, Besancon, France; [Toussirot, Eric] Univ Franche Comte, Dept Therapeut, F-25030 Besancon, France; [Toussirot, Eric; Abbas, Wasim; Khan, Kashif Aziz; Wendling, Daniel; Herbein, Georges] Univ Franche Comte, UPRES EA 4266, Pathogens & Inflammat Lab, SFR FED 4234, F-25030 Besancon, France; [Abbas, Wasim; Khan, Kashif Aziz; Tissot, Marion; Jeudy, Alicia; Baud, Lucile; Herbein, Georges] Univ Hosp Besancon, Dept Virol, Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Toussirot, E (corresponding author), Univ Hosp Besancon, Clin Invest Ctr Biotherapy CBT 506, Besancon, France.	etoussirot@chu-besancon.fr	Khan, Kashif Aziz/B-1938-2008	Khan, Kashif Aziz/0000-0003-3125-1497	CHRU de Besancon (APICHU); INSERM [CBT-506]; Association Franc-Comtoise pour la Recherche et l'Enseignement en Rhumatologie; Groupe de Recherche en Virologie de Franche-Comte; Higher Education Commission, Pakistan	CHRU de Besancon (APICHU); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Franc-Comtoise pour la Recherche et l'Enseignement en Rhumatologie; Groupe de Recherche en Virologie de Franche-Comte; Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This work was supported by a grant from the CHRU de Besancon (APICHU), INSERM CBT-506, Association Franc-Comtoise pour la Recherche et l'Enseignement en Rhumatologie, and Groupe de Recherche en Virologie de Franche-Comte. W. A. and K. A. K. are recipients of doctoral scholarships from the Higher Education Commission, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Fusco S, 2012, CELL CYCLE, V11, P4135, DOI 10.4161/cc.22074; Gillespie J, 2012, ARTHRITIS RHEUM-US, V64, P418, DOI 10.1002/art.33382; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Grabiec AM, 2011, CRIT REV IMMUNOL, V31, P233, DOI 10.1615/CritRevImmunol.v31.i3.40; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Grabiec AM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2489; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Huber LC, 2007, ARTHRITIS RHEUM-US, V56, P3523, DOI 10.1002/art.22948; Huber LC, 2007, ARTHRITIS RHEUM, V56, P1087, DOI 10.1002/art.22512; Kawabata Tomoko, 2010, Arthritis Res Ther, V12, pR133, DOI 10.1186/ar3071; Khan KA, 2009, J IMMUNOL, V182, P7784, DOI 10.4049/jimmunol.0803800; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Li J, 2012, ARTHRITIS RHEUM-US, V64, P1098, DOI 10.1002/art.33423; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Mombelli M, 2011, J INFECT DIS, V204, P1367, DOI 10.1093/infdis/jir553; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Niederer F, 2011, ANN RHEUM DIS, V70, P1866, DOI 10.1136/ard.2010.148957; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Rosato RR, 2004, EXPERT OPIN INV DRUG, V13, P21, DOI 10.1517/eoid.13.1.21.25283; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Strietholt S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2500; Toussirot E, 2010, JOINT BONE SPINE, V77, P395, DOI 10.1016/j.jbspin.2010.03.009; Toussirot E, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0002-6; Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Vojinovic J, 2011, ARTHRITIS RHEUM-US, V63, P1452, DOI 10.1002/art.30238; Zhang FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016795	35	46	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70939	10.1371/journal.pone.0070939	http://dx.doi.org/10.1371/journal.pone.0070939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24039666	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000025
J	Crocetti, S; Beyer, C; Schade, G; Egli, M; Frohlich, J; Franco-Obregon, A				Crocetti, Sara; Beyer, Christian; Schade, Grit; Egli, Marcel; Froehlich, Juerg; Franco-Obregon, Alfredo			Low Intensity and Frequency Pulsed Electromagnetic Fields Selectively Impair Breast Cancer Cell Viability	PLOS ONE			English	Article							MAGNETIC-FIELDS; CALCIUM; APOPTOSIS; MEMBRANE; STIMULATION; MECHANISM	Introduction: A common drawback of many anticancer therapies is non-specificity in action of killing. We investigated the potential of ultra-low intensity and frequency pulsed electromagnetic fields (PEMFs) to kill breast cancer cells. Our criteria to accept this technology as a potentially valid therapeutic approach were: 1) cytotoxicity to breast cancer cells and; 2) that the designed fields proved innocuous to healthy cell classes that would be exposed to the PEMFs during clinical treatment. Methods: MCF7 breast cancer cells and their normal counterparts, MCF10 cells, were exposed to PEMFs and cytotoxic indices measured in order to design PEMF paradigms that best kill breast cancer cells. The PEMF parameters tested were: 1) frequencies ranging from 20 to 50 Hz; 2) intensities ranging from 2 mT to 5 mT and; 3) exposure durations ranging from 30 to 90 minutes per day for up to three days to determine the optimum parameters for selective cancer cell killing. Results: We observed a discrete window of vulnerability of MCF7 cells to PEMFs of 20 Hz frequency, 3 mT magnitude and exposure duration of 60 minutes per day. The cell damage accrued in response to PEMFs increased with time and gained significance after three days of consecutive daily exposure. By contrast, the PEMFs parameters determined to be most cytotoxic to breast cancer MCF-7 cells were not damaging to normal MCF-10 cells. Conclusion: Based on our data it appears that PEMF-based anticancer strategies may represent a new therapeutic approach to treat breast cancer without affecting normal tissues in a manner that is non-invasive and can be potentially combined with existing anti-cancer treatments.	[Crocetti, Sara] Univ Siena, Dept Environm Sci, I-53100 Siena, Italy; [Crocetti, Sara; Franco-Obregon, Alfredo] ETH, Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Beyer, Christian; Froehlich, Juerg] ETH, Swiss Fed Inst Technol, Electromagnet Fields & Microwave Elect Lab, Zurich, Switzerland; [Schade, Grit] Amphasys AG, Technopk Luzern, Luzern, Switzerland; [Egli, Marcel] Lucerne Univ Appl Sci & Arts, Ctr Competence Aerosp Biomed Sci & Technol, Hergiswil, Switzerland; [Franco-Obregon, Alfredo] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore	University of Siena; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore	Franco-Obregon, A (corresponding author), ETH, Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	franco@hest.ethz.ch	Franco-Obregon, Alfredo/F-3056-2019	Franco-Obregon, Alfredo/0000-0002-2514-1083; Frohlich, Jurg/0000-0002-5923-3410	Swiss Federal Office of Public Health [11.003272]	Swiss Federal Office of Public Health	This study was partially supported by the Swiss Federal Office of Public Health (http://www.bag.admin.ch/) under the mandate number 11.003272, "Effects of pulsed electromagnetic fields on the proliferation of different mechano-sensitive cell types". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Barbault A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-51; Blackman CF, 2012, BRIT J CANCER, V106, P241, DOI 10.1038/bjc.2011.576; Cameron IL, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-23; Cheung K, 2005, CYTOM PART A, V65A, P124, DOI 10.1002/cyto.a.20141; Cheung KC, 2010, CYTOM PART A, V77A, P648, DOI 10.1002/cyto.a.20910; Chin S, 2006, INT J NANOMED, V1, P333; Cho Y, 2009, J MICROELECTROMECH S, V18, P808, DOI 10.1109/JMEMS.2009.2021821; Crocetti S, 2011, ELECTROMAGN BIOL MED, V30, P128, DOI 10.3109/15368378.2011.596247; David F, 2012, BIOTECHNOL BIOENG, V109, P483, DOI 10.1002/bit.23345; du Plessis-Stoman D, 2011, AFR J TRADIT COMPLEM, V8, P177; Elson E, 2009, ELECTROMAGN BIOL MED, V28, P275, DOI [10.1080/15368370903114271, 10.3109/15368370903114271]; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Haddad JB, 2007, J ALTERN COMPLEM MED, V13, P485, DOI 10.1089/acm.2007.5270; Ivancsits S, 2003, INT ARCH OCC ENV HEA, V76, P431, DOI 10.1007/s00420-003-0446-5; Khaled AR, 2001, J BIOL CHEM, V276, P6453, DOI 10.1074/jbc.M006391200; Kim JY, 2011, APOPTOSIS, V16, P347, DOI 10.1007/s10495-010-0567-8; Koh EK, 2008, INT J RADIAT BIOL, V84, P945, DOI 10.1080/09553000802460206; Labeed FH, 2006, BBA-GEN SUBJECTS, V1760, P922, DOI 10.1016/j.bbagen.2006.01.018; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nigjeh SE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783690; Opp D, 2009, BIOSENS BIOELECTRON, V24, P2625, DOI 10.1016/j.bios.2009.01.015; Organization W. H., 2007, EXP EXTR LOW FREQ FI; Pierzchalski A, 2012, LAB CHIP, V12, P4533, DOI 10.1039/c2lc40408g; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Radeva M, 2004, BIOELECTROMAGNETICS, V25, P503, DOI 10.1002/bem.20023; Repacholi MH, 1999, BIOELECTROMAGNETICS, V20, P133, DOI 10.1002/(SICI)1521-186X(1999)20:3<133::AID-BEM1>3.0.CO;2-O; Ruiz-Gomez MJ, 2005, INT J RADIAT BIOL, V81, P483, DOI 10.1080/09553000500196805; Schade-Kampmann G, 2008, CELL PROLIFERAT, V41, P830, DOI 10.1111/j.1365-2184.2008.00548.x; Sergeev IN, 2005, J STEROID BIOCHEM, V97, P145, DOI 10.1016/j.jsbmb.2005.06.007; Sergeev IN, 2004, J STEROID BIOCHEM, V89-90, P419, DOI 10.1016/j.jsbmb.2004.03.010; Shapovalov G, 2011, CELL CALCIUM, V50, P295, DOI 10.1016/j.ceca.2011.05.006; Sul AR, 2006, YONSEI MED J, V47, P852, DOI 10.3349/ymj.2006.47.6.852; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang XJ, 2002, BBA-BIOMEMBRANES, V1564, P412, DOI 10.1016/S0005-2736(02)00495-9; Yamaguchi S, 2006, BIOELECTROMAGNETICS, V27, P64, DOI 10.1002/bem.20177; Zhivotosky B, 2001, CURR PROTOC CELL BIO, V18; Zimmerman JW, 2012, BRIT J CANCER, V106, P307, DOI 10.1038/bjc.2011.523	39	71	76	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72944	10.1371/journal.pone.0072944	http://dx.doi.org/10.1371/journal.pone.0072944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039828	Green Published, gold			2022-12-25	WOS:000326734500018
J	Romero, A; Garre, P; Valentin, O; Sanz, J; Perez-Segura, P; Llovet, P; Diaz-Rubio, E; de la Hoya, M; Caldes, T				Romero, Atocha; Garre, Pilar; Valentin, Olivia; Sanz, Julian; Perez-Segura, Pedro; Llovet, Patricia; Diaz-Rubio, Eduardo; de la Hoya, Miguel; Caldes, Trinidad			Frequency and Variability of Genomic Rearrangements on MSH2 in Spanish Lynch Syndrome Families	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DEPENDENT PROBE AMPLIFICATION; MOLECULAR-GENETICS; HNPCC FAMILIES; COPY NUMBER; HMSH2 GENE; MLH1; SEQUENCES; DELETIONS; REPAIR	Large genomic rearrangements (LGRs) in DNA-mismatch-repair (MMR) genes, particularly among MSH2 gene, are frequently involved in the etiology of Lynch syndrome (LS). The Multiplex Ligation and Probe Amplification assay (MLPA) is commonly used to identify such alterations. However, in most cases, the MLPA-identified alteration is not characterized at the molecular level, which might be important to identify recurrent alterations and to analyze the molecular mechanisms underlying these mutational events. Probands from a cohort of Lynch Syndrome families were screened for point mutation in MMR genes, subsequently the MLPA assay was used for LGR screening. The identified MLPA alteration was confirmed by cDNA, CGH-microarrays or massive parallel sequencing. In this study, we have delimited the region of 11 LGRs variants on MSH2 locus. Six of them were fully characterized the breakpoints and 9 of them were considered pathogenic. According to our data, LGR on MSH2 locus constituted the 10.8% (9 out of 83) of pathogenic germline alterations found in LS. The frequency of colorectal cancer (CRC) and endometrial cancer (EC) in LGR carriers was 55% and 11% respectively. Analysis of the breakpoint sequences revealed that in 3 cases, deletions appeared to originate from Alu-mediated recombination events. In the remaining cases, sequence alignment failed to detect microhomology around the breakpoints. The present study provides knowledge on the molecular characterization of MSH2 LGRs, which may have important implications in LS diagnosis and Genetic Counseling. In addition, our data suggests that nonhomologous events would be more frequently involved in the etiology of MSH2 LGRs than expected.	[Romero, Atocha; Garre, Pilar; Valentin, Olivia; Llovet, Patricia; de la Hoya, Miguel; Caldes, Trinidad] Inst Invest Sanitaria San Carlos, Mol Oncol Lab, Madrid, Spain; [Sanz, Julian] Inst Invest Sanitaria San Carlos, Dept Pathol, Madrid, Spain; [Perez-Segura, Pedro; Diaz-Rubio, Eduardo] Inst Invest Sanitaria San Carlos, Dept Med Oncol, Madrid, Spain		Caldes, T (corresponding author), Inst Invest Sanitaria San Carlos, Mol Oncol Lab, Madrid, Spain.	trinidad.caldes@salud.madrid.org	Romero, Atocha/AAS-2862-2021; Sanz, Julian/G-5276-2013; Romero-Alfonso, Atocha/AAC-9879-2021; de la Hoya, MIguel/Z-2911-2019	Romero, Atocha/0000-0002-1634-7397; Sanz, Julian/0000-0002-3049-9338; de la Hoya, Miguel/0000-0002-8113-1410; Garre Rubio, Pilar/0000-0001-8285-4138; Llovet, Patricia/0000-0003-0190-2105; Diaz-Rubio, Eduardo/0000-0003-2792-5348	Instituto de Salud Carlos III (FEDER) [FIS 10/00641, RTICC 12/003606/00]; Rio Hortega Fellowship, Instituto de Salud Carlos III	Instituto de Salud Carlos III (FEDER)(Instituto de Salud Carlos III); Rio Hortega Fellowship, Instituto de Salud Carlos III	This work was supported by the Instituto de Salud Carlos III (FEDER) research grants FIS 10/00641 and RTICC 12/003606/00. AR is supported by Rio Hortega Fellowship, Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissi-Ben Moussa S, 2009, FAM CANCER, V8, P119, DOI 10.1007/s10689-008-9215-7; Baudhuin LM, 2005, GASTROENTEROLOGY, V129, P846, DOI 10.1053/j.gastro.2005.06.026; Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO;2-S; Caldes T, 2004, ONCOL REP, V12, P621; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Caldes T, 2000, AM J GASTROENTEROL, V95, P2389; Eijk-Van Os PGC, 2011, METHODS MOL BIOL, V688, P97, DOI 10.1007/978-1-60761-947-5_8; Godino J, 2001, Hum Mutat, V18, P549, DOI 10.1002/humu.1240; Grabowski M, 2005, GENET TEST, V9, P138, DOI 10.1089/gte.2005.9.138; Gylling A, 2009, INT J CANCER, V124, P2333, DOI 10.1002/ijc.24230; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; Li Lili, 2006, Hum Mutat, V27, P388, DOI 10.1002/humu.9417; Lynch HT, 2008, FAM CANCER, V7, P27, DOI 10.1007/s10689-007-9165-5; Martinez-Bouzas C, 2007, CANCER LETT, V255, P295, DOI 10.1016/j.canlet.2007.05.004; Mattocks CJ, 2010, EUR J HUM GENET, V18, P1276, DOI 10.1038/ejhg.2010.101; McVety S, 2005, CLIN GENET, V68, P234, DOI 10.1111/j.1399-0004.2005.00486.x; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Perez-Cabornero L, 2009, EUR J CANCER, V45, P1485, DOI 10.1016/j.ejca.2009.01.030; Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; de Garibay G, 2012, BREAST CANCER RES TR, V133, P273, DOI 10.1007/s10549-011-1909-0; de Abajo AS, 2005, WORLD J GASTROENTERO, V11, P5770, DOI 10.3748/wjg.v11.i37.5770; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; van der Klift H, 2005, GENE CHROMOSOME CANC, V44, P123, DOI 10.1002/gcc.20219; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795	29	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72195	10.1371/journal.pone.0072195	http://dx.doi.org/10.1371/journal.pone.0072195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039744	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500010
J	Horvat, EA; Zhang, JD; Uhlmann, S; Sahin, O; Zweig, KA				Horvat, Emoeke-Agnes; Zhang, Jitao David; Uhlmann, Stefan; Sahin, Oezguer; Zweig, Katharina Anna			A Network-Based Method to Assess the Statistical Significance of Mild Co-Regulation Effects	PLOS ONE			English	Article							MICROARRAY ANALYSIS; GENE-COEXPRESSION; MESSENGER-RNAS; MICRORNAS; EXPRESSION; GENOME; SHOWS	Recent development of high-throughput, multiplexing technology has initiated projects that systematically investigate interactions between two types of components in biological networks, for instance transcription factors and promoter sequences, or microRNAs (miRNAs) and mRNAs. In terms of network biology, such screening approaches primarily attempt to elucidate relations between biological components of two distinct types, which can be represented as edges between nodes in a bipartite graph. However, it is often desirable not only to determine regulatory relationships between nodes of different types, but also to understand the connection patterns of nodes of the same type. Especially interesting is the co-occurrence of two nodes of the same type, i.e., the number of their common neighbours, which current high-throughput screening analysis fails to address. The co-occurrence gives the number of circumstances under which both of the biological components are influenced in the same way. Here we present SICORE, a novel network-based method to detect pairs of nodes with a statistically significant co-occurrence. We first show the stability of the proposed method on artificial data sets: when randomly adding and deleting observations we obtain reliable results even with noise exceeding the expected level in large-scale experiments. Subsequently, we illustrate the viability of the method based on the analysis of a proteomic screening data set to reveal regulatory patterns of human microRNAs targeting proteins in the EGFR-driven cell cycle signalling system. Since statistically significant co-occurrence may indicate functional synergy and the mechanisms underlying canalization, and thus hold promise in drug target identification and therapeutic development, we provide a platform-independent implementation of SICORE with a graphical user interface as a novel tool in the arsenal of high-throughput screening analysis.	[Horvat, Emoeke-Agnes] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Horvat, Emoeke-Agnes; Zweig, Katharina Anna] Tech Univ Kaiserslautern, Kaiserslautern, Germany; [Uhlmann, Stefan] German Canc Res Inst, Div Mol Genome Anal, Heidelberg, Germany; [Sahin, Oezguer] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	Ruprecht Karls University Heidelberg; University of Kaiserslautern; University of Texas System; UTMD Anderson Cancer Center	Zweig, KA (corresponding author), Tech Univ Kaiserslautern, Kaiserslautern, Germany.	zweig@cs.uni-kl.de	Sahin, Özgür/F-4403-2014	Sahin, Özgür/0000-0002-8033-7089; Zweig, Katharina Anna/0000-0002-4294-9017	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany; German Excellence Initiative [GSC 220]	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany; German Excellence Initiative	EAH is supported by the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany, which is funded by the German Excellence Initiative (GSC 220): http://www.mathcomp.uni-heidelberg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Boldt S, 2012, INT J RADIAT BIOL, V88, P267, DOI 10.3109/09553002.2012.638358; Brandes U, 2003, P 11 EUR S ALG; Brandes U., 2007, ACM J EXPT ALGORITHM, V12, DOI [10.1145/1227161.1227162, DOI 10.1145/1227161.1227162]; Brualdi RA, 2006, DISCRETE MATH, V306, P3054, DOI 10.1016/j.disc.2004.10.028; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cobb GW, 2003, AM MATH MON, V110, P265, DOI 10.2307/3647877; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FREEMAN LC, 1992, AM J SOCIOL, V98, P152, DOI 10.1086/229972; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gionis A., 2007, ACM T KNOWL DISCOV D, V1, P167; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Horvat EA, 2012, P 2012 INT C ADV SOC, P598; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Neeley ES, 2009, BIOINFORMATICS, V25, P1384, DOI 10.1093/bioinformatics/btp174; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Uhlmann S, 2012, MOL SYSTEMS BIOL, V570, P8; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wasserman S., 1999, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Zahoranszky LA, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-12; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zweig KA, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P200, DOI 10.1109/ASONAM.2010.24; Zweig KA, 2011, SOC NETW ANAL MIN, V1, P187, DOI 10.1007/s13278-011-0021-0	53	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73413	10.1371/journal.pone.0073413	http://dx.doi.org/10.1371/journal.pone.0073413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039936	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300072
J	Chen, KL; Zhang, S; Ji, YY; Li, J; An, P; Ren, HT; Liang, RR; Yang, J; Li, ZF				Chen, Kunlun; Zhang, Shu; Ji, Yuanyuan; Li, Jun; An, Peng; Ren, Hongtao; Liang, Rongrui; Yang, Jun; Li, Zongfang			Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway	PLOS ONE			English	Article							MMP-9 EXPRESSION; UP-REGULATION; CANCER-CELLS; KAPPA-B; ACTIVATION; MIGRATION; PHOSPHORYLATION; MAPK; PROLIFERATION; REQUIREMENT	Baicalein, a widely used Chinese herbal medicine, has historically been used in anti-inflammatory and anti-cancer therapies. However, the anti-metastatic effect and molecular mechanism(s) of baicalein on hepatocellular carcinoma (HCC) remain poorly understood. Therefore, the purpose of this study was to assess the anti-metastatic effects of baicalein and related mechanism(s) on HCC. Based on assays utilized in both HCC cell lines and in an animal model, we found that baicalein inhibited tumor cell metastasis in vivo and in vitro. Furthermore, after treatment with baicalein for 24 hours, there was a decrease in the levels of matrix metalloproteinase-2 (MMP-2), MMP-9 and urokinase-type plasminogen activator (u-PA) expression as well as proteinase activity in hepatocellular carcinoma MHCC97H cells. Meanwhile, the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 were increased in a dose-dependent fashion. Moreover, baicalein treatment dramatically decreased the levels of the phosphorylated forms of MEK1 and ERK1/2. MEK1 overexpression partially blocked the anti-metastatic effects of baicalein. Combined treatment with an ERK inhibitor (U0126) and baicalein resulted in a synergistic reduction in MMP-2, MMP-9 and u-PA expression and an increase in TIMP-1 and TIMP-2 expression; the invasive capabilities of MHCC97H cells were also inhibited. In conclusion, baicalein inhibits tumor cell invasion and metastasis by reducing cell motility and migration via the suppression of the ERK pathway, suggesting that baicalein is a potential therapeutic agent for HCC.	[Chen, Kunlun; Zhang, Shu; Li, Zongfang] Xi An Jiao Tong Univ, Gen Surg Dept Cadres Ward, Affiliated Hosp 2, Sch Med, Xian 710049, Peoples R China; [Chen, Kunlun; Zhang, Shu; Ji, Yuanyuan; Li, Jun; An, Peng; Ren, Hongtao; Liang, Rongrui; Yang, Jun; Li, Zongfang] Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Xian 710049, Peoples R China; [Liang, Rongrui; Li, Zongfang] Xi An Jiao Tong Univ, Sch Med, Key Lab Environm & Genes Related Dis, Educ Minist, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Xian 710049, Peoples R China.	yangjundr@yahoo.com.cn; lzf2568@gmail.com	Leung, Rongrui/GQY-7360-2022	Zhang, Shu/0000-0003-0928-6503	Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: 1171]; Fundamental Research Funds for the Central Universities [XJJ2008020]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: 1171), the Fundamental Research Funds for the Central Universities (XJJ2008020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Arii S, 1996, HEPATOLOGY, V24, P316; Bessard A, 2007, J CELL PHYSIOL, V212, P526, DOI 10.1002/jcp.21049; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chandrashekar N, 2012, TOXICOL APPL PHARM, V261, P10, DOI 10.1016/j.taap.2012.02.004; Chen CH, 2000, NUTR CANCER, V38, P287, DOI 10.1207/S15327914NC382_19; Chen YY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/378415; Cohen M, 2006, MOL HUM REPROD, V12, P225, DOI 10.1093/molehr/gal023; Deng WL, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-65; Dong QZ, 2013, AM J PATHOL, V182, P954, DOI 10.1016/j.ajpath.2012.11.019; Du GJ, 2010, EUR J PHARMACOL, V630, P121, DOI 10.1016/j.ejphar.2009.12.014; Fields J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056891; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Giannelli G, 2002, INT J CANCER, V97, P425, DOI 10.1002/ijc.1635; Hazama S, 1999, BRIT J CANCER, V80, P1420, DOI 10.1038/sj.bjc.6690538; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Iguchi K, 2012, YAKUGAKU ZASSHI, V132, P1025, DOI 10.1248/yakushi.132.1025; Itoh T, 1999, CLIN EXP METASTAS, V17, P177, DOI 10.1023/A:1006603723759; Itoh T, 2000, J GASTROEN HEPATOL, V15, P422, DOI 10.1046/j.1440-1746.2000.02150.x; Kantelhardt EJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-140; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Li ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054592; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Liang RR, 2012, INT J ONCOL, V41, P969, DOI 10.3892/ijo.2012.1510; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Liu SQ, 2012, INT J COLORECTAL DIS, V27, P1569, DOI 10.1007/s00384-012-1510-y; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Ma YY, 2010, CANCER-AM CANCER SOC, V116, P3294, DOI 10.1002/cncr.25059; Martin DC, 1996, ONCOGENE, V13, P569; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Okada A, 1999, Gan To Kagaku Ryoho, V26, P2247; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Puxbaum V, 2009, WORLD J HEPATOL, V1, P28, DOI 10.4254/wjh.v1.i1.28; SEGER R, 1992, J BIOL CHEM, V267, P14373; Shimizu T, 2013, CANCER LETT, V336, P270, DOI 10.1016/j.canlet.2013.03.017; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Tang ZY, 2005, J SURG ONCOL, V91, P95, DOI 10.1002/jso.20291; Tang ZY, 1999, CHINESE MED J-PEKING, V112, P887; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; TRYGGVASON K, 1987, BIOCHIM BIOPHYS ACTA, V907, P191, DOI 10.1016/0304-419X(87)90006-0; Wang Q, 2013, ONCOL REP, V29, P2046, DOI 10.3892/or.2013.2304; Wang ZD, 2010, ONCOL REP, V23, P413, DOI 10.3892/or_00000650; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Wu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-527; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055	51	103	117	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72927	10.1371/journal.pone.0072927	http://dx.doi.org/10.1371/journal.pone.0072927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039823	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500029
J	Farkas, C; Martins, CP; Escobar, D; Hepp, MI; Donner, DB; Castro, AF; Evan, G; Gutierrez, JL; Warren, R; Pincheira, R				Farkas, Carlos; Martins, Carla P.; Escobar, David; Hepp, Matias I.; Donner, David B.; Castro, Ariel F.; Evan, Gerard; Gutierrez, Jose L.; Warren, Robert; Pincheira, Roxana			Wild Type p53 Transcriptionally Represses the SALL2 Transcription Factor under Genotoxic Stress	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; RADIATION-INDUCED APOPTOSIS; MOUSE EMBRYO FIBROBLASTS; DNA-DAMAGE; IN-VIVO; TRANSFORMED-CELLS; BREAST-CANCER; T-ANTIGEN; EXPRESSION; PROTEIN	SALL2-a member of the Spalt gene family-is a poorly characterized transcription factor found deregulated in various cancers, which suggests it plays a role in the disease. We previously identified SALL2 as a novel interacting protein of neurotrophin receptors and showed that it plays a role in neuronal function, which does not necessarily explain why or how SALL2 is deregulated in cancer. Previous evidences indicate that SALL2 gene is regulated by the WT1 and AP4 transcription factors. Here, we identified SALL2 as a novel downstream target of the p53 tumor suppressor protein. Bioinformatic analysis of the SALL2 gene revealed several putative p53 half sites along the promoter region. Either overexpression of wild-type p53 or induction of the endogenous p53 by the genotoxic agent doxorubicin repressed SALL2 promoter activity in various cell lines. However R175H, R249S, and R248W p53 mutants, frequently found in the tumors of cancer patients, were unable to repress SALL2 promoter activity, suggesting that p53 specific binding to DNA is important for the regulation of SALL2. Electrophoretic mobility shift assay demonstrated binding of p53 to one of the identified p53 half sites in the Sall2 promoter, and chromatin immunoprecipitation analysis confirmed in vivo interaction of p53 with the promoter region of Sall2 containing this half site. Importantly, by using a p53ER(TAM) knockin model expressing a variant of p53 that is completely dependent on 4-hydroxy-tamoxifen for its activity, we show that p53 activation diminished SALL2 RNA and protein levels during genotoxic cellular stress in primary mouse embryo fibroblasts (MEFs) and radiosensitive tissues in vivo. Thus, our finding indicates that p53 represses SALL2 expression in a context-specific manner, adding knowledge to the understanding of SALL2 gene regulation, and to a potential mechanism for its deregulation in cancer.	[Farkas, Carlos; Escobar, David; Hepp, Matias I.; Castro, Ariel F.; Gutierrez, Jose L.; Pincheira, Roxana] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile; [Martins, Carla P.; Donner, David B.; Evan, Gerard; Warren, Robert] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Universidad de Concepcion; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Pincheira, R (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile.	ropincheira@udec.cl	Farkas, Carlos/HGE-9982-2022; Hepp, Matias/N-8120-2019; Hepp, Matias/S-6557-2018	Hepp, Matias/0000-0003-0993-8794; Hepp, Matias/0000-0003-0993-8794; Gutierrez, Jose/0000-0002-0957-2297; Pincheira, Roxana/0000-0003-4277-5245	University of California, San Francisco; DIUC from Universidad de Concepcion-Chile; Regular Fondecyt Grant [1110821]; CONICYT-Chile; Cancer Research UK [12077] Funding Source: researchfish; Medical Research Council [MC_UP_1101/1] Funding Source: researchfish; MRC [MC_UP_1101/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R55CA067891, R01CA067891] Funding Source: NIH RePORTER	University of California, San Francisco(University of California System); DIUC from Universidad de Concepcion-Chile; Regular Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Academic Senate Individual Investigator Grant from University of California, San Francisco to RP, DIUC grant from Universidad de Concepcion-Chile, and Regular Fondecyt Grant 1110821-Chile to RP. CF was supported by the Regular Fondecyt Grant 1110821-Chile to RP. DE was supported by a PhD fellowship from CONICYT-Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Bandera CA, 1997, CANCER RES, V57, P513; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Botchkarev VA, 2000, CANCER RES, V60, P5002; Braakhuis BJM, 2010, CURR OPIN OTOLARYNGO, V18, P67, DOI 10.1097/MOO.0b013e32833693ce; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chai L, 2011, TRANSFUSION, V51, p87S, DOI 10.1111/j.1537-2995.2011.03371.x; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; de Celis JFaBR, 2008, INT J DEV BIOL, V52, P1, DOI DOI 10.1387/IJDB.072494MR.PUBMED:18033666; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Gartel AL, 2006, MOL CANCER THER, V5, P1385, DOI 10.1158/1535-7163.MCT-06-0163; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Henriquez B, 2011, J CELL PHYSIOL, V226, P3043, DOI 10.1002/jcp.22652; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; JIANG D, 1993, ONCOGENE, V8, P2805; Kemp CJ, 2001, CANCER RES, V61, P327; Koster R, 1997, DEVELOPMENT, V124, P3147; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kultima K., 2010, REPROD TOXICOL, V11, P64; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li DW, 2004, MOL CELL BIOL, V24, P3885, DOI 10.1128/MCB.24.9.3885-3893.2004; Li DW, 2001, P NATL ACAD SCI USA, V98, P14619, DOI 10.1073/pnas.251447198; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Ma YP, 2001, J BIOL CHEM, V276, P48223, DOI 10.1074/jbc.M106468200; Ma YP, 2001, PEDIATR NEPHROL, V16, P701, DOI 10.1007/s004670100624; MCCORMICK F, 1981, NATURE, V292, P63, DOI 10.1038/292063a0; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nielsen TO, 2003, AM J PATHOL, V163, P1449, DOI 10.1016/S0002-9440(10)63502-X; Parroche P, 2011, VIROLOGY, V417, P443, DOI 10.1016/j.virol.2011.05.016; Pincheira R, 2009, EMBO J, V28, P261, DOI 10.1038/emboj.2008.274; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Singh N, 2010, EUR J IMMUNOL, V40, P559, DOI 10.1002/eji.200939736; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Sugimoto M, 2006, MOL CELL BIOL, V26, P502, DOI 10.1128/MCB.26.2.502-512.2006; Sung CK, 2013, MOL ONCOL, V7, P419, DOI 10.1016/j.molonc.2012.11.005; Sung CK, 2011, FASEB J, V25, P1275, DOI 10.1096/fj.10-173674; Sung CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046486; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Takayama K, 1998, GENE THER, V5, P361, DOI 10.1038/sj.gt.3300608; Tang YF, 2006, CANCER RES, V66, P6139, DOI 10.1158/0008-5472.CAN-06-0772; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; van Bodegom D, 2010, BBA-GENE REGUL MECH, V1799, P502, DOI 10.1016/j.bbagrm.2010.04.001; Vater CA, 1996, ONCOGENE, V13, P739; Verhaegh GW, 1997, MOL CELL BIOL, V17, P5699, DOI 10.1128/MCB.17.10.5699; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173; ZANTEMA A, 1985, VIROLOGY, V142, P44, DOI 10.1016/0042-6822(85)90421-0; Zeng YX, 2011, CANCER RES, V71, P2781, DOI 10.1158/0008-5472.CAN-10-3483	66	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73817	10.1371/journal.pone.0073817	http://dx.doi.org/10.1371/journal.pone.0073817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040083	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500060
J	Ghosh, S; Sengupta, A; Sharma, S; Sonawat, HM				Ghosh, Soumita; Sengupta, Arjun; Sharma, Shobhona; Sonawat, Haripalsingh M.			Metabolic Perturbations of Kidney and Spleen in Murine Cerebral Malaria: H-1 NMR-Based Metabolomic Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; FALCIPARUM-MALARIA; SCYLLO-INOSITOL; MAJOR ROLE; SPECTROSCOPY; GLUTAMATE; H-1-NMR; BRAIN; PLASMA; MICE	A significant fraction of global population is under the threat of malaria. Majority of annual death is due to the more complicated form of the infection i.e. the cerebral form, also known as Cerebral Malaria (CM). Host parasite interaction is known to cause a cascade of events in various tissues like brain, liver, kidney, and spleen. We have employed H-1 NMR based metabolomics to understand the specific perturbations of various tissues in CM. In our previous paper we have delineated the differences between CM vis-a-vis non-cerebral malaria (NCM) mice in serum, liver and brain. In this paper we focus on their differences of metabolic profile in kidney and spleen as kidney dysfunction and splenomegaly are known to be associated to neurological outcome of the disease. Moreover we have also looked into how the biological compartments (kidney, spleen and serum) interact with each other. The various metabolites involved in such interactions and their correlational aspects across the compartments have been studied in CM, NCM and control mice. The idea was to find out the specific pathways that are altered in CM mice. Our results demonstrate that both the kidney as well as spleen metabolism are differentially perturbed in CM with respect to NCM. The results point out that glutamate levels are decreased in CM mice with respect to NCM mice both in case of spleen and kidney while creatine, myo-inositol and betaine levels are increased in kidney of CM mice with respect to NCM mice. From the analysis of Multiway Principal Component Analysis (MPCA) we see that lipid metabolism and TCA cycle is altered in kidney and spleen.	[Ghosh, Soumita; Sengupta, Arjun; Sonawat, Haripalsingh M.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Sharma, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sharma@tifr.res.in; hms@tifr.res.in	Sengupta, Arjun/R-5802-2019; Sengupta, Arjun/AAS-8787-2021	Sengupta, Arjun/0000-0003-2210-1876	Tata Institute of Fundamental Research, Mumbai	Tata Institute of Fundamental Research, Mumbai	The study was funded by the in-house annual research grants of the Tata Institute of Fundamental Research, Mumbai. There were no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABaDG Davis, 1983, J MAGN RESON, V65, P355; Abdul Manan Junejo, 2006, J Ayub Med Coll Abbottabad, V18, P47; AHMAD SH, 1989, J TROP PEDIATRICS, V35, P291, DOI 10.1093/tropej/35.6.291; [Anonymous], 2003, J INDIAN ACAD CLIN M; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; AUE WP, 1976, J CHEM PHYS, V64, P4226, DOI 10.1063/1.431994; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Bagot S, 2002, INFECT IMMUN, V70, P2049, DOI 10.1128/IAI.70.4.2049-2056.2002; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Chotivanich K, 2002, J INFECT DIS, V185, P1538, DOI 10.1086/340213; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Das B. S., 2008, Journal of Vector Borne Diseases, V45, P83; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Eiam-Ong S, 1998, AM J KIDNEY DIS, V32, P361, DOI 10.1053/ajkd.1998.v32.pm9740151; Farrar J, 2000, J NEUROL NEUROSUR PS, V68, P135, DOI 10.1136/jnnp.68.2.135; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Ghosh S, 2012, J PROTEOME RES, V11, P4992, DOI 10.1021/pr300562m; Ghosh S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-330; GOLDSTEIN L, 1966, AM J PHYSIOL, V210, P661, DOI 10.1152/ajplegacy.1966.210.3.661; GRAU GE, 1986, J IMMUNOL, V137, P2348; Griffin JL, 2007, J PROTEOME RES, V6, P54, DOI 10.1021/pr0601640; Hermsen CC, 1998, J INFECT DIS, V178, P1225, DOI 10.1086/515691; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; LOOAREESUWAN S, 1987, NEW ENGL J MED, V317, P675, DOI 10.1056/NEJM198709103171105; Martins YC, 2009, INT J EXP PATHOL, V90, P119, DOI 10.1111/j.1365-2613.2008.00622.x; Minerva L, 2011, ANAL CHEM, V83, P7682, DOI 10.1021/ac200888j; Mishra SK, 2007, TROP DOCT, V37, P103, DOI 10.1258/004947507780609220; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Montoliu I, 2009, J PROTEOME RES, V8, P2397, DOI 10.1021/pr8010205; Nacher M, 2001, AM J TROP MED HYG, V65, P639, DOI 10.4269/ajtmh.2001.65.639; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; Olthof MR, 2005, AM J CLIN NUTR, V82, P111, DOI 10.1093/ajcn/82.1.111; Persky AM, 2001, PHARMACOL REV, V53, P161; PITTS RF, 1967, J CLIN INVEST, V46, P530, DOI 10.1172/JCI105554; Prakash J, 2003, J Assoc Physicians India, V51, P265; Rajeshwari K, 2004, INFECT IMMUN, V72, P5515, DOI 10.1128/IAI.72.9.5515-5521.2004; Rao A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-155; REST JR, 1982, T ROY SOC TROP MED H, V76, P410, DOI 10.1016/0035-9203(82)90203-6; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; Santana L, 2006, NEFROLOGIA, V26, P751; Schliess F, 2002, BIOL CHEM, V383, P577, DOI 10.1515/BC.2002.059; Sengupta Arjun, 2011, J Parasitol Res, V2011, P901854, DOI 10.1155/2011/901854; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; SHERMAN WR, 1968, BIOCHIM BIOPHYS ACTA, V158, P197, DOI 10.1016/0304-4165(68)90131-1; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; SIMOES AP, 1991, BIOCHIM BIOPHYS ACTA, V1063, P45, DOI 10.1016/0005-2736(91)90351-8; SIZELAND PCB, 1995, AM J PHYSIOL-RENAL, V268, pF227, DOI 10.1152/ajprenal.1995.268.2.F227; Sowunmi A, 1996, ARCH DIS CHILD, V74, P293, DOI 10.1136/adc.74.4.293; Strange K, 1998, J GEN PHYSIOL, V111, P617, DOI 10.1085/jgp.111.5.617; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Viola A, 2004, MAGN RESON MATER PHY, V17, P47, DOI 10.1007/s10334-004-0044-x; WEBER MW, 1991, TROP MED PARASITOL, V42, P115; Weber MW, 1999, TROP MED INT HEALTH, V4, P390, DOI 10.1046/j.1365-3156.1999.00409.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; WELBOURNE TC, 1995, AM J PHYSIOL-CELL PH, V268, pC1418, DOI 10.1152/ajpcell.1995.268.6.C1418; Yagmur Y, 2000, CRIT CARE, V4, P309, DOI 10.1186/cc713; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P1807, DOI 10.1016/j.bbadis.2012.08.001	65	10	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73113	10.1371/journal.pone.0073113	http://dx.doi.org/10.1371/journal.pone.0073113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039868	gold, Green Submitted, Green Published			2022-12-25	WOS:000324856500035
J	Lal, D; Reinthaler, EM; Altmuller, J; Toliat, MR; Thiele, H; Nurnberg, P; Lerche, H; Hahn, A; Moller, RS; Muhle, H; Sander, T; Zimprich, F; Neubauer, BA				Lal, Dennis; Reinthaler, Eva M.; Altmueller, Janine; Toliat, Mohammad R.; Thiele, Holger; Nuernberg, Peter; Lerche, Holger; Hahn, Andreas; Moller, Rikke S.; Muhle, Hiltrud; Sander, Thomas; Zimprich, Fritz; Neubauer, Bernd A.			RBFOX1 and RBFOX3 Mutations in Rolandic Epilepsy	PLOS ONE			English	Article							BENIGN PARTIAL EPILEPSY; PSEUDO-LENNOX-SYNDROME; CENTROTEMPORAL SPIKES; SPLICING FACTORS; SHARP WAVES; GENE; CHILDHOOD; PHENOTYPES; FAMILIES; CHILDREN	Partial deletions of the gene encoding the neuronal splicing regulator RBFOX1 have been reported in a range of neurodevelopmental diseases, including idiopathic generalized epilepsy. The RBFOX1 protein and its homologues (RBFOX2 and RBFOX3) regulate alternative splicing of many neuronal transcripts involved in the homeostatic control of neuronal excitability. In this study, we explored if structural microdeletions and exonic sequence variations in RBFOX1, RBFOX2, RBFOX3 confer susceptibility to rolandic epilepsy (RE), a common idiopathic focal childhood epilepsy. By high-density SNP array screening of 289 unrelated RE patients, we identified two hemizygous deletions, a 365 kb deletion affecting two untranslated 5'-terminal exons of RBFOX1 and a 43 kb deletion spanning exon 3 of RBFOX3. Exome sequencing of 242 RE patients revealed two novel probably deleterious variants in RBFOX1, a frameshift mutation (p. A233Vfs*74) and a hexanucleotide deletion (p. A299_A300del), and a novel nonsense mutation in RBFOX3 (p. Y287*). Although the three variants were inherited from unaffected parents, they were present in all family members exhibiting the RE trait clinically or electroencephalographically with only one exception. In contrast, no deleterious mutations of RBFOX1 and RBFOX3 were found in the exomes of 6503 non-RE subjects deposited in the Exome Variant Server database. The observed RBFOX3 exon 3 deletion and nonsense mutation suggest that RBFOX3 represents a novel risk factor for RE, indicating that exon deletions and truncating mutations of RBFOX1 and RBFOX3 contribute to the genetic variance of partial and generalized idiopathic epilepsy syndromes.	[Lal, Dennis; Altmueller, Janine; Toliat, Mohammad R.; Thiele, Holger; Nuernberg, Peter; Sander, Thomas] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Lal, Dennis; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Lal, Dennis; Hahn, Andreas; Neubauer, Bernd A.] Univ Med Clin Giessen, Dept Neuropediat, Giessen, Germany; [Reinthaler, Eva M.; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Lerche, Holger] Univ Tubingen, Dept Neurol & Epileptol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Moller, Rikke S.] Danish Epilepsy Ctr, Dianalund, Denmark; [Muhle, Hiltrud] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany	University of Cologne; University of Cologne; Medical University of Vienna; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Kiel; Schleswig Holstein University Hospital	Neubauer, BA (corresponding author), Univ Med Clin Giessen, Dept Neuropediat, Giessen, Germany.	Bernd.A.Neubauer@paediat.med.uni-giessen.de	Thiele, Holger/ABE-6792-2020; Muhle, Hiltrud/F-5715-2010; Zimprich, Fritz/W-1738-2017; Zimprich, Fritz/O-1406-2019; Neubauer, Bernd/AAZ-9391-2020	Thiele, Holger/0000-0002-0169-998X; Zimprich, Fritz/0000-0002-6998-5480; Zimprich, Fritz/0000-0002-6998-5480; Moller, Rikke S./0000-0002-9664-1448; Altmuller, Janine/0000-0003-4372-1521	EuroEPIGENOMICS within the EUROCORES framework of the European science foundation [SA434/5-1, BN416/5-1, LE1030/11-1, NU50/8-1]; Austrian Science Fund (FWF) [I 643] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, UC2HL102924, RC2HL103010, UC2HL102923, RC2HL102924, RC2HL102926, RC2HL102925, UC2HL102926, RC2HL102923, UC2HL102925] Funding Source: NIH RePORTER	EuroEPIGENOMICS within the EUROCORES framework of the European science foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by EuroEPIGENOMICS within the EUROCORES framework of the European science foundation (SA434/5-1, BN416/5-1; LE1030/11-1, NU50/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICARDI J, 1982, DEV MED CHILD NEUROL, V24, P281, DOI 10.1111/j.1469-8749.1982.tb13620.x; Bali B, 2007, EPILEPSIA, V48, P2266; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Billard C, 1981, Rev Electroencephalogr Neurophysiol Clin, V11, P457, DOI 10.1016/S0370-4475(81)80086-X; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Davis LK, 2012, AM J MED GENET A, V158A, P1654, DOI 10.1002/ajmg.a.35396; Doose H, 2001, NEUROPEDIATRICS, V32, P9, DOI 10.1055/s-2001-12215; Doose H, 1997, EPILEPSIA, V38, P788, DOI 10.1111/j.1528-1157.1997.tb01466.x; Dredge BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021585; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; FOURMENT A, 1976, ELECTROEN CLIN NEURO, V40, P457, DOI 10.1016/0013-4694(76)90076-6; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Guerrini R, 1999, ANN NEUROL, V45, P344, DOI 10.1002/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9; Hahn A, 2001, NEUROPEDIATRICS, V32, P1, DOI 10.1055/s-2001-12216; Lal D, 2013, EPILEPSIA, V54, P265, DOI 10.1111/epi.12084; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Neubauer BA, 2008, NEUROLOGY, V71, P177, DOI 10.1212/01.wnl.0000317090.92185.ec; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; O'Brien JE, 2012, MOL CELL NEUROSCI, V49, P120, DOI 10.1016/j.mcn.2011.10.005; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; Pal DK, 2011, CURR OPIN NEUROL, V24, P126, DOI 10.1097/WCO.0b013e328344634a; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; SIDENVALL R, 1993, ACTA PAEDIATR, V82, P60, DOI 10.1111/j.1651-2227.1993.tb12518.x; Strug LJ, 2009, EUR J HUM GENET, V17, P1171, DOI 10.1038/ejhg.2008.267; Sun SY, 2012, RNA, V18, P274, DOI 10.1261/rna.030486.111; Vears DF, 2012, EPILEPSIA, V53, P319, DOI 10.1111/j.1528-1167.2011.03368.x; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; YASUHARA A, 1991, EPILEPSIA, V32, P59, DOI 10.1111/j.1528-1157.1991.tb05612.x	33	77	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73323	10.1371/journal.pone.0073323	http://dx.doi.org/10.1371/journal.pone.0073323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039908	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500038
J	Boncristiani, HF; Evans, JD; Chen, YP; Pettis, J; Murphy, C; Lopez, DL; Simone-Finstrom, M; Strand, M; Tarpy, DR; Rueppell, O				Boncristiani, Humberto F.; Evans, Jay D.; Chen, Yanping; Pettis, Jeff; Murphy, Charles; Lopez, Dawn L.; Simone-Finstrom, Michael; Strand, Micheline; Tarpy, David R.; Rueppell, Olav			In Vitro Infection of Pupae with Israeli Acute Paralysis Virus Suggests Disturbance of Transcriptional Homeostasis in Honey Bees (Apis mellifera)	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; GENE-EXPRESSION; RIBOSOME BIOGENESIS; VARROA-JACOBSONI; QUANTITATIVE-PCR; APOPTOSIS; POLIOVIRUS; DIVERSITY; MICROBES; IMMUNITY	The ongoing decline of honey bee health worldwide is a serious economic and ecological concern. One major contributor to the decline are pathogens, including several honey bee viruses. However, information is limited on the biology of bee viruses and molecular interactions with their hosts. An experimental protocol to test these systems was developed, using injections of Israeli Acute Paralysis Virus (IAPV) into honey bee pupae reared ex-situ under laboratory conditions. The infected pupae developed pronounced but variable patterns of disease. Symptoms varied from complete cessation of development with no visual evidence of disease to rapid darkening of a part or the entire body. Considerable differences in IAPV titer dynamics were observed, suggesting significant variation in resistance to IAPV among and possibly within honey bee colonies. Thus, selective breeding for virus resistance should be possible. Gene expression analyses of three separate experiments suggest IAPV disruption of transcriptional homeostasis of several fundamental cellular functions, including an up-regulation of the ribosomal biogenesis pathway. These results provide first insights into the mechanisms of IAPV pathogenicity. They mirror a transcriptional survey of honey bees afflicted with Colony Collapse Disorder and thus support the hypothesis that viruses play a critical role in declining honey bee health.	[Boncristiani, Humberto F.; Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Evans, Jay D.; Chen, Yanping; Pettis, Jeff; Lopez, Dawn L.] USDA ARS, Bee Res Lab, Beltsville, MD USA; [Murphy, Charles] USDA ARS, Beltsville, MD USA; [Simone-Finstrom, Michael; Tarpy, David R.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Strand, Micheline] US Army Res Off, Div Life Sci, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Greensboro; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Boncristiani, HF (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	humbfb@gmail.com	Rueppell, Olav/G-2679-2010; Evans, Jay D/C-8408-2012	Rueppell, Olav/0000-0001-5370-4229; Evans, Jay D/0000-0002-0036-4651; Tarpy, David/0000-0001-8601-6094; Simone-Finstrom, Michael/0000-0003-2938-9788	USDA-ARS Headquarters Postdoctoral Research Associate Program Grant; National Academy of Science; UNCG; US National Institute of Food and Agriculture AFRI grant [2010-65104-20533]	USDA-ARS Headquarters Postdoctoral Research Associate Program Grant; National Academy of Science; UNCG; US National Institute of Food and Agriculture AFRI grant	The work was supported by the USDA-ARS Headquarters Postdoctoral Research Associate Program Grant and The National Academy of Science for the NRC fellowship grant to HFB and by UNCG and a US National Institute of Food and Agriculture AFRI grant (#2010-65104-20533) to OR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; ALLEN MF, 1986, J APICULT RES, V25, P100, DOI 10.1080/00218839.1986.11100700; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; BAILEY L, 1964, J INSECT PATHOL, V6, P395; BAILEY L, 1967, VIROLOGY, V33, P368, DOI 10.1016/0042-6822(67)90161-4; BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Bailey L., 1991, HONEY BEE PATHOLOGY; Ball B, 1996, BEE WORLD, V77, P117, DOI 10.1080/0005772X.1996.11099302; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Chevin A, 2012, VIRUS RES, V167, P173, DOI 10.1016/j.virusres.2012.04.012; Cho WK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-173; CLARK ME, 1991, EMBO J, V10, P2941, DOI 10.1002/j.1460-2075.1991.tb07844.x; Clem RJ, 2007, CURR DRUG TARGETS, V8, P1069, DOI 10.2174/138945007782151405; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DAS S, 1993, J VIROL, V67, P3326, DOI 10.1128/JVI.67.6.3326-3331.1993; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Genersch E, 2008, VIROLOGY HONEY BEE, P255; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Grabensteiner E, 2001, WIEN TIERARZTL MONAT, V88, P79; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Graveley B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-I11; Groppo R, 2007, J VIROL, V81, P13067, DOI 10.1128/JVI.00185-07; Hardwick JM, 2001, CELL DEATH DIFFER, V8, P109, DOI 10.1038/sj.cdd.4400820; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kuster R, 2012, EXPRESSION LEVELS IM; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; MOORE NF, 1980, J VIROL, V33, P1; Morgado-Palacin L, 2012, CELL CYCLE, V11, P503, DOI 10.4161/cc.11.3.19002; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; OURTH DD, 1993, COMP BIOCHEM PHYS B, V105, P719, DOI 10.1016/0305-0491(93)90111-H; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Radonic A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-7; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Rueckert RR, 1996, VIROLOGY, P609; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTTI PD, 1976, INTERVIROLOGY, V6, P333, DOI 10.1159/000149489; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Shelby KS, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_13.1; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Tarpy DR, 2010, J APICULT RES, V49, P302, DOI 10.3896/IBRA.1.49.4.02; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963	78	49	51	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73429	10.1371/journal.pone.0073429	http://dx.doi.org/10.1371/journal.pone.0073429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039938	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600076
J	Okpechi, IG; Chukwuonye, II; Tiffin, N; Madukwe, OO; Onyeonoro, UU; Umeizudike, TI; Ogah, OS				Okpechi, Ikechi Gareth; Chukwuonye, Innocent Ijezie; Tiffin, Nicki; Madukwe, Okechukwu Ojoemelam; Onyeonoro, Ugochukwu Uchenna; Umeizudike, Theophilus Ifeanyichukwu; Ogah, Okechukwu Samuel			Blood Pressure Gradients and Cardiovascular Risk Factors in Urban and Rural Populations in Abia State South Eastern Nigeria Using the WHO STEPwise Approach	PLOS ONE			English	Article							GLOBAL BURDEN; NONCOMMUNICABLE DISEASE; HYPERTENSION; PREVENTION; PREVALENCE	Background: Developing countries of sub-Saharan Africa (SSA) face a double burden of non-communicable diseases (NCDs) and communicable diseases. As high blood pressure (BP) is a common global cardiovascular (CV) disorder associated with high morbidity and mortality, the relationship between gradients of BP and other CV risk factors was assessed in Abia State, Nigeria. Methods: Using the WHO STEPwise approach to surveillance of chronic disease risk factors, we conducted a population-based cross-sectional survey in Abia state, Nigeria from August 2011 to March 2012. Data collected at various steps included: demographic and behavioral risk factors (Step 1); BP and anthropometric measurements (Step 2), and fasting blood cholesterol and glucose (Step 3). Results: Of the 2983 subjects with complete data for analysis, 52.1% were females and 53.2% were rural dwellers. Overall, the distribution of selected CV disease risk factors was diabetes (3.6%), hypertension (31.4%), cigarette smoking (13.3%), use of smokeless tobacco (4.8%), physical inactivity (64.2%) and being overweight or obese (33.7%). Presence of hypertension, excessive intake of alcohol, smoking (cigarette and smokeless tobacco) and physical inactivity occurred more frequently in males than in females (p<0.05); while low income, lack of any formal education and use of smokeless tobacco were seen more frequently in rural dwellers than in those living in urban areas (p<0.05). The frequency of selected CV risk factors increased as BP was graded from optimal, normal to hypertension; and high BP correlated with age, gender, smokeless tobacco, overweight or obesity, annual income and level of education. Conclusion: Given the high prevalence of hypertension in this part of Nigeria, there is an urgent need to focus on the reduction of preventable CV risk factors we have observed to be associated with hypertension, in order to effectively reduce the burden of NCDs in Africa.	[Okpechi, Ikechi Gareth] Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa; [Okpechi, Ikechi Gareth] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Chukwuonye, Innocent Ijezie] Fed Med Ctr, Dept Med, Div Nephrol, Umuahia, Abia State, Nigeria; [Tiffin, Nicki] Univ Western Cape, South African Natl Bioinformat Inst, MRC, Unit Bioinformat Capac Dev, Cape Town, South Africa; [Madukwe, Okechukwu Ojoemelam; Ogah, Okechukwu Samuel] Minist Hlth, Nnamdi Azikiwe Secretariat, Umuahia, Abia State, Nigeria; [Onyeonoro, Ugochukwu Uchenna] Fed Med Ctr, Dept Community Med, Umuahia, Abia State, Nigeria; [Umeizudike, Theophilus Ifeanyichukwu] Lagos State Univ, Teaching Hosp, Nephrol Unit, Ikeja Lagos, Nigeria; [Ogah, Okechukwu Samuel] Univ Coll Hosp, Dept Med, Div Cardiovasc Med, Ibadan, Oyo State, Nigeria	University of Cape Town; University of Cape Town; University of the Western Cape; Lagos State University; University of Ibadan; University College Hospital, Ibadan	Ogah, OS (corresponding author), Minist Hlth, Nnamdi Azikiwe Secretariat, Umuahia, Abia State, Nigeria.	osogah56156@yahoo.com	Chukwuonye, Innocent/AAD-9051-2022; Tiffin, Nicki/ABA-9391-2020; Onyeonoro, Ugochukwu U/L-9374-2016	Chukwuonye, Innocent/0000-0003-1190-135X; Tiffin, Nicki/0000-0001-5083-2735; Onyeonoro, Ugochukwu U/0000-0003-2132-6221; Ogah, Okechukwu/0000-0002-2093-7787; Umeizudike, Theophilus/0000-0002-0514-0972				Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], 2010, DIS INJ COUNTR EST; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Chen X, 2012, AM J HYPERTENS, V25, P464, DOI 10.1038/ajh.2011.262; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; ELBAGIR M, 1990, J HUM HYPERTENS, V4, P621; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mufunda J, 2006, ETHNIC DIS, V16, P521; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Reddy KS, 2002, PUBLIC HEALTH NUTR, V5, P231, DOI 10.1079/PHN2001298; Sacco WP, 2012, DIABETES RES CLIN PR, V95, P62, DOI 10.1016/j.diabres.2011.08.027; Salako B L, 2007, Cardiovasc J Afr, V18, P77; Seedat Y K, 2011, S Afr Med J, V102, P57; Ulasi II, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/869675; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71; Unwin N, 2001, HEALTH POLICY PLANN, V16, P351, DOI 10.1093/heapol/16.4.351; World Health Organization, 2005, WHO STEPS SURV MAN W; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	27	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73403	10.1371/journal.pone.0073403	http://dx.doi.org/10.1371/journal.pone.0073403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039932	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600072
J	Yoshida, T; Kawabe, A				Yoshida, Takanori; Kawabe, Akira			Importance of Gene Duplication in the Evolution of Genomic Imprinting Revealed by Molecular Evolutionary Analysis of the Type I MADS-Box Gene Family in Arabidopsis Species	PLOS ONE			English	Article							SEED DEVELOPMENT; MEDEA; EXPRESSION; SELECTION; METHYLATION; IDENTIFICATION; PRESERVATION; ENDOSPERM; FIXATION; ALLELE	The pattern of molecular evolution of imprinted genes is controversial and the entire picture is still to be unveiled. Recently, a relationship between the formation of imprinted genes and gene duplication was reported in genome-wide survey of imprinted genes in Arabidopsis thaliana. Because gene duplications influence the molecular evolution of the duplicated gene family, it is necessary to investigate both the pattern of molecular evolution and the possible relationship between gene duplication and genomic imprinting for a better understanding of evolutionary aspects of imprinted genes. In this study, we investigated the evolutionary changes of type I MADS-box genes that include imprinted genes by using relative species of Arabidopsis thaliana (two subspecies of A. lyrata and three subspecies of A. halleri). A duplicated gene family enables us to compare DNA sequences between imprinted genes and its homologs. We found an increased number of gene duplications within species in clades containing the imprinted genes, further supporting the hypothesis that local gene duplication is one of the driving forces for the formation of imprinted genes. Moreover, data obtained by phylogenetic analysis suggested "rapid evolution" of not only imprinted genes but also its closely related orthologous genes, which implies the effect of gene duplication on molecular evolution of imprinted genes.	[Yoshida, Takanori; Kawabe, Akira] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan	Kyoto Sangyo University	Kawabe, A (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan.	akiraka@cc.kyoto-su.ac.jp	Yoshida, Takanori/K-2650-2019; Kawabe, Akira/W-7485-2019	Kawabe, Akira/0000-0001-5770-412X	 [23113003]		This work was supported by Grants-in-Aid for Scientific Research in Innovative Areas (23113003 to AK). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Force A, 1999, GENETICS, V151, P1531; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gossmann TI, 2011, J MOL EVOL, V73, P153, DOI 10.1007/s00239-011-9463-2; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Haun WJ, 2007, PLANT J, V49, P325, DOI 10.1111/j.1365-313X.2006.02965.x; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Ikeda Y, 2012, PLANT CELL PHYSIOL, V53, P809, DOI 10.1093/pcp/pcs049; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Ishikawa R, 2011, PLANT J, V65, P798, DOI 10.1111/j.1365-313X.2010.04466.x; JUKES T H, 1969, P21; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kawabe A, 2007, CURR BIOL, V17, P1885, DOI 10.1016/j.cub.2007.09.051; KIMURA M, 1979, P NATL ACAD SCI USA, V76, P2858, DOI 10.1073/pnas.76.6.2858; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; LI WH, 1980, GENETICS, V95, P237; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002125; McVean GT, 1997, P ROY SOC B-BIOL SCI, V264, P739, DOI 10.1098/rspb.1997.0105; Miyake T, 2009, MOL BIOL EVOL, V26, P843, DOI 10.1093/molbev/msp001; NEI M, 1969, NATURE, V221, P40, DOI 10.1038/221040a0; O'Connell MJ, 2010, MAMM GENOME, V21, P486, DOI 10.1007/s00335-010-9283-5; Ohno S., 1970, P1; Shirzadi R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001303; Smith NGC, 1998, GENETICS, V150, P823; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka KM, 2009, GENET RES, V91, P267, DOI 10.1017/S0016672309000196; Walter J, 2003, HUM MOL GENET, V12, pR215, DOI 10.1093/hmg/ddg296; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang M, 2011, P NATL ACAD SCI USA, V108, P20042, DOI 10.1073/pnas.1112186108	47	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73588	10.1371/journal.pone.0073588	http://dx.doi.org/10.1371/journal.pone.0073588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039992	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600089
J	Aqil, M; Naqvi, AR; Bano, AS; Jameel, S				Aqil, Madeeha; Naqvi, Afsar Raza; Bano, Aalia Shahr; Jameel, Shahid			The HIV-1 Nef Protein Binds Argonaute-2 and Functions as a Viral Suppressor of RNA Interference	PLOS ONE			English	Article							MULTIVESICULAR BODIES; CELLULAR MICRORNAS; VIRUS-INFECTION; EXPRESSION; CELLS; DROSOPHILA; DICER; REPLICATION; TRAFFICKING; SECRETION	The HIV-1 accessory protein Nef is an important virulence factor. It associates with cellular membranes and modulates the endocytic machinery and signaling pathways. Nef also increases the proliferation of multivesicular bodies (MVBs), which are sites for virus assembly and budding in macrophages. The RNA interference (RNAi) pathway proteins Ago2 and GW182 localize to MVBs, suggesting these to be sites for assembly and turnover of the miRNA-induced silencing complex (miRISC). While RNAi affects HIV replication, it is not clear if the virus encodes a suppressor activity to overcome this innate host response. Here we show that Nef colocalizes with MVBs and binds Ago2 through two highly conserved Glycine-Tryptophan (GW) motifs, mutations in which abolish Nef binding to Ago2 and reduce virus yield and infectivity. Nef also inhibits the slicing activity of Ago2 and disturbs the sorting of GW182 into exosomes resulting in the suppression of miRNA-induced silencing. Thus, besides its other activities, the HIV-1 Nef protein is also proposed to function as a viral suppressor of RNAi (VSR).	[Aqil, Madeeha; Naqvi, Afsar Raza; Bano, Aalia Shahr; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	shahid@icgeb.res.in			Indian Council of Medical Research (ICMR); Department of Biotechnology, Government of India; Council for Scientific and Industrial Research, India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by funds from the Indian Council of Medical Research (ICMR) and Department of Biotechnology, Government of India. MA received a Senior Research Fellowship from the Council for Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Christensen HS, 2007, J VIROL, V81, P5121, DOI 10.1128/JVI.01511-06; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Clayton A., 2006, CURR PROTOC CELL BIO; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Echarri A, 1997, EUR J BIOCHEM, V246, P38, DOI 10.1111/j.1432-1033.1997.00038.x; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Freed EO, 2007, FIELDS VIROLOGY; Gibbings D, 2010, TRENDS CELL BIOL, V20, P491, DOI 10.1016/j.tcb.2010.06.001; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kumar A, 2008, J CELL PHYSIOL, V216, P327, DOI 10.1002/jcp.21488; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Ouellet Dominique L., 2009, V487, P415, DOI 10.1007/978-1-60327-547-7_20; Rawlings RA, 2011, J MOL BIOL, V408, P262, DOI 10.1016/j.jmb.2011.02.038; Sanghvi VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017246; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707	46	45	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74472	10.1371/journal.pone.0074472	http://dx.doi.org/10.1371/journal.pone.0074472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023945	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000324515600142
J	Du, L; Zhao, Z; Ma, X; Hsiao, TH; Chen, Y; Young, E; Suraokar, M; Wistuba, I; Minna, JD; Pertsemlidis, A				Du, L.; Zhao, Z.; Ma, X.; Hsiao, T-H; Chen, Y.; Young, E.; Suraokar, M.; Wistuba, I.; Minna, J. D.; Pertsemlidis, A.			miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer	ONCOGENE			English	Article						DAB2; miRNA; miR-93; lung cancer	TUMOR-SUPPRESSOR GENE; OVARIAN-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; DISABLED-2 EXPRESSION; GASTRIC-CANCER; CELL-GROWTH; MICRORNAS; MIR-93; PROTEIN	The disabled homolog 2 (DAB2) gene was recently identified as a tumor suppressor gene with its expression downregulated in multiple cancer types. The role of DAB2 in lung tumorigenesis, however, is not fully characterized, and the mechanisms of DAB2 dysregulation in lung cancer are not defined. Here we show that low DAB2 levels in lung tumor specimens are significantly correlated with poor patient survival, and that DAB2 overexpression significantly inhibits cell growth in cultured lung cancer cells, indicating its potent tumor suppressor function. We next identify that microRNA miR-93 functions as a potent repressor of DAB2 expression by directly targeting the 3'UTR of the DAB2 mRNA. Using in vitro and in vivo approaches, we demonstrate that miR-93 overexpression has an important role in promoting lung cancer cell growth, and that its oncogenic function is primarily mediated by downregulating DAB2 expression. Our clinical investigations further indicate that high tumor levels of miR-93 are correlated with poor survival of lung cancer patients. The correlations of both low DAB2 and high miR-93 expression levels with poor patient survival strongly support the critical role of the miR-93/DAB2 pathway in determining lung cancer progression.	[Du, L.; Zhao, Z.; Ma, X.; Hsiao, T-H; Chen, Y.; Young, E.; Pertsemlidis, A.] UT Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Du, L.; Pertsemlidis, A.] UT Hlth Sci Ctr San Antonio, Dept Cell & Struct Biol, San Antonio, TX 78229 USA; [Chen, Y.] UT Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Suraokar, M.; Wistuba, I.] UT MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA; [Wistuba, I.] UT MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX USA; [Minna, J. D.] UT Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; [Minna, J. D.] UT Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA; [Minna, J. D.] UT Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Pertsemlidis, A.] UT Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio	Du, L (corresponding author), UT Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, 8403 Floyd Curl Dr,MC 7784, San Antonio, TX 78229 USA.	dul2@uthscsa.edu; pertsemlidis@uthscsa.edu	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	Lung Cancer SPORE from NCI [P50 CA70907]; Department of Defense [W81XWH-07-1-0306]; Sun Microsystems [EDUD-7824-021007-US]; Cancer Center [P30 CA054174, P30 CA142543, P30 CA016672];  [R01 CA129632]; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA054174, R01CA129632, P30CA142543, P50CA070907] Funding Source: NIH RePORTER	Lung Cancer SPORE from NCI; Department of Defense(United States Department of Defense); Sun Microsystems; Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Vivienne Rebel and Nicholas Dybdal-Hargreaves for critical reading of the manuscript. This work was supported in part by R01 CA129632 (A Pertsemlidis) and Lung Cancer SPORE P50 CA70907 (JD Minna and II Wistuba) from the NCI, W81XWH-07-1-0306 from the Department of Defense (II Wistuba), Academic Excellence grant EDUD-7824-021007-US (A Pertsemlidis) from Sun Microsystems and Cancer Center Support grants P30 CA054174, P30 CA142543 and P30 CA016672.	Anupam K, 2006, WORLD J GASTROENTERO, V12, P6041, DOI 10.3748/wjg.v12.i37.6041; Bagadi SAR, 2007, BREAST CANCER RES TR, V104, P277, DOI 10.1007/s10549-006-9422-6; Borchert GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-347; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; CARNEY DN, 1985, SEMIN ONCOL, V12, P289; CARNEY DN, 1982, CLIN CHEST MED, V3, P389; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chuang TD, 2012, MOL ENDOCRINOL, V26, P1028, DOI 10.1210/me.2012-1075; Du LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039167; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; Karam JA, 2007, CLIN CANCER RES, V13, P4400, DOI 10.1158/1078-0432.CCR-07-0287; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kluiver J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029275; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mayorga ME, 2012, J CELL MOL MED, V16, P1106, DOI 10.1111/j.1582-4934.2011.01385.x; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tseng CP, 1998, ENDOCRINOLOGY, V139, P3542, DOI 10.1210/en.139.8.3542; Wang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043268; Wang ZZ, 2010, INT J ONCOL, V37, P1315, DOI 10.3892/ijo_00000783; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Xu HT, 2013, APMIS, V121, P111, DOI 10.1111/j.1600-0463.2012.02946.x; Xu HT, 2011, HUM PATHOL, V42, P1491, DOI 10.1016/j.humpath.2011.01.004; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036; Yang L, 2012, J BONE MINER RES, V27, P1598, DOI 10.1002/jbmr.1621; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zhou J, 2005, CANCER RES, V65, P9906, DOI 10.1158/0008-5472.CAN-05-1481	42	60	65	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4307	4315		10.1038/onc.2013.381	http://dx.doi.org/10.1038/onc.2013.381			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24037530	Green Accepted, Bronze			2022-12-25	WOS:000341156900004
J	Greenow, KR; Clarke, AR; Williams, GT; Jones, R				Greenow, K. R.; Clarke, A. R.; Williams, G. T.; Jones, R.			Wnt-driven intestinal tumourigenesis is suppressed by Chk1 deficiency but enhanced by conditional haploinsufficiency	ONCOGENE			English	Article						Chk1; Apc; genomic instability; small intestine; apoptosis	DNA-DAMAGE RESPONSE; ANTICANCER BARRIER; COLORECTAL-CANCER; INSTABILITY; GENE; INHIBITION; CHECKPOINT; EXPRESSION; APOPTOSIS; STRESS	Chk1 is essential in maintaining genomic stability due to its role in cell cycle regulation. Several recent studies have indicated that the abrogation of checkpoints in tumourigenesis through the inhibition of Chk1 may be of therapeutic value. To further investigate the role of Chk1 in the mouse small intestine and its potential role as a therapy for colorectal cancer, we simultaneously deleted Chk1 and Apc in the mouse small intestine. We found that homozygous loss of Chk1 is not compatible with Wnt-driven proliferation and resulted in the suppression of Wnt-driven tumourigenesis in the mouse small intestine. In contrast, heterozygous loss of Chk1 in a Wnt-driven background resulted in an increase in DNA damage and apoptosis and accelerated both tumour development and progression.	[Greenow, K. R.; Clarke, A. R.; Jones, R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Williams, G. T.] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Clarke, AR (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Museum Ave,POB 911, Cardiff CF10 3AX, S Glam, Wales.	clarkeAR@cardiff.ac.uk	clarke, alan r/P-2820-2014	Clarke, Alan/0000-0002-4281-426X	Cancer Research UK; Cancer Research UK [15937] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK. Particular thanks go to Mark Bishop, Lucie Pietzka and Derek Scarborough for technical assistance. The authors declare no conflicts of interest.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartek J, 2012, NAT STRUCT MOL BIOL, V19, P5, DOI 10.1038/nsmb.2220; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Fishler T, 2010, ONCOGENE, V29, P4007, DOI 10.1038/onc.2010.163; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Greenow KR, 2009, ONCOGENE, V28, P1443, DOI 10.1038/onc.2008.482; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Plummer R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2877; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; SALHAB N, 1989, DIS COLON RECTUM, V32, P659, DOI 10.1007/BF02555769; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soreide K, 2006, BRIT J SURG, V93, P395, DOI 10.1002/bjs.5328; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tho LM, 2012, ONCOGENE, V31, P1366, DOI 10.1038/onc.2011.326; Venkatesha VA, 2012, NEOPLASIA, V14, P519, DOI 10.1593/neo.12538; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	27	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4089	4096		10.1038/onc.2013.371	http://dx.doi.org/10.1038/onc.2013.371			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24037525				2022-12-25	WOS:000340595300008
J	Jelinic, M; Leo, CH; Uiterweer, EDP; Sandow, SL; Gooi, JH; Wlodek, ME; Conrad, KP; Parkington, H; Tare, M; Parry, LJ				Jelinic, Maria; Leo, Chen-Huei; Uiterweer, Emiel D. Post; Sandow, Shaun L.; Gooi, Jonathan H.; Wlodek, Mary E.; Conrad, Kirk P.; Parkington, Helena; Tare, Marianne; Parry, Laura J.			Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin- mediated relaxation after in vivo serelaxin treatment	FASEB JOURNAL			English	Article						RXFP1; vasodilation	SPONTANEOUSLY HYPERTENSIVE-RATS; NITRIC-OXIDE; MYOGENIC REACTIVITY; NONPREGNANT RATS; BLOOD-PRESSURE; EMERGING ROLE; PREGNANCY; FLOW; VASCULATURE; VASODILATOR	Relaxin is a potent vasodilator of small resistance arteries and modifies arterial compliance in some systemic vascular beds, yet receptors for relaxin, such as RXFP1, have only been localized to vascular smooth muscle. This study first aimed to localize RXFP1 in rat arteries and veins from different organ beds and determine whether receptors are present in endothelial cells. We then tested the hypothesis that region-specific vascular effects of relaxin may be influenced by the cellular localization of RXFP1 within different blood vessels. The aorta, vena cava, mesenteric artery, and vein had significantly higher (P<0.05) RXFP1 immunostaining in endothelial cells compared with vascular smooth muscle, whereas the femoral artery and vein and small pulmonary arteries had higher (P<0.01) RXFP1 immunostaining in the vascular smooth muscle. Male rats were treated subcutaneously with recombinant human relaxin-2 (serelaxin; 4 g/h) for 5 d; vasodilation and compliance in mesenteric and femoral arteries and veins were compared with placebo controls. Serelaxin significantly (P=0.04) reduced wall stiffness and increased volume compliance in mesenteric arteries but not in the other vessels examined. This was associated with changes in geometrical properties, and not compositional changes in the extracellular matrix. Serelaxin treatment had no effect on acetylcholine-mediated relaxation but significantly (P<0.001) enhanced bradykinin (BK)-mediated relaxation in mesenteric arteries, involving enhanced nitric oxide but not endothelium-derived hyperpolarization or vasodilatory prostanoids. In conclusion, there is differential distribution of RXFP1 on endothelial and smooth muscle across the vasculature. In rats, mesenteric arteries exhibit the greatest functional response to chronic serelaxin treatment.Jelinic, M., Leo, C-H., Post Uiterweer, E. P., Sandow, S. L., Gooi, J. H., Wlodek, M. E., Conrad, K. P., Parkington, H., Tare, M., Parry, L. J. Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment.	[Jelinic, Maria; Leo, Chen-Huei; Gooi, Jonathan H.; Parry, Laura J.] Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia; [Jelinic, Maria; Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia; [Uiterweer, Emiel D. Post] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands; [Sandow, Shaun L.] Univ New S Wales, Dept Physiol, Sydney, NSW, Australia; [Uiterweer, Emiel D. Post; Conrad, Kirk P.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Parkington, Helena; Tare, Marianne] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	University of Melbourne; University of Melbourne; Utrecht University; Utrecht University Medical Center; University of New South Wales Sydney; State University System of Florida; University of Florida; Monash University	Parry, LJ (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia.	ljparry@unimelb.edu.au	wlodek, Mary/A-8939-2019; Gooi, Jonathan/AAS-7982-2020; leo, Chen huei/ABD-2155-2020; Gooi, Jonathan/M-2407-2016; Sandow, Shaun/N-4256-2016	wlodek, Mary/0000-0002-8490-9099; Gooi, Jonathan/0000-0002-8839-1602; leo, Chen huei/0000-0003-1424-9694; Sandow, Shaun/0000-0002-0753-2742; Jelinic, Maria/0000-0001-9773-4972; Post Uiterweer, Emiel/0000-0002-2777-3551; Parry, Laura/0000-0002-6883-3418	Novartis; Australian Research Council [LP110200543]; U.S. National Institutes of Health [HL067937]; Australian and New Zealand Medical Research and Technology in Victoria; Australian Postgraduate Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067937] Funding Source: NIH RePORTER	Novartis(Novartis); Australian Research Council(Australian Research Council); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian and New Zealand Medical Research and Technology in Victoria; Australian Postgraduate Award(Australian Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Dennis Stewart, the coordinator of the research partnership (Novartis Pharma AG, Basel, Switzerland) for helpful advice with the experimental design and critical analysis of the data. The authors also thank Dr. Elaine Unemori for helpful suggestions and manuscript review. The authors are grateful to Dr. Jill Verlander, Professor John Hutson, and Dr. Marc Mazzuca for their valuable contributions to this work, and Professor O. David Sherwood (University of Illinois, Urbana, IL, USA) for his generous gift of the RXFP1 antibody. The authors disclose that this project was partially funded by Novartis, which also provided the serelaxin, as conditions of an Australian Research Council Linkage grant. The research was funded by Australian Research Council Linkage grant LP110200543 (L.J.P., M. T., H. C. P., and M. E. W.), U.S. National Institutes of Health grant HL067937 (K. P. C. and L.J.P.) and an Australian and New Zealand Medical Research and Technology in Victoria grant (L.J.P.). M.J. received an Australian Postgraduate Award.	Adams J, 2012, PLOS ONE, V7; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Chan S. L., 2013, FASEB J, DOI 10.1096/fj.13-230797; Chan SL, 2011, FASEB J, V25, P3229, DOI 10.1096/fj.10-175471; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Conrad KP, 2004, AM J PHYSIOL-REG I, V287, pR250, DOI 10.1152/ajpregu.00672.2003; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; Danielson LA, 1999, J CLIN INVEST, V103, P525, DOI 10.1172/JCI5630; Debrah DO, 2011, J APPL PHYSIOL, V111, P260, DOI 10.1152/japplphysiol.00845.2010; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Dschietzig T, 2012, CARDIOVASC RES, V95, P97, DOI 10.1093/cvr/cvs149; Dschietzig T, 2009, J CARD FAIL, V15, P182, DOI 10.1016/j.cardfail.2009.01.008; Failli P, 2001, FASEB J, V15, P252, DOI 10.1096/fj.01-0569fje; Ferreira VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004845; Fisher C, 2002, CIRCULATION, V106, P292, DOI 10.1161/01.CIR.0000025630.05387.45; Gao YJ, 2008, CAN J PHYSIOL PHARM, V86, P737, DOI 10.1139/Y08-079; Gooi JH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108118; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; Kern A, 2009, ENDOCRINOLOGY, V150, P2419, DOI 10.1210/en.2008-1385; Kubota Y, 2002, MOL HUM REPROD, V8, P900, DOI 10.1093/molehr/8.10.900; Li Y, 2005, REGUL PEPTIDES, V132, P41, DOI 10.1016/j.regpep.2005.09.009; MASSICOTTE G, 1989, P SOC EXP BIOL MED, V190, P254; Mazzuca MQ, 2012, J PHYSIOL-LONDON, V590, P3375, DOI 10.1113/jphysiol.2012.230011; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; Novak J, 2002, AM J PHYSIOL-REG I, V283, pR349, DOI 10.1152/ajpregu.00635.2001; Novak J, 2006, FASEB J, V20, P2352, DOI 10.1096/fj.06-6263com; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Sasser JM, 2011, HYPERTENSION, V58, P197, DOI 10.1161/HYPERTENSIONAHA.110.164392; SHERWOOD OD, 1980, ENDOCRINOLOGY, V107, P691, DOI 10.1210/endo-107-3-691; STLOUIS J, 1985, LIFE SCI, V37, P1351, DOI 10.1016/0024-3205(85)90251-6; Tare M, 2000, BRIT J PHARMACOL, V130, P605, DOI 10.1038/sj.bjp.0703332; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Tse GH, 2013, APPL IMMUNOHISTO M M, V21, P464, DOI 10.1097/PAI.0b013e31827ba0e1; van Drongelen J, 2012, J APPL PHYSIOL, V112, P962, DOI 10.1152/japplphysiol.00470.2011; Drongelen J, 2011, AM J PHYSIOL-HEART C, V300, pH1609, DOI 10.1152/ajpheart.00360.2010; Vodstrcil LA, 2012, FASEB J, V26, P4035, DOI 10.1096/fj.12-210567; Xu Q, 2010, HYPERTENSION, V55, P1260, DOI 10.1161/HYPERTENSIONAHA.109.149369; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	40	73	74	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					275	287		10.1096/fj.13-233429	http://dx.doi.org/10.1096/fj.13-233429			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24036884	Green Published			2022-12-25	WOS:000333526100027
J	Kasbek, C; Wang, F; Price, CM				Kasbek, Christopher; Wang, Feng; Price, Carolyn M.			Human TEN1 Maintains Telomere Integrity and Functions in Genome-wide Replication Restart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; DNA-binding Protein; DNA Replication; Genomic Instability; Telomerase; Telomeres; CST; CTC1; OBFC1; STN1	PROTECTS CHROMOSOME ENDS; LAGGING-STRAND SYNTHESIS; MAINTENANCE COMPONENT 1; DNA-POLYMERASE-ALPHA; HUMAN CST; LENGTH HOMEOSTASIS; DUPLEX REPLICATION; FILL-IN; COMPLEX; CDC13	Background: Although CTC1-STN1-TEN1 (CST) is considered a specialized replication factor, TEN1 is largely uncharacterized. Results: Like CTC1 and STN1, TEN1 is needed for telomere replication and genome-wide replication rescue; however, TEN1 depletion causes more severe phenotypes. Conclusion: TEN1 likely functions with CTC1 and STN1 in most contexts, but TEN1 may have additional roles. Significance: TEN1/CST help solve a diverse array of replication problems. TEN1 is a component of the mammalian CTC1-STN1-TEN1 complex. CTC1 and/or STN1 functions in telomere duplex replication, C-strand fill-in, and genome-wide restart of replication following fork stalling. Here we examine the role of human TEN1 and ask whether it also functions as a specialized replication factor. TEN1 depletion causes an increase in multitelomere fluorescent in situ hybridization (FISH) signals similar to that observed after CTC1 or STN1 depletion. However, TEN1 depletion also results in increased telomere loss. This loss is not accompanied by increased telomere deprotection, recombination, or T-circle release. Thus, it appears that both the multiple telomere signals and telomere loss stem from problems in telomere duplex replication. TEN1 depletion can also affect telomere length, but whether telomeres lengthen or shorten is cell line-dependent. Like CTC1 and STN1, TEN1 is needed for G-overhang processing. Depletion of TEN1 does not effect overhang elongation in mid-S phase, but it delays overhang shortening in late S/G(2). These results indicate a role for TEN1 in C-strand fill-in but do not support a direct role in telomerase regulation. Finally, TEN1 depletion causes a decrease in genome-wide replication restart following fork stalling similar to that observed after STN1 depletion. However, anaphase bridge formation is more severe than with CTC1 or STN1 depletion. Our findings indicate that TEN1 likely functions in conjunction with CTC1 and STN1 at the telomere and elsewhere in the genome. They also raise the possibility that TEN1 has additional roles and indicate that TEN1/CTC1-STN1-TEN1 helps solve a wide range of challenges to the replication machinery.	[Kasbek, Christopher; Wang, Feng; Price, Carolyn M.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Price, CM (corresponding author), Univ Cincinnati, Dept Canc Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	carolyn.price@uc.edu		Wang, Feng/0000-0001-7235-1676; PRICE, Carolyn/0000-0002-7865-2303	National Institutes of Health [GM041803, T32CA117846, F32CA177120]; NATIONAL CANCER INSTITUTE [T32CA117846, F32CA177120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041803, R01GM041803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM041803 (to C. M. P.) and T32CA117846 and F32CA177120 (to C. K).	Anderson BH, 2012, NAT GENET, V44, P338, DOI 10.1038/ng.1084; Bailey SM, 2010, METHODS MOL BIOL, V659, P173, DOI 10.1007/978-1-60761-789-1_12; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Bryan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066756; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; DeZwaan DC, 2009, NAT STRUCT MOL BIOL, V16, P711, DOI 10.1038/nsmb.1616; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Gelinas AD, 2009, P NATL ACAD SCI USA, V106, P19298, DOI 10.1073/pnas.0909203106; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gu P., 2013, AGING CELL, DOI 10.1111/acel.12139; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huang CH, 2012, CELL RES, V22, P1681, DOI 10.1038/cr.2012.132; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Keller RB, 2012, PEDIATR BLOOD CANCER, V59, P311, DOI 10.1002/pbc.24193; Leehy KA, 2013, PLANT CELL, V25, P1343, DOI 10.1105/tpc.112.107425; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Mitton-Fry RM, 2004, J MOL BIOL, V338, P241, DOI 10.1016/j.jmb.2004.01.063; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Oganesian L, 2013, DNA REPAIR, V12, P238, DOI 10.1016/j.dnarep.2012.12.008; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Polvi A, 2012, AM J HUM GENET, V90, P540, DOI 10.1016/j.ajhg.2012.02.002; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Qi HY, 2000, GENE DEV, V14, P1777; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tseng SF, 2009, NUCLEIC ACIDS RES, V37, P3602, DOI 10.1093/nar/gkp235; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Wang F, 2012, CELL REP, V2, P1096, DOI 10.1016/j.celrep.2012.10.007; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	55	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30139	30150		10.1074/jbc.M113.493478	http://dx.doi.org/10.1074/jbc.M113.493478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025336	hybrid, Green Published			2022-12-25	WOS:000329868100014
J	de Jong, BG; Lammers, A; Oberendorf, LAA; Nieuwland, MGB; Savelkoul, HFJ; Parmentier, HK				de Jong, Britt G.; Lammers, Aart; Oberendorf, Leonora A. A.; Nieuwland, Mike G. B.; Savelkoul, Huub F. J.; Parmentier, Henk K.			Genetic and Phenotypic Selection Affect Natural (Auto-) Antibody Reactivity of Chickens	PLOS ONE			English	Article							IMMUNOLOGICAL HOMUNCULUS; AUTOANTIBODY REPERTOIRE; SERUM IGM; SPECIFICITIES; STABILITY; ANTIGENS; SURVIVAL; ISOTYPES; INNATE; MICE	Specificity, antibody isotype distribution and levels of natural antibodies (NAb) may be potential informative parameters for immune mediated natural disease resistance, immune modulation, and maintenance of physiological homeostasis. A large proportion of mammalian NAb have affinity for or are directed against self-antigens; so called natural auto antibodies (N(A)Ab). In the present study we showed the presence and typed levels and isotypes (total immunoglobulins, IgG and IgM) of N(A) Ab in plasma binding the 'auto-antigen' complex chicken liver cell lysate (CLL) of one-year old chickens from different genotype and phenotype backgrounds by ELISA and quantitative Western blotting. Higher levels of N(A) Ab binding CLL were found in plasma from chickens genetically selected for high specific antibody responses. In all birds, extensive staining patterns of plasma antibodies binding CLL were found for all isotypes, with IgG binding the highest number of CLL antigens and also showing the highest variation in staining patterns between individuals. Patterns of IgM antibodies binding CLL appeared to be more similar in all lines. Significant differences of binding patterns of N(A) Ab (antigen fragments of CLL and staining intensity) were detected between the different chicken lines, and lines could be clustered on the basis of their autoantibody profile. In addition, also individual differences within lines were found. The present results indicate that analysis of the levels and the N(A)Ab repertoire of poultry like in mammals could provide a new way of distinguishing differences of immune competence and immune maturation between individuals, and could provide tools to select birds for health traits, or optimize hygiene and husbandry procedures.	[de Jong, Britt G.; Lammers, Aart; Oberendorf, Leonora A. A.; Nieuwland, Mike G. B.; Parmentier, Henk K.] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Oberendorf, Leonora A. A.; Savelkoul, Huub F. J.] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Parmentier, HK (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	Henk.Parmentier@WUR.nl	Savelkoul, Huub FJ/F-6026-2012					AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; BENYEHUDA A, 1992, CANCER INVEST, V10, P525, DOI 10.3109/07357909209024815; Berghof TVL, 2010, POULTRY SCI, V89, P227, DOI 10.3382/ps.2009-00449; Bergstra TJ, 2010, DEV COMP IMMUNOL, V34, P821, DOI 10.1016/j.dci.2010.03.002; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; FRANCOEUR AM, 1988, BIO-TECHNOL, V6, P822, DOI 10.1038/nbt0788-822; Frasca D, 2004, CRIT REV IMMUNOL, V24, P297, DOI 10.1615/CritRevImmunol.v24.i5.10; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Hodes RJ, 1997, IMMUNOL REV, V160, P5, DOI 10.1111/j.1600-065X.1997.tb01022.x; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Kachamakova NM, 2006, FISH SHELLFISH IMMUN, V21, P404, DOI 10.1016/j.fsi.2006.01.005; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Lacroix-Desmazes S, 1999, J CLIN IMMUNOL, V19, P26, DOI 10.1023/A:1020510401233; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; Leps J, 2003, MULTIVARIATE ANAL EC; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Madi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017445; Madi A, 2009, P NATL ACAD SCI USA, V106, P14484, DOI 10.1073/pnas.0901528106; Mouthon L, 1996, SCAND J IMMUNOL, V44, P243, DOI 10.1046/j.1365-3083.1996.d01-306.x; MOUTHON L, 1995, J IMMUNOL, V154, P5769; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; NOBREGA A, 1993, EUR J IMMUNOL, V23, P2851, DOI 10.1002/eji.1830231119; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Ploegaert TCW, 2010, J DAIRY SCI, V93, P5467, DOI 10.3168/jds.2010-3264; Poletaev A, 2003, AUTOIMMUN REV, V2, P264, DOI 10.1016/S1568-9972(03)00033-8; Quintana FJ, 2004, BIOMED PHARMACOTHER, V58, P276, DOI 10.1016/j.biopha.2004.04.011; RADL J, 1975, CLIN EXP IMMUNOL, V22, P84; SAS Institute, 1990, SASR US GUID STAT VE; Stahl D, 2000, J IMMUNOL METHODS, V240, P1, DOI 10.1016/S0022-1759(00)00185-X; Star L, 2007, POULTRY SCI, V86, P1090, DOI 10.1093/ps/86.6.1090; Sun Y, 2011, POULTRY SCI, V90, P2263, DOI 10.3382/ps.2011-01613; Weksler ME, 2000, VACCINE, V18, P1624, DOI 10.1016/S0264-410X(99)00497-1	36	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72276	10.1371/journal.pone.0072276	http://dx.doi.org/10.1371/journal.pone.0072276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039748	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500011
J	Hjalten, J; Axelsson, EP; Julkunen-Tiitto, R; Wennstrom, A; Pilate, G				Hjalten, Joakim; Axelsson, E. Petter; Julkunen-Tiitto, Riitta; Wennstrom, Anders; Pilate, Gilles			Innate and Introduced Resistance Traits in Genetically Modified Aspen Trees and Their Effect on Leaf Beetle Feeding	PLOS ONE			English	Article							PLANT-HERBIVORE INTERACTIONS; CRY1A(A) D-ENDOTOXIN; BACILLUS-THURINGIENSIS; INSECT HERBIVORES; HYBRID POPLAR; PHENOLIC GLYCOSIDES; CHRYSOMELA-TREMULAE; PHRATORA-VITELLINAE; TRANSGENIC ASPEN; BIRCH BETULA	Genetic modifications of trees may provide many benefits, e. g. increase production, and mitigate climate change and herbivore impacts on forests. However, genetic modifications sometimes result in unintended effects on innate traits involved in plant-herbivore interactions. The importance of intentional changes in plant defence relative to unintentional changes and the natural variation among clones used in forestry has not been evaluated. By a combination of biochemical measurements and bioassays we investigated if insect feeding on GM aspens is more affected by intentional (induction Bt toxins) than of unintentional, non-target changes or clonal differences in innate plant defence. We used two hybrid wildtype clones (Populus tremula x P. tremuloides and Populus tremula x P. alba) of aspen that have been genetically modified for 1) insect resistance (two Bt lines) or 2) reduced lignin properties (two lines COMT and CAD), respectively. Our measurements of biochemical properties suggest that unintended changes by GM modifications (occurring due to events in the transformation process) in innate plant defence (phenolic compounds) were generally smaller but fundamentally different than differences seen among different wildtype clones (e. g. quantitative and qualitative, respectively). However, neither clonal differences between the two wildtype clones nor unintended changes in phytochemistry influenced consumption by the leaf beetle (Phratora vitellinae). By contrast, Bt induction had a strong direct intended effect as well as a post experiment effect on leaf beetle consumption. The latter suggested lasting reduction of beetle fitness following Bt exposure that is likely due to intestinal damage suffered by the initial Bt exposure. We conclude that Bt induction clearly have intended effects on a target species. Furthermore, the effect of unintended changes in innate plant defence traits, when they occur, are context dependent and have in comparison to Bt induction probably less pronounced effect on targeted herbivores.	[Hjalten, Joakim; Axelsson, E. Petter] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Julkunen-Tiitto, Riitta] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Wennstrom, Anders] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Pilate, Gilles] INRA, Ameliorat Genet & Physiol Forestieres UR0588, Orleans, France	Swedish University of Agricultural Sciences; University of Eastern Finland; Umea University; INRAE	Hjalten, J (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	joakim.hjalten@slu.se	Julkunen-Tiitto, Riitta/GRR-9781-2022; Pilate, Gilles/E-8784-2017	Pilate, Gilles/0000-0003-4802-8849; Hjalten, Joakim/0000-0002-8279-6633	Swedish research council Formas [209-2006-1279]	Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was financed by the Swedish research council Formas (grant # 209-2006-1279 to J. Hjalten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrectsen BR, 2004, OIKOS, V105, P268, DOI 10.1111/j.0030-1299.2004.12892.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aronson AI, 2001, FEMS MICROBIOL LETT, V195, P1, DOI 10.1111/j.1574-6968.2001.tb10489.x; AUGUSTIN S, 1993, J APPL ENTOMOL, V116, P39, DOI 10.1111/j.1439-0418.1993.tb01166.x; Axelsson EP, 2012, FOREST ECOL MANAG, V276, P217, DOI 10.1016/j.foreco.2012.04.012; Axelsson EP, 2012, FOREST ECOL MANAG, V264, P167, DOI 10.1016/j.foreco.2011.10.006; Axelsson EP, 2011, CHEMOECOLOGY, V21, P161, DOI 10.1007/s00049-011-0080-8; Axelsson EP, 2010, ECOSYSTEMS, V13, P1049, DOI 10.1007/s10021-010-9373-y; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; BINGAMAN BR, 1992, ENVIRON ENTOMOL, V21, P508, DOI 10.1093/ee/21.3.508; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Brodeur-Campbell SE, 2006, ENVIRON ENTOMOL, V35, P1696, DOI 10.1603/0046-225X(2006)35[1696:IHOLTA]2.0.CO;2; Caseys C, 2012, PLANT ECOL DIVERS, V5, P457, DOI 10.1080/17550874.2012.748850; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; CHELIAK WM, 1990, CAN J FOREST RES, V20, P452, DOI 10.1139/x90-062; Clarke K., 2001, PRIMER V5 USER MANUA; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; Coleman HD, 2012, PLANT BIOTECHNOL J, V10, P883, DOI 10.1111/j.1467-7652.2012.00714.x; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Donaldson JR, 2004, ENVIRON ENTOMOL, V33, P1505, DOI 10.1603/0046-225X-33.5.1505; *FAO, 2004, FGR59E FAO FOR RES D; Fenning TM, 2008, NAT BIOTECHNOL, V26, P615, DOI 10.1038/nbt0608-615; Genissel A, 2003, MOL BREEDING, V11, P103, DOI 10.1023/A:1022453220496; Gruppe A, 1999, FOREST ECOL MANAG, V121, P113, DOI 10.1016/S0378-1127(98)00560-X; Hallgren P, 2003, BMC ECOLOGY, V3, p8p; Hjalten J., 2012, PLOS ONE, V7; Hjalten J, 2007, BASIC APPL ECOL, V8, P434, DOI 10.1016/j.baae.2006.09.001; Hu JJ, 2001, EUPHYTICA, V121, P123, DOI 10.1023/A:1012015709363; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Hussein HM, 2005, PEST MANAG SCI, V61, P1186, DOI 10.1002/ps.1112; Julkunen-Tiitto R, 2001, J CHEM ECOL, V27, P779, DOI 10.1023/A:1010358120482; Kaldorf M, 2002, PLANTA, V214, P653, DOI 10.1007/s004250100658; Kleiner KW, 2003, J CHEM ECOL, V29, P2585, DOI 10.1023/A:1026370220613; Kleiner KW, 1998, CAN J FOREST RES, V28, P1055, DOI 10.1139/cjfr-28-7-1055; KOLEHMAINEN J, 1995, ENTOMOL EXP APPL, V74, P235, DOI 10.1007/BF02381787; PALO RT, 1984, J CHEM ECOL, V10, P499, DOI 10.1007/BF00988096; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; Post KH, 2011, ENVIRON ENTOMOL, V40, P955, DOI 10.1603/EN10063; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Ramirez CC, 2004, J ECON ENTOMOL, V97, P1965, DOI 10.1603/0022-0493-97.6.1965; Rank NE, 1998, ECOLOGY, V79, P618, DOI 10.1890/0012-9658(1998)079[0618:HPALPO]2.0.CO;2; ROWELLRAHIER M, 1984, OECOLOGIA, V64, P375, DOI 10.1007/BF00379136; Ruuhola TM, 2001, ANN BOT-LONDON, V88, P483, DOI 10.1006/anbo.2001.1491; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Smeets EMW, 2007, CLIMATIC CHANGE, V81, P353, DOI 10.1007/s10584-006-9163-x; TAHVANAINEN J, 1985, OECOLOGIA, V67, P52, DOI 10.1007/BF00378451; Tiimonen H, 2005, PLANTA, V222, P699, DOI 10.1007/s00425-005-0002-5; Veteli TO, 2003, OECOLOGIA, V137, P312, DOI 10.1007/s00442-003-1298-0; Veteli TO, 2002, GLOBAL CHANGE BIOL, V8, P1240, DOI 10.1046/j.1365-2486.2002.00553.x; Waterman P.G., 1994, OXF BLACKWELL SCI PU, V8, P73; Westbrook JW, 2011, AM NAT, V177, P800, DOI 10.1086/659963	54	6	6	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73819	10.1371/journal.pone.0073819	http://dx.doi.org/10.1371/journal.pone.0073819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040084	Green Published, gold			2022-12-25	WOS:000327538600047
J	Al-Darraji, HAA; Abd Razak, H; Ng, KP; Altice, FL; Kamarulzaman, A				Al-Darraji, Haider Abdulrazzaq Abed; Abd Razak, Humaira; Ng, Kee Peng; Altice, Frederick L.; Kamarulzaman, Adeeba			The Diagnostic Performance of a Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding Survey among HIV-Infected Prisoners in Malaysia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; XPERT MTB/RIF; MYCOBACTERIUM-TUBERCULOSIS; SUBCLINICAL TUBERCULOSIS; UNDIAGNOSED TUBERCULOSIS; ANTIRETROVIRAL THERAPY; PREVALENCE; TB; IMPACT; COMMUNITY	Background: Delays in tuberculosis (TB) diagnosis, particularly in prisons, is associated with detrimental outcomes. The new GeneXpert MTB/RIF assay (Xpert) offers accurate and rapid diagnosis of active TB, but its performance in improving case detection in high-transmission congregate settings has yet to be evaluated. We assessed the diagnostic accuracy of a single Xpert assay in an intensified case finding survey among HIV infected prisoners in Malaysia. Methods: HIV-infected prisoners at a single site provided two early-morning sputum specimens to be examined using fluorescence smear microscopy, BACTEC MGIT 960 liquid culture and a single Xpert. The sensitivity, specificity, negative and positive predictive values of Xpert were calculated relative to gold-standard results using MGIT 960 liquid culture. Relevant clinical and demographic data were used to examine correlates of active TB disease. Results: The majority of enrolled subjects with complete data (N=125) were men (90.4%), age <40 years (61.6%) and had injected drugs (75.2%). Median CD4 lymphocyte count was 337 cells/ae L (IQR 149-492); only 19 (15.2%) were receiving antiretroviral therapy. Of 15 culture-positive TB cases, single Xpert assay accurately detected only eight previously undiagnosed TB cases, resulting in a sensitivity, specificity, positive predictive value and negative predictive value of 53.3% (95% CI 30.12-75.2%), 100% (95% CI 96.6-100%), 100% (95% CI 67.56-100%) and 94.0% (95% CI 88.2-97.1%), respectively. Only 1 of 15 (6.7%) active TB cases was smear-positive. The prevalence (12%) of undiagnosed active pulmonary TB (15 of 125 prisoners) was high and associated with longer duration of drug use (AOR 1.14, 95% CI 1.03-1.26, for each year of drug use). Conclusions: Single Xpert assay improved TB case detection and outperformed AFB smear microscopy, but yielded low screening sensitivity. Further examination of the impact of HIV infection on the diagnostic performance of the new assay alongside other screening methods in correctional settings is warranted.	[Al-Darraji, Haider Abdulrazzaq Abed; Abd Razak, Humaira; Altice, Frederick L.; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia; [Ng, Kee Peng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Altice, Frederick L.; Kamarulzaman, Adeeba] Yale Univ, Sch Med, Dept Internal Med, AIDS Program, New Haven, CT 06510 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA	Universiti Malaya; Universiti Malaya; Yale University; Yale University	Al-Darraji, HAA (corresponding author), Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia.	hdarraji@gmail.com	KAMARULZAMAN, ADEEBA/B-5216-2010; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012	Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Altice, Frederick/0000-0002-7860-693X	University of Malaya [HIRGA E000001-20001]; National Institutes on Drug Abuse for Research [R01 DA025943, K24 DA017072]; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA029910, R01DA025943] Funding Source: NIH RePORTER	University of Malaya(Universiti Malaya); National Institutes on Drug Abuse for Research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by the University of Malaya High Impact Research Grant (HIRGA E000001-20001 for HAAA and AK) and from the National Institutes on Drug Abuse for Research (R01 DA025943 for FLA) and career development (K24 DA017072 for FLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Darraji HAA, 2012, INT J TUBERC LUNG D, V16, P871, DOI 10.5588/ijtld.11.0447; Alvarez-Uria Gerardo, 2012, Tuberc Res Treat, V2012, P932862, DOI 10.1155/2012/932862; [Anonymous], 1901, PRISONS RULES LOCAL, P4; [Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; [Anonymous], 2011, GUID INT TUB CAS FIN; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Carriquiry G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044626; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Choi P, 2010, INT J STD AIDS, V21, P416, DOI 10.1258/ijsa.2009.009180; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Nguyen DTM, 2011, INT J TUBERC LUNG D, V15, P1528, DOI 10.5588/ijtld.10.0777; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; de la Hoz KF, 2001, INT J TUBERC LUNG D, V5, P696; Dean A, 2011, OPENEPI OPEN SOURCE; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Demers AM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-218; Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004; Fu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044249; Getahun H, 2012, CURR OPIN HIV AIDS, V7, P345, DOI 10.1097/COH.0b013e328354bd44; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gupta RK, 2013, INT J TUBERC LUNG D, V17, P1014, DOI 10.5588/ijtld.13.0032; Ijaz K, 2004, INT J TUBERC LUNG D, V8, P994; Iyawoo K, 2004, TUBERCULOSIS, V84, P4, DOI 10.1016/j.tube.2003.08.014; Jittimanee SX, 2007, INT J TUBERC LUNG D, V11, P556; Kirwan DE, 2012, AM J TROP MED HYG, V87, P197, DOI 10.4269/ajtmh.2012.12-0107; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Laserson KF, 2007, B WORLD HEALTH ORGAN, V85, P377, DOI 10.2471/BLT.06.035329; Lawn SD, 2012, AIDS, V26, P2121, DOI 10.1097/QAD.0b013e3283565dd1; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Margolis B, 2013, INT J TUBER IN PRESS; Maxmen A, 2013, NAT MED, V19, P115, DOI 10.1038/nm0213-115; Melchers NVSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053644; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; Noeske J, 2011, INT J TUBERC LUNG D, V15, P223; Ntinginya EN, 2012, INT J TUBERC LUNG D, V16, P1468, DOI 10.5588/ijtld.12.0127; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Portugal I, 1999, INT J TUBERC LUNG D, V3, P207; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Reid SE, 2012, J INFECT DIS, V205, pS265, DOI 10.1093/infdis/jis029; Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633; Saunders DL, 2001, PUBLIC HEALTH REP, V116, P210, DOI 10.1016/S0033-3549(04)50036-5; Schnippel K, 2013, SAMJ S AFR MED J, V103, P101, DOI [10.7196/SAMJ.6182, 10.7196/samj.6182]; Sosa LE, 2008, INT J TUBERC LUNG D, V12, P689; STEAD WW, 1978, JAMA-J AM MED ASSOC, V240, P2544, DOI 10.1001/jama.240.23.2544; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; SURUHANJAYA HAK ASASI MANUSIA MALAYSIA, 2008, STAT PRIS IMM DET CE; Swaminathan S, 2010, CLIN INFECT DIS, V50, P1377, DOI 10.1086/652147; Sylla L, 2007, INT J DRUG POLICY, V18, P306, DOI 10.1016/j.drugpo.2007.03.001; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Walmsley R, 2011, WORLD PRISON POPULAT; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Winetsky DE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001348; Wong K, 2012, 43 UN WORLD C LUNG H; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2008, POL GUID COLL TB HIV; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	74	48	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73717	10.1371/journal.pone.0073717	http://dx.doi.org/10.1371/journal.pone.0073717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040038	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300115
J	Gravez, B; Tarjus, A; Jimenez-Canino, R; El Moghrabi, S; Messaoudi, S; de la Rosa, DA; Jaisser, F				Gravez, Basile; Tarjus, Antoine; Jimenez-Canino, Ruben; El Moghrabi, Soumaya; Messaoudi, Smail; Alvarez de la Rosa, Diego; Jaisser, Frederic			The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; TUMOR VIRUS PROMOTER; MYOCARDIAL FIBROSIS; LOOP DIURETICS; SPIRONOLACTONE; PROTEINS; CELLS; IDENTIFICATION; INFLAMMATION; ANTAGONISTS	Aldosterone binds to the mineralocorticoid receptor (MR) and exerts pleiotropic effects beyond enhancing renal sodium reabsorption. Excessive mineralocorticoid signaling is deleterious during the evolution of cardiac failure, as evidenced by the benefits provided by adding MR antagonists (MRA) to standard care in humans. In animal models of cardiovascular diseases, MRA reduce cardiac fibrosis. Interestingly diuretics such as torasemide also appear efficient to improve cardiovascular morbidity and mortality, through several mechanisms. Among them, it has been suggested that torasemide could block aldosterone binding to the MR. To evaluate whether torasemide acts as a MRA in cardiomyocytes, we compared its effects with a classic MRA such as spironolactone. We monitored ligand-induced nuclear translocation of MR-GFP and MR transactivation activity in the cardiac-like cell line H9C2 using a reporter gene assay and known endogenous aldosterone-regulated cardiac genes. Torasemide did not modify MR nuclear translocation. Aldosterone-induced MR transactivation activity was reduced by the MRA spironolactone, not by torasemide. Spironolactone blocked the induction by aldosterone of endogenous MR-responsive genes (Sgk-1, PAI-1, Orosomucoid-1, Rgs-2, Serpina-3, Tenascin-X), while torasemide was ineffective. These results show that torasemide is not an MR antagonist; its association with MRA in heart failure may however be beneficial, through actions on complementary pathways.	[Gravez, Basile; Tarjus, Antoine; El Moghrabi, Soumaya; Messaoudi, Smail; Jaisser, Frederic] Univ Paris 06, INSERM, U872, Team 1,Ctr Rech Cordeliers, Paris, France; [Jimenez-Canino, Ruben; Alvarez de la Rosa, Diego] Univ La Laguna, Dept Physiol, Tenerife, Spain; [Jimenez-Canino, Ruben; Alvarez de la Rosa, Diego] Univ La Laguna, Inst Biomed Technol, Tenerife, Spain; [Jaisser, Frederic] Ctr Hosp Univ Brabois, Ctr Invest Clin, Inst Lorrain Coeur & Vaisseaux, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universidad de la Laguna; Universidad de la Laguna; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jaisser, F (corresponding author), Univ Paris 06, INSERM, U872, Team 1,Ctr Rech Cordeliers, Paris, France.	frederic.jaisser@inserm.fr	Jaisser, Frederic/P-4287-2017; Alvarez de la Rosa, Diego/H-8500-2015	Jaisser, Frederic/0000-0001-9051-1901; Alvarez de la Rosa, Diego/0000-0002-4324-2793; Tarjus, Antoine/0000-0002-9867-4585	INSERM (Institut National pour la Sante et Recherche Medicale), a CEVA company; Centre de Recherche Industrielle et Technique; Ministerio de Economia y Competitividad (Spain) [BFU2010-16265]; French Ministry of Research; Cajacanarias (Spain)	INSERM (Institut National pour la Sante et Recherche Medicale), a CEVA company; Centre de Recherche Industrielle et Technique; Ministerio de Economia y Competitividad (Spain); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Cajacanarias (Spain)	This work was supported by grants from INSERM (Institut National pour la Sante et Recherche Medicale), a CEVA company research grant, the "Centre de Recherche Industrielle et Technique" and the Ministerio de Economia y Competitividad (Spain), grant BFU2010-16265 to D.A.R. B.G. and A.T. were recipients of PhD grant from the French Ministry of Research. R.J.-C. is supported by a predoctoral fellowship from Cajacanarias (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Sanchez C, 2012, ENDOCRINOLOGY, V153, P3517, DOI 10.1210/en.2012-1210; Butler J, 2012, J CARD FAIL, V18, P265, DOI 10.1016/j.cardfail.2012.02.005; Cosin J, 2002, EUR J HEART FAIL, V4, P507, DOI 10.1016/S1388-9842(02)00122-8; COUETTE B, 1992, ENDOCRINOLOGY, V130, P430, DOI 10.1210/en.130.1.430; Engstrom G, 2009, ATHEROSCLEROSIS, V202, P617, DOI 10.1016/j.atherosclerosis.2008.05.038; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Fejes-Toth G, 2007, ENDOCRINOLOGY, V148, P1502, DOI 10.1210/en.2006-1438; Fortuno A, 1999, HYPERTENSION, V34, P138, DOI 10.1161/01.HYP.34.1.138; Goodfriend TL, 1998, LIFE SCI, V63, pPL45, DOI 10.1016/S0024-3205(98)00265-3; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; Hori Y, 2007, AM J VET RES, V68, P1058, DOI 10.2460/ajvr.68.10.1058; Latouche C, 2010, ENDOCRINOLOGY, V151, P4467, DOI 10.1210/en.2010-0237; Lijnen HR, 2005, J THROMB HAEMOST, V3, P35, DOI 10.1111/j.1538-7836.2004.00827.x; Lopez B, 2004, J AM COLL CARDIOL, V43, P2028, DOI 10.1016/j.jacc.2003.12.052; Lopez B, 2007, J AM COLL CARDIOL, V50, P859, DOI 10.1016/j.jacc.2007.04.080; Lopez B, 2009, HYPERTENSION, V53, P236, DOI 10.1161/HYPERTENSIONAHA.108.125278; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Massaad C, 1997, MOL PHARMACOL, V51, P285, DOI 10.1124/mol.51.2.285; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; Muniz P, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.suppl_1.14; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Ouvrard-Pascaud A, 2004, AM J PHYSIOL-RENAL, V286, pF180, DOI 10.1152/ajprenal.00301.2002; Oyama Mark A, 2011, J Vet Cardiol, V13, P287, DOI 10.1016/j.jvc.2011.10.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Rogerson FM, 2003, J MOL ENDOCRINOL, V31, P573, DOI 10.1677/jme.0.0310573; Satoh M, 2002, CLIN SCI, V102, P381, DOI 10.1042/CS20010219; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Stier CT, 2009, HYPERTENSION, V54, P1211, DOI 10.1161/HYPERTENSIONAHA.109.140384; Taylor J, 2012, EUR HEART J, V33, P1703, DOI 10.1093/eurheartj/ehs138; Tsutamoto T, 2004, J AM COLL CARDIOL, V44, P2252, DOI 10.1016/j.jacc.2004.09.009; UCHIDA T, 1992, PROSTAG LEUKOTR ESS, V45, P121, DOI 10.1016/0952-3278(92)90227-A; UCHIDA T, 1991, EUR J PHARMACOL, V205, P145, DOI 10.1016/0014-2999(91)90812-5; Uechi M, 2003, J VET MED SCI, V65, P1057, DOI 10.1292/jvms.65.1057; Yamato M, 2003, CIRC J, V67, P384; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	42	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73737	10.1371/journal.pone.0073737	http://dx.doi.org/10.1371/journal.pone.0073737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040049	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300122
J	Strandberg, LS; Cui, XZ; Rath, A; Liu, J; Silverman, ED; Liu, XR; Siragam, V; Ackerley, C; Bin Su, B; Yan, JY; Capecchi, M; Biavati, L; Accorroni, A; Yuen, W; Quattrone, F; Lung, K; Jaeggi, ET; Backx, PH; Deber, CM; Hamilton, RM				Strandberg, Linn S.; Cui, Xuezhi; Rath, Arianna; Liu, Jie; Silverman, Earl D.; Liu, Xiaoru; Siragam, Vinayakumar; Ackerley, Cameron; Bin Su, Brenda; Yan, Jane Yuqing; Capecchi, Marco; Biavati, Luca; Accorroni, Alice; Yuen, William; Quattrone, Filippo; Lung, Kalvin; Jaeggi, Edgar T.; Backx, Peter H.; Deber, Charles M.; Hamilton, Robert M.			Congenital Heart Block Maternal Sera Autoantibodies Target an Extracellular Epitope on the alpha(1G) T-Type Calcium Channel in Human Fetal Hearts	PLOS ONE			English	Article							COMPLETE ATRIOVENTRICULAR-BLOCK; ANTI-RO/SSA ANTIBODIES; AMINO-ACID 200-239; CARDIAC L-TYPE; NEONATAL LUPUS; SINUS BRADYCARDIA; CA2+ CHANNEL; SINOATRIAL NODE; CHILDREN; MOTHERS	Background: Congenital heart block (CHB) is a transplacentally acquired autoimmune disease associated with anti-Ro/ SSA anti-La/SSB maternal autoantibodies and is characterized primarily by atrioventricular (AV) block of the fetal heart. This study aims to investigate whether the T-type calcium channel subunit alpha(1G) may be a fetal target of maternal sera autoantibodies in CHB. Methodology/Principal Findings: We demonstrate differential mRNA expression of the T-type calcium channel CACNA1G (alpha(1G) gene) in the AV junction of human fetal hearts compared to the apex (18-22.6 weeks gestation). Using human fetal hearts (20-22 wks gestation), our immunoprecipitation (IP), Western blot analysis and immunofluorescence (IF) staining results, taken together, demonstrate accessibility of the alpha(1G) epitope on the surfaces of cardiomyocytes as well as reactivity of maternal serum from CHB affected pregnancies to the alpha(1G) protein. By ELISA we demonstrated maternal sera reactivity to alpha(1G) was significantly higher in CHB maternal sera compared to controls, and reactivity was epitope mapped to a peptide designated as p305 (corresponding to aa305-319 of the extracellular loop linking transmembrane segments S5-S6 in alpha(1G) repeat 1). Maternal sera from CHB affected pregnancies also reacted more weakly to the homologous region (7/15 amino acids conserved) of the alpha(1H) channel. Electrophysiology experiments with single-cell patch-clamp also demonstrated effects of CHB maternal sera on T-type current in mouse sinoatrial node (SAN) cells. Conclusions/Significance: Taken together, these results indicate that CHB maternal sera antibodies readily target an extracellular epitope of alpha(1G) T-type calcium channels in human fetal cardiomyocytes. CHB maternal sera also show reactivity for alpha(1H) suggesting that autoantibodies can target multiple fetal targets.	[Strandberg, Linn S.; Cui, Xuezhi; Silverman, Earl D.; Liu, Xiaoru; Siragam, Vinayakumar; Ackerley, Cameron; Bin Su, Brenda; Yan, Jane Yuqing; Yuen, William; Lung, Kalvin; Jaeggi, Edgar T.; Hamilton, Robert M.] Hosp Sick Children, Dept Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Rath, Arianna; Deber, Charles M.] Hosp Sick Children, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Liu, Jie; Backx, Peter H.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Liu, Jie; Backx, Peter H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Capecchi, Marco; Biavati, Luca; Accorroni, Alice; Quattrone, Filippo] Scuola Super Sant Anna, Pisa, Italy; [Backx, Peter H.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Scuola Superiore Sant'Anna; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Hamilton, RM (corresponding author), Hosp Sick Children, Dept Physiol & Expt Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Robert.hamilton@sickkids.ca	Quattrone, Filippo/AAX-1650-2021; Capecchi, Marco/AAC-5206-2022	Quattrone, Filippo/0000-0002-7721-9559; Capecchi, Marco/0000-0002-9223-145X	CIHR [225107, 160797]; Swedish Research Council; Gina M. Finzi Memorial Student Summer Fellowship from the Lupus Foundation of America, Inc; Canadian Institutes of Health Research [CIHR FRN-5810]; Hospital for Sick Children Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gina M. Finzi Memorial Student Summer Fellowship from the Lupus Foundation of America, Inc; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children Foundation	This work was supported by CIHR Operating Grant 225107 and 160797 to RM Hamilton. Portions of the work were performed by a postdoctoral fellow, supported by the Swedish Research Council. Additionally, this research was supported by a Gina M. Finzi Memorial Student Summer Fellowship to William Yuen from the Lupus Foundation of America, Inc. This work was also supported, in part, by a grant to CM Deber from the Canadian Institutes of Health Research (CIHR FRN-5810), and by a generous donation from the Caitlin Morris Memorial Fund of the Hospital for Sick Children Foundation to RM Hamilton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi A, 2012, ANN RHEUM DIS, V71, P448, DOI 10.1136/annrheumdis-2011-200414; Boutjdir M, 1997, CIRC RES, V80, P354, DOI 10.1161/01.RES.80.3.354; Brucato A, 2000, CIRCULATION, V102, pE88, DOI 10.1161/01.CIR.102.11.e88; BRUCATO A, 1995, J RHEUMATOL, V22, P533; Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C; BRUCATO A, 1995, J RHEUMATOL, V22, P541; Buyon JP, 1998, J AM COLL CARDIOL, V31, P1658, DOI 10.1016/S0735-1097(98)00161-2; BUYON JP, 1993, LUPUS, V2, P291, DOI 10.1177/096120339300200503; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chockalingam P, 2011, J RHEUMATOL, V38, P2682, DOI 10.3899/jrheum.110720; Clancy RM, 2004, ARTHRITIS RHEUM, V50, P173, DOI 10.1002/art.11430; Cribbs LL, 2001, CIRC RES, V88, P403; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; DORNER T, 1995, J AUTOIMMUN, V8, P675, DOI 10.1006/jaut.1995.0050; Eftekhari P, 2001, EUR J IMMUNOL, V31, P573, DOI 10.1002/1521-4141(200102)31:2<573::AID-IMMU573>3.0.CO;2-9; Eftekhari P, 2000, EUR J IMMUNOL, V30, P2782, DOI 10.1002/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9; Eronen M, 2001, PEDIATR CARDIOL, V22, P385, DOI 10.1007/s002460010256; Eronen M, 2000, PEDIATRICS, V106, P86, DOI 10.1542/peds.106.1.86; Finkelstein Y, 1997, ANN MED INTERNE, V148, P205; Friedman Deborah M, 2007, Curr Rheumatol Rep, V9, P101, DOI 10.1007/s11926-007-0003-4; Greener ID, 2011, J MOL CELL CARDIOL, V50, P642, DOI 10.1016/j.yjmcc.2010.12.017; Groves AMM, 1996, HEART, V75, P190, DOI 10.1136/hrt.75.2.190; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hamilton RM, 1997, J ELECTROCARDIOL, V30, P69; HANCOX JC, 1993, AM J PHYSIOL, V265, pH755, DOI 10.1152/ajpheart.1993.265.2.H755; HO SY, 1986, AM J CARDIOL, V58, P291, DOI 10.1016/0002-9149(86)90064-0; Hu KL, 2004, CIRC RES, V94, pE32, DOI 10.1161/01.RES.0000121566.01778.06; Jaeggi E, 2010, J AM COLL CARDIOL, V55, P2778, DOI 10.1016/j.jacc.2010.02.042; Jaeggi ET, 2009, CIRCULATION, V119, pE539, DOI 10.1161/CIRCULATIONAHA.108.830877; Jaeggi ET, 2005, ULTRASOUND OBST GYN, V26, P16, DOI 10.1002/uog.1919; Jaeggi ET, 2002, J AM COLL CARDIOL, V39, P130, DOI 10.1016/S0735-1097(01)01697-7; JULKUNEN H, 1993, ARTHRITIS RHEUM-US, V36, P1588, DOI 10.1002/art.1780361114; Julkunen H, 1998, SEMIN ARTHRITIS RHEU, V28, P97, DOI 10.1016/S0049-0172(98)80042-5; Karmazinova M, 2010, PFLUG ARCH EUR J PHY, V460, P1015, DOI 10.1007/s00424-010-0874-5; Karnabi E, 2011, J CARDIOVASC ELECTR, V22, P922, DOI 10.1111/j.1540-8167.2011.02032.x; Karnabi E, 2010, J AUTOIMMUN, V34, P80, DOI 10.1016/j.jaut.2009.06.005; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Lazzerini PE, 2011, ARTHRITIS CARE RES H; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; LITSEY SE, 1985, NEW ENGL J MED, V312, P98, DOI 10.1056/NEJM198501103120206; Lopes LM, 2008, CIRCULATION, V118, P1268, DOI 10.1161/CIRCULATIONAHA.107.735118; MACHADO MV, 1988, BRIT HEART J, V60, P512; Mangoni ME, 2006, PROG BIOPHYS MOL BIO, V90, P38, DOI 10.1016/j.pbiomolbio.2005.05.003; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Masumiya H, 1999, RES COMMUN MOL PATH, V104, P321; Mazel JA, 1999, CIRCULATION, V99, P1914, DOI 10.1161/01.CIR.99.14.1914; MCCUE CM, 1977, CIRCULATION, V56, P82, DOI 10.1161/01.CIR.56.1.82; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Menon A, 1998, AM J CARDIOL, V82, P1119, DOI 10.1016/S0002-9149(98)00569-4; MISHRA SK, 1994, CIRC RES, V75, P144, DOI 10.1161/01.RES.75.1.144; Mizuta E, 2010, BIOMED RES-TOKYO, V31, P301, DOI 10.2220/biomedres.31.301; Monteil A, 2000, J BIOL CHEM, V275, P6090, DOI 10.1074/jbc.275.9.6090; Nield LE, 2002, J AM COLL CARDIOL, V40, P796, DOI 10.1016/S0735-1097(02)02004-1; Nield LE, 2002, CIRCULATION, V105, P843, DOI 10.1161/hc0702.104182; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Qu YX, 2005, CIRCULATION, V111, P3034, DOI 10.1161/CIRCULATIONAHA.104.517326; Qu YX, 2001, J MOL CELL CARDIOL, V33, P1153, DOI 10.1006/jmcc.2001.1379; Reed JH, 2007, CLIN EXP IMMUNOL, V148, P153, DOI 10.1111/j.1365-2249.2007.03331.x; Rothenberg F, 2006, ANAT REC PART A, V288A, P3, DOI 10.1002/ar.a.20244; Salomonsson S, 2005, J EXP MED, V201, P11, DOI 10.1084/jem.20041859; Salomonsson S, 2002, ARTHRITIS RHEUM-US, V46, P1233, DOI 10.1002/art.10232; SCHMIDT KG, 1991, J AM COLL CARDIOL, V17, P1360, DOI 10.1016/S0735-1097(10)80148-2; SILVERMAN ED, 1995, CLIN EXP IMMUNOL, V100, P499; Strandberg L, 2008, CLIN EXP IMMUNOL, V154, P30, DOI 10.1111/j.1365-2249.2008.03732.x; Strandberg L, 2006, LUPUS, V15, P346, DOI 10.1191/0961203306lu2309oa; Strandberg LS, 2010, J IMMUNOL, V185, P3574, DOI 10.4049/jimmunol.1001396; Suzuki H, 2005, PEDIATR RES, V57, P557, DOI 10.1203/01.PDR.0000155947.82365.E4; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; TaylorAlbert E, 1997, PEDIATRICS, V99, P733, DOI 10.1542/peds.99.5.733; Xiao GQ, 2001, CIRCULATION, V103, P1599; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070	76	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72668	10.1371/journal.pone.0072668	http://dx.doi.org/10.1371/journal.pone.0072668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039792	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300019
J	VanSaun, MN; Mendonsa, AM; Gorden, DL				VanSaun, Michael N.; Mendonsa, Alisha M.; Gorden, D. Lee			Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; INSULIN-RESISTANCE; GENE-EXPRESSION; TNF-ALPHA; INJURY; PATHOGENESIS; RECRUITMENT; MECHANISMS	Nonalchoholic fatty liver disease (NAFLD) is a problem of increasing prevalence and clinical significance worldwide and is associated with increased risk of development of end stage liver disease and cirrhosis, and can be complicated by hepatocellular carcinoma (HCC). NAFLD is characterized by physical and molecular changes in the liver microenvironment which include an influx of inflammatory cell populations, fibrosis, changes in gene expression, and cytokine production. To better understand changes to the liver in the setting of steatosis, we used a murine model of diet induced hepatic steatosis and corroborated our results with human patient samples of NAFLD. Among the cellular changes, we identified a significant increase in hepatocellular proliferation in the setting of steatosis as compared to controls. Analysis of inflammatory cell populations revealed increased infiltration of CD11b positive myeloid and CD3 positive lymphocytic cell populations in steatotic livers compared to normal livers. Resident Kupffer cells of the liver comprise the largest percentage of these myeloid cells and appear to be responsible for important cytokine alterations impacting proliferation of cells in the liver microenvironment. Significant alterations in cytokine profiles in the plasma and liver tissue lysates from normal and steatotic mice were detected including leptin, CXCL1, CXCL2, and CXCL16 that were further shown to directly increase hepatocyte proliferation in vitro. This increased hepatocellular proliferation and turnover in the setting of steatosis may play important roles in the progression and complications of NAFLD.	[VanSaun, Michael N.; Mendonsa, Alisha M.; Gorden, D. Lee] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37203 USA; [VanSaun, Michael N.; Gorden, D. Lee] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University	Gorden, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37203 USA.	lee.gorden@vanderbilt.edu		VanSaun, Michael/0000-0002-2538-8107	NCI [5U01CA143072-03]; NATIONAL CANCER INSTITUTE [U01CA143072] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NCI grant #5U01CA143072-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2000, J GASTROEN HEPATOL, V15, P1325, DOI 10.1046/j.1440-1746.2000.02328.x; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Colletti LM, 1998, SHOCK, V10, P248, DOI 10.1097/00024382-199810000-00004; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Gambino R, 2011, ANTIOXID REDOX SIGN, V15, P1325, DOI 10.1089/ars.2009.3058; Hallett MA, 2012, CANCER RES, V72, P6338, DOI 10.1158/0008-5472.CAN-12-3544; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Henning JR, 2013, HEPATOLOGY BALTIMORE; Hogaboam CM, 1999, FASEB J, V13, P1565, DOI 10.1096/fasebj.13.12.1565; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ishikawa S, 2011, J HEPATOL, V54, P1195, DOI 10.1016/j.jhep.2010.08.022; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Kakisaka K, 2012, AM J PHYSIOL-GASTR L, V302, pG77, DOI 10.1152/ajpgi.00301.2011; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kirovski G, 2010, INT J CLIN EXP PATHO, V3, P675; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Lamosova D, 2001, PHYSIOL RES, V50, P183; Leclercq IA, 2006, LAB INVEST, V86, P1161, DOI 10.1038/labinvest.3700474; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Matsushita K, 2012, ANN SURG ONCOL, V19, pS518, DOI 10.1245/s10434-011-1993-8; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; McMillan TR, 2008, AM J RESP CRIT CARE, V177, P771, DOI 10.1164/rccm.200708-1184OC; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Nakagawa J, 2007, INT J ONCOL, V30, P803; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Ruiz AG, 2007, OBES SURG, V17, P1374; Shimamura T, 2008, J IMMUNOL, V181, P4656, DOI 10.4049/jimmunol.181.7.4656; Smedile A, EUROPEAN REV MED PHA, V9, P291; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Sun K, 2009, HEPATOLOGY, V49, P1645, DOI 10.1002/hep.22834; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Tsochatzis EA, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/831670; VanSaun MN, 2009, AM J PATHOL, V175, P355, DOI 10.2353/ajpath.2009.080703; Xu HB, 2005, INFECT IMMUN, V73, P4007, DOI 10.1128/IAI.73.7.4007-4016.2005; Xu HB, 2005, WORLD J GASTROENTERO, V11, P4979, DOI 10.3748/wjg.v11.i32.4979; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	58	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73054	10.1371/journal.pone.0073054	http://dx.doi.org/10.1371/journal.pone.0073054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039859	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300046
J	Cericola, F; Portis, E; Toppino, L; Barchi, L; Acciarri, N; Ciriaci, T; Sala, T; Rotino, GL; Lanteri, S				Cericola, Fabio; Portis, Ezio; Toppino, Laura; Barchi, Lorenzo; Acciarri, Nazareno; Ciriaci, Tommaso; Sala, Tea; Rotino, Giuseppe Leonardo; Lanteri, Sergio			The Population Structure and Diversity of Eggplant from Asia and the Mediterranean Basin	PLOS ONE			English	Article							SOLANUM-MELONGENA L.; GENETIC DIVERSITY; CORE COLLECTIONS; ANTIOXIDANT; GERMPLASM; QUALITY; TRAITS; FRUIT; ANTHOCYANIN; PHYLOGENY	A collection of 238 eggplant breeding lines, heritage varieties and selections within local landraces provenanced from Asia and the Mediterranean Basin was phenotyped with respect to key plant and fruit traits, and genotyped using 24 microsatellite loci distributed uniformly throughout the genome. STRUCTURE analysis based on the genotypic data identified two major sub-groups, which to a large extent mirrored the provenance of the entries. With the goal to identify true-breeding types, 38 of the entries were discarded on the basis of microsatellite-based residual heterozygosity, along with a further nine which were not phenotypically uniform. The remaining 191 entries were scored for a set of 19 fruit and plant traits in a replicated experimental field trial. The phenotypic data were subjected to principal component and hierarchical principal component analyses, allowing three major morphological groups to be identified. All three morphological groups were represented in both the "Occidental" and the "Oriental" germplasm, so the correlation between the phenotypic and the genotypic data sets was quite weak. The relevance of these results for evolutionary studies and the further improvement of eggplant are discussed. The population structure of the core set of germplasm shows that it can be used as a basis for an association mapping approach.	[Cericola, Fabio; Portis, Ezio; Barchi, Lorenzo; Lanteri, Sergio] Univ Turin, DISAFA Plant Genet & Breeding, Turin, Italy; [Cericola, Fabio; Toppino, Laura; Sala, Tea; Rotino, Giuseppe Leonardo] Montanaso Lombardo, CRA ORL Res Unit Vegetable Crops, Lodi, Italy; [Acciarri, Nazareno; Ciriaci, Tommaso] Monsampolo Tronto, CRA ORA Res Unit Vegetable Crops, Ascoli Piceno, Italy	University of Turin	Lanteri, S (corresponding author), Univ Turin, DISAFA Plant Genet & Breeding, Turin, Italy.	sergio.lanteri@unito.it	Sala, Tea/AAA-4156-2021; BARCHI, Lorenzo/ABC-4206-2020; Lanteri, Sergio/P-4902-2015	BARCHI, Lorenzo/0000-0001-6414-4239; Acciarri, Nazzareno/0000-0002-0892-5994; PORTIS, Ezio/0000-0002-1548-6096; Lanteri, Sergio/0000-0003-3012-8710; Toppino, Laura/0000-0002-8664-1233	Italian Ministry of Agricultural Alimentary and Forest Politics	Italian Ministry of Agricultural Alimentary and Forest Politics	This research was partially supported by the Italian Ministry of Agricultural Alimentary and Forest Politics in the framework of "ESPLORA" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Akanitapichat P, 2010, FOOD CHEM TOXICOL, V48, P3017, DOI 10.1016/j.fct.2010.07.045; Ali Z, 2011, GENET MOL RES, V10, P1141, DOI 10.4238/vol10-2gmr1279; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Atanassova B, 2001, EUPHYTICA, V120, P357, DOI 10.1023/A:1017524005426; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Barchi L, 2010, GENOME, V53, P805, DOI [10.1139/g10-073, 10.1139/G10-073]; Behera TK, 2006, SCI HORTIC-AMSTERDAM, V107, P352, DOI 10.1016/j.scienta.2005.11.004; Bretting PK, 1995, HORTSCIENCE, V30, P1349, DOI 10.21273/HORTSCI.30.7.1349; Bromham L, 2002, EVOLUTION, V56, P1921; Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535; Chalker-Scott, 1999, PLANTAMNESTY NEWSLET, V11, P4; CHOUDHURY B, 1976, VEGETABLES; Das S, 2011, FOOD FUNCT, V2, P395, DOI 10.1039/c1fo10048c; Daunay Marie-Christine, 2008, P163; Daunay MC, 2007, CHRONICA HORTICULTUR, V47, P16; Demir K, 2010, GENET MOL RES, V9, P1568, DOI 10.4238/vol9-3gmr878; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eleveld-Trancikova D, 2005, J LEUKOCYTE BIOL, V77, P337, DOI 10.1189/jlb.0804441; Ellwood SR, 2006, THEOR APPL GENET, V112, P977, DOI 10.1007/s00122-005-0202-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han SW, 2003, CLIN CHIM ACTA, V328, P39, DOI 10.1016/S0009-8981(02)00377-7; Harlan, 1992, CROPS MAN; Huang HY, 2004, INT J FOOD SCI NUTR, V55, P423, DOI 10.1080/09637480412331324695; Hufford MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047659; Hurtado MA, 2002, THEOR APPL GENET, V105, P182, DOI 10.1007/s00122-002-0936-y; Hurtado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041748; ISSHIKI S, 1994, SCI HORTIC-AMSTERDAM, V59, P171, DOI 10.1016/0304-4238(94)90010-8; Isshiki S, 2003, GENET RESOUR CROP EV, V50, P133, DOI 10.1023/A:1022954229295; Karihaloo JL, 2002, GENET RESOUR CROP EV, V49, P533, DOI 10.1023/A:1021288108928; KARIHALOO JL, 1995, THEOR APPL GENET, V90, P767, DOI 10.1007/BF00222010; Kashyap A., 2010, ANTIQUITY, V84; Knapp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057039; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Lester R. N., 1991, SOLANACEAE, P369; Lo Scalzo R, 2010, J AGR FOOD CHEM, V58, P3371, DOI 10.1021/jf903881s; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; MANTEL N, 1967, CANCER RES, V27, P209; Matsubara K, 2005, J AGR FOOD CHEM, V53, P6272, DOI 10.1021/jf050796r; Matus I., 1996, PLANT GENET RESOUR N, V117, P31; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mennella G, 2012, J AGR FOOD CHEM, V60, P11821, DOI 10.1021/jf3037424; Mennella G, 2010, J AGR FOOD CHEM, V58, P7597, DOI 10.1021/jf101004z; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Miyatake K, 2012, THEOR APPL GENET, V124, P1403, DOI 10.1007/s00122-012-1796-8; Munoz-Falcon JE, 2011, SCI HORTIC-AMSTERDAM, V129, P238, DOI 10.1016/j.scienta.2011.03.034; Munoz-Falcon JE, 2009, J SCI FOOD AGR, V89, P320, DOI 10.1002/jsfa.3452; Nuez FJ, 2002, COLLECTION EGGPLANT; Nunome T, 2003, PLANT BREEDING, V122, P256, DOI 10.1046/j.1439-0523.2003.00816.x; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Olsen KM, 2008, P NATL ACAD SCI USA, V105, P13701, DOI 10.1073/pnas.0807439105; Pag`es J., 2010, APPL MATH DEP; Parker PF, 1986, INFRASPECIFIC CLASSI; Polignano G, 2010, GENET RESOUR CROP EV, V57, P171, DOI 10.1007/s10722-009-9459-6; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J., 2003, Capsicum & Eggplant Newsletter, P135; Prohens J, 2005, J AM SOC HORTIC SCI, V130, P54, DOI 10.21273/JASHS.130.1.54; Prohens J, 2001, VIDA RURAL, V130, P46; Prohens J, 2007, J AM SOC HORTIC SCI, V132, P638, DOI 10.21273/JASHS.132.5.638; R Development Core Team, 2006, R LANG ENV STAT COMP; Rodriguez-Burruezo A, 2008, EUR J HORTIC SCI, V73, P76; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; Sekara, 2007, FOLIA HORTIC, V19, P97; Spooner D. M., 2003, Horticultural Reviews, V28, P1; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; Stommell JR, 2003, J AM SOC HORTIC SCI, V128, P704, DOI 10.21273/JASHS.128.5.0704; Sudheesh S, 1997, PLANT FOOD HUM NUTR, V51, P321, DOI 10.1023/A:1007965927434; Vilanova S, 2012, MOL BREEDING, V30, P647, DOI 10.1007/s11032-011-9650-2; Wang JX, 2008, ANN BOT-LONDON, V102, P891, DOI 10.1093/aob/mcn179; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9	75	70	71	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73702	10.1371/journal.pone.0073702	http://dx.doi.org/10.1371/journal.pone.0073702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040032	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500057
J	Smit, HH; Meijaard, E; van der Laan, C; Mantel, S; Budiman, A; Verweij, P				Smit, Hans Harmen; Meijaard, Erik; van der Laan, Carina; Mantel, Stephan; Budiman, Arif; Verweij, Pita			Breaking the Link between Environmental Degradation and Oil Palm Expansion: A Method for Enabling Sustainable Oil Palm Expansion	PLOS ONE			English	Article							LAND-USE; CONSERVATION; DEFORESTATION; BIODIVERSITY; LANDSCAPE; BIOFUELS; BIOMASS	Land degradation is a global concern. In tropical areas it primarily concerns the conversion of forest into non-forest lands and the associated losses of environmental services. Defining such degradation is not straightforward hampering effective reduction in degradation and use of already degraded lands for more productive purposes. To facilitate the processes of avoided degradation and land rehabilitation, we have developed a methodology in which we have used international environmental and social sustainability standards to determine the suitability of lands for sustainable agricultural expansion. The method was developed and tested in one of the frontiers of agricultural expansion, West Kalimantan province in Indonesia. The focus was on oil palm expansion, which is considered as a major driver for deforestation in tropical regions globally. The results suggest that substantial changes in current land-use planning are necessary for most new plantations to comply with international sustainability standards. Through visualizing options for sustainable expansion with our methodology, we demonstrate that the link between oil palm expansion and degradation can be broken. Application of the methodology with criteria and thresholds similar to ours could help the Indonesian government and the industry to achieve its pro-growth, pro-job, pro-poor and pro-environment development goals. For sustainable agricultural production, context specific guidance has to be developed in areas suitable for expansion. Our methodology can serve as a template for designing such commodity and country specific tools and deliver such guidance.	[Smit, Hans Harmen; van der Laan, Carina; Verweij, Pita] Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands; [Smit, Hans Harmen] Netherlands Dev Org SNV, Energy & Agr Program REAP, REDD, Jakarta, Indonesia; [Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Meijaard, Erik] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Mantel, Stephan] ISRIC World Soil Informat, Wageningen, Netherlands; [Budiman, Arif] Padjadjaran State Univ, Bandung, Indonesia; [Budiman, Arif] World Wide Fund Nat Indonesia, Jakarta, Indonesia	Utrecht University; People & Nature Consulting International; University of Queensland; CGIAR; Center for International Forestry Research (CIFOR); Universitas Padjadjaran	Verweij, P (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands.	p.a.Verweij@uu.nl	Verweij, Pita/H-3450-2011; Meijaard, Erik/A-2687-2016; Van der Laan, Carina/M-5188-2013; Verweij, Paul/H-8108-2014	Verweij, Pita/0000-0002-3577-2524; Meijaard, Erik/0000-0001-8685-3685; Van der Laan, Carina/0000-0003-4702-4184; Verweij, Paul/0000-0002-8600-9860	Packard foundation [2009-33787]	Packard foundation(The David & Lucile Packard Foundation)	This work was supported by a grant (# 2009-33787) received from Packard foundation, (http://www.packard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SA, 2008, ENVIRON MANAGE, V42, P907, DOI 10.1007/s00267-008-9178-3; Achten WMJ, 2011, ECOL SOC, V16, DOI 10.5751/ES-04403-160414; Agus F., 2009, Jurnal Penelitian dan Pengembangan Pertanian, V28, P119; Amigun B, 2011, RENEW SUST ENERG REV, V15, P1360, DOI 10.1016/j.rser.2010.10.015; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Bai ZG, 2008, SOIL USE MANAGE, V24, P223, DOI 10.1111/j.1475-2743.2008.00169.x; Boonkird S, 1985, AGROFOREST SYST, V2, P87; Bradshaw A.D., 1980, RESTORATION LAND ECO; Browne Charles, 1942, LIEBIG LIEBIG CENTUR; Butler RA, 2008, TRENDS ECOL EVOL, V23, P469, DOI 10.1016/j.tree.2008.05.006; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; Corley R., 2003, OIL PALM; DAILY GC, 1995, SCIENCE, V269, P350, DOI 10.1126/science.269.5222.350; de Carvalho CM, 2011, ENERG ENVIRON-UK, V22, P565, DOI 10.1260/0958-305X.22.5.565; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; Eswaran H, 2001, RESPONSE TO LAND DEGRADATION, P20; Fairhurst T, 2009, SUSTAINABLE OIL PALM; Fairhurst T.H., 2003, OIL PALM MANAGEMENT, P382; FAO, 2010, PROGR SUST FOR MAN; FAO, 2011, STAT WORLDS LAND WAT; FAO, 2009, CROP LIV PROD; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Germer J., 2008, Environment Development and Sustainability, V10, P697, DOI 10.1007/s10668-006-9080-1; Gibbs H, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/011007; Gutierrez-Velez VH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044029; HALL DO, 1995, LAND USE POLICY, V12, P37, DOI 10.1016/0264-8377(95)90073-B; Hoogwijk M, 2003, BIOMASS BIOENERG, V25, P119, DOI 10.1016/S0961-9534(02)00191-5; Indonesian. Resource Institute DC, 2008, TOOLK ID HIGH CONS V; INOUE M, 1990, AGROFOREST SYST, V12, P269, DOI 10.1007/BF00137289; Jennings S., 2003, HIGH CONSERVATION VA, V12, P1; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Koh LP, 2009, TRENDS ECOL EVOL, V24, P431, DOI 10.1016/j.tree.2009.03.012; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Leadley P., 2010, BIODIVERSITY SCENARI; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Mantel S, 2007, BIOPHYSICAL LAND SUI; Meijaard E., 2013, ENCY BIODIVERSITY, V2nd, P600; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; Nijsen M, 2010, GLOBAL BIOENERGY POT; Oldeman L. R., 1990, GLOBAL ASSESSMENT SO; OLDEMAN LR, 1998, METHODS ASSESSMENT S, P423; Peh KSH, 2006, DIVERS DISTRIB, V12, P572, DOI 10.1111/j.1366-9516.2006.00257.x; Phalan B, 2009, CONSERV BIOL, V23, P244, DOI 10.1111/j.1523-1739.2008.01151.x; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Plieninger T, 2011, J NAT CONSERV, V19, P18, DOI 10.1016/j.jnc.2010.04.001; Reijnders L, 2008, J CLEAN PROD, V16, P477, DOI 10.1016/j.jclepro.2006.07.054; RSB, 2010, BIOFUELS, V1, P763; *RSPO, 2007, PRINC CRIT SUST PALM; Scherr SJ, 2000, FOOD POLICY, V25, P479, DOI 10.1016/S0306-9192(00)00022-1; Sheil D., 2009, IMPACTS OPPORTUNITIE; Smit HH, 2009, POTENTIAL DEGRADED L; Smit HH, 2013, PATH GREEN EC HEART; Smit HH, 2010, IDENTIFICATION RESPO; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Statistics IPO, 2011, SAW KAL BAR KAL; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tyrie GR, 1999, ENV FRAMEWORK BASIS, P55; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Wielaard N, 2012, PERS COM SMIT HH; Yaap B., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105019	63	30	31	0	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e68610	10.1371/journal.pone.0068610	http://dx.doi.org/10.1371/journal.pone.0068610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039700	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500002
J	Ho, YK; Xu, WT; Too, HP				Ho, Yoon Khei; Xu, Wen Ting; Too, Heng Phon			Direct Quantification of mRNA and miRNA from Cell Lysates Using Reverse Transcription Real Time PCR: A Multidimensional Analysis of the Performance of Reagents and Workflows	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; SEQUENCING TECHNOLOGIES; FRESH-FROZEN; SIGNATURES; GENES; EXTRACTION; STABILITY; TISSUE; BRAIN	Substantial efforts have been devoted to in vitro testing of candidate chemotherapeutics by profiling transcriptional changes across the collection of NCI-60 cell-lines. A work-flow with reagents that enable the direct quantification of RNA of different molecular sizes simultaneously in the same sample without laborious total RNA isolation will invariably increase the throughput and accuracy of the study. MicroRNAs (miRNAs) are known to regulate most cellular functions, acting post-transcriptionally by repressing numerous eukaryotic mRNAs. Recent findings on the remarkable stability of miRNA prompted us to investigate the feasibility of quantifying the expression levels of both mRNA and miRNA directly from cell lysates (cell-to-Ct). Multidimensional analyses of the expressions of mRNA and miRNA across seven NCI-60 cell lines and multiple reagents were conducted to assess the performances of these reagents and workflows for cell-to-Ct measurements using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Quantification of RNA species using lysates prepared from an in-house and one of the commercial reagents demonstrated comparable performance to those prepared by the more laborious and conventional method of using guanidinium-phenol-chloroform. Additionally, miRNA was found to be highly stable in the cell lysates when incubated at room temperature for prolonged period of time and subjected to multiple freeze-thaw cycles. In summary, this study demonstrated significant differences in pre-analytical performance of a variety of commercially available reagents and described a cost-effective reagent useful for rapid, scalable, and high-throughput workflow for the detection of mRNA and miRNA from the same biological sample.	[Ho, Yoon Khei; Too, Heng Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Xu, Wen Ting] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Too, Heng Phon] Singapore Massachusetts Inst Technol Alliance, Singapore, Singapore; [Too, Heng Phon] ASTAR, Singapore, Singapore	National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR)	Too, HP (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	bchtoohp@nus.edu.sg			Agency for Science, Technology and Research (A*STAR) [EPTL/10-S10COT-0011]; Singapore-MIT Alliance [C-382-651-001-091]; National University of Singapore	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); National University of Singapore(National University of Singapore)	The work reported in this manuscript was funded by Agency for Science, Technology and Research (EPTL/10-S10COT-0011, A*STAR) (http://www.etpl.sg/) and Singapore-MIT Alliance (C-382-651-001-091, http://web.mit.edu/sma/research/cpe/index.htm), and supported by National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Bravo V, 2007, BIOCHEM BIOPH RES CO, V353, P1052, DOI 10.1016/j.bbrc.2006.12.135; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen JJ, 2007, PHARMACOGENOMICS J, V7, P212, DOI 10.1038/sj.tpj.6500412; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Khoshnaw SM, 2009, J CLIN PATHOL, V62, P422, DOI 10.1136/jcp.2008.060681; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LEONARD S, 1993, BIOL PSYCHIAT, V33, P456, DOI 10.1016/0006-3223(93)90174-C; Lim QE, 2011, NATURE PROTOCOL EXCH; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Moltzahn F, 2011, JOVE-J VIS EXP, DOI 10.3791/2552; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Muyal JP, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-9; Nelson PT, 2008, BBA-GENE REGUL MECH, V1779, P758, DOI 10.1016/j.bbagrm.2008.03.012; Pervaiz S, 2001, ONCOGENE, V20, P6263, DOI 10.1038/sj.onc.1204840; Port M, 2007, DIAGN MOL PATHOL, V16, P38, DOI 10.1097/01.pdm.0000213472.70054.94; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Staal FJT, 2006, LEUKEMIA, V20, P1385, DOI 10.1038/sj.leu.2404274; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Too HP, 2003, MOL BRAIN RES, V114, P146, DOI 10.1016/S0169-328X(03)00169-4; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wang WX, 2008, BBA-GENE REGUL MECH, V1779, P749, DOI 10.1016/j.bbagrm.2008.01.005; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75	40	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72463	10.1371/journal.pone.0072463	http://dx.doi.org/10.1371/journal.pone.0072463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039771	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600031
J	Lu, YP; Peng, HM; Jin, ZG; Cheng, J; Wang, SF; Ma, MY; Lu, Y; Han, DY; Yao, YQ; Li, YL; Yuan, HJ				Lu, Yanping; Peng, Hongmei; Jin, Zhanguo; Cheng, Jing; Wang, Shufang; Ma, Minyue; Lu, Yu; Han, Dongyi; Yao, Yuanqing; Li, Yali; Yuan, Huijun			Preimplantation Genetic Diagnosis for a Chinese Family with Autosomal Recessive Meckel-Gruber Syndrome Type 3 (MKS3)	PLOS ONE			English	Article							AMPLIFICATION; EMBRYOS; PCR	Meckel-Gruber syndrome type 3 is an autosomal recessive genetic defect caused by mutations in TMEM67 gene. In our previous study, we have identified a homozygous TMEM67 mutation in a Chinese family exhibiting clinical characteristics of MKS3, which provided a ground for further PGD procedure. Here we report the development and the first clinical application of the PGD for this MKS3 family. Molecular analysis protocol for clinical PGD procedure was established using 50 single cells in pre-clinical set-up. After whole genomic amplification by multiple displacement amplification with the DNA from single cells, three techniques were applied simultaneously to increase the accuracy and reliability of genetic diagnosis in single blastomere, including real-time PCR with Taq Man-MGB probe, haplotype analysis with polymorphic STR markers and Sanger sequencing. In the clinical PGD cycle, nine embryos at cleavage-stage were biopsied and subjected to genetic diagnosis. Two embryos diagnosed as free of TMEM67 mutation were transferred and one achieving normal pregnancy. Non-invasive prenatal assessment of trisomy 13, 18 and 21 by multiplex DNA sequencing at 18 weeks' gestation excluded the aneuploidy of the analyzed chromosomes. A healthy boy was delivered by cesarean section at 39 weeks' gestation. DNA sequencing from his cord blood confirmed the result of genetic analysis in the PGD cycle. The protocol developed in this study was proved to be rapid and safe for the detection of monogenic mutations in clinical PGD cycle.	[Lu, Yanping; Peng, Hongmei; Wang, Shufang; Ma, Minyue; Yao, Yuanqing; Li, Yali] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Jin, Zhanguo] Chinese PLA Air Force Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Cheng, Jing; Lu, Yu; Han, Dongyi; Yuan, Huijun] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Air Force General Hospital PLA; Chinese People's Liberation Army General Hospital	Yao, YQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.	yqyao@126.com; li_yali@hotmail.com; yuanhj301@163.com		YAO, YUANQING/0000-0001-5942-4121; Wang, Shufang/0000-0001-5768-9687	National Natural Science Foundation of China [81030017]; National Science Fund for Distinguished Young Scholars [81125008]; National Basic Research Program [2013CB945402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program(National Basic Research Program of China)	These investigations were supported by Key Project of National Natural Science Foundation of China (81030017), National Science Fund for Distinguished Young Scholars (81125008) and The National Basic Research Program (2013CB945402) to HJ Yuan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Chih-Ping, 2007, Taiwan J Obstet Gynecol, V46, P9; de Jong A, 2011, HUM REPROD, V26, P2915, DOI 10.1093/humrep/der268; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Harper JC, 2010, HUM REPROD, V25, P2685, DOI 10.1093/humrep/deq228; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Logan CV, 2011, MOL NEUROBIOL, V43, P12, DOI 10.1007/s12035-010-8154-0; Martinhago CD, 2010, REPROD BIOMED ONLINE, V20, P75, DOI 10.1016/j.rbmo.2009.10.008; Munne S, 1998, FERTIL STERIL, V69, P904, DOI 10.1016/S0015-0282(98)00039-9; Piyamongkol W, 2001, PRENATAL DIAG, V21, P223, DOI 10.1002/1097-0223(200103)21:3<223::AID-PD52>3.0.CO;2-3; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	12	8	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73245	10.1371/journal.pone.0073245	http://dx.doi.org/10.1371/journal.pone.0073245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039893	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600059
J	Rodriguez-Fernandez, M; Grosman, B; Yuraszeck, TM; Helwig, BG; Leon, LR; Doyle, FJ				Rodriguez-Fernandez, Maria; Grosman, Benyamin; Yuraszeck, Theresa M.; Helwig, Bryan G.; Leon, Lisa R.; Doyle, Francis J., III			Modeling the Intra- and Extracellular Cytokine Signaling Pathway under Heat Stroke in the Liver	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; SYSTEMS BIOLOGY; SENSITIVITY-ANALYSIS; OXIDATIVE STRESS; IL-10 PRODUCTION; SHOCK RESPONSE; TARGET GENES	Heat stroke (HS) is a life-threatening illness induced by prolonged exposure to a hot environment that causes central nervous system abnormalities and severe hyperthermia. Current data suggest that the pathophysiological responses to heat stroke may not only be due to the immediate effects of heat exposure per se but also the result of a systemic inflammatory response syndrome (SIRS). The observation that pro- (e.g., IL-1) and anti-inflammatory (e.g., IL-10) cytokines are elevated concomitantly during recovery suggests a complex network of interactions involved in the manifestation of heat-induced SIRS. In this study, we measured a set of circulating cytokine/soluble cytokine receptor proteins and liver cytokine and receptor mRNA accumulation in wild-type and tumor necrosis factor (TNF) receptor knockout mice to assess the effect of neutralization of TNF signaling on the SIRS following HS. Using a systems approach, we developed a computational model describing dynamic changes (intra- and extracellular events) in the cytokine signaling pathways in response to HS that was fitted to novel genomic (liver mRNA accumulation) and proteomic (circulating cytokines and receptors) data using global optimization. The model allows integration of relevant biological knowledge and formulation of new hypotheses regarding the molecular mechanisms behind the complex etiology of HS that may serve as future therapeutic targets. Moreover, using our unique modeling framework, we explored cytokine signaling pathways with three in silico experiments (e.g. by simulating different heat insult scenarios and responses in cytokine knockout strains in silico).	[Rodriguez-Fernandez, Maria; Grosman, Benyamin; Yuraszeck, Theresa M.; Doyle, Francis J., III] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Rodriguez-Fernandez, Maria; Grosman, Benyamin; Yuraszeck, Theresa M.; Doyle, Francis J., III] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Helwig, Bryan G.; Leon, Lisa R.] US Army, Environm Med Res Inst, Thermal & Mt Med Div, Natick, MA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Doyle, FJ (corresponding author), Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.	doyle@engineering.ucsb.edu	Rodriguez-Fernandez, Maria/AAF-7049-2021; Rodriguez-Fernandez, Maria/I-7193-2016	Rodriguez-Fernandez, Maria/0000-0003-1966-2920; Rodriguez-Fernandez, Maria/0000-0003-1966-2920	Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001, W911QY-09-P-0709]	Institute for Collaborative Biotechnologies from the U.S. Army Research Office	The authors acknowledge the financial support provided by the Institute for Collaborative Biotechnologies through grants W911NF-09-0001 and W911QY-09-P-0709 from the U.S. Army Research Office. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Army or the Department of Defense. Citations of commercial organizations and trade names in this report do not constitute an official Department of the Army endorsement or approval of the products or services of these organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Aldrich J, 1997, STAT SCI, V12, P162; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alon U, 2007, INTRO SYSTEMS BIOL D; Amorim F, 2010, HEAT SHOCK PROTEINS, V5, P57, DOI 10.1007/978-90-481-3381-9_4; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bailly S, 1996, EUR CYTOKINE NETW, V7, P125; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Barkhausen T, 2011, CRIT CARE MED, V39, P1407, DOI 10.1097/CCM.0b013e318211ff56; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Borden KA, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-64; BOUCHAMA A, 1993, CHEST, V104, P1498, DOI 10.1378/chest.104.5.1498; BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640; Bouchama A, 2005, J APPL PHYSIOL, V98, P697, DOI 10.1152/japplphysiol.00461.2004; Bouchama A, 2000, INTENS CARE MED, V26, P1646, DOI 10.1007/s001340000665; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dehbi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044100; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Egea JA, 2007, J GLOBAL OPTIM, V37, P481, DOI 10.1007/s10898-006-9075-3; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Fan HY, 2011, BIOCHEMISTRY-US, V50, P1226, DOI 10.1021/bi101432p; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; HALL DM, 1994, J APPL PHYSIOL, V77, P548, DOI 10.1152/jappl.1994.77.2.548; Hammami MM, 1997, CRIT CARE MED, V25, P1314, DOI 10.1097/00003246-199708000-00017; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Hashim IA, 1997, MEDIAT INFLAMM, V6, P135, DOI 10.1080/09629359791839; HAYMAKER W, 1947, J NEUROPATH EXP NEUR, V6, P209; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Helwig BG, 2011, PHYSIOL GENOMICS, V43, P1096, DOI 10.1152/physiolgenomics.00076.2011; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; JACQUEZ JA, 1985, MATH BIOSCI, V77, P201, DOI 10.1016/0025-5564(85)90098-7; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lambert GP, 2002, J APPL PHYSIOL, V92, P1750, DOI 10.1152/japplphysiol.00787.2001; Leon L, 2013, ATTENUATED THE UNPUB; Leon LR, 2007, PROG BRAIN RES, V162, P481, DOI 10.1016/S0079-6123(06)62024-4; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Leon LR, 2006, J THERM BIOL, V31, P67, DOI 10.1016/j.jtherbio.2005.11.023; Leon LR, 2006, J APPL PHYSIOL, V100, P1400, DOI 10.1152/japplphysiol.01040.2005; Leon LR, 2005, AM J PHYSIOL-REG I, V288, pR197, DOI 10.1152/ajpregu.00046.2004; LEPOCK JR, 1993, J CELL BIOL, V122, P1267, DOI 10.1083/jcb.122.6.1267; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XZ, 1999, ANN NY ACAD SCI, V874, P69, DOI 10.1111/j.1749-6632.1999.tb09226.x; MonteroJulian FA, 1997, CLIN CANCER RES, V3, P1443; Montgomery DouglasC, 2010, APPL STAT PROBABILIT; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Peake NJ, 2006, RHEUMATOLOGY, V45, P1485, DOI 10.1093/rheumatology/kel154; Peper A, 1998, INT J HYPERTHER, V14, P97, DOI 10.3109/02656739809018218; Rodriguez-Fernandez M, 2006, BIOSYSTEMS, V83, P248, DOI 10.1016/j.biosystems.2005.06.016; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sawka MN, 2011, COMPR PHYSIOL, V1, P1883, DOI 10.1002/cphy.c100082; Singleton KD, 2006, SHOCK, V25, P295, DOI 10.1097/01.shk.0000196548.10634.02; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Terry AJ, 2011, J THEOR BIOL, V290, P7, DOI 10.1016/j.jtbi.2011.08.036; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vandentorren S, 2004, AM J PUBLIC HEALTH, V94, P1518, DOI 10.2105/AJPH.94.9.1518; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Walter E, 1997, IDENTIFICATION PARAM; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang Q, 2011, MATH BIOSCI, V229, P135, DOI 10.1016/j.mbs.2010.08.003; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje; Zhong J, 2006, BBA-MOL BASIS DIS, V1762, P468, DOI 10.1016/j.bbadis.2005.12.012; Zhou XW, 1998, J INVEST DERMATOL, V111, P194, DOI 10.1046/j.1523-1747.1998.00266.x; Zingarelli B, 2004, AM J PHYSIOL-HEART C, V286, pH1408, DOI 10.1152/ajpheart.00953.2003	95	11	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73393	10.1371/journal.pone.0073393	http://dx.doi.org/10.1371/journal.pone.0073393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039931	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600071
J	LeBlanc, ARH; Reisz, RR				LeBlanc, Aaron R. H.; Reisz, Robert R.			Periodontal Ligament, Cementum, and Alveolar Bone in the Oldest Herbivorous Tetrapods, and Their Evolutionary Significance	PLOS ONE			English	Article							TOOTH ATTACHMENT; HISTOLOGY; TISSUES; DENTITION; APPARATUS; PATTERNS; TEETH	Tooth implantation provides important phylogenetic and functional information about the dentitions of amniotes. Traditionally, only mammals and crocodilians have been considered truly thecodont, because their tooth roots are coated in layers of cementum for anchorage of the periodontal ligament, which is in turn attached to the bone lining the alveolus, the alveolar bone. The histological properties and developmental origins of these three periodontal tissues have been studied extensively in mammals and crocodilians, but the identities of the periodontal tissues in other amniotes remain poorly studied. Early work on dental histology of basal amniotes concluded that most possess a simplified tooth attachment in which the tooth root is ankylosed to a pedestal composed of "bone of attachment", which is in turn fused to the jaw. More recent studies have concluded that stereotypically thecodont tissues are also present in non-mammalian, non-crocodilian amniotes, but these studies were limited to crown groups or secondarily aquatic reptiles. As the sister group to Amniota, and the first tetrapods to exhibit dental occlusion, diadectids are the ideal candidates for studies of dental evolution among terrestrial vertebrates because they can be used to test hypotheses of development and homology in deep time. Our study of Permo-Carboniferous diadectid tetrapod teeth and dental tissues reveal the presence of two types of cementum, periodontal ligament, and alveolar bone, and therefore the earliest record of true thecodonty in a tetrapod. These discoveries in a stem amniote allow us to hypothesize that the ability to produce the tissues that characterize thecodonty in mammals and crocodilians is very ancient and plesiomorphic for Amniota. Consequently, all other forms of tooth implantation in crown amniotes are derived arrangements of one or more of these periodontal tissues and not simply ankylosis of teeth to the jaw by plesiomorphically retaining "bone of attachment", as previously suggested.	[LeBlanc, Aaron R. H.; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	LeBlanc, ARH (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	aaron.leblanc@mail.utoronto.ca		LeBlanc, Aaron/0000-0002-2497-1296	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	ARHL was supported by an NSERC Postgraduate Student doctoral scholarship. RRR was supported by a Discovery Grant from NSERC. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	BERKOVITZ BKB, 1979, J ZOOL, V187, P179; Berman David S., 2004, Bulletin of Carnegie Museum of Natural History, V35, P1, DOI 10.2992/0145-9058(2004)35[1:ANDDOP]2.0.CO;2; Berman DS, NEW MEXICO MUS NAT H, V49, P185; Bosshardt DD, 2005, J DENT RES, V84, P390, DOI 10.1177/154405910508400501; Bosshardt DD, 2008, J ANAT, V212, P319, DOI 10.1111/j.1469-7580.2008.00856.x; Brand Leonard R., 2003, Journal of Taphonomy, V1, P69; Buchtova M, 2013, ARCH ORAL BIOL, V58, P118, DOI 10.1016/j.archoralbio.2012.10.019; Budney LA, 2006, J VERTEBR PALEONTOL, V26, P138, DOI 10.1671/0272-4634(2006)26[138:TSHITC]2.0.CO;2; Cabreira SF, 2009, ACTA PALAEONTOL POL, V54, P743, DOI 10.4202/app.2008.0047; Caldwell MW, 2007, ZOOL J LINN SOC-LOND, V149, P687, DOI 10.1111/j.1096-3642.2007.00280.x; Caldwell MW, 2003, J VERTEBR PALEONTOL, V23, P622, DOI 10.1671/0272-4634(2003)023[0622:HOTATI]2.0.CO;2; Davit-Beal T, 2007, BIOL REV, V82, P49, DOI 10.1111/j.1469-185X.2006.00003.x; Diekwisch TGH, 2001, INT J DEV BIOL, V45, P695; Dixon P. M., 2002, Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners, Orlando, Florida, USA, 4-8 December 2002, P421; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Gaengler P., 2000, P173, DOI 10.1017/CBO9780511542626.012; Garcia RA, 2010, PALAEONTOLOGY, V53, P335, DOI 10.1111/j.1475-4983.2010.00937.x; Jasinoski SC, 2012, J ANAT, V220, P564, DOI 10.1111/j.1469-7580.2012.01494.x; JONES SJ, 1974, CELL TISSUE RES, V148, P83; Kieser JA, 2009, FRONT ORAL BIOL, V13, P80, DOI 10.1159/000242396; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Luan XH, 2009, EVOL DEV, V11, P247, DOI 10.1111/j.1525-142X.2009.00327.x; Macdougall MJ, 2011, J VERTEBR PALEONTOL, V31, P270, DOI 10.1080/02724634.2011.549436; MacNeil RL, 1999, PERIODONTOL 2000, V19, P8, DOI 10.1111/j.1600-0757.1999.tb00144.x; Maxwell EE, 2011, J MORPHOL, V272, P1170, DOI 10.1002/jmor.10972; Maxwell EE, 2011, J VERTEBR PALEONTOL, V31, P553, DOI 10.1080/02724634.2011.557117; Maxwell EE, 2011, J MORPHOL, V272, P129, DOI 10.1002/jmor.10898; McIntosh JE, 2002, MICROSC RES TECHNIQ, V59, P449, DOI 10.1002/jemt.10222; MILLER WA, 1968, ARCH ORAL BIOL, V13, P735, DOI 10.1016/0003-9969(68)90091-5; Peyer B, 1968, COMP ODONTOLOGY; Pretto FA, ACTA PALAEN IN PRESS; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; Reisz RR, 2001, ANN CARNEGIE MUS, V70, P133; Scheyer TM, 2011, SWISS J GEOSCI, V104, pS147, DOI 10.1007/s00015-011-0076-y; Ten Cate AR, 2000, PERIODONTOL, V13, P9; TENCATE AR, 1971, ANAT REC, V170, P365; Warren A, 2005, T ROY SOC EDIN-EARTH, V96, P113, DOI 10.1017/S0263593300001267; Zaher Hussam, 1999, American Museum Novitates, V3271, P1	39	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74697	10.1371/journal.pone.0074697	http://dx.doi.org/10.1371/journal.pone.0074697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023957	Green Submitted, gold, Green Published			2022-12-25	WOS:000324515600151
J	Li, X; Roslan, S; Johnstone, CN; Wright, JA; Bracken, CP; Anderson, M; Bert, AG; Selth, LA; Anderson, RL; Goodall, GJ; Gregory, PA; Khew-Goodall, Y				Li, X.; Roslan, S.; Johnstone, C. N.; Wright, J. A.; Bracken, C. P.; Anderson, M.; Bert, A. G.; Selth, L. A.; Anderson, R. L.; Goodall, G. J.; Gregory, P. A.; Khew-Goodall, Y.			MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways	ONCOGENE			English	Article						miR-200; epithelial-mesenchymal transition; breast cancer; metastasis; actin cytoskeleton	EPITHELIAL-MESENCHYMAL TRANSITION; DIFFERENTIAL EXPRESSION; MIRNA-200 FAMILY; DOWN-REGULATION; CELL-MIGRATION; ZEB1; EMT; PROTEINS; INVASION; TARGETS	The microRNA-200 (miR-200) family has a critical role in regulating epithelial-mesenchymal transition and cancer cell invasion through inhibition of the E-cadherin transcriptional repressors ZEB1 and ZEB2. Recent studies have indicated that the miR-200 family may exert their effects at distinct stages in the metastatic process, with an overall effect of enhancing metastasis in a syngeneic mouse breast cancer model. We find in a xenograft orthotopic model of breast cancer metastasis that ectopic expression of members of the miR-200b/200c/429, but not the miR-141/200a, functional groups limits tumour cell invasion and metastasis. Despite modulation of the ZEB1-E-cadherin axis, restoration of ZEB1 in miR-200b-expressing cells was not able to alter metastatic potential suggesting that other targets contribute to this process. Instead, we found that miR-200b repressed several actin-associated genes, with the knockdown of the ezrin-radixin-moesin family member moesin alone phenocopying the repression of cell invasion by miR-200b. Moesin was verified to be directly targeted by miR-200b, and restoration of moesin in miR-200b-expressing cells was sufficient to alleviate metastatic repression. In breast cancer cell lines and patient samples, the expression of moesin significantly inversely correlated with miR-200 expression, and high levels of moesin were associated with poor relapse-free survival. These findings highlight the context-dependent effects of miR-200 in breast cancer metastasis and demonstrate the existence of a moesin-dependent pathway, distinct from the ZEB1-E-cadherin axis, through which miR-200 can regulate tumour cell plasticity and metastasis.	[Li, X.; Roslan, S.; Wright, J. A.; Bracken, C. P.; Anderson, M.; Bert, A. G.; Goodall, G. J.; Gregory, P. A.; Khew-Goodall, Y.] SA Pathol, Ctr Canc Biol, Div Human Immunol, Adelaide, SA 5000, Australia; [Johnstone, C. N.; Anderson, R. L.] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Johnstone, C. N.; Anderson, R. L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Johnstone, C. N.; Anderson, R. L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Johnstone, C. N.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Wright, J. A.; Bracken, C. P.; Goodall, G. J.; Gregory, P. A.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Selth, L. A.] Univ Adelaide, Hanson Inst, Discipline Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia; [Goodall, G. J.; Khew-Goodall, Y.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Melbourne; University of Adelaide; Hanson Institute; University of Adelaide; University of Adelaide	Gregory, PA (corresponding author), SA Pathol, Ctr Canc Biol, Div Human Immunol, Frome Rd, Adelaide, SA 5000, Australia.	philip.gregory@health.sa.gov.au; yeesim.khew-goodall@health.sa.gov.au	Selth, Luke/AAH-4823-2021; Anderson, Robin/I-2306-2013; Anderson, Robin/K-6966-2019; Gregory, Philip/F-4089-2013; Anderson, Robin/S-1005-2017	Selth, Luke/0000-0002-4686-1418; Gregory, Philip/0000-0002-0999-0632; Anderson, Robin/0000-0002-6841-7422; Goodall, Gregory/0000-0003-1294-0692; Wright, Josephine/0000-0003-4588-8827; Bracken, Cameron/0000-0001-7722-625X; Bert, Andrew/0000-0003-3876-1537	National Breast Cancer Foundation of Australia [ECF-09-08, PF-09-03]; National Health and Medical Research Council of Australia [566871, APP1020280]; Cancer Council South Australia; Prostate Cancer Foundation of Australia [YI 0810]; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Breast Cancer Foundation of Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council South Australia(Cancer Council South Australia); Prostate Cancer Foundation of Australia; National Breast Cancer Foundation	We thank Professor Joan Massague for providing the MDA-MB-231 LM2 cell line and Dr Ross Dickins for providing the pLMP-puro-GFP construct. We thank Dr Agatha Labrinidis and Ms Yuka Harata-Lee for assistance with bioluminescence imaging and inoculation of tumour cells, respectively, Dr Peter Diamond for help with bone histological analysis and Professors Andreas Evdokiou and Shaun McColl for insightful discussions. This work was supported by fellowships from the National Breast Cancer Foundation of Australia (PAG, CPB and RLA, nos ECF-09-08 and PF-09-03) and grants from the National Health and Medical Research Council of Australia (PAG, YK-G, GJG, RLA and CNJ, nos 566871 and APP1020280), Cancer Council South Australia (GJG, PAG and YK-G) and Prostate Cancer Foundation of Australia (LAS, no. YI 0810).	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Charafe-Jauffret E, 2007, INT J CANCER, V121, P1779, DOI 10.1002/ijc.22923; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Giusiano S, 2010, INT J ONCOL, V36, P889, DOI 10.3892/ijo_00000567; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Lo WL, 2011, J PATHOL, V223, P482, DOI 10.1002/path.2826; Lussier YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028650; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Sun BC, 2008, CLIN CANCER RES, V14, P7050, DOI 10.1158/1078-0432.CCR-08-0520; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xue CS, 2003, CANCER RES, V63, P3386	54	89	93	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4077	4088		10.1038/onc.2013.370	http://dx.doi.org/10.1038/onc.2013.370			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24037528				2022-12-25	WOS:000340595300007
J	Sosa, LJ; Postma, NL; Estrada-Bernal, A; Hanna, M; Guo, R; Busciglio, J; Pfenninger, KH				Sosa, Lucas J.; Postma, Nienke L.; Estrada-Bernal, Adriana; Hanna, M.; Guo, R.; Busciglio, Jorge; Pfenninger, Karl H.			Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome	FASEB JOURNAL			English	Article						brain development; neurodevelopmental disorders	ALZHEIMERS-DISEASE; MOUSE MODEL; NEURITE OUTGROWTH; GROWTH CONES; RAT-BRAIN; INTERFERENCE REFLECTION; EXPRESSION PATTERN; MESSENGER-RNA; APP-BINDING; IN-VITRO	Amyloid precursor protein (APP), encoded on Hsa21, functions as a cell adhesion molecule (CAM) in axonal growth cones (GCs) of the developing brain. We show here that axonal GCs of human fetal Down syndrome (DS) neurons (and of a DS mouse model) overexpress APP protein relative to euploid controls. We investigated whether DS neurons generate an abnormal, APP-dependent GC phenotype in vitro. On laminin, which binds APP and 1 integrins (Itgb1), DS neurons formed enlarged and faster-advancing GCs compared to controls. On peptide matrices that bind APP only, but not on those binding exclusively Itgb1 or L1CAM, DS GCs were significantly enlarged (2.0-fold), formed increased close adhesions (1.8-fold), and advanced faster (1.4-fold). In assays involving alternating stripes of monospecific matrices, human control GCs exhibited no preference for any of the substrates, whereas DS GCs preferred the APP-binding matrix (cross-over decreased significantly from 48.2 to 27.2%). Reducing APP expression in DS GCs with siRNA normalized most measures of the phenotype, including substrate choice. These experiments show that human DS neurons exhibit an APP-dependent, abnormal GC phenotype characterized by increased adhesion and altered contact guidance. The results suggest that APP overexpression may perturb axonal pathfinding and circuit formation in developing DS brain.Sosa, L. J., Postma, N. L., Estrada-Bernal, A., Hanna, M., Guo, R., Busciglio, J., Pfenninger, K. H. Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome.	[Sosa, Lucas J.; Postma, Nienke L.; Estrada-Bernal, Adriana; Pfenninger, Karl H.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [Sosa, Lucas J.; Postma, Nienke L.; Estrada-Bernal, Adriana; Pfenninger, Karl H.] Univ Colorado, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr, Aurora, CO 80045 USA; [Guo, R.] Univ Colorado, Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [Hanna, M.; Busciglio, Jorge] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Hanna, M.; Busciglio, Jorge] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of California System; University of California Irvine	Pfenninger, KH (corresponding author), Univ Colorado, Dept Pediat, Mailbox 8313,12800 E 19th Ave, Aurora, CO 80045 USA.	karl.pfenninger@ucdenver.edu		Sosa, Lucas/0000-0002-9153-7537	U.S. National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke [R01 NS061940]; Anna and John J. Sie Foundation (Denver, CO, USA); Linda Crnic Institute for Down Syndrome (Denver, CO, USA); Colorado Children's Hospital Research Institute (Aurora, CO, USA); NIH/National Institute of Child Health and Human Development [R01 HD38466]; University of California-Irvine Alzheimer's Disease Research Center [NIH AG16573, 2]; NIH/National Center for Advancing Translational Sciences Colorado Clinical Translation and Science Institute [UL1 TR000154]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038466] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke; Anna and John J. Sie Foundation (Denver, CO, USA); Linda Crnic Institute for Down Syndrome (Denver, CO, USA); Colorado Children's Hospital Research Institute (Aurora, CO, USA); NIH/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of California-Irvine Alzheimer's Disease Research Center; NIH/National Center for Advancing Translational Sciences Colorado Clinical Translation and Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Katheleen Gardiner for reviewing the manuscript and for many helpful discussions; Drs. Ken Maclean and Hua Jiang for their assistance with breeding and genotyping Ts65Dn mice; Dr. Martin Grumet (Rutgers W. M. Keck Center for Collaborative Neuroscience, Piscataway, NJ, USA) for the generous gift of eL1 recombinant protein; and Carmel Harberg for excellent assistance with the preparation of the manuscript. This research was supported by grants from the U.S. National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (R01 NS061940), the Anna and John J. Sie Foundation (Denver, CO, USA), the Linda Crnic Institute for Down Syndrome (Denver, CO, USA), and the Colorado Children's Hospital Research Institute (Aurora, CO, USA) to K. H. P.; NIH/National Institute of Child Health and Human Development (R01 HD38466) and University of California-Irvine Alzheimer's Disease Research Center (NIH AG16573, Project 2) to J. B.; and NIH/National Center for Advancing Translational Sciences Colorado Clinical Translation and Science Institute (UL1 TR000154). Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; ARAI H, 1994, BRAIN RES, V642, P132, DOI 10.1016/0006-8993(94)90914-8; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Cataldo AM, 2003, J NEUROSCI, V23, P6788; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; Coulson EJ, 1997, BRAIN RES, V770, P72, DOI 10.1016/S0006-8993(97)00757-9; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; De Strooper B, 2000, J CELL SCI, V113, P1857; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Engidawork E, 2001, AMINO ACIDS, V21, P331, DOI 10.1007/s007260170001; Griffin WST, 1998, NEUROBIOL AGING, V19, P401, DOI 10.1016/S0197-4580(98)00074-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Haydar TF, 2012, TRENDS NEUROSCI, V35, P81, DOI 10.1016/j.tins.2011.11.001; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Hunter CL, 2003, NEUROSCI RES, V45, P437, DOI 10.1016/S0168-0102(03)00005-1; IZZARD CS, 1976, J CELL SCI, V21, P129; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009; Kirazov E, 2001, INT J DEV NEUROSCI, V19, P287, DOI 10.1016/S0736-5748(01)00012-0; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; LEMMON V, 1992, J NEUROSCI, V12, P818; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Lohse K, 1996, DEV BRAIN RES, V96, P83, DOI 10.1016/0165-3806(96)00076-4; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; Mikule K, 2002, J NEUROSCI, V22, P4932, DOI 10.1523/JNEUROSCI.22-12-04932.2002; Neve RL, 1996, MOL BRAIN RES, V39, P185, DOI 10.1016/0169-328X(96)00007-1; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; PFENNINGER KH, 1981, J CELL BIOL, V89, P547, DOI 10.1083/jcb.89.3.547; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Rahman A.S., 2010, JOVE-J VIS EXP, P2384; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SMALL DH, 1994, J NEUROSCI, V14, P2117; Song P., 2012, PLOS ONE, V7; Sosa LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064521; Spellman C, 2013, GENE, V512, P219, DOI 10.1016/j.gene.2012.10.051; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trazzi S, 2013, J BIOL CHEM, V288, P20817, DOI 10.1074/jbc.M113.451088; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	64	13	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					195	205		10.1096/fj.13-232686	http://dx.doi.org/10.1096/fj.13-232686			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24036883	Green Published, Green Submitted			2022-12-25	WOS:000333526100020
J	Weissmuller, T; Glover, LE; Fennimore, B; Curtis, VF; MacManus, CF; Ehrentraut, SF; Campbell, EL; Scully, M; Grove, BD; Colgan, SP				Weissmueller, Thomas; Glover, Louise E.; Fennimore, Blair; Curtis, Valerie F.; MacManus, Christopher F.; Ehrentraut, Stefan F.; Campbell, Eric L.; Scully, Melanie; Grove, Bryon D.; Colgan, Sean P.			HIF-dependent regulation of AKAP12 ( gravin) in the control of human vascular endothelial function	FASEB JOURNAL			English	Article						hypoxia-inducible factor; permeability; barrier function; angiogenesis	PROTEIN-KINASE-A; SIGNALING PATHWAYS; BARRIER FUNCTION; HYPOXIA; INDUCTION; ADENOSINE; ANGIOGENESIS; SSECKS/GRAVIN/AKAP12; INFLAMMATION; SUPPRESSION	Hypoxia has been widely implicated in many pathological conditions, including those associated with inflammation and tumorigenesis. A number of recent studies have implicated hypoxia in the control of vasculogenesis and permeability, the basis for which is not fully understood. Here we examine the transcriptional regulation of angiogenesis and permeability by hypoxia in endothelial cells. Guided by a global profiling approach in cultured endothelial cells, these studies revealed the selective induction of human gravin (protein kinase A anchoring protein 12) by hypoxia. Analysis of the cloned gravin promoter identified a functional hypoxia-responsive region including 2 binding sites for hypoxia-inducible factor (HIF). Site-directed mutagenesis identified the most distal HIF-binding site as essential for the induction of gravin by hypoxia. Further studies examining gravin gain and loss of function confirmed strong dependence of gravin in control of microvascular endothelial tube formation, wherein gravin functions as a braking system for angiogenesis. Additional studies in confluent endothelia revealed that gravin functionally couples to control endothelial barrier function in response to protein kinase A (PKA) agonists. Taken together, these results demonstrate transcriptional coordination of gravin by HIF-1 and amplified PKA-dependent endothelial responses. These findings provide an important link between hypoxia and metabolic conditions associated with inflammation and angiogenesis.Weissmuller, T., Glover, L. E., Fennimore, B., Curtis, V. F., MacManus, C. F., Ehrentraut, S. F., Campbell, E. L., Scully, M., Grove, B. D., Colgan, S. P. HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function.	[Weissmueller, Thomas; Glover, Louise E.; Fennimore, Blair; Curtis, Valerie F.; MacManus, Christopher F.; Ehrentraut, Stefan F.; Campbell, Eric L.; Scully, Melanie; Colgan, Sean P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Weissmueller, Thomas; Glover, Louise E.; Fennimore, Blair; Curtis, Valerie F.; MacManus, Christopher F.; Ehrentraut, Stefan F.; Campbell, Eric L.; Scully, Melanie; Colgan, Sean P.] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO 80045 USA; [Weissmueller, Thomas; Glover, Louise E.; Fennimore, Blair; Curtis, Valerie F.; MacManus, Christopher F.; Ehrentraut, Stefan F.; Campbell, Eric L.; Scully, Melanie; Colgan, Sean P.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Aurora, CO 80045 USA; [Weissmueller, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Ehrentraut, Stefan F.] Univ Bonn, Dept Anesthesiol, Bonn, Germany; [Grove, Bryon D.] Univ N Dakota, Dept Anat & Cell Biol, Grand Forks, ND 58201 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bonn; University of North Dakota Grand Forks	Colgan, SP (corresponding author), Univ Colorado, Mucosal Inflammat Program, 12700 E 19th Ave, Aurora, CO 80045 USA.	sean.colgan@ucdenver.edu	Campbell, Eric/N-5357-2015	Campbell, Eric/0000-0003-0744-6577; Ehrentraut, Stefan/0000-0001-5747-6737; Glover, Louise/0000-0001-9056-1810	U.S. National Institutes of Health [HL60569, DK50189, DK095491]; Crohn's and Colitis Foundation of America; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050189, R01DK050189, T32DK007038, R01DK095491, R37DK050189] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants HL60569, DK50189, and DK095491 and by funding from the Crohn's and Colitis Foundation of America. The authors declare no conflicts of interest.	Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dormond O, 2003, THROMB HAEMOSTASIS, V90, P577, DOI 10.1160/TH03-03-0196; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Feoktistov I, 2004, HYPERTENSION, V44, P649, DOI 10.1161/01.HYP.0000144800.21037.a5; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gelman IH, 2012, CANCER METAST REV, V31, P493, DOI 10.1007/s10555-012-9360-1; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; GORDON T, 1992, J CLIN INVEST, V90, P992, DOI 10.1172/JCI115976; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hu JM, 2011, MOL CANCER RES, V9, P1520, DOI 10.1158/1541-7786.MCR-11-0090; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kwon HB, 2012, EXP MOL MED, V44, P225, DOI 10.3858/emm.2012.44.3.017; Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Liu YZ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-105; Louis NA, 2005, FASEB J, V19, P950, DOI 10.1096/fj.04-3251com; MacManus CF, 2011, FASEB J, V25, P1856, DOI 10.1096/fj.10-170316; Ochoa CD, 2012, AM J PHYSIOL-LUNG C, V302, pL275, DOI [10.1152/ajplung.00215.2011., 10.1152/ajplung.00215.2011]; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL., 2011, COLD SPRING HARB SYM, V2011, P22; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Thamotharan S, 2013, AM J PHYSIOL-ENDOC M, V304, pE583, DOI 10.1152/ajpendo.00513.2012; Troger J, 2012, BRIT J PHARMACOL, V166, P420, DOI 10.1111/j.1476-5381.2011.01796.x; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; You QH, 2010, INFLAMM RES, V59, P949, DOI 10.1007/s00011-010-0207-3; You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019; Zan LK, 2011, NEUROCHEM INT, V58, P872, DOI 10.1016/j.neuint.2011.02.014	38	16	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					256	264		10.1096/fj.13-238741	http://dx.doi.org/10.1096/fj.13-238741			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24029533	Green Published			2022-12-25	WOS:000333526100025
J	Lee, KW; Okot-Kotber, C; LaComb, JF; Bogenhagen, DF				Lee, Ken-Wing; Okot-Kotber, Cynthia; LaComb, Joseph F.; Bogenhagen, Daniel F.			Mitochondrial Ribosomal RNA (rRNA) Methyltransferase Family Members Are Positioned to Modify Nascent rRNA in Foci near the Mitochondrial DNA Nucleoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERRESOLUTION FLUORESCENCE MICROSCOPY; REGULATES TRANSLATION; PROTEIN COMPLEX; LARGE SUBUNIT; BIOGENESIS; TRANSCRIPTION; REVEALS; METHYLATION; MEMBRANE; SITE	We have identified RNMTL1, MRM1, and MRM2 (FtsJ2) as members of the RNA methyltransferase family that may be responsible for the three known 2 '-O-ribose modifications of the 16 S rRNA core of the large mitochondrial ribosome subunit. These proteins are confined to foci located in the vicinity of mtDNA nucleoids. They show distinct patterns of association with mtDNA nucleoids and/or mitochondrial ribosomes in cell fractionation studies. We focused on the role of the least studied protein in this set, RNMTL1, to show that this protein interacts with the large ribosomal subunit as well as with a series of non-ribosomal proteins that may be involved in coupling of the rate of rRNA transcription and ribosome assembly in mitochondria. siRNA-directed silencing of RNMTL1 resulted in a significant inhibition of translation on mitochondrial ribosomes. Our results are consistent with a role for RNMTL1 in methylation of G(1370) of human 16 S rRNA.	[Lee, Ken-Wing; Okot-Kotber, Cynthia; LaComb, Joseph F.; Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu		LaComb, Joseph/0000-0002-2981-1072	Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported in part by a Senior Scholar Award from the Ellison Medical Foundation (to D.F.B.).	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; BAER RJ, 1981, NUCLEIC ACIDS RES, V9, P323, DOI 10.1093/nar/9.2.323; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2010, METHODS, V51, P458, DOI 10.1016/j.ymeth.2010.01.001; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; DUBIN DT, 1978, J MOL BIOL, V121, P523, DOI 10.1016/0022-2836(78)90398-4; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fischer RS, 2011, TRENDS CELL BIOL, V21, P682, DOI 10.1016/j.tcb.2011.09.008; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Koc EC, 2010, ISR J CHEM, V50, P45, DOI 10.1002/ijch.201000002; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016/j.molcel.2007.04.005; Luongo CL, 1998, J BIOL CHEM, V273, P23773, DOI 10.1074/jbc.273.37.23773; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; Mangat CS, 2008, MOL MICROBIOL, V70, P1051, DOI 10.1111/j.1365-2958.2008.06484.x; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Uchiumi T, 2010, NUCLEIC ACIDS RES, V38, P5554, DOI 10.1093/nar/gkq305; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wredenberg A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003178; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027	62	56	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31386	31399		10.1074/jbc.M113.515692	http://dx.doi.org/10.1074/jbc.M113.515692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036117	Green Published, hybrid			2022-12-25	WOS:000330778900055
J	Harvey, L; Fortin, D				Harvey, Lea; Fortin, Daniel			Spatial Heterogeneity in the Strength of Plant-Herbivore Interactions under Predation Risk: The Tale of Bison Foraging in Wolf Country	PLOS ONE			English	Article							PREY SHELL GAMES; HABITAT SELECTION; PATCH USE; ENERGY EXPENDITURES; SEARCHING BEHAVIOR; DECISION-MAKING; SCALE MOVEMENT; PLAINS BISON; ECOLOGY; INFORMATION	Spatial heterogeneity in the strength of trophic interactions is a fundamental property of food web spatial dynamics. The feeding effort of herbivores should reflect adaptive decisions that only become rewarding when foraging gains exceed 1) the metabolic costs, 2) the missed opportunity costs of not foraging elsewhere, and 3) the foraging costs of anti-predator behaviour. Two aspects of these costs remain largely unexplored: the link between the strength of plant-herbivore interactions and the spatial scale of food-quality assessment, and the predator-prey spatial game. We modeled the foraging effort of free-ranging plains bison (Bison bison bison) in winter, within a mosaic of discrete meadows. Spatial patterns of bison herbivory were largely driven by a search for high net energy gains and, to a lesser degree, by the spatial game with grey wolves (Canis lupus). Bison decreased local feeding effort with increasing metabolic and missed opportunity costs. Bison herbivory was most consistent with a broad-scale assessment of food patch quality, i.e., bison grazed more intensively in patches with a low missed opportunity cost relative to other patches available in the landscape. Bison and wolves had a higher probability of using the same meadows than expected randomly. This co-occurrence indicates wolves are ahead in the spatial game they play with bison. Wolves influenced bison foraging at fine scale, as bison tended to consume less biomass at each feeding station when in meadows where the risk of a wolf's arrival was relatively high. Also, bison left more high-quality vegetation in large than small meadows. This behavior does not maximize their energy intake rate, but is consistent with bison playing a shell game with wolves. Our assessment of bison foraging in a natural setting clarifies the complex nature of plant-herbivore interactions under predation risk, and reveals how spatial patterns in herbivory emerge from multi-scale landscape heterogeneity.	[Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Ctr Etud Foret, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Fortin, D (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	daniel.fortin@bio.ulaval.ca	Fortin, Daniel/ABG-3554-2020		Parks Canada Species at Risk Action and Education Fund; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Hydro-Quebec	Parks Canada Species at Risk Action and Education Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Hydro-Quebec	This work was supported by Parks Canada Species at Risk Action and Education Fund, the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation to D. F., and a scholarship to L. H. from Hydro-Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altendorf KB, 2001, J MAMMAL, V82, P430, DOI 10.1644/1545-1542(2001)082&lt;0430:AEOPRO&gt;2.0.CO;2; ANDERSON HG, 1980, CAN J BOT, V58, P985, DOI 10.1139/b80-121; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; BAILEY AW, 1974, J RANGE MANAGE, V27, P263, DOI 10.2307/3896819; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Bell AV, 2009, THEOR POPUL BIOL, V76, P52, DOI 10.1016/j.tpb.2009.03.008; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; BOERTJE RD, 1985, J RANGE MANAGE, V38, P468, DOI 10.2307/3899725; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Clavijo-Baquet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037069; Courant S, 2012, ANIM BEHAV, V84, P1039, DOI 10.1016/j.anbehav.2012.08.003; Courant S, 2012, OIKOS, V121, P1163, DOI 10.1111/j.1600-0706.2011.19994.x; Dias MP, 2009, ANIM BEHAV, V77, P1203, DOI 10.1016/j.anbehav.2009.02.002; FANCY SG, 1985, J WILDLIFE MANAGE, V49, P987, DOI 10.2307/3801384; Flaxman SM, 2009, J THEOR BIOL, V256, P187, DOI 10.1016/j.jtbi.2008.09.024; Flint R. F., 1971, GLACIAL QUATERNARY G; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fortin D, 2003, OECOLOGIA, V134, P219, DOI 10.1007/s00442-002-1112-4; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2003, BEHAV ECOL SOCIOBIOL, V54, P194, DOI 10.1007/s00265-003-0599-y; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Fortin M-E, 2007, EFFETS TAILLE GROUPE; Gese EM, 1996, CAN J ZOOL, V74, P784, DOI 10.1139/z96-090; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hochman V, 2007, BEHAV ECOL, V18, P368, DOI 10.1093/beheco/arl087; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; ILLIUS AW, 1992, J ANIM ECOL, V61, P183, DOI 10.2307/5521; Illius AW, 2002, OIKOS, V98, P558, DOI 10.1034/j.1600-0706.2002.980323.x; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kotler BP, 2002, EVOL ECOL RES, V4, P495; KOTLER BP, 1994, J WILDLIFE MANAGE, V58, P299, DOI 10.2307/3809395; KREBS JR, 1992, AM NAT, V140, pS63, DOI 10.1086/285397; Labbe M-C, 2012, JEU PREDATEUR PROIE; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Lecomte N, 2008, J ANIM ECOL, V77, P439, DOI 10.1111/j.1365-2656.2008.01354.x; Li Z, 2009, J ZOOL, V277, P302, DOI 10.1111/j.1469-7998.2008.00541.x; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; Matthews A, 2010, WILDLIFE RES, V37, P175, DOI 10.1071/WR09121; MCNAMARA JM, 1993, J THEOR BIOL, V164, P219, DOI 10.1006/jtbi.1993.1150; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Mogerman JH, 2010, ZOO FORAGING ECOLOGY; MURDEN SB, 1993, ECOL APPL, V3, P497, DOI 10.2307/1941918; NAIMAN RJ, 1994, ECOLOGY, V75, P905, DOI 10.2307/1939415; Olsson O, 1999, OIKOS, V87, P251, DOI 10.2307/3546740; Olsson O, 2007, ISR J ECOL EVOL, V53, P263, DOI 10.1560/IJEE.53.3.263; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; PINAY G, 1991, ARCH HYDROBIOL, V123, P187; REAL LA, 1992, AM NAT, V140, pS108, DOI 10.1086/285399; Rieucau G, 2007, CAN J ZOOL, V85, P839, DOI 10.1139/Z07-062; SCHAEFER JA, 1995, OECOLOGIA, V104, P39, DOI 10.1007/BF00365560; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; SCHWARTZ CC, 1988, J WILDLIFE MANAGE, V52, P26, DOI 10.2307/3801052; Searle KR, 2007, ISR J ECOL EVOL, V53, P297, DOI 10.1560/IJEE.53.3.297; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; Sih A., 1987, P203; Sih Andrew, 2005, P240; Sih Andrew, 1998, P221; Stephens D.W., 1986, pi; Strong WL, 2005, J BIOGEOGR, V32, P1043, DOI 10.1111/j.1365-2699.2004.01223.x; Taylor CA, 2012, RANGELAND ECOL MANAG, V65, P21, DOI 10.2111/REM-D-10-00124.1; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; TURNER MG, 1994, ECOL APPL, V4, P472, DOI 10.2307/1941951; Vickery WL, 2011, OIKOS, V120, P999, DOI 10.1111/j.1600-0706.2010.18448.x; Vonesh EF, 1997, LINEAR NONLINEAR MOD, P419; Westbrook CJ, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1359; Williams AC, 2012, ANIM BEHAV, V83, P883, DOI 10.1016/j.anbehav.2012.01.008; Wolf M, 2009, ECOGRAPHY, V32, P401, DOI 10.1111/j.1600-0587.2008.05626.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	85	20	20	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73324	10.1371/journal.pone.0073324	http://dx.doi.org/10.1371/journal.pone.0073324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039909	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500030
J	Mineva, ND; Paulson, KE; Naber, SP; Yee, AS; Sonenshein, GE				Mineva, Nora D.; Paulson, K. Eric; Naber, Stephen P.; Yee, Amy S.; Sonenshein, Gail E.			Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN PROSTATE-CANCER; GREEN-TEA-CATECHINS; VEGF-D PROMOTES; FOLLOW-UP; TUMOR LYMPHANGIOGENESIS; INVASIVE PHENOTYPE; GENE-EXPRESSION; POLYPHENON-E; RHOC GTPASE	Inflammatory Breast Cancer (IBC) is a highly aggressive form of cancer characterized by high rates of proliferation, lymphangiogenesis and metastasis, and an overall poor survival. As regular green tea consumption has been associated with improved prognosis of breast cancer patients, including decreased risk of recurrence, here the effects of the green tea polyphenol epigallocatechin-3-gallate (EGCG) were tested on two IBC lines: SUM-149 and SUM-190. EGCG decreased expression of genes that promote proliferation, migration, invasion, and survival. Consistently, growth, invasive properties, and survival of IBC cells were reduced by EGCG treatment. EGCG also reduced lymphangiogenesis-promoting genes, in particular VEGF-D. Conditioned media from EGCG-treated IBC cells displayed decreased VEGF-D secretion and reduced ability to promote lymphangiogenesis in vitro as measured by hTERT-HDLEC lymphatic endothelial cell migration and tube formation. Tumorsphere formation by SUM-149 cells was robustly inhibited by EGCG, suggesting effects on self-renewal ability. Stem-like SUM-149 cells with high aldehyde dehydrogenase (ALDH) activity, previously implicated in poor patient prognosis, were isolated. EGCG treatment reduced growth and induced apoptosis of the stem-like SUM-149 cells in culture. In an orthotopic mouse model, EGCG decreased growth of pre-existing tumors derived from ALDH-positive stem-like SUM-149 cells and their expression of VEGF-D, which correlated with a significant decrease in peritumoral lymphatic vessel density. Thus, EGCG inhibits the overall aggressive IBC phenotype. Reduction of the stem-like cell compartment by EGCG may explain the decreased risk of breast cancer recurrence among green tea drinkers. Recent clinical trials demonstrate the efficacy of green tea polyphenol extracts in treatment of prostate cancer and lymphocytic leukemia with low toxicity. Given the poor prognosis of IBC patients, our findings suggest further exploration of EGCG or green tea in combinatorial treatments against active IBC disease or in maintenance regimens to avoid recurrence is warranted.	[Mineva, Nora D.; Paulson, K. Eric; Yee, Amy S.; Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol & Lab Med, Boston, MA USA	Tufts University; Tufts Medical Center	Sonenshein, GE (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.	gail.sonenshein@tufts.edu			National Institutes of Health (NIH) [R01 CA129129, P01 ES011624]; NATIONAL CANCER INSTITUTE [R01CA129129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by National Institutes of Health (NIH) grants R01 CA129129 and P01 ES011624 (G. E. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2003, EUR J CANCER PREV, V12, P383, DOI 10.1097/00008469-200310000-00007; Anderson William F, 2005, Breast Dis, V22, P9; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Brausi M, 2008, EUR UROL, V54, P472, DOI 10.1016/j.eururo.2008.03.100; Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567; Cariati M, 2005, SURG ONCOL, V14, P133, DOI 10.1016/j.suronc.2005.07.004; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Choudhary S, 2012, CARCINOGENESIS, V33, P876, DOI 10.1093/carcin/bgs097; Cristofanilli M, 2007, CANCER-AM CANCER SOC, V110, P1436, DOI 10.1002/cncr.22927; Currie MJ, 2013, HUM PATHOL, V44, P402, DOI 10.1016/j.humpath.2012.06.004; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Inoue M, 2001, CANCER LETT, V167, P175, DOI 10.1016/S0304-3835(01)00486-4; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim HJ, 2007, MOL CANCER RES, V5, P321, DOI 10.1158/1541-7786.MCR-06-0218; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Koch M, 2009, J PATHOL, V219, P356, DOI 10.1002/path.2605; Lerebours F, 2005, BREAST CANCER RES, V7, P52, DOI 10.1186/bcr997; Li J, 2011, ONCOLOGIST, V16, P1675, DOI 10.1634/theoncologist.2011-0196; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Merajver SD, 2004, DIS BREAST; Mineva ND, 2009, J CELL PHYSIOL, V220, P593, DOI 10.1002/jcp.21765; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Nakachi K, 1998, JPN J CANCER RES, V89, P254, DOI 10.1111/j.1349-7006.1998.tb00556.x; Nakamura Y, 2003, CLIN CANCER RES, V9, P716; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tomlinson JS, 2001, CANCER RES, V61, P5231; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Van der Auwera I, 2005, CLIN CANCER RES, V11, P7637, DOI 10.1158/1078-0432.CCR-05-1142; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Yamaguchi K, 1997, J IMMUNOL, V158, P2165; Yang CS, 2010, NUTR CANCER, V62, P931, DOI 10.1080/01635581.2010.509536; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	50	62	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73464	10.1371/journal.pone.0073464	http://dx.doi.org/10.1371/journal.pone.0073464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039951	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500033
J	Nuding, S; Gersemann, M; Hosaka, Y; Konietzny, S; Schaefer, C; Beisner, J; Schroeder, BO; Ostaff, MJ; Saigenji, K; Ott, G; Schaller, M; Stange, EF; Wehkamp, J				Nuding, Sabine; Gersemann, Michael; Hosaka, Yoshio; Konietzny, Sabrina; Schaefer, Christian; Beisner, Julia; Schroeder, Bjoern O.; Ostaff, Maureen J.; Saigenji, Katunori; Ott, German; Schaller, Martin; Stange, Eduard F.; Wehkamp, Jan			Gastric Antimicrobial Peptides Fail to Eradicate Helicobacter pylori Infection Due to Selective Induction and Resistance	PLOS ONE			English	Article							CAG PATHOGENICITY ISLAND; BETA-DEFENSINS; CROHNS-DISEASE; HOST-DEFENSE; GASTROINTESTINAL-TRACT; EPITHELIAL-CELLS; MUCOSAL TISSUES; INNATE IMMUNITY; EXPRESSION; STOMACH	Background: Although antimicrobial peptides protect mucus and mucosa from bacteria, Helicobacter pylori is able to colonize the gastric mucus. To clarify in which extend Helicobacter escapes the antimicrobial defense, we systematically assessed susceptibility and expression levels of different antimicrobial host factors in gastric mucosa with and without H. pylori infection. Materials and Methods: We investigated the expression levels of HBD1 (gene name DEFB1), HBD2 (DEFB4A), HBD3 (DEFB103A), HBD4 (DEFB104A), LL37 (CAMP) and elafin (PI3) by real time PCR in gastric biopsy samples in a total of 20 controls versus 12 patients colonized with H. pylori. Immunostaining was performed for HBD2 and HBD3. We assessed antimicrobial susceptibility by flow cytometry, growth on blood agar, radial diffusion assay and electron microscopy. Results: H. pylori infection was associated with increased gastric levels of the inducible defensin HBD2 and of the antiprotease elafin, whereas the expression levels of the constitutive defensin HBD1, inducible HBD3 and LL37 remained unchanged. HBD4 was not expressed in significant levels in gastric mucosa. H. pylori strains were resistant to the defensins HBD1 as well as to elafin, and strain specific minimally susceptible to HBD2, whereas HBD3 and LL37 killed all H. pylori strains effectively. We demonstrated the binding of HBD2 and LL37 on the surface of H. pylori cells. Comparing the antibacterial activity of extracts from H. pylori negative and positive biopsies, we found only a minimal killing against H. pylori that was not increased by the induction of HBD2 in H. pylori positive samples. Conclusion: These data support the hypothesis that gastric H. pylori evades the host defense shield to allow colonization.	[Nuding, Sabine; Beisner, Julia; Schroeder, Bjoern O.; Ostaff, Maureen J.; Wehkamp, Jan] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Nuding, Sabine; Beisner, Julia; Schroeder, Bjoern O.; Ostaff, Maureen J.; Wehkamp, Jan] Univ Tubingen, Stuttgart, Germany; [Gersemann, Michael; Konietzny, Sabrina; Schaefer, Christian; Stange, Eduard F.; Wehkamp, Jan] Robert Bosch Krankenhaus, Dept Internal Med 1, Stuttgart, Germany; [Hosaka, Yoshio] Isuzu Hosp, Dept Internal Med, Tokyo, Japan; [Saigenji, Katunori] Kitasato Univ, Dept Gastroenterol, Kanagawa, Japan; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Bosch; Robert Bosch Krankenhaus; Kitasato University; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nuding, S (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.	Sabine.Nuding@ikp-stuttgart.de	Schroeder, Bjoern O/F-3353-2011; Wehkamp, Jan/B-7319-2011	Schroeder, Bjoern O/0000-0002-6716-8284; Wehkamp, Jan/0000-0001-6788-841X	Robert Bosch Foundation Stuttgart	Robert Bosch Foundation Stuttgart	This work was supported by the Robert Bosch Foundation Stuttgart. (www.bosch-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj-Elliott M, 2002, GUT, V51, P356, DOI 10.1136/gut.51.3.356; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Canny G, 2002, P NATL ACAD SCI USA, V99, P3902, DOI 10.1073/pnas.052533799; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; George JT, 2003, MOL IMMUNOL, V40, P451, DOI 10.1016/S0161-5890(03)00158-5; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Hamanaka Y, 2001, GUT, V49, P481, DOI 10.1136/gut.49.4.481; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Hornsby MJ, 2008, GASTROENTEROLOGY, V134, P1049, DOI 10.1053/j.gastro.2008.01.018; Hosaka Y, 2008, EUR J GASTROEN HEPAT, V20, P1151, DOI 10.1097/MEG.0b013e3283052ddb; Hu Y, 2012, WORLD J GASTROENTERO, V18, P1257, DOI 10.3748/wjg.v18.i11.1257; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Isomoto H, 2005, WORLD J GASTROENTERO, V11, P4782, DOI 10.3748/wjg.v11.i31.4782; Kawauchi K, 2006, WORLD J GASTROENTERO, V12, P5793, DOI 10.3748/wjg.v12.i36.5793; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Meyer-Hoffert U, 2003, EXP DERMATOL, V12, P418, DOI 10.1034/j.1600-0625.2002.120409.x; Nishi Y, 2005, WORLD J GASTROENTERO, V11, P99, DOI 10.3748/wjg.v11.i1.99; O'Neil DA, 2000, INFECT IMMUN, V68, P5412, DOI 10.1128/IAI.68.9.5412-5415.2000; Ohara T, 2005, HEPATO-GASTROENTEROL, V52, P1320; Otte JM, 2009, EUR J CLIN INVEST, V39, P126, DOI 10.1111/j.1365-2362.2008.02071.x; Ouellette AJ, 2004, BEST PRACT RES CL GA, V18, P405, DOI 10.1016/j.bpg.2003.10.010; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; Schmid M, 2007, J LEUKOCYTE BIOL, V81, P907, DOI 10.1189/jlb.0906581; Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Taha AS, 2005, DIGEST LIVER DIS, V37, P51, DOI 10.1016/j.dld.2004.07.019; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Vordenbaumen S, 2010, J PEDIATR GASTR NUTR, V50, P596, DOI 10.1097/MPG.0b013e3181cd26cd; Wada A, 1999, BIOCHEM BIOPH RES CO, V263, P770, DOI 10.1006/bbrc.1999.1452; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2003, J CLIN PATHOL, V56, P352, DOI 10.1136/jcp.56.5.352; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zilberstein B, 2007, CLINICS, V62, P47, DOI 10.1590/S1807-59322007000100008; Zullo A, 2009, AM J GASTROENTEROL, V104, P1932, DOI 10.1038/ajg.2009.314	44	25	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73867	10.1371/journal.pone.0073867	http://dx.doi.org/10.1371/journal.pone.0073867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040100	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500057
J	Behm, JE; Yang, XD; Chen, J				Behm, Jocelyn E.; Yang, Xiaodong; Chen, Jin			Slipping through the Cracks: Rubber Plantation Is Unsuitable Breeding Habitat for Frogs in Xishuangbanna, China	PLOS ONE			English	Article							GLOBAL AMPHIBIAN DECLINES; FOREST CANOPY; HYLA-CHRYSOSCELIS; OVIPOSITION SITE; DIVERSITY; CONSERVATION; POPULATION; SELECTION; FRAGMENTATION; LANDSCAPE	Conversion of tropical forests into agriculture may present a serious risk to amphibian diversity if amphibians are not able to use agricultural areas as habitat. Recently, in Xishuangbanna Prefecture, Yunnan Province - a hotspot of frog diversity within China - two-thirds of the native tropical rainforests have been converted into rubber plantation agriculture. We conducted surveys and experiments to quantify habitat use for breeding and non-breeding life history activities of the native frog species in rainforest, rubber plantation and other human impacted sites. Rubber plantation sites had the lowest species richness in our non-breeding habitat surveys and no species used rubber plantation sites as breeding habitat. The absence of breeding was likely not due to intrinsic properties of the rubber plantation pools, as our experiments indicated that rubber plantation pools were suitable for tadpole growth and development. Rather, the absence of breeding in the rubber plantation was likely due to a misalignment of breeding and non-breeding habitat preferences. Analyses of our breeding surveys showed that percent canopy cover over pools was the strongest environmental variable influencing breeding site selection, with species exhibiting preferences for pools under both high and low canopy cover. Although rubber plantation pools had high canopy cover, the only species that bred in high canopy cover sites used the rainforest for both non-breeding and breeding activities, completing their entire life cycle in the rainforest. Conversely, the species that did use the rubber plantation for non-breeding habitat preferred to breed in low canopy sites, also avoiding breeding in the rubber plantation. Rubber plantations are likely an intermediate habitat type that 'slips through the cracks' of species habitat preferences and is thus avoided for breeding. In summary, unlike the rainforests they replaced, rubber plantations alone may not be able to support frog populations.	[Behm, Jocelyn E.; Yang, Xiaodong; Chen, Jin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Menglun, Yunnan, Peoples R China; [Behm, Jocelyn E.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Behm, Jocelyn E.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University of Wisconsin System; University of Wisconsin Madison; Vrije Universiteit Amsterdam	Behm, JE (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Menglun, Yunnan, Peoples R China.	jebehm@wisc.edu			Fulbright Institute of International Education; US National Science foundation Integrated Graduate Education Research and Training Grant - Biodiversity and Sustainable Development in Southwest China [DGE-0549369]; University of Wisconsin Department of Zoology	Fulbright Institute of International Education; US National Science foundation Integrated Graduate Education Research and Training Grant - Biodiversity and Sustainable Development in Southwest China; University of Wisconsin Department of Zoology	Work funded by Fulbright Institute of International Education (http://www.iie.org/fulbright); US National Science foundation Integrated Graduate Education Research and Training Grant - Biodiversity and Sustainable Development in Southwest China (Grant No. DGE-0549369; http://swchina.wisc.edu/ and http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12759), and the University of Wisconsin Department of Zoology (http://www.zoology.wisc.edu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Bates D, 2001, LME4 LINEAR MIXED EF; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Becker CG, 2007, J NAT HIST, V41, P1739, DOI 10.1080/00222930701443145; Binckley CA, 2003, OIKOS, V102, P623, DOI 10.1034/j.1600-0706.2003.12483.x; Binckley CA, 2002, OECOLOGIA, V130, P157, DOI 10.1007/s004420100781; Binckley CA, 2007, OECOLOGIA, V153, P951, DOI 10.1007/s00442-007-0780-5; Boone MD, 2007, ECOL APPL, V17, P291, DOI 10.1890/1051-0761(2007)017[0291:MSIACE]2.0.CO;2; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Cao M, 2006, BIOTROPICA, V38, P306, DOI 10.1111/j.1744-7429.2006.00146.x; Chen YH, 2007, CURR SCI INDIA, V92, P480; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; da Silva FR, 2012, BIODIVERS CONSERV, V21, P1411, DOI 10.1007/s10531-012-0252-z; Silva Fernando Rodrigues da, 2009, Biota Neotrop., V9, P253, DOI 10.1590/S1676-06032009000400026; Funk WC, 2005, BIOL LETT-UK, V1, P13, DOI 10.1098/rsbl.2004.0270; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gelman A., 2007, DATA ANAL USING REGR; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gosner K. L., 1960, Herpetologica, V16, P183; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guardiola-Claramonte M, 2008, ECOHYDROLOGY, V1, P13, DOI 10.1002/eco.3; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Jackson MM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00116.1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Li HM, 2009, BIODIVERS CONSERV, V18, P3421, DOI 10.1007/s10531-009-9651-1; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oksanen J, 2011, EGAN COMMUNITY ECOLO; Parris KM, 2004, ACTA OECOL, V25, P93, DOI 10.1016/j.actao.2003.11.006; Patrick DA, 2008, BIOL CONSERV, V141, P807, DOI 10.1016/j.biocon.2007.12.026; Petranka JW, 2003, WETLANDS, V23, P1030, DOI 10.1672/0277-5212(2003)023[1030:ROATRO]2.0.CO;2; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Core Team, 2016, R FDN STAT COMP; Relyea RA, 2004, ENVIRON TOXICOL CHEM, V23, P1737, DOI 10.1897/03-493; Resetarits WJ, 2005, ECOL LETT, V8, P480, DOI 10.1111/j.1461-0248.2005.00747.x; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; Rothermel BB, 2004, ECOL APPL, V14, P1535, DOI 10.1890/03-5206; Rowe CL, 2001, ARCH ENVIRON CON TOX, V40, P399; Rowley J, 2010, BIOL LETTERS, V6, P336, DOI 10.1098/rsbl.2009.0793; Schiesari L, 2006, FRESHWATER BIOL, V51, P412, DOI 10.1111/j.1365-2427.2005.01497.x; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Sheridan Jennifer A., 2008, Herpetological Review, V39, P165; Silva FR, 2012, LANDSCAPE ECOL, V27, P87, DOI 10.1007/s10980-011-9670-7; Silva WG., 2007, Braz. J. Biol., V67, P403, DOI 10.1590/S1519-69842007000300004; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P983, DOI 10.1890/0012-9658(2002)083[0983:FCATPO]2.0.CO;2; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Sodhi NS, 2009, BIOTROPICA, V41, P103, DOI 10.1111/j.1744-7429.2008.00460.x; Storfer A, 2003, DIVERS DISTRIB, V9, P151, DOI 10.1046/j.1472-4642.2003.00014.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sullivan KB, 2003, ENVIRON TOXICOL CHEM, V22, P627, DOI [10.1897/1551-5028(2003)022&lt;0627:EOSCOA&gt;2.0.CO;2, 10.1002/etc.5620220323]; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Thurgate NY, 2007, J WILDLIFE MANAGE, V71, P1845, DOI 10.2193/2005-586; Vallan D, 2000, BIOL CONSERV, V96, P31, DOI 10.1016/S0006-3207(00)00041-0; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; VANGELDER JJ, 1973, OECOLOGIA, V13, P93, DOI 10.1007/BF00379622; Vonesh JR, 2007, OECOLOGIA, V154, P219, DOI 10.1007/s00442-007-0811-2; Wanger TC, 2009, J APPL ECOL, V46, P823, DOI 10.1111/j.1365-2664.2009.01663.x; Weir LA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P307; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Williams BK, 2008, OECOLOGIA, V155, P377, DOI 10.1007/s00442-007-0920-y; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Yu GB, 2007, EFFECTS EARTHWORM SO, P5	70	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73688	10.1371/journal.pone.0073688	http://dx.doi.org/10.1371/journal.pone.0073688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040026	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600038
J	Nouraee, N; Van Roosbroeck, K; Vasei, M; Semnani, S; Samaei, NM; Naghshvar, F; Omidi, AA; Calin, GA; Mowla, SJ				Nouraee, Nazila; Van Roosbroeck, Katrien; Vasei, Mohammad; Semnani, Shahriar; Samaei, Nader Mansour; Naghshvar, Farshad; Omidi, Abbas Ali; Calin, George A.; Mowla, Seyed Javad			Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; TGF-BETA; IN-SITU; DOWN-REGULATION; CANCER; INVASION; PROLIFERATION; APOPTOSIS; TARGETS; BREAST	Objective: MiR-21 is an oncomir expressed by malignant cells and/or tumor microenvironment components. In this study we focused on understanding the effects of stromal miR-21 on esophageal malignant cells. Design: MiR-21 expression was evaluated in formalin-fixed paraffin-embedded samples from patients with esophageal squamous-cell carcinoma (SCC) by quantitative RT-PCR. MiR-21 tissue distribution was visualized with in situ hybridization. A co-culture system of normal fibroblasts and esophageal cancer cells was used to determine the effects of fibroblasts on miR-21 expression levels, and on SCC cell migration and invasion. Results: MiR-21 was overexpressed in SCCs, when compared to the adjacent non-tumor tissues (P = 0.0007), and was mainly localized in the cytoplasm of stromal cells adjacent to malignant cells. Accordingly, miR-21 expression was increased in tumors with high versus low stromal content (P = 0.04). When co-cultured with normal fibroblasts, miR-21 expression was elevated in SCC cells (KYSE-30), while its expression was restricted to fibroblasts when co-cultured with adenocarcinoma cells (OE-33 and FLO-1). MiR-21 was detected in conditioned media of cancer cell lines, illustrating the release of this miRNA into the environment. Co-culturing with normal fibroblasts or addition of fibroblast conditioned media caused a significant increase in cell migration and invasion potency of KYSE-30 cells (P<0.0001). In addition, co-culturing cancer cells with fibroblasts and expression of miR-21 induced the expression of the cancer associated fibroblast (CAF) marker S100A4. Conclusions: MiR-21 expression is mostly confined to the SCC stroma and its release from fibroblasts influences the migration and invasion capacity of SCC cells. Moreover, miR-21 may be an important factor in "activating" fibroblasts to CAFs. These findings provide new insights into the role of CAFs and the extracellular matrix in tumor microenvironment formation and in tumor cell maintenance, and suggest miR-21 may contribute to cellular crosstalk in the tumor microenvironment.	[Nouraee, Nazila; Mowla, Seyed Javad] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran; [Nouraee, Nazila; Van Roosbroeck, Katrien; Calin, George A.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Vasei, Mohammad] Univ Tehran Med Sci, Pathol Lab, Shariati Hosp, Tehran, Iran; [Semnani, Shahriar] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Samaei, Nader Mansour] Golestan Univ Med Sci, Dept Human Genet, Gorgan, Iran; [Naghshvar, Farshad] Mazandaran Univ Med Sci, Dept Pathol, Sari, Iran; [Omidi, Abbas Ali] Mashhad Univ Med Sci, Dept Pathol, Mashhad, Iran	Tarbiat Modares University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Tehran University of Medical Sciences; Golestan University of Medical Sciences; Golestan University of Medical Sciences; Mazandaran University Medical Sciences; Mashhad University Medical Science	Calin, GA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gcalin@mdanderson.org; sjmowla@modares.ac.ir	Semnani, Shahryar/N-2270-2016; Naghshvar, Farshad/R-7280-2018; Calin, George/E-9390-2011; Omidi, Abdollah/G-8161-2017	Semnani, Shahryar/0000-0002-8768-6142; Mansour Samaei, nader/0000-0002-1317-366X; Nouraee, Nazila/0000-0001-8560-1451; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578; Omidi, Abdollah/0000-0001-5538-7693; Mowla, Seyed Javad/0000-0002-3300-6332	Golestan University of Medical Sciences; University of Texas MD Anderson Research Trust; University of Texas System Regents Research Scholar; King Baudouin Foundation; Belgian American Educational Foundation (B.A.E.F.)	Golestan University of Medical Sciences; University of Texas MD Anderson Research Trust; University of Texas System Regents Research Scholar; King Baudouin Foundation; Belgian American Educational Foundation (B.A.E.F.)	NN is partially supported by a research grant from the research deputy of Golestan University of Medical Sciences. GC is the Alan M. Gewirtz Leukemia & Lymphoma Society Scholar. He is also supported as a Fellow of The University of Texas MD Anderson Research Trust and as a University of Texas System Regents Research Scholar. KVR is a Henri Benedictus Fellow of the King Baudouin Foundation and the Belgian American Educational Foundation (B.A.E.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi I, 2011, DIS ESOPHAGUS, V24, P523, DOI 10.1111/j.1442-2050.2011.01177.x; Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bozoky B, 2013, INT J CANCER, V133, P286, DOI 10.1002/ijc.28035; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cirri P, 2011, AM J CANCER RES, V1, P482; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Delgado M Dolore, 2006, Clin Transl Oncol, V8, P780; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Islami F, 2009, EUR J CANCER, V45, P3156, DOI 10.1016/j.ejca.2009.09.018; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kimura S, 2010, ONCOL REP, V23, P1625, DOI 10.3892/or_00000804; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Mandinova A, 1998, J CELL SCI, V111, P2043; Mase Y, 2012, REPROD SCI, V19, P1030, DOI 10.1177/1933719112442245; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; McPherson RA, 2011, HENRYS CLIN DIAGNOSI; Mori Y, 2009, MOL MED REP, V2, P235, DOI 10.3892/mmr_00000089; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Patnaik SK, 2010, J GASTROINTEST ONCOL, V1, P55, DOI 10.3978/j.issn.2078-6891.2010.011; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Rask L, 2011, APMIS, V119, P663, DOI 10.1111/j.1600-0463.2011.02782.x; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tejani MA, 2012, CURR TREAT OPTION ON, V13, P390, DOI 10.1007/s11864-012-0193-5; Vallbohmer D, 2010, J GASTROINTEST SURG, V14, P75, DOI 10.1007/s11605-009-1021-5; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Wentz-Hunter K K, 2011, Mol Biol Int, V2011, P839872, DOI 10.4061/2011/839872; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wu BL, 2011, WORLD J GASTROENTERO, V17, P79, DOI 10.3748/wjg.v17.i1.79; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	56	83	87	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73009	10.1371/journal.pone.0073009	http://dx.doi.org/10.1371/journal.pone.0073009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039846	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600013
J	de Oliveira-Carlos, V; Ganz, J; Hans, S; Kaslin, J; Brand, M				de Oliveira-Carlos, Vanessa; Ganz, Julia; Hans, Stefan; Kaslin, Jan; Brand, Michael			Notch Receptor Expression in Neurogenic Regions of the Adult Zebrafish Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; RADIAL GLIAL IDENTITY; PROGENITOR CELLS; NERVOUS-SYSTEM; SPINAL-CORD; ACTIVATION; MAINTENANCE; GLIOGENESIS; HOMOLOG; GENE	The adult zebrash brain has a remarkable constitutive neurogenic capacity. The regulation and maintenance of its adult neurogenic niches are poorly understood. In mammals, Notch signaling is involved in stem cell maintenance both in embryonic and adult CNS. To better understand how Notch signaling is involved in stem cell maintenance during adult neurogenesis in zebrafish we analysed Notch receptor expression in five neurogenic zones of the adult zebrafish brain. Combining proliferation and glial markers we identified several subsets of Notch receptor expressing cells. We found that 90 % of proliferating radial glia express notch1a, notch1b and notch3. In contrast, the proliferating non-glial populations of the dorsal telencephalon and hypothalamus rarely express notch3 and about half express notch1a/1b. In the non-proliferating radial glia notch3 is the predominant receptor throughout the brain. In the ventral telencephalon and in the mitotic area of the optic tectum, where cells have neuroepithelial properties, notch1a/1b/3 are expressed in most proliferating cells. However, in the cerebellar niche, although progenitors also have neuroepithelial properties, only notch1a/1b are expressed in a high number of PCNA (+) cells. In this region notch3 expression is mostly in Bergmann glia and at low levels in few PCNA (+) cells. Additionally, we found that in the proliferation zone of the ventral telencephalon, Notch receptors display an apical high to basal low gradient of expression. Notch receptors are also expressed in subpopulations of oligodendrocytes, neurons and endothelial cells. We suggest that the partial regional heterogeneity observed for Notch expression in progenitor cells might be related to the cellular diversity present in each of these neurogenic niches.	[Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Brand, M (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Ganz, Julia/A-7819-2010; Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Kaslin, Jan/0000-0002-6207-1889	Deutsche Forschungsgemeinschaft [SFB 655-A3]; EU (Zf-Health); FCT [SFRH/BD/43328/2008]; POPH-QREN	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU (Zf-Health); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH-QREN	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 655-A3) and the EU (Zf-Health). VOC is funded by an FCT fellowship (SFRH/BD/43328/2008, financed by POPH-QREN; www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Alunni A, 2013, DEVELOPMENT, V140, P3335, DOI 10.1242/dev.095018; Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beatus P, 1999, DEVELOPMENT, V126, P3925; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Butler A. B., 2005, COMP VERTEBRATE NEUR; CamposOrtega JA, 1997, PERSPECT DEV NEUROBI, V4, P267; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chapouton P, 2006, DEVELOPMENT, V133, P4293, DOI 10.1242/dev.02573; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Cisneros E, 2008, MOL CELL NEUROSCI, V37, P820, DOI 10.1016/j.mcn.2008.01.011; D'Angelo L, 2012, MICROSC RES TECHNIQ, V75, P441, DOI 10.1002/jemt.21075; Dang L, 2006, DEV NEUROSCI-BASEL, V28, P58, DOI 10.1159/000090753; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dias TB, 2012, J NEUROSCI, V32, P3245, DOI 10.1523/JNEUROSCI.6398-11.2012; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kishimoto N, 2011, DIS MODEL MECH; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Komine O, 2007, DEV BIOL, V311, P238, DOI 10.1016/j.ydbio.2007.08.042; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kroehne V, 2011, DEVELOPMENT; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Lindsey BW, 2012, J COMP NEUROL, V520, P2275, DOI 10.1002/cne.23065; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Marz M, 2010, DEV DYNAM, V239, P3336, DOI 10.1002/dvdy.22455; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mueller T., 2005, ATLAS EARLY ZEBRAFIS; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; NYE JS, 1994, DEVELOPMENT, V120, P2421; Park HC, 2007, DEV DYNAM, V236, P3402, DOI 10.1002/dvdy.21365; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Schebesta M, 2009, DEV DYNAM, V238, P887, DOI 10.1002/dvdy.21909; Scheer N, 2001, DEVELOPMENT, V128, P1099; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shin J, 2007, DEVELOPMENT, V134, P1911, DOI 10.1242/dev.001602; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Sullivan SA, 1997, DEV GENET, V20, P208, DOI 10.1002/(SICI)1520-6408(1997)20:3<208::AID-DVG4>3.0.CO;2-B; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Vilas-Boas F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-58; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Wulliman MF, 1996, NEUROANATOMY ZEBRAFI; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007	99	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73384	10.1371/journal.pone.0073384	http://dx.doi.org/10.1371/journal.pone.0073384			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039926	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300070
J	Eglit, T; Ringmets, I; Lember, M				Eglit, Triin; Ringmets, Inge; Lember, Margus			Obesity, High-Molecular-Weight (HMW) Adiponectin, and Metabolic Risk Factors: Prevalence and Gender-Specific Associations in Estonia	PLOS ONE			English	Article							ADIPOSE-TISSUE DYSFUNCTION; BLOOD-PRESSURE; HEALTHY; WOMEN; POPULATION; OVERWEIGHT; ADIPOKINES; MARKERS; PLASMA; FORM	Background: The metabolic consequences of obesity are associated with an imbalance of adipocytokines, e. g. adiponectin. However, some obese subjects remain metabolically healthy and have adiponectin levels similar to normal body weight subjects. Current estimates of the prevalence of obesity in Estonia have relied only on self-report data. Objectives: To estimate the prevalence of obesity in Estonia, to test for associations between HMW adiponectin and metabolic risk factors and to test if HMW adiponectin levels differentiate metabolically healthy and metabolically unhealthy subjects. Methods: We conducted a population-based cross-sectional multicentre study to gather history, examination and blood test results for 495 subjects aged 20-74. Metabolically healthy subjects were free from hypertension, dyslipidaemia, impaired glucose regulation and insulin resistance. Metabolically unhealthy subjects had at least one of these four metabolic abnormalities. Results: The prevalence of obesity was 29% in men and 34% in women. HMW adiponectin was positively correlated with HDL cholesterol and negatively correlated with triglycerides, obesity, insulin resistance and blood glucose. This effect was driven by metabolically unhealthy subjects in men, but by both metabolically healthy and metabolically unhealthy subjects in women. Metabolically healthy women had higher HMW adiponectin levels than metabolically unhealthy women. 12% of all obese subjects were metabolically healthy, and their HMW adiponectin levels were similar to normal weight subjects. Conclusions: Obesity is more prevalent in Estonian adults than previously thought. HMW adiponectin levels were associated with various metabolic risk factors in metabolically healthy women but not in metabolically healthy men. For both genders, HMW adiponectin differentiates metabolically healthy obese subjects from metabolically unhealthy obese subjects.	[Eglit, Triin; Lember, Margus] Univ Tartu, Dept Internal Med, EE-50090 Tartu, Estonia; [Eglit, Triin; Lember, Margus] Tartu Univ Hosp, Tartu, Estonia; [Ringmets, Inge] Univ Tartu, Dept Publ Hlth, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Eglit, T (corresponding author), Univ Tartu, Dept Internal Med, Ulikooli 18, EE-50090 Tartu, Estonia.	triin.eglit@kliinikum.ee	Lember, Margus/H-2306-2015; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Estonian Ministry of Education and Science [SF0180081s07]; Institutional Research Funding [IUT2-8]; Estonian Science Foundation [ETF8872]	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Institutional Research Funding; Estonian Science Foundation	This study was supported by targeted funding No. SF0180081s07 by the Estonian Ministry of Education and Science, by Institutional Research Funding IUT2-8 and by Estonian Science Foundation Grant No. ETF8872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alam I, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/456456; Andreasson AN, 2012, AM J HUM BIOL, V24, P595, DOI 10.1002/ajhb.22279; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Aprahamian TR, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/376909; Baden MY, 2013, CLIN ENDOCRINOL, V78, P226, DOI 10.1111/j.1365-2265.2012.04370.x; Bik W, 2010, NEUROENDOCRINOL LETT, V31, P497; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Doumatey AP, 2012, J ENDOCRINOL METAB, V2, P51, DOI 10.4021/jem95w; Eglit T, 2013, EUR J ENDOCRINOL, V168, P385, DOI 10.1530/EJE-12-0688; Elisha B, 2010, DIABETES METAB, V36, P319, DOI 10.1016/j.diabet.2010.03.004; Erglis A, 2012, MEDICINA-LITHUANIA, V48, P310, DOI 10.3390/medicina48060046; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Kawamoto R, 2011, CLIN EXP HYPERTENS, V33, P336, DOI 10.3109/10641963.2010.531847; Khan UI, 2012, METABOLISM, V61, P1261, DOI 10.1016/j.metabol.2012.02.005; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Nyholm M, 2008, OBESITY, V16, P896, DOI 10.1038/oby.2007.134; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Okamoto Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/313179; Organization WH, 1998, WELLB MEAS PRIM HLTH; Pataky Z, 2010, INT J OBESITY, V34, pS18, DOI 10.1038/ijo.2010.235; Poljicanin T, 2012, COLLEGIUM ANTROPOL, V36, P9, DOI 10.5671/ca.2012361s.9; R Core Team, 2021, R LANG ENV STAT COMP; Rathmann W, 2007, INT J OBESITY, V31, P770, DOI 10.1038/sj.ijo.0803471; Riestra P, 2013, HORM RES PAEDIAT, V79, P83, DOI 10.1159/000346898; Spahija Bujar, 2012, Med Arch, V66, P16; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Sun YY, 2009, CARDIOVASC THER, V27, P59, DOI 10.1111/j.1755-5922.2008.00069.x; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tekkel M, 2009, HLTH BEHAV ESTONIAN; Tsigos C, 2008, OBESITY FACTS, V1, P106, DOI 10.1159/000126822; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yasui T, 2007, CLIN CHIM ACTA, V386, P69, DOI 10.1016/j.cca.2007.08.001; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]	42	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73273	10.1371/journal.pone.0073273	http://dx.doi.org/10.1371/journal.pone.0073273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039900	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300062
J	Jin, YJ; Tachibana, I; Takeda, Y; He, P; Kang, SJ; Suzuki, M; Kuhara, H; Tetsumoto, S; Tsujino, K; Minami, T; Iwasaki, T; Nakanishi, K; Kohmo, S; Hirata, H; Takahashi, R; Inoue, K; Nagatomo, I; Kida, H; Kijima, T; Ito, M; Saya, H; Kumanogoh, A				Jin, Yingji; Tachibana, Isao; Takeda, Yoshito; He, Ping; Kang, Sujin; Suzuki, Mayumi; Kuhara, Hanako; Tetsumoto, Satoshi; Tsujino, Kazuyuki; Minami, Toshiyuki; Iwasaki, Takeo; Nakanishi, Kaori; Kohmo, Satoshi; Hirata, Haruhiko; Takahashi, Ryo; Inoue, Koji; Nagatomo, Izumi; Kida, Hiroshi; Kijima, Takashi; Ito, Mari; Saya, Hideyuki; Kumanogoh, Atsushi			Statins Decrease Lung Inflammation in Mice by Upregulating Tetraspanin CD9 in Macrophages	PLOS ONE			English	Article							PULMONARY INFLAMMATION; NEGATIVE REGULATOR; LIPID RAFTS; LIPOPOLYSACCHARIDE; EXPRESSION; CD14; INHIBITION; ACTIVATION; PATHOPHYSIOLOGY; COMORBIDITIES	Tetraspanins organize protein complexes in tetraspanin-enriched membrane microdomains that are distinct from lipid rafts. Our previous studies suggested that reduction in the levels of tetraspanins CD9 and CD81 may be involved in the progression of inflammatory lung diseases, especially COPD. To search for agents that increase the levels of these tetraspanins, we screened 1,165 drugs in clinical use and found that statins upregulate CD9 and CD81 in RAW264.7 macrophages. The lipophilic statins, fluvastatin and simvastatin, reversed LPS-induced downregulation of CD9 and CD81, simultaneously preventing TNF-alpha and matrix metalloproteinase-9 production and spreading of RAW264.7 cells. These statins exerted anti-inflammatory effects in vitro in wild-type macrophages but not in CD9 knockout macrophages, and decreased lung inflammation in vivo in wild-type mice but not in CD9 knockout mice, suggesting that their effects are dependent on CD9. Mechanistically, the statins promoted reverse transfer of the LPS-signaling mediator CD14 from lipid rafts into CD9-enriched microdomains, thereby preventing LPS receptor formation. Finally, upregulation of CD9/CD81 by statins was related to blockade of GTPase geranylgeranylation in the mevalonate pathway. Our data underscore the importance of the negative regulator CD9 in lung inflammation, and suggest that statins exert anti-inflammatory effects by upregulating tetraspanin CD9 in macrophages.	[Jin, Yingji; Tachibana, Isao; Takeda, Yoshito; He, Ping; Kang, Sujin; Suzuki, Mayumi; Kuhara, Hanako; Tetsumoto, Satoshi; Tsujino, Kazuyuki; Minami, Toshiyuki; Iwasaki, Takeo; Nakanishi, Kaori; Kohmo, Satoshi; Hirata, Haruhiko; Takahashi, Ryo; Inoue, Koji; Nagatomo, Izumi; Kida, Hiroshi; Kijima, Takashi; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan; [He, Ping] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Xian 710049, Shaanxi, Peoples R China; [Kang, Sujin; Kumanogoh, Atsushi] Osaka Univ, Dept Immunopathol, WPI Immunol Frontier Res Ctr, CREST,JST, Suita, Osaka, Japan; [Ito, Mari] Dainippon Sumitomo Pharma Co Ltd, Drug Res Div, Osaka, Japan; [Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku, Tokyo, Japan	Osaka University; Xi'an Jiaotong University; Japan Science & Technology Agency (JST); Osaka University; Dainippon Sumitomo Pharmaceutical Company; Keio University	Tachibana, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan.	itachi02@imed3.med.osaka-u.ac.jp	Saya, Hideyuki/J-4325-2013	Nogami-Itoh, Mari/0000-0001-7917-2830; Saya, Hideyuki/0000-0001-6610-1902; Nakanishi, Kaori/0000-0002-4153-5277	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program) and Special Coordination Funds for Promoting Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program) and Special Coordination Funds for Promoting Science and Technology	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare; a grant from "Kansai Biomedical Cluster" project in Saito, which is promoted by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to IT); and the Funding Program for Next Generation World-Leading Researchers (NEXT Program) and Special Coordination Funds for Promoting Science and Technology (to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; Dobler Claudia C, 2009, BMC Pulm Med, V9, P32, DOI 10.1186/1471-2466-9-32; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Furberg CD, 2001, CURR CONTR TRIALS C, V2, P205, DOI 10.1186/CVM-2-5-205; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hothersall E, 2006, THORAX, V61, P729, DOI 10.1136/thx.2005.057976; Huang KC, 2003, J BIOMED SCI, V10, P396, DOI 10.1159/000071159; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lemaire-Ewing S, 2012, ATHEROSCLEROSIS, V221, P303, DOI 10.1016/j.atherosclerosis.2011.10.016; Leung PO, 2011, TOXICOL LETT, V207, P159, DOI 10.1016/j.toxlet.2011.09.004; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Malhotra D, 2011, J CLIN INVEST, V121, P4289, DOI 10.1172/JCI45144; Matarazzo S, 2012, MOL PHARMACOL, V82, P246, DOI 10.1124/mol.112.078915; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ou XM, 2009, RESPIROLOGY, V14, P734, DOI 10.1111/j.1440-1843.2009.01549.x; Ridley AJ, 2008, J MICROSC-OXFORD, V231, P518, DOI 10.1111/j.1365-2818.2008.02064.x; Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Singla Sunit, 2012, Pulm Circ, V2, P397, DOI 10.4103/2045-8932.105028; Sundararaj KP, 2008, J LEUKOCYTE BIOL, V84, P1120, DOI 10.1189/jlb.0108064; Suzuki M, 2009, J IMMUNOL, V182, P6485, DOI 10.4049/jimmunol.0802797; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Tang QO, 2008, EXPERT OPIN INV DRUG, V17, P1435, DOI 10.1517/13543784.17.10.1435 ; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Wang XQ, 2002, BIOCHEM BIOPH RES CO, V294, P660, DOI 10.1016/S0006-291X(02)00523-5; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	44	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73706	10.1371/journal.pone.0073706	http://dx.doi.org/10.1371/journal.pone.0073706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040034	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300113
J	Matsutani, M; Ogawa, M; Takaoka, N; Hanaoka, N; Toh, H; Yamashita, A; Oshima, K; Hirakawa, H; Kuhara, S; Suzuki, H; Hattori, M; Kishimoto, T; Ando, S; Azuma, Y; Shirai, M				Matsutani, Minenosuke; Ogawa, Motohiko; Takaoka, Naohisa; Hanaoka, Nozomu; Toh, Hidehiro; Yamashita, Atsushi; Oshima, Kenshiro; Hirakawa, Hideki; Kuhara, Satoru; Suzuki, Harumi; Hattori, Masahira; Kishimoto, Toshio; Ando, Shuji; Azuma, Yoshinao; Shirai, Mutsunori			Complete Genomic DNA Sequence of the East Asian Spotted Fever Disease Agent Rickettsia japonica	PLOS ONE			English	Article							PROTEIN; EVOLUTION; GENES; ACQUISITION; PROWAZEKII; ALIGNMENT; CONORII	Rickettsia japonica is an obligate intracellular alphaproteobacteria that causes tick-borne Japanese spotted fever, which has spread throughout East Asia. We determined the complete genomic DNA sequence of R. japonica type strain YH (VR-1363), which consists of 1,283,087 base pairs (bp) and 971 protein-coding genes. Comparison of the genomic DNA sequence of R. japonica with other rickettsiae in the public databases showed that 2 regions (4,323 and 216 bp) were conserved in a very narrow range of Rickettsia species, and the shorter one was inserted in, and disrupted, a preexisting open reading frame (ORF). While it is unknown how the DNA sequences were acquired in R. japonica genomes, it may be a useful signature for the diagnosis of Rickettsia species. Instead of the species-specific inserted DNA sequences, rickettsial genomes contain Rickettsia-specific palindromic elements (RPEs), which are also capable of locating in preexisting ORFs. Precise alignments of protein and DNA sequences involving RPEs showed that when a gene contains an inserted DNA sequence, each rickettsial ortholog carried an inserted DNA sequence at the same locus. The sequence, ATGAC, was shown to be highly frequent and thus characteristic in certain RPEs (RPE-4, RPE-6, and RPE-7). This finding implies that RPE-4, RPE-6, and RPE-7 were derived from a common inserted DNA sequence.	[Matsutani, Minenosuke; Takaoka, Naohisa; Suzuki, Harumi; Azuma, Yoshinao; Shirai, Mutsunori] Yamaguchi Univ, Sch Med, Dept Microbiol & Immunol, Ube, Yamaguchi 755, Japan; [Ogawa, Motohiko; Hanaoka, Nozomu; Kishimoto, Toshio; Ando, Shuji] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Toh, Hidehiro; Yamashita, Atsushi; Oshima, Kenshiro; Hattori, Masahira] Kitasato Univ, Kitasato Inst Life Sci, Sagamihara, Kanagawa 228, Japan; [Hirakawa, Hideki; Kuhara, Satoru] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Azuma, Yoshinao] Kinki Univ BOST, Dept Sci & Technol Food Safety, Wakayama, Japan	Yamaguchi University; National Institute of Infectious Diseases (NIID); Kitasato University; Kyushu University	Azuma, Y (corresponding author), Yamaguchi Univ, Sch Med, Dept Microbiol & Immunol, Ube, Yamaguchi 755, Japan.	azuma@waka.kindai.ac.jp	Hattori, Masahira/C-6958-2016; hanaoka, nozomu/L-7717-2019; Suzuki, Harumi/L-1271-2013; Hattori, Masahira/AAD-3785-2019	Hattori, Masahira/0000-0001-9467-0344; Suzuki, Harumi/0000-0003-3616-9361; hanaoka, nozomu/0000-0002-1039-6278	Japan Society for the Promotion of Science, Research for the FutureProgram [JSPS-RETF 00L01411]; Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI: 14013043, 15019069, 16012245]; Venture Business Laboratory; Yamaguchi University	Japan Society for the Promotion of Science, Research for the FutureProgram(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Venture Business Laboratory; Yamaguchi University	This study was supported by the Japan Society for the Promotion of Science, Research for the FutureProgram (JSPS-RETF 00L01411), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI: 14013043, 15019069, 16012245), and the Venture Business Laboratory, Yamaguchi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Camer GA, 2003, JPN J INFECT DIS, V56, P26; Chung MH, 2006, EMERG INFECT DIS, V12, P1122, DOI 10.3201/eid1207.051372; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dong X, 2012, J BACTERIOL, V194, P6992, DOI 10.1128/JB.01928-12; Duan CS, 2011, J BACTERIOL, V193, P5564, DOI 10.1128/JB.05852-11; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fournier PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002289; Gaywee J, 2007, EMERG INFECT DIS, V13, P671; Gillespie JJ, 2012, J BACTERIOL, V194, P376, DOI 10.1128/JB.06244-11; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Hanaoka N, 2009, EMERG INFECT DIS, V15, P1994, DOI 10.3201/eid1512.090252; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Mahara F, 2006, ANN NY ACAD SCI, V1078, P60, DOI 10.1196/annals.1374.007; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2005, TRENDS MICROBIOL, V13, P253, DOI 10.1016/j.tim.2005.03.013; Ogata H, 2002, GENOME RES, V12, P808, DOI 10.1101/gr.227602; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Sakiyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P670, DOI 10.1271/bbb.64.670; STOTHARD DR, 1994, INT J SYST BACTERIOL, V44, P798, DOI 10.1099/00207713-44-4-798; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; UCHIDA T, 1986, MICROBIOL IMMUNOL, V30, P1323, DOI 10.1111/j.1348-0421.1986.tb03053.x; UCHIDA T, 1992, INT J SYST BACTERIOL, V42, P303, DOI 10.1099/00207713-42-2-303; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; Uchiyama T, 2012, FEMS IMMUNOL MED MIC, V64, P42, DOI 10.1111/j.1574-695X.2011.00879.x; Walker DH, 2007, CLIN INFECT DIS, V45, pS39, DOI 10.1086/518145; WINKLER HH, 1982, INFECT IMMUN, V38, P109, DOI 10.1128/IAI.38.1.109-113.1982; Yada T, 1999, BIOINFORMATICS, V15, P987, DOI 10.1093/bioinformatics/15.12.987	50	8	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e71861	10.1371/journal.pone.0071861	http://dx.doi.org/10.1371/journal.pone.0071861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039725	Green Published, gold			2022-12-25	WOS:000326405300003
J	Florea, V; Bhagavatula, N; Simovic, G; Macedo, FY; Fock, RA; Rodrigues, CO				Florea, Victoria; Bhagavatula, Nithya; Simovic, Gordana; Macedo, Francisco Y.; Fock, Ricardo A.; Rodrigues, Claudia O.			c-Myc Is Essential to Prevent Endothelial Pro-Inflammatory Senescent Phenotype	PLOS ONE			English	Article							GROWTH-FACTOR MIDKINE; SMOOTH-MUSCLE-CELLS; TRANSCRIPTIONAL REPRESSION; OXIDATIVE STRESS; EXPRESSION; TL1A; ANGIOGENESIS; CYTOKINE; CYCLE; BETA	The proto-oncogene c-Myc is vital for vascular development and promotes tumor angiogenesis, but the mechanisms by which it controls blood vessel growth remain unclear. In the present work we investigated the effects of c-Myc knockdown in endothelial cell functions essential for angiogenesis to define its role in the vasculature. We provide the first evidence that reduction in c-Myc expression in endothelial cells leads to a pro-inflammatory senescent phenotype, features typically observed during vascular aging and pathologies associated with endothelial dysfunction. c-Myc knockdown in human umbilical vein endothelial cells using lentivirus expressing specific anti-c-Myc shRNA reduced proliferation and tube formation. These functional defects were associated with morphological changes, increase in senescence-associated-bgalactosidase activity, upregulation of cell cycle inhibitors and accumulation of c-Myc-deficient cells in G1-phase, indicating that c-Myc knockdown in endothelial cells induces senescence. Gene expression analysis of c-Myc-deficient endothelial cells showed that senescent phenotype was accompanied by significant upregulation of growth factors, adhesion molecules, extracellular-matrix components and remodeling proteins, and a cluster of pro-inflammatory mediators, which include Angptl4, Cxcl12, Mdk, Tgfb2 and Tnfsf15. At the peak of expression of these cytokines, transcription factors known to be involved in growth control (E2f1, Id1 and Myb) were downregulated, while those involved in inflammatory responses (RelB, Stat1, Stat2 and Stat4) were upregulated. Our results demonstrate a novel role for c-Myc in the prevention of vascular pro-inflammatory phenotype, supporting an important physiological function as a central regulator of inflammation and endothelial dysfunction.	[Florea, Victoria; Bhagavatula, Nithya; Simovic, Gordana; Macedo, Francisco Y.; Fock, Ricardo A.; Rodrigues, Claudia O.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33152 USA; [Rodrigues, Claudia O.] Univ Miami, Leonard M Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL USA	University of Miami; University of Miami	Rodrigues, CO (corresponding author), Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33152 USA.	crodrigues@med.miami.edu	Fock, Ricardo Ambrosio/C-6105-2012	Fock, Ricardo Ambrosio/0000-0002-7964-5973	Florida Department of Health, James and Esther King Program [09KN-12]; Florida Heart Institute; Brazilian National Research Council Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Florida Department of Health, James and Esther King Program; Florida Heart Institute; Brazilian National Research Council Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Florida Department of Health, James and Esther King Program (09KN-12), and Florida Heart Institute. R.A.F. was a fellow of the Brazilian National Research Council Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lamki RS, 2008, J AM SOC NEPHROL, V19, P953, DOI 10.1681/ASN.2007060706; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Andersen DK, 2013, CURR OPIN ENDOCRINOL; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Banno H, 2006, J VASC SURG, V44, P633, DOI 10.1016/j.jvs.2006.04.044; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Campaner S, 2010, CELL CYCLE, V9, P3655, DOI 10.4161/cc.9.18.13049; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; de Nigris F, 2000, CIRCULATION, V102, P2111, DOI 10.1161/01.CIR.102.17.2111; de Nigris F, 2006, CELL CYCLE, V5, P1621, DOI 10.4161/cc.5.15.3138; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Erol A, 2011, CELL SIGNAL, V23, P1076, DOI 10.1016/j.cellsig.2010.11.023; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hurley NE, 2010, J VASC RES, V47, P80, DOI 10.1159/000235928; Kang YJ, 2005, CYTOKINE, V29, P229, DOI 10.1016/j.cyto.2004.12.001; Kokai E, 2009, CIRC RES, V104, P1151, DOI 10.1161/CIRCRESAHA.108.191460; Kosugi T, 2006, AM J PATHOL, V168, P9, DOI 10.2353/ajpath.2006.050488; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee MYK, 2010, J VASC RES, V47, P287, DOI 10.1159/000265563; Li CX, 2002, CLIN HEMORHEOL MICRO, V26, P117; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; Lucas S, 2010, PEDIATR INT, V52, P75, DOI 10.1111/j.1442-200X.2009.02885.x; Mallette FA, 2007, J BIOL CHEM, V282, P34938, DOI 10.1074/jbc.M707074200; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MARIN ML, 1993, J VASC SURG, V18, P170, DOI 10.1016/0741-5214(93)90596-E; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Muck C, 2010, J GERONTOL A-BIOL, V65, P1165, DOI 10.1093/gerona/glq129; Napoli C, 2002, NEOPLASIA, V4, P185, DOI 10.1038/sj.neo.7900232; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; PARKES JL, 1991, AM J PATHOL, V138, P765; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Perdiguero EG, 2011, J BIOL CHEM, V286, P36841, DOI 10.1074/jbc.M111.220061; Ramirez JA, 1996, J SURG RES, V61, P323, DOI 10.1006/jsre.1996.0124; Rodrigues CO, 2008, DEVELOPMENT, V135, P1903, DOI 10.1242/dev.011296; Sakamoto K, 2012, PATHOL INT, V62, P445, DOI 10.1111/j.1440-1827.2012.02815.x; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stokes MB, 2005, THESCIENTIFICWORLDJO, V5, P828, DOI 10.1100/tsw.2005.106; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Taraban VY, 2011, MUCOSAL IMMUNOL, V4, P186, DOI 10.1038/mi.2010.70; van der Horst E, 2008, NEOPLASIA, V10, P340, DOI 10.1593/neo.07820; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Weckbach LT, 2011, THESCIENTIFICWORLDJO, V11, P2491, DOI 10.1100/2011/517152; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang Z, 2012, CANC MICROENVIRON	79	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73146	10.1371/journal.pone.0073146	http://dx.doi.org/10.1371/journal.pone.0073146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039874	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500036
J	Xu, SY; Kuzin, AP; Seetharaman, J; Gutjahr, A; Chan, SH; Chen, Y; Xiao, R; Acton, TB; Montelione, GT; Tong, L				Xu, Shuang-yong; Kuzin, Alexandre P.; Seetharaman, Jayaraman; Gutjahr, Alice; Chan, Siu-Hong; Chen, Yang; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Tong, Liang			Structure Determination and Biochemical Characterization of a Putative HNH Endonuclease from Geobacter metallireducens GS-15	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; COLI MCRA; PROTEIN; RESTRICTION; REDUCTION; SEQUENCE; PHENIX; GENES	The crystal structure of a putative HNH endonuclease, Gmet_0936 protein from Geobacter metallireducens GS-15, has been determined at 2.6 angstrom resolution using single-wavelength anomalous dispersion method. The structure contains a two-stranded anti-parallel beta-sheet that are surrounded by two helices on each face, and reveals a Zn ion bound in each monomer, coordinated by residues Cys38, Cys41, Cys73, and Cys76, which likely plays an important structural role in stabilizing the overall conformation. Structural homologs of Gmet_0936 include Hpy99I endonuclease, phage T4 endonuclease VII, and other HNH endonucleases, with these enzymes sharing 15-20% amino acid sequence identity. An overlay of Gmet_0936 and Hpy99I structures shows that most of the secondary structure elements, catalytic residues as well as the zinc binding site (zinc ribbon) are conserved. However, Gmet_0936 lacks the N-terminal domain of Hpy99I, which mediates DNA binding as well as dimerization. Purified Gmet_0936 forms dimers in solution and a dimer of the protein is observed in the crystal, but with a different mode of dimerization as compared to Hpy99I. Gmet_0936 and its N77H variant show a weak DNA binding activity in a DNA mobility shift assay and a weak Mn2+-dependent nicking activity on supercoiled plasmids in low pH buffers. The preferred substrate appears to be acid and heat-treated DNA with AP sites, suggesting Gmet_0936 may be a DNA repair enzyme.	[Xu, Shuang-yong; Gutjahr, Alice; Chan, Siu-Hong] New England Biolabs Inc, Res Dept, Ipswich, MA USA; [Kuzin, Alexandre P.; Seetharaman, Jayaraman; Chen, Yang; Tong, Liang] Columbia Univ, Dept Biol Sci, Northeast Struct Genom Consortium, New York, NY 10027 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med,Dept Mol Biol & Biochem, Dept Biochem,Northeast Struct Genom Consortium, Piscataway, NJ 08854 USA	New England Biolabs; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Xu, SY (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA USA.	xus@neb.com; ltong@columbia.edu		Montelione, Gaetano/0000-0002-9440-3059; Tong, Liang/0000-0002-0563-6468; Chan, Siu-Hong/0000-0002-9554-7273	Protein Structure Initiative of the National Institutes of Health [U54 GM074958, U54 GM094597]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, U54GM094597] Funding Source: NIH RePORTER	Protein Structure Initiative of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Northeast Structural Genomics Consortium was funded by the Protein Structure Initiative of the National Institutes of Health (U54 GM074958 and U54 GM094597). The open access fee was paid for by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Altermark B, 2008, ACTA CRYSTALLOGR D, V64, P368, DOI 10.1107/S0907444908000097; Anton BP, 2004, J BACTERIOL, V186, P5699, DOI 10.1128/JB.186.17.5699-5707.2004; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Call DF, 2009, APPL ENVIRON MICROB, V75, P7579, DOI 10.1128/AEM.01760-09; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jansson M, 1996, J BIOMOL NMR, V7, P131; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Liu CX, 2002, BIOTECHNOL BIOENG, V80, P637, DOI 10.1002/bit.10430; Liu GA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001253; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Moodley S, 2012, PROTEIN GP74 BACTERI; Mulligan EA, 2008, PROTEIN EXPRES PURIF, V62, P98, DOI 10.1016/j.pep.2008.06.016; Murray I.A., 2012, NUCL ACIDS RES; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pediaditakis M, 2012, J BACTERIOL, V194, P6184, DOI 10.1128/JB.05283-11; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pommer AJ, 1999, J BIOL CHEM, V274, P27153, DOI 10.1074/jbc.274.38.27153; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Shen BW, 2010, STRUCTURE, V18, P734, DOI 10.1016/j.str.2010.03.009; Sokolowska M, 2009, NUCLEIC ACIDS RES, V37, P3799, DOI 10.1093/nar/gkp228; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Xu HL, 2005, ACTA CRYSTALLOGR D, V61, P976, DOI 10.1107/S0907444905011558; Xu SY, 2012, NUCL ACIDS RES	30	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72114	10.1371/journal.pone.0072114	http://dx.doi.org/10.1371/journal.pone.0072114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039739	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500013
J	Carriero, MM; Adriano, EA; Silva, MRM; Ceccarelli, PS; Maia, AAM				Carriero, Mateus Maldonado; Adriano, Edson A.; Silva, Marcia R. M.; Ceccarelli, Paulo S.; Maia, Antonio A. M.			Molecular Phylogeny of the Myxobolus and Henneguya Genera with Several New South American Species	PLOS ONE			English	Article							MYXOSPOREAN PARASITES; MAXIMUM-LIKELIHOOD; MYXOZOA MYXOSPOREA; COMMON BREAM; LIFE-CYCLE; N. MYXOZOA; SPP.; ULTRASTRUCTURE; FISHES; HISTOPATHOLOGY	The present study consists of a detailed phylogenetic analysis of myxosporeans of the Myxobolus and Henneguya genera, including sequences from 12 Myxobolus/Henneguya species, parasites of South American pimelodids, bryconids and characids. Maximum likelihood and maximum parsimony analyses, based on 18 S rDNA gene sequences, showed that the strongest evolutionary signal is the phylogenetic affinity of the fish hosts, with clustering mainly occurring according to the order and/or family of the host. Of the 12 South American species studied here, six are newly described infecting fish from the Brazilian Pantanal wetland. Henneguya maculosus n. sp. and Myxobolus flavus n. sp. were found infecting both Pseudoplatystoma corruscans and Pseudoplatystoma reticulatum; Myxobolus aureus n. sp. and Myxobolus pantanalis n. sp. were observed parasitizing Salminus brasiliensis and Myxobolus umidus n. sp. and Myxobolus piraputangae n. sp. were detected infecting Brycon hilarii.	[Carriero, Mateus Maldonado; Silva, Marcia R. M.; Maia, Antonio A. M.] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Vet Med, Pirassununga, SP, Brazil; [Adriano, Edson A.] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil; [Adriano, Edson A.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Ceccarelli, Paulo S.] Inst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Peixes Continenta, Pirassununga, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas	Adriano, EA (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil.	edapadriano@gmail.com	Carriero, Mateus M/G-1488-2012; Maia, Antonio/O-4646-2017; Adriano, Edson A/D-8723-2013	Carriero, Mateus M/0000-0002-8949-4400; Adriano, Edson A/0000-0002-6903-9531; Maia, Antonio/0000-0002-9166-4720	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [06/59075-6]; Centro Nacional de Pesquisa e Conservacao de Peixes Continentais of the Instituto Chico Mendes de Conservacao da Biodiversidade; FAPESP [2009/03320-0]; Brazilian Fostering Agency CNPq [477658/2010-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro Nacional de Pesquisa e Conservacao de Peixes Continentais of the Instituto Chico Mendes de Conservacao da Biodiversidade; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Fostering Agency CNPq	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (Proc. no 06/59075-6) and by the Centro Nacional de Pesquisa e Conservacao de Peixes Continentais of the Instituto Chico Mendes de Conservacao da Biodiversidade. MMC was supported by a master's scholarship from FAPESP (Proc. no 2009/03320-0). Research productivity grant from the Brazilian Fostering Agency CNPq (Proc. no 477658/2010-5) to EAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano EA, 2012, VET PARASITOL, V185, P110, DOI 10.1016/j.vetpar.2011.10.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andree KB, 1999, J PARASITOL, V85, P68, DOI 10.2307/3285702; Atkinson SD, 2009, PARASITOL RES, V104, P1173, DOI 10.1007/s00436-008-1308-6; Bahri S, 2003, J EUKARYOT MICROBIOL, V50, P463, DOI 10.1111/j.1550-7408.2003.tb00272.x; Barta JR, 1997, J PARASITOL, V83, P262, DOI 10.2307/3284453; Bartholomew JL, 2008, INT J PARASITOL, V38, P1199, DOI 10.1016/j.ijpara.2008.01.008; Broughton RE, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.2ca8041495ffafd0c92756e75247483e; Diamant A, 2004, J PARASITOL, V90, P1434, DOI 10.1645/GE-336R; Easy RH, 2005, SYST PARASITOL, V61, P115, DOI 10.1007/s11230-005-3135-9; Eiras JC, 2012, SYST PARASITOL, V83, P95, DOI 10.1007/s11230-012-9374-7; Eiras JC, 2005, ACTA PARASITOL, V50, P267; Eiras JC, 2005, SYST PARASITOL, V61, P1, DOI 10.1007/s11230-004-6343-9; El-Mansy A, 2005, DIS AQUAT ORGAN, V63, P205, DOI 10.3354/dao063205; Eszterbauer E, 2004, DIS AQUAT ORGAN, V58, P35, DOI 10.3354/dao058035; Eszterbauer E, 2001, DIS AQUAT ORGAN, V44, P35, DOI 10.3354/dao044035; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; Feist Stephen W., 2006, P230, DOI 10.1079/9780851990156.0230; Ferguson JA, 2008, J PARASITOL, V94, P1322, DOI 10.1645/GE-1606.1; Fiala I, 2006, INT J PARASITOL, V36, P1521, DOI 10.1016/j.ijpara.2006.06.016; Fiala I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-228; Gleeson RJ, 2012, PARASITOL INT, V61, P267, DOI 10.1016/j.parint.2011.10.008; Gleeson RJ, 2010, PARASITOLOGY, V137, P1885, DOI 10.1017/S0031182010000855; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gunter NL, 2009, SYST PARASITOL, V73, P1, DOI 10.1007/s11230-008-9162-6; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hallett SL, 2001, DIS AQUAT ORGAN, V46, P197, DOI 10.3354/dao046197; Hartigan A, 2012, PARASITOLOGY, V139, P478, DOI 10.1017/S0031182011002149; Hartigan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018871; Kalman M, 2011, ACTA PARASITOL, V56, P263, DOI 10.2478/s11686-011-0054-6; Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; Liu Y, 2010, PARASITOL RES, V107, P67, DOI 10.1007/s00436-010-1835-9; LOM J, 1989, J FISH DIS, V12, P151, DOI 10.1111/j.1365-2761.1989.tb00287.x; LOM J, 1992, J PROTOZOOL, V39, P16, DOI 10.1111/j.1550-7408.1992.tb01279.x; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Mallatt J, 2012, MOL PHYLOGENET EVOL, V64, P603, DOI 10.1016/j.ympev.2012.05.016; Marton S, 2011, FOLIA PARASIT, V58, P157, DOI 10.14411/fp.2011.015; Milanin T, 2010, MEM I OSWALDO CRUZ, V105, P762, DOI 10.1590/S0074-02762010000600006; Molnar K, 2002, J FISH DIS, V25, P643, DOI 10.1046/j.1365-2761.2002.00409.x; Molnar K, 2008, J FISH DIS, V31, P613, DOI 10.1111/j.1365-2761.2008.00904.x; Molnar K, 2006, DIS AQUAT ORGAN, V73, P49, DOI 10.3354/dao073049; Molnar K, 1998, ACTA PROTOZOOL, V37, P241; Molnar K, 1998, FOLIA PARASIT, V45, P261; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Naldoni J, 2011, VET PARASITOL, V177, P247, DOI 10.1016/j.vetpar.2010.12.008; Nesnidal MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054576; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palenzuela O, 2002, PARASITOLOGY, V124, P369, DOI 10.1017/S0031182001001354; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prunescu CC, 2007, FOLIA PARASIT, V54, P159, DOI 10.14411/fp.2007.022; Roberts JF, 2008, DIS AQUAT ORGAN, V80, P199, DOI 10.3354/dao01912; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Szekely C, 2009, DIS AQUAT ORGAN, V85, P147, DOI 10.3354/dao02068; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WOLF K, 1984, SCIENCE, V225, P1449, DOI 10.1126/science.225.4669.1449; Xiao CX, 2000, SYST PARASITOL, V46, P81, DOI 10.1023/A:1006323207759; Yokoyama H, 2001, BULL EUR ASSN FISH P, V21, P266	58	130	135	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73713	10.1371/journal.pone.0073713	http://dx.doi.org/10.1371/journal.pone.0073713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040037	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600094
J	Henriquez, M; Gonzalez, E; Marshall, SH; Henriquez, V; Gomez, FA; Martinez, I; Altamirano, C				Henriquez, Mirtha; Gonzalez, Ernesto; Marshall, Sergio H.; Henriquez, Vitalia; Gomez, Fernando A.; Martinez, Irene; Altamirano, Claudia			A Novel Liquid Medium for the Efficient Growth of the Salmonid Pathogen Piscirickettsia salmonis and Optimization of Culture Conditions	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; BACTERIAL PATHOGEN; FISH; AGAR	Piscirickettsia salmonis is the bacterium that causes Piscirickettsiosis, a systemic disease of salmonid fish responsible for significant economic losses within the aquaculture industry worldwide. The growth of the bacterium for vaccine formulation has been traditionally accomplished by infecting eukaryotic cell lines, a process that involves high production costs and is time-consuming. Recent research has demonstrated that it is possible to culture pure P. salmonis in a blood containing (cell-free) medium. In the present work we demonstrate the growth of P. salmonis in a liquid medium free from blood and serum components, thus establishing a novel and simplified bacteriological medium. Additionally, the new media reported provides improved growth conditions for P. salmonis, where biomass concentrations of approximately 800 mg cell dry weight L-1 were obtained, about eight times higher than those reported for the blood containing medium. A 2-level full factorial design was employed to evaluate the significance of the main medium components on cell growth and an optimal temperature range of 23-27 degrees C was determined for the microorganism to grow in the novel liquid media. Therefore, these results represent a breakthrough regarding P. salmonis research in order to optimize pure P. salmonis growth in liquid blood and serum free medium.	[Henriquez, Mirtha; Gonzalez, Ernesto; Martinez, Irene; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Marshall, Sergio H.; Henriquez, Vitalia; Gomez, Fernando A.] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile; [Marshall, Sergio H.] Nucleo Biotecnol Curauma, NBC, Valparaiso, Chile; [Altamirano, Claudia] GORE Reg Valparaiso, CREAS CONICYT REG, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Altamirano, C (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.	claudia.altamirano@ucv.cl	González, Ernesto A/B-3205-2011; Martinez, Irene/U-5251-2017	González, Ernesto A/0000-0002-2693-1554; Gomez, Fernando/0000-0002-8191-2153; Henriquez, Vitalia/0000-0002-3447-4031; marshall, sergio/0000-0003-0438-8252; Altamirano, Claudia/0000-0002-6389-086X	FONDEF [D10I1185]; CONICYT	FONDEF; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDEF Grant D10I1185 to CA, SM, IM, and VH; and by CONICYT Doctoral Scholarship to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkush KD, 2005, DIS AQUAT ORGAN, V63, P139, DOI 10.3354/dao063139; Athanassopoulou F, 2004, J APPL ICHTHYOL, V20, P525, DOI 10.1111/j.1439-0426.2004.00571.x; BARKER J, 1986, J MED MICROBIOL, V22, P97, DOI 10.1099/00222615-22-2-97; Birkbeck TH, 2004, INFECT IMMUN, V72, P3693, DOI 10.1128/IAI.72.6.3693-3694.2004; Bravo S., 1989, CHILE PESQUERO, V54, P47; Cvitanich JD, 1990, AM FISHERIES SOC FIS, V18, P1; Devos Liesbet, 2005, Reviews in Environmental Science and Bio/Technology, V4, P61, DOI 10.1007/s11157-004-8174-1; Ewann F, 2006, APPL ENVIRON MICROB, V72, P3993, DOI 10.1128/AEM.00684-06; Fryer J. L., 2005, BERGEYS MANUAL SYS B, V2, P180; Fryer JL, 2003, J FISH DIS, V26, P251, DOI 10.1046/j.1365-2761.2003.00460.x; FRYER JL, 1990, FISH PATHOL, V25, P107, DOI 10.3147/jsfp.25.107; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Gomez F, 2009, ARCH MED VET, V41, P261, DOI 10.4067/S0301-732X2009000300011; KAPLAN A, 1969, Methods of Biochemical Analysis, V17:, P311, DOI 10.1002/9780470110355.ch7; Marshall SH, 2012, RES MICROBIOL, V163, P557, DOI 10.1016/j.resmic.2012.08.002; Mauel MJ, 2008, J VET DIAGN INVEST, V20, P213, DOI 10.1177/104063870802000211; Mikalsen J, 2008, FEMS MICROBIOL LETT, V278, P43, DOI 10.1111/j.1574-6968.2007.00977.x; MOEINI H, 2004, ELECTRON J BIOTECHN, V7, P252; Rajas V, 2009, J CELL BIOCHEM, V108, P631, DOI 10.1002/jcb.22295; Sangkharak K, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-2; Tobar JA, 2011, VACCINE, V317, P83; Rojas MV, 2008, MICROB PATHOGENESIS, V44, P370, DOI 10.1016/j.micpath.2007.10.012; Yanez AJ, 2012, DIS AQUAT ORGAN, V97, P197, DOI 10.3354/dao02403	23	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71830	10.1371/journal.pone.0071830	http://dx.doi.org/10.1371/journal.pone.0071830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039723	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600013
J	Wu, BL; Li, CQ; Zhang, PX; Yao, QL; Wu, JY; Han, JW; Liao, LD; Xu, YJ; Lin, RJ; Xiao, DW; Xu, LY; Li, EM; Li, X				Wu, Bingli; Li, Chunquan; Zhang, Pixian; Yao, Qianlan; Wu, Jianyi; Han, Junwei; Liao, Liandi; Xu, Yanjun; Lin, Ruijun; Xiao, Dawei; Xu, Liyan; Li, Enmin; Li, Xia			Dissection of miRNA-miRNA Interaction in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; MICRORNAS; NETWORK; MIGRATION; PROFILES; INVASION; PROLIFERATION; INVASIVENESS; INTEGRATION	The relationships between miRNAs and their regulatory influences in esophageal carcinoma remain largely unknown. Accumulated evidence suggests that delineation of subpathways within an entire pathway can underlie complex diseases. To analyze the regulation of differentially expressed miRNAs in subpathways of esophageal squamous cell carcinoma (ESCC), we constructed bipartite miRNA and subpathway networks to determine miRNA regulatory influences on subpathways. The miRNA-subpathway network indicated that miRNAs regulate numerous subpathways. Two principal biological networks were derived from the miRNA-subpathway network by the hypergeometric test. This miRNA-miRNA network revealed the co-regulation of subpathways between the upregulated and downregulated miRNAs. Subpathway-subpathway networks characterized scale free, small world, and modular architecture. K-clique analysis revealed co-regulation of subpathways between certain downregulated and upregulated miRNAs. When ESCC patients were grouped according to their expression levels of paired upregulation of miR-31 and downregulation of miR-338-3p, survival time analysis revealed a significant difference based on miR-31-miR-338-3p interaction. These findings can facilitate the understanding of the biological meaning of miRNA-miRNA interactions with either the same or opposite expression trend.	[Wu, Bingli; Li, Chunquan; Yao, Qianlan; Han, Junwei; Xu, Yanjun; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Wu, Bingli; Zhang, Pixian; Wu, Jianyi; Li, Enmin] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Peoples R China; [Liao, Liandi; Xu, Liyan] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou, Peoples R China; [Lin, Ruijun; Xiao, Dawei] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Cardiothorac Surg, Shantou, Peoples R China	Harbin Medical University; Shantou University; Shantou University; Shantou University	Li, EM (corresponding author), Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Peoples R China.	nmli@stu.edu.cn; lixia@hrbmu.edu.cn	Li, Chunquan/AAI-1072-2020; li, xia/HHZ-7468-2022; xu, li/GNH-3667-2022; Han, Junwei/T-9849-2018	Li, Chunquan/0000-0002-4700-5496; Han, Junwei/0000-0002-3276-0819; qianlan, yao/0000-0003-0737-4147	NSFC-GuangDong Joint Fund [U0932001]; National Basic Research Program [2012CB526608]; National High Technology Research and Development Program of China [2012AA02A503, 2012AA02A209]; National Science Foundation of China [30900560, 61170154, 31200996]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [LYM09081]	NSFC-GuangDong Joint Fund; National Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong	This work was supported by grants from the NSFC-GuangDong Joint Fund (U0932001), the National Basic Research Program (2012CB526608), the National High Technology Research and Development Program of China (2012AA02A503 and 2012AA02A209), the National Science Foundation of China (30900560, 61170154 and 31200996) and the Foundation for Distinguished Young Talents in Higher Education of Guangdong (LYM09081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bork S, 2011, J CELL PHYSIOL, V226, P2226, DOI 10.1002/jcp.22557; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu HL, 2013, CELL BIOCH BIOPHYS; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li X, 2012, BRIEF BIOINFORM, V13, P175, DOI 10.1093/bib/bbr043; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Li XB, 2011, THORAC CANCER, V2, P134, DOI 10.1111/j.1759-7714.2011.00059.x; Lin RJ, 2012, J SURG ONCOL, V105, P175, DOI 10.1002/jso.22066; Liu F, 2013, MOL CELL BIOCH; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Ooi CH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002415; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shinozuka E, 2013, BIOCHEM BIOPH RES CO, V430, P101, DOI 10.1016/j.bbrc.2012.11.005; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; Takeshita N, 2012, INT J ONCOL, V41, P1653, DOI 10.3892/ijo.2012.1614; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang N, 2013, DIG DIS SCI; Wu BL, 2011, WORLD J GASTROENTERO, V17, P79, DOI 10.3748/wjg.v17.i1.79; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Yuan Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-57; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207; Zhang XL, 2013, BBA-MOL BASIS DIS, V1832, P1207, DOI 10.1016/j.bbadis.2013.03.009	48	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73191	10.1371/journal.pone.0073191	http://dx.doi.org/10.1371/journal.pone.0073191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039884	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600056
J	Chen, AH; Robinson-Mosher, A; Savage, DF; Silver, PA; Polka, JK				Chen, Anna H.; Robinson-Mosher, Avi; Savage, David F.; Silver, Pamela A.; Polka, Jessica K.			The Bacterial Carbon-Fixing Organelle Is Formed by Shell Envelopment of Preassembled Cargo	PLOS ONE			English	Article							HALOTHIOBACILLUS-NEAPOLITANUS CARBOXYSOMES; PROTEIN; MICROCOMPARTMENT; ULTRASTRUCTURE; PROKARYOTES; DYNAMICS; RUBISCO	Background: Cyanobacteria play a significant role in the global carbon cycle. In Synechococcus elongatus, the carbon-fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) is concentrated into polyhedral, proteinaceous compartments called carboxysomes. Methodology/Principal Findings: Using live cell fluorescence microscopy, we show that carboxysomes are first detected as small seeds of RuBisCO that colocalize with existing carboxysomes. These seeds contain little or no shell protein, but increase in RuBisCO content over several hours, during which time they are exposed to the solvent. The maturing seed is then enclosed by shell proteins, a rapid process that seals RuBisCO from the cytosol to establish a distinct, solvent-protected microenvironment that is oxidizing relative to the cytosol. These closure events can be spatially and temporally coincident with the appearance of a nascent daughter RuBisCO seed. Conclusions/Significance: Carboxysomes assemble in a stepwise fashion, inside-to-outside, revealing that cargo is the principle organizer of this compartment's biogenesis. Our observations of the spatial relationship of seeds to previously formed carboxysomes lead us to propose a model for carboxysome replication via sequential fission, polymerization, and encapsulation of their internal cargo.	[Chen, Anna H.; Robinson-Mosher, Avi; Silver, Pamela A.; Polka, Jessica K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Chen, Anna H.; Robinson-Mosher, Avi; Silver, Pamela A.; Polka, Jessica K.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Savage, David F.] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Savage, David F.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu		Polka, Jessica/0000-0001-6610-9293	NIH [GM080177]; NSF; NRSA postdoctoral fellowship; Jane Coffin Childs postdoctoral fellowship; Department of Defense Life Sciences Division of the US Army Research Office [W911NF-09-0226]; Wyss Institute of Biologically Inspired Engineering at Harvard University; Department of Energy Office of Science Early Career Research Program through the Office of Basic Energy Sciences [DE-SC0006394]; Energy Biosciences Institute at UC Berkeley; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs postdoctoral fellowship; Department of Defense Life Sciences Division of the US Army Research Office; Wyss Institute of Biologically Inspired Engineering at Harvard University; Department of Energy Office of Science Early Career Research Program through the Office of Basic Energy Sciences(United States Department of Energy (DOE)); Energy Biosciences Institute at UC Berkeley; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH (www.nih.gov/) Grant GM080177 and an NSF (www.nsf.gov/) Graduate Research Fellowship (to AHC), an NRSA postdoctoral fellowship (to ARM), and a Jane Coffin Childs (www.jccfund.org/) postdoctoral fellowship (to JKP), a Department of Defense Life Sciences Division of the US Army Research Office (http://www.arl.army.mil/www/default.cfm?page=200) Grant W911NF-09-0226 (to PAS) and funds from the Wyss Institute of Biologically Inspired Engineering at Harvard University (http://wyss.harvard.edu/). DFS was supported by a Department of Energy Office of Science Early Career Research Program (http://science.energy.gov/early-career/) (DE-SC0006394) through the Office of Basic Energy Sciences and the Energy Biosciences Institute at UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; CODD GA, 1984, BIOL REV, V59, P389, DOI 10.1111/j.1469-185X.1984.tb00710.x; EDELSTEIN A, 2001, COMPUTER CONTROL MIC, DOI DOI 10.1002/0471142727.MB1420S92/ABSTRACT.ACCESSED; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; MCKAY RML, 1993, ARCH MICROBIOL, V159, P21, DOI 10.1007/BF00244259; Menon BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003570; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; ORUS MI, 1995, PLANT PHYSIOL, V107, P1159, DOI 10.1104/pp.107.4.1159; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	30	59	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e76127	10.1371/journal.pone.0076127	http://dx.doi.org/10.1371/journal.pone.0076127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023971	gold, Green Published, Green Submitted			2022-12-25	WOS:000324515600165
J	Kim, J; Kim, SH				Kim, Jiyeon; Kim, Seong Hwan			CK2 Inhibitor CX-4945 Blocks TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells	PLOS ONE			English	Article							PROTEIN-KINASE CK2; FOCAL-ADHESION KINASE; GROWTH-FACTOR-BETA; BLADDER-CANCER CELLS; TGF-BETA; E-CADHERIN; GENE-EXPRESSION; INVASION; MIGRATION; CATENIN	Background: The epithelial-to-mesenchymal transition (EMT) is a major phenotype of cancer metastasis and invasion. As a druggable cancer target, the inhibition of protein kinase CK2 (formally named to casein kinase 2) has been suggested as a promising therapeutic strategy to treat EMT-controlled cancer metastasis. This study aimed to evaluate the effect of the CK2 inhibitor CX-4945 on the processes of cancer migration and invasion during the EMT in A549 human lung adenocarcinoma cells. Materials and Methods: The effect of CX-4945 on TGF-beta 1-induced EMT was evaluated in A549 cells treated with TGF-beta 1 (5 ng/ml) and CX-4945. The effect of CX-4945 on TGF-beta 1-induced cadherin switch and activation of key signaling molecules involved in Smad, non-Smad, Wnt and focal adhesion signaling pathways were investigated by Western blot analysis, immunocytochemistry and reporter assay. Additionally, the effect of CX-4945 on TGF-beta 1-induced migration and invasion was investigated by wound healing assay, Boyden chamber assay, gelatin zymography, and the quantitative real-time PCR. Results: CX-4945 inhibits the TGF-beta 1-induced cadherin switch and the activation of key signaling molecules involved in Smad (Smad2/3, Twist and Snail), non-Smad (Akt and Erk), Wnt (beta-catenin) and focal adhesion signaling pathways (FAK, Src and paxillin) that cooperatively regulate the overall process of EMT. As a result, CX-4945 inhibits the migration and invasion of A549 cells accompanied with the downregulation of MMP-2 and 9. Conclusions: Clinical evaluation of CX-4945 in humans as a single agent in solid tumors and multiple myeloma has established its promising pharmacokinetic, pharmacodynamic, and safety profiles. Beyond regression of tumor mass, CX-4945 may be advanced as a new therapy for cancer metastasis and EMT-related disorders.	[Kim, Jiyeon; Kim, Seong Hwan] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Div Drug Discovery Res, Lab Translat Therapeut, Taejon 305606, South Korea	Korea Research Institute of Chemical Technology (KRICT)	Kim, SH (corresponding author), Korea Res Inst Chem Technol, Pharmacol Res Ctr, Div Drug Discovery Res, Lab Translat Therapeut, Taejon 305606, South Korea.	hwan@krict.re.kr			KRICT's project [SI-1304]; Ministry of Knowledge Economy, Republic of Korea	KRICT's project; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by KRICT's project, SI-1304 funded by the Ministry of Knowledge Economy, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 1999, CRIT REV EUKAR GENE, V9, P329, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.170; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frame MC, 2008, DEV CELL, V15, P494, DOI 10.1016/j.devcel.2008.09.016; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Gonzalez-Santiago AE, 2011, J CLIN LAB ANAL, V25, P238, DOI 10.1002/jcla.20465; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huang YT, 2005, ANTICANCER RES, V25, P2017; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim J, 2012, ARCH PHARM RES, V35, P1293, DOI 10.1007/s12272-012-0800-9; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kodate M, 1997, PATHOL INT, V47, P461, DOI 10.1111/j.1440-1827.1997.tb04525.x; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; MACKAY AR, 1990, CANCER RES, V50, P5997; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Ponce DP, 2011, MOL CELL BIOCHEM, V356, P127, DOI 10.1007/s11010-011-0965-4; Ryu BJ, 2012, BIOORG MED CHEM LETT, V22, P5470, DOI 10.1016/j.bmcl.2012.07.031; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; Wei JC, 2008, ANTICANCER RES, V28, P327; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yokoyama T, 2004, BIOL PHARM BULL, V27, P1895, DOI 10.1248/bpb.27.1895; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	70	44	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74342	10.1371/journal.pone.0074342	http://dx.doi.org/10.1371/journal.pone.0074342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023938	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600137
J	Macdonald, FH; Yao, D; Quinn, JA; Greenhalgh, DA				Macdonald, F. H.; Yao, D.; Quinn, J. A.; Greenhalgh, D. A.			PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition	ONCOGENE			English	Article						epidermis; transgenic; carcinogenesis; ras(Ha); fos; PTEN	UP-REGULATION; DNA-DAMAGE; TUMOR SUPPRESSION; CELL-CYCLE; MALIGNANT CONVERSION; GENE-EXPRESSION; FOS; P53; DIFFERENTIATION; P21(WAF1/CIP1)	To investigate tumour progression mechanism in transgenic mouse skin carcinogenesis, inducible PTEN ablation (Delta 5PTEN(flx)) was targeted to the epidermis of mice expressing activated ras(Ha)/fos oncogenes (HK1.ras and HK1.fos). RU486-treated HK1.ras/fos-Delta 5PTEN(flx) epidermis exhibited significant keratinocyte proliferation resulting in hyperplasia and proliferating cysts. While HK1.ras/fos-Delta 5PTEN(flx) papillomatogenesis was accelerated, malignant conversion was delayed and tumours exhibited well-differentiated squamous cell carcinoma (wdSCC) histotypes, suggesting inhibition of early-stage malignant progression. Immediate elevated p53/p21 expression was observed in HK1.ras/fos-Delta 5PTEN(flx) hyperplasia, cysts and papillomas, and while malignant conversion required p53 loss, elevated p21 expression persisted in most wdSCCs to limit further progression, unless p21 was also lost and wdSCC progressed to more aggressive carcinomas. In contrast, TPA-promoted (that is, c-fos-activated) bi-genic HK1.ras-Delta 5PTEN(flx) cohorts lost p53/p21 expression during early papillomatogenesis and rapidly produced poorly differentiated carcinomas (pdSCCs) with high BrdU-labelling and elevated cyclin D1/E2 expression levels, indicative of a progression mechanism driven by failures in cell-cycle control. Intriguingly, HK1.ras/fos-Delta 5PTEN(flx) wdSCCs did not exhibit similar failures, as western and immunofluorescence analysis found downregulated cyclin E2 whenever p21 persisted; further, while westerns detected elevated cyclin D1, immunofluorescence identified reduced expression in proliferative basal layer nuclei and a redistributed expression profile throughout p21-positive wdSCC keratinocytes. These data demonstrate that rapid early epidermal responses to ras(Ha)/fos/Delta PTEN co-operation involve induction of p53/p21 to alter differentiation and divert excessive proliferation into cyst formation. Further, despite three potent oncogenic insults p53 loss was required for malignant conversion, and following p53 loss persistent, p53-independent p21 expression possessed the potency to limit early-stage malignant progression via cyclin D1/E2 inhibition.	[Macdonald, F. H.; Yao, D.; Quinn, J. A.; Greenhalgh, D. A.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med Dent & Nursing, Dermatol Sect, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	Greenhalgh, DA (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Sch Med Dent & Nursing, Dermatol Sect, Robertson Bldg Level 6,56 Dumbarton Rd, Glasgow G11 6NU, Lanark, Scotland.	david.greenhalgh@glasgow.ac.uk	Quinn, Jean/J-6440-2015	Quinn, Jean/0000-0002-8267-0993; Yao, Denggao/0000-0002-3031-126X	British Skin Foundation from Cancer Research UK [610, 3013, C1361/A2395]; Scott Endowment	British Skin Foundation from Cancer Research UK; Scott Endowment	We would like to thank Professor Hong Wu, Department of Molecular and Medical Pharmacology, UCLA, for the original gift of PTEN mice. Professor Dennis Roop, Center for Regenerative Medicine and Stem Cell Biology, Uiversity of Colorado, for the gift of K14.creP mice. Graham Chadwick for assistance with figure preparation; Dennis Duggan for assistance with animal husbandry and Ms Claire Gilbert for assistance with cyclin immunefluorescence analysis. This work was supported by: British Skin Foundation (Grants 610 & 3013), based on initial funding from Cancer Research UK (grant C1361/A2395) and the Scott Endowment to GU Dermatology.	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Berton TR, 2000, GENESIS, V26, P160, DOI 10.1002/(SICI)1526-968X(200002)26:2<160::AID-GENE20>3.0.CO;2-#; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Fistarol SK, 2002, EUR J DERMATOL, V12, P411; Floor SL, 2012, TRENDS MOL MED, V18, P509, DOI 10.1016/j.molmed.2012.06.005; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Ghaffar SA, 2007, CLIN EXP DERMATOL, V32, P223, DOI 10.1111/j.1365-2230.2006.02303.x; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; GREENHALGH DA, 1993, CANCER RES, V53, P5071; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He G, 2006, BRIT J CANCER, V95, P1514, DOI 10.1038/sj.bjc.6603448; Hinds PW, 2006, MOL CELL, V22, P432, DOI 10.1016/j.molcel.2006.05.006; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Jirawatnotai S, 2012, CANCER RES, V72, P4289, DOI 10.1158/0008-5472.CAN-11-3549; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Koul D, 2007, MOL CELL BIOCHEM, V300, P77, DOI 10.1007/s11010-006-9371-8; Leong WF, 2009, MOL CANCER RES, V7, P354, DOI 10.1158/1541-7786.MCR-08-0373; Macias E, 2008, AM J PATHOL, V173, P526, DOI 10.2353/ajpath.2008.071124; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Milde-Langosch K, 2000, INT J CANCER, V87, P468, DOI 10.1002/1097-0215(20000815)87:4<468::AID-IJC2>3.0.CO;2-R; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Niemann C, 2002, DEVELOPMENT, V129, P95; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Schlingemann J, 2003, INT J CANCER, V104, P699, DOI 10.1002/ijc.11008; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Suzuki A, 2003, CANCER RES, V63, P674; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; Tibarewal P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002138; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Torchia EC, 2012, ONCOGENE, V31, P2680, DOI 10.1038/onc.2011.441; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weinberg WC, 1999, CANCER RES, V59, P2050; Yao DG, 2008, J CELL SCI, V121, P1758, DOI 10.1242/jcs.021147; Yao DG, 2006, CANCER RES, V66, P1302, DOI 10.1158/0008-5472.CAN-05-2341; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986	52	10	10	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4132	4143		10.1038/onc.2013.372	http://dx.doi.org/10.1038/onc.2013.372			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24037529				2022-12-25	WOS:000340595700004
J	Kajimoto, K; Allan, A; Cunningham, LA				Kajimoto, Kenta; Allan, Andrea; Cunningham, Lee Anna			Fate Analysis of Adult Hippocampal Progenitors in a Murine Model of Fetal Alcohol Spectrum Disorder (FASD)	PLOS ONE			English	Article							PRENATAL ETHANOL EXPOSURE; NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; DENTATE GRANULE CELLS; ENVIRONMENTAL ENRICHMENT; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; MOUSE MODEL; STEM/PROGENITOR CELLS; VOLUNTARY EXERCISE	Prenatal alcohol exposure can lead to fetal alcohol spectrum disorder (FASD) and associated behavioral impairments that may be linked to disruptions in adult hippocampal neurogenesis. Social and physical enrichment has been proposed as a potential therapeutic approach toward reversing behavioral deficits associated with FASD and is also a potent stimulator of adult hippocampal neurogenesis. In the present study, we utilized a genetic fate mapping approach in nestin-CreER(T2)/YFP bitransgenic mice to identify the stage-specific impact of prenatal alcohol exposure on the stepwise maturation of adult hippocampal progenitors. Using a limited alcohol access "drinking-in-the-dark" model of FASD, we confirm previous findings that moderate prenatal alcohol exposure has no effect on adult neurogenesis under standard housing conditions, but abolishes the neurogenic response to enriched environment (EE). Furthermore, we demonstrate that this effect is primarily due to failed EE-mediated survival of postmitotic neurons. Finally, we demonstrate that the neurogenic deficit is associated with impaired spatial pattern recognition, as demonstrated by delayed learning of FASD-EE mice in an A-B contextual discrimination task. These results identify a potential maturational stage-specific mechanism(s) underlying impaired neurogenic function in a preclinical model of FASD, and provide a basis for testing regulatory pathways in this model through conditional and inducible manipulation of gene expression in the adult hippocampal progenitor population.	[Kajimoto, Kenta; Allan, Andrea; Cunningham, Lee Anna] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico	Cunningham, LA (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	leeanna@salud.unm.edu	Allan, Andrea M/L-8919-2015	Allan, Andrea/0000-0002-6745-4352	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [5R01AA017449]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017449] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Source of Funding: National Institute on Alcohol Abuse and Alcoholism (NIAAA) 5R01AA017449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Allan AM, 1998, J PHARMACOL EXP THER, V284, P250; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Boehm SL, 2008, DEV PSYCHOBIOL, V50, P566, DOI 10.1002/dev.20320; Boehme F, 2011, EUR J NEUROSCI, V33, P1799, DOI 10.1111/j.1460-9568.2011.07676.x; Brady ML, 2013, J NEUROSCI, V33, P1062, DOI 10.1523/JNEUROSCI.1217-12.2013; Brady ML, 2012, ALCOHOL CLIN EXP RES, V36, P457, DOI 10.1111/j.1530-0277.2011.01644.x; Brocardo PS, 2012, NEUROPHARMACOLOGY, V62, P1607, DOI 10.1016/j.neuropharm.2011.10.006; Caldwell KK, 2008, PHARMACOL BIOCHEM BE, V90, P614, DOI 10.1016/j.pbb.2008.05.004; Choi IY, 2005, ALCOHOL CLIN EXP RES, V29, P2053, DOI 10.1097/01.alc.0000187037.02670.59; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Duveau V, 2011, EUR J NEUROSCI, V34, P362, DOI 10.1111/j.1460-9568.2011.07782.x; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Feng MJ, 2005, BRAIN RES, V1042, P125, DOI 10.1016/j.brainres.2005.02.017; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gil-Mohapel J, 2010, BRAIN RES REV, V64, P283, DOI 10.1016/j.brainresrev.2010.04.011; Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105; Hamilton GF, 2012, ALCOHOL CLIN EXP RES, V36, P1196, DOI 10.1111/j.1530-0277.2011.01726.x; Helfer JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051344; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hodge RD, 2013, J NEUROSCI, V33, P4165, DOI 10.1523/JNEUROSCI.4185-12.2013; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ieraci A, 2007, NEUROBIOL DIS, V26, P597, DOI 10.1016/j.nbd.2007.02.011; Iqbal U, 2004, BEHAV BRAIN RES, V150, P117, DOI 10.1016/S0166-4328(03)00246-8; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Kelly SJ, 2000, NEUROTOXICOL TERATOL, V22, P143, DOI 10.1016/S0892-0362(99)00073-2; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; Kodituwakku PW, 2011, NEUROPSYCHOL REV, V21, P204, DOI 10.1007/s11065-011-9170-1; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Li GN, 2013, NEURON, V78, P658, DOI 10.1016/j.neuron.2013.03.019; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Maier SE, 1999, ALCOHOL CLIN EXP RES, V23, P726, DOI 10.1111/j.1530-0277.1999.tb04176.x; Martin LA, 2002, J NEUROSCI, V22, P3520; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Muhuri PK, 2009, MATERN CHILD HLTH J, V13, P376, DOI 10.1007/s10995-008-0375-8; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Samudio-Ruiz SL, 2010, ALCOHOL CLIN EXP RES, V34, P342, DOI 10.1111/j.1530-0277.2009.01096.x; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; SAVAGE DD, 1992, ALCOHOL, V9, P37, DOI 10.1016/0741-8329(92)90007-W; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Streissguth A P, 2000, Semin Clin Neuropsychiatry, V5, P177, DOI 10.1053/scnp.2000.6729; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Sutherland RJ, 1997, HIPPOCAMPUS, V7, P232, DOI 10.1002/(SICI)1098-1063(1997)7:2<232::AID-HIPO9>3.0.CO;2-O; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Varaschin RK, 2010, J PHARMACOL EXP THER, V334, P191, DOI 10.1124/jpet.109.165027; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Yamada K, 2003, J PHARMACOL SCI, V91, P267	74	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73788	10.1371/journal.pone.0073788	http://dx.doi.org/10.1371/journal.pone.0073788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040071	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500050
J	Surgucheva, I; Gunewardena, S; Rao, HS; Surguchov, A				Surgucheva, Irina; Gunewardena, Sumedha; Rao, H. Shanker; Surguchov, Andrei			Cell-Specific Post-Transcriptional Regulation of gamma-Synuclein Gene by Micro-RNAs	PLOS ONE			English	Article							BREAST-CANCER CELLS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ABERRANT EXPRESSION; ALZHEIMERS-DISEASE; COLORECTAL-CANCER; METASTASIS; PROMOTES; SURVIVAL; TARGETS	gamma-Synuclein is a member of the synucleins family of small proteins, which consists of three members: alpha, beta- and gamma-synuclein. gamma-Synuclein is abnormally expressed in a high percentage of advanced and metastatic tumors, but not in normal or benign tissues. Furthermore, gamma-synuclein expression is strongly correlated with disease progression, and can stimulate proliferation, induce invasion and metastasis of cancer cells. gamma-Synuclein transcription is regulated basically through the binding of AP-1 to specific sequences in intron 1. Here we show that gamma-synuclein expression may be also regulated by micro RNAs (miRs) on post-transcriptional level. According to prediction by several methods, the 3'-untranslated region (UTR) of gamma-synuclein gene contains targets for miRs. Insertion of gamma-synuclein 3'-UTR downstream of the reporter luciferase (LUC) gene causes a 51% reduction of LUC activity after transfection into SKBR3 and Y79 cells, confirming the presence of efficient targets for miRs in this fragment. Expression of miR-4437 and miR-4674 for which putative targets in 3'-UTR were predicted caused a 61.2% and 60.1% reduction of endogenous gamma-synuclein expression confirming their role in gene expression regulation. On the other hand, in cells overexpressing gamma-synuclein no significant effect of miRs on gamma-synuclein expression was found suggesting that miRs exert their regulatory effect only at low or moderate, but not at high level of gamma-synuclein expression. Elevated level of gamma-synuclein differentially changes the level of several miRs expression, upregulating the level of some miRs and downregulating the level of others. Three miRs upregulated as a result of gamma-synuclein overexpression, i.e., miR-885-3p, miR-138 and miR-497 have putative targets in 3'-UTR of the gamma-synuclein gene. Some of miRs differentially regulated by gamma-synuclein may modulate signaling pathways and cancer related gene expression. This study demonstrates that miRs might provide cell-specific regulation of gamma-synuclein expression and set the stage to further evaluate their role in pathophysiological processes.	[Surgucheva, Irina; Surguchov, Andrei] Vet Adm Med Ctr, Retinal Biol Res Lab, Kansas City, MO 64128 USA; [Surgucheva, Irina; Surguchov, Andrei] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Gunewardena, Sumedha; Rao, H. Shanker] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Surguchov, A (corresponding author), Vet Adm Med Ctr, Retinal Biol Res Lab, Kansas City, MO 64128 USA.	asurguchov@kumc.edu			VA Merit review grant; Glaucoma Foundation	VA Merit review grant(US Department of Veterans Affairs); Glaucoma Foundation	This work was supported by VA Merit review grant and the Glaucoma Foundation grant. VA merit Review grant is a federal funding, the Glaucoma foundation is a private funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chen KC, 2012, INVEST OPHTH VIS SCI, V53, P2732, DOI 10.1167/iovs.11-9272; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Espinosa C. E. Stahlhut, 2006, YALE J BIOL MED, V79, P131; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Ghelani HS, 2012, J PHARMACOL PHARMACO, V3, P217, DOI 10.4103/0976-500X.99416; Gordanpour A, 2011, ANTICANCER RES, V31, P403; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Gupta A, 2003, CANCER RES, V63, P664; Hafez MM, 2012, ASIAN PAC J CANCER P, V13, P591, DOI 10.7314/APJCP.2012.13.2.591; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Imam JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052397; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2003, CANCER RES, V63, P3899; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khodr CE, 2012, DEV NEUROBIOL, V72, P906, DOI 10.1002/dneu.20989; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Lee YS, 2006, CURR OPIN INVEST DR, V7, P560; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Liu JW, 2000, BREAST CANCER RES TR, V62, P99, DOI 10.1023/A:1006418219012; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052280; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Lu AP, 2002, J BIOL CHEM, V277, P31364, DOI 10.1074/jbc.M201060200; Lu AP, 2001, ONCOGENE, V20, P5173, DOI 10.1038/sj.onc.1204668; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw Walter J, 2012, Int J Biochem Mol Biol, V3, P105; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Lupini Laura, 2013, Frontiers in Genetics, V4, P64, DOI 10.3389/fgene.2013.00064; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Mouradian MM, 2012, NEUROBIOL DIS, V46, P279, DOI 10.1016/j.nbd.2011.12.046; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Ninkina NN, 1998, HUM MOL GENET, V7, P1417, DOI 10.1093/hmg/7.9.1417; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; Rubio-Somoza I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003374; Saito Yoshimasa, 2012, Frontiers in Genetics, V3, P194, DOI 10.3389/fgene.2012.00194; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shi YE, 2010, AM J PATHOL, V177, P964, DOI 10.2353/ajpath.2010.100061; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva I, 2008, J MOL NEUROSCI, V35, P267, DOI 10.1007/s12031-008-9074-6; Surgucheva I, 2006, CELL MOTIL CYTOSKEL, V63, P447, DOI 10.1002/cm.20135; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Surgucheva Irina, 2010, J Ocul Biol Dis Infor, V3, P41, DOI 10.1007/s12177-010-9054-2; Surgucheva I, 2008, J BIOL CHEM, V283, P36377, DOI 10.1074/jbc.M806660200; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Takeda A, 1998, AM J PATHOL, V152, P367; Thomas MP, 2013, IMMUNOL REV, V253, P237, DOI 10.1111/imr.12052; Wibrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041688; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	84	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73786	10.1371/journal.pone.0073786	http://dx.doi.org/10.1371/journal.pone.0073786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040069	gold, Green Submitted, Green Published			2022-12-25	WOS:000326734500049
J	Uddin, M; Lau, LC; Seumois, G; Vijayanand, P; Staples, KJ; Bagmane, D; Cornelius, V; Dorinsky, P; Davies, DE; Djukanovic, R				Uddin, Mohib; Lau, Laurie C.; Seumois, Gregory; Vijayanand, Pandurangan; Staples, Karl J.; Bagmane, Dinesh; Cornelius, Victoria; Dorinsky, Paul; Davies, Donna E.; Djukanovic, Ratko			EGF-Induced Bronchial Epithelial Cells Drive Neutrophil Chemotactic and Anti-Apoptotic Activity in Asthma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ALLERGIC AIRWAY INFLAMMATION; ACUTE LUNG INJURY; PHOSPHOINOSITIDE 3-KINASE; FACTOR RECEPTOR; GM-CSF; INHALED CORTICOSTEROIDS; BINDING DOMAIN; SMOOTH-MUSCLE; IN-VITRO	Chronic damage and repair of the bronchial epithelium are features of asthma. We have previously reported that ex vivo stimulation of normal bronchial epithelial cells with epidermal growth factor (EGF), a key factor of epithelial repair, enhances the mechanisms of neutrophil accumulation, thereby promoting neutrophil defences during acute injury but potentially enhancing inflammation in chronic airway diseases. We have now sought to (i) determine whether this EGF-dependent pro-neutrophil activity is increased in asthma, where EGF and its epithelial receptor are over-expressed, and (ii) elucidate some of the mechanisms underlying this asthmatic epithelial-neutrophil interaction. Primary bronchial epithelial cells (PBEC) from healthy subjects, mild asthmatics and moderate-to-severe asthmatics (Mod/Sev) were stimulated with EGF, a model that mimics a repairing epithelium. Conditioned culture media (EGF-CM) were assessed for neutrophil chemotactic and antiapoptotic activities and inflammatory mediator production. EGF induced the epithelium to produce soluble mediators with neutrophil chemotactic (p<0.001) and pro-survival (p = 0.021) activities which were related to the clinical severity of asthma (trend p = 0.010 and p = 0.009, respectively). This was associated with enhanced IL-6, IL-8, GM-CSF and TNF-alpha release, and cytokine-neutralising experiments using EGF-CM from Mod/Sev asthmatics demonstrated a role for GM-CSF in neutrophil survival (p<0.001). Pre-treatment of neutrophils with specific inhibitors of the myeloid-restricted class I phosphatidylinositol-3-OH kinase (PI(3) K) isoforms showed that neutrophil chemotaxis induced by EGF-CM from Mod/Sev asthmatics depended on the gamma (p<0.021) but not delta isoforms, while neutrophil survival required multiple class I PI(3)Ks. The EGF-induced chemotactic, but not pro-survival activity, involved RhoA signaling in neutrophils (p = 0.012). EGF whose activity is upregulated in asthma induces ex vivo the epithelium from asthmatic patients to produce pro-neutrophil activities; these are related to asthma severity and, in moderate-to-severe asthmatics, involves class IB PI(3)K gamma signaling, providing a potential therapeutic target for neutrophilic forms of asthma.	[Uddin, Mohib; Lau, Laurie C.; Seumois, Gregory; Vijayanand, Pandurangan; Staples, Karl J.; Bagmane, Dinesh; Cornelius, Victoria; Davies, Donna E.; Djukanovic, Ratko] Univ Southampton, Southampton Univ Hosp, Fac Med, Acad Unit Clin & Expt Sci, Southampton, Hants, England; [Uddin, Mohib; Lau, Laurie C.; Seumois, Gregory; Vijayanand, Pandurangan; Staples, Karl J.; Bagmane, Dinesh; Cornelius, Victoria; Davies, Donna E.; Djukanovic, Ratko] Univ Southampton, Southampton Univ Hosp, Sir Henry Wellcome Labs, NIHR Southampton Resp Biomed Res Unit,Fac Med, Southampton, Hants, England; [Dorinsky, Paul] GlaxoSmithKline, Resp Med Dev Ctr, Durham, NC USA	University of Southampton; University of Southampton; GlaxoSmithKline	Djukanovic, R (corresponding author), Univ Southampton, Southampton Univ Hosp, Fac Med, Acad Unit Clin & Expt Sci, Southampton, Hants, England.	R.Djukanovic@soton.ac.uk	Uddin, Mohib/E-1459-2019; Davies, Donna E/H-2993-2012	Uddin, Mohib/0000-0002-2412-2657; Davies, Donna/0000-0002-5117-2991; Djukanovic, Ratko/0000-0001-6039-5612; Seumois, Gregory/0000-0002-8164-6852; Cornelius, Victoria/0000-0002-0080-1065; Staples, Karl/0000-0003-3844-6457	British Lung Foundation [P04/14]; GlaxoSmithKline; Asthma UK [08/026] Funding Source: researchfish	British Lung Foundation; GlaxoSmithKline(GlaxoSmithKline); Asthma UK	This research was funded by the British Lung Foundation Project Grant (P04/14; www.blf.org.uk) and an industrial collaborative grant from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAZIZ MM, 1995, AM J RESP CELL MOL, V13, P728, DOI 10.1165/ajrcmb.13.6.7576711; Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Arold SP, 2009, RESP RES, V10, DOI [10.1186/1465-9921-10-5, 10.1186/1465-9921-10-9]; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; Brown MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037044; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Devalia JL, 1999, INT ARCH ALLERGY IMM, V118, P437, DOI 10.1159/000024157; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Erin EM, 2008, AM J RESP CRIT CARE, V177, P132, DOI 10.1164/rccm.200603-311OC; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Ge Q, 2012, J CELL PHYSIOL, V227, P3044, DOI 10.1002/jcp.23046; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hamilton LM, 2005, EUR RESPIR J, V25, P978, DOI 10.1183/09031936.05.00098604; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Holgate ST, 2012, TRENDS IMMUNOL, V33, P238, DOI 10.1016/j.it.2012.02.003; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Juss JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045933; Kim DI, 2012, J CLIN IMMUNOL, V32, P340, DOI 10.1007/s10875-011-9628-1; Kim KW, 2009, CHEST, V136, P805, DOI 10.1378/chest.08-2972; Kuhn MA, 2002, ANTIOXID REDOX SIGN, V4, P639, DOI 10.1089/15230860260220148; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Ottonello L, 2001, BRIT J CANCER, V85, P463, DOI 10.1054/bjoc.2001.1940; Park SJ, 2008, RESPIROLOGY, V13, P764, DOI 10.1111/j.1440-1843.2008.01369.x; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pinho V, 2007, J IMMUNOL, V179, P7891, DOI 10.4049/jimmunol.179.11.7891; Polosa R, 2002, J ALLERGY CLIN IMMUN, V109, P75, DOI 10.1067/mai.2002.120274; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Richter A, 2001, AM J RESP CELL MOL, V25, P385, DOI 10.1165/ajrcmb.25.3.4437; Rocourt DV, 2007, J SURG RES, V139, P269, DOI 10.1016/j.jss.2006.10.047; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rytila P, 2006, EUR RESPIR J, V28, P1163, DOI 10.1183/09031936.00149005; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; SOUSA AR, 1993, AM REV RESPIR DIS, V147, P1557, DOI 10.1164/ajrccm/147.6_Pt_1.1557; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Thomas MJ, 2005, EUR J IMMUNOL, V35, P1283, DOI 10.1002/eji.200425634; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Uddin M, 2008, EUR RESPIR J, V31, P714, DOI 10.1183/09031936.00144307; Uddin M, 2010, THORAX, V65, P684, DOI 10.1136/thx.2009.120741; von Gunten S, 2007, AUTOPHAGY, V3, P67, DOI 10.4161/auto.3436; Yagi Y, 2006, EUR J PHARMACOL, V536, P19, DOI 10.1016/j.ejphar.2006.02.024; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601; Zhang HY, 2012, SURGERY, V151, P594, DOI 10.1016/j.surg.2011.10.001	69	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72502	10.1371/journal.pone.0072502	http://dx.doi.org/10.1371/journal.pone.0072502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039773	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000326734500015
J	Benton, DCH; Garbarg, M; Moss, GWJ				Benton, David Charles Hammond; Garbarg, Monique; Moss, Guy William John			The Relationship between Functional Inhibition and Binding for K(Ca)2 Channel Blockers	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; BIS-QUINOLINIUM CYCLOPHANES; GUINEA-PIG HEPATOCYTES; SMALL-CONDUCTANCE; MOLECULAR DETERMINANTS; NONPEPTIDIC BLOCKER; APAMIN SENSITIVITY; HEK-293 CELLS; MODULATORS	Small conductance calcium-activated potassium channels (K(Ca)2.1,2.2,2.3) are blocked with high affinity by both peptide toxins (e. g. apamin) and small molecule blockers (e. g. UCL 1848). In electrophysiological experiments, apamin shows subtype selectivity with IC(50)s of similar to 100 pM and similar to 1 nM for block K(Ca)2.2 and K(Ca)2.3 respectively. In binding studies, however, apamin appears not to discriminate between K(Ca)2.2 and 2.3 and is reported to have a significantly higher (similar to 20-200-fold) affinity (similar to 5 pM). This discrepancy between binding and block has been suggested to reflect an unusual mode of action of apamin. However, these binding and electrophysiological block experiments have not been conducted in the same ionic conditions, so it is also possible that the discrepancy arises simply because of differences in experimental conditions. We have now examined this latter possibility. Thus, we measured I-125-apamin binding to intact HEK 293 cells expressing K(Ca)2 channels under the same ionic conditions (i.e. normal physiological conditions) that we also used for current block measurements. We find that binding and block experiments agree well if the same ionic conditions are used. Further, the binding of apamin and other blockers showed subtype selectivity when measured in normal physiological solutions (e. g. I-125-apamin bound to K(Ca)2.2 with K-L 91 +/- 40 pM and to K(Ca)2.3 with K-L 711 +/- 126 pM, while inhibiting K(Ca)2.2 current at IC50 103 +/- 2 pM). We also examined K(Ca)2 channel block in Ca2+ and Mg2+ free solutions that mimic conditions reported in the literature for binding experiments. Under these (non-physiological) conditions the IC50 for apamin block of K(Ca)2.2 was reduced to 20 +/- 3 pM. Our results therefore suggest that the apparent discrepancy between blocking and binding reported in the literature can be largely accounted for by the use of non-physiological ionic conditions in binding experiments.	[Benton, David Charles Hammond; Garbarg, Monique; Moss, Guy William John] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Benton, DCH (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	d.benton@ucl.ac.uk			Wellcome Trust [059878]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Wellcome Trust(www.wellcome.ac.uk) Grant number 059878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bahia PK, 2005, J NEUROSCI, V25, P3489, DOI 10.1523/JNEUROSCI.0597-05.2005; BANKS BEC, 1979, NATURE, V282, P415, DOI 10.1038/282415a0; Benton DCH, 2003, J PHYSIOL-LONDON, V553, P13, DOI 10.1113/jphysiol.2003.054551; Chen JQ, 2000, J MED CHEM, V43, P3478, DOI 10.1021/jm000904v; COOK NS, 1983, FEBS LETT, V152, P265, DOI 10.1016/0014-5793(83)80393-7; COOK NS, 1985, J PHYSIOL-LONDON, V358, P373, DOI 10.1113/jphysiol.1985.sp015556; Dale TJ, 2002, N-S ARCH PHARMACOL, V366, P470, DOI 10.1007/s00210-002-0622-2; Dilly S, 2011, CHEMBIOCHEM, V12, P1808, DOI 10.1002/cbic.201100236; Finlayson K, 2001, NEUROPHARMACOLOGY, V41, P341, DOI 10.1016/S0028-3908(01)00067-3; Hanselmann C, 1996, J PHYSIOL-LONDON, V496, P627, DOI 10.1113/jphysiol.1996.sp021714; Hosseini R, 2001, J PHYSIOL-LONDON, V535, P323, DOI 10.1111/j.1469-7793.2001.00323.x; HUGUES M, 1982, P NATL ACAD SCI-BIOL, V79, P1308, DOI 10.1073/pnas.79.4.1308; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jager H, 2000, FEBS LETT, V469, P196, DOI 10.1016/S0014-5793(00)01236-9; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lamy C, 2010, J BIOL CHEM, V285, P27067, DOI 10.1074/jbc.M110.110072; Liegeois JF, 2003, CURR MED CHEM, V10, P625, DOI 10.2174/0929867033457908; Martell A. E., 1974, CRITICAL STABILITY C; Nolting A, 2007, J BIOL CHEM, V282, P3478, DOI 10.1074/jbc.M607213200; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Pedarzani P, 2000, J PHYSIOL-LONDON, V527, P283, DOI 10.1111/j.1469-7793.2000.t01-1-00283.x; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; SEAGAR MJ, 1984, J BIOL CHEM, V259, P1491; Shah M, 2000, BRIT J PHARMACOL, V129, P627, DOI 10.1038/sj.bjp.0703111; Sorensen US, 2008, J MED CHEM, V51, P7625, DOI 10.1021/jm800809f; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; WADSWORTH JDF, 1994, J BIOL CHEM, V269, P18053; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73328	10.1371/journal.pone.0073328	http://dx.doi.org/10.1371/journal.pone.0073328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039913	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600026
J	Son, H; Kim, MG; Min, K; Seo, YS; Lim, JY; Choi, GJ; Kim, JC; Chae, SK; Lee, YW				Son, Hokyoung; Kim, Myung-Gu; Min, Kyunghun; Seo, Young-Su; Lim, Jae Yun; Choi, Gyung Ja; Kim, Jin-Cheol; Chae, Suhn-Kee; Lee, Yin-Won			AbaA Regulates Conidiogenesis in the Ascomycete Fungus Fusarium graminearum	PLOS ONE			English	Article							GIBBERELLA-ZEAE ANAMORPH; ASPERGILLUS-NIDULANS; FUNCTIONAL ANALYSES; ASEXUAL SPORULATION; ACETYL-COENZYME; GENETIC-CONTROL; PATHOGENESIS; PATHOGENICITY; DIFFERENTIATION; MORPHOGENESIS	Fusarium graminearum (teleomorph Gibberella zeae) is a prominent pathogen that infects major cereal crops such as wheat, barley, and maize. Both sexual (ascospores) and asexual (conidia) spores are produced in F. graminearum. Since conidia are responsible for secondary infection in disease development, our objective of the present study was to reveal the molecular mechanisms underlying conidiogenesis in F. graminearum based on the framework previously described in Aspergillus nidulans. In this study, we firstly identified and functionally characterized the ortholog of AbaA, which is involved in differentiation from vegetative hyphae to conidia and known to be absent in F. graminearum. Deletion of abaA did not affect vegetative growth, sexual development, or virulence, but conidium production was completely abolished and thin hyphae grew from abnormally shaped phialides in abaA deletion mutants. Overexpression of abaA resulted in pleiotropic defects such as impaired sexual and asexual development, retarded conidium germination, and reduced trichothecene production. AbaA localized to the nuclei of phialides and terminal cells of mature conidia. Successful interspecies complementation using A. nidulans AbaA and the conserved AbaA-WetA pathway demonstrated that the molecular mechanisms responsible for AbaA activity are conserved in F. graminearum as they are in A. nidulans. Results from RNA-sequencing analysis suggest that AbaA plays a pivotal role in conidiation by regulating cell cycle pathways and other conidiation-related genes. Thus, the conserved roles of the AbaA ortholog in both A. nidulans and F. graminearum give new insight into the genetics of conidiation in filamentous fungi.	[Son, Hokyoung; Kim, Myung-Gu; Min, Kyunghun; Lim, Jae Yun; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Son, Hokyoung; Kim, Myung-Gu; Min, Kyunghun; Lim, Jae Yun; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Seo, Young-Su] Pusan Natl Univ, Dept Microbiol, Pusan, South Korea; [Choi, Gyung Ja; Kim, Jin-Cheol] Korea Res Inst Chem Technol, Ecofriendly New Mat Res Grp, Res Ctr Biobased Chem, Div Convergence Chem, Taejon 305606, South Korea; [Chae, Suhn-Kee] Paichai Univ, Dept Biochem, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Korea Research Institute of Chemical Technology (KRICT); Pai Chai University	Lee, YW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	lee2443@snu.ac.kr		Chae, Suhn-Kee/0000-0003-2164-1053; Son, Hokyoung/0000-0001-5080-7951; Min, Kyunghun/0000-0002-2682-4660	National Research Foundation of Korea (NRF); Korean government (MSIP) [2008-0061897]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2008-0061897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Borneman AR, 2000, MOL MICROBIOL, V38, P1034, DOI 10.1046/j.1365-2958.2000.02202.x; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Fischer R., 2006, MYCOTA, V1, P263, DOI DOI 10.1007/3-540-28135-5; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; GARNJOBST L, 1967, GENETICS, V57, P579; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Goh YK, 2009, BIOCONTROL SCI TECHN, V19, P151, DOI 10.1080/09583150802627033; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Hong SY, 2010, FUNGAL GENET BIOL, V47, P364, DOI 10.1016/j.fgb.2010.01.005; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Leslie J. F., 2006, FUSARIUM LAB MANUAL, DOI 10.1002/9780470278376; Li YM, 2011, MOL PLANT MICROBE IN, V24, P487, DOI 10.1094/MPMI-10-10-0233; Lin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037859; Lin YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022924; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; MARTINELLI SD, 1971, J GEN MICROBIOL, V69, P261, DOI 10.1099/00221287-69-2-261; Miller BL, 1990, SEMIN DEV BIOL, V1, P207; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; NYVALL RF, 1970, PHYTOPATHOLOGY, V60, P1175, DOI 10.1094/Phyto-60-1175; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; Rittenour WR, 2008, FUNGAL GENET BIOL, V45, P933, DOI 10.1016/j.fgb.2008.01.007; Sambrook J., 2001, MOL CLONING LAB MANU; Seong KY, 2008, FUNGAL GENET BIOL, V45, P389, DOI 10.1016/j.fgb.2007.09.002; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Shi ZX, 1995, MOL PLANT MICROBE IN, V8, P949, DOI 10.1094/MPMI-8-0949; Si HY, 2012, MOL MICROBIOL, V85, P252, DOI 10.1111/j.1365-2958.2012.08108.x; Son H, 2013, MICROBIOL-SGM, V159, P1077, DOI 10.1099/mic.0.064287-0; Son H, 2012, MICROBIOL RES, V167, P608, DOI 10.1016/j.micres.2012.04.001; Son H, 2012, EUKARYOT CELL, V11, P1143, DOI 10.1128/EC.00104-12; Son H, 2012, FEMS MICROBIOL LETT, V329, P123, DOI 10.1111/j.1574-6968.2012.02511.x; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Ye XS, 1999, EMBO J, V18, P6994, DOI 10.1093/emboj/18.24.6994; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zheng WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045432; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	75	54	57	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72915	10.1371/journal.pone.0072915	http://dx.doi.org/10.1371/journal.pone.0072915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039821	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600011
J	Korrapati, MC; Howell, LH; Shaner, BE; Megyesi, JK; Siskind, LJ; Schnellmann, RG				Korrapati, Midhun C.; Howell, Lauren H.; Shaner, Brooke E.; Megyesi, Judit K.; Siskind, Leah J.; Schnellmann, Rick G.			Suramin: A Potential Therapy for Diabetic Nephropathy	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; RENAL INJURY; TGF-BETA; MECHANISMS; FIBROSIS; PROTEINURIA; PATHOLOGY; RECOVERY; DISEASE; STRESS	Objective: To determine whether delayed administration of a single dose of suramin, a drug that has been used extensively in humans to treat trypanosomiasis, attenuates renal injury in a leptin receptor deficient C57BLKS/J db/db type 2 diabetic nephropathy (T2DN) mouse model. Research Design and Methods: Groups of female non-diabetic (control) db/m and diabetic db/db mice of 8 and 16 weeks of age, respectively, were treated with suramin (10 mg/kg) or saline i.v. All animals were euthanized one week later. Measurements in mice 1 week following treatment included the following: body weight; blood glucose; urinary protein excretion; pathological lesions in glomeruli and proximal tubules; changes in protein expression of pro-inflammatory transcription factor nuclear factor kappa B (NF-kappa B) and intracellular adhesion molecule-1 (ICAM-1), profibrotic transforming growth factor-beta 1 (TGF-beta 1), phospho-SMAD-3 and alpha-smooth muscle actin (alpha-SMA); and immunohistochemical analysis of leukocyte infiltration and collagen 1A2 (COL1A2) deposition. Results: Immunoblot analysis revealed increased NF-kappa B, ICAM-1, TGF-beta 1, phospho-SMAD-3, and alpha-SMA proteins in both 9 and 17 week db/db mice as compared to db/m control mice. Immunohistochemical analysis revealed moderate leukocyte infiltration and collagen 1A2 (COL1A2) deposition in 9 week db/db mice that was increased in the 17 week db/db mice. Importantly, suramin significantly decreased expression of all these markers in 9 week db/db mice and partially decreased in 17 week db/db mice without altering body weight, blood glucose or urinary protein excretion. There was no difference in creatinine clearance between 9 week db/m and db/db mice +/- suramin. Importantly, in the 17 week db/db mice suramin intervention reversed the impaired creatinine clearance and overt histological damage. Conclusions: Delayed administration of a single dose of suramin in a model of T2DN attenuated inflammation and fibrosis as well as improved renal function, supporting the use of suramin in T2DN.	[Korrapati, Midhun C.; Howell, Lauren H.; Shaner, Brooke E.; Siskind, Leah J.; Schnellmann, Rick G.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Megyesi, Judit K.] Univ Arkansas Med Sci, Div Nephrol, Coll Med, Dept Internal Med, Little Rock, AR 72205 USA; [Siskind, Leah J.; Schnellmann, Rick G.] Ralph H Johnson Vet Adm Med Ctr, Charleston, SC USA	Medical University of South Carolina; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Siskind, LJ (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	leah.siskind@louisville.edu		Siskind, Leah/0000-0001-5026-5187	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK093462]; Cancer Center Support Grant [P30 CA138313]; Centers of Biomedical Research Excellence in Lipidomics and Pathobiology [NIH/NCRR P20 RR17677]; South Carolina Centers of Biomedical Research Excellence in Oxidants, Redox Balance and Stress Signaling [P20 GM103542]; National Institutes of Health [GM 084147, C06 RR-015455]; Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs; South Carolina Clinical & Translational Research (SCTR) Institute; Medical University of South Carolina CTSA, NIH/NCRR [UL1RR029882]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, UL1RR029882, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542, R01GM084147] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Center Support Grant; Centers of Biomedical Research Excellence in Lipidomics and Pathobiology; South Carolina Centers of Biomedical Research Excellence in Oxidants, Redox Balance and Stress Signaling; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs(US Department of Veterans Affairs); South Carolina Clinical & Translational Research (SCTR) Institute; Medical University of South Carolina CTSA, NIH/NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported in part by National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, [R01DK093462] (to L.J.S.), the Lipidomics Shared Resource of the Hollings Cancer Center at the Medical University of South Carolina supported by a Cancer Center Support Grant [P30 CA138313], pilot project from the [NIH/NCRR P20 RR17677] Centers of Biomedical Research Excellence in Lipidomics and Pathobiology (to L.J.S), South Carolina Centers of Biomedical Research Excellence in Oxidants, Redox Balance and Stress Signaling [P20 GM103542], pilot project from the [NIH/NCRR P20 RR17677], National Institutes of Health Grant [GM 084147] and by the Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs. Animal facilities were funded by National Institutes of Health grant [C06 RR-015455]. This reseach was supported in part by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina CTSA, NIH/NCRR Grant Number UL1RR029882. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, VA, or National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakumar P, 2009, PHARMACOL RES, V60, P24, DOI 10.1016/j.phrs.2009.02.002; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Cohen MP, 2001, METABOLISM, V50, P1435, DOI 10.1053/meta.2001.28074; COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fornoni A, 2008, CURR DIABETES REV, V4, P10, DOI 10.2174/157339908783502361; Fragiadaki M, 2011, MATRIX BIOL, V30, P396, DOI 10.1016/j.matbio.2011.07.004; GARTNER K, 1978, DIABETOLOGIA, V15, P59, DOI 10.1007/BF01219330; Genetos DC, 2011, EXP CELL RES, V317, P737, DOI 10.1016/j.yexcr.2011.01.007; Goto T, 2006, CYTOKINE, V33, P28, DOI 10.1016/j.cyto.2005.11.012; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kopple JD, 2011, J RENAL NUTR, V21, P66, DOI 10.1053/j.jrn.2010.10.009; Korrapati MC, 2012, J PHARMACOL EXP THER, V343, P34, DOI 10.1124/jpet.112.196964; Korrapati MC, 2012, J PHARMACOL EXP THER, V341, P126, DOI 10.1124/jpet.111.190249; Kuhad A, 2009, LIFE SCI, V84, P296, DOI 10.1016/j.lfs.2008.12.014; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Liu N, 2011, J PHARMACOL EXP THER, V338, P758, DOI 10.1124/jpet.111.181727; Liu N, 2011, CURR CLIN PHARMACOL, V6, P137, DOI 10.2174/157488411796151174; Mathew A, 2011, CONTRIB NEPHROL, V170, P217, DOI 10.1159/000325671; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Nayak Barun K, 2005, Indian J Ophthalmol, V53, P1; Ohga S, 2007, AM J PHYSIOL-RENAL, V292, pF1141, DOI 10.1152/ajprenal.00288.2005; Peters V, 2012, EXP CLIN ENDOCR DIAB, V120, P191, DOI 10.1055/s-0032-1304569; Quezada C, 2013, CURR DRUG TARGETS, V14, P490; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Sharma B, 2008, FOOD CHEM TOXICOL, V46, P2376, DOI 10.1016/j.fct.2008.03.020; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; Song JH, 2006, NEPHROL DIAL TRANSPL, V21, P683, DOI 10.1093/ndt/gfi310; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Titan SM, 2011, CLIN NEPHROL, V76, P273, DOI 10.5414/CN107013; Wang LH, 2011, PHARMACOLOGY, V88, P88, DOI 10.1159/000329419; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xiao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060173; Zhuang SG, 2009, KIDNEY INT, V75, P304, DOI 10.1038/ki.2008.506	48	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73655	10.1371/journal.pone.0073655	http://dx.doi.org/10.1371/journal.pone.0073655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040012	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300104
J	Tsai, CL; Wu, HM; Lin, CY; Lin, YJ; Chao, A; Wang, TH; Hsueh, S; Lai, CH; Wang, HS				Tsai, Chia-Lung; Wu, Hsien-Ming; Lin, Chiao-Yun; Lin, Yi-Jun; Chao, Angel; Wang, Tzu-Hao; Hsueh, Swei; Lai, Chyong-Huey; Wang, Hsin-Shih			Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor a (ER alpha)	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; INDUCED PHOSPHOPROTEIN 1; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; GENE-EXPRESSION; LAPATINIB GW572016; PROLIFERATION; INHIBITOR; 17-BETA-ESTRADIOL; 4-HYDROXYTAMOXIFEN	Estrogens and tamoxifen (an antiestrogen) exert their actions by activation of estrogen receptor (ER) through genomic and non-genomic mechanisms and are implicated in the development of endometrial cancer. Previous reports have demonstrated that estradiol and tamoxifen induce proliferation of human endometrial cancer cells through GPR30 (non-genomic ER) signaling pathway. Herein, we demonstrate that phosphorylation of focal adhesion kinase (FAK) is involved in cell migration induced by estradiol, tamoxifen and G1 (a GPR30 agonist) through the transmembrane ER (GPR30) in endometrial cancer cell lines with or without ER alpha (Ishikawa and RL95-2). Additionally, the GPR30-mediated cell migration was further abolished by administration of either specific RNA interference targeting GPR30 or an FAK inhibitor. Moreover, we have validated that the signaling between GPR30 and phosphorylated FAK is indeed mediated by the EGFR/PI3K/ERK pathway. Clinically, a significant correlation between levels of GPR30 and phophorylated FAK (pFAK) observed in human endometrial cancer tissues with low or without ER alpha further suggested that estrogen-induced phosphorylation of FAK and cell migration were most likely triggered by GPR30 activation. These results provided new insights for understanding the pathophysiological functions of GPR30 in human endometrial cancers.	[Tsai, Chia-Lung; Wu, Hsien-Ming; Lin, Chiao-Yun; Lin, Yi-Jun; Chao, Angel; Wang, Tzu-Hao; Lai, Chyong-Huey; Wang, Hsin-Shih] Chang Gung Univ, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Lin Kou Med Ctr, Tao Yuan, Taiwan; [Tsai, Chia-Lung; Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Tao Yuan, Taiwan; [Hsueh, Swei] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pathol, Lin Kou Med Ctr, Tao Yuan, Taiwan; [Wang, Hsin-Shih] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wang, HS (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Lin Kou Med Ctr, Tao Yuan, Taiwan.	hswang@cgmh.org.tw	Lai, Chyong-Huey/AAE-5731-2022	Lai, Chyong-Huey/0000-0002-9977-9645; Migliaccio, Antimo/0000-0002-4197-2055	National Science Council, Taiwan [NSC-96-2314-B-182-016, NSC-97-2314-B-182-014-MY3, NSC-99-2321-B-182A-003-MY3]; Chang Gung Memorial Hospital [CMRPG381671]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Grants NSC-96-2314-B-182-016 and NSC-97-2314-B-182-014-MY3 (to HSW) and NSC-99-2321-B-182A-003-MY3 (to CLT) from the National Science Council, Taiwan; and CMRPG381671 (to HMW) from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Ahola TM, 2002, ENDOCRINOLOGY, V143, P3376, DOI 10.1210/en.2001-211445; Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Chao A, 2010, CANCER LETT, V291, P99, DOI 10.1016/j.canlet.2009.10.005; Chu I, 2005, CANCER RES, V65, P18; Creasman WT, 2002, GYNECOL ONCOL, V86, P1, DOI 10.1006/gyno.2001.6499; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Flamini MI, 2011, FERTIL STERIL, V95, P722, DOI 10.1016/j.fertnstert.2010.08.039; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kovacs EJ, 2002, MOL CELL ENDOCRINOL, V193, P129, DOI 10.1016/S0303-7207(02)00106-5; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Lepine J, 2010, J CLIN ENDOCR METAB, V95, P2689, DOI 10.1210/jc.2010-2648; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Moorthy B, 1997, BIOCHEM PHARMACOL, V53, P663, DOI 10.1016/S0006-2952(96)00875-1; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Shibutani S, 2000, CARCINOGENESIS, V21, P1461, DOI 10.1093/carcin/21.8.1461; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Swerdlow AJ, 2005, JNCI-J NATL CANCER I, V97, P375, DOI 10.1093/jnci/dji057; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tsai CL, 2012, CELL REP, V2, P283, DOI 10.1016/j.celrep.2012.07.002; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang TH, 2010, MOL CELL PROTEOMICS, V9, P1873, DOI 10.1074/mcp.M110.000802; Wang TH, 2009, FERTIL STERIL, V92, P96, DOI 10.1016/j.fertnstert.2008.05.038; WAY DL, 1983, IN VITRO CELL DEV B, V19, P147	51	44	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72999	10.1371/journal.pone.0072999	http://dx.doi.org/10.1371/journal.pone.0072999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039841	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300042
J	Voolstra, O; Bartels, JP; Oberegelsbacher, C; Pfannstiel, J; Huber, A				Voolstra, Olaf; Bartels, Jonas-Peter; Oberegelsbacher, Claudia; Pfannstiel, Jens; Huber, Armin			Phosphorylation of the Drosophila Transient Receptor Potential Ion Channel Is Regulated by the Phototransduction Cascade and Involves Several Protein Kinases and Phosphatases	PLOS ONE			English	Article							PDZ-DOMAIN PROTEIN; TRP CA2+ CHANNEL; RETINAL DEGENERATION; SIGNALING COMPLEX; IN-VIVO; GENE; LOCALIZATION; DEGRADATION; MECHANISM; ENCODES	Protein phosphorylation plays a cardinal role in regulating cellular processes in eukaryotes. Phosphorylation of proteins is controlled by protein kinases and phosphatases. We previously reported the light-dependent phosphorylation of the Drosophila transient receptor potential (TRP) ion channel at multiple sites. TRP generates the receptor potential upon stimulation of the photoreceptor cell by light. An eye-enriched protein kinase C (eye-PKC) has been implicated in the phosphorylation of TRP by in vitro studies. Other kinases and phosphatases of TRP are elusive. Using phosphospecific antibodies and mass spectrometry, we here show that phosphorylation of most TRP sites depends on the phototransduction cascade and the activity of the TRP ion channel. A candidate screen to identify kinases and phosphatases provided in vivo evidence for an involvement of eye-PKC as well as other kinases and phosphatases in TRP phosphorylation.	[Voolstra, Olaf; Bartels, Jonas-Peter; Oberegelsbacher, Claudia; Huber, Armin] Univ Hohenheim, Inst Physiol, Dept Biosensor, Stuttgart, Germany; [Pfannstiel, Jens; Huber, Armin] Univ Hohenheim, Life Sci Ctr, Stuttgart, Germany	University Hohenheim; University Hohenheim	Voolstra, O (corresponding author), Univ Hohenheim, Inst Physiol, Dept Biosensor, Stuttgart, Germany.	voolstra@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	Deutsche Forschungsgemeinschaft [VO 1741/1-1]; German-Israeli Foundation for Scientific Research and Development (G.I.F. grant) [I-1001-96.13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development (G.I.F. grant)	This work was supported by the Deutsche Forschungsgemeinschaft (VO 1741/1-1), www.dfg.de; and the German-Israeli Foundation for Scientific Research and Development (G.I.F. grant I-1001-96.13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Cao JG, 2011, EMBO J, V30, P3701, DOI 10.1038/emboj.2011.254; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Lee SJ, 2004, CURR BIOL, V14, P2076, DOI 10.1016/j.cub.2004.11.054; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Liu CH, 2007, J NEUROSCI, V27, P604, DOI 10.1523/JNEUROSCI.4099-06.2007; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; Liu T, 2010, J CELL SCI, V123, P2708, DOI 10.1242/jcs.068726; Meyer NE, 2008, FLY, V2, P36, DOI 10.4161/fly.5773; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Sato K, 2007, P NATL ACAD SCI USA, V104, P7455, DOI 10.1073/pnas.0610052104; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Shieh BH, 2002, J BIOCHEM, V132, P523, DOI 10.1093/oxfordjournals.jbchem.a003252; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Takaesu G, 1998, 39 ANN DROS RES C WA, p344C; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Voolstra O, 2010, J BIOL CHEM; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73787	10.1371/journal.pone.0073787	http://dx.doi.org/10.1371/journal.pone.0073787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040070	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300130
J	Wang, D; Zhu, GR; Wang, N; Zhou, XX; Yang, YF; Zhou, SQ; Xiong, J; He, J; Jiang, LJ; Li, CR; Xu, DM; Huang, L; Zhou, JF				Wang, Di; Zhu, Guangrong; Wang, Na; Zhou, Xiaoxi; Yang, Yunfan; Zhou, Shiqiu; Xiong, Jie; He, Jing; Jiang, Lijun; Li, Chunrui; Xu, Danmei; Huang, Liang; Zhou, Jianfeng			SIL-TAL1 Rearrangement is Related with Poor Outcome: A Study from a Chinese Institution	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DISSEMINATED INTRAVASCULAR COAGULATION; T-CELL LEUKEMIA; TUMOR LYSIS SYNDROME; NOD/SCID MICE; CHILDHOOD; GENE; LYMPHOMA; CHILDREN; MODEL	SIL-TAL1 rearrangement is common in T-cell acute lymphoblastic leukemia (T-ALL), however its prognostic implication remains controversial. To investigate the clinical characteristics and outcome of this subtype in Chinese population, we systemically reviewed 62 patients with newly diagnosed T-ALL, including 15 patients with SIL-TAL1 rearrangement. We found that SIL-TAL1+T-ALL was characterized by higher white blood cell count (P = 0.029) at diagnosis, predominant cortical T-ALL immunophenotype (P = 0.028) of the leukemic blasts, and a higher prevalence of tumor lysis syndrome (TLS, P<0.001) and disseminated intravascular coagulation (DIC, P<0.001), which led to a higher early mortality (P = 0.011). Compared with SIL-TAL1 2 patients, SIL-TAL1+patients had shorter relapse free survival (P = 0.007) and overall survival (P = 0.002). Our NOD/SCID xenotransplantation model also demonstrated that SIL-TAL1+mice models had earlier disease onset, higher leukemia cell load in peripheral blood and shorter overall survival (P<0.001). Moreover, the SIL-TAL1+mice models exerted a tendency of TLS/DIC and seemed vulnerable towards chemotherapy, which further simulated our clinical settings. These data demonstrate that SIL-TAL1 rearrangement identifies a distinct subtype with inferior outcome which could allow for individual therapeutic stratification for T-ALL patients.	[Wang, Di; Zhu, Guangrong; Wang, Na; Zhou, Xiaoxi; Yang, Yunfan; Zhou, Shiqiu; Xiong, Jie; He, Jing; Jiang, Lijun; Li, Chunrui; Xu, Danmei; Huang, Liang; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Zhu, Guangrong] Nanjing Univ Tradit Chinese Med, Affiliated Hosp, Dept Hematol, Nanjing, Jiangsu, Peoples R China	Huazhong University of Science & Technology; Nanjing University of Chinese Medicine	Huang, L (corresponding author), Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	lhuang@tjh.tjmu.edu.cn	Huang, Liang/I-3299-2019; Huang, Liang/L-6106-2013; Chunrui, Li/AAY-7506-2021	Huang, Liang/0000-0002-8370-3232; Huang, Liang/0000-0002-8370-3232; Chunrui, Li/0000-0001-5134-7133; Xu, Danmei/0000-0001-8476-9623	National Natural Science Foundation of China [81090414, 81200380]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant numbers 81090414 and 81200380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; APLAN PD, 1992, BLOOD, V79, P1327; ARICO M, 1995, CANCER, V75, P1684, DOI 10.1002/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO;2-2; Arico M, 2002, BLOOD, V100, P420, DOI 10.1182/blood.V100.2.420; Ballerini P, 2008, HAEMATOL-HEMATOL J, V93, P1658, DOI 10.3324/haematol.13291; BASH RO, 1993, BLOOD, V81, P2110; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; BUNIN NJ, 1985, J CLIN ONCOL, V3, P1590, DOI 10.1200/JCO.1985.3.12.1590; EGUIGUREN JM, 1992, BLOOD, V79, P871; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Han X, 2007, AM J CLIN PATHOL, V127, P528, DOI 10.1309/2QE3A6EKQ8UUDYRC; Higuchi T, 2005, LEUKEMIA LYMPHOMA, V46, P1169, DOI 10.1080/10428190500102662; Higuchi T, 1998, ANN HEMATOL, V76, P263, DOI 10.1007/s002770050399; KIKUCHI A, 1993, LEUKEMIA, V7, P933; Lauten M, 2012, HAEMATOL-HEMATOL J, V97, P1048, DOI 10.3324/haematol.2011.047613; Lock RB, 2005, METH MOLEC MED, V111, P323; Mansur MB, 2009, LEUKEMIA LYMPHOMA, V50, P1318, DOI 10.1080/10428190903040014; Montesinos P, 2007, HAEMATOLOGICA, V93, P67, DOI 10.3324/haematol.11575; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Porcu P, 2002, THER APHER, V6, P15, DOI 10.1046/j.1526-0968.2002.00402.x; Porcu P, 2000, LEUKEMIA LYMPHOMA, V39, P1, DOI 10.3109/10428190009053534; STOCK W, 1995, CLIN CANCER RES, V1, P459; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Teitell MA, 2009, ANNU REV PATHOL-MECH, V4, P175, DOI 10.1146/annurev.pathol.4.110807.092227; Tosi P, 2008, HAEMATOL-HEMATOL J, V93, P1877, DOI 10.3324/haematol.13290; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Wang D, 2012, J HUAZHONG U SCI-MED, V32, P511, DOI 10.1007/s11596-012-0088-5; Wang N, 2011, CHINESE MED J-PEKING, V124, P3074, DOI 10.3760/cma.j.issn.0366-6999.2011.19.023	30	4	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73865	10.1371/journal.pone.0073865	http://dx.doi.org/10.1371/journal.pone.0073865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040098	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300137
J	Wu, Q; Li, YQ; Li, YY; Gao, SG; Wang, M; Zhang, TL; Chen, J				Wu, Qiong; Li, Yaqian; Li, Yingying; Gao, Shigang; Wang, Meng; Zhang, Tailong; Chen, Jie			Identification of a Novel Fungus, Leptosphaerulina chartarum SJTU59 and Characterization of Its Xylanolytic Enzymes	PLOS ONE			English	Article							OXIDATIVE STRESS; ACTIVE XYLANASE; WHEAT BRAN; RICE STRAW; EXPRESSION; FAMILIES; BURST; GENE	Xylanolytic enzymes are widely used in processing industries, e. g., pulp and paper, food, livestock feeds, and textile. Furthermore, certain xylanotic enzymes have demonstrated the capability to improve the resistance and immunity of plants. Screening of high-yield microbial xylanolytic enzyme producers is significant for improving large-scale cost-effective xylanolytic enzyme production. This study provided new evidence of high-level xylanolytic enzyme production by a novel fungus, designated Leptosphaerulina chartarum SJTU59. Under laboratory conditions, L. chartarum SJTU59 produced xylanolytic enzymes of up to 17.566 U/mL (i.e., 878.307 U/g substrate). The enzyme solution was relatively stable over a wide range of pH (pH 3.0 to pH 9.0) and temperature (40 degrees C to 65 degrees C) while showing high resistance to the majority of metal ions tested. Composition analysis of the hydrolytic products of xylan showed sufficient degradation by xylanolytic enzymes from L. chartarum SJTU59, mainly the monosaccharide xylose, and a small amount of xylobiose were enzymatically produced; whereas in the presence of sufficient xylan substrates, mainly xylooligosaccharides, an emerging prebiotic used in food industry, were produced. In addition, the xylanolytic enzyme preparation from L. chartarum SJTU59 could initiate tissue necrosis and oxidative burst in tobacco leaves, which may be related to enhanced plant defense to adversity and disease. L. chartarum SJTU59 possessed a complex xylanolytic enzyme system, from which two novel endo-beta-1,4-xylanases of the glycoside hydrolase (GH) family 10, one novel endo-beta-1,4-xylanase of the GH family 11, and one novel beta-xylosidase of the GH family 43 were obtained via rapid amplification of complementary DNA ends. Given the high yield and stable properties of xylanolytic enzymes produced by L. chartarum SJTU59, future studies will be conducted to characterize the properties of individual xylanolytic enzymes from L. chartarum SJTU59. xylanolytic enzymes-encoding gene(s) of potential use for industrial and agricultural applications will be screened to construct genetically engineered strains.	[Wu, Qiong; Li, Yaqian; Li, Yingying; Gao, Shigang; Wang, Meng; Zhang, Tailong; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	jiechen59@gmail.com		ZHANG, Tailong/0000-0001-8375-4585	China Agriculture Research System [CARS-02]; National High Technology Research and Development Program of China [2011AA10A205]	China Agriculture Research System; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by China Agriculture Research System (No. CARS-02) and the National High Technology Research and Development Program of China (No. 2011AA10A205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachary AA, 2011, COMPR REV FOOD SCI F, V10, P2, DOI 10.1111/j.1541-4337.2010.00135.x; Alves-Prado HF, 2010, APPL BIOCHEM BIOTECH, V161, P333, DOI 10.1007/s12010-009-8823-5; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Azin M, 2007, ENZYME MICROB TECH, V40, P801, DOI 10.1016/j.enzmictec.2006.06.013; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Damaso MCT, 2003, APPL ENVIRON MICROB, V69, P6064, DOI 10.1128/AEM.69.10.6064-6072.2003; DEAN JFD, 1991, PLANT PHYSIOL, V95, P316, DOI 10.1104/pp.95.1.316; Enkerli J, 1999, PLANT PHYSIOL, V121, P391, DOI 10.1104/pp.121.2.391; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Kaur A, 2011, WORLD J MICROB BIOT, V27, P459, DOI 10.1007/s11274-010-0457-9; Kim B, 2000, INT J SYST EVOL MICR, V50, P505, DOI 10.1099/00207713-50-2-505; Kim DY, 2009, PROCESS BIOCHEM, V44, P1055, DOI 10.1016/j.procbio.2009.05.005; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Lopez G, 2011, J IND MICROBIOL BIOT, V38, P113, DOI 10.1007/s10295-010-0836-0; Lyon PF, 2000, CAN J MICROBIOL, V46, P1029, DOI 10.1139/cjm-46-11-1029; Maity C, 2012, APPL BIOCHEM BIOTECH, V167, P1208, DOI 10.1007/s12010-012-9556-4; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Milagres AMF, 2004, PROCESS BIOCHEM, V39, P1387, DOI 10.1016/S0032-9592(03)00272-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MISHRA C, 1985, ENZYME MICROB TECH, V7, P295, DOI 10.1016/0141-0229(85)90089-4; Mishra M, 2010, BIODEGRADATION, V21, P967, DOI 10.1007/s10532-010-9356-x; Oliveira LA, 2006, BIORESOURCE TECHNOL, V97, P862, DOI 10.1016/j.biortech.2005.04.017; RAGAUSKAS AJ, 1994, ENZYME MICROB TECH, V16, P492, DOI 10.1016/0141-0229(94)90019-1; Sa-Pereira P, 2002, ENZYME MICROB TECH, V30, P924, DOI 10.1016/S0141-0229(02)00034-0; Sakamoto T, 2012, J BIOTECHNOL, V158, P203, DOI 10.1016/j.jbiotec.2011.06.025; Selinger LB, 1996, ANAEROBE, V2, P263, DOI 10.1006/anae.1996.0036; SHAMALA TR, 1987, ENZYME MICROB TECH, V9, P97, DOI 10.1016/0141-0229(87)90150-5; Souza DT, 2012, APPL BIOCHEM BIOTECH, V166, P1575, DOI 10.1007/s12010-012-9563-5; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng C, 2011, BIORESOURCE TECHNOL, V102, P1822, DOI 10.1016/j.biortech.2010.09.055; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Wang GZ, 2011, BIORESOURCE TECHNOL, V102, P3330, DOI 10.1016/j.biortech.2010.11.004; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Wang SY, 2012, APPL MICROBIOL BIOT, V93, P1503, DOI 10.1007/s00253-011-3480-3; Yang VW, 1995, J IND MICROBIOL, V15, P434, DOI 10.1007/BF01569971; [No title captured]	40	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73729	10.1371/journal.pone.0073729	http://dx.doi.org/10.1371/journal.pone.0073729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040044	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300119
J	Wu, ZY; Zhao, G; Peng, L; Du, JL; Wang, SM; Huang, YJ; Ou, JR; Jian, ZX				Wu, Zeyu; Zhao, Gang; Peng, Lin; Du, Jialin; Wang, Sanming; Huang, Yijie; Ou, Jinrui; Jian, Zhixiang			Protein Kinase C beta Mediates CD40 Ligand-Induced Adhesion of Monocytes to Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE CORONARY SYNDROMES; SUBCELLULAR FRACTIONATION; ATHEROSCLEROSIS; ACTIVATION; PHOSPHORYLATION; INFLAMMATION; ACETYLATION; MECHANISMS; EXPRESSION	Accumulating evidence supports the early involvement of monocyte/macrophage recruitment to activated endothelial cells by leukocyte adhesion molecules during atherogenesis. CD40 and its ligand CD40L are highly expressed in vascular endothelial cells, but its impact on monocyte adhesion and the related molecular mechanisms are not fully understood. The present study was designed to evaluate the direct effect of CD40L on monocytic cell adhesion and gain mechanistic insight into the signaling coupling CD40L function to the proinflammatory response. Exposure of cultured human aortic endothelial cells (HAECs) to clinically relevant concentrations of CD40L (20 to 80 ng/mL) dose-dependently increased human monocytic THP-1 cells to adhere to them under static condition. CD40L treatment induced the expression of vascular cell adhesion molecule-1 (VCAM-1) mRNA and protein expression in HAECs. Furthermore, exposure of HAECs to CD40L robustly increased the activation of protein kinase C beta (PKC beta) in ECs. A selective inhibitor of PKC beta prevented the rise in VCAM-1 and THP-1 cell adhesion to ECs. Moreover, stimulation of ECs to CD40L induced nuclear factor-kappa B (NF-kappa B) activation. PKC beta inhibition abolished CD40L-induced NF-kappa B activation, and NF-kB inhibition reduced expression of VCAM-1, each resulting in reduced THP-1 cell adhesion. Our findings provide the evidence that CD40L increases VCAM-1 expression in ECs by activating PKC beta and NF-kB, suggesting a novel mechanism for EC activation. Finally, administration of CD40L resulted in PKC beta activation, increased VCAM-1 expression and activated monocytes adhesiveness to HAECs, processes attenuated by PKC beta inhibitor. Therefore, CD40L may contribute directly to atherogenesis by activating ECs and recruiting monocytes to them.	[Wu, Zeyu; Zhao, Gang; Peng, Lin; Du, Jialin; Wang, Sanming; Huang, Yijie; Ou, Jinrui; Jian, Zhixiang] Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Wu, Zeyu; Zhao, Gang; Peng, Lin; Du, Jialin; Wang, Sanming; Huang, Yijie; Ou, Jinrui; Jian, Zhixiang] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wu, ZY (corresponding author), Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.	zywu1977@163.com; JZX-118@163.com			Science and Technology Planning Project of Guangdong Province, China [2011B080701078, 20120318083]	Science and Technology Planning Project of Guangdong Province, China	Supported by the Science and Technology Planning Project of Guangdong Province, China (No.2011B080701078, No. 20120318083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Garlichs CD, 2001, CIRCULATION, V104, P2395, DOI 10.1161/hc4501.099312; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hoffmann K, 2005, ANAL BIOANAL CHEM, V381, P1138, DOI 10.1007/s00216-004-3009-z; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kawakami A, 2006, CIRCULATION, V113, P691, DOI 10.1161/CIRCULATIONAHA.105.591743; Kawakami A, 2002, CIRC RES, V91, P263, DOI 10.1161/01.RES.0000028454.42385.8B; Kouroedov A, 2004, CIRCULATION, V110, P91, DOI 10.1161/01.CIR.0000133384.38551.A8; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; LI H, 1993, ARTERIOSCLER THROMB, V13, P197, DOI 10.1161/01.ATV.13.2.197; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Mach F, 1998, ATHEROSCLEROSIS, V137, pS89, DOI 10.1016/S0021-9150(97)00309-2; Phipps RP, 2000, P NATL ACAD SCI USA, V97, P6930, DOI 10.1073/pnas.97.13.6930; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Srinivas KS, 2004, J BIOCHEM BIOPH METH, V60, P23, DOI 10.1016/j.jbbm.2004.04.011; Xia M, 2007, ARTERIOSCL THROM VAS, V27, P519, DOI 10.1161/01.ATV.0000254672.04573.2d; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453	28	18	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72593	10.1371/journal.pone.0072593	http://dx.doi.org/10.1371/journal.pone.0072593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039784	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300015
J	Yin, J; Zheng, GP; Jia, XT; Zhang, ZJ; Zhang, WJ; Song, Y; Xiong, Y; He, ZM				Yin, Jiang; Zheng, Guopei; Jia, Xiaoting; Zhang, Zhijie; Zhang, Weijia; Song, Ying; Xiong, Yan; He, Zhimin			A Bmi1-miRNAs Cross-Talk Modulates Chemotherapy Response to 5-Fluorouracil in Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MULTIPLE-DRUG RESISTANCE; STEM-CELLS; BMI-1; CHEMORESISTANCE; MICRORNAS; IDENTIFICATION; EXPRESSION; INK4A-ARF; THERAPY	The polycomb group transcriptional modifier Bmi1 is often upregulated in numerous cancers and is intensely involved in normal and cancer stem cells, and importantly is as a prognostic indicator for some cancers, but its role in breast cancer remains unclear. Here, we found Bmi1 overexpression in 5-Fu (5-fluorouracil)-resistant MCF-7 cells (MCF-7/5-Fu) derived from MCF-7 breast cancer cells, MDA-MB-231 and MDA-MB-453 breast cancer cells compared to MCF-7 cells, was related with 5-Fu resistance and enrichment of CD44(+)/CD24(-) stem cell subpopulation. Bmi1 knockdown enhanced the sensitivity of breast cancer cells to 5-Fu and 5-Fu induced apoptosis via mitochondrial apoptotic pathway, and decreased the fraction of CD44(+)/CD24(-) subpopulation. In addition, our analysis showed inverse expression pattern between Bmi1 and miR-200c and miR-203 in selected breast cancer cell lines, and miR-200c and miR-203 directly repressed Bmi1 expression in protein level confirmed by luciferase reporter assay. MiR-200c and miR-203 overexpression in breast cancer cells downregulated Bmi1 expression accompanied with reversion of resistance to 5-Fu mediated by Bmi1. Inversely, Bmi1 overexpression inhibited miR-200c expression in MCF-7 cells, but not miR-203, however ectopic wild-type p53 expression reversed Bmi1 mediated miR-200c downregulation, suggesting the repressive effect of Bmi1 on miR-200c maybe depend on p53. Thus, our study suggests a cross-talk between Bmi1 and miR-200c mediated by p53, and Bmi1 interference would improve chemotherapy efficiency in breast cancer via susceptive apoptosis induction and cancer stem cell enrichment inhibition.	[Yin, Jiang; Zheng, Guopei; Jia, Xiaoting; Zhang, Zhijie; Zhang, Weijia; Song, Ying; He, Zhimin] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Yin, Jiang; Zheng, Guopei; Jia, Xiaoting; Zhang, Zhijie; Zhang, Weijia; Song, Ying; He, Zhimin] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Xiong, Yan] Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	He, ZM (corresponding author), Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	Hezhimin2005@yahoo.com			National Natural Science Foundation of China [81272450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation (81272450) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052568; Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Calao M, 2012, ONCOGENE, V32, P1; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ellis LM, 2009, CLIN CANCER RES, V15, P7471, DOI 10.1158/1078-0432.CCR-09-1070; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Grayson M, 2012, NATURE, V485, pS49, DOI 10.1038/485S49a; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lerner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036490; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061858; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; O'Driscoll L, 2006, CURR CANCER DRUG TAR, V6, P365, DOI 10.2174/156800906777723958; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Proctor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055820; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Sawa M, 2005, INT J HEMATOL, V82, P42, DOI 10.1532/IJH97.05013; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Zhang WJ, 2012, BIOCHEM BIOPH RES CO, V417, P679, DOI 10.1016/j.bbrc.2011.11.142; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743; Zheng GP, 2010, J CANCER RES CLIN, V136, P1477, DOI 10.1007/s00432-010-0805-z	42	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73268	10.1371/journal.pone.0073268	http://dx.doi.org/10.1371/journal.pone.0073268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039897	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300060
J	Castanera, R; Omarini, A; Santoyo, F; Perez, G; Pisabarro, AG; Ramirez, L				Castanera, Raul; Omarini, Alejandra; Santoyo, Francisco; Perez, Gumer; Pisabarro, Antonio G.; Ramirez, Lucia			Non-Additive Transcriptional Profiles Underlie Dikaryotic Superiority in Pleurotus ostreatus Laccase Activity	PLOS ONE			English	Article							BASIDIOMYCETE FUNGUS; GENE-EXPRESSION; GROWTH-RATE; INDUCTION; ISOENZYMES; MAP	Background: The basidiomycete Pleurotus ostreatus is an efficient producer of laccases, a group of enzymes appreciated for their use in multiple industrial processes. The aim of this study was to reveal the molecular basis of the superiority of laccase production by dikaryotic strains compared to their parental monokaryons. Methodology/Principal Findings: We bred and studied a set of dikaryotic strains starting from a meiotic population of monokaryons. We then completely characterised the laccase allelic composition, the laccase gene expression and activity profiles in the dikaryotic strain N001, in two of its meiotic full-sib monokaryons and in the dikaryon formed from their mating. Conclusions/Significance: Our results suggested that the dikaryotic superiority observed in laccase activity was due to non-additive transcriptional increases in lacc6 and lacc10 genes. Furthermore, the expression of these genes was divergent in glucose- vs. lignocellulose-supplemented media and was highly correlated to the detected extracellular laccase activity. Moreover, the expression profile of lacc2 in the dikaryotic strains was affected by its allelic composition, indicating a putative single locus heterozygous advantage.	[Castanera, Raul; Omarini, Alejandra; Santoyo, Francisco; Perez, Gumer; Pisabarro, Antonio G.; Ramirez, Lucia] Univ Publ Navarra, Dept Agrarian Prod, Genet & Microbiol Res Grp, Pamplona, Navarre, Spain	Universidad Publica de Navarra	Ramirez, L (corresponding author), Univ Publ Navarra, Dept Agrarian Prod, Genet & Microbiol Res Grp, Pamplona, Navarre, Spain.	lramirez@unavarra.es	Pisabarro, Antonio G./K-3622-2014; Castanera, Raúl/D-4823-2019; Pérez, Gumer/L-7970-2014; Ramírez, Lucía/K-3845-2014	Pisabarro, Antonio G./0000-0001-6987-5794; Castanera, Raúl/0000-0002-3772-7727; Ramírez, Lucía/0000-0002-0023-4240; Perez, Gumer/0000-0003-2153-1962; Omarini, Alejandra Beatriz/0000-0001-9830-8334	Spanish National Research Plan [AGL2011-30495]; Bioethanol-Euroinnova; Autonomous Government of Navarre; Public University of Navarre	Spanish National Research Plan(Spanish Government); Bioethanol-Euroinnova; Autonomous Government of Navarre; Public University of Navarre	This work was supported by funds obtained from AGL2011-30495 of the Spanish National Research Plan; Bioethanol-Euroinnova, the Autonomous Government of Navarre; and by additional institutional support from the Public University of Navarre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arjona D, 2009, MYCOL RES, V113, P552, DOI 10.1016/j.mycres.2008.12.006; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Baldrian P, 2000, APPL ENVIRON MICROB, V66, P2471, DOI 10.1128/AEM.66.6.2471-2478.2000; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; Castanera R, 2012, APPL ENVIRON MICROB, V78, P4037, DOI 10.1128/AEM.07880-11; Clark TA, 2004, GENETICS, V167, P1663, DOI 10.1534/genetics.104.027235; Croft JH, 1965, AM NAT, V99, P453; Giardina P, 2007, APPL MICROBIOL BIOT, V75, P1293, DOI 10.1007/s00253-007-0954-4; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Larraya L, 1999, CURR GENET, V34, P486, DOI 10.1007/s002940050424; Larraya LM, 2002, APPL ENVIRON MICROB, V68, P1109, DOI 10.1128/AEM.68.3.1109-1114.2002; Larraya LM, 2001, APPL ENVIRON MICROB, V67, P3385, DOI 10.1128/AEM.67.8.3385-3390.2001; Larraya LM, 2000, APPL ENVIRON MICROB, V66, P5290, DOI 10.1128/AEM.66.12.5290-5300.2000; Larraya LM, 1999, APPL ENVIRON MICROB, V65, P3413; Larrondo LF, 2007, MICROBIOL-SGM, V153, P1772, DOI 10.1099/mic.0.2006/003442-0; Mansur M, 2003, MYCOLOGIA, V95, P1013, DOI 10.2307/3761909; MARTINEZ AT, 1994, FEMS MICROBIOL REV, V13, P265, DOI 10.1016/0168-6445(94)90084-1; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Miyazaki K, 2008, BREEDING SCI, V58, P23, DOI 10.1270/jsbbs.58.23; Palmieri G, 2003, ENZYME MICROB TECH, V33, P220, DOI 10.1016/S0141-0229(03)00117-0; Palmieri G, 2000, APPL ENVIRON MICROB, V66, P920, DOI 10.1128/AEM.66.3.920-924.2000; Parenti A, 2013, BIORESOURCE TECHNOL, V133, P142, DOI 10.1016/j.biortech.2013.01.072; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; SIMCHEN G, 1966, HEREDITY, V21, P241, DOI 10.1038/hdy.1966.21; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VYAS BRM, 1995, APPL ENVIRON MICROB, V61, P3919, DOI 10.1128/AEM.61.11.3919-3927.1995; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	34	15	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73282	10.1371/journal.pone.0073282	http://dx.doi.org/10.1371/journal.pone.0073282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039902	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600063
J	Mandel, Y; Laufer, S; Belkin, M; Rubinsky, B; Pe'er, J; Frenkel, S				Mandel, Yossi; Laufer, Shlomi; Belkin, Michael; Rubinsky, Boris; Pe'er, Jacob; Frenkel, Shahar			Irreversible Electroporation of Human Primary Uveal Melanoma in Enucleated Eyes	PLOS ONE			English	Article							CHOROIDAL MELANOMA; GENE-TRANSFER; OCULAR COMPLICATIONS; TISSUE ABLATION; BRACHYTHERAPY; PARAMETERS; CELLS	Uveal melanoma (UM) is the most common primary intraocular tumor in adults and is characterized by high rates of metastatic disease. Although brachytherapy is the most common globe-sparing treatment option for small- and medium-sized tumors, the treatment is associated with severe adverse reactions and does not lead to increased survival rates as compared to enucleation. The use of irreversible electroporation (IRE) for tumor ablation has potential advantages in the treatment of tumors in complex organs such as the eye. Following previous theoretical work, herein we evaluate the use of IRE for uveal tumor ablation in human ex vivo eye model. Enucleated eyes of patients with uveal melanoma were treated with short electric pulses (50-100 ms, 1000-2000 V/cm) using a customized electrode design. Tumor bioimpedance was measured before and after treatment and was followed by histopathological evaluation. We found that IRE caused tumor ablation characterized by cell membrane disruption while sparing the non-cellular sclera. Membrane disruption and loss of cellular capacitance were also associated with significant reduction in total tumor impedance and loss of impedance frequency dependence. The effect was more pronounced near the pulsing electrodes and was dependent on time from treatment to fixation. Future studies should further evaluate the potential of IRE as an alternative method of uveal melanoma treatment.	[Mandel, Yossi] Stanford Univ, Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Mandel, Yossi; Laufer, Shlomi] Hebrew Univ Jerusalem, Ctr Bioengn Serv Humanity & Soc, Sch Engn & Comp Sci, Jerusalem, Israel; [Belkin, Michael] Tel Aviv Univ, Sackler Sch Med, Goldschleger Eye Inst, Ophthalm Technol Lab, Ramat Gan, Israel; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Pe'er, Jacob; Frenkel, Shahar] Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, Jerusalem, Israel	Stanford University; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Mandel, Y (corresponding author), Stanford Univ, Hansen Expt Phys Lab, Stanford, CA 94305 USA.	yossi.mandel@gmail.com	Frenkel, Shahar/AAQ-1909-2020	Frenkel, Shahar/0000-0002-3688-8676; Laufer, Shlomi/0000-0003-1469-5985				Abbas AK, 2003, CELLULAR MOL IMMUNOL; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bobanovic F, 1999, FASEB J, V13, P365, DOI 10.1096/fasebj.13.2.365; Charpentier KP, 2010, HPB, V12, P348, DOI 10.1111/j.1477-2574.2010.00174.x; Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684; Damato B, 2004, OPHTHALMOLOGY, V111, P977, DOI 10.1016/j.ophtha.2003.09.028; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Davalos RV, 2002, IEEE T BIO-MED ENG, V49, P400, DOI 10.1109/10.991168; Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639; Edd JF, 2007, TECHNOL CANCER RES T, V6, P275, DOI 10.1177/153303460700600403; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; Frenkel S, 2009, ISR MED ASSOC J, V11, P280; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Hofmann F, 1999, J MEMBRANE BIOL, V169, P103, DOI 10.1007/s002329900522; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Ivorra Antoni, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5056; Ivorra A, 2009, PHYS MED BIOL, V54, P5949, DOI 10.1088/0031-9155/54/19/019; JENSEN OA, 1982, ACTA OPHTHALMOL, V60, P161; Jones R, 2002, INT J RADIAT ONCOL, V52, P989, DOI 10.1016/S0360-3016(01)02723-7; Karkhaneh R, 2007, RETINA-J RET VIT DIS, V27, P908, DOI 10.1097/IAE.0b013e31802fa2db; Laufer S, 2010, PHYSIOL MEAS, V31, P995, DOI 10.1088/0967-3334/31/7/009; Logan PT, 2008, CLIN EXP METASTAS, V25, P509, DOI 10.1007/s10585-008-9158-2; Mandel Y, 2011, INVEST OPHTHALMOL VI, V52; Mandel Y, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005203; Mann AL, 2007, OPHTHALMOLOGY, V114, P1363, DOI 10.1016/j.ophtha.2006.10.039; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; NEUMANN E, 1989, ELECTROPORATION ELEC, P61; Puusaari I, 2004, OPHTHALMOLOGY, V111, P1768, DOI 10.1016/j.ophtha.2004.03.027; Rols MP, 1998, BIOPHYS J, V75, P1415, DOI 10.1016/S0006-3495(98)74060-3; Rols MP, 1998, NAT BIOTECHNOL, V16, P168, DOI 10.1038/nbt0298-168; Rols MP, 1998, METH MOL B, V91, P141; Rols MP, 1998, EUR J BIOCHEM, V254, P382, DOI 10.1046/j.1432-1327.1998.2540382.x; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; SCOTTO J, 1976, J NATL CANCER I, V56, P489, DOI 10.1093/jnci/56.3.489; Singh AD, 2008, BRIT J OPHTHALMOL, V92, P1015, DOI 10.1136/bjo.2008.145805; Tracy CR, 2011, BJU INT, V107, P1982, DOI 10.1111/j.1464-410X.2010.09797.x; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Wen JC, 2009, EYE, V23, P1254, DOI 10.1038/eye.2009.43; WOLF H, 1994, BIOPHYS J, V66, P524, DOI 10.1016/S0006-3495(94)80805-7	42	6	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71789	10.1371/journal.pone.0071789	http://dx.doi.org/10.1371/journal.pone.0071789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039721	gold, Green Published			2022-12-25	WOS:000324481600012
J	Nasreen, S; Khan, SU; Azziz-Baumgartner, E; Hancock, K; Veguilla, V; Wang, D; Rahman, M; Alamgir, ASM; Sturm-Ramirez, K; Gurley, ES; Luby, SP; Katz, JM; Uyeki, TM				Nasreen, Sharifa; Khan, Salah Uddin; Azziz-Baumgartner, Eduardo; Hancock, Kathy; Veguilla, Vic; Wang, David; Rahman, Mahmudur; Alamgir, A. S. M.; Sturm-Ramirez, Katharine; Gurley, Emily S.; Luby, Stephen P.; Katz, Jacqueline M.; Uyeki, Timothy M.			Seroprevalence of Antibodies against Highly Pathogenic Avian Influenza A (H5N1) Virus among Poultry Workers in Bangladesh, 2009	PLOS ONE			English	Article							RISK-FACTORS; INFECTION; MARKETS; RESPONSES; VIETNAM	We conducted a cross-sectional study in 2009 to determine the seroprevalence and risk factors for highly pathogenic avian influenza A (H5N1) [HPAI H5N1] virus antibodies among poultry workers at farms and live bird markets with confirmed/suspected poultry outbreaks during 2009 in Bangladesh. We tested sera by microneutralization assay using A/Bangladesh/207095/2008 (H5N1; clade 2.2.2) virus with confirmation by horse red blood cell hemagglutination inhibition and H5-specific Western blot assays. We enrolled 212 workers from 87 farms and 210 workers from three live bird markets. One hundred and two farm workers (48%) culled poultry. One hundred and ninety-three farm workers (91%) and 178 market workers (85%) reported direct contact with poultry that died during a laboratory confirmed HPAI H5N1 poultry farm outbreak or market poultry die-offs from suspected HPAI H5N1. Despite exposure to sick poultry, no farm or market poultry workers were seropositive for HPAI H5N1 virus antibodies (95% confidence interval 0-1%).	[Nasreen, Sharifa; Khan, Salah Uddin; Sturm-Ramirez, Katharine; Gurley, Emily S.; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Azziz-Baumgartner, Eduardo; Hancock, Kathy; Veguilla, Vic; Wang, David; Sturm-Ramirez, Katharine; Luby, Stephen P.; Katz, Jacqueline M.; Uyeki, Timothy M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Rahman, Mahmudur; Alamgir, A. S. M.] Govt Bangladesh, Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Nasreen, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, GPO Box 128, Dhaka 1000, Bangladesh.	drsharifa74@gmail.com	Gurley, Emily S/B-7903-2010; Khan, Salah Uddin/I-4015-2019	Gurley, Emily S/0000-0002-8648-9403; Khan, Salah Uddin/0000-0001-5928-9257; Nasreen, Sharifa/0000-0002-9793-113X	Centers for Disease Control and Prevention (CDC) [5U51CI000298]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000298] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research study was funded by the Centers for Disease Control and Prevention (CDC) through their cooperative agreement with icddr, b (CA/Grant#5U51CI000298). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDC provided technical support for testing of the specimens. Eight co-authors of this manuscript are CDC employees who have contributed significantly and fulfill authorship criteria.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Alam J, 2010, WORLD POULTRY SCI J, V66, P455, DOI 10.1017/S004393391000053X; [Anonymous], FACT SHEET; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Brooks WA, 2009, EMERG INFECT DIS, V15, P1311, DOI 10.3201/eid1508.090283; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; *BUR BANGL STAT VO, 2011, POP HOUS CENS PREL R; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; *FAO, 2011, PPROACH CONTR PREV E; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Hoschler K, 2007, INFLUENZA OTHER RESP, V1, P199, DOI 10.1111/j.1750-2659.2007.00033.x; *ICDDRB, 2008, HLTH SCI B, V6, P11; *ICDDRB, 2008, HLTH SCI B, V6, P1; *IEDCR, 2013, EV H 5N1 CAS BANGL; *IEDCR, 2012, IFTH 6 H 5N1 HUM CAS; *IEDCR, 2012, OURTH H 5NI HUM CAS; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; International Centre for Diarrhoeal Disease Research Bangladesh/Government of The People's Republic of Bangladesh, 2011, HSB (Health Science Bulletin), V9, P5; Islam MR, 2012, TRANSBOUND EMERG DIS, V59, P460, DOI 10.1111/j.1865-1682.2011.01297.x; JIAHAI L, 2008, CHINESE MED J, V121, P2050; KHAN SU, 2011, 4 ESWI INFL C MALT; KHAN SU, 2011, 60 ANN M AM SOC TROP; KHAN SU, 2010, INT ATL GA US C EM I; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; *MIN FISH LIV, 2009, 2 NAT AV PAND INFL P; Negovetich NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019311; OIE, 2013, 42 OIE; Ortiz JR, 2007, EMERG INFECT, V7, P1; Powell TJ, 2012, J INFECT DIS, V205, P20, DOI 10.1093/infdis/jir689; Rabinowitz P, 2010, ZOONOSES PUBLIC HLTH, V57, P227, DOI 10.1111/j.1863-2378.2008.01223.x; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; *WHO, 2006, WHO CAS DEF HUM INF; World Health Organization, 2010, SER DIAGN INFL MICR; World Health Organization, 2006, GUID HLTH FOOD MARK; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030252; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	44	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73200	10.1371/journal.pone.0073200	http://dx.doi.org/10.1371/journal.pone.0073200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039887	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600057
J	Santos-Martin, F; Martin-Lopez, B; Garcia-Llorente, M; Aguado, M; Benayas, J; Montes, C				Santos-Martin, Fernando; Martin-Lopez, Berta; Garcia-Llorente, Marina; Aguado, Mateo; Benayas, Javier; Montes, Carlos			Unraveling the Relationships between Ecosystems and Human Wellbeing in Spain	PLOS ONE			English	Article							BIODIVERSITY; SERVICES; INDICATORS; CONSERVATION; IMPACT	National ecosystem assessments provide evidence on the status and trends of biodiversity, ecosystem conditions, and the delivery of ecosystem services to society. I this study, we analyze the complex relationships established between ecosystems and human systems in Spain through the combination of Driver-Pressure-State-Impact-Response framework and structural equation models. Firstly, to operationalize the framework, we selected 53 national scale indicators that provide accurate, long-term information on each of the components. Secondly, structural equation models were performed to understand the relationships among the components of the framework. Trend indicators have shown an overall progressive biodiversity loss, trade-offs between provisioning and cultural services associated with urban areas vs. regulating and cultural services associated with rural areas, a decoupling effect between material and non-material dimensions of human wellbeing, a rapid growing trend of conservation responses in recent years and a constant growing linear trend of direct or indirect drivers of change. Results also show that all the components analyzed in the model are strongly related. On one hand, the model shows that biodiversity erosion negatively affect the supply of regulating services, while it is positively related with the increase of provisioning service delivery. On the other hand, the most important relationship found in the model is the effect of pressures on biodiversity loss, indicating that response options for conserving nature cannot counteract the effect of the drivers of change. These results suggest that there is an insufficient institutional response to address the underlying causes (indirect drivers of change) of biodiversity loos in Spain. We conclude that more structural changes are required in the Spanish institutional framework to reach 2020 biodiversity conservation international targets.	[Santos-Martin, Fernando; Martin-Lopez, Berta; Garcia-Llorente, Marina; Aguado, Mateo; Benayas, Javier; Montes, Carlos] Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain; [Garcia-Llorente, Marina] Univ Carlos III Madrid, Social Anal Dept, Sociol & Environm Res Area, Madrid, Spain	Autonomous University of Madrid; Universidad Carlos III de Madrid	Santos-Martin, F (corresponding author), Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain.	fernando.santos.martin@uam.es	García-Llorente, Marina/L-3550-2014; Llorente, Marina Garcia/P-1644-2017; Benayas, Javier/E-5663-2017; GARCIA, MARINA/AAH-8893-2019; Montes, Carlos/M-1449-2014; Martin-Lopez, Berta/R-9397-2017	García-Llorente, Marina/0000-0002-3527-9318; Llorente, Marina Garcia/0000-0002-3527-9318; Benayas, Javier/0000-0002-5906-9569; GARCIA, MARINA/0000-0002-3527-9318; Montes, Carlos/0000-0001-9280-2083; Martin-Lopez, Berta/0000-0003-2622-0135; Santos Martin, Fernando/0000-0002-2301-5876	Biodiversity Foundation of the Spanish Ministry of Agriculture, Food and Environment	Biodiversity Foundation of the Spanish Ministry of Agriculture, Food and Environment	This work was conducted within the framework of the project Millennium Ecosystem assessment of Spain funded by the Biodiversity Foundation (http://www.fundacion-biodiversidad.es/) of the Spanish Ministry of Agriculture, Food and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado M., 2012, PAPELES RELACIONES E, V148, P49; Amato S, 2005, GLOBAL GOODNESS OF F; [Anonymous], 2005, EC HUM WELL BEING SY; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Balzano S, 2010, STAT METHODS EVALUAT, P55; Biggs RJS, 2004, SO AFRICA MILLENNIUM; Bubb P.J., 2009, IUCN RED LIST INDEX; Burkhard B, 2008, ECOL INDIC, V8, P828, DOI 10.1016/j.ecolind.2007.06.003; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carpintero O, 2005, METABOLISMO EC ESPAN; Chin WW, 1998, QUANT METH SER, P295; Convention on Biological Diversity, 2010, GLOB BIOD OUT 3; Costanza R, 2007, ECOL ECON, V61, P267, DOI 10.1016/j.ecolecon.2006.02.023; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; EC, 2011, OUR LIF INS OUR NAT; European Environment Agency, 2007, 2 EEA; Fischer J, 2012, FRONT ECOL ENVIRON, V10, P153, DOI 10.1890/110079; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Floridi M, 2011, ECOL ECON, V70, P1440, DOI 10.1016/j.ecolecon.2011.03.003; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Garcia-Llorente M, 2012, ENVIRON SCI POLICY, V19-20, P136, DOI 10.1016/j.envsci.2012.01.006; Gardner G, 2004, STATE WORLD 2004 WOR, P164; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00048.1; Graham C., 2005, WORLD ECON, V6, P41; Haines-Young R., 2010, PROPOSAL COMMON INT; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Kandziora M, 2013, ECOL INDIC, V28, P54, DOI 10.1016/j.ecolind.2012.09.006; Layke C, 2012, ECOL INDIC, V17, P77, DOI 10.1016/j.ecolind.2011.04.025; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; Martin-Lopez B, 2011, BIODIVERS CONSERV, V20, P663, DOI 10.1007/s10531-010-9973-z; Martin-Lopez B, 2009, HANDBOOK OF NATURE CONSERVATION: GLOBAL, ENVIRONMENTAL AND ECONOMIC ISSUES, P261; Mediterranean Wetlands Observatory, 2010, STAT TRENDS SPEC MED; Ministerio de Medio Ambiente y Medio Rural y Marino, 2011, PLAN ESTR PATR NAT B; Montes C, 2011, ECOSISTEMAS BIODIVER; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Muller F, 2012, ECOSYST SERV, V1, P26, DOI 10.1016/j.ecoser.2012.06.001; Norgaard RB, 2008, CONSERV BIOL, V22, P862, DOI 10.1111/j.1523-1739.2008.00922.x; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pereira HM, 2004, PORTUGAL MILLENNIUM; Pyke CR, 2007, ECOL SOC, V12; Quijas S, 2012, J APPL ECOL, V49, P929, DOI 10.1111/j.1365-2664.2012.02153.x; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rapport D., 1979, COMPREHENSIVE FRAMEW; Rescia AJ, 2010, LANDSCAPE URBAN PLAN, V98, P26, DOI 10.1016/j.landurbplan.2010.07.007; Rounsevell MDA, 2010, BIODIVERS CONSERV, V19, P2823, DOI 10.1007/s10531-010-9838-5; Smith LM, 2013, ECOL INDIC, V28, P79, DOI 10.1016/j.ecolind.2012.02.032; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; UKNEA, 2011, UK NAT EC ASS SYNTH; van Oudenhoven APE, 2012, ECOL INDIC, V21, P110, DOI 10.1016/j.ecolind.2012.01.012	55	71	77	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73249	10.1371/journal.pone.0073249	http://dx.doi.org/10.1371/journal.pone.0073249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039894	gold, Green Published			2022-12-25	WOS:000324481600060
J	Crossman, J; Futter, MN; Whitehead, PG				Crossman, Jill; Futter, Martyn N.; Whitehead, Paul G.			The Significance of Shifts in Precipitation Patterns: Modelling the Impacts of Climate Change and Glacier Retreat on Extreme Flood Events in Denali National Park, Alaska	PLOS ONE			English	Article							WATER; SNOW; STREAMFLOW; TRENDS; TEMPERATURE; CATCHMENT; RECESSION; FREQUENCY; HYDROLOGY; MELT	In glacier-fed systems climate change may have various effects over a range of time scales, including increasing river discharge, flood frequency and magnitude. This study uses a combination of empirical monitoring and modelling to project the impacts of climate change on the glacial-fed Middle Fork Toklat River, Denali National Park, Alaska. We use a regional calibration of the model HBV to account for a paucity of long term observed flow data, validating a local application using glacial mass balance data and summer flow records. Two Global Climate Models (HADCM3 and CGCM2) and two IPCC scenarios (A2 and B2) are used to ascertain potential changes in meteorological conditions, river discharge, flood frequency and flood magnitude. Using remote sensing methods this study refines existing estimates of glacial recession rates, finding that since 2000, rates have increased from 24m per year to 68.5m per year, with associated increases in ablation zone ice loss. GCM projections indicate that over the 21st century these rates will increase still further, most extensively under the CGCM2 model, and A2 scenarios. Due to greater winter precipitation and ice and snow accumulation, glaciers release increasing meltwater quantities throughout the 21st century. Despite increases in glacial melt, results indicate that it is predominantly precipitation that affects river discharge. Three of the four IPCC scenarios project increases in flood frequency and magnitude, events which were primarily associated with changing precipitation patterns, rather than extreme temperature increases or meltwater release. Results suggest that although increasing temperatures will significantly increase glacial melt and winter baseflow, meltwater alone does not pose a significant flood hazard to the Toklat River catchment. Projected changes in precipitation are the primary concern, both through changing snow volumes available for melt, and more directly through increasing catchment runoff.	[Crossman, Jill] Trent Univ, Dept Chem, Peterborough, ON K9J 7B8, Canada; [Crossman, Jill; Whitehead, Paul G.] Univ Oxford, Sch Geog & Environm, Oxford, Oxon, England; [Futter, Martyn N.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	Trent University; University of Oxford; Swedish University of Agricultural Sciences	Crossman, J (corresponding author), Trent Univ, Dept Chem, Peterborough, ON K9J 7B8, Canada.	jillcrossman@trentu.ca	whitehead, paul g/K-8689-2012; Futter, Martyn N/G-6238-2011	Futter, Martyn N/0000-0002-9789-7138; Crossman, Jill/0000-0003-2679-5991	Center for Ecology and Hydrology, Wallingford	Center for Ecology and Hydrology, Wallingford	Funding for this study consisted solely of in-kind contributions, including equipment supplied from the Center for Ecology and Hydrology, Wallingford, and accommodation provided by Alaska Geographic, Murie Science and Learning Center. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Adema GW, 2003, LONG TERM ECOLOGICAL; Anisimov OA, 1996, GLOBAL PLANET CHANGE, V14, P59, DOI 10.1016/0921-8181(96)00002-1; [Anonymous], NORDIC HBV MODEL; [Anonymous], 1986, LANDSAT MSS TM POSTC; Arnell NW, 2005, J GEOPHYS RES, V110, P1; Baggaley NJ, 2009, SCI TOTAL ENVIRON, V407, P4633, DOI 10.1016/j.scitotenv.2009.04.015; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Barry RG, 2006, PROG PHYS GEOG, V30, P285, DOI 10.1191/0309133306pp478ra; Bates B.C., 2008, CLIMATE CHANGE WATER; Carter T., 2007, GEN GUIDELINES USE S; CAYAN DR, 1993, WATER RESOUR RES, V29, P1127, DOI 10.1029/92WR02802; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Clow DW, 2003, GROUND WATER, V41, P937, DOI 10.1111/j.1745-6584.2003.tb02436.x; Crossman J, 2012, REMOTE SENS ENVIRON, V123, P116, DOI 10.1016/j.rse.2012.03.023; Crossman J, 2011, ARCT ANTARCT ALP RES, V43, P364, DOI 10.1657/1938-4246-43.3.364; DOUGLAS DA, 1989, J ECOL, V77, P112, DOI 10.2307/2260920; Emmett W.W., 1996, INT J SEDIMENT RES, V11, P8; Fourier J.-B.J., 1827, MEMOIRES LACAD MIE R, VVII, P570; Giorgi F, 2000, CLIM DYNAM, V16, P169, DOI 10.1007/PL00013733; GLEICK PH, 1986, J HYDROL, V88, P97, DOI 10.1016/0022-1694(86)90199-X; GLEICK PH, 1989, REV GEOPHYS, V27, P329, DOI 10.1029/RG027i003p00329; Hall MHP, 2003, BIOSCIENCE, V53, P131, DOI 10.1641/0006-3568(2003)053[0131:MCIGCI]2.0.CO;2; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Hock R, 2005, PROG PHYS GEOG, V29, P362, DOI 10.1191/0309133305pp453ra; Hood E, 2008, NAT GEOSCI, V1, P583, DOI 10.1038/ngeo280; Jansson P, 2003, J HYDROL, V282, P116, DOI 10.1016/S0022-1694(03)00258-0; Konig M, 2001, REV GEOPHYS, V39, P1, DOI 10.1029/1999RG000076; Konz M, 2010, J HYDROL, V385, P238, DOI 10.1016/j.jhydrol.2010.02.025; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Kundzewiczs ZW, 2007, CLIMATE CHANGE 2007, P173, DOI DOI 10.1007/S11269-006-3091-4; Landsat Project Science Office, 2002, LANDS 7 SCI DAT US H; Lawrence D., 2009, 1 NVE; Liu J, 2001, COLD REGIONS SCI TEC, V37, P15; Masiokas MH, 2008, GLOBAL PLANET CHANGE, V60, P85, DOI 10.1016/j.gloplacha.2006.07.031; Oni SK, 2010, ONT J GREAT LAKES RE, DOI [10.1016/j.jglr.2010.05.003, DOI 10.1016/J.JGLR.2010.05.003]; Parr TW, 2003, SCI TOTAL ENVIRON, V310, P1, DOI 10.1016/S0048-9697(03)00257-2; Parry M. L., 2007, CLIMATE CHANGE 2007; Perovich DK, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001079; Petrow T, 2009, J HYDROL, V371, P129, DOI 10.1016/j.jhydrol.2009.03.024; RAMANATHAN V, 1988, SCIENCE, V240, P293, DOI 10.1126/science.240.4850.293; Refsgaard J. C., 1996, Distributed hydrological modelling., P41; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; Rosenthal W, 1996, WATER RESOUR RES, V32, P115, DOI 10.1029/95WR02718; Schalk B, 2001, WETLANDS ENG RIVER R, V69, P1; Singh P, 1997, J HYDROL, V193, P316, DOI 10.1016/S0022-1694(96)03142-3; Theakstone WH, 1996, HYDROL PROCESS, V10, P523, DOI 10.1002/(SICI)1099-1085(199604)10:4&lt;523::AID-HYP390&gt;3.0.CO;2-8; THOURET JC, 1990, J VOLCANOL GEOTH RES, V41, P177, DOI 10.1016/0377-0273(90)90088-W; U. S Geological Survey, 2012, NAT WAT INF SYST USG; U. S. Geological Survey, 2012, EARTH RES OBS SCI CT; Wagener T, 2004, RAINFALL RUNOFF MODE; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Whitehead PG, 2009, HYDROL RES, V40, P323, DOI 10.2166/nh.2009.069; Wilby RL, 1997, PROG PHYS GEOG, V21, P530, DOI 10.1177/030913339702100403; Wilby RL, 2002, ENVIRON MODELL SOFTW, V17, P147; Wilby RL, 2007, DSM 4 2 DECISION SUP; Wilson FH, 1998, 98133 OF US DEP INT; Woo MK, 2008, PHILOS T R SOC B, V363, P2251, DOI 10.1098/rstb.2007.2197; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Yocum L, 2006, 102 ANN M CORD SECT	59	13	13	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74054	10.1371/journal.pone.0074054	http://dx.doi.org/10.1371/journal.pone.0074054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023925	Green Published, Green Submitted, gold			2022-12-25	WOS:000324238400091
J	Morgan-Fisher, M; Couchman, JR; Yoneda, A				Morgan-Fisher, Marie; Couchman, John R.; Yoneda, Atsuko			Phosphorylation and mRNA Splicing of Collapsin Response Mediator Protein-2 Determine Inhibition of Rho-associated Protein Kinase (ROCK) II Function in Carcinoma Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAYS; MYOSIN; ACTIVATION; SURVIVAL; CANCER; GSK-3; TARGET; CRMP-2	The Rho-associated protein kinases (ROCK I and II) are central regulators of important cellular processes such as migration and invasion downstream of the GTP-Rho. Recently, we reported collapsin response mediator protein (CRMP)-2 as an endogenous ROCK II inhibitor. To reveal how the CRMP-2-ROCK II interaction is controlled, we further mapped the ROCK II interaction site of CRMP-2 and examined whether phosphorylation states of CRMP-2 affected the interaction. Here, we show that an N-terminal fragment of the long CRMP-2 splice variant (CRMP-2L) alone binds ROCK II and inhibits colon carcinoma cell migration and invasion. Furthermore, the interaction of CRMP-2 and ROCK II is partially regulated by glycogen synthase kinase (GSK)-3 phosphorylation of CRMP-2, downstream of PI3K. Inhibition of PI3K reduced interaction of CRMP-2 with ROCK II, an effect rescued by simultaneous inhibition of GSK3. Inhibition of PI3K also reduced colocalization of ROCK II and CRMP-2 at the cell periphery in human breast carcinoma cells. Mimicking GSK3 phosphorylation of CRMP-2 significantly reduced CRMP-2 binding of recombinant full-length and catalytic domain of ROCK II. These data implicate GSK3 in the regulation of ROCK II-CRMP-2 interactions. Using phosphorylation-mimetic and -resistant CRMP-2L constructs, it was revealed that phosphorylation of CRMP-2L negatively regulates its inhibitory function in ROCK-dependent haptotactic cell migration, as well as invasion of human colon carcinoma cells. Collectively, the presented data show that CRMP-2-dependent regulation of ROCK II activity is mediated through interaction of the CRMP-2L N terminus with the ROCK II catalytic domain as well as by GSK3-dependent phosphorylation of CRMP-2.	[Morgan-Fisher, Marie; Couchman, John R.; Yoneda, Atsuko] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Morgan-Fisher, Marie; Couchman, John R.; Yoneda, Atsuko] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Yoneda, Atsuko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, Hachioji, Tokyo 1920392, Japan	University of Copenhagen; University of Copenhagen; Tokyo University of Pharmacy & Life Sciences	Yoneda, A (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	ayoneda@toyaku.ac.jp			Danish Medical Research Council; Novo Nordisk Foundation; Danish Cancer Research Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25440091]; Danish National Research Foundation; Lundbeck Foundation; Faculty of Health and Medical Sciences at the University of Copenhagen	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Research Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Faculty of Health and Medical Sciences at the University of Copenhagen	This work was supported by the Danish Medical Research Council (to A. Y. and J. R. C.), the Novo Nordisk Foundation (to A. Y. and J. R. C.), the Danish Cancer Research Foundation and Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 25440091 (to A. Y.), the Danish National Research Foundation (to J. R. C.), the Lundbeck Foundation (to J. R. C.), and the Faculty of Health and Medical Sciences at the University of Copenhagen (to J. R. C. and M. M.-F.).	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Mesquita DD, 2001, FEBS LETT, V502, P84, DOI 10.1016/S0014-5793(01)02669-2; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hall C, 2001, J BIOL CHEM, V276, P43482, DOI 10.1074/jbc.C100455200; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Kher SS, 2011, EXP CELL RES, V317, P2845, DOI 10.1016/j.yexcr.2011.09.009; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komers R, 2011, CURR OPIN NEPHROL HY, V20, P77, DOI 10.1097/MNH.0b013e32834131f8; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; Lydolph MC, 2009, EXP CELL RES, V315, P3312, DOI 10.1016/j.yexcr.2009.09.022; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Morgan-Fisher M, 2013, J HISTOCHEM CYTOCHEM, V61, P185, DOI 10.1369/0022155412470834; Niault T, 2009, J CELL BIOL, V187, P335, DOI 10.1083/jcb.200906178; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rahajeng J, 2010, J BIOL CHEM, V285, P31918, DOI 10.1074/jbc.C110.166066; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shimada K, 2014, BREAST CANCER-TOKYO, V21, P715, DOI 10.1007/s12282-013-0447-5; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2012, MOL CELL BIOL, V32, P1788, DOI 10.1128/MCB.06235-11; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31229	31240		10.1074/jbc.M113.505602	http://dx.doi.org/10.1074/jbc.M113.505602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036111	Green Published, hybrid			2022-12-25	WOS:000330778900039
J	Perni, S; Close, M; Franzini-Armstrong, C				Perni, Stefano; Close, Matthew; Franzini-Armstrong, Clara			Novel Details of Calsequestrin Gel Conformation in Situ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE UNITS; CAPACITY CA2+ BINDING; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; SMOOTH-MUSCLE; PROTEIN; PURIFICATION; OVEREXPRESSION; JUNCTIN; FIBERS	Calsequestrin (CASQ) is the major component of the sarcoplasmic reticulum (SR) lumen in skeletal and cardiac muscles. This calcium-binding protein localizes to the junctional SR (jSR) cisternae, where it is responsible for the storage of large amounts of Ca2+, whereas it is usually absent, at least in its polymerized form, in the free SR. The retention of CASQ inside the jSR is due partly to its association with other jSR proteins, such as junctin and triadin, and partly to its ability to polymerize, in a high Ca2+ environment, into an intricate gel that holds the protein in place. In this work, we shed some light on the still poorly described in situ structure of polymerized CASQ using detailed EM images from thin sections, with and without tilting, and from deep-etched rotary-shadowed replicas. The latter directly illustrate the fundamental network nature of polymerized CASQ, revealing repeated nodal points connecting short segments of the linear polymer.	[Perni, Stefano; Franzini-Armstrong, Clara] Univ Penn, Dept Cell Dev Biol, Philadelphia, PA 19104 USA; [Close, Matthew] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	University of Pennsylvania; Lehigh University	Close, M (corresponding author), Univ Colorado, Dept Physiol & Biophys, Anschutz Med Campus, Aurora, CO 80045 USA.	stefano.perni@ucdenver.edu	Perni, Stefano/M-1925-2016	Perni, Stefano/0000-0002-0591-4376	National Institutes of Health [AR055104]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055104, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR055104 (to K. G. Beam).	Boncompagni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039962; Boncompagni S, 2012, AGE, V34, P27, DOI 10.1007/s11357-011-9211-y; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Cala S E, 1990, Semin Cell Biol, V1, P265; CALA SE, 1983, J BIOL CHEM, V258, P1932; Franzini-Armstrong C, 2010, CURR TOP MEMBR, V66, P3, DOI 10.1016/S1063-5823(10)66001-2; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; FRANZINIARMSTRONG C, 1984, TISSUE CELL, V16, P647, DOI 10.1016/0040-8166(84)90038-7; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; INUI M, 1988, J BIOL CHEM, V263, P10843; JORGENSEN AO, 1985, J CELL BIOL, V101, P257, DOI 10.1083/jcb.101.1.257; Lee KW, 2012, J BIOL CHEM, V287, P1679, DOI 10.1074/jbc.M111.254045; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MAURER A, 1985, P NATL ACAD SCI USA, V82, P4036, DOI 10.1073/pnas.82.12.4036; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; PEACHEY LD, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.3.209; Renken C, 2009, J STRUCT BIOL, V165, P53, DOI 10.1016/j.jsb.2008.09.011; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; VILLA A, 1991, J CELL BIOL, V113, P779, DOI 10.1083/jcb.113.4.779; VILLA A, 1993, J CELL BIOL, V121, P1041, DOI 10.1083/jcb.121.5.1041; VOLPE P, 1991, BIOCHEM BIOPH RES CO, V181, P28, DOI 10.1016/S0006-291X(05)81377-4; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; WUYTACK F, 1987, BIOCHIM BIOPHYS ACTA, V899, P151, DOI 10.1016/0005-2736(87)90395-6; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	31	20	20	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31358	31362		10.1074/jbc.M113.507749	http://dx.doi.org/10.1074/jbc.M113.507749			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025332	hybrid, Green Published			2022-12-25	WOS:000330778900052
J	Douka, K; Bergman, CA; Hedges, REM; Wesselingh, FP; Higham, TFG				Douka, Katerina; Bergman, Christopher A.; Hedges, Robert E. M.; Wesselingh, Frank P.; Higham, Thomas F. G.			Chronology of Ksar Akil (Lebanon) and Implications for the Colonization of Europe by Anatomically Modern Humans	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; AURIGNACIAN; MIDDLE; DISPERSAL; ORIGINS; CAVE; ART	The Out-of-Africa model holds that anatomically modern humans (AMH) evolved and dispersed from Africa into Asia, and later Europe. Palaeoanthropological evidence from the Near East assumes great importance, but AMH remains from the region are extremely scarce. 'Egbert', a now-lost AMH fossil from the key site of Ksar Akil (Lebanon) and 'Ethelruda', a recently re-discovered fragmentary maxilla from the same site, are two rare examples where human fossils are directly linked with early Upper Palaeolithic archaeological assemblages. Here we radiocarbon date the contexts from which Egbert and Ethelruda were recovered, as well as the levels above and below the findspots. In the absence of well-preserved organic materials, we primarily used marine shell beads, often regarded as indicative of behavioural modernity. Bayesian modelling allows for the construction of a chronostratigraphic framework for Ksar Akil, which supports several conclusions. The model-generated age estimates place Egbert between 40.8-39.2 ka cal BP (68.2% prob.) and Ethelruda between 42.4-41.7 ka cal BP (68.2% prob.). This indicates that Egbert is of an age comparable to that of the oldest directly-dated European AMH (Pestera cu Oase). Ethelruda is older, but on current estimates not older than the modern human teeth from Cavallo in Italy. The dating of the so-called "transitional'' or Initial Upper Palaeolithic layers of the site may indicate that the passage from the Middle to Upper Palaeolithic at Ksar Akil, and possibly in the wider northern Levant, occurred later than previously estimated, casting some doubts on the assumed singular role of the region as a locus for human dispersals into Europe. Finally, tentative interpretations of the fossil's taxonomy, combined with the chronometric dating of Ethelruda's context, provides evidence that the transitional/IUP industries of Europe and the Levant, or at least some of them, may be the result of early modern human migration(s).	[Douka, Katerina; Hedges, Robert E. M.; Higham, Thomas F. G.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford, England; [Bergman, Christopher A.] URS Corp, Cincinnati, OH USA; [Wesselingh, Frank P.] Nat Biodivers Ctr, Leiden, Netherlands	University of Oxford; Naturalis Biodiversity Center	Douka, K (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford, England.	katerina.douka@rlaha.ox.ac.uk	Douka, Katerina/L-3287-2014; Higham, Tom/Y-2707-2019; Wesselingh, Frank/C-1367-2018	Douka, Katerina/0000-0002-0558-0011; Higham, Tom/0000-0002-5949-598X; Wesselingh, Frank/0000-0003-3655-0701	NERC-NRCF (UK) [NF/2008/2/2]; State Scholarships Foundation; A.G. Leventis Foundation; European Research Council [ERC-2012-AdG-324139]; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	NERC-NRCF (UK); State Scholarships Foundation; A.G. Leventis Foundation; European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The dating component of this research was funded by a NERC-NRCF (UK) grant (NF/2008/2/2). During the period this work was undertaken, KD was funded by the State Scholarships Foundation (I.K.Y., Greece/www.iky.gr) and the A.G. Leventis Foundation (www.leventisfoundation.org) with two separate postgraduate scholarships. KD and TFGH are members of the European Research Council Grant "PALAECHRON'' (ERC-2012-AdG-324139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altena C.O.Van Regteren, 1962, ZOOLOGISCHE MEDEDELI, V38, P87; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Azoury I., 1986, BAR INT SERIES, V289; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; Bar-Yosef O., 2006, TRABALHOS ARQUEOLOGI, V45, P317; BarYosef O, 1996, J ARCHAEOL SCI, V23, P297, DOI 10.1006/jasc.1996.0028; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; BERGMAN C. A., 2003, MORE MEETS EYE STUDI, P185; Bergman C.A., 1987, BAR INT SERIES, V329; Besancon J, 1975, PALEORIENT, V3, P5; Beyin A., 2006, AFR ARCHAEOL REV, V23, P5, DOI DOI 10.1007/S10437-006-9005-2; Bird MI, 1999, RADIOCARBON, V41, P127, DOI 10.1017/S0033822200019482; Boeda E., 1993, CAHIERS LEUPHRATE, V7, P47; Braidwood R.J., 1951, J NEAR E STUD, V10, P113; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Copeland L, 2002, MELANGES U SAINT JOS, V55, P121; Douka K, 2011, THESIS U OXFORD OXFO; Douka K, 2010, RADIOCARBON, V52, P735, DOI 10.1017/S0033822200045756; Douka K, 2011, J ARCHAEOL SCI, V38, P429, DOI 10.1016/j.jas.2010.09.026; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Ewing J.F., 1949, THOUGHT, V24, P255; Ewing J.F., 1960, 5 INT C ANTH ETH SCI, P535; Ewing J.F., 1947, ANTIQUITY, V21, P186; EWING JF, 1963, AM J PHYS ANTHROPOL, V21, P101, DOI 10.1002/ajpa.1330210202; EWING JF, 1966, AM J PHYS ANTHROPOL, V24, P275, DOI 10.1002/ajpa.1330240218; Frumkin A, 2011, J HUM EVOL, V60, P437, DOI 10.1016/j.jhevol.2010.03.010; Garcea E.A.A., 2010, SE MEDITERRANEAN PEO, P126; Garcea EAA, 2012, QUATERN INT, V270, P119, DOI 10.1016/j.quaint.2011.06.034; Goren-Inbar N., 2004, HUMAN PALEOECOLOGY L; Goring-Morris AN, 2004, TRABALHOS ARQUEOLOGI, P297; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Gulec E, 2011, 1 M EUR SOC STUD HUM; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hooijer D. A., 1961, ZOOLOGISCHE VERHANDE, V49, P4; Inizan M-L., 1978, PALEORIENT, V4, P295, DOI [10.3406/paleo.1978.4232, DOI 10.3406/PALEO.1978.4232]; Kozlowski JK, 2000, J ANTHROPOL RES, V56, P513, DOI 10.1086/jar.56.4.3630929; Kozlowski JK, 2004, ANTHROPOLOGIE, V43, P289; Kuhn S, 2003, LOGY AURIGNACIAN TRA, P61; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Marks A.E., 1986, PALEORIENT, V12, P5; Marks A. E., 1983, ADV WORLD ARCHAEOLOG, V2, P51; Marks A.E., 1992, EVOLUTION DISPERSAL, P229; Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Metni MC, 1999, AM J PHYS ANTHROPOL, P202; Millard AR, 2008, J HUM EVOL, V54, P848, DOI 10.1016/j.jhevol.2007.11.002; Ohnuma K., 1990, EMERGENCE MODERN HUM, P91; Ohnuma K, 1988, BAR INT SERIES, V426; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rebollo NR, 2011, J ARCHAEOL SCI, V38, P2424, DOI 10.1016/j.jas.2011.05.010; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Shea JJ, 2003, J WORLD PREHIST, V17, P313, DOI 10.1023/B:JOWO.0000020194.01496.fe; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Street M, 2006, J HUM EVOL, V51, P551, DOI 10.1016/j.jhevol.2006.04.014; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Stringer C., 1989, PALEORIENT, V15, P99, DOI DOI 10.3406/paleo.1989.4512; Svensson A, 2006, QUATERNARY SCI REV, V25, P3258, DOI 10.1016/j.quascirev.2006.08.003; Svoboda JA, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P30; Tixier J, 1974, PALEORIENT, V2, P187; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; Williams J. K., 2010, PALEORIENT, V36, P117, DOI [10.3406/paleo.2010.5391, DOI 10.3406/PALEO.2010.5391]; Yazbeck C., 2004, PALEORIENT, V30, P111, DOI [DOI 10.3406/paleo.2004.1015, 10.3406/paleo.2004.1015]; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1	70	70	71	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72931	10.1371/journal.pone.0072931	http://dx.doi.org/10.1371/journal.pone.0072931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	248VW	24039825	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500017
J	Zhao, C; Feng, Q; Dou, ZP; Yuan, W; Sui, CG; Zhang, XH; Xia, GM; Sun, HF; Ma, J				Zhao, Chen; Feng, Qiang; Dou, Zengpei; Yuan, Wei; Sui, Chenguang; Zhang, Xinghua; Xia, Guimin; Sun, Hongfang; Ma, Jie			Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; IN-VIVO; COLORECTAL-CANCER; GENE DELIVERY; DRUG; SIZE; BIODISTRIBUTION; CHEMOEMBOLIZATION; OXALIPLATIN; EXPRESSION	Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration was substantially improved in liver as well as a decrease in blood and other organs by spleen injection mimicking portal vein perfusion (regional administration). To further investigate the targeted therapeutic effect of galactosylated liposome encapsulated doxorubicin (Dox) by regional administration, liver targeting liposomes were prepared by incorporating galactosylated-DPPE to conventional liposomes. Liposome uptake and targeting were verified in vitro and in vivo by fluorescence microscopy and xenogen IVIS imaging system, respectively. The results showed that galactose targeted liposomes presented a stronger specific cell uptake by human hepatocellular carcinoma HepG2 cells compared to the non-targeted liposomes. In vivo fluorescence imaging showed that the intra-hepatic deposition of conventional and galactosylated liposomes via spleen injection was more than that via tail vein administration, and galactosylated liposomes had higher fluorescent intensity over conventional liposomes in the liver post spleen administration. The anti-tumor effect of various drug administration routes for both liposomal formulations was evaluated using a murine liver metastasis model of colon cancer. The results indicated that tumor progression in the liver and mesenteric lymph nodes was significantly suppressed by Dox-loaded galactosylated liposomes via spleen injection, while no significance was observed in non-targeted formulations. Our data indicated that local perfusion of galactosylated liposomal doxorubicin had a great promise for the treatment of liver metastasis from colon cancer.	[Zhao, Chen; Yuan, Wei; Sui, Chenguang; Zhang, Xinghua; Ma, Jie] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Feng, Qiang] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Abdominal Surg Dept, Beijing 100730, Peoples R China; [Dou, Zengpei; Sun, Hongfang] Peking Univ, Coll Chem & Mol Engn, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Xia, Guimin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biotechnol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Sciences; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College	Ma, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	majie1965@163.com			National Basic Research Program of China [2011CB911004]; Beijing Natural Science Foundation of China [7122150]; National Novel Drug Development Foundation of China [2009ZX09303-008]	National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); National Novel Drug Development Foundation of China	This research was supported by National Basic Research Program of China 2011CB911004, Beijing Natural Science Foundation of China 7122150 and National Novel Drug Development Foundation of China 2009ZX09303-008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN NB, 1972, CANCER, V29, P435, DOI 10.1002/1097-0142(197202)29:2<435::AID-CNCR2820290227>3.0.CO;2-K; Alberts SR, 2005, J CLIN ONCOL, V23, P9243, DOI 10.1200/JCO.2005.07.740; Andre N, 2005, GUT, V54, P1194, DOI 10.1136/gut.2004.062745; [Anonymous], 2011, Drug Ther Bull, V49, P42, DOI 10.1136/dtb.2011.02.0022; Arnold D, 2010, GUT, V59, P838, DOI 10.1136/gut.2009.196006; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Becker B, 1999, CARBOHYD RES, V315, P148, DOI 10.1016/S0008-6215(98)00330-9; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; COLLINS JM, 1984, J CLIN ONCOL, V2, P498, DOI 10.1200/JCO.1984.2.5.498; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dong Y H, 1993, J Vasc Interv Radiol, V4, P621, DOI 10.1016/S1051-0443(93)71935-1; Eliaz RE, 2001, CANCER RES, V61, P2592; ENSMINGER WD, 1984, CANCER TREAT REP, V68, P101; Faure AC, 2009, SMALL, V5, P2565, DOI 10.1002/smll.200900563; Fumoto S, 2004, MOL THER, V10, P719, DOI 10.1016/j.ymthe.2004.07.015; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Gung BW, 2002, ORG LETT, V4, P2517, DOI 10.1021/ol026145n; Hanna WC, 2006, ARCH SURG-CHICAGO, V141, P93, DOI 10.1001/archsurg.141.1.93; He XX, 2008, ANAL CHEM, V80, P9597, DOI 10.1021/ac801882g; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; Immordino ML, 2006, INT J NANOMED, V1, P297; Ishikawa T, 2007, WORLD J GASTROENTERO, V13, P4306, DOI 10.3748/wjg.v13.i32.4306; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kakeji Y, 1998, CANCER, V82, P2307, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2307::AID-CNCR2>3.0.CO;2-P; KAN ZX, 1993, RADIOLOGY, V187, P621, DOI 10.1148/radiology.187.3.8497606; Kawakami S, 2001, J PHARM SCI, V90, P105, DOI 10.1002/1520-6017(200102)90:2<105::AID-JPS1>3.0.CO;2-1; Kelly C, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/727241; Kheirolomoom A, 2007, BIOMATERIALS, V28, P4311, DOI 10.1016/j.biomaterials.2007.06.008; Kumada T, 1999, ONCOLOGY-BASEL, V57, P216, DOI 10.1159/000012034; LASIC DD, 1992, FEBS LETT, V312, P255, DOI 10.1016/0014-5793(92)80947-F; Li Yan, 2008, Current Drug Delivery, V5, P299, DOI 10.2174/156720108785915069; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Matsuda I, 2001, SURG TODAY, V31, P414, DOI 10.1007/s005950170132; Peeters MJTFDV, 1996, BIOTECHNIQUES, V20, P278; RAO AVR, 1987, SYNTHETIC COMMUN, V17, P1339, DOI 10.1080/00397918708057756; Rossi P, 2000, MED RADIOL; ROUGIER P, 1992, J CLIN ONCOL, V10, P1112, DOI 10.1200/JCO.1992.10.7.1112; Sapra P, 2004, CLIN CANCER RES, V10, P1100, DOI 10.1158/1078-0432.CCR-03-0041; SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981; Schipper ML, 2009, SMALL, V5, P126, DOI 10.1002/smll.200800003; SHIRATORI Y, 1995, DIGEST DIS SCI, V40, P2398, DOI 10.1007/BF02063244; Sun X, 2005, J DRUG TARGET, V13, P121, DOI 10.1080/10611860400024714; Wang SN, 2010, AAPS PHARMSCITECH, V11, P870, DOI 10.1208/s12249-010-9450-8; Wang SL, 2008, J DRUG TARGET, V16, P233, DOI [10.1080/10611860801902609, 10.1080/10611860801902609 ]; Wang SN, 2006, EUR J PHARM BIOPHARM, V62, P32, DOI 10.1016/j.ejpb.2005.07.004; Wisse E, 2008, GENE THER, V15, P1193, DOI 10.1038/gt.2008.60; Wu J, 2002, FRONT BIOSCI, V7, pD717, DOI 10.2741/wu2; Xie Yi-bin, 2010, Zhonghua Yi Xue Za Zhi, V90, P2126; Yagi Yoshinori, 2000, Gastric Cancer, V3, P71, DOI 10.1007/PL00011699	52	29	29	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73860	10.1371/journal.pone.0073860	http://dx.doi.org/10.1371/journal.pone.0073860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040096	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500056
J	Healer, J; Thompson, JK; Riglar, DT; Wilson, DW; Chiu, YHC; Miura, K; Chen, L; Hodder, AN; Long, CA; Hansen, DS; Baum, J; Cowman, AF				Healer, Julie; Thompson, Jennifer K.; Riglar, David T.; Wilson, Danny W.; Chiu, Yu-H. C.; Miura, Kazutoyo; Chen, Lin; Hodder, Anthony N.; Long, Carole A.; Hansen, Diana S.; Baum, Jake; Cowman, Alan F.			Vaccination with Conserved Regions of Erythrocyte-Binding Antigens Induces Neutralizing Antibodies against Multiple Strains of Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITE INVASION; GLYCOPHORIN-C; RECEPTOR; PROTEINS; EBA-175; EXPRESSION; PATHWAYS; PROTECTION; IDENTIFICATION; POLYMORPHISMS	Background: A highly effective vaccine against Plasmodium falciparum malaria should induce potent, strain transcending immunity that broadly protects against the diverse population of parasites circulating globally. We aimed to identify vaccine candidates that fulfill the criteria. Methods: We have measured growth inhibitory activity of antibodies raised to a range of antigens to identify those that can efficiently block merozoite invasion for geographically diverse strains of P. falciparum. Results: This has shown that the conserved Region III-V, of the P. falciparum erythrocyte-binding antigen (EBA)-175 was able to induce antibodies that potently inhibit merozoite invasion across diverse parasite strains, including those reliant on invasion pathways independent of EBA-175 function. Additionally, the conserved RIII-V domain of EBA-140 also induced antibodies with strong in vitro parasite growth inhibitory activity. Conclusion: We identify an alternative, highly conserved region (RIV-V) of EBA-175, present in all EBA proteins, that is the target of potent, strain transcending neutralizing antibodies, that represents a strong candidate for development as a component in a malaria vaccine.	[Healer, Julie; Thompson, Jennifer K.; Riglar, David T.; Wilson, Danny W.; Chiu, Yu-H. C.; Chen, Lin; Hodder, Anthony N.; Hansen, Diana S.; Baum, Jake; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Miura, Kazutoyo; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Riglar, David T.; Chiu, Yu-H. C.; Hansen, Diana S.; Baum, Jake; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Wilson, Danny W/E-6186-2019; Miura, Kazutoyo/AAY-9751-2020	Wilson, Danny W/0000-0002-5073-1405; Miura, Kazutoyo/0000-0003-4455-2432; Riglar, David/0000-0002-5004-4373; Chiu, Yu Ho Chris/0000-0002-5380-1114; Baum, Jake/0000-0002-0275-352X	National Health and Medical Research Council of Australia [637406, 1011453]; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS; Howard Hughes International Scholar [55007645]; Bill and Melinda Gates Foundation; PATH/MVI; USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes International Scholar; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); PATH/MVI; USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Health and Medical Research Council of Australia by a Program grant (637406) and a project grant (1011453). This work was also supported through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. AFC is a Howard Hughes International Scholar (55007645). This work was also supported by grants from the Bill and Melinda Gates Foundation, PATH/MVI, and USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Baum J, 2003, GENETICS, V163, P1327; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bustamante LY, 2012, VACCINE; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Nery S, 2006, MOL BIOCHEM PARASIT, V149, P208, DOI 10.1016/j.molbiopara.2006.05.014; Ockenhouse CF, 2001, MOL BIOCHEM PARASIT, V113, P9, DOI 10.1016/S0166-6851(00)00375-3; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Ohas EA, 2004, INFECT IMMUN, V72, P735, DOI 10.1128/IAI.72.2.735-741.2004; Pandey AK, 2012, INFECT IMMUN; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; RABOUDI N, 1992, J BIOL CHEM, V267, P11930; Ranjan A, 1999, P NATL ACAD SCI USA, V96, P14067, DOI 10.1073/pnas.96.24.14067; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIM BKL, 1992, MOL BIOCHEM PARASIT, V51, P157, DOI 10.1016/0166-6851(92)90211-2; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Triglia T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002075; WARE LA, 1993, MOL BIOCHEM PARASIT, V60, P105, DOI 10.1016/0166-6851(93)90033-T; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	63	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72504	10.1371/journal.pone.0072504	http://dx.doi.org/10.1371/journal.pone.0072504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039774	Green Published, gold			2022-12-25	WOS:000327538600007
J	Shrestha, S; Grilley, M; Fosso, MY; Chang, CWT; Takemoto, JY				Shrestha, Sanjib; Grilley, Michelle; Fosso, Marina Y.; Chang, Cheng-Wei T.; Takemoto, Jon Y.			Membrane Lipid-Modulated Mechanism of Action and Non-Cytotoxicity of Novel Fungicide Aminoglycoside FG08	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PLANT DEFENSIN; ANTIBACTERIAL; SPHINGOLIPIDS; ANTIBIOTICS; STIMULATION; REQUIREMENT	A novel aminoglycoside, FG08, that differs from kanamycin B only by a C8 alkyl chain at the 4 ''-O position, was previously reported. Unlike kanamycin B, FG08 shows broad-spectrum fungicidal but not anti-bacterial activities. To understand its specificity for fungi, the mechanism of action of FG08 was studied using intact cells of the yeast Saccharomyces cerevisiae and small unilamellar membrane vesicles. With exposure to FG08 (30 mu g mL(-1)), 8-fold more cells were stained with fluorescein isothiocyanate, cells had 4 to 6-fold higher K+ efflux rates, and 18-fold more cells were stained with SYTOX Green in comparison to exposure to kanamycin B (30 mu g mL(-1)). Yeast mutants with aberrant membrane sphingolipids (no sphingoid base C4 hydroxyl group, truncated very long fatty acid chain, or lacking the terminal phosphorylinositol group of mannosyl-diinositolphosphorylphytoceramide were 4 to 8-fold less susceptible to growth inhibition with FG08 and showed 2 to 10-fold lower SYTOX Green dye uptake rates than did the isogenic wild-type strain. FG08 caused leakage of pre-loaded calcein from 50% of small unilamellar vesicles with glycerophospholipid and sterol compositions that mimic the compositions of fungal plasma membranes. Less than 5 and 10% of vesicles with glycerophospholipid and sterol compositions that mimic bacterial and mammalian cell plasma membranes, respectively, showed calcein leakage. In tetrazolium dye cytotoxicity tests, mammalian cell lines NIH3T3 and C8161.9 showed FG08 toxicity at concentrations that were 10 to 20-fold higher than fungicidal minimal inhibitory concentrations. It is concluded that FG08's growth inhibitory specificity for fungi lie in plasma membrane permeability changes involving mechanisms that are modulated by membrane lipid composition.	[Shrestha, Sanjib; Grilley, Michelle; Takemoto, Jon Y.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Fosso, Marina Y.; Chang, Cheng-Wei T.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Shrestha, Sanjib] Utah State Univ, Synthet Bioprod Ctr USTAR, North Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Takemoto, JY (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	jon.takemoto@usu.edu	Takemoto, Jon/A-5309-2011	Takemoto, Jon/0000-0001-9919-9168; Chang, Tom/0000-0002-8978-4520	Utah Science Technology and Research (USTAR) initiative; Baicor LC; National Institutes of Health [AI053138]; Utah Agricultural Experiment Station, Utah State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053138] Funding Source: NIH RePORTER	Utah Science Technology and Research (USTAR) initiative; Baicor LC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Utah Agricultural Experiment Station, Utah State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support from the Utah Science Technology and Research (USTAR) initiative, Baicor LC, and the National Institutes of Health (AI053138 to C-W. T. Chang) is acknowledged. This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 8573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG EJ, 1995, BRIT J CLIN PHARMACO, V39, P597; Chang CWT, 2010, J ANTIBIOT, V63, P667, DOI 10.1038/ja.2010.110; Dickson RC, 2010, ADV EXP MED BIOL, V688, P217; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Lee HB, 2005, J APPL MICROBIOL, V99, P836, DOI 10.1111/j.1365-2672.2005.02684.x; Lynch SR, 2001, J MOL BIOL, V306, P1037, DOI 10.1006/jmbi.2000.4420; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; Takemoto JY, 2003, CEL MOL MEC TOX ACT, V5, P260; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; UMEZAWA H, 1957, J ANTIBIOT, V10, P181; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; WILHELM JM, 1978, BIOCHEMISTRY-US, V17, P1143, DOI 10.1021/bi00600a001; ZHANG L, 1989, BIOCHIM BIOPHYS ACTA, V987, P171, DOI 10.1016/0005-2736(89)90540-3; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	20	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73843	10.1371/journal.pone.0073843	http://dx.doi.org/10.1371/journal.pone.0073843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040088	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600048
J	Aires, RD; Capettini, LSA; Silva, JF; Rodrigues-Machado, MD; Pinho, V; Teixeira, MM; Cortes, SF; Lemos, VS				Aires, Rosaria D.; Capettini, Luciano S. A.; Silva, Josiane F.; Rodrigues-Machado, Maria da Gloria; Pinho, Vanessa; Teixeira, Mauro M.; Cortes, Steyner F.; Lemos, Virginia S.			Paraquat Poisoning Induces TNF-alpha-Dependent iNOS/NO Mediated Hyporesponsiveness of the Aorta to Vasoconstrictors in Rats	PLOS ONE			English	Article							SYNTHASE GENE-EXPRESSION; RESPIRATORY-DISTRESS-SYNDROME; INDUCED OXIDATIVE STRESS; NITRIC-OXIDE; HYDROGEN-PEROXIDE; LUNG TOXICITY; DYSFUNCTION; MECHANISM; ANGIOTENSIN-(1-7); ACCUMULATION	Paraquat is a toxic herbicide that may induce acute lung injury, circulatory failure and death. The present work aimed at investigating whether there is systemic inflammation and vascular dysfunction after paraquat exposure and whether these parameters were related. There was neutrophilia and accumulation of neutrophils in lung and bronchoalveolar lavage of animals given paraquat. This was associated with an increase in serum levels of TNF-alpha. In rats given paraquat, the relaxant response of aortic rings to acetylcholine was not modified but the contractile response to phenylephrine was greatly reduced. Endothelium removal or treatment with non-selective (L-NAME) or selective (L-NIL) inhibitors of inducible nitric oxide synthase (iNOS) restored contraction of aortas. There was greater production of nitric oxide (NO), which was restored to basal level by L-NIL, and greater expression of iNOS in endothelial cells, as seen by Western blot analyses and confocal microscopy. Blockade of TNF-alpha reduced pulmonary and systemic inflammation and vascular dysfunction. Together, our results clearly show that paraquat causes pulmonary and systemic inflammation, and vascular dysfunction in rats. Vascular dysfunction is TNF-alpha dependent, associated with enhanced expression of iNOS in aortic endothelial cells and greater NO production, which accounts for the decreased responsiveness of aortas to vasoconstrictors. Blockers of TNF-alpha may be useful in patients with paraquat poisoning.	[Aires, Rosaria D.; Silva, Josiane F.; Rodrigues-Machado, Maria da Gloria; Lemos, Virginia S.] Univ Fed Minas Gerais, Dept Physiol & Biophys, ICB, Belo Horizonte, MG, Brazil; [Capettini, Luciano S. A.; Cortes, Steyner F.] Univ Fed Minas Gerais, Dept Pharmacol, ICB, Belo Horizonte, MG, Brazil; [Pinho, Vanessa] Univ Fed Minas Gerais, Dept Morphol, ICB, Belo Horizonte, MG, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, ICB, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Lemos, VS (corresponding author), Univ Fed Minas Gerais, Dept Physiol & Biophys, ICB, Belo Horizonte, MG, Brazil.	vslemos@icb.ufmg.br	pinho, vanessa/AAC-8437-2020; Silva, Josiane/AAC-8361-2019; Pinho, Vanessa/AAR-1686-2021; Teixeira, Mauro M/A-4587-2008; da Glória Rodrigues-Machado, Maria/H-1484-2019; Cortes, Steyner F./F-5449-2010; Pinho, Vanessa/GXM-8532-2022; Lemos, Virginia/B-7305-2018	pinho, vanessa/0000-0003-1038-2324; Silva, Josiane/0000-0002-6623-7946; Teixeira, Mauro M/0000-0002-6944-3008; Cortes, Steyner F./0000-0002-4340-2574; Lemos, Virginia/0000-0003-1234-9325; Capettini, Luciano/0000-0002-6487-9558	FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais)/PRONEX; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/Brazil	FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais)/PRONEX(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais)/PRONEX and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2003, ARCH TOXICOL, V77, P353, DOI 10.1007/s00204-003-0449-8; Barcelos LS, 2009, MICROVASC RES, V78, P148, DOI 10.1016/j.mvr.2009.04.009; BERISHA HI, 1994, P NATL ACAD SCI USA, V91, P7445, DOI 10.1073/pnas.91.16.7445; BUS JS, 1976, ENVIRON HEALTH PERSP, V16, P139, DOI 10.2307/3428594; Capettini LSA, 2011, BRIT J PHARMACOL, V164, P1738, DOI 10.1111/j.1476-5381.2011.01500.x; Capettini LSA, 2008, AM J PHYSIOL-HEART C, V295, pH2503, DOI 10.1152/ajpheart.00731.2008; Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025; Dinis-Oliveira RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007149; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Gocgeldi E, 2008, EXP BIOL MED, V233, P1133, DOI 10.3181/0802-RM-65; Hecker M, 1999, GEN PHARMACOL, V32, P9, DOI 10.1016/S0306-3623(98)00082-2; HOFFER E, 1993, TOXICOL APPL PHARM, V120, P8, DOI 10.1006/taap.1993.1080; Hong SY, 2000, TOXICOL LETT, V118, P53, DOI 10.1016/S0378-4274(00)00264-2; HSU KS, 1995, EUR J PHARM-ENVIRON, V292, P315; Jo YH, 2011, RESUSCITATION, V82, P487, DOI 10.1016/j.resuscitation.2010.11.028; Kang YJ, 2003, BIOCHEM PHARMACOL, V65, P457, DOI 10.1016/S0006-2952(02)01549-6; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; Lemos VS, 2002, BRIT J PHARMACOL, V135, P1743, DOI 10.1038/sj.bjp.0704630; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luh Shi-Ping, 2007, Journal of Zhejiang University-Science B, V8, P60, DOI 10.1631/jzus.2007.B0060; Mainwaring G, 2006, TOXICOLOGY, V225, P157, DOI 10.1016/j.tox.2006.05.017; Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009; Margolis AS, 2000, BBA-GEN SUBJECTS, V1524, P253, DOI 10.1016/S0304-4165(00)00167-7; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Mitra S, 2006, BBA-MOL BASIS DIS, V1762, P732, DOI 10.1016/j.bbadis.2006.06.011; Moran JM, 2010, J BIOCHEM MOL TOXIC, V24, P402, DOI 10.1002/jbt.20348; Nandi J, 2010, MOL CELL BIOCHEM, V336, P17, DOI 10.1007/s11010-009-0259-2; ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0; ROSE MS, 1974, NATURE, V252, P314, DOI 10.1038/252314b0; Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC; Silva DMR, 2007, PEPTIDES, V28, P702, DOI 10.1016/j.peptides.2006.10.007; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Suratt BT, 2006, CLIN CHEST MED, V27, P579, DOI 10.1016/j.ccm.2006.06.005; Takizawa M, 2007, TOXICOL IN VITRO, V21, P355, DOI 10.1016/j.tiv.2006.09.003; Tsukamoto M, 2002, TOXICOL APPL PHARM, V178, P82, DOI 10.1006/taap.2001.9325; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; Zerin T, 2012, TOXICOL LETT, V208, P101, DOI 10.1016/j.toxlet.2011.10.019; Zocrato LBR, 2010, TOXICOL IN VITRO, V24, P1019, DOI 10.1016/j.tiv.2009.12.003	42	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73562	10.1371/journal.pone.0073562	http://dx.doi.org/10.1371/journal.pone.0073562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039983	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300092
J	Rajagopalan, V; Liu, Z; Allexandre, D; Zhang, LD; Wang, XF; Pioro, EP; Yue, GH				Rajagopalan, Venkateswaran; Liu, Zao; Allexandre, Didier; Zhang, Luduan; Wang, Xiao-Feng; Pioro, Erik P.; Yue, Guang H.			Brain White Matter Shape Changes in Amyotrophic Lateral Sclerosis (ALS): A Fractal Dimension Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; DIFFUSION TENSOR MRI; MOTOR-NEURON INVOLVEMENT; CORTICOSPINAL TRACT; MULTIPLE-SCLEROSIS; IMAGES; TESTS; NEURODEGENERATION; DEGENERATION; TRACTOGRAPHY	Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disorder. Current diagnosis time is about 12-months due to lack of objective methods. Previous brain white matter voxel based morphometry (VBM) studies in ALS reported inconsistent results. Fractal dimension (FD) has successfully been used to quantify brain WM shape complexity in various neurological disorders and aging, but not yet studied in ALS. Therefore, we investigated WM morphometric changes using FD analyses in ALS patients with different clinical phenotypes. We hypothesized that FD would better capture clinical features of the WM morphometry in different ALS phenotypes than VBM analysis. High resolution MRI T1-weighted images were acquired in controls (n = 11), and ALS patients (n = 89). ALS patients were assigned into four subgroups based on their clinical phenotypes. VBM analysis was carried out using SPM8. FD values were estimated for brain WM skeleton, surface and general structure in both controls and ALS patients using our previously published algorithm. No significant VBM WM changes were observed between controls and ALS patients and among the ALS subgroups. In contrast, significant (p<0.05) FD reductions in skeleton and general structure were observed between ALS with dementia and other ALS subgroups. No significant differences in any of the FD measures were observed between control and ALS patients. FD correlated significantly with revised ALS functional rating scale (ALSFRS-R) score a clinical measure of function. Results suggest that brain WM shape complexity is more sensitive to ALS disease process when compared to volumetric VBM analysis and FD changes are dependent on the ALS phenotype. Correlation between FD and clinical measures suggests that FD could potentially serve as a biomarker of ALS pathophysiology, especially after confirmation by longitudinal studies.	[Rajagopalan, Venkateswaran; Liu, Zao; Allexandre, Didier; Zhang, Luduan; Yue, Guang H.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Rajagopalan, Venkateswaran; Allexandre, Didier; Yue, Guang H.] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ USA; [Wang, Xiao-Feng] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Pioro, Erik P.] Cleveland Clin, Neuromuscular Ctr, Cleveland, OH 44106 USA; [Pioro, Erik P.] Cleveland Clin, Dept Neurol, Neurol Inst, Cleveland, OH 44106 USA; [Pioro, Erik P.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Yue, Guang H.] Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA	Cleveland Clinic Foundation; Kessler Institute for Rehabilitation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yue, GH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA.	gyue@kesslerfoundation.org	R, Venkateswaran/GOV-7176-2022; Pioro, Erik P/AAZ-5318-2020	R, Venkateswaran/0000-0001-9040-0785; Pioro, Erik P/0000-0002-0737-6065; Allexandre, Didier/0000-0002-0178-0956				Abe O, 2004, NMR BIOMED, V17, P411, DOI 10.1002/nbm.907; Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Arndt S, 1996, J CEREBR BLOOD F MET, V16, P1271, DOI 10.1097/00004647-199611000-00023; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BULLMORE E, 1994, PSYCHOL MED, V24, P771, DOI 10.1017/S0033291700027926; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Cluskey S, 2001, J CLIN PATHOL-MOL PA, V54, P386; Comi G, 1999, EUR J NEUROL, V6, P629, DOI 10.1046/j.1468-1331.1999.660629.x; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Esteban FJ, 2007, NEUROIMAGE, V36, P543, DOI 10.1016/j.neuroimage.2007.03.057; Esteban FJ, 2009, J NEUROL SCI, V282, P67, DOI 10.1016/j.jns.2008.12.023; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hong YH, 2004, J NEUROL SCI, V227, P73, DOI 10.1016/j.jns.2004.08.014; Hsu J., 1996, MULTIPLE COMP THEORY; Kaufmann P, 2004, NEUROLOGY, V62, P1753, DOI 10.1212/01.WNL.0000125182.17874.59; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Matsusue E, 2007, AM J NEURORADIOL, V28, P1505, DOI 10.3174/ajnr.A0605; McCulloch S, 2001, GEN LINEAR MIXED MOD; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Rajagopalan Venkateswaran, 2011, J Aging Res, V2011, P481745, DOI 10.4061/2011/481745; Rousseeuw PJaL, 1987, ROBUST REGRESSION OU; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shook SJ, 2009, ANN NEUROL, V65, pS10, DOI 10.1002/ana.21545; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takahata N, 1976, Folia Psychiatr Neurol Jpn, V30, P41; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; YAGISHITA A, 1994, RADIOLOGY, V191, P455, DOI 10.1148/radiology.191.2.8153321; Zhang LD, 2006, J NEUROSCI METH, V150, P242, DOI 10.1016/j.jneumeth.2005.06.021; Zhang L, 2007, NEUROBIOL AGING, V28, P1543, DOI 10.1016/j.neurobiolaging.2006.06.020; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	38	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73614	10.1371/journal.pone.0073614	http://dx.doi.org/10.1371/journal.pone.0073614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040000	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300098
J	Tomeczkowski, J; Stern, S; Muller, A; von Heymann, C				Tomeczkowski, Joerg; Stern, Sean; Mueller, Alfred; von Heymann, Christian			Potential Cost Saving of Epoetin alfa in Elective Hip or Knee Surgery due to Reduction in Blood Transfusions and Their Side Effects: A Discrete-Event Simulation Model	PLOS ONE			English	Article							PREOPERATIVE ANEMIA; ORTHOPEDIC-SURGERY; INTRAOPERATIVE TRANSFUSION; CONSERVATION ALGORITHM; IRON SUPPLEMENTATION; DEMOGRAPHIC-CHANGES; ERYTHROPOIETIN; ARTHROPLASTY; MANAGEMENT; REPLACEMENT	Objectives: Transfusion of allogeneic blood is still common in orthopedic surgery. This analysis evaluates from the perspective of a German hospital the potential cost savings of Epoetin alfa (EPO) compared to predonated autologous blood transfusions or to a nobloodconservationstrategy (allogeneic blood transfusion strategy)during elective hip and knee replacement surgery. Methods: Individual patients (N=50,000) were simulated based on data from controlled trials, the German DRG institute (InEK) and various publications and entered into a stochastic model (Monte-Carlo) of three treatment arms: EPO, preoperative autologous donation and nobloodconservationstrategy. All three strategies lead to a different risk for an allogeneic blood transfusion. The model focused on the costs and events of the three different procedures. The costs were obtained from clinical trial databases, the German DRG system, patient records and medical publications: transfusion (allogeneic red blood cells: (sic)320/unit and autologous red blood cells: (sic)250/unit), pneumonia treatment ((sic)5,000), and length of stay ((sic)300/day). Probabilistic sensitivity analyses were performed to determine which factors had an influence on the model's clinical and cost outcomes. Results: At acquisition costs of (sic)200/40,000 IU EPO is cost saving compared to autologous blood donation, and costeffective compared to a nobloodconservationstrategy. The results were most sensitive to the cost of EPO, blood units and hospital days. Conclusions: EPO might become an attractive blood conservation strategy for anemic patients at reasonable costs due to the reduction in allogeneic blood transfusions, in the modeled incidence of transfusion-associated pneumonia and the prolongedlength of stay.	[Tomeczkowski, Joerg] Janssen Cilag GmbH, Dept Hlth Econ, Neuss, Germany; [Stern, Sean] United Biosource Corp, Bethesda, MD USA; [Mueller, Alfred] Analyt Serv GmbH, Munich, Germany; [von Heymann, Christian] Charite, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany	Johnson & Johnson; United Biosource Corporation; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Tomeczkowski, J (corresponding author), Janssen Cilag GmbH, Dept Hlth Econ, Neuss, Germany.	jtomeczk@its.jnj.com			Janssen-Cilag Germany GmbH	Janssen-Cilag Germany GmbH	The work on the model was funded by Janssen-Cilag Germany GmbH. Confounding and bias is therefore possible.	Abraham I, 2012, TRANSFUSION, V52, P1983, DOI 10.1111/j.1537-2995.2011.03532.x; Alsaleh KA, 2013, J ARTHROPLASTY; [Anonymous], 2010, OPERATIONEN PROZEDUR; [Anonymous], 2011, G DRG REP BROWS HA V; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Borkent-Raven BA, 2010, TRANSFUSION, V50, P2455, DOI 10.1111/j.1537-2995.2010.02716.x; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461; Coyle D, 1999, TRANSFUSION MED, V9, P21; Davis L, 2006, COST EFECTIVENESS CE, V10; Delasotta LA, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/595027; Delasotta Lawrence A, 2012, Open Orthop J, V6, P179, DOI 10.2174/1874325001206010179; Feagan BG, 2000, ANN INTERN MED, V133, P845, DOI 10.7326/0003-4819-133-11-200012050-00008; Feagan BG, 2001, TRANSFUSION MED, V11, P87, DOI 10.1046/j.1365-3148.2001.00291.x; Fergusson DA, 2005, CAN J ANAESTH, V52, P347; Ferraris VA, 2011, ANN THORAC SURG, V91, P1674, DOI 10.1016/j.athoracsur.2011.01.025; Flegel WA, 2012, BLOOD TRANSFUS-ITALY, V10, P247, DOI 10.2450/2012.0105-12; Freedman J, 2008, TRANSFUSION, V48, P237, DOI 10.1111/j.1537-2995.2007.01515.x; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 1998, CLIN ORTHOP RELAT R, P82; Green WS, 2010, J ARTHROPLASTY, V25, P93, DOI 10.1016/j.arth.2008.10.005; Greinacher A, 2011, TRANSFUSION, V51, P702, DOI 10.1111/j.1537-2995.2010.02882.x; Greinacher A, 2010, TRANSFUS MED HEMOTH, V37, P141, DOI 10.1159/000313949; Grosflam J M, 1995, Arthritis Care Res, V8, P167, DOI 10.1002/art.1790080309; Hardwick ME, 2004, CLIN ORTHOP RELAT R, P240, DOI 10.1097/01.blo.0000130206.58617.9e; Henry DA, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003602; Henseler O, 2011, REPORT NOTIFICATIONS; Hod EA, 2011, BLOOD, V118, P6675, DOI 10.1182/blood-2011-08-371849; Janssen-Cilag GmbH, FACH ERYPO; Karkouti K, 2012, ANESTHESIOLOGY, V117, P1175, DOI 10.1097/ALN.0b013e318271604e; Katherine Luke RN, ONTRAC ONTARIO NURSE; Kendoff D, 2011, ORTHOPADE, V40, P1018, DOI 10.1007/s00132-011-1789-3; Kotze A, 2012, BRIT J ANAESTH, V108, P943, DOI 10.1093/bja/aes135; Mahadevan D, 2010, J ORTHOP TRAUMATOL, V11, P159, DOI 10.1007/s10195-010-0105-z; Martinez V, 2007, BRIT J ANAESTH, V99, P794, DOI 10.1093/bja/aem266; Muller-Lobeck Lutz, THESIS RUPRECHT KARL; Munoz M, 2009, VOX SANG, V96, P1, DOI 10.1111/j.1423-0410.2008.01108.x; Olijhoek G, 2001, TRANSFUSION, V41, P957, DOI 10.1046/j.1537-2995.2001.41070957.x; Pandey Prashant, 2010, Asian J Transfus Sci, V4, P78, DOI 10.4103/0973-6247.67021; Pedersen AB, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-167; Pierson JL, 2004, J BONE JOINT SURG AM, V86A, P1512, DOI 10.2106/00004623-200407000-00022; Rashiq S, 2004, ANESTH ANALG, V99, P1239, DOI 10.1213/01.ANE.0000132928.45858.92; Rosencher N, 2005, CAN J ANAESTH, V52, P160, DOI 10.1007/BF03027722; Rosencher N, 2003, TRANSFUSION, V43, P459, DOI 10.1046/j.1537-2995.2003.00348.x; Sauer J, 2004, Z ORTHOP GRENZGEB, V142, P673, DOI 10.1055/s-2004-820380; Seifried E, 2011, Vox Sang, V100, P10, DOI 10.1111/j.1423-0410.2010.01446.x; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Slappendel R, 2005, TIJDSCHRIFTVOORORTHO, V12, P212; Slappendel R, 2006, ACTA ORTHOP, V77, P677, DOI 10.1080/17453670610012782; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; Stowell CP, 1999, ORTHOPEDICS, V22, pS105; VinniJuneja M, CONTINUING REASSESSM; Weber EWG, 2005, EUR J ANAESTH, V22, P249, DOI 10.1017/S0265021505000426; Weber EWG, 2005, ANESTH ANALG, V100, P1416, DOI 10.1213/01.ANE.0000150610.44631.9D; Wong CJ, 2007, TRANSFUSION, V47, P832, DOI 10.1111/j.1537-2995.2007.01197.x; World Health Organization, 2006, APPR CLIN US BLOOD B	57	11	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72949	10.1371/journal.pone.0072949	http://dx.doi.org/10.1371/journal.pone.0072949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039829	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300037
J	Liu, Z; He, JL; Kapoor, K; Srivastava, J				Liu, Zhen; He, Jia-Lin; Kapoor, Komal; Srivastava, Jaideep			Correlations between Community Structure and Link Formation in Complex Networks	PLOS ONE			English	Article							PREDICTION; MODEL	Background: Links in complex networks commonly represent specific ties between pairs of nodes, such as protein-protein interactions in biological networks or friendships in social networks. However, understanding the mechanism of link formation in complex networks is a long standing challenge for network analysis and data mining. Methodology/Principal Findings: Links in complex networks have a tendency to cluster locally and form so-called communities. This widely existed phenomenon reflects some underlying mechanism of link formation. To study the correlations between community structure and link formation, we present a general computational framework including a theory for network partitioning and link probability estimation. Our approach enables us to accurately identify missing links in partially observed networks in an efficient way. The links having high connection likelihoods in the communities reveal that links are formed preferentially to create cliques and accordingly promote the clustering level of the communities. The experimental results verify that such a mechanism can be well captured by our approach. Conclusions/Significance: Our findings provide a new insight into understanding how links are created in the communities. The computational framework opens a wide range of possibilities to develop new approaches and applications, such as community detection and missing link prediction.	[Liu, Zhen; He, Jia-Lin] Univ Elect Sci & Technol China, Web Sci Ctr, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China; [Liu, Zhen; Kapoor, Komal; Srivastava, Jaideep] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA	University of Electronic Science & Technology of China; University of Minnesota System; University of Minnesota Twin Cities	Liu, Z (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	quake.liu0625@gmail.com; srivasta@cs.umn.edu		Liu, Zhen/0000-0001-8762-0664; Srivastava, Jaideep/0000-0001-9385-7545	Army Research Laboratory [W911NF-09-2-0053]; National Natural Science Foundation of China [60903073, 61103109]; HuaWei University-Enterprise cooperation project [YBCB2011057]; research funds for central universities [ZYGX2012J085]	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HuaWei University-Enterprise cooperation project(Huawei Technologies); research funds for central universities	KK and JS acknowledge support from the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053. ZL and JLH acknowledge the funds of National Natural Science Foundation of China under grant Nos. 60903073, 61103109 and HuaWei University-Enterprise cooperation project (No. YBCB2011057) and the research funds for central universities under grant No. ZYGX2012J085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ahmad M. A., 2010, 2010 IEEE INT C DAT, P911; [Anonymous], 2002, CONNECTIONS; Backstrom L., 2011, P 4 ACM INT C WEB SE, P635; Bagrow JP, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046108; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cancho RFI, 2003, LECT NOTES PHYS, V625, P114; Cannistraci CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01613; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; DAWAH HA, 1995, J ANIM ECOL, V64, P708, DOI 10.2307/5850; Dong YX, 2012, IEEE DATA MINING, P181, DOI 10.1109/ICDM.2012.140; Feng X, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20207-x; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hyo-Jung Oh, 2000, SIGIR Forum, V34, P264; Kumpula JM, 2007, EUR PHYS J B, V56, P41, DOI 10.1140/epjb/e2007-00088-4; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Ostergard PRJ, 2002, DISCRETE APPL MATH, V120, P197, DOI 10.1016/S0166-218X(01)00290-6; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reitz JM, 2002, P 4 ACM C REC SYST R; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; Symeonidis P, 2010, P 4 ACM C RECOMMENDE, P183; Voy BH, 2006, PLOS COMPUT BIOL, V2, P757, DOI 10.1371/journal.pcbi.0020089; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu F, 2004, EUR PHYS J B, V38, P331, DOI 10.1140/epjb/e2004-00125-x; Yan BW, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056112; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	43	35	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72908	10.1371/journal.pone.0072908	http://dx.doi.org/10.1371/journal.pone.0072908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039818	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500027
J	Vocking, O; Uhl, G; Michalik, P				Voecking, Oliver; Uhl, Gabriele; Michalik, Peter			Sperm Dynamics in Spiders (Araneae): Ultrastructural Analysis of the Sperm Activation Process in the Garden Spider Argiope bruennichi (Scopoli, 1772)	PLOS ONE			English	Article							PHOLCUS-PHALANGIOIDES FUESSLIN; ACCESSORY-GLANDS; FEMALE CHOICE; YOUNG SPERM; PHOLCIDAE; PROTEINS; FLUID; SPERMIOGENESIS; SPERMATHECA; SPERMATOZOA	Storage of sperm inside the female genital tract is an integral phase of reproduction in many animal species. The sperm storage site constitutes the arena for sperm activation, sperm competition and female sperm choice. Consequently, to understand animal mating systems information on the processes that occur from sperm transfer to fertilization is required. Here, we focus on sperm activation in spiders. Male spiders produce sperm whose cell components are coiled within the sperm cell and that are surrounded by a proteinaceous sheath. These inactive and encapsulated sperm are transferred to the female spermathecae where they are stored for later fertilization. We analyzed the ultrastructural changes of sperm cells during residency time in the female genital system of the orb-web spider Argiope bruennichi. We found three clearly distinguishable sperm conditions: encapsulated sperm (secretion sheath present), decapsulated (secretion sheath absent) and uncoiled sperm (cell components uncoiled, presumably activated). After insemination, sperm remain in the encapsulated condition for several days and become decapsulated after variable periods of time. A variable portion of the decapsulated sperm transforms rapidly to the uncoiled condition resulting in a simultaneous occurrence of decapsulated and uncoiled sperm. After oviposition, only decapsulated and uncoiled sperm are left in the spermathecae, strongly suggesting that the activation process is not reversible. Furthermore, we found four different types of secretion in the spermathecae which might play a role in the decapsulation and activation process.	[Voecking, Oliver; Uhl, Gabriele; Michalik, Peter] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Dept Gen & Systemat Zool, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Uhl, G (corresponding author), Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Dept Gen & Systemat Zool, Greifswald, Germany.	gabriele.uhl@uni-greifswald.de; michalik@uni-greifswald.de	Voecking, Oliver/AFR-2194-2022; Michalik, Peter/E-6757-2010	Voecking, Oliver/0000-0001-5388-2287; Michalik, Peter/0000-0003-2459-9153; Uhl, Gabriele/0000-0001-8758-7913				Adams EM, 2007, J INSECT PHYSIOL, V53, P319, DOI 10.1016/j.jinsphys.2006.12.003; ALBERTI G, 1990, Acta Zoologica Fennica, P17; Alberti G, 2000, REPRO BIOL, V9, P311; Berendonck B, 2005, J MORPHOL, V263, P118, DOI 10.1002/jmor.10296; Birkhead TR, 1998, SPERM COMPETITION SE; BROWN SG, 1985, J COMP PSYCHOL, V99, P167, DOI 10.1037/0735-7036.99.2.167; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Dallai R, 2003, J STRUCT BIOL, V142, P311, DOI 10.1016/S1047-8477(03)00032-7; Dallai R, 2010, ZOOMORPHOLOGY, V129, P61, DOI 10.1007/s00435-009-0100-1; Dallai R, 2008, J MORPHOL, V269, P1122, DOI 10.1002/jmor.10649; Dallai R, 2008, J MORPHOL, V269, P464, DOI 10.1002/jmor.10595; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 1998, J ARACHNOL, V26, P342; Foelix R. F., 2011, BIOL SPIDERS; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; Herberstein ME, 2011, BEHAV ECOL, V22, P692, DOI 10.1093/beheco/arr053; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; Jamieson B.G.M., 1999, INSECTS THEIR SPERMA; Klenk M, 2004, APIDOLOGIE, V35, P371, DOI 10.1051/apido:2004029; Martin D., 2012, ROTE LISTE SPINNEN A; Michalik P, 2006, ZOOLOGY, V109, P14, DOI 10.1016/j.zool.2005.09.010; Michalik P, 2005, J MORPHOL, V263, P284, DOI 10.1002/jmor.10309; Michalik Peter, 2005, Front Zool, V2, P12, DOI 10.1186/1742-9994-2-12; Michalik P, 2013, ZOOMORPHOLOGY, V132, P11, DOI 10.1007/s00435-012-0166-z; Michalik Peter, 2009, Contributions to Natural History (Bern), V12, P959; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; RAO HV, 1969, J INSECT PHYSIOL, V15, P1815, DOI 10.1016/0022-1910(69)90014-6; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RUTTNER F, 1971, Z VERGL PHYSIOL, V72, P411, DOI 10.1007/BF00300712; Schneider JM, 2006, ANIM BEHAV, V71, P781, DOI 10.1016/j.anbehav.2005.05.012; Simmons L.W., 2002, SPERM COMPETITION IT; Siva-Jothy MT, 2000, ECOL LETT, V3, P172; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Uhl G, 1996, J ZOOL, V240, P153, DOI 10.1111/j.1469-7998.1996.tb05492.x; UHL G, 1994, ACTA ZOOL-STOCKHOLM, V75, P1, DOI 10.1111/j.1463-6395.1994.tb00957.x; UHL G, 1994, ACTA ZOOL-STOCKHOLM, V75, P13, DOI 10.1111/j.1463-6395.1994.tb00958.x; Useta G, 2007, EUR J ENTOMOL, V104, P777, DOI 10.14411/eje.2007.099; Wagner RH, 2004, P ROY SOC B-BIOL SCI, V271, pS134, DOI 10.1098/rsbl.2003.0142; Werner M, 2008, BIOL REV, V83, P191, DOI 10.1111/j.1469-185X.2008.00039.x	40	25	26	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72660	10.1371/journal.pone.0072660	http://dx.doi.org/10.1371/journal.pone.0072660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039790	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500025
J	Wightman, PJ; Jackson, GR; Dipple, KM				Wightman, Patrick J.; Jackson, George R.; Dipple, Katrina M.			Disruption of Glycerol Metabolism by RNAi Targeting of Genes Encoding Glycerol Kinase Results in a Range of Phenotype Severity in Drosophila	PLOS ONE			English	Article							RECEPTOR-TRANSLOCATION PROMOTER; SIMPLE MENDELIAN DISORDERS; ESCHERICHIA-COLI; DESICCATION-RESISTANCE; FAT-METABOLISM; COMPLEX TRAITS; DEFICIENCY; EXPRESSION; MELANOGASTER; LIVER	In Drosophila, RNAi targeting of either dGyk or dGK can result in two alternative phenotypes: adult glycerol hypersensitivity or larval lethality. Here we compare these two phenotypes at the level of glycerol kinase (GK) phosphorylation activity, dGyk and dGK-RNA expression, and glycerol levels. We found both phenotypes exhibit reduced but similar levels of GK phosphorylation activity. Reduced RNA expression levels of dGyk and dGK corresponded with RNAi progeny that developed into glycerol hypersensitive adult flies. However, quantification of dGyk/dGK expression levels for the larval lethality phenotype revealed unexpected levels possibly due to a compensatory mechanism between dGyk and dGK or RNAi inhibition. The enzymatic role of glycerol kinase converts glycerol to glycerol 3-phosphate. As expected, elevated glycerol levels were observed in larvae that went on to develop into glycerol hypersensitive adults. Interestingly, larvae that died before eclosion revealed extremely low glycerol levels. Further characterization identified a wing phenotype that is enhanced by a dGpdh null mutation, indicating disrupted glycerol metabolism underlies the wing phenotype. In humans, glycerol kinase deficiency (GKD) exhibits a wide range of phenotypic variation with no obvious genotype-phenotype correlations. Additionally, disease severity often does not correlate with GK phosphorylation activity. It is intriguing that both human GKD patients and our GKD Drosophila model show a range of phenotype severity. Additionally, the lack of correlation between GK phosphorylation and dGyk/dGK-RNA expression with phenotypic severity suggests further study including understanding the alternative functions of the GK protein, could provide insights into the complex pathogenic mechanism observed in human GKD patients.	[Wightman, Patrick J.; Dipple, Katrina M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Brain Res Inst, Los Angeles, CA 90095 USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Dipple, Katrina M.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dipple, KM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	kdipple@mednet.ucla.edu			UCLA Faculty Senate grant; UCLA School of Medicine Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	UCLA Faculty Senate grant; UCLA School of Medicine Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by a UCLA Faculty Senate grant and UCLA School of Medicine Funds. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; Almena M, 2011, TRENDS BIOCHEM SCI, V36, P593, DOI 10.1016/j.tibs.2011.06.005; Basel-Vanagaite L, 2012, AM J HUM GENET, V90, P49, DOI 10.1016/j.ajhg.2011.11.028; Birchler JA, 2011, FLY AUSTIN, V5; BRAND AH, 1993, DEVELOPMENT, V118, P401; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Dipple KM, 2000, AM J HUM GENET, V67, P65; Dipple KM, 2000, PEDIATR RES, V47, p239A; Dipple KM, 2001, HUM GENET, V109, P55, DOI 10.1007/s004390100545; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Folk DG, 2001, J EXP BIOL, V204, P3323; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Hamel S, 2010, J CELL BIOL, V188, P581, DOI 10.1083/jcb.200907116; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huq AHMM, 1997, HUM MOL GENET, V6, P1803, DOI 10.1093/hmg/6.11.1803; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Ioffe E, 1998, P NATL ACAD SCI USA, V95, P11852, DOI 10.1073/pnas.95.20.11852; KOTARSKI MA, 1983, GENETICS, V105, P387; Kuwada N, 2005, BIOCHEM BIOPH RES CO, V335, P247, DOI 10.1016/j.bbrc.2005.07.066; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; MacLennan NK, 2006, HUM MOL GENET, V15, P405, DOI 10.1093/hmg/ddi457; Agosto JAM, 2006, MOL GENET METAB, V88, P334, DOI 10.1016/j.ymgme.2006.01.002; MCCABE ERB, 1977, BIOCHEM BIOPH RES CO, V78, P1327, DOI 10.1016/0006-291X(77)91437-1; McCabe ERB, 2001, DISORDERS GLYCEROL M, P2217; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Nagel AC, 2002, DEV GENES EVOL, V212, P93, DOI 10.1007/s00427-002-0210-y; OKAMOTO K, 1994, J BIOCHEM-TOKYO, V115, P862, DOI 10.1093/oxfordjournals.jbchem.a124431; OKAMOTO K, 1993, BIOCHEM BIOPH RES CO, V193, P848, DOI 10.1006/bbrc.1993.1703; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Ormo M, 1998, BIOCHEMISTRY-US, V37, P16565, DOI 10.1021/bi981616s; Philip BN, 2010, J INSECT PHYSIOL, V56, P679, DOI 10.1016/j.jinsphys.2009.12.003; Rahib L, 2007, EUR J HUM GENET, V15, P646, DOI 10.1038/sj.ejhg.5201801; Rozen S, 2000, Methods Mol Biol, V132, P365; Sargent CA, 2000, J MED GENET, V37, P434, DOI 10.1136/jmg.37.6.434; Sjarif DR, 2000, J INHERIT METAB DIS, V23, P529, DOI 10.1023/A:1005660826652; SONDERGAARD L, 1993, TRENDS GENET, V9, P193, DOI 10.1016/0168-9525(93)90113-V; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Sriram G, 2010, METAB ENG, V12, P332, DOI 10.1016/j.ymben.2010.04.001; Wightman PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031779; Xie WW, 2011, GENETICS, V188, P823, DOI 10.1534/genetics.111.128470; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113	50	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e71664	10.1371/journal.pone.0071664	http://dx.doi.org/10.1371/journal.pone.0071664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039719	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500008
J	Kim, SH; Liu, KH; Lee, SY; Hong, SJ; Cho, BK; Lee, H; Lee, CG; Choi, HK				Kim, So-Hyun; Liu, Kwang-Hyeon; Lee, Seok-Young; Hong, Seong-Joo; Cho, Byung-Kwan; Lee, Hookeun; Lee, Choul-Gyun; Choi, Hyung-Kyoon			Effects of Light Intensity and Nitrogen Starvation on Glycerolipid, Glycerophospholipid, and Carotenoid Composition in Dunaliella tertiolecta Culture	PLOS ONE			English	Article							BUBBLE-COLUMN PHOTOBIOREACTORS; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; LIPID-COMPOSITION; SALT STRESS; ALGAE; METABOLISM; PHOSPHOLIPIDS; SEPARATION; DISCOVERY	Time-course variation of lipid and carotenoid production under high light (300 mu E/m(2)s) and nitrogen starvation conditions was determined in a Dunaliella tertiolecta strain. Nanoelectrospray (nanoESI) chip based direct infusion was used for lipid analysis and ultra-performance liquid chromatography (UPLC) coupled with a photodiode array (PDA) or atmospheric chemical ionization mass spectrometry (APCI-MS) was used for carotenoid analysis. A total of 29 lipids and 7 carotenoids were detected. Alterations to diacylglyceryltrimethylhomoserine (DGTS) and digalactosyldiacylglycerol (DGDG) species were significant observations under stress conditions. Their role in relation to the regulation of photosynthesis under stress condition is discussed in this study. The total carotenoid content was decreased under stress conditions, while a (a) over tilde -carotene was increased under nitrate-deficient cultivation. The highest productivity of carotenoid was attained under high light and nitrate sufficiency (HLNS) condition, which result from the highest level of biomass under HLNS. When stress was induced at stationary phase, the substantial changes to the lipid composition occurred, and the higher carotenoid content and productivity were exhibited. This is the first report to investigate the variation of lipids, including glycerolipid, glycerophospholipid, and carotenoid in D. tertiolecta in response to stress conditions using lipidomics tools.	[Kim, So-Hyun; Lee, Seok-Young; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Liu, Kwang-Hyeon] Kyungpook Natl Univ, Coll Pharm, Taegu, South Korea; [Hong, Seong-Joo; Lee, Choul-Gyun] Inha Univ, Dept Biol Engn, Inst Ind Biotechnol, Inchon, South Korea; [Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Hookeun] Gachon Univ, Coll Pharm, Inchon, South Korea	Chung Ang University; Kyungpook National University; Inha University; Korea Advanced Institute of Science & Technology (KAIST); Gachon University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	hykychoi@cau.ac.kr	Cho, Byung-Kwan/C-1830-2011	Lee, Choul-Gyun/0000-0002-4684-7990; Lee, Hookeun/0000-0002-0696-8421	National Research Foundation of Korea; Korean government (MEST) [NRF-2011-0021055]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the National Research Foundation of Korea funded by the Korean government (MEST) (no. NRF-2011-0021055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzegari A, 2010, MOL BIOL REP, V37, P3427, DOI 10.1007/s11033-009-9933-4; BENAMOTZ A, 1990, TRENDS BIOTECHNOL, V8, P121, DOI 10.1016/0167-7799(90)90152-N; Bohoyo-Gil D, 2012, EUR FOOD RES TECHNOL, V235, P1055, DOI 10.1007/s00217-012-1838-0; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Choi SL, 2003, ENZYME MICROB TECH, V33, P403, DOI 10.1016/S0141-0229(03)00137-6; EVANS RW, 1982, BIOCHIM BIOPHYS ACTA, V712, P186, DOI 10.1016/0005-2760(82)90101-1; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu W, 2012, ANAL BIOANAL CHEM, V404, P3145, DOI 10.1007/s00216-012-6434-4; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Goss R, 2009, ADV PHOTOSYNTH RESP, V30, P117; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; He H, 2011, ENERG FUEL, V25, P4770, DOI 10.1021/ef201061J; Hoelzl G, 2007, PROG LIPID RES, V46, P225, DOI 10.1016/j.plipres.2007.05.001; Hu CX, 2009, J CHROMATOGR B, V877, P2836, DOI 10.1016/j.jchromb.2009.01.038; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kaiser P, 2012, J MICROBIOL METH, V88, P28, DOI 10.1016/j.mimet.2011.10.001; Khotimchenko SV, 2002, CHEM NAT COMPD+, V38, P223, DOI 10.1023/A:1020471709232; Kind T, 2012, J CHROMATOGR A, V1244, P139, DOI 10.1016/j.chroma.2012.04.074; Lamers PP, 2010, BIOTECHNOL BIOENG, V106, P638, DOI 10.1002/bit.22725; Larsen A, 2001, RAPID COMMUN MASS SP, V15, P2393, DOI 10.1002/rcm.520; Lee HS, 2006, ENZYME MICROB TECH, V39, P447, DOI 10.1016/j.enzmictec.2005.11.038; Lee MT, 2001, CHROMATOGRAPHIA, V54, P613, DOI 10.1007/BF02492187; Lu N, 2012, EUR J LIPID SCI TECH, V114, P253, DOI 10.1002/ejlt.201100248; Montero O, 2012, J BIOSCIENCES, V37, P635, DOI 10.1007/s12038-012-9234-2; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rivera S, 2011, ANAL BIOANAL CHEM, V400, P1339, DOI 10.1007/s00216-011-4825-6; Sato N, 2004, J PLANT RES, V117, P495, DOI 10.1007/s10265-004-0183-1; SATO N, 1992, BOT MAG TOKYO, V105, P185, DOI 10.1007/BF02489414; Scaife MA, 2012, BIORESOURCE TECHNOL, V111, P276, DOI 10.1016/j.biortech.2012.01.155; Sozer O, 2011, FRONT BIOSCI-LANDMRK, V16, P619, DOI 10.2741/3710; Tafreshi AH, 2009, J APPL MICROBIOL, V107, P14, DOI 10.1111/j.1365-2672.2009.04153.x; Tammam AA, 2011, AFR J BIOTECHNOL, V10, P3795; Tang HY, 2011, APPL ENERG, V88, P3324, DOI 10.1016/j.apenergy.2010.09.013; TORNABENE TG, 1983, ENZYME MICROB TECH, V5, P435, DOI 10.1016/0141-0229(83)90026-1; TOUCHSTONE JC, 1995, J CHROMATOGR B, V671, P169, DOI 10.1016/0378-4347(95)00232-8; Vallejo MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039463; VOGEL G, 1992, PLANT CELL PHYSIOL, V33, P427; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	39	50	53	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72415	10.1371/journal.pone.0072415	http://dx.doi.org/10.1371/journal.pone.0072415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039760	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600026
J	Li, J; Yan, HT; Che, JX; Bai, SR; Qiu, QM; Ren, L; Pan, F; Sun, XQ; Tian, FZ; Li, DX; Tang, LJ				Li, Jun; Yan, Hong-Tao; Che, Jian-Xiang; Bai, Shu-Rong; Qiu, Qing-Ming; Ren, Ling; Pan, Fan; Sun, Xiao-Qin; Tian, Fu-Zhou; Li, Dong-Xuan; Tang, Li-Jun			Effects of Neurolytic Celiac Plexus Block on Liver Regeneration in Rats with Partial Hepatectomy	PLOS ONE			English	Article							CARBON-DIOXIDE PNEUMOPERITONEUM; INFLAMMATORY RESPONSE SYNDROME; SURVIVAL; CANCER; MODEL; PAIN	Liver regeneration is the basic physiological process after partial hepatectomy (PH), and is important for the functional rehabilitation of the liver after acute hepatic injury. This study was designed to explore the effects of neurolytic celiac plexus block (NCPB) on liver regeneration after PH. We established a model of PH in rats, assessing hepatic blood flow, liver function, and serum CRP, TNF-alpha, IL-1 beta and IL-6 concentrations of the residuary liver after PH. Additionally, histopathological studies, immunohistochemistry, and western blotting were also performed. Our results indicated that NCPB treatment after PH improved liver regeneration and survival rates, increased hepatic blood flow, reduced hepatocyte damage, decreased the secretion and release of inflammatory cytokines, increased the expression of B cell lymphoma/leukemia-2 (Bcl-2), and decreased the expression of Bcl-2 associated X protein (Bax). Additionally, Western blotting revealed that the expression of NF-kappa B p65 and c-Jun were decreased in liver after NCPB. In conclusion, the results of our present study indicate that NCPB treatment has a favorable effect on liver regeneration after PH. We suggest that NCPB can be utilized as an effective therapeutic method to help the functional rehabilitation of the liver after acute hepatic injury or liver cancer surgery.	[Li, Jun; Bai, Shu-Rong; Ren, Ling; Pan, Fan; Sun, Xiao-Qin] Gen Hosp Chengdu Mil Command Area, Dept Anesthesia, Chengdu, Sichuan Provinc, Peoples R China; [Yan, Hong-Tao; Tian, Fu-Zhou; Li, Dong-Xuan; Tang, Li-Jun] Gen Hosp Chengdu Mil Command Area, Gen Surg Ctr PLA, Chengdu, Sichuan Provinc, Peoples R China; [Che, Jian-Xiang; Qiu, Qing-Ming] 44th Hosp PLA, Dept Anesthesia, Guiyang, Guizhou Provinc, Peoples R China		Li, DX (corresponding author), Gen Hosp Chengdu Mil Command Area, Gen Surg Ctr PLA, Chengdu, Sichuan Provinc, Peoples R China.	dongxuanligcd@126.com; lijuntanggcd@126.com			China Postdoctoral Science Foundation [20100471764]; Hospital Foundation of General Hospital of Chengdu Military Command Area [2013YG-B010]; Medical Science and Technology Research Projects of Chengdu Military Command Area [c12005]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hospital Foundation of General Hospital of Chengdu Military Command Area; Medical Science and Technology Research Projects of Chengdu Military Command Area	This work was supported by China Postdoctoral Science Foundation (No. 20100471764), Hospital Foundation of General Hospital of Chengdu Military Command Area (No. 2013YG-B010), and the Medical Science and Technology Research Projects of Chengdu Military Command Area (c12005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Bauer B, 1996, EXP TOXICOL PATHOL, V48, P415; Bockhorn M, 2007, J SURG RES, V138, P291, DOI 10.1016/j.jss.2006.07.027; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Erdek MA, 2010, PAIN MED, V11, P92, DOI 10.1111/j.1526-4637.2009.00756.x; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Garcea G, 2009, DIGEST LIVER DIS, V41, P798, DOI 10.1016/j.dld.2009.01.015; Greene AK, 2003, ANN SURG, V237, P530, DOI 10.1097/00000658-200304000-00015; Higgins GM, 1931, ARCH PATHOL, V12, P186; [姜长林 JIANG ChangLin], 2008, [中国疼痛医学杂志, Chinese Journal of Pain Medicine], V14, P233; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Li J, 2012, MOL CELL BIOCHEM, V364, P29, DOI 10.1007/s11010-011-1201-y; Li J, 2012, MOL MED REP, V5, P1099, DOI 10.3892/mmr.2012.750; Li J, 2011, WORLD J GASTROENTERO, V17, P3652, DOI 10.3748/wjg.v17.i31.3652; Marcu AC, 2006, RESUSCITATION, V71, P379, DOI 10.1016/j.resuscitation.2006.03.020; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Omari A, 2007, J LAPAROENDOSC ADV S, V17, P419, DOI 10.1089/lap.2006.0160; Shimizu H, 2005, WORLD J GASTROENTERO, V11, P7254, DOI 10.3748/wjg.v11.i46.7254; Sjowall C, 2007, CLIN CHIM ACTA, V378, P13, DOI 10.1016/j.cca.2006.12.002; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Vorenkamp KE, 2011, TECH REGION ANESTH P, V15, P28; Wang Y, 2011, PHARMAZIE, V66, P445, DOI 10.1691/ph.2011.0844; Wong GY, 2004, JAMA-J AM MED ASSOC, V291, P1092, DOI 10.1001/jama.291.9.1092; Xie ZZ, 1997, CHIN J APPL PHYSL, V13, P302	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73101	10.1371/journal.pone.0073101	http://dx.doi.org/10.1371/journal.pone.0073101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039865	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600052
J	Muto, M; Kubota, C; Tanaka, M; Satoh, A; Matsumoto, M; Yoshino, T; Tanaka, T				Muto, Masaki; Kubota, Chihiro; Tanaka, Masayoshi; Satoh, Akira; Matsumoto, Mitsufumi; Yoshino, Tomoko; Tanaka, Tsuyoshi			Identification and Functional Analysis of Delta-9 Desaturase, a Key Enzyme in PUFA Synthesis, Isolated from the Oleaginous Diatom Fistulifera	PLOS ONE			English	Article							CARRIER PROTEIN DESATURASE; MARINE PENNATE DIATOM; GENETIC-TRANSFORMATION; ACID; GENOME; BIODIESEL; OIL; PRODUCTIVITY; TOPOLOGY; REVEALS	Oleaginous microalgae are one of the promising resource of nonedible biodiesel fuel (BDF) feed stock alternatives. Now a challenge task is the decrease of the long-chain polyunsaturated fatty acids (PUFAs) content affecting on the BDF oxidative stability by using gene manipulation techniques. However, only the limited knowledge has been available concerning the fatty acid and PUFA synthesis pathways in microalgae. Especially, the function of Delta(9) desaturase, which is a key enzyme in PUFA synthesis pathway, has not been determined in diatom. In this study, 4 Delta(9) desaturase genes (fD9desA, fD9desB, fD9desC and fD9desD) from the oleaginous diatom Fistulifera were newly isolated and functionally characterized. The putative Delta(9) acyl-CoA desaturases in the endoplasmic reticulum (ER) showed 3 histidine clusters that are well-conserved motifs in the typical Delta(9) desaturase. Furthermore, the function of these Delta(9) desaturases was confirmed in the Saccharomyces cerevisiae ole1 gene deletion mutant (Delta ole1). All the putative Delta(9) acyl-CoA desaturases showed Delta(9) desaturation activity for C16:0 fatty acids; fD9desA and fD9desB also showed desaturation activity for C18:0 fatty acids. This study represents the first functional analysis of Delta(9) desaturases from oleaginous microalgae and from diatoms as the first enzyme to introduce a double bond in saturated fatty acids during PUFA synthesis. The findings will provide beneficial insights into applying metabolic engineering processes to suppressing PUFA synthesis in this oleaginous microalgal strain.	[Muto, Masaki; Kubota, Chihiro; Tanaka, Masayoshi; Yoshino, Tomoko; Tanaka, Tsuyoshi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Muto, Masaki; Tanaka, Masayoshi; Satoh, Akira; Matsumoto, Mitsufumi; Tanaka, Tsuyoshi] CREST, JST, Chiyoda Ku, Tokyo, Japan; [Satoh, Akira] Yamaha Motor Co Ltd, Ctr Technol, Res & Dev Sect, BT Dev Grp, Fukuroi, Shizuoka, Japan; [Matsumoto, Mitsufumi] Elect Power Dev Co Ltd, Biotechnol Lab, Wakamatsu Ku, Kitakyushu, Japan	Tokyo University of Agriculture & Technology; Japan Science & Technology Agency (JST); Yamaha Motor Company	Tanaka, T (corresponding author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo, Japan.	tsuyo@cc.tuat.ac.jp	Yoshino, Tomoko/E-9066-2013; Tanaka, Tsuyoshi/B-9949-2013; Tanaka, Masayoshi/O-5259-2018	Yoshino, Tomoko/0000-0002-4505-2774; Tanaka, Tsuyoshi/0000-0003-2601-2256; Tanaka, Masayoshi/0000-0002-4701-5352	JST-CREST	JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST-CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cahoon EB, 1997, PLANT MOL BIOL, V33, P1105, DOI 10.1023/A:1005821007291; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Domergue F, 2003, PLANT PHYSIOL, V131, P1648, DOI 10.1104/pp.102.018317; Domergue F, 2002, EUR J BIOCHEM, V269, P4105, DOI 10.1046/j.1432-1033.2002.03104.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Griffiths MJ, 2012, J APPL PHYCOL, V24, P989, DOI 10.1007/s10811-011-9723-y; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Itoh R, 1998, CURR GENET, V33, P165, DOI 10.1007/s002940050323; Ramos MJ, 2009, BIORESOURCE TECHNOL, V100, P261, DOI 10.1016/j.biortech.2008.06.039; KNUTZON DS, 1992, P NATL ACAD SCI USA, V89, P2624, DOI 10.1073/pnas.89.7.2624; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leung DYC, 2006, FUEL PROCESS TECHNOL, V87, P883, DOI 10.1016/j.fuproc.2006.06.003; Lim DKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040751; Liu Q, 2002, PLANT PHYSIOL, V129, P1732, DOI 10.1104/pp.001933; Lu J, 2011, ENERG ENVIRON SCI, V4, P2451, DOI 10.1039/c0ee00593b; MacKenzie DA, 2002, MICROBIOL-SGM, V148, P1725, DOI 10.1099/00221287-148-6-1725; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matsumoto M, 2010, APPL BIOCHEM BIOTECH, V161, P483, DOI 10.1007/s12010-009-8766-x; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Muto M, 2013, MAR BIOTECHNOL, V15, P48, DOI 10.1007/s10126-012-9457-0; Nascimento IA, 2013, BIOENERG RES, V6, P1, DOI 10.1007/s12155-012-9222-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Sato R, 2013, ALGAL RES UNPUB; Satoh A, 2013, BIORESOURCE TECHNOL, V137, P132, DOI [10.1016/j.biortech.2013.03.087, 10.1016/j.biortech.2]; Sforza E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038975; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Singh AK, 2011, MOL PLANT MICROBE IN, V24, P506, DOI 10.1094/MPMI-09-10-0201; STOURNAS S, 1995, J AM OIL CHEM SOC, V72, P433, DOI 10.1007/BF02636084; Tanaka T, 2011, PHOTOSYNTH RES, V109, P223, DOI 10.1007/s11120-011-9622-8; Tonon T, 2005, FEBS J, V272, P3401, DOI 10.1111/j.1742-4658.2005.04755.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tyson K. S., 2006, BIODIESEL HANDLING U; Vanhercke T, 2011, J BIOL CHEM, V286, P12860, DOI 10.1074/jbc.M110.191098; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	43	17	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73507	10.1371/journal.pone.0073507	http://dx.doi.org/10.1371/journal.pone.0073507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039966	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600083
J	Saavedra, A; Giralt, A; Arumi, H; Alberch, J; Perez-Navarro, E				Saavedra, Ana; Giralt, Albert; Arumi, Helena; Alberch, Jordi; Perez-Navarro, Esther			Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington's Disease	PLOS ONE			English	Article							PASSIVE-AVOIDANCE RESPONSE; OBJECT RECOGNITION MEMORY; OXIDE SYNTHASE ACTIVITY; SYNAPTIC PLASTICITY; MESSENGER-RNA; PHOSPHODIESTERASE INHIBITION; PROTEIN EXPRESSION; MOUSE MODEL; CAG REPEAT; SILDENAFIL	Huntington's disease (HD) patients and mouse models show learning and memory impairment associated with hippocampal dysfunction. The neuronal nitric oxide synthase/3',5'-cyclic guanosine monophosphate (nNOS/cGMP) pathway is implicated in synaptic plasticity, and in learning and memory processes. Here, we examined the nNOS/cGMP pathway in the hippocampus of HD mice to determine whether it can be a good therapeutic target for cognitive improvement in HD. We analyzed hippocampal nNOS and phosphodiesterase (PDE) 5 and 9 levels in R6/1 mice, and cGMP levels in the hippocampus of R6/1, R6/2 and Hdh(Q7/Q111) mice, and of HD patients. We also investigated whether sildenafil, a PDE5 inhibitor, could improve cognitive deficits in R6/1 mice. We found that hippocampal cGMP levels were 3-fold lower in 12-week-old R6/1 mice, when they show deficits in object recognition memory and in passive avoidance learning. Consistent with hippocampal cGMP levels, nNOS levels were down-regulated, while there were no changes in the levels of PDE5 and PDE9 in R6/1 mice. A single intraperitoneal injection of sildenafil (3 mg/Kg) immediately after training increased cGMP levels, and improved memory in R6/1 mice, as assessed by using the novel object recognition and the passive avoidance test. Importantly, cGMP levels were also reduced in R6/2 mouse and human HD hippocampus. Therefore, the regulation of hippocampal cGMP levels can be a suitable treatment for cognitive impairment in HD.	[Saavedra, Ana; Giralt, Albert; Arumi, Helena; Alberch, Jordi; Perez-Navarro, Esther] Univ Barcelona, Fac Med, Dept Cellular Biol, Barcelona 7, Spain; [Saavedra, Ana; Giralt, Albert; Arumi, Helena; Alberch, Jordi; Perez-Navarro, Esther] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Saavedra, Ana; Giralt, Albert; Arumi, Helena; Alberch, Jordi; Perez-Navarro, Esther] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED	Perez-Navarro, E (corresponding author), Univ Barcelona, Fac Med, Dept Cellular Biol, Barcelona 7, Spain.	estherperez@ub.edu	Giralt, Albert/AAA-5308-2020; Alberch, Jordi/K-5702-2014; Giralt, Albert/M-7672-2015; Perez-Navarro, Esther/F-4749-2016	Alberch, Jordi/0000-0002-8684-2721; Giralt, Albert/0000-0001-5334-0963; Perez-Navarro, Esther/0000-0001-9165-6539	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain [PI10/01072]; Redes Tematicas de Investigacion Cooperativa Sanitaria [RD06/0010/0006]; Ministerio de Economia y Competitividad, Spain [SAF2011-29507]; Generalitat de Catalunya, Spain [2009SGR-00326]; Ministerio de Economia y Competitividad, Spain (Juan de la Cierva subprograme) [JCI-2010-08207, CAPLE2009-0089]	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Redes Tematicas de Investigacion Cooperativa Sanitaria; Ministerio de Economia y Competitividad, Spain; Generalitat de Catalunya, Spain(Generalitat de Catalunya); Ministerio de Economia y Competitividad, Spain (Juan de la Cierva subprograme)	This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain (PI10/01072 to EP-N), Redes Tematicas de Investigacion Cooperativa Sanitaria (grant number RD06/0010/0006), Ministerio de Economia y Competitividad, Spain (SAF2011-29507 to JA), and Generalitat de Catalunya, Spain (2009SGR-00326 to JA). AS and AG and are supported by Ministerio de Economia y Competitividad, Spain (Juan de la Cierva subprograme, JCI-2010-08207 and CAPLE2009-0089, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratti CM, 1999, BEHAV PHARMACOL, V10, P731, DOI 10.1097/00008877-199912000-00004; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bernabeu R, 1996, NEUROREPORT, V7, P585, DOI 10.1097/00001756-199601310-00050; Bernabeu R, 1997, NEUROREPORT, V8, P2221, DOI 10.1097/00001756-199707070-00026; BERNABEU R, 1995, NEUROREPORT, V6, P1498, DOI 10.1097/00001756-199507310-00008; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Boolell M, 1996, Int J Impot Res, V8, P47; Cauli O, 2010, NEUROSCIENCE, V171, P506, DOI 10.1016/j.neuroscience.2010.08.065; Cowin RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028409; Cuadrado-Tejedor M, 2011, BRIT J PHARMACOL, V164, P2029, DOI 10.1111/j.1476-5381.2011.01517.x; Deckel AW, 2002, NEUROREPORT, V13, P707, DOI 10.1097/00001756-200204160-00034; Deckel AW, 2002, BRAIN RES, V939, P76, DOI 10.1016/S0006-8993(02)02550-7; Deckel AW, 2001, BRAIN RES, V919, P70, DOI 10.1016/S0006-8993(01)03000-1; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Devan BD, 2004, PHARMACOL BIOCHEM BE, V79, P691, DOI 10.1016/j.pbb.2004.09.019; Domek-Lopacinska K, 2008, BRAIN RES, V1216, P68, DOI 10.1016/j.brainres.2008.02.108; Domek-Lopacinska KU, 2010, MOL NEUROBIOL, V41, P129, DOI 10.1007/s12035-010-8104-x; Erceg S, 2005, HEPATOLOGY, V41, P299, DOI 10.1002/hep.20565; Furini CR, 2010, HIPPOCAMPUS, V20, P672, DOI 10.1002/hipo.20656; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Giralt A, 2009, NEUROSCIENCE, V158, P1234, DOI 10.1016/j.neuroscience.2008.11.024; Giralt A, 2012, J HUNTINGTONS DIS, V1, P155, DOI 10.3233/JHD-120023; Giralt A, 2011, HUM MOL GENET, V20, P4232, DOI 10.1093/hmg/ddr351; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Hosseini-Sharifabad A, 2012, PHARMACOL BIOCHEM BE, V101, P311, DOI 10.1016/j.pbb.2012.01.017; Jarabek BR, 2004, BRAIN, V127, P505, DOI 10.1093/brain/awh058; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Kots Alexander Y., 2009, V191, P1, DOI 10.1007/978-3-540-68964-5_1; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Lorenzini CGA, 1997, BRAIN RES, V768, P242, DOI 10.1016/S0006-8993(97)00651-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marte A, 2008, J NEUROSCI RES, V86, P3338, DOI 10.1002/jnr.21788; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Norris PJ, 1996, NEUROSCIENCE, V72, P1037, DOI 10.1016/0306-4522(95)00596-X; Orejana L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.018; Palmeri A, 2013, BEHAV BRAIN RES, V240, P11, DOI 10.1016/j.bbr.2012.10.060; Patil CS, 2006, PHARMACOL REP, V58, P373; Patil CS, 2004, PHARMACOLOGY, V72, P190, DOI 10.1159/000080104; Perez-Severiano F, 2002, BRAIN RES, V951, P36, DOI 10.1016/S0006-8993(02)03102-5; Prickaerts J, 2005, PSYCHOPHARMACOLOGY, V177, P381, DOI 10.1007/s00213-004-1967-7; Prickaerts J, 2002, EUR J PHARMACOL, V436, P83, DOI 10.1016/S0014-2999(01)01614-4; Prickaerts J, 2002, NEUROSCIENCE, V113, P351, DOI 10.1016/S0306-4522(02)00199-9; Puerta E, 2009, J NEUROCHEM, V108, P755, DOI 10.1111/j.1471-4159.2008.05825.x; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Puzzo Daniela, 2008, Neuropsychiatr Dis Treat, V4, P371; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Rose GM, 2005, CURR PHARM DESIGN, V11, P3329, DOI 10.2174/138161205774370799; Rue L, 2013, NEUROBIOL DIS, V52, P219, DOI 10.1016/j.nbd.2012.12.008; Saavedra A, 2011, J NEUROSCI, V31, P8150, DOI 10.1523/JNEUROSCI.3446-10.2011; Shim YS, 2011, INT J IMPOT RES, V23, P109, DOI 10.1038/ijir.2011.13; Siuciak JA, 2008, CNS DRUGS, V22, P983, DOI 10.2165/0023210-200822120-00002; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Xu Y, 2011, HANDB EXP PHARMACOL, V204, P447, DOI 10.1007/978-3-642-17969-3_19; Zhang JF, 2013, BEHAV BRAIN RES, V250, P230, DOI 10.1016/j.bbr.2013.05.017; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	59	47	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73664	10.1371/journal.pone.0073664	http://dx.doi.org/10.1371/journal.pone.0073664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040016	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600092
J	Scott, JC; Klein, BA; Duran-Pinedo, A; Hu, LD; Duncan, MJ				Scott, Jodie C.; Klein, Brian A.; Duran-Pinedo, Ana; Hu, Linden; Duncan, Margaret J.			A Two-Component System Regulates Hemin Acquisition in Porphyromonas gingivalis	PLOS ONE			English	Article							CYSTEINE PROTEINASE; RESPONSE REGULATOR; EPITHELIAL-CELLS; GENOME SEQUENCE; OUTER-MEMBRANE; STRAIN W83; GENES; IDENTIFICATION; HEMOGLOBIN; TRANSPORTERS	Porphyromonas gingivalis is a Gram-negative oral anaerobe associated with infection of the periodontia. The organism has a small number of two-component signal transduction systems, and after comparing genome sequences of strains W83 and ATCC 33277 we discovered that the latter was mutant in histidine kinase (PGN_0752), while the cognate response regulator (PGN_0753) remained intact. Microarray-based transcriptional profiling and ChIP-seq assays were carried out with an ATCC 33277 transconjugant containing the functional histidine kinase from strain W83 (PG0719). The data showed that the regulon of this signal transduction system contained genes that were involved in hemin acquisition, including gingipains, at least three transport systems, as well as being self-regulated. Direct regulation by the response regulator was confirmed by electrophoretic mobility shift assays. In addition, the system appears to be activated by hemin and the regulator acts as both an activator and repressor.	[Scott, Jodie C.; Duran-Pinedo, Ana; Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Klein, Brian A.] Tufts Univ, Sackler Sch Biomed Sci, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Hu, Linden] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	Harvard University; Forsyth Institute; Tufts University; Tufts Medical Center	Duncan, MJ (corresponding author), Forsyth Inst, Dept Microbiol, Cambridge, MA USA.	mduncan@forsyth.org	Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558; Duran-Pinedo, Ana/0000-0001-5648-6597; Klein, Brian/0000-0002-7233-2114	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01 DE015931, F31 DE02249, R21 DE016859]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015931, F31DE022491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016859] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award numbers R01 DE015931 (MD), F31 DE02249 (BK), and R21 DE016859 (LTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Chen T, 2004, MICROB PATHOGENESIS, V36, P205, DOI 10.1016/j.micpath.2003.12.001; Dashper SG, 2000, J BACTERIOL, V182, P6456, DOI 10.1128/JB.182.22.6456-6462.2000; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Dietz P, 2002, J BACTERIOL, V184, P350, DOI 10.1128/JB.184.2.350-362.2002; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Hirano T, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00079; Hosogi Y, 2005, INFECT IMMUN, V73, P2327, DOI 10.1128/IAI.73.4.2327-2335.2005; Kiyama-Kishikawa Michiko, 2005, J Oral Sci, V47, P191, DOI 10.2334/josnusd.47.191; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Lewis JP, 1998, INFECT IMMUN, V66, P3035, DOI 10.1128/IAI.66.7.3035-3042.1998; Matsumoto-Mashimo C, 2004, RES MICROBIOL, V155, P455, DOI 10.1016/j.resmic.2004.03.001; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nakayama K, 1998, MOL MICROBIOL, V27, P51, DOI 10.1046/j.1365-2958.1998.00656.x; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Nishikawa K, 2004, MOL MICROBIOL, V54, P546, DOI 10.1111/j.1365-2958.2004.04291.x; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Okamoto K, 1998, J BIOL CHEM, V273, P21225, DOI 10.1074/jbc.273.33.21225; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Slakeski N, 2000, ORAL MICROBIOL IMMUN, V15, P388, DOI 10.1034/j.1399-302x.2000.150609.x; Smalley JW, 2006, MICROBIOL-SGM, V152, P1839, DOI 10.1099/mic.0.28835-0; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989	36	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73351	10.1371/journal.pone.0073351	http://dx.doi.org/10.1371/journal.pone.0073351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039921	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600066
J	Xiao, J; Zhou, YC; Lai, H; Lei, S; Chi, LH; Mo, XW				Xiao, Jun; Zhou, Yongchun; Lai, Hao; Lei, Shi; Chi, Lisa H.; Mo, Xianwei			Transcription Factor NF-Y Is a Functional Regulator of the Transcription of Core Clock Gene Bmal1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN TRANSCRIPTION; SP1; PROMOTER	The circadian clock enables organisms to adjust to daily environmental changes and synchronize multiple molecular, biochemical, physiological, and behavioral processes accordingly. In mammalian clock work, Bmal1 is the most important core clock gene, which works with another core clock gene Clock to drive the expression of other clock genes and clock-controlled genes. However, the regulation of Bmal1 has not been fully understood. This work was aimed at identifying the positive regulator(s) of Bmal1 transcription. A series of 5' deletion reporter constructs was generated, and binding site mutations of mouse Bmal1 promoter fragments were cloned into pGL3-basic and pGL3(R2.1)-basic plasmids and transfected into NIH 3T3 cells. Luciferase activity was either measured 48 h after transfection or recorded for 4 days after serum shock. DNA affinity precipitation assay was used to detect the transcription factors binding to Bmal1 promoter. Small interfering RNA against nuclear factor Y, subunit A (NF-YA) and dominant negative NF-YA were employed to study the role of NF-Y in Bmal1 transcription regulation. Deletion and mutation analyses identified two clusters of CCAAT/GC-boxes at the proximal region of Bmal1 promoter as the activating cis-elements. Bmal1 promoter activity was up-regulated by NF-Y and/or Sp1 and repressed by dominant negative NF-YA or siRNA against NF-YA. The activation of Bmal1 promoter activity by NF-Y and Sp1 was inhibited by Rev-Erb alpha. DNA affinity precipitation assay showed that NF-Y and Sp1 bound to the two CCAAT/GC clusters of Bmal1 promoter. These results indicate that NF-Y is a functional activator of Bmal1 transcription and it cooperates with Sp1 and Rev-Erb alpha to generate the daily cycle of Bmal1 expression.	[Xiao, Jun; Lai, Hao; Mo, Xianwei] Guangxi Med Univ, Dept Gastrointestinal Surg, Tumour Hosp, Nanning 530021, Guangxi, Peoples R China; [Zhou, Yongchun] Guigang City Peoples Hosp, Dept Gastrointestinal Surg, Guigang 537100, Guangxi Autonom, Peoples R China; [Lei, Shi] Chi Sci, Jiangyin 214434, Jiangsu, Peoples R China; [Chi, Lisa H.] CHI Sci Inc, Maynard, MA 01754 USA	Guangxi Medical University	Lei, S (corresponding author), Chi Sci, 85 Shashan Rd, Jiangyin 214434, Jiangsu, Peoples R China.	shi.lei@chiscientific.cn; lyzlyynanning@aliyun.com						Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Armengol S, 2013, BIOCHIMIE, V95, P735, DOI 10.1016/j.biochi.2012.10.029; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032590; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Smith JEH, 2011, NEW SYNTH HIST LIB, V67, P1, DOI 10.1007/978-94-007-0041-3_1; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wu YF, 2010, ACTA MED OKAYAMA, V64, P95	19	12	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31930	31936		10.1074/jbc.M113.507038	http://dx.doi.org/10.1074/jbc.M113.507038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24030830	Green Published, hybrid			2022-12-25	WOS:000330596200045
J	Chu, PY; Cheng, CJ; Wu, YC; Fang, YW; Chau, T; Uchida, S; Sasaki, S; Yang, SS; Lin, SH				Chu, Pei-Yi; Cheng, Chih-Jen; Wu, Yi-Chang; Fang, Yu-Wei; Chau, Tom; Uchida, Shinichi; Sasaki, Sei; Yang, Sung-Sen; Lin, Shih-Hua			SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation	PLOS ONE			English	Article							NA-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; ALANINE-RICH KINASE; KELCH-LIKE 3; GITELMAN-SYNDROME; BLOOD-PRESSURE; MOLECULAR PATHOGENESIS; INHERITED HYPERTENSION; PROTEIN-KINASES; REGULATE NKCC1	Stimulation of the OSR1 (Oxidative stress-responsive kinase-1)/SPAK [STE20 (sterile 20)/SPS1-related proline/alanine-rich kinase]-NCC (Na+-Cl- cotransporter) signaling cascade plays an important role in the WNK [With-No-Lysine (K)] kinase 4 D561A knock-in mouse model of pseudohypoaldosteronism type II (PHA II) characterized by salt-sensitive hypertension and hyperkalemia. The aim of this study was to investigate the respective roles of Osr1 and Spak in the pathogenesis of PHA II in vivo. Wnk4(D561A/+) mice were crossed with kidney tubule-specific (KSP) Osr1 knockout (KSP-Osr1(-/-)) and Spak knockout (Spak(-/-)) mice. Blood pressure, plasma and urine biochemistries, and the relevant protein expression in the kidneys were examined. Wnk4(D561A/+), KSP-Osr1(-/-), and Spak(-/-) mice recapitulated the phenotypes of PHA II, Bartter-like syndrome, and Gitelman syndrome, respectively. Wnk4(D561A/+). KSP-Osr1(-/-) remained phenotypically PHA II while Wnk4(D561A/+). Spak(-/-) mice became normotensive and lacked the PHA II phenotype. Phosphorylated Spak and Ncc were similarly increased in both Wnk4(D561A/+) and Wnk4(D561A/+). KSP-Osr1(-/-) mice while phosphorylated Ncc normalized in Wnk4(D561A/+). Spak(-/-) mice. Furthermore, Wnk4(D561A/+). KSP-Osr1(-/-) mice exhibited exaggerated salt excretion in response to thiazide diuretics while Wnk4(D561A/+). Spak(-/-) mice exhibited normal responses. Wnk4(D561A/+). Spak (-/-). KSP-Osr1(-/-) triple mutant mice had low blood pressure and diminished phosphorylated Ncc. Both SPAK and OSR1 are important in the maintenance of blood pressure but activation of SPAK-NCC plays the dominant role in PHA II. SPAK may be a therapeutic target for disorders with salt-sensitive hypertension related to WNK4 activation.	[Chu, Pei-Yi; Fang, Yu-Wei; Yang, Sung-Sen; Lin, Shih-Hua] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Cheng, Chih-Jen; Yang, Sung-Sen; Lin, Shih-Hua] Triserv Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Wu, Yi-Chang] Taoyuan Armed Forces Gen Hosp, Tao Yuan, Taiwan; [Fang, Yu-Wei] Shin Kong Wu Ho Su Mem Hosp, Div Nephrol, Taipei, Taiwan; [Chau, Tom] Providence St Vincent Med Ctr, Dept Med, Portland, OR USA; [Uchida, Shinichi; Sasaki, Sei] Tokyo Med & Dent Univ, Grad Sch Med, Dept Nephrol, Tokyo, Japan	National Defense Medical Center; Tri-Service General Hospital; Shin Kong Wu Ho Su Memorial Hospital; Tokyo Medical & Dental University (TMDU)	Yang, SS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	sungsenyang@hotmail.com; l521116@gamil.com	Cheng, Chih-Jen/AAM-3305-2021		NSC, Taiwan [NSC-100-2314-B-016-018-MY3, NSC-100-2314-B-016-019-MY3]; Research Fund of Tri-Service General Hospital [TSGH-C-101-113]; Japan-Taiwan Joint Research Program, Interchange Association, Japan	NSC, Taiwan(Ministry of Science and Technology, Taiwan); Research Fund of Tri-Service General Hospital; Japan-Taiwan Joint Research Program, Interchange Association, Japan	This study was supported in part by a grant from the NSC, Taiwan (NSC-100-2314-B-016-018-MY3; NSC-100-2314-B-016-019-MY3) and by a grant from the Research Fund of Tri-Service General Hospital (TSGH-C-101-113), and Japan-Taiwan Joint Research Program, Interchange Association, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Bergaya S, 2012, CURR OPIN NEPHROL HY, V21, P39, DOI 10.1097/MNH.0b013e32834d2fde; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Castaneda-Bueno M, 2012, P NATL ACAD SCI US; Chiga M, 2011, J CELL SCI, V124, P1391, DOI 10.1242/jcs.084111; Cruz DN, 2001, KIDNEY INT, V59, P710, DOI 10.1046/j.1523-1755.2001.059002710.x; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; Golbang AP, 2005, HYPERTENSION, V46, P295, DOI 10.1161/01.HYP.0000174326.96918.d6; Gong H, 2008, ENDOCRINE, V33, P230, DOI 10.1007/s12020-008-9084-8; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Kamide K, 2004, AM J HYPERTENS, V17, P446, DOI 10.1016/j.amjhyper.2003.12.020; Lemmink HH, 1998, KIDNEY INT, V54, P720, DOI 10.1046/j.1523-1755.1998.00070.x; Lin SH, 2005, J CLIN ENDOCR METAB, V90, P2500, DOI 10.1210/jc.2004-1905; Lin SH, 2004, AM J KIDNEY DIS, V43, P304, DOI 10.1053/j.ajkd.2003.10.018; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Liu Z, 2011, HUM MOL GENET, V20, P855, DOI 10.1093/hmg/ddq525; Louis-Dit-Picard H, 2012, NAT GENET, V44, P609, DOI 10.1038/ng0512-609; Mastroianni N, 1996, AM J HUM GENET, V59, P1019; Mayan H, 2002, J CLIN ENDOCR METAB, V87, P3248, DOI 10.1210/jc.87.7.3248; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Monkawa T, 2000, J AM SOC NEPHROL, V11, P65, DOI 10.1681/ASN.V11165; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Ohno M, 2011, HISTOCHEM CELL BIOL, V136, P25, DOI 10.1007/s00418-011-0827-x; Ohta A, 2013, BIOCH J; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Reungjui S, 2007, KIDNEY INT, V72, P1483, DOI 10.1038/sj.ki.5002564; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sohara E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024277; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Susa K, 2012, CLIN EXP NEPHROL; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; van der Lubbe N, 2012, PFLUGERS ARCH; van der Lubbe N, 2011, KIDNEY INT, V79, P66, DOI 10.1038/ki.2010.290; VELAZQUEZ H, 1986, AM J PHYSIOL, V250, P1013, DOI 10.1152/ajprenal.1986.250.6.F1013; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wakabayashi M, 2013, CELL REP; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; [杨世凤 Yang Shifeng], 2011, [振动、测试与诊断, Journal of Vibration, Measurement and Diagnosis], V31, P11; Yang SS, 2005, BIOCHEM BIOPH RES CO, V330, P410, DOI 10.1016/j.bbrc.2005.02.172; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yang SS, 2010, HUM MUTAT, V31, P1304, DOI 10.1002/humu.21364; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Yang SS, 2010, ENDOCRINOLOGY, V151, P1829, DOI 10.1210/en.2009-0951; Zhang C, 2011, NEPHRON PHYSIOL, V118, pP53, DOI 10.1159/000321879; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275	60	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72969	10.1371/journal.pone.0072969	http://dx.doi.org/10.1371/journal.pone.0072969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039833	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500019
J	Schutzer, SE; Angel, TE; Liu, T; Schepmoes, AA; Xie, F; Bergquist, J; Vecsei, L; Zadori, D; Camp, DG; Holland, BK; Smith, RD; Coyle, PK				Schutzer, Steven E.; Angel, Thomas E.; Liu, Tao; Schepmoes, Athena A.; Xie, Fang; Bergquist, Jonas; Vecsei, Laszlo; Zadori, Denes; Camp, David G., II; Holland, Bart K.; Smith, Richard D.; Coyle, Patricia K.			Gray Matter Is Targeted in First-Attack Multiple Sclerosis	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CLINICALLY ISOLATED SYNDROMES; ACCURATE MASS; PROTEIN IDENTIFICATIONS; PEPTIDE IDENTIFICATION; AXONAL REGENERATION; NOGO-A; CHROMATOGRAPHY; PROTEOMICS; STRATEGY	The cause of multiple sclerosis (MS), its driving pathogenesis at the earliest stages, and what factors allow the first clinical attack to manifest remain unknown. Some imaging studies suggest gray rather than white matter may be involved early, and some postulate this may be predictive of developing MS. Other imaging studies are in conflict. To determine if there was objective molecular evidence of gray matter involvement in early MS we used high-resolution mass spectrometry to identify proteins in the cerebrospinal fluid (CSF) of first-attack MS patients (two independent groups) compared to established relapsing remitting (RR) MS and controls. We found that the CSF proteins in first-attack patients were differentially enriched for gray matter components (axon, neuron, synapse). Myelin components did not distinguish these groups. The results support that gray matter dysfunction is involved early in MS, and also may be integral for the initial clinical presentation.	[Schutzer, Steven E.; Holland, Bart K.] Rutgers State Univ, Sch Med, Dept Med, Newark, NJ 07102 USA; [Schutzer, Steven E.; Holland, Bart K.] Rutgers State Univ, Sch Med, Dept Epidemiol & Biostat, Newark, NJ 07102 USA; [Angel, Thomas E.; Liu, Tao; Schepmoes, Athena A.; Xie, Fang; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Bergquist, Jonas] Uppsala Univ, Analyt Chem & SciLife Lab, Dept Chem, Biomed Ctr, Uppsala, Sweden; [Vecsei, Laszlo; Zadori, Denes] Hungarian Acad Sci, Albert Szent Gyorgyi Clin Ctr, Fac Med, Szeged, Hungary; [Vecsei, Laszlo; Zadori, Denes] Hungarian Acad Sci, Neurosci Res Grp, Szeged, Hungary; [Vecsei, Laszlo; Zadori, Denes] Univ Szeged, Szeged, Hungary; [Coyle, Patricia K.] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; United States Department of Energy (DOE); Pacific Northwest National Laboratory; SciLifeLab; Uppsala University; Hungarian Academy of Sciences; Szeged University; Hungarian Academy of Sciences; Neuroscience Research Group, HAS; Szeged University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Schutzer, SE (corresponding author), Rutgers State Univ, Sch Med, Dept Med, Newark, NJ 07102 USA.	schutzer@njms.rutgers.edu	Vecsei, Laszlo/ABA-6137-2021; Smith, Richard D/J-3664-2012; Vécsei, László/B-2066-2010; Bergquist, Jonas/C-5894-2015	Smith, Richard D/0000-0002-2381-2349; Vécsei, László/0000-0001-8037-3672; Zadori, Denes/0000-0003-0749-7980; Bergquist, Jonas/0000-0002-4597-041X	National Institutes of Health, through NIAID [AI088765]; NIDA [DA021071]; National Center for Research Resources [5 P41 RR018522-10]; National Institute of General Medical Sciences from the National Institutes of Health and Laboratory Directed Research and Development program at Pacific Northwest National Laboratory [8 P41 GM103493-10]; Swedish Research Council [621-2008-3562, 621-2011-4423]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021071] Funding Source: NIH RePORTER	National Institutes of Health, through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health and Laboratory Directed Research and Development program at Pacific Northwest National Laboratory; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institutes of Health, through NIAID (grant AI088765), NIDA (grant DA021071), National Center for Research Resources (5 P41 RR018522-10), and the National Institute of General Medical Sciences (8 P41 GM103493-10) from the National Institutes of Health and Laboratory Directed Research and Development program at Pacific Northwest National Laboratory. PNNL proteomics research described was performed in the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy/BER national scientific user facility at Pacific Northwest National Laboratory, operated by Battelle Memorial Institute; the Swedish Research Council (621-2008-3562, 621-2011-4423), Uppsala Berzelii Technology Center for Neurodiagnostics, SciLifeLab-Uppsala. The authors acknowledge assistance of Peter Klivenyi, Krisztina Bencsik, Judit Fuvesi, Cecilia Rajda. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabrese M, 2011, NEUROLOGY, V77, P257, DOI 10.1212/WNL.0b013e318220abd4; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Dhaunchak AS, 2012, ANN NEUROL, V71, P601, DOI 10.1002/ana.22693; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Fu QL, 2011, INVEST OPHTH VIS SCI, V52, P8374, DOI 10.1167/iovs.11-7667; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Hulst HE, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-153; Iannucci G, 1999, J NEUROL SCI, V171, P121, DOI 10.1016/S0022-510X(99)00259-2; Jurewicz A, 2007, NEUROLOGY, V68, P283, DOI 10.1212/01.wnl.0000252357.30287.1d; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kroksveen AC, 2012, J PROTEOMICS; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Miller DH, 2012, LANCET NEUROL, V11, P157, DOI 10.1016/S1474-4422(11)70274-5; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng XM, 2010, J BIOL CHEM, V285, P2783, DOI 10.1074/jbc.M109.046425; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Stanley JR, 2011, ANAL CHEM, V83, P6135, DOI 10.1021/ac2009806; Steinman L, 2009, P NATL ACAD SCI USA, V106, P8083, DOI 10.1073/pnas.0903377106; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Xie F, 2011, J BIOL CHEM, V286, P25443, DOI 10.1074/jbc.R110.199703; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	36	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e66117	10.1371/journal.pone.0066117	http://dx.doi.org/10.1371/journal.pone.0066117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039694	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600001
J	Zhang, SC; Ma, PD; Yang, DF; Li, WJ; Liang, ZS; Liu, Y; Liu, FH				Zhang, Shuncang; Ma, Pengda; Yang, Dongfeng; Li, Wenjing; Liang, Zongsuo; Liu, Yan; Liu, Fenghua			Cloning and Characterization of a Putative R2R3 MYB Transcriptional Repressor of the Rosmarinic Acid Biosynthetic Pathway from Salvia miltiorrhiza	PLOS ONE			English	Article							CHINESE MEDICINAL PREPARATIONS; SWISS-MODEL; GENE FAMILY; FUNCTIONAL-CHARACTERIZATION; SECONDARY METABOLISM; PHENOLIC-ACIDS; HIGHER-PLANTS; TANSHINONE-I; ARABIDOPSIS; PROTEIN	Salvia miltiorrhiza Bunge is one of the most renowned traditional medicinal plants in China. Phenolic acids that are derived from the rosmarinic acid pathway, such as rosmarinic acid and salvianolic acid B, are important bioactive components in S. miltiorrhiza. Accumulations of these compounds have been reported to be induced by various elicitors, while little is known about transcription factors that function in their biosynthetic pathways. We cloned a subgroup 4 R2R3 MYB transcription factor gene (SmMYB39) from S. miltiorrhiza and characterized its roles through overexpression and RNAi-mediated silencing. As the results showed, the content of 4-coumaric acid, rosmarinic acid, salvianolic acid B, salvianolic acid A and total phenolics was dramatically decreased in SmMYB39-overexpressing S. miltiorrhiza lines while being enhanced by folds in SmMYB39-RNAi lines. Quantitative real-time PCR and enzyme activities analyses showed that SmMYB39 negatively regulated transcripts and enzyme activities of 4-hydroxylase (C4H) and tyrosine aminotransferase (TAT). These data suggest that SmMYB39 is involved in regulation of rosmarinic acid pathway and acts as a repressor through suppressing transcripts of key enzyme genes.	[Zhang, Shuncang; Ma, Pengda; Li, Wenjing; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Yang, Dongfeng; Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Yan; Liu, Fenghua] Tianjin Tasly Modern Tradit Chinese Med Resources, Tianjin, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China.	liangzs@ms.iswc.ac.cn	Zhang, Shuncang/A-7021-2013	Zhang, Shuncang/0000-0001-6856-0408	National Natural Science Foundation of China [81373908]; Ph.D. Programs Foundation of Ministry of Education of China [20110204110028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	The work has been supported by the National Natural Science Foundation of China (Grant No. 81373908; http://www.nsfc.gov.cn/Portal0/default152.htm) and the Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20110204110028; http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Carra A, 2005, ACTA HORTIC, P529, DOI 10.17660/ActaHortic.2005.689.65; Chen H, 2001, ENZYME MICROB TECH, V28, P100, DOI 10.1016/S0141-0229(00)00284-2; China Pharmacopoeia Committee, 2010, CHIN PHARM PEOPL REP, V71; Colquhoun TA, 2011, J EXP BOT, V62, P1133, DOI 10.1093/jxb/erq342; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Don MJ, 2006, PHYTOCHEMISTRY, V67, P497, DOI 10.1016/j.phytochem.2005.11.005; ELLIS BE, 1970, BIOCHEM J, V118, P291, DOI 10.1042/bj1180291; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Gao JJ, 2011, PLANT CELL TISS ORG, V106, P235, DOI 10.1007/s11240-010-9912-4; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heichel, 1996, OXYGENIC PHOTOSYNTHE, P69, DOI DOI 10.1007/0-306-48127-8; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Laitinen RAE, 2008, J EXP BOT, V59, P3691, DOI 10.1093/jxb/ern216; LAMB CJ, 1975, ANAL BIOCHEM, V68, P554, DOI 10.1016/0003-2697(75)90651-X; Legay S, 2007, PLANT SCI, V173, P542, DOI 10.1016/j.plantsci.2007.08.007; Li LN, 1998, PURE APPL CHEM, V70, P547, DOI 10.1351/pac199870030547; Liang ZS, 2012, PLANT CELL REP, V31, P873, DOI 10.1007/s00299-011-1208-6; Liu AH, 2006, J PHARMACEUT BIOMED, V41, P48, DOI 10.1016/j.jpba.2005.10.021; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Liu XY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-287; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nizamutdinova IT, 2008, INT J ONCOL, V33, P485, DOI 10.3892/ijo_00000031; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; PETERSEN M, 1993, PLANTA, V189, P10, DOI 10.1007/BF00201337; Petersen M, 2009, PHYTOCHEMISTRY, V70, P1663, DOI 10.1016/j.phytochem.2009.05.010; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Sandorf I, 2002, PLANTA, V216, P173, DOI 10.1007/s00425-002-0888-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Shi ZH, 2005, J PHARMACEUT BIOMED, V37, P481, DOI 10.1016/j.jpba.2004.11.015; Song J, 2011, J PLANT RES, V124, P183, DOI 10.1007/s10265-010-0350-5; Song YH, 2008, INT J BIOL MACROMOL, V43, P170, DOI 10.1016/j.ijbiomac.2008.04.012; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Wan JMF, 2006, INT IMMUNOPHARMACOL, V6, P750, DOI 10.1016/j.intimp.2005.11.008; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Wu JY, 2008, APPL MICROBIOL BIOT, V78, P441, DOI 10.1007/s00253-007-1332-y; Xiao Y, 2010, BIOSCIENCE REP, V30, P33, DOI 10.1042/BSR20080124; Xu H, 2010, J MED PLANTS RES, V4, P2591; Yan Q, 2006, PLANT SCI, V170, P853, DOI 10.1016/j.plantsci.2005.12.004; Yan YP, 2007, PLANT CELL TISS ORG, V88, P175, DOI 10.1007/s11240-006-9187-y; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zhang YA, 2010, J AGR FOOD CHEM, V58, P12168, DOI 10.1021/jf103203e; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	54	62	69	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73259	10.1371/journal.pone.0073259	http://dx.doi.org/10.1371/journal.pone.0073259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039895	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600022
J	Cloke, T; Munder, M; Bergin, P; Herath, S; Modolell, M; Taylor, G; Muller, I; Kropf, P				Cloke, Tom; Munder, Markus; Bergin, Philip; Herath, Shanthi; Modolell, Manuel; Taylor, Graham; Mueller, Ingrid; Kropf, Pascale			Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients	PLOS ONE			English	Article							ARGINASE ACTIVITY; ARGININE; EXPRESSION; DISEASE	We have recently identified a novel population of activated low-density granulocytes (LDGs) in peripheral blood mononuclear cells of HIV seropositive patients. LDGs have a similar morphology to normal density granulocytes (NDGs), but are phenotypically different. Here we measured the expression levels of different phenotypic markers of granulocytes in the blood of HIV seropositive patients at different stages of HIV infection to determine whether the phenotype of NDGs and LDGs are affected by disease severity. Our results reveal that the phenotype of NDGs, but not that of LDGs, varies according to the severity of the disease.	[Cloke, Tom; Herath, Shanthi; Mueller, Ingrid; Kropf, Pascale] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London, England; [Munder, Markus] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Bergin, Philip] Univ London Imperial Coll Sci Technol & Med, Fac Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England; [Modolell, Manuel] Max Planck Inst Immunobiol & Epigenet, Dept Cellular Immunol, Freiburg, Germany; [Taylor, Graham] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, London, England	Imperial College London; Johannes Gutenberg University of Mainz; Imperial College London; International AIDS Vaccine Initiative; Max Planck Society; Imperial College London	Kropf, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London, England.	p.kropf@imperial.ac.uk	Munder, Markus/K-6737-2013	Bergin, Philip/0000-0001-5522-8350	Wellcome Trust [07664/Z/05/Z]; Imperial College London MB/PhD fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College London MB/PhD fellowship	This work was supported by a grant from The Wellcome Trust (07664/Z/05/Z, PK) and TC is a recipient of a Imperial College London MB/PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEBE T, 2013, PLOS NTD IN PRESS; Abebe T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001684; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; Cloke TE, 2010, J INFECT DIS, V202, P374, DOI 10.1086/653736; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; DRESCHER B, 2012, VIRUS RES; ELBIM C, 1994, BLOOD, V84, P2759, DOI 10.1182/blood.V84.8.2759.bloodjournal8482759; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; KUIJPERS TW, 1991, BLOOD, V78, P1105; Kuritzkes DR, 2000, CLIN INFECT DIS, V30, P256, DOI 10.1086/313642; Martin-Martin B, 2000, BLOOD, V96, P2574; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Munder M, 2009, EUR J IMMUNOL, V39, P2161, DOI 10.1002/eji.200839041; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Popovic PJ, 2007, J NUTR, V137, p1681S, DOI 10.1093/jn/137.6.1681S; Rotondo R, 2011, J LEUKOCYTE BIOL, V89, P721, DOI 10.1189/jlb.1109737; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; TAKELE Y, 2012, PLOS NTD, V7, pe1977; Weinberg JM, 2008, CUTIS, V81, P21; Zea AH, 2006, J INFECT DIS, V194, P1385, DOI 10.1086/508200	24	41	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72034	10.1371/journal.pone.0072034	http://dx.doi.org/10.1371/journal.pone.0072034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039734	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300007
J	Ehrhart, F; Mettler, E; Bose, T; Weber, MM; Vasquez, JA; Zimmermann, H				Ehrhart, Friederike; Mettler, Esther; Boese, Thomas; Weber, Matthias Max; Vasquez, Julio Alberto; Zimmermann, Heiko			Biocompatible Coating of Encapsulated Cells Using Ionotropic Gelation	PLOS ONE			English	Article							ALGINATE-BASED MICROCAPSULES; PANCREATIC-ISLETS; MAMMALIAN-CELLS; PLL CAPSULES; TRANSPLANTATION; MODEL; IMMOBILIZATION; TECHNOLOGY; ACTIVATION; PROTECTION	The technique of immunoisolated transplantation has seen in the last twenty years improvements in biocompatibility, long term stability and methods for avoidance of fibrosis in alginate capsules. However, two major problems are not yet solved: living cellular material that is not centered in the capsule is not properly protected from the hosts' immune system and the total transplant volume needs to be reduced. To solve these problems, we present a method for applying fully biocompatible alginate multilayers to a barium-alginate core without the use of polycations. We report on the factors that influence layer formation and stability and can therefore provide data for full adjustability of the additional layer. Although known for yeast and plant cells, this technique has not previously been demonstrated with mammalian cells or ultra-high viscous alginates. Viability of murine insulinoma cells was investigated by live-dead staining and live cell imaging, for murine Langerhans' islets viability and insulin secretion have been measured. No hampering effects of the second alginate layer were found. This multi-layer technique therefore has great potential for clinical and in vitro use and is likely to be central in alginate matrix based immunoisolated cell therapy.	[Ehrhart, Friederike; Boese, Thomas; Zimmermann, Heiko] Fraunhofer IBMT, Biophys & Kryotechnol, Sankt Ingbert, Germany; [Mettler, Esther; Weber, Matthias Max] Univ Med Mainz, Mainz, Germany; [Vasquez, Julio Alberto] Univ Catolica Norte, Dept Marine Biol, Coquimbo, Chile; [Zimmermann, Heiko] Univ Saarbrucken, Lehrstuhl Mol & Zellulare Biotechnol Nanotechnol, Saarbrucken, Germany	Johannes Gutenberg University of Mainz; Universidad Catolica del Norte	Zimmermann, H (corresponding author), Fraunhofer IBMT, Biophys & Kryotechnol, Sankt Ingbert, Germany.	heiko.zimmermann@ibmt.fraunhofer.de		Mettler, Esther Maria/0000-0001-9910-5870; Ehrhart, Friederike/0000-0002-7770-620X; Zimmermann, Heiko/0000-0001-8595-1304	Bundesministerium fur Bildung und Forschung (BMBF) [031581B]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank Bundesministerium fur Bildung und Forschung (BMBF) for granting (Grant No. 031581B (given to HZ)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235; Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g; Brandhorst H, 2008, TRANSPL P, V40, P370, DOI 10.1016/j.transproceed.2008.01.013; Coutinho DF, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035003; de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060; Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698; Ehrhart F, 2009, CRYOBIOLOGY, V58, P119, DOI 10.1016/j.cryobiol.2008.11.005; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; Hang HL, 2010, LIVER INT, V30, P611, DOI 10.1111/j.1478-3231.2009.02197.x; Juste S, 2005, J BIOMED MATER RES A, V72A, P389, DOI 10.1002/jbm.a.30254; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Koch S, 2003, J MICROENCAPSUL, V20, P303, DOI 10.1080/0265204021000058438; Koyama K, 2004, J BIOSCI BIOENG, V97, P111, DOI 10.1016/S1389-1723(04)70177-2; Krishnamurthy N. V., 2011, Critical Reviews in Biomedical Engineering, V39, P473, DOI 10.1615/CritRevBiomedEng.v39.i6.10; Krol S, 2006, NANO LETT, V6, P1933, DOI 10.1021/nl061049r; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; MORRIS ER, 1978, CARBOHYD RES, V66, P145, DOI 10.1016/S0008-6215(00)83247-4; Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014; PUEYO ME, 1993, J BIOMAT SCI-POLYM E, V5, P197; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687; Schneider S, 2003, ARTIF CELL BLOOD SUB, V31, P383, DOI 10.1081/BIO-120025409; Schneider S, 2001, BIOMATERIALS, V22, P1961, DOI 10.1016/S0142-9612(00)00380-X; Schwinger C, 2002, J MICROENCAPSUL, V19, P273, DOI 10.1080/02652040110105328; Storz H, 2009, CARBOHYD RES, V344, P985, DOI 10.1016/j.carres.2009.02.016; Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243; Tam SK, 2005, BIOMATERIALS, V26, P6950, DOI 10.1016/j.biomaterials.2005.05.007; TANAKA H, 1989, J FERMENT BIOENG, V68, P216, DOI 10.1016/0922-338X(89)90141-4; Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51; van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086; VORLOP KD, 1987, ANN NY ACAD SCI, V501, P339, DOI 10.1111/j.1749-6632.1987.tb45732.x; Zhu HG, 2005, BIOMACROMOLECULES, V6, P2221, DOI 10.1021/bm0501656; Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2; Zimmermann H, 2003, BIOMATERIALS, V24, P2083, DOI 10.1016/S0142-9612(02)00639-7; Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1; Zimmermann H, 2007, BIOMATERIALS, V28, P1327, DOI 10.1016/j.biomaterials.2006.11.032	36	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73498	10.1371/journal.pone.0073498	http://dx.doi.org/10.1371/journal.pone.0073498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039964	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300083
J	Gao, P; Wang, B; Zhang, GC				Gao Peng; Wang Bing; Zhang Guangcan			Influence of Sub-Surface Irrigation on Soil Conditions and Water Irrigation Efficiency in a Cherry Orchard in a Hilly Semi-Arid Area of Northern China	PLOS ONE			English	Article							DRIP IRRIGATION	Sub-surface irrigation (SUI) is a new water-saving irrigation technology. To explore the influence of SUI on soil conditions in a cherry orchard and its water-saving efficiency, experiments were conducted from 2009 to 2010 using both SUI and flood irrigation (FLI) and different SUI quotas in hilly semi-arid area of northern China. The results demonstrated the following: 1) The bulk density of the soil under SUI was 6.8% lower than that of soil under FLI (P<0.01). The total soil porosity, capillary porosity and non-capillary porosity of soils using SUI were 11.7% (P<0.01), 8.7% (P<0.01) and 43.8% (P<0.01) higher than for soils using FLI. 2) The average soil temperatures at 0, 5, 10, 15 and 20 cm of soil depth using SUI were 1.7, 1.1, 0.7, 0.4 and 0.3 degrees C higher than those for FLI, specifically, the differences between the surface soil layers were more significant. 3) Compared with FLI, the average water-saving efficiency of SUI was 55.6%, and SUI increased the irrigation productivity by 7.9-12.3 kg m(-3) ha(-1). 4) The soil moisture of different soil layers using SUI increased with increases in the irrigation quotas, and the soil moisture contents under SUI were significantly higher in the 0-20 cm layer and in the 21-50 cm layer than those under FLI (P<0.01). 5) The average yields of cherries under SUI with irrigation quotas of 80-320 m(3) ha(-1) were 8.7%-34.9% higher than those in soil with no irrigation (CK2). The average yields of cherries from soils using SUI were 4.5%-12.2% higher than using FLI. It is appropriate to irrigate 2-3 times with 230 m(3) ha(-1) per application using SUI in a year with normal rainfall. Our findings indicated that SUI could maintain the physical properties, greatly improve irrigation water use efficiency, and significantly increase fruit yields in hilly semi-arid areas of northern China.	[Gao Peng; Zhang Guangcan] Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Shandong Prov Key Lab Soil Eros & Ecol Restorat, Tai An, Shandong, Peoples R China; [Wang Bing] Chinese Acad Forestry, Res Inst Forest Ecol Environm Protect, Beijing, Peoples R China	Shandong Agricultural University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Gao, P (corresponding author), Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Shandong Prov Key Lab Soil Eros & Ecol Restorat, Tai An, Shandong, Peoples R China.	gaopengy@163.com; wangbing@caf.ac.cn			National Basic Research and Development Program of China (973 Program) [2011CB403201, 2012CB416904]; CFERN&GENE Award Funds on Ecological Paper	National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); CFERN&GENE Award Funds on Ecological Paper	This research was funded by the National Basic Research and Development Program of China (973 Program) of Grant "No2011CB403201" and Grant "No2012CB416904" and subsidized by CFERN&GENE Award Funds on Ecological Paper. The funders were involved in the data collection and analysis in the study, and participated in the consultation of decision to publication.	Battam MA, 2003, IRRIGATION SCI, V22, P135, DOI 10.1007/s00271-003-0079-1; David A, 2003, GEOMORPHOLOGY, V53, P45, DOI [10.1016/S0169-555X(02)00347-1, DOI 10.1016/S0169-555X(02)00347-1]; Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047680; Feng YP, 1998, AGR RES ARID AREAS, V16, P73; Gao P, 2009, PLANT SOIL ENVIRON, V55, P146, DOI 10.17221/1642-PSE; Gao P, 2002, CHINESE J MOUNTAIN S, V20, P232; Hamilton AJ, 2007, VADOSE ZONE J, V6, P823, DOI 10.2136/vzj2007.0026; Hammecker C, 2003, EUR J SOIL SCI, V54, P491, DOI 10.1046/j.1365-2389.2003.00482.x; Huang C.Y., 2000, SOIL SCI, P66; Kalfountzos I, 2006, WATER RESOUR MANAG, V34, P278; Li JL, 2002, ECOLOGICAL ENG SCI D, P22; Li MingSi, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P49; Liu CM, 1993, ECOL AGR RES, V1, P21; Liu ZX, 2002, CHINESE J APPL ECOLO, V13, P409; Lu WD, 2005, SPSS12 0 WINDOWS STA, P1; Ma FuSheng, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P37; ORON G, 1991, J IRRIG DRAIN ENG, V117, P25, DOI 10.1061/(ASCE)0733-9437(1991)117:1(25); Phene C. J., 1987, Acta Horticulturae, P101; Philip BC, 2003, IRRIGATION SCI, V22, P171, DOI [10.1007/s00271-003-0082-6, DOI 10.1007/S00271-003-0082-6]; Piper CS, 1944, SOIL PLANT ANAL, P10; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Qadir M, 2007, AGR WATER MANAGE, V87, P2, DOI 10.1016/j.agwat.2006.03.018; Romero P, 2006, IRRIGATION SCI, V24, P175, DOI 10.1007/s00271-005-0008-6; Roy RC, 2007, CAN J PLANT SCI, V87, P373, DOI 10.4141/P05-228; Wahba M. A. S., 2006, Irrigation and Drainage Systems, V20, P267, DOI 10.1007/s10795-006-9007-x; Wang, 1993, SOIL PHYS SCI, P34; Wang H, 2007, CAN J PLANT SCI, V87, P289, DOI 10.4141/P06-076; Wang SH, 2008, T CSAE S, V21, P92; Wang ZhiGuo, 2010, Xinjiang Agricultural Sciences, V47, P1590; Wu PT, 2002, STUDY ARTIFICIAL RAI, P1; Zhen WC, 2000, J NAT RESOURCES, V15, P246; Zhuge YuPing, 2002, Transactions of the Chinese Society of Agricultural Engineering, V18, P53	32	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73570	10.1371/journal.pone.0073570	http://dx.doi.org/10.1371/journal.pone.0073570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039986	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300093
J	Gravina, S; Dolle, MET; Wang, T; van Steeg, H; Hasty, P; Hoeijmakers, J; Vijg, J				Gravina, Silvia; Dolle, Martijn E. T.; Wang, Tao; van Steeg, Harry; Hasty, Paul; Hoeijmakers, Jan; Vijg, Jan			High Preservation of CpG Cytosine Methylation Patterns at Imprinted Gene Loci in Liver and Brain of Aged Mice	PLOS ONE			English	Article							DNA-METHYLATION; MASS-SPECTROMETRY; PRENATAL EXPOSURE; MOUSE; GENOME; REPAIR; SENESCENCE; EXPRESSION; TWINS	A gradual loss of the correct patterning of 5-methyl cytosine marks in gene promoter regions has been implicated in aging and age-related diseases, most notably cancer. While a number of studies have examined DNA methylation in aging, there is no consensus on the magnitude of the effects, particularly at imprinted loci. Imprinted genes are likely candidate to undergo age-related changes because of their demonstrated plasticity in utero, for example, in response to environmental cues. Here we quantitatively analyzed a total of 100 individual CpG sites in promoter regions of 11 imprinted and non-imprinted genes in liver and cerebral cortex of young and old mice using mass spectrometry. The results indicate a remarkably high preservation of methylation marks during the aging process in both organs. To test if increased genotoxic stress associated with premature aging would destabilize DNA methylation we analyzed two DNA repair defective mouse models showing a host of premature aging symptoms in liver and brain. However, also in these animals, at the end of their life span, we found a similarly high preservation of DNA methylation marks. We conclude that patterns of DNA methylation in gene promoters of imprinted genes are surprisingly stable over time in normal, postmitotic tissues and that the multiple documented changes with age are likely to involve exceptions to this pattern, possibly associated with specific cellular responses to age-related changes other than genotoxic stress.	[Gravina, Silvia; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Dolle, Martijn E. T.; van Steeg, Harry] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Wang, Tao] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78229 USA; [Hoeijmakers, Jan] Erasmus MC, CBG Canc Genom Ctr, MGC Dept Genet, Rotterdam, Netherlands	Yeshiva University; Netherlands National Institute for Public Health & the Environment; Yeshiva University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Erasmus University Rotterdam; Erasmus MC	Gravina, S (corresponding author), Albert Einstein Coll Med, Dept Genet, New York, NY USA.	silvia.gravina@einstein.yu.edu; jan.vijg@einstein.yu.edu	Hoeijmakers, Jan/AAX-6972-2021	Hasty, Paul/0000-0003-3046-0131	National Institutes of Health [AG 17242]; ERC; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health grant AG 17242. JHJH was also supported by an ERC advanced grant DamAge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gravina S, 2010, PFLUG ARCH EUR J PHY, V459, P247, DOI 10.1007/s00424-009-0730-7; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431; Pogribny IP, 2012, CANC LETT; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Salpea P, 2012, NUCLEIC ACIDS RES, V40, P6477, DOI 10.1093/nar/gks312; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; SLAGBOOM PE, 1992, ANN NY ACAD SCI, V673, P58, DOI 10.1111/j.1749-6632.1992.tb27437.x; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73496	10.1371/journal.pone.0073496	http://dx.doi.org/10.1371/journal.pone.0073496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039963	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300082
J	Tomiyama, T; Ueda, Y; Katakai, T; Kondo, N; Okazaki, K; Kinashi, T				Tomiyama, Takashi; Ueda, Yoshihiro; Katakai, Tomoya; Kondo, Naoyuki; Okazaki, Kazuichi; Kinashi, Tatsuo			Antigen-Specific Suppression and Immunological Synapse Formation by Regulatory T Cells Require the Mst1 Kinase	PLOS ONE			English	Article							DENDRITIC CELLS; ACTIVATION; MICROCLUSTERS; MOLECULES; RESPONSES; MOTILITY; ADHESION; INHIBIT; BINDING; DOCK8	Although the cell-to-cell contact between CD4(+)Foxp3(+) regulatory T (Treg) and their target cells is important for the suppressor function of Treg cells, the regulation of this process is not well understood. Here we show that the Mst1 kinase plays a critical role in the suppressor function of Treg cells through regulation of cell contact dependent processes. Mst1(-/-) Treg cells failed to prevent the development of experimental colitis and antigen-specific suppression of naive T cells proliferation in vitro. Mst1(-/-) Treg cells exhibited defective interactions with antigen-presenting dendritic cells (DCs), resulting in reduced down-regulation of costimulatory molecules. While wild-type CD4(+)Foxp3(+) Treg cells formed mobile immunological synapses on supported planar membrane, Mst1(-/-) Treg cells did not exhibit ICAM-1 ring or central peptide-MHC clustering. Using two-photon imaging we showed that antigen-specific wild-type Treg cells exhibited dynamic mobile contacts with antigen-pulsed DCs bearing stably associated naive T cells. In contrast, Mst1(-/-) Treg had impairments in their interactions with DCs. Thus, Mst1 is required for Treg cells to mediate contact-dependent suppressor functions.	[Tomiyama, Takashi; Okazaki, Kazuichi] Kansai Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med 3, Hirakata, Osaka, Japan; [Tomiyama, Takashi; Ueda, Yoshihiro; Katakai, Tomoya; Kondo, Naoyuki; Kinashi, Tatsuo] Kansai Med Univ, Japan Sci & Technol Agcy, Inst Biomed Sci, Dept Mol Genet, Hirakata, Osaka, Japan; [Tomiyama, Takashi; Ueda, Yoshihiro; Katakai, Tomoya; Kondo, Naoyuki; Kinashi, Tatsuo] Kansai Med Univ, Japan Sci & Technol Agcy, Hirakata, Osaka, Japan	Kansai Medical University; Japan Science & Technology Agency (JST); Kansai Medical University; Japan Science & Technology Agency (JST); Kansai Medical University	Kinashi, T (corresponding author), Kansai Med Univ, Japan Sci & Technol Agcy, Inst Biomed Sci, Dept Mol Genet, Hirakata, Osaka, Japan.	kinashi@takii.kmu.ac.jp	Tomiyama, Takashi/AAZ-9910-2020; Kondo, Naoyuki/W-5845-2019; Katakai, Tomoya/AAX-1434-2021	Kondo, Naoyuki/0000-0002-6624-5989; Katakai, Tomoya/0000-0002-4290-7028	Core Research for Evolutional Science and Technology, Japan Science Technology Agency (Research Area: Ethological basics of and techniques for treatment of allergic and autoimmune diseases); KAKENHI from the Ministry of Education, Science, Sport and Culture of Japan [30202039, 21790482]; Ministry of Health, Labor and Welfare of Japan	Core Research for Evolutional Science and Technology, Japan Science Technology Agency (Research Area: Ethological basics of and techniques for treatment of allergic and autoimmune diseases); KAKENHI from the Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Core Research for Evolutional Science and Technology, Japan Science Technology Agency (Research Area: Ethological basics of and techniques for treatment of allergic and autoimmune diseases), and KAKENHI from the Ministry of Education, Science, Sport and Culture of Japan (a Grant-in-Aid for Scientific Research (Researcher Number: 30202039), a Grant-in-Aid on Innovative Areas (Researcher Number: 30202039) and a Grant-in-Aid for Young Scientists (Research Project Number: 21790482) and "Research Measures for Intractable Disease" Project: matching fund subsidy from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Dustin ML, 2008, ANNU REV CELL DEV BI, V24, P577, DOI 10.1146/annurev.cellbio.24.110707.175226; Dustin Michael L, 2007, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1813s76; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Marski M, 2005, J IMMUNOL, V175, P7889, DOI 10.4049/jimmunol.175.12.7889; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang Y, 2008, J IMMUNOL, V180, P8118, DOI 10.4049/jimmunol.180.12.8118; Wernimont SA, 2011, J IMMUNOL, V187, P6256, DOI 10.4049/jimmunol.1102028; Wohler J, 2009, MOL IMMUNOL, V46, P2424, DOI 10.1016/j.molimm.2009.04.004; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	40	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73874	10.1371/journal.pone.0073874	http://dx.doi.org/10.1371/journal.pone.0073874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040101	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300138
J	Albert, H; Nakiyingi, L; Sempa, J; Mbabazi, O; Mukkada, S; Nyesiga, B; Perkins, MD; Manabe, YC				Albert, Heidi; Nakiyingi, Lydia; Sempa, Joseph; Mbabazi, Olive; Mukkada, Sheena; Nyesiga, Barnabas; Perkins, Mark D.; Manabe, Yukari C.			Operational Implementation of LED Fluorescence Microscopy in Screening Tuberculosis Suspects in an Urban HIV Clinic in Uganda	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; SMEAR MICROSCOPY; PERFORMANCE; BACILLI; SPUTUM; COST	Background: Light emitting diode (LED) fluorescence microscopy (FM) is an affordable, technology targeted for use in resource-limited settings and recommended for widespread roll-out by the World Health Organization (WHO). We sought to compare the operational performance of three LED FM methods compared to light microscopy in a cohort of HIV-positive tuberculosis (TB) suspects at an urban clinic in a high TB burden country. Methods: Two spot specimens collected from TB suspects were included in the study. Smears were stained using auramine O method and read after blinding by three LED-based FM methods by trained laboratory technicians in the Infectious Diseases Institutelaboratory. Leftover portions of the refrigerated sputum specimens were transported to the FIND Tuberculosis Research Laboratory for Ziehl Neelsen (ZN) smear preparation and reading by experienced technologist as well as liquid and solid culture. Results: 174 of 627 (27.8%) specimens collected yielded one or more positive mycobacterial cultures. 94.3% (164/174) were M. tuberculosis complex. LED FM was between 7.3-11.0% more sensitive compared to ZN microscopy. Of the 592 specimens examined by all microscopy methods, there was no significant difference in sensitivity between the three LED FM methods. The specificity of the LED FM methods was between 6.1% and 7.7% lower than ZN microscopy (P<0.001), although exclusion of the single poor reader resulted in over 98% specificity for all FM methods. Conclusions: Laboratory technicians in routine settings can be trained to use FM which is more sensitive than ZN microscopy. Despite rigorous proficiency testing, there were operator-dependent accuracy issues which highlight the critical need for intensive quality assurance procedures during LED FM implementation. The low sensitivity of FM for HIV-positive individuals particularly those with low CD4 T cell counts, will limit the number of additional patients found by LED FM in countries with high rates of HIV co-infection.	[Albert, Heidi; Mukkada, Sheena; Nyesiga, Barnabas] FIND, Kampala, Uganda; [Nakiyingi, Lydia; Sempa, Joseph; Mbabazi, Olive; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Perkins, Mark D.] FIND, Geneva, Switzerland; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Foundation For Innovative New Diagnostics; Makerere University; Foundation For Innovative New Diagnostics; Johns Hopkins University	Manabe, YC (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	ymanabe@jhmi.edu	Nakiyingi, Lydia/ABG-7669-2020	Nakiyingi, Lydia/0000-0001-7263-3198; Bukulu Sempa, Joseph/0000-0003-1062-0417	Foundation for Innovative New Diagnostics (FIND)	Foundation for Innovative New Diagnostics (FIND)	This study was designed and supervised by the sponsor, the Foundation for Innovative New Diagnostics (FIND). Data were collected by investigators at the study site, and statistical analyses were performed by a statistician who was not involved in the data collection.	Affolabi D, 2010, INT J TUBERC LUNG D, V14, P160; Albert H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015206; Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; HAGEMANN P. K. H., 1937, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, V140, P184; Hermans S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-674; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Lange C, 2012, EUR RESPIR MONOGR, P1; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Minion J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022495; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Trusov A, 2009, INT J TUBERC LUNG D, V13, P836; Turnbull ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027125; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Whitelaw A, 2011, EUR RESPIR J, V38, P1393, DOI 10.1183/09031936.00023211	18	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72556	10.1371/journal.pone.0072556	http://dx.doi.org/10.1371/journal.pone.0072556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039780	Green Submitted, gold, Green Published			2022-12-25	WOS:000324856500022
J	Madsen, CB; Lavrsen, K; Steentoft, C; Vester-Christensen, MB; Clausen, H; Wandall, HH; Pedersen, AE				Madsen, Caroline B.; Lavrsen, Kirstine; Steentoft, Catharina; Vester-Christensen, Malene B.; Clausen, Henrik; Wandall, Hans H.; Pedersen, Anders Elm			Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing	PLOS ONE			English	Article							O-GLYCOSYLATION; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; SIALOMUCIN COMPLEX; DENDRITIC CELL; HUMAN COLON; INFILTRATION; CARCINOMA; CYTOTOXICITY; TROGOCYTOSIS	Membrane bound mucins are up-regulated and aberrantly glycosylated during malignant transformation in many cancer cells. This results in a negatively charged glycoprotein coat which may protect cancer cells from immune surveillance. However, only limited data have so far demonstrated the critical steps in glycan elongation that make aberrantly glycosylated mucins affect the interaction between cancer cells and cytotoxic effector cells of the immune system. Tn (GalNAc-Ser/Thr), STn (NeuAc alpha 2-6GalNAc-Ser/Thr), T (Gal beta 1-3GalNAc-Ser/Thr), and ST (NeuAc alpha 2-6Gal beta 1-3GalNAc-Ser/Thr) antigens are recognized as cancer associated truncated glycans, and are expressed in many adenocarcinomas, e. g. breast- and pancreatic cancer cells. To investigate the role of the cancer associated glycan truncations in immune-mediated killing we created glyco-engineered breast-and pancreatic cancer cells expressing only the shortest possible mucin-like glycans (Tn and STn). Glyco-engineering was performed by zinc finger nuclease (ZFN) knockout (KO) of the Core 1 enzyme chaperone COSMC, thereby preventing glycan elongation beyond the initial GalNAc residue in O-linked glycans. We find that COSMC KO in the breast and pancreatic cancer cell lines T47D and Capan-1 increases sensitivity to both NK cell mediated antibody-dependent cellular-cytotoxicity (ADCC) and cytotoxic T lymphocyte (CTL)-mediated killing. In addition, we investigated the association between total cell surface expression of MUC1/MUC16 and NK or CTL mediated killing, and observed an inverse correlation between MUC16/MUC1 expression and the sensitivity to ADCC and CTL-mediated killing. Together, these data suggest that up-regulation of membrane bound mucins protects cells from immune mediated killing, and that particular glycosylation steps, as demonstrated for glycan elongation beyond Tn and STn, can be important for fine tuning of the immune escape mechanisms in cancer cells.	[Madsen, Caroline B.; Lavrsen, Kirstine; Steentoft, Catharina; Vester-Christensen, Malene B.; Clausen, Henrik; Wandall, Hans H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark; [Madsen, Caroline B.; Pedersen, Anders Elm] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Wandall, HH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark.	hhw@sund.ku.dk; elmpedersen@sund.ku.dk	clausen, henrik/AAD-8016-2021; Mathiesen, Caroline B K/AAM-7156-2020	Steentoft, Catharina/0000-0002-1424-6736; Pedersen, Anders Elm/0000-0003-4705-1801; Wandall, Hans H./0000-0003-0240-9232; Clausen, Henrik/0000-0002-0915-5055	Danish Medical Research Council; Lundbeck Foundation [UCPHs 2016]; Danish National Research Foundation [DNRF107]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond)	This project was supported by the Danish Medical Research Council, The Lundbeck Foundation (UCPHs 2016) funds, and The Danish National Research Foundation (DNRF107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Bauer K, 2011, FAM CANCER, V10, P557, DOI 10.1007/s10689-011-9449-7; Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Beum PV, 2011, J IMMUNOL, V187, P3438, DOI 10.4049/jimmunol.1101189; Beum PV, 2008, J IMMUNOL, V181, P8120, DOI 10.4049/jimmunol.181.11.8120; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Bohm CM, 1997, SCAND J IMMUNOL, V46, P27, DOI 10.1046/j.1365-3083.1996.d01-91.x; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; BURCHELL J, 1987, CANCER RES, V47, P5476; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chiricolo M, 2006, GLYCOBIOLOGY, V16, P146, DOI 10.1093/glycob/cwj045; Emens LA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-70; Fridman WH, 2011, CURR TOP MICROBIOL, V344, P1, DOI 10.1007/82_2010_46; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Gubbels JAA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-11; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hubert P, 2011, CANCER RES, V71, P5134, DOI 10.1158/0008-5472.CAN-10-4222; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Komatsu M, 1999, CANCER RES, V59, P2229; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Ladanyi A, 2011, CANCER IMMUNOL IMMUN, V60, P1729, DOI 10.1007/s00262-011-1071-x; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lee WC, 2012, SURGERY, V151, P213, DOI 10.1016/j.surg.2011.07.029; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; McCann FE, 2003, J IMMUNOL, V170, P2862, DOI 10.4049/jimmunol.170.6.2862; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pedersen AE, 2011, IMMUNOLOGY, V133, P239, DOI 10.1111/j.1365-2567.2011.03434.x; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shevach EM, 2004, NAT MED, V10, P900, DOI 10.1038/nm0904-900; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Sledge GW, 2003, EUR J CANCER, V39, P1668, DOI 10.1016/S0959-8049(03)00273-9; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061; Suzuki Y, 2012, INT J ONCOL, V40, P1831, DOI 10.3892/ijo.2012.1411; Sznurkowski JJ, 2011, INT J GYNECOL CANCER, V21, P717, DOI 10.1097/IGC.0b013e3182131f36; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; THURNHER M, 1993, IMMUNOL LETT, V36, P239, DOI 10.1016/0165-2478(93)90095-J; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Vasir B, 2005, J IMMUNOL, V174, P2376, DOI 10.4049/jimmunol.174.4.2376; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; Wright SE, 2012, EXPERT OPIN BIOL TH, V12, P479, DOI 10.1517/14712598.2012.665445; Zhang QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003097	58	28	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72413	10.1371/journal.pone.0072413	http://dx.doi.org/10.1371/journal.pone.0072413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039759	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500017
J	Merz, C; Catchen, JM; Hanson-Smith, V; Emerson, KJ; Bradshaw, WE; Holzapfel, CM				Merz, Clayton; Catchen, Julian M.; Hanson-Smith, Victor; Emerson, Kevin J.; Bradshaw, William E.; Holzapfel, Christina M.			Replicate Phylogenies and Post-Glacial Range Expansion of the Pitcher-Plant Mosquito, Wyeomyia smithii, in North America	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; VEGETATION; MODEL	Herein we tested the repeatability of phylogenetic inference based on high throughput sequencing by increased taxon sampling using our previously published techniques in the pitcher-plant mosquito, Wyeomyia smithii in North America. We sampled 25 natural populations drawn from different localities nearby 21 previous collection localities and used these new data to construct a second, independent phylogeny, expressly to test the reproducibility of phylogenetic patterns. Comparison of trees between the two data sets based on both maximum parsimony and maximum likelihood with Bayesian posterior probabilities showed close correspondence in the grouping of the most southern populations into clear clades. However, discrepancies emerged, particularly in the middle of W. smithii's current range near the previous maximum extent of the Laurentide Ice Sheet, especially concerning the most recent common ancestor to mountain and northern populations. Combining all 46 populations from both studies into a single maximum parsimony tree and taking into account the post-glacial historical biogeography of associated flora provided an improved picture of W. smithii's range expansion in North America. In a more general sense, we propose that extensive taxon sampling, especially in areas of known geological disruption is key to a comprehensive approach to phylogenetics that leads to biologically meaningful phylogenetic inference.	[Merz, Clayton; Catchen, Julian M.; Hanson-Smith, Victor; Emerson, Kevin J.; Bradshaw, William E.; Holzapfel, Christina M.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon	Bradshaw, WE (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	mosquito@uoregon.edu; mosquito@uoregon.edu	Catchen, Julian/D-9795-2016; Emerson, Kevin/AAC-8207-2020	Emerson, Kevin/0000-0003-3283-0693	National Science Foundation [IOS-083998, IOS-1048276, DEB-0917827]; National Institutes of Health NSRA Fellowship [5F3GM095213]; National Science Foundation IGERT [DGE0504727]; National Institutes of Health [1R24GM079486-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM079486, F32GM095213] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NSRA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation IGERT(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants IOS-083998, IOS-1048276, and DEB-0917827 to Dr. William E. Bradshaw from the National Science Foundation (http://www.nsf.gov), grant 5F3GM095213 to Dr. Julian M. Catchen from the National Institutes of Health NSRA Fellowship (http://www.nih.gov), grant DGE0504727 to Dr. Victor Hanson-Smith from the National Science Foundation IGERT (http://www.nsf.gov), and 1R24GM079486-01A1 to Dr. John Postlethwait from the National Institutes of Health (Http://www.nih.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Armbruster P, 1998, EVOLUTION, V52, P1697, DOI 10.1111/j.1558-5646.1998.tb02249.x; BRADSHAW WE, 1977, EVOLUTION, V31, P546, DOI [10.2307/2407521, 10.1111/j.1558-5646.1977.tb01044.x]; Bradshaw WE, 2012, P ROY SOC B-BIOL SCI, V279, P4551, DOI 10.1098/rspb.2012.1917; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Colgan P.M, 2003, GLACIAL LANDSYSTEMS, P111; COLMAN SM, 1988, PALAEOGEOGR PALAEOCL, V68, P99, DOI 10.1016/0031-0182(88)90033-8; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Gorham E, 2007, QUATERNARY SCI REV, V26, P300, DOI 10.1016/j.quascirev.2006.08.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall B. G., 2008, PHYLOGENETIC TREES M; Halsey LA, 2000, BRYOLOGIST, V103, P334, DOI 10.1639/0007-2745(2000)103[0334:SDPINA]2.0.CO;2; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Istock CA, 1987, EVOL ECOL, V1, P348, DOI 10.1007/BF02071558; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Johnson C. W., 1985, BOGS NE; Kleiven HF, 2008, SCIENCE, V319, P60, DOI 10.1126/science.1148924; Li W. H, 1997, MOL EVOLUTION; Liu L, 2009, SYST BIOL, V58, P452, DOI 10.1093/sysbio/syp034; Nei M., 2000, MOL EVOLUTION PHYLOG; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRENTICE IC, 1991, ECOLOGY, V72, P2038, DOI 10.2307/1941558; SGS, 1998, CHES BAY GEOL PROD R; TOSCANO MA, 1992, QUATERNARY SCI REV, V11, P301, DOI 10.1016/0277-3791(92)90003-Q; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	29	14	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72262	10.1371/journal.pone.0072262	http://dx.doi.org/10.1371/journal.pone.0072262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039746	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500015
J	Ochiai, T; Suehiro, Y; Nishinari, K; Kubo, T; Takeuchi, H				Ochiai, Takashi; Suehiro, Yuji; Nishinari, Katsuhiro; Kubo, Takeo; Takeuchi, Hideaki			A New Data-Mining Method to Search for Behavioral Properties That Induce Alignment and Their Involvement in Social Learning in Medaka Fish (Oryzias Latipes)	PLOS ONE			English	Article							INFORMATION; MECHANISMS; GUPPY; DYNAMICS; ANIMALS; INSECTS; SHOAL; FEAR	Background: Coordinated movement in social animal groups via social learning facilitates foraging activity. Few studies have examined the behavioral cause-and-effect between group members that mediates this social learning. Methodology/Principal Findings: We first established a behavioral paradigm for visual food learning using medaka fish and demonstrated that a single fish can learn to associate a visual cue with a food reward. Grouped medaka fish (6 fish) learn to respond to the visual cue more rapidly than a single fish, indicating that medaka fish undergo social learning. We then established a data-mining method based on Kullback-Leibler divergence (KLD) to search for candidate behaviors that induce alignment and found that high-speed movement of a focal fish tended to induce alignment of the other members locally and transiently under free-swimming conditions without presentation of a visual cue. The high-speed movement of the informed and trained fish during visual cue presentation appeared to facilitate the alignment of naive fish in response to some visual cues, thereby mediating social learning. Compared with naive fish, the informed fish had a higher tendency to induce alignment of other naive fish under free-swimming conditions without visual cue presentation, suggesting the involvement of individual recognition in social learning. Conclusions/Significance: Behavioral cause-and-effect studies of the high-speed movement between fish group members will contribute to our understanding of the dynamics of social behaviors. The data-mining method used in the present study is a powerful method to search for candidates factors associated with inter-individual interactions using a dataset for time-series coordinate data of individuals.	[Ochiai, Takashi; Suehiro, Yuji; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Suehiro, Yuji] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Nishinari, Katsuhiro] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	University of Tokyo; Tokyo Women's Medical University; University of Tokyo	Takeuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	takeuchi@biol.s.u-tokyo.ac.jp	TAKEUCHI, HIDEAKI/G-4969-2014; KUBO, TAKEO/G-4951-2014; Nishinari, Katsuhiro/AAQ-9858-2020; Takeuchi, Hideaki/W-6739-2018	Takeuchi, Hideaki/0000-0001-6610-3895; Kubo, Takeo/0000-0002-5914-5269	NIBB (National Institute for Basic Biology) Cooperative Research Program [10-104]; Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23300115] Funding Source: KAKEN	NIBB (National Institute for Basic Biology) Cooperative Research Program; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the NIBB (National Institute for Basic Biology) Cooperative Research Program (10-104) and the Ministry of Education, Culture, Sports, Science, and Technology Grant-in-Aid for Scientific Research (B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Coolen I, 2005, CURR BIOL, V15, P1931, DOI 10.1016/j.cub.2005.09.015; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Cover TM, 1991, ELEMENTS INFORM THEO; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Hershey RJ, 2007, P IEEE INT C AC SPEE, V4, pIV; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoare DJ, 2003, FISH FISH, V4, P269, DOI 10.1046/j.1467-2979.2003.00130.x; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Johannessen LE, 2006, ANIM BEHAV, V72, P83, DOI 10.1016/j.anbehav.2005.09.019; Krause J, 2002, LIVING GROUPS; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Langridge EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P523, DOI 10.1007/s00265-004-0824-3; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Mann RP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002308; Mei Q., 2005, P ACM SIGKDD INT C K, P198, DOI [10.1145/1081870.1081895, DOI 10.1145/1081870.1081895]; MINEKA S, 1993, J EXP PSYCHOL GEN, V122, P23, DOI 10.1037/0096-3445.122.1.23; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; PITCHER TJ, 1987, ETHOLOGY, V76, P161; Ramirez J, 2004, IEEE SIGNAL PROC LET, V11, P266, DOI 10.1109/LSP.2003.821762; Reader SM, 2000, ANIM BEHAV, V60, P175, DOI 10.1006/anbe.2000.1450; Reader SM, 2003, ANIM BEHAV, V66, P729, DOI 10.1006/anbe.2003.2252; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reznikova ZI, 2004, ZH OBSHCH BIOL, V65, P136; RYER CH, 1992, ANIM BEHAV, V44, P69, DOI 10.1016/S0003-3472(05)80756-0; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817	37	12	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e71685	10.1371/journal.pone.0071685	http://dx.doi.org/10.1371/journal.pone.0071685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039720	gold, Green Submitted, Green Published			2022-12-25	WOS:000324856500009
J	Song, Y; Pinniger, GJ; Bakker, AJ; Moss, TJM; Noble, PB; Berry, CA; Pillow, JJ				Song, Yong; Pinniger, Gavin J.; Bakker, Anthony J.; Moss, Timothy J. M.; Noble, Peter B.; Berry, Clare A.; Pillow, Jane J.			Lipopolysaccharide-Induced Weakness in the Preterm Diaphragm Is Associated with Mitochondrial Electron Transport Chain Dysfunction and Oxidative Stress	PLOS ONE			English	Article							SKELETAL-MUSCLE; INTRAAMNIOTIC ENDOTOXIN; FETAL; CHORIOAMNIONITIS; SEPSIS	Diaphragmatic contractility is reduced in preterm lambs after lipopolysaccharide (LPS) exposure in utero. The mechanism of impaired fetal diaphragm contractility after LPS exposure is unknown. We hypothesise that in utero exposure to LPS induces a deficiency of mitochondrial complex activity and oxidative damage in the fetal diaphragm. To test this hypothesis, we used a well-established preterm ovine model of chorioamnionitis: Pregnant ewes received intra-amniotic (IA) saline or 10 mg LPS, at 2 d or 7 d prior to surgical delivery at 121 d GA (term = 150 d). The fetus was killed humanely immediately after delivery for tissue sampling. Mitochondrial fractions were prepared from the isolated diaphragm and mitochondrial electron transfer chain activities were evaluated using enzymatic assays. Oxidative stress was investigated by quantifying mitochondrial oxidative protein levels and determining antioxidant gene and protein (catalase, superoxide dismutase 2 and glutathione peroxidase 1) expression. The activity of the erythroid 2-related factor 2 (Nrf2)-mediated antioxidant signalling pathway was examined by quantifying the Nrf2 protein content of cell lysate and nuclear extract. A 2 d LPS exposure in utero significantly decreased electron transfer chain complex II and IV activity (p<0.05). A 7 d LPS exposure inhibited superoxide dismutase 2 and catalase expression at gene and protein levels, and Nrf2 pathway activity (p<0.05) compared with control and 2 d LPS groups, respectively. Diaphragm mitochondria accumulated oxidised protein after a 7 d LPS exposure. We conclude that intrauterine exposure to LPS induces mitochondrial oxidative stress and electron chain dysfunction in the fetal diaphragm, that is further exacerbated by impairment of the antioxidant signalling pathway and decreased antioxidant activity.	[Song, Yong; Pinniger, Gavin J.; Bakker, Anthony J.; Noble, Peter B.; Pillow, Jane J.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Song, Yong; Noble, Peter B.; Berry, Clare A.; Pillow, Jane J.] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Moss, Timothy J. M.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Moss, Timothy J. M.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Pillow, Jane J.] King Edward Mem Hosp, Women & Newborns Hlth Serv, Perth, WA, Australia; [Pillow, Jane J.] Princess Margaret Hosp, Women & Newborns Hlth Serv, Perth, WA, Australia	University of Western Australia; University of Western Australia; Monash University; Monash University; King Edward Memorial Hospital; University of Western Australia	Pillow, JJ (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia.	jane.pillow@uwa.edu.au	Song, Yong/C-2407-2013; Pillow, Jane/A-3335-2009; Pinniger, Gavin/F-1421-2013; Bakker, Anthony/B-8163-2014; Moss, Timothy/A-6633-2008	Pillow, Jane/0000-0002-6500-0138; Pinniger, Gavin/0000-0002-4400-0817; Bakker, Anthony/0000-0002-6889-8932; Moss, Timothy/0000-0002-9408-4027; Song, Yong/0000-0002-8178-5641; Noble, Peter/0000-0001-9028-7751	Ada Bartholomew Medical Research Trust; NHMRC [APP1010665, 1045824]; Sylvia and Charles Viertel Senior Medical Research Fellowship	Ada Bartholomew Medical Research Trust; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Research Fellowship	This study was supported by the Ada Bartholomew Medical Research Trust (YS), NHMRC APP1010665, a Sylvia and Charles Viertel Senior Medical Research Fellowship (JJP), and NHMRC Career Development Fellowship No. 1045824 (PBN).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FH, 2001, FASEB J, V15, P309; Berry CA, 2011, REPROD SCI, V18, P1092, DOI 10.1177/1933719111404609; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey David, 2003, Curr Infect Dis Rep, V5, P365, DOI 10.1007/s11908-003-0015-9; Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC; Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysiol.01157.2004; Callahan LA, 2001, FREE RADICAL BIO MED, V30, P129, DOI 10.1016/S0891-5849(00)00454-8; Callahan LA, 2001, AM J RESP CELL MOL, V24, P210, DOI 10.1165/ajrcmb.24.2.4075; Cheah FC, 2008, PEDIATR RES, V63, P274, DOI 10.1203/PDR.0b013e31815f653b; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; MAXWELL LC, 1989, ANAT RECORD, V224, P66, DOI 10.1002/ar.1092240109; McClung JM, 2010, EXP PHYSIOL, V95, P222, DOI 10.1113/expphysiol.2009.049650; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Song Y, 2013, AM J RESP CELL MOL, V49, P866, DOI 10.1165/rcmb.2013-0107OC; Song Y, 2013, EXP BIOL MED, V238, P913, DOI 10.1177/1535370213494562; Song Y, 2012, ANAT REC, V295, P864, DOI 10.1002/ar.22436; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Supinski GS, 2007, J APPL PHYSIOL, V102, P2056, DOI 10.1152/japplphysiol.01138.2006; Supinski GS, 2006, FREE RADICAL BIO MED, V40, P127, DOI 10.1016/j.freeradbiomed.2005.09.025; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478	32	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73457	10.1371/journal.pone.0073457	http://dx.doi.org/10.1371/journal.pone.0073457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039949	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500044
J	Chang, CH; Li, JR; Shu, KH; Fu, YC; Wu, MJ				Chang, Chi-Hao; Li, Jian-Ri; Shu, Kuo-Hsiung; Fu, Yun-Ching; Wu, Ming-Ju			Hydronephrotic Urine in the Obstructed Kidney Promotes Urothelial Carcinoma Cell Proliferation, Migration, Invasion through the Activation of mTORC2-AKT and ERK Signaling Pathways	PLOS ONE			English	Article							URETERAL OBSTRUCTION; BINDING PARTNER; BLADDER-CANCER; RAPAMYCIN TOR; GROWTH; MTOR; RICTOR; RAPTOR; NUTRIENT; COMPLEX	Obstructive nephropathy is the most common presentation of urothelial carcinoma. The role of the urine in the obstructed kidney namely "hydronephrotic urine" in urothelial carcinoma has not been extensively explored. This study aims to evaluate whether hydronephrotic urine in the obstructed kidney could promote urothelial carcinoma. The hydronephrotic urine was collected from the obstructed kidneys of Sprague-Dawley rats induced by different periods of unilateral ureteral obstruction (UUO). By the inhibition of LY294002 and PD184352, we confirm that hydronephrotic urine promotes urothelial carcinoma cell (T24) and immortalized normal urothelial cells (E6) proliferation, migration and invasion in a dose-dependent manner through the activation of the mTORC2-AKT and ERK signaling pathways. Hydronephrotic urine also increases the expression of cyclin-D2, cyclin-B and CDK2. It also decreases the expression of p27 and p21 in both urothelial carcinoma cells and normal urothelial cells. By the protein array study, we demonstrate that many growth factors which promote tumor cell survival and metastasis are over-expressed in a time-dependent manner in the hydronephrotic urine, including beta-FGF, IFN-gamma, PDGF-BB, PIGF, TGF-beta, VEGF-A, VEGF-D and EGF. These results suggest that hydronephrotic urine promotes normal and malignant urothelial cells proliferation, migration and invasion, through the activation of the mTORC2-AKT and ERK signaling pathways. Further investigation using live animal models of tumor growth may be needed to clarify aspects of these statements.	[Chang, Chi-Hao; Fu, Yun-Ching; Wu, Ming-Ju] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Li, Jian-Ri] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan; [Shu, Kuo-Hsiung; Wu, Ming-Ju] Taichung Vet Gen Hosp, Div Nephrol, Dept Med, Taichung, Taiwan; [Fu, Yun-Ching] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Shu, Kuo-Hsiung; Wu, Ming-Ju] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Ju] China Med Univ, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wu, Ming-Ju] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; China Medical University Taiwan; National Chung Hsing University	Wu, MJ (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	wmj530@gmail.com			Taichung Veterans General Hospital [TCVHG-1003603C]	Taichung Veterans General Hospital	This work was supported by grant number TCVHG-1003603C from Taichung Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; CHEN KS, 1995, AM J KIDNEY DIS, V25, P694, DOI 10.1016/0272-6386(95)90544-8; Chen RJ, 2010, TOXICOL SCI, V115, P118, DOI 10.1093/toxsci/kfq028; Cheng HL, 2002, J CLIN ONCOL, V20, P1544, DOI 10.1200/JCO.20.6.1544; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Colquhoun AJ, 2002, POSTGRAD MED J, V78, P584, DOI 10.1136/pmj.78.924.584; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hoshino K, 2012, JPN J CLIN ONCOL, V42, P202, DOI 10.1093/jjco/hyr199; Ito Y, 2011, J UROLOGY, V185, P1621, DOI 10.1016/j.juro.2010.12.035; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KIYOKAWA E, 1994, CANCER RES, V54, P3645; Klahr S, 2000, INTERNAL MED, V39, P355, DOI 10.2169/internalmedicine.39.355; Lai MN, 2010, AM J KIDNEY DIS, V55, P507, DOI 10.1053/j.ajkd.2009.10.055; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Manucha W, 2007, BIOCELL, V31, P1; Ng CK, 2011, UROL ONCOL-SEMIN ORI, V29, P27, DOI 10.1016/j.urolonc.2008.10.023; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shokeir AA, 2008, INDIAN J UROL, V24, P313, DOI 10.4103/0970-1591.42611; Tai HC, 2009, TRANSPL INT, V22, P403, DOI 10.1111/j.1432-2277.2008.00798.x; Truong LD, 2011, CONTRIB NEPHROL, V169, P311, DOI 10.1159/000314578; Verhoest G, 2011, WORLD J UROL, V29, P495, DOI 10.1007/s00345-011-0710-3; Wagner M, 2008, EUR J PEDIATR SURG, V18, P156, DOI 10.1055/s-2008-1038445; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Wu MJ, 2012, UROL ONCOL-SEMIN ORI, V30, P69, DOI 10.1016/j.urolonc.2009.11.009; Wu MJ, 2004, AM J KIDNEY DIS, V43, P1091, DOI 10.1053/j.ajkd.2004.03.016; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30	37	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74300	10.1371/journal.pone.0074300	http://dx.doi.org/10.1371/journal.pone.0074300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023933	gold, Green Submitted, Green Published			2022-12-25	WOS:000324515600133
J	Zhang, XD; Jia, X; Chen, YY; Shao, JJ; Wu, XR; Shang, L; Li, B				Zhang, Xiao-dong; Jia, Xin; Chen, Yang-yun; Shao, Jun-jiong; Wu, Xin-ru; Shang, Lei; Li, Bo			Crabs Mediate Interactions between Native and Invasive Salt Marsh Plants: A Mesocosm Study	PLOS ONE			English	Article							SPARTINA-ALTERNIFLORA; NITROGEN ADDITION; ECOSYSTEM CARBON; HERBIVORY; FACILITATION; COMPETITION; RESPONSES; IMPACTS; ESTUARY; GRASS	Soil disturbance has been widely recognized as an important factor influencing the structure and dynamics of plant communities. Although soil reworkers were shown to increase habitat complexity and raise the risk of plant invasion, their role in regulating the interactions between native and invasive species remains unclear. We proposed that crab activities, via improving soil nitrogen availability, may indirectly affect the interactions between invasive Spartina alterniflora and native Phragmites australis and Scirpus mariqueter in salt marsh ecosystems. We conducted a two-year mesocosm experiment consisting of five species combinations, i.e., monocultures of three species and pair-wise mixtures of invasive and native species, with crabs being either present or absent for each combination. We found that crabs could mitigate soil nitrogen depletion in the mesocosm over the two years. Plant performance of all species, at both the ramet-level (height and biomass per ramet) and plot-level (density, total above-and belowground biomass), were promoted by crab activities. These plants responded to crab disturbance primarily by clonal propagation, as plot-level performance was more sensitive to crabs than ramet-level. Moreover, crab activities altered the competition between Spartina and native plants in favor of the former, since Spartina was more promoted than native plants by crab activities. Our results suggested that crab activities may increase the competition ability of Spartina over native Phragmites and Scirpus through alleviating soil nitrogen limitation.	[Zhang, Xiao-dong; Chen, Yang-yun; Shao, Jun-jiong; Wu, Xin-ru; Shang, Lei; Li, Bo] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Inst Biodivers Sci,Minist Educ, Shanghai 200433, Peoples R China; [Zhang, Xiao-dong] Chinese Acad Forestry, Inst Wetland Res, Key Lab Wetland Serv & Restorat, Beijing, Peoples R China; [Jia, Xin] Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China	Fudan University; Chinese Academy of Forestry; Institute of Wetland Research, CAF; Beijing Forestry University	Li, B (corresponding author), Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Inst Biodivers Sci,Minist Educ, Shanghai 200433, Peoples R China.	bool@fudan.edu.cn	Shao, Junjiong/G-1010-2016; Li, Bo/B-8016-2010; Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-0439-5666; Li, Bo/0000-0002-7294-6888	National Basic Research Program of China [2013CB430404]; National Science Foundation of China [30930019]; Science and Technology Commission of Shanghai Municipality [10JC1400700, 12XD1400500]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was financially supported by National Basic Research Program of China (Grant No. 2013CB430404), National Science Foundation of China (Grant No. 30930019), and the Science and Technology Commission of Shanghai Municipality (Grant No. 10JC1400700 and 12XD1400500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2008, ECOLOGY, V89, P155, DOI 10.1890/07-0045.1; Badano EI, 2007, J ECOL, V95, P682, DOI 10.1111/j.1365-2745.2007.01262.x; Brooks ML, 2003, J APPL ECOL, V40, P344, DOI 10.1046/j.1365-2664.2003.00789.x; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Crain CM, 2007, ESTUAR COAST, V30, P26, DOI 10.1007/BF02782964; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Cushman JH, 2011, J ECOL, V99, P524, DOI 10.1111/j.1365-2745.2010.01776.x; Dai T, 1997, ESTUAR COAST SHELF S, V45, P273, DOI 10.1006/ecss.1996.0175; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Jiang LF, 2009, ESTUAR COAST SHELF S, V81, P74, DOI 10.1016/j.ecss.2008.09.018; Lee SY, 1998, MAR FRESHWATER RES, V49, P335, DOI 10.1071/MF97179; Liao CZ, 2007, ECOSYSTEMS, V10, P1351, DOI 10.1007/s10021-007-9103-2; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Madrigal J, 2011, ECOLOGY, V92, P282, DOI 10.1890/10-0643.1; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Medina-Roldan E, 2012, OECOLOGIA, V170, P159, DOI 10.1007/s00442-012-2287-y; Mothershead K, 2000, ECOLOGY, V81, P30, DOI 10.2307/177131; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Peng RH, 2011, OECOLOGIA, V165, P797, DOI 10.1007/s00442-010-1887-7; Poelman EH, 2011, ECOL LETT, V14, P670, DOI 10.1111/j.1461-0248.2011.01629.x; Qin HM, 2010, MAR ECOL PROG SER, V415, P177, DOI 10.3354/meps08771; R Core Team, 2021, R LANG ENV STAT COMP; Rickey MA, 2004, J APPL ECOL, V41, P888, DOI 10.1111/j.0021-8901.2004.00948.x; Robinson CH, 1995, OIKOS, V74, P503, DOI 10.2307/3545996; Sessions L, 2002, OIKOS, V96, P102, DOI 10.1034/j.1600-0706.2002.960111.x; STRAUSS SY, 1991, TRENDS ECOL EVOL, V6, P206, DOI 10.1016/0169-5347(91)90023-Q; Tyler AC, 2007, ECOL APPL, V17, P1886, DOI 10.1890/06-0822.1; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Vazquez DP, 2004, ECOL MONOGR, V74, P281, DOI 10.1890/02-4055; Wang CH, 2009, THESIS FUDAN U CHINA; Wang CH, 2009, ECOLOGICAL RES, V25, P347; Wang JQ, 2010, ECOSYSTEMS, V13, P586, DOI 10.1007/s10021-010-9342-5; Wang JQ, 2008, THESIS FUDAN U CHINA; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Yurkonis KA, 2005, J ECOL, V93, P1053, DOI 10.1111/j.1365-2745.2005.01029.x; Zeng DH, 2010, BIOGEOCHEMISTRY, V98, P185, DOI 10.1007/s10533-009-9385-x	39	10	10	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74095	10.1371/journal.pone.0074095	http://dx.doi.org/10.1371/journal.pone.0074095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023926	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600129
J	Marwarha, G; Berry, DC; Croniger, CM; Noy, N				Marwarha, Gurdeep; Berry, Daniel C.; Croniger, Colleen M.; Noy, Noa			The retinol esterifying enzyme LRAT supports cell signaling by retinol- binding protein and its receptor STRA6	FASEB JOURNAL			English	Article						vitamin A metabolism; JAK; STAT; cytokine receptors; insulin receptor; obesity	VITAMIN-A; INSULIN-RESISTANCE; ESTER BIOSYNTHESIS; RAT-LIVER; ACID; ACYLTRANSFERASE; ESTERIFICATION; HOMEOSTASIS; TRANSTHYRETIN; LECITHIN	Vitamin A, retinol, circulates in blood bound to retinol-binding protein (RBP). At some tissues, holo-RBP is recognized by a plasma membrane receptor termed STRA6, which serves a dual role: it mediates transport of retinol from RBP into cells, and it functions as a cytokine receptor that, on binding holo-RBP, activates JAK2/STAT5 signaling. As STAT target genes include SOCS3, an inhibitor of insulin receptor, holo-RBP suppresses insulin responses in STRA6-expressing cells. We have shown previously that the two functions of STRA6 are interdependent. These observations suggest factors that regulate STRA6-mediated retinol transport may also control STRA6-mediated cell signaling. One such factor is retinol metabolism, which enables cellular uptake of retinol by maintaining an inward-directed concentration gradient. We show here that lecithin:retinol acyl transferase (LRAT), which catalyzes esterification of retinol to its storage species retinyl esters, is necessary for activation of the STRA6/JAK2/STAT5 cascade by holo-RBP. In accordance, LRAT-null mice are protected from holo-RBP-induced suppression of insulin responses. Hence, STRA6 signaling, which requires STRA6-mediated retinol transport, is supported by LRAT-catalyzed retinol metabolism. The observations demonstrate that STRA6 regulates key cellular processes by coupling circulating holo-RBP levels and intracellular retinol metabolism to cell signaling.Marwarha, G., Berry, D.C., Croniger, C.M., Noy, N. The retinol esterifying enzyme LRAT supports cell signaling by retinol-binding protein and its receptor STRA6.	[Marwarha, Gurdeep; Berry, Daniel C.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Berry, Daniel C.; Croniger, Colleen M.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu		MARWARHA, GURDEEP/0000-0001-5556-0003	U.S. National Institutes of Health (NIH) [RO1 DK088969]; NIH [DK59630]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, R01DK088969, U24DK059630] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to Krzysztof Palczewski (Case Western Reserve University) for sharing the Lrat-null mice and Lrat expression vector, Norbert Ghyselinck (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg, France) for STRA6 antibodies, and Silke Vogel (Columbia University School of Physicians and Surgeons, New York, NY, USA) for the RBP expression construct. This work was supported by U.S. National Institutes of Health (NIH) grant RO1 DK088969. The Mouse Metabolic Phenotyping Center (MMPC) of Case Western Reserve University is supported by NIH grant DK59630.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Berry D. C., 2013, J BIOL CHEM; Berry DC, 2012, MOL CELL BIOL, V32, P3851, DOI 10.1128/MCB.00775-12; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Jiang WY, 2012, BBA-GEN SUBJECTS, V1820, P859, DOI 10.1016/j.bbagen.2012.03.016; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mody N, 2008, AM J PHYSIOL-ENDOC M, V294, pE785, DOI 10.1152/ajpendo.00521.2007; NAPOLI JL, 1995, J STEROID BIOCHEM, V53, P497, DOI 10.1016/0960-0760(95)00096-I; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; ONG DE, 1988, J BIOL CHEM, V263, P5789; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; POSCH KC, 1992, J BIOL CHEM, V267, P19676; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; RAZ A, 1969, J BIOL CHEM, V244, P3230; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; SOPRANO DR, 1981, J BIOL CHEM, V256, P8256; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; YOST RW, 1988, J BIOL CHEM, V263, P18693	36	20	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					26	34		10.1096/fj.13-234310	http://dx.doi.org/10.1096/fj.13-234310			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24036882	Green Published			2022-12-25	WOS:000333526100005
J	Casper, BM; Halvorsen, MB; Matthews, F; Carlson, TJ; Popper, AN				Casper, Brandon M.; Halvorsen, Michele B.; Matthews, Frazer; Carlson, Thomas J.; Popper, Arthur N.			Recovery of Barotrauma Injuries Resulting from Exposure to Pile Driving Sound in Two Sizes of Hybrid Striped Bass	PLOS ONE			English	Article								The effects of loud sounds on fishes, such as those produced during impulsive pile driving, are an increasing concern in the management of aquatic ecosystems. However, very little is known about such effects. Accordingly, a High Intensity Controlled Impedance Fluid Filled wave Tube (HICI-FT) was used to investigate the effects of sounds produced by impulsive pile driving on two size groups of hybrid striped bass (white bass Morone chrysops x striped bass Morone saxatilis). The larger striped bass (mean size 17.2 g) had more severe injuries, as well as more total injuries, than the smaller fish (mean size 1.3 g). However, fish in each size group recovered from most injuries within 10 days of exposure. A comparison with different species from previously published studies show that current results support the observation that fishes with physoclistous swim bladders are more susceptible to injury from impulsive pile driving than are fishes with physostomous swim bladders.	[Casper, Brandon M.; Matthews, Frazer; Popper, Arthur N.] Univ Maryland, Dept Biol, Ctr Comparat & Evolutionary Biol Hearing, College Pk, MD 20742 USA; [Halvorsen, Michele B.; Carlson, Thomas J.] Pacific NW Natl Lab, Marine Sci Lab, Sequim, WA USA	University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Casper, BM (corresponding author), New London Submarine Base, Naval Submarine Med Res Lab, Groton, CT USA.	bcasper@umd.edu	Matthews, Fiona/O-6932-2015	Matthews, Fiona/0000-0002-1728-2388	Bureau of Ocean Energy Management, California Transportation Authority, National Cooperative Highway Research Program	Bureau of Ocean Energy Management, California Transportation Authority, National Cooperative Highway Research Program	Bureau of Ocean Energy Management, California Transportation Authority, National Cooperative Highway Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolle LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033052; Carlson T. J., 2007, UPDATE RECOMMENDATIO; Casper BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039593; Dalecki D, 2008, BIOACOUSTICS, V17, P299, DOI [10.1080/09524622.2008.9753855., DOI 10.1080/09524622.2008.9753855]; Govoni JJ, 2003, J AQUAT ANIM HEALTH, V15, P111, DOI 10.1577/H02-030; Halvorsen M. B., 2011, PREDICTING MITIGATIN; Halvorsen MB, 2012, P ROY SOC B-BIOL SCI, V279, P4705, DOI 10.1098/rspb.2012.1544; Halvorsen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038968; Hastings MC, 2005, EFFECTS SOUND FISH, P1; MacGillivray A, 2005, SOUND PRESSURE PARTI, P1; Normandeau Associates, 2012, EFF NOIS FISH FISH I; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper A.N., 2012, EFFECTS NOISE AQUATI; Stadler JH, 2009, ASSESSING EFFECTS FI; Woodbury D, 2008, BIOACOUSTICS, V17, P289, DOI DOI 10.1080/09524622.2008.9753852; Yelverton JT, 1975, 3677T DNA LOV FDN	16	40	40	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73844	10.1371/journal.pone.0073844	http://dx.doi.org/10.1371/journal.pone.0073844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040089	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500055
J	de Tayrac, M; Saikali, S; Aubry, M; Bellaud, P; Boniface, R; Quillien, V; Mosser, J				de Tayrac, Marie; Saikali, Stephan; Aubry, Marc; Bellaud, Pascale; Boniface, Rachel; Quillien, Veronique; Mosser, Jean			Prognostic Significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, Four New Markers in High-Grade Gliomas	PLOS ONE			English	Article							ASSEMBLY FACTOR-I; ENDOTHELIN-B RECEPTOR; GLIOBLASTOMA-MULTIFORME; BREAST-CANCER; FOLLOW-UP; CENP-A; EXPRESSION; CELLS; OVEREXPRESSION; CARCINOMA	Background: Recent studies have highlighted the heterogeneity of gliomas and demonstrated that molecular and genetic analysis could help in their classification and in the design of treatment protocols. In a previous study we have identified a 4-gene signature highly correlated with survival of glioma patients. The aim of this study is to confirm and extend these findings by investigating the expression of these genes at the protein level and their association with outcome of patients with high grade gliomas. Methodology/Principal Findings: Immunohistochemical staining for EDN/RB, HJURP, p60/CAF-1 and PDLI4 was studied on archive materials from 96 patients (64 glioblastomas and 32 grade III gliomas). The levels of all four proteins differed significantly between grade III and grade IV tumours. The levels of the EDN/RB, HJURP and p60/CAF-1 proteins were strongly associated with overall survival (p<0.001, p<0.001 and p=0.002, respectively), whereas the one of PDLI4 was not (P=0.11). A risk criterion defined as high levels of at least two of the EDN/RB, HJURP and p60/CAF-1 proteins accurately predicted the prognosis of patients. Multivariate analysis confirmed that this criterion was an independent negative prognostic marker (hazard ratio = 2.225; 95% CI, 1.248 to 3.966, p=0.007). Conclusions: The expression of the EDN/RB, HJURP, p60/CAF-1 and PDLI4 proteins is disrupted in high grade gliomas and increases in the levels of these proteins are closely linked to tumour aggressiveness and poor outcome.	[de Tayrac, Marie; Boniface, Rachel; Quillien, Veronique; Mosser, Jean] Inst Genet & Dev Rennes, CNR, UMR 6290, Rennes, France; [de Tayrac, Marie; Boniface, Rachel; Quillien, Veronique; Mosser, Jean] Univ Rennes 1, UEB Univ Europeenne Bretagne, Fac Med, Biosit, Rennes, France; [de Tayrac, Marie; Mosser, Jean] CHU Rennes, Serv Genet Mol & Genom, Rennes, France; [Saikali, Stephan] CHU Rennes, Serv Anat & Cytol Pathol, Rennes, France; [Aubry, Marc; Mosser, Jean] Biosit, Plate Forme Genom Sante Biogenouest, Rennes, France; [Bellaud, Pascale] Biosit, Plate Forme Histopathol, Rennes, France; [Quillien, Veronique] Ctr Eugene Marquis, Dept Biol Med, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; CHU Rennes; CHU Rennes; UNICANCER; Centre Eugene Marquis	Mosser, J (corresponding author), Inst Genet & Dev Rennes, CNR, UMR 6290, Rennes, France.	jean.mosser@univ-rennes1.fr	Aubry, Marc/GNW-2661-2022; de Tayrac, Marie/AAG-7800-2020	Quillien, Veronique/0000-0002-1465-3753	Canceropole Grand-Ouest Glioma Project; Institut national du cancer (INCa); Ligue contre le Cancer foundation (LNCC); Region Bretagne (PRIR); CRITT Sante Bretagne	Canceropole Grand-Ouest Glioma Project; Institut national du cancer (INCa)(Institut National du Cancer (INCA) France); Ligue contre le Cancer foundation (LNCC); Region Bretagne (PRIR)(Region Bretagne); CRITT Sante Bretagne	This work was supported by grants from the Canceropole Grand-Ouest Glioma Project, Institut national du cancer (INCa), Ligue contre le Cancer foundation (LNCC), Region Bretagne (PRIR) and CRITT Sante Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SI, 2000, AM J RESP CELL MOL, V22, P422, DOI 10.1165/ajrcmb.22.4.3795; Anguelova E, 2005, MOL BRAIN RES, V137, P77, DOI 10.1016/j.molbrainres.2005.02.015; Bagnato A, 1999, CANCER RES, V59, P720; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; Demunter A, 2001, VIRCHOWS ARCH, V438, P485, DOI 10.1007/s004280000362; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Karayan-Tapon L, 2010, J NEURO-ONCOL, V97, P311, DOI 10.1007/s11060-009-0031-1; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mascolo M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-63; Naidoo V, 2005, CANCER-AM CANCER SOC, V104, P1049, DOI 10.1002/cncr.21277; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Polo SE, 2004, CANCER RES, V64, P2371, DOI 10.1158/0008-5472.CAN-03-2893; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Staibano S, 2007, HISTOPATHOLOGY, V50, P911, DOI 10.1111/j.1365-2559.2007.02698.x; Staibano S, 2009, HISTOPATHOLOGY, V54, P580, DOI 10.1111/j.1365-2559.2009.03266.x; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Valente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062200; Vanaja DK, 2006, CLIN CANCER RES, V12, P1128, DOI 10.1158/1078-0432.CCR-05-2072; Wulfing C, 2005, EUR UROL, V47, P593, DOI 10.1016/j.eururo.2004.12.019; Wulfing P, 2003, CLIN CANCER RES, V9, P4125	27	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73332	10.1371/journal.pone.0073332	http://dx.doi.org/10.1371/journal.pone.0073332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039914	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500031
J	Longdon, B; Cao, C; Martinez, J; Jiggins, FM				Longdon, Ben; Cao, Chuan; Martinez, Julien; Jiggins, Francis M.			Previous Exposure to an RNA Virus Does Not Protect against Subsequent Infection in Drosophila melanogaster	PLOS ONE			English	Article							RED FLOUR BEETLE; ANTIVIRAL IMMUNITY; C-VIRUS; MEALWORM BEETLE; INNATE IMMUNITY; INSECT; INTERFERENCE; SPECIFICITY; POPULATION; RESISTANCE	Background: Immune priming has been shown to occur in a wide array of invertebrate taxa, with individuals exposed to a pathogen showing increased protection upon subsequent exposure. However, the mechanisms underlying immune priming are poorly understood. The antiviral RNAi response in Drosophila melanogaster is an ideal candidate for providing a specific and acquired response to subsequent infection. We exposed D. melanogaster to two challenges of a virus known to produce an antiviral RNAi response, to examine whether any protective effects of prior exposure on survival were observed. Results: In this experiment we found no evidence that prior exposure to Drosophila C Virus (DCV) protects flies from a subsequent lethal challenge, with almost identical levels of mortality in flies previously exposed to DCV or a control. Conclusions: Our results confirm the finding that 'acquired' immune responses are not ubiquitous across all invertebrate-pathogen interactions. We discuss why we may have observed no effect in this study, with focus on the mechanistic basis of the RNAi pathway.	[Longdon, Ben; Cao, Chuan; Martinez, Julien; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge	Longdon, B (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	b.longdon@gen.cam.ac.uk	Longdon, Ben/F-4132-2010; Martinez, Julien/AAW-6287-2020; Longdon, Ben/AAE-4224-2021	Longdon, Ben/0000-0001-6936-1697; Martinez, Julien/0000-0001-8210-2921; Jiggins, Francis Michael/0000-0001-7470-8157; Cao, Chuan/0000-0002-0320-1110	European Research Council [281668]; Junior Research Fellowship from Christ's College, Cambridge; Royal Society University Research Fellowship; Wellcome Trust [WT094664MA]; Cambridge Overseas Trust/Chinese Scholarship Council studentship	European Research Council(European Research Council (ERC)European Commission); Junior Research Fellowship from Christ's College, Cambridge; Royal Society University Research Fellowship(Royal Society of London); Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge Overseas Trust/Chinese Scholarship Council studentship	This work is supported by a European Research Council grant (281668, DrosophilaInfection: FMJ and BL), a Junior Research Fellowship from Christ's College, Cambridge (BL), a Royal Society University Research Fellowship (FMJ), a Wellcome Trust Grant (WT094664MA: JM) and a Cambridge Overseas Trust/Chinese Scholarship Council studentship (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Best A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0887; Boldogh I, 1996, MED MICROBIOLOGY; Brun G., 1980, Genetics and Biology of Drosophila, V2d, P625; BUCHENOSMOND C, 2006, ICTVDB UNIVERSAL VIR; Christian P.D., 1987, STUDIES DROSOPHILA C; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Filipe D, 1998, ENDOCYTOBIOSIS CELL, V12, P163; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542; GOMARIZZILBER E, 1995, J INVERTEBR PATHOL, V65, P243, DOI 10.1006/jipa.1995.1037; Gonzalez-Tokman DM, 2010, PHYSIOL ENTOMOL, V35, P364, DOI 10.1111/j.1365-3032.2010.00752.x; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Huszart T, 2008, ADV VIRUS RES, V72, P227, DOI 10.1016/S0065-3527(08)00406-5; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; JOUSSET FX, 1975, ANN INST PASTEUR MIC, VB126, P231; Karlikow M, 2013, DEV COMP IMMUNOL; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; LAUTIEHARIVEL N, 1990, BIOL CELL, V69, P35, DOI 10.1016/0248-4900(90)90326-X; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Linder JE, 2009, FLY, V3, P143, DOI 10.4161/fly.8051; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Little TJ, 2004, TRENDS ECOL EVOL, V19, P58, DOI 10.1016/j.tree.2003.11.011; Longdon B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S8; Longdon B, 2010, P ROY SOC B-BIOL SCI, V277, P35, DOI 10.1098/rspb.2009.1472; Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; McTaggart SJ, 2012, BIOL LETTERS, V8, P972, DOI 10.1098/rsbl.2012.0581; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Reber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035372; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2009, BIOL LETTERS, V5, P798, DOI 10.1098/rsbl.2009.0458; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Therneau T, 2012, COXME MIXED EFFECTS; Tidbury H., 2012, EVOLUTIONARY ECOLOGY; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Vale PF, 2009, HEREDITY, V103, P102, DOI 10.1038/hdy.2009.54; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vodovar N, 2012, ADV INSECT PHYSIOL, V42, P1, DOI 10.1016/B978-0-12-387680-5.00001-X; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Wu JL, 2002, FISH SHELLFISH IMMUN, V13, P391, DOI 10.1006/fsim.2002.0414; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu J, 2013, DEV COMP IMMUNOL	63	32	32	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73833	10.1371/journal.pone.0073833	http://dx.doi.org/10.1371/journal.pone.0073833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040086	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500053
J	Dahan, L; Huang, LY; Kedmi, R; Behlke, MA; Peer, D				Dahan, Liya; Huang, Lingyan; Kedmi, Ranit; Behlke, Mark A.; Peer, Dan			SNP Detection in mRNA in Living Cells Using Allele Specific FRET Probes	PLOS ONE			English	Article							HARVEY-RAS GENE; CANCER; EXPRESSION; DESIGN	Live mRNA detection allows real time monitoring of specific transcripts and genetic alterations. The main challenge of live genetic detection is overcoming the high background generated by unbound probes and reaching high level of specificity with minimal off target effects. The use of Fluorescence Resonance Energy Transfer (FRET) probes allows differentiation between bound and unbound probes thus decreasing background. Probe specificity can be optimized by adjusting the length and through use of chemical modifications that alter binding affinity. Herein, we report the use of two oligonucleotide FRET probe system to detect a single nucleotide polymorphism (SNP) in murine Hras mRNA, which is associated with malignant transformations. The FRET oligonucleotides were modified with phosphorothioate (PS) bonds, 2'OMe RNA and LNA residues to enhance nuclease stability and improve SNP discrimination. Our results show that a point mutation in Hras can be detected in endogenous RNA of living cells. As determined by an Acceptor Photobleaching method, FRET levels were higher in cells transfected with perfect match FRET probes whereas a single mismatch showed decreased FRET signal. This approach promotes in vivo molecular imaging methods and could further be applied in cancer diagnosis and theranostic strategies.	[Dahan, Liya; Kedmi, Ranit; Peer, Dan] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Dahan, Liya; Kedmi, Ranit; Peer, Dan] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel; [Huang, Lingyan; Behlke, Mark A.] Integrated DNA Technol, Coralville, IA 52241 USA	Tel Aviv University; Tel Aviv University	Behlke, MA (corresponding author), Integrated DNA Technol, Coralville, IA 52241 USA.	mbehlke@idtdna.com; peer@tauex.tau.ac.il	Peer, Dan/A-1785-2011	Peer, Dan/0000-0001-8238-0673; Behlke, Mark/0000-0002-4218-857X	Israeli Centre of Research Excellence (I- CORE), Gene Regulation in Complex Human Disease [41/11]; Lewis Family Trust\	Israeli Centre of Research Excellence (I- CORE), Gene Regulation in Complex Human Disease; Lewis Family Trust\	This work was supported in part by the grants from the Lewis Family Trust, the Israeli Centre of Research Excellence (I- CORE), Gene Regulation in Complex Human Disease, Center No 41/11; FTA: Nanomedicine for Personalized Theranostics, and by The Leona M. and Harry B. Helmsley Nanotechnology Research Fund awarded to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; [Anonymous], 2012, ELEGANT BIOSENSOR MO; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Bao Gang, 2010, Nanomedicine (Chichester), P143; Bao G, 2009, ANNU REV BIOMED ENG, V11, P25, DOI 10.1146/annurev-bioeng-061008-124920; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; BLAND KI, 1995, ANN SURG, V221, P706, DOI 10.1097/00000658-199506000-00010; Chen AK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq436; Chen AK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp837; Chen AK, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn331; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fenech M, 2002, TOXICOLOGY, V181, P411, DOI 10.1016/S0300-483X(02)00480-8; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hung SC, 1997, ANAL BIOCHEM, V252, P78, DOI 10.1006/abio.1997.2287; JU JY, 1995, ANAL BIOCHEM, V231, P131, DOI 10.1006/abio.1995.1512; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Khan GA, 2005, J INVEST DERMATOL, V125, P567, DOI 10.1111/j.0022-202X.2005.23845.x; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Lennox KA, 2010, PHARM RES-DORDR, V27, P1788, DOI 10.1007/s11095-010-0156-0; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Molenaar C, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e89; Okabe K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1196; Rodrigo JP, 2005, HEAD NECK-J SCI SPEC, V27, P995, DOI 10.1002/hed.20257; Tsourkas A, 2003, ANAL CHEM, V75, P3697, DOI 10.1021/ac034295l; Tsuji A, 2000, BIOPHYS J, V78, P3260, DOI 10.1016/S0006-3495(00)76862-7; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; van Dam RM, 2002, GENOME RES, V12, P145, DOI 10.1101/gr.198901; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	31	15	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72389	10.1371/journal.pone.0072389	http://dx.doi.org/10.1371/journal.pone.0072389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039756	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300009
J	Davies, SW; Matz, MV; Vize, PD				Davies, Sarah W.; Matz, Mikhail V.; Vize, Peter D.			Ecological Complexity of Coral Recruitment Processes: Effects of Invertebrate Herbivores on Coral Recruitment and Growth Depends Upon Substratum Properties and Coral Species	PLOS ONE			English	Article							FLOWER GARDEN BANKS; GULF-OF-MEXICO; PHASE-SHIFTS; SCLERACTINIAN CORALS; MASS MORTALITY; SEA-URCHIN; DIADEMA-ANTILLARUM; LIFE-HISTORIES; CARIBBEAN REEF; ALGAL TURFS	Background: The transition from planktonic planula to sessile adult corals occurs at low frequencies and post settlement mortality is extremely high. Herbivores promote settlement by reducing algal competition. This study investigates whether invertebrate herbivory might be modulated by other ecological factors such as substrata variations and coral species identity. Methodology/Principal Findings: The experiment was conducted at the Flower Garden Banks, one of the few Atlantic reefs not experiencing considerable degradation. Tiles of differing texture and orientation were kept in bins surrounded by reef (24 m). Controls contained no herbivores while treatment bins contained urchins (Diadema antillarum) or herbivorous gastropods (Cerithium litteratum). Juvenile corals settling naturally were monitored by photography for 14 months to evaluate the effects of invertebrate herbivory and substratum properties. Herbivory reduced algae cover in urchin treatments. Two genera of brooding coral juveniles were observed, Agaricia and Porites, both of which are common but not dominant on adjacent reef. No broadcast spawning corals were observed on tiles. Overall, juveniles were more abundant in urchin treatments and on vertical, rough textured surfaces. Although more abundant, Agaricia juveniles were smaller in urchin treatments, presumably due to destructive overgrazing. Still, Agaricia growth increased with herbivory and substrata texture-orientation interactions were observed with reduced growth on rough tiles in control treatments and increased growth on vertical tiles in herbivore treatments. In contrast to Agaricia, Porites juveniles were larger on horizontal tiles, irrespective of herbivore treatment. Mortality was affected by substrata orientation with vertical surfaces increasing coral survival. Conclusions/Significance: We further substantiate that invertebrate herbivores play major roles in early settlement processes of corals and highlight the need for deeper understanding of ecological interactions modulating these effects. The absence of broadcast-spawning corals, even on a reef with consistently high coral cover, continues to expose the recruitment failure of these reef-building corals throughout the Caribbean.	[Davies, Sarah W.; Matz, Mikhail V.] Univ Texas Austin, Integrat Biol Sect, Austin, TX 78712 USA; [Davies, Sarah W.; Vize, Peter D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Texas System; University of Texas Austin; University of Calgary	Davies, SW (corresponding author), Univ Texas Austin, Integrat Biol Sect, Austin, TX 78712 USA.	daviessw@gmail.com	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819	Natural Sciences and Engineering Research Council of Canada (NSERC) PGS-M; University of Calgary; National Science Foundation [DEB-1054766]	Natural Sciences and Engineering Research Council of Canada (NSERC) PGS-M(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary; National Science Foundation(National Science Foundation (NSF))	Natural Sciences and Engineering Research Council of Canada (NSERC) PGS-M to SWD; ACCESS Funding from the University of Calgary to SWD; National Science Foundation grant DEB-1054766 to MVM. Boat time provided by FGBNMS under permit#FGBNMS-2007-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Babcock RC, 1985, P 5 COR REEF S TAH, V4, P279; BAK RPM, 1984, MAR ECOL PROG SER, V17, P105, DOI 10.3354/meps017105; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bright, 1985, P 5 INT COR REEF C, V4, P379; BRIGHT T J, 1974, P435; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; Carpenter SR, 1997, OIKOS, V78, P3, DOI 10.2307/3545794; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Continental Shelf Associates Inc. (CSA), 1984, IMP ASS FOLL ANCH IN, P25; Edmunds PJ, 2004, MAR ECOL PROG SER, V269, P111, DOI 10.3354/meps269111; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Gardner TA, 2003, SCIENCE, V302, P392; Graham EM, 2013, OECOLOGIA; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HARRISON PL, 1990, CORAL REEFS ECOSYSTE, V25, P133; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; KARLSON RH, 1988, ECOLOGY, V69, P1219, DOI 10.2307/1941277; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P4822, DOI 10.1073/pnas.091107198; Korzen L, 2011, J MARINE BIOL, V2011, P1; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lang JC, 2001, CORAL REEFS, V20, P126, DOI 10.1007/s003380000111; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; Nozawa Yoko, 2010, Galaxea - Tokyo, V12, P31; Nozawa Y, 2008, J EXP MAR BIOL ECOL, V367, P127, DOI 10.1016/j.jembe.2008.09.004; Omori M, 2006, CORAL REEFS, V25, P280, DOI 10.1007/s00338-006-0103-z; Petersen D, 2005, AQUACULTURE, V249, P317, DOI 10.1016/j.aquaculture.2005.04.048; Pfister CA, 2002, ECOLOGY, V83, P59; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; R Core Development Team, 2013, R LANG ENV STAT COMP; REZAK R, 1990, AM ZOOL, V30, P23; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; ROGERS CS, 1984, CORAL REEFS, V3, P69, DOI 10.1007/BF00263756; RYLAARSDAM KW, 1983, MAR ECOL PROG SER, V13, P249, DOI 10.3354/meps013249; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Sammarco PW, 1982, P 4 COR REEF S MAN, V2, P339; Schmahl George R., 2008, V1, P221, DOI 10.1007/978-1-4020-6847-8_6; Spieler RE, 2001, B MAR SCI, V69, P1013; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Vermeij Mark J.A., 2011, Diversity, V3, P296, DOI 10.3390/d3030296; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Zimmer B., 2010, LONG TERM MONITORING	66	25	25	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72830	10.1371/journal.pone.0072830	http://dx.doi.org/10.1371/journal.pone.0072830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039807	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300030
J	Jiang, XD; Li, QM; Liang, HS; Zhao, SY; Zhang, LH; Zhao, YL; Chen, LQ; Yang, W; Xiang, XY				Jiang, Xiaodong; Li, Qingmei; Liang, Huishuang; Zhao, Shiye; Zhang, Lihua; Zhao, Yunlong; Chen, Liqiao; Yang, Wei; Xiang, Xingyu			Clonal Variation in Growth Plasticity within a Bosmina longirostris Population: The Potential for Resistance to Toxic Cyanobacteria	PLOS ONE			English	Article							EUTROPHIC LAKE TAIHU; PHENOTYPIC PLASTICITY; DAPHNIA-MAGNA; PROTEASE INHIBITORS; MICROCYSTIS-AERUGINOSA; INDUCIBLE TOLERANCE; GENETIC-VARIATION; B-PELLUCIDA; ZOOPLANKTON; EVOLUTION	Many aquatic organisms respond phenotypically, through morphological, behavioral, and physiological plasticity, to environmental changes. The small-size cladoceran Bosmina longirostris, a dominant zooplankter in eutrophic waters, displayed reduced growth rates in response to the presence of a toxic cyanobacterium, Microcystis aeruginosa, in their diets. The magnitude of growth reduction differed among 15 clones recently isolated from a single population. A significant interaction between clone and food type indicated a genetic basis for the difference in growth plasticity. The variation in phenotypic plasticity was visualized by plotting reaction norms with two diets. The resistance of each clone to dietary cyanobacteria was measured as the relative change in growth rates on the "poor" diet compared with the "good" diet. The enhanced resistance to M. aeruginosa in B. longirostris was derived from both the reduced slope of reaction norms and the increased mean growth rates with two diets. The large clonal variation within a B. longirostris population may contribute to local adaptation to toxic cyanobacteria and influence ecosystem function via clonal succession.	[Jiang, Xiaodong; Li, Qingmei; Liang, Huishuang; Zhao, Shiye; Zhang, Lihua; Zhao, Yunlong; Chen, Liqiao; Yang, Wei; Xiang, Xingyu] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Jiang, XD (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	xdjiang@bio.ecnu.edu.cn	Jiang, Xiaodong/F-9678-2013	Jiang, Xiaodong/0000-0001-7998-0440; Chen, Liqiao/0000-0003-0138-7828; Zhao, Shiye/0000-0003-1559-502X	National Science Foundation of China [31272307]; Special Fund for Agro-scientific Research in the Public Interest [201203065]; Fundamental Research Funds for the Central Universities	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science Foundation of China (31272307, http://www.nsfc.gov.cn), Special Fund for Agro-scientific Research in the Public Interest (201203065, http://www.most.gov.cn/), and Fundamental Research Funds for the Central Universities (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes N, 2009, ANN LIMNOL-INT J LIM, V45, P237, DOI 10.1051/limn/2009027; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; CARVALHO GR, 1987, J ANIM ECOL, V56, P469, DOI 10.2307/5061; Chen FZ, 2012, LIMNOLOGICA, V42, P189, DOI 10.1016/j.limno.2011.11.001; Dao TS, 2010, TOXICON, V55, P1244, DOI 10.1016/j.toxicon.2010.01.014; de Kluijver A, 2012, LIMNOL OCEANOGR, V57, P1245, DOI 10.4319/lo.2012.57.4.1245; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; GILBERT JJ, 1990, ECOLOGY, V71, P1727, DOI 10.2307/1937581; Guo NC, 2006, ENVIRON POLLUT, V143, P513, DOI 10.1016/j.envpol.2005.11.044; Gustafsson S, 2005, ECOLOGY, V86, P2561, DOI 10.1890/04-1710; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; Hairston NG, 1996, ECOLOGY, V77, P2382, DOI 10.2307/2265740; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; HEBERT PDN, 1980, SCIENCE, V207, P1363, DOI 10.1126/science.207.4437.1363; Jeppesen E, 2001, TRENDS ECOL EVOL, V16, P191, DOI 10.1016/S0169-5347(01)02100-0; Jiang XD, 2013, ENVIRON POLLUT, V178, P142, DOI 10.1016/j.envpol.2013.03.017; Jiang XD, 2013, HYDROBIOLOGIA, V702, P105, DOI 10.1007/s10750-012-1312-9; Jiang XD, 2011, LIMNOL OCEANOGR, V56, P947, DOI 10.4319/lo.2011.56.3.0947; Kappes H, 2005, MAR FRESHW BEHAV PHY, V38, P199, DOI 10.1080/10236240500310013; Kappes H, 2002, FRESHWATER BIOL, V47, P1944, DOI 10.1046/j.1365-2427.2002.00943.x; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; KOIVISTO S, 1995, AQUAT TOXICOL, V32, P255, DOI 10.1016/0166-445X(94)00094-7; Lemaire V, 2012, EVOL APPL, V5, P168, DOI 10.1111/j.1752-4571.2011.00225.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Ortiz-Rodriguez R, 2012, J EXP BIOL, V215, P2795, DOI 10.1242/jeb.069211; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schwarzenberger A, 2013, OECOLOGIA, V172, P11, DOI 10.1007/s00442-012-2479-5; Schwarzenberger A, 2012, MOL ECOL, V21, P4898, DOI 10.1111/j.1365-294X.2012.05753.x; Schwarzenberger Anke, 2010, BMC Physiology, V10, P6, DOI 10.1186/1472-6793-10-6; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; Stirling G, 2000, ANIM BEHAV, V59, P929, DOI 10.1006/anbe.1999.1386; URABE J, 1991, FRESHWATER BIOL, V26, P57, DOI 10.1111/j.1365-2427.1991.tb00508.x; von Elert E, 2012, J EXP BIOL, V215, P2051, DOI 10.1242/jeb.068742; White JD, 2011, LIMNOL OCEANOGR, V56, P1714, DOI 10.4319/lo.2011.56.5.1714; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915	41	12	12	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73540	10.1371/journal.pone.0073540	http://dx.doi.org/10.1371/journal.pone.0073540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039976	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300088
J	Nakane, T; Nomura, T; Shi, S; Nakamura, M; Naruse, TK; Kimura, A; Matano, T; Yamamoto, H				Nakane, Taku; Nomura, Takushi; Shi, Shoi; Nakamura, Midori; Naruse, Taeko K.; Kimura, Akinori; Matano, Tetsuro; Yamamoto, Hiroyuki			Limited Impact of Passive Non-Neutralizing Antibody Immunization in Acute SIV Infection on Viremia Control in Rhesus Macaques	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; IMMUNODEFICIENCY VIRUS-REPLICATION; HIV-1 VACCINE EFFICACY; NEUTRALIZING ANTIBODIES; SIVMAC251 CHALLENGE; PROTECTIVE EFFICACY; DENDRITIC CELLS; TYPE-1; IGG; INHIBITION	Background: Antiviral antibodies, especially those with neutralizing activity against the incoming strain, are potentially important immunological effectors to control human immunodeficiency virus (HIV) infection. While neutralizing activity appears to be central in sterile protection against HIV infection, the entity of inhibitory mechanisms via HIV and simian immunodeficiency virus (SIV)-specific antibodies remains elusive. The recent HIV vaccine trial RV144 and studies in nonhuman primate models have indicated controversial protective efficacy of HIV/SIV-specific non-neutralizing binding antibodies (non-NAbs). While reports on HIV-specific non-NAbs have demonstrated virus inhibitory activity in vitro, whether non-NAbs could also alter the pathogenic course of established SIV replication in vivo, likewise via neutralizing antibody (NAb) administration, has been unclear. Here, we performed post-infection passive immunization of SIV-infected rhesus macaques with polyclonal SIV-specific, antibody-dependent cell-mediated viral inhibition (ADCVI)-competent non-NAbs. Methods and Findings: Ten lots of polyclonal immunoglobulin G (IgG) were prepared from plasma of ten chronically SIVmac239-infected, NAb-negative rhesus macaques, respectively. Their binding capacity to whole SIVmac239 virions showed a propensity similar to ADCVI activity. A cocktail of three non-NAb lots showing high virion-binding capacity and ADCVI activity was administered to rhesus macaques at day 7 post-SIVmac239 challenge. This resulted in an infection course comparable with control animals, with no significant difference in set point plasma viral loads or immune parameters. Conclusions: Despite virus-specific suppressive activity of the non-NAbs having been observed in vitro, their passive immunization post-infection did not result in SIV control in vivo. Virion binding and ADCVI activity with lack of virus neutralizing activity were indicated to be insufficient for antibody-triggered non-sterile SIV control. More diverse effector functions or sophisticated localization may be required for non-NAbs to impact HIV/SIV replication in vivo.	[Nakane, Taku; Nomura, Takushi; Shi, Shoi; Nakamura, Midori; Matano, Tetsuro; Yamamoto, Hiroyuki] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Nakane, Taku; Nomura, Takushi; Shi, Shoi; Nakamura, Midori; Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Naruse, Taeko K.; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; Tokyo Medical & Dental University (TMDU)	Matano, T (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	tmatano@nih.go.jp; hiyamamoto-tky@umin.ac.jp	Kimura, Akinori/I-5989-2018; Naruse, Taeko/ABA-3089-2021	Kimura, Akinori/0000-0002-4933-2132; 	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, and grants-in-aid from the Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akari H, 1996, VIROLOGY, V218, P382, DOI 10.1006/viro.1996.0207; Arguello JR, 1998, TISSUE ANTIGENS, V52, P57, DOI 10.1111/j.1399-0039.1998.tb03024.x; Asmal M, 2011, J VIROL, V85, P5465, DOI 10.1128/JVI.00313-11; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forthal DN, 2001, AIDS RES HUM RETROV, V17, P553, DOI 10.1089/08892220151126661; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Haigwood NL, 1996, IMMUNOL LETT, V51, P107, DOI 10.1016/0165-2478(96)02563-1; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Hirsch VM, 2004, J VIROL, V78, P275, DOI 10.1128/JVI.78.1.275-284.2004; Holl V, 2006, BLOOD, V107, P4466, DOI 10.1182/blood-2005-08-3490; Holl V, 2004, J IMMUNOL, V173, P6274, DOI 10.4049/jimmunol.173.10.6274; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Iwamoto N, 2010, AIDS, V24, P2777, DOI 10.1097/QAD.0b013e3283402206; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Miller CJ, 2007, J VIROL, V81, P5024, DOI 10.1128/JVI.02444-06; Naruse TK, 2010, IMMUNOGENETICS, V62, P601, DOI 10.1007/s00251-010-0462-z; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Nomura T, 2012, J VIROL, V86, P6481, DOI 10.1128/JVI.07077-11; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Tanaka-Takahashi Y, 2007, ELECTROPHORESIS, V28, P918, DOI 10.1002/elps.200600586; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540; Yamamoto T, 2009, J VIROL, V83, P5514, DOI 10.1128/JVI.00145-09	38	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73453	10.1371/journal.pone.0073453	http://dx.doi.org/10.1371/journal.pone.0073453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039947	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300077
J	Senthivinayagam, S; McIntosh, AL; Moon, KC; Atshaves, BP				Senthivinayagam, Subramanian; McIntosh, Avery L.; Moon, Kenneth C.; Atshaves, Barbara P.			Plin2 Inhibits Cellular Glucose Uptake through Interactions with SNAP23, a SNARE Complex Protein	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; LIPID DROPLET FORMATION; INSULIN-RESISTANCE; BINDING PROTEIN; ADIPOSE-TISSUE; EXPRESSION; FSP27; ACCUMULATION; METABOLISM; PROMOTES	Although a link between excess lipid storage and aberrant glucose metabolism has been recognized for many years, little is known what role lipid storage droplets and associated proteins such as Plin2 play in managing cellular glucose levels. To address this issue, the influence of Plin2 on glucose uptake was examined using 2-NBD-Glucose and [H-3]-2-deoxyglucose to show that insulin-mediated glucose uptake was decreased 1.7- and 1.8-fold, respectively in L cell fibroblasts overexpressing Plin2. Conversely, suppression of Plin2 levels by RNAi-mediated knockdown increased 2-NBD-Glucose uptake several fold in transfected L cells and differentiated 3T3-L1 cells. The effect of Plin2 expression on proteins involved in glucose uptake and transport was also examined. Expression of the SNARE protein SNAP23 was increased 1.6-fold while levels of syntaxin-5 were decreased 1.7-fold in Plin2 overexpression cells with no significant changes observed in lipid droplet associated proteins Plin1 or FSP27 or with the insulin receptor, GLUT1, or VAMP4. FRET experiments revealed a close proximity of Plin2 to SNAP23 on lipid droplets to within an intramolecular distance of 51 angstrom. The extent of targeting of SNAP23 to lipid droplets was determined by co-localization and co-immunoprecipitation experiments to show increased partitioning of SNAP23 to lipid droplets when Plin2 was overexpressed. Taken together, these results suggest that Plin2 inhibits glucose uptake by interacting with, and regulating cellular targeting of SNAP23 to lipid droplets. In summary, the current study for the first time provides direct evidence for the role of Plin2 in mediating cellular glucose uptake.	[Senthivinayagam, Subramanian; Moon, Kenneth C.; Atshaves, Barbara P.] Michigan State Univ, E Lansing, MI 48824 USA; [McIntosh, Avery L.] Texas A&M Univ, College Stn, TX USA	Michigan State University; Texas A&M University System; Texas A&M University College Station	Atshaves, BP (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	atshaves@msu.edu			USPHS, National Institutes of Health [DK70965]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK070965, R01DK070965, P30DK020572] Funding Source: NIH RePORTER	USPHS, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the USPHS, National Institutes of Health grant DK70965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Atshaves BP, 2007, LIPIDS, V42, P871, DOI 10.1007/s11745-007-3091-z; Atshaves BP, 2009, J LIPID RES, V50, P1429, DOI 10.1194/jlr.M900020-JLR200; Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200; Atshaves BP, 1999, J LIPID RES, V40, P610; Atshaves BP, 2002, AM J PHYSIOL-CELL PH, V283, pC688, DOI 10.1152/ajpcell.00586.2001; Atshaves BP, 2001, J BIOL CHEM, V276, P25324, DOI 10.1074/jbc.M100560200; Atshaves BP, 2000, J BIOL CHEM, V275, P36852, DOI 10.1074/jbc.M003434200; Baldwin SA, 1995, BIOSCIENCE REP, V15, P419, DOI 10.1007/BF01204346; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, P1870, DOI 10.2337/db09-1503; Bostrom P, 2009, BIOCHEM SOC T, V37, P981, DOI 10.1042/BST0370981; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Bryant NJ, 2011, TRAFFIC, V12, P657, DOI 10.1111/j.1600-0854.2011.01163.x; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Ebstensen R D, 1972, Proc Natl Acad Sci U S A, V69, P1430; Faleck DM, 2010, AM J PHYSIOL-ENDOC M, V299, pE249, DOI 10.1152/ajpendo.00646.2009; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Fukushima M, 2005, IN VITRO CELL DEV-AN, V41, P321; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Kern PA, 2004, J CLIN ENDOCR METAB, V89, P1352, DOI 10.1210/jc.2003-031388; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Loaiza A, 2003, J NEUROSCI, V23, P7337; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; MARZO A, 1971, CLIN CHEM, V17, P145; McArthur MJ, 1999, J LIPID RES, V40, P1371; MCGOWAN KM, 1995, PHARMACOL THERAPEUT, V66, P465, DOI 10.1016/0163-7258(95)00007-4; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1; McManaman JL, 2013, J LIPID RES IN PRESS; Millership S, 2012, P NATL ACAD SCI USA, V109, P20943, DOI 10.1073/pnas.1210022110; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; MOULDER JW, 1970, J BACTERIOL, V104, P1189, DOI 10.1128/JB.104.3.1189-1196.1970; Murphy EJ, 1996, ARCH BIOCHEM BIOPHYS, V335, P267, DOI 10.1006/abbi.1996.0507; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG237, DOI 10.1152/ajpgi.1998.275.2.G237; Murphy EJ, 2000, J LIPID RES, V41, P788; Murphy EJ, 1997, BBA-LIPID LIPID MET, V1345, P283, DOI 10.1016/S0005-2760(97)00003-9; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Petrescu AD, 2003, J BIOL CHEM, V278, P51813, DOI 10.1074/jbc.M303858200; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Serrero G, 2000, BBA-MOL CELL BIOL L, V1488, P245, DOI 10.1016/S1388-1981(00)00128-1; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tai ES, 2007, CURR OPIN LIPIDOL, V18, P152, DOI 10.1097/MOL.0b013e328086aeab; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Willenborg M, 2005, J LIPID RES, V46, P2559, DOI 10.1194/jlr.M500131-JLR200; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	72	25	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73696	10.1371/journal.pone.0073696	http://dx.doi.org/10.1371/journal.pone.0073696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040030	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500055
J	Bautista-Arredondo, S; Colchero, MA; Romero, M; Conde-Glez, CJ; Sosa-Rubi, SG				Bautista-Arredondo, Sergio; Arantxa Colchero, M.; Romero, Martin; Conde-Glez, Carlos J.; Sosa-Rubi, Sandra G.			Is the HIV Epidemic Stable among MSM in Mexico? HIV Prevalence and Risk Behavior Results from a Nationally Representative Survey among Men Who Have Sex with Men	PLOS ONE			English	Article							PREVENTION; INFECTION	Background: Recent evidence points to the apparent increase of HIV prevalence among men who have sex with men (MSM) in different settings with concentrated epidemics, including the Latin American region. In 2011, Mexico implemented an ambitious HIV prevention program in all major cities, funded by the Global Fund to Fight Aids, Tuberculosis and Malaria. The program was intended to strengthen the prevention response for the most at risk populations: MSM and injecting drug users. This paper presents the HIV prevalence results of a nationally representative baseline survey in 24 Mexican cities throughout the 5 regions in the country and reports the socio-demographic and sexual risk behaviors that predict the probability of infection. Methods: The survey was implemented in two phases. We first identified and characterized places where MSM gather in each city and then conducted in a second phase, a seroprevalence survey that included rapid HIV testing and a self-administered questionnaire. The prevalence of HIV was estimated by adjusting for positive predicted value. We applied a probit model to estimate the probability of having a positive result from the HIV test as a function of socio-demographic characteristics and self-reported sexual risk behaviors. Results: We found an overall HIV prevalence among MSM gathering in meeting points of 16.9% [95% CI: 15.6-18.3], significantly higher than previously reported estimates. Our regression results suggest that the risk of infection increases with age, with the number of sexual partners, and among those who play a receptive sexual role, and the risk decreases with higher education. Discussion: Our findings suggest a higher HIV prevalence among MSM than previously acknowledged and that a significant regional variability exist throughout the country. These two findings combined, signal an important dynamic in the epidemic that should be better understood and promptly addressed with strong prevention efforts targeted at key populations.	[Bautista-Arredondo, Sergio; Arantxa Colchero, M.; Romero, Martin; Conde-Glez, Carlos J.; Sosa-Rubi, Sandra G.] Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Colchero, MA (corresponding author), Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico.	acolchero@insp.mx	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011	Global Fund to Fight AIDS, Malaria and Tuberculosis	Global Fund to Fight AIDS, Malaria and Tuberculosis	The HIV seroprevalence survey was funded by the Global Fund to Fight AIDS, Malaria and Tuberculosis through the principal recipient for Mexico: Fundacion Mexicana para la Salud (FUNSALUD). The funders had no role on what cities were selected for the survey, study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bautista-Arredondo S, 2012, CTR INVESTIGACION EV, V3; Bautista-Arredondo S, 2008, SALUD PUBLICA MEXICO, V50, pS437; Centro Nacional para la Prevencion y Control de SIDA, 2009, VIH SIDA MEX; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Crabtree-Ramirez B, 2012, SALUD PUBLICA MEXICO, V54, P506, DOI 10.1590/S0036-36342012000500007; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; De Walque D, 2012, ECON DEV CULT CHANGE, V61, P97, DOI 10.1086/666951; Galarraga O, 2013, EUR J HLTH EC; Gayet C, 2007, SERIE ANGULOS SIDA, V8; Glinica Especializada Gondesa, 2011, B SIST INF SIDA COND, V03; Joint United Nations Programme on HIV/AIDS, 2011, WORLD AIDS DAY REP 2; Kerr LR, 2013, AIDS, V27, P427; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Magis C, 2005, INFORME RESULTADOS E; Mechoulan S, 2007, FORUM HLTH EC POLICY, V10; NIMH Multisite HIV STD Prevent Tri, 2008, JAIDS-J ACQ IMM DEF, V49, pS52, DOI 10.1097/QAI.0b013e318184481a; Pals SL, 2009, HEALTH EDUC BEHAV, V36, P182, DOI 10.1177/1090198108327731; Secretaria de Salud Direccion General de Epidemiologia, REG NAC COS VIH SIDA; The MSM initiative, 2008, MSM HIV ROAD UN ACC; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; UNAIDS, 2009, ANN REP 2009; *USAID UNAIDS WHO, 2004, COV SEL SERV HIV AID; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Weir SS, 2003, AIDS, V17, P895, DOI 10.1097/00002030-200304110-00015	26	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72616	10.1371/journal.pone.0072616	http://dx.doi.org/10.1371/journal.pone.0072616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24039786	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600033
J	de Mendizabal, NV; Hutmacher, MM; Troconiz, IF; Goni, J; Villoslada, P; Bagnato, F; Bies, RR				de Mendizabal, Nieves Velez; Hutmacher, Matthew M.; Troconiz, Inaki F.; Goni, Joaquin; Villoslada, Pablo; Bagnato, Francesca; Bies, Robert R.			Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach	PLOS ONE			English	Article							ENHANCING LESION COUNTS; CLINICAL-TRIALS; POISSON REGRESSION; MRI; EVOLUTION; MS	Background: Relapsing-remitting dynamics are a hallmark of autoimmune diseases such as Multiple Sclerosis (MS). A clinical relapse in MS reflects an acute focal inflammatory event in the central nervous system that affects signal conduction by damaging myelinated axons. Those events are evident in T1-weighted post-contrast magnetic resonance imaging (MRI) as contrast enhancing lesions (CEL). CEL dynamics are considered unpredictable and are characterized by high intra- and interpatient variability. Here, a population approach (nonlinear mixed-effects models) was applied to analyse of CEL progression, aiming to propose a model that adequately captures CEL dynamics. Methods and Findings: We explored several discrete distribution models to CEL counts observed in nine MS patients undergoing a monthly MRI for 48 months. All patients were enrolled in the study free of immunosuppressive drugs, except for intravenous methylprednisolone or oral prednisone taper for a clinical relapse. Analyses were performed with the nonlinear mixed-effect modelling software NONMEM 7.2. Although several models were able to adequately characterize the observed CEL dynamics, the negative binomial distribution model had the best predictive ability. Significant improvements in fitting were observed when the CEL counts from previous months were incorporated to predict the current month's CEL count. The predictive capacity of the model was validated using a second cohort of fourteen patients who underwent monthly MRIs during 6-months. This analysis also identified and quantified the effect of steroids for the relapse treatment. Conclusions: The model was able to characterize the observed relapsing-remitting CEL dynamic and to quantify the interpatient variability. Moreover, the nature of the effect of steroid treatment suggested that this therapy helps resolve older CELs yet does not affect newly appearing active lesions in that month. This model could be used for design of future longitudinal studies and clinical trials, as well as for the evaluation of new therapies.	[de Mendizabal, Nieves Velez; Bies, Robert R.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [de Mendizabal, Nieves Velez; Bies, Robert R.] Indiana Clin & Translat Sci Inst CTSI, Indianapolis, IN USA; [Hutmacher, Matthew M.] Ann Arbor Pharmacometr Grp A2PG, Ann Arbor, MI USA; [Troconiz, Inaki F.] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain; [Goni, Joaquin] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Villoslada, Pablo] Hosp Clin Barcelona, Inst Biomed Res August Pi Sunyer IDIBAPS, Ctr Neuroimmunol, Barcelona, Spain; [Bagnato, Francesca] Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, NIH, Bethesda, MD USA; [Bagnato, Francesca] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA	Indiana University System; Indiana University Bloomington; University of Navarra; Indiana University System; Indiana University Bloomington; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University System of Maryland; University of Maryland Baltimore	de Mendizabal, NV (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.	nvelezde@iupui.edu	Troconiz, Iñaki/ABA-2543-2020; Villoslada, Pablo/AAF-9547-2019; Troconiz, Inaki F/I-1740-2017	Troconiz, Iñaki/0000-0003-3700-8658; Troconiz, Inaki F/0000-0003-3700-8658; Villoslada, Pablo/0000-0002-8735-6119	Eli Lilly and Company through Indiana Clinical and Translational Sciences Institute (CTSI)	Eli Lilly and Company through Indiana Clinical and Translational Sciences Institute (CTSI)	NVM and RRB were supported through Eli Lilly and Company through the Indiana Clinical and Translational Sciences Institute (CTSI). FB contribution to this work was sustained by the intramural program of the NINDS NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; BASTIANELLO S, 1990, NEUROLOGY, V40, P591, DOI 10.1212/WNL.40.4.591; Chiu AW, 2009, ARCH NEUROL-CHICAGO, V66, P39, DOI 10.1001/archneur.66.1.noc80047; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; GODFREY CJ, 2007, PHARMACOMETRICS SCI; Gupta SK, 1999, CLIN PHARMACOL THER, V65, P672, DOI 10.1016/S0009-9236(99)90089-9; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Healy BC, 2010, MULT SCLER J, V16, P840, DOI 10.1177/1352458510371409; Jonker DM, 2004, EPILEPSIA, V45, P424, DOI 10.1111/j.0013-9580.2004.50503.x; LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McFarland H F, 1996, Mult Scler, V2, P198; Meier DS, 2006, NEUROIMAGE, V32, P531, DOI 10.1016/j.neuroimage.2006.04.181; Miller DH, 2002, CLIN NEUROL NEUROSUR, V104, P236, DOI 10.1016/S0303-8467(02)00045-8; Miller R, 2003, CLIN PHARMACOL THER, V73, P491, DOI 10.1016/S0009-9236(03)00049-3; Paty DW, 1998, J NEUROL NEUROSUR PS, V64, pS47; Plan EL, 2009, J PHARMACOKINET PHAR, V36, P353, DOI 10.1007/s10928-009-9126-8; Sormani M, 2012, MULT SCLER J, V18, P229, DOI 10.1177/1352458511414965; Sormani MP, 2001, J NEUROL NEUROSUR PS, V70, P494, DOI 10.1136/jnnp.70.4.494; Sormani MP, 2001, MULT SCLER, V7, P298, DOI 10.1191/135245801681137997; Sormani MP, 1999, J NEUROL SCI, V163, P74, DOI 10.1016/S0022-510X(99)00015-5; Troconiz IF, 2009, J PHARMACOKINET PHAR, V36, P461, DOI 10.1007/s10928-009-9131-y; van den Elskamp IJ, 2009, MULT SCLER, V15, P42, DOI 10.1177/1352458508096683; de Mendizabal NV, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-114; Vollmer T, 2007, J NEUROL SCI, V256, pS5, DOI 10.1016/j.jns.2007.01.065; Wang PM, 1996, BIOMETRICS, V52, P381, DOI 10.2307/2532881; Winkelmann R, 1994, Math Popul Stud, V4, P205; Yang Z, 2007, BIOMETRICAL J, V49, P565, DOI 10.1002/bimj.200610340	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73361	10.1371/journal.pone.0073361	http://dx.doi.org/10.1371/journal.pone.0073361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039924	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600067
J	Fahrer, J; Rausch, J; Barth, H				Fahrer, Joerg; Rausch, Johannes; Barth, Holger			A Cell-Permeable Fusion Protein Based on Clostridium botulinum C2 Toxin for Delivery of p53 Tumorsuppressor into Cancer Cells	PLOS ONE			English	Article							ENZYME COMPONENT C2I; MEMBRANE TRANSLOCATION; ADP-RIBOSYLATION; DRUG-DELIVERY; SYSTEM; RHO; CYTOSOL; ACTIN; RECOMBINANT; INTERACTS	Genetically engineered bacterial protein toxins are attractive systems for delivery of exogenous proteins into the cytosol of mammalian cells. The binary C2 toxin from C. botulinum has emerged as powerful delivery vehicle, which rests on its binding/translocation component C2IIa and the genetically modified adaptor domain C2IN that act in concert to trigger cell uptake. The p53 tumor suppressor protein has a crucial function in suppressing carcinogenesis and is frequently inactivated by diverse mechanisms in human tumor cells. Therefore, we constructed a C2IN-p53 fusion protein, which is internalized into cancer cells by C2IIa. To this end, the C2IN-p53 fusion construct was overexpressed in E. coli with good solubility, purified by heparin affinity chromatography and protein identity was confirmed by immunoblotting. We demonstrated that the fusion protein is capable of binding to the p53 consensus-DNA with high affinity in a p53-specific manner in vitro. Next, the internalization of C2IN-p53 was monitored in HeLa cells by cell fractionation and immunoblot analysis, which revealed a C2IIa-mediated translocation of the fusion protein into the cytosol. The uptake was also shown in A549 and Saos-2 cells with similar efficiency. These findings were further corroborated by confocal immunofluorescence analyses of C2IN-p53/C2IIa-treated HeLa and A549 cells, displaying predominantly cytoplasmic localization of the fusion construct.	[Fahrer, Joerg; Rausch, Johannes; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol, D-89069 Ulm, Germany; [Fahrer, Joerg] Univ Med Ctr Mainz, Inst Toxicol, Mainz, Germany	Ulm University; Johannes Gutenberg University of Mainz	Barth, H (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol, D-89069 Ulm, Germany.	fahrer@uni-mainz.de; holger.barth@uni-ulm.de			Medical Faculty of the University of Ulm [L.SBN.0060]; Experimental Medicine Program Ulm	Medical Faculty of the University of Ulm; Experimental Medicine Program Ulm	This work was supported by the Medical Faculty of the University of Ulm (Bausteinprojekt L.SBN.0060 to JF) and a research stipendium from the Experimental Medicine Program Ulm to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 1999, J BIOL CHEM, V274, P27407, DOI 10.1074/jbc.274.39.27407; Barth H, 2002, J BIOL CHEM, V277, P5074, DOI 10.1074/jbc.M109167200; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barth H, 2008, CURR MED CHEM, V15, P459, DOI 10.2174/092986708783503195; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Fahrer J, 2013, BIOCONJUGATE CHEM, V24, P595, DOI 10.1021/bc300563c; Fahrer J, 2010, BIOL CHEM, V391, P1315, DOI 10.1515/BC.2010.132; Fahrer J, 2010, BIOCONJUGATE CHEM, V21, P130, DOI 10.1021/bc900365b; Haug G, 2003, BIOCHEMISTRY-US, V42, P15284, DOI 10.1021/bi0354278; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huo MR, 2012, BIOMATERIALS, V33, P6393, DOI 10.1016/j.biomaterials.2012.05.052; Kaiser E, 2012, CELL MICROBIOL, V14, P1193, DOI 10.1111/j.1462-5822.2012.01788.x; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; Kim DH, 2011, MOL CARCINOGEN, V50, P222, DOI 10.1002/mc.20709; LaFevre-Bernt M, 2008, MOL CANCER THER, V7, P1420, DOI 10.1158/1535-7163.MCT-08-0078; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; Mechaly A, 2012, MBIO, V3, DOI 10.1128/mBio.00088-12; Nagahama M, 2009, INFECT IMMUN, V77, P5139, DOI 10.1128/IAI.00638-09; Ng DY, 2013, ADV HEALTHC MAT; Pust S, 2007, J BIOL CHEM, V282, P10272, DOI 10.1074/jbc.M610254200; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sorensen V, 2008, MOL CELL BIOL, V28, P4129, DOI 10.1128/MCB.02117-07; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Sun Xiu Zhu, 2003, Methods Mol Biol, V234, P17; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Xu Q, 2013, BIOMATERIALS; Yotsumoto F, 2009, ANTICANCER RES, V29, P4879; Zhao D, 2012, MOL PHARM	48	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72455	10.1371/journal.pone.0072455	http://dx.doi.org/10.1371/journal.pone.0072455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039769	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600030
J	Taylor, CM; Golding, J; Hibbeln, J; Emond, AM				Taylor, Caroline M.; Golding, Jean; Hibbeln, Joseph; Emond, Alan M.			Environmental Factors Predicting Blood Lead Levels in Pregnant Women in the UK: The ALSPAC Study	PLOS ONE			English	Article							PORT PIRIE COHORT; ESSENTIAL ELEMENTS; HEAVY-METALS; EXPOSURE; MERCURY; DIET; ORGANOCHLORINES; DETERMINANTS; MOBILIZATION; INCREASES	Background: Lead is a widespread environmental toxin. The behaviour and academic performance of children can be adversely affected even at low blood lead levels (BLL) of 5-10 mu g/dl. An important contribution to the infant's lead load is provided by maternal transfer during pregnancy. Objectives: Our aim was to determine BLL in a large cohort of pregnant women in the UK and to identify the factors that contribute to BLL in pregnant women. Methods: Pregnant women resident in the Avon area of the UK were enrolled in the Avon Longitudinal Study of Parents and Children (ALSPAC) in 1991-1992. Whole blood samples were collected at median gestational age of 11 weeks and analysed by inductively coupled plasma dynamic reaction cell mass spectrometry (n = 4285). Self-completion postal questionnaires were used to collect data during pregnancy on lifestyle, diet and other environmental exposures. Statistical analysis was carried out with SPSS v19. Results: The mean +/- SD BLL was 3.67 +/- 1.47 (median 3.41, range 0.41-19.14) mu g/dl. Higher educational qualification was found to be one of the strongest independent predictor of BLL in an adjusted backwards stepwise logistic regression to predict maternal BLL <5 or >= 5 mu g/dl (odds ratio 1.26, 95% confidence interval 1.12-1.42; p<0.001). Other predictive factors included cigarette smoking, alcohol and coffee drinking, and heating the home with a coal fire, with some evidence for iron and calcium intake having protective effects. Conclusion: The mean BLL in this group of pregnant women is higher than has been found in similar populations in developed countries. The finding that high education attainment was independently associated with higher BLL was unexpected and currently unexplained. Reduction in maternal lead levels can best be undertaken by reducing intake of the social drugs cigarettes, alcohol and caffeine, although further investigation of the effect of calcium on lead levels is needed.	[Taylor, Caroline M.; Golding, Jean; Emond, Alan M.] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Hibbeln, Joseph] NIAAA, NIH, Rockville, MD 20852 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Taylor, CM (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	caroline.m.taylor@bristol.ac.uk		Taylor, Caroline/0000-0001-8347-5092; Golding, Jean/0000-0003-2826-3307	Wellcome Trust [092731]; NOAA; Daphne Jackson Trust Fellowship; University of Bristol; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115] Funding Source: NIH RePORTER; Medical Research Council [G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Daphne Jackson Trust Fellowship; University of Bristol; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The assays of the maternal blood samples were carried out at the Centres for Disease Control with funding from NOAA. C. M. Taylor was supported by a Daphne Jackson Trust Fellowship sponsored by the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahab N, 2010, NEUROTOXICOL TERATOL, V32, P256, DOI 10.1016/j.ntt.2009.08.010; Al-Jawadi Asma A, 2009, BMC Res Notes, V2, P47, DOI 10.1186/1756-0500-2-47; Al-Saleh I, 2011, INT J HYG ENVIR HEAL, V214, P79, DOI 10.1016/j.ijheh.2010.10.001; Amaral JH, 2010, BASIC CLIN PHARMACOL, V107, P971, DOI 10.1111/j.1742-7843.2010.00616.x; Anda EE, 2007, J ENVIRON MONITOR, V9, P884, DOI 10.1039/b706717h; Audrey S, 2002, SCI TOTAL ENVIRON, V290, P157, DOI 10.1016/S0048-9697(01)01071-3; BAGHURST PA, 1987, MED J AUSTRALIA, V146, P69, DOI 10.5694/j.1326-5377.1987.tb136265.x; BAGHURST PA, 1987, NEUROTOXICOLOGY, V8, P395; Bellinger DC, 2004, PEDIATRICS, V113, P1016; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bjerregaard P, 2000, SCI TOTAL ENVIRON, V245, P195, DOI 10.1016/S0048-9697(99)00444-1; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Centers for Disease Control and Prevention, 2005, PREV LEAD POIS YOUNG; Chandramouli K, 2009, ARCH DIS CHILD, V94, P844, DOI 10.1136/adc.2008.149955; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI [10.1289/ehp.11868, 10.1289/ehp.1171c26]; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; Food Standards Agency, 2009, SURV MEAS CONC MET O; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Golding J, 1998, ALSPAC STUDY LEAD CH, P35; GRANDJEAN P, 1992, ARCH ENVIRON HEALTH, V47, P185, DOI 10.1080/00039896.1992.9938348; GRANDJEAN P, 1981, INT ARCH OCC ENV HEA, V48, P391, DOI 10.1007/BF00378687; Gromov S, 1998, ADV AIR POLLUT SER, V6, P597; Gulson BL, 1999, ENVIRON HEALTH PERSP, V107, P257, DOI 10.2307/3434591; Gulson BL, 1997, J LAB CLIN MED, V130, P51, DOI 10.1016/S0022-2143(97)90058-5; Gundacker C, 2010, SCI TOTAL ENVIRON, V408, P5744, DOI 10.1016/j.scitotenv.2010.07.079; Hansen S, 2011, J ENVIRON MONITOR, V13, P2143, DOI 10.1039/c1em10051c; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; Heaney RP, 2002, FOOD CHEM TOXICOL, V40, P1263, DOI 10.1016/S0278-6915(02)00094-7; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Hertz-Picciotto I, 2000, AM J IND MED, V38, P300, DOI 10.1002/1097-0274(200009)38:3<300::AID-AJIM9>3.0.CO;2-C; Lagerkvist BJ, 1996, AM J PUBLIC HEALTH, V86, P1247, DOI 10.2105/AJPH.86.9.1247; Llop S, 2011, SCI TOTAL ENVIRON, V409, P2298, DOI 10.1016/j.scitotenv.2011.02.004; MCMICHAEL AJ, 1985, MED J AUSTRALIA, V143, P499, DOI 10.5694/j.1326-5377.1985.tb119911.x; NEWTON D, 1992, HUM EXP TOXICOL, V11, P3, DOI 10.1177/096032719201100101; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Primatesta P, 1998, SURVEY BLOOD LEAD LE, P9; Reis MF, 2007, INT J HYG ENVIR HEAL, V210, P447, DOI 10.1016/j.ijheh.2007.01.020; ROTHENBERG SJ, 1989, NEUROTOXICOL TERATOL, V11, P85, DOI 10.1016/0892-0362(89)90046-9; ROTHENBERG SJ, 1994, ENVIRON HEALTH PERSP, V102, P876, DOI 10.2307/3432121; Rudge CV, 2009, J ENVIRON MONITOR, V11, P1322, DOI 10.1039/b903805a; Sanders AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031354; Schell LM, 2003, ENVIRON HEALTH PERSP, V111, P195, DOI 10.1289/ehp.5592; SMART GA, 1990, FOOD ADDIT CONTAM, V7, P93, DOI 10.1080/02652039009373825; Sowers M, 2002, ARCH ENVIRON HEALTH, V57, P489, DOI 10.1080/00039890209601442; Vrijheid M, 2012, J EPIDEMIOL COMMUN H, V66, P106, DOI 10.1136/jech.2010.117408; Walker JB, 2006, ENVIRON RES, V100, P295, DOI 10.1016/j.envres.2005.05.006; Watt GCM, 1996, BRIT MED J, V313, P979, DOI 10.1136/bmj.313.7063.979; Wells EM, 2011, ENVIRON HEALTH PERSP, V119, P664, DOI 10.1289/ehp.1002666; World Economic and Financial Surveys, 2012, WORLD EC OUTL GROWTH; ZIEGLER EE, 1978, PEDIATR RES, V12, P29, DOI 10.1203/00006450-197801000-00008	51	38	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72371	10.1371/journal.pone.0072371	http://dx.doi.org/10.1371/journal.pone.0072371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039753	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600024
J	Blus-Kadosh, I; Zilka, A; Yerushalmi, G; Banin, E				Blus-Kadosh, Inna; Zilka, Anat; Yerushalmi, Gal; Banin, Ehud			The Effect of pstS and phoB on Quorum Sensing and Swarming Motility in Pseudomonas aeruginosa	PLOS ONE			English	Article							PHOSPHATE STARVATION; BACTERIAL VIRULENCE; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; RHAMNOLIPIDS; PATHOGENESIS; GENES; EXPRESSION; BIOFILMS; SYSTEMS	Pseudomonas aeruginosa is an opportunistic pathogen that can cause a wide range of infections and inflammations in a variety of hosts, such as chronic biofilm associated lung infections in Cystic Fibrosis patients. Phosphate, an essential nutrient, has been recognized as an important signal that affects virulence in P. aeruginosa. In the current study we examined the connection between phosphate regulation and surface motility in P. aeruginosa. We focused on two important genes, pstS, which is involved in phosphate uptake, and phoB, a central regulator that responds to phosphate starvation. We found that a mutant lacking pstS is constantly starved for phosphate and has a hyper swarming phenotype. Phosphate starvation also induced swarming in the wild type. The phoB mutant, on the other hand, did not express phosphate starvation even when phosphate was limited and showed no swarming. A double mutant lacking both genes (pstS and phoB) showed a similar phenotype to the phoB mutant (i.e. no swarming). This highlights the role of phoB in controlling swarming motility under phosphate-depleted conditions. Finally, we were able to demonstrate that PhoB controls swarming by up-regulating the Rhl quorum sensing system in P. aeruginosa, which resulted in hyper production of rhamonlipids: biosurfactants that are known to induce swarming motility.	[Blus-Kadosh, Inna; Zilka, Anat; Yerushalmi, Gal; Banin, Ehud] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Ramat Gan, Israel; [Blus-Kadosh, Inna; Zilka, Anat; Yerushalmi, Gal; Banin, Ehud] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Banin, E (corresponding author), Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Ramat Gan, Israel.	ehud.banin@biu.ac.il			Israel Science Foundation [366/07, 1124/12]	Israel Science Foundation(Israel Science Foundation)	The work was supported by the Israel Science Foundation Grants No. 366/07 and 1124/12 to E. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Bains M, 2012, APPL ENVIRON MICROB, V78, P6762, DOI 10.1128/AEM.01015-12; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Glick R, 2010, J BACTERIOL, V192, P2973, DOI 10.1128/JB.01601-09; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Hou CI, 1996, J BACTERIOL, V92, P851; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Madhusudhan KT, 2003, J BASIC MICROB, V43, P36, DOI 10.1002/jobm.200390002; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; ROSENBERG H, 1977, J BACTERIOL, V131, P505, DOI 10.1128/JB.131.2.505-511.1977; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Soualhine H, 2005, MOL MICROBIOL, V58, P1430, DOI 10.1111/j.1365-2958.2005.04914.x; tover CK, 2000, NATURE, V406, P959; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043	38	42	47	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74444	10.1371/journal.pone.0074444	http://dx.doi.org/10.1371/journal.pone.0074444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023943	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600140
J	Duan, F; Huang, Q; Liao, JY; Pang, DJ; Lin, XF; Wu, KL				Duan, Fang; Huang, Qiang; Liao, Jingyu; Pang, Dajun; Lin, Xiaofeng; Wu, Kaili			How Often Are Major Blood-Borne Pathogens Found in Eye Patients? A Serosurvey at an Eye Hospital in Southern China	PLOS ONE			English	Article							HEALTH-CARE WORKERS; HEPATITIS-B; OCCUPATIONAL-EXPOSURE; RISK-FACTORS; INCREASING PREVALENCE; VIRAL-INFECTIONS; HIV; SYPHILIS; VIRUS; SEX	Background: The hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV) and treponema pallidum (TP) are blood-borne pathogens. They can lead to nosocomial and occupational infections in health care settings. We aimed to identify the prevalence of and risk factors associated with HBV, HCV, HIV and TP infections among patients with eye diseases at a tertiary eye hospital in Southern China. Methods: From July 2011 to June 2012, a total of 26,386 blood units were collected from eye patients, including inpatients and the day surgery patients at Zhongshan Ophthalmic Center, one of the biggest eye hospitals in China. Based on the primary diagnoses from this period, the subjects were classified into different ocular disease groups. All blood samples were tested for HBsAg, anti-HCV, anti-HIV and anti-TP. Result: The overall prevalence of HBV, HCV, TP and HIV was 9.79%, 0.99%, 2.43% and 0.11%, respectively. The prevalence of HBsAg was much lower among patients younger than 20 years compared to other age groups. In addition, the risk of HBsAg was associated with the male gender, ocular trauma and glaucoma. The prevalence of TP increased with age and the prevalence among patients older than 30 was higher than that in patients younger than 20 years. Conclusions: The prevalence of HBV, HCV, HIV and TP in patients with eye diseases was identified. This information can be utilised to strengthen the health education and implementation of universal safety precautions to prevent the spread of blood-borne pathogens in health care settings.	[Duan, Fang; Huang, Qiang; Liao, Jingyu; Pang, Dajun; Lin, Xiaofeng; Wu, Kaili] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wu, KL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	wukaili@mail.sysu.edu.cn		Wu, Kaili/0000-0003-3606-683X	National Natural Science Foundation of China [81070765, 81170827]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (grant numbers. 81070765, 81170827) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLASHI D V, 1987, Journal of Experimental Pathology (New York), V3, P693; Beltrami EM, 2000, CLIN MICROBIOL REV, V13, P385, DOI 10.1128/CMR.13.3.385-407.2000; Butsashvili M, 2012, OCCUP MED-OXFORD, V62, P620, DOI 10.1093/occmed/kqs121; Campos Lorenza Nogueira, 2008, Cad. Saúde Pública, V24, ps607; Cardo DM, 1997, INFECT DIS CLIN N AM, V11, P331, DOI 10.1016/S0891-5520(05)70359-7; Chandra M, 2004, INTERVIROLOGY, V47, P374, DOI 10.1159/000080883; de Paula Erich V, 2005, J Clin Virol, V34 Suppl 2, pS27, DOI 10.1016/S1386-6532(05)80031-9; Dong RL, 2011, BIOMED ENVIRON SCI, V24, P207, DOI 10.3967/0895-3988.2011.03.001; Frijstein G, 2011, NETH J MED, V69, P465; Gerberding JL, 2003, NEW ENGL J MED, V348, P826, DOI 10.1056/NEJMcp020892; GERBERDING JL, 1990, NEW ENGL J MED, V322, P1788, DOI 10.1056/NEJM199006213222506; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Han Y, 2011, AIDS, V25, P1925, DOI 10.1097/QAD.0b013e32834b3578; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; HIV/AIDS World Health Organization and Joined United Nations Programme on, 2007, MAL CIRC GLOB TRENDS; Ippolito G, 1998, JAMA-J AM MED ASSOC, V280, P28, DOI 10.1001/jama.280.1.28; Ji ZH, 2012, INT J INFECT DIS; Kennedy I, 2000, OCCUP MED-OXFORD, V50, P387, DOI 10.1093/occmed/50.6.387; Kwon YS, 2001, YONSEI MED J, V42, P134, DOI 10.3349/ymj.2001.42.1.134; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Liu FF, 2009, EMERG INFECT DIS, V15, P1819, DOI [10.3201/eid1511.0900263, 10.3201/eid1511.090263]; Liu J, 2012, TRANSFUSION, V52, P1741, DOI 10.1111/j.1537-2995.2011.03527.x; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; MARCUS R, 1988, NEW ENGL J MED, V319, P1118, DOI 10.1056/NEJM198810273191703; Rachitskaya AV, 2012, EUR J OPHTHALMOL, V22, P284, DOI 10.5301/ejo.5000037; SARTORI M, 1993, SCAND J INFECT DIS, V25, P270, DOI 10.3109/00365549309008497; Segbena AY, 2005, TRANSFUS CLIN BIOL, V12, P423, DOI 10.1016/j.tracli.2005.12.003; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Teng CJ, 2011, CLINICS, V66, P2055, DOI 10.1590/S1807-59322011001200010; Vinelli Elizabeth, 2005, J Clin Virol, V34 Suppl 2, pS53, DOI 10.1016/S1386-6532(05)80035-6; Wang XF, 2012, CHINESE MED J-PEKING, V125, P2819, DOI 10.3760/cma.j.issn.0366-6999.2012.16.004; Ward JW, 2007, PUBLIC HEALTH REP, V122, P99, DOI 10.1177/00333549071220S220; Wei S, 2013, AIDS BEHAV, V17, P1151, DOI 10.1007/s10461-011-0110-0; WHO, 2004, HEP B; WHO, 2020, HEP C; World Health Organization, 2001, GLOB PREV INC SEL CU; World Health Organization, 2002, WHO AID MEM BLOOD SA; Wu J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-657; Xiao JP, 2012, INT J INFECT DIS, V16, pE692, DOI 10.1016/j.ijid.2012.05.1027; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047808; Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73994	10.1371/journal.pone.0073994	http://dx.doi.org/10.1371/journal.pone.0073994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023922	gold, Green Submitted, Green Published			2022-12-25	WOS:000324515600128
J	Pedram, P; Wadden, D; Amini, P; Gulliver, W; Randell, E; Cahill, F; Vasdev, S; Goodridge, A; Carter, JC; Zhai, GJ; Ji, YQ; Sun, G				Pedram, Pardis; Wadden, Danny; Amini, Peyvand; Gulliver, Wayne; Randell, Edward; Cahill, Farrell; Vasdev, Sudesh; Goodridge, Alan; Carter, Jacqueline C.; Zhai, Guangju; Ji, Yunqi; Sun, Guang			Food Addiction: Its Prevalence and Significant Association with Obesity in the General Population	PLOS ONE			English	Article							UNITED-STATES; VALIDATION; SUGAR; FAT; CRAVINGS; BRAIN	Background: 'Food addiction' shares a similar neurobiological and behavioral framework with substance addiction. However whether, and to what degree, 'food addiction' contributes to obesity in the general population is unknown. Objectives: to assess 1) the prevalence of 'food addiction' in the Newfoundland population; 2) if clinical symptom counts of 'food addiction' were significantly correlated with the body composition measurements; 3) if food addicts were significantly more obese than controls, and 4) if macronutrient intakes are associated with 'food addiction'. Design: A total of 652 adults (415 women, 237 men) recruited from the general population participated in this study. Obesity was evaluated by Body Mass Index (BMI) and Body Fat percentage measured by dual-energy X-ray absorptiometry. 'Food addiction' was assessed using the Yale Food Addiction Scale and macronutrient intake was determined from the Willet Food Frequency Questionnaire. Results: The prevalence of 'food addiction' was 5.4% (6.7% in females and 3.0% in males) and increased with obesity status. The clinical symptom counts of 'food addiction' were positively correlated with all body composition measurements across the entire sample (p<0.001). Obesity measurements were significantly higher in food addicts than controls; Food addicts were 11.7 (kg) heavier, 4.6 BMI units higher, and had 8.2% more body fat and 8.5% more trunk fat. Furthermore, food addicts consumed more calories from fat and protein compared with controls. Conclusion: Our results demonstrated that 'food addiction' contributes to severity of obesity and body composition measurements from normal weight to obese individuals in the general population with higher rate in women as compared to men.	[Pedram, Pardis; Wadden, Danny; Amini, Peyvand; Gulliver, Wayne; Cahill, Farrell; Vasdev, Sudesh; Goodridge, Alan; Ji, Yunqi; Sun, Guang] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Discipline Lab Med, St John, NF, Canada; [Carter, Jacqueline C.] Mem Univ Newfoundland, Fac Sci, Dept Psychol, St John, NF, Canada; [Zhai, Guangju] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada.	gsun@mun.ca			CIHR [CIHR: MOP192552]; CFI	CIHR(Canadian Institutes of Health Research (CIHR)); CFI(Canada Foundation for Innovation)	The study has been funded by a CIHR operating grant and CFI equipment grant to Dr. Guang Sun (CIHR: MOP192552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2012, METHODS MOL BIOL, V829, P351, DOI 10.1007/978-1-61779-458-2_23; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Barry D, 2009, AM J ADDICTION, V18, P439, DOI 10.3109/10550490903205579; Blumenthal DM, 2010, CURR OPIN CLIN NUTR, V13, P359, DOI 10.1097/MCO.0b013e32833ad4d4; Bray GA., 2003, CONT DIAGNOSIS MANAG; Clark SM, 2013, EAT BEHAV, V14, P216, DOI 10.1016/j.eatbeh.2013.01.002; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Di Leone RJ, 2012, NAT NEUROSCI, V15, P1330, DOI 10.1038/nn.3202; Eichen DM, 2013, APPETITE, V67, P22, DOI 10.1016/j.appet.2013.03.008; Fortuna JL, 2012, J PSYCHOACTIVE DRUGS, V44, P56, DOI 10.1080/02791072.2012.662092; Gearhardt AN, 2012, INT J EAT DISORDER, V45, P657, DOI 10.1002/eat.20957; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Granados K, 2012, APPL PHYSIOL NUTR ME, V37, P323, DOI [10.1139/h2012-002, 10.1139/H2012-002]; Green KK, 2010, CLIN MED INSIGHTS-EN, V3, P25; Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035; International_Obesity_Taskforce, 2010, GLOB EP; Javaras KN, 2008, INT J EAT DISORDER, V41, P174, DOI 10.1002/eat.20484; Kennedy AP, 2009, OBESITY, V17, P2094, DOI 10.1038/oby.2009.101; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Meule A, 2012, DIAGNOSTICA, V58, P115, DOI 10.1026/0012-1924/a000047; Meule A, 2012, EAT BEHAV, V13, P252, DOI 10.1016/j.eatbeh.2012.02.001; Meule Adrian, 2011, Front Psychiatry, V2, P61, DOI 10.3389/fpsyt.2011.00061; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Pataky Z, 2010, EXP CLIN ENDOCR DIAB, V118, P427, DOI 10.1055/s-0029-1233448; Pelchat ML, 1997, APPETITE, V28, P103, DOI 10.1006/appe.1996.0063; Public_Health_Agency_of_Canada, 2011, OB CAN; Smith DG, 2013, BIOL PSYCHIAT, V73, P804, DOI 10.1016/j.biopsych.2012.08.026; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taylor VH, 2010, CAN MED ASSOC J, V182, P327, DOI 10.1503/cmaj.091142; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Von Deneen KM, 2012, ADDICTIONS PATHOPHYS, P259; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; World_Health_Organization, 2013, OB OV; World_Helath_Organization, 2013, BMI CLASS; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212; Zilberter Tanya, 2012, Front Neuroenergetics, V4, P7, DOI 10.3389/fnene.2012.00007	42	176	181	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74832	10.1371/journal.pone.0074832	http://dx.doi.org/10.1371/journal.pone.0074832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023964	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000324515600158
J	Men, XJ; Li, JJ; Zhang, BJ; Zhang, L; Li, HY; Lu, ZQ				Men, Xuejiao; Li, Jiejie; Zhang, Bingjun; Zhang, Lei; Li, Haiyan; Lu, Zhengqi			Homocysteine and C-Reactive Protein Associated with Progression and Prognosis of Intracranial Branch Atheromatous Disease	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ACUTE ISCHEMIC-STROKE; INFLAMMATORY RESPONSE; RISK-FACTORS; ATHEROSCLEROSIS; DISABILITY	Background and Objectives: C-reactive protein (CRP) is a biomarker of inflammation and a sensitive predictor of stroke, and high homocysteine (Hcy) is also associated with stroke. However, the roles of CRP and Hcy in the pathogenesis, progression and prognosis of branch atheromatous disease (BAD) and lipohyalinotic degeneration (LD) are largely unknown. We sought to determine the relation between them in Chinese patients. Methods: According to the lesion presences shown by diffusion-weighted imaging (DWI), we retrospectively recruited a cohort of 308 patients with a diagnosis of BAD and LD from a total of 1458 consecutive patients with acute ischemic stroke. Progression was defined as worsening by > or = 1-point in the NIHSS for motor function within the first 5 days. Good outcome was deemed as Modified Rankin Scale (mRS) <= 2 and poor outcome was mRS > 2 recorded at one month after onset. Results: This study comprised a total of 179 patients with BAD and 129 patients with LD. Subjects in patients with LD significantly had an elevated Hcy (p = 0.030), a lower NIHSS score on admission (p<0.001) and mRS score at one month after ictus (p<0.001) than those in patients with BAD. Elevated Hcy (P = 0.004) and increased CRP (P = 0.025) were associated with progression in patients with BAD, and CRP (p = 0.006) and diabetes mellitus (p = 0.011) were found to be associated with poor outcome in patients with BAD. However, no association was observed in patients with LD on progression and prognosis. After multivariate logistic regression analysis, elevated Hcy (p = 0.002) remained the only independent predictor for the progression, and increased CRP (p = 0.027) and smoking (p = 0.012) became the independent predictors for the poor outcome in patients with BAD. Conclusions: In patients with BAD, elevated Hcy and increased CRP may independently predict progression and prognosis, respectively.	[Men, Xuejiao; Li, Jiejie; Zhang, Bingjun; Zhang, Lei; Li, Haiyan; Lu, Zhengqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lu, ZQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lzq1828@yahoo.com.cn	li, jiejie/AAF-9063-2021	li, jiejie/0000-0002-2415-4843	Natural Science Foundation of China [30971027]; Natural Science Foundation of Guangdong [9151008901000171]; Science and Technology program of Guangzhou [2011Y200017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Science and Technology program of Guangzhou	This study was funded by the Natural Science Foundation of China (30971027), the Natural Science Foundation of Guangdong (9151008901000171), and Science and Technology program of Guangzhou (2011Y200017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner RW, 2003, STROKE, V34, P653, DOI 10.1161/01.STR.0000058486.68044.3B; Blaschke F, 2004, CIRCULATION, V110, P579, DOI 10.1161/01.CIR.0000136999.77584.A2; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; CAPLAN LR, 1989, NEUROLOGY, V39, P1246, DOI 10.1212/WNL.39.9.1246; Delgado P, 2008, STROKE, V39, P1730, DOI 10.1161/STROKEAHA.107.500876; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Elkind MSV, 2006, NEUROLOGIST, V12, P140, DOI 10.1097/01.nrl.0000215789.70804.b0; FISHER CM, 1965, NEUROLOGY, V15, P774, DOI 10.1212/WNL.15.8.774; Godoy-Torres DA, 2005, REV NEUROLOGIA, V40, P492, DOI 10.33588/rn.4008.2004236; Hankey GJ, 2001, CURR OPIN NEUROL, V14, P95, DOI 10.1097/00019052-200102000-00015; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Ichihara Y, 2002, CIRC J, V66, P677, DOI 10.1253/circj.66.677; Iwase M, 1998, DIABETES RES CLIN PR, V42, P109, DOI 10.1016/S0168-8227(98)00103-X; Kelly PJ, 2004, STROKE, V35, P12, DOI 10.1161/01.STR.0000106481.59944.2F; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Nakase T, 2008, J NEUROL SCI, V271, P104, DOI 10.1016/j.jns.2008.03.020; Park CS, 2010, AM J CARDIOL, V105, P1284, DOI 10.1016/j.amjcard.2009.12.045; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Raoul PK, 2011, ATHEROSCLEROSIS, V216, P461; Rodriguez-Oroz MC, 2009, MOVEMENT DISORD, V24, P1437, DOI 10.1002/mds.22522; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rouhl RPW, 2012, NEUROBIOL AGING, V33, P1800, DOI 10.1016/j.neurobiolaging.2011.04.008; Seo WK, 2012, J STROKE CEREBROVASC, V21, P181, DOI 10.1016/j.jstrokecerebrovasdis.2010.06.002; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Song IU, 2010, EUR NEUROL, V64, P304, DOI 10.1159/000321415; Spence JD, 2007, LANCET NEUROL, V6, P830, DOI 10.1016/S1474-4422(07)70219-3; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yamamoto Y, 2011, J NEUROL SCI, V304, P78, DOI 10.1016/j.jns.2011.02.006; Yoldas T, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/15929; Youssef MYZ, 2007, TRANSL RES, V150, P158, DOI 10.1016/j.trsl.2007.02.006	31	20	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73030	10.1371/journal.pone.0073030	http://dx.doi.org/10.1371/journal.pone.0073030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039853	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500023
J	Howie, D; Rueda, HG; Brown, MH; Waldmann, H				Howie, Duncan; Rueda, Hugo Garcia; Brown, Marion H.; Waldmann, Herman			Secreted and Transmembrane 1A Is a Novel Co-Stimulatory Ligand	PLOS ONE			English	Article							REGULATORY T-CELLS; HERPESVIRUS ENTRY MEDIATOR; RECEPTOR-LIGAND; CO-STIMULATION; K12 SECTM1; ACTIVATION; LYMPHOCYTE; TNF; CD7; EXPRESSION	Most T cell responses to pathogens or self antigens are modulated through the action of regulatory T cells and tissue-specific inhibitory mechanisms. To this end, several receptor-ligand pairs have evolved which either augment or diminish T cell function. Here we describe the tissue ligand SECTM1A (Secreted and transmembrane1A) as an alternative murine CD7 ligand. We show that SECTM1A, like SECTM1B, binds strongly to CD7, and that SECTM1B was able to compete with SECTM1A for CD7 binding. SECTM1A is ubiquitously expressed and has two major alternative transcripts which differ in expression between tissues. Both immobilised soluble forms of SECTM1A and SECTM1B and cell surface anchored forms demonstrated opposing effects on CD4+ T cell activation. Whereas SECTM1A acted as a co-stimulator of T cells, enhancing IL-2 production and proliferation, SECTM1B proved inhibitory to TCR mediated T cell activation. Surprisingly, both functional outcomes proved to be CD7-independent, indicating the existence of alternative receptors for both ligands. We used a SECTM1A-Fc fusion protein to immunoprecipitate potential alternative ligands from detergent lysates of CD7(-/-) T cells and, using mass spectrometry, identified GITR as a SECTM1A binder. SECTM1A was found to bind to activated CD4+ and CD8+ T cells as well as to CHO cells expressing cell surface GITR. Binding of SECTM1A to activated primary T cells was inhibited by either GITRL-Fc or anti GITR antibodies. Thus SECTM1A and SECTM1B represent novel reciprocal alternative ligands which may function to modulate the activation of effector and regulatory T cells. The ability of SECTM1A to activate T cells may be explained by its ability to bind to GITR.	[Howie, Duncan; Rueda, Hugo Garcia; Brown, Marion H.; Waldmann, Herman] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Howie, D (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	duncan.howie@path.ox.ac.uk	waldmann, herman/W-8051-2019; waldmann, herman/F-7412-2011	Waldmann, Herman/0000-0001-7519-6720	Medical Research Council [G0400808, G7904009]; Medical Research Council [G1000215] Funding Source: researchfish; MRC [G0400808, G1000215, G7904009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by two programme grants from the Medical Research Council www.mrc.ac.uk G0400808 (MHB) and G7904009 (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Daley SR, 2007, J IMMUNOL, V179, P3648, DOI 10.4049/jimmunol.179.6.3648; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Huyton T, 2011, BBA-GEN SUBJECTS, V1810, P1294, DOI 10.1016/j.bbagen.2011.06.020; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Koch C, 1999, INT IMMUNOL, V11, P777, DOI 10.1093/intimm/11.5.777; Lam GK, 2005, J CLIN IMMUNOL, V25, P41, DOI 10.1007/s10875-005-0356-5; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lyman SD, 2000, J BIOL CHEM, V275, P3431, DOI 10.1074/jbc.275.5.3431; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Nelson CA, 2008, J IMMUNOL, V180, P940, DOI 10.4049/jimmunol.180.2.940; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; RABINOWICH H, 1994, J IMMUNOL, V152, P517; Sarrias MR, 2000, MOL IMMUNOL, V37, P665, DOI 10.1016/S0161-5890(00)00089-4; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Sempowski GD, 2004, J IMMUNOL, V172, P787, DOI 10.4049/jimmunol.172.2.787; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Slentz-Kesler KA, 1998, GENOMICS, V47, P327, DOI 10.1006/geno.1997.5151; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Wang T, 2012, J LEUKOCYTE BIOL, V91, P449, DOI 10.1189/jlb.1011498; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428	31	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73610	10.1371/journal.pone.0073610	http://dx.doi.org/10.1371/journal.pone.0073610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039998	gold, Green Published			2022-12-25	WOS:000327538600034
J	Windak, R; Muller, J; Felley, A; Akhmedov, A; Wagner, EF; Pedrazzini, T; Sumara, G; Ricci, R				Windak, Renata; Mueller, Julius; Felley, Allison; Akhmedov, Alexander; Wagner, Erwin F.; Pedrazzini, Thierry; Sumara, Grzegorz; Ricci, Romeo			The AP-1 Transcription Factor c-Jun Prevents Stress-Imposed Maladaptive Remodeling of the Heart	PLOS ONE			English	Article							N-TERMINAL KINASE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; SIGNALING PATHWAY; P53-MEDIATED APOPTOSIS; MYOCARDIAL FIBROSIS; CALCINEURIN-NFAT; GROWTH-FACTORS; ACTIVATION; MYOCYTES	Systemic hypertension increases cardiac workload and subsequently induces signaling networks in heart that underlie myocyte growth (hypertrophic response) through expansion of sarcomeres with the aim to increase contractility. However, conditions of increased workload can induce both adaptive and maladaptive growth of heart muscle. Previous studies implicate two members of the AP-1 transcription factor family, junD and fra-1, in regulation of heart growth during hypertrophic response. In this study, we investigate the function of the AP-1 transcription factors, c-jun and c-fos, in heart growth. Using pressure overload-induced cardiac hypertrophy in mice and targeted deletion of Jun or Fos in cardiomyocytes, we show that c-jun is required for adaptive cardiac hypertrophy, while c-fos is dispensable in this context. c-jun promotes expression of sarcomere proteins and suppresses expression of extracellular matrix proteins. Capacity of cardiac muscle to contract depends on organization of principal thick and thin filaments, myosin and actin, within the sarcomere. In line with decreased expression of sarcomere-associated proteins, Jun-deficient cardiomyocytes present disarrangement of filaments in sarcomeres and actin cytoskeleton disorganization. Moreover, Jun-deficient hearts subjected to pressure overload display pronounced fibrosis and increased myocyte apoptosis finally resulting in dilated cardiomyopathy. In conclusion, c-jun but not c-fos is required to induce a transcriptional program aimed at adapting heart growth upon increased workload.	[Windak, Renata; Mueller, Julius; Sumara, Grzegorz; Ricci, Romeo] ETHZ, Inst Cell Biol, Zurich, Switzerland; [Felley, Allison; Pedrazzini, Thierry] Univ Lausanne, Sch Med, Dept Med, Expt Cardiol Unit, Lausanne, Switzerland; [Akhmedov, Alexander] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Wagner, Erwin F.] Spanish Natl Canc Res Ctr CNIO, F BBVA Canc Cell Biol Programme, Genes Dev & Dis Grp, Madrid, Spain; [Sumara, Grzegorz; Ricci, Romeo] Univ Strasbourg, Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, IGBMC, Illkirch Graffenstaden, France; [Ricci, Romeo] Univ Strasbourg, Hop Univ Strasbourg, Nouvel Hop Civil, Lab Biochim & Biol Mol, Strasbourg, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; University of Zurich; Centro Nacional de Investigaciones Oncologicas (CNIO); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sumara, G (corresponding author), ETHZ, Inst Cell Biol, Zurich, Switzerland.	grzegorz.sumara@uni-wuerzburg.de; ricci@igbmc.fr	Ricci, Romeo/K-3009-2013	Ricci, Romeo/0000-0002-9766-4369; Sumara, Grzegorz/0000-0003-1502-6265; Muller, Julius/0000-0002-1046-2968; Wagner, Erwin F/0000-0001-7872-0196	Roche Research Foundation; Swiss National Science Foundation SNSF [PP0033-114856]	Roche Research Foundation; Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF))	This work was supported by the Roche Research Foundation and by the Swiss National Science Foundation SNSF (PP0033-114856). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; BISHOPRIC NH, 1992, J BIOL CHEM, V267, P25535; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Brooks WW, 2000, J MOL CELL CARDIOL, V32, P187, DOI 10.1006/jmcc.1999.1065; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHIEN KR, 1993, ANNU REV PHYSIOL, V55, P77, DOI 10.1146/annurev.ph.55.030193.000453; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fujita T, 2011, CIRC J, V75, P1811, DOI 10.1253/circj.CJ-11-0025; Gravning J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052120; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hilfiker-Kleiner D, 2005, CIRCULATION, V112, P1470, DOI 10.1161/CIRCULATIONAHA.104.518472; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Kang PM, 2003, TRENDS MOL MED, V9, P177, DOI 10.1016/S1471-4914(03)00025-X; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Katsuragi N, 2004, CIRCULATION, V110, P1806, DOI 10.1161/01.CIR.0000142607.33398.54; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KOVACICMILIVOJEVIC B, 1992, MOL CELL BIOL, V12, P292, DOI 10.1128/MCB.12.1.292; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Li B, 2013, MOL BIOL REP, V40, P1677, DOI 10.1007/s11033-012-2218-3; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; Moe IT, 2013, J CELL COMMUN SIGNAL, V7, P31, DOI 10.1007/s12079-012-0183-1; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Omura T, 2002, HYPERTENSION, V39, P81, DOI 10.1161/hy0102.100783; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Paradis P, 1996, J BIOL CHEM, V271, P10827, DOI 10.1074/jbc.271.18.10827; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; Petrich BG, 2003, FASEB J, V17, P749, DOI 10.1096/fj.02-0438fje; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Ricci R, 2005, GENE DEV, V19, P208, DOI 10.1101/gad.327005; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; ROSENZWEIG A, 1991, CIRCULATION, V84, P1256, DOI 10.1161/01.CIR.84.3.1256; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; SCHNEIDER MD, 1992, BASIC RES CARDIOL, V87, P33; Seeland U, 2002, EUR J CLIN INVEST, V32, P295, DOI 10.1046/j.1365-2362.2002.00985.x; Shanmugam P, 2011, J MOL CELL CARDIOL, V50, P928, DOI 10.1016/j.yjmcc.2011.02.012; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Sugden PH, 2001, ANN MED, V33, P611; Tachibana H, 2006, BIOCHEM BIOPH RES CO, V343, P1060, DOI 10.1016/j.bbrc.2006.03.065; Taimor G, 2004, AM J PHYSIOL-HEART C, V286, pH2369, DOI 10.1152/ajpheart.00741.2003; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Villarreal FJ, 1996, J MOL CELL CARDIOL, V28, P735, DOI 10.1006/jmcc.1996.0068; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	71	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73294	10.1371/journal.pone.0073294	http://dx.doi.org/10.1371/journal.pone.0073294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039904	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600023
J	Wittchen, ES; Nishimura, E; McCloskey, M; Wang, H; Quilliam, LA; Chrzanowska-Wodnicka, M; Hartnett, ME				Wittchen, Erika S.; Nishimura, Eiichi; McCloskey, Manabu; Wang, Haibo; Quilliam, Lawrence A.; Chrzanowska-Wodnicka, Magdalena; Hartnett, M. Elizabeth			Rap1 GTPase Activation and Barrier Enhancement in RPE Inhibits Choroidal Neovascularization In Vivo	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL-CELL TRANSMIGRATION; GROWTH-FACTOR; MACULAR DEGENERATION; LIGHT-CHAIN; RHO-GTPASES; ANGIOGENESIS; JUNCTIONS; CONTACT; VEGF	Loss of barrier integrity precedes the development of pathologies such as metastasis, inflammatory disorders, and blood-retinal barrier breakdown present in neovascular age-related macular degeneration. Rap1 GTPase is involved in regulating both endothelial and epithelial cell junctions; the specific role of Rap1A vs. Rap1B isoforms is less clear. Compromise of retinal pigment epithelium barrier function is a contributing factor to the development of AMD. We utilized shRNA of Rap1 isoforms in cultured human retinal pigment epithelial cells, along with knockout mouse models to test the role of Rap1 on promoting RPE barrier properties, with emphasis on the dynamic junctional regulation that is triggered when the adhesion between cells is challenged. In vitro, Rap1A shRNA reduced steady-state barrier integrity, whereas Rap1B shRNA affected dynamic junctional responses. In a laser-induced choroidal neovascularization (CNV) model of macular degeneration, Rap1b(-/-) mice exhibited larger CNV volumes compared to wild-type or Rap1a(-/-). In vivo, intravitreal injection of a cAMP analog (8CPT-2'-O-Me-cAMP) that is a known Rap1 activator significantly reduced laser-induced CNV volume, which correlated with the inhibition of CEC transmigration across 8CPT-2'O-Me-cAMP-treated RPE monolayers in vitro. Rap1 activation by 8CPT-2'-O-Me-cAMP treatment increased recruitment of junctional proteins and F-actin to cell-cell contacts, increasing both the linearity of junctions in vitro and in cells surrounding laser-induced lesions in vivo. We conclude that in vitro, Rap1A may be important for steady state barrier integrity, while Rap1B is involved more in dynamic junctional responses such as resistance to junctional disassembly induced by EGTA and reassembly of cell junctions following disruption. Furthermore, activation of Rap1 in vivo inhibited development of choroidal neovascular lesions in a laser-injury model. Our data suggest that targeting Rap1 isoforms in vivo with 8CPT-2'-O-Me-cAMP may be a viable pharmacological means to strengthen the RPE barrier against the pathological choroidal endothelial cell invasion that occurs in macular degeneration.	[Wittchen, Erika S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Nishimura, Eiichi; McCloskey, Manabu; Wang, Haibo; Hartnett, M. Elizabeth] Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84108 USA; [Quilliam, Lawrence A.] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; [Chrzanowska-Wodnicka, Magdalena] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Nishimura, Eiichi] Showa Univ, Dept Ophthalmol, Tokyo, Japan	University of North Carolina; University of North Carolina Chapel Hill; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis; Versiti Blood Center of Wisconsin; Showa University	Hartnett, ME (corresponding author), Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84108 USA.	ME.Hartnett@hsc.utah.edu	Quilliam, Lawrence/Q-4987-2019; Quilliam, Lawrence/B-6447-2015	Chrzanowska, Magdalena/0000-0003-4182-2126	National Institutes of Health (NIH) [R01 EY017011, R01 EY015130]; U.S. Department of Defense [W81XWH1110355]; NIH [R01 HL111582]; American Heart Association [10SDG3430042];  [R01-GM029860];  [P01 HL-080166]; NATIONAL EYE INSTITUTE [R01EY015130, R01EY017011, P30EY014800] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111582, P01HL080166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) R01 EY017011 and R01 EY015130 (to M. E. H.); U.S. Department of Defense award W81XWH1110355 (to L. A. Q.); NIH R01 HL111582 (to M.C.-W.); American Heart Association Scientist Development Grant 10SDG3430042 (to E. S. W.); R01-GM029860, and P01 HL-080166. Department support from Research to Prevent Blindness (University of Utah). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Asuri S, 2008, J CELL BIOCHEM, V105, P1027, DOI 10.1002/jcb.21902; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Birukova AA, 2008, J CELL PHYSL; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009; Boettner B, 2007, MOL CELL BIOL, V27, P7966, DOI 10.1128/MCB.01275-07; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Christoforidis JB, 2011, CURR DRUG TARGETS, V12, P221; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2010, VASC PHARMACOL, V53, P1, DOI 10.1016/j.vph.2010.03.003; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Cunningham KE, 2012, ANN NY ACAD SCI, V1258, P34, DOI 10.1111/j.1749-6632.2012.06526.x; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuhra S, 2006, J BIOCHEM MOL BIOL, V39, P132; Geisen P, 2008, MOL VIS, V14, P345; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Geisen P, 2006, CURR EYE RES, V31, P739, DOI 10.1080/02713680600837408; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; McLachlan RW, 2011, CYTOSKELETON, V68, P32, DOI 10.1002/cm.20492; MILLER H, 1986, INVEST OPHTH VIS SCI, V27, P1644; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Nakajima H, 2011, J CELL BIOL, V195, P245, DOI 10.1083/jcb.201104118; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; O'Keefe DD, 2012, DEV BIOL; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007; Shirinifard A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002440; Shivanna M, 2010, MOL VIS, V16, P1781; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Srinivas SP, 2004, EXP EYE RES, V79, P543, DOI 10.1016/j.exer.2004.06.027; Stevens TS, 1997, ARCH OPHTHALMOL-CHIC, V115, P345, DOI 10.1001/archopht.1997.01100150347006; Stokman G, 2011, J AM SOC NEPHROL, V22, P859, DOI 10.1681/ASN.2010040423; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Wang H, 2011, EYE BRAIN, V3, P19, DOI 10.2147/EB.S24951; Wang H, 2011, INVEST OPHTH VIS SCI, V52, P570, DOI 10.1167/iovs.10-5595; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wittchen ES, 2011, INVEST OPHTH VIS SCI, V52, P7455, DOI 10.1167/iovs.11-7295; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Xu J, 2012, ANGIOGENESIS, V15, P213, DOI 10.1007/s10456-012-9254-4; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	74	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73070	10.1371/journal.pone.0073070	http://dx.doi.org/10.1371/journal.pone.0073070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039860	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600015
J	Khan, S; Bano, Z; Singh, LR; Hassan, MI; Islam, A; Ahmad, F				Khan, Sheeza; Bano, Zehra; Singh, Laishram R.; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan			Testing the Ability of Non-Methylamine Osmolytes Present in Kidney Cells to Counteract the Deleterious Effects of Urea on Structure, Stability and Function of Proteins	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; MEDULLARY ORGANIC OSMOLYTES; COLLECTING DUCT CELLS; RAT RENAL INNER; ELASMOBRANCH FISHES; THERMAL-STABILITY; MYOINOSITOL TRANSPORT; ALPHA-LACTALBUMIN; MAMMALIAN KIDNEY; GLYCINE BETAINE	Human kidney cells are under constant urea stress due to its urine concentrating mechanism. It is believed that the deleterious effect of urea is counteracted by methylamine osmolytes (glycine betaine and glycerophosphocholine) present in kidney cells. A question arises: Do the stabilizing osmolytes, non-methylamines (myo-inositol, sorbitol and taurine) present in the kidney cells also counteract the deleterious effects of urea? To answer this question, we have measured structure, thermodynamic stability (Delta G(D)(degrees)) and functional activity parameters (K-m and k(cat)) of different model proteins in the presence of various concentrations of urea and each non-methylamine osmolyte alone and in combination. We observed that (i) for each protein myo-inositol provides perfect counteraction at 1:2 ([myo-inositol]:[urea]) ratio, (ii) any concentration of sorbitol fails to refold urea denatured proteins if it is six times less than that of urea, and (iii) taurine regulates perfect counteraction in a protein specific manner; 1.5:2.0, 1.2:2.0 and 1.0:2.0 ([taurine]:[urea]) ratios for RNase-A, lysozyme and alpha-lactalbumin, respectively.	[Khan, Sheeza; Bano, Zehra; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Singh, Laishram R.] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	Jamia Millia Islamia; University of Delhi	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	fahmad@jmi.ac.in	Islam, Asimul/V-4526-2019; Hassan, Mohammad/GZA-7507-2022; Khan, Sheeza/AGH-0964-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Md Imtaiyaz/G-7072-2017; Ahmad, Faizan/AGH-4493-2022	Islam, Asimul/0000-0001-9060-7970; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Ahmad, Faizan/0000-0001-7021-7502	CSIR, the Council of Scientific and Industrial Research (India)	CSIR, the Council of Scientific and Industrial Research (India)	The authors are grateful to CSIR, the Council of Scientific and Industrial Research (India), for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P283; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; BURG MB, 1988, J CLIN INVEST, V81, P635, DOI 10.1172/JCI113366; Burg MB, 1998, AM J PHYSIOL-RENAL, V274, pF762, DOI 10.1152/ajprenal.1998.274.4.F762; Burg MB, 1996, KIDNEY INT, V50, pS100; DELPINO IMP, 1995, BIOCHEMISTRY-US, V34, P8621, DOI 10.1021/bi00027a011; DEMEIS L, 1988, J BIOL CHEM, V263, P157; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; GREENE DA, 1987, NEW ENGL J MED, V316, P599; Grunewaldt RW, 1999, J EXP ZOOL, V283, P708, DOI 10.1002/(SICI)1097-010X(19990601)283:7<708::AID-JEZ9>3.0.CO;2-V; GUDER WG, 1990, KLIN WOCHENSCHR, V68, P1091, DOI 10.1007/BF01798058; Hamaguchi K., 1968, J BIOCH, V54, P497; HAMMERMAN MR, 1980, AM J PHYSIOL, V239, pF113, DOI 10.1152/ajprenal.1980.239.2.F113; Haque I, 2005, FEBS LETT, V579, P3891, DOI 10.1016/j.febslet.2005.06.005; Haque I, 2005, BIOPHYS CHEM, V117, P1, DOI 10.1016/j.bpc.2005.04.004; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; HUTTON JC, 1975, AUST J EXP BIOL MED, V53, P49, DOI 10.1038/icb.1975.5; Kaushik JK, 1998, J PHYS CHEM B, V102, P7058, DOI 10.1021/jp981119l; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Lee R.E. Jr, 1991, P17; MACMILLEN RE, 1967, SCIENCE, V158, P383, DOI 10.1126/science.158.3799.383; Mahler S, 1998, AM J PHYSIOL-RENAL, V274, pF342, DOI 10.1152/ajprenal.1998.274.2.F342; MAKHATADZE GI, 1992, J MOL BIOL, V226, P491, DOI 10.1016/0022-2836(92)90963-K; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9; MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NAKANISHI T, 1993, AM J PHYSIOL, V264, pF472, DOI 10.1152/ajprenal.1993.264.3.F472; NOZAKI Y, 1963, J BIOL CHEM, V238, P4074; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Pace C N, 1986, Methods Enzymol, V131, P266; PEHLING G, 1956, Pflugers Arch Gesamte Physiol Menschen Tiere, V262, P551; PFEIL W, 1985, STUD BIOPHYS, V109, P163; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Qu YX, 2003, BIOCHEMISTRY-US, V42, P5837, DOI 10.1021/bi0206457; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; Ratnaparkhi GS, 2001, J BIOL CHEM, V276, P28789, DOI 10.1074/jbc.M101906200; Ruhfus B, 1996, KIDNEY BLOOD PRESS R, V19, P317, DOI 10.1159/000174094; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P5278, DOI 10.1021/bi00138a006; Santos BC, 1998, AM J PHYSIOL-RENAL, V274, pF1167, DOI 10.1152/ajprenal.1998.274.6.F1167; SCHIMASSEK H, 1959, BIOCHEM Z, V331, P87; SCHMOLKE M, 1989, RENAL PHYSIOL BIOCH, V12, P347; SCHMOLKE M, 1991, CONTRIB NEPHROL, V95, P255; Schmolke M, 1996, EUR J CLIN CHEM CLIN, V34, P499; Schmolke M, 1996, AM J PHYSIOL-RENAL, V271, pF645, DOI 10.1152/ajprenal.1996.271.3.F645; Singh LR, 2011, J IRAN CHEM SOC, V8, P1; Singh LR, 2009, BBA-PROTEINS PROTEOM, V1794, P929, DOI 10.1016/j.bbapap.2009.02.005; Singh LR, 2007, BBA-PROTEINS PROTEOM, V1774, P1555, DOI 10.1016/j.bbapap.2007.09.006; Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; STOKES JB, 1987, AM J PHYSIOL, V253, pF251, DOI 10.1152/ajprenal.1987.253.2.F251; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; VONRECKLINGHAUSEN IR, 1991, BIOCHIM BIOPHYS ACTA, V1091, P179, DOI 10.1016/0167-4889(91)90059-7; WIRTHENSOHN G, 1989, AM J PHYSIOL, V256, pF128, DOI 10.1152/ajprenal.1989.256.1.F128; WOLFF SD, 1990, ANNU REV PHYSIOL, V52, P727; Yadav S, 2000, ANAL BIOCHEM, V283, P207, DOI 10.1006/abio.2000.4641; YANCEY PH, 1980, J EXP ZOOL, V212, P205, DOI 10.1002/jez.1402120207; YANCEY PH, 1989, AM J PHYSIOL, V257, pF602, DOI 10.1152/ajprenal.1989.257.4.F602; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1978, J COMP PHYSIOL, V125, P135, DOI 10.1007/BF00686749; Yancey PH, 2003, BIOLOGIST, V50, P126	68	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72533	10.1371/journal.pone.0072533	http://dx.doi.org/10.1371/journal.pone.0072533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039776	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300012
J	Shibata, K; Fujita, S; Morita, H; Okamoto, Y; Sohmiya, K; Hoshiga, M; Ishizaka, N				Shibata, Kensaku; Fujita, Shu-ichi; Morita, Hideaki; Okamoto, Yusuke; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu			Association between Circulating Fibroblast Growth Factor 23, alpha-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PARATHYROID-HORMONE; HEMODIALYSIS-PATIENTS; VITAMIN-D; CARDIOVASCULAR-DISEASE; HYPERTROPHY; RISK; COMMUNITY; ADULTS; MORTALITY	Background: Fibroblast growth factor 23 (FGF23), with its co-receptor Klotho, plays a crucial role in phosphate metabolism. Several recent studies suggested that circulating FGF23 and alpha-Klotho concentrations might be related to cardiovascular abnormalities in patients with advanced renal failure. Purpose: Using data from 100 cardiology inpatients who were not undergoing chronic hemodialysis, the association of circulating levels of FGF23, alpha-Klotho, and other calcium-phosphate metabolism-related parameters with the left ventricular ejection fraction (LVEF) and left ventricular mass (LVM) was analyzed. Methods and Results: LVEF was measured using the modified Simpson method for apical 4-chamber LV images and the LVM index (LVMI) was calculated by dividing the LVM by body surface area. Univariate analysis showed that log transformed FGF23, but not that of alpha-Klotho, was significantly associated with LVEF and LVMI with a standardized beta of -0.35 (P<0.001) and 0.26 (P<0.05), respectively. After adjusting for age, sex, estimated glomerular filtration rate, and serum concentrations of intact parathyroid hormone, and 25-hydroxyvitamin D as covariates into the statistical model, log-transformed FGF23 was found to be a statistically positive predictor for decreased left ventricular function and left ventricular hypertrophy. Conclusions: In cardiology department inpatients, circulating FGF23 concentrations were found to be associated with the left ventricular mass and LVEF independent of renal function and other calcium-phosphate metabolism-related parameters. Whether modulation of circulating FGF23 levels would improve cardiac outcome in such a high risk population awaits further investigation.	[Shibata, Kensaku; Fujita, Shu-ichi; Morita, Hideaki; Okamoto, Yusuke; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Osaka Medical College	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@poh.osaka-med.ac.jp			Meiji Yasuda Life Foundation of Health and Welfare; Mitsui Life Social Welfare Foundation; Novartis Aging and Geriatric Medicine Research Funding; Grants-in-Aid for Scientific Research [25461261] Funding Source: KAKEN	Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); Mitsui Life Social Welfare Foundation; Novartis Aging and Geriatric Medicine Research Funding; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by grants from Meiji Yasuda Life Foundation of Health and Welfare, Mitsui Life Social Welfare Foundation, and Novartis Aging and Geriatric Medicine Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2013, KIDNEY INT, V83, P160, DOI 10.1038/ki.2012.327; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Fall T, 2012, EUR J HEART FAIL, V14, P985, DOI 10.1093/eurjhf/hfs091; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gosse P, 2005, J HYPERTENS, V23, pS27, DOI 10.1097/01.hjh.0000165625.79933.9a; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Heine GH, 2012, NEPHROL DIAL TRANSPL, V27, P3072, DOI 10.1093/ndt/gfs259; Ibrahim S, 2009, INT UROL NEPHROL, V41, P163, DOI 10.1007/s11255-008-9466-0; Imamura A, 2006, CLIN CHIM ACTA, V371, P66, DOI 10.1016/j.cca.2006.02.021; Isakova T, 2012, CURR OPIN NEPHROL HY, V21, P334, DOI 10.1097/MNH.0b013e328351a391; Ix JH, 2009, CLIN J AM SOC NEPHRO, V4, P609, DOI 10.2215/CJN.04100808; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; Kacso IM, 2012, CLIN BIOCHEM, V45, P1415, DOI 10.1016/j.clinbiochem.2012.07.098; Kamycheva E, 2013, EUR J HEART FAIL; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Larsson TE, 2010, ARTERIOSCL THROM VAS, V30, P333, DOI 10.1161/ATVBAHA.109.196675; Lopez FL, 2012, AM J CARDIOL; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Negishi K, 2010, CIRC J, V74, P2734, DOI 10.1253/circj.CJ-10-0355; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Seiler C, 2011, EUR HEART J, V32, P261, DOI [10.1093/eurheartj/ehq314, 10.1093/eurheartj/ehr215]; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Silver J, 2010, PEDIATR NEPHROL, V25, P2241, DOI 10.1007/s00467-010-1565-3; Sugimoto T, 2013, HEART, V99, P111, DOI 10.1136/heartjnl-2012-302779; Touchberry CD, 2013, AM J PHYSL ENDOCRINO; Unsal A, 2012, KIDNEY BLOOD PRESS R, V36, P55, DOI 10.1159/000339026; van Ballegooijen AJ, 2013, AM J CARDIOL, V111, P418, DOI 10.1016/j.amjcard.2012.10.021; Wachtell K, 2000, HYPERTENSION, V35, P6, DOI 10.1161/01.HYP.35.1.6; Westerberg PA, 2007, NEPHROL DIAL TRANSPL, V22, P3202, DOI 10.1093/ndt/gfm347; Westerberg PA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-85; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yokoyama K, 2012, CLIN NEPHROL, V77, P347, DOI 10.5414/CN107204	48	49	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73184	10.1371/journal.pone.0073184	http://dx.doi.org/10.1371/journal.pone.0073184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039882	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300056
J	Petanidis, S; Anestakis, D; Argyraki, M; Hadzopoulou-Cladaras, M; Salifoglou, A				Petanidis, Savvas; Anestakis, Doxakis; Argyraki, Maria; Hadzopoulou-Cladaras, Margarita; Salifoglou, Athanasios			Differential Expression of IL-17, 22 and 23 in the Progression of Colorectal Cancer in Patients with K-ras Mutation: Ras Signal Inhibition and Crosstalk with GM-CSF and IFN-gamma	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CELL LUNG-CANCER; INTERFERON-GAMMA; FARNESYLTRANSFERASE INHIBITORS; INTESTINAL INFLAMMATION; DEVELOPMENTAL DISORDERS; PANCREATIC-CANCER; PATHWAY; RESPONSES; PROMOTES	Recent studies have suggested that aberrant K-ras signaling is responsible for triggering immunological responses and inflammation-driven tumorigenesis. Interleukins IL-17, IL-22, and IL-23 have been reported in various types of malignancies, but the exact mechanistic role of these molecules remains to be elucidated. Given the role of K-ras and the involvement of interleukins in colorectal tumorigenesis, research efforts are reported for the first time, showing that differentially expressed interleukin IL-17, IL-22, and IL-23 levels are associated with K-ras in a stage-specific fashion along colorectal cancer progression. Specifically, a) the effect of K-ras signaling was investigated in the overall expression of interleukins in patients with colorectal cancer and healthy controls, and b) an association was established between mutant K-ras and cytokines GM-CSF and IFN-gamma. The results indicate that specific interleukins are differentially expressed in K-ras positive patients and the use of K-ras inhibitor Manumycin A decreases both interleukin levels and apoptosis in Caco-2 cells by inhibiting cell viability. Finally, inflammation-driven GM-CSF and IFN-gamma levels are modulated through interleukin expression in tumor patients, with interleukin expression in the intestinal lumen and cancerous tissue mediated by aberrant K-ras signaling. Collectively, the findings a) indicate that interleukin expression is influenced by ras signaling and specific interleukins play an oncogenic promoter role in colorectal cancer, highlighting the molecular link between inflammation and tumorigenesis, and b) accentuate the interwoven molecular correlations as leads to new therapeutic approaches in the future.	[Petanidis, Savvas; Salifoglou, Athanasios] Aristotle Univ Thessaloniki, Dept Chem Engn, GR-54006 Thessaloniki, Greece; [Anestakis, Doxakis; Argyraki, Maria] Aristotle Univ Thessaloniki, Lab Gen Biol, Sch Med, GR-54006 Thessaloniki, Greece; [Hadzopoulou-Cladaras, Margarita] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, Sch Biol, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Salifoglou, A (corresponding author), Aristotle Univ Thessaloniki, Dept Chem Engn, GR-54006 Thessaloniki, Greece.	salif@auth.gr	petanidis, savvas/P-5637-2018; Argyraki, Maria/GXA-1863-2022; Petanidis, Savvas/AAC-3082-2022	petanidis, savvas/0000-0001-7482-6559; Anestakis, Doxakis/0000-0001-8004-7666	EU-ESF; Greek national funds through the NSRF-Heracleitus II program	EU-ESF; Greek national funds through the NSRF-Heracleitus II program	This work was co-financed by the EU-ESF and Greek national funds through the NSRF-Heracleitus II program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Beaupre DM, 1999, CANCER RES, V59, P2971; Braun T, 2008, BRIT J HAEMATOL, V141, P576, DOI 10.1111/j.1365-2141.2008.07099.x; Broughton SE, 2012, IMMUNOL REV, V250, P277, DOI 10.1111/j.1600-065X.2012.01164.x; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Cunningham CC, 2001, CANCER, V92, P1265, DOI 10.1002/1097-0142(20010901)92:5<1265::AID-CNCR1447>3.0.CO;2-5; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Gjertsen MK, 2001, INT J CANCER, V92, P441, DOI 10.1002/ijc.1205; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guthrie GJK, 2013, CANCER TREAT REV, V39, P89, DOI 10.1016/j.ctrv.2012.07.003; Hatanaka K, 2004, J GENE MED, V6, P1139, DOI 10.1002/jgm.602; Hira SK, 2012, CELL IMMUNOL, V275, P69, DOI 10.1016/j.cellimm.2012.02.015; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang YC, 2000, CANCER RES, V60, P3200; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KROWN SE, 1991, HEMATOL ONCOL CLIN N, V5, P311, DOI 10.1016/S0889-8588(18)30443-X; Lee MS, 2009, J IMMUNOL, V183, P3390, DOI 10.4049/jimmunol.0804314; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; Nakada Y, 2001, PANCREATOLOGY, V1, P314, DOI 10.1159/000055830; Nelson N, 1996, J IMMUNOL, V156, P3711; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Riemensberger J, 2002, CLIN EXP IMMUNOL, V127, P20, DOI 10.1046/j.1365-2249.2002.01734.x; Rizzo A, 2011, WORLD J GASTROENTERO, V17, P3092, DOI 10.3748/wjg.v17.i26.3092; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shih IM, 2001, CANCER RES, V61, P818; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.26164; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Traversari C, 1997, GENE THER, V4, P1029, DOI 10.1038/sj.gt.3300489; Tsimberidou AM, 2010, EXPERT OPIN INV DRUG, V19, P1569, DOI 10.1517/13543784.2010.535516; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Ward AF, 2012, BLOOD, V120, P3397, DOI 10.1182/blood-2012-05-378596; Weyand CM, 2011, CURR OPIN RHEUMATOL, V23, P43, DOI 10.1097/BOR.0b013e32833ee946; Windbichler GH, 2000, BRIT J CANCER, V82, P1138; YAMAGATA S, 1995, CANCER, V75, P953, DOI 10.1002/1097-0142(19950215)75:4<953::AID-CNCR2820750409>3.0.CO;2-R; Yang H, 2012, CANCER RES, V72, P779, DOI 10.1158/0008-5472.CAN-11-2941; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401	52	45	47	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73616	10.1371/journal.pone.0073616	http://dx.doi.org/10.1371/journal.pone.0073616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040001	Green Submitted, gold, Green Published			2022-12-25	WOS:000324856500050
J	Fujiwara, T; Ohnuma, M; Yoshida, M; Kuroiwa, T; Hirano, T				Fujiwara, Takayuki; Ohnuma, Mio; Yoshida, Masaki; Kuroiwa, Tsuneyoshi; Hirano, Tatsuya			Gene Targeting in the Red Alga Cyanidioschyzon merolae: Single- and Multi-Copy Insertion Using Authentic and Chimeric Selection Markers	PLOS ONE			English	Article							ORGANELLE DIVISION CYCLES; MITOTIC-CYCLE; SEQUENCE; GENOME; CHLOROPLASTS; EXPRESSION	The unicellular red alga Cyanidioschyzon merolae is an emerging model organism for studying organelle division and inheritance: the cell is composed of an extremely simple set of organelles (one nucleus, one mitochondrion and one chloroplast), and their genomes are completely sequenced. Although a fruitful set of cytological and biochemical methods have now been developed, gene targeting techniques remain to be fully established in this organism. Thus far, only a single selection marker, URA(Cm-Gs), has been available that complements the uracil-auxotrophic mutant M4. URA(Cm-Gs), a chimeric URA5.3 gene of C. merolae and the related alga Galdieria sulphuraria, was originally designed to avoid gene conversion of the mutated URA5.3 allele in the parental strain M4. Although an early example of targeted gene disruption by homologous recombination was reported using this marker, the genome structure of the resultant transformants had never been fully characterized. In the current study, we showed that the use of the chimeric URA(Cm-Gs) selection marker caused multicopy insertion at high frequencies, accompanied by undesired recombination events at the targeted loci. The copy number of the inserted fragments was variable among the transformants, resulting in high yet uneven levels of transgene expression. In striking contrast, when the authentic URA5.3 gene (URA(Cm-Cm)) was used as a selection marker, efficient single-copy insertion was observed at the targeted locus. Thus, we have successfully established a highly reliable and reproducible method for gene targeting in C. merolae. Our method will be applicable to a number of genetic manipulations in this organism, including targeted gene disruption, replacement and tagging.	[Fujiwara, Takayuki; Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan; [Ohnuma, Mio; Kuroiwa, Tsuneyoshi] Rikkyo Univ, Fac Sci, Toshima Ku, Tokyo 171, Japan; [Yoshida, Masaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ohnuma, Mio; Kuroiwa, Tsuneyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	RIKEN; Rikkyo University; University of Tsukuba; Japan Science & Technology Agency (JST)	Hirano, T (corresponding author), RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan.	hiranot@riken.jp	Hirano, Tatsuya/F-6008-2011	Hirano, Tatsuya/0000-0002-4219-6473	Grants-in-Aid for Scientific Research [13J03172] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; Fujiwara T, 2013, MOL BIOL CELL, DOI 10.1091/mbc.E13-04-0208; Fujiwara T, 2009, DNA RES, V16, P59, DOI 10.1093/dnares/dsn032; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Imamura S, 2010, PLANT CELL PHYSIOL, V51, P707, DOI 10.1093/pcp/pcq043; Imamura S, 2009, P NATL ACAD SCI USA, V106, P12548, DOI 10.1073/pnas.0902790106; Imoto Y, 2011, J ELECTRON MICROSC, V60, pS117, DOI 10.1093/jmicro/dfr034; Kuroiwa Tsuneyoshi, 1994, Cytologia (Tokyo), V59, P149; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087; Nishida K, 2004, J HISTOCHEM CYTOCHEM, V52, P843, DOI 10.1369/jhc.4C6315.2004; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Ohnuma M, 2008, PLANT CELL PHYSIOL, V49, P117, DOI 10.1093/pcp/pcm157; Ohnuma M, 2009, PROTOPLASMA, V236, P107, DOI 10.1007/s00709-009-0056-5; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; SUZUKI K, 1994, EUR J CELL BIOL, V63, P280; Toda K, 1998, BBA-MOL CELL RES, V1403, P72, DOI 10.1016/S0167-4889(98)00031-7; Watanabe S, 2011, J GEN APPL MICROBIOL, V57, P69, DOI 10.2323/jgam.57.69; Yoshida Y, 2010, SCIENCE, V329, P949, DOI 10.1126/science.1190791	20	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73608	10.1371/journal.pone.0073608	http://dx.doi.org/10.1371/journal.pone.0073608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039997	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600090
J	Kaur, I; Puri, M; Ahmed, Z; Blanchet, FP; Mangeat, B; Piguet, V				Kaur, Inderdeep; Puri, Munish; Ahmed, Zahra; Blanchet, Fabien P.; Mangeat, Bastien; Piguet, Vincent			Inhibition of HIV-1 Replication by Balsamin, a Ribosome Inactivating Protein of Momordica balsamina	PLOS ONE			English	Article							IN-VITRO; ANTI-HIV; TYPE-1; PLANT; MAP30; CELLS	Ribosome-inactivating proteins (RIPs) are endowed with several medicinal properties, including antiviral activity. We demonstrate here that the recently identified type I RIP from Momordica balsamina also possesses antiviral activity, as determined by viral growth curve assays and single-round infection experiments. Importantly, this activity is at play even as doses where the RIP has no cytotoxic effect. In addition, balsamin inhibits HIV-1 replication not only in T cell lines but also in human primary CD4(+) T cells. This antiviral compound exerts its activity at a viral replicative step occurring later than reverse-transcription, most likely on viral protein translation, prior to viral budding and release. Finally, we demonstrate that balsamin antiviral activity is broad since it also impedes influenza virus replication. Altogether our results demonstrate that type I RIP can exert a potent anti-HIV-1 activity which paves the way for new therapeutic avenues for the treatment of viral infections.	[Kaur, Inderdeep; Mangeat, Bastien; Piguet, Vincent] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Kaur, Inderdeep; Puri, Munish] Punjabi Univ, Dept Biotechnol, Fermentat & Prot Biotechnol Lab, Patiala, Punjab, India; [Ahmed, Zahra; Blanchet, Fabien P.; Mangeat, Bastien; Piguet, Vincent] Cardiff Univ, Sch Med, Inst Infect & Immun, Dept Dermatol & Wound Healing, Cardiff, Wales	University of Geneva; Punjabi University; Cardiff University	Mangeat, B (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland.	bastien.mangeat@unige.ch; piguetv@cardiff.ac.uk	Puri, Munish/M-5577-2019; Blanchet, Fabien/AAL-1379-2021; Puri, Munish/C-2398-2013	Puri, Munish/0000-0003-2469-3326; BLANCHET, Fabien/0000-0003-3168-0697; Mangeat, Bastien/0000-0003-2592-0236; Piguet, Vincent/0000-0001-6079-4517	Indo-Swiss Joint Research Program (ISJRP) [RF17]; Cardiff University; Wellcome Trust-ISSF Seedcorn award	Indo-Swiss Joint Research Program (ISJRP); Cardiff University; Wellcome Trust-ISSF Seedcorn award	This work was supported by the Indo-Swiss Joint Research Program (ISJRP) RF17 to VP, MP and IK. The project was also supported by Cardiff University and a Wellcome Trust-ISSF Seedcorn award to VP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Au TK, 2000, FEBS LETT, V471, P169, DOI 10.1016/S0014-5793(00)01389-2; Benoit-Vical F, 2006, CHEMOTHERAPY, V52, P288, DOI 10.1159/000095960; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Huang PL, 1999, BIOCHEM BIOPH RES CO, V262, P615, DOI 10.1006/bbrc.1999.1213; KARUMI Y, 1999, BIOCHEMISTRY-US, V9, P795; Kaur I, 2012, AMINO ACIDS, V43, P973, DOI 10.1007/s00726-011-1162-1; Kaur Inderdeep, 2011, Virologica Sinica, V26, P357, DOI 10.1007/s12250-011-3223-8; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Law SKY, 2010, NUCLEIC ACIDS RES, V38, P6803, DOI 10.1093/nar/gkq551; Lee-Huang S, 1996, US Patent, Patent No. 5484889; LEEHUANG S, 1990, FEBS LETT, V272, P12, DOI 10.1016/0014-5793(90)80438-O; LEEHUANG S, 1995, P NATL ACAD SCI USA, V92, P8818, DOI 10.1073/pnas.92.19.8818; Mak ANS, 2007, NUCLEIC ACIDS RES, V35, P6259, DOI 10.1093/nar/gkm687; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ng TB, 2010, CURR PROTEIN PEPT SC, V11, P37, DOI 10.2174/138920310790274662; Ng YM, 2011, J STRUCT BIOL, V174, P164, DOI 10.1016/j.jsb.2010.12.007; Parikh BA, 2004, MINI-REV MED CHEM, V4, P523, DOI 10.2174/1389557043403800; Pirie CM, 2011, J BIOL CHEM, V286, P4165, DOI 10.1074/jbc.M110.186973; Puri M, 2009, CURR MOL MED, V9, P1080, DOI 10.2174/156652409789839071; Puri M, 2011, AMINO ACIDS, V41, pS67; Puri M, 2012, DRUG DISCOV TODAY, V17, P774, DOI 10.1016/j.drudis.2012.03.007; Puri M, 2010, CURR PHARM BIOTECHNO, V11, P229, DOI 10.2174/138920110790909696; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; TOMLINSON JA, 1974, J GEN VIROL, V22, P225, DOI 10.1099/0022-1317-22-2-225; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Wang JH, 2003, BIOCHEM BIOPH RES CO, V302, P89, DOI 10.1016/S0006-291X(03)00119-0; Wang JH, 2002, FEBS LETT, V531, P295, DOI 10.1016/S0014-5793(02)03539-1; Zhao WL, 2010, MOL BIOL REP, V37, P2093, DOI 10.1007/s11033-009-9668-2; Zheng YT, 1999, ACTA PHARMACOL SIN, V20, P239	32	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73780	10.1371/journal.pone.0073780	http://dx.doi.org/10.1371/journal.pone.0073780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040067	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000324481600098
J	Margue, C; Philippidou, D; Reinsbach, SE; Schmitt, M; Behrmann, I; Kreis, S				Margue, Christiane; Philippidou, Demetra; Reinsbach, Susanne E.; Schmitt, Martina; Behrmann, Iris; Kreis, Stephanie			New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion	PLOS ONE			English	Article							MALIGNANT-MELANOMA; TRANSCRIPTION FACTOR; EXPRESSION; MIR-211; PROGRESSION; PROGNOSIS; DIFFERENTIATION; SIGNATURES; TUMORS; LINES	The non-coding microRNAs (miRNA) have tissue-and disease-specific expression patterns. They down-regulate target mRNAs, which likely impacts on most fundamental cellular processes. Differential expression patterns of miRNAs are currently being exploited for identification of biomarkers for early disease diagnosis, prediction of progression for melanoma and other cancers and as promising drug targets, since they can easily be inhibited or replaced in a given cellular context. Before successfully manipulating miRNAs in clinical settings, their precise expression levels, endogenous functions and thus their target genes have to be determined. MiR-211, a melanocyte lineage-specific small non-coding miRNA, is located in an intron of TRPM1, a target gene of the microphtalmia-associated transcription factor (MITF). By transcriptionally up-regulating TRPM1, MITF, which is critical for both melanocyte differentiation and survival and for melanoma progression, indirectly drives the expression of miR-211. Expression of this miRNA is often reduced in melanoma samples. Here, we investigated functional roles of miR-211 by identifying and studying new target genes. We show that MITF-correlated miR-211 expression levels are mostly but not always reduced in a panel of 11 melanoma cell lines and in primary and metastatic melanoma compared to normal melanocytes and nevi, respectively. MiR-211 itself only marginally impacted on cell invasion and migration, while perturbation of some new miR-211 target genes, such as AP1S2, SOX11, IGFBP5, and SERINC3 significantly increased invasion. These results and the variable expression levels of miR-211 raise serious doubts on the value of miR-211 as a melanoma tumor-suppressing miRNA and/or as a biomarker for melanoma.	[Margue, Christiane; Philippidou, Demetra; Reinsbach, Susanne E.; Schmitt, Martina; Behrmann, Iris; Kreis, Stephanie] Univ Luxembourg, Signal Transduct Lab, Life Sci Res Unit, Luxembourg, Luxembourg	University of Luxembourg	Kreis, S (corresponding author), Univ Luxembourg, Signal Transduct Lab, Life Sci Res Unit, Luxembourg, Luxembourg.	stephanie.kreis@uni.lu		Behrmann, Iris/0000-0003-3688-3645; Kreis, Stephanie/0000-0003-1865-3889	University of Luxembourg [F1R_LSC-PUL-09MIRN]	University of Luxembourg	This study was funded by a research grant from the University of Luxembourg (F1R_LSC-PUL-09MIRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Asuthkar S, 2012, ONCOTARGET, V3, P1439; Bell RE, 2011, PIGM CELL MELANOMA R, V24, P1088, DOI 10.1111/j.1755-148X.2011.00931.x; Bonazzi VF, 2012, MELANOMA RES, V22, P101, DOI 10.1097/CMR.0b013e32834f6fbb; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen JZ, 2010, HUM MOL GENET, V19, P2524, DOI 10.1093/hmg/ddq131; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chitnis NS, 2012, MOL CELL, V48, P353, DOI 10.1016/j.molcel.2012.08.025; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Glud M, 2013, J EUR ACAD DERMATOL, V27, P142, DOI 10.1111/j.1468-3083.2012.04579.x; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027400; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Sakurai E, 2011, INT J ONCOL, V39, P665, DOI 10.3892/ijo.2011.1084; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Segura MF, 2012, CARCINOGENESIS, V33, P1823, DOI 10.1093/carcin/bgs205; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568	39	57	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73473	10.1371/journal.pone.0073473	http://dx.doi.org/10.1371/journal.pone.0073473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039954	gold, Green Published			2022-12-25	WOS:000324481600080
J	Zheng, YL; Li, CY; Hu, YF; Cao, L; Wang, H; Li, B; Lu, XH; Bao, L; Luo, HY; Shukla, V; Amin, ND; Pant, HC				Zheng, Ya-Li; Li, Congyu; Hu, Ya-Fang; Cao, Li; Wang, Hui; Li, Bo; Lu, Xiao-Hua; Bao, Li; Luo, Hong-Yan; Shukla, Varsha; Amin, Niranjana D.; Pant, Harish C.			Cdk5 Inhibitory Peptide (CIP) Inhibits Cdk5/p25 Activity Induced by High Glucose in Pancreatic Beta Cells and Recovers Insulin Secretion from p25 Damage	PLOS ONE			English	Article							GENE-TRANSCRIPTION; ACTIVATOR P35; PPAR-GAMMA; TAU; PHOSPHORYLATION; OVEREXPRESSION; REDUCTION; DISEASE; OBESITY; KINASE	Cdk5/p25 hyperactivity has been demonstrated to lead to neuron apoptosis and degenerations. Chronic exposure to high glucose (HG) results in hyperactivity of Cdk5 and reduced insulin secretion. Here, we set out to determine whether abnormal upregulation of Cdk5/p25 activity may be induced in a pancreatic beta cell line, Min6 cells. We first confirmed that p25 were induced in overexpressed p35 cells treated with HG and increased time course dependence. Next, we showed that no p25 was detected under short time HG stimulation (4-12 hrs), however was detectable in the long exposure in HG cells (24 hrs and 48 hrs). Cdk5 activity in the above cells was much higher than low glucose treated cells and resulted in more than 50% inhibition of insulin secretion. We confirmed these results by overexpression of p25 in Min6 cells. As in cortical neurons, CIP, a small peptide, inhibited Cdk5/p25 activity and restored insulin secretion. The same results were detected in co-infection of dominant negative Cdk5 (DNCdk5) with p25. CIP also reduced beta cells apoptosis induced by Cdk5/p25. These studies indicate that Cdk5/p25 hyperactivation deregulates insulin secretion and induces cell death in pancreatic beta cells and suggests that CIP may serve as a therapeutic agent for type 2 diabetes.	[Zheng, Ya-Li; Cao, Li; Wang, Hui; Li, Bo; Lu, Xiao-Hua; Bao, Li; Luo, Hong-Yan] Ningxia Peoples Hosp, Dept Nephrol, Yinchuan, Ningxia Provinc, Peoples R China; [Li, Congyu] Pharmerit North Amer, Bethesda, MD USA; [Shukla, Varsha; Amin, Niranjana D.; Pant, Harish C.] NINDS, Neurochem Lab, Bethesda, MD USA; [Hu, Ya-Fang] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Southern Medical University - China	Zheng, YL (corresponding author), Ningxia Peoples Hosp, Dept Nephrol, Yinchuan, Ningxia Provinc, Peoples R China.	yalinew@yahoo.com			National Natural Science Foundation of China [81060066]; Natural Science Foundation of Ningxia Province [NZ10162]; Department of Science and Technology of Ningxia Province [KGX-19-10-16, 2011ZYH169]; NIH; NINDS/NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ningxia Province; Department of Science and Technology of Ningxia Province; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grant sponsors: National Natural Science Foundation of China (grant No. 81060066, http://isisdemo.nsfc.gov.cn/miniiris/miniiris.asp), Natural Science Foundation of Ningxia Province (grant No. NZ10162), Department of Science and Technology of Ningxia Province (grant No. KGX-19-10-16 and 2011ZYH169), and NIH intramural funds (a collaboration with NINDS/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Gourcerol G, 2007, OBESITY, V15, P2643, DOI 10.1038/oby.2007.316; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Harashima SI, 2007, CLIN EXP IMMUNOL, V150, P49, DOI 10.1111/j.1365-2249.2007.03455.x; Houtkooper RH, 2010, NATURE, V466, P443, DOI 10.1038/466443a; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127; PARK BH, 1995, BIOCHEM BIOPH RES CO, V210, P1, DOI 10.1006/bbrc.1995.1619; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Veeranna, 1998, J NEUROSCI, V18, P4008; Wei FY, 2007, MINI-REV MED CHEM, V7, P1070, DOI 10.2174/138955707782110114; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zheng YL, 2010, J NEUROL SCI, V299, P101, DOI 10.1016/j.jns.2010.08.067; Zheng YL, 2010, J BIOL CHEM, V285, P34202, DOI 10.1074/jbc.M110.134643; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x	29	44	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e63332	10.1371/journal.pone.0063332	http://dx.doi.org/10.1371/journal.pone.0063332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039692	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600002
J	Wibbelt, G; Puechmaille, SJ; Ohlendorf, B; Muhldorfer, K; Bosch, T; Gorfol, T; Passior, K; Kurth, A; Lacremans, D; Forget, F				Wibbelt, Gudrun; Puechmaille, Sebastien J.; Ohlendorf, Bernd; Muehldorfer, Kristin; Bosch, Thijs; Goerfoel, Tamas; Passior, Karsten; Kurth, Andreas; Lacremans, Daniel; Forget, Frederic			Skin Lesions in European Hibernating Bats Associated with Geomyces destructans, the Etiologic Agent of White-Nose Syndrome	PLOS ONE			English	Article							MYOTIS-LUCIFUGUS; EMERGING DISEASE; INFECTION	White-nose syndrome (WNS) has claimed the lives of millions of hibernating insectivorous bats in North America. Its etiologic agent, the psychrophilic fungus Geomyces destructans, causes skin lesions that are the hallmark of the disease. The fungal infection is characterized by a white powdery growth on muzzle, ears and wing membranes. While WNS may threaten some species of North American bats with regional extinction, infection in hibernating bats in Europe seems not to be associated with significant mortality. We performed histopathological investigations on biopsy samples of 11 hibernating European bats, originating from 4 different countries, colonized by G. destructans. One additional bat was euthanized to allow thorough examination of multiple strips of its wing membranes. Molecular analyses of touch imprints, swabs and skin samples confirmed that fungal structures were G. destructans. Additionally, archived field notes on hibernacula monitoring data in the Harz Mountains, Germany, over an 11-year period (2000-2011) revealed multiple capture-recapture events of 8 banded bats repeatedly displaying characteristic fungal colonization. Skin lesions of G. destructans-affected hibernating European bats are intriguingly similar to the epidermal lesions described in North American bats. Nevertheless, deep invasion of fungal hyphae into the dermal connective tissue with resulting ulceration like in North American bats was not observed in the biopsy samples of European bats; all lesions found were restricted to the layers of the epidermis and its adnexae. Two bats had mild epidermal cupping erosions as described for North American bats. The possible mechanisms for any difference in outcomes of G. destructans infection in European and North American bats still need to be elucidated.	[Wibbelt, Gudrun; Muehldorfer, Kristin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Puechmaille, Sebastien J.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Puechmaille, Sebastien J.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany; [Puechmaille, Sebastien J.] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, D-17489 Greifswald, Germany; [Ohlendorf, Bernd] Fed Off Bat Protect Saxony Anhalt, Rossla, Germany; [Bosch, Thijs] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Goerfoel, Tamas] Szent Istvan Univ, Fac Vet Sci, Inst Biol, Budapest, Hungary; [Goerfoel, Tamas] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Passior, Karsten] Nat & Biodivers Conservat Union Southern Lower Sa, Nordstemmen, Germany; [Kurth, Andreas] Robert Koch Inst, Berlin, Germany; [Lacremans, Daniel] Inst Pathogenet, Gosselies, Belgium; [Forget, Frederic] Natagora, Plecotus Working Grp, Namur, Belgium	Leibniz Institut fur Zoo und Wildtierforschung; University College Dublin; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Wageningen University & Research; Hungarian University of Agriculture & Life Sciences; Robert Koch Institute	Wibbelt, G (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	wibbelt@izw-berlin.de	Puechmaille, Sebastien/D-1612-2010; Yen, Jeng-Hsien/A-1335-2010; Tsai, Wen-Chan/C-7348-2009; Görföl, Tamás/F-7688-2010	Puechmaille, Sebastien/0000-0001-9517-5775; Yen, Jeng-Hsien/0000-0002-1291-1739; Görföl, Tamás/0000-0002-1910-4024; Bosch, Thijs/0000-0001-7905-7402				Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Fuller NW, 2011, ECOHEALTH, V8, P154, DOI 10.1007/s10393-011-0705-y; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Lindner DL, 2011, MYCOLOGIA, V103, P241, DOI 10.3852/10-262; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, ACTA CHIROPTEROL, V13, P217, DOI 10.3161/150811011X578778; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Simmons NB, 2009, ECOLOGICAL BEHAV MET, P863; U.S. Fish and Wildlife Service, 2012, INF WHIT NOS BATS; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	27	32	32	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74105	10.1371/journal.pone.0074105	http://dx.doi.org/10.1371/journal.pone.0074105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023927	Green Published, gold, Green Submitted			2022-12-25	WOS:000324515600130
J	Aydin, H; Smrke, BM; Lee, JE				Aydin, Halil; Smrke, Brianna M.; Lee, Jeffrey E.			Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism	FASEB JOURNAL			English	Article						ASLV; TM; helix dipole moment; HTLV-1	EBOLA-VIRUS GLYCOPROTEIN; HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; INDUCED CONFORMATIONAL-CHANGES; ALPHA-HELIX DIPOLE; AVIAN-SARCOMA; LOW-PH; ENVELOPE GLYCOPROTEIN; RECEPTOR-BINDING; CRYSTAL-STRUCTURE; INFLUENZA HEMAGGLUTININ	Entry of enveloped viruses into host cells is mediated by their surface envelope glycoproteins (Env). On the surface of the virus, Env is in a metastable, prefusion state, primed to catalyze the fusion of the viral and host membranes. An external trigger is needed to promote the drastic conformational changes necessary for the fusion subunit to fold into the low-energy, 6-helix bundle. These triggers typically facilitate pH-independent entry at the plasma membrane or pH-dependent entry in a low-pH endosomal compartment. The alpha-retrovirus avian sarcoma leukosis virus (ASLV) has a rare, 2-step entry mechanism with both pH-dependent and pH-independent features. Here, we present the 2.0-angstrom-resolution crystal structure of the ASLV transmembrane (TM) fusion protein. Our structural and biophysical studies indicated that unlike other pH-dependent or pH-independent viral TMs, the ASLV fusion subunit is stable irrespective of pH. Two histidine residues (His490 and His492) in the chain reversal region confer stability at low pH. A structural comparison of class I viral fusion proteins suggests that the presence of a positive charge, either a histidine or arginine amino acid, stabilizes a helical dipole moment and is a signature of fusion proteins active at low pH. The structure now reveals key residues and features that explain its 2-step mechanism, and we discuss the implications of the ASLV TM structure in the context of general mechanisms required for membrane fusion.	[Aydin, Halil; Smrke, Brianna M.; Lee, Jeffrey E.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto	Lee, JE (corresponding author), 1 Kings Coll Cir,Rm 6316, Toronto, ON M5S 1A8, Canada.	jeff.lee@utoronto.ca			University of Toronto startup funds; Canada Research Chair in Structural Virology; Canadian Institutes of Health Research (CIHR) [MOP-115066]; New Investigator award [MSH-113554]; University of Toronto graduate fellowship; Ontario Genomics Institute Summer Research Fellowship; Canadian Society for Immunology Summer Internship Award	University of Toronto startup funds; Canada Research Chair in Structural Virology; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); New Investigator award; University of Toronto graduate fellowship; Ontario Genomics Institute Summer Research Fellowship; Canadian Society for Immunology Summer Internship Award	The research was supported in part by University of Toronto startup funds, a Canada Research Chair in Structural Virology, a Canadian Institutes of Health Research (CIHR) open operating grant (MOP-115066), and a New Investigator award (MSH-113554) to J.E.L. H. A. was supported by a University of Toronto graduate fellowship, and B. M. S. was funded by an Ontario Genomics Institute Summer Research Fellowship and Canadian Society for Immunology Summer Internship Award. The authors thank the Molecular Structure and Function program at the Hospital for Sick Children Research Institute (Toronto, ON, Canada) for generous access to a circular dichroism spectropolarimeter, and Aiping Dong, Dr. Aled Edwards, and Dr. Cheryl Arrowsmith (Structural Genomics Consortium, Toronto, ON, Canada) for access to the X-ray diffraction facility. ASLV TM crystal structure and structure factors have been deposited into the Protein Data Bank (accession code 4JPR).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babel AR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000171; Barnard RJO, 2006, VIROLOGY, V344, P25, DOI 10.1016/j.virol.2005.09.021; Barnard RJO, 2004, J VIROL, V78, P10433, DOI 10.1128/JVI.78.19.10433-10441.2004; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; BenTal N, 1996, BIOPHYS J, V71, P3046, DOI 10.1016/S0006-3495(96)79498-5; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Brown JH, 1996, PROTEINS, V26, P134; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033734; Damico R, 1999, J VIROL, V73, P3087, DOI 10.1128/JVI.73.4.3087-3094.1999; Delos SE, 2005, J VIROL, V79, P3488, DOI 10.1128/JVI.79.6.3488-3499.2005; Delos SE, 2010, J VIROL, V84, P5687, DOI 10.1128/JVI.02583-09; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; DOMS RW, 1986, J VIROL, V60, P833, DOI 10.1128/JVI.60.3.833-839.1986; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Earp LJ, 2003, J VIROL, V77, P3058, DOI 10.1128/JVI.77.5.3058-3066.2003; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; GILBERT JM, 1995, J VIROL, V69, P7410, DOI 10.1128/JVI.69.12.7410-7415.1995; Harrison JS, 2012, BIOCHEMISTRY-US, V51, P2515, DOI 10.1021/bi3000353; Harrison JS, 2011, PROTEIN SCI, V20, P1587, DOI 10.1002/pro.688; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Katritzky AR, 2009, J MED CHEM, V52, P7631, DOI 10.1021/jm900450n; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Koellhoffer JF, 2012, BIOCHEMISTRY-US, V51, P7665, DOI 10.1021/bi300976m; Lamb D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001268; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Li KJ, 2007, VIROLOGY, V361, P149, DOI 10.1016/j.virol.2006.11.013; Liu K, 2008, J MED CHEM, V51, P7843, DOI 10.1021/jm800869t; Maerz AL, 2000, J VIROL, V74, P6614, DOI 10.1128/JVI.74.14.6614-6621.2000; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Markovic I, 2001, J CELL BIOL, V155, P833, DOI 10.1083/jcb.200103005; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsuyama S, 2004, J VIROL, V78, P8201, DOI 10.1128/JVI.78.15.8201-8209.2004; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Morizono K, 2011, CURR OPIN VIROL, V1, P13, DOI 10.1016/j.coviro.2011.05.001; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Netter RC, 2004, J VIROL, V78, P13430, DOI 10.1128/JVI.78.24.13430-13439.2004; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Plemper RK, 2011, CURR OPIN VIROL, V1, P92, DOI 10.1016/j.coviro.2011.06.002; Prevost M, 1996, J MOL BIOL, V260, P99, DOI 10.1006/jmbi.1996.0384; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; Rojek JM, 2008, J VIROL, V82, P1505, DOI 10.1128/JVI.01331-07; SALI D, 1988, NATURE, V335, P740, DOI 10.1038/335740a0; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Sengupta D, 2005, STRUCTURE, V13, P849, DOI 10.1016/j.str.2005.03.010; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; Wallin M, 2004, EMBO J, V23, P54, DOI 10.1038/sj.emboj.7600012; Wang HT, 2009, ANTIMICROB AGENTS CH, V53, P4987, DOI 10.1128/AAC.00670-09; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yaddanapudi K, 2006, FASEB J, V20, P2519, DOI 10.1096/fj.06-6151com	74	12	12	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5059	5071		10.1096/fj.13-232371	http://dx.doi.org/10.1096/fj.13-232371			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24036886	Green Published			2022-12-25	WOS:000329999000038
J	Hardy, MC; Daly, NL; Mobli, M; Morales, RAV; Keng, GF				Hardy, Margaret C.; Daly, Norelle L.; Mobli, Mehdi; Morales, Rodrigo A. V.; Keng, Glenn F.			Isolation of an Orally Active Insecticidal Toxin from the Venom of an Australian Tarantula	PLOS ONE			English	Article							CYSTINE KNOT; PEPTIDE TOXINS; NEUROTOXINS; ATRACOTOXIN; MECHANISMS; SPIDERS; PRODUCT; MODEL	Many insect pests have developed resistance to existing chemical insecticides and consequently there is much interest in the development of new insecticidal compounds with novel modes of action. Although spiders have deployed insecticidal toxins in their venoms for over 250 million years, there is no evolutionary selection pressure on these toxins to possess oral activity since they are injected into prey and predators via a hypodermic needle-like fang. Thus, it has been assumed that spider-venom peptides are not orally active and are therefore unlikely to be useful insecticides. Contrary to this dogma, we show that it is possible to isolate spider-venom peptides with high levels of oral insecticidal activity by directly screening for per os toxicity. Using this approach, we isolated a 34-residue orally active insecticidal peptide (OAIP-1) from venom of the Australian tarantula Selenotypus plumipes. The oral LD50 for OAIP-1 in the agronomically important cotton bollworm Helicoverpa armigera was 104.2 +/- 0.6 pmol/g, which is the highest per os activity reported to date for an insecticidal venom peptide. OAIP-1 is equipotent with synthetic pyrethroids and it acts synergistically with neonicotinoid insecticides. The three-dimensional structure of OAIP-1 determined using NMR spectroscopy revealed that the three disulfide bonds form an inhibitor cystine knot motif; this structural motif provides the peptide with a high level of biological stability that probably contributes to its oral activity. OAIP-1 is likely to be synergized by the gut-lytic activity of the Bacillus thuringiensis Cry toxin (Bt) expressed in insect-resistant transgenic crops, and consequently it might be a good candidate for trait stacking with Bt.	[Hardy, Margaret C.; Daly, Norelle L.; Mobli, Mehdi; Morales, Rodrigo A. V.; Keng, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Keng, GF (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	glenn.king@imb.uq.edu.au	Daly, Norelle L/D-4302-2013; King, Glenn F/J-5059-2012; Mobli, Mehdi/O-7244-2014; Hardy, Margaret C/A-5576-2009	Daly, Norelle L/0000-0002-4697-6602; King, Glenn F/0000-0002-2308-2200; Mobli, Mehdi/0000-0003-2420-4262; Hardy, Margaret C/0000-0001-5033-4322; Morales, Rodrigo/0000-0002-7973-356X	Australian Research Council [DP0774245]; University of Queensland Research Scholarship; Australian Government International Postgraduate Research Scholarship	Australian Research Council(Australian Research Council); University of Queensland Research Scholarship(University of Queensland); Australian Government International Postgraduate Research Scholarship(Australian Government)	The authors acknowledge financial support from the Australian Research Council (Discovery Grant DP0774245 to G. F. K.). M.C.H. was supported by a University of Queensland Research Scholarship and an Australian Government International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Cao CW, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20001; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi SJ, 2004, FEBS LETT, V572, P109, DOI 10.1016/j.febslet.2004.07.019; Cooper J, 2007, CROP PROT, V26, P1337, DOI 10.1016/j.cropro.2007.03.022; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; Einerwold J, 2001, BIOCHEMISTRY-US, V40, P14404, DOI 10.1021/bi011499s; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Fath-Goodin A, 2006, J INSECT PHYSIOL, V52, P576, DOI 10.1016/j.jinsphys.2006.02.005; Fitches EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039389; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Fountain SJ, 2009, PURINERG SIGNAL, V5, P269, DOI 10.1007/s11302-008-9127-x; Fujitani N, 2002, J BIOL CHEM, V277, P23651, DOI 10.1074/jbc.M111120200; Gentz MC, 2009, HOLZFORSCHUNG, V63, P113, DOI 10.1515/HF.2009.025; Gentz MC, 2009, TOXICON, V53, P496, DOI 10.1016/j.toxicon.2009.01.025; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Gunning SJ, 2008, FEBS J, V275, P4045, DOI 10.1111/j.1742-4658.2008.06545.x; GUNTERT P, 2004, TECHNIQUES, V278, P353; Hernandez-Campuzano B, 2009, TOXICON, V53, P122, DOI 10.1016/j.toxicon.2008.10.020; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jungo F, 2012, TOXICON, V60, P551, DOI 10.1016/j.toxicon.2012.03.010; Khan SA, 2006, TRANSGENIC RES, V15, P349, DOI 10.1007/s11248-006-0007-2; King GF, 2002, J TOXICOL-TOXIN REV, V21, P359, DOI 10.1081/TXR-120014409; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maggio F, 2002, J BIOL CHEM, V277, P22806, DOI 10.1074/jbc.M202297200; Martin T, 2002, PESTIC BIOCHEM PHYS, V74, P17, DOI 10.1016/S0048-3575(02)00117-7; Mukherjee AK, 2006, TOXICON, V47, P182, DOI 10.1016/j.toxicon.2005.10.011; Nation J, 2002, INSECT PHYSL BIOCH, P485; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Omar A, 2012, ASIAN J MANAG CASES, V9, P33, DOI 10.1177/097282011100900105; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; Pimentel D, 1997, TECHNIQUES REDUCING, P51; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; Qaim M, 2010, NEW BIOTECHNOL, V27, P552, DOI 10.1016/j.nbt.2010.07.009; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shen HY, 2009, PESTIC BIOCHEM PHYS, V93, P144, DOI 10.1016/j.pestbp.2009.02.004; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Soberon M, 2007, TOXICON, V49, P597, DOI 10.1016/j.toxicon.2006.11.008; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Tedford HW, 2007, PEPTIDES, V28, P51, DOI 10.1016/j.peptides.2006.08.026; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375	61	40	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73136	10.1371/journal.pone.0073136	http://dx.doi.org/10.1371/journal.pone.0073136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039872	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326734500025
J	Hoque, M; Dave, S; Gupta, P; Saleemuddin, M				Hoque, Mehboob; Dave, Sandeep; Gupta, Pawan; Saleemuddin, Mohammed			Oleic Acid May Be the Key Contributor in the BAMLET-Induced Erythrocyte Hemolysis and Tumoricidal Action	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; NONSELECTIVE CATION CHANNEL; MONOUNSATURATED FATTY-ACID; KILLS TUMOR-CELLS; OLIVE OIL; CANCER-CELLS; CYTOTOXIC COMPLEXES; FOLDING VARIANT; MILK PROTEIN; HAMLET	A chance discovery of the tumoricidal action of a human milk fraction led to the characterization of the active component as oleic acid complex of the alpha-lactalbumin, which was given the acronym HAMLET. We report in this study that the oleic acid complex of bovine alpha-lactalbumin (BAMLET) is hemolytic to human erythrocytes as well as to those derived from some other mammals. Indirect immunofluorescence analysis suggested binding of BAMLET to erythrocytes prior to induction of hemolysis. Free OA was hemolytic albeit at higher concentrations, while sodium oleate caused hemolysis at far lower concentrations. Amiloride and BaCl2 offered protection against BAMLET-induced hemolysis suggesting the involvement of a cation leak channel in the process. BAMLET coupled to CNBr-activated Sepharose was not only hemolytic but also tumoricidal to Jurkat and MCF-7 cells in culture. The Sepharose-linked preparation was however not toxic to non-cancerous peritoneal macrophages and primary adipocytes. The tumoricidal action was studied using the MTT-assay while apoptosis induction measured by the annexin V-propidium iodide assay. Repeated incubation of the immobilized BAMLET with erythrocytes depleted oleic acid and decreased the hemolytic activity of the complex. Incubation of MCF-7 and Jurkat cells with OA, soluble or immobilized BAMLET resulted in increase in the uptake of Lyso Tracker Red and Nile red by the cells. The data presented support the contention that oleic acid plays the key role, both in BAMLET-induced hemolysis and tumoricidal action.	[Hoque, Mehboob; Saleemuddin, Mohammed] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Dave, Sandeep; Gupta, Pawan] CSIR, Inst Microbial Technol, Chandigarh, India	Aligarh Muslim University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Saleemuddin, M (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	msaleemuddin@rediffmail.com	Hoque, Mehboob/U-9159-2019	Hoque, Mehboob/0000-0001-8450-7738; Gupta, Pawan/0000-0001-6692-7237; Dave, Sandeep/0000-0003-2832-2098	Department of Biotechnology, Government of India; UGC-BSR faculty fellowship; UGC-Maulana Azad National Junior Research fellowship	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); UGC-BSR faculty fellowship; UGC-Maulana Azad National Junior Research fellowship	The authors are grateful to the Department of Biotechnology, Government of India for support. MS is a recipient of UGC-BSR faculty fellowship and MH UGC-Maulana Azad National Junior Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; BENNEKOU P, 1993, BIOCHIM BIOPHYS ACTA, V1147, P165, DOI 10.1016/0005-2736(93)90328-W; Brinkmann CR, 2011, J DAIRY SCI, V94, P2159, DOI 10.3168/jds.2010-3622; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; Casbarra A, 2004, PROTEIN SCI, V13, P1322, DOI 10.1110/ps.03474704; CHRISTOPHERSEN P, 1991, BIOCHIM BIOPHYS ACTA, V1065, P103, DOI 10.1016/0005-2736(91)90017-3; Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Fast J, 2005, PROTEIN SCI, V14, P329, DOI 10.1110/ps.04982905; Fauser JK, 2011, CANCER BIOL THER, V11, P724, DOI 10.4161/cbt.11.8.15281; Foller M, 2008, CELL PHYSIOL BIOCHEM, V21, P183, DOI 10.1159/000113760; Fontana A, 2013, BBA-PROTEINS PROTEOM, V1834, P1125, DOI 10.1016/j.bbapap.2013.02.041; GORE J, 1994, REPROD NUTR DEV, V34, P439, DOI 10.1051/rnd:19940505; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; HO CSJ, 2013, J BIOL CHEM, DOI DOI 10.1074/JBC.M113.468405; Ho CSJ, 2012, FUTURE ONCOL, V8, P1301, DOI [10.2217/fon.12.122, 10.2217/FON.12.122]; Johnke M, 2012, MILK PROTEIN, P119, DOI 10.5772/47433; Kaestner L, 2002, BIOELECTROCHEMISTRY, V55, P71, DOI 10.1016/S1567-5394(01)00164-5; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Kehoe J.J., 2012, FOOD HYDROCOLLOID, DOI DOI 10.1016/J.F00DHYD.2012.09.009; Khamaisie H, 2011, ANTICANCER RES, V31, P177; LIN IC, 2008, FOOD CHEM TOXICOL, V46, P42, DOI DOI 10.1016/J.FCT.2008.09.032; Lipworth L, 1997, PREV MED, V26, P181, DOI 10.1006/pmed.1996.9977; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Mahajan S, 2012, J INFECT DIS, V206, P366, DOI 10.1093/infdis/jis354; MARTINMORENO JM, 1994, INT J CANCER, V58, P774, DOI 10.1002/ijc.2910580604; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; Menendez JA, 2006, EUR J CANCER, V42, P2425, DOI 10.1016/j.ejca.2005.10.016; Messner B, 2012, TOXICOL LETT, V212, P268, DOI 10.1016/j.toxlet.2012.05.026; Mok KH, 2007, BIOCHEM BIOPH RES CO, V354, P1, DOI 10.1016/j.bbrc.2006.12.167; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Nakahara W, 1925, J EXP MED, V41, P347, DOI 10.1084/jem.41.3.347; Nakahara W, 1924, J EXP MED, V40, P363, DOI 10.1084/jem.40.3.363; Nakamura T, 2013, J BIOL CHEM, V288, P14408, DOI 10.1074/jbc.M112.437889; Nielsen SB, 2010, J MOL BIOL, V398, P351, DOI 10.1016/j.jmb.2010.03.012; Permyakov SE, 2011, BIOCHIMIE, V93, P1495, DOI 10.1016/j.biochi.2011.05.002; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson J, 2006, BIOCHEM BIOPH RES CO, V345, P260, DOI 10.1016/j.bbrc.2006.04.081; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sharp JA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-48; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Sternhagen LG, 2001, ADV EXP MED BIOL, V501, P115; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; STORM P, 2012, THESIS LUNDSUNIVERSI; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058578; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wawrik B, 2010, J MICROBIOL METH, V80, P262, DOI 10.1016/j.mimet.2010.01.016; White D.A., 1973, PHOSPHOLIPID COMPOSI; Xiao ZW, 2013, BJU INT, V112, pE201, DOI 10.1111/j.1464-410X.2012.11737.x; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	69	39	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e68390	10.1371/journal.pone.0068390	http://dx.doi.org/10.1371/journal.pone.0068390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039698	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500002
J	Lutz, BD; Bernhardt, ES; Schlesinger, WH				Lutz, Brian D.; Bernhardt, Emily S.; Schlesinger, William H.			The Environmental Price Tag on a Ton of Mountaintop Removal Coal	PLOS ONE			English	Article							FORESTS; LAND	While several thousand square kilometers of land area have been subject to surface mining in the Central Appalachians, no reliable estimate exists for how much coal is produced per unit landscape disturbance. We provide this estimate using regional satellite-derived mine delineations and historical county-level coal production data for the period 1985-2005, and further relate the aerial extent of mining disturbance to stream impairment and loss of ecosystem carbon sequestration potential. To meet current US coal demands, an area the size of Washington DC would need to be mined every 81 days. A one-year supply of coal would result in similar to 2,300 km of stream impairment and a loss of ecosystem carbon sequestration capacity comparable to the global warming potential of >33,000 US homes. For the first time, the environmental impacts of surface coal mining can be directly scaled with coal production rates.	[Lutz, Brian D.] Kent State Univ, Dept Biol, Kent, OH 44242 USA; [Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC USA; [Schlesinger, William H.] Cary Inst Ecosyst Studies, Millbrook, NY USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Duke University; Cary Institute of Ecosystem Studies	Lutz, BD (corresponding author), Kent State Univ, Dept Biol, Kent, OH 44242 USA.	blutz6@kent.edu	Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010	Bernhardt, Emily S/0000-0003-3031-621X; 				Amichev BY, 2008, FOREST ECOL MANAG, V256, P1949, DOI 10.1016/j.foreco.2008.07.020; Anderson J.R., 1976, 964 US GEOL SURV, DOI 10.3133/pp964; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Bernhardt ES, 2012, ENVIRON SCI TECHNOL, V46, P8115, DOI 10.1021/es301144q; DOE, 1980, LAND US EN; EIA, 2011, COAL PRIC SEL YEARS; EIA, 2011, COAL PROD STAT MIN T; EPA, 2003, AFF ENV CONS MTM VF; EPA, 1998, BIT SUBB COAL COMB; GAO, 2009, SURF COAL MIN CHAR M; Kentucky Geological Survey, 2013, COAL PROD DAT; KY Office of State Budget, 2010, COAL SEV PROC TAX; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; Pond GJ, 2013, ENVIRON MONIT ASSESS, V185, P1515, DOI 10.1007/s10661-012-2648-3; POUCH GW, 1990, PHOTOGRAMM ENG REM S, V56, P475; Saylor KL, 2008, LAND COVER TRENDS CE; Short N., 1982, REMOTE SENSING TUTOR; Simmons JA, 2008, ECOL APPL, V18, P104, DOI 10.1890/07-1117.1; USGS, 2009, COAL RES AV REC EC E; West Virginia Geological and Economic Survey, 2010, COAL SUMM STAT; Wood GH, 1980, COAL RESOURCE CLASSI; WV State Tax Department, 2007, W VIRG COAL SEV TAX; Zipper CE, 2011, ENVIRON MANAGE, V47, P751, DOI 10.1007/s00267-011-9670-z	24	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73203	10.1371/journal.pone.0073203	http://dx.doi.org/10.1371/journal.pone.0073203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039888	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500028
J	Penney, D; Wadsworth, C; Fox, G; Kennedy, SL; Preziosi, RF; Brown, TA				Penney, David; Wadsworth, Caroline; Fox, Graeme; Kennedy, Sandra L.; Preziosi, Richard F.; Brown, Terence A.			Absence of Ancient DNA in Sub-Fossil Insect Inclusions Preserved in 'Anthropocene' Colombian Copal	PLOS ONE			English	Article							EXTRACTION; AMBER; SEQUENCES	Insects preserved in copal, the sub-fossilized resin precursor of amber, have potential value in molecular ecological studies of recently-extinct species and of extant species that have never been collected as living specimens. The objective of the work reported in this paper was therefore to determine if ancient DNA is present in insects preserved in copal. We prepared DNA libraries from two stingless bees (Apidae: Meliponini: Trigonisca ameliae) preserved in 'Anthropocene' Colombian copal, dated to 'post-Bomb' and 10,612 +/- 62 cal yr BP, respectively, and obtained sequence reads using the GS Junior 454 System. Read numbers were low, but were significantly higher for DNA extracts prepared from crushed insects compared with extracts obtained by a non-destructive method. The younger specimen yielded sequence reads up to 535 nucleotides in length, but searches of these sequences against the nucleotide database revealed very few significant matches. None of these hits was to stingless bees though one read of 97 nucleotides aligned with two non-contiguous segments of the mitochondrial cytochrome oxidase subunit I gene of the East Asia bumblebee Bombus hypocrita. The most significant hit was for 452 nucleotides of a 470-nucleotide read that aligned with part of the genome of the root-nodulating bacterium Bradyrhizobium japonicum. The other significant hits were to proteobacteria and an actinomycete. Searches directed specifically at Apidae nucleotide sequences only gave short and insignificant alignments. All of the reads from the older specimen appeared to be artefacts. We were therefore unable to obtain any convincing evidence for the preservation of ancient DNA in either of the two copal inclusions that we studied, and conclude that DNA is not preserved in this type of material. Our results raise further doubts about claims of DNA extraction from fossil insects in amber, many millions of years older than copal.	[Penney, David; Fox, Graeme; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Wadsworth, Caroline; Kennedy, Sandra L.; Brown, Terence A.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester; University of Manchester	Penney, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	david.penney@manchester.ac.uk	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655	University of Manchester; Natural Environment Research Council	University of Manchester; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DP was supported by a 2-month University of Manchester research grant awarded to TAB and RFP, CW acknowledges a Natural Environment Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashmole P., 2000, ST HELENA ASCENSION; Austin JJ, 1997, P ROY SOC B-BIOL SCI, V264, P467, DOI 10.1098/rspb.1997.0067; Bosselaers J, 2010, ZOOTAXA, P25, DOI 10.11646/zootaxa.2427.1.3; Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109; Brown T, 2011, P 2011 PART ACC C; Bunning SL, 2012, J ARCHAEOL SCI, V39, P2780, DOI 10.1016/j.jas.2012.04.012; CANO R J, 1992, Medical Science Research, V20, P619; CANO R J, 1992, Medical Science Research, V20, P249; CANO RJ, 1993, NATURE, V363, P536, DOI 10.1038/363536a0; Chapco W, 2004, MOL PHYLOGENET EVOL, V30, P810, DOI 10.1016/S1055-7903(03)00209-4; DESALLE R, 1993, EXPERIENTIA, V49, P906, DOI 10.1007/BF01952607; DESALLE R, 1992, SCIENCE, V257, P1933, DOI 10.1126/science.1411508; DESALLE R, 1994, CURR OPIN GENET DEV, V4, P810, DOI 10.1016/0959-437X(94)90064-7; Fox R, 2011, INSECT CONSERV DIVER, V4, P159, DOI 10.1111/j.1752-4598.2010.00117.x; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Hinojosa-Diaz IA, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3589[1:ANFOBI]2.0.CO;2; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; King GA, 2009, J ARCHAEOL SCI, V36, P1179, DOI 10.1016/j.jas.2009.01.006; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Koller B, 2005, P ROY SOC B-BIOL SCI, V272, P121, DOI 10.1098/rspb.2004.2939; Kothamasi D, 2009, CONSERV BIOL, V23, P1328, DOI 10.1111/j.1523-1739.2009.01252.x; Larsen Torben B., 2005, Entomologist's Record and Journal of Variation, V117, P109; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Paredes UM, 2012, J ZOOL SYST EVOL RES, V50, P247, DOI 10.1111/j.1439-0469.2012.00657.x; Penney D., 2010, BIODIVERSITY FOSSILS; Penney D, 2011, FOSSILS AMBER SNAPSH; PENNEY D, 2005, J AFROTROPICAL ZOOLO, V2, P43; Penney D, 2007, ZOOTAXA, P47; Penney David, 2013, Paleontological Contributions, P1; Penney D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047651; Penney David, 2010, P299; Penney David, 2012, Bulletin of the British Arachnological Society, V15, P241; PHILLIPS AJ, 1995, ANN ENTOMOL SOC AM, V88, P281, DOI 10.1093/aesa/88.3.281; Pohl H, 2010, NATURWISSENSCHAFTEN, V97, P855, DOI 10.1007/s00114-010-0703-x; Tagliavia M, 2011, ANAL LETT, V44, P1058, DOI 10.1080/00032719.2010.506939; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Watts PC, 2007, J INSECT CONSERV, V11, P195, DOI 10.1007/s10841-006-9024-y	40	18	18	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73150	10.1371/journal.pone.0073150	http://dx.doi.org/10.1371/journal.pone.0073150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039876	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500026
J	Qin, LJ; Chen, YS; Liu, XH; Ye, SX; Yu, KF; Huang, Z; Yu, JW; Zhou, XY; Chen, H; Mo, DL				Qin, Lijun; Chen, Yaosheng; Liu, Xiaohong; Ye, Sanxing; Yu, Kaifan; Huang, Zheng; Yu, Jingwei; Zhou, Xingyu; Chen, Hu; Mo, Delin			Integrative Analysis of Porcine microRNAome during Skeletal Muscle Development	PLOS ONE			English	Article							PROMOTES MYOGENIC DIFFERENTIATION; DOWN-REGULATION; CELL-PROLIFERATION; MYOBLAST DIFFERENTIATION; EXPRESSION; PROTEIN; MIR-206; GROWTH; TARGETS; GENE	Pig is an important agricultural animal for meat production and provides a valuable model for many human diseases. Functional studies have demonstrated that microRNAs (miRNAs) play critical roles in almost all aspects of skeletal muscle development and disease pathogenesis. To investigate the miRNAs involved in regulating different periods of skeletal muscle development, we herein performed a comprehensive research for porcine microRNAome (miRNAome) during 10 skeletal muscle developmental stages including 35, 49, 63, 77, 91 dpc (days post coitum) and 2, 28, 90, 120, 180 dpn (days postnatal) using Solexa sequencing technology. Our results extend the repertoire of pig miRNAome to 247 known miRNAs processed from 210 pre-miRNAs and 297 candidate novel miRNAs through comparison with known miRNAs in the miRBase. Expression analysis of the 15 most abundant miRNAs in every library indicated that functional miRNAome may be smaller and tend to be highly expressed. A series of muscle-related miRNAs summarized in our study present different patterns between myofibers formation phase and muscle maturation phase, providing valuable reference for investigation of functional miRNAs during skeletal muscle development. Analysis of temporal profiles of miRNA expression identifies 18 novel candidate myogenic miRNAs in pig, which might provide new insight into regulation mechanism mediated by miRNAs underlying muscle development.	[Qin, Lijun; Chen, Yaosheng; Liu, Xiaohong; Ye, Sanxing; Yu, Kaifan; Huang, Zheng; Yu, Jingwei; Zhou, Xingyu; Chen, Hu; Mo, Delin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Mo, DL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	modelin@mail.sysu.edu.cn	zhou, xingyu/GXF-7454-2022	Chen, Yaosheng/0000-0002-3871-7651; Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [U1201213, 31272417]; China Agriculture Research System [CARS-36]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This research was supported by the National Natural Science Foundation of China (U1201213, 31272417) and the China Agriculture Research System (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shanti N, 2009, BIOL REV, V84, P637, DOI 10.1111/j.1469-185X.2009.00090.x; Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anand A, 2007, IEEE C EVOL COMPUTAT, P297, DOI 10.1109/CEC.2007.4424485; Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009; Biggar KK, 2012, CELL CYCLE, V11, P1705, DOI 10.4161/cc.19790; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; De Arcangelis V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012098; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Hou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052123; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kim D, 2010, J BIOL CHEM, V285, P26900, DOI 10.1074/jbc.M110.115105; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kumar A, 2004, FASEB J, V18, P1524, DOI 10.1096/fj.04-2414com; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, pC1149, DOI 10.1152/ajpcell.00487.2002; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lin SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-306; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Maciotta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043464; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; Mayeuf A, 2011, M S-MED SCI, V27, P521, DOI 10.1051/medsci/2011275018; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Motohashi N, 2012, STEM CELLS DEV, V21, P3031, DOI 10.1089/scd.2011.0721; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Pirskanen A, 2000, DEV BIOL, V224, P189, DOI 10.1006/dbio.2000.9784; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Raychaudhuri S, 2012, PLOS ONE, V7; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; SWATLAND HJ, 1973, J ANIM SCI, V37, P536, DOI 10.2527/jas1973.372536x; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Takahiro H, 2007, CIRCULATION, V116, P163; Tang HB, 2012, FASEB J, V26, P4710, DOI 10.1096/fj.11-197467; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; WIGMORE PMC, 1983, GROWTH, V47, P67; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhang TH, 2011, ANTICANCER RES, V31, P3859; Zhao SP, 2012, INT J BIOL SCI, V8, P459, DOI 10.7150/ijbs.3821; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou L, 2012, J BIOL CHEM, V287, P25255, DOI 10.1074/jbc.M112.357053	133	35	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72418	10.1371/journal.pone.0072418	http://dx.doi.org/10.1371/journal.pone.0072418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039761	gold, Green Published			2022-12-25	WOS:000326734500013
J	Yang, J; Zheng, M; Chen, SQ; Ou, S; Zhang, J; Wang, N; Cao, YY; Miao, QQ; Zhang, XX; Hao, L; Lou, JH; Guo, HJ; Li, N; Wang, J				Yang, Juan; Zheng, Min; Chen, Shuqun; Ou, Shu; Zhang, Jie; Wang, Ni; Cao, Yingying; Miao, Qiaoqiao; Zhang, Xingxiu; Hao, Ling; Lou, Jinhe; Guo, Huijuan; Li, Nan; Wang, Jian			A Survey of the Perceived Risk for Stroke among Community Residents in Western Urban China	PLOS ONE			English	Article							WARNING SIGNS; KNOWLEDGE; PROJECT	Background and Purpose: Persons who perceive their risk for stroke can promote the intervention of stroke risk factors and reduce the risk of stroke occurrence. Our purpose was to assess the knowledge of stroke risk factors and the level of perceived risk for stroke. Methods: In 2011, a population-based face-to-face interview survey was conducted in Yuzhong district, Chongqing. A total of 1500 potential participants aged >= 18 years old were selected using a multi-stage sampling method. The knowledge of stroke risk factors and perceived risk for stroke was surveyed. Results: A total of 941 participants completed the questionnaire survey. The respondents' awareness rate of stroke risk factors ranged between 53.3% and 87.2%. The community residents' perceived risk for stroke was only 17.7%. Multiple logistic regression analysis showed that 45-64 years age group, a history of hypertension, hyperlipidemia, heart disease, and stroke were independent predictors of perceived risk for stroke. Perceived risk for stroke increased as the number of risk factors increased (P<0.001). However, even for respondents with three or more risk factors, only 41% perceived themselves to be at risk for stroke. Conclusions: In this population-based survey, few community residents perceived risk for stroke, even among those with multiple stroke risk factors, most did not perceive themselves to be at risk for stroke. Persons with 45-64 years old, a history of hypertension, hyperlipidemia, heart disease or stroke were more likely to perceive risk for stroke. The awareness of the risk for stroke has yet to be enhanced among community residents.	[Yang, Juan; Ou, Shu; Zhang, Jie; Wang, Ni; Cao, Yingying; Miao, Qiaoqiao; Zhang, Xingxiu; Hao, Ling; Lou, Jinhe; Guo, Huijuan; Li, Nan; Wang, Jian] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China; [Zheng, Min] Chongqing Med Univ, Basic Med Coll, Chongqing, Peoples R China; [Chen, Shuqun] Chongqing Med Univ, Dept Prevent Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Wang, J (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China.	jian.wx@163.com						Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Chen Z, 2008, 3 SAMPLING SURVEY RE; Cheng X, 1992, CHINESE J PREVENTION, V2, P43; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fogle Crystelle C, 2008, J Public Health Manag Pract, V14, pe17, DOI 10.1097/01.PHH.0000316496.78282.47; Fogle CC, 2010, J STROKE CEREBROVASC, V19, P370, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.007; FORTMANN SP, 1995, AM J EPIDEMIOL, V142, P576, DOI 10.1093/oxfordjournals.aje.a117678; Gupta A, 2002, INT J CLIN PRACT, V56, P634; Harwell TS, 2005, PREV MED, V41, P791, DOI 10.1016/j.ypmed.2005.07.003; Hodgson C, 2009, HEALTH PROMOT J AUST, V20, P58, DOI 10.1071/HE09058; KJELSBERG MO, 1990, JAMA-J AM MED ASSOC, V263, P1795; KREUTER MW, 1995, HEALTH PSYCHOL, V14, P56, DOI 10.1037/0278-6133.14.1.56; Ma G, 2006, CHINESE RESIDENTS NU, V6, P174; Ministry of Health of the People's Republic of China, 2004, CHINESE J CARDIOVASC, V2, P919; Payne GH, 2010, J PUBLIC HEALTH MAN, V16, P345, DOI 10.1097/PHH.0b013e3181c8cb79; PUSKA P, 1989, ANN MED, V21, P169, DOI 10.3109/07853898909149928; Reeves MJ, 2008, CEREBROVASC DIS, V25, P385, DOI 10.1159/000121338; Samsa GP, 1997, STROKE, V28, P916, DOI 10.1161/01.STR.28.5.916; Schneider AT, 2003, JAMA-J AM MED ASSOC, V289, P343, DOI 10.1001/jama.289.3.343; Wu J, 2005, NEUROLOGY; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; 王文志, 2011, [中华神经科杂志, Chinese Journal of Neurology], V44, P282	24	12	12	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73578	10.1371/journal.pone.0073578	http://dx.doi.org/10.1371/journal.pone.0073578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039989	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500039
J	Damulewicz, M; Rosato, E; Pyza, E				Damulewicz, Milena; Rosato, Ezio; Pyza, Elzbieta			Circadian Regulation of the Na+/K+-Atpase Alpha Subunit in the Visual System Is Mediated by the Pacemaker and by Retina Photoreceptors in Drosophila Melanogaster	PLOS ONE			English	Article							RHYTHMIC SIZE CHANGES; 1ST OPTIC NEUROPIL; PERIOD CLOCK GENE; SYNAPTIC-TRANSMISSION; MUSCA-DOMESTICA; CELL-SIZE; EXPRESSION; NEUROPEPTIDE; CRYPTOCHROME; RECEPTOR	We investigated the diurnal oscillation in abundance of the catalytic alpha subunit of the sodium/potassium pump (ATP alpha) in the brain of Drosophila melanogaster. This rhythm is bimodal and is particularly robust in the glia cells of the lamina, the first optic neuropil. We observed loss of ATP alpha cycling in lamina glia in behaviourally arrhythmic per(01) and tim(01) mutants and in flies overexpressing the pro-apoptotic gene hid in the PDF-positive clock neurons. Moreover, the rhythm of ATP alpha abundance was altered in cry(01) and Pdf(0) mutants, in flies with a weakened clock mechanism in retina photoreceptor cells and in those subject to downregulation of the neuropeptide ITP by RNAi. This complex, rhythmic regulation of the alpha subunit suggests that the sodium/potassium pump may be a key target of the circadian pacemaker to impose daily control on brain activities, such as rhythmic changes in neuronal plasticity, which are best observed in the visual system.	[Damulewicz, Milena; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland; [Rosato, Ezio] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Jagiellonian University; University of Leicester	Pyza, E (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland.	elzbieta.pyza@uj.edu.pl	Damulewicz, Milena/AAK-2606-2020	Rosato, Ezio/0000-0001-7297-4697	Polish Ministry of Science and High Education [NN301 038240, NN303 814840]; BBSRC [BB/H018093/1]; Biotechnology and Biological Sciences Research Council [BB/H018093/1, BB/F008988/1] Funding Source: researchfish; BBSRC [BB/F008988/1] Funding Source: UKRI	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by NN301 038240 and NN303 814840 grants from the Polish Ministry of Science and High Education to Elzbieta Pyza and by the grant BB/H018093/1 from the BBSRC to Ezio Rosato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; BRAND AH, 1993, DEVELOPMENT, V118, P401; Damulewicz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021258; Depetris-Chauvin A, 2011, CURR BIOL, V21, P1783, DOI 10.1016/j.cub.2011.09.027; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Duvall LB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001337; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Glossop NRJ, 2002, J CELL SCI, V115, P3369; Gorska-Andrzejak J, 2013, DEV NEUROBIOL, V73, P14, DOI 10.1002/dneu.22032; Gorska-Andrzejak J, 2009, J INSECT PHYSIOL, V55, P459, DOI 10.1016/j.jinsphys.2009.02.003; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hermann C, 2012, 14 EUR DROS NEUR C, P160; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kahsai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011480; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Pyza E, 2004, J INSECT PHYSIOL, V50, P985, DOI 10.1016/j.jinsphys.2004.08.003; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; Pyza E., 1995, Society for Neuroscience Abstracts, V21, P408; Pyza E, 2003, NEUROPEPTIDES, V37, P277, DOI 10.1016/j.npep.2003.06.001; Pyza E, 1996, J COMP PHYSIOL A, V178, P33, DOI 10.1007/BF00189588; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 2010, ENCY EYE, P302; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Scuri R, 2007, EUR J NEUROSCI, V25, P159, DOI 10.1111/j.1460-9568.2006.05257.x; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Sun BH, 2001, COMP BIOCHEM PHYS B, V130, P521, DOI 10.1016/S1096-4959(01)00470-5; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07; Wang HY, 2004, J NEUROPHYSIOL, V92, P2295, DOI 10.1152/jn.00061.2004; Weber P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004290; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784	52	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73690	10.1371/journal.pone.0073690	http://dx.doi.org/10.1371/journal.pone.0073690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040028	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600039
J	Jaaskelainen, A; Schwab, U; Kolehmainen, M; Kaakinen, M; Savolainen, MJ; Froguel, P; Cauchi, S; Jarvelin, MR; Laitinen, J				Jaaskelainen, Anne; Schwab, Ursula; Kolehmainen, Marjukka; Kaakinen, Marika; Savolainen, Markku J.; Froguel, Philippe; Cauchi, Stephane; Jarvelin, Marjo-Riitta; Laitinen, Jaana			Meal Frequencies Modify the Effect of Common Genetic Variants on Body Mass Index in Adolescents of the Northern Finland Birth Cohort 1986	PLOS ONE			English	Article							WEIGHT-CONTROL BEHAVIORS; GENOME-WIDE ASSOCIATION; CHILDHOOD OBESITY; DIETARY-INTAKE; BREAKFAST CONSUMPTION; EATING PATTERNS; ADULT OBESITY; FAT MASS; CHILDREN; RISK	Recent studies suggest that meal frequencies influence the risk of obesity in children and adolescents. It has also been shown that multiple genetic loci predispose to obesity already in youth. However, it is unknown whether meal frequencies could modulate the association between single nucleotide polymorphisms (SNPs) and the risk of obesity. We examined the effect of two meal patterns on weekdays -5 meals including breakfast (regular) and <= 4 meals with or without breakfast (meal skipping) - on the genetic susceptibility to increased body mass index (BMI) in Finnish adolescents. Eight variants representing 8 early-life obesity-susceptibility loci, including FTO and MC4R, were genotyped in 2215 boys and 2449 girls aged 16 years from the population-based Northern Finland Birth Cohort 1986. A genetic risk score (GRS) was calculated for each individual by summing the number of BMI-increasing alleles across the 8 loci. Weight and height were measured and dietary data were collected using self-administered questionnaires. Among meal skippers, the difference in BMI between high-GRS and low-GRS (<8 and >= 8 BMI-increasing alleles) groups was 0.90 (95% CI 0.63,1.17) kg/m(2), whereas in regular eaters, this difference was 0.32 (95% CI 0.06,0.57) kg/m(2) (p(interaction) = 0.003). The effect of each MC4R rs17782313 risk allele on BMI in meal skippers (0.47 [95% CI 0.22,0.73] kg/m(2)) was nearly three-fold compared with regular eaters (0.18 [95% CI-0.06,0.41] kg/m(2)) (p(interaction) = 0.016). Further, the per-allele effect of the FTO rs1421085 was 0.24 (95% CI 0.05,0.42) kg/m(2) in regular eaters and 0.46 (95% CI 0.27,0.66) kg/m(2) in meal skippers but the interaction between FTO genotype and meal frequencies on BMI was significant only in boys (p(interaction) = 0.015). In summary, the regular five-meal pattern attenuated the increasing effect of common SNPs on BMI in adolescents. Considering the epidemic of obesity in youth, the promotion of regular eating may have substantial public health implications.	[Jaaskelainen, Anne; Schwab, Ursula; Kolehmainen, Marjukka] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Schwab, Ursula] Kuopio Univ Hosp, Inst Clin Med, SF-70210 Kuopio, Finland; [Kaakinen, Marika; Savolainen, Markku J.; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Savolainen, Markku J.] Univ Oulu, Inst Clin Med, Oulu, Finland; [Savolainen, Markku J.] Oulu Univ Hosp, Dept Internal Med, Clin Res Ctr, Oulu, Finland; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Froguel, Philippe; Cauchi, Stephane] Lille Pasteur Inst, CNRS UMR 8199, Lille, France; [Froguel, Philippe; Cauchi, Stephane] Univ Lille 2, Lille, France; [Froguel, Philippe; Cauchi, Stephane] EGID, Lille, France; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Finland National Institute for Health & Welfare; Imperial College London; University of Oulu; Finnish Institute of Occupational Health	Jaaskelainen, A (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland.	anne.jaaskelainen@uef.fi; m.jarvelin@imperial.ac.uk	FROGUEL, Philippe/O-6799-2017	FROGUEL, Philippe/0000-0003-2972-0784; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Kaakinen, Marika/0000-0002-9228-0462	Academy of Finland (SALVE program) [129269]; Nordic Centre of Excellence on 'Systems biology in controlled dietary interventions and cohort studies' (SYSDIET) [070014]; MRC [G1002084] Funding Source: UKRI; Medical Research Council [G1002084] Funding Source: researchfish	Academy of Finland (SALVE program); Nordic Centre of Excellence on 'Systems biology in controlled dietary interventions and cohort studies' (SYSDIET); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work in this study was conducted with the support of the Academy of Finland (SALVE program, grant number 129269; URL http://www.aka.fi/en-GB/A/Programmes-and-cooperation/Research-programmes/Completed/SALVE/) and the Nordic Centre of Excellence on 'Systems biology in controlled dietary interventions and cohort studies' (SYSDIET, project number 070014; URL http://www.sysdiet.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienertova-Vasku J, 2010, BRIT J NUTR, V103, P352, DOI 10.1017/S0007114509991887; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Day FR, 2011, J NUTRIGENET NUTRIGE, V4, P222, DOI 10.1159/000332158; de Krom M, 2007, DIABETES, V56, P276, DOI 10.2337/db06-0473; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P777, DOI 10.1016/0031-9384(93)90188-L; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fernandez JR, 2012, INT J OBESITY, V36, P479, DOI 10.1038/ijo.2011.236; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hasselbalch AL, 2008, J NUTR, V138, P2406, DOI 10.3945/jn.108.087668; Jaaskelainen A, 2013, NUTR METAB CARDIOVAS, V23, P1002, DOI 10.1016/j.numecd.2012.07.006; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Keller Kathleen L, 2002, Curr Atheroscler Rep, V4, P176, DOI 10.1007/s11883-002-0017-3; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kim JH, 2012, IRAN J PUBLIC HEALTH, V41, P50; Koletzko B, 2010, CRIT REV FOOD SCI, V50, P100, DOI 10.1080/10408390903467431; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mikkila V, 2004, EUR J CLIN NUTR, V58, P1038, DOI 10.1038/sj.ejcn.1601929; Moleres A, 2012, BRIT J NUTR, V107, P533, DOI 10.1017/S0007114511003424; Morandi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049919; Neumark-Sztainer D, 2000, PREV MED, V30, P381, DOI 10.1006/pmed.2000.0653; Neumark-Sztainer D, 2012, J ADOLESCENT HEALTH, V50, P80, DOI 10.1016/j.jadohealth.2011.05.010; Nicklas TA, 2004, J AM DIET ASSOC, V104, P753, DOI 10.1016/j.jada.2004.02.030; Nicklas TA, 2001, J AM COLL NUTR, V20, P599, DOI 10.1080/07315724.2001.10719064; Patro B, 2010, CURR OPIN CLIN NUTR, V13, P300, DOI 10.1097/MCO.0b013e32833681a2; Pearson N, 2012, BRIT J NUTR, V108, P932, DOI 10.1017/S000711451100612X; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Siega-Riz AM, 1998, J ADOLESCENT HEALTH, V22, P29, DOI 10.1016/S1054-139X(97)00125-0; Spruijt-Metz D, 2011, J RES ADOLESCENCE, V21, P129, DOI 10.1111/j.1532-7795.2010.00719.x; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; Veltsista A, 2010, J NUTR EDUC BEHAV, V42, P417, DOI 10.1016/j.jneb.2009.12.004; Willett WC, 1998, NUTR EPIDEMIOLOGY, P101, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.06; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	37	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73802	10.1371/journal.pone.0073802	http://dx.doi.org/10.1371/journal.pone.0073802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040077	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600045
J	Lopez-Martinez, JO; Sanaphre-Villanueva, L; Dupuy, JM; Hernandez-Stefanoni, JL; Meave, JA; Gallardo-Cruz, JA				Omar Lopez-Martinez, Jorge; Sanaphre-Villanueva, Lucia; Manuel Dupuy, Juan; Luis Hernandez-Stefanoni, Jose; Arturo Meave, Jorge; Alberto Gallardo-Cruz, Jose			beta-Diversity of Functional Groups of Woody Plants in a Tropical Dry Forest in Yucatan	PLOS ONE			English	Article							SEED-DISPERSAL SYNDROMES; RAIN-FOREST; SECONDARY SUCCESSION; ECOLOGICAL DATA; LIFE-FORMS; COMMUNITY; PATTERNS; REGENERATION; LIANAS; TREE	Two main theories have attempted to explain variation in plant species composition (beta-diversity). Niche theory proposes that most of the variation is related to environment (environmental filtering), whereas neutral theory posits that dispersal limitation is the main driver of beta-diversity. In this study, we first explored how alpha- and beta-diversity of plant functional groups defined by growth form (trees, shrubs and lianas, which represent different strategies of resource partitioning), and dispersal syndrome (autochory, anemochory and zoochory, which represent differences in dispersal limitation) vary with successional age and topographic position in a tropical dry forest. Second, we examined the effects of environmental, spatial, and spatially-structured environmental factors on beta-diversity of functional groups; we used the spatial structure of sampling sites as a proxy for dispersal limitation, and elevation, soil properties and forest stand age as indicators of environmental filtering. We recorded 200 species and 22,245 individuals in 276 plots; 120 species were trees, 41 shrubs and 39 lianas. We found that beta-diversity was highest for shrubs, intermediate for lianas and lowest for trees, and was slightly higher for zoochorous than for autochorous and anemochorous species. All three dispersal syndromes, trees and shrubs varied in composition among vegetation classes (successional age and topographic position), whilst lianas did not. beta-diversity was influenced mostly by proxies of environmental filtering, except for shrubs, for which the influence of dispersal limitation was more important. Stand age and topography significantly influenced alpha-diversity across functional groups, but showed a low influence on beta-diversity-possibly due to the counterbalancing effect of resprouting on plant distribution and composition. Our results show that considering different plant functional groups reveals important differences in both alpha- and beta-diversity patterns and correlates that are not apparent when focusing on overall woody plant diversity, and that have important implications for ecological theory and biodiversity conservation.	[Omar Lopez-Martinez, Jorge; Sanaphre-Villanueva, Lucia; Manuel Dupuy, Juan; Luis Hernandez-Stefanoni, Jose] Ctr Invest Cient Yucatan, Merida, Mexico; [Arturo Meave, Jorge; Alberto Gallardo-Cruz, Jose] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico	Centro de Investigacion Cientifica de Yucatan; Universidad Nacional Autonoma de Mexico	Dupuy, JM (corresponding author), Ctr Invest Cient Yucatan, Merida, Mexico.	jmdupuy@cicy.mx	Gallardo-Cruz, José Alberto/AAG-1579-2020; López-Martínez, Jorge Omar/C-9772-2010; Sanaphre, Lucia/AAF-8334-2020; Meave, Jorge/B-3673-2008	Gallardo-Cruz, José Alberto/0000-0002-0509-7003; López-Martínez, Jorge Omar/0000-0001-7903-8498; Sanaphre, Lucia/0000-0001-5566-7230; Meave, Jorge/0000-0002-6241-8803; Hernandez-Stefanoni, Jose Luis/0000-0002-9559-7131	Fondo Mixto CONACYT-Gobierno del Estado de Yucatan (FOMIX-Yucatan) project [YUC-2008-C06-108863]; Centro de Investigacion Cientifica de Yucatan, A.C. (CICY)	Fondo Mixto CONACYT-Gobierno del Estado de Yucatan (FOMIX-Yucatan) project; Centro de Investigacion Cientifica de Yucatan, A.C. (CICY)	Fondo Mixto CONACYT-Gobierno del Estado de Yucatan (FOMIX-Yucatan) project YUC-2008-C06-108863. Centro de Investigacion Cientifica de Yucatan, A.C. (CICY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gallardo-Cruz J, 2009, LANDSCAPE ECOL, V24, P473, DOI 10.1007/s10980-009-9332-1; Alvarez-Anorve MY, 2012, AM J BOT, V99, P816, DOI 10.3732/ajb.1100200; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; [Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 1994, CHANGES MARINE COMMU; ARMESTO JJ, 1989, J BIOGEOGR, V16, P219, DOI 10.2307/2845258; Bautista Zuniga F., 2003, NATURALEZA SOC AREA, P21, DOI DOI 10.5154/R.RCHSCFA.2014.08.032; Ben-Hur E, 2012, ECOL LETT, V15, P1276, DOI 10.1111/j.1461-0248.2012.01850.x; Bin Y, 2010, PLANT ECOL, V209, P237, DOI 10.1007/s11258-009-9708-y; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Burnham RJ, 2004, FOREST ECOL MANAG, V190, P43, DOI 10.1016/j.foreco.2003.10.005; Butler DW, 2007, J BIOGEOGR, V34, P1736, DOI 10.1111/j.1365-2699.2007.01734.x; Ceccon E, 2006, BRAZ ARCH BIOL TECHN, V49, P305, DOI 10.1590/S1516-89132006000300016; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Chazdon RL, 2010, BIOTROPICA, V42, P31, DOI 10.1111/j.1744-7429.2009.00566.x; CLARK DB, 1990, J TROP ECOL, V6, P321, DOI 10.1017/S0266467400004570; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; Crawley MJ., 2007, R BOOK; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; Du YJ, 2009, FOREST ECOL MANAG, V258, P1147, DOI 10.1016/j.foreco.2009.06.004; Duncan RS, 1999, ECOL APPL, V9, P998, DOI 10.1890/1051-0761(1999)009[0998:SDAPFS]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Finegan B, 1996, TRENDS ECOL EVOL, V11, P119, DOI 10.1016/0169-5347(96)81090-1; Flores J.S., 1994, ETNOFLORA YUCATANENS; Gallardo-Cruz J. A., 2010, Community Ecology, V11, P202, DOI 10.1556/ComEc.11.2010.2.8; Griz LMS, 2001, J TROP ECOL, V17, P303, DOI 10.1017/S0266467401001201; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jara-Guerrero A, 2011, BIOTROPICA, V43, P722, DOI 10.1111/j.1744-7429.2011.00754.x; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Jongman RHG, 1987, DATA ANAL COMMUNITY, P324; Kennard DK, 2002, J TROP ECOL, V18, P53, DOI 10.1017/S0266467402002031; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Lebrija-Trejos E, 2011, J TROP ECOL, V27, P477, DOI 10.1017/S0266467411000253; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Leibold MA, 2008, NATURE, V454, P39, DOI 10.1038/454039a; Lopez-Martinez JO, 2013, J VEG SCI, V24, P33, DOI 10.1111/j.1654-1103.2012.01446.x; Hernandez-Stefanoni JL, 2011, LANDSCAPE ECOL, V26, P355, DOI 10.1007/s10980-010-9561-3; Madeira B, 2009, PLANT ECOL, V201, P291, DOI [10.1007/978-90-481-2795-5_22, 10.1007/s11258-009-9580-9]; Dupuy JM, 2012, BIOTROPICA, V44, P151, DOI 10.1111/j.1744-7429.2011.00783.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Medina Ernesto, 1995, P221, DOI 10.1017/CBO9780511753398.009; Miller PM, 1998, BIOTROPICA, V30, P538, DOI 10.1111/j.1744-7429.1998.tb00094.x; Motzkin G, 1999, J VEG SCI, V10, P903, DOI 10.2307/3237315; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Nabe-Nielsen J, 2001, J TROP ECOL, V17, P1, DOI 10.1017/S0266467401001018; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; OPLER PA, 1980, BIOTROPICA, V12, P40, DOI 10.2307/2388155; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; PRIMACK RB, 1992, CONSERV BIOL, V6, P513, DOI 10.1046/j.1523-1739.1992.06040513.x; Qian H, 2005, ECOL LETT, V8, P15, DOI 10.1111/j.1461-0248.2004.00682.x; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; RICO-GRAY V, 1991, Journal of Ethnobiology, V11, P135; Ruokolainen K, 2002, SCIENCE, V297; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; SWAINE MD, 1992, J VEG SCI, V3, P365, DOI 10.2307/3235762; SWAINE MD, 1983, J ECOL, V71, P601, DOI 10.2307/2259737; Swaine MD, 1996, J ECOL, V84, P419, DOI 10.2307/2261203; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Tuomisto H, 1996, J BIOGEOGR, V23, P283, DOI 10.1046/j.1365-2699.1996.00044.x; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; van Breugel M, 2007, BIOTROPICA, V39, P610, DOI 10.1111/j.1744-7429.2007.00316.x; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; Vieira DLM, 2006, RESTOR ECOL, V14, P11, DOI 10.1111/j.1526-100X.2006.00100.x; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; WESTOBY M, 1990, ECOLOGY, V71, P1307, DOI 10.2307/1938268; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Zuur Alain F., 2009, P1	86	40	43	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73660	10.1371/journal.pone.0073660	http://dx.doi.org/10.1371/journal.pone.0073660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040014	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600036
J	Troscianko, J; Lown, AE; Hughes, AE; Stevens, M				Troscianko, Jolyon; Lown, Alice E.; Hughes, Anna E.; Stevens, Martin			Defeating Crypsis: Detection and Learning of Camouflage Strategies	PLOS ONE			English	Article							DISRUPTIVE COLORATION; VISUAL-SEARCH; IMAGE; POLYMORPHISM; PREY; ENHANCEMENT; CRYPTICITY; PREDATION; ATTENTION; EVOLUTION	Camouflage is perhaps the most widespread defence against predators in nature and an active area of interdisciplinary research. Recent work has aimed to understand what camouflage types exist (e. g. background matching, disruptive, and distractive patterns) and their effectiveness. However, work has almost exclusively focused on the efficacy of these strategies in preventing initial detection, despite the fact that predators often encounter the same prey phenotype repeatedly, affording them opportunities to learn to find those prey more effectively. The overall value of a camouflage strategy may, therefore, reflect both its ability to prevent detection by predators and resist predator learning. We conducted four experiments with humans searching for hidden targets of different camouflage types (disruptive, distractive, and background matching of various contrast levels) over a series of touch screen trials. As with previous work, disruptive coloration was the most successful method of concealment overall, especially with relatively high contrast patterns, whereas potentially distractive markings were either neutral or costly. However, high contrast patterns incurred faster decreases in detection times over trials compared to other stimuli. In addition, potentially distractive markings were sometimes learnt more slowly than background matching markings, despite being found more readily overall. Finally, learning effects were highly dependent upon the experimental paradigm, including the number of prey types seen and whether subjects encountered targets simultaneously or sequentially. Our results show that the survival advantage of camouflage strategies reflects both their ability to avoid initial detection (sensory mechanisms) and predator learning (perceptual mechanisms).	[Troscianko, Jolyon; Lown, Alice E.; Stevens, Martin] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Hughes, Anna E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Exeter; University of Cambridge	Troscianko, J (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, England.	jt@jolyon.co.uk		Stevens, Martin/0000-0001-7768-3426; Hughes, Anna/0000-0003-2677-1965; Troscianko, Jolyon/0000-0001-9071-2594	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G022887/1]; BBSRC CASE studentship; BBSRC [BB/G022887/2, BB/G022887/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/1, BB/G022887/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JT, AEL and MS were supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship (BB/G022887/1) to MS and AEH was supported by a BBSRC CASE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; BOND AB, 1983, J EXP PSYCHOL ANIM B, V9, P292, DOI 10.1037/0097-7403.9.3.292; Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; BOND AB, 1991, ETHOLOGY, V87, P203; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Cott H.B., 1940, ADAPTIVE COLORATION; Crawley MJ, 2005, STAT INTRO USING R; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2009, PHILOS T R SOC B, V364, P489, DOI 10.1098/rstb.2008.0266; Dimitrova M, 2009, P R SOC B, V276, P1905, DOI 10.1098/rspb.2009.0052; Fraser S, 2007, P ROY SOC B-BIOL SCI, V274, P1325, DOI 10.1098/rspb.2007.0153; Kono H, 1998, ANIM BEHAV, V56, P963, DOI 10.1006/anbe.1998.0847; Langley CM, 1996, J EXP PSYCHOL ANIM B, V22, P152, DOI 10.1037/0097-7403.22.2.152; Langley CM, 1996, J EXP PSYCHOL ANIM B, V22, P139, DOI 10.1037/0097-7403.22.2.139; Merilaita Sami, 2011, P17; OSORIO D, 1991, P ROY SOC B-BIOL SCI, V244, P81, DOI 10.1098/rspb.1991.0054; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; PLAISTED KC, 1995, ANIM BEHAV, V50, P1219, DOI 10.1016/0003-3472(95)80039-5; Poulton EB, 1890, INT SCI SERIES; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband W.S., 1997, IMAGE J; REID PJ, 1992, J EXP PSYCHOL ANIM B, V18, P273, DOI 10.1037/0097-7403.18.3.273; Schaefer HM, 2006, P R SOC B, V273, P2427, DOI 10.1098/rspb.2006.3615; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2008, BIOL LETTERS, V4, P648, DOI 10.1098/rsbl.2008.0486; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2013, BEHAV ECOL, V24, P213, DOI 10.1093/beheco/ars156; Stevens M, 2009, P ROY SOC B-BIOL SCI, V276, P781, DOI 10.1098/rspb.2008.1450; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stobbe N, 2008, P ROY SOC B-BIOL SCI, V275, P1535, DOI 10.1098/rspb.2008.0209; Thayer GH, 1909, CONCEALING COLORATIO; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Zuur Alain F., 2009, P1	35	49	50	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73733	10.1371/journal.pone.0073733	http://dx.doi.org/10.1371/journal.pone.0073733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040046	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000327538600041
J	Bastrup-Birk, S; Skjoedt, MO; Munthe-Fog, L; Strom, JJ; Ma, YJ; Garred, P				Bastrup-Birk, Simone; Skjoedt, Mikkel-Ole; Munthe-Fog, Lea; Strom, Jens J.; Ma, Ying Jie; Garred, Peter			Pentraxin-3 Serum Levels Are Associated with Disease Severity and Mortality in Patients with Systemic Inflammatory Response Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INNATE IMMUNITY; PATTERN-RECOGNITION; SEVERE SEPSIS; PTX3; POLYMORPHISMS; EPIDEMIOLOGY; DEFINITIONS; CROSSROADS	The long pentraxin-3 (PTX3) is a key component of the humoral arm of the innate immune system. PTX3 is produced locally in response to pro-inflammatory stimuli. To investigate PTX3 levels and its use as a biomarker in patients with systemic inflammation, we developed a solid-phase enzyme-linked immunosorbent assay based on novel anti-PTX3 monoclonal antibodies detecting PTX3 with high sensitivity. The assay was applied on 261 consecutive patients admitted to an intensive care unit prospectively monitored with the systemic inflammatory response syndrome (SIRS). 100 blood donors were included as controls. PTX3 levels were elevated in patients (median = 71.3 ng/ml) compared with the controls (median = 0 ng/ml) (Mann-Whitney, p<0.0001). ROC analysis showed that PTX3 levels were significantly specific (85.0%) and sensitive (89.1%) to discriminate between healthy controls and patients (area under the curve (AUC) 0.922 (95% CI 0.892 to 0.946, p<0.0001)). Higher levels of PTX3 were associated with the development of sepsis, severe sepsis and septic shock (p = 0.0001). The serum levels of PTX3 correlated significantly with SAPS2 score (Spearman's rho 0.28, p<0.0001). Patients with high levels of PTX3 at admission did have a higher 90 day mortality rate than patients with the 25% lowest levels (Cox regression analysis, hazard ratio 3.0, p = 0.0009). In conclusion, we have established a highly sensitive and robust assay for measurement of PTX3 and found that its serum concentrations correlated with disease severity and mortality in patients with SIRS and sepsis.	[Bastrup-Birk, Simone; Skjoedt, Mikkel-Ole; Munthe-Fog, Lea; Ma, Ying Jie; Garred, Peter] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Lab Mol Med,Dept Clin Immunol,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Strom, Jens J.] Univ Copenhagen, Fac Hlth Sci, Glostrup Hosp, Dept Anaesthesiol,Copenhagen Univ Hosp, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Garred, P (corresponding author), Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Lab Mol Med,Dept Clin Immunol,Fac Hlth Sci, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Jie, Ying/AAJ-4697-2021	Jie, Ying/0000-0003-4003-2579; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Bastrup Israelsen, Simone/0000-0002-0653-1289; Garred, Peter/0000-0002-2876-8586; Munthe-Fog, Lea/0000-0003-1345-176X	Novo Nordisk Research Foundation; Benzon Foundation; Danish Medical Research Council; Svend Andersen Research Foundation; Research Foundation of the Capital Region of Denmark and Rigshospitalet	Novo Nordisk Research Foundation(Novo Nordisk Foundation); Benzon Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Svend Andersen Research Foundation; Research Foundation of the Capital Region of Denmark and Rigshospitalet	This work was supported by The Novo Nordisk Research Foundation, The Benzon Foundation, the Danish Medical Research Council, The Svend Andersen Research Foundation, The Research Foundation of the Capital Region of Denmark and Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2009, ADV EXP MED BIOL, V653, P98; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Claus RA, 2010, CURR MOL MED, V10, P227, DOI 10.2174/156652410790963358; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Guo TM, 2012, J CLIN IMMUNOL, V32, P330, DOI 10.1007/s10875-011-9615-6; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017653; Inforzato A, 2011, TISSUE ANTIGENS, V77, P271, DOI 10.1111/j.1399-0039.2011.01645.x; Inforzato A, 2012, ADV EXP MED BIOL, V946, P1, DOI 10.1007/978-1-4614-0106-3_1; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Kastrup J, 2012, IMMUNOBIOLOGY, V217, P483, DOI 10.1016/j.imbio.2011.04.007; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kornblit B, 2008, CRIT CARE, V12, DOI 10.1186/cc6935; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Uusitalo-Seppala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053661; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110	31	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73119	10.1371/journal.pone.0073119	http://dx.doi.org/10.1371/journal.pone.0073119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039869	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300050
J	He, XH; Zhang, LF; Yao, XL; Hu, J; Yu, LH; Jia, H; An, R; Liu, ZL; Xu, YM				He, Xianghua; Zhang, Lifang; Yao, Xiaoli; Hu, Jing; Yu, Lihua; Jia, Hua; An, Ran; Liu, Zhuolin; Xu, Yanming			Association Studies of MMP-9 in Parkinson's Disease and Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; TISSUE INHIBITORS; NEURON; DEMENTIA; GENE; ALS; EXPRESSION; C9ORF72; SERUM	Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) share several clinical and neuropathologic features, and studies suggest that several gene mutations and polymorphisms are involved in both conditions. Matrix metalloproteinase-9 (MMP-9) is implicated in the pathogenesis of PD and ALS, and the C(-1562)T polymorphism in the MMP-9 gene leads to higher promoter activity. We therefore investigated whether this polymorphism predisposes to both PD and sporadic ALS (sALS). Samples from 351 subjects with PD and 351 healthy controls from two major cities in China were compared, while samples from 226 subjects with sALS were compared to the same number of controls from three centers in China. A possible association between the C(-1562)T polymorphism in the MMP-9 gene and PD or sALS was assessed by restriction fragment length polymorphism (RFLP) analysis. Our results show a significant association between the C(-1562)T polymorphism in the MMP-9 gene and risk of PD (odds ratio = 2.268, 95% CI 1.506-3.416, p<0.001) as well as risk of sALS (odds ratio = 2.163, 95% CI 1.233-3.796, p = 0.006), supporting a role for MMP-9 polymorphism in the risk for PD and sALS.	[He, Xianghua; Yu, Lihua; Jia, Hua; An, Ran; Xu, Yanming] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan Provinc, Peoples R China; [Zhang, Lifang] Ning Xia Med Univ, Gen Hosp, Dept Neurol, Yinchuan, Ningxia Provinc, Peoples R China; [Yao, Xiaoli; Liu, Zhuolin] Hebei Med Univ, Hosp 3, Dept Neurol, Sijiazhuang, Hebei Province, Peoples R China; [Hu, Jing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sichuan University; Hebei Medical University; Sun Yat Sen University	Xu, YM (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan Provinc, Peoples R China.	neuroxym@163.com	Xu, yanming/Q-4931-2019		National Natural Science Foundation of China [30700243]; Sichuan Project of Science and Technology Support [2010SZ0086]; National "863" High-Technology Research and Development Program [2006AA02A408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Project of Science and Technology Support; National "863" High-Technology Research and Development Program(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (number 30700243), the Sichuan Project of Science and Technology Support (number 2010SZ0086) and the National "863" High-Technology Research and Development Program (number 2006AA02A408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Fang LB, 2009, J NEUROL SCI, V285, P62, DOI 10.1016/j.jns.2009.05.025; Farnikova K, 2010, J NEUROL SCI, V296, P47, DOI 10.1016/j.jns.2010.06.011; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Gilbert RMW, 2010, MOVEMENT DISORD, V25, P1868, DOI 10.1002/mds.23200; HEDERA P, 1995, J NEUROL SCI, V128, P219, DOI 10.1016/0022-510X(94)00222-A; HUDSON AJ, 1991, CAN J NEUROL SCI, V18, P387, DOI 10.1017/S0317167100032509; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ilzecka J, 2011, ACTA NEUROL SCAND, V124, P424, DOI 10.1111/j.1600-0404.2011.01519.x; Joo SH, 2010, NEUROSCI LETT, V469, P352, DOI 10.1016/j.neulet.2009.12.026; Kiaei M, 2007, EXP NEUROL, V205, P74, DOI 10.1016/j.expneurol.2007.01.036; Kim SY, 2010, NEUROCHEM INT, V56, P437, DOI 10.1016/j.neuint.2009.11.019; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lesnick TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001449; Lim GP, 1996, J NEUROCHEM, V67, P251; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Lorenzl S, 2004, NEUROMOL MED, V5, P119, DOI 10.1385/NMM:5:2:119; Lorenzl S, 2003, J NEUROL SCI, V207, P71, DOI 10.1016/S0022-510X(02)00398-2; Lorenzl S, 2006, EXP NEUROL, V200, P166, DOI 10.1016/j.expneurol.2006.01.026; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Majounie E, 2012, NEUROBIOL AGING, V33; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Mates JM, 2010, FREE RADICAL BIO MED, V49, P1328, DOI 10.1016/j.freeradbiomed.2010.07.028; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x; O'Dowd S, 2012, MOVEMENT DISORD, V27, P1072, DOI 10.1002/mds.25022; Oshiro S., 2011, ADV PHARM SCI, V2011, DOI DOI 10.1155/2011/378278; Quadri M, 2011, NEUROGENETICS, V12, P203, DOI 10.1007/s10048-011-0288-3; Ranganathan AC, 2001, J BIOL CHEM, V276, P14264, DOI 10.1074/jbc.M100199200; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Sokolowska B, 2009, J PHYSIOL PHARMACOL, V60, P117; Uitti R J, 1995, Parkinsonism Relat Disord, V1, P21, DOI 10.1016/1353-8020(95)00004-P; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; van Rheenen W, 2012, NEUROLOGY, V79, P878, DOI 10.1212/WNL.0b013e3182661d14; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Xi ZR, 2012, ARCH NEUROL-CHICAGO, V69, P1583, DOI 10.1001/archneurol.2012.2016; Zawislak D, 2009, NEUROL NEUROCHIR POL, V43, P121; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788	39	38	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73777	10.1371/journal.pone.0073777	http://dx.doi.org/10.1371/journal.pone.0073777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040066	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300129
J	Hidasi-Neto, J; Loyola, RD; Cianciaruso, MV				Hidasi-Neto, Jose; Loyola, Rafael Dias; Cianciaruso, Marcus Vinicius			Conservation Actions Based on Red Lists Do Not Capture the Functional and Phylogenetic Diversity of Birds in Brazil	PLOS ONE			English	Article							PRIORITIES; BIODIVERSITY; CONSEQUENCES; EXTINCTION; PATTERNS; TRAITS; AREAS	Red Lists of threatened species play a critical role in conservation science and practice. However, policy-making based on Red Lists ignores ecological and evolutionary consequences of losing biodiversity because these lists focus on species alone. To decide if relying on Red Lists alone can help to conserve communities' functional (FD) and phylogenetic (PD) diversity, it is useful to evaluate whether Red List categories represent species with diverse ecological traits and evolutionary histories. Additionally, local scale analyses using regional Red Lists should represent more realistic pools of co-occurring species and thereby better capture eventual losses of FD and PD. Here, we used 21 life-history traits and a phylogeny for all Brazilian birds to determine whether species assigned under the IUCN global Red List, the Brazilian national, and regional Red Lists capture more FD and PD than expected by chance. We also built local Red Lists and analysed if they capture more FD and PD at the local scale. Further, we investigated whether individual threat categories have species with greater FD and PD than expected by chance. At any given scale, threat categories did not capture greater FD or PD than expected by chance. Indeed, mostly categories captured equal or less FD or PD than expected by chance. These findings would not have great consequences if Red Lists were not often considered as a major decision support tool for policy-making. Our results challenge the practice of investing conservation resources based only on species Red Lists because, from an ecological and evolutionary point of view, this would be the same as protecting similar or random sets of species. Thus, new prioritization methods, such as the EDGE of Existence initiative, should be developed and applied to conserve species' ecological traits and evolutionary histories at different spatial scales.	[Hidasi-Neto, Jose] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [Loyola, Rafael Dias; Cianciaruso, Marcus Vinicius] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Cianciaruso, MV (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	cianciaruso@gmail.com	Loyola, Rafael/A-4425-2008; Loyola, Rafael/S-3978-2019; Cianciaruso, Marcus V/B-9509-2012; Neto, José Hidasi/AAT-9518-2021; Fapesp, Biota/F-8655-2017	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; Cianciaruso, Marcus V/0000-0001-5866-5345; Fapesp, Biota/0000-0002-9887-8449; Hidasi-Neto, Jose/0000-0003-4097-7353	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [563621/2010-9]; Conservation International Brazil; CNPq [304703/2011-7, 306843/2012-9]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation International Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We are grateful to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior for the scholarship granted to the first author. Rafael Loyola's research is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (project #563621/2010-9), Conservation International Brazil, and by a research productivity grant awarded by CNPq (grant #304703/2011-7). Marcus Cianciaruso also has a productivity grant awarded by CNPq (grant #306843/2012-9). This is a paper from the SISBIOTA - Top Predators network. The authors thank CNPq and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; [Anonymous], 2012, R LANG ENV STAT COMP; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Batalha MA, 2010, NAT CONSERVACAO, V8, P34, DOI 10.4322/natcon.00801005; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Bender M. G., 2012, Endangered Species Research, V18, P247, DOI 10.3354/esr00449; Bergallo H.G., 2000, FAUNA AMEACADA EXTIN; BIODIVERSITAS, 2006, LIST FAUN AM EXT MIN; Bottrill MC, 2009, TRENDS ECOL EVOL, V24, P183, DOI 10.1016/j.tree.2008.11.007; Bressian P, 2009, FAUNA AMEACADA EXTIN; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Brooker RW, 2009, AM NAT, V174, P919, DOI 10.1086/648058; Brum FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060742; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cianciaruso MV, 2012, PERSPECT PLANT ECOL, V14, P205, DOI 10.1016/j.ppees.2011.11.004; Comite Brasileiro de Registros Ornitologicos, 2009, LIST AV BRAS; Darwall WRT, 2005, FISHERIES MANAG ECOL, V12, P287, DOI 10.1111/j.1365-2400.2005.00449.x; de Carvalho RA, 2010, NAT CONSERVACAO, V8, P171, DOI 10.4322/natcon.00802011; Del Hoyo J., 2007, HDB BIRDS WORLD; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Diniz JAF, 2012, CONSERV GENET, V13, P1085, DOI 10.1007/s10592-012-0356-8; Gardenfors U, 2001, CONSERV BIOL, V15, P1206, DOI 10.1046/j.1523-1739.2001.00112.x; Gareca EE, 2010, BIODIVERS CONSERV, V19, P3327, DOI 10.1007/s10531-010-9895-9; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hidasi-Neto J, 2012, ANIM CONSERV, V15, P407, DOI 10.1111/j.1469-1795.2012.00528.x; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2022, IUCN RED LIST THREAT; IUCN Standards and Petitions Subcommittee, 2011, GUID US IUCN RED LIS; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Lortie CJ, 2004, OIKOS, V107, P433, DOI 10.1111/j.0030-1299.2004.13250.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; Marques A, 2002, LISTA ESPECIES AMEAC; Mattila M, 2008, BIOL CONSERV, V141, P2322, DOI 10.1016/j.biocon.2008.06.024; Mikich SB, 2004, LIVRO VERMELHO FAUNA; Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rolland J, 2012, BIOL LETTERS, V8, P692, DOI 10.1098/rsbl.2011.1024; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sick H, 2001, ORNITOLOGIA BRASILEI; Simon JE, 2007, LIVRO VERMELHO ESPEC, P47; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Strecker AL, 2011, ECOL APPL, V21, P3002, DOI 10.1890/11-0599.1; Szabo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047080; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Trindade J, 2012, BIODIVERS CONSERV, V21, P2709, DOI 10.1007/s10531-012-0326-y; Trindade J, 2012, BIOL CONSERV, V146, P155, DOI 10.1016/j.biocon.2011.12.004; Vie Jean-Christophe, 2008, P1; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Zar JH, 1999, BIOSTATISTICAL ANAL	73	27	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73431	10.1371/journal.pone.0073431	http://dx.doi.org/10.1371/journal.pone.0073431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039939	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300073
J	Korja, M; Silventoinen, K; Laatikainen, T; Jousilahti, P; Salomaa, V; Hernesniemi, J; Kaprio, J				Korja, Miikka; Silventoinen, Karri; Laatikainen, Tiina; Jousilahti, Pekka; Salomaa, Veikko; Hernesniemi, Juha; Kaprio, Jaakko			Risk Factors and heir Combined Effects on the Incidence Rate of Subarachnoid Hemorrhage - A Population-Based Cohort Study	PLOS ONE			English	Article								Background: Prospective studies on the risk factors for subarachnoid hemorrhage (SAH) are limited. Moreover, the effect of risk factors on the incidence rates of SAH is not well known about. Aims: In this study, we aimed to identify risk factors for SAH and characterize subgroups in a population with a high incidence of SAH. Methods: After recording multiple potential risk factors for SAH at the time of enrolment, first ever SAH events between 1972 and 2009 were recorded through the nationwide Causes of Death Register and Hospital Discharge Register for the population-based cohort of 64 349 participants, who participated in the National FINRISK Study between 1972 and 2007 in Finland. Results: During the follow-up time of 1.26 million person-years (median 17.9 years, range 0 to 37.9 years), 437 persons experienced fatal or non-fatal SAH. Crude SAH incidence was 34.8 (95% confidence interval: 31.7-38.2) per 100 000 person-years among >= 25-year-old persons. Female sex, high blood pressure values and current smoking were confirmed as risk factors for SAH. Previous myocardial infarction, history of premature stroke (any kind) in mother and elevated cholesterol levels in men were identified as new risk factors for SAH. Depending on the combination of risk factors, SAH incidence varied between 8 and 171 per 100 000 person-years. Conclusions: New and previously reported risk factors appear to have a much stronger association with the incidence of SAH than is ordinarily seen in cardiovascular diseases. Risk factor assessments may facilitate the identification of high-risk persons who should be the focus of preventive interventions.	[Korja, Miikka; Hernesniemi, Juha] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland; [Korja, Miikka] Macquarie Univ, Australian Sch Adv Med, Neurosurg Unit, Sydney, NSW 2109, Australia; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Laatikainen, Tiina; Jousilahti, Pekka; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Laatikainen, Tiina] Hosp Dist North Karelia, Joensuu, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med FIMM, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Macquarie University; University of Helsinki; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Helsinki; Finland National Institute for Health & Welfare	Korja, M (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland.	mkorja@mqneurosurgery.com	Korja, Miikka/E-4292-2016; Kaprio, Jaakko/A-1820-2008; Laatikainen, Tiina/ABD-6622-2021	Korja, Miikka/0000-0002-4463-6954; Kaprio, Jaakko/0000-0002-3716-2455; Laatikainen, Tiina/0000-0002-6614-4782; Silventoinen, Karri/0000-0003-1759-3079	Pro Humanitate Foundation; Maire Taponen Foundation; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Biomedicum Helsinki Foundation; Orion-Farmos Research Foundation; Finnish Medical Foundation; Academy of Finland Centre of Excellence in Complex Disease Genetics; Finnish Academy [129494]; Finnish Foundation for Cardiovascular Research	Pro Humanitate Foundation; Maire Taponen Foundation; Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biomedicum Helsinki Foundation; Orion-Farmos Research Foundation; Finnish Medical Foundation; Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); Finnish Academy(Academy of Finland); Finnish Foundation for Cardiovascular Research	This study was supported by personal grants from the Pro Humanitate Foundation, Maire Taponen Foundation, Emil Aaltonen Foundation, Sigrid Juselius Foundation, Biomedicum Helsinki Foundation, Orion-Farmos Research Foundation and Finnish Medical Foundation to MK. JK acknowledges the support of the Academy of Finland Centre of Excellence in Complex Disease Genetics. VS was supported by the Finnish Academy (grant number 129494) and the Finnish Foundation for Cardiovascular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Huxley RR, 2011, LANCET; KNEKT P, 1991, J CLIN EPIDEMIOL, V44, P933, DOI 10.1016/0895-4356(91)90056-F; Korja M, 2013, NEUROLOGY, V80, P481, DOI 10.1212/WNL.0b013e31827f0fb5; Lahtinen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041675; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Lindekleiv H, 2011, NEUROLOGY, V76, P637, DOI 10.1212/WNL.0b013e31820c30d3; Lindekleiv H, 2012, STROKE, V43, P1885, DOI 10.1161/STROKEAHA.112.651315; Sandvei MS, 2009, STROKE, V40, P1958, DOI 10.1161/STROKEAHA.108.539544; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330	10	67	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73760	10.1371/journal.pone.0073760	http://dx.doi.org/10.1371/journal.pone.0073760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040058	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300124
J	Svensson, JP; Pesudo, LQ; McRee, SK; Adeleye, Y; Carmichael, P; Samson, LD				Svensson, J. Peter; Pesudo, Laia Quiros; McRee, Siobhan K.; Adeleye, Yeyejide; Carmichael, Paul; Samson, Leona D.			Genomic Phenotyping by Barcode Sequencing Broadly Distinguishes between Alkylating Agents, Oxidizing Agents, and Non-Genotoxic Agents, and Reveals a Role for Aromatic Amino Acids in Cellular Recovery after Quinone Exposure	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; YEAST; DNA; SYSTEM; GENES; GENERATION; TRYPTOPHAN; MUTANTS; DEFENSE	Toxicity screening of compounds provides a means to identify compounds harmful for human health and the environment. Here, we further develop the technique of genomic phenotyping to improve throughput while maintaining specificity. We exposed cells to eight different compounds that rely on different modes of action: four genotoxic alkylating (methyl methanesulfonate (MMS), N-Methyl-N-nitrosourea (MNU), N,N'-bis(2-chloroethyl)-N-nitroso-urea (BCNU), N-ethylnitrosourea (ENU)), two oxidizing (2-methylnaphthalene-1,4-dione (menadione, MEN), benzene-1,4-diol (hydroquinone, HYQ)), and two non-genotoxic (methyl carbamate (MC) and dimethyl sulfoxide (DMSO)) compounds. A library of S. cerevisiae 4,852 deletion strains, each identifiable by a unique genetic 'barcode', were grown in competition; at different time points the ratio between the strains was assessed by quantitative high throughput 'barcode' sequencing. The method was validated by comparison to previous genomic phenotyping studies and 90% of the strains identified as MMS-sensitive here were also identified as MMS-sensitive in a much lower throughput solid agar screen. The data provide profiles of proteins and pathways needed for recovery after both genotoxic and non-genotoxic compounds. In addition, a novel role for aromatic amino acids in the recovery after treatment with oxidizing agents was suggested. The role of aromatic acids was further validated; the quinone subgroup of oxidizing agents were extremely toxic in cells where tryptophan biosynthesis was compromised.	[Svensson, J. Peter; Pesudo, Laia Quiros; McRee, Siobhan K.; Samson, Leona D.] MIT, Biol Engn Dept, Cambridge, MA 02139 USA; [Svensson, J. Peter; Pesudo, Laia Quiros; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Svensson, J. Peter] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Adeleye, Yeyejide; Carmichael, Paul] Safety & Environm Assurance Ctr, Sharnbrook, Beds, England; [Samson, Leona D.] MIT, Dept Biol, Cambridge, MA USA; [Samson, Leona D.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Karolinska Institutet; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Samson, LD (corresponding author), MIT, Biol Engn Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsamson@mit.edu	Svensson, J Peter/B-4276-2008	Svensson, J Peter/0000-0002-5863-6250; McRee, Siobhan/0000-0002-1539-2946; Carmichael, Paul/0000-0003-1353-9032	Unilever; NCI [R01-CA055042, R01-ES022872]; CEHS center [NIEHS P30-ES002109]; Spanish Ministry of Science and Innovation; NATIONAL CANCER INSTITUTE [R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, R01ES022872] Funding Source: NIH RePORTER	Unilever(Unilever); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CEHS center; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Unilever and this work was supported by NCI R01-CA055042 (now R01-ES022872), the CEHS center grant NIEHS P30-ES002109, and Unilever. LDS is an American Cancer Society Research Professor. LQP was supported by a Spanish Ministry of Science and Innovation Fellowship. Authors AY and PC are employees of Unilever and contributed with ideas and discussions. With the exception of Unilever, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoul-Carime H, 2004, J AM CHEM SOC, V126, P12158, DOI 10.1021/ja047517l; Alia M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Brombacher K, 2006, YEAST, V23, P741, DOI 10.1002/yea.1392; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fowler P, 2012, MUTAT RES-GEN TOX EN, V742, P11, DOI 10.1016/j.mrgentox.2011.10.014; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gorner H, 2007, J PHOTOCH PHOTOBIO B, V88, P83, DOI 10.1016/j.jphotobiol.2007.05.003; Gresham D, 2011, GENETICS, V187, P299, DOI 10.1534/genetics.110.120766; Gutierrez PL, 2000, FRONT BIOSCI-LANDMRK, V5, pD629, DOI 10.2741/gutier; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; He XJ, 2009, EUKARYOT CELL, V8, P768, DOI 10.1128/EC.00021-09; HEITMAN J, 1993, MOL CELL BIOL, V13, P5010, DOI 10.1128/MCB.13.8.5010; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho CH, 2011, CURR OPIN CHEM BIOL, V15, P66, DOI 10.1016/j.cbpa.2010.10.023; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Palmer LK, 2002, GENETICS, V161, P563; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Svensson JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037368; Svensson JP, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-157; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Vahey MD, 2013, LAB CHIP IN PRESS; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vasil'ev YV, 2006, J AM CHEM SOC, V128, P5506, DOI 10.1021/ja058464q	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73736	10.1371/journal.pone.0073736	http://dx.doi.org/10.1371/journal.pone.0073736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040048	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300121
J	Wei, F; Huang, PT; Li, SY; Chen, J; Zhang, Y; Hong, YR; Wei, SM; Cosgrove, D				Wei, Fang; Huang, Pintong; Li, Shiyan; Chen, Jian; Zhang, Ying; Hong, Yurong; Wei, Shumei; Cosgrove, David			Enhancement Patterns of Gastric Carcinoma on Contrast-Enhanced Ultrasonography: Relationship with Clinicopathological Features	PLOS ONE			English	Article							ENDOSCOPIC DIAGNOSIS; PROGNOSTIC-FACTORS; GADOLINIUM-DTPA; CANCER; ULTRASOUND; CT; ADENOCARCINOMA; CLASSIFICATION; PATHOLOGY; AGENT	The aim of this study was to assess the relationship between the enhancement patterns and clinicopathological features of gastric cancer using intravenous contrast-enhanced ultrasonography (CEUS). In this Ethics Committee-approved prospective study, five hundred fifty two patients with gastric cancer who gave informed consent were examined preoperatively with CEUS. The enhancement pattern of each tumor was analyzed visually. Gross and histopathological findings on the postoperative specimens were compared with the preoperative CEUS findings. The most common CEUS pattern in differentiated gastric cancer was homogeneous enhancement, whereas heterogeneous enhancement was the most common pattern in undifferentiated gastric cancer. The proportion of heterogeneous enhancement was significantly different between the two histological subtypes (Chi- square = 146.735, P<0.001). The sensitivity and specificity of early heterogeneous enhancement on CEUS in diagnosing undifferentiated gastric cancer were 78.84% and 72.59% respectively. Gastric cancers with heterogeneous enhancement were more often Borrmann III and IV macroscopic types than those with homogeneous enhancement (66.56% vs. 30.80%, P<0.001), more commonly T3 and T4 depth of invasion than those with homogeneous enhancement (71.52% vs. 59.60%, P<0.05), more often showed lymphatic invasion than those with homogeneous enhancement (84.44% vs. 76.40%, P<0.05), and were less likely to receive curative gastrectomy than those with homogeneous enhancement (74.83% vs. 86.40%, P<0.005). The intra- and inter-observer reproducibility were both almost perfect for assessing enhancement patterns, with Kappa values of 0.916 (P<0.001) for intra-observer and 0.842 (P<0.001) for inter-observer reproducibility. CEUS provided detailed information about tumor vascularity and contrast enhancement patterns in gastric cancer. CEUS is promising as a new and useful method to predict the histological type of gastric cancer.	[Wei, Fang; Huang, Pintong; Zhang, Ying; Hong, Yurong] Zhejiang Univ, Affiliated Hosp 2, Dept Ultrasound, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Shiyan] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Diagnost Ultrasound & Echocardiog, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jian] Zhejiang Univ, Affiliated Hosp 2, Dept Surg, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Shumei] Zhejiang Univ, Affiliated Hosp 2, Dept Pathol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Cosgrove, David] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Imaging Sci Dept, London, England	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Imperial College London	Huang, PT (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Ultrasound, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	huangpintong@126.com			Health Bureau of Zhejiang Province [2010KYB059]; Main International Project of Zhejiang Province of China [2009C14017]; Wenzhou Science & Technology Bureau [H20060039]	Health Bureau of Zhejiang Province; Main International Project of Zhejiang Province of China; Wenzhou Science & Technology Bureau	This study was supported by Health Bureau of Zhejiang Province (Project No. 2010KYB059), the Main International Project of Zhejiang Province of China (No. 2009C14017) and Wenzhou Science & Technology Bureau (Project No. H20060039), which is gratefully acknowledged and with no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2000, CANCER-AM CANCER SOC, V89, P1418; Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; ANFORAKER SH, 1981, ACTA CYTOL, V25, P361; Badea R, 2012, MED ULTRASON, V14, P197; Barr R G, 1999, Diagn Imaging (San Franc), V21, P56; Borrmann R., 1926, HDB SPEZIELLEN PATHO, P864; Bozzetti F, 1999, ANN SURG, V230, P170, DOI 10.1097/00000658-199908000-00006; BRASCH RC, 1984, AM J ROENTGENOL, V142, P625, DOI 10.2214/ajr.142.3.625; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; CHIN SY, 1994, ABDOM IMAGING, V19, P521, DOI 10.1007/BF00198254; Choi JY, 2011, J GASTRIC CANCER, V11, P46, DOI 10.5230/jgc.2011.11.1.46; Danila M, 2010, MED ULTRASON, V12, P145; EVANS E, 1985, AUST NZ J SURG, V55, P541, DOI 10.1111/j.1445-2197.1985.tb00941.x; Gore Richard M, 2005, Cancer Imaging, V5, P95, DOI 10.1102/1470-7330.2005.0020; Greene F. L., 2002, DIG SYST STOM AJCC C, P99; Harisinghani MG, 1997, CLIN RADIOL, V52, P224, DOI 10.1016/S0009-9260(97)80277-2; Huang PT, 2011, ARCH MED SCI, V7, P287, DOI 10.5114/aoms.2011.22080; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Kang BC, 2000, ABDOM IMAGING, V25, P14, DOI 10.1007/s002619910003; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee MH, 2012, ABDOM IMAGING, V37, P531, DOI 10.1007/s00261-011-9780-3; LEVINE MS, 1990, RADIOLOGY, V175, P151, DOI 10.1148/radiology.175.1.2156284; Li S, 2012, Ultraschall Med, V33, pE218, DOI 10.1055/s-0032-1312958; Li SY, 2009, ULTRASOUND MED BIOL, V35, P1086, DOI 10.1016/j.ultrasmedbio.2009.03.010; LIM JH, 1994, ABDOM IMAGING, V19, P527, DOI 10.1007/BF00198255; LLANOS O, 1982, ANN SURG, V195, P224, DOI 10.1097/00000658-198202000-00018; MAEHARA Y, 1993, CANCER-AM CANCER SOC, V71, P302, DOI 10.1002/1097-0142(19930115)71:2<302::AID-CNCR2820710206>3.0.CO;2-R; NAKAMURA K, 1992, CANCER, V70, P1030, DOI 10.1002/1097-0142(19920901)70:5&lt;1030::AID-CNCR2820700504&gt;3.0.CO;2-C; Paprottka PM, 2010, CLIN HEMORHEOL MICRO, V46, P149, DOI 10.3233/CH-2010-1341; Park MS, 2002, RADIOLOGY, V223, P540, DOI 10.1148/radiol.2232010905; Phillips P, 2004, EUR RADIOL, V14, pP4, DOI 10.1007/s10406-004-0075-4; QIZILBASH AH, 1980, ACTA CYTOL, V24, P313; RODER JD, 1993, CANCER-AM CANCER SOC, V72, P2089, DOI 10.1002/1097-0142(19931001)72:7<2089::AID-CNCR2820720706>3.0.CO;2-H; Rossi M, 1999, AM J ROENTGENOL, V172, P383, DOI 10.2214/ajr.172.2.9930788; Roukos DH, 2000, CANCER TREAT REV, V26, P243, DOI 10.1053/ctrv.2000.0164; Satoh A, 2010, DIGEST SURG, V27, P253, DOI 10.1159/000288703; SCHNEEBERGER AL, 1990, CANCER, V65, P1206, DOI 10.1002/1097-0142(19900301)65:5<1206::AID-CNCR2820650529>3.0.CO;2-J; Schneider M, 1999, EUR RADIOL, V9, pS347, DOI 10.1007/PL00014071; SCHNEIDER M, 1995, INVEST RADIOL, V30, P451, DOI 10.1097/00004424-199508000-00001; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS3, DOI 10.1007/s10120-011-0069-6; Shi H, 2012, WORLD J GASTROENTERO, V18, P4136, DOI 10.3748/wjg.v18.i31.4136; Shin HS, 1996, J KOREAN RADIOL SOC, V35, P81; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; STRICH G, 1985, RADIOLOGY, V154, P723, DOI 10.1148/radiology.154.3.3969477; TADA M, 1993, ENDOSCOPY, V25, P445, DOI 10.1055/s-2007-1010365; Tschmelitsch J, 2000, SURG ONCOL, V9, P23, DOI 10.1016/S0960-7404(00)00020-7; Wei WZ, 2005, WORLD J GASTROENTERO, V11, P4592, DOI 10.3748/wjg.v11.i29.4592; WINAWER SJ, 1975, GASTROENTEROLOGY, V69, P1183; Xue NY, 2011, ARCH MED SCI, V7, P457, DOI 10.5114/aoms.2011.23412; Zheng ZQ, 2011, AM J SURG, V202, P605, DOI 10.1016/j.amjsurg.2010.09.033; Zhou JH, 2011, AM J ROENTGENOL, V196, P13, DOI 10.2214/AJR.10.4734	53	12	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73050	10.1371/journal.pone.0073050	http://dx.doi.org/10.1371/journal.pone.0073050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039857	Green Published, Green Submitted			2022-12-25	WOS:000324856500034
J	He, ZQ; Alazmi, M; Zhang, JF; Xu, D				He, Zhiquan; Alazmi, Meshari; Zhang, Jingfen; Xu, Dong			Protein Structural Model Selection by Combining Consensus and Single Scoring Methods	PLOS ONE			English	Article							STRUCTURE PREDICTION; QUALITY ASSESSMENT; TASSER; SERVER; ALIGNMENT; GENOMICS; FEATURES; MUFOLD	Quality assessment (QA) for predicted protein structural models is an important and challenging research problem in protein structure prediction. Consensus Global Distance Test (CGDT) methods assess each decoy (predicted structural model) based on its structural similarity to all others in a decoy set and has been proved to work well when good decoys are in a majority cluster. Scoring functions evaluate each single decoy based on its structural properties. Both methods have their merits and limitations. In this paper, we present a novel method called PWCom, which consists of two neural networks sequentially to combine CGDT and single model scoring methods such as RW, DDFire and OPUS-Ca. Specifically, for every pair of decoys, the difference of the corresponding feature vectors is input to the first neural network which enables one to predict whether the decoy-pair are significantly different in terms of their GDT scores to the native. If yes, the second neural network is used to decide which one of the two is closer to the native structure. The quality score for each decoy in the pool is based on the number of winning times during the pairwise comparisons. Test results on three benchmark datasets from different model generation methods showed that PWCom significantly improves over consensus GDT and single scoring methods. The QA server (MUFOLD-Server) applying this method in CASP 10 QA category was ranked the second place in terms of Pearson and Spearman correlation performance.	[He, Zhiquan; Alazmi, Meshari; Zhang, Jingfen; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [He, Zhiquan; Alazmi, Meshari; Zhang, Jingfen; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Xu, D (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	xudong@missouri.edu	Alazmi, Meshari/AAX-7790-2021; alazmi, meshari/AAQ-4746-2021	alazmi, meshari/0000-0001-9074-1029	National Institutes of Health [R21/R33-GM078601, R01-GM100701]; University of Hail, Saudi Arabia; Direct For Biological Sciences [1126992] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100701, R21GM078601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Hail, Saudi Arabia; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Institutes of Health grants R21/R33-GM078601 and R01-GM100701, and University of Hail, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Benkert P, 2009, PROTEINS, V77, P173, DOI 10.1002/prot.22532; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng JL, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22487; Cozzetto D, 2008, CURR PROTEIN PEPT SC, V9, P567, DOI 10.2174/138920308786733958; Domingues FS, 2000, FEBS LETT, V476, P98, DOI 10.1016/S0014-5793(00)01678-1; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Gao X, 2007, GENOME INFORM SER, V19, P27; Gao X, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-28; He Z, 2011, STAT ITS INTERFACE, V0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Petrey D, 2000, PROTEIN SCI, V9, P2181, DOI 10.1110/ps.9.11.2181; Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shi XH, 2011, CURR PROTEIN PEPT SC, V12, P540, DOI 10.2174/138920311796957658; Simons KT, 1999, PROTEINS, P171; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774; Wang QG, 2011, PROTEINS, V79, P185, DOI 10.1002/prot.23185; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu YH, 2007, PROTEIN SCI, V16, P1449, DOI 10.1110/ps.072796107; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang JF, 2010, PROTEINS, V78, P1137, DOI 10.1002/prot.22634; Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724; Zheng WM, 2005, LECT NOTES COMPUT SC, V3680, P59, DOI 10.1109/WOCC.2005.1553741	33	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74006	10.1371/journal.pone.0074006	http://dx.doi.org/10.1371/journal.pone.0074006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023923	Green Submitted, Green Published, gold			2022-12-25	WOS:000324238400089
J	Ferrero, JJ; Alvarez, AM; Ramirez-Franco, J; Godino, MC; Bartolome-Martin, D; Aguado, C; Torres, M; Lujan, R; Ciruela, F; Sanchez-Prieto, J				Ferrero, Jose J.; Alvarez, Ana M.; Ramirez-Franco, Jorge; Godino, Maria C.; Bartolome-Martin, David; Aguado, Carolina; Torres, Magdalena; Lujan, Rafael; Ciruela, Francisco; Sanchez-Prieto, Jose			beta-Adrenergic Receptors Activate Exchange Protein Directly Activated by cAMP (Epac), Translocate Munc13-1, and Enhance the Rab3A-RIM1 alpha Interaction to Potentiate Glutamate Release at Cerebrocortical Nerve Terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; PHOSPHOLIPASE-C; RIM PROTEINS; KINASE-C; METABOTROPIC GLUTAMATE-RECEPTOR-7; NEUROTRANSMITTER RELEASE; PYRAMIDAL NEURONS	The adenylyl cyclase activator forskolin facilitates synaptic transmission presynaptically via cAMP-dependent protein kinase (PKA). In addition, cAMP also increases glutamate release via PKA-independent mechanisms, although the downstream presynaptic targets remain largely unknown. Here, we describe the isolation of a PKA-independent component of glutamate release in cerebrocortical nerve terminals after blocking Na+ channels with tetrodotoxin. We found that 8-pCPT-2 '-O-Me- cAMP, a specific activator of the exchange protein directly activated by cAMP (Epac), mimicked and occluded forskolin-induced potentiation of glutamate release. This Epac-mediated increase in glutamate release was dependent on phospholipase C, and it increased the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Moreover, the potentiation of glutamate release by Epac was independent of protein kinase C, although it was attenuated by the diacylglycerol-binding site antagonist calphostin C. Epac activation translocated the active zone protein Munc13-1 from soluble to particulate fractions; it increased the association between Rab3A and RIM1 alpha and redistributed synaptic vesicles closer to the presynaptic membrane. Furthermore, these responses were mimicked by the beta-adrenergic receptor (beta AR) agonist isoproterenol, consistent with the immunoelectron microscopy and immunocytochemical data demonstrating presynaptic expression of beta ARs in a subset of glutamatergic synapses in the cerebral cortex. Based on these findings, we conclude that beta ARs couple to a cAMP/Epac/PLC/Munc13/Rab3/RIM-dependent pathway to enhance glutamate release at cerebrocortical nerve terminals.	[Ferrero, Jose J.; Alvarez, Ana M.; Ramirez-Franco, Jorge; Godino, Maria C.; Bartolome-Martin, David; Torres, Magdalena; Sanchez-Prieto, Jose] Univ Complutense, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain; [Aguado, Carolina; Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete 02006, Spain; [Ciruela, Francisco] Univ Barcelona, Fac Med, IDIBELL, Dept Patol & Terapeut Expt,Unitat Farmacol, Barcelona 08907, Spain	Complutense University of Madrid; Universidad de Castilla-La Mancha; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Sanchez-Prieto, J (corresponding author), Univ Complutense, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain.	jsprieto@vet.ucm.es	Lujan, Rafael/G-2555-2015; Ramirez-Franco, Jorge/J-1082-2018; Martín, David Bartolomé/AAX-5855-2020; Torres, Magdalena/E-6150-2017; Ciruela, F./A-5096-2013; Aguado, Carolina CA/G-3067-2015	Ramirez-Franco, Jorge/0000-0002-2426-6140; Martín, David Bartolomé/0000-0003-0258-7477; Torres, Magdalena/0000-0002-3893-8569; Ciruela, F./0000-0003-0832-3739; Aguado, Carolina CA/0000-0003-0265-8124; Ferrero Lopez, Jose J/0000-0002-4043-3906; Sanchez-Prieto, Jose/0000-0002-8513-3501; Lujan Miras, Rafael/0000-0003-2001-9545	Spanish Ministerio de Educacion y Ciencia [BFU2010-16947, SAF2011-24779, CSD2008-00005]; CONSOLIDER [CSD2008-00005]; Instituto de Salud Carlos III [RD06/0026, RD12/0014]; Comunidad de Madrid [CAM-I2M2 2011-BMD-2349]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grants BFU2010-16947 (to J.S.-P.) and SAF2011-24779 and CSD2008-00005 (to F. C.) and CONSOLIDER (CSD2008-00005) (to R. L. and F. C.), Instituto de Salud Carlos III Grants RD06/0026 and RD12/0014, and Comunidad de Madrid Grant CAM-I2M2 2011-BMD-2349 (to J.S.-P. and M.T.).	AOKI C, 1989, BRAIN RES, V493, P331, DOI 10.1016/0006-8993(89)91168-2; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN TC, 1995, J BIOL CHEM, V270, P7750, DOI 10.1074/jbc.270.13.7750; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; HERRERO I, 1991, NEUROSCI LETT, V126, P41, DOI 10.1016/0304-3940(91)90366-2; Herrero I, 1996, J BIOL CHEM, V271, P30554, DOI 10.1074/jbc.271.48.30554; Huang CC, 2006, MOL PHARMACOL, V69, P846, DOI 10.1124/mol.105.018093; Huang CC, 1996, J NEUROSCI, V16, P1026; Hurley JH, 1997, PROTEIN SCI, V6, P477; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kobayashi M, 2009, SYNAPSE, V63, P269, DOI 10.1002/syn.20604; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Leenders AGM, 2001, MOL BIOL CELL, V12, P3095, DOI 10.1091/mbc.12.10.3095; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; Martin R, 2011, J NEUROCHEM, V116, P476, DOI 10.1111/j.1471-4159.2010.07134.x; Martin R, 2010, J BIOL CHEM, V285, P17907, DOI 10.1074/jbc.M109.080838; Millan C, 2003, J NEUROCHEM, V87, P1101, DOI 10.1046/j.1471-4159.2003.02065.x; Millan C, 2003, J BIOL CHEM, V278, P23955, DOI 10.1074/jbc.M211471200; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Park JH, 2012, ENDOCRINOLOGY, V153, P574, DOI 10.1210/en.2011-0259; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	70	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31370	31385		10.1074/jbc.M113.463877	http://dx.doi.org/10.1074/jbc.M113.463877			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036110	Green Published, hybrid			2022-12-25	WOS:000330778900054
J	Abdul-Hussein, S; Rahl, K; Moslemi, AR; Tajsharghi, H				Abdul-Hussein, Saba; Rahl, Karin; Moslemi, Ali-Reza; Tajsharghi, Homa			Phenotypes of Myopathy-Related Beta-Tropomyosin Mutants in Human and Mouse Tissue Cultures	PLOS ONE			English	Article							NEMALINE MYOPATHY; SKELETAL-MUSCLE; CAP DISEASE; IMMUNOELECTRON MICROSCOPY; DISTAL ARTHROGRYPOSIS; CONGENITAL MYOPATHY; ISOFORM COMPOSITION; ACTIN CYTOSKELETON; RARE CAUSE; GENE TPM2	Mutations in TPM2 result in a variety of myopathies characterised by variable clinical and morphological features. We used human and mouse cultured cells to study the effects of beta-TM mutants. The mutants induced a range of phenotypes in human myoblasts, which generally changed upon differentiation to myotubes. Human myotubes transfected with the E41K-beta-TMEGFP mutant showed perinuclear aggregates. The G53ins-beta-TMEGFP mutant tended to accumulate in myoblasts but was incorporated into filamentous structures of myotubes. The K49del-beta-TMEGFP and E122K-beta-TMEGFP mutants induced the formation of rod-like structures in human cells. The N202K-beta-TMEGFP mutant failed to integrate into thin filaments and formed accumulations in myotubes. The accumulation of mutant beta-TMEGFP in the perinuclear and peripheral areas of the cells was the striking feature in C2C12. We demonstrated that human tissue culture is a suitable system for studying the early stages of altered myofibrilogenesis and morphological changes linked to myopathy-related beta-TM mutants. In addition, the histopathological phenotype associated with expression of the various mutant proteins depends on the cell type and varies with the maturation of the muscle cell. Further, the phenotype is a combinatorial effect of the specific amino acid change and the temporal expression of the mutant protein.	[Abdul-Hussein, Saba; Rahl, Karin; Moslemi, Ali-Reza; Tajsharghi, Homa] Gothenburg Univ, Dept Pathol, S-41124 Gothenburg, Sweden; [Tajsharghi, Homa] Gothenburg Univ, Dept Clin & Med Genet, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Tajsharghi, H (corresponding author), Gothenburg Univ, Dept Pathol, S-41124 Gothenburg, Sweden.	homa.tajsharghi@gu.se			Swedish Research Council [073018]; Ake Wiberg's Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg's Foundation	The study was supported by a grant from the Swedish Research Council (Project No. 073018 to HT) and Ake Wiberg's Foundation to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMPHLETT GW, 1976, FEBS LETT, V63, P22, DOI 10.1016/0014-5793(76)80186-X; Bathe FS, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-2; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Brandis A, 2008, NEUROMUSCULAR DISORD, V18, P1005, DOI [10.1016/j.nmd.2008.07.007, 10.1016/j.nmd.2008.04.008]; Clarke NF, 2009, NEUROMUSCULAR DISORD, V19, P348, DOI 10.1016/j.nmd.2009.03.003; Corbett MA, 2005, ANN NEUROL, V57, P42, DOI 10.1002/ana.20305; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; D'Agostino C, 2011, NEUROPATH APPL NEURO, V37, P315, DOI 10.1111/j.1365-2990.2010.01108.x; Domazetovska A, 2007, ANN NEUROL, V62, P597, DOI 10.1002/ana.21200; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; FIDZIANSKA A, 1981, NEUROLOGY, V31, P1113, DOI 10.1212/WNL.31.9.1113; Fidzianska A, 2002, J NEUROL SCI, V201, P27, DOI 10.1016/S0022-510X(02)00156-9; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HEELEY DH, 1985, BIOCHEM J, V226, P461, DOI 10.1042/bj2260461; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Ilkovski B, 2008, J NEUROPATH EXP NEUR, V67, P867, DOI 10.1097/NEN.0b013e318183a44f; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; LEGER J, 1976, PFLUG ARCH EUR J PHY, V362, P271, DOI 10.1007/BF00581181; Lehtokari VL, 2007, NEUROMUSCULAR DISORD, V17, P433, DOI 10.1016/j.nmd.2007.02.015; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Marttila M, 2011, BIOCH J; Marttila M, 2012, BIOCHEM J, V442, P231, DOI 10.1042/BJ20111030; Monnier N, 2009, NEUROMUSCULAR DISORD, V19, P118, DOI 10.1016/j.nmd.2008.11.009; Nilsson J, 2008, EUR J NEUROL, V15, P573, DOI 10.1111/j.1468-1331.2008.02131.x; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Ohlsson M, 2008, NEUROLOGY, V71, P1896, DOI 10.1212/01.wnl.0000336654.44814.b8; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Ryan MM, 2003, NEUROLOGY, V60, P665, DOI 10.1212/01.WNL.0000046585.81304.BC; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; SHAFIQ SA, 1967, BRAIN, V90, P817, DOI 10.1093/brain/90.4.817; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Tajsharghi H, 2007, NEUROLOGY, V68, P772, DOI 10.1212/01.wnl.0000256339.40667.fb; Tajsharghi H, 2005, ANN NEUROL, V58, P442, DOI 10.1002/ana.20594; Tajsharghi H, 2012, NEUROMUSCUL DISORD; Tajsharghi H, 2007, ARCH NEUROL-CHICAGO, V64, P1334, DOI 10.1001/archneur.64.9.1334; Vandebrouck A, 2010, J NEUROPATH EXP NEUR, V69, P429, DOI 10.1097/NEN.0b013e3181d892c6; vanderLoop FTL, 1996, EUR J CELL BIOL, V69, P301; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Wallgren-Pettersson C, 2000, Neuromuscul Disord, V10, P299, DOI 10.1016/S0960-8966(99)00129-7; Wallgren-Pettersson Carina, 2003, Neuromuscul Disord, V13, P501, DOI 10.1016/S0960-8966(03)00007-5; Wattanasirichaigoon D, 2002, NEUROLOGY, V59, P613, DOI 10.1212/WNL.59.4.613	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72396	10.1371/journal.pone.0072396	http://dx.doi.org/10.1371/journal.pone.0072396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039757	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600006
J	Hoxhaj, G; Dissanayake, K; MacKintosh, C				Hoxhaj, Gerta; Dissanayake, Kumara; MacKintosh, Carol			Effect of IRS4 Levels on PI 3-Kinase Signalling	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE; ACUTE LYMPHOBLASTIC-LEUKEMIA; T-ANTIGEN; RAT-BRAIN; 4 GENE; PROTEIN; CELLS; IDENTIFICATION; EXPRESSION; PROLIFERATION	Insulin receptor substrate 1 (IRS1) and IRS2 are well-characterized adapter proteins that relay signals from receptor tyrosine kinases to downstream components of signalling pathways. In contrast, the function of IRS4 is not well understood. IRS4 overexpression has been associated with acute lymphoblastic leukaemia and subungual exostosis, while point mutations of IRS4 have been found in melanomas. Here, we show that while IRS4 expression is low in most cancer cell lines, IRS4 mRNA and protein levels are markedly elevated in certain cells including the NCI-H720, DMS114, HEK293T and HEK293AAV lines. Surprisingly, IRS4 expression was also strongly induced when HEK293 cells were infected with retroviral particles and selected under puromycin, making IRS4 expression a potential off-target effect of retroviral expression vectors. Cells with high expression of IRS4 displayed high phosphatidylinositol (3,4,5)-trisphosphate (PIP3) levels, as well as elevated Akt and p70 S6 kinase activities, even in the absence of growth factors. PI 3-kinase (PI3K) signalling in these cells depends on IRS4, even though these cells also express IRS1/2. Knockdown of IRS4 also inhibited cell proliferation in cells with high levels of IRS4. Together, these findings suggest IRS4 as a potential therapeutic target for cancers with high expression of this protein.	[Hoxhaj, Gerta; MacKintosh, Carol] Univ Dundee, Coll Life Sci, Prot Phosphorylat Unit, Med Res Council, Dundee, Scotland; [Dissanayake, Kumara; MacKintosh, Carol] Univ Dundee, Div Cell & Dev Biol, Coll Life Sci, Dundee, Scotland	University of Dundee; University of Dundee	Hoxhaj, G (corresponding author), Univ Dundee, Coll Life Sci, Prot Phosphorylat Unit, Med Res Council, Dundee, Scotland.	g.hoxhaj@dundee.ac.uk; c.mackintosh@dundee.ac.uk	MacKintosh, Carol/B-8210-2011	MacKintosh, Carol/0000-0001-9166-589X; Hoxhaj, Gerta/0000-0001-6179-3583	UK Medical Research Council; Diabetes UK [12/0004557] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK)	The authors thank the UK Medical Research Council and pharmaceutical companies that support the Division of Signal Transduction Therapy (DSTT) at University of Dundee (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck-Serono and Pfizer) for financial support. The Oncomine data (Supporting Table 1) was searched as part of a collaboration with AstraZeneca. AstraZeneca had no further role in the study design, data collection and analysis, nor in the decision to publish, nor preparation of the manuscript. None of the other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Division of Signal Transduction Therapy (DSTT) is an academic laboratory within the University of Dundee (http://www.lifesci.dundee.ac.uk/research/dstt). No contract research is carried out for the companies.	Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chakraborty C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016580; Chiba T, 2009, NEUROBIOL AGING, V30, P474, DOI 10.1016/j.neurobiolaging.2007.07.008; Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; Escribano O, 2003, HEPATOLOGY, V37, P1461, DOI 10.1053/jhep.2003.50245; Fantin VR, 1998, J BIOL CHEM, V273, P10726, DOI 10.1074/jbc.273.17.10726; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Fantin VR, 1999, BIOCHEM BIOPH RES CO, V260, P718, DOI 10.1006/bbrc.1999.0967; FEI ZL, 1995, MOL CELL BIOL, V15, P4232; Giovannone B, 2000, DIABETES-METAB RES, V16, P434, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR159>3.0.CO;2-8; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hinsby AM, 2004, J BIOL CHEM, V279, P46438, DOI 10.1074/jbc.M404537200; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Karrman K, 2011, BRIT J HAEMATOL, V155, P516, DOI 10.1111/j.1365-2141.2011.08709.x; Karrman K, 2009, BRIT J HAEMATOL, V144, P546, DOI 10.1111/j.1365-2141.2008.07453.x; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Li JY, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-95; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Luo YD, 2009, CELL SIGNAL, V21, P1370, DOI 10.1016/j.cellsig.2009.04.004; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Masanobu S, 2012, DNA RES, V19, P305, DOI 10.1093/dnares/dss012; Mertens F, 2011, INT J CANCER, V128, P487, DOI 10.1002/ijc.25353; Mihindukulasuriya KA, 2004, J BIOL CHEM, V279, P46588, DOI 10.1074/jbc.M408067200; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nash K, 2009, J VIROL, V83, P454, DOI 10.1128/JVI.01939-08; Numan S, 1999, MOL BRAIN RES, V72, P97, DOI 10.1016/S0169-328X(99)00160-6; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shimwell NJ, 2009, ONCOGENE, V28, P686, DOI 10.1038/onc.2008.417; Shull AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043369; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Villarreal RS, 2006, MOL CELL BIOCHEM, V293, P35, DOI 10.1007/s11010-006-2492-2; Wauman J, 2008, MOL ENDOCRINOL, V22, P965, DOI 10.1210/me.2007-0414; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619	39	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73327	10.1371/journal.pone.0073327	http://dx.doi.org/10.1371/journal.pone.0073327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039912	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600025
J	Cheng, S; Al-Agha, R; Araujo, PB; Serri, O; Asa, SL; Ezzat, S				Cheng, Sonia; Al-Agha, Rany; Araujo, Paula B.; Serri, Omar; Asa, Sylvia L.; Ezzat, Shereen			Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly	PLOS ONE			English	Article							SOMATOSTATIN ANALOGS; PEGVISOMANT; GUIDELINES; MANAGEMENT; CONSENSUS; GROWTH; RISK; HYPERPROLACTINEMIA; OCTREOTIDE; SECRETION	Introduction: Acromegaly is frequently associated with impaired glucose tolerance and/or diabetes. To evaluate the relationship between glucose metabolism and acromegaly disease, we evaluated 269 consecutive patients from two referral centres. Methods: Clinical presentation, pituitary tumor size and invasiveness, and pituitary pathology were captured in a dedicated database. Results: 131 women and 138 men with a mean age of 53.8 years were included. Of these, 201 (74.7%) presented with a macroadenoma and 18 (6.7%) with a microadenoma. Radiographic invasion was present in 91 cases (33.8%). Mean tumor diameter was 1.86 cm (0.2-4.6). Pituitary histopathologic findings revealed pure GH-producing somatotroph adenomas (SA) in 147 patients, prolactin-production by mixed lactotroph (LA) and SA or mammosomatotroph adenoma (MSA) in 46 [22.4%], acidophil stem cell adenoma in 6 [2.9%], and other diagnoses in 6 [2.9%]. Medical treatment included octreotide in 96 [36.9%] and in combination with pegvisomant or dopamine agonists in 63 [24.2%]. Nearly 80% of patients achieved IGF-1 normalization. Importantly, patients with pure somatotroph adenomas were significantly more likely to present with abnormal glucose metabolism [48.7%] than those with mixed adenomas [9.7%] [p<0.001] independent of GH/IGF-1 levels or tumor invasiveness. Abnormal glucose metabolism and pituitary pathology also remained linked following IGF-1 normalization. Moreover patients with pure SA and abnormal glucose metabolism were significantly (p<0.001) less likely to achieve disease remission despite the same therapeutic strategies. Conversely, patients with mixed adenomas were more likely (OR: 2.766 (95% CI: 1.490-5.136) to achieve disease remission. Conclusions: Patients with pure somatotroph adenomas are more likely than those with mixed adenomas to exhibit abnormal glucose metabolism.	[Cheng, Sonia; Al-Agha, Rany; Araujo, Paula B.; Ezzat, Shereen] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Asa, Sylvia L.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Serri, Omar] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite de Montreal	Ezzat, S (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	shereen.ezzat@utoronto.ca		Asa, Sylvia/0000-0001-8418-5054				Asa S, 1998, ATLAS TUMOR PATHOLOG; Asa SL, 2002, NAT REV CANCER, V2, P836, DOI 10.1038/nrc926; Barkan AL, 2005, J CLIN ENDOCR METAB, V90, P5684, DOI 10.1210/jc.2005-0331; Bhayana S, 2005, J CLIN ENDOCR METAB, V90, P6290, DOI 10.1210/jc.2005-0998; Campbell PG, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10153; Colao A, 2000, J CLIN ENDOCR METAB, V85, P3132, DOI 10.1210/jc.85.9.3132; Colao A, 2009, J CLIN ENDOCR METAB, V94, P528, DOI 10.1210/jc.2008-1546; Cook David M, 2004, Endocr Pract, V10, P213; Silva CMD, 2011, OBESITY, V19, P800, DOI 10.1038/oby.2010.150; EZZAT S, 1992, ENDOCRIN METAB CLIN, V21, P753, DOI 10.1016/S0889-8529(18)30212-3; EZZAT S, 1994, MEDICINE, V73, P233, DOI 10.1097/00005792-199409000-00001; Ezzat S, 1997, ENDOCRIN METAB CLIN, V26, P703, DOI 10.1016/S0889-8529(05)70278-4; Ezzat S, 2006, CLIN INVEST MED, V29, P29; Ezzat S, 2013, CELL METAB, V17, P929, DOI 10.1016/j.cmet.2013.05.002; Furman K, 1998, PSYCHOTHER PSYCHOSOM, V67, P147, DOI 10.1159/000012275; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; Heinzle C, 2012, CANCER RES, V72, P5767, DOI 10.1158/0008-5472.CAN-11-3654; Higham CE, 2009, CLIN ENDOCRINOL, V71, P86, DOI 10.1111/j.1365-2265.2008.03469.x; Katznelson L, 2011, ENDOCR PRACT, V17, P1; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Melmed S, 2005, J CLIN ENDOCR METAB, V90, P4405, DOI 10.1210/jc.2004-2466; Melmed S, 2005, EUR J ENDOCRINOL, V153, P737, DOI 10.1530/eje.1.02036; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; MOLLER N, 1992, J CLIN ENDOCR METAB, V74, P1012, DOI 10.1210/jc.74.5.1012; Neggers SJCMM, 2011, GROWTH HORM IGF RES, V21, P129, DOI 10.1016/j.ghir.2011.03.004; Nilsson L, 2005, BIOCHEM BIOPH RES CO, V331, P1120, DOI 10.1016/j.bbrc.2005.04.026; Serri O, 2006, CLIN ENDOCRINOL, V64, P366, DOI 10.1111/j.1365-2265.2006.02469.x; Serri O, 2004, J CLIN ENDOCR METAB, V89, P658, DOI 10.1210/jc.2003-030915; Tanimoto K, 2008, EUR J ENDOCRINOL, V159, P375, DOI 10.1530/EJE-08-0243; Tateno T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002400; van Thiel SW, 2005, EUR J ENDOCRINOL, V153, P231, DOI 10.1530/eje.1.01955; Wang M, 2012, EUR J ENDOCRINOL, V166, P797, DOI 10.1530/EJE-11-1119	33	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73543	10.1371/journal.pone.0073543	http://dx.doi.org/10.1371/journal.pone.0073543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039977	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300089
J	Luo, FL; Sun, XM; Wang, YB; Wang, QL; Wu, YH; Pan, Q; Fang, C; Zhang, XL				Luo, Fengling; Sun, Xiaoming; Wang, Yubin; Wang, Qilong; Wu, Yanhong; Pan, Qin; Fang, Chao; Zhang, Xiao-Lian			Ficolin-2 Defends against Virulent Mycobacteria Tuberculosis Infection In Vivo, and Its Insufficiency Is Associated with Infection in Humans	PLOS ONE			English	Article							PATTERN-RECOGNITION MOLECULES; LECTIN-COMPLEMENT PATHWAY; MANNAN-BINDING LECTIN; TUMOR-NECROSIS-FACTOR; GENE; CLONING; PROTEIN; P35; IDENTIFICATION; INTERFERON	Human ficolin-2 (ficolin-2/P35) is a lectin complement pathway activator that is present in normal human plasma and is associated with infectious diseases; however, little is known regarding the roles and mechanisms of ficolin-2 during Mycobacterium tuberculosis (Mtb) infection. Here, we describe our novel findings that the ficolin-2 serum levels of 107 pulmonary tuberculosis (TB) patients were much lower compared with 107 healthy controls. In vitro analysis showed that ficolin-2 bound to the virulent Mtb H37Rv strain much more strongly than to the non-virulent M. bovis BCG and M. smegmatis. Ficolin-2 bound to the surface glycolipid portion of H37Rv and blocked H37Rv infection in human lung A549 cells. Opsonophagocytosis was also promoted by ficolin-2. Importantly, we found that administration of exogenous ficolin-2 had a remarkable protective effect against virulent Mtb H37Rv infection in both C57BL/6J and BALB/c mice. Ficolin-A (a ficolin-2-like molecule in mouse) knockout mice exhibited increased susceptibility to H37Rv infection. We further demonstrated that ficolin-2 could defend against virulent Mtb H37Rv infection at least partially by activating JNK phosphorylation and stimulating the secretion of interferon (IFN)-Upsilon, interleukin (IL)-17, IL-6, tumor necrosis factor (TNF)-alpha, and nitric oxide (NO) production by macrophages. Our data provide a new immunotherapeutic strategy against TB based on the innate immune molecule ficolin-2 and indicate that ficolin-2 insufficiency is associated with higher susceptibility to infection in humans.	[Luo, Fengling; Sun, Xiaoming; Wang, Yubin; Wang, Qilong; Wu, Yanhong; Pan, Qin; Zhang, Xiao-Lian] Wuhan Univ, State Key Lab Virol, Dept Immunol, Hubei Prov Key Lab Allergy & Immunol,Sch Med, Wuhan 430072, Peoples R China; [Fang, Chao] Wuhan Univ, Dept Anesthesiol, Zhongnan Hosp, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zhang, XL (corresponding author), Wuhan Univ, State Key Lab Virol, Dept Immunol, Hubei Prov Key Lab Allergy & Immunol,Sch Med, Wuhan 430072, Peoples R China.	zhangxiaolian@whu.edu.cn			National Special Fund of China for the Important Infectious Diseases [2012ZX10003002-015]; 973 Program of China [2009CB522507, 2012CB720604]; National Natural Science Foundation of China [30921001, 30800038]; National Outstanding Youth Foundation of China [81025008, 81000714]; Program for Changjiang Scholars and Innovative Research Team in University; 211 program [303-581045]; Science and Technology Program of Wuhan [201150530141]; 3551 plan; SFB/Transregio [TRR60]	National Special Fund of China for the Important Infectious Diseases; 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Outstanding Youth Foundation of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 211 program; Science and Technology Program of Wuhan; 3551 plan; SFB/Transregio	This work was supported by grants from the National Special Fund of China for the Important Infectious Diseases (2012ZX10003002-015), the 973 Program of China (2009CB522507, 2012CB720604), National Natural Science Foundation of China (30921001, 30800038) and National Outstanding Youth Foundation of China (81025008, 81000714), the Program for Changjiang Scholars and Innovative Research Team in University, the 211 program (303-581045), the Science and Technology Program of Wuhan (201150530141) and 3551 plan, and SFB/Transregio TRR60. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Endo Y, 1996, GENOMICS, V36, P515, DOI 10.1006/geno.1996.0497; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Endo Y, 2012, J IMMUNOL, V189, P5860, DOI 10.4049/jimmunol.1200836; Fujimori Y, 1998, BIOCHEM BIOPH RES CO, V244, P796, DOI 10.1006/bbrc.1998.8344; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Golub JE, 2008, AIDS, V22, P2527, DOI 10.1097/QAD.0b013e328311ac4e; Greco E, 2010, IMMUNOLOGY, V129, P125, DOI 10.1111/j.1365-2567.2009.03145.x; Hu YL, 2013, SCAND J IMMUNOL, V77, P144, DOI 10.1111/sji.12014; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2008, IMMUNOL LETT, V118, P152, DOI 10.1016/j.imlet.2008.03.014; Kwon S, 2007, J BIOCHEM MOL BIOL, V40, P532; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Ma YF, 2011, MICROBES INFECT, V13, P1099, DOI 10.1016/j.micinf.2011.06.012; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Nahid AM, 2006, DEV COMP IMMUNOL, V30, P335, DOI 10.1016/j.dci.2005.04.002; NAUCIEL C, 1992, INFECT IMMUN, V60, P450, DOI 10.1128/IAI.60.2.450-454.1992; O'Rourke JP, 2002, J VIROL, V76, P1510, DOI 10.1128/JVI.76.3.1510-1515.2002; Pan Q, 2012, J INNATE IMMUN, V4, P312, DOI 10.1159/000335670; Robinson CM, 2012, CYTOKINE, V60, P233, DOI 10.1016/j.cyto.2012.06.012; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; SUPER M, 1990, CLIN EXP IMMUNOL, V79, P144; Taira S, 2000, Fukushima J Med Sci, V46, P13; Tsuji S, 2002, NITRIC OXIDE-BIOL CH, V7, P283, DOI 10.1016/S1089-8603(02)00110-6; Zhou JY, 2013, J CLIN INVEST, V123, P2629, DOI 10.1172/JCI64704	44	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73859	10.1371/journal.pone.0073859	http://dx.doi.org/10.1371/journal.pone.0073859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040095	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300136
J	Niu, HJ; Li, Z; Liao, XH; Wang, JH; Zhao, TD; Shu, N; Zhao, XH; He, Y				Niu, Haijing; Li, Zhen; Liao, Xuhong; Wang, Jinhui; Zhao, Tengda; Shu, Ni; Zhao, Xiaohu; He, Yong			Test-Retest Reliability of Graph Metrics in Functional Brain Networks: A Resting-State fNIRS Study	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; NEAR-INFRARED SPECTROSCOPY; SMALL-WORLD; LOW-FREQUENCY; CEREBRAL HEMODYNAMICS; THEORETICAL ANALYSIS; CORTICAL NETWORKS; MOTOR CORTEX; NIRS-FMRI; CONNECTIVITY	Recent research has demonstrated the feasibility of combining functional near-infrared spectroscopy (fNIRS) and graph theory approaches to explore the topological attributes of human brain networks. However, the test-retest (TRT) reliability of the application of graph metrics to these networks remains to be elucidated. Here, we used resting-state fNIRS and a graph-theoretical approach to systematically address TRT reliability as it applies to various features of human brain networks, including functional connectivity, global network metrics and regional nodal centrality metrics. Eighteen subjects participated in two resting-state fNIRS scan sessions held similar to 20 min apart. Functional brain networks were constructed for each subject by computing temporal correlations on three types of hemoglobin concentration information (HbO, HbR, and HbT). This was followed by a graph-theoretical analysis, and then an intraclass correlation coefficient (ICC) was further applied to quantify the TRT reliability of each network metric. We observed that a large proportion of resting-state functional connections (similar to 90%) exhibited good reliability (0.6< ICC <0.74). For global and nodal measures, reliability was generally threshold-sensitive and varied among both network metrics and hemoglobin concentration signals. Specifically, the majority of global metrics exhibited fair to excellent reliability, with notably higher ICC values for the clustering coefficient (HbO: 0.76; HbR: 0.78; HbT: 0.53) and global efficiency (HbO: 0.76; HbR: 0.70; HbT: 0.78). Similarly, both nodal degree and efficiency measures also showed fair to excellent reliability across nodes (degree: 0.52 similar to 0.84; efficiency: 0.50 similar to 0.84); reliability was concordant across HbO, HbR and HbT and was significantly higher than that of nodal betweenness (0.28 similar to 0.68). Together, our results suggest that most graph-theoretical network metrics derived from fNIRS are TRT reliable and can be used effectively for brain network research. This study also provides important guidance on the choice of network metrics of interest for future applied research in developmental and clinical neuroscience.	[Niu, Haijing; Li, Zhen; Zhao, Tengda; Shu, Ni; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liao, Xuhong; Wang, Jinhui] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Xuhong] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Zhao, Xiaohu] Tongji Univ, Shanghai TongJi Hosp, Dept Imaging, Shanghai 200092, Peoples R China	Beijing Normal University; Hangzhou Normal University; Tongji University	Zhao, XH (corresponding author), Tongji Univ, Shanghai TongJi Hosp, Dept Imaging, Shanghai 200092, Peoples R China.	xhzhao999@gmail.com; yong.he@bnu.edu.cn	Wang, jinhui/AAF-8668-2019; He, Yong/Q-5756-2018; He, Yong/C-2161-2009	He, Yong/0000-0002-7039-2850	Natural Science Foundation of China [81201122, 81030028, 31221003, 30970818, 81271552]; Fundamental Research Funds for the Central Universities [2012LYB06]; Specialized Research Fund for the Doctoral Program of Higher Education; National Science Fund for Distinguished Young Scholars [81225012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Natural Science Foundation of China (Grant Nos. 81201122, 81030028, 31221003, 30970818 and 81271552), the Fundamental Research Funds for the Central Universities (Grant No. 2012LYB06), the Specialized Research Fund for the Doctoral Program of Higher Education, and the National Science Fund for Distinguished Young Scholars (Grant No. 81225012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; Cooper RJ, 2012, NEUROIMAGE, V59, P3128, DOI 10.1016/j.neuroimage.2011.11.028; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Diamond SG, 2009, MATH BIOSCI, V220, P102, DOI 10.1016/j.mbs.2009.05.002; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gagnon L, 2012, NEUROIMAGE, V59, P3933, DOI 10.1016/j.neuroimage.2011.10.054; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Gagnon L, 2011, NEUROIMAGE, V56, P1362, DOI 10.1016/j.neuroimage.2011.03.001; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Kohno S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2814249; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Niu HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045771; Niu HJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3561687; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Payne SJ, 2009, ANN BIOMED ENG, V37, P2288, DOI 10.1007/s10439-009-9763-5; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saager RB, 2011, NEUROIMAGE, V55, P1679, DOI 10.1016/j.neuroimage.2011.01.043; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sampat M P, 2006, Br J Radiol, V79 Spec No 2, pS134, DOI 10.1259/bjr/96723280; Sasai S, 2012, NEUROIMAGE, V63, P179, DOI 10.1016/j.neuroimage.2012.06.011; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stone JV, 2002, TRENDS COGN SCI, V6, P59, DOI 10.1016/S1364-6613(00)01813-1; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Toronov V, 2000, MED PHYS, V27, P801, DOI 10.1118/1.598943; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White BR, 2011, NEUROIMAGE; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Winer B.J., 1962, STAT PRINCIPLES EXPT; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhang H, 2010, NEUROIMAGE, V51, P1150, DOI 10.1016/j.neuroimage.2010.02.080; Zhang Q, 2007, J BIOMEDICAL OPTICS, V12; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048; Zhang YJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462973	78	61	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72425	10.1371/journal.pone.0072425	http://dx.doi.org/10.1371/journal.pone.0072425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039763	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300010
J	Stenvinkel, P; Frobert, O; Anderstam, B; Palm, F; Eriksson, M; Bragfors-Helin, AC; Qureshi, AR; Larsson, T; Friebe, A; Zedrosser, A; Josefsson, J; Svensson, M; Sahdo, B; Bankir, L; Johnson, RJ				Stenvinkel, Peter; Frobert, Ole; Anderstam, Bjorn; Palm, Fredrik; Eriksson, Monica; Bragfors-Helin, Ann-Christin; Qureshi, Abdul Rashid; Larsson, Tobias; Friebe, Andrea; Zedrosser, Andreas; Josefsson, Johan; Svensson, My; Sahdo, Berolla; Bankir, Lise; Johnson, Richard J.			Metabolic Changes in Summer Active and Anuric Hibernating Free-Ranging Brown Bears (Ursus arctos)	PLOS ONE			English	Article							AMINO-ACID-CONCENTRATIONS; CHRONIC KIDNEY-DISEASE; B UREA TRANSPORTER; OXIDATIVE STRESS; BLACK BEARS; URSODEOXYCHOLIC ACID; UNCOUPLING PROTEIN-2; SEASONAL-CHANGES; RENAL-FUNCTION; POTENTIAL-ROLE	The brown bear (Ursus arctos) hibernates for 5 to 6 months each winter and during this time ingests no food or water and remains anuric and inactive. Despite these extreme conditions, bears do not develop azotemia and preserve their muscle and bone strength. To date most renal studies have been limited to small numbers of bears, often in captive environments. Sixteen free-ranging bears were darted and had blood drawn both during hibernation in winter and summer. Samples were collected for measurement of creatinine and urea, markers of inflammation, the calcium-phosphate axis, and nutritional parameters including amino acids. In winter the bear serum creatinine increased 2.5 fold despite a 2-fold decrease in urea, indicating a remarkable ability to recycle urea nitrogen during hibernation. During hibernation serum calcium remained constant despite a decrease in serum phosphate and a rise in FGF23 levels. Despite prolonged inactivity and reduced renal function, inflammation does not ensue and bears seem to have enhanced antioxidant defense mechanisms during hibernation. Nutrition parameters showed high fat stores, preserved amino acids and mild hyperglycemia during hibernation. While total, essential, non-essential and branched chain amino acids concentrations do not change during hibernation anorexia, changes in individual amino acids ornithine, citrulline and arginine indicate an active, although reduced urea cycle and nitrogen recycling to proteins. Serum uric acid and serum fructose levels were elevated in summer and changes between seasons were positively correlated. Further studies to understand how bears can prevent the development of uremia despite minimal renal function during hibernation could provide new therapeutic avenues for the treatment of human kidney disease.	[Stenvinkel, Peter; Anderstam, Bjorn; Eriksson, Monica; Bragfors-Helin, Ann-Christin; Qureshi, Abdul Rashid; Larsson, Tobias] Karolinska Inst, Dept Clin Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Frobert, Ole; Josefsson, Johan] Univ Hosp Orebro, Dept Cardiol, Orebro, Sweden; [Palm, Fredrik] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Friebe, Andrea] Goethe Univ Frankfurt, Inst Zool, Frankfurt, Germany; [Zedrosser, Andreas] Telemark Univ Coll, Dept Environm & Hlth Studies, Fac Arts & Sci, Porsgrunn, Norway; [Zedrosser, Andreas] Univ Nat Res & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Austria; [Svensson, My] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Sahdo, Berolla] Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, SE-70182 Orebro, Sweden; [Bankir, Lise] Ctr Rech Cordeliers, INSERM, Unit E2 872, Paris, France; [Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Denver, CO 80202 USA	Karolinska Institutet; Orebro University; Linkoping University; Goethe University Frankfurt; University College of Southeast Norway; Aarhus University; Orebro University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Colorado System; University of Colorado Denver	Stenvinkel, P (corresponding author), Karolinska Inst, Dept Clin Intervent & Technol, Div Renal Med, Stockholm, Sweden.	peter.stenvinkel@ki.se	BANKIR, Lise/AAK-2733-2020; Qureshi, Abdul Rashid Tony/G-1358-2010	BANKIR, Lise/0000-0002-3321-0819; Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Stenvinkel, Peter/0000-0002-8785-4820; Frobert, Ole/0000-0002-5846-345X	Swedish Medical Research Council (VR); Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Research Council of Norway; Austrian Science Foundation a Nordforsk research network [44042]; Lundbeck Foundation [R126-2012-12408]	Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Research Council of Norway(Research Council of Norway); Austrian Science Foundation a Nordforsk research network; Lundbeck Foundation(Lundbeckfonden)	Peter Stenvinkel's research benefited from support by Swedish Medical Research Council (VR). The authors thank the field personnel of the Scandinavian Brown Bear Research Project (SBBRP). The SBBRP was funded by the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, the Research Council of Norway, and the Austrian Science Foundation a Nordforsk research network grant (project no. 44042) and The Lundbeck Foundation (R126-2012-12408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQUIST DA, 1984, J COMP PHYSIOL B, V155, P75, DOI 10.1007/BF00688794; Anderstam B, 2013, SCAND J CLIN LAB INV, V73, P154, DOI 10.3109/00365513.2012.758386; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Antoniucci DM, 2005, J CLIN ENDOCR METAB, V90, P4566, DOI 10.1210/jc.2005-0290; Arinell K, 2012, CTS-CLIN TRANSL SCI, V5, P269, DOI 10.1111/j.1752-8062.2011.00370.x; Auger J, 2002, AM MIDL NAT, V147, P352, DOI 10.1674/0003-0031(2002)147[0352:AABBUA]2.0.CO;2; Bairlein F, 2002, NATURWISSENSCHAFTEN, V89, P1, DOI 10.1007/s00114-001-0279-6; Barboza PS, 1997, CAN J ZOOL, V75, P2129, DOI 10.1139/z97-848; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; BOUBY N, 1993, KIDNEY INT, V44, P676, DOI 10.1038/ki.1993.300; BROSNAN JT, 1987, CAN J PHYSIOL PHARM, V65, P2355, DOI 10.1139/y87-373; BROWN DC, 1971, AM J PHYSIOL, V220, P293, DOI 10.1152/ajplegacy.1971.220.1.293; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136; Chen G, 2012, J CELL BIOCHEM, V113, P3559, DOI 10.1002/jcb.24233; Chesney RW, 2009, ADV EXP MED BIOL, V643, P325, DOI 10.1007/978-0-387-75681-3_33; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040520; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; FLORANT GL, 1985, AM J PHYSIOL, V249, pR159, DOI 10.1152/ajpregu.1985.249.2.R159; Franch HA, 2005, CURR OPIN CLIN NUTR, V8, P271, DOI 10.1097/01.mco.0000165005.01331.45; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/157339909788166800; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Hissa R, 1998, ANN ZOOL FENN, V35, P205; Houser DS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P838, DOI 10.1086/422055; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Inoue H, 2005, AM J PHYSIOL-RENAL, V289, pF451, DOI 10.1152/ajprenal.00376.2004; Inoue H, 2004, AM J PHYSIOL-CELL PH, V287, pC30, DOI 10.1152/ajpcell.00443.2003; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Johnson RJ, 2009, J COMP PHYSIOL B, V179, P67, DOI 10.1007/s00360-008-0291-7; KRISTOFF.R, 1968, EXPERIENTIA, V24, P148, DOI 10.1007/BF02146952; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; Lohuis TD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P257, DOI 10.1086/513190; Lohuis TD, 2005, CAN J ZOOL, V83, P1257, DOI 10.1139/Z05-120; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; Martinez-Moya P, 2013, INT IMMUNOPHARMACOL, V15, P372, DOI 10.1016/j.intimp.2012.11.017; McGee Lawrence M. E., 2009, J BIOMECH, V42, P1378; McLarney MJ, 1996, J NUTR, V126, P1871; NAGY S, 1980, J AGR FOOD CHEM, V28, P8, DOI 10.1021/jf60227a026; Nelson CJ, 2009, PHYSIOL GENOMICS, V37, P43, DOI 10.1152/physiolgenomics.90323.2008; Nelson R.A., 1989, P299; NELSON RA, 1975, MAYO CLIN PROC, V50, P141; NELSON RA, 1984, SCIENCE, V226, P841, DOI 10.1126/science.6494914; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; Novak JE, 2008, KIDNEY INT, V74, P1121, DOI 10.1038/ki.2008.286; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Sahdo B, 2013, INT J MED SCI, V10, P508, DOI 10.7150/ijms.4476; Simmons NL, 2009, J ANIM SCI, V87, P3288, DOI 10.2527/jas.2008-1710; Sola S, 2006, COMP BIOCHEM PHYS C, V143, P204, DOI 10.1016/j.cbpc.2006.02.002; Stearns S.C., 1992, pi; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stenvinkel P, 2013, KIDNEY INT, V83, P207, DOI 10.1038/ki.2012.396; Suliman ME, 2005, AM J CLIN NUTR, V82, P342, DOI 10.1093/ajcn/82.2.342; Suliman ME, 1996, KIDNEY INT, V50, P1713, DOI 10.1038/ki.1996.490; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Vestergaard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021483; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	68	38	38	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72934	10.1371/journal.pone.0072934	http://dx.doi.org/10.1371/journal.pone.0072934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039826	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300035
J	Strakova, E; Bobek, J; Zikova, A; Vohradsky, J				Strakova, Eva; Bobek, Jan; Zikova, Alice; Vohradsky, Jiri			Global Features of Gene Expression on the Proteome and Transcriptome Levels in S-coelicolor during Germination	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; STREPTOMYCES-COELICOLOR; SIGMA-FACTOR; MESSENGER-RNA; BACILLUS-SUBTILIS; OXIDATIVE STRESS; AERIAL SPORES; A3(2); GRANATICOLOR; ACTIVATION	Streptomycetes have been studied mostly as producers of secondary metabolites, while the transition from dormant spores to an exponentially growing culture has largely been ignored. Here, we focus on a comparative analysis of fluorescently and radioactively labeled proteome and microarray acquired transcriptome expressed during the germination of Streptomyces coelicolor. The time-dynamics is considered, starting from dormant spores through 5.5 hours of growth with 13 time points. Time series of the gene expressions were analyzed using correlation, principal components analysis and an analysis of coding genes utilization. Principal component analysis was used to identify principal kinetic trends in gene expression and the corresponding genes driving S. coelicolor germination. In contrast with the correlation analysis, global trends in the gene/protein expression reflected by the first principal components showed that the prominent patterns in both the protein and the mRNA domains are surprisingly well correlated. Analysis of the number of expressed genes identified functional groups activated during different time intervals of the germination.	[Strakova, Eva; Bobek, Jan; Zikova, Alice; Vohradsky, Jiri] Acad Sci Czech Republic, Inst Microbiol, Lab Bioinformat, Prague, Czech Republic; [Bobek, Jan] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Vohradsky, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Lab Bioinformat, Prague, Czech Republic.	vohr@biomed.cas.cz	Bobek, Jan/J-6356-2017	Bobek, Jan/0000-0002-5645-7208	Czech Science Foundation [P302-11-0229, P302/10/0468]; Grant Agency of the Charles University [17409]; Charles University in Prague [PRVOUK-P24/LF1/3];  [RVO: 61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Charles University; Charles University in Prague; 	This work was supported by grants of the Czech Science Foundation (www.gacr.cz) P302-11-0229 to JV; P302/10/0468 to JB; a grant of the Grant Agency of the Charles University (www.cuni.cz/UK-33.html) under contract no. 17409 to ES; a project of Charles University in Prague: PRVOUK-P24/LF1/3 (www.cuni.cz/UK-3885.html?) to JB; RVO: 61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Bobek J, 2004, PROTEOMICS, V4, P3864, DOI 10.1002/pmic.200400818; Cowan AE, 2003, P NATL ACAD SCI USA, V100, P4209, DOI 10.1073/pnas.0636762100; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haiser HJ, 2009, J BACTERIOL, V191, P6501, DOI 10.1128/JB.00767-09; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; Homerova D, 2012, GENE, V492, P71, DOI 10.1016/j.gene.2011.11.011; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim MJ, 2007, PROTEIN J, V26, P51, DOI 10.1007/s10930-006-9044-1; Kim MS, 2012, MOL MICROBIOL, V85, P326, DOI 10.1111/j.1365-2958.2012.08115.x; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; MIKULIK K, 1977, FOLIA MICROBIOL, V22, P252, DOI 10.1007/BF02877654; Mikulik K, 2002, BIOCHEM BIOPH RES CO, V299, P335, DOI 10.1016/S0006-291X(02)02606-2; Mikulik K, 2000, BIOCHEM BIOPH RES CO, V268, P282, DOI 10.1006/bbrc.2000.2127; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Ramsden JJ, 1998, PHYS REV E, V58, P7777, DOI 10.1103/PhysRevE.58.7777; RANADE N, 1993, CAN J MICROBIOL, V39, P377, DOI 10.1139/m93-055; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Sevcikova B, 2010, J BACTERIOL, V192, P5674, DOI 10.1128/JB.00828-10; Strakova E, 2012, J PROTEOME RES; Vohradsky J, 2001, FASEB J, V15, P2054, DOI 10.1096/fj.00-0889fje; Vohradsky J, 2007, PROTEOMICS, V7, P3853, DOI 10.1002/pmic.200700005	35	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72842	10.1371/journal.pone.0072842	http://dx.doi.org/10.1371/journal.pone.0072842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039809	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300031
J	Vikrant; Kumar, R; Yadav, LR; Nakhwa, P; Waghmare, SK; Goyal, P; Varma, AK				Vikrant; Kumar, Rajan; Yadav, Lumbini R.; Nakhwa, Pallavi; Waghmare, Sanjeev K.; Goyal, Peyush; Varma, Ashok K.			Structural and Functional Implication of RAP80 Delta Glu81 Mutation	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; DNA-DAMAGE-RESPONSE; DOUBLE-STRAND BREAKS; CIRCULAR-DICHROISM; POLYUBIQUITIN CHAINS; GENOMIC STABILITY; HISTONE H2AX; BRCA1; BINDING; RECOGNITION	Receptor Associated Protein 80 (RAP80) is a member of RAP80-BRCA1-CCDC98 complex family and helps in its recruitment to the DNA damage site for effective homologous recombination repair. It encompasses two tandem UIMs (UIM1 and UIM2) motif at its N-terminus, which interact with K-63 linked polyubiquitin chain(s) on H2AX and thereby assemble the RAP80-BRCA1 complex at the damage site. Nevertheless, how RAP80 helps in the structural integrity of BRCA1 complex is still elusive. Considering the role of RAP80 in the recruitment of BRCA1 complex at the DNA damage site, we attempted to explore the molecular mechanism associated with RAP80 and mutation that causes chromosomal aberrations due to its loss of function. There is a significant loss in structural characteristics of RAP80 Delta E81, which impairs its binding affinity with the polyubiquitin chain. This leads to the defective recruitment of RAP80 and BRCA1 complex at the DNA damage site. The results presented here are very useful in understanding the cause of various repair defects (chromosomal aberration) that arise due to this mutation. Comparative study of wild type and DE81 could be helpful in designing the small molecules that can potentially compensate the deleterious effect(s) of DE81 and hence useful for therapeutic application.	[Vikrant; Kumar, Rajan; Yadav, Lumbini R.; Nakhwa, Pallavi; Waghmare, Sanjeev K.; Varma, Ashok K.] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Goyal, Peyush] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); All India Institute of Medical Sciences (AIIMS) New Delhi	Varma, AK (corresponding author), Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	avarma@actrec.gov.in			Department of Biotechnology, Government of India [BT/PR10765/BRB/664/2008, BT/PR12565/BID/07/303/2009]; Tata Memorial Centre; CSIR fellowship [09/513 (0072)/2008-EMR-I]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Tata Memorial Centre; CSIR fellowship(Council of Scientific & Industrial Research (CSIR) - India)	Funding for this study was supported by Department of Biotechnology, Government of India (No. BT/PR10765/BRB/664/2008 and BT/PR12565/BID/07/303/2009), Seed in Air grant from Tata Memorial Centre to AKV. Vikrant is supported by CSIR fellowship (09/513 (0072)/2008-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Bian CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040406; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Markin CJ, 2010, J AM CHEM SOC, V132, P11247, DOI 10.1021/ja103869x; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Pace C N, 1986, Methods Enzymol, V131, P266; Patil R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012029; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Sekiyama N, 2012, J BIOMOL NMR, V52, P339, DOI 10.1007/s10858-012-9614-9; Shiotani B, 2009, J CELL SCI, V122, P301, DOI 10.1242/jcs.035105; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; STEPHENS PJ, 1981, BIOCHEMISTRY-US, V20, P2857, DOI 10.1021/bi00513a023; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Venkitaraman AR, 1999, SCIENCE, V286, P1100, DOI 10.1126/science.286.5442.1100; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Yan J, 2009, J BIOL CHEM, V284, P19280, DOI 10.1074/jbc.M109.013102; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yin ZY, 2012, CANCER RES, V72, P5080, DOI 10.1158/0008-5472.CAN-12-1484	53	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72707	10.1371/journal.pone.0072707	http://dx.doi.org/10.1371/journal.pone.0072707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039796	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300022
J	Zhang, Y; Wang, RJ; Du, WJ; Wang, SX; Yang, L; Pan, ZW; Li, XL; Xiong, XH; He, H; Shi, YF; Liu, X; Yu, SN; Bi, ZG; Lu, YJ; Shan, HL				Zhang, Ying; Wang, Renjun; Du, Weijie; Wang, Shuxuan; Yang, Lei; Pan, Zhenwei; Li, Xuelian; Xiong, Xuehui; He, Hua; Shi, Yongfang; Liu, Xue; Yu, Shaonan; Bi, Zhengang; Lu, Yanjie; Shan, Hongli			Downregulation of miR-151-5p Contributes to Increased Susceptibility to Arrhythmogenesis during Myocardial Infarction with Estrogen Deprivation	PLOS ONE			English	Article							CORONARY HEART-DISEASE; VENTRICULAR MYOCYTES; REPLACEMENT THERAPY; SARCOLEMMAL PROTEIN; NA+/CA2+ EXCHANGE; PHOSPHOLEMMAN; MICRORNAS; PHOSPHORYLATION; CONTRACTILITY; REPRESSION	Estrogen deficiency is associated with increased incidence of cardiovascular diseases. But merely estrogen supplementary treatment can induce many severe complications such as breast cancer. The present study was designed to elucidate molecular mechanisms underlying increased susceptibility of arrhythmogenesis during myocardial infarction with estrogen deprivation, which provides us a new target to cure cardiac disease accompanied with estrogen deprivation. We successfully established a rat model of myocardial ischemia (MI) accompanied with estrogen deprivation by coronary artery ligation and ovariectomy (OVX). Vulnerability and mortality of ventricular arrhythmias increased in estrogen deficiency rats compared to non estrogen deficiency rats when suffered MI, which was associated with down-regulation of microRNA-151-5p (miR-151-5p). Luciferase Reporter Assay demonstrated that miR-151-5p can bind to the 3'-UTR of FXYD1 (coding gene of phospholemman, PLM) and inhibit its expression. We found that the expression of PLM was increased in (OVX+MI) group compared with MI group. More changes such as down-regulation of Kir2.1/I-K1, calcium overload had emerged in (OVX+MI) group compared to MI group merely. Transfection of miR-151-5p into primary cultured myocytes decreased PLM levels and [Ca2+](i), however, increased Kir2.1 levels. These effects were abolished by the antisense oligonucleotides against miR-151-5p. Co-immunoprecipitation and immunofluorescent experiments confirmed the co-localization between Kir2.1 and PLM in rat ventricular tissue. We conclude that the increased ventricular arrhythmias vulnerability in response to acute myocardial ischemia in rat is critically dependent upon down-regulation of miR-151-5p. These findings support the proposal that miR-151-5p could be a potential therapeutic target for the prevention of ischemic arrhythmias in the subjects with estrogen deficiency.	[Zhang, Ying; Wang, Renjun; Du, Weijie; Wang, Shuxuan; Pan, Zhenwei; Li, Xuelian; Xiong, Xuehui; He, Hua; Shi, Yongfang; Liu, Xue; Yu, Shaonan; Lu, Yanjie; Shan, Hongli] Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res,Minist Educ, Harbin, Peoples R China; [Yang, Lei; Bi, Zhengang] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Lu, YJ (corresponding author), Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res,Minist Educ, Harbin, Peoples R China.	yjlu86@yahoo.com; shanhongli72@aliyun.com	Wang, Renjun/AHC-3186-2022	Wang, Renjun/0000-0003-0058-6219; Xuelian, Li/0000-0001-9043-8580	Creative Research Groups [81121003]; Major Program of National Natural Science Foundation of China [81130088]; National Nature Science Foundation of China [31171094, 81100122, 81202527]	Creative Research Groups; Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Funds for Creative Research Groups (81121003) and the Major Program (81130088) of National Natural Science Foundation of China, and the National Nature Science Foundation of China (No.31171094, No.81100122 and No.81202527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Chen T, 2010, ENVIRON HEALTH PERSP, V118, P1597, DOI 10.1289/ehp.1002153; Chu WF, 2006, BASIC CLIN PHARMACOL, V98, P104, DOI 10.1111/j.1742-7843.2006.pto_313.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Dong DL, 2004, ACTA PHARMACOL SIN, V25, P751; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; EAKER ED, 1993, CIRCULATION, V88, P1999, DOI 10.1161/01.CIR.88.4.1999; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jackson RJ, 2007, SCI STKE; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li XL, 2009, BIOL PHARM BULL, V32, P1521, DOI 10.1248/bpb.32.1521; LINDEMANN JP, 1986, J BIOL CHEM, V261, P4860; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; Mirza MA, 2004, AM J PHYSIOL-HEART C, V286, pH1322, DOI 10.1152/ajpheart.00997.2003; Pang L, 2003, FEBS LETT, V546, P349, DOI 10.1016/S0014-5793(03)00629-X; PRESTI CF, 1985, J BIOL CHEM, V260, P3879; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; Sehl PD, 2000, CIRCULATION, V101, P1990, DOI 10.1161/01.CIR.101.16.1990; Shan HL, 2009, BRIT J PHARMACOL, V158, P1227, DOI 10.1111/j.1476-5381.2009.00377.x; Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; Song JL, 2002, AM J PHYSIOL-HEART C, V283, pH576, DOI 10.1152/ajpheart.00197.2002; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang HZ, 2002, CANCER RES, V62, P4843; Wang XM, 2010, BIOPHYS J, V98, P1149, DOI 10.1016/j.bpj.2009.11.032; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang BF, 2005, CELL PHYSIOL BIOCHEM, V16, P163, DOI 10.1159/000089842; Yang BF, 1998, ACTA PHARMACOL SIN, V19, P269; Yin C, 2008, FEBS LETT, V582, P4137, DOI 10.1016/j.febslet.2008.11.014; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005; Zhang XQ, 2003, AM J PHYSIOL-HEART C, V284, pH225, DOI 10.1152/ajpheart.00698.2002; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V340, P1192, DOI 10.1016/j.bbrc.2005.12.124	44	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72985	10.1371/journal.pone.0072985	http://dx.doi.org/10.1371/journal.pone.0072985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039836	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300038
J	Kowalski, GM; Carey, AL; Selathurai, A; Kingwell, BA; Bruce, CR				Kowalski, Greg M.; Carey, Andrew L.; Selathurai, Ahrathy; Kingwell, Bronwyn A.; Bruce, Clinton R.			Plasma Sphingosine-1-Phosphate Is Elevated in Obesity	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; INSULIN SENSITIVITY; IN-VIVO; CERAMIDE; METABOLISM; LIPOLYSIS; BLOOD; GLUCONEOGENESIS; ASSOCIATION; SUPPRESSION	Background: Dysfunctional lipid metabolism is a hallmark of obesity and insulin resistance and a risk factor for various cardiovascular and metabolic complications. In addition to the well known increase in plasma triglycerides and free fatty acids, recent work in humans and rodents has shown that obesity is associated with elevations in the bioactive class of sphingolipids known as ceramides. However, in obesity little is known about the plasma concentrations of sphinogsine-1-phosphate (S1P), the breakdown product of ceramide, which is an important signaling molecule in mammalian biology. Therefore, the purpose of this study was to examine the impact of obesity on circulating S1P concentration and its relationship with markers of glucose metabolism and insulin sensitivity. Methodology/Principal Findings: Plasma S1P levels were determined in high-fat diet (HFD)-induced and genetically obese (ob/ob) mice along with obese humans. Circulating S1P was elevated in both obese mouse models and in obese humans compared with lean healthy controls. Furthermore, in humans, plasma S1P positively correlated with total body fat percentage, body mass index (BMI), waist circumference, fasting insulin, HOMA-IR, HbA1c (%), total and LDL cholesterol. In addition, fasting increased plasma S1P levels in lean healthy mice. Conclusion: We show that elevations in plasma S1P are a feature of both human and rodent obesity and correlate with metabolic abnormalities such as adiposity and insulin resistance.	[Kowalski, Greg M.; Selathurai, Ahrathy; Bruce, Clinton R.] Monash Univ, Dept Physiol, Integrat Physiol & Metab Lab, Clayton, Vic 3168, Australia; [Carey, Andrew L.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia	Monash University; Baker Heart and Diabetes Institute	Kowalski, GM (corresponding author), Monash Univ, Dept Physiol, Integrat Physiol & Metab Lab, Clayton, Vic 3168, Australia.	greg.kowalski@monash.edu	Kingwell, Bronwyn A/B-1183-2009	Kowalski, Greg/0000-0002-1599-017X; Bruce, Clinton/0000-0002-0515-3343; Carey, Andrew/0000-0003-3452-1501	National Health and Medical Research Council (NHMRC) of Australia [1023570]; Career Development Award from the NHMRC; NHMRC Principal Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia, Project Grant 1023570. Clinton R. Bruce is supported by a Career Development Award from the NHMRC. Bronwyn A. Kingwell is supported by an NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AS, 2011, KIDNEY INT, V79, P1090, DOI 10.1038/ki.2010.544; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Baranowski M, 2011, ACTA PHYSIOL, V203, P373, DOI 10.1111/j.1748-1716.2011.02322.x; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Boon J, 2012, DIABETES; Bruce CR, 2013, ENDOCRINOLOGY, V154, P65, DOI 10.1210/en.2012-1847; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; EBELING P, 1993, J CLIN INVEST, V92, P1623, DOI 10.1172/JCI116747; Egom EE, 2013, CURR OPIN LIPIDOL; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V278, pE1144, DOI 10.1152/ajpendo.2000.278.6.E1144; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Ichi I, 2006, LIPIDS, V41, P859, DOI 10.1007/s11745-006-5041-6; JENSEN MD, 1987, J CLIN INVEST, V79, P207, DOI 10.1172/JCI112785; Jun DJ, 2006, ENDOCRINOLOGY, V147, P5835, DOI 10.1210/en.2006-0579; Knapp M, 2011, J PHYSIOL PHARMACOL, V62, P601; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; NURJHAN N, 1992, J CLIN INVEST, V89, P169, DOI 10.1172/JCI115558; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2011, TRENDS MOL MED, V17, P463, DOI 10.1016/j.molmed.2011.03.002; Rapizzi E, 2009, CELL MOL LIFE SCI, V66, P3207, DOI 10.1007/s00018-009-0106-3; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Sattler K, 2009, CARDIOVASC RES, V82, P201, DOI 10.1093/cvr/cvp070; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stanford JC, 2012, J BIOL CHEM, V287, P13457, DOI 10.1074/jbc.M111.268185; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	52	115	117	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72449	10.1371/journal.pone.0072449	http://dx.doi.org/10.1371/journal.pone.0072449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039766	gold, Green Published			2022-12-25	WOS:000324856500019
J	Yoo, MH; Carlson, BA; Gladyshev, VN; Hatfield, DL				Yoo, Min-Hyuk; Carlson, Bradley A.; Gladyshev, Vadim N.; Hatfield, Dolph L.			Abrogated Thioredoxin System Causes Increased Sensitivity to TNF-alpha-Induced Apoptosis via Enrichment of p-ERK 1/2 in the Nucleus	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; MAMMALIAN THIOREDOXIN; CANCER-CELLS; REDUCTASE; PROTEIN; GROWTH; ROLES; OVEREXPRESSION; SELENOCYSTEINE; ACTIVATION	Thioredoxin (Trx) and thioredoxin reductase 1 (TR1) are among the major redox regulators in mammalian cells and have a wide variety of roles, including removal of intracellular reactive oxygen species (ROS) and prevention of cell death. Tumor necrosis factor-alpha (TNF-alpha) induces cancer cell death. Although ROS have been proposed to participate in this process, the role of the thioredoxin system in TNF-alpha stimulated cell death remains unclear. We investigated the possibility that the thioredoxin system protects against TNF-alpha-induced cancer cell death by examining whether TR1/Trx1 status controls TNF-alpha-induced apoptosis in EMT6 murine breast cancer cells. TR1-deficient cells were more sensitive to TNF-alpha than control cells. Increased sensitivity to TNF-alpha was most pronounced in Trx1-deficient cells. TNF-alpha-induced nuclear localization of phosphorylated ERK 1/2 (p-ERK 1/2) correlated with increased apoptosis in TR1- and Trx1-deficient cells, suggesting a pro-apoptotic role for nuclear p-ERK 1/2 in TNF-alpha-induced apoptosis. In addition, phosphoinositide 3-kinase (PI3K) inhibition dramatically reduced TNF-alpha-stimulated apoptosis and nuclear localization of p-ERK 1/2. In contrast, inhibition of ROS, MEK, JNK, or p38 did not significantly alter p-ERK 1/2 localization or apoptosis in TR1- and Trx1-deficient cells compared to control cells. Further, NF-kappa B p65 localization was not changed in TR1- and Trx1-deficient cells in response to TNF-alpha relative to control cells. Our data suggest that the thioredoxin system plays a critical role in protecting against TNF-alpha-induced apoptosis by regulating the levels of nuclear p-ERK 1/2 in a PI3K-dependent manner.	[Yoo, Min-Hyuk; Carlson, Bradley A.; Hatfield, Dolph L.] NIH, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hatfield, DL (corresponding author), NIH, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov		Gladyshev, Vadim/0000-0002-0372-7016	Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health; National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005317, R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health (DLH) and by National Institutes of Health grants (VNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bharadwaj S., 2008, J CANC MOL, V4, P139; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Jeong DW, 2002, J BIOL CHEM, V277, P17871, DOI 10.1074/jbc.M200808200; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; LASTER SM, 1988, J IMMUNOL, V141, P2629; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Lincoln DT, 2010, ANTICANCER RES, V30, P767; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Lu J, 2009, BBA-GEN SUBJECTS, V1790, P1513, DOI 10.1016/j.bbagen.2009.04.013; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Mochizuki M, 2009, ANTIOXID REDOX SIGN, V11, P2957, DOI [10.1089/ars.2009.2623, 10.1089/ARS.2009.2623]; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Namura S, 1998, J NEUROSCI, V18, P3659; Nguyen P, 2006, CANCER LETT, V236, P164, DOI 10.1016/j.canlet.2005.04.028; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Tobe R, 2012, BIOCHEM J, V445, P423, DOI 10.1042/BJ20120618; Turanov AA, 2010, BIOCHEM J, V430, P285, DOI 10.1042/BJ20091378; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang ZS, 2001, CANCER RES, V61, P7171; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200; Zhu XJ, 2011, ORAL ONCOL, V47, P609, DOI 10.1016/j.oraloncology.2011.05.006; Zuckerbraun BS, 2003, CIRCULATION, V108, P876, DOI 10.1161/01.CIR.0000081947.00070.07	47	9	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e71427	10.1371/journal.pone.0071427	http://dx.doi.org/10.1371/journal.pone.0071427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039713	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500006
J	Zulet, A; Gil-Monreal, M; Villamor, JG; Zabalza, A; van der Hoorn, RAL; Royuela, M				Zulet, Amaia; Gil-Monreal, Miriam; Villamor, Joji Grace; Zabalza, Ana; van der Hoorn, Renier A. L.; Royuela, Mercedes			Proteolytic Pathways Induced by Herbicides That Inhibit Amino Acid Biosynthesis	PLOS ONE			English	Article							ACETOLACTATE SYNTHASE INHIBITORS; VACUOLAR PROCESSING ENZYME; PROGRAMMED CELL-DEATH; CASPASE-LIKE ACTIVITY; ARABIDOPSIS-THALIANA; SELECTIVE INHIBITORS; CYSTEINE PROTEASES; 20S PROTEASOME; CADMIUM STRESS; PEA-PLANTS	Background: The herbicides glyphosate (Gly) and imazamox (Imx) inhibit the biosynthesis of aromatic and branched-chain amino acids, respectively. Although these herbicides inhibit different pathways, they have been reported to show several common physiological effects in their modes of action, such as increasing free amino acid contents and decreasing soluble protein contents. To investigate proteolytic activities upon treatment with Gly and Imx, pea plants grown in hydroponic culture were treated with Imx or Gly, and the proteolytic profile of the roots was evaluated through fluorogenic kinetic assays and activity-based protein profiling. Results: Several common changes in proteolytic activity were detected following Gly and Imx treatment. Both herbicides induced the ubiquitin-26 S proteasome system and papain-like cysteine proteases. In contrast, the activities of vacuolar processing enzymes, cysteine proteases and metacaspase 9 were reduced following treatment with both herbicides. Moreover, the activities of several putative serine protease were similarly increased or decreased following treatment with both herbicides. In contrast, an increase in YVADase activity was observed under Imx treatment versus a decrease under Gly treatment. Conclusion: These results suggest that several proteolytic pathways are responsible for protein degradation upon herbicide treatment, although the specific role of each proteolytic activity remains to be determined.	[Zulet, Amaia; Gil-Monreal, Miriam; Zabalza, Ana; Royuela, Mercedes] Univ Publ Navarra, Dept Ciencias Medio Nat, Pamplona, Spain; [Villamor, Joji Grace; van der Hoorn, Renier A. L.] Max Planck Inst Plant Breeding Res, Plant Chemet Lab, Cologne, Germany	Universidad Publica de Navarra; Max Planck Society	Royuela, M (corresponding author), Univ Publ Navarra, Dept Ciencias Medio Nat, Pamplona, Spain.	royuela@unavarra.es	Zabalza, Ana/E-6203-2016; Gil-Monreal, Miriam/AAP-7634-2020; van der Hoorn, Renier/AAU-1005-2020; Royuela, Mercedes/D-1229-2011	Zabalza, Ana/0000-0001-6954-6317; Gil-Monreal, Miriam/0000-0002-6622-2234; van der Hoorn, Renier/0000-0002-3692-7487; Royuela, Mercedes/0000-0002-1085-2229	Ministerio de Educacion; Universidad Publica de Navarra; Spanish Ministry of Education and Science [AGL-2010-18621]; Max Planck Society; COST Action [CM1004]	Ministerio de Educacion; Universidad Publica de Navarra; Spanish Ministry of Education and Science(Spanish Government); Max Planck Society(Max Planck SocietyFoundation CELLEX); COST Action(European Cooperation in Science and Technology (COST))	A. Zulet and M. Gil-Monreal received funding from Spanish fellowships through the Ministerio de Educacion and the Universidad Publica de Navarra, respectively. This work was financially supported through grants from the Spanish Ministry of Education and Science (AGL-2010-18621) and Max Planck Society and the COST Action CM1004 for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PC, 1985, WEED SCI, V33, P479, DOI 10.1017/S0043174500082692; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Basset G, 2002, PLANT PHYSIOL, V128, P1149, DOI 10.1104/pp.010612; Belenghi B, 2004, J EXP BOT, V55, P889, DOI 10.1093/jxb/erh097; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Bosch M, 2007, P NATL ACAD SCI USA, V104, P18327, DOI 10.1073/pnas.0705826104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Cobb A, 2010, HERBICIDES PLANT PHY, V2010, P176; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Gaston S, 2002, PHYSIOL PLANTARUM, V114, P524, DOI 10.1034/j.1399-3054.2002.1140404.x; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Gruys KJ, 1999, BOOK SOIL P, P357; Gu C, 2010, PLANT J, V62, P160, DOI 10.1111/j.1365-313X.2009.04122.x; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Ingvardsen C, 2001, PHYSIOL PLANTARUM, V112, P451, DOI 10.1034/j.1399-3054.2001.1120401.x; Kaschani F, 2009, PLANT J, V57, P373, DOI 10.1111/j.1365-313X.2008.03683.x; Kaschani F, 2012, BIOORGAN MED CHEM, V20, P597, DOI 10.1016/j.bmc.2011.06.040; Kaschani F, 2009, MOL CELL PROTEOMICS, V8, P1082, DOI 10.1074/mcp.M800494-MCP200; Kolodziejek I, 2010, CURR OPIN BIOTECH, V21, P225, DOI 10.1016/j.copbio.2010.02.003; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Kurepa J, 2010, PLANT CELL REP, V29, P249, DOI 10.1007/s00299-010-0818-8; Misas-Villamil JC, 2013, PLANT J, V73, P689, DOI 10.1111/tpj.12062; Orcaray L, 2012, J PLANT PHYSIOL, V169, P27, DOI 10.1016/j.jplph.2011.08.009; Orcaray L, 2010, PEST MANAG SCI, V66, P262, DOI 10.1002/ps.1868; Pena LB, 2008, CHEMOSPHERE, V72, P741, DOI 10.1016/j.chemosphere.2008.03.024; Pena LB, 2007, PHYTOCHEMISTRY, V68, P1139, DOI 10.1016/j.phytochem.2007.02.022; Pena LB, 2006, PLANT SCI, V171, P531, DOI 10.1016/j.plantsci.2006.06.003; Powles SB, 2008, PEST MANAG SCI, V64, P360, DOI 10.1002/ps.1525; RHODES D, 1987, PLANT PHYSIOL, V84, P775, DOI 10.1104/pp.84.3.775; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; SHANER DL, 1986, PESTIC BIOCHEM PHYS, V25, P248, DOI 10.1016/0048-3575(86)90051-9; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wittenbach VA, 1999, BOOK SOIL P, P385; Zabalza A, 2005, J AGR FOOD CHEM, V53, P7486, DOI 10.1021/jf050654x; Zabalza A, 2004, J AGR FOOD CHEM, V52, P7601, DOI 10.1021/jf0486996; Zabalza A, 2006, J AGR FOOD CHEM, V54, P8818, DOI 10.1021/jf0618224; Zabalza A, 2013, J PLANT PHYSIOL, V170, P814, DOI 10.1016/j.jplph.2013.01.003; Zabalza A, 2011, J PLANT PHYSIOL, V168, P1568, DOI 10.1016/j.jplph.2011.02.015; Zhou Q, 2007, PESTIC BIOCHEM PHYS, V89, P89, DOI 10.1016/j.pestbp.2007.04.004	50	41	43	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73847	10.1371/journal.pone.0073847	http://dx.doi.org/10.1371/journal.pone.0073847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040092	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500061
J	Byakika-Tusiime, J; Polley, EC; Oyugi, JH; Bangsberg, DR				Byakika-Tusiime, Jayne; Polley, Eric C.; Oyugi, Jessica H.; Bangsberg, David R.			Free HIV Antiretroviral Therapy Enhances Adherence among Individuals on Stable Treatment: Implications for Potential Shortfalls in Free Antiretroviral Therapy	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; BARRIERS; EPIDEMIOLOGY; KAMPALA; UGANDA; ADULTS; HAART; TIME	Objective: To estimate the population-level causal effect of source of payment for HIV medication on treatment adherence using Marginal Structural Models. Methods: Data were obtained from an observational cohort of 76 HIV-infected individuals with at least 24 weeks of antiretroviral therapy treatment from 2002 to 2007 in Kampala, Uganda. Adherence was the primary outcome and it was measured using the 30-day visual analogue scale. Marginal structural models (MSM) were used to estimate the effect of source of payment for HIV medication on adherence, adjusting for confounding by income, duration on antiretroviral therapy (ART), timing of visit, prior adherence, prior CD4(+) T cell count and prior plasma HIV RNA. Traditional association models were also examined and the results compared. Results: Free HIV treatment was associated with a 3.8% improvement in adherence in the marginal structural model, while the traditional statistical models showed a 3.1-3.3% improvement in adherence associated with free HIV treatment. Conclusion: Removing a financial barrier to treatment with ART by providing free HIV treatment appears to significantly improve adherence to antiretroviral therapy. With sufficient information on confounders, MSMs can be used to make robust inferences about causal effects in epidemiologic research.	[Byakika-Tusiime, Jayne] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Polley, Eric C.] NCI, Biometr Res Branch, Bethesda, MD 20892 USA; [Oyugi, Jessica H.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Bangsberg, David R.] Massachusetts Gen Hosp Global Hlth, Dept Med, Boston, MA USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA	Makerere University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Makerere University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Byakika-Tusiime, J (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.	tusjayne@hotmail.com			National Institutes of Health [NIMH RO-154907, NIMH RO-3 66654, NIAAA R-21 014784, NIMH K-24 87227]; Fogarty AIDS International Training and Research Program/University of California, Berkeley [1D43 TW00003]; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907, R03MH066654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty AIDS International Training and Research Program/University of California, Berkeley(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)University of California System); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported partly by the National Institutes of Health (NIMH RO-154907, NIMH RO-3 66654, NIAAA R-21 014784, NIMH K-24 87227) and the Fogarty AIDS International Training and Research Program/University of California, Berkeley (1D43 TW00003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar LM, 2004, AM J EPIDEMIOL, V159, P926, DOI 10.1093/aje/kwh131; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Collins D, 1996, HEALTH POLICY PLANN, V11, P52, DOI 10.1093/heapol/11.1.52; Crane JT, 2006, AIDS BEHAV, V10, P437, DOI 10.1007/s10461-006-9080-z; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Gruber S, 2009, UC BERKELEY DIVISION, V252; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Maneesriwongul WL, 2006, JAIDS-J ACQ IMM DEF, V43, pS119, DOI 10.1097/01.qai.0000248346.79888.78; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Molinaro A, 2004, TECHNICAL REPORT; Mortimer KM, 2005, AM J EPIDEMIOL, V162, P382, DOI 10.1093/aje/kwi208; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Petersen ML, 2006, JAIDS-J ACQ IMM DEF, V43, pS96, DOI 10.1097/01.qai.0000248344.95135.8d; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Robins JM, 1999, SYNTHESE, V121, P151, DOI 10.1023/A:1005285815569; Sinisi S., 2004, J STAT METHODS MOL B, V3; Souteyrand YP, 2008, AIDS S1, V22, pS161; Tuller DM, AIDS BEHAV, V14, P778; van der Laan M.J., 2006, INT J BIOSTATISTICS, V2; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2006, PROGR GLOB ACC HIV A	32	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e70375	10.1371/journal.pone.0070375	http://dx.doi.org/10.1371/journal.pone.0070375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039704	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600005
J	He, S; Zheng, Y; Shu, Y; He, JY; Wang, Y; Chen, XP				He, Sen; Zheng, Yi; Shu, Yan; He, Jiyun; Wang, Yong; Chen, Xiaoping			Hypertriglyceridemic Waist Might Be an Alternative to Metabolic Syndrome for Predicting Future Diabetes Mellitus	PLOS ONE			English	Article							CHOLESTEROL EDUCATION-PROGRAM; ENLARGED WAIST; HEALTH SURVEY; PHENOTYPE; DEFINITIONS; ASSOCIATION; FEDERATION; PREVALENCE; DISEASE; MEN	Background: In some cross-sectional studies, hypertriglyceridemic waist (HTGW) has been recommended as an alternative to metabolic syndrome (MetS) for screening individuals at high risk for diabetes mellitus (DM). However, little information is about the predictive power of HTGW for future DM. The aims of the study were to assess the DM predictive power of HTGW compared with MetS based on the follow-up data over 15 years collected from a general Chinese population. Methods: And Findings: The data were collected in 1992 and then again in 2007 from the same group of 687 individuals without DM in 1992. For the whole population (n = 687), multivariate analysis showed presence of HTGW was associated with a 4.1-fold (95% CI: 2.4-7.0, p < 0.001) increased risk and presence of MetS was associated with a 3.7-fold (95% CI: 2.2-6.2, p < 0.001) increased risk for future DM. For the population without elevated fasting plasma glucose (n = 650), multivariate analysis showed presence of HTGW was associated with a 3.9-fold (95% CI: 2.2- 7.0, p < 0.001) increased risk and presence of MetS was associated with a 3.7-fold (95% CI: 2.1-6.6, p < 0.001) increased risk for future DM. Conclusions: HTGW could predict future DM independently, and the predictive power was similar to MetS. HTGW might be an alternative to MetS for predicting future DM. For simpler and fewer components, HTGW might be more practical than MetS, and it might be recommended in most clinical practices. This finding might be more useful for the individuals who only have elevated WC and TG. Although these individuals are without MetS, they are still at high risk for future DM, similarly to the individuals with MetS.	[He, Sen; Zheng, Yi; He, Jiyun; Wang, Yong; Chen, Xiaoping] Sichuan Univ, West China Hosp, Dept Cardiovasc Med, Chengdu 610064, Peoples R China; [Shu, Yan] Sichuan Prov Peoples Hosp, Dept Cardiovasc Med, Chengdu, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital	Chen, XP (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiovasc Med, Chengdu 610064, Peoples R China.	happensky@163.com			National Eighth Five-Year Research Plan, China [85-915-01-02]; Mega-projects of Science Research for the 11th Five-Year Plan, China [2006BAI01A01]; National Natural Science Foundation of China [30900626]	National Eighth Five-Year Research Plan, China; Mega-projects of Science Research for the 11th Five-Year Plan, China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a project from the National Eighth Five-Year Research Plan, China (grant no: 85-915-01-02), by Mega-projects of Science Research for the 11th Five-Year Plan, China (grant no: 2006BAI01A01), and by National Natural Science Foundation of China (grant no: 30900626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amini M, 2011, J RES MED SCI, V16, P156; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Blackburn P, 2009, METABOLISM, V58, P1123, DOI 10.1016/j.metabol.2009.03.012; Brisson D, 2010, CAN MED ASSOC J, V182, pE722, DOI 10.1503/cmaj.100378; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Egeland GM, 2011, CAN MED ASSOC J, V183, P1022, DOI 10.1503/cmaj.101801; Gomez-Huelgas R, 2011, INT J OBESITY, V35, P292, DOI 10.1038/ijo.2010.127; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; He S, 2013, INT J CARDIOL, V168, P511, DOI 10.1016/j.ijcard.2012.09.196; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Kahn HS, 2003, AM J CLIN NUTR, V78, P928, DOI 10.1093/ajcn/78.5.928; Lemieux I, 2002, CAN J CARDIOL, V18, P725; Lemieux I, 2007, CAN J CARDIOL, V23, p23B, DOI 10.1016/S0828-282X(07)71007-3; Nawabzad Raphael, 2010, Rev Prat, V60, P15; Povel CM, 2013, DIABETES CARE, V36, P362, DOI 10.2337/dc11-2546; Reaven GM, 2009, CAN MED ASSOC J, V180, P601, DOI 10.1503/cmaj.090092; Ren J, 2010, ATHEROSCLEROSIS, V211, P327, DOI 10.1016/j.atherosclerosis.2010.02.020; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Tanko LB, 2005, CIRCULATION, V111, P1883, DOI 10.1161/01.CIR.0000161801.65408.8D; Wang JJ, 2007, ATHEROSCLEROSIS, V192, P161, DOI 10.1016/j.atherosclerosis.2006.04.027; Yu D, 2010, CLIN NUTR, V29, P192, DOI 10.1016/j.clnu.2009.06.008; Yu ZJ, 2012, EUR J CLIN INVEST, V42, P1100, DOI 10.1111/j.1365-2362.2012.02702.x	24	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73292	10.1371/journal.pone.0073292	http://dx.doi.org/10.1371/journal.pone.0073292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039903	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600064
J	Piotti, A; Leonardi, S; Heuertz, M; Buiteveld, J; Geburek, T; Gerber, S; Kramer, K; Vettori, C; Vendramin, GG				Piotti, Andrea; Leonardi, Stefano; Heuertz, Myriam; Buiteveld, Joukje; Geburek, Thomas; Gerber, Sophie; Kramer, Koen; Vettori, Cristina; Vendramin, Giovanni Giuseppe			Within-Population Genetic Structure in Beech (Fagus sylvatica L.) Stands Characterized by Different Disturbance Histories: Does Forest Management Simplify Population Substructure?	PLOS ONE			English	Article							EUROPEAN BEECH; POPULUS-TRICHOCARPA; NATURAL-POPULATIONS; PLANT-POPULATIONS; POLLEN DISPERSAL; ESTIMATING SEED; F-STATISTICS; NULL ALLELES; DOUGLAS-FIR; WHITE-PINE	The fine-scale assessment of both spatially and non-spatially distributed genetic variation is crucial to preserve forest genetic resources through appropriate forest management. Cryptic within-population genetic structure may be more common than previously thought in forest tree populations, which has strong implications for the potential of forests to adapt to environmental change. The present study was aimed at comparing within-population genetic structure in European beech (Fagus sylvatica L.) plots experiencing different disturbance levels. Five plot pairs made up by disturbed and undisturbed plots having the same biogeographic history were sampled throughout Europe. Overall, 1298 individuals were analyzed using four highly polymorphic nuclear microsatellite markers (SSRs). Bayesian clustering within plots identified 3 to 11 genetic clusters (within-plot theta(ST) ranged from 0.025 to 0.124). The proportion of within-population genetic variation due to genetic substructuring (F-CluPlot = 0.067) was higher than the differentiation among the 10 plots (F-PlotTot = 0.045). Focusing on the comparison between managed and unmanaged plots, disturbance mostly explains differences in the complexity of within-population genetic structure, determining a reduction of the number of genetic clusters present in a standardized area. Our results show that: i) genetic substructuring needs to be investigated when studying the within-population genetic structure in forest tree populations, and ii) indices describing subtle characteristics of the within-population genetic structure are good candidates for providing early signals of the consequences of forest management, and of disturbance events in general.	[Piotti, Andrea; Vettori, Cristina; Vendramin, Giovanni Giuseppe] CNR, Plant Genet Inst, Sesto Fiorentino, Italy; [Piotti, Andrea; Leonardi, Stefano] Univ Parma, Dipartimento Biosci, I-43100 Parma, Italy; [Heuertz, Myriam] CIFOR INIA, Dept Forest Ecol & Genet, Madrid, Spain; [Buiteveld, Joukje; Kramer, Koen] Alterra, Wageningen, Netherlands; [Geburek, Thomas] Fed Res Ctr Forests, Vienna, Austria; [Gerber, Sophie] INRA, UMR BIOGECO 1202, Cestas, France; [Gerber, Sophie] Univ Bordeaux, UMR BIOGECO 1202, Talence, France	Consiglio Nazionale delle Ricerche (CNR); University of Parma; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Wageningen University & Research; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Vendramin, GG (corresponding author), CNR, Plant Genet Inst, Sesto Fiorentino, Italy.	giovanni.vendramin@igv.cnr.it	Vettori, Cristina/L-4651-2013; Piotti, Andrea/C-1304-2009; Vendramin, Giovanni G/K-9731-2014; Leonardi, Stefano/I-9067-2014; Heuertz, Myriam/A-7831-2011	Vettori, Cristina/0000-0003-2475-773X; Piotti, Andrea/0000-0002-3324-5325; Vendramin, Giovanni G/0000-0001-9921-7872; Leonardi, Stefano/0000-0002-9133-318X; Heuertz, Myriam/0000-0002-6322-3645; buiteveld, joukje/0000-0003-1892-6760	European Commission [QLRT-1999-01210, KBBE-289119]; Italian MIUR project [RBAP10A2T4]; Dutch Ministry of Economics, Agriculture and Innovation [KB-14-002-033]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian MIUR project(Ministry of Education, Universities and Research (MIUR)); Dutch Ministry of Economics, Agriculture and Innovation	This study was financially supported by the European Commission through the Dynabeech project (5th Framework Programme, QLRT-1999-01210) and finalised based on the financial support by the European Commission through the FP7-project FORGER: Towards the Sustainable Management of Forest Genetic Resources in Europe (KBBE-289119). AP was supported by the Italian MIUR project "Approccio multitaxa allo studio delle risposte della biodiversita italiana al cambiamento climatico'' (RBAP10A2T4). KK was in addition supported with co-funding by the Dutch Ministry of Economics, Agriculture and Innovation in the project (KB-14-002-033) of the Knowledge-Base Green Space and Biodiversity. This support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WT, 1998, FOREST SCI, V44, P390; Bradshaw RHW, 2004, FOREST ECOL MANAG, V197, P203, DOI 10.1016/j.foreco.2004.05.025; Buiteveld J, 2007, FOREST ECOL MANAG, V247, P98, DOI 10.1016/j.foreco.2007.04.018; Carnus JM, 2006, J FOREST, V104, P65; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chybicki IJ, 2011, HEREDITY, V107, P589, DOI 10.1038/hdy.2011.51; Chybicki IJ, 2009, BOTANY, V87, P791, DOI 10.1139/B09-049; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; De-Lucas AI, 2009, MOL ECOL, V18, P4564, DOI 10.1111/j.1365-294X.2009.04372.x; El-Kassaby YA, 2003, THEOR APPL GENET, V107, P598, DOI 10.1007/s00122-003-1291-3; Epperson BK, 2001, AM J BOT, V88, P1006, DOI 10.2307/2657081; Finkeldey R, 2004, FOREST ECOL MANAG, V197, P231, DOI 10.1016/j.foreco.2004.05.036; FORSTREUTER M, 2004, EFFECTS SILVICULTURA, P9; Garcia-Gil MR, 2009, HEREDITY, V103, P90, DOI 10.1038/hdy.2009.33; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hampe A, 2010, MOL ECOL, V19, P459, DOI 10.1111/j.1365-294X.2009.04492.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heuertz M, 2003, MOL ECOL, V12, P2483, DOI 10.1046/j.1365-294X.2003.01923.x; Jansson S, 2010, HEREDITY, V105, P331, DOI 10.1038/hdy.2010.101; Jump AS, 2012, HEREDITY, V108, P633, DOI 10.1038/hdy.2012.1; Jump AS, 2007, MOL ECOL, V16, P925, DOI 10.1111/j.1365-294X.2006.03203.x; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Kramer K, 2008, ECOL MODEL, V216, P333, DOI 10.1016/j.ecolmodel.2008.05.004; Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023; Kunstler G, 2007, DIVERS DISTRIB, V13, P799, DOI 10.1111/j.1472-4642.2007.00404.x; Leonardi S, 1996, HEREDITY, V77, P359, DOI 10.1038/hdy.1996.154; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Marquardt PE, 2007, CAN J FOREST RES, V37, P2652, DOI 10.1139/X07-114; Marquardt PE, 2004, MOL ECOL, V13, P3305, DOI 10.1111/j.1365-294X.2004.02341.x; Milleron M, 2013, MOL ECOL, V22, P1531, DOI 10.1111/mec.12200; Neale DB, 2008, CURR OPIN PLANT BIOL, V11, P149, DOI 10.1016/j.pbi.2007.12.004; NEALE DB, 1985, FOREST SCI, V31, P995; NILSSON SG, 1985, OIKOS, V44, P157, DOI 10.2307/3544057; Oddou-Muratorio S, 2011, MOL ECOL, V20, P1997, DOI 10.1111/j.1365-294X.2011.05039.x; Oddou-Muratorio S, 2010, FOREST ECOL MANAG, V259, P2151, DOI 10.1016/j.foreco.2010.03.001; Oddou-Muratorio S, 2009, CONSERV GENET, V10, P1343, DOI 10.1007/s10592-008-9648-4; Paffetti D, 2012, FOREST ECOL MANAG, V284, P34, DOI 10.1016/j.foreco.2012.07.026; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piotti A, 2012, HEREDITY, V108, P322, DOI 10.1038/hdy.2011.77; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Robledo-Arnuncio JJ, 2004, FOREST ECOL MANAG, V197, P245, DOI 10.1016/j.foreco.2004.05.016; Sagnard F, 2011, TREE GENET GENOMES, V7, P37, DOI 10.1007/s11295-010-0313-y; Sebro R, 2012, HEREDITY, V108, P563, DOI 10.1038/hdy.2011.124; Slavov GT, 2010, HEREDITY, V105, P348, DOI 10.1038/hdy.2010.73; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	53	26	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73391	10.1371/journal.pone.0073391	http://dx.doi.org/10.1371/journal.pone.0073391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039930	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600070
J	Savari, S; Liu, MH; Zhang, Y; Sime, W; Sjolander, A				Savari, Sayeh; Liu, Minghui; Zhang, Yuan; Sime, Wondossen; Sjolander, Anita			CysLT(1)R Antagonists Inhibit Tumor Growth in a Xenograft Model of Colon Cancer	PLOS ONE			English	Article							CYSTEINYL LEUKOTRIENE-1 RECEPTOR; IN-VIVO; VASCULAR-PERMEABILITY; CELL-GROWTH; SURVIVAL; EXPRESSION; PROLIFERATION; PHARMACOLOGY; EICOSANOIDS; PREVENTION	The expression of the inflammatory G-protein coupled receptor CysLT(1)R has been shown to be upregulated in colon cancer patients and associated with poor prognosis. The present study investigated the correlation between CysLT(1)R and colon cancer development in vivo using CysLT(1)R antagonists (ZM198,615 or Montelukast) and the nude mouse xenograft model. Two drug administration regimens were established. The first regimen was established to investigate the importance of CysLT(1)R in tumor initiation. Nude mice were inoculated with 50 mu M CysLT(1)R antagonist-pretreated HCT-116 colon cancer cells and received continued treatment (5 mg/kg/day, intraperitoneally). The second regimen aimed to address the role of CysLT(1)R in tumor progression. Nude mice were inoculated with non-pretreated HCT-116 cells and did not receive CysLT(1)R antagonist treatment until recordable tumor appearance. Both regimens resulted in significantly reduced tumor size, attributed to changes in proliferation and apoptosis as determined by reduced Ki-67 levels and increased levels of p21(WAF/Cip1) (P<0.01), cleaved caspase 3, and the caspase-cleaved product of cytokeratin 18. Decreased levels of VEGF (P<0.01) and reduced vessel size (P<0.05) were also observed, the latter only in the ZM198,615-pretreatment group. Furthermore, we performed a series of in vitro studies using the colon cancer cell line HCT-116 and CysLT(1)R antagonists. In addition to significant reductions in cell proliferation, adhesion and colony formation, we observed induction of cell cycle arrest and apoptosis in a dose-dependent manner. The ability of Montelukast to inhibit growth of human colon cancer xenograft was further validated by using two additional colon cancer cell lines, SW-480 and HT-29. Our results demonstrate that CysLT(1)R antagonists inhibit growth of colon cancer xenografts primarily by reducing proliferation and inducing apoptosis of the tumor cells.	[Savari, Sayeh; Liu, Minghui; Zhang, Yuan; Sime, Wondossen; Sjolander, Anita] Lund Univ, Dept Lab Med, Skane Univ Hosp, Div Cell & Expt Pathol, Malmo, Sweden	Lund University; Skane University Hospital	Sjolander, A (corresponding author), Lund Univ, Dept Lab Med, Skane Univ Hosp, Div Cell & Expt Pathol, Malmo, Sweden.	Anita.Sjolander@med.lu.se		Zhang, Yuan/0000-0001-9747-1391	Swedish Cancer Foundation [CAN 2009/1185, 10 0478]; Swedish Medical Research Council [X-10356]; Gunnar Nilsson Cancer Foundation; Osterlund Foundation; Foundation at Skane University Hospital; WS the Royal Physiographic Society in Lund	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Gunnar Nilsson Cancer Foundation; Osterlund Foundation; Foundation at Skane University Hospital; WS the Royal Physiographic Society in Lund	The work was supported by grants for AS from the Swedish Cancer Foundation (CAN 2009/1185, 10 0478), the Swedish Medical Research Council (X-10356), Gunnar Nilsson Cancer Foundation (www.cancerstiftelsen.com), the Osterlund Foundation, the Foundation at Skane University Hospital, and for WS the Royal Physiographic Society in Lund (www.fysiografen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONY D, 1988, ANN NY ACAD SCI, V524, P162, DOI 10.1111/j.1749-6632.1988.tb38539.x; Arjona AA, 2006, CANC DRUG DISC DEV, P151, DOI 10.1007/978-1-59745-035-5_8; BARNES NC, 1984, THORAX, V39, P500, DOI 10.1136/thx.39.7.500; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bonville CA, 2006, ANTIVIR RES, V69, P53, DOI 10.1016/j.antiviral.2005.10.004; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Cathcart MC, 2011, CANCER METAST REV, V30, P363, DOI 10.1007/s10555-011-9324-x; CHAN CC, 1990, EUR J PHARMACOL, V191, P273; Cianchi F, 2006, MOL CANCER THER, V5, P2716, DOI 10.1158/1535-7163.MCT-06-0318; DRAZEN JM, 1980, P NATL ACAD SCI-BIOL, V77, P4354, DOI 10.1073/pnas.77.7.4354; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fabre JE, 2002, J CLIN INVEST, V109, P1373, DOI 10.1172/JCI200214869; FAULER J, 1994, ARTHRITIS RHEUM-US, V37, P93, DOI 10.1002/art.1780370114; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Ferlay J, 2010, INT J CANC; Genovese T, 2008, BRIT J PHARMACOL, V153, P568, DOI 10.1038/sj.bjp.0707577; Guay D, 1998, BIOORG MED CHEM LETT, V8, P453, DOI 10.1016/S0960-894X(98)00051-1; Hammerbeck DM, 1996, INFLAMMATION, V20, P413, DOI 10.1007/BF01486743; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; KRELL RD, 1987, J PHARMACOL EXP THER, V243, P557; Lee KS, 2004, J ALLERGY CLIN IMMUN, V114, P1093, DOI 10.1016/j.jaci.2004.07.039; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2002, J BIOL CHEM, V277, P20820, DOI 10.1074/jbc.M203163200; Magnusson C, 2007, CANCER RES, V67, P9190, DOI 10.1158/0008-5472.CAN-07-0771; Magnusson C, 2011, INT J CANCER, V129, P9, DOI 10.1002/ijc.25648; Magnusson C, 2010, EUR J CANCER, V46, P826, DOI 10.1016/j.ejca.2009.12.022; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; Matsuyama M, 2007, ONCOL REP, V18, P99; Matsuyama M, 2010, MOL MED REP, V3, P245, DOI 10.3892/mmr_00000247; Matsuyama M, 2009, UROLOGY, V73, P916, DOI 10.1016/j.urology.2008.11.005; Nicosia S, 2001, PULM PHARMACOL THER, V14, P3, DOI 10.1006/pupt.2000.0262; Nobili E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041786; Nozaki Masako, 2010, Keio Journal of Medicine, V59, P10; Ohd JF, 2000, GASTROENTEROLOGY, V119, P1007, DOI 10.1053/gast.2000.18141; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Parhamifar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014439; Paruchuri S, 2006, ONCOGENE, V25, P6660, DOI 10.1038/sj.onc.1209666; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Shiota N, 2006, EUR J PHARMACOL, V548, P158, DOI 10.1016/j.ejphar.2006.07.046; STENSON WF, 1990, SCAND J GASTROENTERO, V25, P13, DOI 10.3109/00365529009091903; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Sveinbjornsson B, 2008, FASEB J, V22, P3525, DOI 10.1096/fj.07-103457; Truong H, 2009, CELL ADHES MIGR, V3, P179, DOI 10.4161/cam.3.2.8036; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Ye YN, 2005, CARCINOGENESIS, V26, P827, DOI 10.1093/carcin/bgi012; Yuan YM, 2009, J PHARMACOL SCI, V109, P285, DOI 10.1254/jphs.08321FP; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	51	49	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73466	10.1371/journal.pone.0073466	http://dx.doi.org/10.1371/journal.pone.0073466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039952	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600079
J	Mandelbaum, M; Kolega, J; Dolan, JM; Siddiqui, AH; Meng, H				Mandelbaum, Max; Kolega, John; Dolan, Jennifer M.; Siddiqui, Adnan H.; Meng, Hui			A Critical Role for Proinflammatory Behavior of Smooth Muscle Cells in Hemodynamic Initiation of Intracranial Aneurysm	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ABDOMINAL AORTIC-ANEURYSMS; CEREBRAL ANEURYSMS; BASILAR TERMINUS; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; ARTERIAL INJURY; RABBIT MODEL; KAPPA-B; ATHEROSCLEROSIS	Background: Intracranial aneurysm initiation is poorly understood, although hemodynamic insult is believed to play an important role in triggering the pathology. It has recently been found in a rabbit model that while macrophages are absent during hemodynamic aneurysm initiation, matrix metalloproteinases (MMPs) are elevated and co-localize with smooth muscle cells (SMCs). This study investigates whether SMCs play a mechanistic role in aneurysm initiation triggered by hemodynamics. Methods: Aneurysmal damage was induced at the basilar terminus via bilateral common carotid artery ligation in rabbits (n = 45, plus 7 sham controls). 16 ligated rabbits were treated with doxycycline to inhibit MMPs, 7 received clodronate liposomes to deplete circulating monocytes, and the rest received no drug. Effects of the treatments on aneurysm development were assessed histologically 5 days and 6 months after ligation. MMP production and expression of inflammatory markers by SMCs was monitored by immunohistochemistry and in situ hybridization. Results: Treatment with doxycycline attenuated aneurysmal development examined at 5 days and 6 months, suggesting that MMPs contribute to aneurysm initiation. However, systemic depletion of macrophages did not decrease MMPs or suppress aneurysmal development. Immunofluorescence showed that during aneurysm initiation MMP-2 and MMP-9 were distributed in SMCs, and in situ hybridization indicated that they were transcribed by SMCs. In regions of early aneurysmal lesion, SMCs exhibited decreased expression of smooth muscle actin and increased NF-kappa B and MCP-1 expressions. Conclusions: During aneurysm initiation triggered by hemodynamics, SMCs rather than macrophages are responsible for MMP production that is critical for aneurysmal lesion development. These SMCs exhibit proinflammatory behavior.	[Mandelbaum, Max; Meng, Hui] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Dolan, Jennifer M.; Siddiqui, Adnan H.; Meng, Hui] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Siddiqui, Adnan H.] SUNY Buffalo, Dept Radiol, Buffalo, NY 14260 USA; [Meng, Hui] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Mandelbaum, Max; Kolega, John; Dolan, Jennifer M.; Siddiqui, Adnan H.; Meng, Hui] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Meng, H (corresponding author), SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA.	huimeng@buffalo.edu	Meng, Hui/F-7929-2010; Siddiqui, Adnan H./AAG-9781-2019; Kolega, John/J-8386-2016	Kolega, John/0000-0001-6933-8681	NIH [R01NS064592]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported in part by NIH grant R01NS064592. Dr. Meng is the principal investigator and Drs. Kolega and Siddiqui are coinvestigators on this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535921; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2; BOCKER R, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2116; Bourcier T, 1997, J BIOL CHEM, V272, P15817, DOI 10.1074/jbc.272.25.15817; BROWN RD, 1990, J NEUROSURG, V73, P859, DOI 10.3171/jns.1990.73.6.0859; Buus CL, 2001, CIRC RES, V89, P180, DOI 10.1161/hh1401.093575; Castro MM, 2011, PHARMACOL RES, V64, P567, DOI 10.1016/j.phrs.2011.04.002; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; CUNHA BA, 1982, THER DRUG MONIT, V4, P115, DOI 10.1097/00007691-198206000-00001; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gao L, 2008, STROKE, V39, P2085, DOI 10.1161/STROKEAHA.107.509422; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; HANSSON GK, 1989, J EXP MED, V170, P1595, DOI 10.1084/jem.170.5.1595; HASHIMOTO N, 1978, SURG NEUROL, V10, P3; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; HASSLER O, 1963, J NEUROSURG, V20, P1, DOI 10.3171/jns.1963.20.1.0001; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Hoi YM, 2008, J NEUROSURG, V109, P1141, DOI 10.3171/JNS.2008.109.12.1141; Honda HM, 2001, ATHEROSCLEROSIS, V158, P385, DOI 10.1016/S0021-9150(01)00462-2; Humphrey JD, 2008, ANNU REV BIOMED ENG, V10, P221, DOI 10.1146/annurev.bioeng.10.061807.160439; Ishibashi Akira, 1993, Kurume Medical Journal, V40, P21; Ishikawa T, 1997, NEUROSURGERY, V40, P403, DOI 10.1097/00006123-199702000-00038; Jamous MA, 2007, J NEUROSURG, V107, P405, DOI 10.3171/JNS-07/08/0405; Kadasi LM, 2013, J NEUROINTERV SURG, V5, P201, DOI 10.1136/neurintsurg-2012-010285; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840; LOVEJOY B, 1994, ANN NY ACAD SCI, V732, P375, DOI 10.1111/j.1749-6632.1994.tb24758.x; Meng H, 2010, J NEUROSURG; Meng H, 2012, INT REV THROMBOSIS, V7; Meng H, 2007, STROKE, V38, P1924, DOI 10.1161/STROKEAHA.106.481234; Meng H, 2011, J NEUROSURG, V114, P1095, DOI 10.3171/2010.9.JNS10368; Metaxa E, 2010, STROKE, V41, P1774, DOI 10.1161/STROKEAHA.110.585992; Nakajima N, 2000, ACTA NEUROPATHOL, V100, P475, DOI 10.1007/s004010000220; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; RAINES EW, 1993, BRIT HEART J, V69, pS30; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheth RA, 2010, ATHEROSCLEROSIS, V212, P181, DOI 10.1016/j.atherosclerosis.2010.05.012; SORSA T, 1994, ANN NY ACAD SCI, V732, P112, DOI 10.1111/j.1749-6632.1994.tb24729.x; STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823; TAKEYA M, 1993, HUM PATHOL, V24, P534, DOI 10.1016/0046-8177(93)90166-E; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83	53	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74357	10.1371/journal.pone.0074357	http://dx.doi.org/10.1371/journal.pone.0074357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023941	Green Published, gold, Green Submitted			2022-12-25	WOS:000324238400097
J	Epple, LM; Dodd, RD; Merz, AL; Dechkovskaia, AM; Herring, M; Winston, BA; Lencioni, AM; Russell, RL; Madsen, H; Nega, M; Dusto, NL; White, J; Bigner, DD; Nicchitta, CV; Serkova, NJ; Graner, MW				Epple, Laura M.; Dodd, Rebecca D.; Merz, Andrea L.; Dechkovskaia, Anjelika M.; Herring, Matthew; Winston, Benjamin A.; Lencioni, Alex M.; Russell, Rae L.; Madsen, Helen; Nega, Meheret; Dusto, Nathaniel L.; White, Jason; Bigner, Darell D.; Nicchitta, Christopher V.; Serkova, Natalie J.; Graner, Michael W.			Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GROWTH-FACTOR RECEPTOR; EPITHELIUM-DERIVED FACTOR; HUMAN GLIOBLASTOMA CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; BRAIN-TUMORS; TGF-BETA; THIOREDOXIN REDUCTASE; SIGNALING PATHWAY	The unfolded protein response (UPR) is an endoplasmic reticulum (ER)-based cytoprotective mechanism acting to prevent pathologies accompanying protein aggregation. It is frequently active in tumors, but relatively unstudied in gliomas. We hypothesized that UPR stress effects on glioma cells might protect tumors from additional exogenous stress (ie, chemotherapeutics), postulating that protection was concurrent with altered tumor cell metabolism. Using human brain tumor cell lines, xenograft tumors, human samples and gene expression databases, we determined molecular features of glioma cell UPR induction/activation, and here report a detailed analysis of UPR transcriptional/translational/metabolic responses. Immunohistochemistry, Western and Northern blots identified elevated levels of UPR transcription factors and downstream ER chaperone targets in gliomas. Microarray profiling revealed distinct regulation of stress responses between xenograft tumors and parent cell lines, with gene ontology and network analyses linking gene expression to cell survival and metabolic processes. Human glioma samples were examined for levels of the ER chaperone GRP94 by immunohistochemistry and for other UPR components by Western blotting. Gene and protein expression data from patient gliomas correlated poor patient prognoses with increased expression of ER chaperones, UPR target genes, and metabolic enzymes (glycolysis and lipogenesis). NMR-based metabolomic studies revealed increased metabolic outputs in glucose uptake with elevated glycolytic activity as well as increased phospholipid turnover. Elevated levels of amino acids, antioxidants, and cholesterol were also evident upon UPR stress; in particular, recurrent tumors had overall higher lipid outputs and elevated specific UPR arms. Clonogenicity studies following temozolomide treatment of stressed or unstressed cells demonstrated UPR-induced chemoresistance. Our data characterize the UPR in glioma cells and human tumors, and link the UPR to chemoresistance possibly via enhanced metabolism. Given the role of the UPR in the balance between cell survival and apoptosis, targeting the UPR and/or controlling metabolic activity may prove beneficial for malignant glioma therapeutics.	[Epple, Laura M.; Herring, Matthew; Winston, Benjamin A.; Lencioni, Alex M.; Russell, Rae L.; Madsen, Helen; Nega, Meheret; Dusto, Nathaniel L.; White, Jason] Univ Colorado Denver, Anschutz Med Ctr, Dept Neurosurg, Aurora, CO USA; [Epple, Laura M.; Graner, Michael W.] Colorado State Univ, Coll Vet Med & Biomed Sci, Cell & Mol Biol Program, Ft Collins, CO 80523 USA; [Dodd, Rebecca D.] Duke Univ, Med Ctr, Div Radiat Oncol, Durham, NC 27710 USA; [Merz, Andrea L.; Serkova, Natalie J.] Univ Colorado Denver, Anschutz Med Ctr, Canc Ctr Metab Core, Aurora, CO USA; [Dechkovskaia, Anjelika M.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA; [Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Serkova, Natalie J.] Univ Colorado Denver, Dept Anesthesiol, Anschutz Med Ctr, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University; Duke University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Graner, MW (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.	michael.graner@ucdenver.edu		Dodd, Rebecca/0000-0001-7295-1882	Duke University Brain Cancer SPORE Career Development Award; University of Colorado Cancer Center, Cancer League of Colorado; Anschutz Medical Campus Cancer Grant; Skippy Frank Fund Scholar for Translational Research; LABCOATS (Links to Advancement in Biomedical Science Career Opportunity and Training Section) Program at UC Denver (NIH/ NIGMS) [R25GM083333]; University of Colorado Cancer Center [P30 CA046934]; Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083333] Funding Source: NIH RePORTER	Duke University Brain Cancer SPORE Career Development Award; University of Colorado Cancer Center, Cancer League of Colorado; Anschutz Medical Campus Cancer Grant; Skippy Frank Fund Scholar for Translational Research; LABCOATS (Links to Advancement in Biomedical Science Career Opportunity and Training Section) Program at UC Denver (NIH/ NIGMS); University of Colorado Cancer Center; Colorado Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by grants to MWG (Duke University Brain Cancer SPORE Career Development Award; University of Colorado Cancer Center, Cancer League of Colorado), to MWG and NJS (Anschutz Medical Campus Cancer Grant), to CVN (Duke University Brain Cancer SPORE Career Development Award) and to LME (Skippy Frank Fund Scholar for Translational Research). MN was supported by the LABCOATS (Links to Advancement in Biomedical Science Career Opportunity and Training Section) Program at UC Denver (NIH/ NIGMS #R25GM083333). NMR Metabolomics Shared Resources Core facility is supported by the University of Colorado Cancer Center grant (P30 CA046934) and Colorado Clinical and Translational Sciences Institute grant (UL1 RR025780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2001, CANCER RES, V61, P3599; Al-Rawashdeh FY, 2010, EUR J GASTROEN HEPAT, V22, P1099, DOI 10.1097/MEG.0b013e3283378405; ALVORD EC, 1995, AM J NEURORADIOL, V16, P1013; Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brewer J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/738471; Carcaboso AM, 2010, CANCER RES, V70, P4499, DOI 10.1158/0008-5472.CAN-09-4264; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; Chen VY, 2006, PHARM RES, V23, P1687, DOI 10.1007/s11095-006-9043-0; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Cobbs CS, 2002, CANCER RES, V62, P3347; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Cullman SB, 2006, SEMIN ONCOL, V33, P457, DOI 10.1053/j.seminoncol.2006.04.001; DAVIS LW, 1989, INT J RADIAT ONCOL, V16, P1355, DOI 10.1016/0360-3016(89)90936-X; Ding Q, 2009, ENDOCRINOLOGY, V150, P1688, DOI 10.1210/en.2008-0952; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; FAMULLA S, INT J OBES LOND; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; FRIEDMAN HS, 1988, CANCER RES, V48, P4189; FRIEDMAN HS, 1994, CANCER CHEMOTH PHARM, V34, P171; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Fukushima T, 2007, J BIOL CHEM, V282, P18634, DOI 10.1074/jbc.M609567200; Furman C, 2004, FREE RADICAL BIO MED, V37, P71, DOI 10.1016/j.freeradbiomed.2004.04.016; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gilbert MR, 2011, SEMIN ONCOL, V38, pS21, DOI 10.1053/j.seminoncol.2011.09.008; Goldbrunner RH, 1998, MICROSC RES TECHNIQ, V43, P250, DOI 10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Graner MW, 2009, CANCER SCI, V100, P1870, DOI 10.1111/j.1349-7006.2009.01269.x; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Hegi ME, 2012, CURR OPIN NEUROL, V25, P774, DOI 10.1097/WCO.0b013e328359b0bc; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iemata M, 2007, J CELL PHYSIOL, V213, P721, DOI 10.1002/jcp.21145; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Ji C, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/216450; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Johnson GG, 2011, CURR PHARM DESIGN, V17, P284; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Kokkinakis DM, 2004, CANCER RES, V64, P7513, DOI 10.1158/0008-5472.CAN-04-0592; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Learn CA, 2007, J NEUROIMMUNOL, V182, P63, DOI 10.1016/j.jneuroim.2006.09.016; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee Geung-Joo, 2007, V2, P1; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Lefranc Florence, 2006, Neurosurg Focus, V20, pE7, DOI 10.3171/foc.2006.20.4.4; Lefranc Florence, 2011, World J Biol Chem, V2, P193, DOI 10.4331/wjbc.v2.i9.193; Lehnhardt FG, 2001, NMR BIOMED, V14, P307, DOI 10.1002/nbm.708; Levati L, 2011, INT J ONCOL, V38, P241, DOI 10.3892/ijo_00000844; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Lowe CE, 2012, INT J OBESITY, V36, P1248, DOI 10.1038/ijo.2011.233; Lu C, 2008, MOL CELL BIOCHEM, V312, P71, DOI 10.1007/s11010-008-9722-8; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Lu ZM, 2009, CANCER RES, V69, P9105, DOI 10.1158/0008-5472.CAN-09-2775; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mao XR, 2010, MOL CELL BIOL, V30, P5033, DOI 10.1128/MCB.00922-10; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Maziere C, 2002, BIOCHEM BIOPH RES CO, V293, P1327, DOI 10.1016/S0006-291X(02)00389-3; McArdle J, 2011, J VIROL, V85, P705, DOI 10.1128/JVI.01557-10; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Miyaguchi K, 2004, HISTOCHEM CELL BIOL, V121, P371, DOI 10.1007/s00418-004-0623-y; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; MU YG, 2006, ZHENG AI, V25, P326; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Nagane M, 1996, CANCER RES, V56, P5079; Nakamura Y, 2013, BBA-MOL BASIS DIS, V1832, P1117, DOI 10.1016/j.bbadis.2013.03.010; Nguyen P, 2006, CANCER LETT, V236, P164, DOI 10.1016/j.canlet.2005.04.028; Ning J, 2011, ENDOCRINOLOGY, V152, P2247, DOI 10.1210/en.2010-1036; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ogunrinu TA, 2010, J BIOL CHEM, V285, P37716, DOI 10.1074/jbc.M110.161190; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Potter MD, 2002, J BIOL CHEM, V277, P23314, DOI 10.1074/jbc.M202559200; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Ray SK, 2002, J NEUROSCI RES, V69, P197, DOI 10.1002/jnr.10265; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roller C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00010; Rouschop KM, 2013, P NATL ACAD SCI USA, V110, P4622, DOI 10.1073/pnas.1210633110; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sasaki T, 2004, ONCOL REP, V11, P1219; Sato A, 2011, STEM CELLS, V29, P1942, DOI 10.1002/stem.753; Savaskan NE, 2010, ANN ANAT, V192, P309, DOI 10.1016/j.aanat.2010.07.003; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Shang YY, 2009, FEBS J, V276, P2752, DOI 10.1111/j.1742-4658.2009.06998.x; Sheikh-Ali M, 2010, NUTRITION, V26, P1146, DOI 10.1016/j.nut.2009.08.019; Shinjo S, 2013, BIOSCI BIOTECH BIOCH, V77, P729, DOI 10.1271/bbb.120812; Smart DDK, 2004, CANCER RES, V64, P6716, DOI 10.1158/0008-5472.CAN-03-3990; SONG T, 2013, BIOMED PHARMACOTHER, P2052; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; Trog D, 2005, AMINO ACIDS, V28, P213, DOI 10.1007/s00726-005-0171-3; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; Utriainen M, 2003, J NEURO-ONCOL, V62, P329, DOI 10.1023/A:1023342516925; Venkatesan PV, 1998, ANTI-CANCER DRUG, V9, P449, DOI 10.1097/00001813-199806000-00012; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Wikstrand CJ, 1998, J NEUROVIROL, V4, P148, DOI 10.3109/13550289809114515; Wikstrand CJ, 1997, CANCER RES, V57, P4130; Wilson M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-6; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; YokoyamaKobayashi M, 1997, J BIOCHEM-TOKYO, V122, P622; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915; Zhang X, 1999, BIOCHEM BIOPH RES CO, V255, P59, DOI 10.1006/bbrc.1999.0148; Zheng Z, 2010, WORLD J HEPATOL, V2, P203, DOI 10.4254/wjh.v2.i6.203; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674; Zwingmann C, 2003, NMR BIOMED, V16, P370, DOI 10.1002/nbm.850	152	49	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e73267	10.1371/journal.pone.0073267	http://dx.doi.org/10.1371/journal.pone.0073267			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24039668	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000118
J	Wilson, SL; Guilbert, M; Sule-Suso, J; Torbet, J; Jeannesson, P; Sockalingum, GD; Yang, Y				Wilson, Samantha L.; Guilbert, Marie; Sule-Suso, Josep; Torbet, Jim; Jeannesson, Pierre; Sockalingum, Ganesh D.; Yang, Ying			A microscopic and macroscopic study of aging collagen on its molecular structure, mechanical properties, and cellular response	FASEB JOURNAL			English	Article						AGEs; fibrillogenesis; fiber alignment; contraction; elastic modulus	GLYCATION END-PRODUCTS; HUMAN-SKIN FIBROBLASTS; AGE-RELATED-CHANGES; I COLLAGEN; DIAMAGNETIC ANISOTROPY; INDENTATION TECHNIQUE; HYDROGELS; MODEL; DIFFERENTIATION; CARBAMYLATION	During aging, collagen structure changes, detrimentally affecting tissues' biophysical and biomechanical properties due to an accumulation of advanced glycation end-products (AGEs). In this investigation, we conducted a parallel study of microscopic and macroscopic properties of different-aged collagens from newborn to 2-yr-old rats, to examine the effect of aging on fibrillogenesis, mechanical and contractile properties of reconstituted hydrogels from these collagens seeded with or without fibroblasts. In addition to fibrillogenesis of collagen under the conventional conditions, some fibrillogenesis was conducted alongside a 12-T magnetic field, and gelation rate and AGE content were measured. A nondestructive indentation technique and optical coherence tomography were used to determine the elastic modulus and dimensional changes, respectively. It was revealed that in comparison to younger specimens, older collagens exhibited higher viscosity, faster gelation rates, and a higher AGE-specific fluorescence. Exceptionally, only young collagens formed highly aligned fibrils under magnetic fields. The youngest collagen demonstrated a higher elastic modulus and contraction in comparison to the older collagen. We conclude that aging changes collagen monomer structure, which considerably affects the fibrillogenesis process, the architecture of the resulting collagen fibers and the global network, and the macroscopic properties of the formed constructs.Wilson, S. L., Guilbert, M., Sule-Suso, J., Torbet, J., Jeannesson, P., Sockalingum, G. D., Yang, Y. A microscopic and macroscopic study of aging collagen on its molecular structure, mechanical properties, and cellular response.	[Wilson, Samantha L.; Sule-Suso, Josep; Yang, Ying] Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England; [Guilbert, Marie; Jeannesson, Pierre; Sockalingum, Ganesh D.] Univ Reims, Unite Matrice Extracellulaire & Dynam Cellulaire, Equipe Med Dynam Intracellulaire & Architecture N, Unite Format & Rech UFR Pharm,CNRS, Reims, France; [Sule-Suso, Josep] Univ Hosp North Staffordshire, Ctr Canc, Stoke On Trent, Staffs, England; [Torbet, Jim] CNRS, Consortium Rech Emergence Technol Avancees CRETA, Grenoble, France	Keele University; Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS)	Yang, Y (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.	y.yang@keele.ac.uk		Yang, Ying/0000-0002-1362-6040	Engineering and Physical Sciences Research Council (EPSRC; Swindon, UK) [EP/F/500491/1]; Alliance bilateral program (Egide and British Council); exchange program in EuroMagNET II (Grenoble, France); Region Champagne-Ardenne, France; Engineering and Physical Sciences Research Council [EP/I017801/1] Funding Source: researchfish; EPSRC [EP/I017801/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC; Swindon, UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alliance bilateral program (Egide and British Council); exchange program in EuroMagNET II (Grenoble, France); Region Champagne-Ardenne, France(Region Grand-Est); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The corneal specimens from Birmingham and Midland Eye Centre (UK) are highly appreciated. Funding from the Engineering and Physical Sciences Research Council (EPSRC; Swindon, UK) Doctoral Training Centre (DTC) in Regenerative Medicine (grant EP/F/500491/1), Alliance bilateral program (Egide and British Council) and the exchange program in EuroMagNET II (Grenoble, France) are gratefully acknowledged. M. G. is a recipient of a fellowship from the Region Champagne-Ardenne, France. The authors thank the Consortium de Recherche pour l'Emergence de Technologies Avancees (CRETA)/Centre National de la Recherche Scientifique (CNRS) laboratory (Grenoble, France) for the use of their magnet and for technical help. Special thanks to Mr. S. J. Wilson and associates at KMF Precision Sheet Metal Ltd. (Newcastle, UK) for the kind donation of the specimen clamping apparatus.	Ahearne M, 2008, BRIT J OPHTHALMOL, V92, P268, DOI 10.1136/bjo.2007.130104; Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9; Ahearne M, 2010, TISSUE ENG PART C-ME, V16, P319, DOI 10.1089/ten.TEC.2008.0650; Ahearne M, 2010, EXP EYE RES, V91, P584, DOI 10.1016/j.exer.2010.07.013; Bailey A. J., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P529; Bailey AJ, 1999, P INDIAN AS-CHEM SCI, V111, P57; Bartling B, 2009, FASEB J, V23, P1510, DOI 10.1096/fj.08-122648; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BELLMUNT MJ, 1995, BBA-MOL BASIS DIS, V1272, P53, DOI 10.1016/0925-4439(95)00069-G; Brown RA, 2006, BIOTECHNOL INTELL UN, P7; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Damodarasamy M, 2010, J GERONTOL A-BIOL, V65, P209, DOI 10.1093/gerona/glp202; DANIELSEN CC, 1987, MECH AGEING DEV, V40, P9, DOI 10.1016/0047-6374(87)90030-3; Garnotel R, 2000, J IMMUNOL, V164, P5928, DOI 10.4049/jimmunol.164.11.5928; GUIDRY C, 1985, J CELL SCI, V79, P67; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; HAAR JL, 1971, ANAT REC, V170, P199, DOI 10.1002/ar.1091700206; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Isobe Y, 2012, MATERIALS, V5, P501, DOI 10.3390/ma5030501; Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005; Jiang ST, 2000, KIDNEY INT, V57, P1539, DOI 10.1046/j.1523-1755.2000.00998.x; Kollias N, 1998, J INVEST DERMATOL, V111, P776, DOI 10.1046/j.1523-1747.1998.00377.x; Lingelbach LB, 2000, J NUTR, V130, P1247, DOI 10.1093/jn/130.5.1247; Liu KK, 2001, J PHYS D APPL PHYS, V34, pL91, DOI 10.1088/0022-3727/34/15/102; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; Mikulikova K, 2008, PHYSIOL RES, V57, P89, DOI 10.33549/physiolres.931093; Mikulikova K, 2007, J CHROMATOGR A, V1155, P125, DOI 10.1016/j.chroma.2007.01.020; Miyahara T., 1982, J GERONTOL, V37; Mocan E., 2011, CURIERUL MED, V2, P3; Newman S, 1997, BIOPOLYMERS, V41, P337, DOI 10.1002/(SICI)1097-0282(199703)41:3<337::AID-BIP9>3.0.CO;2-T; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; PAULING L, 1979, P NATL ACAD SCI USA, V76, P2293, DOI 10.1073/pnas.76.5.2293; Pia de la Maza M., 2012, J DIABETES MELLIT, V02, P221, DOI DOI 10.4236/JDM.2012.22035; REISER KM, 1991, P SOC EXP BIOL MED, V196, P17; RUBIN AL, 1963, SCIENCE, V139, P37, DOI 10.1126/science.139.3549.37; Said G, 2012, INT J ONCOL, V40, P1797, DOI 10.3892/ijo.2012.1393; Schulze C, 2012, CLIN PLAST SURG, V39, P9, DOI 10.1016/j.cps.2011.09.008; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; SILVER FH, 1980, J BIOL CHEM, V255, P9427; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; STEVEN FS, 1967, BIOCHEM J, V104, P534, DOI 10.1042/bj1040534; Torbet J., 1984, BIOCH J, V219; Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024; Trappe S, 2003, J PHYSIOL-LONDON, V552, P47, DOI 10.1113/jphysiol.2003.044966; Willems NMBK, 2010, CALCIFIED TISSUE INT, V86, P307, DOI 10.1007/s00223-010-9339-2; Wilson SL, 2012, ADV FUNCT MATER, V22, P3641, DOI 10.1002/adfm.201200655; WORCESTER DL, 1978, P NATL ACAD SCI USA, V75, P5475, DOI 10.1073/pnas.75.11.5475; Yang Y, 2007, J R SOC INTERFACE, V4, P1169, DOI 10.1098/rsif.2007.1044	49	22	22	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					14	25		10.1096/fj.13-227579	http://dx.doi.org/10.1096/fj.13-227579			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24025727	Green Published			2022-12-25	WOS:000333526100004
J	Fan, J; Kamphorst, JJ; Rabinowitz, JD; Shlomi, T				Fan, Jing; Kamphorst, Jurre J.; Rabinowitz, Joshua D.; Shlomi, Tomer			Fatty Acid Labeling from Glutamine in Hypoxia Can Be Explained by Isotope Exchange without Net Reductive Isocitrate Dehydrogenase (IDH) Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KREBS CYCLE; METABOLOMIC ANALYSIS; CELLS; CONVERSION; GROWTH; GLUCONEOGENESIS; CARBOXYLATION; CARBOHYDRATE; LIPOGENESIS; EXPRESSION	Acetyl-CoA is an important anabolic precursor for lipid biosynthesis. In the conventional view of mammalian metabolism, acetyl-CoA is primarily derived by the oxidation of glucose-derived pyruvate in mitochondria. Recent studies have employed isotope tracers to show that in cancer cells grown in hypoxia or with defective mitochondria, a major fraction of acetyl-CoA is produced via another route, reductive carboxylation of glutamine- derived alpha-ketoglutarate (catalyzed by reverse flux through isocitrate dehydrogenase, IDH). Here, we employ a quantitative flux model to show that in hypoxia and in cells with defective mitochondria, oxidative IDH flux persists and may exceed the reductive flux. Therefore, IDH flux may not be a net contributor to acetyl-CoA production, although we cannot rule out net reductive IDH flux in some compartments. Instead of producing large amounts of net acetyl-CoA reductively, the cells adapt by reducing their demand for acetyl-CoA by importing rather than synthesizing fatty acids. Thus, fatty acid labeling from glutamine in hypoxia can be explained by spreading of label without net reductive IDH flux.	[Fan, Jing; Kamphorst, Jurre J.; Rabinowitz, Joshua D.; Shlomi, Tomer] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem & Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Technion Israel Institute of Technology	Shlomi, T (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	tomersh@cs.technion.ac.il	Rabinowitz, Joshua/GPP-4019-2022; damiani, chiara/R-4256-2016	Rabinowitz, Joshua/0000-0002-1247-4727; Kamphorst, Jurre/0000-0002-2042-5474; Fan, Jing/0000-0002-5326-5358	NATIONAL CANCER INSTITUTE [R01CA163591] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA163591] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILEY JW, 1990, AM J PHYSIOL, V258, pE850, DOI 10.1152/ajpendo.1990.258.5.E850; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOSUGI K, 1986, J BIOL CHEM, V261, P3179; Krebs H A, 1972, Essays Biochem, V8, P1; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; LANDAU BR, 1992, METABOLISM, V41, P457, DOI 10.1016/0026-0495(92)90199-K; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; SCHUMANN WC, 1991, J BIOL CHEM, V266, P6985; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; SPENCER A, 1964, BIOCHEM J, V93, P378, DOI 10.1042/bj0930378; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; WEINMAN EO, 1957, PHYSIOL REV, V37, P252, DOI 10.1152/physrev.1957.37.2.252; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	31	51	51	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31363	31369		10.1074/jbc.M113.502740	http://dx.doi.org/10.1074/jbc.M113.502740			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030823	Green Published, hybrid			2022-12-25	WOS:000330778900053
J	Baty, F; Rothschild, S; Fruh, M; Betticher, D; Droge, C; Cathomas, R; Rauch, D; Gautschi, O; Bubendorf, L; Crowe, S; Zappa, F; Pless, M; Brutsche, M				Baty, Florent; Rothschild, Sacha; Frueh, Martin; Betticher, Daniel; Droege, Cornelia; Cathomas, Richard; Rauch, Daniel; Gautschi, Oliver; Bubendorf, Lukas; Crowe, Susanne; Zappa, Francesco; Pless, Miklos; Brutsche, Martin		Swiss Grp Clinical Canc Res	EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-II TRIAL; CISPLATIN PLUS GEMCITABINE; GENE COPY NUMBER; 1ST-LINE THERAPY; GEFITINIB SENSITIVITY; MOLECULAR PREDICTORS; PROTEIN EXPRESSION; OPEN-LABEL; CHEMOTHERAPY	Activating epidermal growth factor receptor (EGFR) mutations are recognized biomarkers for patients with metastatic non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitors (TKIs). EGFR TKIs can also have activity against NSCLC without EGFR mutations, requiring the identification of additional relevant biomarkers. Previous studies on tumor EGFR protein levels and EGFR gene copy number revealed inconsistent results. The aim of the study was to identify novel biomarkers of the response to TKIs in NSCLC by investigating whole genome expression at the exon-level. We used exon arrays and clinical samples from a previous trial (SAKK19/05) to investigate the expression variations at the exon-level of 3 genes potentially playing a key role in modulating treatment response: EGFR, V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and vascular endothelial growth factor (VEGFA). We identified the expression of EGFR exon 18 as a new predictive marker for patients with untreated metastatic NSCLC treated with bevacizumab and erlotinib in the first line setting. The overexpression of EGFR exon 18 in tumor was significantly associated with tumor shrinkage, independently of EGFR mutation status. A similar significant association could be found in blood samples. In conclusion, exonic EGFR expression particularly in exon 18 was found to be a relevant predictive biomarker for response to bevacizumab and erlotinib. Based on these results, we propose a new model of EGFR testing in tumor and blood.	[Baty, Florent; Brutsche, Martin] Cantonal Hosp, Div Pulm Med, St Gallen, Switzerland; [Rothschild, Sacha; Droege, Cornelia] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Frueh, Martin] Cantonal Hosp, Dept Oncol, St Gallen, Switzerland; [Betticher, Daniel] Cantonal Hosp, Dept Oncol, Fribourg, Switzerland; [Cathomas, Richard] Cantonal Hosp, Dept Oncol, Chur, Switzerland; [Rauch, Daniel] Reg Hosp, Thun, Switzerland; [Gautschi, Oliver] Cantonal Hosp, Luzern, Switzerland; [Bubendorf, Lukas] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Crowe, Susanne] Swiss Grp Clin Canc Res, Coordinating Ctr, Bern, Switzerland; [Zappa, Francesco] Oncol Inst Southern Switzerland, Dept Med Oncol, Bellinzona, Switzerland; [Pless, Miklos] Cantonal Hosp, Dept Oncol, Winterthur, Switzerland	Kantonsspital St. Gallen; University of Basel; Kantonsspital St. Gallen; Lucerne Cantonal Hospital; University of Basel; Swiss Group for Clinical Cancer Research (SAKK); Institute of Oncology Research (IOR)	Brutsche, M (corresponding author), Cantonal Hosp, Div Pulm Med, St Gallen, Switzerland.	martin.brutsche@kssg.ch	Rothschild, Sacha/AAV-4003-2020; Bubendorf, Lukas/G-5299-2015; Pless, Miklos/ABC-4054-2021	Rothschild, Sacha/0000-0003-1304-9340; Bubendorf, Lukas/0000-0001-5970-1803; Brutsche, Martin/0000-0002-1612-3609	Swiss Group for Clinical Cancer Research (SAKK); Swiss State Secretariat for Education and Research (SER); Roche Pharma (Schweiz) AG	Swiss Group for Clinical Cancer Research (SAKK); Swiss State Secretariat for Education and Research (SER); Roche Pharma (Schweiz) AG	The Exon Array analysis was financed by the Swiss Group for Clinical Cancer Research (SAKK). The main trial activities were supported by the Swiss State Secretariat for Education and Research (SER) and Roche Pharma (Schweiz) AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Baty F, 2010, AM J RESP CRIT CARE, V181, P181, DOI 10.1164/rccm.200812-1807OC; Brugger W, 2011, J CLIN ONCOL, V29, P4113, DOI 10.1200/JCO.2010.31.8162; Cappuzzo F, 2009, P ASCO 2009, V27; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; D'Addario G, 2008, ANN ONCOL, V19, P739, DOI 10.1093/annonc/mdm564; De Pas T, 2011, J THORAC ONCOL, V6, P1895, DOI 10.1097/JTO.0b013e318227e8c6; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Dziadziuszko R, 2006, CLIN CANCER RES, V12, P3078, DOI 10.1158/1078-0432.CCR-06-0106; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gridelli C, 2010, P ASCO 2010, V28; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hijiya N, 2008, HUM PATHOL, V39, P316, DOI 10.1016/j.humpath.2007.10.027; Hirsch FR, 2007, ANN ONCOL, V18, P752, DOI 10.1093/annonc/mdm003; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Ichihara S, 2007, INT J CANCER, V120, P1239, DOI 10.1002/ijc.22513; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Kabbinavar FF, 2010, P ASCO 2010, V28; Kris MG, 2011, P ASCO 2011, V29; Lilenbaum R, 2008, J CLIN ONCOL, V26, P863, DOI 10.1200/JCO.2007.13.2720; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Okamoto I, 2003, CANCER SCI, V94, P50, DOI 10.1111/j.1349-7006.2003.tb01351.x; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Perol M, 2010, P ASCO 2010, V28; R Core Team, 2012, R LANG ENV STAT COMP; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Reiter JL, 1996, NUCLEIC ACIDS RES, V24, P4050, DOI 10.1093/nar/24.20.4050; Reiter JL, 2001, GENOMICS, V71, P1, DOI 10.1006/geno.2000.6341; Rosell R, 2011, P ASCO 2011, V29; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Savic S, 2008, BRIT J CANCER, V98, P154, DOI 10.1038/sj.bjc.6604142; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Thomas M, 2011, P ASCO 2011, V29; Zappa F, 2012, LUNG CANCER, V78, P239, DOI 10.1016/j.lungcan.2012.08.017; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu YJ, 2010, CHINESE MED J-PEKING, V123, P3200, DOI 10.3760/cma.j.issn.0366-6999.2010.22.005	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72966	10.1371/journal.pone.0072966	http://dx.doi.org/10.1371/journal.pone.0072966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039832	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600012
J	Be, NA; Thissen, JB; Gardner, SN; McLoughlin, KS; Fofanov, VY; Koshinsky, H; Ellingson, SR; Brettin, TS; Jackson, PJ; Jaing, CJ				Be, Nicholas A.; Thissen, James B.; Gardner, Shea N.; McLoughlin, Kevin S.; Fofanov, Viacheslav Y.; Koshinsky, Heather; Ellingson, Sally R.; Brettin, Thomas S.; Jackson, Paul J.; Jaing, Crystal J.			Detection of Bacillus anthracis DNA in Complex Soil and Air Samples Using Next-Generation Sequencing	PLOS ONE			English	Article							THURINGIENSIS; INHALATION; CEREUS; TOXIN; ARRAY; ASSAY; PCR	Bacillus anthracis is the potentially lethal etiologic agent of anthrax disease, and is a significant concern in the realm of biodefense. One of the cornerstones of an effective biodefense strategy is the ability to detect infectious agents with a high degree of sensitivity and specificity in the context of a complex sample background. The nature of the B. anthracis genome, however, renders specific detection difficult, due to close homology with B. cereus and B. thuringiensis. We therefore elected to determine the efficacy of next-generation sequencing analysis and microarrays for detection of B. anthracis in an environmental background. We applied next-generation sequencing to titrated genome copy numbers of B. anthracis in the presence of background nucleic acid extracted from aerosol and soil samples. We found next-generation sequencing to be capable of detecting as few as 10 genomic equivalents of B. anthracis DNA per nanogram of background nucleic acid. Detection was accomplished by mapping reads to either a defined subset of reference genomes or to the full GenBank database. Moreover, sequence data obtained from B. anthracis could be reliably distinguished from sequence data mapping to either B. cereus or B. thuringiensis. We also demonstrated the efficacy of a microbial census microarray in detecting B. anthracis in the same samples, representing a cost-effective and high-throughput approach, complementary to next-generation sequencing. Our results, in combination with the capacity of sequencing for providing insights into the genomic characteristics of complex and novel organisms, suggest that these platforms should be considered important components of a biosurveillance strategy.	[Be, Nicholas A.; Thissen, James B.; Jackson, Paul J.; Jaing, Crystal J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Gardner, Shea N.; McLoughlin, Kevin S.] Lawrence Livermore Natl Lab, Global Secur Directorates, Livermore, CA USA; [Fofanov, Viacheslav Y.; Koshinsky, Heather] Eureka Genom, Hercules, CA USA; [Ellingson, Sally R.] Univ Tennessee, Dept Genome Sci & Technol, Knoxville, TN USA; [Brettin, Thomas S.] Oak Ridge Natl Lab, Oak Ridge, TN USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Jaing, CJ (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	jaing2@llnl.gov		McLoughlin, Kevin/0000-0001-9651-4951; Thissen, James/0000-0002-4693-5886; Jaing, Crystal/0000-0001-9933-3005	Department of Homeland Security, Science and Technology Directorate [HSHQDC-09-X-00168]	Department of Homeland Security, Science and Technology Directorate(United States Department of Homeland Security (DHS))	Funding for this research was provided through contract HSHQDC-09-X-00168 to Lawrence Livermore National Laboratory by the Department of Homeland Security, Science and Technology Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzard GS, 2012, FORENSIC SCI INT, V223, P292, DOI 10.1016/j.forsciint.2012.10.003; Chen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012397; Cummings Craig A, 2010, Investig Genet, V1, P5, DOI 10.1186/2041-2223-1-5; Driks A, 2009, MOL ASPECTS MED, V30, P368, DOI 10.1016/j.mam.2009.08.001; Edwards KA, 2006, ANAL BIOANAL CHEM, V384, P73, DOI 10.1007/s00216-005-0090-x; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Giegerich R, 2003, SOFTWARE PRACT EXPER, V33, P1035, DOI 10.1002/spe.535; Han T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-217; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Herzog AB, 2009, APPL ENVIRON MICROB, V75, P6331, DOI 10.1128/AEM.00288-09; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Irenge LM, 2012, APPL MICROBIOL BIOT, V93, P1411, DOI 10.1007/s00253-011-3845-7; Jaing C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002163; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kumar S, 2009, J MICROBIOL BIOTECHN, V19, P1475, DOI 10.4014/jmb.0902.0101; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Peters CJ, 2002, LANCET, V359, P710, DOI 10.1016/S0140-6736(02)07792-9; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rozen S, 2000, Methods Mol Biol, V132, P365; Sohni Y, 2008, CLIN BIOCHEM, V41, P640, DOI 10.1016/j.clinbiochem.2008.01.007; Song YJ, 2000, J MICROBIOL METH, V39, P225, DOI 10.1016/S0167-7012(99)00123-2; Wang J, 2011, APPL ENVIRON MICROB, V77, P4241, DOI 10.1128/AEM.01834-10; Wright AM, 2011, ARCH PATHOL LAB MED, V135, P1447, DOI 10.5858/2011-0362-SAIR.1; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	32	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73455	10.1371/journal.pone.0073455	http://dx.doi.org/10.1371/journal.pone.0073455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039948	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300078
J	Hamer, PCD; Hendriks, EJ; Mandonnet, E; Barkhof, F; Zwinderman, AH; Duffau, H				Hamer, Philip C. De Witt; Hendriks, Eef J.; Mandonnet, Emmanuel; Barkhof, Frederik; Zwinderman, Aeilko H.; Duffau, Hugues			Resection Probability Maps for Quality Assessment of Glioma Surgery without Brain Location Bias	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; FALSE DISCOVERY RATE; GLIOBLASTOMA-MULTIFORME; SURGICAL RESECTION; PROGNOSTIC-FACTORS; BREAST-CANCER; II GLIOMAS; SURVIVAL; EXTENT; STIMULATION	Background: Intraoperative brain stimulation mapping reduces permanent postoperative deficits and extends tumor removal in resective surgery for glioma patients. Successful functional mapping is assumed to depend on the surgical team's expertise. In this study, glioma resection results are quantified and compared using a novel approach, so-called resection probability maps (RPM), exemplified by a surgical team comparison, here with long and short experience in mapping. Methods: Adult patients with glioma were included by two centers with two and fifteen years of mapping experience. Resective surgery was targeted at non-enhanced MRI extension and was limited by functional boundaries. Neurological outcome was compared. To compare resection results, we applied RPMs to quantify and compare the resection probability throughout the brain at 1 mm resolution. Considerations for spatial dependence and multiple comparisons were taken into account. Results: The senior surgical team contributed 56, and the junior team 52 patients. The patient cohorts were comparable in age, preoperative tumor volume, lateralization, and lobe localization. Neurological outcome was similar between teams. The resection probability on the RPMs was very similar, with none (0%) of 703,967 voxels in left-sided tumors being differentially resected, and 124 (0.02%) of 644,153 voxels in right-sided tumors. Conclusion: RPMs provide a quantitative volumetric method to compare resection results, which we present as standard for quality assessment of resective glioma surgery because brain location bias is avoided. Stimulation mapping is a robust surgical technique, because the neurological outcome and functional-based resection results using stimulation mapping are independent of surgical experience, supporting wider implementation.	[Hamer, Philip C. De Witt; Hendriks, Eef J.] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Mandonnet, Emmanuel] Hop Lariboisiere, Dept Neurosurg, F-75475 Paris, France; [Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Image Anal Ctr, Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Duffau, Hugues] CHU Montpellier, Hop Gui de Chauliac, Dept Neurosurg, Montpellier, France	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Universite de Montpellier; CHU de Montpellier	Hamer, PCD (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands.	p.dewitthamer@vumc.nl	Barkhof, Frederik/AAJ-6226-2020; De Witt Hamer, Philip/E-7630-2013	Barkhof, Frederik/0000-0003-3543-3706; De Witt Hamer, Philip/0000-0003-2988-8544				AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Anwar S, 2012, J EVAL CLIN PRACT, V18, P5, DOI 10.1111/j.1365-2753.2010.01525.x; Berger MS, 2007, NEUROSURGERY, V61, P279, DOI 10.1227/01.NEU.0000255489.88321.18; Chang EF, 2008, J NEUROSURG, V109, P817, DOI 10.3171/JNS/2008/109/11/0817; Chen SN, 2009, HUM BRAIN MAPP, V30, P2304, DOI 10.1002/hbm.20669; Claus EB, 2005, CANCER-AM CANCER SOC, V103, P1227, DOI 10.1002/cncr.20867; Deras P, 2012, NEUROSURGERY, V71, P764, DOI 10.1227/NEU.0b013e3182647ab8; Dooley WC, 2011, ANN SURG ONCOL, V18, P3248, DOI 10.1245/s10434-011-1771-7; Duffau H, 2005, J NEUROL NEUROSUR PS, V76, P845, DOI 10.1136/jnnp.2004.048520; Edgington E. S., 1995, RANDOMIZATION TESTS; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron BT R, 1993, INTRO BOOTSTRAP, P208; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/S1053-8119(09)70884-5, DOI 10.1016/S1053-8119(09)70884-5]; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Good P. I, 2004, PERMUTATION PARAMETR; Gordon TA, 1999, J AM COLL SURGEONS, V189, P46, DOI 10.1016/S1072-7515(99)00072-1; Hamer PCD, 2012, J CLIN ONCOL, V30, P2559, DOI 10.1200/JCO.2011.38.4818; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Johannesen TB, 2003, J NEUROSURG, V99, P854, DOI 10.3171/jns.2003.99.5.0854; Kingsmore D, 2004, BRIT J CANCER, V90, P1920, DOI 10.1038/sj.bjc.6601846; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lau KKW, 2013, J THORAC ONCOL, V8, P68, DOI 10.1097/JTO.0b013e3182762315; Logan BR, 2004, NEUROIMAGE, V22, P95, DOI 10.1016/j.neuroimage.2003.12.047; Mandonnet E, 2007, NEURO-ONCOLOGY, V9, P63, DOI 10.1215/15228517-2006-015; Mandonnet E, 2010, ACTA NEUROCHIR, V152, P185, DOI 10.1007/s00701-009-0469-0; Manly BFJ, 1997, RANDOMIZATION BOOTST, P81; Marchini J, 2004, NEUROIMAGE, V22, P1203, DOI 10.1016/j.neuroimage.2004.03.030; Marriott FHC., 1979, APPLIED STATISTICS, V28, P75, DOI [DOI 10.2307/2346816, 10.2307/2346816]; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Pouratian N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09239; Rezvan A, 2009, ACTA NEUROCHIR, V151, P1359, DOI 10.1007/s00701-009-0435-x; Schomas DA, 2009, NEURO-ONCOLOGY, V11, P437, DOI 10.1215/15228517-2008-102; Schwartzman A, 2009, NEUROIMAGE, V44, P71, DOI 10.1016/j.neuroimage.2008.04.182; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; Shaw EG, 2008, J NEUROSURG, V109, P835, DOI 10.3171/JNS/2008/109/11/0835; Shinoda J, 2001, J NEURO-ONCOL, V52, P161, DOI 10.1023/A:1010624504311; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Szelenyi A, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09237; Tharin S, 2007, NEUROSURGERY, V60, P185, DOI 10.1227/01.0000255386.95464.52; van Heek NT, 2005, ANN SURG, V242, P781, DOI 10.1097/01.sla.0000188462.00249.36; van Veelen MLC, 1998, J NEUROL NEUROSUR PS, V64, P581, DOI 10.1136/jnnp.64.5.581; WHITCHER B, 2011, J STAT SOFTW, V44, P1; Yeh SA, 2005, BRIT J RADIOL, V78, P230, DOI 10.1259/bjr/28534346; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333	48	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73353	10.1371/journal.pone.0073353	http://dx.doi.org/10.1371/journal.pone.0073353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039922	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500039
J	Veyrat-Durebex, C; Poher, AL; Caillon, A; Somm, E; Vallet, P; Charnay, Y; Rohner-Jeanrenaud, F				Veyrat-Durebex, Christelle; Poher, Anne-Laure; Caillon, Aurelie; Somm, Emmanuel; Vallet, Philippe; Charnay, Yves; Rohner-Jeanrenaud, Francoise			Improved Leptin Sensitivity as a Potential Candidate Responsible for the Spontaneous Food Restriction of the Lou/C Rat	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; DIET-INDUCED OBESITY; ENERGY-BALANCE; INSULIN SENSITIVITY; RESISTANT; TRANSPORT; GLUCAGON; NEURONS; BDNF; HOMEOSTASIS	The Lou/C rat, an inbred strain of Wistar origin, was described as a model of resistance to age-and diet-induced obesity. Although such a resistance involves many metabolic parameters described in our previous studies, Lou/C rats also exhibit a spontaneous food restriction due to decreased food consumption during the nocturnal period. We then attempted to delineate the leptin sensitivity and mechanisms implicated in this strain, using different protocols of acute central and peripheral leptin administration. A first analysis of the meal patterns revealed that Lou/C rats eat smaller meals, without any change in meal number compared to age-matched Wistar animals. Although the expression of the recognized leptin transporters (leptin receptors and megalin) measured in the choroid plexus was normal in Lou/C rats, the decreased triglyceridemia observed in these animals is compatible with an increased leptin transport across the blood brain barrier. Improved hypothalamic leptin signaling in Lou/C rats was also suggested by the higher pSTAT3/STAT3 (signal transducer and activator of transcription 3) ratio observed following acute peripheral leptin administration, as well as by the lower hypothalamic mRNA expression of the suppressor of cytokine signaling 3 (SOCS3), known to downregulate leptin signaling. To conclude, spontaneous hypophagia of Lou/C rats appears to be related to improved leptin sensitivity. The main mechanism underlying such a phenomenon consists in improved leptin signaling through the Ob-Rb leptin receptor isoform, which seems to consequently lead to overexpression of brain-derived neurotrophic factor (BDNF) and thyrotropin-releasing hormone (TRH).	[Veyrat-Durebex, Christelle; Poher, Anne-Laure; Caillon, Aurelie; Rohner-Jeanrenaud, Francoise] Univ Geneva, Fac Med, Dept Internal Med Specialties, Lab Metab, Geneva, Switzerland; [Somm, Emmanuel] Univ Hosp Geneva, Dept Pediat, Div Dev & Growth, Geneva, Switzerland; [Vallet, Philippe; Charnay, Yves] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Veyrat-Durebex, C (corresponding author), Univ Geneva, Fac Med, Dept Internal Med Specialties, Lab Metab, Geneva, Switzerland.	christelle.veyrat-durebex@unige.ch		Poher, Anne-Laure/0000-0002-6657-4336; Veyrat-Durebex, Christelle/0000-0001-5301-6493	Swiss National Science Foundation [31003A-134919]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (31003A-134919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Alliot J, 2002, J GERONTOL A-BIOL, V57, pB312, DOI 10.1093/gerona/57.8.B312; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; Banks WA, 2003, CURR PHARM DESIGN, V9, P801, DOI 10.2174/1381612033455350; Banks WA, 1999, PEPTIDES, V20, P1341, DOI 10.1016/S0196-9781(99)00139-4; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008; Fox EA, 2004, AM J PHYSIOL-REG I, V286, pR994, DOI 10.1152/ajpregu.00727.2003; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; Helies JM, 2005, OBES RES, V13, P3, DOI 10.1038/oby.2005.3; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kappeler L, 2004, J NEUROENDOCRINOL, V16, P980, DOI 10.1111/j.1365-2826.2004.01259.x; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Levin BE, 2007, AM J PHYSIOL-REG I, V293, pR988, DOI 10.1152/ajpregu.00434.2007; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR382, DOI 10.1152/ajpregu.1999.276.2.R382; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Mitchell SE, 2006, J ENDOCRINOL, V190, P571, DOI 10.1677/joe.1.06576; Moran TH, 2006, PHYSIOL BEHAV, V89, P511, DOI 10.1016/j.physbeh.2006.04.020; Moyse E, 2012, MECH AGEING DEV, V133, P83, DOI 10.1016/j.mad.2012.01.004; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Nillni EA, 2000, J BIOL CHEM, V275, P36124, DOI 10.1074/jbc.M003549200; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Taleux N, 2008, INT J OBESITY, V32, P639, DOI 10.1038/sj.ijo.0803759; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; VETTOR R, 1994, DIABETOLOGIA, V37, P1202, DOI 10.1007/s001250050236; Veyrat-Durebex C, 1998, MECH AGEING DEV, V103, P223, DOI 10.1016/S0047-6374(98)00013-X; Veyrat-Durebex C, 1997, PHYSIOL BEHAV, V62, P1273, DOI 10.1016/S0031-9384(97)00304-1; Veyrat-Durebex C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1146, DOI 10.1152/ajpendo.00575.2010; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73452	10.1371/journal.pone.0073452	http://dx.doi.org/10.1371/journal.pone.0073452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039946	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500043
J	Yi, G; Lapelosa, M; Bradley, R; Mariano, TM; Dietz, DE; Hughes, S; Wrin, T; Petropoulos, C; Gallicchio, E; Levy, RM; Arnold, E; Arnold, GF				Yi, Guohua; Lapelosa, Mauro; Bradley, Rachel; Mariano, Thomas M.; Dietz, Denise Elsasser; Hughes, Scott; Wrin, Terri; Petropoulos, Chris; Gallicchio, Emilio; Levy, Ronald M.; Arnold, Eddy; Arnold, Gail Ferstandig			Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; COMMON COLD VIRUS; TYPE-1 HIV-1; BROAD NEUTRALIZATION; MONOCLONAL-ANTIBODY; GP41 ECTODOMAIN; HEAVY-CHAIN; MEMBRANE; 2F5	Background: The development of an effective AIDS vaccine has been a formidable task, but remains a critical necessity. The well conserved membrane-proximal external region (MPER) of the HIV-1 gp41 glycoprotein is one of the crucial targets for AIDS vaccine development, as it has the necessary attribute of being able to elicit antibodies capable of neutralizing diverse isolates of HIV. Methodology/Principle Findings: Guided by X-ray crystallography, molecular modeling, combinatorial chemistry, and powerful selection techniques, we designed and produced six combinatorial libraries of chimeric human rhinoviruses (HRV) displaying the MPER epitopes corresponding to mAbs 2F5, 4E10, and/or Z13e1, connected to an immunogenic surface loop of HRV via linkers of varying lengths and sequences. Not all libraries led to viable chimeric viruses with the desired sequences, but the combinatorial approach allowed us to examine large numbers of MPER-displaying chimeras. Among the chimeras were five that elicited antibodies capable of significantly neutralizing HIV-1 pseudoviruses from at least three subtypes, in one case leading to neutralization of 10 pseudoviruses from all six subtypes tested. Conclusions: Optimization of these chimeras or closely related chimeras could conceivably lead to useful components of an effective AIDS vaccine. While the MPER of HIV may not be immunodominant in natural infection by HIV-1, its presence in a vaccine cocktail could provide critical breadth of protection.	[Yi, Guohua; Lapelosa, Mauro; Bradley, Rachel; Mariano, Thomas M.; Dietz, Denise Elsasser; Hughes, Scott; Gallicchio, Emilio; Levy, Ronald M.; Arnold, Eddy; Arnold, Gail Ferstandig] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Yi, Guohua; Lapelosa, Mauro; Bradley, Rachel; Mariano, Thomas M.; Dietz, Denise Elsasser; Hughes, Scott; Arnold, Eddy; Arnold, Gail Ferstandig] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wrin, Terri; Petropoulos, Chris] Monogram Biosci, San Francisco, CA USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	arnold@cabm.rutgers.edu; gfarnold@biomaps.rutgers.edu	Yi, Guohua/H-3742-2014; Yi, Guohua/H-1835-2013	Arnold, Gail/0000-0002-3335-6965; Gallicchio, Emilio/0000-0002-2606-4913	NIH [GM30580, AI071874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant GM30580 (to RML) and by NIH grant AI071874 (to GFA). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; ARNOLD E, 1990, USE OF X-RAY CRYSTALLOGRAPHY IN THE DESIGN OF ANTIVIRAL AGENTS, P283; ARNOLD E, 1990, J MOL BIOL, V211, P763, DOI 10.1016/0022-2836(90)90076-X; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 1996, AIDS RES HUM RETROV, V12, P911, DOI 10.1089/aid.1996.12.911; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Biron Z, 2005, BIOCHEMISTRY-US, V44, P13602, DOI 10.1021/bi0509245; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; CONANT RM, 1968, J IMMUNOL, V100, P107; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Lapelosa M, 2010, J MOL BIOL, V397, P752, DOI 10.1016/j.jmb.2010.01.064; Lapelosa M, 2009, J MOL BIOL, V385, P675, DOI 10.1016/j.jmb.2008.10.089; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Marthas ML, 2007, CURR OPIN HIV AIDS, V2, P367, DOI 10.1097/COH.0b013e3282cecf21; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Montefiori DC, 2007, CURR OPIN HIV AIDS, V2, P169, DOI 10.1097/COH.0b013e3280ef691e; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOSSER AG, 1989, MOL ASPECTS PICORNAV, P00155; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munoz-Barroso I, 1999, J VIROL, V73, P6089; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; PAI E, 2000, Patent No. 0061618; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RESNICK DA, 1994, AIDS RES HUM RETROV, V10, pS47; RESNICK DA, 1995, J VIROL, V69, P2406, DOI 10.1128/JVI.69.4.2406-2411.1995; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SHERRY B, 1985, J VIROL, V53, P137, DOI 10.1128/JVI.53.1.137-143.1985; SMITH AD, 1994, J VIROL, V68, P575, DOI 10.1128/JVI.68.1.575-579.1994; Smith AD, 1998, J VIROL, V72, P651, DOI 10.1128/JVI.72.1.651-659.1998; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Sun M, 2008, THESIS STATE U NEW J; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; ZHANG AQ, 1993, J MOL BIOL, V230, P857, DOI 10.1006/jmbi.1993.1206; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001	84	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72205	10.1371/journal.pone.0072205	http://dx.doi.org/10.1371/journal.pone.0072205			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039745	Green Published, gold			2022-12-25	WOS:000324856500014
J	Carbo, A; Bassaganya-Riera, J; Pedragosa, M; Viladomiu, M; Marathe, M; Eubank, S; Wendelsdorf, K; Bisset, K; Hoops, S; Deng, XW; Alam, M; Kronsteiner, B; Mei, YG; Hontecillas, R				Carbo, Adria; Bassaganya-Riera, Josep; Pedragosa, Mireia; Viladomiu, Monica; Marathe, Madhav; Eubank, Stephen; Wendelsdorf, Katherine; Bisset, Keith; Hoops, Stefan; Deng, Xinwei; Alam, Maksudul; Kronsteiner, Barbara; Mei, Yongguo; Hontecillas, Raquel			Predictive Computational Modeling of the Mucosal Immune Responses during Helicobacter pylori Infection	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; REGULATORY T-CELLS; PPAR-GAMMA; IFN-GAMMA; DENDRITIC CELLS; TH17 CELLS; CD4(+); EXPRESSION; PROTECTION; T(H)17	T helper (Th) cells play a major role in the immune response and pathology at the gastric mucosa during Helicobacter pylori infection. There is a limited mechanistic understanding regarding the contributions of CD4+ T cell subsets to gastritis development during H. pylori colonization. We used two computational approaches: ordinary differential equation (ODE)-based and agent-based modeling (ABM) to study the mechanisms underlying cellular immune responses to H. pylori and how CD4+ T cell subsets influenced initiation, progression and outcome of disease. To calibrate the model, in vivo experimentation was performed by infecting C57BL/6 mice intragastrically with H. pylori and assaying immune cell subsets in the stomach and gastric lymph nodes (GLN) on days 0, 7, 14, 30 and 60 post-infection. Our computational model reproduced the dynamics of effector and regulatory pathways in the gastric lamina propria (LP) in silico. Simulation results show the induction of a Th17 response and a dominant Th1 response, together with a regulatory response characterized by high levels of mucosal Treg) cells. We also investigated the potential role of peroxisome proliferator-activated receptor gamma (PPAR gamma) activation on the modulation of host responses to H. pylori by using loss-of-function approaches. Specifically, in silico results showed a predominance of Th1 and Th17 cells in the stomach of the cell-specific PPAR gamma knockout system when compared to the wild-type simulation. Spatio-temporal, object-oriented ABM approaches suggested similar dynamics in induction of host responses showing analogous T cell distributions to ODE modeling and facilitated tracking lesion formation. In addition, sensitivity analysis predicted a crucial contribution of Th1 and Th17 effector responses as mediators of histopathological changes in the gastric mucosa during chronic stages of infection, which were experimentally validated in mice. These integrated immunoinformatics approaches characterized the induction of mucosal effector and regulatory pathways controlled by PPAR gamma during H. pylori infection affecting disease outcomes.	[Carbo, Adria; Bassaganya-Riera, Josep; Pedragosa, Mireia; Viladomiu, Monica; Hoops, Stefan; Kronsteiner, Barbara; Mei, Yongguo; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA; [Carbo, Adria; Bassaganya-Riera, Josep; Pedragosa, Mireia; Viladomiu, Monica; Marathe, Madhav; Eubank, Stephen; Wendelsdorf, Katherine; Bisset, Keith; Hoops, Stefan; Deng, Xinwei; Alam, Maksudul; Kronsteiner, Barbara; Mei, Yongguo; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA USA; [Marathe, Madhav; Eubank, Stephen; Wendelsdorf, Katherine; Bisset, Keith; Alam, Maksudul] Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA USA; [Bassaganya-Riera, Josep] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Deng, Xinwei] Virginia Tech, Dept Stat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Hontecillas, R (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu	Eubank, Stephen/AAD-5089-2021; Alam, Maksudul/Q-9238-2019; Viladomiu, Monica/GNM-6447-2022; Deng, Xinwei/AAH-8310-2021; Eubank, Stephen/D-7497-2011	Alam, Maksudul/0000-0002-4941-463X; Deng, Xinwei/0000-0002-1560-2405; Kronsteiner-Dobramysl, Barbara/0000-0003-0867-2867; Eubank, Stephen/0000-0002-7177-309X	National Institutes of Health [5R01AT004308]; NIAID [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health (5R01AT004308) to JBR, NIAID Contract No. HHSN272201000056C to JBR, and funds from the Nutritional Immunology and Molecular Medicine Laboratory (URL:www.modelingimmunity.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037349; Adria Carbo RH, 2013, PLOS COMPUT IN PRESS; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Ando T., 2007, Inflammopharmacology, V15, P10, DOI 10.1007/s10787-006-1556-y; Andres S, 2011, FEMS IMMUNOL MED MIC, V61, P168, DOI 10.1111/j.1574-695X.2010.00761.x; [Anonymous], 2007, GASTROENTEROLOGY, V133, P6; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Bassaganya-Riera J, 2012, PLOS ONE IN PRESS; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034676; Bazargani A, 2010, SCAND J GASTROENTERO, V45, P1162, DOI 10.3109/00365521.2010.499959; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bimczok D, 2011, GASTROENTEROLOGY, V141, P929, DOI 10.1053/j.gastro.2011.06.006; Bisset K, 2012, INT PARALL DISTRIB P, P48, DOI 10.1109/IPDPS.2012.15; Blaser MJ, 2008, CANCER PREV RES, V1, P308, DOI 10.1158/1940-6207.CAPR-08-0170; Blaser MJ, 2008, GUT; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Chow WH, 1998, CANCER RES, V58, P588; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Hitzler I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00142; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jang TJ, 2010, PATHOL RES PRACT, V206, P34, DOI 10.1016/j.prp.2009.07.019; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Kennedy J, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P303, DOI 10.1109/ICEC.1997.592326; Klotz L, 2011, FEBS LETT, V585, P3764, DOI 10.1016/j.febslet.2011.06.027; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Konturek PC, 2004, J PHARMACOL SCI, V96, P134, DOI 10.1254/jphs.FPJ04016X; Krakowka S, 1996, VET IMMUNOL IMMUNOP, V52, P159, DOI 10.1016/0165-2427(95)05547-9; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Lei J, 2010, J IMMUNOL, V185, P7186, DOI 10.4049/jimmunol.1001437; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lundgren A, 2005, INFECT IMMUN, V73, P5612, DOI 10.1128/IAI.73.9.5612-5619.2005; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McCune A, 2003, EUR J GASTROEN HEPAT, V15, P637, DOI 10.1097/00042737-200306000-00010; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Naumann M, 2004, TRENDS MICROBIOL, V12, P29, DOI 10.1016/j.tim.2003.11.005; Olokoba A B, 2013, Niger Med J, V54, P1, DOI 10.4103/0300-1652.108884; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Parsonnet J, 2004, NEW ENGL J MED, V350, P213, DOI 10.1056/NEJMp038200; Philipson CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057812; Quiding-Jarbrink M, 2001, CLIN EXP IMMUNOL, V123, P81, DOI 10.1046/j.1365-2249.2001.01427.x; Quiding-Jarbrink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015018; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sayi A, 2009, J IMMUNOL, V182, P7085, DOI 10.4049/jimmunol.0803293; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Son Seong Hyun, 2007, Korean J Gastroenterol, V49, P72; Spiegelman BM, 1998, CELL, V93, P153, DOI 10.1016/S0092-8674(00)81567-6; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x; Vieth M, 2000, DIGESTION, V62, P225, DOI 10.1159/000007820; Viladomiu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047525; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Wong BLW, 2009, AM J PATHOL, V174, P1319, DOI 10.2353/ajpath.2009.080708; Wu L, 2012, BLOOD, V119, P115, DOI 10.1182/blood-2011-06-363093; Yao LP, 2010, HYBRIDOMA, V29, P341, DOI 10.1089/hyb.2010.0013; Zhang M, 2010, GUT MICROBES, V1, P325, DOI 10.4161/gmic.1.5.13052; Zhang MA, 2012, P NATL ACAD SCI USA, V109, P9505, DOI 10.1073/pnas.1118458109; Zhuang YA, 2011, IMMUNOBIOLOGY, V216, P200, DOI 10.1016/j.imbio.2010.05.005	71	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73365	10.1371/journal.pone.0073365	http://dx.doi.org/10.1371/journal.pone.0073365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039925	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600068
J	Cron, KR; Zhu, KY; Kushwaha, DS; Hsieh, G; Merzon, D; Rameseder, J; Chen, CC; D'Andrea, AD; Kozono, D				Cron, Kyle R.; Zhu, Kaya; Kushwaha, Deepa S.; Hsieh, Grace; Merzon, Dmitry; Rameseder, Jonathan; Chen, Clark C.; D'Andrea, Alan D.; Kozono, David			Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRAND BREAKS; MULTIPLE-MYELOMA; MAMMALIAN-CELLS; GENE-EXPRESSION; SOLID TUMORS; BORTEZOMIB; ADENOCARCINOMA; RECOMBINATION; CHEMOTHERAPY	Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most reproducibly increase NSCLC cytotoxicity. These screens identified several proteasome subunits among top hits, including the topmost hit PSMA1, a component of the core 20 S proteasome. Radiation and proteasome inhibition showed synergistic effects. Proteasome inhibition resulted in an 80-90% decrease in homologous recombination (HR), a 50% decrease in expression of NF-kappa B-inducible HR genes BRCA1 and FANCD2, and a reduction of BRCA1, FANCD2 and RAD51 ionizing radiation-induced foci. I kappa B alpha RNAi knockdown rescued NSCLC radioresistance. Irradiation of mice with NCI-H460 xenografts after inducible PSMA1 shRNA knockdown markedly increased murine survival compared to either treatment alone. Proteasome inhibition is a promising strategy for NSCLC radiosensitization via inhibition of NF-kappa B-mediated expression of Fanconi Anemia/HR DNA repair genes.	[Cron, Kyle R.; Zhu, Kaya; Kushwaha, Deepa S.; Hsieh, Grace; Merzon, Dmitry; D'Andrea, Alan D.; Kozono, David] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Rameseder, Jonathan] MIT, Cambridge, MA 02139 USA; [Chen, Clark C.] Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA; [D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute	Kozono, D (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	dkozono@lroc.harvard.edu	Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277	American Society for Radiation Oncology (ASTRO) Junior Faculty Career Research Training Award; Joint Center for Radiation Therapy Foundation Grant; Dana-Farber/Harvard Cancer Center SPORE Developmental Research Project Award in Lung Cancer Research; National Cancer Institute of the National Institutes of Health [K08CA172354]; NATIONAL CANCER INSTITUTE [K08CA172354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	American Society for Radiation Oncology (ASTRO) Junior Faculty Career Research Training Award; Joint Center for Radiation Therapy Foundation Grant; Dana-Farber/Harvard Cancer Center SPORE Developmental Research Project Award in Lung Cancer Research; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by an American Society for Radiation Oncology (ASTRO) Junior Faculty Career Research Training Award, a Joint Center for Radiation Therapy Foundation Grant, a Dana-Farber/Harvard Cancer Center SPORE Developmental Research Project Award in Lung Cancer Research, and the National Cancer Institute of the National Institutes of Health under Award Number K08CA172354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Allen AM, 2008, CANCER-AM CANCER SOC, V112, P1106, DOI 10.1002/cncr.23283; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Davies AM, 2009, J THORAC ONCOL, V4, P87, DOI 10.1097/JTO.0b013e3181915052; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Edelman Martin J, 2005, Clin Lung Cancer, V7 Suppl 2, pS64, DOI 10.3816/CLC.2005.s.011; Edelman MJ, 2010, LUNG CANCER, V68, P84, DOI 10.1016/j.lungcan.2009.05.003; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Juvekar A, 2011, MOL CANCER RES, V9, P183, DOI 10.1158/1541-7786.MCR-10-0368; Kahle KT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09212; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li TH, 2010, LUNG CANCER, V68, P89, DOI 10.1016/j.lungcan.2009.05.009; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Neri P, 2011, BLOOD, V118, P6368, DOI 10.1182/blood-2011-06-363911; Ngwa W, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2575; OSTASHEVSKY JY, 1989, RADIAT RES, V118, P437, DOI 10.2307/3577405; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Ponn RB, 2005, GEN THORACIC SURG, V6, P1548; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Russo A, 2007, EXPERT OPIN THER TAR, V11, P1571, DOI 10.1517/14728222.11.12.1571; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Stuschke M, 2002, INT J RADIAT BIOL, V78, P807, DOI 10.1080/09553000210148903; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Williamson MJ, 2009, MOL CANCER THER, V8, P3234, DOI 10.1158/1535-7163.MCT-09-0239; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616	51	40	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73710	10.1371/journal.pone.0073710	http://dx.doi.org/10.1371/journal.pone.0073710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040035	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600093
J	Lavery, PS; Mateo, MA; Serrano, O; Rozaimi, M				Lavery, Paul S.; Mateo, Miguel-Angel; Serrano, Oscar; Rozaimi, Mohammad			Variability in the Carbon Storage of Seagrass Habitats and Its Implications for Global Estimates of Blue Carbon Ecosystem Service	PLOS ONE			English	Article							POSIDONIA-OCEANICA; ORGANIC-MATTER; SEDIMENT ACCUMULATION; SOUTHEAST QUEENSLAND; ZOSTERA-NOLTII; HOLOCENE; PRESERVATION; RETENTION; SHELF; RATES	The recent focus on carbon trading has intensified interest in 'Blue Carbon'-carbon sequestered by coastal vegetated ecosystems, particularly seagrasses. Most information on seagrass carbon storage is derived from studies of a single species, Posidonia oceanica, from the Mediterranean Sea. We surveyed 17 Australian seagrass habitats to assess the variability in their sedimentary organic carbon (C-org) stocks. The habitats encompassed 10 species, in mono-specific or mixed meadows, depositional to exposed habitats and temperate to tropical habitats. There was an 18-fold difference in the C-org stock (1.09-20.14 mg C-org cm(-3) for a temperate Posidonia sinuosa and a temperate, estuarine P. australis meadow, respectively). Integrated over the top 25 cm of sediment, this equated to an areal stock of 262-4833 g C-org m(-2). For some species, there was an effect of water depth on the C-org stocks, with greater stocks in deeper sites; no differences were found among sub-tidal and inter-tidal habitats. The estimated carbon storage in Australian seagrass ecosystems, taking into account inter-habitat variability, was 155 Mt. At a 2014-15 fixed carbon price of A$25.40 t(-1) and an estimated market price of $35 t(-1) in 2020, the C-org stock in the top 25 cm of seagrass habitats has a potential value of $AUD 3.9-5.4 bill. The estimates of annual C-org accumulation by Australian seagrasses ranged from 0.093 to 6.15 Mt, with a most probable estimate of 0.93 Mt y(-1) (10.1 t. km(-2) y(-1)). These estimates, while large, were one-third of those that would be calculated if inter-habitat variability in carbon stocks were not taken into account. We conclude that there is an urgent need for more information on the variability in seagrass carbon stock and accumulation rates, and the factors driving this variability, in order to improve global estimates of seagrass Blue Carbon storage.	[Lavery, Paul S.; Serrano, Oscar; Rozaimi, Mohammad] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia; [Lavery, Paul S.; Serrano, Oscar; Rozaimi, Mohammad] Edith Cowan Univ, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Mateo, Miguel-Angel] CSIC, Ctr Estudios Avanzados Blanes, Blanes, Girona, Spain; [Serrano, Oscar] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [Rozaimi, Mohammad] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia	Edith Cowan University; Edith Cowan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Western Australia; Universiti Kebangsaan Malaysia	Lavery, PS (corresponding author), Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia.	p.lavery@ecu.edu.au	Rozaimi, Mohammad/E-3658-2017; Rozaimi, Mohammad/Q-4282-2019; Serrano, Oscar/AAI-1167-2019	Rozaimi, Mohammad/0000-0001-6631-8677; Serrano, Oscar/0000-0002-5973-0046; Mateo, Miguel/0000-0001-7567-0277; Lavery, Paul/0000-0001-5162-273X	Faculty of Health, Engineering & Science at Edith Cowan University [25139.9256.RG.06.01]; Spanish Ministry for Science and Innovation (MICINN) [CTM2006-12492/MAR]	Faculty of Health, Engineering & Science at Edith Cowan University; Spanish Ministry for Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was funded by a Visiting Research Fellows grant from the Faculty of Health, Engineering & Science at Edith Cowan University, project number 25139.9256.RG.06.01 (http://www.ecu.edu.au/faculties/computing-health-and-science). Part of this study was funded by the Spanish Ministry for Science and Innovation (MICINN) with the grant CTM2006-12492/MAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2002, ESTUARIES, V25, P1205, DOI 10.1007/BF02692217; ALCOVERRO T, 1995, MAR ECOL PROG SER, V120, P203, DOI 10.3354/meps120203; [Anonymous], 2012, AUSTR NATL GREENHOUS; Batjes NH, 2011, AGR ECOSYST ENVIRON, V142, P365, DOI 10.1016/j.agee.2011.06.007; BELPERIO AP, 1983, BMR J AUST GEOL GEOP, V8, P179; Bostock HC, 2007, SEDIMENT GEOL, V201, P321, DOI 10.1016/j.sedgeo.2007.07.001; Brunskill GJ, 2002, ESTUAR COAST SHELF S, V54, P677, DOI 10.1006/ecss.2001.0852; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Carruthers TJB, 2007, J EXP MAR BIOL ECOL, V350, P21, DOI 10.1016/j.jembe.2007.05.036; Clavier J, 2011, AQUAT BOT, V95, P24, DOI 10.1016/j.aquabot.2011.03.005; Coles R, 2004, SEAGRASSES QUEENSLAN; Collier CJ, 2007, MAR ECOL PROG SER, V337, P103, DOI 10.3354/meps337103; Collier CJ, 2009, J EXP MAR BIOL ECOL, V370, P89, DOI 10.1016/j.jembe.2008.12.003; Commonwealth of Australia Attorney-Genaral's Department, 2008, AUSTR LOW POLL FUT E; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Creese RG, 2009, MAPPING HABITATS NSW; den Hartog C, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P1; Donaldson P., 2012, TIDAL CHARACTERISTIC; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Eddyvane KS, 1999, CONSERVING MARINE 2; FONSECA MS, 1989, ESTUAR COAST SHELF S, V29, P501, DOI 10.1016/0272-7714(89)90083-8; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Gacia E, 2002, LIMNOL OCEANOGR, V47, P23, DOI 10.4319/lo.2002.47.1.0023; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Gruber RK, 2010, LIMNOL OCEANOGR, V55, P2285, DOI 10.4319/lo.2010.55.6.2285; Hancock GJ, 1999, MAR FRESHWATER RES, V50, P533, DOI 10.1071/MF98053; Hansen JCR, 2012, MAR ECOL PROG SER, V448, P271, DOI 10.3354/meps09225; Heap AD, 2001, MAR GEOL, V176, P39, DOI 10.1016/S0025-3227(01)00145-1; Hedges JI, 1999, AM J SCI, V299, P529, DOI 10.2475/ajs.299.7-9.529; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hemminga MA, 1996, MAR ECOL PROG SER, V140, P285, DOI 10.3354/meps140285; James NP, 2009, SPEC PUBL INT ASS SE, V41, P123; KEIL RG, 1993, CHEM GEOL, V107, P385, DOI 10.1016/0009-2541(93)90215-5; Kendrick GA, 2001, GLOBAL SEAGRASS RES, P1; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kirkman H, 1997, STATE ENV TECHNICAL; Klap VA, 2000, MAR ECOL PROG SER, V194, P1, DOI 10.3354/meps194001; Laffoley D., 2009, MANAGEMENT NATURAL C; Lawrence A, 2012, OPTIMISING MANAGING; Lo Iacono C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034773; Macreadie PI, 2012, GLOBAL CHANGE BIOL, V18, P891, DOI 10.1111/j.1365-2486.2011.02582.x; Mateo MA, 1997, MAR ECOL PROG SER, V151, P43, DOI 10.3354/meps151043; Mateo MA, 1997, DYNAMICS MILLENARY O, P103; Mateo MA, 2012, MEDITERRANEAN SEAGRA, P80; Mateo MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P159; Matthai C, 2001, J ENVIRON RADIOACTIV, V52, P67, DOI 10.1016/S0265-931X(00)00104-1; McKenzie LJ, 2012, ANN REPORT FR SAMPLI; Michot BTC, 2002, 03181 OFR; Morelli G, 2012, CHEM GEOL, V300, P152, DOI 10.1016/j.chemgeo.2012.01.023; Nellemann C, 2009, BLUE CARBON RAPID RE; Ouisse V, 2011, MAR ECOL PROG SER, V437, P79, DOI 10.3354/meps09274; Pedersen MO, 2011, AQUAT MICROB ECOL, V65, P169, DOI 10.3354/ame01543; Phillip J., 1997, Journal of the Royal Society of Western Australia, V80, P63; Puttonen I, 2006, AUST J EARTH SCI, V53, P565, DOI 10.1080/08120090600632433; ROMERO J, 1994, AQUAT BOT, V47, P13, DOI 10.1016/0304-3770(94)90044-2; Serrano O, 2012, GEODERMA, V185, P26, DOI 10.1016/j.geoderma.2012.03.020; Silva J, 2005, J EXP MAR BIOL ECOL, V317, P87, DOI 10.1016/j.jembe.2004.11.010; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Torbatinejad NM, 2007, J AGR FOOD CHEM, V55, P4021, DOI 10.1021/jf063061a; Twiggs EJ, 2010, MAR GEOL, V275, P20, DOI 10.1016/j.margeo.2010.04.004; Walker D, 1999, SEAGRASS AUSTR STRAT, P1; West R.J., 1985, FISHERIES B, V2; Wilkie L, 2012, AQUAT BOT, V102, P15, DOI 10.1016/j.aquabot.2012.04.004; Woolfe KJ, 1998, AUST J EARTH SCI, V45, P611, DOI 10.1080/08120099808728416	66	248	252	9	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73748	10.1371/journal.pone.0073748	http://dx.doi.org/10.1371/journal.pone.0073748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040052	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600095
J	Cao, YX; Xu, W; Xiong, SD				Cao, Yanxia; Xu, Wei; Xiong, Sidong			Adoptive Transfer of Regulatory T Cells Protects against Coxsackievirus B3-Induced Cardiac Fibrosis	PLOS ONE			English	Article							TNF-ALPHA; INTERLEUKIN-10; LIVER; INFLAMMATION	Background: Cardiac fibrogenesis in the late stage of viral myocarditis causing contractile dysfunction and ventricular dilatation, is a major pathogenic factor for the progression of myocarditis to serious cardiovascular diseases including dilated cardiomyopathy (DCM) and congestive heart failure (HF). Recent studies indicate that regulatory T cells (Tregs) are involved in the fibrotic process of liver and lung fibosis. However, the role of Tregs in the development of viral myocarditis-caused cardiac fibrosis and their therapeutic potential remains unclear. Methodology/Principal Findings: Myocardial fibrosis was induced in BALB/c mice by intraperitoneal injection of Coxsackievirus B3 (CVB3) assessed by picrosirius red staining and detection of expression levels of collagen I, matrix metalloproteinase-1 (MMP-1), matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of metalloproteinase-1 (TIMP-1). Myocardial Treg frequency was down-regulated during the course of viral myocarditis and a negative correlation with the severity of cardiac fibrosis was found. To explore the role of Tregs in CVB-induced cardiac fibrosis, Treg was in vivo depleted by injecting anti-CD25 mAb which resulted in aggravation of cardiac fibrosis. In consistent with that, after adoptive transfer of isolated Tregs into mice, significant amelioration of CVB3-induced cardiac fibrosis was confirmed. Interleukin-10 (IL-10) neutralizing antibodies were used in vivo and in vitro to explore the molecular mechanism of the therapeutic effect of Treg. It was found that administration of anti-IL-10 mAb after Treg transfer abrogated Treg's treating effect and the inhibition of Treg on collagen production by cardiac fibroblasts was mediated mainly through IL-10. Conclusion/Significance: Our data suggested that Tregs have a protective role in the fibrotic process of CVB3-induced cardiac fibrosis via secreting IL-10 and might provide an alternative option for the future treatment of cardiac fibrosis.	[Cao, Yanxia; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200433, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China	Fudan University; Soochow University - China	Xu, W (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China.	xuweifd828@126.com; sdxiongfd@126.com			National Science Foundation of China [81072413, 31270973, 31170878, 81072409]; Major State Basic Research Development Program of China [2013CB531501]; Jiangsu "Pan-Deng" Project [BK2010004]; natural science foundation [12KJB310015]; QingLan Project; Priority Academic Program Development (PAPD) of the Jiangsu higher education institutions; Jiangsu "333" project of cultivation of high-level talents; Jiangsu Provincial Innovative Team; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1075]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Jiangsu "Pan-Deng" Project; natural science foundation(National Natural Science Foundation of China (NSFC)); QingLan Project(Jiangsu Polytech Institute); Priority Academic Program Development (PAPD) of the Jiangsu higher education institutions; Jiangsu "333" project of cultivation of high-level talents; Jiangsu Provincial Innovative Team; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the National Science Foundation of China (81072413, 31270973, 31170878, 81072409), Major State Basic Research Development Program of China (2013CB531501), Jiangsu "Pan-Deng" Project (BK2010004), the natural science foundation (12KJB310015) and QingLan Project as well as Priority Academic Program Development (PAPD) of the Jiangsu higher education institutions, Jiangsu "333" project of cultivation of high-level talents, Jiangsu Provincial Innovative Team, and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Brodlie M, 2011, EUR RESPIR J, V37, P1378, DOI 10.1183/09031936.00067110; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; HEDA K, 2009, CIRCULATION, V119, P2904, DOI DOI 10.1161/CIRCULATI0NAHA.108.832782.PUBMED:19470887; Huber SA, 2005, J VIROL, V79, P2659, DOI 10.1128/JVI.79.5.2659-2665.2005; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kong XN, 2013, J GASTROEN HEPATOL, V28, P56, DOI 10.1111/jgh.12032; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Lang C, 2008, J MOL MED-JMM, V86, P49, DOI 10.1007/s00109-007-0249-3; LESLIE KO, 1990, AM J PATHOL, V136, P683; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0; OREILLY S, 2013, BIOFACTORS, DOI DOI 10.1002/BI0F.1117; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Shi JH, 2013, ARCH DERMATOL RES, V305, P341, DOI 10.1007/s00403-013-1314-0; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tu CT, 2012, INT IMMUNOPHARMACOL, V14, P410, DOI 10.1016/j.intimp.2012.08.013; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEHLING HM, 2010, PLOS ONE, V5, P10763, DOI DOI 10.1371/J0URNAL.P0NE.0010763.PUBMED:20505827; Wei L, 2011, EXP MOL PATHOL, V90, P74, DOI 10.1016/j.yexmp.2010.10.004; Yu M, 2013, J CLIN IMMUNOL, V33, P1002, DOI 10.1007/s10875-013-9889-y; Yuan C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/617145; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zimmermann O, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003293	37	50	53	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74955	10.1371/journal.pone.0074955	http://dx.doi.org/10.1371/journal.pone.0074955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023968	Green Submitted, Green Published, gold			2022-12-25	WOS:000324515600162
J	Lewrenz, I; Rietzschel, N; Guiard, B; Lill, R; van der Laan, M; Voos, W				Lewrenz, Ilka; Rietzschel, Nicole; Guiard, Bernard; Lill, Roland; van der Laan, Martin; Voos, Wolfgang			The Functional Interaction of Mitochondrial Hsp70s with the Escort Protein Zim17 Is Critical for Fe/S Biogenesis and Substrate Interaction at the Inner Membrane Preprotein Translocase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S CLUSTER BIOGENESIS; MOLECULAR CHAPERONES; SACCHAROMYCES-CEREVISIAE; INTERDOMAIN LINKER; ATPASE ACTIVITY; IMPORT MOTOR; IN-VIVO; SCAFFOLD; DNAJ; BINDING	The yeast protein Zim17 belongs to a unique class of co-chaperones that maintain the solubility of Hsp70 proteins in mitochondria and plastids of eukaryotic cells. However, little is known about the functional cooperation between Zim17 and mitochondrial Hsp70 proteins in vivo. To analyze the effects of a loss of Zim17 function in the authentic environment, we introduced novel conditional mutations within the ZIM17 gene of the model organism Saccharomyces cerevisiae that allowed a recovery of temperature-sensitive but respiratory competent zim17 mutant cells. On fermentable growth medium, the mutant cells were prone to acquire respiratory deficits and showed a strong aggregation of the mitochondrial Hsp70 Ssq1 together with a concomitant defect in Fe/S protein biogenesis. In contrast, under respiring conditions, the mitochondrial Hsp70s Ssc1 and Ssq1 exhibited only a partial aggregation. We show that the induction of the zim17 mutant phenotype leads to strong import defects for Ssc1-dependent matrix-targeted precursor proteins that correlate with a significantly reduced binding of newly imported substrate proteins to Ssc1. We conclude that Zim17 is not only required for the maintenance of mtHsp70 solubility but also directly assists the functional interaction of mtHsp70 with substrate proteins in a J-type co-chaperone-dependent manner.	[Lewrenz, Ilka; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Rietzschel, Nicole; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Guiard, Bernard] Univ Paris 06, CNRS, Lab Propre, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [van der Laan, Martin] Univ Freiburg, Inst Biochem & Mol Biol ZBMZ, D-79104 Freiburg, Germany; [van der Laan, Martin] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Bonn; Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Freiburg; University of Freiburg	Voos, W (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de		Lill, Roland/0000-0002-8345-6518; van der Laan, Martin/0000-0003-0789-9912	Deutsche Forschungsgemeinschaft [VO657/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant VO657/5-1 (to W. V.).	Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Becker D, 2009, J BIOL CHEM, V284, P2934, DOI 10.1074/jbc.M803557200; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Blamowska M, 2012, J CELL BIOL, V199, P125, DOI 10.1083/jcb.201205012; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Westermann B, 1996, MOL CELL BIOL, V16, P7063; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200; Zhai P, 2011, BIOCHEM BIOPH RES CO, V408, P589, DOI 10.1016/j.bbrc.2011.04.066	41	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30931	30943		10.1074/jbc.M113.465997	http://dx.doi.org/10.1074/jbc.M113.465997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030826	Green Published, hybrid			2022-12-25	WOS:000330778900013
J	Shea, ME; Juarez, O; Cho, J; Barquera, B				Shea, Michael E.; Juarez, Oscar; Cho, Jonathan; Barquera, Blanca			Aspartic Acid 397 in Subunit B of the Na+-pumping NADH:Quinone Oxidoreductase from Vibrio cholerae Forms Part of a Sodium-binding Site, Is Involved in Cation Selectivity, and Affects Cation-binding Site Cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; QUINONE OXIDOREDUCTASE; UBIQUINONE OXIDOREDUCTASE; ALGINOLYTICUS; TRANSPORT; PROGRESS; DRIVEN; STEPS; CYCLE	The Na+-pumping NADH: quinone complex is found in Vibrio cholerae and other marine and pathogenic bacteria. NADH: ubiquinone oxidoreductase oxidizes NADH and reduces ubiquinone, using the free energy released by this reaction to pump sodium ions across the cell membrane. In a previous report, a conserved aspartic acid residue in the NqrB subunit at position 397, located in the cytosolic face of this protein, was proposed to be involved in the capture of sodium. Here, we studied the role of this residue through the characterization of mutant enzymes in which this aspartic acid was substituted by other residues that change charge and size, such as arginine, serine, lysine, glutamic acid, and cysteine. Our results indicate that NqrB-Asp-397 forms part of one of the at least two sodium-binding sites and that both size and charge at this position are critical for the function of the enzyme. Moreover, we demonstrate that this residue is involved in cation selectivity, has a critical role in the communication between sodium-binding sites, by promoting cooperativity, and controls the electron transfer step involved in sodium uptake (2Fe-2S -> FMNC).	Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Rm 2239 CBIS, Troy, NY 12180 USA.	barqub@rpi.edu		Cho, Jonathan/0000-0001-6280-9030; Juarez, Oscar/0000-0002-2915-8413				Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Dashper SG, 2001, J BACTERIOL, V183, P4142, DOI 10.1128/JB.183.14.4142-4148.2001; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P458, DOI 10.1016/0005-2728(86)90114-3; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kojima S, 1999, J BACTERIOL, V181, P1927, DOI 10.1128/JB.181.6.1927-1930.1999; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Roitel O, 1999, BIOCHEMISTRY-US, V38, P16084, DOI 10.1021/bi9912802; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Steuber J, 1997, EUR J BIOCHEM, V249, P770, DOI 10.1111/j.1432-1033.1997.t01-2-00770.x	19	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31241	31249		10.1074/jbc.M113.510776	http://dx.doi.org/10.1074/jbc.M113.510776			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030824	Green Published, hybrid			2022-12-25	WOS:000330778900040
J	Roldan, JLO; Casares, S; Jensen, MR; Cardenes, N; Bravo, J; Blackledge, M; Azuaga, AI; van Nuland, NAJ				Ortega Roldan, Jose L.; Casares, Salvador; Ringkjobing Jensen, Malene; Cardenes, Nayra; Bravo, Jeronimo; Blackledge, Martin; Azuaga, Ana I.; van Nuland, Nico A. J.			Distinct Ubiquitin Binding Modes Exhibited by SH3 Domains: Molecular Determinants and Functional Implications	PLOS ONE			English	Article							PROTEIN-STRUCTURE; DOWN-REGULATION; CIN85; CBL; QUALITY; SUBSET	SH3 domains constitute a new type of ubiquitin-binding domains. We previously showed that the third SH3 domain (SH3-C) of CD2AP binds ubiquitin in an alternative orientation. We have determined the structure of the complex between first CD2AP SH3 domain and ubiquitin and performed a structural and mutational analysis to decipher the determinants of the SH3-C binding mode to ubiquitin. We found that the Phe-to-Tyr mutation in CD2AP and in the homologous CIN85 SH3-C domain does not abrogate ubiquitin binding, in contrast to previous hypothesis and our findings for the first two CD2AP SH3 domains. The similar alternative binding mode of the SH3-C domains of these related adaptor proteins is characterised by a higher affinity to C-terminal extended ubiquitin molecules. We conclude that CD2AP/CIN85 SH3-C domain interaction with ubiquitin constitutes a new ubiquitin-binding mode involved in a different cellular function and thus changes the previously established mechanism of EGF-dependent CD2AP/CIN85 mono-ubiquitination.	[Ortega Roldan, Jose L.; Casares, Salvador; Azuaga, Ana I.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain; [Ortega Roldan, Jose L.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ringkjobing Jensen, Malene; Blackledge, Martin] CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, UJF UMR 5075, Grenoble, France; [Cardenes, Nayra] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Bravo, Jeronimo] CSIC, IBV, Valencia, Spain; [van Nuland, Nico A. J.] Vrije Univ Brussel, Brussels, Belgium; [van Nuland, Nico A. J.] VIB, Dept Biol Struct, Brussels, Belgium	University of Granada; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Azuaga, AI (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain.	aiazuaga@ugr.es; nvnuland@vub.ac.be	Bravo, Jeronimo/K-9103-2014; Orega-Roldan, Jose/K-4396-2019	Bravo, Jeronimo/0000-0001-6695-2846; Orega-Roldan, Jose/0000-0002-6316-4390; Jensen, Malene R./0000-0003-0419-2196	Spanish Ministry of Education and Science (MEC) [BIO2005-04650]; Andalucia Regional Government [FQM-02838]; Spanish Ministry of Education and Innovation [SAF2009-10667]; Federation of European Biochemical Societies (FEBS); University of Granada; European Union	Spanish Ministry of Education and Science (MEC)(Spanish Government); Andalucia Regional Government; Spanish Ministry of Education and Innovation(Spanish Government); Federation of European Biochemical Societies (FEBS); University of Granada; European Union(European Commission)	This research was funded by grant BIO2005-04650 from the Spanish Ministry of Education and Science (MEC) and FQM-02838 from the Andalucia Regional Government. Work at J.B. laboratory was funded by the Spanish Ministry of Education and Innovation (SAF2009-10667). J.L.O.R. is supported by a Federation of European Biochemical Societies (FEBS) post-doctoral grant. S. C. A. is supported by a resettlement contract from the University of Granada. N.A.J.v.N is a group leader of the Vlaams Instituut voor Biotechnologie (VIB). The 600 MHz spectra were recorded in the Centre for Scientific Instrumentation (CIC) of the University of Granada and at the RALF Large Scale Facility in Grenoble, which is funded by the 'Access to Research Infrastructures' program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bezsonova I, 2008, BIOCHEMISTRY-US, V47, P8937, DOI 10.1021/bi800439t; Casares S, 2007, PROTEINS, V67, P531, DOI 10.1002/prot.21284; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Goddart TD, 1993, SPARKY 3; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; He Y, 2007, J MOL BIOL, V373, P190, DOI 10.1016/j.jmb.2007.07.074; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hus JC, 2000, J MOL BIOL, V298, P927, DOI 10.1006/jmbi.2000.3714; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kang J, 2008, BBA-PROTEINS PROTEOM, V1784, P1335, DOI 10.1016/j.bbapap.2008.04.031; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Korzhnev DM, 2009, J MOL BIOL, V386, P391, DOI 10.1016/j.jmb.2008.11.055; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Ortega-Roldan JL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp211; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ortega-Roldan JL, 2011, J BIOMOL NMR; Pawson T, 2002, FEBS LETT, V513, P2, DOI 10.1016/S0014-5793(01)03292-6; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Philippe D, 2011, BIOCHEMISTRY; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Salmon L, 2011, ANGEW CHEM INT EDIT, V50, P3755, DOI 10.1002/anie.201100310; Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stamenova SD, 2007, MOL CELL, V25, P273, DOI 10.1016/j.molcel.2006.12.016; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Verdier F, 2002, EUR J BIOCHEM, V269, P3402, DOI 10.1046/j.1432-1033.2002.03031.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73018	10.1371/journal.pone.0073018	http://dx.doi.org/10.1371/journal.pone.0073018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039852	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500022
J	Meplan, C; Dragsted, LO; Ravn-Haren, G; Tjonneland, A; Vogel, U; Hesketh, J				Meplan, Catherine; Dragsted, Lars Ove; Ravn-Haren, Gitte; Tjonneland, Anne; Vogel, Ulla; Hesketh, John			Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GPX1 PRO198LEU POLYMORPHISM; NO ASSOCIATION; ALCOHOL INTAKE; HEREDITARY BREAST; OXIDATIVE STRESS; DNA-DAMAGE; SELENIUM; ESTROGEN; CONSUMPTION	Breast cancer (BC) is one of the most common cancers in women. Evidence suggests that genetic variation in antioxidant enzymes could influence BC risk, but to date the relationship between selenoproteins and BC risk remains unclear. In this report, a study population including 975 Danish cases and 975 controls matched for age and hormone replacement therapy (HRT) use was genotyped for five functional single nucleotide polymorphisms (SNPs) in SEPP1, GPX1, GPX4 and the antioxidant enzyme SOD2 genes. The influence of genetic polymorphisms on breast cancer risk was assessed using conditional logistic regression. Additionally pre-diagnosis erythrocyte GPx (eGPx) activity was measured in a sub-group of the population. A 60% reduction in risk of developing overall BC and ductal BC was observed in women who were homozygous Thr carriers for SEPP1 rs3877899. Additionally, Leu carriers for GPX1 Pro198Leu polymorphism (rs1050450) were at similar to 2 fold increased risk of developing a non-ductal BC. Pre-diagnosis eGPx activity was found to depend on genotype for rs713041 (GPX4), rs3877899 (SEPP1), and rs1050450 (GPX1) and on HRT use. Moreover, depending on genotype and HRT use, eGPx activity was significantly lower in women who developed BC later in life compared with controls. Furthermore, GPx1 protein levels increased in human breast adenocarcinoma MCF7 cells exposed to beta-estradiol and sodium selenite. In conclusion, our data provide evidence that SNPs in SEPP1 and GPX1 modulate risk of BC and that eGPx activity is modified by SNPs in SEPP1, GPX4 and GPX1 and by estrogens. Our data thus suggest a role of selenoproteins in BC development.	[Meplan, Catherine; Hesketh, John] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Meplan, Catherine; Hesketh, John] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dragsted, Lars Ove; Ravn-Haren, Gitte] Univ Copenhagen, Dept Human Nutr, Frederiksberg, Denmark; [Ravn-Haren, Gitte] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark	Newcastle University - UK; Newcastle University - UK; University of Copenhagen; Technical University of Denmark; Danish Cancer Society; National Research Centre for the Working Environment	Vogel, U (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.	ubv@nrcwe.dk; j.e.hesketh@ncl.ac.uk	Vogel, Ulla B/I-5048-2012; Dragsted, Lars O./N-3384-2014; Ravn-Haren, Gitte/I-8551-2018; Vogel, Ulla/ABC-2212-2020; Dragsted, Lars Ove/AAT-1713-2020	Vogel, Ulla B/0000-0001-6807-1524; Dragsted, Lars O./0000-0003-0609-6317; Ravn-Haren, Gitte/0000-0002-4587-089X; Vogel, Ulla/0000-0001-6807-1524; Dragsted, Lars Ove/0000-0003-0609-6317; Tjonneland, Anne/0000-0003-4385-2097	Newcastle Healthcare Charity; Biotechnology and Biological Sciences Research Council; Nutrition Biomics Innovation (NuBI) from The Danish Ministry of Food, Agriculture and Fisheries [3304-FVFP-060696]	Newcastle Healthcare Charity; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nutrition Biomics Innovation (NuBI) from The Danish Ministry of Food, Agriculture and Fisheries	CM was supported by Newcastle Healthcare Charity and Biotechnology and Biological Sciences Research Council. The work was supported by the grant Nutrition Biomics Innovation (NuBI) from The Danish Ministry of Food, Agriculture and Fisheries (J.nr. 3304-FVFP-060696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2005, CANCER EPIDEM BIOMAR, V14, P2459, DOI 10.1158/1055-9965.EPI-05-0459; Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Bermano G, 2010, CANCER BIOMARK, V7, P39, DOI 10.3233/CBM-2010-0146; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Charalabopoulos K, 2006, BRIT J CANCER, V95, P674, DOI 10.1038/sj.bjc.6603292; Cooper ML, 2008, CANCER RES, V68, P10171, DOI 10.1158/0008-5472.CAN-08-1827; Cox DG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-217; Cox DG, 2004, CANCER EPIDEM BIOMAR, V13, P1821; Crawford A, 2012, GENE, V501, P89, DOI 10.1016/j.gene.2012.04.011; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Elston C W, 2002, Histopathology, V41, P154; Forsberg L, 2000, BLOOD CELL MOL DIS, V26, P423, DOI 10.1006/bcmd.2000.0325; Ha EJ, 2003, J AM COLL NUTR, V22, P43, DOI 10.1080/07315724.2003.10719274; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Hesketh J, 2011, P NUTR SOC, V70, P365, DOI 10.1017/S0029665111000115; Hu J, 2010, BREAST CANCER RES TR, V124, P425, DOI 10.1007/s10549-010-0841-z; Hu YJ, 2005, J NUTR, V135, p3021S, DOI 10.1093/jn/135.12.3021S; Hu YJ, 2003, CANCER RES, V63, P3347; Jablonska E, 2009, EUR J NUTR, V48, P383, DOI 10.1007/s00394-009-0023-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Knight JA, 2004, CANCER EPIDEM BIOMAR, V13, P146, DOI 10.1158/1055-9965.EPI-03-0164; Larsen SB, 2010, CANCER LETT, V295, P191, DOI 10.1016/j.canlet.2010.02.023; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; Lopez-Saez JB, 2003, ONCOLOGY-BASEL, V64, P227, DOI 10.1159/000069312; Meindl A, 2011, DTSCH ARZTEBL INT, V108, P323, DOI 10.3238/arztebl.2011.0323; Meplan C, 2008, AM J CLIN NUTR, V87, P1019, DOI 10.1093/ajcn/87.4.1019; Meplan C, 2007, FASEB J, V21, P3063, DOI 10.1096/fj.07-8166com; Meplan C, 2009, ANTIOXID REDOX SIGN, V11, P2631, DOI [10.1089/ars.2009.2533, 10.1089/ARS.2009.2533]; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Petersen RK, 2012, CANCER LETT, V315, P59, DOI 10.1016/j.canlet.2011.10.009; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Rayman MP, 2002, P NUTR SOC, V61, P203, DOI 10.1079/PNS2002153; Riscuta Gabriela, 2012, Methods Mol Biol, V863, P343, DOI 10.1007/978-1-61779-612-8_22; ROY D, 1989, CANCER RES, V49, P1475; Saito Y, 2004, BIOCHEM J, V381, P841, DOI 10.1042/BJ20040328; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P2958, DOI 10.1158/1055-9965.EPI-10-0364; Terry MB, 2006, CARCINOGENESIS, V27, P840, DOI 10.1093/carcin/bgi285; Tjonneland A, 2004, J NUTR, V134, P173, DOI 10.1093/jn/134.1.173; Tsai SM, 2012, ANN CLIN BIOCHEM, V49, P152, DOI 10.1258/acb.2011.011098; Udler M, 2007, J CLIN ONCOL, V25, P3015, DOI 10.1200/JCO.2006.10.0099; Vera-Ramirez L, 2013, CRIT REV FOOD SCI, V53, P49, DOI 10.1080/10408398.2010.521600; Villette S, 2002, BLOOD CELL MOL DIS, V29, P174, DOI 10.1006/bcmd.2002.0556; Vogel U, 2003, CANCER EPIDEM BIOMAR, V12, P170; Vogel U, 2007, CARCINOGENESIS, V28, P427, DOI 10.1093/carcin/bgl170; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027642; Yager J D, 2000, J Natl Cancer Inst Monogr, P67; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Zhou XD, 2012, J NUTR BIOCHEM, V23, P532, DOI 10.1016/j.jnutbio.2011.02.008	56	56	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73316	10.1371/journal.pone.0073316	http://dx.doi.org/10.1371/journal.pone.0073316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039907	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600024
J	Muller, V; Sanger, J; Lindenberger, U				Mueller, Viktor; Saenger, Johanna; Lindenberger, Ulman			Intra- and Inter-Brain Synchronization during Musical Improvisation on the Guitar	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; PHASE SYNCHRONIZATION; CORTICAL NETWORKS; VIRTUAL BRAIN; EEG; FREQUENCY; COMPLEX; MEG	Humans interact with the environment through sensory and motor acts. Some of these interactions require synchronization among two or more individuals. Multiple-trial designs, which we have used in past work to study interbrain synchronization in the course of joint action, constrain the range of observable interactions. To overcome the limitations of multiple-trial designs, we conducted single-trial analyses of electroencephalography (EEG) signals recorded from eight pairs of guitarists engaged in musical improvisation. We identified hyper-brain networks based on a complex interplay of different frequencies. The intra-brain connections primarily involved higher frequencies (e. g., beta), whereas inter-brain connections primarily operated at lower frequencies (e. g., delta and theta). The topology of hyper-brain networks was frequency-dependent, with a tendency to become more regular at higher frequencies. We also found hyper-brain modules that included nodes (i.e., EEG electrodes) from both brains. Some of the observed network properties were related to musical roles during improvisation. Our findings replicate and extend earlier work and point to mechanisms that enable individuals to engage in temporally coordinated joint action.	[Mueller, Viktor; Saenger, Johanna; Lindenberger, Ulman] Max Planck Inst Human Dev & Educ, Ctr Lifespan Psychol, Berlin, Germany	Max Planck Society	Muller, V (corresponding author), Max Planck Inst Human Dev & Educ, Ctr Lifespan Psychol, Berlin, Germany.	vmueller@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021	Muller, Viktor/0000-0002-3716-5445	Max Planck Society; German Research Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Max Planck Society and the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Andres FG, 1999, BRAIN, V122, P855, DOI 10.1093/brain/122.5.855; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Babiloni F, 2007, P ANN INT IEEE EMBS, P4957, DOI 10.1109/IEMBS.2007.4353453; Babiloni F, 2007, P ANN INT IEEE EMBS, P4953, DOI 10.1109/IEMBS.2007.4353452; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Boersma M, 2011, HUM BRAIN MAPP, V32, P413, DOI 10.1002/hbm.21030; Caplan JB, 2003, J NEUROSCI, V23, P4726; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; De Vico Fallani F, NEUROIMAGE IN PRESS, DOI [org/10.1016/j.neuro-image.2013.06.032, DOI 10.1016/J.NEUR0-IMAGE.2013.06.032]; Deiber MP, 2001, CLIN NEUROPHYSIOL, V112, P1419, DOI 10.1016/S1388-2457(01)00536-3; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hoffmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003004; Jin CW, 2011, NEUROSCI LETT, V503, P105, DOI 10.1016/j.neulet.2011.08.017; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Jirsa V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00078; Joudaki Amir, 2012, PLoS One, V7, pe35673, DOI 10.1371/journal.pone.0035673; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Mizuhara H, 2005, NEUROIMAGE, V27, P553, DOI 10.1016/j.neuroimage.2005.04.030; Muller V, 2012, DEVELOPMENTAL SCI, V15, P540, DOI 10.1111/j.1467-7687.2012.01153.x; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sanger J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00312; Sanger Johanna, 2011, Commun Integr Biol, V4, P655; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Smit DJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036896; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Telesford QK, 2011, BRAIN CONNECT, V1, P295, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; van Straaten ECW, 2013, EUR NEUROPSYCHOPHARM, V23, P7, DOI 10.1016/j.euroneuro.2012.10.010; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	67	80	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73852	10.1371/journal.pone.0073852	http://dx.doi.org/10.1371/journal.pone.0073852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040094	gold, Green Published			2022-12-25	WOS:000327538600049
J	Oliferenko, PV; Oliferenko, AA; Poda, GI; Osolodkin, DI; Pillai, GG; Bernier, UR; Tsikolia, M; Agramonte, NM; Clark, GG; Linthicum, KJ; Katritzky, AR				Oliferenko, Polina V.; Oliferenko, Alexander A.; Poda, Gennadiy I.; Osolodkin, Dmitry I.; Pillai, Girinath G.; Bernier, Ulrich R.; Tsikolia, Maia; Agramonte, Natasha M.; Clark, Gary G.; Linthicum, Kenneth J.; Katritzky, Alan R.			Promising Aedes aegypti Repellent Chemotypes Identified through Integrated QSAR, Virtual Screening, Synthesis, and Bioassay	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; YELLOW-FEVER-MOSQUITO; ANOPHELES-GAMBIAE; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ESSENTIAL OILS; INSECT; RECEPTORS; MALARIA; INHIBITION	Molecular field topology analysis, scaffold hopping, and molecular docking were used as complementary computational tools for the design of repellents for Aedes aegypti, the insect vector for yellow fever, chikungunya, and dengue fever. A large number of analogues were evaluated by virtual screening with Glide molecular docking software. This produced several dozen hits that were either synthesized or procured from commercial sources. Analysis of these compounds by a repellent bioassay resulted in a few highly active chemicals (in terms of minimum effective dosage) as viable candidates for further hit-to-lead and lead optimization effort.	[Oliferenko, Polina V.; Oliferenko, Alexander A.; Pillai, Girinath G.; Katritzky, Alan R.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Poda, Gennadiy I.] Ontario Inst Canc Res, Toronto, ON, Canada; [Osolodkin, Dmitry I.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Pillai, Girinath G.] Univ Tartu, Inst Chem, EE-50090 Tartu, Estonia; [Bernier, Ulrich R.; Tsikolia, Maia; Agramonte, Natasha M.; Clark, Gary G.; Linthicum, Kenneth J.] ARS, USDA, CMAVE, Gainesville, FL USA; [Katritzky, Alan R.] King Abdulaziz Univ, Dept Chem, Jeddah 21413, Saudi Arabia	State University System of Florida; University of Florida; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Lomonosov Moscow State University; University of Tartu; United States Department of Agriculture (USDA); King Abdulaziz University	Bernier, UR (corresponding author), ARS, USDA, CMAVE, Gainesville, FL USA.	uli.bernier@ars.usda.gov; katritzky@chem.ufl.edu	Agramonte, Natasha/AAS-1401-2020; Osolodkin, Dmitry/D-6732-2011; Pillai, Girinath G./C-6459-2009	Agramonte, Natasha/0000-0002-6247-3837; Osolodkin, Dmitry/0000-0002-0462-2945; Pillai, Girinath G./0000-0003-3770-9585; Bernier, Ulrich/0000-0002-4710-6801	Deployed War-Fighter Protection Research Program; United States Department of Defense through the Armed Forces Pest Management Board; Ontario Ministry of Economic Development and Innovation, Ontario, Canada	Deployed War-Fighter Protection Research Program; United States Department of Defense through the Armed Forces Pest Management Board(United States Department of Defense); Ontario Ministry of Economic Development and Innovation, Ontario, Canada	This work was partly supported by the Deployed War-Fighter Protection Research Program and funded by the United States Department of Defense through the Armed Forces Pest Management Board. Funding for OICR is provided by the Ontario Ministry of Economic Development and Innovation, Ontario, Canada. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belova OA, 2012, TICKS TICK-BORNE DIS, V3, P240, DOI 10.1016/j.ttbdis.2012.05.005; Bhattacharjee AK, 2005, QSAR COMB SCI, V24, P593, DOI 10.1002/qsar.200430914; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; BLOMQUIST GJ, 2003, INSECT PHEROMONE BIO, pCH14; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152; Chupakhin VI, 2008, DOKL CHEM, V422, P227, DOI 10.1134/S0012500808090073; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Crasto CJ, 2009, CURR BIOINFORM, V4, P8, DOI 10.2174/157489309787158143; CROCKER DR, 1990, P 14 VERT PEST C; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Debboun M, 2007, INSECT REPELLENTS PR; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Enan E, 2001, COMP BIOCHEM PHYS C, V130, P325, DOI 10.1016/S1532-0456(01)00255-1; *EPA, 1999, EPA PROD PERF TEST G; Garcia-Domenech R, 2008, CHEM REV, V108, P1127, DOI 10.1021/cr0780006; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Ha TS, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.010.2009; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; JACHOWSKI LA, 1946, SCIENCE, V104, P266, DOI 10.1126/science.104.2699.266; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; JONES HA, 1946, Patent No. 2396013; Kaissling KE, 2009, J COMP PHYSIOL A, V195, P895, DOI 10.1007/s00359-009-0461-4; Katritzky AR, 2008, P NATL ACAD SCI USA, V105, P7359, DOI 10.1073/pnas.0800571105; Katritzky AR, 2010, J MED ENTOMOL, V47, P924, DOI 10.1603/ME09284; Kaufman PE, 2010, PEST MANAG SCI, V66, P497, DOI 10.1002/ps.1899; Kostyukovsky M, 2002, PEST MANAG SCI, V58, P1101, DOI 10.1002/ps.548; LAGARDE A, 2007, BIOCHEM J, V437, P423; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; MCGOVERN TP, 1975, MOSQ NEWS, V35, P204; Mel'nikov AA, 2005, DOKL CHEM, V402, P81, DOI 10.1007/s10631-005-0039-9; Natarajan R, 2008, CROAT CHEM ACTA, V81, P333; Paluch G, 2010, PEST MANAG SCI, V66, P925, DOI 10.1002/ps.1974; Paluch G, 2009, J AGR FOOD CHEM, V57, P7618, DOI 10.1021/jf900964e; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851; POSEY KH, 1981, MOSQ NEWS, V41, P566; Prateek Sharma, 2011, Journal of Chemical and Pharmaceutical Research, V3, P403; Radchenko EV, 2008, DOKL BIOCHEM BIOPHYS, V418, P47, DOI 10.1134/S1607672908010122; REN H, 2011, PROTEIN DATA BANK RE; Rospars JP, 2007, BIOSYSTEMS, V89, P101, DOI 10.1016/j.biosystems.2006.05.015; Rospars JP, 2003, EUR J NEUROSCI, V18, P1135, DOI 10.1046/j.1460-9568.2003.02766.x; RYAN MF, 1988, J CHEM ECOL, V14, P1965, DOI 10.1007/BF01013489; Sandstrom M, 2009, J COMPUT NEUROSCI, V27, P337, DOI 10.1007/s10827-009-0147-5; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Schmuker M, 2007, P NATL ACAD SCI USA, V104, P20285, DOI 10.1073/pnas.0705683104; Schultze A, 2012, INSECT MOL BIOL, V21, P187, DOI 10.1111/j.1365-2583.2011.01125.x; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; STECK K, 2012, SCI REP, V361, P1; SURYANARAYANA MVS, 1991, J PHARM SCI, V80, P1055, DOI 10.1002/jps.2600801111; Syed Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017705; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; WHO, 2009, GUID EFF TEST MOSQ R; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015403; Yang G, 2011, PROTEIN EXPRES PURIF, V75, P165, DOI 10.1016/j.pep.2010.09.004; Zhan WQ, 2007, J MED CHEM, V50, P5655, DOI 10.1021/jm070679i	74	31	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e64547	10.1371/journal.pone.0064547	http://dx.doi.org/10.1371/journal.pone.0064547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039693	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500001
J	Chen, ZL; Zhong, YW; Wang, Y; Xu, S; Liu, Z; Baskakov, IV; Monteiro, MJ; Karbowski, M; Shen, YX; Fang, SY				Chen, Zhiliang; Zhong, Yongwang; Wang, Yang; Xu, Shan; Liu, Zheng; Baskakov, Ilia V.; Monteiro, Mervyn J.; Karbowski, Mariusz; Shen, Yuxian; Fang, Shengyun			Ubiquitination-Induced Fluorescence Complementation (UiFC) for Detection of K48 Ubiquitin Chains In Vitro and in Live Cells	PLOS ONE			English	Article							HIGH-THROUGHPUT SCREEN; BINDING-PROTEIN; POLYUBIQUITIN CHAINS; LIGASE ACTIVITY; DEGRADATION; PROTEASOME; IDENTIFICATION; LOCALIZATION; INHIBITORS; SYSTEM	Proteins can be modified with eight homogenous ubiquitin chains linked by an isopeptide bond between the C-terminus of one ubiquitin and an amine from one of the seven lysines or the N-terminal methionine of the next ubiquitin. These topologically distinct ubiquitin chains signal for many essential cellular functions, such as protein degradation, cell cycle progression, DNA repair, and signal transduction. The lysine 48 (K48)-linked ubiquitin chain is one of the most abundant chains and a major proteasome-targeting signal in cells. Despite recent advancements in imaging linkage-specific polyubiquitin chains, no tool is available for imaging K48 chains in live cells. Here we report on a ubiquitination-induced fluorescence complementation (UiFC) assay for detecting K48 ubiquitin chains in vitro and in live cells. For this assay, two nonfluorescent fragments of a fluorescent protein were fused to the ubiquitin-interacting motifs (UIMs) of epsin1 protein. Upon simultaneous binding to a ubiquitin chain, the nonfluorescent fragments of the two fusion proteins are brought in close proximity to reconstitute fluorescence. When used in vitro, UiFC preferentially detected K48 ubiquitin chains with excellent signal-to-noise ratio. Time-lapse imaging revealed that UiFC is capable of monitoring increases in polyubiquitination induced by treatment with proteasome inhibitor, by agents that induce stress, and during mitophagy in live cells.	[Chen, Zhiliang; Zhong, Yongwang; Wang, Yang; Xu, Shan; Liu, Zheng; Baskakov, Ilia V.; Monteiro, Mervyn J.; Karbowski, Mariusz; Fang, Shengyun] Anhui Med Univ, Ctr Biomed Engn & Technol, Hefei, Peoples R China; [Chen, Zhiliang; Zhong, Yongwang; Wang, Yang; Liu, Zheng; Fang, Shengyun] Anhui Med Univ, Dept Physiol, Hefei, Peoples R China; [Wang, Yang; Shen, Yuxian] Anhui Med Univ, Sch Basic Med Sci, Hefei, Peoples R China; [Wang, Yang; Shen, Yuxian] Anhui Med Univ, Biopharmaceut Res Inst, Hefei, Peoples R China; [Xu, Shan; Karbowski, Mariusz; Fang, Shengyun] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; University System of Maryland; University of Maryland Baltimore	Karbowski, M (corresponding author), Anhui Med Univ, Ctr Biomed Engn & Technol, Hefei, Peoples R China.	mkarbowski@umaryland.edu; shenyx@ustc.edu.cn; sfang@umaryland.edu	Zhong, Yongwang/A-2527-2012; Fang, Shengyun/H-3802-2011; Xu, Shan/F-7268-2014	Fang, Shengyun/0000-0001-7280-5463; Shen, Yuxian/0000-0002-0916-0743	 [NSF1120833];  [NSFC30772557];  [RO1GM083131]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102177, R01GM083131] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants NSF1120833 to SF, NSFC30772557 to YS and RO1GM083131 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Braten O, 2012, BIOCHEM J, V444, P611, DOI 10.1042/BJ20111840; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Davydov IV, 2004, J BIOMOL SCREEN, V9, P695, DOI 10.1177/1087057104267956; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Engels IH, 2009, ANAL BIOCHEM, V390, P85, DOI 10.1016/j.ab.2009.03.035; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Fushman David, 2011, F1000 Biol Rep, V3, P26, DOI 10.3410/B3-26; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu JB, 2008, AM J PHYSIOL-HEART C, V295, pH2541, DOI 10.1152/ajpheart.01052.2008; Mandili G, 2012, FEBS J, V279, P2182, DOI 10.1111/j.1742-4658.2012.08602.x; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Murray MF, 2007, J BIOMOL SCREEN, V12, P1050, DOI 10.1177/1087057107308556; NATHAN JA, 2013, EMBO J; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Parvatiyar K, 2010, SCIENCE, V328, P1244, DOI 10.1126/science.1192296; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sasiela CA, 2008, J BIOMOL SCREEN, V13, P229, DOI 10.1177/1087057108315038; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yagishita N, 2012, INT J MOL MED, V30, P1281, DOI 10.3892/ijmm.2012.1129; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906	60	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73482	10.1371/journal.pone.0073482	http://dx.doi.org/10.1371/journal.pone.0073482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039955	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600081
J	Evans-Illidge, EA; Logan, M; Doyle, J; Fromont, J; Battershill, CN; Ericson, G; Wolff, CW; Muirhead, A; Kearns, P; Abdo, D; Kininmonth, S; Llewellyn, L				Evans-Illidge, Elizabeth A.; Logan, Murray; Doyle, Jason; Fromont, Jane; Battershill, Christopher N.; Ericson, Gavin; Wolff, Carsten W.; Muirhead, Andrew; Kearns, Phillip; Abdo, David; Kininmonth, Stuart; Llewellyn, Lyndon			Phylogeny Drives Large Scale Patterns in Australian Marine Bioactivity and Provides a New Chemical Ecology Rationale for Future Biodiscovery	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NATURAL-PRODUCTS; BIODIVERSITY HOTSPOTS; CYTOTOXIC MACROLIDES; SPONGES; ELEUTHEROBIN; PACLITAXEL; DIVERSITY; DEFENSE; CONSERVATION	5 Twenty-five years of Australian marine bioresources collecting and research by the Australian Institute of Marine Science (AIMS) has explored the breadth of latitudinally and longitudinally diverse marine habitats that comprise Australia's ocean territory. The resulting AIMS Bioresources Library and associated relational database integrate biodiversity with bioactivity data, and these resources were mined to retrospectively assess biogeographic, taxonomic and phylogenetic patterns in cytotoxic, antimicrobial, and central nervous system (CNS)-protective bioactivity. While the bioassays used were originally chosen to be indicative of pharmaceutically relevant bioactivity, the results have qualified ecological relevance regarding secondary metabolism. In general, metazoan phyla along the deuterostome phylogenetic pathway (eg to Chordata) and their ancestors (eg Porifera and Cnidaria) had higher percentages of bioactive samples in the assays examined. While taxonomy at the phylum level and higher-order phylogeny groupings helped account for observed trends, taxonomy to genus did not resolve the trends any further. In addition, the results did not identify any biogeographic bioactivity hotspots that correlated with biodiversity hotspots. We conclude with a hypothesis that high-level phylogeny, and therefore the metabolic machinery available to an organism, is a major determinant of bioactivity, while habitat diversity and ecological circumstance are possible drivers in the activation of this machinery and bioactive secondary metabolism. This study supports the strategy of targeting phyla from the deuterostome lineage (including ancestral phyla) from biodiverse marine habitats and ecological niches, in future biodiscovery, at least that which is focused on vertebrate (including human) health.	[Evans-Illidge, Elizabeth A.; Logan, Murray; Doyle, Jason; Battershill, Christopher N.; Ericson, Gavin; Wolff, Carsten W.; Muirhead, Andrew; Kearns, Phillip; Abdo, David; Kininmonth, Stuart; Llewellyn, Lyndon] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Fromont, Jane] Western Australian Museum, Welshpool, WA, Australia	Australian Institute of Marine Science; Western Australian Museum	Evans-Illidge, EA (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	e.evansillidge@aims.gov.au	Llewellyn, Lyndon E/F-6030-2011; Kininmonth, Stuart/N-9299-2013; Evans-Illidge, Libby/AAK-1521-2021; Battershill, Christopher/G-2663-2013	Llewellyn, Lyndon E/0000-0003-1680-1796; Kininmonth, Stuart/0000-0001-9198-3396; Logan, Murray/0000-0001-5102-3972; Battershill, Christopher/0000-0002-5586-0417	Australian Institute of Marine Science; US National Cancer Institute; Western Australian Marine Science Institution; Australian biotechnology research and development company, AMRAD Corporation Ltd.	Australian Institute of Marine Science; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Western Australian Marine Science Institution; Australian biotechnology research and development company, AMRAD Corporation Ltd.	The paper presents a collation and analysis of the results of a composite of research projects conducted over 25 years. During this time, funding has come primarily from the Australian Institute of Marine Science (government appropriation funding). Funding support was also provided from the US National Cancer Institute, the Western Australian Marine Science Institution, and the Australian biotechnology research and development company, AMRAD Corporation Ltd. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2007, J CHEM ECOL, V33, P1635, DOI 10.1007/s10886-007-9326-x; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; Arrieta JM, 2010, P NATL ACAD SCI USA, V107, P18318, DOI 10.1073/pnas.0911897107; Atta-ur-Rahman, 2002, PURE APPL CHEM, V74, P511; Bai RL, 2011, J CHEM INF MODEL, V51, P1393, DOI 10.1021/ci200077t; Battershill Chris, 2005, Biologist (London), V52, P107; Becerro MA, 1997, HYDROBIOLOGIA, V355, P77, DOI 10.1023/A:1003019221354; Becerro MA, 1997, J CHEM ECOL, V23, P1527, DOI 10.1023/B:JOEC.0000006420.04002.2e; Bergquist P.R., 1978, SPONGES; Bialonska D, 2009, MAR DRUGS, V7, P166, DOI 10.3390/md7020166; Blunt J, 2010, MARINLIT; Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Carrizosa S, 2004, MARINE BIODIVERSITY; Castoldi D, 2006, CHEM-EUR J, V12, P51, DOI 10.1002/chem.200500749; CBD, 2005, HDB CONV BIOL DIV IN, V3rd; Chandrasekhar S, 2004, BIOORG MED CHEM LETT, V14, P3687, DOI 10.1016/j.bmcl.2004.05.017; Chiang GCH, 2005, CHEM COMMUN, P1860, DOI 10.1039/b413426e; Colasanti M, 1998, MOL NEUROBIOL, V17, P157, DOI 10.1007/BF02802029; Doyle JR, 2005, J BIOMOL SCREEN, V10, P67, DOI 10.1177/1087057104269978; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Erickson KL, 1997, J ORG CHEM, V62, P8188, DOI 10.1021/jo971556g; Evans-Illidge EA, 2007, J BIOLAW BUSINESS S, P23; Evans-Illidge Elizabeth A., 1999, Memoirs of the Queensland Museum, V44, P161; Ferretti C, 2009, MAR ECOL-EVOL PERSP, V30, P327, DOI 10.1111/j.1439-0485.2008.00278.x; Fromont J, 2006, BIODIVERS CONSERV, V15, P3731, DOI 10.1007/s10531-004-1871-9; Fromont J, 2012, HYDROBIOLOGIA, V687, P127, DOI 10.1007/s10750-011-0845-7; Garson MJ, 2001, CRC MAR SCI, P71; Gelman A., 2007, DATA ANAL USING REGR; GHISALBERTI E L, 1990, Journal of the Royal Society of Western Australia, V72, P95; Giovine M, 2001, NITRIC OXIDE-BIOL CH, V5, P427, DOI 10.1006/niox.2001.0366; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Heyward Andrew, 2010, Open Marine Biology Journal, V4, P3; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Hooper JNA, 2002, INVERTEBR SYST, V16, P637, DOI 10.1071/IS02015; Hooper JNA, 2002, BIODIVERS CONSERV, V11, P851, DOI 10.1023/A:1015370312077; Hooper John N. A., 1999, Memoirs of the Queensland Museum, V44, P263; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Izumi H, 2010, FEMS MICROBIOL LETT, V313, P33, DOI 10.1111/j.1574-6968.2010.02118.x; JEFFREY SW, 1968, BIOCHIM BIOPHYS ACTA, V162, P271, DOI 10.1016/0005-2728(68)90109-6; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; KIM K, 1994, CORAL REEFS, V13, P75, DOI 10.1007/BF00300764; Koh EGL, 1997, J CHEM ECOL, V23, P379, DOI 10.1023/B:JOEC.0000006366.58633.f4; Labowitch S, 2011, ENVIRON PLAN LAW J, V28; Laird S., 2008, QUEENSLAND BIODISCOV; Leal MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030580; Lindel T, 1997, J AM CHEM SOC, V119, P8744, DOI 10.1021/ja9717828; Lindquist N, 2002, J CHEM ECOL, V28, P1987, DOI 10.1023/A:1020745810968; Long BH, 1998, CANCER RES, V58, P1111; Marquis CP, 2005, CORAL REEFS, V24, P248, DOI 10.1007/s00338-005-0473-7; Marti R, 2003, J CHEM ECOL, V29, P1307, DOI 10.1023/A:1024201100811; McBARRON E. J., 1966, AUST VET J, V42, P449, DOI 10.1111/j.1751-0813.1966.tb14471.x; McKee TC, 1998, J ORG CHEM, V63, P7805, DOI 10.1021/jo980939r; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nickel M, 2011, J EXP BIOL, V214, P1692, DOI 10.1242/jeb.049148; Page M, 2005, J CHEM ECOL, V31, P1161, DOI 10.1007/s10886-005-4254-0; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rae ID, 2009, HIST REC AUST SCI, V20, P209, DOI 10.1071/HR09013; Reinheimer G., 1992, AQUATIC MICROBIOLOGY; Rimmer M., 2003, S CROSS U LAW REV, V7, P1; Roberge M, 2000, CANCER RES, V60, P5052; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Safavi-Hemami H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010379; Scalabrino G, 2003, ORG BIOMOL CHEM, V1, P318, DOI 10.1039/b207800g; Simmons TL, 2005, MOL CANCER THER, V4, P333; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Taglialatela-Scafati O, 2002, ORG LETT, V4, P4085, DOI 10.1021/ol026831m; Tapiolas DM, 2009, J NAT PROD, V72, P1115, DOI 10.1021/np900099j; Taysi I, 2009, AQUAT BIOL, V8, P55; Ten Kate K, 1999, COMMERCIAL USE BIODI; Thakur NL, 2000, J CHEM ECOL, V26, P57, DOI 10.1023/A:1005485310488; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; THOMPSON JE, 1987, BIOCHEM SYST ECOL, V15, P595, DOI 10.1016/0305-1978(87)90111-6; Thoms C, 2006, J CHEM ECOL, V32, P97, DOI 10.1007/s10886-006-9355-x; Thoms C, 2008, J CHEM ECOL, V34, P1242, DOI 10.1007/s10886-008-9518-z; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; UNEP, 2011, NAG PROT ACC GEN RES; VALDESCOLLAZO L, 1987, APPL ENVIRON MICROB, V53, P1762, DOI 10.1128/AEM.53.8.1762-1767.1987; Volkman JK, 1999, MAR FRESHWATER RES, V50, P761, DOI 10.1071/MF99084; WAHL M, 1995, J EXP MAR BIOL ECOL, V191, P239, DOI 10.1016/0022-0981(95)00018-M; WAHL M, 1994, MAR ECOL PROG SER, V110, P45, DOI 10.3354/meps110045; Ward TM, 2006, CONT SHELF RES, V26, P25, DOI 10.1016/j.csr.2005.09.006; WEATHERALL M, 1990, SEARCH CURE HIST PHA; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Wenberg T, 2011, J EXPT MARINE BIOL E, V400, P7; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P222, DOI 10.1111/j.1439-0485.2009.00355.x; Wilson BR, 1987, FAUNA AUSTR GEN ARTI; Winkler JD, 2003, ORG LETT, V5, P1805, DOI 10.1021/ol0345226; Zimmer RK, 2008, J CHEM ECOL, V34, P822, DOI 10.1007/s10886-008-9486-3	98	15	16	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73800	10.1371/journal.pone.0073800	http://dx.doi.org/10.1371/journal.pone.0073800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040076	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600101
J	Groepenhoff, H; Vonk-Noordegraaf, A; van de Veerdonk, MC; Boonstra, A; Westerhof, N; Bogaard, HJ				Groepenhoff, Herman; Vonk-Noordegraaf, Anton; van de Veerdonk, Marielle C.; Boonstra, Anco; Westerhof, Nico; Bogaard, Harm J.			Prognostic Relevance of Changes in Exercise Test Variables in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							6-MINUTE WALK TEST; GAS-EXCHANGE; THERAPY; SURVIVAL; PROSTACYCLIN; IMPACT	Introduction: Exercise variables determined in patients with pulmonary arterial hypertension (PAH) at the time of diagnosis, predict survival. It is unknown whether upon treatment, subsequent changes in these exercise variables reflect improvements in survival. The aim of this study was to determine changes in exercise variables in PAH patients and to relate these changes to survival. Methods: Baseline cardiopulmonary exercise test (CPET) variables and six-minute-walk-distance (6MWD) were available from 65 idiopathic PAH patients (50 females; mean age 45 +/- 2yrs). The same variables were determined after treatment (13months) in a sub group of 43 patients. To estimate the association between changes in exercise variables and changes in cardiac function, right-ventricle ejection fraction (RVEF) was measured by cardiac MRI at baseline and after treatment in 34 patients. Mean follow-up time after the second CPET was 53 (range: 4-111) months. Kaplan-Meier analysis was used to relate survival to baseline and treatment-associated changes in exercise variables. Results: Survivors showed a significantly greater change in maximal oxygen uptake than non-survivors and this change in aerobic capacity was significantly related to changes in RVEF. From baseline until the end of the study period, two patients underwent a lung transplantation and 19 patients died. Survival analysis showed that baseline 6MWD (p<0.0001), maximal heart rate (p<0.0001) and the slope relating ventilation with carbon dioxide production (p=0.05) were significant predictors of survival, whereas baseline oxygen uptake and oxygen pulse held no predictive value. Treatment associated changes in 6MWD (p<0.01), maximal heart rate (p<0.05), oxygen uptake (p<0.001) and oxygen pulse predicted survival (p<0.05), whereas changes in the slope relating ventilation with carbon dioxide production did not. Conclusion: Exercise variables with prognostic significance when determined at baseline, retain their prognostic relevance after treatment. However, when changes in exercise variables upon treatment are considered, a different set of variables provides prognostic information.	[Groepenhoff, Herman; Vonk-Noordegraaf, Anton; van de Veerdonk, Marielle C.; Boonstra, Anco; Bogaard, Harm J.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Pulmonol, Amsterdam, Netherlands; [Westerhof, Nico] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Groepenhoff, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Pulmonol, Amsterdam, Netherlands.	h.groepenhoff@vumc.nl	boonstra, anco/J-5446-2014	Bogaard, Harm Jan/0000-0001-5371-0346				Barst RJ, 2004, AM J RESP CRIT CARE, V169, P441, DOI 10.1164/rccm.200307-957OC; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Barst RJ, 2003, J AM COLL CARDIOL, V41, P2119, DOI 10.1016/S0735-1097(03)00463-7; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Ciarka A, 2006, CIRCULATION, V113, P252, DOI 10.1161/CIRCULATIONAHA.105.560649; Ciarka A, 2010, AM J RESP CRIT CARE, V181, P1269, DOI 10.1164/rccm.200912-1856OC; Deboeck G, 2012, EUR RESPIR J, V40, P1410, DOI 10.1183/09031936.00217911; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Oudiz RJ, 2007, EUR J HEART FAIL, V9, P917, DOI 10.1016/j.ejheart.2007.06.013; Oudiz RJ, 2010, AM J CARDIOL, V105, P1186, DOI 10.1016/j.amjcard.2009.12.024; Peacock AJ, 2009, EUR RESPIR J, V34, P231, DOI 10.1183/09031936.00107108; Provencher S, 2008, EUR RESPIR J, V32, P393, DOI 10.1183/09031936.00009008; Provencher S, 2006, EUR RESPIR J, V27, P114, DOI 10.1183/09031936.06.00042705; Provencher S, 2006, EUR HEART J, V27, P589, DOI 10.1093/eurheartj/ehi728; Ross RM, 2003, AM J RESP CRIT CARE, V167, P1451, DOI 10.1164/ajrccm.167.10.950; Schwaiblmair M, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-23; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Tabet JY, 2003, EUR J CARDIOV PREV R, V10, P267, DOI 10.1097/00149831-200308000-00008; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Velez-Roa S, 2004, CIRCULATION, V110, P1308, DOI 10.1161/01.CIR.0000140724.90898.D3; Wax D, 1999, CHEST, V116, P914, DOI 10.1378/chest.116.4.914; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A	28	42	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72013	10.1371/journal.pone.0072013	http://dx.doi.org/10.1371/journal.pone.0072013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039732	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600016
J	Tuo, S; Nakashima, K; Pringle, JR				Tuo, Shanshan; Nakashima, Kenichi; Pringle, John R.			Role of Endocytosis in Localization and Maintenance of the Spatial Markers for Bud-Site Selection in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL POLARITY; ACTIN CYTOSKELETON; BUDDING PATTERN; AXIAL LANDMARK; GENE DELETION; PROTEIN; ESTABLISHMENT; POLARIZATION; CDC42	The yeast Saccharomyces cerevisiae normally selects bud sites (and hence axes of cell polarization) in one of two distinct patterns, the axial pattern of haploid cells and the bipolar pattern of diploid cells. These patterns depend on distinct sets of cortical-marker proteins that transmit positional information through a common signaling pathway based on a Ras-type GTPase. It has been reported previously that various proteins of the endocytic pathway may be involved in determining the bipolar pattern but not the axial pattern. To explore this question systematically, we constructed and analyzed congenic haploid and diploid deletion mutants for 14 genes encoding proteins that are involved in endocytosis. The mutants displayed a wide range of severities in their overall endocytosis defects, as judged by their growth rates and abilities to take up the lipophilic dye FM 4-64. Consistent with the previous reports, none of the mutants displayed a significant defect in axial budding, but they displayed defects in bipolar budding that were roughly correlated with the severities of their overall endocytosis defects. Both the details of the mutant budding patterns and direct examination of GFP-tagged marker proteins suggested that both initial formation and maintenance of the normally persistent bipolar marks depend on endocytosis, as well as polarized exocytosis, in actively growing cells. Interestingly, maintenance of the bipolar marks in non-growing cells did not appear to require normal levels of endocytosis. In some cases, there was a striking lack of correlation between the overall severities of the general-endocytosis defect and the bud-site selection defect, suggesting that various endocytosis proteins may differ in their importance for the uptake of various plasma-membrane targets.	[Tuo, Shanshan; Nakashima, Kenichi; Pringle, John R.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University	Pringle, JR (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	jpringle@stanford.edu			National Institutes of Health [GM-31006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031006, R01GM031006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health Grant GM-31006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Fujita A, 2004, GENE, V327, P161, DOI 10.1016/j.gene.2003.11.021; Gagny B, 2000, J CELL SCI, V113, P3309; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Guthrie C, 1991, METHODS ENZYMOL, V194; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; HICKS JB, 1977, GENETICS, V85, P395; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Jose M, 2013, J CELL BIOL, V200, P407, DOI 10.1083/jcb.201206081; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kang PJ, 2013, J CELL SCI, V126, P1218, DOI 10.1242/jcs.118521; Kang PJ, 2012, J CELL SCI, V125, P3840, DOI 10.1242/jcs.103697; Kang PJ, 2010, MOL BIOL CELL, V21, P3007, DOI 10.1091/mbc.E10-03-0232; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Kato Y, 2010, BIOCHEM BIOPH RES CO, V399, P525, DOI 10.1016/j.bbrc.2010.07.102; Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426; Krappmann AB, 2007, MOL BIOL CELL, V18, P3323, DOI 10.1091/mbc.E06-10-0899; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lo WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056665; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lord M, 2002, CURR BIOL, V12, P1347, DOI 10.1016/S0960-9822(02)01042-4; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Sambrook J, 2001, MOL CLONING LAB MANU; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Schenkman LR, 2002, J CELL BIOL, V156, P829, DOI 10.1083/jcb.200107041; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Tcheperegine SE, 2005, MOL CELL BIOL, V25, P8567, DOI 10.1128/MCB.25.19.8567-8580.2005; Tuo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047621; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Yang S, 1997, J CELL BIOL, V136, P111, DOI 10.1083/jcb.136.1.111; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	53	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72123	10.1371/journal.pone.0072123	http://dx.doi.org/10.1371/journal.pone.0072123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039741	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600019
J	Wirkner, J; Weymar, M; Low, A; Hamm, AO				Wirkner, Janine; Weymar, Mathias; Loew, Andreas; Hamm, Alfons O.			Effects of Pre-Encoding Stress on Brain Correlates Associated with the Long-Term Memory for Emotional Scenes	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; RECOGNITION MEMORY; DECLARATIVE MEMORY; RETRIEVAL; AMYGDALA; CONSOLIDATION; RECOLLECTION; FAMILIARITY; POTENTIALS; ACTIVATION	Recent animal and human research indicates that stress around the time of encoding enhances long-term memory for emotionally arousing events but neural evidence remains unclear. In the present study we used the ERP old/new effect to investigate brain dynamics underlying the long-term effects of acute pre-encoding stress on memory for emotional and neutral scenes. Participants were exposed either to the Socially Evaluated Cold Pressure Test (SECPT) or a warm water control procedure before viewing 30 unpleasant, 30 neutral and 30 pleasant pictures. Two weeks after encoding, recognition memory was tested using 90 old and 90 new pictures. Emotional pictures were better recognized than neutral pictures in both groups and related to an enhanced centro-parietal ERP old/new difference (400-800 ms) during recognition, which suggests better recollection. Most interestingly, pre-encoding stress exposure specifically increased the ERP old/new-effect for emotional (unpleasant) pictures, but not for neutral pictures. These enhanced ERP/old new differences for emotional (unpleasant) scenes were particularly pronounced for those participants who reported high levels of stress during the SECPT. The results suggest that acute pre-encoding stress specifically strengthens brain signals of emotional memories, substantiating a facilitating role of stress on memory for emotional scenes.	[Wirkner, Janine; Weymar, Mathias; Loew, Andreas; Hamm, Alfons O.] Ernst Moritz Arndt Univ Greifswald, Dept Biol & Clin Psychol, Greifswald, Germany; [Weymar, Mathias] Univ Florida, Ctr Study Emot & Attent, Gainesville, FL USA	Ernst Moritz Arndt Universitat Greifswald; State University System of Florida; University of Florida	Wirkner, J (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Biol & Clin Psychol, Greifswald, Germany.	janine.wirkner@uni-greifswald.de; hamm@uni-greifswald.de	Löw, Andreas/H-7313-2019	Löw, Andreas/0000-0001-8014-9611; Weymar, Mathias/0000-0002-3968-9656				Abercrombie HC, 2006, PSYCHONEUROENDOCRINO, V31, P187, DOI 10.1016/j.psyneuen.2005.06.008; BOWER GH, 1987, BEHAV RES THER, V25, P443, DOI 10.1016/0005-7967(87)90052-0; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buchanan TW, 2006, LEARN MEMORY, V13, P382, DOI 10.1101/lm.206306; Buchanan TW, 2001, PSYCHONEUROENDOCRINO, V26, P307, DOI 10.1016/S0306-4530(00)00058-5; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Domes G, 2002, PSYCHONEUROENDOCRINO, V27, P843, DOI 10.1016/S0306-4530(01)00085-3; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eich E, 2000, PSYCHOL SCI, V11, P244, DOI 10.1111/1467-9280.00249; Ferrari V, 2013, SOC COGN AFFECT NEUR, V8, P847, DOI 10.1093/scan/nss081; Ferrari V, 2010, J COGNITIVE NEUROSCI, V22, P404, DOI 10.1162/jocn.2009.21244; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P467, DOI 10.1111/j.1469-8986.2007.00628.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Gerdes ABM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00175; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Jelicic M, 2004, INT J NEUROSCI, V114, P1343, DOI 10.1080/00207450490476101; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang P.J., 2008, A8 U FLOR; McIntyre CK, 2012, NEUROSCI BIOBEHAV R, V36, P1750, DOI 10.1016/j.neubiorev.2011.11.001; Newsome RN, 2012, NEUROPSYCHOLOGIA, V50, P3370, DOI 10.1016/j.neuropsychologia.2012.09.024; Oyarzun JP, 2012, J NEUROSCI, V32, P9771, DOI 10.1523/JNEUROSCI.2318-12.2012; Payne JD, 2006, MEMORY, V14, P1, DOI 10.1080/09658210500139176; Payne JD, 2007, LEARN MEMORY, V14, P861, DOI 10.1101/lm.743507; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Qin SZ, 2012, J NEUROSCI, V32, P4032, DOI 10.1523/JNEUROSCI.3101-11.2012; Rasmussen A, 2007, J NERV MENT DIS, V195, P137, DOI 10.1097/01.nmd.0000254748.38784.2f; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schaefer A, 2011, NEUROIMAGE, V54, P714, DOI 10.1016/j.neuroimage.2010.07.030; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Schwabe L, 2010, NEUROBIOL LEARN MEM, V93, P183, DOI 10.1016/j.nlm.2009.09.009; Schwabe L, 2009, LEARN MEMORY, V16, P110, DOI 10.1101/lm.1257509; Shackman AJ, 2011, J NEUROSCI, V31, P1156, DOI 10.1523/JNEUROSCI.3384-10.2011; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Versace F, 2010, EXP BRAIN RES, V205, P223, DOI 10.1007/s00221-010-2356-6; Voss J. L., 2008, MEMORY SYSTEMS LEARN, P79, DOI DOI 10.1016/B978-012370509-9.00106-6; Voss JL, 2011, PSYCHOPHYSIOLOGY, V48, P532, DOI 10.1111/j.1469-8986.2010.01085.x; Wessa M., 2010, Z KL PSYCH PSYCHOTH, V39, P77, DOI [10.1026/1616-3443/a000036, DOI 10.1026/1616-3443/A000036]; Weymar M, 2012, J COGNITIVE NEUROSCI, V24, P1511, DOI 10.1162/jocn_a_00174; Weymar M, 2011, HUM BRAIN MAPP, V32, P632, DOI 10.1002/hbm.21051; Weymar M, 2010, NEUROREPORT, V21, P827, DOI 10.1097/WNR.0b013e32833d180a; Weymar M, 2010, NEUROIMAGE, V49, P2800, DOI 10.1016/j.neuroimage.2009.10.025; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	63	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e68212	10.1371/journal.pone.0068212	http://dx.doi.org/10.1371/journal.pone.0068212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24039697	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600004
J	Smadja-Lamere, N; Shum, M; Deleris, P; Roux, PP; Abe, J; Marette, A				Smadja-Lamere, Nicolas; Shum, Michael; Deleris, Paul; Roux, Philippe P.; Abe, Jun-ichi; Marette, Andre			Insulin Activates RSK (p90 Ribosomal S6 Kinase) to Trigger a New Negative Feedback Loop That Regulates Insulin Signaling for Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; RECEPTOR SUBSTRATE-1; SERINE PHOSPHORYLATION; TUBEROUS SCLEROSIS; PROTEIN-KINASES; MICE LACKING; AMINO-ACID; IN-VITRO; RESISTANCE; EXPRESSION	We previously demonstrated that the mTORC1/S6K1 pathway is activated by insulin and nutrient overload (e.g. amino acids (AA)), which leads to the inhibition of the PI3K/Akt pathway via the inhibitory serine phosphorylation of IRS-1, notably on serine 1101 (Ser-1101). However, even in the absence of AA, insulin can still promote IRS-1 Ser-1101 phosphorylation by other kinases that remain to be fully characterized. Here, we describe a new negative regulator of IRS-1, the p90 ribosomal S6 kinase (RSK). Computational analyses revealed that Ser-1101 within IRS-1 falls into the consensus motif of RSK. Moreover, recombinant RSK phosphorylated IRS-1 C-terminal fragment on Ser-1101, which was prevented by mutations of this site or when a kinase-inactive mutant of RSK was used. Using antibodies directed toward the phosphorylation sites located in the activation segment of RSK (Ser-221 or Ser-380), we found that insulin activates RSK in L6 myocytes in the absence of AA overload. Inhibition of RSK using either the pharmacological inhibitor BI-D1870 or after adenoviral expression of a dominant negative RSK1 mutant (RSK1-DN) showed that RSK selectively phosphorylates IRS-1 on Ser-1101. Accordingly, expression of the RSK1-DN mutant in L6 myocytes and FAO hepatic cells improved insulin action on glucose uptake and glucose production, respectively. Furthermore, RSK1 inhibition prevented insulin resistance in L6 myocytes chronically exposed to high glucose and high insulin. These results show that RSK is a novel regulator of insulin signaling and glucose metabolism and a potential mediator of insulin resistance, notably through the negative phosphorylation of IRS-1 on Ser-1101.	[Smadja-Lamere, Nicolas; Shum, Michael; Marette, Andre] Univ Laval, Quebec Heart & Lung Inst, Ste Foy, PQ G1V 4G5, Canada; [Deleris, Paul; Roux, Philippe P.] Univ Montreal, IRIC, Fac Med, Montreal, PQ H3C 3J7, Canada; [Roux, Philippe P.] Univ Montreal, Dept Pathol & Cell Biol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Abe, Jun-ichi] Univ Rochester, Med Ctr, ACVRI, Rochester, NY 14642 USA	Laval University; Quebec Heart & Lung Institute; Universite de Montreal; Universite de Montreal; University of Rochester	Marette, A (corresponding author), Hop Laval, Dept Med, Fac Med, Quebec Heart & Lung Inst, Pavillon Marguerite dYouville,Room Y4308, Ste Foy, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250; Marette, Andre/0000-0003-3950-5973; Shum, Michael/0000-0001-8784-9928	Canadian Institutes of Health Research (CIHR) [FRN-57878]; CIHR; National Science and Engineering Research Council (NSERC); obesity training program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); obesity training program	This work was funded by Grant FRN-57878 from the Canadian Institutes of Health Research (CIHR) (to A. M.) and in part by grants from the CIHR and the National Science and Engineering Research Council (NSERC).; Supported by a postdoctoral scholarship from the obesity training program funded by CIHR.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; CHANG PY, 1995, J BIOL CHEM, V270, P29928; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Cieslik KA, 2005, J BIOL CHEM, V280, P18411, DOI 10.1074/jbc.M410017200; Dardevet D, 1999, J ENDOCRINOL, V162, P77, DOI 10.1677/joe.0.1620077; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Drummond MJ, 2008, CLIN NUTR, V27, P447, DOI 10.1016/j.clnu.2008.01.012; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; El-Haschimi K, 2003, DIABETES, V52, P1340, DOI 10.2337/diabetes.52.6.1340; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pilon G., PLOS ONE, V5; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Veilleux A, 2010, MOL ENDOCRINOL, V24, P766, DOI 10.1210/me.2009-0328; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	49	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31165	31176		10.1074/jbc.M113.474148	http://dx.doi.org/10.1074/jbc.M113.474148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036112	Green Published, hybrid			2022-12-25	WOS:000330778900034
J	Li, LB; Zhang, WL; Liu, QS; Gao, Y; Gao, Y; Wang, Y; Wang, DZ; Li, ZG; Wang, T				Li, Lianbo; Zhang, Weili; Liu, Qisong; Gao, Yu; Gao, Ying; Wang, Yun; Wang, David Zhigang; Li, Zigang; Wang, Tao			Structural Insights on the Bacteriolytic and Self-protection Mechanism of Muramidase Effector Tse3 in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Peptidoglycan; Protein Complexes; Pseudomonas aeruginosa; Toxins; Antitoxins; Immune Protein Tsi3; Muramidase Effector Tse3; Type VI Secretion System	VI SECRETION SYSTEM; CRYSTAL-STRUCTURE; COMPLEX; INHIBITION; REVEALS	The warfare among microbial species as well as between pathogens and hosts is fierce, complicated, and continuous. In Pseudomonas aeruginosa, the muramidase effector Tse3 (Type VI secretion exported 3) can be injected into the periplasm of neighboring bacterial competitors by a Type VI secretion apparatus, eventually leading to cell lysis and death. However, P. aeruginosa protects itself from lysis by expressing immune protein Tsi3 (Type six secretion immunity 3). Here, we report the crystal structure of the Tse3-Tsi3 complex at 1.8 resolution, revealing that Tse3 possesses one open accessible, goose-type lysozyme-like domain with peptidoglycan hydrolysis activity. Calcium ions bind specifically in the Tse3 active site and are identified to be crucial for its bacteriolytic activity. In combination with biochemical studies, the structural basis of self-protection mechanism of Tsi3 is also elucidated, thus providing an understanding and new insights into the effectors of Type VI secretion system.	[Li, Lianbo; Zhang, Weili; Gao, Yu; Gao, Ying; Wang, Yun; Wang, Tao] Peking Univ, Shenzhen Grad Sch, Lab Computat Chem & Drug Design, Shenzhen 518055, Peoples R China; [Liu, Qisong; Wang, David Zhigang; Li, Zigang] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China	Peking University; University Town of Shenzhen; Peking University; University Town of Shenzhen	Wang, DZ (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China.	dzw@pkusz.edu.cn; lizg@pkusz.edu.cn; tau@pku.edu.cn	Li, Lianbo/H-1152-2011	Li, Lianbo/0000-0003-0107-7125	Ministry of Science and Technology (MOST) of China [2013CB911501, NSFC31300600]; Shenzhen Science and Technology Innovation (SZSTI) Program [ZDSY20120614144410389, JCYJ20120614150904060]; PKUSZ; SZSTI Program [SW201110060, SW201110018]; Peacock Program [KQTD201103]; MOST of China [2012CB722602]; SZSTI "Shuang Bai Project";  [NSFC21102007];  [NSFC20872004];  [NSFC20972008];  [NSFC21290180]	Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Shenzhen Science and Technology Innovation (SZSTI) Program; PKUSZ; SZSTI Program; Peacock Program; MOST of China(Ministry of Science and Technology, China); SZSTI "Shuang Bai Project"; ; ; ; 	This work was supported by Ministry of Science and Technology (MOST) of China 2013CB911501 and NSFC31300600, Shenzhen Science and Technology Innovation (SZSTI) Program ZDSY20120614144410389 and JCYJ20120614150904060, and a startup fund from PKUSZ (to T. W.); NSFC21102007, SZSTI Program SW201110060 and SW201110018, and Peacock Program KQTD201103 (to Z. L.); and MOST of China 2012CB722602, NSFC20872004, NSFC20972008, and NSFC21290180 and SZSTI "Shuang Bai Project" (to D. Z. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Artola-Recolons C, 2011, BIOCHEMISTRY-US, V50, P2384, DOI 10.1021/bi200085y; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Benz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067362; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Dong C, 2013, BIOCHEM J, V454, P59, DOI 10.1042/BJ20130193; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jackson SA, 2012, BBA-BIOENERGETICS, V1817, P1331, DOI 10.1016/j.bbabio.2012.02.032; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shang GJ, 2012, BIOCHEM J, V448, P201, DOI 10.1042/BJ20120668; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steiner RA, 2001, ACTA CRYSTALLOGR D, V57, P516, DOI 10.1107/S0907444901002530; Stewart M, 2000, J MOL BIOL, V299, P213, DOI 10.1006/jmbi.2000.3733; Strynadka N C, 1996, EXS, V75, P185; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; WEAVER LH, 1985, J MOL EVOL, V21, P97, DOI 10.1007/BF02100084; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036; Zou TT, 2012, J MOL BIOL, V417, P351, DOI 10.1016/j.jmb.2012.01.040	41	22	24	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30607	30613		10.1074/jbc.C113.506097	http://dx.doi.org/10.1074/jbc.C113.506097			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025333	Green Published, hybrid			2022-12-25	WOS:000329868100061
J	Kontogiannatos, D; Swevers, L; Maenaka, K; Park, EY; Iatrou, K; Kourti, A				Kontogiannatos, Dimitrios; Swevers, Luc; Maenaka, Katsumi; Park, Enoch Y.; Iatrou, Kostas; Kourti, Anna			Functional Characterization of a Juvenile Hormone Esterase Related Gene in the Moth Sesamia nonagrioides through RNA Interference	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ECDYSONE RECEPTOR; SILKWORM; METAMORPHOSIS; CLONING; TRANSCRIPTION; LARVAE	Juvenile hormone esterase (JHE) is a carboxylesterase that has attracted great interest because of its critical role in regulating larval to adult transition in insects and other arthropods. Previously, we characterized an ecdysteroid sensitive and juvenile hormone non-susceptible juvenile hormone esterase related gene (SnJHER) in the corn stalk borer, Sesamia nonagrioides. SnJHER was rhythmically up-regulated close to each molt during the corn stalk borer's larval development. In this paper we attempted to functionally characterize SnJHER using several reverse genetics techniques. To functionally characterize SnJHER, we experimented with different dsRNA administration methods, including hemolymph, bacterial or baculovirus-mediated RNA interference, (RNAi). Our findings indicate the potential implication of SnJHER in the developmental programming of Sesamia nonagrioides. It is still unclear whether SnJHER is closely related to the authentic JHE gene, with different or similar biological functions.	[Kontogiannatos, Dimitrios; Kourti, Anna] Agr Univ Athens, Dept Agr Biotechnol, Mol Biol Lab, GR-11855 Athens, Greece; [Swevers, Luc; Iatrou, Kostas] Demokritos Natl Ctr Sci Res, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol Grp, GR-15310 Athens, Greece; [Maenaka, Katsumi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomol Chem, Kita Ku, Sapporo, Hokkaido, Japan; [Park, Enoch Y.] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan	Agricultural University of Athens; National Centre of Scientific Research "Demokritos"; Hokkaido University; Shizuoka University	Kourti, A (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Mol Biol Lab, GR-11855 Athens, Greece.	akourti@aua.gr	Park, Enoch/AAU-2614-2020; Kontogiannatos, Dimitrios/J-3907-2015	Kontogiannatos, Dimitrios/0000-0002-2407-3680	State Scholarships Foundation (Lifelong Learning Programme, European Social Fund, NSRF)	State Scholarships Foundation (Lifelong Learning Programme, European Social Fund, NSRF)	Dimitrios Kontogiannatos is funded by the State Scholarships Foundation (Lifelong Learning Programme, European Social Fund, NSRF 2007-2013) http://www.iky.gr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bortolotti L, 2005, EUR J ENTOMOL, V102, P27, DOI 10.14411/eje.2005.004; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Denlinger D.L., 1985, P353; ELDRIDGE R, 1992, APPL ENVIRON MICROB, V58, P1583, DOI 10.1128/AEM.58.5.1583-1591.1992; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; Goodman W.G., 2005, P319; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Hajos JP, 1999, INSECT MOL BIOL, V8, P539, DOI 10.1046/j.1365-2583.1999.00150.x; Hammock B.D., 1985, P431; Hirai M, 2002, INSECT BIOCHEM MOLEC, V32, P627, DOI 10.1016/S0965-1748(01)00141-2; Kang KD, 1998, KOREAN J SERIC SCI, V40, P105; Kethidi DR, 2005, J INSECT PHYSIOL, V51, P393, DOI 10.1016/j.jinsphys.2004.12.007; Kontogiannatos D, 2011, J INSECT PHYSIOL, V57, P1000, DOI 10.1016/j.jinsphys.2011.04.017; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Mizoguchi A, 2001, J INSECT PHYSIOL, V47, P767, DOI 10.1016/S0022-1910(01)00052-X; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; OREILLY DR, 1991, INSECT BIOCHEM, V21, P795, DOI 10.1016/0020-1790(91)90121-T; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford Lynn M., 1996, P223; ROE RM, 1990, MORPHOGENETIC HORMON, V1, P126; Schafellner C, 2008, J INSECT PHYSIOL, V54, P916, DOI 10.1016/j.jinsphys.2008.04.015; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; VENKATARAMAN V, 1994, DEV GENET, V15, P391, DOI 10.1002/dvg.1020150502; Vermunt AMW, 1997, INSECT BIOCHEM MOLEC, V27, P919, DOI 10.1016/S0965-1748(97)00073-8; WROBLEWSKI VJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P461, DOI 10.1016/0003-9861(90)90285-7; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058	41	36	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73834	10.1371/journal.pone.0073834	http://dx.doi.org/10.1371/journal.pone.0073834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040087	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500054
J	Reddy, P; Deguchi, M; Cheng, Y; Hsueh, AJW				Reddy, Pradeep; Deguchi, Masashi; Cheng, Yuan; Hsueh, Aaron J. W.			Actin Cytoskeleton Regulates Hippo Signaling	PLOS ONE			English	Article							F-ACTIN; CELL-PROLIFERATION; GROWTH-CONTROL; PROMOTES APOPTOSIS; TISSUE-GROWTH; YAP PATHWAY; CCN FAMILY; DROSOPHILA; PROTEIN; WARTS	Hippo pathway controls the organ size by modulating cell proliferation and apoptosis. However, the upstream regulation of hippo signaling by actin cytoskeleton is not clear. To elucidate the role of actin as an upstream regulator of Hippo signaling, the levels of F (filamentous)-actin in cells were elevated using jasplakinolide, an actin-stabilizing drug. Induction of F-actin formation in HeLa cells resulted in decreased phosphorylation of YAP, a key effector molecule for Hippo signaling. The activated YAP is localized to the cell nucleus and YAP increase was associated with increased expression of downstream CCN growth factors CCN1/CYR61 and CCN2/CTGF. The effect of the actin-stabilizing drug was blocked when YAP levels were suppressed in YAP "knock-down" cells. In summary, using an actin-stabilizing drug we show that actin cytoskeleton is one of the upstream regulators of Hippo signaling capable of activating YAP and increasing its downstream CCN growth factors.	[Reddy, Pradeep] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Deguchi, Masashi; Cheng, Yuan; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA	Salk Institute; Stanford University	Hsueh, AJW (corresponding author), Stanford Univ, Sch Med, Dept Obstet Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu	Reddy, Pradeep/G-1770-2014	Reddy, Pradeep/0000-0002-9173-3845	NIH NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD068158]; Swedish Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD068158, U54HD068158] Funding Source: NIH RePORTER	NIH NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by funds from the NIH NICHD (U54 HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research) (A. H.). Postdoctoral fellowship from Swedish Research Council (PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badouel C, 2009, CURRENT OPINION CELL; BODEN P, 1986, ACTA OTO-LARYNGOL, V101, P278, DOI 10.3109/00016488609132838; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fan R, 2013, REGULATION HIPPO PAT; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Ota M, 2008, DEVELOPMENT; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Ubelmann F, 2013, P NATL ACAD SCI USA, V110, pE1380, DOI 10.1073/pnas.1218446110; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; White SR, 2001, AM J RESP CELL MOL, V24, P282, DOI 10.1165/ajrcmb.24.3.3995; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zeidan A, 2008, CARDIOVASC RES, V77, P64, DOI 10.1093/cvr/cvm020; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	35	45	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73763	10.1371/journal.pone.0073763	http://dx.doi.org/10.1371/journal.pone.0073763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040060	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500048
J	Arsenijevic, T; Gregoire, F; Chiadak, J; Courtequisse, E; Bolaky, N; Perret, J; Delporte, C				Arsenijevic, Tatjana; Gregoire, Francoise; Chiadak, Jeanne; Courtequisse, Elodie; Bolaky, Nargis; Perret, Jason; Delporte, Christine			Pituitary Adenylate Cyclase Activating Peptide (PACAP) Participates in Adipogenesis by Activating ERK Signaling Pathway	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; INSULIN-SECRETION; GENE-EXPRESSION; POLYPEPTIDE PACAP; RECEPTOR-GAMMA; C/EBP DELTA; PPAR-GAMMA; CYCLIC-AMP; IN-VITRO; BETA	Pituitary adenylate cyclase activating peptide (PACAP) belongs to the secretin/glucagon/vasoactive intestinal peptide (VIP) family. Its action can be mediated by three different receptor subtypes: PAC1, which has exclusive affinity for PACAP, and VPAC1 and VPAC2 which have equal affinity for PACAP and VIP. We showed that all three receptors are expressed in 3T3- L1 cells throughout their differentiation into adipocytes. We established the activity of these receptors by cAMP accumulation upon induction by PACAP. Together with insulin and dexamethasone, PACAP induced adipogenesis in 3T3-L1 cell line. PACAP increased cAMP production within 15 min upon stimulation and targeted the expression and phosphorylation of MAPK (ERK1/2), strengthened by the ERK1/2 phosphorylation being partially or completely abolished by different combinations of PACAP receptors antagonists. We therefore speculate that ERK1/2 activation is crucial for the activation of CCAAT/enhancer-binding protein beta (C/EBP beta).	[Arsenijevic, Tatjana; Gregoire, Francoise; Chiadak, Jeanne; Courtequisse, Elodie; Bolaky, Nargis; Perret, Jason; Delporte, Christine] Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium	Universite Libre de Bruxelles	Delporte, C (corresponding author), Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium.	cdelport@ulb.ac.be	Delporte, Christine/A-5733-2012	Gregoire, Francoise/0000-0003-0452-8868; Delporte, Christine/0000-0003-0385-5824	FNRS fellowship (FNRS, Belgium); BRIC fellowship	FNRS fellowship (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); BRIC fellowship	TA is recipient of FNRS fellowship (FNRS, Belgium) and JC is a recipient of a BRIC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BA, 2008, ENDOCRINOLOGY, V149, P1571, DOI 10.1210/en.2007-0515; Akesson L, 2005, ENDOCRINOLOGY, V146, P744, DOI 10.1210/en.2004-0504; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Cardinaux JR, 1996, J NEUROSCI, V16, P919; Dickson L, 2006, NEUROPHARMACOLOGY, V51, P1086, DOI 10.1016/j.neuropharm.2006.07.017; FRIDOLF T, 1992, CELL TISSUE RES, V269, P275, DOI 10.1007/BF00319618; Gourlet P, 1997, PEPTIDES, V18, P1555, DOI 10.1016/S0196-9781(97)00230-1; Gray SL, 2001, MOL ENDOCRINOL, V15, P1739, DOI 10.1210/me.15.10.1739; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HAIGH RJ, 1995, BIOCHEM SOC T, V23, pS179, DOI 10.1042/bst023179s; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Jamen F, 2002, ENDOCRINOLOGY, V143, P1253, DOI 10.1210/en.143.4.1253; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KAWAI K, 1992, LIFE SCI, V50, P257, DOI 10.1016/0024-3205(92)90332-J; Kishida K, 2001, J BIOL CHEM, V276, P48572, DOI 10.1074/jbc.M108213200; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Moreno D, 2000, PEPTIDES, V21, P1543, DOI 10.1016/S0196-9781(00)00309-0; Nakata M, 1999, PEPTIDES, V20, P943, DOI 10.1016/S0196-9781(99)00085-6; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Robberecht P, 1996, J Pharm Belg, V51, P165; Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tomimoto S, 2008, J PHARMACOL SCI, V107, P41, DOI 10.1254/jphs.FP0072173; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaudry D, 2000, PHARMACOL REV, V52, P269; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wei Y, 1996, ANN NY ACAD SCI, V805, P624; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; YADA T, 1994, J BIOL CHEM, V269, P1290; Yada T, 1997, J PHYSIOL-LONDON, V505, P319, DOI 10.1111/j.1469-7793.1997.319bb.x	40	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72607	10.1371/journal.pone.0072607	http://dx.doi.org/10.1371/journal.pone.0072607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039785	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300016
J	Jowers, MJ; Leniaud, L; Cerda, X; Alasaad, S; Caut, S; Amor, F; Aron, S; Boulay, RR				Jowers, Michael J.; Leniaud, Laurianne; Cerda, Xim; Alasaad, Samer; Caut, Stephane; Amor, Fernando; Aron, Serge; Boulay, Raphael R.			Social and Population Structure in the Ant Cataglyphis emmae	PLOS ONE			English	Article							GENETIC-STRUCTURE; HIERARCHICAL ANALYSIS; COLONY; DISPERSAL; EVOLUTION; NUMBER; SEX; DNA; PARTHENOGENESIS; CONNECTIVITY	Dispersal has consequences not only for individual fitness, but also for population dynamics, population genetics and species distribution. Social Hymenoptera show two contrasting colony reproductive strategies, dependent and independent colony foundation modes, and these are often associated to the population structures derived from inter and intra-population gene flow processes conditioned by alternative dispersal strategies. Here we employ microsatellite and mitochondrial markers to investigate the population and social genetic structure and dispersal patterns in the ant Cataglyphis emmae at both, local and regional scales. We find that C. emmae is monogynous and polyandrous. Lack of detection of any population viscosity and population structure with nuclear markers at the local scale suggests efficient dispersal, in agreement with a lack of inbreeding. Contrasting demographic differences before and during the mating seasons suggest that C. emmae workers raise sexuals in peripheric nest chambers to reduce intracolonial conflicts. The high genetic differentiation recovered from the mtDNA haplotypes, together with the significant correlation of such to geographic distance, and presence of new nuclear alleles between areas (valleys) suggest long-term historical isolation between these regions, indicative of limited dispersal at the regional scale. Our findings on the ecological, social and population structure of this species increases our understanding of the patterns and processes involved under independent colony foundation.	[Jowers, Michael J.; Cerda, Xim; Alasaad, Samer; Caut, Stephane; Amor, Fernando] CSIC, EBD, Dept Etol & Conservac Biodiversidad, E-41080 Seville, Spain; [Jowers, Michael J.; Boulay, Raphael R.] Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain; [Leniaud, Laurianne; Aron, Serge] Univ Libre Bruxelles, Dept Evolutionary Biol & Ecol, Brussels, Belgium; [Boulay, Raphael R.] Univ Tours, IRBI, Tours, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada; Universite Libre de Bruxelles; Universite de Tours	Jowers, MJ (corresponding author), CSIC, EBD, Dept Etol & Conservac Biodiversidad, E-41080 Seville, Spain.	michaeljowers@hotmail.com	Angelone, Samer/G-4727-2013; Boulay, Raphael/I-3735-2015; Jowers, Michael/AAT-8514-2021; Cerda, Xim/P-6461-2014	Angelone, Samer/0000-0003-0868-7276; Boulay, Raphael/0000-0002-0138-0856; Cerda, Xim/0000-0002-3222-2471; Jowers, Michael J/0000-0001-8935-5913	MICINN; FEDER [GL 2009-09690, CGL 2009 CGL 527 2009-12472, CSD2008-00040]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FEDER(European Commission)	This work was funded by MICINN and FEDER (GL 2009-09690 to XC and CGL 2009 CGL 527 2009-12472 to RB and project CONSOLIDER-MONTES CSD2008-00040 to RB, XC and MJJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTI D, 1990, J NAT HIST, V24, P1457, DOI 10.1080/00222939000770851; Amor F, 2011, THESIS; Amor F, 2011, BEHAV ECOL SOCIOBIOL, V65, P1473, DOI 10.1007/s00265-011-1157-7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boomsma Jacobus J., 2009, P3; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Boulay R, 2007, BEHAV ECOL SOCIOBIOL, V61, P1531, DOI 10.1007/s00265-007-0385-3; Cerda X, 2002, ECOL ENTOMOL, V27, P7, DOI 10.1046/j.0307-6946.2001.00386.x; Cheron B, 2011, ECOLOGY, V92, P1448, DOI 10.1890/10-2347.1; Chesser RK, 1996, GENETICS, V144, P1225; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clemencet J, 2005, MOL ECOL, V14, P3735, DOI 10.1111/j.1365-294X.2005.02706.x; Cole BJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P79, DOI 10.1007/s002650050318; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; Doums C, 2002, MOL ECOL, V11, P2251, DOI 10.1046/j.1365-294X.2002.01619.x; DROUAL R, 1984, ANIM BEHAV, V32, P1054, DOI 10.1016/S0003-3472(84)80221-3; Earl D.A., 2011, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Eyer PA, 2013, MOL ECOL, V22, P947, DOI 10.1111/mec.12141; Foster KR, 2001, MOL ECOL, V10, P1003, DOI 10.1046/j.1365-294X.2001.01228.x; Galarza JA, 2012, OIKOS, V121, P605, DOI 10.1111/j.1600-0706.2011.19859.x; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hardy OJ, 2008, BIOL J LINN SOC, V93, P465, DOI 10.1111/j.1095-8312.2007.00898.x; Heinze J, 1995, RES POPUL ECOL, V37, P135, DOI 10.1007/BF02515814; Heinze J, 2004, INSECT SOC, V51, P275, DOI 10.1007/s00040-004-0740-6; Holldobler B., 1990, pi; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; KELLER L, 1991, ETHOL ECOL EVOL, V3, P307, DOI 10.1080/08927014.1991.9525359; Knaden Markus, 2006, Front Zool, V3, P21, DOI 10.1186/1742-9994-3-21; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leniaud L, 2013, INSECT SOC, V60, P337, DOI 10.1007/s00040-013-0298-2; Leniaud L, 2012, CURR BIOL, V22, P1188, DOI 10.1016/j.cub.2012.04.060; Leniaud L, 2011, BIOL J LINN SOC, V104, P866, DOI 10.1111/j.1095-8312.2011.01772.x; Lenoir Alain, 2010, Israel Journal of Entomology, V39, P1; Liautard C, 2001, EVOLUTION, V55, P2484, DOI 10.1111/j.0014-3820.2001.tb00763.x; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; Molet M, 2008, AM NAT, V172, P75, DOI 10.1086/588079; Nichols J., 2001, DISPERSAL; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; O'Neill Kevin M., 1994, Psyche (Cambridge), V101, P93, DOI 10.1155/1994/38217; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Queller DC, 1989, EVOLUTION, V43, P58; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronce O, 2010, P ROY SOC B-BIOL SCI, V277, P3659, DOI 10.1098/rspb.2010.1095; Ross KG, 1997, GENETICS, V147, P643; Rousset F, 1997, GENETICS, V145, P1219; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; SCHMIDHEMPEL P, 1994, PHILOS T R SOC B, V346, P313, DOI 10.1098/rstb.1994.0148; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; Schooley RL, 2000, AM MIDL NAT, V144, P439, DOI 10.1674/0003-0031(2000)144[0439:MDCFBQ]2.0.CO;2; Seppa P, 2004, EVOLUTION, V58, P2462; Seppa P, 2006, INSECT SOC, V53, P362, DOI 10.1007/s00040-006-0882-9; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; SINCLAIR DF, 1985, ECOLOGY, V66, P1084, DOI 10.2307/1940568; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sundstrom L, 2003, EVOLUTION, V57, P1552, DOI 10.1111/j.0014-3820.2003.tb00363.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Timmermans I, 2008, HEREDITY, V101, P490, DOI 10.1038/hdy.2008.72; Timmermans I, 2010, INSECT SOC, V57, P39, DOI 10.1007/s00040-009-0048-7; TRANIELLO JFA, 1986, OECOLOGIA, V69, P413, DOI 10.1007/BF00377064; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargo EL, 2003, EVOLUTION, V57, P2805, DOI 10.1111/j.0014-3820.2003.tb01522.x; VARGO EL, 1991, BEHAV ECOL SOCIOBIOL, V28, P161, DOI 10.1007/BF00172167; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Yoder JM, 2004, BEHAV ECOL, V15, P469, DOI 10.1093/beheco/arh037	77	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72941	10.1371/journal.pone.0072941	http://dx.doi.org/10.1371/journal.pone.0072941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039827	Green Published, gold			2022-12-25	WOS:000326405300036
J	Lu, Y; Wang, WM; Wang, JC; Yang, CZ; Mao, HM; Fu, XL; Wu, YL; Cai, JP; Han, JY; Xu, ZG; Zhuang, ZP; Liu, ZM; Hu, H; Chen, BG				Lu, Ying; Wang, Weimin; Wang, Junchen; Yang, Chunzhang; Mao, Huiming; Fu, Xuelian; Wu, Yanling; Cai, Jingping; Han, Junyi; Xu, Zengguang; Zhuang, Zhengping; Liu, Zhongmin; Hu, Hai; Chen, Bingguan			Overexpression of Arginine Transporter CAT-1 Is Associated with Accumulation of L-Arginine and Cell Growth in Human Colorectal Cancer Tissue	PLOS ONE			English	Article							NITRIC-OXIDE; ARGININOSUCCINATE SYNTHETASE; AMINO-ACIDS; IN-VITRO; POLYAMINES; CITRULLINE; DISEASE; PROLIFERATION; DEPRIVATION; METABOLISM	We previously showed that L-arginine (Arg) accumulates in colorectal cancer tissues. The aim of this study was to investigate the mechanism by which Arg accumulates and determine its biological significance. The concentration of Arg and Citrulline (Cit) in sera and tumor tissues from colorectal cancer (CRC) patients was analyzed by high-performance liquid chromatography (HPLC). The expression of Arg transporters was analyzed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemical analysis of tissue microarray. We also transfected the colon cancer cell line HCT-116 with siRNA specific for the Arg transporter CAT-1 and measured the induction of apoptosis by flow cytometry and cell proliferation by MTT assay. Consistent with our previous results, serum Arg and Cit concentrations in colorectal cancer patients were significantly lower than those in normal volunteers, while Arg and Cit concentrations in colorectal cancer tissues were significantly higher than in matched adjacent normal colon tissues. Quantitative RT-PCR showed that the CAT-1 gene was highly overexpressed in 70.5% of colorectal cancer tissue samples relative to adjacent normal colon tissues in all 122 patients with colorectal cancer. Immunohistochemical analysis of tissue microarray confirmed that the expression of CAT-1 was higher in all 25 colorectal cancer tissues tested. CAT-1 siRNA significantly induced apoptosis of HCT-116 cells and subsequently inhibited cell growth by 20-50%. Our findings indicate that accumulation of L-Arg and Cit and cell growth in colorectal cancer tissues is associated with over-expression of the Arg transporter gene CAT-1. Our results may be useful for the development of molecular diagnostic tools and targeted therapy for colorectal cancer.	[Lu, Ying; Wang, Junchen; Mao, Huiming; Fu, Xuelian; Wu, Yanling; Han, Junyi; Xu, Zengguang; Liu, Zhongmin; Hu, Hai; Chen, Bingguan] Tongji Univ, Clin Translat Med Res Ctr, Shanghai East Hosp, Sch Med, Shanghai 200092, Peoples R China; [Wang, Weimin; Cai, Jingping] Second Mil Med Univ, Changzheng Hosp, Dept Surg, Shanghai, Peoples R China; [Yang, Chunzhang; Zhuang, Zhengping] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	Tongji University; Naval Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hu, H (corresponding author), Tongji Univ, Clin Translat Med Res Ctr, Shanghai East Hosp, Sch Med, Shanghai 200092, Peoples R China.	huhailc@sina.com; chen.bingguan@seimc.com.cn	, 小寒飞刀～东方胃士/GMW-4890-2022	Yang, Chunzhang/0000-0001-6433-0867	National Natural Science Foundation of China [81172157]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003052] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Natural Science Foundation of China (81172157) to Bingguan Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SA, 2011, J CELL BIOCHEM, V112, P1084, DOI 10.1002/jcb.23022; Bowles TL, 2008, INT J CANCER, V123, P1950, DOI 10.1002/ijc.23723; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; CENDAN JC, 1995, ANN SURG ONCOL, V2, P257, DOI 10.1007/BF02307033; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Cheng PNM, 2007, CANCER RES, V67, P309, DOI 10.1158/0008-5472.CAN-06-1945; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Closs EI, 2004, J NUTR, V134, p2752S, DOI 10.1093/jn/134.10.2752S; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Ensor CM, 2002, CANCER RES, V62, P5443; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hagan Suzanne, 2013, EPMA J, V4, P3, DOI 10.1186/1878-5085-4-3; Huang CC, 2009, J BIOL CHEM, V284, P32312, DOI 10.1074/jbc.M109.024471; ISSELBACHER KJ, 1972, P NATL ACAD SCI USA, V69, P585, DOI 10.1073/pnas.69.3.585; Kanaan Z, 2012, HUM MUTAT, V33, P551, DOI 10.1002/humu.22021; Kaneko S, 2007, AM J PHYSIOL-CELL PH, V293, pC729, DOI 10.1152/ajpcell.00018.2007; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Kunte DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045591; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Ma QY, 2007, CLIN CANCER RES, V13, P7407, DOI 10.1158/1078-0432.CCR-07-0751; Mao HM, 2011, MICROCHEM J, V97, P291, DOI 10.1016/j.microc.2010.10.001; Mao HM, 2010, CLIN BIOCHEM, V43, P1141, DOI 10.1016/j.clinbiochem.2010.05.017; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Nicholls SJ, 2007, CIRCULATION, V116, P2315, DOI 10.1161/CIRCULATIONAHA.107.693986; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rotondo R, 2008, INT J CANCER, V123, P1108, DOI 10.1002/ijc.23437; Sandstrom K, 2000, J IMMUNOL METHODS, V240, P55, DOI 10.1016/S0022-1759(00)00176-9; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Yang CZ, 2013, P NATL ACAD SCI USA, V110, P966, DOI 10.1073/pnas.1221046110; Yoon CY, 2007, INT J CANCER, V120, P897, DOI 10.1002/ijc.22322; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	45	38	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73866	10.1371/journal.pone.0073866	http://dx.doi.org/10.1371/journal.pone.0073866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040099	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500063
J	Martiny, VY; Carbonell, P; Lagorce, D; Villoutreix, BO; Moroy, G; Miteva, MA				Martiny, Virginie Y.; Carbonell, Pablo; Lagorce, David; Villoutreix, Bruno O.; Moroy, Gautier; Miteva, Maria A.			In Silico Mechanistic Profiling to Probe Small Molecule Binding to Sulfotransferases	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; METABOLIZING-ENZYMES; STRUCTURAL GENOMICS; DRUG-METABOLISM; SITE; INHIBITION; DYNAMICS; DOCKING; PREDICTION; SULFATION	Drug metabolizing enzymes play a key role in the metabolism, elimination and detoxification of xenobiotics, drugs and endogenous molecules. While their principal role is to detoxify organisms by modifying compounds, such as pollutants or drugs, for a rapid excretion, in some cases they render their substrates more toxic thereby inducing severe side effects and adverse drug reactions, or their inhibition can lead to drug-drug interactions. We focus on sulfotransferases (SULTs), a family of phase II metabolizing enzymes, acting on a large number of drugs and hormones and showing important structural flexibility. Here we report a novel in silico structure-based approach to probe ligand binding to SULTs. We explored the flexibility of SULTs by molecular dynamics (MD) simulations in order to identify the most suitable multiple receptor conformations for ligand binding prediction. Then, we employed structure-based docking-scoring approach to predict ligand binding and finally we combined the predicted interaction energies by using a QSAR methodology. The results showed that our protocol successfully prioritizes potent binders for the studied here SULT1 isoforms, and give new insights on specific molecular mechanisms for diverse ligands' binding related to their binding sites plasticity. Our best QSAR models, introducing predicted protein-ligand interaction energy by using docking, showed accuracy of 67.28%, 78.00% and 75.46%, for the isoforms SULT1A1, SULT1A3 and SULT1E1, respectively. To the best of our knowledge our protocol is the first in silico structure-based approach consisting of a protein-ligand interaction analysis at atomic level that considers both ligand and enzyme flexibility, along with a QSAR approach, to identify small molecules that can interact with II phase dug metabolizing enzymes.	[Martiny, Virginie Y.; Lagorce, David; Villoutreix, Bruno O.; Moroy, Gautier; Miteva, Maria A.] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, Mol Therapeut In Silico,UMR S 973, Paris, France; [Martiny, Virginie Y.; Lagorce, David; Villoutreix, Bruno O.; Moroy, Gautier; Miteva, Maria A.] INSERM, U973, Paris, France; [Carbonell, Pablo] Univ Evry, iSSB, Evry, France; [Carbonell, Pablo] CNRS, iSSB, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Miteva, MA (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, Mol Therapeut In Silico,UMR S 973, Paris, France.	maria.miteva@univ-paris-diderot.fr	Villoutreix, Bruno/I-4565-2015; Carbonell, Pablo/A-3572-2011; Moroy, Gautier/AAT-1608-2020; Miteva, Maria M/N-2419-2018	Villoutreix, Bruno/0000-0002-6456-7730; Carbonell, Pablo/0000-0002-0993-5625; Moroy, Gautier/0000-0002-8973-0477; Miteva, Maria M/0000-0001-6895-1214	doctoral school 'MTCE' at the University Paris Descartes; doctoral school 'MTCE' at the University Paris Diderot	doctoral school 'MTCE' at the University Paris Descartes; doctoral school 'MTCE' at the University Paris Diderot	V.Y.M. was supported by the doctoral school 'MTCE' at the Universities Paris Descartes and Paris Diderot. P. C. was supported by Genopole (ATIGE grant) and Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Berger I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026794; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidwell LM, 1999, J MOL BIOL, V293, P521, DOI 10.1006/jmbi.1999.3153; Bojarova P, 2008, CURR OPIN CHEM BIOL, V12, P573, DOI 10.1016/j.cbpa.2008.06.018; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Campagna-Slater V, 2009, J CHEM INF MODEL, V49, P2082, DOI 10.1021/ci900219u; Carbonell P, 2013, J CHEM INF MODEL; Cavasotto CN, 2011, METHODS MOL BIOL, V685, P155, DOI 10.1007/978-1-60761-931-4_8; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Dong D, 2012, EXPERT OPIN DRUG MET, V8, P635, DOI 10.1517/17425255.2012.677027; Eagle K, 2012, J APPL TOXICOL, V32, P751, DOI 10.1002/jat.2764; Ekuase EJ, 2011, CHEM RES TOXICOL, V24, P1720, DOI 10.1021/tx200260h; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Gleeson MP, 2012, CURR PHARM DESIGN, V18, P1266; Grigorov MG, 2011, METHODS MOL BIOL, V719, P153, DOI 10.1007/978-1-61779-027-0_7; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hamon J, 2009, FUTURE MED CHEM, V1, P645, DOI 10.4155/FMC.09.51; Isvoran A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-24; Ivetac A, 2011, CURR PHARM DESIGN, V17, P1663, DOI 10.2174/138161211796355056; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lagorce D, 2011, ADMET MED CHEMISTS, P29; Lagorce D, 2011, BIOINFORMATICS, V27, P2018, DOI 10.1093/bioinformatics/btr333; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lu JH, 2005, BIOCHEM BIOPH RES CO, V335, P417, DOI 10.1016/j.bbrc.2005.07.091; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martiny VY, 2013, PREDICTIVE ADMETINTE; Meng SN, 2012, MOL PHARMACEUT, V9, P862, DOI 10.1021/mp200400s; Merlot C, 2010, DRUG DISCOV TODAY, V15, P16, DOI 10.1016/j.drudis.2009.09.010; Michielan L, 2010, J CHEM INF MODEL, V50, P961, DOI 10.1021/ci100072z; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; Najmanovich RJ, 2007, BIOINFORMATICS, V23, pE104, DOI 10.1093/bioinformatics/btl292; Nigsch F, 2011, EXPERT OPIN DRUG MET, V7, P1497, DOI 10.1517/17425255.2011.632632; R Development Core Team, 2009, R FDN STAT COMP; Rohn KJ, 2012, DRUG METAB DISPOS, V40, P1588, DOI 10.1124/dmd.112.045583; Rueda M, 2009, J CHEM INF MODEL, V49, P716, DOI 10.1021/ci8003732; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Sharma V, 2005, METHOD ENZYMOL, V400, P249, DOI 10.1016/S0076-6879(05)00014-5; Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p; Shevtsov S, 2003, ENVIRON HEALTH PERSP, V111, P884, DOI 10.1289/ehp.6056; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Sipila J, 2003, J CHEM INF COMP SCI, V43, P1563, DOI 10.1021/ci034089e; Sperandio O, 2011, IN SILICO LEAD DISCOVERY, P20; Sperandio O, 2010, EUR BIOPHYS J BIOPHY, V39, P1365, DOI 10.1007/s00249-010-0592-0; Stjernschantz E, 2010, MOL CELL ENDOCRINOL, V317, P127, DOI 10.1016/j.mce.2009.12.001; Stoll F, 2011, DRUG DISCOV TODAY, V16, P530, DOI 10.1016/j.drudis.2011.04.008; Sun H, 2010, CHEM BIOL DRUG DES, V75, P3, DOI 10.1111/j.1747-0285.2009.00899.x; Surh YJ, 1998, CHEM-BIOL INTERACT, V109, P221, DOI 10.1016/S0009-2797(97)00134-8; Taboureau O, 2012, CHEM BIOL, V19, P29, DOI 10.1016/j.chembiol.2011.12.007; Taskinen J, 2003, DRUG METAB DISPOS, V31, P1187, DOI 10.1124/dmd.31.9.1187; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Testa B, 2012, DRUG DISCOV TODAY, V17, P549, DOI 10.1016/j.drudis.2012.01.017; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varnek A, 2012, J CHEM INF MODEL, V52, P1413, DOI 10.1021/ci200409x; Vaz RJ, 2010, EXPERT OPIN DRUG MET, V6, P851, DOI 10.1517/17425255.2010.499123; Vedani A, 2009, ATLA-ALTERN LAB ANIM, V37, P477, DOI 10.1177/026119290903700506; Veith H, 2009, NAT BIOTECHNOL, V27, P1050, DOI 10.1038/nbt.1581; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Wang JL, 2007, EXPERT OPIN DRUG MET, V3, P641, DOI 10.1517/17425225.3.5.641; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xie L, 2011, CURR OPIN STRUC BIOL, V21, P189, DOI 10.1016/j.sbi.2011.01.004; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	78	18	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73587	10.1371/journal.pone.0073587	http://dx.doi.org/10.1371/journal.pone.0073587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039991	gold, Green Published			2022-12-25	WOS:000324856500048
J	Gladman, JT; Mandal, M; Srinivasan, V; Mahadevan, MS				Gladman, Jordan T.; Mandal, Mahua; Srinivasan, Varadamurthy; Mahadevan, Mani S.			Age of Onset of RNA Toxicity Influences Phenotypic Severity: Evidence from an Inducible Mouse Model of Myotonic Dystrophy (DM1)	PLOS ONE			English	Article							SKELETAL-MUSCLE; BINDING PROTEIN; CHILDHOOD TYPE; GENE-TRANSFER; OVEREXPRESSION; COMPLICATIONS; PATHOGENESIS; DEFECTS; BRITAIN; REPEAT	Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in adults. It is caused by an expanded (CTG)n tract in the 3' UTR of the Dystrophia Myotonica Protein Kinase (DMPK) gene. This causes nuclear retention of the mutant mRNA into ribonuclear foci and sequestration of interacting RNA-binding proteins (such as muscleblind-like 1 (MBNL1)). More severe congenital and childhood-onset forms of the disease exist but are less understood than the adult disease, due in part to the lack of adequate animal models. To address this, we utilized transgenic mice over-expressing the DMPK 3' UTR as part of an inducible RNA transcript to model early-onset myotonic dystrophy. In mice in which transgene expression was induced during embryogenesis, we found that by two weeks after birth, mice reproduced cardinal features of myotonic dystrophy, including myotonia, cardiac conduction abnormalities, muscle weakness, histopathology and mRNA splicing defects. Notably, these defects were more severe than in adult mice induced for an equivalent period of exposure to RNA toxicity. Additionally, the utility of the model was tested by over-expressing MBNL1, a key therapeutic strategy being actively pursued for treating the disease phenotypes associated with DM1. Significantly, increased MBNL1 in skeletal muscle partially corrected myotonia and splicing defects present in these mice, demonstrating the responsiveness of the model to relevant therapeutic interventions. Furthermore, these results also represent the first murine model for early-onset DM1 and provide a tool to investigate the effects of RNA toxicity at various stages of development.	[Gladman, Jordan T.; Mandal, Mahua; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Srinivasan, Varadamurthy] Parexel Int, Bethesda, MD USA	University of Virginia; Parexel International	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	mahadevan@virginia.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [5R01AR045992-10]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052771, R01AR045992] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant 5R01AR045992-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamberlain CM, 2012, HUM MOL GENET, V21, P4645, DOI 10.1093/hmg/dds306; Dansithong W, 2011, EMBO REP, V12, P735, DOI 10.1038/embor.2011.86; Day John W, 2005, Curr Neurol Neurosci Rep, V5, P55, DOI 10.1007/s11910-005-0024-1; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; DU H, NAT STRUCT MOL BIOL, V17, P187; Franco D, 2001, EUR J MORPHOL, V39, P169, DOI 10.1076/ejom.39.3.169.4670; Goossens E, 2000, GENET COUNSEL, V11, P317; HARPER P S, 1974, Birth Defects Original Article Series, V10, P120; HARPER PS, 1989, LANCET, V2, P1269; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HARPER PS, 1975, ARCH DIS CHILD, V50, P505, DOI 10.1136/adc.50.7.505; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Morales F, 2012, HUM MOL GENET, V21, P3558, DOI 10.1093/hmg/dds185; OBRIEN TA, 1984, DEV MED CHILD NEUROL, V26, P62; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Ravel-Chapuis A, 2012, J CELL BIOL, V196, P699, DOI 10.1083/jcb.201108113; Schertzer Jonathan D., 2008, V433, P115, DOI 10.1007/978-1-59745-237-3_7; Steyaert J, 2000, AM J MED GENET, V96, P888, DOI 10.1002/1096-8628(20001204)96:6<888::AID-AJMG42>3.0.CO;2-7; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Wu CL, 2012, METHODS MOL BIOL, V798, P231, DOI 10.1007/978-1-61779-343-1_13; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28	28	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72907	10.1371/journal.pone.0072907	http://dx.doi.org/10.1371/journal.pone.0072907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039817	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600042
J	Jacobson, F; Karkehabadi, S; Hansson, H; Goedegebuur, F; Wallace, L; Mitchinson, C; Piens, K; Stals, I; Sandgren, M				Jacobson, Frida; Karkehabadi, Saeid; Hansson, Henrik; Goedegebuur, Frits; Wallace, Louise; Mitchinson, Colin; Piens, Kathleen; Stals, Ingeborg; Sandgren, Mats			The Crystal Structure of the Core Domain of a Cellulose Induced Protein (Cip1) from Hypocrea jecorina, at 1.5 angstrom Resolution	PLOS ONE			English	Article							FUNGUS TRICHODERMA-REESEI; CARBOHYDRATE-BINDING MODULES; POLYSACCHARIDE LYASE FAMILY; ELECTRON-DENSITY MAPS; MACROMOLECULAR STRUCTURES; GLYCOSYL HYDROLASES; MAXIMUM-LIKELIHOOD; REFINEMENT; SIMILARITIES; MECHANISMS	In an effort to characterise the whole transcriptome of the fungus Hypocrea jecorina, cDNA clones of this fungus were identified that encode for previously unknown proteins that are likely to function in biomass degradation. One of these newly identified proteins, found to be co-regulated with the major H. jecorina cellulases, is a protein that was denoted Cellulose induced protein 1 (Cip1). This protein consists of a glycoside hydrolase family 1 carbohydrate binding module connected via a linker region to a domain with yet unknown function. After cloning and expression of Cip1 in H. jecorina, the protein was purified and biochemically characterised with the aim of determining a potential enzymatic activity for the novel protein. No hydrolytic activity against any of the tested plant cell wall components was found. The proteolytic core domain of Cip1 was then crystallised, and the three-dimensional structure of this was determined to 1.5 angstrom resolution utilising sulphur single-wavelength anomalous dispersion phasing (sulphor-SAD). A calcium ion binding site was identified in a sequence conserved region of Cip1 and is also seen in other proteins with the same general fold as Cip1, such as many carbohydrate binding modules. The presence of this ion was found to have a structural role. The Cip1 structure was analysed and a structural homology search was performed to identify structurally related proteins. The two published structures with highest overall structural similarity to Cip1 found were two poly-lyases: CsGL, a glucuronan lyase from H. jecorina and vAL-1, an alginate lyase from the Chlorella virus. This indicates that Cip1 may be a lyase. However, initial trials did not detect significant lyase activity for Cip1. Cip1 is the first structure to be solved of the 23 currently known Cip1 sequential homologs (with a sequence identity cut-off of 25%), including both bacterial and fungal members.	[Jacobson, Frida; Karkehabadi, Saeid; Hansson, Henrik; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden; [Goedegebuur, Frits] DuPont Co Inc, Ind Biosci, Leiden, Netherlands; [Wallace, Louise; Mitchinson, Colin] DuPont Co Inc, Ind Biosci, Palo Alto, CA USA; [Piens, Kathleen] Univ Ghent, Dept Biochem Physiol & Microbiol, B-9000 Ghent, Belgium; [Stals, Ingeborg] Univ Coll Ghent, Fac Appl Biosci Engn, Ghent, Belgium; [Stals, Ingeborg] Univ Ghent, B-9000 Ghent, Belgium	Swedish University of Agricultural Sciences; DuPont; Ghent University; HOGENT University College of Applied Sciences & Arts; Ghent University	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden.	mats.sandgren@slu.se		Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534	National Resources Faculty of Swedish University of Agricultural Sciences; Engineering and Physical Sciences Research Council [EP/D032210/1] Funding Source: researchfish; EPSRC [EP/D032210/1] Funding Source: UKRI	National Resources Faculty of Swedish University of Agricultural Sciences; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work in this paper was funded by the National Resources Faculty of Swedish University of Agricultural Sciences. (www.slu.se) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BOWER B, 1998, CARBOHYDRASES TRICHO, P327; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAKRABARTI P, 1991, ARCH BIOCHEM BIOPHYS, V290, P387, DOI 10.1016/0003-9861(91)90556-X; Claeyssens M, 1988, BIOCH GENETICS CELLU, P393; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Garcia R, 2001, BIOTECHNOL APPL BIOC, V33, P141, DOI 10.1042/BA20000085; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Konno N, 2009, APPL ENVIRON MICROB, V75, P101, DOI 10.1128/AEM.01749-08; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; Kuhls K, 1996, P NATL ACAD SCI USA, V93, P7755, DOI 10.1073/pnas.93.15.7755; La Fortelle Ed, 1997, CRYSTALLOGRAPHIC COM; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; McPherson A, 1982, PREPARATION ANAL PRO; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; OKUDA J, 1977, CARBOHYD RES, V58, P267, DOI 10.1016/S0008-6215(00)84353-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Roske Y, 2004, J MOL BIOL, V340, P543, DOI 10.1016/j.jmb.2004.04.072; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simon A, 2004, NUCL INSTRUM METH B, V219, P405, DOI 10.1016/j.nimb.2004.01.091; TOMME P, 1988, METHOD ENZYMOL, V160, P187; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; VANTILBEURGH H, 1988, METHOD ENZYMOL, V160, P45; WOOD PJ, 1988, METHOD ENZYMOL, V160, P59; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	49	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e70562	10.1371/journal.pone.0070562	http://dx.doi.org/10.1371/journal.pone.0070562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039705	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600006
J	Wang, EL; Jin, WF; Duan, WY; Qiao, B; Sun, SN; Huang, GY; Shi, KH; Jin, L; Wang, HY				Wang, Erli; Jin, Wenfei; Duan, Wenyuan; Qiao, Bin; Sun, Shuna; Huang, Guoying; Shi, Kaihu; Jin, Li; Wang, Hongyan			Association of Two Variants in SMAD7 with the Risk of Congenital Heart Disease in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER RISK; TGF-BETA; CARDIOVASCULAR DEFECTS; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; EXPRESSION; GENETICS; COUNCIL; 18Q21	SMAD7 is a general antagonist of TGF-beta signaling and has been found to be involved in cardiogenesis in mouse models, but its role in human congenital heart disease (CHD) has yet to be investigated. To examine if SMAD7 is associated with CHD, we conducted a case-control study in the Han Chinese population. Exon1 and exon4 of SMAD7, which encode the functional MH1 and MH2 domains, were directly sequenced in 1,201 sporadic CHD patients and 1,116 control individuals. A total of 18 sequence variations were identified. Two common variants rs3809922 and rs3809923 are located at exon4 of SMAD7, and were found in strong linkage disequilibrium with each other (r(2) = 0.93). We analyzed the association of these two loci with CHD in 3 independent subgroup case-control studies, and found that in some subgroups, rs3809922 and rs3809923 were significantly associated with CHD through genetic model analysis. In the combined data set, TT genotype in rs3809922 significantly increased the risk of CHD compared with CC and CT, while GG genotype in rs3809923 significantly increased the risk of CHD compared with CC and CG, particularly in the recessive model. In addition, haplotype analyses showed that haplotype TG significantly increased the risk of CHD (P = 6.9x10(-6)); this finding supports the results from the analyses based on single locus. According to data from the 1000 Genomes Project, the frequencies of the two risk alleles varied greatly between populations worldwide, which indicate the identified associations might have a population difference. To our knowledge, this is the first report that genetic variants in SMAD7 influence susceptibility to CHD risk.	[Wang, Erli; Jin, Wenfei; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG Partner, Shanghai, Peoples R China; [Wang, Erli; Jin, Li; Wang, Hongyan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Erli; Jin, Li; Wang, Hongyan] Fudan Univ, Sch Life Sci, Minist Educ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Duan, Wenyuan; Qiao, Bin] Gen Hosp Jinan Mil Reg, Inst Cardiovasc Dis, Jinan, Peoples R China; [Sun, Shuna; Huang, Guoying] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Shi, Kaihu] Anhui Med Univ, Hosp 2, Hefei, Peoples R China; [Wang, Hongyan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University; Fudan University; Fudan University; Anhui Medical University; Fudan University	Jin, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG Partner, Shanghai, Peoples R China.	ljin007@gmail.com; wanghy@fudan.edu.cn	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Jin, Wenfei/H-5330-2011; Jin, Wenfei/V-9944-2019	Jin, Li/0000-0002-4546-2415; Jin, Wenfei/0000-0002-0028-3739; Jin, Wenfei/0000-0002-0028-3739	National Science Fund for Distinguished Young Scholars [81025003]; 973 Program [2010CB529601]; Ministry of Education of China [20110071110026]; Commission for Science and Technology of Shanghai Municipality [10JC1401300, 11XD1400900]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); Commission for Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the grants from the National Science Fund for Distinguished Young Scholars (81025003), the 973 Program (2010CB529601), Doctoral Fund of Ministry of Education of China (20110071110026), and the Commission for Science and Technology of Shanghai Municipality (10JC1401300, 11XD1400900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hariharan R, 2009, ONCOL REP, V21, P1001, DOI 10.3892/or_00000315; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hurst LD, 2011, NATURE, V471, P582, DOI 10.1038/471582a; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Leng AM, 2009, EXP MOL PATHOL, V87, P48, DOI 10.1016/j.yexmp.2009.03.003; Lewis CM, 2012, COLD SPRING HARB PRO, V2012, P297; Miyake T, 2010, MOL CELL BIOL, V30, P722, DOI 10.1128/MCB.01005-09; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Song QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033318; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan HL, 2012, HUM MUTAT, V33, P720, DOI 10.1002/humu.22030; Tang SY, 2010, DEV BIOL, V344, P233, DOI 10.1016/j.ydbio.2010.05.004; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tojo M, 2012, J BIOCHEM, V151, P621, DOI 10.1093/jb/mvs022; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	29	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72423	10.1371/journal.pone.0072423	http://dx.doi.org/10.1371/journal.pone.0072423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039762	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600027
J	Young, RC; Kitaysky, AS; Haussmann, MF; Descamps, S; Orben, RA; Elliott, KH; Gaston, AJ				Young, Rebecca C.; Kitaysky, Alexander S.; Haussmann, Mark F.; Descamps, Sebastien; Orben, Rachael A.; Elliott, Kyle H.; Gaston, Anthony J.			Age, Sex, and Telomere Dynamics in a Long-Lived Seabird with Male-Biased Parental Care	PLOS ONE			English	Article							PCR ASSAY; LENGTH; EVOLUTION; SURVIVAL; LONGEVITY; SELECTION; FITNESS; SNAKES; RATES; LINK	The examination of telomere dynamics is a recent technique in ecology for assessing physiological state and age-related traits from individuals of unknown age. Telomeres shorten with age in most species and are expected to reflect physiological state, reproductive investment, and chronological age. Loss of telomere length is used as an indicator of biological aging, as this detrimental deterioration is associated with lowered survival. Lifespan dimorphism and more rapid senescence in the larger, shorter-lived sex are predicted in species with sexual size dimorphism, however, little is known about the effects of behavioral dimorphism on senescence and life history traits in species with sexual monomorphism. Here we compare telomere dynamics of thick-billed murres (Uria lomvia), a species with male-biased parental care, in two ways: 1) cross-sectionally in birds of known-age (0-28 years) from one colony and 2) longitudinally in birds from four colonies. Telomere dynamics are compared using three measures: the telomere restriction fragment (TRF), a lower window of TRF (TOE), and qPCR. All showed age-related shortening of telomeres, but the TRF measure also indicated that adult female murres have shorter telomere length than adult males, consistent with sex-specific patterns of ageing. Adult males had longer telomeres than adult females on all colonies examined, but chick telomere length did not differ by sex. Additionally, inter-annual telomere changes may be related to environmental conditions; birds from a potentially low quality colony lost telomeres, while those at more hospitable colonies maintained telomere length. We conclude that sex-specific patterns of telomere loss exist in the sexually monomorphic thick-billed murre but are likely to occur between fledging and recruitment. Longer telomeres in males may be related to their homogamous sex chromosomes (ZZ) or to selection for longer life in the care-giving sex. Environmental conditions appeared to be the primary drivers of annual changes in adult birds.	[Young, Rebecca C.; Kitaysky, Alexander S.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK USA; [Haussmann, Mark F.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Descamps, Sebastien] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Orben, Rachael A.] Univ Calif Santa Cruz, Long Marine Lab, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Elliott, Kyle H.; Gaston, Anthony J.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Alaska System; University of Alaska Fairbanks; Bucknell University; Norwegian Polar Institute; University of California System; University of California Santa Cruz; University of Manitoba	Young, RC (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK USA.	rcyoung@alaska.edu	Orben, Rachael A./H-9460-2019; Elliott, Kyle/S-9185-2019	Orben, Rachael A./0000-0002-0802-407X; Elliott, Kyle/0000-0001-5304-3993	North Pacific Research Board Graduate Student Research Award; BEST-BSIERP program through NPRB [B67, B77]; MOSJ; SEAPOP; Polar Continental Shelf Project; International Polar Year Project	North Pacific Research Board Graduate Student Research Award; BEST-BSIERP program through NPRB; MOSJ; SEAPOP; Polar Continental Shelf Project(Natural Resources Canada); International Polar Year Project	Funding was provided by the North Pacific Research Board Graduate Student Research Award 2008 (to RC Young) and the BEST-BSIERP program through NPRB (B67 & B77 to AS Kitaysky). Research at Diabasodden was supported by MOSJ (http://mosj.npolar.no/) and SEAPOP (http://seapop.no/), and research at Coats Island was supported by the Polar Continental Shelf Project and the 2007-08 International Polar Year Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2013, FUNCT ECOL, V27, P342, DOI 10.1111/1365-2435.12041; Aubry LM, 2011, J ANIM ECOL, V80, P375, DOI 10.1111/j.1365-2656.2010.01784.x; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bouwhuis S, 2010, J ANIM ECOL, V79, P1251, DOI 10.1111/j.1365-2656.2010.01730.x; Bronikowski AM, 2008, AGE, V30, P169, DOI 10.1007/s11357-008-9060-5; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cameron-MacMillan ML, 2007, BEHAV ECOL, V18, P81, DOI 10.1093/beheco/arl048; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; DESCAMPS S, OECOLOGIA; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Foote C.G., 2008, AVIAN TELOMERE DYNAM; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Foote CG, 2011, BEHAV ECOL, V22, P156, DOI 10.1093/beheco/arq178; Gaston A.J., 1998, THE AUKS ALCIDAE; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Harding AMA, 2009, ANIM BEHAV, V78, P321, DOI 10.1016/j.anbehav.2009.05.009; HARDING AMA, DEEP SEA RES 2; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2008, MOL ECOL RESOUR, V8, P264, DOI 10.1111/j.1471-8286.2007.01973.x; Haussmann MF, 2007, EXP GERONTOL, V42, P610, DOI 10.1016/j.exger.2007.03.004; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; Johnstone RA, 2010, P ROY SOC B-BIOL SCI, V277, P3765, DOI 10.1098/rspb.2010.0988; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Kyo S, 1999, CANCER RES, V59, P5917; Martin JGA, 2011, ECOL LETT, V14, P576, DOI 10.1111/j.1461-0248.2011.01621.x; Nager RG, 2001, J AVIAN BIOL, V32, P159, DOI 10.1034/j.1600-048X.2001.320209.x; Nakagawa S, 2004, MOL ECOL, V13, P2523, DOI 10.1111/j.1365-294X.2004.02291.x; Olsson M, 2011, MOL ECOL, V20, P2085, DOI 10.1111/j.1365-294X.2011.05085.x; Olsson M, 2010, BIOL LETTERS, V6, P651, DOI 10.1098/rsbl.2010.0126; Paredes R, 2012, MAR ECOL PROG SER, V471, P253, DOI 10.3354/meps10034; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REED TE, 2008, AM NAT, P171; Ricklefs RE, 2010, FUNCT ECOL, V24, P588, DOI 10.1111/j.1365-2435.2009.01684.x; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Tower John, 2009, Journal of Biology (London), V8, P38, DOI 10.1186/jbiol141; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	49	41	41	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74931	10.1371/journal.pone.0074931	http://dx.doi.org/10.1371/journal.pone.0074931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023967	gold, Green Published			2022-12-25	WOS:000324515600161
J	Kosari, F; Ida, C; Aubry, MC; Yang, L; Kovtun, IV; Klein, JLS; Li, Y; Erdogan, S; Tomaszek, S; Murphy, SJ; Bolette, LC; Kolbert, CP; Yang, P; Wigle, DA; Vasmatzis, G				Kosari, F.; Ida, C. M.; Aubry, M-C; Yang, L.; Kovtun, I. V.; Klein, J. L. S.; Li, Y.; Erdogan, S.; Tomaszek, S. C.; Murphy, S. J.; Bolette, L. C.; Kolbert, C. P.; Yang, P.; Wigle, D. A.; Vasmatzis, G.			ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation	ONCOGENE			English	Article						prognostic biomarker; MASH1; lung cancer; neuroendocrine; microarray	MEDULLARY-THYROID CANCER; ACHAETE-SCUTE HOMOLOG-1; GENE-EXPRESSION; CIGARETTE-SMOKING; CELLS; MICE; PROTOONCOGENE; FEATURES; SUBTYPE; FUSIONS	ASCL1 is an important regulatory transcription factor in pulmonary neuroendocrine (NE) cell development, but its value as a biomarker of NE differentiation in lung adenocarcinoma (AD) and as a potential prognostic biomarker remains unclear. We examined ASCL1 expression in lung cancer samples of varied histologic subtype, clinical outcome and smoking status and compared with expression of traditional NE markers. ASCL1 mRNA expression was found almost exclusively in smokers with AD, in contrast to nonsmokers and other lung cancer subtypes. ASCL1 protein expression by immunohistochemical (IHC) analysis correlated best with synaptophysin compared with chromogranin and CD56/NCAM. Analysis of a compendium of 367 microarray-based gene expression profiles in stage I lung adenocarcinomas identified significantly higher expression levels of the RET oncogene in ASCL1-positive tumors (ASCL1(+)) compared with ASCL1(-) tumors (q-value < 10(-9)). High levels of RET expression in ASCL1(+) but not in ASCL1(-) tumors was associated with significantly shorter overall survival (OS) in stage 1 (P = 0.007) and in all AD (P = 0.037). RET protein expression by IHC had an association with OS in the context of ASCL1 expression. In silico gene set analysis and in vitro experiments by ASCL1 shRNA in AD cells with high endogenous expression of ASCL1 and RET implicated ASCL1 as a potential upstream regulator of the RET oncogene. Also, silencing ASCL1 in AD cells markedly reduced cell growth and motility. These results suggest that ASCL1 and RET expression defines a clinically relevant subgroup of similar to 10% of AD characterized by NE differentiation.	[Kosari, F.; Klein, J. L. S.; Murphy, S. J.; Vasmatzis, G.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Ida, C. M.; Aubry, M-C; Yang, L.; Erdogan, S.; Bolette, L. C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Kovtun, I. V.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Li, Y.; Yang, P.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Tomaszek, S. C.; Wigle, D. A.] Mayo Clin, Dept Surg & Adv Genom Technol Ctr, Rochester, MN 55905 USA; [Kolbert, C. P.] Mayo Clin, Adv Genom Technol Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Vasmatzis, G (corresponding author), Mayo Clin, Lab Med & Pathol, 200 First Str SW, Rochester, MN 55905 USA.	vasmatzis.george@mayo.edu	Kovtun, Irina/ABA-8484-2020		Waterman Biomarker Discovery grant; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	Waterman Biomarker Discovery grant; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Waterman Biomarker Discovery grant and by the Mayo Clinic Center for Individualized Medicine.	Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Boldrini L, 2009, ONCOL REP, V22, P683, DOI 10.3892/or_00000488; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Burton MD, 1997, J AUTONOM NERV SYST, V63, P137, DOI 10.1016/S0165-1838(97)00002-7; Chen H, 1996, SURGERY, V120, P168, DOI 10.1016/S0039-6060(96)80284-4; Dauger S, 2001, PHYSIOL GENOMICS, V7, P149, DOI 10.1152/physiolgenomics.00056.2001; Dauger S, 1999, PEDIATR RES, V46, P535, DOI 10.1203/00006450-199911000-00008; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Fujiwara T, 2012, LUNG CANCER, V75, P119, DOI 10.1016/j.lungcan.2011.05.028; Huber K, 2005, DEV BIOL, V279, P501, DOI 10.1016/j.ydbio.2005.01.007; Huber K, 2002, DEVELOPMENT, V129, P4729; Ionescu DN, 2007, AM J SURG PATHOL, V31, P26, DOI 10.1097/01.pas.0000213319.04919.97; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kouvaraki MA, 2005, THYROID, V15, P531, DOI 10.1089/thy.2005.15.531; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Linnoila RI, 2000, CANCER RES, V60, P4005; Lo LC, 1998, DEVELOPMENT, V125, P609; Lodish MB, 2008, EXPERT REV ANTICANC, V8, P625, DOI 10.1586/14737140.8.4.625; Marsh DJ, 2011, ADV OTO-RHINO-LARYNG, V70, P84, DOI 10.1159/000322479; Massion PP, 2008, AM J RESP CRIT CARE, V178, P1164, DOI 10.1164/rccm.200801-142OC; Osada H, 2005, CANCER RES, V65, P10680, DOI 10.1158/0008-5472.CAN-05-1404; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Poulsen TT, 2008, CANCER GENE THER, V15, P563, DOI 10.1038/cgt.2008.24; Powell CA, 2003, AM J RESP CELL MOL, V29, P157, DOI 10.1165/rcmb.2002-0183RC; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shoba T, 2002, NEUROSCI LETT, V318, P129, DOI 10.1016/S0304-3940(01)02491-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wang R, 2012, J CLIN ONCOL, V30, P4352, DOI 10.1200/JCO.2012.44.1477	35	37	38	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3776	3783		10.1038/onc.2013.359	http://dx.doi.org/10.1038/onc.2013.359			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	24037524	Green Accepted			2022-12-25	WOS:000339394100003
J	Walker, R; Gissot, M; Huot, L; Alayi, TD; Hot, D; Marot, G; Schaeffer-Reiss, C; Van Dorsselaer, A; Kim, K; Tomavo, S				Walker, Robert; Gissot, Mathieu; Huot, Ludovic; Alayi, Tchilabalo Dilezitoko; Hot, David; Marot, Guillemette; Schaeffer-Reiss, Christine; Van Dorsselaer, Alain; Kim, Kami; Tomavo, Stanislas			Toxoplasma Transcription Factor TgAP2XI-5 Regulates the Expression of Genes Involved in Parasite Virulence and Host Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; GONDII; DIMERIZATION; APICOMPLEXA; CYST	Gene regulation in apicomplexan parasites, a phylum containing important protozoan parasites such as Plasmodium and Toxoplasma, is poorly understood. The life cycle of Toxoplasma gondii is complex, with multiple proliferation and differentiation steps, of which tachyzoite proliferation is the most relevant to pathogenesis in humans and animals. Tachyzoites express invasion and virulence factors that are crucial for their survival and manipulation of host cell functions. The expression of those factors is tightly controlled during the tachyzoite cell cycle to permit their correct packaging in newly formed apical secretory organelles named micronemes and rhoptries in the daughter cells. However, little is known about the factors that control the expression of genes encoding the virulence factors present in these parasite-specific secretory organelles. We report that the plant-like nuclear factor TgAP2XI-5 targets more than 300 gene promoters and actively controls the transcription of these genes. Most of these target genes, including those that are essential for parasite virulence, showed a peak of expression in the S and M phases of the cell cycle. Furthermore, we identified the cis-regulatory element recognized by TgAP2XI-5 and demonstrated its ability to actively drive gene transcription. Our results demonstrated that TgAP2XI-5 is a novel DNA sequence-specific transcription factor associated with promoter activation. TgAP2XI-5 may regulate gene transcription of crucial virulence factors in T. gondii.	[Walker, Robert; Gissot, Mathieu; Huot, Ludovic; Hot, David; Van Dorsselaer, Alain; Tomavo, Stanislas] Univ Lille Nord France, Ctr Infect & Immun Lille, CNRS UMR 8204, Inst Pasteur Lille,INSERM 1019, F-59000 Lille, France; [Alayi, Tchilabalo Dilezitoko; Schaeffer-Reiss, Christine] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, IPHC, CNRS UMR 7178, F-67087 Strasbourg, France; [Marot, Guillemette] INRIA MODAL Team, F-59650 Villeneuve Dascq, France; [Kim, Kami] Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yeshiva University; Albert Einstein College of Medicine	Tomavo, S (corresponding author), Univ Lille Nord France, Ctr Infect & Immun Lille, CNRS UMR 8204, Inst Pasteur Lille,INSERM 1019, F-59000 Lille, France.	Stan.Tomavo@pasteur-lille.fr	Walker, Robert/C-3202-2013; Marot, Guillemette/O-6525-2014; Gissot, Mathieu/AFN-3127-2022; Alayi, Tchilabalo Dilezitoko/X-7191-2018; Hot, David/M-6775-2016	Walker, Robert/0000-0003-0032-9925; Marot, Guillemette/0000-0002-7437-8239; Gissot, Mathieu/0000-0003-0047-8189; Alayi, Tchilabalo Dilezitoko/0000-0002-7291-531X; Hot, David/0000-0002-2361-0616; Kim, Kami/0000-0003-3384-152X	National Institutes of Health [R01AI087625, RC4AI092801]; CNRS; INSERM; French National Research Agency [ANR-09-MIEN-002-01]; National Agency for Research [ANR-11-LABX-0024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092801, R01AI087625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French National Research Agency(French National Research Agency (ANR)); National Agency for Research(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI087625 and RC4AI092801. (to K. K.). This work was also supported by the CNRS, INSERM, French National Research Agency Grant ANR-09-MIEN-002-01 (BradyToxoFT), and Grant ANR-11-LABX-0024 from the National Agency for Research to the Laboratoire d'Excellence ParaFrap.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Boyle JP, 2008, EUKARYOT CELL, V7, P1403, DOI 10.1128/EC.00073-08; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Gissot M, 2009, INT J PARASITOL, V39, P145, DOI 10.1016/j.ijpara.2008.10.002; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Gissot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032671; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindner SE, 2010, J MOL BIOL, V395, P558, DOI 10.1016/j.jmb.2009.11.004; Naguleswaran A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001232; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Toedling J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000227; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	27	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31127	31138		10.1074/jbc.M113.486589	http://dx.doi.org/10.1074/jbc.M113.486589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025328	hybrid, Green Published			2022-12-25	WOS:000330778900031
J	Akita, K; Hasezawa, S; Higaki, T				Akita, Kae; Hasezawa, Seiichiro; Higaki, Takumi			Breaking of Plant Stomatal One-Cell-Spacing Rule by Sugar Solution Immersion	PLOS ONE			English	Article							SUCROSE SYNTHASE; SECRETORY PEPTIDE; GENE-EXPRESSION; ARABIDOPSIS; DIFFERENTIATION; DENSITY; CALLOSE; DIVISIONS; MUTATION; KINASES	The spatial distribution of plant stomata is a model system to study epidermal cell pattern formation. Molecular genetic approaches have identified several key genes required for stomatal distribution patterning, but environmental conditions that perturb the stomatal spacing distribution have not yet been identified. We found that immersing hydroponic cultures in 1-5% sucrose solution induced abnormally clustered stomata in the cotyledons of Arabidopsis seedlings. Clustered stomata were also induced by treatment with glucose or fructose solution but not by mannitol solution, suggesting that osmotic stress was not a cause of the disturbed stomatal patterns. Stomatal lineage cell-specific enhancer trap lines revealed that the sugar solution treatment led to ectopic expression of stomatal lineage cell-specific genes in non-stomatal lineage cells. Aniline blue staining also showed that there was reduced deposition of callose, a plant cell wall component, in new cell walls during formation of stomatal precursor cells (meristemoids). These results suggested that the immersion treatment with sugar solution permitted ectopic guard cell differentiation through dysfunction of the cell wall dividing stomatal- and non-stomatal lineage cells. Our simple induction system for clustered stomata provides a suitable tool for further studies to investigate the one-cell-spacing rule during plant stomatal development.	[Akita, Kae; Hasezawa, Seiichiro; Higaki, Takumi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Hasezawa, Seiichiro] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Higaki, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	higaki@k.u-tokyo.ac.jp	Higaki, Takumi/N-1216-2015		JST; MEXT KAKENHI [24114007, 24114704]; JSPS; KAKENHI [25711017]	JST(Japan Science & Technology Agency (JST)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by an Advanced Measurement and Analysis grant from JST to SH; MEXT KAKENHI grant numbers 24114007 and 24114704 to SH and JSPS; and KAKENHI grant number 25711017 to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Barratt DHP, 2011, PLANT PHYSIOL, V155, P328, DOI 10.1104/pp.110.166330; Barratt DHP, 2001, PLANT PHYSIOL, V127, P655, DOI 10.1104/pp.010297; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Chen XY, 2009, PLANT PHYSIOL, V150, P105, DOI 10.1104/pp.108.133918; Dong J, 2009, CELL, V137, P1320, DOI 10.1016/j.cell.2009.04.018; Gardner MJ, 2009, J EXP BOT, V60, P213, DOI 10.1093/jxb/ern292; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Guseman JM, 2010, DEVELOPMENT, V137, P1731, DOI 10.1242/dev.049197; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Higaki T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00405; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Kuwabara A, 2011, PLANT PHYSIOL, V156, P2196, DOI 10.1104/pp.111.176073; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Matsushima R, 2003, PLANT J, V33, P493, DOI 10.1046/j.1365-313X.2003.01636.x; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Sachs T, 1991, PATTERN FORMATION PL; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	24	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72456	10.1371/journal.pone.0072456	http://dx.doi.org/10.1371/journal.pone.0072456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039770	gold, Green Submitted, Green Published			2022-12-25	WOS:000326734500014
J	Bratcher, PE; Gaggar, A				Bratcher, Preston E.; Gaggar, Amit			Characterization and Prevention of the Adsorption of Surfactant Protein D to Polypropylene	PLOS ONE			English	Article							LUNG	Surfactant Protein D (SP-D) is a multifunctional protein present in the lung and in respiratory secretions. In the process of developing new experimental approaches to examine SP-D function, we observed that SP-D adsorbs to polypropylene tubes to a great extent, thereby depleting SP-D from the solution. Although it is well known that proteins adsorb nonspecifically to plastic, this effect is usually diminished by treatments to make the plastic "low-retention" or "low-binding". However, these treatments actually increased the binding of SP-D to the plastic. In addition, this adsorption affected the results of several assays, including proteolytic cleavage assays. In order to block SP-D from adsorbing to polypropylene and the effects caused by this adsorption, we coated the tubes with bovine serum albumin (BSA), as is commonly performed for ELISAs. This coating greatly diminished the amount of SP-D sticking to the plastic, providing an inexpensive and effective method for preventing adsorption and the artifacts resulting from this adsorption.	[Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gaggar, Amit] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] Univ Alabama Birmingham, Lung Hlth Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] Med Serv, US Dept Vet Affairs, Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs	Bratcher, PE (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bratcher@uab.edu			National Institutes of Health [HL102371, 5T32HL105346-02]; Cystic Fibrosis Foundation [GAGGAR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102371, T32HL105346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health (HL102371 to AG, 5T32HL105346-02 to PEB) and the Cystic Fibrosis Foundation (GAGGAR07 to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratcher PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041881; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Duvoix A, 2011, IMMUNOBIOLOGY, V216, P72, DOI 10.1016/j.imbio.2010.03.006; Hartl D, 2006, EUR J CLIN INVEST, V36, P423, DOI 10.1111/j.1365-2362.2006.01648.x; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kotecha S, 2013, THORAX, V68, P460, DOI 10.1136/thoraxjnl-2012-202729; Mariencheck WI, 2003, AM J RESP CELL MOL, V28, P528, DOI 10.1165/rcmb.2002-0141OC; von Bredow C, 2003, LUNG, V181, P79, DOI 10.1007/s00408-003-1008-z	11	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73467	10.1371/journal.pone.0073467	http://dx.doi.org/10.1371/journal.pone.0073467			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039953	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500034
J	Robbins, LL; Wynn, JG; Lisle, JT; Yates, KK; Knorr, PO; Byrne, RH; Liu, XW; Patsavas, MC; Azetsu-Scott, K; Takahashi, T				Robbins, Lisa L.; Wynn, Jonathan G.; Lisle, John T.; Yates, Kimberly K.; Knorr, Paul O.; Byrne, Robert H.; Liu, Xuewu; Patsavas, Mark C.; Azetsu-Scott, Kumiko; Takahashi, Taro			Baseline Monitoring of the Western Arctic Ocean Estimates 20% of Canadian Basin Surface Waters Are Undersaturated with Respect to Aragonite	PLOS ONE			English	Article							CARBON-CYCLE; INORGANIC CARBON; ACIDIFICATION; IMPACT; CO2; SEAWATER; SATURATION; CALCITE; BALANCE; GROWTH	Marine surface waters are being acidified due to uptake of anthropogenic carbon dioxide, resulting in surface ocean areas of undersaturation with respect to carbonate minerals, including aragonite. In the Arctic Ocean, acidification is expected to occur at an accelerated rate with respect to the global oceans, but a paucity of baseline data has limited our understanding of the extent of Arctic undersaturation and of regional variations in rates and causes. The lack of data has also hindered refinement of models aimed at projecting future trends of ocean acidification. Here, based on more than 34,000 data records collected in 2010 and 2011, we establish a baseline of inorganic carbon data (pH, total alkalinity, dissolved inorganic carbon, partial pressure of carbon dioxide, and aragonite saturation index) for the western Arctic Ocean. This data set documents aragonite undersaturation in similar to 20% of the surface waters of the combined Canada and Makarov basins, an area characterized by recent acceleration of sea ice loss. Conservative tracer studies using stable oxygen isotopic data from 307 sites show that while the entire surface of this area receives abundant freshwater from meteoric sources, freshwater from sea ice melt is most closely linked to the areas of carbonate mineral undersaturation. These data link the Arctic Ocean's largest area of aragonite undersaturation to sea ice melt and atmospheric CO2 absorption in areas of low buffering capacity. Some relatively supersaturated areas can be linked to localized biological activity. Collectively, these observations can be used to project trends of ocean acidification in higher latitude marine surface waters where inorganic carbon chemistry is largely influenced by sea ice meltwater.	[Robbins, Lisa L.; Lisle, John T.; Yates, Kimberly K.; Knorr, Paul O.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL 33701 USA; [Wynn, Jonathan G.] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Byrne, Robert H.; Liu, Xuewu; Patsavas, Mark C.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Azetsu-Scott, Kumiko] Bedford Inst Oceanog, Dept Fisheries & Oceans, Ocean Sci Div, Dartmouth, NS, Canada; [Takahashi, Taro] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Columbia University	Robbins, LL (corresponding author), US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL 33701 USA.	lrobbins@usgs.gov	Wynn, Jonathan/C-1646-2010		U.S. Geological Survey Coastal and Marine Program; U.S. Geological Survey's Office of the Regional Executive-Alaska; NOAA [NA10NOS4000073]; NSF [ARC-1220032]; LLR, NOAA Ocean Acidification Program; Directorate For Geosciences [1220032] Funding Source: National Science Foundation	U.S. Geological Survey Coastal and Marine Program; U.S. Geological Survey's Office of the Regional Executive-Alaska; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); LLR, NOAA Ocean Acidification Program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The study was funded by U.S. Geological Survey Coastal and Marine Program and U.S. Geological Survey's Office of the Regional Executive-Alaska to LLR. Ship time for the ECS cruises was funded by NOAA grant NA10NOS4000073. Additional support came from NSF grant ARC-1220032 to JGW and LLR, NOAA Ocean Acidification Program to RHB and the Office of Climate Observation of NOAA to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EXTENT CONTROLS OCEA; ANTONOV JI, 1998, WORLD OCEAN ATLAS 19; Azetsu-Scott K, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008172; Azetsu-Scott K, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005917; Bates NR, 2012, BIOGEOSCIENCES, V9, P2509, DOI 10.5194/bg-9-2509-2012; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2011, OCEANOGRAPHY, V24, P186, DOI 10.5670/oceanog.2011.71; Bates NR, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004862; Bates NR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027028; BAUCH D, 1995, PROG OCEANOGR, V35, P53, DOI 10.1016/0079-6611(95)00005-2; Bauch D, 2005, GLOBAL PLANET CHANGE, V48, P165, DOI 10.1016/j.gloplacha.2004.12.011; Bauch D, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007282; Cai WJ, 2010, SCIENCE, V329, P556, DOI 10.1126/science.1189338; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CHAYES D, 2010, HLY1002 DATA D UNPUB; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; Chierici M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007184; Cooper LW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035007; Cooper LW, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000031; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Nguyen D, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007343; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Feely RA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004157; FETTERER F, 2009, SEA ICE INDEX, DOI DOI 10.7265/N5QJ7F7W.ACCESSED:2013; Garneau ME, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004281; Giles KA, 2012, NAT GEOSCI, V5, P194, DOI [10.1038/NGEO1379, 10.1038/ngeo1379]; Jakobsson M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033520; JIAO N, 2010, MICROBIAL CARBON PUM; Jones P, 2010, CITY FOR EMPIRE: AN ANCHORAGE HISTORY, 1914-1941, P1; Jutterstrom S, 2005, MAR CHEM, V94, P101, DOI 10.1016/j.marchem.2004.08.010; Jutterstrom S, 2010, MAR CHEM, V122, P96, DOI 10.1016/j.marchem.2010.07.002; Kirchman DL, 2009, DEEP-SEA RES PT II, V56, P1237, DOI 10.1016/j.dsr2.2008.10.018; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Lee K, 2010, GEOCHIM COSMOCHIM AC, V74, P1801, DOI 10.1016/j.gca.2009.12.027; Liu XW, 2011, ENVIRON SCI TECHNOL, V45, P4862, DOI 10.1021/es200665d; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Martinson DG, 2001, GEOPHYS RES LETT, V28, P307, DOI 10.1029/2000GL011549; Maslanik J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047735; Mathis JT, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051574; Mathis JT, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006453; McPhee MG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037525; MELLING H, 1995, CONT SHELF RES, V15, P89, DOI 10.1016/0278-4343(94)P1814-R; Morison J, 2012, NATURE, V481, P66, DOI 10.1038/nature10705; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; National Research Council, 2010, OC AC NAT STRAT MEET; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; OSTLUND HG, 1984, J GEOPHYS RES-OCEANS, V89, P6373, DOI 10.1029/JC089iC04p06373; Parmentier FJW, 2013, NAT CLIM CHANGE, V3, P195, DOI [10.1038/nclimate1784, 10.1038/NCLIMATE1784]; Perovich DK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034007; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Pfirman S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020666; Polyakov IV, 2010, J PHYS OCEANOGR, V40, P2743, DOI 10.1175/2010JPO4339.1; Popova E. E., 2013, BIOGEOSCIENCES DISCU, V10, P2937, DOI [10.5194/bgd-10-2937-2013, DOI 10.5194/BGD-10-2937-2013]; Rabe B, 2011, DEEP-SEA RES PT I, V58, P173, DOI 10.1016/j.dsr.2010.12.002; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Rysgaard S, 2011, TELLUS B, V63, P823, DOI 10.1111/j.1600-0889.2011.00571.x; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Stroeve JC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045662; TAKAHASHI T, 2012, ORNLCDIAC160 US DEP, DOI DOI 10.3334/CDIAC/0TG.NDP088(V2011); Takahashi T, 2012, OCEANOGRAPHY, V25, P26, DOI 10.5670/oceanog.2012.71; TAN FC, 1980, J GEOPHYS RES-OCEANS, V85, P1925, DOI 10.1029/JC085iC04p01925; Wang ZHA, 2007, ANAL CHIM ACTA, V596, P23, DOI 10.1016/j.aca.2007.05.048; Yamamoto A, 2012, BIOGEOSCIENCES, V9, P2365, DOI 10.5194/bg-9-2365-2012; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; Yamamoto-Kawai M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045501; Yamamoto-Kawai M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003858; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Zhang JL, 2013, GEOPHYS RES LETT, V40, P720, DOI 10.1002/grl.50190	71	39	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73796	10.1371/journal.pone.0073796	http://dx.doi.org/10.1371/journal.pone.0073796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040074	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500052
J	Di Tomo, P; Pipino, C; Lanuti, P; Morabito, C; Pierdomenico, L; Sirolli, V; Bonomini, M; Miscia, S; Mariggio, MA; Marchisio, M; Barboni, B; Pandolfi, A				Di Tomo, Pamela; Pipino, Caterina; Lanuti, Paola; Morabito, Caterina; Pierdomenico, Laura; Sirolli, Vittorio; Bonomini, Mario; Miscia, Sebastiano; Mariggio, Maria Addolorata; Marchisio, Marco; Barboni, Barbara; Pandolfi, Assunta			Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; BONE; OSTEOBLASTS; CLONING; ZETA; CAR	Amniotic fluid-derived stem (AFS) cells have been identified as a promising source for cell therapy applications in bone traumatic and degenerative damage. Calcium Sensing Receptor (CaSR), a G protein-coupled receptor able to bind calcium ions, plays a physiological role in regulating bone metabolism. It is expressed in different kinds of cells, as well as in some stem cells. The bone CaSR could potentially be targeted by allosteric modulators, in particular by agonists such as calcimimetic R-568, which may potentially be helpful for the treatment of bone disease. The aim of our study was first to investigate the presence of CaSR in ovine Amniotic Fluid Mesenchymal Stem Cells (oAFMSCs) and then the potential role of calcimimetics in in vitro osteogenesis. oAFMSCs were isolated, characterized and analyzed to examine the possible presence of CaSR by western blotting and flow cytometry analysis. Once we had demonstrated CaSR expression, we worked out that 1 mu M R-568 was the optimal and effective concentration by cell viability test (MTT), cell number, Alkaline Phosphatase (ALP) and Alizarin Red S (ARS) assays. Interestingly, we observed that basal diffuse CaSR expression in oAFMSCs increased at the membrane when cells were treated with R-568 (1 mu M), potentially resulting in activation of the receptor. This was associated with significantly increased cell mineralization (ALP and ARS staining) and augmented intracellular calcium and Inositol trisphosphate (IP3) levels, thus demonstrating a potential role for calcimimetics during osteogenic differentiation. Calhex-231, a CaSR allosteric inhibitor, totally reversed R-568 induced mineralization. Taken together, our results demonstrate for the first time that CaSR is expressed in oAFMSCs and that calcimimetic R-568, possibly through CaSR activation, can significantly improve the osteogenic process. Hence, our study may provide useful information on the mechanisms regulating osteogenesis in oAFMSCs, perhaps prompting the use of calcimimetics in bone regenerative medicine.	[Di Tomo, Pamela; Pipino, Caterina; Pandolfi, Assunta] Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Di Tomo, Pamela; Pipino, Caterina; Lanuti, Paola; Morabito, Caterina; Pierdomenico, Laura; Miscia, Sebastiano; Mariggio, Maria Addolorata; Marchisio, Marco; Pandolfi, Assunta] Univ G dAnnunzio, Univ G dAnnunzio Fdn Chieti, Aging Res Ctr, Ce SI, Chieti, Italy; [Di Tomo, Pamela; Pipino, Caterina; Lanuti, Paola; Morabito, Caterina; Pierdomenico, Laura; Miscia, Sebastiano; Mariggio, Maria Addolorata; Marchisio, Marco; Barboni, Barbara; Pandolfi, Assunta] Univ G dAnnunzio, StemTeCh Grp Chieti, Chieti, Italy; [Lanuti, Paola; Morabito, Caterina; Pierdomenico, Laura; Sirolli, Vittorio; Bonomini, Mario; Miscia, Sebastiano; Marchisio, Marco] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Morabito, Caterina; Mariggio, Maria Addolorata] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Barboni, Barbara] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Teramo	Pandolfi, A (corresponding author), Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy.	pandolfi@unich.it	Pipino, Caterina/N-2078-2019; pandolfi, assunta/K-4595-2016; Sirolli, Vittorio/AAB-2290-2019; Mariggiò, Maria Addolorata/T-9047-2017	Pipino, Caterina/0000-0002-4350-8686; pandolfi, assunta/0000-0003-4135-7631; Mariggiò, Maria Addolorata/0000-0001-5306-7143; Marchisio, Marco/0000-0003-3058-3422; Mariggio, Maria Addolorata/0000-0002-3508-8706; Morabito, Caterina/0000-0002-5144-2584	CariChieti Foundation; ERA-Amgen [2010547324]; Era-Amgen, USA	CariChieti Foundation; ERA-Amgen; Era-Amgen, USA	This study was supported by CariChieti Foundation and ERA-Amgen (Contract#2010547324). The authors received funding from a commercial source (Era-Amgen, USA), this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci I, 2011, CELL TRANSPLANT, V20, P789, DOI 10.3727/096368910X539074; Antonucci I, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-9; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Berardinelli P, 2013, CLIN ORAL INVEST, V17, P1661, DOI 10.1007/s00784-012-0857-3; Bollini S, 2011, STEM CELLS DEV, V20, P1985, DOI 10.1089/scd.2010.0424; Bonomini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030682; Brown E. M., 2007, V45, P139; Brown E. M., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P412; Chang W, 2013, SCI SIGNAL, V1, P1; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Colosimo A, 2013, CELL TRANSPLANT, V22, P99, DOI 10.3727/096368912X638883; D'Alimonte I, 2013, STEM CELL REV REP, V9, P642, DOI 10.1007/s12015-013-9436-5; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Drueke TB, 2009, CLIN J AM SOC NEPHRO, V4, P234, DOI 10.2215/CJN.04520908; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Gray FL, 2012, J PEDIATR SURG, V47, P1072, DOI 10.1016/j.jpedsurg.2012.03.006; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gutwald R, 2010, BRIT J ORAL MAX SURG, V48, P285, DOI 10.1016/j.bjoms.2009.06.226; Hebert SC, 2004, CELL CALCIUM, V35, P239, DOI 10.1016/j.ceca.2003.10.015; House MG, 1997, J BONE MINER RES, V12, P1959, DOI 10.1359/jbmr.1997.12.12.1959; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; Kanatani N, 1999, BIOCHEM BIOPH RES CO, V261, P144, DOI 10.1006/bbrc.1999.0932; Lam BS, 2011, BLOOD, V117, P1167, DOI 10.1182/blood-2010-05-286294; Lanuti P, 2006, J IMMUNOL METHODS, V315, P37, DOI 10.1016/j.jim.2006.06.015; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082; Martino NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017714; Mauro A, 2010, VET RES COMMUN, V34, pS25, DOI 10.1007/s11259-010-9393-2; Miller S, 1999, CELLS, V140, P1911; Miscia S, 2009, NEUROBIOL AGING, V30, P394, DOI 10.1016/j.neurobiolaging.2007.07.011; Orciani M, 2011, J BIOL REG HOMEOS AG, V25, P115; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Piccoli M, 2012, STEM CELLS, V30, P1675, DOI 10.1002/stem.1134; Pipino C, 2013, BRIT MED BULL, V105, P43, DOI 10.1093/bmb/lds033; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Sedrakyan S, 2012, CURR UROL REP, V13, P47, DOI 10.1007/s11934-011-0230-0; Shaw SWS, 2011, CELL TRANSPLANT, V20, P1015, DOI 10.3727/096368910X543402; Song IH, 2009, J ORTHOP RES, V27, P916, DOI 10.1002/jor.20838; Turner CG, 2011, J PEDIATR SURG, V46, P57, DOI 10.1016/j.jpedsurg.2010.09.063; Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382, DOI 10.1152/ajpcell.2001.280.2.C382; Yamaguchi T, 2008, J BONE MINER METAB, V26, P301, DOI 10.1007/s00774-008-0843-7; Yamauchi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE608, DOI 10.1152/ajpendo.00229.2004	45	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73816	10.1371/journal.pone.0073816	http://dx.doi.org/10.1371/journal.pone.0073816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040082	Green Published, gold			2022-12-25	WOS:000326405300133
J	Elms, J; Powell, KL; van Raay, L; Dedeurwaerdere, S; O'Brien, TJ; Morris, MJ				Elms, Johanna; Powell, Kim L.; van Raay, Leena; Dedeurwaerdere, Stefanie; O'Brien, Terence J.; Morris, Margaret J.			Long-Term Valproate Treatment Increases Brain Neuropeptide Y Expression and Decreases Seizure Expression in a Genetic Rat Model of Absence Epilepsy	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC ACID; TEMPORAL-LOBE EPILEPSY; SODIUM VALPROATE; HISTONE DEACETYLASE; ANTIEPILEPTIC ACTIONS; NEUROTROPHIC FACTOR; MESSENGER-RNA; FOOD-INTAKE; IN-VITRO; RECEPTORS	The mechanisms by which valproate, one of the most widely prescribed anti-epileptic drugs, suppresses seizures have not been fully elucidated but may involve up-regulation of neuropeptide Y (NPY). We investigated the effects of valproate treatment in Genetic Absence Epilepsy Rats from Strasbourg (GAERS) on brain NPY mRNA expression and seizure control. GAERS were administered either valproate (42 mg.kg(-1) hr(-1)) or saline continuously for 5 days. Electroencephalograms were recorded for 24 hrs on treatment days 1, 3 and 5 and the percentage of time spent in seizure activity was analysed. NPY mRNA expression was measured in different brain regions using qPCR. Valproate treatment suppressed seizures by 80% in GAERS (p<0.05) and increased NPY mRNA expression in the thalamus (p<0.05) compared to saline treatment. These results demonstrate that long-term valproate treatment results in an upregulation of thalamic expression of NPY implicating this as a potential contributor to the mechanism by which valproate suppresses absence seizures.	[Elms, Johanna; Morris, Margaret J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Elms, Johanna; Powell, Kim L.; van Raay, Leena; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Dedeurwaerdere, Stefanie] Univ Antwerp, Dept Translat Neurosci, Antwerp, Belgium	University of New South Wales Sydney; Royal Melbourne Hospital; University of Melbourne; University of Antwerp	Morris, MJ (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	m.morris@unsw.edu.au	Dedeurwaerdere, Stefanie/G-2524-2011; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Morris, Margaret J/J-4285-2013	Dedeurwaerdere, Stefanie/0000-0003-4869-1923; O'Brien, Terence/0000-0002-7198-8621; Morris, Margaret/0000-0003-2285-5117; Powell, Kim/0000-0002-9007-4614	National Health and Medical Research Council (NHMRC) of Australia [568729]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by project grant support from the National Health and Medical Research Council (NHMRC grant # 568729) of Australia to MJM and TJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript" to the Financial Disclosure.	Abaci A, 2009, PEDIATR NEUROL, V41, P435, DOI 10.1016/j.pediatrneurol.2009.06.003; ALTRUP U, 1992, EPILEPSIA, V33, P743, DOI 10.1111/j.1528-1157.1992.tb02356.x; Arens TL, 2001, BIOPHARM DRUG DISPOS, V22, P243, DOI 10.1002/bdd.259; BALDINO F, 1981, BRAIN RES, V219, P231, DOI 10.1016/0006-8993(81)90288-2; Baraban SC, 2004, NEUROPEPTIDES, V38, P261, DOI 10.1016/j.npep.2004.04.006; Baraban SC, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.43.s.5.13.x; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; BENDOTTI C, 1991, NEUROSCI LETT, V132, P175, DOI 10.1016/0304-3940(91)90295-5; Bijak Maria, 1995, Polish Journal of Pharmacology, V47, P461; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Brill J, 2007, PEPTIDES, V28, P250, DOI 10.1016/j.peptides.2006.08.043; Brill J, 2006, J NEUROSCI, V26, P6813, DOI 10.1523/JNEUROSCI.5320-05.2006; Castro LMR, 2005, J NEUROCHEM, V95, P1227, DOI 10.1111/j.1471-4159.2005.03457.x; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; CHAPMAN AG, 1982, NEUROCHEM RES, V7, P1089, DOI 10.1007/BF00964888; Dedeurwaerdere S, 2011, SEIZURE-EUR J EPILEP, V20, P72, DOI 10.1016/j.seizure.2010.10.011; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Furtinger S, 2001, J NEUROSCI, V21, P5804, DOI 10.1523/JNEUROSCI.21-15-05804.2001; GALL C, 1990, PROG BRAIN RES, V83, P371; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hamed SA, 2007, EPILEPSY RES, V75, P1, DOI 10.1016/j.eplepsyres.2007.04.001; HARITON C, 1984, BIOPHARM DRUG DISPOS, V5, P409, DOI 10.1002/bdd.2510050412; IADAROLA MJ, 1979, EUR J PHARMACOL, V59, P125, DOI 10.1016/0014-2999(79)90034-7; Kim SH, 2007, ONCOL REP, V17, P647; Klapstein GJ, 1997, J NEUROPHYSIOL, V78, P1651, DOI 10.1152/jn.1997.78.3.1651; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Liu LG, 2006, J PHARMACOL EXP THER, V319, P790, DOI 10.1124/jpet.106.104968; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; LOSCHER W, 1984, LANCET, V2, P225; LOSCHER W, 1985, BIOCHEM PHARMACOL, V34, P1747, DOI 10.1016/0006-2952(85)90645-8; LOSCHER W, 1985, EPILEPSIA, V26, P314, DOI 10.1111/j.1528-1157.1985.tb05656.x; LOSCHER W, 1981, LIFE SCI, V28, P2383, DOI 10.1016/0024-3205(81)90504-X; LOSCHER W, 1980, EPILEPSIA, V21, P611, DOI 10.1111/j.1528-1157.1980.tb04314.x; LUCKE A, 1993, BRAIN RES, V631, P187, DOI 10.1016/0006-8993(93)91534-Y; Manning JPA, 2003, TRENDS PHARMACOL SCI, V24, P542, DOI 10.1016/j.tips.2003.08.006; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Martin CK, 2009, J PSYCHOPHARMACOL, V23, P814, DOI 10.1177/0269881108091595; Martin ED, 2004, NEUROPHARMACOLOGY, V46, P555, DOI 10.1016/j.neuropharm.2003.10.013; MCLEAN MJ, 1986, J PHARMACOL EXP THER, V237, P1001; MOLINARI M, 1987, BRAIN RES, V426, P270, DOI 10.1016/0006-8993(87)90881-X; MORRIS BJ, 1989, J COMP NEUROL, V290, P358, DOI 10.1002/cne.902900305; Morris MJ, 2007, EUR J NEUROSCI, V25, P1136, DOI 10.1111/j.1460-9568.2007.05348.x; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PITKANEN A, 1989, NEUROPEPTIDES, V14, P197, DOI 10.1016/0143-4179(89)90045-0; Powell KL, 2008, NEUROBIOL DIS, V31, P261, DOI 10.1016/j.nbd.2008.04.012; Redrobe JP, 1999, BRAIN RES, V848, P153, DOI 10.1016/S0006-8993(99)02119-8; Reibel S, 2000, EUR J NEUROSCI, V12, P595, DOI 10.1046/j.1460-9568.2000.00941.x; Reibel S, 2003, HIPPOCAMPUS, V13, P557, DOI 10.1002/hipo.10110; Reibel S, 2000, EPILEPSIA, V41, pS127, DOI 10.1111/j.1528-1157.2000.tb01571.x; ROWAN AJ, 1979, EPILEPSIA, V20, P61, DOI 10.1111/j.1528-1157.1979.tb04776.x; SCHWARZER C, 1995, NEUROSCIENCE, V69, P831, DOI 10.1016/0306-4522(95)00268-N; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Stroud LM, 2005, BRAIN RES, V1033, P151, DOI 10.1016/j.brainres.2004.11.022; Sun QQ, 2003, J NEUROSCI, V23, P9639; Thomas A, 1996, TREATMENT EPILEPSY P, P700; van Raay L, 2012, EPILEPSIA, V53, P477, DOI 10.1111/j.1528-1167.2011.03370.x; van Raay L, 2009, J NEUROSCI METH, V179, P184, DOI 10.1016/j.jneumeth.2009.01.024; Vezzani A, 2002, NEUROSCIENCE, V110, P237, DOI 10.1016/S0306-4522(01)00581-4; Woldbye DPD, 2005, NEUROBIOL DIS, V20, P760, DOI 10.1016/j.nbd.2005.05.010; Woldbye DPD, 1997, NAT MED, V3, P761, DOI 10.1038/nm0797-761; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Yang L, 2009, J NEUROSCI, V29, P179, DOI 10.1523/JNEUROSCI.4379-08.2009; ZACHRISSON O, 1995, MOL BRAIN RES, V31, P71, DOI 10.1016/0169-328X(95)00033-O	67	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73505	10.1371/journal.pone.0073505	http://dx.doi.org/10.1371/journal.pone.0073505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039965	Green Published, gold			2022-12-25	WOS:000326405300084
J	Fan, XZ; Li, DG; Lichti, CF; Green, TA				Fan, Xiuzhen; Li, Dingge; Lichti, Cheryl F.; Green, Thomas A.			Dynamic Proteomics of Nucleus Accumbens in Response to Acute Psychological Stress in Environmentally Enriched and Isolated Rats	PLOS ONE			English	Article							14-3-3 PROTEINS; MAP KINASE; BRAIN; AMPHETAMINE; EXPRESSION; DISORDERS; PHOSPHORYLATION; HIPPOCAMPUS; COMORBIDITY; ACTIVATION	Our prior research has shown that environmental enrichment (i.e. rats reared in an environment with novel objects, social contact with conspecifics) produces a protective antidepressant-like phenotype in rats and decreases neurobiological effects of acute psychological stress. Although CREB activity has been identified as a major player, the downstream molecular mechanisms remain largely unexplored. Thus, the current study investigates proteomic differences in the accumbens of rats raised in an enriched condition (EC) versus those raised in an isolated control condition (IC) under basal conditions and after 30 min of acute restraint stress. Results showed that under basal conditions, EC rats generally expressed less mitochondria-related proteins, particularly those involved in TCA cycle and electron transport compared to IC rats. After 30 min of acute stress, EC rats displayed increased expression of energy metabolism enzymes (among others) while IC rats exhibited decreased expression of similar proteins. Further, network and pathway analyses also identified links to AKT signaling proteins, 14-3-3 family proteins, heat-shock proteins, and ubiquitin-interacting proteins. The protein ENO1 showed marked differential expression and regulation; EC rats expressed higher levels under basal conditions that increased subsequent to stress, while the basal IC expression was lower and decreased further still after stress. The results of this study define differential protein expression in a protective rat model for major depression and additionally identify a dynamic and coordinated differential response to acute stress between the two groups. These results provide new avenues for exploration of the molecular determinants of depression and the response to acute stress.	[Fan, Xiuzhen; Li, Dingge; Lichti, Cheryl F.; Green, Thomas A.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Addict Res Ctr, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Green, TA (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Addict Res Ctr, Galveston, TX 77555 USA.	tom.green@utmb.edu		Lichti, Cheryl/0000-0003-4099-4954	National Institute on Drug Abuse, part of NIH in the USA [DA029091]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029091] Funding Source: NIH RePORTER	National Institute on Drug Abuse, part of NIH in the USA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by DA029091 (funding by DA029091 is from the National Institute on Drug Abuse, part of NIH in the USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Bevins RA, 2002, BEHAV BRAIN RES, V129, P41, DOI 10.1016/S0166-4328(01)00326-6; Blackburn AC, 1999, FREE RADICAL BIO MED, V27, P262, DOI 10.1016/S0891-5849(99)00065-9; BOWLING SL, 1994, PHARMACOL BIOCHEM BE, V48, P459, DOI 10.1016/0091-3057(94)90553-3; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Calamia V, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-237; CALCAGNETTI DJ, 1992, PHYSIOL BEHAV, V51, P667, DOI 10.1016/0031-9384(92)90101-7; Carboni L, 2006, NEUROSCIENCE, V137, P1237, DOI 10.1016/j.neuroscience.2005.10.045; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHEN X, 1995, NEUROSCIENCE, V64, P675, DOI 10.1016/0306-4522(94)00532-A; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cooper LC, 2011, BIOCHEM BIOPH RES CO, V413, P550, DOI 10.1016/j.bbrc.2011.08.136; CROWDER WF, 1992, PHARMACOL BIOCHEM BE, V41, P817, DOI 10.1016/0091-3057(92)90233-6; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Fan XZ, 2011, TOXICOL APPL PHARM, V255, P103, DOI 10.1016/j.taap.2011.06.005; Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Forsberg L, 2006, J BIOTECHNOL, V126, P582, DOI 10.1016/j.jbiotec.2006.05.020; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Gardner A, 2011, PROG NEURO-PSYCHOPH, V35, P730, DOI 10.1016/j.pnpbp.2010.07.030; Gomez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044149; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Green TA, 2001, BIOCHEM PHARMACOL, V62, P1597, DOI 10.1016/S0006-2952(01)00838-3; Green TA, 2006, EFFECT ENV ENRICHMEN; Green TA, 2008, J NEUROSCI, V28, P2025, DOI 10.1523/JNEUROSCI.5273-07.2008; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khawaja X, 2004, J NEUROSCI RES, V75, P451, DOI 10.1002/jnr.10869; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Lee SA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S20; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Little A, 2009, AM FAM PHYSICIAN, V80, P167; Liu YY, 2011, NEUROCHEM INT, V58, P904, DOI 10.1016/j.neuint.2011.02.019; LOUILOT A, 1986, BRAIN RES, V397, P395, DOI 10.1016/0006-8993(86)90646-3; Mallei A, 2011, NEUROPHARMACOLOGY, V60, P1243, DOI 10.1016/j.neuropharm.2010.12.012; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Silva E, 2010, J PROTEOME RES, V9, P1522, DOI 10.1021/pr9010298; Stairs DJ, 2011, PSYCHOPHARMACOLOGY, V218, P293, DOI 10.1007/s00213-011-2448-4; Steinacker P, 2011, SEMIN CELL DEV BIOL, V22, P696, DOI 10.1016/j.semcdb.2011.08.005; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wilson SM, 2011, CHANNELS, V5, P447, DOI 10.4161/chan.5.5.17363; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zhu J, 2004, BEHAV BRAIN RES, V148, P107, DOI 10.1016/S0166-4328(03)00190-6	61	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73689	10.1371/journal.pone.0073689	http://dx.doi.org/10.1371/journal.pone.0073689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040027	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300111
J	Konfino, J; Mekonnen, TA; Coxson, PG; Ferrante, D; Bibbins-Domingo, K				Konfino, Jonatan; Mekonnen, Tekeshe A.; Coxson, Pamela G.; Ferrante, Daniel; Bibbins-Domingo, Kirsten			Projected Impact of a Sodium Consumption Reduction Initiative in Argentina: An Analysis from the CVD Policy Model - Argentina	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; 24-H URINARY SODIUM; POTASSIUM EXCRETION; SALT INTAKE; CARDIOVASCULAR-DISEASE; RISK; STROKE; MORTALITY; COST	Background: Cardiovascular disease (CVD) is the leading cause of death in adults in Argentina. Sodium reduction policies targeting processed foods were implemented in 2011 in Argentina, but the impact has not been evaluated. The aims of this study are to use Argentina-specific data on sodium excretion and project the impact of Argentina's sodium reduction policies under two scenarios - the 2-year intervention currently being undertaken or a more persistent 10 year sodium reduction strategy. Methods: We used Argentina-specific data on sodium excretion by sex and projected the impact of the current strategy on sodium consumption and blood pressure decrease. We assessed the projected impact of sodium reduction policies on CVD using the Cardiovascular Disease (CVD) Policy Model, adapted to Argentina, modeling two alternative policy scenarios over the next decade. Results: Our study finds that the initiative to reduce sodium consumption currently in place in Argentina will have substantial impact on CVD over the next 10 years. Under the current proposed policy of 2-year sodium reduction, the mean sodium consumption is projected to decrease by 319-387 mg/day. This decrease is expected to translate into an absolute reduction of systolic blood pressure from 0.93 mmHg to 1.81 mmHg. This would avert about 19,000 all-cause mortality, 13,000 total myocardial infarctions, and 10,000 total strokes over the next decade. A more persistent sodium reduction strategy would yield even greater CVD benefits. Conclusion: The impact of the Argentinean initiative would be effective in substantially reducing mortality and morbidity from CVD. This paper provides evidence-based support to continue implementing strategies to reduce sodium consumption at a population level.	[Konfino, Jonatan] Ctr Estudios Estado & Soc, Dept Hlth, Buenos Aires, DF, Argentina; [Konfino, Jonatan; Ferrante, Daniel] Minist Hlth, Directorate Hlth Promot & Control Non Communicabl, Buenos Aires, DF, Argentina; [Mekonnen, Tekeshe A.; Coxson, Pamela G.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Mekonnen, Tekeshe A.; Coxson, Pamela G.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Konfino, J (corresponding author), Ctr Estudios Estado & Soc, Dept Hlth, Buenos Aires, DF, Argentina.	jkonfino@gmail.com	Konfino, Jonatan/Y-7189-2019	Konfino, Jonatan/0000-0003-4731-5117	University of California, Pacific Rim Research Program; International Development Research Centre (IDRC) - Canada [106881-10]	University of California, Pacific Rim Research Program(University of California System); International Development Research Centre (IDRC) - Canada	This paper was funded in part by the University of California, Pacific Rim Research Program, and from the International Development Research Centre (IDRC) - Canada, Grant number 106881-10. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Blanco Patricia, 2007, Rev. argent. cardiol., V75, P163; Caccavo Alberto, 2007, Rev. argent. cardiol., V75, P185; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; *DEP HLTH HUM SERV, 2005, FRAM HEART STUD; Elliot P, 2007, SODIUM INTAKES WORLD; Ferrante D, 2012, REV PANAM SALUD PUBL, V32, P274, DOI 10.1590/S1020-49892012001000005; Ferrante D, 2011, REV PANAM SALUD PUBL, V29, P69, DOI 10.1590/S1020-49892011000200001; Hashimoto T, 2008, INTERNAL MED, V47, P399, DOI 10.2169/internalmedicine.47.0622; He FJ, 2004, COCHRANE DB SYST REV, V2001, P3; Kawamura M, 2006, HYPERTENS RES, V29, P397, DOI 10.1291/hypres.29.397; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Konfino J, 2012, TOBACCO CONTROL; Lavados PM, 2005, LANCET, V365, P2206, DOI 10.1016/S0140-6736(05)66779-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Ministerio de Salud de la Nacion, 2012, DIR EST INF SAL; Ministerio de Salud de la Nacion, 2013, ESTR PIL RED CONS SA; Ministerio de Salud de la Nacion, 2011, ESTR MEN SAL MAS VID; Ministerio de Salud de la Nacion, 2011, B VIGILANCIA, V5, P5; Ministerio de Salud de la Nacion; Instituto Nacional de Estadisticas y Censos, 2011, 2 ENC NAC FACT RIESG; Moodie R, 2013, LANCET; Moran A, 2011, INT J CARDIOL, V150, P332, DOI 10.1016/j.ijcard.2011.04.013; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; Naghavi M, 2010, POPULATION HLTH METR, V8; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Sposato LA, 2008, STROKE, V39, P3036, DOI 10.1161/STROKEAHA.108.521062; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; TOSTESON ANA, 1990, AM J PUBLIC HEALTH, V80, P1481, DOI 10.2105/AJPH.80.12.1481; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization, 2008, 2008 2013 ACT PLAN G	37	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73824	10.1371/journal.pone.0073824	http://dx.doi.org/10.1371/journal.pone.0073824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244QV	24040085	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300134
J	Ottesen, AR; Gonzalez, A; Bell, R; Arce, C; Rideout, S; Allard, M; Evans, P; Strain, E; Musser, S; Knight, R; Brown, E; Pettengill, JB				Ottesen, Andrea R.; Gonzalez, Antonio; Bell, Rebecca; Arce, Caroline; Rideout, Steven; Allard, Marc; Evans, Peter; Strain, Errol; Musser, Steven; Knight, Rob; Brown, Eric; Pettengill, James B.			Co-Enriching Microflora Associated with Culture Based Methods to Detect Salmonella from Tomato Phyllosphere	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEDIA; OUTBREAK; BIAS	The ability to detect a specific organism from a complex environment is vitally important to many fields of public health, including food safety. For example, tomatoes have been implicated numerous times as vehicles of foodborne outbreaks due to strains of Salmonella but few studies have ever recovered Salmonella from a tomato phyllosphere environment. Precision of culturing techniques that target agents associated with outbreaks depend on numerous factors. One important factor to better understand is which species co-enrich during enrichment procedures and how microbial dynamics may impede or enhance detection of target pathogens. We used a shotgun sequence approach to describe taxa associated with samples pre-enrichment and throughout the enrichment steps of the Bacteriological Analytical Manual's (BAM) protocol for detection of Salmonella from environmental tomato samples. Recent work has shown that during efforts to enrich Salmonella (Proteobacteria) from tomato field samples, Firmicute genera are also co-enriched and at least one co-enriching Firmicute genus (Paenibacillus sp.) can inhibit and even kills strains of Salmonella. Here we provide a baseline description of microflora that co-culture during detection efforts and the utility of a bioinformatic approach to detect specific taxa from metagenomic sequence data. We observed that uncultured samples clustered together with distinct taxonomic profiles relative to the three cultured treatments (Universal Pre-enrichment broth (UPB), Tetrathionate (TT), and Rappaport-Vassiliadis (RV)). There was little consistency among samples exposed to the same culturing medias, suggesting significant microbial differences in starting matrices or stochasticity associated with enrichment processes. Interestingly, Paenibacillus sp. (Salmonella inhibitor) was significantly enriched from uncultured to cultured (UPB) samples. Also of interest was the sequence based identification of a number of sequences as Salmonella despite indication by all media, that samples were culture negative for Salmonella. Our results substantiate the nascent utility of metagenomic methods to improve both biological and bioinformatic pathogen detection methods.	[Ottesen, Andrea R.; Bell, Rebecca; Arce, Caroline; Allard, Marc; Evans, Peter; Strain, Errol; Musser, Steven; Brown, Eric; Pettengill, James B.] US FDA, Mol Methods & Subtyping Branch, Div Microbiol, Off Regulatory Sci,Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Gonzalez, Antonio] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Rideout, Steven] Virginia Tech, Virginia Agr Expt Stn, Painter, VA USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	US Food & Drug Administration (FDA); University of Colorado System; University of Colorado Boulder; Virginia Polytechnic Institute & State University; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ottesen, AR (corresponding author), US FDA, Mol Methods & Subtyping Branch, Div Microbiol, Off Regulatory Sci,Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	Andrea.Ottesen@fda.hhs.gov	Gonzalez, Antonio/A-6421-2018	Knight, Rob/0000-0002-0975-9019	federal tax dollars designated for food borne pathogen prevention	federal tax dollars designated for food borne pathogen prevention	This research was supported by federal tax dollars designated for food borne pathogen prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; BAILEY JS, 1992, J FOOD PROTECT, V55, P256, DOI 10.4315/0362-028X-55.4.256; Dunbar J, 1997, APPL ENVIRON MICROB, V63, P1326, DOI 10.1128/AEM.63.4.1326-1331.1997; Gorski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034722; Hammack TS, 2006, J AOAC INT, V89, P180; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knox R, 1942, J PATHOL BACTERIOL, V54, P469, DOI 10.1002/path.1700540409; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mande SS, 2012, BRIEF BIOINFORM, V13, P669, DOI 10.1093/bib/bbs054; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muniesa M, 2005, APPL ENVIRON MICROB, V71, P4269, DOI 10.1128/AEM.71.8.4269-4275.2005; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Pettengill James B, 2012, BMC Res Notes, V5, P378, DOI 10.1186/1756-0500-5-378; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAPPAPORT F, 1956, J CLIN PATHOL, V9, P261, DOI 10.1136/jcp.9.3.261; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P4264, DOI 10.1093/nar/gkf549; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; VASSILIADIS P, 1978, J APPL BACTERIOL, V44, P233, DOI 10.1111/j.1365-2672.1978.tb00795.x; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11	29	38	38	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73079	10.1371/journal.pone.0073079	http://dx.doi.org/10.1371/journal.pone.0073079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039862	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300047
J	Saravanan, R; Joshi, M; Mohanram, H; Bhunia, A; Mangoni, ML; Bhattacharjya, S				Saravanan, Rathi; Joshi, Mangesh; Mohanram, Harini; Bhunia, Anirban; Mangoni, Maria Luisa; Bhattacharjya, Surajit			NMR Structure of Temporin-1 Ta in Lipopolysaccharide Micelles: Mechanistic Insight into Inactivation by Outer Membrane	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; GRAM-NEGATIVE BACTERIA; ANTIMICROBIAL PEPTIDES; OLIGOMERIC STRUCTURE; MOLECULAR-MECHANISM; NEUTRALIZATION; SPECTROSCOPY; BINDING; PERMEABILIZATION; EPIDEMIOLOGY	Background: Antimicrobial peptides (AMPs) play important roles in the innate defense mechanism. The broad spectrum of activity of AMPs requires an efficient permeabilization of the bacterial outer and inner membranes. The outer leaflet of the outer membrane of Gram negative bacteria is made of a specialized lipid called lipopolysaccharide (LPS). The LPS layer is an efficient permeability barrier against anti-bacterial agents including AMPs. As a mode of protection, LPS can induce self associations of AMPs rendering them inactive. Temporins are a group of short-sized AMPs isolated from frog skin, and many of them are inactive against Gram negative bacteria as a result of their self-association in the LPS-outer membrane. Principal Findings: Using NMR spectroscopy, we have determined atomic resolution structure and characterized localization of temporin-1Ta or TA (FLPLIGRVLSGIL-amide) in LPS micelles. In LPS micelles, TA adopts helical conformation for residues L4-I12, while residues F1-L3 are found to be in extended conformations. The aromatic sidechain of residue F1 is involved in extensive packing interactions with the sidechains of residues P3, L4 and I5. Interestingly, a number of long-range NOE contacts have been detected between the N-terminal residues F1, P3 with the C-terminal residues S10, I12, L13 of TA in LPS micelles. Saturation transfer difference (STD) NMR studies demonstrate close proximity of residues including F1, L2, P3, R7, S10 and L13 with the LPS micelles. Notably, the LPS bound structure of TA shows differences with the structures of TA determined in DPC and SDS detergent micelles. Significance: We propose that TA, in LPS lipids, forms helical oligomeric structures employing N- and C-termini residues. Such oligomeric structures may not be translocated across the outer membrane; resulting in the inactivation of the AMP. Importantly, the results of our studies will be useful for the development of antimicrobial agents with a broader spectrum of activity.	[Saravanan, Rathi; Joshi, Mangesh; Mohanram, Harini; Bhunia, Anirban; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Mangoni, Maria Luisa] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Fondazione Cenci Bolognetti; Sapienza University Rome	Bhattacharjya, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	surajit@ntu.edu.sg	Mohanram, Harini/L-9207-2019	Mohanram, Harini/0000-0002-8179-2665; Mangoni, Maria Luisa/0000-0002-5991-5868; Bhunia, Anirban/0000-0002-8752-2842; Saravanan, Rathi/0000-0002-3884-6023	Ministry of Education (MOE), Singapore [RG11/12]	Ministry of Education (MOE), Singapore(Ministry of Education, Singapore)	This work is supported by a grant from Ministry of Education (MOE), RG11/12, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Abbassi F, 2010, J BIOL CHEM, V285, P16880, DOI 10.1074/jbc.M109.097204; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Auvynet C, 2009, FEBS J, V276, P6497, DOI 10.1111/j.1742-4658.2009.07360.x; Azmi S, 2013, J MED CHEM, V56, P924, DOI 10.1021/jm301407k; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bhattacharjya S, 2010, CURR MED CHEM, V17, P3080, DOI 10.2174/092986710791959756; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; Bhunia A, 2011, BIOPOLYMERS, V96, P273, DOI 10.1002/bip.21530; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Capparelli R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007191; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Grieco P, 2013, BBA-BIOMEMBRANES, V1828, P652, DOI 10.1016/j.bbamem.2012.08.027; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Mangoni ML, 2008, ANTIMICROB AGENTS CH, V52, P85, DOI 10.1128/AAC.00796-07; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mangoni ML, 2011, J MED CHEM, V54, P1298, DOI 10.1021/jm1012853; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Saravanan R, 2011, BBA-BIOMEMBRANES, V1808, P369, DOI 10.1016/j.bbamem.2010.10.001; Saviello MR, 2010, BIOCHEMISTRY-US, V49, P1477, DOI 10.1021/bi902166d; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simonetti O, 2008, PEPTIDES, V29, P520, DOI 10.1016/j.peptides.2007.12.011; Srivastava RM, 2012, J BIOL CHEM, V287, P1980, DOI 10.1074/jbc.M111.302893; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070725, 10.1371/journal.pone.0060462, 10.1371/journal.pone.0077273, 10.1371/journal.pone.0081882]; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yount NY, 2013, ANN NY ACAD SCI, V1277, P127, DOI 10.1111/nyas.12005; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	67	33	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72718	10.1371/journal.pone.0072718	http://dx.doi.org/10.1371/journal.pone.0072718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039798	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300024
J	Truong, DT; Bonet, A; Rendall, AR; Rosen, GD; Fitch, RH				Truong, Dongnhu T.; Bonet, Ashley; Rendall, Amanda R.; Rosen, Glenn D.; Fitch, Roslyn H.			A Behavioral Evaluation of Sex Differences in a Mouse Model of Severe Neuronal Migration Disorder	PLOS ONE			English	Article							AUDITORY-PROCESSING DEFICITS; IN-UTERO RNAI; MORRIS WATER MAZE; ULTRASONIC VOCALIZATIONS; WILLIAMS-SYNDROME; MEMORY DEFICITS; MUS-MUSCULUS; MICE; DYSLEXIA; MICROGYRIA	Disruption of neuronal migration in humans is associated with a wide range of behavioral and cognitive outcomes including severe intellectual disability, language impairment, and social dysfunction. Furthermore, malformations of cortical development have been observed in a number of neurodevelopmental disorders (e. g. autism and dyslexia), where boys are much more commonly diagnosed than girls (estimates around 4 to 1). The use of rodent models provides an excellent means to examine how sex may modulate behavioral outcomes in the presence of comparable abnormal neuroanatomical presentations. Initially characterized by Rosen et al. 2012, the BXD29-Tlr4(lps-2J)/J mouse mutant exhibits a highly penetrant neuroanatomical phenotype that consists of bilateral midline subcortical nodular heterotopia with partial callosal agenesis. In the current study, we confirm our initial findings of a severe impairment in rapid auditory processing in affected male mice. We also report that BXD29-Tlr4(lps-2J)/J (mutant) female mice show no sparing of rapid auditory processing, and in fact show deficits similar to mutant males. Interestingly, female BXD29-Tlr4(lps-2J)/J mice do display superiority in Morris water maze performance as compared to wild type females, an affect not seen in mutant males. Finally, we report new evidence that BXD29-Tlr4(lps-2J)/J mice, in general, show evidence of hyper-social behaviors. In closing, the use of the BXD29-Tlr4(lps-2J)/J strain of mice - with its strong behavioral and neuroanatomical phenotype - may be highly useful in characterizing sex independent versus dependent mechanisms that interact with neural reorganization, as well as clinically relevant abnormal behavior resulting from aberrant neuronal migration.	[Truong, Dongnhu T.; Bonet, Ashley; Rendall, Amanda R.; Fitch, Roslyn H.] Univ Connecticut, Dept Psychol Behav Neurosci, Storrs, CT 06269 USA; [Rosen, Glenn D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of Connecticut; Harvard University; Beth Israel Deaconess Medical Center	Truong, DT (corresponding author), Univ Connecticut, Dept Psychol Behav Neurosci, Storrs, CT 06269 USA.	dongnhu.truong@uconn.edu	Fitch, Roslyn Holly/A-2562-2014		NIH [P01HD57853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057853] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD020806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant P01HD57853 (http://www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaruddin DH, 2007, CHILD PSYCHIAT HUM D, V38, P287, DOI 10.1007/s10578-007-0065-6; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Boscariol Mirela, 2010, Pró-Fono R. Atual. Cient., V22, P537, DOI 10.1590/S0104-56872010000400030; Chang BS, 2005, NEUROLOGY, V64, P799, DOI 10.1212/01.WNL.0000152874.57180.AF; Cimadevilla JM, 1999, BEHAV PROCESS, V46, P159, DOI 10.1016/S0376-6357(99)00034-0; Clark MG, 2000, J COGNITIVE NEUROSCI, V12, P828, DOI 10.1162/089892900562435; Cook DN, 2006, GENETICS, V172, P1751, DOI 10.1534/genetics.105.042820; Cook DN, 2004, GENOMICS, V83, P961, DOI 10.1016/j.ygeno.2003.12.008; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DENENBERG VH, 1991, BRAIN RES, V562, P98, DOI 10.1016/0006-8993(91)91192-4; DIZINNO G, 1978, BEHAV BIOL, V22, P104, DOI 10.1016/S0091-6773(78)92094-1; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; Ferland RJ, 2006, AM J MED GENET A, V140A, P1305, DOI 10.1002/ajmg.a.31259; Fisher SE, 2006, TRENDS COGN SCI, V10, P250, DOI 10.1016/j.tics.2006.04.003; Fishman I, 2011, J NEURODEV DISORD, V3, P185, DOI 10.1007/s11689-011-9086-3; Fitch RH, 2008, BRAIN RES BULL, V76, P1, DOI 10.1016/j.brainresbull.2007.07.013; Fitch RH, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-45; Fitch RH, 1997, BEHAV NEUROSCI, V111, P404, DOI 10.1037/0735-7044.111.2.404; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gomes AM, 2012, CHILD NEUROPSYCHOL, V18, P392, DOI 10.1080/09297049.2011.613810; Guerreiro MM, 2002, NEUROLOGY, V59, P245, DOI 10.1212/WNL.59.2.245; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Guo R, 2011, ZOOL STUD, V50, P24; Herman AE, 1997, CEREB CORTEX, V7, P453, DOI 10.1093/cercor/7.5.453; Hill CA, 2011, INT J DEV NEUROSCI, V29, P381, DOI 10.1016/j.ijdevneu.2011.03.005; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Jenner AR, 2000, CEREB CORTEX, V10, P1005, DOI 10.1093/cercor/10.10.1005; JERET JS, 1987, BRAIN DEV-JPN, V9, P255, DOI 10.1016/S0387-7604(87)80042-6; Laing E, 2001, J CHILD PSYCHOL PSYC, V42, P729, DOI 10.1111/1469-7610.00769; Liederman J, 2005, J LEARN DISABIL-US, V38, P109, DOI 10.1177/00222194050380020201; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Luders E, 2007, NEUROREPORT, V18, P203, DOI 10.1097/WNR.0b013e3280115942; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Naumburg E, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/541892; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; NYBY J, 1983, BEHAV NEURAL BIOL, V38, P32, DOI 10.1016/S0163-1047(83)90354-0; Peiffer AM, 2004, DEV BRAIN RES, V148, P53, DOI 10.1016/j.devbrainres.2003.09.020; Peiffer AM, 2002, NEUROREPORT, V13, P2277, DOI 10.1097/00001756-200212030-00021; Peiffer AM, 2001, NEUROREPORT, V12, P2875, DOI 10.1097/00001756-200109170-00024; Rial D, 2009, BRAIN RES BULL, V79, P177, DOI 10.1016/j.brainresbull.2009.02.003; ROOF RL, 1993, BEHAV BRAIN RES, V53, P1, DOI 10.1016/S0166-4328(05)80261-X; Rosen GD, 2013, CEREB CORTEX, V23, P859, DOI 10.1093/cercor/bhs080; Rosen GD, 2000, J COMP NEUROL, V418, P423; Rosen GD, 1999, CEREB CORTEX, V9, P27, DOI 10.1093/cercor/9.1.27; SCHROTT LM, 1993, BRAIN BEHAV IMMUN, V7, P205, DOI 10.1006/brbi.1993.1022; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; SIPOS ML, 1992, BEHAV NEURAL BIOL, V58, P138, DOI 10.1016/0163-1047(92)90375-E; Szalkowski CE, 2011, GENES BRAIN BEHAV, V10, P244, DOI 10.1111/j.1601-183X.2010.00662.x; Szalkowski CE, 2013, DEV NEUROSCI-BASEL, V35, P50, DOI 10.1159/000348431; Szalkowski CE, 2012, INT J DEV NEUROSCI, V30, P293, DOI 10.1016/j.ijdevneu.2012.01.009; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; Threlkeld SW, 2006, BRAIN RES, V1109, P22, DOI 10.1016/j.brainres.2006.06.022; Threlkeld SW, 2012, BEHAV BRAIN RES, V235, P130, DOI 10.1016/j.bbr.2012.07.031; Threlkeld SW, 2009, J NEURODEV DISORD, V1, P237, DOI 10.1007/s11689-009-9026-7; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Whitehouse AJO, 2010, J SPEECH LANG HEAR R, V53, P1015, DOI 10.1044/1092-4388(2009/09-0078); Yang Y, 2011, BIOL PSYCHIAT, V69, P63, DOI 10.1016/j.biopsych.2010.08.020	67	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73144	10.1371/journal.pone.0073144	http://dx.doi.org/10.1371/journal.pone.0073144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039873	Green Published, gold			2022-12-25	WOS:000326405300051
J	Huserbraten, MBO; Moland, E; Knutsen, H; Olsen, EM; Andre, C; Stenseth, NC				Huserbraten, Mats Brockstedt Olsen; Moland, Even; Knutsen, Halvor; Olsen, Esben Moland; Andre, Carl; Stenseth, Nils Chr			Conservation, Spillover and Gene Flow within a Network of Northern European Marine Protected Areas	PLOS ONE			English	Article							HOMARUS-GAMMARUS LINNAEUS; PALINURUS-ELEPHAS; SPATIAL SCALE; RESERVES; FISHERY; FUTURE; DIFFERENTIATION; CONNECTIVITY; POPULATIONS; SKAGERRAK	To ensure that marine protected areas (MPAs) benefit conservation and fisheries, the effectiveness of MPA designs has to be evaluated in field studies. Using an interdisciplinary approach, we empirically assessed the design of a network of northern MPAs where fishing for European lobster (Homarus gammarus) is prohibited. First, we demonstrate a high level of residency and survival (50%) for almost a year (363 days) within MPAs, despite small MPA sizes (0.5-1 km(2)). Second, we demonstrate limited export (4.7%) of lobsters tagged within MPAs (N = 1810) to neighbouring fished areas, over a median distance of 1.6 km out to maximum 21 km away from MPA centres. In comparison, median movement distance of lobsters recaptured within MPAs was 164 m, and recapture rate was high (40%). Third, we demonstrate a high level of gene flow within the study region, with an estimated F-ST of less than 0.0001 over a approximate to 400 km coastline. Thus, the restricted movement of older life stages, combined with a high level of gene flow suggests that connectivity is primarily driven by larval drift. Larval export from the MPAs can most likely affect areas far beyond their borders. Our findings are of high importance for the design of MPA networks for sedentary species with pelagic early life stages.	[Huserbraten, Mats Brockstedt Olsen; Knutsen, Halvor; Olsen, Esben Moland; Stenseth, Nils Chr] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Moland, Even; Knutsen, Halvor; Olsen, Esben Moland; Stenseth, Nils Chr] Inst Marine Res, Arendal, Norway; [Knutsen, Halvor; Olsen, Esben Moland; Stenseth, Nils Chr] Univ Agder, Dept Nat Sci, Kristiansand, Norway; [Andre, Carl] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Oslo; Institute of Marine Research - Norway; University of Agder; University of Gothenburg	Huserbraten, MBO (corresponding author), Univ Oslo, CEES, Dept Biosci, Oslo, Norway.	m.huserbraten@gmail.com	Andre, Carl/B-4237-2010; Moland, Even/A-7788-2013; Olsen, Esben Moland/B-1894-2012; Knutsen, Halvor/A-4261-2009; Stenseth, Nils Chr./G-5212-2016	Andre, Carl/0000-0003-4404-7292; Olsen, Esben Moland/0000-0003-3807-7524; Knutsen, Halvor/0000-0002-7627-7634; Stenseth, Nils Chr./0000-0002-1591-5399	Norwegian Institute of Marine Research; European Union and the Norwegian government; Research Council of Norway	Norwegian Institute of Marine Research; European Union and the Norwegian government; Research Council of Norway(Research Council of Norway)	Field work was financed by the Norwegian Institute of Marine Research (www.imr.no) through the Coastal Zone Ecosystem Program and the European Union and the Norwegian government through the 'INTERREG III A' program (www.interreg-sverige-norge.com). Preparation of this manuscript was supported by the Research Council of Norway (www.forskningsradet.no), the Research Council of Sweden, through the Center for evolutionary Marine Biology, and the Regional Research Fund Agder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnalt AL, 2007, ICES J MAR SCI, V64, P288, DOI 10.1093/icesjms/fsl020; AIKEN DE, 1973, J FISH RES BOARD CAN, V30, P1337, DOI 10.1139/f73-214; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Andre C, 2010, CONSERV GENET RESOUR, V2, P233, DOI 10.1007/s12686-009-9151-3; Antao T, 2008, MAR ECOL PR IN PRESS, V9, P323, DOI 10.1186/1471-2105-9-323; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; BANNISTER RCA, 1994, CRUSTACEANA, V67, P156, DOI 10.1163/156854094X00530; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browne RM, 2001, HYDROBIOLOGIA, V465, P49, DOI 10.1023/A:1014517614770; COX DR, 1972, J R STAT SOC B, V34, P187; Danielssen DS, 1997, ICES J MAR SCI, V54, P753, DOI 10.1006/jmsc.1996.0210; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Follesa MC, 2011, AQUAT CONSERV, V21, P564, DOI 10.1002/aqc.1213; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goni R, 2006, MAR ECOL PROG SER, V308, P207, DOI 10.3354/meps308207; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Incze L, 2010, FISH OCEANOGR, V19, P1, DOI 10.1111/j.1365-2419.2009.00522.x; Jorde PE, 2007, MAR ECOL PROG SER, V343, P229, DOI 10.3354/meps06922; Kleiven AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031216; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Moland E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2679; Moland E, 2011, CAN J FISH AQUAT SCI, V68, P1197, DOI 10.1139/F2011-053; NICHOLS JH, 1987, J NAT HIST, V21, P825, DOI 10.1080/00222938700770491; Oresland V, 2013, ENET DATA ANAL COMPU, V70, P532, DOI 10.1093/icesjms/fst019; Oresland V, 2013, ICES J MAR SCI, V70, P532, DOI 10.1093/icesjms/fst019; OUG E, 2010, 2010 NORWEGIAN RED L, P209; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; PANDIAN TJ, 1970, MAR BIOL, V5, P154, DOI 10.1007/BF00352599; Pelc RA, 2009, MAR ECOL PROG SER, V394, P65, DOI 10.3354/meps08326; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Schmalenbach I, 2010, MAR BIOL, V157, P1127, DOI 10.1007/s00227-010-1394-8; Steneck RS, 2006, J CRUSTACEAN BIOL, V26, P628, DOI 10.1651/S-2753.1; Sundelof A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058160; Ungfors A, 2009, ICES J MAR SCI, V66, P462, DOI 10.1093/icesjms/fsn223; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Wright S, 1943, GENETICS, V28, P114	49	28	28	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73388	10.1371/journal.pone.0073388	http://dx.doi.org/10.1371/journal.pone.0073388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039927	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324856500040
J	Wang, Y; Chen, AD; Lei, YM; Shan, GQ; Zhang, LY; Lu, X; Chen, ZL				Wang, Yan; Chen, A-De; Lei, Yan-Mei; Shan, Gui-Qiu; Zhang, Li-Yun; Lu, Xiao; Chen, Zheng-Liang			Mannose-Binding Lectin Inhibits Monocyte Proliferation through Transforming Growth Factor-beta 1 and p38 Signaling Pathways	PLOS ONE			English	Article							CYTOKINE PRODUCTION; CELL-PROLIFERATION; ADAPTIVE IMMUNITY; DENDRITIC CELLS; HUMAN PLASMA; PROTEIN; INNATE; DEFICIENCY; ACTIVATION; RECEPTOR	Mannose-binding lectin (MBL), a plasma C-type lectin, plays an important role in innate immunity. However, the interaction, and the consequences of it, between MBL and the immune system remain ill defined. We have investigated the contributing mechanisms and effects of MBL on the proliferation of human monocytes. At lower concentrations (<= 4 mg/ml) MBL was shown to partially enhance monocyte proliferation. By contrast, at higher concentrations (8-20 mg/ml) of MBL, cell proliferation was markedly attenuated. MBL-induced growth inhibition was associated with G0/G1 arrest, down-regulation of cyclin D1/D3, cyclin-dependent kinase (Cdk) 2/Cdk4 and up-regulation of the Cdk inhibitory protein Cip1/p21. Additionally, MBL induced apoptosis, and did so through caspase-3 activation and poly ADP-ribose polymerase (PARP) cleavage. Moreover, transforming growth factor (TGF)-beta 1 levels increased in the supernatants of MBL-stimulated monocyte cultures. We also found that MBL-dependent inhibition of monocyte proliferation could be reversed by the TGF-beta receptor antagonist SB-431542, or by anti-TGF-beta 1 antibody, or by the mitogen-activated protein kinase (MAPK) inhibitors specific for p38 (SB203580), but not ERK (U0126) or JNK (SP600125). Thus, at high concentrations, MBL can affect the immune system by inhibiting monocyte proliferation, which suggests that MBL may exhibit anti-inflammatory effects.	[Wang, Yan; Chen, A-De; Lei, Yan-Mei; Shan, Gui-Qiu; Zhang, Li-Yun; Lu, Xiao; Chen, Zheng-Liang] Southern Med Univ, Dept Immunol, Guangzhou, Guangdong, Peoples R China; [Wang, Yan] Guangdong Med Coll, Sch Basic Med, Dept Microbiol & Immunol, Dongguan, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Medical University	Chen, ZL (corresponding author), Southern Med Univ, Dept Immunol, Guangzhou, Guangdong, Peoples R China.	zhlchen@fimmu.com			National Nature Science Foundation of China [30972679]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China [grant numbers 30972679]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; Deretic V, 2009, DIGEST DIS, V27, P246, DOI 10.1159/000228557; Downing I, 2005, SCAND J IMMUNOL, V62, P507, DOI 10.1111/j.1365-3083.2005.01693.x; Dumestre-Perard C, 2002, MOL IMMUNOL, V39, P465, DOI 10.1016/S0161-5890(02)00119-0; Eikelenboom P, 2012, NEURODEGENER DIS, V10, P271, DOI 10.1159/000334287; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Fraser DA, 2010, J IMMUNOL, V185, P3932, DOI 10.4049/jimmunol.1002080; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P4857, DOI 10.1210/jc.2003-030742; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hong QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005755; Linker RA, 2009, CRIT REV IMMUNOL, V29, P43, DOI 10.1615/CritRevImmunol.v29.i1.20; Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371; MacDonald SL, 2010, HUM IMMUNOL, V71, P1077, DOI 10.1016/j.humimm.2010.07.011; MacDonald SL, 2008, BIOCHEM SOC T, V36, P1497, DOI 10.1042/BST0361497; Martin-Caballero J, 2004, ONCOGENE, V23, P8231, DOI 10.1038/sj.onc.1207863; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pradhan Vandana, 2010, J Assoc Physicians India, V58, P688; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schafranski MD, 2004, CLIN EXP IMMUNOL, V138, P521, DOI 10.1111/j.1365-2249.2004.02645.x; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Takahashi K, 2002, MICROBES INFECT, V4, P773, DOI 10.1016/S1286-4579(02)01597-6; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Truong LN, 2011, J MOL CELL BIOL, V3, P13, DOI 10.1093/jmcb/mjq052; Turner M W, 2000, Rev Immunogenet, V2, P305; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-1; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Yao GH, 2006, MOL IMMUNOL, V43, P915, DOI 10.1016/j.molimm.2005.06.031; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	39	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72505	10.1371/journal.pone.0072505	http://dx.doi.org/10.1371/journal.pone.0072505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039775	Green Submitted, gold, Green Published			2022-12-25	WOS:000324856500020
J	Kalia, AA; Schrater, PR; Legge, GE				Kalia, Amy A.; Schrater, Paul R.; Legge, Gordon E.			Combining Path Integration and Remembered Landmarks When Navigating without Vision	PLOS ONE			English	Article							NONVISUAL NAVIGATION; VISUAL-PERCEPTION; LOCOMOTION; CUE; INFORMATION; INFERENCE; DISTANCE; INPUTS; SPACE; BLIND	This study investigated the interaction between remembered landmark and path integration strategies for estimating current location when walking in an environment without vision. We asked whether observers navigating without vision only rely on path integration information to judge their location, or whether remembered landmarks also influence judgments. Participants estimated their location in a hallway after viewing a target (remembered landmark cue) and then walking blindfolded to the same or a conflicting location (path integration cue). We found that participants averaged remembered landmark and path integration information when they judged that both sources provided congruent information about location, which resulted in more precise estimates compared to estimates made with only path integration. In conclusion, humans integrate remembered landmarks and path integration in a gated fashion, dependent on the congruency of the information. Humans can flexibly combine information about remembered landmarks with path integration cues while navigating without visual information.	[Kalia, Amy A.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Schrater, Paul R.; Legge, Gordon E.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA	Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities	Kalia, AA (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	akalia@mit.edu		Legge, Gordon/0000-0002-3742-1680	The University of Minnesota College of Liberal Arts and Department of Psychology's Graduate Research Partnership Program; National Institutes of Health (NIH) [T32 HD007151, T32 EY07133, F32EY019622, EY02857]; U.S. Department of Education through SenderoGroup LLC [H133A011903];  [EY017835-01];  [EY015616-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007151] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY019622, P30EY011374, R01EY017835, R43EY015616, R44EY015616, R01EY002857, T32EY007133] Funding Source: NIH RePORTER	The University of Minnesota College of Liberal Arts and Department of Psychology's Graduate Research Partnership Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Education through SenderoGroup LLC; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by The University of Minnesota College of Liberal Arts and Department of Psychology's Graduate Research Partnership Program, and National Institutes of Health (NIH) grants T32 HD007151 (Interdisciplinary Training Program in Cognitive Science), T32 EY07133 (Training Program in Visual Neuroscience), F32EY019622, EY02857, U.S. Department of Education (H133A011903) through a subcontract through SenderoGroup LLC, EY017835-01 (Designing Visually Accessible Spaces), and EY015616-03 (Magnetic Wayfinding). The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MA, 1997, PERCEPT PSYCHOPHYS, V59, P404, DOI 10.3758/BF03211907; Andel D, 2004, P ROY SOC B-BIOL SCI, V271, P1485, DOI 10.1098/rspb.2004.2749; Brouwer AM, 2009, J VISION, V9, DOI 10.1167/9.1.24; Chance SS, 1998, PRESENCE-TELEOP VIRT, V7, P168, DOI 10.1162/105474698565659; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Collett M, 1998, NATURE, V394, P269, DOI 10.1038/28378; Ellard CG, 2003, PERCEPTION, V32, P567, DOI 10.1068/p5041; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; ETIENNE AS, 1990, ANIM BEHAV, V39, P17, DOI 10.1016/S0003-3472(05)80723-7; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Fukusima SS, 1997, J EXP PSYCHOL HUMAN, V23, P86, DOI 10.1037/0096-1523.23.1.86; Gallistel C. R., 1990, ORG LEARNING; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lew AR, 2011, PSYCHOL BULL, V137, P484, DOI 10.1037/a0022315; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Loomis JM, 2002, J EXP PSYCHOL LEARN, V28, P335, DOI 10.1037//0278-7393.28.2.335; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; Mamassian P, 2002, NEU INF PRO, P13; Miles WR, 1930, J GEN PSYCHOL, V3, P412, DOI 10.1080/00221309.1930.9918218; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Odell NV, 2008, J AAPOS, V12, P555, DOI 10.1016/j.jaapos.2008.04.012; Philbeck JW, 2005, PSICOLOGICA, V26, P7; RIESER JJ, 1990, PERCEPTION, V19, P675, DOI 10.1068/p190675; Stankiewicz BJ, 2007, J EXP PSYCHOL HUMAN, V33, P378, DOI 10.1037/0096-1523.33.2.378; Tarampi MR, 2010, ATTEN PERCEPT PSYCHO, V72, P23, DOI 10.3758/APP.72.1.23; Tcheang L, 2011, P NATL ACAD SCI USA, V108, P1152, DOI 10.1073/pnas.1011843108; THOMSON JA, 1983, J EXP PSYCHOL HUMAN, V9, P427, DOI 10.1037/0096-1523.9.3.427; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355	32	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72170	10.1371/journal.pone.0072170	http://dx.doi.org/10.1371/journal.pone.0072170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24039742	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600020
J	Kikkawa, Y; Ogawa, T; Sudo, R; Yamada, Y; Katagiri, F; Hozumi, K; Nomizu, M; Miner, JH				Kikkawa, Yamato; Ogawa, Takaho; Sudo, Ryo; Yamada, Yuji; Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi; Miner, Jeffrey H.			The Lutheran/Basal Cell Adhesion Molecule Promotes Tumor Cell Migration by Modulating Integrin-mediated Cell Attachment to Laminin-511 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP GLYCOPROTEIN; IMMUNOGLOBULIN SUPERFAMILY; BINDING-SITE; IN-VIVO; EXPRESSION; RECEPTOR; SPECTRIN; LAMININ-ALPHA-5; ALPHA-3-BETA-1; IDENTIFICATION	Cell-matrix interactions are critical for tumor cell migration. Lutheran (Lu), also known as basal cell adhesion molecule (B-CAM), competes with integrins for binding to laminin alpha 5, a subunit of LM-511, a major component of basement membranes. Here we show that the preferential binding of Lu/B-CAM to laminin alpha 5 promotes tumor cell migration. The attachment of Lu/B-CAM transfectants to LM-511 was slightly weaker than that of control cells, and this was because Lu/B-CAM disturbed integrin binding to laminin alpha 5. Lu/B-CAM induced a spindle cell shape with pseudopods and promoted cell migration on LM-511. In addition, blocking with an anti-Lu/B-CAM antibody led to a flat cell shape and inhibited migration on LM-511, similar to the effects of an activating integrin beta 1 antibody. We conclude that tumor cell migration on LM-511 requires that Lu/B-CAM competitively modulates cell attachment through integrins. We suggest that this competitive interaction is involved in a balance between static and migratory cell behaviors.	[Kikkawa, Yamato; Ogawa, Takaho; Yamada, Yuji; Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan; [Sudo, Ryo] Keio Univ, Sch Integrated Design Engn, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan; [Miner, Jeffrey H.] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA	Tokyo University of Pharmacy & Life Sciences; Keio University; Washington University (WUSTL)	Kikkawa, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan.	kikkawa@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010; Sudo, Ryo/D-2319-2010	Hozumi, Kentaro/0000-0002-6671-4386; Sudo, Ryo/0000-0002-1053-9662; Yamada, Yuji/0000-0003-2338-6906	National Institutes of Health [R01DK078314]; Ministry of Education, Sciences Sports and Culture, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078314] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25249018] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Sciences Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK078314 (to J. H. M.). This work was also supported by Ministry of Education, Sciences Sports and Culture, Japan grants (to Y. K.).	Alais S, 2001, J CELL SCI, V114, P1847; An XL, 2008, BLOOD, V112, P5212, DOI 10.1182/blood-2008-03-146068; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Burton NM, 2008, BLOOD CELL MOL DIS, V40, P446, DOI 10.1016/j.bcmd.2008.01.004; CAMPBELL IG, 1994, CANCER RES, V54, P5761; Collec E, 2011, BIOCHEM J, V436, P699, DOI 10.1042/BJ20101717; De Grandis M, 2013, BLOOD, V121, P658, DOI 10.1182/blood-2012-07-440487; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 1999, J BIOL CHEM, V274, P31903, DOI 10.1074/jbc.274.45.31903; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kikkawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023329; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kroviarski Y, 2004, BRIT J HAEMATOL, V126, P255, DOI 10.1111/j.1365-2141.2004.05010.x; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Moulson CL, 2001, DEV DYNAM, V222, P101, DOI 10.1002/dvdy.1169; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Pouliot N, 2013, CELL ADHES MIGR, V7, P142, DOI 10.4161/cam.22125; Rahuel C, 2008, AM J PHYSIOL-RENAL, V294, pF393, DOI 10.1152/ajprenal.00315.2007; Richard M, 2006, TRANSFUSION, V46, P1011, DOI 10.1111/j.1537-2995.2006.00836.x; Ritie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037710; Shannon MB, 2006, J AM SOC NEPHROL, V17, P1913, DOI 10.1681/ASN.2005121298; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Spenle C, 2013, CELL ADHES MIGR, V7, P90, DOI 10.4161/cam.22236; Tanimizu N, 2012, J BIOL CHEM, V287, P28586, DOI 10.1074/jbc.M112.350488; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204	38	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30990	31001		10.1074/jbc.M113.486456	http://dx.doi.org/10.1074/jbc.M113.486456			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036115	hybrid, Green Published			2022-12-25	WOS:000330778900018
J	Weber, M; Buceta, J				Weber, Marc; Buceta, Javier			Stochastic Stabilization of Phenotypic States: The Genetic Bistable Switch as a Case Study	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN EXPRESSION; TOGGLE SWITCH; NOISE; CONSEQUENCES; CIRCUITS; SYSTEMS; LEVEL	We study by means of analytical calculation and stochastic simulations how intrinsic noise modifies the bifurcation diagram of gene regulatory processes that can be effectively described by the Langevin formalism. In a general context, our study raises the intriguing question of how biochemical fluctuations redesign the epigenetic landscape in differentiation processes. We have applied our findings to a general class of regulatory processes that includes the simplest case that displays a bistable behavior and hence phenotypic variability: the genetic auto-activating switch. Thus, we explain why and how the noise promotes the stability of the low-state phenotype of the switch and show that the bistable region is extended when increasing the intensity of the fluctuations. This phenomenology is found in a simple one-dimensional model of the genetic switch as well as in a more detailed model that takes into account the binding of the protein to the promoter region. Altogether, we prescribe the analytical means to understand and quantify the noise-induced modifications of the bifurcation points for a general class of regulatory processes where the genetic bistable switch is included.	[Weber, Marc; Buceta, Javier] Parc Cient Barcelona, Comp Simulat & Modelling Co S Mo, Barcelona, Spain		Buceta, J (corresponding author), Parc Cient Barcelona, Comp Simulat & Modelling Co S Mo, Barcelona, Spain.	javier.buceta@pcb.ub.es	Weber, Marc/P-4718-2019; Weber, Marc/A-3500-2013; Buceta, Javier/E-3705-2010; Buceta, Javier/ABB-1696-2021	Weber, Marc/0000-0001-7920-5655; Weber, Marc/0000-0001-7920-5655; Buceta, Javier/0000-0003-1791-0011; Buceta, Javier/0000-0003-1791-0011	MICINN [BFU2010-21847-C02-01/BMC]; DURSI [2009-SGR/01055]; Spanish MICINN [FPU AP2008-03272]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); DURSI; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support was provided by MICINN under grant BFU2010-21847-C02-01/BMC, and by DURSI through project 2009-SGR/01055. M. W. acknowledges the support of the Spanish MICINN through a doctoral fellowship (FPU AP2008-03272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Choi PJ, 2009, SCIENCE NEW YORK NY, V322, P442; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Frigola D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031407; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Horsthemke W., 1984, NOISE INDUCED TRANSI; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jaruszewicz J, 2013, J THEOR BIOL, V317, P140, DOI 10.1016/j.jtbi.2012.10.004; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Morelli MJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821957; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2009, SCIENCE NEW YORK NY, V319, P339; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Scott M, 2007, P NATL ACAD SCI USA, V104, P7402, DOI 10.1073/pnas.0610468104; Song C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000699; Trueba FJ, 1998, ARCH MICROBIOL, V169, P491, DOI 10.1007/s002030050601; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-6; Zakharova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019696; Zuk PJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055002	33	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73487	10.1371/journal.pone.0073487	http://dx.doi.org/10.1371/journal.pone.0073487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039958	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500035
J	Garcia-Lagunas, N; Romero-Geraldo, R; Hernandez-Saavedra, NY				Garcia-Lagunas, Norma; Romero-Geraldo, Reyna; Hernandez-Saavedra, Norma Y.			Genomics Study of the Exposure Effect of Gymnodinium catenatum, a Paralyzing Toxin Producer, on Crassostrea gigas' Defense System and Detoxification Genes	PLOS ONE			English	Article							PARALYTIC SHELLFISH TOXINS; PACIFIC OYSTER; MOLECULAR-IDENTIFICATION; ALEXANDRIUM-CATENELLA; BIVALVE MOLLUSKS; DINOFLAGELLATE; EXPRESSION; BIOTRANSFORMATION; HEMOCYTES; ENZYMES	Background: Crassostrea gigas accumulates paralytic shellfish toxins (PST) associated with red tide species as Gymnodinium catenatum. Previous studies demonstrated bivalves show variable feeding responses to toxic algae at physiological level; recently, only one study has reported biochemical changes in the transcript level of the genes involved in C. gigas stress response. Principal Findings: We found that 24 h feeding on toxic dinoflagellate cells (acute exposure) induced a significant decrease in clearance rate and expression level changes of the genes involved in antioxidant defense (copper/zinc superoxide dismutase, Cu/Zn-SOD), cell detoxification (glutathione S-transferase, GST and cytochrome P450, CPY450), intermediate immune response activation (lipopolysaccharide and beta glucan binding protein, LGBP), and stress responses (glutamine synthetase, GS) in Pacific oysters compared to the effects with the non-toxic microalga Isochrysis galbana. A sub-chronic exposure feeding on toxic dinoflagellate cells for seven and fourteen days (30x10(3) cells mL(-1)) showed higher gene expression levels. A significant increase was observed in Cu/Zn-SOD, GST, and LGBP at day 7 and a major increase in GS and CPY450 at day 14. We also observed that oysters fed only with G. catenatum (3x10(3) cells mL(-1)) produced a significant increase on the transcription level than in a mixed diet (3x10(3) cells mL(-1) of G. catenatum+0.75x10(6) cells mL(-1) I. galbana) in all the analyzed genes. Conclusions: Our results provide gene expression data of PST producer dinoflagellate G. catenatum toxic effects on C. gigas, a commercially important bivalve. Over expressed genes indicate the activation of a potent protective mechanism, whose response depends on both cell concentration and exposure time against these toxic microalgae. Given the importance of dinoflagellate blooms in coastal environments, these results provide a more comprehensive overview of how oysters respond to stress generated by toxic dinoflagellate exposure.	[Garcia-Lagunas, Norma; Romero-Geraldo, Reyna; Hernandez-Saavedra, Norma Y.] Ctr Invest Biol Noroeste CIBNOR, Genet Mol Lab, La Paz, Baja California, Mexico; [Romero-Geraldo, Reyna] Inst Tecnol La Paz, La Paz, Baja California, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Hernandez-Saavedra, NY (corresponding author), Ctr Invest Biol Noroeste CIBNOR, Genet Mol Lab, La Paz, Baja California, Mexico.	nhernan04@cibnor.mx	Hernandez Saavedra, Norma Yolanda/ABB-4249-2021	Hernandez Saavedra, Norma Yolanda/0000-0002-7004-299X	CONACyT [083442, CB07 083442]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT for scholarship (#083442), funding project CONACyT CB07 083442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JA, 2008, J SHELLFISH RES, V27, P567, DOI 10.2983/0730-8000(2008)27[567:DPOFAP]2.0.CO;2; Band-Schmidt CJ, 2010, MAR DRUGS, V8, P1935, DOI 10.3390/md8061935; Band-Schmidt CJ, 2005, HARMFUL ALGAE, V4, P21, DOI 10.1016/j.hal.2003.10.004; BARDOUIL M, 1993, J SHELLFISH RES, V12, P417; Bougrier S, 2003, AQUAT LIVING RESOUR, V16, P347, DOI 10.1016/S0990-7440(03)00080-9; Boutet I, 2004, MAR BIOL, V146, P53, DOI 10.1007/s00227-004-1423-6; Boutet I, 2004, BBA-GENE STRUCT EXPR, V1679, P29, DOI 10.1016/j.bbaexp.2004.04.001; Boutet I, 2004, GENE, V329, P147, DOI 10.1016/j.gene.2003.12.027; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; BRICELJ VM, 1991, MAR ECOL PROG SER, V74, P33, DOI 10.3354/meps074033; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Campa-Cordova AI, 2009, HIDROBIOLOGICA, V19, P151; Choi MC, 2003, MAR BIOL, V143, P927, DOI 10.1007/s00227-003-1148-y; Collin H, 2010, J EXP BIOL, V213, P4010, DOI 10.1242/jeb.048033; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; Romero-Geraldo RD, 2014, AQUAC RES, V45, P1512, DOI 10.1111/are.12100; Estrada N, 2007, COMP BIOCHEM PHYS C, V146, P502, DOI 10.1016/j.cbpc.2007.06.003; Gagnaire B, 2006, CELL BIOL TOXICOL, V22, P1, DOI 10.1007/s10565-006-0011-6; Gainey LF., 1988, J SHELLFISH RES, V7, P623; Garate-Lizarraga I, 2004, MAR POLLUT BULL, V48, P397, DOI 10.1016/j.marpolbul.2003.10.032; Gifford D.J., 2000, P193, DOI 10.1016/B978-012327645-2/50006-2; Giron-Perez MI, 2010, ISJ-INVERT SURVIV J, V7, P149; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haberkorn H, 2010, HARMFUL ALGAE, V9, P427, DOI 10.1016/j.hal.2010.01.003; Haberkorn H, 2010, AQUAT TOXICOL, V97, P96, DOI 10.1016/j.aquatox.2009.12.006; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hegaret H, 2007, MAR BIOL, V152, P441, DOI 10.1007/s00227-007-0703-3; Hegaret H, 2012, HARMFUL ALGAE, V18, P74, DOI 10.1016/j.hal.2012.04.006; Helm MM, 2004, HATCHERY CULTURE BIV, P177; Hernandez-Sandoval FE, 2009, HIDROBIOLOGICA, V19, P245; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Jenny MJ, 2004, EUR J BIOCHEM, V271, P1702, DOI 10.1111/j.1432-1033.2004.04071.x; Keppler CJ, 2007, B ENVIRON CONTAM TOX, V78, P57, DOI 10.1007/s00128-007-9007-z; Kodama Masaaki, 2010, Aqua-Bioscience Monographs, V3, P1; Laabir M, 2007, AQUAT LIVING RESOUR, V20, P51, DOI 10.1051/alr:2007015; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lassus P, 2004, AQUAT LIVING RESOUR, V17, P207, DOI 10.1051/alr:2004012; Lassus P., 1996, HARMFUL TOXIC ALGAL, P409; Lassus P, 2007, AQUAT LIVING RESOUR, V20, P59, DOI 10.1051/alr:2007016; LEHANE L, 2000, PARALYTIC SHELLFISH; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Li SC, 2002, MAR ENVIRON RES, V53, P145, DOI 10.1016/S0141-1136(01)00117-9; Linares JP, 2009, TOXICON, V53, P185, DOI 10.1016/j.toxicon.2008.10.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manduzio H., 2005, ISJ, V2, P91; Meistertzheim AL, 2007, FEBS J, V274, P6392, DOI 10.1111/j.1742-4658.2007.06156.x; Mello DF, 2012, MAR DRUGS, V10, P583, DOI 10.3390/md10030583; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Navarro JM, 2010, MAR BIOL, V157, P1967, DOI 10.1007/s00227-010-1465-x; Perez-Linares J, 2008, J FOOD SCI, V73, pT69, DOI 10.1111/j.1750-3841.2008.00710.x; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Tanguy A, 2002, BIOMARKERS, V7, P439, DOI 10.1080/13547500210157531; Tomanek L, 2011, ANNU REV MAR SCI, V3, P373, DOI 10.1146/annurev-marine-120709-142729; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VROLIJK NH, 1992, MAR ECOL PROG SER, V88, P237, DOI 10.3354/meps088237; Whalen KE, 2008, ARCH BIOCHEM BIOPHYS, V478, P7, DOI 10.1016/j.abb.2008.07.007; Wildish D, 1998, AQUAT LIVING RESOUR, V11, P35, DOI 10.1016/S0990-7440(99)80029-1; ZIEGLER DM, 1993, ANNU REV PHARMACOL, V33, P179, DOI 10.1146/annurev.pharmtox.33.1.179	65	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72323	10.1371/journal.pone.0072323	http://dx.doi.org/10.1371/journal.pone.0072323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039751	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600005
J	Balabanova, Y; Klar, S; Delere, Y; Wilking, H; Faber, MS; Lassen, SG; Gilsdorf, A; Dupke, S; Nitschke, M; Sayk, F; Grunow, R; Krause, G				Balabanova, Yanina; Klar, Stefanie; Delere, Yvonne; Wilking, Hendrik; Faber, Mirko S.; Lassen, Sofie Gillesberg; Gilsdorf, Andreas; Dupke, Susann; Nitschke, Martin; Sayk, Friedhelm; Grunow, Roland; Krause, Gerard			Serological Evidence of Asymptomatic Infections during Escherichia coli O104:H4 Outbreak in Germany in 2011	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; HUMORAL IMMUNE-RESPONSE; CHILDREN; O157; LIPOPOLYSACCHARIDE	Introduction: The largest known outbreak caused by a rare hybrid strain of Shiga toxin-producing E.coli (STEC) andenteroaggregative E.coli (EAEC) (E.coli O104:H4) of serotype O104:H4 occurred in Germany in 2011. Fenugreek sprouts acted as a transmission vehicle and were widely consumed in the outbreak area at the time of the epidemic. In total 3,842 people developed a clinical illness caused by this strain; however the rates of asymptomatic infections remain unclear. We aimed to develop a serological assay for detection of E.coli O104 LPS specific antibodies and to establish the post-outbreak levels of seropositivity among people with documented exposure to contaminated sprouts. Results and Discussion: Developed serological assays (ELISA with 84% sensitivity, 63% specificity and Western Blot with 100% sensitivity, 82.5% specificity) identified 33% (16/49) level of asymptomatic infection.Relatively small sample size and a significant time- lapse between the onset of symptoms and serum samples collection (appr. 8 weeks) might explain the assay variability. No association was found between clinical or demographic characteristics and assay positivity. Larger studies are needed to understand the complexity of human immune response and factors influencing development of clinical symptoms.Development of intra-outbreak research plans will substantially aid the conduct of more thorough scientific investigation during an outbreak period.	[Balabanova, Yanina; Klar, Stefanie; Delere, Yvonne; Wilking, Hendrik; Faber, Mirko S.; Lassen, Sofie Gillesberg; Gilsdorf, Andreas; Dupke, Susann; Grunow, Roland; Krause, Gerard] Robert Koch Inst, Berlin, Germany; [Lassen, Sofie Gillesberg] European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Nitschke, Martin; Sayk, Friedhelm] Univ Hosp Lubeck, Lubeck, Germany; [Krause, Gerard] Helmholtz Ctr Infect Res, Braunschweig, Germany	Robert Koch Institute; University of Lubeck; Helmholtz Association; Helmholtz-Center for Infection Research	Balabanova, Y (corresponding author), Robert Koch Inst, Berlin, Germany.	LenzY@rki.de	Nitschke, Martin/ABA-9388-2021; Lassen, Sofie Gillesberg/AAL-2876-2021; Faber, MIrko/O-1191-2018	Nitschke, Martin/0000-0002-2716-7527; Lassen, Sofie Gillesberg/0000-0001-6226-5416; Faber, MIrko/0000-0002-9196-570X; Klar, Stefanie/0000-0001-5852-5692; Krause, Gerard/0000-0003-3328-8808; Gilsdorf, Andreas/0000-0001-8572-2798; Wilking, Hendrik/0000-0002-8574-5831	Robert Koch Institute	Robert Koch Institute	The study was funded by the Robert Koch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askar M, 2011, EUROSURVEILLANCE, V16, P22; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P501; Chart H, 1999, J APPL MICROBIOL, V86, P731, DOI 10.1046/j.1365-2672.1999.00766.x; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DEVINE DA, 1989, J MED MICROBIOL, V30, P295, DOI 10.1099/00222615-30-4-295; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; KOGAN G, 1992, FEMS MICROBIOL LETT, V91, P135; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludwig K, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000020086.66597.3A; Ludwig K, 2002, J INFECT DIS, V186, P566, DOI 10.1086/341781; Navarro A, 2003, CLIN DIAGN LAB IMMUN, V10, P797, DOI 10.1128/CDLI.10.5.797-801.2003; Porsch-Ozcurumez M, 2004, CLIN DIAGN LAB IMMUN, V11, P1008, DOI 10.1128/CDLI.11.6.1008-1015.2004; Robert Koch Institute, 2011, REP FIN PRES EV EP F; Robert Koch-Institut, 2012, ROB KOCH I INF JB 20	17	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73052	10.1371/journal.pone.0073052	http://dx.doi.org/10.1371/journal.pone.0073052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039858	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300045
J	Cruz, J; Glen, AS; Pech, RP				Cruz, Jennyffer; Glen, Alistair S.; Pech, Roger P.			Modelling Landscape-Level Numerical Responses of Predators to Prey: The Case of Cats and Rabbits	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE; NEW-ZEALAND; ORYCTOLAGUS-CUNICULUS; SOUTH ISLAND; FELIS-CATUS; POPULATION-DYNAMICS; ORONGORONGO VALLEY; WILD RABBITS; CONSERVATION; IMPACT	Predator-prey systems can extend over large geographical areas but empirical modelling of predator-prey dynamics has been largely limited to localised scales. This is due partly to difficulties in estimating predator and prey abundances over large areas. Collection of data at suitably large scales has been a major problem in previous studies of European rabbits (Oryctolagus cuniculus) and their predators. This applies in Western Europe, where conserving rabbits and predators such as Iberian lynx (Lynx pardinus) is important, and in other parts of the world where rabbits are an invasive species supporting populations of introduced, and sometimes native, predators. In pastoral regions of New Zealand, rabbits are the primary prey of feral cats (Felis catus) that threaten native fauna. We estimate the seasonal numerical response of cats to fluctuations in rabbit numbers in grassland-shrubland habitat across the Otago and Mackenzie regions of the South Island of New Zealand. We use spotlight counts over 1645 km of transects to estimate rabbit and cat abundances with a novel modelling approach that accounts simultaneously for environmental stochasticity, density dependence and varying detection probability. Our model suggests that cat abundance is related consistently to rabbit abundance in spring and summer, possibly through increased rabbit numbers improving the fecundity and juvenile survival of cats. Maintaining rabbits at low abundance should therefore suppress cat numbers, relieving predation pressure on native prey. Our approach provided estimates of the abundance of cats and rabbits over a large geographical area. This was made possible by repeated sampling within each season, which allows estimation of detection probabilities. A similar approach could be applied to predator-prey systems elsewhere, and could be adapted to any method of direct observation in which there is no double-counting of individuals. Reliable estimates of numerical responses are essential for managing both invasive and threatened predators and prey.	[Cruz, Jennyffer; Glen, Alistair S.; Pech, Roger P.] Landcare Res, Lincoln, New Zealand	Landcare Research - New Zealand	Cruz, J (corresponding author), Landcare Res, Lincoln, New Zealand.	cruzbernalj@landcareresearch.co.nz	Glen, Alistair Stuart/AGH-1175-2022	Glen, Alistair Stuart/0000-0002-7777-7630; Cruz, Jennyffer/0000-0002-5321-8017	Ministry of Business, Innovation and Employment's Science and Innovation Group	Ministry of Business, Innovation and Employment's Science and Innovation Group(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This research was supported by Core funding for Crown Research Institutes to Landcare Research from the Ministry of Business, Innovation and Employment's Science and Innovation Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Banks PB, 2000, J WILDLIFE MANAGE, V64, P401, DOI 10.2307/3803238; Barlow ND, 2001, WILDLIFE RES, V28, P87, DOI 10.1071/WR99090; Bayliss P, 2002, PHILOS T ROY SOC B, V357, P1233, DOI 10.1098/rstb.2002.1124; Berman D, 2011, WILDLIFE RES, V38, P77, DOI 10.1071/WR09178; BOUTIN S, 1995, WILDLIFE RES, V22, P89, DOI 10.1071/WR9950089; Caley PA, 2002, J WILDLIFE MANAGE, V66, P131, DOI 10.2307/3802879; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Clark J. S, 2007, MODELS ECOLOGICAL DA; CLOUT MN, 1995, IBIS, V137, pS181, DOI 10.1111/j.1474-919X.1995.tb08440.x; Courchamp F, 1999, BIOL CONSERV, V89, P219, DOI 10.1016/S0006-3207(98)00131-1; Courchamp F, 2000, J ANIM ECOL, V69, P154, DOI 10.1046/j.1365-2656.2000.00383.x; Davey C, 2006, ECOSYSTEMS, V9, P992, DOI 10.1007/s10021-004-0173-0; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Dowding JE, 2001, BIOL CONSERV, V99, P47, DOI 10.1016/S0006-3207(00)00187-7; Edwards GP, 2001, AUSTRAL ECOL, V26, P93, DOI 10.1111/j.1442-9993.2001.01091.pp.x; Engeman RM, 2000, WILDLIFE RES, V27, P553, DOI 10.1071/WR98090; Fernandez-De-Simon J, 2011, EUR J WILDLIFE RES, V57, P1091, DOI 10.1007/s10344-011-0524-z; Fitzgerald B. Mike, 2000, P151; FITZGERALD BM, 1979, NEW ZEAL J ZOOL, V6, P107; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gibb JA, 1998, NEW ZEAL J ZOOL, V25, P231, DOI 10.1080/03014223.1998.9518153; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Gillies C, 2005, HDB NZ MAMMALS, P308; Glen AS, 2013, BIOL INVASIONS, V15, P2127, DOI 10.1007/s10530-013-0439-6; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; HANSKI I, 1995, ECOLOGY, V76, P840, DOI 10.2307/1939349; Holden C, 2002, WILDLIFE RES, V29, P615, DOI 10.1071/WR00101; Hone J, 2007, WILDLIFE RES, V34, P335, DOI 10.1071/WR06171; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; JAKSIC FM, 1992, OECOLOGIA, V89, P90, DOI 10.1007/BF00319020; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; King C., 1984, IMMIGRANT KILLERS IN; Lees AC, 2008, MAMMAL REV, V38, P304, DOI 10.1111/j.1365-2907.2008.00116.x; Linden A, 2011, OIKOS, V120, P1065, DOI 10.1111/j.1600-0706.2010.18970.x; Magle SB, 2012, BIODIVERS CONSERV, V21, P2803, DOI 10.1007/s10531-012-0339-6; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McLennan JA, 1996, NEW ZEAL J ECOL, V20, P27; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; Moseby KE, 2009, WILDLIFE RES, V36, P422, DOI 10.1071/WR08098; Murphy EC, 2004, WILDLIFE RES, V31, P631, DOI 10.1071/WR03033; Mutze G, 2002, WILDLIFE RES, V29, P577, DOI 10.1071/WR00100; NEWSOME AE, 1989, OECOLOGIA, V78, P458, DOI 10.1007/BF00378734; Newsome AE, 1997, POTENTIAL IMPACTS AU; Norbury G, 2008, ANIM CONSERV, V11, P17, DOI 10.1111/j.1469-1795.2007.00142.x; Norbury G, 2002, WILDLIFE RES, V29, P599, DOI 10.1071/WR00085; Norbury G, 2001, J APPL ECOL, V38, P1350, DOI 10.1046/j.0021-8901.2001.00685.x; Norbury G, 1996, WILDLIFE RES, V23, P93, DOI 10.1071/WR9960093; Norbury G., 2005, HDB NZ MAMMALS, P131; ODonoghue M, 1997, OIKOS, V80, P150, DOI 10.2307/3546526; Parkes JP, 2008, WILDLIFE RES, V35, P775, DOI 10.1071/WR08008; PECH RP, 1992, OECOLOGIA, V89, P102, DOI 10.1007/BF00319021; PECH RP, 1995, WILDLIFE RES, V22, P55, DOI 10.1071/WR9950055; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Ramsey DSL, 2009, AUSTRAL ECOL, V34, P409, DOI 10.1111/j.1442-9993.2009.01942.x; Reardon JT, 2012, NEW ZEAL J ECOL, V36, P141; Recio MR, 2010, NEW ZEAL J ECOL, V34, P288; Reddiex B, 2002, WILDLIFE RES, V29, P627, DOI 10.1071/WR00088; Reddiex B, 2004, THESIS LINCOLN U LIN; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Sinclair ARE, 2002, PHILOS T ROY SOC B, V357, P1221, DOI 10.1098/rstb.2002.1123; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Terborgh John, 1999, P39; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vine SJ, 2009, WILDLIFE RES, V36, P436, DOI 10.1071/WR08069; Wittmer HU, 2013, CONSERV BIOL, V27, P254, DOI 10.1111/cobi.12005	78	20	20	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73544	10.1371/journal.pone.0073544	http://dx.doi.org/10.1371/journal.pone.0073544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039978	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300090
J	Branch-Elliman, W; Lee, GM; Golen, TH; Gold, HS; Baldini, LM; Wright, SB				Branch-Elliman, Westyn; Lee, Grace M.; Golen, Toni H.; Gold, Howard S.; Baldini, Linda M.; Wright, Sharon B.			Health and Economic Burden of Post-Partum Staphylococcus aureus Breast Abscess	PLOS ONE			English	Article							SURGICAL SITE INFECTION; NOSOCOMIAL METHICILLIN-RESISTANT; ULTRASOUND-GUIDED DRAINAGE; CESAREAN-SECTION; FEEDING WOMEN; RISK-FACTORS; MASTITIS; ASPIRATION; BACTEREMIA; MANAGEMENT	Objectives: To determine the health and economic burdens of post-partum Staphylococcus aureus breast abscess. Study design: We conducted a matched cohort study (N = 216) in a population of pregnant women (N = 32,770) who delivered at our center during the study period from 10/1/03-9/30/10. Data were extracted from hospital databases, or via chart review if unavailable electronically. We compared cases of S. aureus breast abscess to controls matched by delivery date to compare health services utilization and mean attributable medical costs in 2012 United States dollars using Medicare and hospital-based estimates. We also evaluated whether resource utilization and health care costs differed between cases with methicillin-resistant and -susceptible S. aureus isolates. Results: Fifty-four cases of culture-confirmed post-partum S. aureus breast abscess were identified. Breastfeeding cessation (41%), milk fistula (11.1%) and hospital readmission (50%) occurred frequently among case patients. Breast abscess case patients had high rates of health services utilization compared to controls, including high rates of imaging and drainage procedures. The mean attributable cost of post-partum S. aureus breast abscess ranged from $2,340-$4,012, depending on the methods and data sources used. Mean attributable costs were not significantly higher among methicillin-resistant vs. susceptible S. aureus cases. Conclusions: Post-partum S. aureus breast abscess is associated with worse health and economic outcomes for women and their infants, including high rates of breastfeeding cessation. Future study is needed to determine the optimal treatment and prevention of these infections.	[Branch-Elliman, Westyn; Gold, Howard S.; Wright, Sharon B.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Branch-Elliman, Westyn; Gold, Howard S.; Baldini, Linda M.; Wright, Sharon B.] Beth Israel Deaconess Med Ctr, Div Infect Control, Hosp Epidemiol, Silverman Inst Hlth Care Qual & Safety, Boston, MA 02215 USA; [Lee, Grace M.] Harvard Pilgrim Inst, Ctr Child Hlth Care Studies, Dept Populat Med, Boston, MA USA; [Lee, Grace M.] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Div Pediat Infect Dis, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Golen, Toni H.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Branch-Elliman, W (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	wbranche@bidmc.harvard.edu		Branch-Elliman, Westyn/0000-0002-9658-5124	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Amir LH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-62; Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Barker P, 1988, J R Coll Surg Edinb, V33, P106; Ben-David D, 2009, INFECT CONT HOSP EP, V30, P453, DOI 10.1086/596731; Berens P, 2010, BREASTFEED MED, V5, P113, DOI 10.1089/bfm.2009.0030; Berna-Serna JD, 2004, ULTRASOUND MED BIOL, V30, P1, DOI 10.1016/j.ultrasmedbio.2003.10.003; Branch-Elliman W, 2012, CLIN INFECT DIS, V54, P71, DOI 10.1093/cid/cir751; del Monte MCC, 2010, AM J INFECT CONTROL, V38, P467, DOI 10.1016/j.ajic.2009.10.008; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P51476; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P74122; Chen CY, 2010, J AM COLL SURGEONS, V210, P148, DOI 10.1016/j.jamcollsurg.2009.11.003; Christensen AF, 2005, BRIT J RADIOL, V78, P186, DOI 10.1259/bjr/26372381; Chuwa EWL, 2009, ASIAN J SURG, V32, P55, DOI 10.1016/S1015-9584(09)60010-5; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; EISENBERG JM, 1986, JAMA-J AM MED ASSOC, V255, P1584, DOI 10.1001/jama.255.12.1584; Elagili F, 2007, ASIAN J SURG, V30, P40, DOI 10.1016/S1015-9584(09)60126-3; Eryilmaz R, 2005, BREAST, V14, P375, DOI 10.1016/j.breast.2004.12.001; KARSTRUP S, 1993, RADIOLOGY, V188, P807, DOI 10.1148/radiology.188.3.8351352; Kinlay JR, 1998, MED J AUSTRALIA, V169, P310, DOI 10.5694/j.1326-5377.1998.tb140282.x; Leborgne F, 2003, AM J ROENTGENOL, V181, P1089, DOI 10.2214/ajr.181.4.1811089; Maraqa NF, 2011, AM J INFECT CONTROL, V39, P35, DOI 10.1016/j.ajic.2010.07.013; Mitrano JA, 2009, PHARMACOTHERAPY, V29, P1103, DOI 10.1592/phco.29.9.1103; Moazzez A, 2007, ARCH SURG-CHICAGO, V142, P881, DOI 10.1001/archsurg.142.9.881; MOIRBUSSY BR, 1984, J HOSP INFECT, V5, P359, DOI 10.1016/0195-6701(84)90003-3; Nahum GG, 2006, OBSTET GYNECOL, V107, P1120, DOI 10.1097/01.AOG.0000216197.26783.b5; Olsen MA, 2010, INFECT CONT HOSP EP, V31, P872, DOI 10.1086/655435; Ozseker B, 2008, EMERG RADIOL, V15, P105, DOI 10.1007/s10140-007-0683-0; Reddy P, 2007, EMERG INFECT DIS, V13, P298, DOI 10.3201/eid1302.060989; SCHACKMUTH EM, 1993, AM J ROENTGENOL, V161, P961, DOI 10.2214/ajr.161.5.8273635; Schwarz RJ, 2001, AM J SURG, V182, P117, DOI 10.1016/S0002-9610(01)00683-3; Scott JA, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-21; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Stafford I, 2008, OBSTET GYNECOL, V112, P533, DOI 10.1097/AOG.0b013e31818187b0; Statistics USDoL, 2012, US DEP LAB STAT CONS; Thomson Healthcare (Firm), 2004, RED BOOK; Vogel A, 1999, BIRTH-ISS PERINAT C, V26, P218, DOI 10.1046/j.1523-536x.1999.00218.x; Wise ME, 2010, OUTBREAK METHICILLIN; Yassa D, 2010, MUPRIOCIN RESISTANT	39	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73155	10.1371/journal.pone.0073155	http://dx.doi.org/10.1371/journal.pone.0073155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039877	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600055
J	Bote, ME; Garcia, JJ; Hinchado, MD; Ortega, E				Elena Bote, Maria; Jose Garcia, Juan; Dolores Hinchado, Maria; Ortega, Eduardo			Fibromyalgia: Anti-Inflammatory and Stress Responses after Acute Moderate Exercise	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; INDUCED STIMULATION; CYTOKINE; NEUROENDOCRINE; INNATE; HSP72; CLASSIFICATION; INTERLEUKIN-18; CHEMOTAXIS; MEDIATORS	Fibromyalgia (FM) is characterized in part by an elevated inflammatory status, and "modified exercise'' is currently proposed as being a good therapeutic help for these patients. However, the mechanisms involved in the exercise-induced benefits are still poorly understood. The objective was to evaluate the effect of a single bout of moderate cycling (45 min at 55% VO2 max) on the inflammatory (serum IL-8; chemotaxis and O-2(-) production by neutrophils; and IL-1 beta, TNF-alpha, IL-6, IL-10, and IL-18 release by monocytes) and stress (cortisol; NA; and eHsp72) responses in women diagnosed with FM compared with an aged-matched control group of healthy women (HW). IL-8, NA, and eHsp72 were determined by ELISA. Cytokines released by monocytes were determined by Bio-Plex (R) system (LUMINEX). Cortisol was determined by electrochemoluminiscence, chemotaxis was evaluated in Boyden chambers and O-2(-) production by NBT reduction. In the FM patients, the exercise induced a decrease in the systemic concentration of IL-8, cortisol, NA, and eHsp72; as well as in the neutrophil's chemotaxis and O-2(-) production and in the inflammatory cytokine release by monocytes. This was contrary to the completely expected exercise-induced increase in all those biomarkers in HW. In conclusion, single sessions of moderate cycling can improve the inflammatory status in FM patients, reaching values close to the situation of aged-matched HW at their basal status. The neuroendocrine mechanism seems to be an exercise-induced decrease in the stress response of these patients.	[Elena Bote, Maria; Jose Garcia, Juan; Dolores Hinchado, Maria; Ortega, Eduardo] Univ Extremadura, Dept Physiol, Badajoz, Spain	Universidad de Extremadura	Ortega, E (corresponding author), Univ Extremadura, Dept Physiol, Badajoz, Spain.	orincon@unex.es	Garcia, Juan J/C-7383-2013; Ortega, Eduardo/H-9891-2016; Ortega, Eduardo/GXN-2560-2022	Garcia, Juan J/0000-0002-8222-4213; Ortega, Eduardo/0000-0002-7007-7615; Bote, Maria Elena/0000-0002-3112-9259; SANCHEZ-MORO, MARIA DOLORES/0000-0002-9709-4714	MICINN-FEDER of Spain [DEP2009-10041]; Junta de Extremadura-FEDER [PRI09A003, GR10020]	MICINN-FEDER of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura-FEDER	This work was supported by grants from MICINN-FEDER (DEP2009-10041) of Spain, Junta de Extremadura-FEDER (PRI09A003, GR10020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225; Bote ME, 2012, NEUROIMMUNOMODULAT, V19, P343, DOI 10.1159/000341664; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Fleshner M, 2003, EXERC IMMUNOL REV, V9, P6; Giraldo E, 2008, MOL CELL BIOCHEM, V313, P147, DOI 10.1007/s11010-008-9752-2; Giraldo E, 2010, BRAIN BEHAV IMMUN, V24, P672, DOI 10.1016/j.bbi.2010.02.003; Giraldo E, 2009, NEUROIMMUNOMODULAT, V16, P237, DOI 10.1159/000212384; IIZASA H, 2001, CYTOKINE REFERENCE, P1061; Kohno K, 1998, CLIN IMMUNOL IMMUNOP, V86, P11, DOI 10.1006/clin.1997.4475; Mannerkorpi K, 2007, BEST PRACT RES CL RH, V21, P513, DOI 10.1016/j.berh.2007.04.001; Meksawan K, 2004, J AM COLL NUTR, V23, P331, DOI 10.1080/07315724.2004.10719376; Muller W, 2007, RHEUMATOL INT, V27, P1005, DOI 10.1007/s00296-007-0403-9; NORTHOFF H, 1994, INT J SPORTS MED, V15, pS167, DOI 10.1055/s-2007-1021132; Ortega E, 2006, EUR J APPL PHYSIOL, V98, P250, DOI 10.1007/s00421-006-0269-7; ORTEGA E, 1993, EUR J APPL PHYSIOL O, V66, P60, DOI 10.1007/BF00863401; Ortega E, 2003, EXERC IMMUNOL REV, V9, P70; Ortega E, 2012, SCAND J MED SCI SPOR, V22, P104, DOI 10.1111/j.1600-0838.2010.01132.x; Ortega E, 2009, EXERC IMMUNOL REV, V15, P42; Ortega E, 1997, J PHYSIOL-LONDON, V498, P729, DOI 10.1113/jphysiol.1997.sp021897; Ortega E, 2007, NEUROIMMUNOMODULAT, V14, P206, DOI 10.1159/000110648; Ortega E, 2010, HEAT SHOCK PROTEINS, V5, P327, DOI 10.1007/978-90-481-3381-9_19; Ortega E, 2009, STRESS, V12, P240, DOI 10.1080/10253890802309853; Ortega Rincon E, 1994, INT J SPORTS MED, V15, P173; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Ploeger HE, 2009, EXERC IMMUNOL REV, V15, P6; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; van West D, 2001, BIODRUGS, V15, P521, DOI 10.2165/00063030-200115080-00004; Wallace DJ, 2001, RHEUMATOLOGY, V40, P743, DOI 10.1093/rheumatology/40.7.743; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Woods JA, 2006, NEUROL CLIN, V24, P585, DOI 10.1016/j.ncl.2006.03.008	34	57	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74524	10.1371/journal.pone.0074524	http://dx.doi.org/10.1371/journal.pone.0074524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023948	gold, Green Submitted, Green Published			2022-12-25	WOS:000324515600144
J	Mishra, MV; Bennett, M; Vincent, A; Lee, OT; Lallas, CD; Trabulsi, EJ; Gomella, LG; Dicker, AP; Showalter, TN				Mishra, Mark V.; Bennett, Michele; Vincent, Armon; Lee, Olivia T.; Lallas, Costas D.; Trabulsi, Edouard J.; Gomella, Leonard G.; Dicker, Adam P.; Showalter, Timothy N.			Identifying Barriers to Patient Acceptance of Active Surveillance: Content Analysis of Online Patient Communications	PLOS ONE			English	Article							LOCALIZED PROSTATE-CANCER; DECISION-MAKING; SUPPORT GROUP; HEALTH-CARE; MEN; EXPERIENCE; MANAGEMENT	Objectives: Qualitative research aimed at identifying patient acceptance of active surveillance (AS) has been identified as a public health research priority. The primary objective of this study was to determine if analysis of a large-sample of anonymous internet conversations (ICs) could be utilized to identify unmet public needs regarding AS. Methods: English-language ICs regarding prostate cancer (PC) treatment with AS from 2002-12 were identified using a novel internet search methodology. Web spiders were developed to mine, aggregate, and analyze content from the world-wide-web for ICs centered on AS. Collection of ICs was not restricted to any specific geographic region of origin. NLP was used to evaluate content and perform a sentiment analysis. Conversations were scored as positive, negative, or neutral. A sentiment index (SI) was subsequently calculated according to the following formula to compare temporal trends in public sentiment towards AS: [(# Positive IC/# Total IC) - (# Negative IC/# Total IC) x 100]. Results: A total of 464 ICs were identified. Sentiment increased from -13 to +2 over the study period. The increase sentiment has been driven by increased patient emphasis on quality-of-life factors and endorsement of AS by national medical organizations. Unmet needs identified in these ICs include: a gap between quantitative data regarding long-term outcomes with AS vs. conventional treatments, desire for treatment information from an unbiased specialist, and absence of public role models managed with AS. Conclusions: This study demonstrates the potential utility of online patient communications to provide insight into patient preferences and decision-making. Based on our findings, we recommend that multidisciplinary clinics consider including an unbiased specialist to present treatment options and that future decision tools for AS include quantitative data regarding outcomes after AS.	[Mishra, Mark V.; Dicker, Adam P.] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Bennett, Michele; Vincent, Armon] Wool Labs Inc, Wayne, PA USA; [Lee, Olivia T.] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Lallas, Costas D.; Trabulsi, Edouard J.; Gomella, Leonard G.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Showalter, Timothy N.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22903 USA	University System of Maryland; University of Maryland Baltimore; University of California System; University of California Davis; Jefferson University; University of Virginia	Showalter, TN (corresponding author), Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22903 USA.	TNS3B@hscmail.mcc.virginia.edu		Showalter, Timothy/0000-0003-1373-8496; Dicker, Adam/0000-0003-0733-3337	Kimmel Cancer Center's NCI Cancer Center Support Grant P30 [CA56036]; Prostate Cancer Foundation Ben Franklin Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER	Kimmel Cancer Center's NCI Cancer Center Support Grant P30; Prostate Cancer Foundation Ben Franklin Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported in part by the Kimmel Cancer Center's NCI Cancer Center Support Grant P30 (CA56036) and the Prostate Cancer Foundation Ben Franklin Young Investigator Award (T. Showalter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A., 2011, P WORKSHOP LANGUAGES, P30; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Coulson NS, 2007, PATIENT EDUC COUNS, V68, P173, DOI 10.1016/j.pec.2007.06.002; Dale W, 2012, NAT REV UROL, V9, P357, DOI [10.1038/nruro1.2012.115, 10.1038/nrurol.2012.115]; Davison BJ, 2011, BJU INT, V108, P1787, DOI 10.1111/j.1464-410X.2011.10200.x; Davison BJ, 2009, ONCOL NURS FORUM, V36, P89, DOI 10.1188/09.ONF.89-96; Davison BJ, 2011, BJU INT; Davison BJ, 2012, PATIENT EDUC COUNS; Diefenbach Michael A, 2002, Semin Urol Oncol, V20, P55, DOI 10.1053/suro.2002.30399; Ganz PA, 2012, ANN INTERN MED, V156, P591, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00010]; Gomella LG, 2010, J ONCOL PRACT, V6, pE5, DOI 10.1200/JOP.2010.000071; Gomella LG, 2012, UROLOGY; Greaves F, 2013, BMJ QUAL SAF, V22, P251, DOI 10.1136/bmjqs-2012-001527; Gwede CK, 2005, CANCER-AM CANCER SOC, V104, P1381, DOI 10.1002/cncr.21330; Hills C, 2012, INTERNET EMERGING DA; Institute of Medicine, 2001, CROSSING QUALITY CHA, P337; Jang TL, 2010, ARCH INTERN MED, V170, P440, DOI 10.1001/archinternmed.2010.1; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Nambisan P, 2011, HEALTH CARE MANAGE R, V36, P124, DOI 10.1097/HMR.0b013e3182099f82; Newell A., 1963, COMPUTERS THOUGHT; Oliffe JL, 2010, HEALTH PROMOT PRACT, V11, P562, DOI 10.1177/1524839908328990; Ramsey SD, 2009, UROLOGY, V74, P509, DOI 10.1016/j.urology.2009.01.090; van de Poll-Franse LV, 2008, SUPPORT CARE CANCER, V16, P1189, DOI 10.1007/s00520-008-0419-z; Winzelberg AJ, 2003, CANCER-AM CANCER SOC, V97, P1164, DOI 10.1002/cncr.11174; Zeliadt SB, 2006, CANCER-AM CANCER SOC, V106, P1865, DOI 10.1002/cncr.21822	25	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e68563	10.1371/journal.pone.0068563	http://dx.doi.org/10.1371/journal.pone.0068563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	248VW	24039699	Green Published, gold			2022-12-25	WOS:000326734500003
J	Nakano, N; Nakai, Y; Seo, TB; Homma, T; Yamada, Y; Ohta, M; Suzuki, Y; Nakatani, T; Fukushima, M; Hayashibe, M; Ide, C				Nakano, Norihiko; Nakai, Yoshiyasu; Seo, Tae-Beom; Homma, Tamami; Yamada, Yoshihiro; Ohta, Masayoshi; Suzuki, Yoshihisa; Nakatani, Toshio; Fukushima, Masanori; Hayashibe, Miki; Ide, Chizuka			Effects of Bone Marrow Stromal Cell Transplantation through CSF on the Subacute and Chronic Spinal Cord Injury in Rats	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; CEREBROSPINAL-FLUID; AXON GROWTH; REGENERATION; CONTUSION; REPAIR; PHOSPHACAN; EXPRESSION; PLASTICITY; NEUROCAN	It has been demonstrated that the infusion of bone marrow stromal cells (BMSCs) through the cerebrospinal fluid (CSF) has beneficial effects on acute spinal cord injury (SCI) in rats. The present study examined whether BMSC infusion into the CSF is effective for subacute (1- and 2-week post-injury), and/or chronic (4-week post-injury) SCI in rats. The spinal cord was contused by dropping a weight at the thoracic 8-9 levels. BMSCs cultured from GFP-transgenic rats of the same strain were injected three times (once weekly) into the CSF through the fourth ventricle, beginning at 1, 2 and 4 weeks post-injury. At 4 weeks after initial injection, the average BBB score for locomotor assessment increased from 1.0-3.5 points before injection to 9.0-10.9 points in the BMSC-injection subgroups, while, in the PBS (vehicle)-injection subgroups, it increased only from 0.5-4.0 points before injection to 3.0-5.1 points. Numerous axons associated with Schwann cells extended longitudinally through the connective tissue matrices in the astrocyte-devoid lesion without being blocked at either the rostral or the caudal borders in the BMSC-injection subgroups. A small number of BMSCs were found to survive within the spinal cord lesion in SCI of the 1-week post-injury at 2 days of injection, but none at 7 days. No BMSCs were found in the spinal cord lesion at 2 days or at 7 days in the SCI of the 2-week and the 4-week post-injury groups. In an in vitro experiment, BMSC-injected CSF promoted the survival and the neurite extension of cultured neurons more effectively than did the PBS-injected CSF. These results indicate that BMSCs had beneficial effects on locomotor improvement as well as on axonal regeneration in both subacute and chronic SCI rats, and the results also suggest that BMSCs might function as neurotrophic sources via the CSF.	[Nakano, Norihiko; Nakai, Yoshiyasu; Seo, Tae-Beom; Homma, Tamami; Ide, Chizuka] Aino Univ, Sch Nursing & Rehabil, Inst Regenerat & Rehabil, Osaka, Japan; [Hayashibe, Miki; Ide, Chizuka] Aino Univ, Sch Nursing & Rehabil, Dept Occupat Therapy, Osaka, Japan; [Yamada, Yoshihiro] Aino Univ, Sch Nursing & Rehabil, Dept Phys Therapy, Osaka, Japan; [Ohta, Masayoshi; Suzuki, Yoshihisa] Kitano Hosp, Tazuke Med Res Inst, Dept Plast & Reconstruct Surg, Osaka, Japan; [Nakatani, Toshio] Kansai Med Univ, Emergency & Crit Care Ctr, Osaka, Japan; [Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan	Kitano Hospital; Kansai Medical University; Institute for Biomedical Research & Innovation (IBRI)	Ide, C (corresponding author), Aino Univ, Sch Nursing & Rehabil, Inst Regenerat & Rehabil, Osaka, Japan.	c-ide@ot-u.aino.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [20300122, 23300125, 19590598]; Grants-in-Aid for Scientific Research [25870950] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (numbers 20300122 and 23300125 to CI, and number 19590598 to NN). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Boido M, 2014, WORLD NEUROSURG, V81, P183, DOI 10.1016/j.wneu.2012.08.014; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413; Condic ML, 2002, NEUROREPORT, V13, pA37, DOI 10.1097/00001756-200203040-00002; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Dezawa M, 2005, CURR MOL MED, V5, P723, DOI 10.2174/156652405774641070; Dietz V, 2006, J SPINAL CORD MED, V29, P481; Goldshmit Y, 2008, J NEUROTRAUM, V25, P449, DOI 10.1089/neu.2007.0392; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Joosten EA, 2000, J NEUROSCI RES, V62, P233; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Lee YS, 2004, J NEUROPATH EXP NEUR, V63, P233, DOI 10.1093/jnen/63.3.223-a; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062; Nandoe Tewarie RD, 2009, J NEUROTRAUM, V26, P1, DOI [10.1089/neu.2008.0543, DOI 10.1089/NEU.2008.0543.PUBMED:19196178]; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Nishida H, 2011, AM J VET RES, V72, P1118, DOI 10.2460/ajvr.72.8.1118; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Peters A, 1976, FINE STRUCTURE NERVO, P295; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; REIER PJ, 1992, EXP NEUROL, V115, P177, DOI 10.1016/0014-4886(92)90245-L; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Saito F, 2008, J TRAUMA, V64, P53, DOI 10.1097/TA.0b013e31815b847d; Saito F, 2012, RESTOR NEUROL NEUROS, V30, P127, DOI 10.3233/RNN-2011-0629; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Sharma S, 2010, J NEUROSCI RES, V88, P2869, DOI 10.1002/jnr.22452; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tsai EC, 2005, J NEUROPATH EXP NEUR, V64, P230, DOI 10.1093/jnen/64.3.230; Wakao N, 2011, NEUROSCI LETT, V488, P299, DOI 10.1016/j.neulet.2010.11.051; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wright KT, 2007, BIOCHEM BIOPH RES CO, V354, P559, DOI 10.1016/j.bbrc.2007.01.013; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Xu Y, 2006, NEUROSCI LETT, V397, P174, DOI 10.1016/j.neulet.2005.12.051; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f	56	37	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73494	10.1371/journal.pone.0073494	http://dx.doi.org/10.1371/journal.pone.0073494			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039961	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500036
J	van Nuland, R; Schram, AW; van Schaik, FMA; Jansen, PWTC; Vermeulen, M; Timmers, HTM				van Nuland, Rick; Schram, Andrea W.; van Schaik, Frederik M. A.; Jansen, Pascal W. T. C.; Vermeulen, Michiel; Timmers, H. T. Marc			Multivalent Engagement of TFIID to Nucleosomes	PLOS ONE			English	Article							RNA-POLYMERASE-II; YEAST TFIIA/TBP/DNA COMPLEX; EMBRYONIC STEM-CELLS; TRANSCRIPTION INITIATION; RECOMBINANT HISTONES; PROTEIN INTERACTIONS; CHROMATIN-STRUCTURE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; DNA-SEQUENCES	The process of eukaryotic transcription initiation involves the assembly of basal transcription factor complexes on the gene promoter. The recruitment of TFIID is an early and important step in this process. Gene promoters contain distinct DNA sequence elements and are marked by the presence of post-translationally modified nucleosomes. The contributions of these individual features for TFIID recruitment remain to be elucidated. Here, we use immobilized reconstituted promoter nucleosomes, conventional biochemistry and quantitative mass spectrometry to investigate the influence of distinct histone modifications and functional DNA-elements on the binding of TFIID. Our data reveal synergistic effects of H3K4me3, H3K14ac and a TATA box sequence on TFIID binding in vitro. Stoichiometry analyses of affinity purified human TFIID identified the presence of a stable dimeric core. Several peripheral TAFs, including those interacting with distinct promoter features, are substoichiometric yet present in substantial amounts. Finally, we find that the TAF3 subunit of TFIID binds to poised promoters in an H3K4me3-dependent manner. Moreover, the PHD-finger of TAF3 is important for rapid induction of target genes. Thus, fine-tuning of TFIID engagement on promoters is driven by synergistic contacts with both DNA-elements and histone modifications, eventually resulting in a high affinity interaction and activation of transcription.	[van Nuland, Rick; Schram, Andrea W.; van Schaik, Frederik M. A.; Jansen, Pascal W. T. C.; Vermeulen, Michiel; Timmers, H. T. Marc] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [van Nuland, Rick; Schram, Andrea W.; van Schaik, Frederik M. A.; Timmers, H. T. Marc] Netherlands Prote Ctr, Utrecht, Netherlands; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Vermeulen, M (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands.	m.vermeulen-3@umcutrecht.nl; h.t.m.timmers@umcutrecht.nl	Vermeulen, Michiel/C-8883-2013	Vermeulen, Michiel/0000-0003-0836-6894	Netherlands Proteomics Center; Netherlands organization for scientific research (NWO-VIDI); Dutch Cancer Society	Netherlands Proteomics Center; Netherlands organization for scientific research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	Work in the Timmers lab is supported by the Netherlands Proteomics Center. Work in the Vermeulen lab is supported by the Netherlands organization for scientific research (NWO-VIDI) and the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nikolov M, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.M110.005371; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schram AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070035; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73495	10.1371/journal.pone.0073495	http://dx.doi.org/10.1371/journal.pone.0073495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039962	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500037
J	Yin, DM; Wang, Y; Zhang, XG; Li, HM; Lu, X; Zhang, JS; Zhang, WK; Chen, SY				Yin, Dongmei; Wang, Yun; Zhang, Xingguo; Li, Hemin; Lu, Xiang; Zhang, Jinsong; Zhang, Wanke; Chen, Shouyi			De Novo Assembly of the Peanut (Arachis hypogaea L.) Seed Transcriptome Revealed Candidate Unigenes for Oil Accumulation Pathways	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; FATTY-ACID DESATURASE; GENE; ANNOTATION; GENOMICS; OILSEEDS; GENERATION; OLEOSINS; RNA	Peanuts are one of the most important edible oil crops in the world. In order to survey key genes controlling peanut oil accumulation, we analyzed the seed transcriptome in different developmental stages of high-and low-oil peanut varieties. About 54 million high quality clean reads were generated, which corresponded to 4.85 Gb total nucleotides. These reads were assembled into 59,236 unique sequences. Differential mRNA processing events were detected for most of the peanut Unigenes and found that 15.8% and 18.0% of the Unigenes were differentially expressed between high- and low-oil varieties at 30 DAF and 50 DAF, respectively. Over 1,500 Unigenes involved in lipid metabolism were identified, classified, and found to participate in FA synthesis and TAG assembly. There were seven possible metabolic pathways involved in the accumulation of oil during seed development. This dataset provides more sequence resource for peanut plant and will serve as the foundation to understand the mechanisms of oil accumulation in oil crops.	[Yin, Dongmei; Wang, Yun; Zhang, Xingguo; Li, Hemin] Henan Agr Univ, Zhengzhou, Peoples R China; [Yin, Dongmei; Lu, Xiang; Zhang, Jinsong; Zhang, Wanke; Chen, Shouyi] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	Henan Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhang, JS (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	jszhang@genetics.ac.cn; wkzhang@genetics.ac.cn	陆, 翔/A-1329-2019	陆, 翔/0000-0002-1176-5389	National Key Basic Research Projects [2011CB109301, 2010CB125903]; National Transgenic Research Projects [2013ZX08004-003]; Program for New Century Excellent Talents in University; National Natural Science Funds [NCET-09-0121]; National Natural Science Foundation of China [U1204317]	National Key Basic Research Projects(National Basic Research Program of China); National Transgenic Research Projects; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Projects (2011CB109301 and 2010CB125903), National Transgenic Research Projects (2013ZX08004-003), Program for New Century Excellent Talents in University and the National Natural Science Funds (NCET-09-0121) and the National Natural Science Foundation of China (U1204317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bi YP, 2010, GENOME, V53, P832, DOI [10.1139/G10-074, 10.1139/g10-074]; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Chen MJ, 2009, PLANT PHYSIOL, V150, P27, DOI 10.1104/pp.108.134882; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo BZ, 2008, J INTEGR PLANT BIOL, V50, P1281, DOI 10.1111/j.1744-7909.2008.00739.x; Guo BZ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-12; Guo Baozhu, 2009, Int J Plant Genomics, V2009, P715605, DOI 10.1155/2009/715605; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; JAYASHREE B, 2005, ELECTRON J BIOTECHN, V8, P226, DOI DOI 10.2225/V0L8-ISSUE3-FULLTEXT-3; Jung S, 2000, MOL GEN GENET, V263, P796, DOI 10.1007/s004380000244; Li CL, 2009, J EXP BOT, V60, P4371, DOI 10.1093/jxb/erp275; Luo M, 2005, CROP SCI, V45, P346, DOI 10.2135/cropsci2005.0346; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murphy DJ, 2005, BIOL SCI SER, P1; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Payton P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-265; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shimada TL, 2008, PLANT J, V55, P798, DOI 10.1111/j.1365-313X.2008.03553.x; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Tirumalaraju SV, 2011, J PLANT PHYSIOL, V168, P481, DOI 10.1016/j.jplph.2010.08.006; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin DM, 2007, PLANT MOL BIOL REP, V25, P154, DOI 10.1007/s11105-007-0017-0; Yin DM, 2011, MOL BIOTECHNOL, V49, P187, DOI 10.1007/s12033-011-9391-9; Yin Dongmei, 2007, Journal of Genetics and Genomics, V34, P81, DOI 10.1016/S1673-8527(07)60009-5; Yu, 2009, P BMEI, P1, DOI DOI 10.1109/APMRC.2009.4925424; Yu SL, 2008, J GENET GENOMICS, V35, P679, DOI 10.1016/S1673-8527(08)60090-9; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	37	52	55	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73767	10.1371/journal.pone.0073767	http://dx.doi.org/10.1371/journal.pone.0073767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040062	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600043
J	Francis, MB; Allen, CA; Sorg, JA				Francis, Michael B.; Allen, Charlotte A.; Sorg, Joseph A.			Muricholic Acids Inhibit Clostridium difficile Spore Germination and Growth	PLOS ONE			English	Article							BILE-ACIDS; INTESTINAL MICROBIOTA; CHENODEOXYCHOLIC ACID; TOXIN-B; HAMSTERS; DISEASE; METABOLISM; INFECTION; COLITIS; ANALOGS	Infections caused by Clostridium difficile have increased steadily over the past several years. While studies on C. difficile virulence and physiology have been hindered, in the past, by lack of genetic approaches and suitable animal models, newly developed technologies and animal models allow these processes to be studied in detail. One such advance is the generation of a mouse-model of C. difficile infection. The development of this system is a major step forward in analyzing the genetic requirements for colonization and infection. While important, it is equally as important in understanding what differences exist between mice and humans. One of these differences is the natural bile acid composition. Bile acid-mediated spore germination is an important step in C. difficile colonization. Mice produce several different bile acids that are not found in humans. These muricholic acids have the potential to impact C. difficile spore germination. Here we find that the three muricholic acids (alpha-muricholic acid, beta-muricholic acid and v-muricholic acid) inhibit C. difficile spore germination and can impact the growth of vegetative cells. These results highlight an important difference between humans and mice and may have an impact on C. difficile virulence in the mouse-model of C. difficile infection.	[Francis, Michael B.; Allen, Charlotte A.; Sorg, Joseph A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sorg, JA (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	jsorg@bio.tamu.edu		Sorg, Joseph/0000-0001-7822-2656	American Heart Association [11SDG7160013]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association National Scientist Development grant to J.A.S (No. 11SDG7160013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoachere M, 2007, J BIOL CHEM, V282, P12112, DOI 10.1074/jbc.M611432200; Allen CA, 2013, ANTIMICROB AGENTS CH, V57, P664, DOI 10.1128/AAC.01611-12; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; BARTLETT JG, 1978, AM J VET RES, V39, P1525; BENSON GM, 1993, J LIPID RES, V34, P2121; BORRIELLO SP, 1987, J MED MICROBIOL, V24, P53, DOI 10.1099/00222615-24-1-53; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; CZUPRYNSKI CJ, 1983, INFECT IMMUN, V39, P1368, DOI 10.1128/IAI.39.3.1368-1376.1983; Dodatko T, 2010, MICROBIOL-SGM, V156, P1244, DOI 10.1099/mic.0.030270-0; Drudy D, 2007, CLIN MICROBIOL INFEC, V13, P298, DOI 10.1111/j.1469-0691.2006.01634.x; EYSSEN H, 1983, APPL ENVIRON MICROB, V45, P141, DOI 10.1128/AEM.45.1.141-147.1983; EYSSEN H, 1977, LIFE SCI, V21, P707, DOI 10.1016/0024-3205(77)90079-0; Eyssen HJ, 1999, APPL ENVIRON MICROB, V65, P3158; Fekety FR, 1979, REV INFECT DIS, V1, P386; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Hong YJ, 2007, J AGR FOOD CHEM, V55, P9750, DOI 10.1021/jf071798+; Howerton A, 2013, J INFECT DIS; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; LARSON HE, 1990, ANTIMICROB AGENTS CH, V34, P1348, DOI 10.1128/AAC.34.7.1348; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Liggins M, 2011, J BACTERIOL, V193, P2776, DOI 10.1128/JB.00058-11; Marsh JW, 2012, J CLIN MICROBIOL; Miyata M, 2009, J PHARMACOL EXP THER, V331, P1079, DOI 10.1124/jpet.109.160093; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; Pawlowski SW, 2010, J INFECT DIS, V202, P1708, DOI 10.1086/657086; Ramirez N, 2010, J BACTERIOL, V192, P4215, DOI 10.1128/JB.00488-10; Ramirez N, 2010, J BACTERIOL, V192, P418, DOI 10.1128/JB.01226-09; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; UNE M, 1990, J LIPID RES, V31, P1015; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wheeldon LJ, 2008, J APPL MICROBIOL, V105, P2223, DOI 10.1111/j.1365-2672.2008.03965.x; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982	51	44	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73653	10.1371/journal.pone.0073653	http://dx.doi.org/10.1371/journal.pone.0073653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040011	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300103
J	Hwang, JY; Kim, EB; Ka, H; Lee, CK				Hwang, Jae Yeon; Kim, Eun Bae; Ka, Hakhyun; Lee, Chang-Kyu			Identification of the Porcine XIST Gene and Its Differential CpG Methylation Status in Male and Female Pig Cells	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; MOUSE DEVELOPMENT; PROMOTER REGION; EXPRESSION; EMBRYOS; CONSERVATION; TRANSCRIPT; INITIATION; EVOLUTION; ELEMENTS	XIST, a long non-coding RNA, plays an important role in triggering X chromosome inactivation in eutherians, and is used extensively for qualifying stem cells and cloned embryos. However, a porcine XIST has not yet been thoroughly identified despite its biological importance in a wide variety of research fields. Here, we present a full-length porcine XIST sequence assembled using known sequences (GenBank), RNA-Seq data (NCBI SRA), and PCR/sequencing. The proposed porcine XIST gene model encodes a 25,215-bp transcript consisting of 7 exons, including two conserved and two porcine-specific repeat regions. Transcription covering the entire XIST region was observed specifically in female cells, but not in male cells. We also identified eight transcription starting sites (TSSs) and evaluated CpG methylation patterns in the upstream (+2.0 kb) and downstream (-2.0 kb) regions. Sixty-seven CG di-nucleotides identified in the target region were considered to be candidate CpG sites, and were enriched in the following two regions: -284 to +53 bp (13 sites) and +285 to +1,727 bp (54 sites) from the selected TSS. Male 5 region of XIST (64.5 sites, 96.26%) had a higher level of CpG methylation than female DNA (33.4 sites, 49.85%). Taken together, our results revealed that the porcine XIST gene is expressed exclusively in female cells, which is influenced by the lower level of CpG methylation in the putative promoter region compared with male cells. The porcine XIST presented in this study represents a useful tool for related research areas such as porcine embryology and stem cell biology.	[Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kim, Eun Bae] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Kim, Eun Bae] Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Prod & Food Sci, Chunchon, Kangwon Do, South Korea; [Ka, Hakhyun] Yonsei Univ, Div Biol Sci & Technol, Inst Biomat, Wonju, Kangwon Do, South Korea; [Ka, Hakhyun] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Wonju, Kangwon Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of California System; University of California Davis; Kangwon National University; Yonsei University; Yonsei University	Lee, CK (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	leeck@snu.ac.kr		Hwang, Jae Yeon/0000-0002-6493-4182	Rural Development Administration [PJ009493]; National Research Foundation of Korea (NRF); Ministry of Education, Republic of Korea [NRF-2012R1A1A2006276]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Education (MOE), Republic of Korea)	This research was supported by the Next BioGreen 21 program (PJ009493), Rural Development Administration, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2006276), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bischoff SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055345; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brown CJ, 1997, AM J HUM GENET, V61, P5, DOI 10.1086/513914; Cepica S, 2006, ANIM GENET, V37, P603, DOI 10.1111/j.1365-2052.2006.01536.x; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Hendrich BD, 1997, NUCLEIC ACIDS RES, V25, P2661, DOI 10.1093/nar/25.13.2661; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Johnston CM, 1998, CELL, V94, P809, DOI 10.1016/S0092-8674(00)81739-0; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; McDonald LE, 1998, GENOMICS, V54, P379, DOI 10.1006/geno.1998.5570; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pillet N, 1995, P NATL ACAD SCI USA, V92, P12515, DOI 10.1073/pnas.92.26.12515; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Sheardown SA, 1997, GENE, V203, P159, DOI 10.1016/S0378-1119(97)00507-6; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002	40	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73677	10.1371/journal.pone.0073677	http://dx.doi.org/10.1371/journal.pone.0073677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040022	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300109
J	Tashiro, M; Inoue, H; Konishi, M				Tashiro, Michiko; Inoue, Hana; Konishi, Masato			Magnesium Homeostasis in Cardiac Myocytes of Mg-Deficient Rats	PLOS ONE			English	Article							FLUORESCENT INDICATOR; EXTRACELLULAR CONCENTRATIONS; FUNCTIONAL-CHARACTERIZATION; INTRACELLULAR MG2+; MODULATION; TRANSPORT; EFFLUX; SLC41A1; TRPM7; CA2+	To study possible modulation of Mg2+ transport in low Mg2+ conditions, we fed either a Mg-deficient diet or a Mg-containing diet (control) to Wistar rats for 1-6 weeks. Total Mg concentrations in serum and cardiac ventricular tissues were measured by atomic absorption spectroscopy. Intracellular free Mg2+ concentration ([Mg2+](i)) of ventricular myocytes was measured with the fluorescent indicator furaptra. Mg2+ transport rates, rates of Mg2+ influx and Mg2+ efflux, were estimated from the rates of change in [Mg2+](i) during Mg loading/depletion and recovery procedures. In Mg-deficient rats, the serum total Mg concentration (0.29 +/- 0.026 mM) was significantly lower than in control rats (0.86 +/- 0.072 mM) after 4-6 weeks of Mg deficiency. However, neither total Mg concentration in ventricular tissues nor [Mg2+](i) of ventricular myocytes was significantly different between Mg-deficient rats and control rats. The rates of Mg2+ influx and efflux were not significantly different in both groups. In addition, quantitative RT-PCR revealed that Mg deficiency did not substantially change mRNA expression levels of known Mg2+ channels/transporters (TRPM6, TRPM7, MagT1, SLC41A1 and ACDP2) in heart and kidney tissues. These results suggest that [Mg2+](i) as well as the total Mg content of cardiac myocytes, was well maintained even under chronic hypomagnesemia without persistent modulation in function and expression of major Mg2+ channels/transporters in the heart.	[Tashiro, Michiko; Inoue, Hana; Konishi, Masato] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	Tokyo Medical University	Tashiro, M (corresponding author), Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan.	tashiro@tokyo-med.ac.jp	Inoue, Hana/AFN-8856-2022; Tashiro, Michiko/AAR-2227-2021	Inoue, Hana/0000-0002-2278-5617; Tashiro, Michiko/0000-0002-2680-6702	Tokyo Medical University	Tokyo Medical University	Financial support for this study was provided by Tokyo Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet S, 2009, J GEN PHYSIOL, V134, P81, DOI 10.1085/jgp.200910209; Bussiere FI, 2002, EUR J NUTR, V41, P197, DOI 10.1007/s00394-002-0376-0; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Gusev K, 2008, J GEN PHYSIOL, V132, P721, DOI 10.1085/jgp.200810119; Handy RD, 1996, J MOL CELL CARDIOL, V28, P1641, DOI 10.1006/jmcc.1996.0154; HONGO K, 1994, JPN J PHYSIOL, V44, P357, DOI 10.2170/jjphysiol.44.357; Ishihara K, 2009, J MOL CELL CARDIOL, V47, P76, DOI 10.1016/j.yjmcc.2009.03.008; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kimura Y, 1996, J NUTR SCI VITAMINOL, V42, P407, DOI 10.3177/jnsv.42.407; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; KONISHI M, 1993, BIOPHYS J, V64, P1331, DOI 10.1016/S0006-3495(93)81494-2; Mastrototaro L, 2011, MAGNESIUM RES, V24, pS122, DOI 10.1684/mrh.2011.0291; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Tashiro M, 2005, BIOPHYS J, V89, P3235, DOI 10.1529/biophysj.105.068890; Tashiro M, 2002, JPN J PHYSIOL, V52, P541, DOI 10.2170/jjphysiol.52.541; Tashiro M, 2000, AM J PHYSIOL-CELL PH, V279, pC1955, DOI 10.1152/ajpcell.2000.279.6.C1955; Tashiro M, 2011, J PHYSIOL SCI, V61, pS192; Tashiro M, 2006, BIOPHYS J, V91, P244, DOI 10.1529/biophysj.106.082495; Tashiro M, 2009, BIOPHYS J, V96, P4941, DOI 10.1016/j.bpj.2009.02.013; Tursun P, 2005, BIOPHYS J, V88, P1911, DOI 10.1529/biophysj.104.055517; Wang M, 2007, ARCH BIOCHEM BIOPHYS, V458, P65, DOI 10.1016/j.abb.2006.10.022; Watanabe M, 2001, PFLUG ARCH EUR J PHY, V442, P35, DOI 10.1007/s004240000499; Watanabe M, 2011, LIFE SCI, V88, P658, DOI 10.1016/j.lfs.2011.01.027; Wolf FI, 2010, J CELL PHYSIOL, V222, P374, DOI 10.1002/jcp.21961; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	30	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73171	10.1371/journal.pone.0073171	http://dx.doi.org/10.1371/journal.pone.0073171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039880	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300054
J	Million, M; Zhao, JF; Luckey, A; Czimmer, J; Maynard, GD; Kehne, J; Hoffman, DC; Tache, Y				Million, Mulugeta; Zhao, Jing-Fang; Luckey, Andrew; Czimmer, Jozsef; Maynard, George D.; Kehne, John; Hoffman, Diane C.; Tache, Yvette			The Newly Developed CRF1-Receptor Antagonists, NGD 98-2 and NGD 9002, Suppress Acute Stress-Induced Stimulation of Colonic Motor Function and Visceral Hypersensitivity in Rats	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CRF1 RECEPTOR ANTAGONIST; COLORECTAL DISTENSION; NONPEPTIDE ANTAGONIST; SIGNALING PATHWAYS; RECTAL DISTENSION; TYPE-1 RECEPTOR; PHARMACOLOGY; HYPERALGESIA; PAIN	Corticotropin releasing factor receptor 1 (CRF1) is the key receptor that mediates stress-related body responses. However to date there are no CRF1 antagonists that have shown clinical efficacy in stress-related diseases. We investigated the inhibitory effects of a new generation, topology 2 selective CRF1 antagonists, NGD 98-2 and NGD 9002 on exogenous and endogenous CRF-induced stimulation of colonic function and visceral hypersensitivity to colorectal distension (CRD) in conscious rats. CRF1 antagonists or vehicle were administered orogastrically (og) or subcutaneously (sc) before either intracerebroventricular (icv) or intraperitoneal (ip) injection of CRF (10 mu g/kg), exposure to water avoidance stress (WAS, 60 min) or repeated CRD (60 mmHg twice, 10 min on/off at a 30 min interval). Fecal pellet output (FPO), diarrhea and visceromotor responses were monitored. In vehicle (og)-pretreated rats, icv CRF stimulated FPO and induced diarrhea in >50% of rats. NGD 98-2 or NGD 9002 (3, 10 and 30 mg/kg, og) reduced the CRF-induced FPO response with an inhibitory IC50 of 15.7 and 4.3 mg/kg respectively. At the highest dose, og NGD 98-2 or NGD 9002 blocked icv CRF-induced FPO by 67-87% and decreased WAS-induced-FPO by 23-53%. When administered sc, NGD 98-2 or NGD 9002 (30 mg/kg) inhibited icv and ip CRF-induced-FPO. The antagonists also prevented the development of nociceptive hyper-responsivity to repeated CRD. These data demonstrate that topology 2 CRF1 antagonists, NGD 98-2 and NGD 9002, administered orally, prevented icv CRF-induced colonic secretomotor stimulation, reduced acute WAS-induced defecation and blocked the induction of visceral sensitization to repeated CRD.	[Million, Mulugeta; Zhao, Jing-Fang; Luckey, Andrew; Czimmer, Jozsef; Tache, Yvette] Univ Calif Los Angeles, David Geffen Sch Med, CURE Digest Dis Res Ctr, Div Digest Dis,Dept Med, Los Angeles, CA 90095 USA; [Million, Mulugeta; Tache, Yvette] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Family Ctr Neurobiol Stress, Div Digest Dis,Dept Med, Los Angeles, CA 90095 USA; [Million, Mulugeta; Zhao, Jing-Fang; Luckey, Andrew; Czimmer, Jozsef; Tache, Yvette] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Maynard, George D.; Kehne, John; Hoffman, Diane C.] Neurogen Corp, Branford, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Million, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, CURE Digest Dis Res Ctr, Div Digest Dis,Dept Med, Los Angeles, CA 90095 USA.	millionmulugeta@mednet.ucla.edu	Kehne, John/AAD-1425-2019; Kehne, John/GQI-3393-2022		Neurogen-Aventis CRF Collaboration, Branford, Connecticut, USA; Veterans Administration Research Career Scientist Award; NIH [RO1 DK-078676, R01 DK-57238, P50 DK-64539, DK-41301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064539, R01DK057238, R01DK078676, P30DK041301] Funding Source: NIH RePORTER	Neurogen-Aventis CRF Collaboration, Branford, Connecticut, USA; Veterans Administration Research Career Scientist Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an investigator initiated fund from the Neurogen-Aventis CRF Collaboration, Branford, Connecticut, USA (YT, MM); The Veterans Administration Research Career Scientist Award (YT), Center Grant NIH DK-41301 (Animal Model Core, YT, MM); RO1 DK-078676 (MM); R01 DK-57238 (YT) and P50 DK-64539 (YT, MM). The funders had no decision role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2007, AUTON NEUROSCI-BASIC, V133, P136, DOI 10.1016/j.autneu.2006.11.002; Bailey JE, 2011, J PSYCHOPHARMACOL, V25, P1199, DOI 10.1177/0269881111400650; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Binneman B, 2008, AM J PSYCHIAT, V165, P617, DOI 10.1176/appi.ajp.2008.07071199; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; Bouin M, 2002, GASTROENTEROLOGY, V122, P1771, DOI 10.1053/gast.2002.33601; Chen C, 2006, CURR MED CHEM, V13, P1261, DOI 10.2174/092986706776873014; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Farrokhi CB, 2007, CNS DRUG REV, V13, P423, DOI 10.1111/j.1527-3458.2007.00027.x; Fleck BA, 2012, J PHARMACOL EXP THER, V341, P518, DOI 10.1124/jpet.111.188714; Gaudreau GA, 2004, BEHAV BRAIN RES, V150, P185, DOI 10.1016/j.bbr.2003.07.004; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Griebel G, 2002, J PHARMACOL EXP THER, V301, P333, DOI 10.1124/jpet.301.1.333; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; Hodgetts KJ, 2011, J MED CHEM, V54, P4187, DOI 10.1021/jm200365y; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1680, DOI 10.1152/jn.00341.2003; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; Ising M, 2007, NEUROPSYCHOPHARMACOL, V32, P1941, DOI 10.1038/sj.npp.1301328; Kehne J, 2002, CNS NEUROL DISORD-DR, V1, P467, DOI 10.2174/1568007023339049; Kehne JH, 2010, PHARMACOL THERAPEUT, V128, P460, DOI 10.1016/j.pharmthera.2010.08.011; Kimura T, 2007, AM J PHYSIOL-GASTR L, V293, pG903, DOI 10.1152/ajpgi.00066.2007; Larauche M, 2008, AM J PHYSIOL-GASTR L, V294, pG1033, DOI 10.1152/ajpgi.00507.2007; Larauche M, 2011, J NEUROGASTROENTEROL, V17, P213, DOI 10.5056/jnm.2011.17.3.213; Larauche M, 2009, AM J PHYSIOL-GASTR L, V297, pG215, DOI 10.1152/ajpgi.00072.2009; Larsson M, 2003, NEUROGASTROENT MOTIL, V15, P371, DOI 10.1046/j.1365-2982.2003.00418.x; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; Maillot C, 2000, GASTROENTEROLOGY, V119, P1569, DOI 10.1053/gast.2000.20251; Martinez V, 1997, J PHARMACOL EXP THER, V280, P754; Martinez V, 2001, BRAIN RES, V893, P29, DOI 10.1016/S0006-8993(00)03277-7; Martinez V., 2006, CURR PHARM DESIGN, V12, P1; Miampamba M, 2002, AM J PHYSIOL-GASTR L, V282, pG857, DOI 10.1152/ajpgi.00434.2001; Million M, 2007, GUT, V56, P1482, DOI 10.1136/gut.2007.129304; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2004.051391; Million M, 2005, PEPTIDES, V26, P1188, DOI 10.1016/j.peptides.2005.02.004; Million M, 2003, BRAIN RES, V985, P32, DOI 10.1016/S0006-8993(03)03027-0; Munakata J, 1997, GASTROENTEROLOGY, V112, P55, DOI 10.1016/S0016-5085(97)70219-1; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935; Paez-Pereda M, 2011, EXPERT OPIN INV DRUG, V20, P519, DOI 10.1517/13543784.2011.565330; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Saunders PR, 2002, EUR J PHARMACOL, V435, P231, DOI 10.1016/S0014-2999(01)01574-6; Schulz DW, 1996, P NATL ACAD SCI USA, V93, P10477, DOI 10.1073/pnas.93.19.10477; Schwetz I, 2005, AM J PHYSIOL-GASTR L, V289, pG704, DOI 10.1152/ajpgi.00498.2004; Sengupta Jyoti N, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79090-7_2; Seymour PA, 2003, CNS DRUG REV, V9, P57, DOI 10.1111/j.1527-3458.2003.tb00244.x; Stengel A, 2010, EXP BIOL MED, V235, P1168, DOI 10.1258/ebm.2010.009347; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Sweetser S, 2009, AM J PHYSIOL-GASTR L, V296, pG1299, DOI 10.1152/ajpgi.00011.2009; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Tache Y, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P791; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Tache Y, 2008, ANN NY ACAD SCI, V1148, P29, DOI 10.1196/annals.1410.007; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; WILLIAMS CL, 1987, AM J PHYSIOL, V253, pG582, DOI 10.1152/ajpgi.1987.253.4.G582; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9; Zorrilla EP, 2013, DRUG ALCOHOL DEPEN, V128, P175, DOI 10.1016/j.drugalcdep.2012.12.017; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	61	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73749	10.1371/journal.pone.0073749	http://dx.doi.org/10.1371/journal.pone.0073749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040053	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500059
J	Murthy, M; Selvam, S; Jesuraj, N; Bennett, S; Doherty, M; Grewal, HMS; Vaz, M				Murthy, Maitreyi; Selvam, Sumithra; Jesuraj, Nelson; Bennett, Sean; Doherty, Mark; Grewal, Harleen M. S.; Vaz, Mario		TB Trials Study Grp	Two-Step Tuberculin Skin Testing in School-Going Adolescents with Initial 0-4 Millimeter Responses in a High Tuberculosis Prevalence Setting in South India	PLOS ONE			English	Article							LATENT TUBERCULOSIS; BOOSTER; INFECTION; CONVERSION; DIAGNOSIS; CHILDREN; ADULTS; ASSAYS; AGE	Background: The utility of two-step tuberculin skin testing among adolescents in high tuberculosis prevalence settings is not well established. Objectives: To determine the proportion and determinants of a 0-4 mm response to an initial standard tuberculin skin test (TST) and evaluating 'boosting' with repeat testing. Methods: Adolescents between 11 and 18 years attending schools/colleges underwent a TST; those with a response of between 0-4 mm had a repeat TST 1-4 weeks later. Results: Initial TST was done for 6608/6643 participants; 1257 (19%) developed a 0-4 mm response to the initial TST. Younger age and under-nutrition were more likely to be associated with a 0-4 mm response, while the presence of BCG (Bacillus Calmette Guerin) scar and higher socio-economic class were less likely to be associated with a 0-4 mm response. On repeat testing boosting was seen in 13.2% (145/1098; >= 6 mm over the initial test) while 4.3% showed boosting using a more conservative cutoff of a repeat TST >= 10 mm with an increment of at least 6 mm (47/1098). History of exposure to a tuberculosis (TB) case was associated with enhanced response. Conclusion: The proportion of adolescents who demonstrated boosting on two-step TST testing in our study was relatively low. As a result repeat testing did not greatly alter the prevalence of TST positivity. However, the two-step TST helps identify individuals who can potentially boost their immune response to a second test, and thus, prevents them from being misclassified as those with newly acquired infection, or tuberculin converters. While two-step tuberculin skin testing may have a limited role in population-level TST surveys, it may be useful where serial tuberculin testing needs to be performed to distinguish those who show an enhanced response or boosters from those who indeed have a new infection, or converters.	[Murthy, Maitreyi; Grewal, Harleen M. S.] Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway; [Murthy, Maitreyi; Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Murthy, Maitreyi; Jesuraj, Nelson; Vaz, Mario] St Johns Res Inst, Bangalore, Karnataka, India; [Selvam, Sumithra] St Johns Res Inst, Div Epidemiol Biostat & Populat Hlth, Bangalore, Karnataka, India; [Bennett, Sean] Aeras Global TB Vaccine Fdn, Rockville, MD USA; [Doherty, Mark] GlaxoSmithKline, Dept Infect Dis Immunol, Copenhagen, Denmark; [Vaz, Mario] St Johns Med Coll, Bangalore, Karnataka, India	University of Bergen; University of Bergen; Haukeland University Hospital; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; GlaxoSmithKline; St. John's National Academy of Health Sciences; St. John's Medical College	Grewal, HMS (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway.	Harleen.Grewal@k2.uib.no; mariovaz@sjri.res.in	Lindtjorn, Bernt/K-9465-2018; Grewal, Harleen/ABC-5831-2020	Lindtjorn, Bernt/0000-0002-6267-6984; 	Research Council of Norway [GLOBVAC:179342]; Aeras Global TB Vaccine Foundation, USA	Research Council of Norway(Research Council of Norway); Aeras Global TB Vaccine Foundation, USA	The epidemiological study was funded by the Research Council of Norway (GLOBVAC:179342-through the Indo-Norway Programme; Indian partner-Department of Biotechnology) and the Aeras Global TB Vaccine Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULRAHMAN MA, 2004, INFECT CONT HOSP EP, V25, P1117, DOI DOI 10.1086/502355.PUBMED:15636304; AGRAWAL S, 1998, INDIAN PEDIATR, V35, P582; Casas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006686; *CDC, 2012, TUB TUB SKIN TEST; *CDC, 2012, AS TB FACTS; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; FRIEDLAND IR, 1990, S AFR MED J, V77, P387; Gallant CJ, 2010, INT J TUBERC LUNG D, V14, P952; Garcia-Sancho MC, 2006, INT J EPIDEMIOL, V35, P1447, DOI 10.1093/ije/dyl213; Gonzalez-Salazar F, 2011, TUBERCULOSIS, V91, pS34, DOI 10.1016/j.tube.2011.10.007; Hizel K, 2004, CLIN MICROBIOL INFEC, V10, P980, DOI 10.1111/j.1469-0691.2004.00970.x; HOROWITZ HW, 1995, AM J INFECT CONTROL, V23, P181, DOI 10.1016/0196-6553(95)90039-X; HUEBNER RE, 1994, CLIN INFECT DIS, V19, P26, DOI 10.1093/clinids/19.1.26; Jani MN, 2011, J GLOB INFECT DIS, V3, P94, DOI 10.4103/0974-777X.77305; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MENZIES R, 1994, ANN INTERN MED, V120, P190, DOI 10.7326/0003-4819-120-3-199402010-00003; NARAIN R, 1974, B WORLD HEALTH ORGAN, V51, P273; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Roth A, 2005, VACCINE, V23, P3991, DOI 10.1016/j.vaccine.2004.10.022; Saito M, 2004, INT J TUBERC LUNG D, V8, P842; Sakha K, 2008, Pak J Biol Sci, V11, P930, DOI 10.3923/pjbs.2008.930.933; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; Shanaube K, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018206, DOI 10.1371/journal.pone.0018206]; Silva VMC, 2000, INT J TUBERC LUNG D, V4, P420; Srour-Fihmi S, 2000, J HOSP INFECT, V46, P141, DOI 10.1053/jhin.2000.0787; Teixeira EG, 2008, INT J TUBERC LUNG D, V12, P1407; TRAJMAN A, 2013, PULMONARY MED, V2013, P1; *WHO, 2012, UB; *WHO, 1955, B WORLD HEALTH ORGAN, V22, P63	30	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e71470	10.1371/journal.pone.0071470	http://dx.doi.org/10.1371/journal.pone.0071470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039716	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500007
J	Peak, IR; Srikhanta, YN; Weynants, VE; Feron, C; Poolman, JT; Jennings, MP				Peak, Ian R.; Srikhanta, Yogitha N.; Weynants, Vincent E.; Feron, Christiane; Poolman, Jan T.; Jennings, Michael P.			Evaluation of Truncated NhhA Protein as a Candidate Meningococcal Vaccine Antigen	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NEISSERIA-MENINGITIDIS NHHA; HAEMOPHILUS-INFLUENZAE; PILIN GLYCOSYLATION; TRANSLOCATOR DOMAIN; B MENINGOCOCCUS; ADHESIN; IDENTIFICATION; EXPRESSION; ANTIBODIES	NhhA (Neisseria hia homologue) is an outer membrane protein from Neisseria meningitidis, the causative agent of meningococcal disease. The protein is surface exposed and its expression in a wide range of meningococcal strains suggests it is a promising vaccine candidate. In addition, immunization of mice with outer membrane vesicles of strains that overexpress NhhA in conjunction with one of TbpA, Omp85 or NspA results in synergistic bactericidal responses. We previously showed that the NhhA sequence is highly conserved between strains, with the majority of the differences localized to four distinct variable regions located in the amino-terminal region of the mature protein. In this study, N. meningitidis strains were constructed that over-express wild-type NhhA. Strains expressing truncated versions of NhhA, with deletions from the amino-terminal region that removed the most variable regions, were also made. These expression strains were also modified so that immunodominant, phase-and antigenically-variable outer membrane proteins were not expressed, truncated lipooligosaccharide (LOS) expression was genetically fixed (no phase variability), and capsular polysaccharide expression abolished. Outer membrane vesicles derived from these strains were used to immunize mice. As previously observed, a synergistic effect involving another antigen, TbpA, was required to demonstrate bactericidal activity. The highest bactericidal response against a heterologous strain was obtained with a truncated variant of NhhA. These results indicate that removal of (a) variable region(s) does not reduce bactericidal responses against NhhA, and that bactericidal targets exist in regions other than the variable N-teminus. This provides the basis for future examination of responses against truncated NhhA in protecting against heterologous NhhA strains, and further evaluation of truncated NhhA as a candidate for inclusion in a vaccine against all serogroups of N. meningitidis.	[Peak, Ian R.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Srikhanta, Yogitha N.] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia; [Weynants, Vincent E.; Feron, Christiane; Poolman, Jan T.] GlaxoSmithKline Vaccines, Rixensart, Belgium	Griffith University; University of Queensland; GlaxoSmithKline	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Jennings, Michael P/G-4822-2013; Peak, Ian R/C-5677-2009	Jennings, Michael P/0000-0002-1027-4684; Srikhanta, Yogitha/0000-0002-7513-9969	NHMRC [565526]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The work in MPJ's laboratory was supported by NHMRC Program Grant 565526 to MPJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barenkamp SJ, 1996, MOL MICROBIOL, V19, P1215, DOI 10.1111/j.1365-2958.1996.tb02467.x; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Echenique-Rivera H, 2011, INFECT IMMUN, V79, P4308, DOI 10.1128/IAI.00198-11; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; JANIK A, 1976, J CLIN MICROBIOL, V4, P71; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Koretke KK, 2006, J STRUCT BIOL, V155, P154, DOI 10.1016/j.jsb.2006.03.012; Kortekaas J, 2007, VACCINE, V25, P72, DOI 10.1016/j.vaccine.2006.07.016; Kortekaas J, 2006, MICROBES INFECT, V8, P2145, DOI 10.1016/j.micinf.2006.04.011; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; OLYHOEK AJM, 1991, MICROB PATHOGENESIS, V11, P249, DOI 10.1016/0882-4010(91)90029-A; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Scarselli M, 2001, MICROBIOL-UK, V147, P250, DOI 10.1099/00221287-147-2-250; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Sjolinder H, 2008, INFECT IMMUN, V76, P5412, DOI 10.1128/IAI.00478-08; Sjolinder M, 2012, INFECT IMMUN, V80, P4027, DOI 10.1128/IAI.00456-12; St Geme JW, 2000, J BACTERIOL, V182, P6005, DOI 10.1128/JB.182.21.6005-6013.2000; StGeme JW, 1996, J BACTERIOL, V178, P6281, DOI 10.1128/jb.178.21.6281-6287.1996; Surana NK, 2004, J BIOL CHEM, V279, P14679, DOI 10.1074/jbc.M311496200; van Ulsen P, 2001, FEMS IMMUNOL MED MIC, V32, P53, DOI 10.1016/S0928-8244(01)00271-1; VanDerVoort ER, 1996, INFECT IMMUN, V64, P2745, DOI 10.1128/IAI.64.7.2745-2751.1996; Vermont Clementien L, 2003, Expert Rev Vaccines, V2, P673, DOI 10.1586/14760584.2.5.673; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; Warren MJ, 2004, FEMS IMMUNOL MED MIC, V41, P43, DOI 10.1016/j.femsim.2004.01.002; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Wiertz EJHJ, 1996, INFECT IMMUN, V64, P298, DOI 10.1128/IAI.64.1.298-304.1996; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e72003	10.1371/journal.pone.0072003	http://dx.doi.org/10.1371/journal.pone.0072003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24039731	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500010
J	Alexander, NS; Stein, RA; Koteiche, HA; Kaufmann, KW; Mchaourab, HS; Meiler, J				Alexander, Nathan S.; Stein, Richard A.; Koteiche, Hanane A.; Kaufmann, Kristian W.; Mchaourab, Hassane S.; Meiler, Jens			RosettaEPR: Rotamer Library for Spin Label Structure and Dynamics	PLOS ONE			English	Article							PROTEIN-STRUCTURE DETERMINATION; ABC TRANSPORTER MSBA; ELECTRON-PARAMAGNETIC-RESONANCE; NITROXIDE SIDE-CHAIN; STRUCTURE PREDICTION; T4 LYSOZYME; DISTANCE MEASUREMENTS; RESOLUTION; EPR; MOTION	An increasingly used parameter in structural biology is the measurement of distances between spin labels bound to a protein. One limitation to these measurements is the unknown position of the spin label relative to the protein backbone. To overcome this drawback, we introduce a rotamer library of the methanethiosulfonate spin label (MTSSL) into the protein modeling program Rosetta. Spin label rotamers were derived from conformations observed in crystal structures of spin labeled T4 lysozyme and previously published molecular dynamics simulations. Rosetta's ability to accurately recover spin label conformations and EPR measured distance distributions was evaluated against 19 experimentally determined MTSSL labeled structures of T4 lysozyme and the membrane protein LeuT and 73 distance distributions from T4 lysozyme and the membrane protein MsbA. For a site in the core of T4 lysozyme, the correct spin label conformation (X-1 and X-2) is recovered in 99.8% of trials. In surface positions 53% of the trajectories agree with crystallized conformations in X-1 and X-2. This level of recovery is on par with Rosetta performance for the 20 natural amino acids. In addition, Rosetta predicts the distance between two spin labels with a mean error of 4.4 angstrom. The width of the experimental distance distribution, which reflects the flexibility of the two spin labels, is predicted with a mean error of 1.3 angstrom. RosettaEPR makes full-atom spin label modeling available to a wide scientific community in conjunction with the powerful suite of modeling methods within Rosetta.	[Alexander, Nathan S.; Kaufmann, Kristian W.; Mchaourab, Hassane S.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Alexander, Nathan S.; Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Stein, Richard A.; Koteiche, Hanane A.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	jens.meiler@vanderbilt.edu		Meiler, Jens/0000-0001-8945-193X	National Institutes of Health (NIH) [R01 GM080403, R01 MH090192, R01 GM099842]; National Science Foundation (NSF) [0742762]; NIH NIMH [F31-MH08622];  [GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R01GM080403, R01GM099842, R01GM077659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work in the Meiler laboratory is supported through National Institutes of Health (NIH) (R01 GM080403, R01 MH090192, R01 GM099842), and National Science Foundation (NSF) (Career 0742762). Support for NSA was provided by NIH NIMH Award Number F31-MH08622. RAS, HAK, and HSM are supported by GM077659. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Czogalla A, 2007, ACTA BIOCHIM POL, V54, P235, DOI 10.18388/abp.2007_3243; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Durham E, 2009, J MOL MODEL, V15, P1093, DOI 10.1007/s00894-009-0454-9; Fajer MI, 2007, J AM CHEM SOC, V129, P13840, DOI 10.1021/ja071404v; Fleissner MR, 2009, PROTEIN SCI, V18, P893, DOI 10.1002/pro.96; Ganguly S, 2011, STRUCTURE, V19, P441, DOI 10.1016/j.str.2011.03.008; Guo ZF, 2008, PROTEIN SCI, V17, P228, DOI 10.1110/ps.073174008; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0; Hilger D, 2009, BIOPHYS J, V96, P217, DOI 10.1016/j.bpj.2008.09.030; Hirst SJ, 2011, J STRUCT BIOL, V173, P506, DOI 10.1016/j.jsb.2010.10.013; Jeschke G, 2004, J MAGN RESON, V169, P1, DOI 10.1016/j.jmr.2004.03.024; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Kamarainen JK, 2003, PATTERN RECOGN LETT, V24, P2009, DOI 10.1016/S0167-8655(03)00039-4; Kazmier K, 2011, J STRUCT BIOL, V173, P549, DOI 10.1016/j.jsb.2010.11.003; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Sale K, 2002, J MAGN RESON, V156, P104, DOI 10.1006/jmre.2002.2529; Sale K, 2005, J AM CHEM SOC, V127, P9334, DOI 10.1021/ja051652w; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shapovalov Maxim V, 2011, STRUCTURE LONDON ENG, V19, P844; Tombolato F, 2006, J PHYS CHEM B, V110, P26248, DOI 10.1021/jp0629487; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	49	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72851	10.1371/journal.pone.0072851	http://dx.doi.org/10.1371/journal.pone.0072851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039810	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600038
J	Boddy, LG; Bradford, KJ; Fischer, AJ				Boddy, Louis G.; Bradford, Kent J.; Fischer, Albert J.			Stratification Requirements for Seed Dormancy Alleviation in a Wetland Weed	PLOS ONE			English	Article							THERMAL-TIME MODEL; AFTER-RIPENING TIME; AVICULARE L. SEEDS; HERBICIDE-RESISTANT; ECHINOCHLOA-PHYLLOPOGON; HYDROTHERMAL TIME; GERMINATION; TEMPERATURES; RELEASE; RICE	Echinochloaoryzicola(syn.E. phyllopogon) is an exotic weed of California rice paddies that has evolved resistance to multiple herbicides. Elimination of seedlingsthroughcertain weed control methods can limit the spread of this weed, but is contingent on accurate predictions of germination and emergence timing, which are influenced by seed dormancy levels. In summer annuals, dormancy can often be relieved through stratification, a period of prolonged exposure to cold and moist conditions. We used population-based threshold models to quantify the effects of stratification on seed germination of four E. Oryzicola populations at a range of water potential (Psi) and oxygen levels. We also determined how stratification temperatures, moisture levels and durations contributed to dormancy release. Stratification released dormancy by decreasing base Psi and hydrotimerequired for germination and by eliminating any germination sensitivity to oxygen. Stratification also increased average germination rates (GR), which were used as a proxy for relative dormancy levels. Alternating temperatures nearly doubled GR in all populations, indicating that seeds could be partially dormant despite achieving high final germination percentages. Stratification at Psi=0 MPa increased GR compared to stratification at lower water potentials, demonstrating that Psi contributed to regulating dormancy release. Maximum GR occurred after 2-4 weeks of stratification at 0 MPa; GR were often more rapid for herbicide-resistant than for herbicide-susceptible seeds, implying greater dormancy in the latter. Manipulation of field conditions to promote dormancy alleviation of E. oryzicola seeds might improve the rate and uniformity of germination for seed bank depletion through seedling weed control. Our results suggest field soil saturation in winter would contribute towards E. oryzicola dormancy release and decrease the time to seedling emergence.	[Boddy, Louis G.] Marrone Bio Innovat, Dept Plant Sci, Davis, CA USA; [Bradford, Kent J.; Fischer, Albert J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Boddy, LG (corresponding author), Marrone Bio Innovat, Dept Plant Sci, Davis, CA USA.	lboddy@marronebio.com			California Rice Research Board	California Rice Research Board	This study was partially funded by the California Rice Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALANI A, 1985, PLANT PHYSIOL, V79, P885, DOI 10.1104/pp.79.3.885; ALLEN PS, 1995, J EXP BOT, V46, P1737, DOI 10.1093/jxb/46.11.1737; Alvarado V, 2005, SEED SCI RES, V15, P77, DOI 10.1079/SSR2005198; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bair NB, 2006, SEED SCI RES, V16, P17, DOI 10.1079/SSR2005237; BARRETT SCH, 1983, ECON BOT, V37, P255, DOI 10.1007/BF02858881; Baskin CC, 2001, SEEDS ECOLOGY BIOGEO, p[16, 57, 187]; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Batlla D, 2004, SEED SCI RES, V14, P277, DOI 10.1079/SSR2004177; Batlla D, 2003, SEED SCI RES, V13, P55, DOI 10.1079/SSR2002124; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; Bewley JD, 2013, SEEDS PHYSL DEV GERM; Boddy LG, 2012, J APPL ECOL, V49, P1225, DOI 10.1111/j.1365-2664.2012.02206.x; Boddy LG, 2012, WEED SCI, V60, P401, DOI 10.1614/WS-D-11-00150.1; Bradford KJ, 2007, SEED SCI RES, V17, P33, DOI 10.1017/S0960258507657389; BRADFORD KJ, 1990, PLANT PHYSIOL, V94, P840, DOI 10.1104/pp.94.2.840; Bradford KJ, 2002, WEED SCI, V50, P248, DOI 10.1614/0043-1745(2002)050[0248:AOHTTQ]2.0.CO;2; Chantre GR, 2010, WEED RES, V50, P218, DOI 10.1111/j.1365-3180.2010.00770.x; Chantre GR, 2009, ANN BOT-LONDON, V103, P1291, DOI 10.1093/aob/mcp070; Chao WS, 2011, FUNCT INTEGR GENOMIC, V11, P637, DOI 10.1007/s10142-011-0253-0; DAHAL P, 1990, J EXP BOT, V41, P1431, DOI 10.1093/jxb/41.11.1431; Donohue K, 2005, SEED SCI RES, V15, P175, DOI 10.1079/SSR2005208; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Finch-Savage WE, 2005, NEW PHYTOL, V165, P825, DOI 10.1111/j.1469-8137.2004.01272.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; FINCHSAVAGE WE, 1993, J EXP BOT, V44, P407, DOI 10.1093/jxb/44.2.407; Fischer AJ, 2000, WEED SCI, V48, P225, DOI 10.1614/0043-1745(2000)048[0225:HREOAE]2.0.CO;2; Fischer AJ, 2009, P ANN M WEED SCISOC; Fitzgerald GJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P767, DOI 10.1029/2000GB001259; Gianinetti A, 2007, SEED SCI RES, V17, P253, DOI 10.1017/S0960258507841523; Gordon AG, 1973, SEED ECOLOGY, P391; Grundy AC, 2003, WEED RES, V43, P1, DOI 10.1046/j.1365-3180.2003.00317.x; GUMMERSON RJ, 1986, J EXP BOT, V37, P729, DOI 10.1093/jxb/37.6.729; Hilhorst HWM, 2011, METHODS MOL BIOL, V773, P43, DOI 10.1007/978-1-61779-231-1_3; Hill J. E., 1985, Proceedings of the Western Society of Weed Science., P100; JOHNSON WC, 1995, WEED SCI, V43, P293, DOI 10.1017/S0043174500081200; Lambers H, 2008, PLANT PHYSL ECOLOGY, P169; Linquist B, 2008, CALIF AGR, V62, P24, DOI 10.3733/ca.v062n01p24; Matilla AJ, 2000, SEED SCI RES, V10, P111, DOI 10.1017/S096025850000012X; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Patrick Jr W. H., 1971, FERTILIZER TECHNOLOG, P187; Peters J, 2000, TETRAZOLIUM TESTING, V29; Phil SA, 2007, SEED DEV DORMANCY GE, P72; Pittelkow CM, 2012, FIELD CROP RES, V130, P128, DOI 10.1016/j.fcr.2012.02.011; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; Ritz C, 2005, J STAT SOFTW, V12, P1; Huarte HR, 2010, SEED SCI RES, V20, P39, DOI 10.1017/S0960258509990249; Ruiz-Santaella JP, 2006, J PLANT DIS PROTECT, P95; Steadman KJ, 2003, FUNCT PLANT BIOL, V30, P345, DOI 10.1071/FP02175; Totterdell S., 1979, Plant, Cell and Environment, V2, P131, DOI 10.1111/j.1365-3040.1979.tb00783.x; TOTTERDELL S, 1980, PLANT CELL ENVIRON, V3, P3, DOI 10.1111/1365-3040.ep11580392; Tsuji R, 2003, WEED SCI, V51, P740, DOI 10.1614/P2002-143; Wang WQ, 2009, J EXP BOT, V60, P3397, DOI 10.1093/jxb/erp178; WILLEMSEN RW, 1975, AM J BOT, V62, P1, DOI 10.2307/2442073; Yamasue Yuji, 2001, Weed Biology and Management, V1, P28, DOI 10.1046/j.1445-6664.2001.00008.x; Yasuor H, 2008, PEST MANAG SCI, V64, P1031, DOI 10.1002/ps.1604; Yasuor H, 2012, PEST MANAG SCI, V68, P108, DOI 10.1002/ps.2230; Yun MS, 2005, PESTIC BIOCHEM PHYS, V83, P107, DOI 10.1016/j.pestbp.2005.04.002	59	5	5	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71457	10.1371/journal.pone.0071457	http://dx.doi.org/10.1371/journal.pone.0071457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039714	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600010
J	Furumi, F; Koyasu, M				Furumi, Fumikazu; Koyasu, Masuo			Role-Play Experience Facilitates Reading the Mind of Individuals with Different Perception	PLOS ONE			English	Article							PERSPECTIVE; KNOWLEDGE; REPRESENTATION; BELIEFS; AUTISM	The present study examined effects of role-play experience on reading the mind of people with different perception. It is normally difficult but very important in daily life to understand people with different characteristics, including those with restricted color vision. We explored the mechanisms of reading the mind of people with different perception. Forty university students were introduced to a communication task in which the use of mindreading was essential. During each trial, participants viewed a shelf, presented on a laptop computer, which contained several familiar objects, and they were instructed to touch an object on the shelf following an instruction issued by a partner who stood at the opposite side of the shelf. There were two partners: one was a monkey with normal color vision and the other was a dog with restricted color vision. The monkey could see all the objects in the same colors as the participants, whereas the dog saw some objects in different colors (e. g., he saw as yellow objects that the participants saw as red). Participants were required to respond according to the partner's instruction. In the restricted color vision condition, the dog saw the colors of objects differently; thus, participants had to work out his intentions (i.e., mind read), according to his different perspective. In the normal color vision condition, all objects were in the same colors as those seen by the monkey. Before the test phase, the role-play group had a role-play experience in which participants assumed the role of people with restricted color vision. No-role-play participants made significantly more errors in the restricted color vision condition than in the normal color vision condition, whereas among role-play participants, there was no difference between conditions. These results suggest that role-play experience facilitates reading the mind of people with perceptual experiences different from our own.	[Furumi, Fumikazu; Koyasu, Masuo] Kyoto Univ, Grad Sch Educ, Kyoto, Japan; [Furumi, Fumikazu] Japan Soc Promot Sci, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Furumi, F (corresponding author), Kyoto Univ, Grad Sch Educ, Kyoto, Japan.	fumikazu.furumi@gmail.com	FURUMI, FUMIKAZU/Q-2535-2019	FURUMI, FUMIKAZU/0000-0002-4716-3056				Apperly I., 2011, MINDREADERS; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Birch J, 2012, J OPT SOC AM A, V29, P313, DOI 10.1364/JOSAA.29.000313; Dumontheil I, 2010, NEUROIMAGE, V52, P1574, DOI 10.1016/j.neuroimage.2010.05.056; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; FLAVELL JH, 1981, DEV PSYCHOL, V17, P99, DOI 10.1037/0012-1649.17.1.99; Furumi Fumikazu, 2012, Shinrigaku Kenkyu, V83, P18; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Keysar B, 2000, PSYCHOL SCI, V11, P32, DOI 10.1111/1467-9280.00211; Komeda H, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-20; Komeda H, 2009, COGNITION EMOTION, V23, P135, DOI 10.1080/02699930801949116; Lin SH, 2010, J EXP SOC PSYCHOL, V46, P551, DOI 10.1016/j.jesp.2009.12.019; Oyserman D, 2008, PSYCHOL BULL, V134, P311, DOI 10.1037/0033-2909.134.2.311; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Senju A, 2012, NEUROSCIENTIST, V18, P108, DOI 10.1177/1073858410397208; SHEPARD RN, 1992, PSYCHOL SCI, V3, P97, DOI 10.1111/j.1467-9280.1992.tb00006.x; Surtees ADR, 2012, BRIT J DEV PSYCHOL, V30, P75, DOI 10.1111/j.2044-835X.2011.02063.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	20	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74899	10.1371/journal.pone.0074899	http://dx.doi.org/10.1371/journal.pone.0074899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023966	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600160
J	Wakabayashi, H; Fay, PJ				Wakabayashi, Hironao; Fay, Philip J.			Replacing the Factor VIII C1 Domain with a Second C2 Domain Reduces Factor VIII Stability and Affinity for Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-C; WILLEBRAND FACTOR-BINDING; RESONANCE ENERGY-TRANSFER; COFACTOR ACTIVITY; MEMBRANE-BINDING; LIGHT-CHAIN; PHOSPHOLIPID-BINDING; BLOOD-COAGULATION; CHARGED RESIDUES; INTERACTIVE SITE	Factor VIII (FVIII) consists of a heavy chain (A1(a1)A2(a2)B domains) and light chain ((a3)A3C1C2 domains). To gain insights into a role of the FVIII C domains, we eliminated the C1 domain by replacing it with the homologous C2 domain. FVIII stability of the mutant (FVIIIC2C2) as measured by thermal decay at 55 degrees C of FVIII activity was markedly reduced (similar to 11-fold), whereas the decay rate of FVIIIa due to A2 subunit dissociation was similar to WT FVIIIa. The binding affinity of FVIIIC2C2 for phospholipid membranes as measured by fluorescence resonance energy transfer was modestly lower (similar to 2.8-fold) than that for WT FVIII. Among several anti-FVIII antibodies tested (anti-C1 (GMA8011), anti-C2 (ESH4 and ESH8), and anti-A3 (2D2) antibody), only ESH4 inhibited membrane binding of both WT FVIII and FVIIIC2C2. FVIIIa cofactor activity measured in the presence of each of the above antibodies was examined by FXa generation assays. The activity of WT FVIIIa was inhibited by both GMA8011 and ESH4, whereas the activity of FVIIIC2C2 was inhibited by both the anti-C2 antibodies, ESH4 and ESH8. Interestingly, factor IXa (FIXa) binding affinity for WT FVIIIa was significantly reduced in the presence of GMA8011 (similar to 10-fold), whereas the anti-C2 antibodies reduced FIXa binding affinity of FVIIIC2C2 variant (similar to 4-fold). Together, the reduced stability plus impaired FIXa interaction of FVIIIC2C2 suggest that the C1 domain resides in close proximity to FIXa in the FXase complex and contributes a critical role to FVIII structure and function.	[Wakabayashi, Hironao; Fay, Philip J.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL38199 (to P. J. F.).	Ahmad SS, 2005, BIOCHEMISTRY-US, V44, P13858, DOI 10.1021/bi0511033; Albert T, 2008, THROMB HAEMOSTASIS, V99, P634, DOI 10.1160/TH07-06-0400; Ansong C, 2006, BIOCHEMISTRY-US, V45, P13140, DOI 10.1021/bi061202w; DeAngelis JP, 2012, J BIOL CHEM, V287, P15409, DOI 10.1074/jbc.M111.333948; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; GILBERT GE, 1993, BIOCHEMISTRY-US, V32, P9577, DOI 10.1021/bi00088a009; Gilbert GE, 1996, J BIOL CHEM, V271, P11120, DOI 10.1074/jbc.271.19.11120; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Griffiths AE, 2013, J BIOL CHEM, V288, P15057, DOI 10.1074/jbc.M113.456467; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lewis DA, 2003, THROMB HAEMOSTASIS, V89, P795, DOI 10.1055/s-0037-1613464; Liu Z, 2010, J BIOL CHEM, V285, P8824, DOI 10.1074/jbc.M109.080168; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Matsumoto T, 2012, THROMB HAEMOSTASIS, V107, P288, DOI 10.1160/TH11-05-0331; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Novakovic VA, 2011, BIOCHEM J, V435, P187, DOI 10.1042/BJ20101797; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Takeyama M, 2013, THROMB HAEMOSTASIS, V109, P187, DOI 10.1160/TH12-08-0561; Varfaj F, 2006, BIOCHEM J, V396, P355, DOI 10.1042/BJ20060117; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2013, BIOCHEMISTRY-US, V52, P3921, DOI 10.1021/bi400295x; Wakabayashi H, 2013, BIOCHEM J, V452, P293, DOI 10.1042/BJ20130025; Wakabayashi H, 2011, J BIOL CHEM, V286, P25748, DOI 10.1074/jbc.M111.241109; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013	37	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31289	31297		10.1074/jbc.M113.497289	http://dx.doi.org/10.1074/jbc.M113.497289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030831	Green Published, hybrid			2022-12-25	WOS:000330778900045
J	Griffin, M; Sebastian, A; Colthurst, J; Bayat, A				Griffin, Michelle; Sebastian, Anil; Colthurst, James; Bayat, Ardeshir			Enhancement of Differentiation and Mineralisation of Osteoblast-like Cells by Degenerate Electrical Waveform in an In Vitro Electrical Stimulation Model Compared to Capacitive Coupling	PLOS ONE			English	Article							PULSED ELECTROMAGNETIC-FIELDS; BONE EXTRACELLULAR-MATRIX; DOUBLE-BLIND TRIAL; PROGRESSIVE DEVELOPMENT; PROLIFERATION; EXPRESSION; PHENOTYPE; FRACTURES; NONUNION; INCREASE	Electrical stimulation (ES) is effective in enhancing bone healing, however the best electrical waveform, mode of application and mechanisms remains unclear. We recently reported the in vitro differential healing response of a novel electrical waveform called degenerate sine wave (DW) compared to other forms of ES. This study further explores this original observation on osteoblast cells. Here, we electrically stimulated SaOS-2 osteoblast-like cells with DW in an in vitro ES chamber (referred to as 'DW stimulation') and compared the intracellular effects to capacitive coupling (CC) stimulation. ES lasted for 4 h, followed by an incubation period of 20 h and subsequent ES for 4 additional hours. Cytotoxicity, proliferation, differentiation and mineralisation of the osteoblast-like cells were evaluated to determine the cell maturation process. DW significantly enhanced the differentiation of cells when compared to CC stimulation with increased alkaline phosphatase and collagen I gene expression by quantitative real time-polymerase chain reaction analysis (p<0.01). Moreover, DW significantly increased the mineralisation of cells compared to CC stimulation. Furthermore the transcription of osteocalcin, osteonectin, osteopontin and bone sialoprotein (p<0.05) was also up regulated by DW. However, ES did not augment the proliferation of cells. Translational analysis by immunocytochemistry and Western blotting showed increased collagen I, osteocalcin and osteonectin expression after DW than CC stimulation. In summary, we have demonstrated for the first time that DW stimulation in an in vitro ES chamber has a significant effect on maturation of osteoblast-like cells compared to CC stimulation of the same magnitude.	[Griffin, Michelle; Sebastian, Anil; Bayat, Ardeshir] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Colthurst, James] Fenzian Ltd, Hungerford, Berks, England; [Bayat, Ardeshir] Univ S Manchester Hosp, Wythenshawe Hosp, Fdn Trust, Dept Plast & Reconstruct Surg, Manchester M20 8LR, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Wythenshawe Hosp, Univ S Manchester Hosp, Fdn Trust,Manchester Acad,Hlth Sci Ctr,Inst Infla, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Bayat, A (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	ardeshir.bayat@manchester.ac.uk		BAYAT, ARDESHIR/0000-0002-4116-6491	NIHR (UK)	NIHR (UK)(National Institute for Health Research (NIHR))	The authors would like to thank the support of NIHR (UK) to the senior author Dr. Ardeshir Bayat. In addition the authors would like to thank Steve and Kathy Fitzpatrick for generous donation towards their research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnaba S, 2013, PHYSIOTHER RES INT, V18, P109, DOI 10.1002/pri.1536; BASSETT CAL, 1982, J BONE JOINT SURG AM, V64, P1214, DOI 10.2106/00004623-198264080-00011; BENAZZO F, 1995, CLIN ORTHOP RELAT R, P145; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; BORSALINO G, 1988, CLIN ORTHOP RELAT R, P256; BRIGHTON CT, 1995, CLIN ORTHOP RELAT R, P223; Brown MJLL, 1994, J CELL BIOL, V127; Chang WHS, 2004, BIOELECTROMAGNETICS, V25, P457, DOI 10.1002/bem.20016; De Mattei M, 1999, BIOELECTROMAGNETICS, V20, P177, DOI 10.1002/(SICI)1521-186X(1999)20:3<177::AID-BEM4>3.0.CO;2-#; Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032; Esmail MY, 2012, ELECTROMAGN BIOL MED, V31, P375, DOI 10.3109/15368378.2012.662196; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Goodwin CB, 1999, SPINE, V24, P1349, DOI 10.1097/00007632-199907010-00013; Griffin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023404; Griffin Michelle, 2011, Eplasty, V11, pe34; Hannay G, 2005, BIOELECTROMAGNETICS, V26, P670, DOI 10.1002/bem.20166; Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100; JAFFE LF, 1977, NATURE, V265, P600, DOI 10.1038/265600a0; JENSH RP, 1966, STAIN TECHNOL, V41, P179, DOI 10.3109/10520296609116302; Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417; Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7; Martino CF, 2008, BIOELECTROMAGNETICS, V29, P125, DOI 10.1002/bem.20372; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Perry D, 2010, J WOUND CARE, V19, P447, DOI 10.12968/jowc.2010.19.10.79092; SCOTT G, 1994, J BONE JOINT SURG AM, V76A, P820, DOI 10.2106/00004623-199406000-00005; Sebastian A, 2011, WOUND REPAIR REGEN, V19, P693, DOI 10.1111/j.1524-475X.2011.00736.x; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; SHARRARD WJW, 1990, J BONE JOINT SURG BR, V72, P347, DOI 10.1302/0301-620X.72B3.2187877; Sollazzo V, 2010, CLIN ORTHOP RELAT R, V468, P2260, DOI 10.1007/s11999-010-1341-5; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Teven CM, 2012, J CRANIOFAC SURG, V23, P586, DOI 10.1097/SCS.0b013e31824cd6de; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Tsai MT, 2007, BIOELECTROMAGNETICS, V28, P519, DOI 10.1002/bem.20336; WAHLSTROM O, 1984, CLIN ORTHOP RELAT R, P293; Wiesmann HP, 2001, BBA-MOL CELL RES, V1538, P28, DOI 10.1016/S0167-4889(00)00135-X; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Yang W, 2008, ELECTROMAGN BIOL MED, V27, P298, DOI 10.1080/15368370802289604; Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796; Zhou Jian, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P353, DOI 10.3881/j.issn.1000-503X.2012.04.008	40	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72978	10.1371/journal.pone.0072978	http://dx.doi.org/10.1371/journal.pone.0072978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039834	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500020
J	Nakashima, Y; Haneji, T				Nakashima, Yoshiki; Haneji, Tatsuji			Stimulation of Osteoclast Formation by RANKL Requires Interferon Regulatory Factor-4 and Is Inhibited by Simvastatin in a Mouse Model of Bone Loss	PLOS ONE			English	Article							SEQUENCE BINDING-PROTEIN; T-CELLS; EPIGENETIC REGULATION; KINASE ACTIVATION; RESPONSE ELEMENT; GENE-EXPRESSION; NUCLEAR-FACTOR; ACTIN RING; IN-VITRO; DIFFERENTIATION	Diseases of bone loss are a major public health problem. Here, we report the novel therapeutic action of simvastatin in osteoclastogenesis and osteoprotection, demonstrated by the ability of simvastatin to suppress osteoclast formation in vitro and in vivo. We found that in vitro, IRF4 expression is upregulated during osteoclast differentiation induced by RANKL (receptor activator of nuclear factor-kappa B ligand), while simvastatin blocks RANKL-induced osteoclastogenesis and decreases expression of NFATc1 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1), IRF4 and osteoclast markers. We also show that IRF4 acts in cooperation with NFATc2 and NF-kappa B on the promoter region of NFATc1 to accelerate its initial transcription during the early stage of osteoclastogenesis. Moreover, our study using IRF4 siRNA knockdown directly demonstrates the requirement for IRF4 in NFATc1 mRNA transcription and its necessity in RANKL-induced osteoclast differentiation. Our results suggest that the reduction in osteoclastogenesis is partly due to the inhibition of IRF4 production in RANKL-induced osteoclast differentiation. To investigate the in vivo effects of simvastatin in RANKL-treated mice, we examined the bone mineral density (BMD) of a mouse model of bone loss, and found that simvastatin significantly reduced bone loss by suppressing osteoclast numbers in vivo, even in the presence of high concentrations of RANKL. These results suggest that the depletion of osteoclasts is not due to the reduction in RANKL produced by osteoblasts in vivo. The results are consistent with the hypothesis that simvastatin blocks RANKL-induced IRF4 expression in osteoclastogenesis. We propose that the expression of IRF4 by osteoclasts could be a promising new therapeutic target in bone-loss diseases.	[Nakashima, Yoshiki; Haneji, Tatsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Tokushima 770, Japan	Tokushima University	Nakashima, Y (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Tokushima 770, Japan.	nakashimayoshiki@tokushima-u.ac.jp		Nakashima, Yoshiki/0000-0003-1827-7609	MEXT/JSPS KAKENHI [21592330]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI (grant number 21592330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Chellaiah MA, 2003, J BIOL CHEM, V278, P29086, DOI 10.1074/jbc.M211074200; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Crotti TN, 2008, J CELL PHYSIOL, V215, P636, DOI 10.1002/jcp.21344; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Edwards CJ, 2000, LANCET, V355, P2218, DOI 10.1016/S0140-6736(00)02408-9; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Haneji T, 2012, ACTA HISTOCHEM CYTOC, V45, P1, DOI 10.1267/ahc.11041; Hirai F, 2007, BIOCHEM BIOPH RES CO, V356, P279, DOI 10.1016/j.bbrc.2007.02.121; Hu LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013305; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Lee MS, 2009, J IMMUNOL, V183, P3390, DOI 10.4049/jimmunol.0804314; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Markovic-Plese S, 2008, FUTUR NEUROL, V3, P153, DOI 10.2217/14796708.3.2.153; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakashima Y, 2010, ANN NY ACAD SCI, V1200, P104, DOI 10.1111/j.1749-6632.2010.05504.x; Okamura H, 2012, J CELL PHYSL; Park EK, 2004, BIOCHEM BIOPH RES CO, V325, P1472, DOI 10.1016/j.bbrc.2004.10.197; Pedchenko TV, 2005, AM J PHYSIOL-LUNG C, V289, pL429, DOI 10.1152/ajplung.00046.2005; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rosenbauer F, 1999, BLOOD, V94, P4274, DOI 10.1182/blood.V94.12.4274.424k05_4274_4281; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teramachi J, 2010, EXP CELL RES, V316, P3254, DOI 10.1016/j.yexcr.2010.08.006; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Woo JT, 2000, J BONE MINER RES, V15, P650, DOI 10.1359/jbmr.2000.15.4.650; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yasui T, 2011, ANN NY ACAD SCI, V1240, P7, DOI 10.1111/j.1749-6632.2011.06245.x; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Zhang X, 2011, J IMMUNOL, V187, P3431, DOI 10.4049/jimmunol.1100580; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	49	29	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e72033	10.1371/journal.pone.0072033	http://dx.doi.org/10.1371/journal.pone.0072033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24039733	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500008
J	Liu, LJ; Li, Y; Sha, K; Wang, Y; He, X				Liu, Li-Juan; Li, Yun; Sha, Kun; Wang, Yue; He, Xiang			Patient Assessment of Chronic Illness Care, Glycemic Control and the Utilization of Community Health Care among the Patients with Type 2 Diabetes in Shanghai, China	PLOS ONE			English	Article							SELF-MANAGEMENT; EXERCISE; MELLITUS; PROGRAM	Objectives: To evaluate the relationship between Patient Assessment of Chronic Illness Care in community health centers and self-management behaviors and glycemic control and to examine the relationship between Patient Assessment of Chronic Illness Care in community health centers and the utilization of community health centers for monitoring and treating diabetes among the patients with type 2 diabetes. Methods: A questionnaire including self-management behaviors, glycemic control, Patient Assessment of Chronic Illness Care in community health centers and the most often utilized medical institutions for monitoring and treating diabetes (community health centers vs. hospitals) was administered to 960 patients with type 2 diabetes in Shanghai, China. The relationships between Patient Assessment of Chronic Illness Care and self-management behaviors, self-management behaviors and glycemic control, Patient Assessment of Chronic Illness Care and glycemic control, Patient Assessment of Chronic Illness Care and the most often utilized medical institutions for monitoring and treating diabetes were examined. Results: Wilcoxon rank sum tests showed that the high scores of total Patient Assessment of Chronic Illness Care and five subscales in community health centers were positively related to almost all the proper self-management behaviors and good glycemic control (p<0.05). Almost all of the proper self-management behaviors were positively related to good glycemic control (p<0.01). High summary score of the Patient Assessment of Chronic Illness Care was positively associated with the utilization of community health centers for monitoring and treating diabetes (p<0.001). Conclusions: Patient Assessment of Chronic Illness Care (implementation of the Chronic Care Model) in community health centers was associated with patients' self-management behaviors and glycemic control, and finally was associated with the utilization of community health centers for monitoring and treating diabetes.	[Liu, Li-Juan; Wang, Yue] Second Mil Med Univ, Training Dept, Off Med Educ, Shanghai, Peoples R China; [Li, Yun] Univ Illinois, Urbana, IL 61801 USA; [Sha, Kun; He, Xiang] Second Mil Med Univ, Training Dept, Shanghai, Peoples R China	Naval Medical University; University of Illinois System; University of Illinois Urbana-Champaign; Naval Medical University	Wang, Y (corresponding author), Second Mil Med Univ, Training Dept, Off Med Educ, Shanghai, Peoples R China.	profwangyue@aliyun.com; profhexiang@aliyun.com	Wang, Yue/AIC-2138-2022		National Natural Science Foundation [70903072]; Shanghai municipal health bureau, Republic of China [2008QN013]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai municipal health bureau, Republic of China	The study was supported by the National Natural Science Foundation (No. 70903072) and Shanghai municipal health bureau, Republic of China (No. 2008QN013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Dib HH, 2010, HEALTH PLACE, V16, P477, DOI 10.1016/j.healthplace.2009.12.005; Duclos M, 2011, PHYSICIAN SPORTSMED, V39, P98, DOI 10.3810/psm.2011.05.1899; Fogelholm M, 2006, SCAND J PUBLIC HEALT, V34, P632, DOI 10.1080/14034940600616039; Fu DB, 2003, B WORLD HEALTH ORGAN, V81, P174; Fu D, 2006, PATIENT EDUC COUNS, V61, P389, DOI 10.1016/j.pec.2005.05.002; Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Gugiu C, 2010, J EVAL CLIN PRACT, V16, P509, DOI 10.1111/j.1365-2753.2009.01151.x; Jylha M, 2004, CAN J AGING, V23, P157, DOI 10.1353/cja.2004.0023; Marrelli Tina, 2011, Home Healthc Nurse, V29, P397, DOI 10.1097/NHH.0b013e318224de9e; Pan XL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-93; Schmittdiel JA, 2006, ANN FAM MED, V4, P117, DOI 10.1370/afm.520; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; *SPSS INC, 1999, SPSS VERS 10 0 WIND; WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002; Xu JL, 2010, RES ASTRON ASTROPHYS, V10, P151, DOI 10.1088/1674-4527/10/2/006; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	20	9	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73010	10.1371/journal.pone.0073010	http://dx.doi.org/10.1371/journal.pone.0073010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039847	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600014
J	Pitzschke, A				Pitzschke, Andrea			Tropaeolum Tops Tobacco - Simple and Efficient Transgene Expression in the Order Brassicales	PLOS ONE			English	Article							TRANSIENT GENE-EXPRESSION; PLANT TRANSFORMATION; MAJUS L.; ARABIDOPSIS; PROTEIN; SYSTEM; COMPLEMENTS; MUTAGENESIS; SEEDLINGS	Transient expression systems are valuable tools in molecular biology. Agrobacterial infiltration of leaves is well-established in tobacco, but has led to limited success in the model plant Arabidopsis thaliana. An efficient expression system combining the advantages of Arabidopsis (well-characterised) and the simplicity of leaf infiltration is desirable. Here, I describe Agrobacterium tumefaciens-mediated transformation of Tropaeolum majus (nasturtium, order Brassicales) as a remarkably simple, cheap and highly efficient transient expression system. It provides the Arabidopsis community with a tool to study subcellular localisation, protein-protein interactions and reporter gene activities (e. g. luciferase, beta-glucuronidase) in a genetic background that is closely related to their primary model organism. Unlike Arabidopsis, Tropaeolum is capable of engaging in endomycorrhizal associations and is therefore relevant also to symbiosis research. RNAi-based approaches are more likely to succeed than in the distantly-related Nicotiana transformation system. Tropaeolum majus was voted the "medicinal plant of the year 2013". Conquering this plant for genetic manipulations harbours potential for biotechnological and pharmacological applications.	Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Pitzschke, A (corresponding author), Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	andrea.pitzschke@boku.ac.at		Pitzschke, Andrea/0000-0002-3451-1429	Austrian Science Foundation [V167-B09]; Austrian Science Fund (FWF) [V 167, P 21851] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	AP gratefully acknowledges the Austrian Science Foundation for funding (Elise-Richter-Grant V167-B09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews LB, 2005, BIOTECHNOL PROGR, V21, P946, DOI 10.1021/bp049569k; Lourenco ELB, 2012, J ETHNOPHARMACOL, V141, P418, DOI 10.1016/j.jep.2012.03.004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crombie HJ, 1998, PLANT J, V15, P27, DOI 10.1046/j.1365-313X.1998.00182.x; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Gasparotto A, 2009, J ETHNOPHARMACOL, V122, P517, DOI 10.1016/j.jep.2009.01.021; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; INITIATIVE AG, 2000, NATURE, V408, P796, DOI DOI 10.1038/35048692; Kleinwachter M, 2008, J AGR FOOD CHEM, V56, P11165, DOI 10.1021/jf802053n; Rivera AL, 2012, PHYS LIFE REV, V9, P308, DOI 10.1016/j.plrev.2012.06.002; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Mietkiewska E, 2006, PLANT SCI, V171, P187, DOI 10.1016/j.plantsci.2006.03.006; Parinov S, 2000, CURR OPIN BIOTECH, V11, P157, DOI 10.1016/S0958-1669(00)00075-6; Persak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057547; PINTAO AM, 1995, PLANTA MED, V61, P233, DOI 10.1055/s-2006-958062; Piotrzkowski N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045803; Pitzschke A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-14; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Rakoczy-Trojanowska M, 2002, CELL MOL BIOL LETT, V7, P849; Silva MEPF, 2011, AN ACAD BRAS CIENC, V83, P1251, DOI 10.1590/S0001-37652011005000046; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x	28	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73355	10.1371/journal.pone.0073355	http://dx.doi.org/10.1371/journal.pone.0073355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039923	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600028
J	Yeon, SE; No, DY; Lee, SH; Nam, SW; Oh, IH; Lee, J; Kuh, HJ				Yeon, Sang-Eun; No, Da Yoon; Lee, Sang-Hoon; Nam, Suk Woo; Oh, Il-Hoan; Lee, Jaehwi; Kuh, Hyo-Jeong			Application of Concave Microwells to Pancreatic Tumor Spheroids Enabling Anticancer Drug Evaluation in a Clinically Relevant Drug Resistance Model	PLOS ONE			English	Article							CANCER; CULTURE; CELLS; MICROENVIRONMENT; SIZE; ADENOCARCINOMA; PENETRATION; SCAFFOLDS; GROWTH; 3-D	Intrinsic drug resistance of pancreatic ductal adenocarcinoma (PDAC) warrants studies using models that are more clinically relevant for identifying novel resistance mechanisms as well as for drug development. Tumor spheroids (TS) mimic in vivo tumor conditions associated with multicellular resistance and represent a promising model for efficient drug screening, however, pancreatic cancer cells often fail to form spheroids using conventional methods such as liquid overlay. This study describes the induction of TS of human pancreatic cancer cells (Panc-1, Aspc-1, Capan-2) in concave polydimethylsiloxane (PDMS) microwell plates and evaluation of their usefulness as an anticancer efficacy test model. All three cell lines showed TS formation with varying degree of necrosis inside TS. Among these, Panc-1 spheroid with spherical morphology, a rather rough surface, and unique adhesion structures were successfully produced with no notable necrosis in concave microwell plates. Panc-1 TS contained growth factors or enzymes such as TGF-beta 1, CTGF, and MT1-MMP, and extracellular matrix proteins such as collagen type I, fibronectin, and laminin. Panc-1 cells grown as TS showed changes in stem cell populations and in expression levels of miRNAs that may play roles in chemoresistance. Visualization of drug penetration and detection of viability indicators, such as Ki-67 and MitoSOX, were optimized for TS for quantitative analysis. Water-soluble tetrazolium (MTS) and acid phosphatase (APH) assays were also successfully optimized. Overall, we demonstrated that concave PDMS microwell plates are a novel platform for preparation of TS of weakly aggregating cells and that Panc-1 spheroids may represent a novel three-dimensional model for anti-pancreatic cancer drug screening.	[Yeon, Sang-Eun; Kuh, Hyo-Jeong] Catholic Univ Korea, Coll Med, Dept Biomed Sci, Lab Oncopharmacol & Expt Therapeut, Seoul, South Korea; [Nam, Suk Woo] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul, South Korea; [Oh, Il-Hoan] Catholic Univ Korea, Coll Med, Catholic High Performance Cell Therapy Ctr, Seoul, South Korea; [Nam, Suk Woo; Oh, Il-Hoan; Kuh, Hyo-Jeong] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea; [No, Da Yoon; Lee, Sang-Hoon] Korea Univ, Coll Hlth Sci, Dept Biomed Engn, Seoul, South Korea; [Lee, Jaehwi] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Korea University; Chung Ang University	Kuh, HJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Biomed Sci, Lab Oncopharmacol & Expt Therapeut, Seoul, South Korea.	hkuh@catholic.ac.kr			National Research Foundation of Korea (NRF); Korea government (MEST) [2012R1A2A2A01003361, 2012R1A5A2047939]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A2A2A01003361 and No. 2012R1A5A2047939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Al-Abd AM, 2008, CANCER SCI, V99, P423, DOI 10.1111/j.1349-7006.2007.00700.x; Anada T, 2010, SENSOR ACTUAT B-CHEM, V147, P376, DOI 10.1016/j.snb.2010.01.065; Bednar F, 2011, J GASTROENTEROL, V46, P1345, DOI 10.1007/s00535-011-0494-7; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115; Costello E, 2012, NAT REV GASTRO HEPAT, V9, P435, DOI 10.1038/nrgastro.2012.119; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gaviraghi M, 2011, BIOSCIENCE REP, V31, P45, DOI 10.1042/BSR20100018; Hicks KO, 2006, JNCI-J NATL CANCER I, V98, P1118, DOI 10.1093/jnci/djj306; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Hu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057250; Jeong GS, 2012, LAB CHIP, V12, P159, DOI 10.1039/c1lc20619b; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Joung KE, 2012, BIOMOL THER, V20, P81, DOI 10.4062/biomolther.2012.20.1.081; Kang E, 2012, ADV MATER, V24, P4271, DOI 10.1002/adma.201201232; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kim SH, 2009, ARCH PHARM RES, V32, P915, DOI 10.1007/s12272-009-1614-2; Kim Sung Eun, 2012, Journal of Pharmaceutical Investigation, V42, P9, DOI 10.1007/s40005-012-0003-x; LaBarbera DV, 2012, EXPERT OPIN DRUG DIS, V7, P819, DOI 10.1517/17460441.2012.708334; Lee BR, 2012, BIOMATERIALS, V33, P837, DOI 10.1016/j.biomaterials.2011.10.014; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Melo SA, 2012, CLIN CANCER RES, V18, P4234, DOI 10.1158/1078-0432.CCR-11-2010; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nirmalanandhan VS, 2010, ASSAY DRUG DEV TECHN, V8, P581, DOI 10.1089/adt.2010.0276; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Park JY, 2009, LAB CHIP, V9, P2043, DOI 10.1039/b820955c; Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Takagi A, 2007, ANTICANCER RES, V27, P45; Wei HJ, 2011, HEPATOB PANCREAT DIS, V10, P428, DOI 10.1016/S1499-3872(11)60073-8; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028	41	75	77	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73345	10.1371/journal.pone.0073345	http://dx.doi.org/10.1371/journal.pone.0073345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039920	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600027
J	Bouta, EM; Ju, YW; Rahimi, H; de Mesy-Bentley, KL; Wood, RW; Xing, LP; Schwarz, EM				Bouta, Echoe M.; Ju, Yawen; Rahimi, Homaira; de Mesy-Bentley, Karen L.; Wood, Ronald W.; Xing, Lianping; Schwarz, Edward M.			Power Doppler Ultrasound Phenotyping of Expanding versus Collapsed Popliteal Lymph Nodes in Murine Inflammatory Arthritis	PLOS ONE			English	Article							MICROBUBBLE CONTRAST AGENT; EARLY RHEUMATOID-ARTHRITIS; TRANSGENIC MICE; MOUSE MODEL; SYNOVITIS; QUANTIFICATION; JOINTS; LYMPHANGIOGENESIS; ULTRASONOGRAPHY; RELIABILITY	Rheumatoid arthritis is a chronic inflammatory disease manifested by episodic flares in affected joints that are challenging to predict and treat. Longitudinal contrast enhanced-MRI (CE-MRI) of inflammatory arthritis in tumor necrosis factor-transgenic (TNF-Tg) mice has demonstrated that popliteal lymph nodes (PLN) increase in volume and contrast enhancement during the pre-arthritic "expanding" phase of the disease, and then suddenly "collapse" during knee flare. Given the potential of this biomarker of arthritic flare, we aimed to develop a more cost-effective means of phenotyping PLN using ultrasound (US) imaging. Initially we attempted to recapitulate CE-MRI of PLN with subcutaneous footpad injection of US microbubbles (DEFINITY (R)). While this approach allowed for phenotyping via quantification of lymphatic sinuses in PLN, which showed a dramatic decrease in collapsed PLN versus expanding or wild-type (WT) PLN, electron microscopy demonstrated that DEFINITY (R) injection also resulted in destruction of the lymphatic vessels afferent to the PLN. In contrast, Power Doppler (PD) US is innocuous to and efficiently quantifies blood flow within PLN of WT and TNF-Tg mice. PD-US demonstrated that expanding PLN have a significantly higher normalized PD volume (NPDV) versus collapsed PLN (0.553 +/- 0.007 vs. 0.008 +/- 0.003; p < 0.05). Moreover, we define the upper (>0.030) and lower (<0.016) quartile NPDVs in this cohort of mice, which serve as conservative thresholds to phenotype PLN as expanding and collapsed, respectively. Interestingly, of the 12 PLN phenotyped by the two methods, there was disagreement in 4 cases in which they were determined to be expanding by CE-MRI and collapsed by PD-US. Since the adjacent knee had evidence of synovitis in all 4 cases, we concluded that the PD-US phenotyping was correct, and that this approach is currently the safest and most cost-effective in vivo approach to phenotype murine PLN as a biomarker of arthritic flare.	[Bouta, Echoe M.; Ju, Yawen; Rahimi, Homaira; Xing, Lianping; Schwarz, Edward M.] Univ Rochester, Sch Med, Ctr Musculoskeletal Res, Rochester, NY 14627 USA; [Bouta, Echoe M.; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Biomed Engn, Rochester, NY USA; [Ju, Yawen; Xing, Lianping; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Rahimi, Homaira; de Mesy-Bentley, Karen L.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Wood, Ronald W.; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Wood, Ronald W.; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Urol, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Schwarz, EM (corresponding author), Univ Rochester, Sch Med, Ctr Musculoskeletal Res, Rochester, NY 14627 USA.	Edward_Schwarz@URMC.Rochester.edu	Wood, Ronald W/J-5481-2015	Wood, Ronald W/0000-0002-9691-5111; Rahimi, Homaira/0000-0003-4028-7723	National Institutes of Health PHS [T32 AR053459, R01s AR048697, AR053586, AR056702, P01 AI078907, DP2OD006501, P30 AR061307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061307, T32AR053459, R01AR056702, R01AR048697] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006501] Funding Source: NIH RePORTER	National Institutes of Health PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research grants from the National Institutes of Health PHS awards (T32 AR053459; R01s AR048697, AR053586 and AR056702; P01 AI078907; DP2OD006501; and P30 AR061307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrero CG, 2011, NAT REV RHEUMATOL, V7, P85, DOI 10.1038/nrrheum.2010.173; Bruyn GAW, 2012, RHEUMATOLOGY, V51, P1655, DOI 10.1093/rheumatology/kes103; Clavel G, 2008, ANN RHEUM DIS, V67, P1765, DOI 10.1136/ard.2007.083915; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gaffney K, 1998, ANN RHEUM DIS, V57, P152, DOI 10.1136/ard.57.3.152; Green K, 1992, Lens Eye Toxic Res, V9, P85; Gullick NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012516; Guo RL, 2009, ARTHRITIS RHEUM-US, V60, P2666, DOI 10.1002/art.24764; Hammer HB, 2012, CURR RHEUMATOL REP, V14, P438, DOI 10.1007/s11926-012-0266-2; Hammer HB, 2011, ANN RHEUM DIS, V70, P1995, DOI 10.1136/ard.2011.152926; Hammer HB, 2010, ANN RHEUM DIS, V69, P1349, DOI 10.1136/ard.2009.126995; Hartung W, 2012, ARTHRIT CARE RES, V64, P675, DOI 10.1002/acr.21574; Huh YM, 2005, KOREAN J RADIOL, V6, P117, DOI 10.3348/kjr.2005.6.2.117; Hwang JH, 2005, ULTRASOUND MED BIOL, V31, P553, DOI 10.1016/j.ultrasmedbio.2004.12.014; Jee DH, 2010, JPN J OPHTHALMOL, V54, P602, DOI 10.1007/s10384-010-0884-z; Ju YW, 2012, ARTHRITIS RHEUM-US, V64, P2048, DOI 10.1002/art.34448; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Klauser AS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3185; Li J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3452; Li J, 2010, J IMMUNOL, V184, P6142, DOI 10.4049/jimmunol.0903489; Li P, 2003, SPRINGER SEMIN IMMUN, V25, P19, DOI 10.1007/s00281-003-0125-3; Manzo A, 2011, RHEUMATOLOGY, V50, P1395, DOI 10.1093/rheumatology/ker076; McGonagle D, 1999, ARTHRITIS RHEUM, V42, P1706, DOI 10.1002/1529-0131(199908)42:8<1706::AID-ANR20>3.0.CO;2-Z; McHugh KP, 2012, ARTHRITIS RHEUM-US, V64, pS12; McQueen FM, 1998, ANN RHEUM DIS, V57, P350, DOI 10.1136/ard.57.6.350; McQueen FM, 2000, RHEUMATOLOGY, V39, P700, DOI 10.1093/rheumatology/39.7.700; Mitamura Y, 2000, RETINA-J RET VIT DIS, V20, P59, DOI 10.1097/00006982-200001000-00011; Ostergaard M, 1999, ARTHRITIS RHEUM, V42, P918, DOI 10.1002/1529-0131(199905)42:5<918::AID-ANR10>3.0.CO;2-2; Ostergaard M, 1998, MAGN RESON IMAGING, V16, P743, DOI 10.1016/S0730-725X(98)00008-3; Proulx ST, 2008, ARTHRITIS RHEUM-US, V58, P2019, DOI 10.1002/art.23546; Proulx ST, 2007, ANN NY ACAD SCI, V1117, P106, DOI 10.1196/annals.1402.016; Proulx ST, 2007, ARTHRITIS RHEUM-US, V56, P4024, DOI 10.1002/art.23128; Qiu L, 2012, RHEUMATOL INT, V32, P1569, DOI 10.1007/s00296-011-1817-y; Rednic N, 2011, MED ULTRASON, V13, P220; Schueller-Weidekamm C, 2013, RADIOLOGY, V268, P161, DOI 10.1148/radiol.13121733; Stone M, 2001, J RHEUMATOL, V28, P1979; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Tan YK, 2012, RHEUMATOLOGY, V51, P36, DOI 10.1093/rheumatology/kes329; Teh J, 2003, BRIT J RADIOL, V76, P875, DOI 10.1259/bjr/40466706; ter Haar G, 2009, MED BIOL ENG COMPUT, V47, P893, DOI 10.1007/s11517-009-0507-3; Wakefield RJ, 2000, ARTHRITIS RHEUM-US, V43, P2762, DOI 10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-#; Zachary JF, 2006, ULTRASOUND MED BIOL, V32, P1781, DOI 10.1016/j.ultrasmedbio.2005.11.013; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Zhou Q, 2011, ARTHRITIS RHEUM-US, V63, P2318, DOI 10.1002/art.30421	45	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73766	10.1371/journal.pone.0073766	http://dx.doi.org/10.1371/journal.pone.0073766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040061	Green Published, gold			2022-12-25	WOS:000326405300125
J	Harvey, BG; Strulovici-Barel, Y; Vincent, TL; Mezey, JG; Raviram, R; Gordon, C; Salit, J; Tilley, AE; Chung, A; Sanders, A; Crystal, RG				Harvey, Ben-Gary; Strulovici-Barel, Yael; Vincent, Thomas L.; Mezey, Jason G.; Raviram, Ramya; Gordon, Cynthia; Salit, Jacqueline; Tilley, Ann E.; Chung, Augustine; Sanders, Abraham; Crystal, Ronald G.			High Correlation of the Response of Upper and Lower Lobe Small Airway Epithelium to Smoking	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BLOOD-FLOW DISTRIBUTION; GENE-EXPRESSION; CIGARETTE-SMOKING; LUNG-CANCER; TOBACCO-SMOKE; PARTICLE-SIZE; EMPHYSEMA; DEPOSITION; GRAVITY	The distribution of lung disease induced by inhaled cigarette smoke is complex, depending on many factors. With the knowledge that the small airway epithelium (SAE) is the earliest site of smoking-induced lung disease, and that the SAE gene expression is likely sensitive to inhaled cigarette smoke, we compared upper vs. lower lobe gene expression in the SAE within the same cigarette smokers to determine if the gene expression patterns were similar or different. Active smokers (n = 11) with early evidence of smoking-induced lung disease (normal spirometry but low diffusing capacity) underwent bronchoscopy and brushing of the upper and lower lobe SAE in order to compare upper vs lower lobe genome-wide and smoking-responsive gene expression by microarray. Cluster and principal component analysis demonstrated that, for each individual, the expression of the known SAE smoking-responsive genes were highly correlated in upper and lower lobe pairs, although, as expected, there were differences in the smoking-induced changes in gene expression from individual to individual. These observations support the concept that the heterogeneity observed among smokers in the anatomic distribution of smoking-induced disease are not secondary to the topographic differences in the effects of cigarette smoke on the airway epithelium.	[Harvey, Ben-Gary; Tilley, Ann E.; Sanders, Abraham; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY 10021 USA; [Harvey, Ben-Gary; Strulovici-Barel, Yael; Vincent, Thomas L.; Mezey, Jason G.; Raviram, Ramya; Gordon, Cynthia; Salit, Jacqueline; Tilley, Ann E.; Chung, Augustine; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY 10021 USA.	geneticmedicine@med.cornell.edu			National Institutes of Health [P50 HL084936, UL1-RR024143, K23 HL103837]; JP Smith Clinical Scholar Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103837, P50HL084936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JP Smith Clinical Scholar Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health P50 HL084936, and UL1-RR024143; B-GH is supported, in part, by the JP Smith Clinical Scholar Award. AET was supported, in part, by National Institutes of Health, K23 HL103837. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BAKE B, 1974, J APPL PHYSIOL, V37, P8, DOI 10.1152/jappl.1974.37.1.8; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Bernstein DM, 2004, INHAL TOXICOL, V16, P675, DOI 10.1080/08958370490476587; BYERS TE, 1984, JNCI-J NATL CANCER I, V72, P1271; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; COSIO MG, 1980, AM REV RESPIR DIS, V122, P265; de Torres JP, 2011, CHEST, V139, P36, DOI 10.1378/chest.10-0984; DeMeo DL, 2007, AM J RESP CRIT CARE, V176, P42, DOI 10.1164/rccm.200612-1797OC; Galvin I, 2007, BRIT J ANAESTH, V98, P420, DOI 10.1093/bja/aem036; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gietema HA, 2010, RESP MED, V104, P76, DOI 10.1016/j.rmed.2009.08.004; Glenny RW, 2000, J APPL PHYSIOL, V89, P1239, DOI 10.1152/jappl.2000.89.3.1239; Glenny RW, 2000, J APPL PHYSIOL, V89, P742, DOI 10.1152/jappl.2000.89.2.742; Glenny RW, 1997, J APPL PHYSIOL, V82, P902, DOI 10.1152/jappl.1997.82.3.902; GLENNY RW, 1992, J APPL PHYSIOL, V72, P2378, DOI 10.1152/jappl.1992.72.6.2378; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; HARVEY BG, 2008, AM J RESP CRIT CARE, V177, pA960; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hlastala MP, 1996, J APPL PHYSIOL, V81, P1051, DOI 10.1152/jappl.1996.81.3.1051; Hlastala MP, 1998, J APPL PHYSIOL, V84, P1278, DOI 10.1152/jappl.1998.84.4.1278; Hlastala MP, 1999, NEWS PHYSIOL SCI, V14, P182; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; HUGHES JA, 1982, THORAX, V37, P32, DOI 10.1136/thx.37.1.32; HUHTI E, 1983, EUR J RESPIR DIS, V64, P460; Jaffrezic F, 2007, GENET RES, V89, P19, DOI 10.1017/S0016672307008646; Jaques PA, 2000, INHAL TOXICOL, V12, P715; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Kane DB, 2010, INHAL TOXICOL, V22, P199, DOI 10.3109/08958370903161224; Lee BW, 1998, AM J RESP CRIT CARE, V158, P1197, DOI 10.1164/ajrccm.158.4.9804089; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; MacNee W, 2000, CHEST, V117, p303S, DOI 10.1378/chest.117.5_suppl_1.303S-a; NIL R, 1986, CLIN SCI, V71, P595, DOI 10.1042/cs0710595; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; PEARSON MG, 1985, J APPL PHYSIOL, V59, P1828, DOI 10.1152/jappl.1985.59.6.1828; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Robertson HT, 2005, RESP PHYSIOL NEUROBI, V148, P85, DOI 10.1016/j.resp.2005.05.008; SAITO K, 1995, AM J RESP CRIT CARE, V151, P1373, DOI 10.1164/ajrccm.151.5.7735587; Saitoh T, 2000, INVEST RADIOL, V35, P235, DOI 10.1097/00004424-200004000-00004; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Stavngaard T, 2006, RESP MED, V100, P94, DOI 10.1016/j.rmed.2005.04.001; Steiling K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005043; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strulovici-Barel Y, 2010, AM J RESP CRIT CARE, V182, P1524, DOI 10.1164/rccm.201002-0294OC; Surgeon General, 1988, HLTH CONS SMOK NIC A; TAYLOR DR, 1988, THORAX, V43, P65, DOI 10.1136/thx.43.1.65; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Wang GQ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-21; WEIBEL ER, 1997, LUNG SCI FDN, V0001, P01061; WRIGHT JL, 1984, THORAX, V39, P282, DOI 10.1136/thx.39.4.282	57	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72669	10.1371/journal.pone.0072669	http://dx.doi.org/10.1371/journal.pone.0072669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039793	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300020
J	Khan, AM; Ashfaq, M; Kiss, Z; Khan, AA; Mansoor, S; Falk, BW				Khan, Arif Muhammad; Ashfaq, Muhammad; Kiss, Zsofia; Khan, Azhar Abbas; Mansoor, Shahid; Falk, Bryce W.			Use of Recombinant Tobacco Mosaic Virus To Achieve RNA Interference in Plants against the Citrus Mealybug, Planococcus citri (Hemiptera: Pseudococcidae)	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA; GENE; DSRNA; EXPRESSION; KNOCKDOWN; INGESTION; INSECTS; GENOME	The citrus mealybug, Planococcus citri, is an important plant pest with a very broad plant host range. P. citri is a phloem feeder and loss of plant vigor and stunting are characteristic symptoms induced on a range of host plants, but P. citri also reduces fruit quality and causes fruit drop leading to significant yield reductions. Better strategies for managing this pest are greatly needed. RNA interference (RNAi) is an emerging tool for functional genomics studies and is being investigated as a practical tool for highly targeted insect control. Here we investigated whether RNAi effects can be induced in P. citri and whether candidate mRNAs could be identified as possible targets for RNAi-based P. citri control. RNAi effects were induced in P. citri, as demonstrated by specific target reductions of P. citri actin, chitin synthase 1 and V-ATPase mRNAs after injection of the corresponding specific double-stranded RNA inducers. We also used recombinant Tobacco mosaic virus (TMV) to express these RNAi effectors in Nicotiana benthamiana plants. We found that P. citri showed lower fecundity and pronounced death of crawlers after feeding on recombinant TMV-infected plants. Taken together, our data show that actin, chitin synthase 1 and V-ATPase mRNAs are potential targets for RNAi against P. citri, and that recombinant TMV is an effective tool for evaluating candidate RNAi effectors in plants.	[Khan, Arif Muhammad; Ashfaq, Muhammad; Mansoor, Shahid] NIBGE, Faisalabad, Pakistan; [Khan, Arif Muhammad] PIEAS, Islamabad, Pakistan; [Khan, Arif Muhammad; Kiss, Zsofia; Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Ashfaq, Muhammad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Khan, Azhar Abbas] Univ Sargodha, Dept Entomol, Sargodha, Pakistan	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; University of California System; University of California Davis; University of Guelph; University of Sargodha	Falk, BW (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bwfalk@ucdavis.edu	Ashfaq, Muhammad/J-4723-2019; Khan, Azhar/AAQ-6876-2020; Khan, Azhar Abbas/ABH-1865-2020	Ashfaq, Muhammad/0000-0003-1351-4126; Khan, Azhar Abbas/0000-0002-3227-5186; Mansoor, Shahid/0000-0001-7418-1826; Yan, Zhiyong/0000-0001-8253-0694	University of California; Higher Education Commission of Pakistan	University of California(University of California System); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The authors would like to thank Higher Education Commission of Pakistan for providing funding to Mr. Arif Muhammad Khan for conducting this research. This work also was supported in part by the University of California The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Bhaskar PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005812; BIVINS JL, 1973, CALIF AGR, V27, P5; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carrington JC, 2001, VIROLOGY, V281, P1, DOI 10.1006/viro.2000.0812; Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281; Fayyaz-ur-Rehman M, 2009, OPEN ENZYM INHIB J, V2, P8; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Griebler M, 2008, J INSECT PHYSIOL, V54, P997, DOI 10.1016/j.jinsphys.2008.04.019; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Marcus JM, 2005, EVOL DEV, V7, P108, DOI 10.1111/j.1525-142X.2005.05012.x; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; Rosa C, 2012, PEST MANAG SCI, V68, P995, DOI 10.1002/ps.3253; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Swevers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020250; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	43	36	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73657	10.1371/journal.pone.0073657	http://dx.doi.org/10.1371/journal.pone.0073657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040013	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300105
J	Kodama, Y; Johannessen, H; Furnes, MW; Zhao, CM; Johnsen, G; Marvik, R; Kulseng, B; Chen, D				Kodama, Yosuke; Johannessen, Helene; Furnes, Marianne W.; Zhao, Chun-Mei; Johnsen, Gjermund; Marvik, Ronald; Kulseng, Bard; Chen, Duan			Mechanistic Comparison between Gastric Bypass vs. Duodenal Switch with Sleeve Gastrectomy in Rat Models	PLOS ONE			English	Article							BODY-WEIGHT LOSS; ENERGY-EXPENDITURE; METABOLIC SURGERY; EATING BEHAVIOR; OBESITY; LIFE; FOOD	Background: Both gastric bypass (GB) and duodenal switch with sleeve gastrectomy (DS) have been widely used as bariatric surgeries, and DS appears to be superior to GB. The aim of this study was to better understand the mechanisms leading to body weight loss by comparing these two procedures in experimental models of rats. Methods: Animals were subjected to GB, DS or laparotomy (controls), and monitored by an open-circuit indirect calorimeter composed of comprehensive laboratory animal monitoring system and adiabatic bomb calorimeter. Results: Body weight loss was greater after DS than GB. Food intake was reduced after DS but not GB. Energy expenditure was increased after either GB or DS. Fecal energy content was increased after DS but not GB. Conclusion: GB induced body weight loss by increasing energy expenditure, whereas DS induced greater body weight loss by reducing food intake, increasing energy expenditure and causing malabsorption in rat models.	[Kodama, Yosuke; Johannessen, Helene; Furnes, Marianne W.; Zhao, Chun-Mei; Kulseng, Bard; Chen, Duan] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Johnsen, Gjermund; Marvik, Ronald; Kulseng, Bard; Chen, Duan] St Olavs Univ Hosp, Dept Surg, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Chen, D (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	duan.chen@ntnu.no	Chen, De/D-4330-2015	Chen, De/0000-0002-5609-5825; Johannessen, Helene/0000-0002-1743-5321	Central Norway Regional Health Authority; European Union Seventh Framework Programme (FP7/2007-2013) [266408]	Central Norway Regional Health Authority; European Union Seventh Framework Programme (FP7/2007-2013)	The present research has been supported by funding from the Central Norway Regional Health Authority, and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n 266408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthone GJ, 2003, ANN SURG, V238, P618, DOI 10.1097/01.sla.0000090941.61296.8f; Ashrafian H, 2010, OBES REV, V11, P907, DOI 10.1111/j.1467-789X.2009.00701.x; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Bueter M, 2011, INT J OBESITY, V35, pS35, DOI 10.1038/ijo.2011.146; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Dapri G, 2011, SURG OBES RELAT DIS, V7, P703, DOI 10.1016/j.soard.2011.09.007; DEMEESTER TR, 1987, ANN SURG, V206, P414, DOI 10.1097/00000658-198710000-00003; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; EARLAM R, 1983, BRIT J SURG, V70, P393, DOI 10.1002/bjs.1800700702; Furnes MW, 2008, EUR SURG RES, V40, P279, DOI 10.1159/000114966; Furnes MW, 2008, OBES SURG, V18, P415, DOI 10.1007/s11695-007-9392-8; Furnes MW, 2009, OBES SURG, V19, P1430, DOI 10.1007/s11695-009-9863-1; Hill JO, 1999, AM J CLIN NUTR, V69, P1064; Iossa S, 1999, J NUTR, V129, P1593, DOI 10.1093/jn/129.8.1593; Johannessen H, 2013, OBES SURG, V23, P39, DOI 10.1007/s11695-012-0750-9; Kodama Y, 2010, J GASTROINTEST SURG, V14, P1502, DOI 10.1007/s11605-010-1315-7; Laurenius A, 2012, INT J OBESITY, V36, P348, DOI 10.1038/ijo.2011.217; Laurenius A, 2010, SURG OBES RELAT DIS, V6, P408, DOI 10.1016/j.soard.2010.03.293; Lee WJ, 2012, OBES SURG; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; MacLean LD, 2000, ANN SURG, V231, P524, DOI 10.1097/00000658-200004000-00011; Mathes CM, 2012, PHYSIOL BEHAV, V107, P476, DOI 10.1016/j.physbeh.2012.02.013; Mathes CM, 2012, PHYSL BEHAV; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Nestoridi E, 2012, ENDOCRINOLOGY; Noun R, 2012, OBES SURG, V22, P697, DOI 10.1007/s11695-012-0618-z; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Owen SV, 1998, RES NURS HEALTH, V21, P557, DOI 10.1002/(SICI)1098-240X(199812)21:6<557::AID-NUR9>3.0.CO;2-Z; Prachand VN, 2006, ANN SURG, V244, P611, DOI 10.1097/01.sla.0000239086.30518.2a; Prachand VN, 2010, J GASTROINTEST SURG, V14, P211, DOI 10.1007/s11605-009-1101-6; Roberts SB, 2005, PUBLIC HEALTH NUTR, V8, P1028, DOI 10.1079/PHN2005794; Pereferrer FS, 2011, OBES SURG, V21, P1617, DOI 10.1007/s11695-011-0367-4; Sovik TT, 2010, BRIT J SURG, V97, P160, DOI 10.1002/bjs.6802; Sovik TT, 2011, ANN INTERN MED, V155, P281, DOI 10.7326/0003-4819-155-5-201109060-00005; Stenstrom B, 2006, J GASTROINTEST SURG, V10, P1384, DOI 10.1016/j.gassur.2006.07.005; Strain GW, 2007, SURG OBES RELAT DIS, V3, P31, DOI 10.1016/j.soard.2006.09.002; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Takayama S, 2002, J INT MED RES, V30, P442, DOI 10.1177/147323000203000413; Topart P, 2012, SURG OBES RELAT DIS; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Victorzon M, 2012, MINERVA CHIR, V67, P153; Ward M, 2009, GASTROINTEST ENDOSC, V70, P985, DOI 10.1016/j.gie.2009.09.001; Zelova J, 2011, COMP BIOCHEM PHYS A, V158, P17, DOI 10.1016/j.cbpa.2010.07.026; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72896	10.1371/journal.pone.0072896	http://dx.doi.org/10.1371/journal.pone.0072896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039816	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300034
J	Li, JQ; Ba, Q; Yin, J; Wu, SJ; Zhuan, FF; Xu, SC; Li, JY; Salazar, JK; Zhang, W; Wang, H				Li, Jingquan; Ba, Qian; Yin, Jun; Wu, Songjie; Zhuan, Fangfang; Xu, Songci; Li, Junyang; Salazar, Joelle K.; Zhang, Wei; Wang, Hui			Surface Display of Recombinant Drosophila melanogaster Acetylcholinesterase for Detection of Organic Phosphorus and Carbamate Pesticides	PLOS ONE			English	Article							CHRONIC NEUROLOGICAL SEQUELAE; CAPILLARY GAS-CHROMATOGRAPHY; YEAST-CELL-SURFACE; INSECTICIDE RESIDUES; ORGANOPHOSPHORUS PESTICIDES; MASS SPECTROMETRY; WASHINGTON-STATE; PICHIA-PASTORIS; EXPRESSION; CLONING	Acetylcholinesterase (AChE) is commonly used for the detection of organophosphate (OP) and carbamate (CB) insecticides. However, the cost of this commercially available enzyme is high, making high- throughput insecticide detection improbable. In this study we constructed a new AChE yeast expression system in Saccharomyces cerevisiae for the expression of a highly reactive recombinant AChE originating from Drosophila melanogaster (DmAChE). Specifically, the coding sequence of DmAChE was fused with the 3'-terminal half of an alpha-agglutinin anchor region, along with an antigen tag for the detection of the recombinant protein. The target sequence was cloned into the yeast expression vector pYes-DEST52, and the signal peptide sequence was replaced with a glucoamylase secretion region for induced expression. The resultant engineered vector was transformed into S. cerevisiae. DmAChE was expressed and displayed on the cell surface after galactose induction. Our results showed that the recombinant protein displayed activity comparable to the commercial enzyme. We also detected different types of OP and CB insecticides through enzyme inhibition assays, with the expressed DmAChE showing high sensitivity. These results show the construction of a new yeast expression system for DmAChE, which can subsequently be used for detecting OP and CB insecticides with reduced economic costs.	[Li, Jingquan; Ba, Qian; Yin, Jun; Wu, Songjie; Zhuan, Fangfang; Xu, Songci; Li, Junyang; Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai, Peoples R China; [Salazar, Joelle K.; Zhang, Wei] Illinois State Univ, Inst Food Safety & Hlth, Bedford Pk, IL USA; [Li, Jingquan; Ba, Qian; Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	Ba, Qian/AAZ-2623-2021	Ba, Qian/0000-0002-7253-7566	One Hundred Talents Program of the Chinese Academy of Sciences; Science and Technology Commission of Shanghai Municipality [10391902100, 08391910800]; National Nature Science Foundation [81125020, 91029715, 31070680, 31101261]; Ministry of Science and Technology of China [2012BAK01B00, 2011BAK10B00, 2009CB919000]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001]; Xuhui Central Hospital [CRC2010002, CRC2011001, CRC2011004]; Director Foundation [20090101]; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS; SIBS; CAS	One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Xuhui District of Shanghai Municipality; Xuhui Central Hospital; Director Foundation; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS; SIBS; CAS(Chinese Academy of Sciences)	This study was supported by grants from One Hundred Talents Program of the Chinese Academy of Sciences, the Science and Technology Commission of Shanghai Municipality (10391902100, 08391910800), the National Nature Science Foundation (81125020, 91029715, 31070680 and 31101261), the Ministry of Science and Technology of China (2012BAK01B00, 2011BAK10B00 and 2009CB919000), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001), and Xuhui Central Hospital (CRC2010002, CRC2011001 and CRC2011004), Director Foundation (20090101) and the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albero B, 2003, J AGR FOOD CHEM, V51, P6915, DOI 10.1021/jf030414m; Barrett JC, 1997, ENVIRON HEALTH PERSP, V105, P699, DOI 10.2307/3433276; Berg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026039; Blanc-Lapierre A, 2012, REV EPIDEMIOL SANTE, V60, P389, DOI 10.1016/j.respe.2012.03.006; Boublik Y, 2002, PROTEIN ENG, V15, P43, DOI 10.1093/protein/15.1.43; COPPAGE DL, 1974, B ENVIRON CONTAM TOX, V11, P483, DOI 10.1007/BF01685308; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eskenazi B, 1999, ENVIRON HEALTH PERSP, V107, P409, DOI 10.1289/ehp.99107s3409; Estrada-Mondaca S, 1998, ARCH INSECT BIOCHEM, V38, P84, DOI 10.1002/(SICI)1520-6327(1998)38:2&lt;84::AID-ARCH4&gt;3.0.CO;2-V; Fernandez M, 2001, J AGR FOOD CHEM, V49, P3540, DOI 10.1021/jf010238m; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gera N, 2013, METHODS, V60, P15, DOI 10.1016/j.ymeth.2012.03.014; Han Z, 2012, ANAL CHIM ACTA, V720, P126, DOI 10.1016/j.aca.2012.01.041; Hicks DA, 2013, CHEM-BIOL INTERACT, V203, P302, DOI 10.1016/j.cbi.2012.09.019; Hofmann JN, 2010, ANN OCCUP HYG, V54, P640, DOI 10.1093/annhyg/meq038; Hofmann JN, 2010, OCCUP ENVIRON MED, V67, P375, DOI 10.1136/oem.2009.046391; Hofmann JN, 2009, AAOHN J, V57, P359, DOI 10.3928/08910162-20090817-01; Hussein AS, 1999, J BIOL CHEM, V274, P9312, DOI 10.1074/jbc.274.14.9312; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; Mendelson I, 1998, BIOCHEM J, V334, P251, DOI 10.1042/bj3340251; Morel N, 1997, BIOCHEM J, V328, P121, DOI 10.1042/bj3280121; MUTERO A, 1992, J BIOL CHEM, V267, P1695; ROSENSTOCK L, 1991, LANCET, V338, P223, DOI 10.1016/0140-6736(91)90356-T; Sandra P, 2003, J CHROMATOGR A, V1000, P299, DOI 10.1016/S0021-9673(03)00508-9; SAVAGE EP, 1988, ARCH ENVIRON HEALTH, V43, P38, DOI 10.1080/00039896.1988.9934372; Scholz NL, 2006, ENVIRON TOXICOL CHEM, V25, P1200, DOI 10.1897/05-030R1.1; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; STEENLAND K, 1994, AM J PUBLIC HEALTH, V84, P731, DOI 10.2105/AJPH.84.5.731; Tan FR, 2011, BIOPROC BIOSYST ENG, V34, P305, DOI 10.1007/s00449-010-0472-0; Temeyer KB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-31; Tham LG, 2009, J ENVIRON BIOL, V30, P135; Uccelletti D, 2002, BIOCHEM BIOPH RES CO, V298, P559, DOI 10.1016/S0006-291X(02)02513-5; Ueda M, 2000, BIOTECHNOL ADV, V18, P121, DOI 10.1016/S0734-9750(00)00031-8; Villatte F, 1998, BIOSENS BIOELECTRON, V13, P157, DOI 10.1016/S0956-5663(97)00108-5; Vinas P, 2003, J AGR FOOD CHEM, V51, P3704, DOI 10.1021/jf021106b; WHITTAKER VP, 1990, TRENDS PHARMACOL SCI, V11, P8, DOI 10.1016/0165-6147(90)90034-6; Wu AB, 2008, CHEM-BIOL INTERACT, V175, P403, DOI 10.1016/j.cbi.2008.04.020; Xu SC, 2007, BIOMOL ENG, V24, P253, DOI 10.1016/j.bioeng.2006.12.002; Yazal JE, 2001, TOXICOL SCI, V63, P223, DOI 10.1093/toxsci/63.2.223; Zhao PC, 2010, J BIOCHEM MOL TOXIC, V24, P51, DOI 10.1002/jbt.20311	40	7	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72986	10.1371/journal.pone.0072986	http://dx.doi.org/10.1371/journal.pone.0072986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039837	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300039
J	Meijaard, E; Abram, NK; Wells, JA; Pellier, AS; Ancrenaz, M; Gaveau, DLA; Runting, RK; Mengersen, K				Meijaard, Erik; Abram, Nicola K.; Wells, Jessie A.; Pellier, Anne-Sophie; Ancrenaz, Marc; Gaveau, David L. A.; Runting, Rebecca K.; Mengersen, Kerrie			People's Perceptions about the Importance of Forests on Borneo	PLOS ONE			English	Article							LAND-USE CHANGE; ENVIRONMENTAL SERVICES; ECOSYSTEM SERVICES; TROPICAL FORESTS; EAST KALIMANTAN; CONSERVATION; MANAGEMENT; IMPACT; DEFORESTATION; PLANTATIONS	We ascertained villagers' perceptions about the importance of forests for their livelihoods and health through 1,837 reliably answered interviews of mostly male respondents from 185 villages in Indonesian and Malaysian Borneo. Variation in these perceptions related to several environmental and social variables, as shown in classification and regression analyses. Overall patterns indicated that forest use and cultural values are highest among people on Borneo who live close to remaining forest, and especially among older Christian residents. Support for forest clearing depended strongly on the scale at which deforestation occurs. Deforestation for small-scale agriculture was generally considered to be positive because it directly benefits people's welfare. Large-scale deforestation (e.g., for industrial oil palm or acacia plantations), on the other hand, appeared to be more context-dependent, with most respondents considering it to have overall negative impacts on them, but with people in some areas considering the benefits to outweigh the costs. The interviews indicated high awareness of negative environmental impacts of deforestation, with high levels of concern over higher temperatures, air pollution and loss of clean water sources. Our study is unique in its geographic and trans-national scale. Our findings enable the development of maps of forest use and perceptions that could inform land use planning at a range of scales. Incorporating perspectives such as these could significantly reduce conflict over forest resources and ultimately result in more equitable development processes.	[Meijaard, Erik; Abram, Nicola K.; Wells, Jessie A.; Ancrenaz, Marc; Gaveau, David L. A.; Runting, Rebecca K.] People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia; [Meijaard, Erik; Wells, Jessie A.; Runting, Rebecca K.] Univ Queensland, Ctr Biodivers & Conservat Sci, Australian Res Council Ctr Excellence Environm De, Brisbane, Qld, Australia; [Meijaard, Erik; Pellier, Anne-Sophie; Gaveau, David L. A.] Ctr Int Forestry Res, Bogor, Indonesia; [Abram, Nicola K.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc] Hutan Kinabatangan Orang Utan Conservat Programme, Sandakan, Sabah, Malaysia; [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England; [Ancrenaz, Marc] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia	People & Nature Consulting International; University of Queensland; CGIAR; Center for International Forestry Research (CIFOR); University of Kent; Queensland University of Technology (QUT)	Meijaard, E (corresponding author), People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia.	emeijaard@gmail.com	Runting, Rebecca/I-1470-2013; Mengersen, Kerrie/AHC-4096-2022; Wells, Jessie A/F-7318-2010; Meijaard, Erik/A-2687-2016; Abram, Nicola/K-2060-2014	Runting, Rebecca/0000-0003-0614-1456; Wells, Jessie A/0000-0002-3555-5108; Meijaard, Erik/0000-0001-8685-3685; Mengersen, Kerrie/0000-0001-8625-9168; Abram, Nicola/0000-0003-1886-7297	Arcus Foundation; United States Agency for International Development (USAID); Sall Family Foundation	Arcus Foundation; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Sall Family Foundation(European Commission)	The studies were financially supported by the Arcus Foundation, donors of the Nature Conservancy's Adopt an Acre program, the United States Agency for International Development (USAID) (www.usaid.gov/), and the Sall Family Foundation. USAID agreed to the study being conducted. The Arcus Foundation, USAID, the Sall Family Foundation, and People and Nature Consulting International had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiefnawati R, 2011, 102 ICRAF; Ancrenaz M, ORYX IN PRESS; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Asquith NM, 2008, ECOL ECON, V65, P675, DOI 10.1016/j.ecolecon.2007.12.014; Ave J., 1986, PEOPLE WEEPING FORES; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Benz B., 2012, NAT ED KNOWL, V3, P4; Brown KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024107; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chao S., 2012, FOREST PEOPLES NUMBE; CLEARY M, 1992, BORNEO CHANGE DEV; Colfer C.J.P., 2006, FORESTS HUMAN HLTH A; Dewi S, 2005, WORLD DEV, V33, P1419, DOI 10.1016/j.worlddev.2004.10.006; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forestry Planning Agency, 2011, FOR STAT IND 2011 EX; Forestry Planning Agency, 2001, FOR STAT IND 2001 VE; Godoy R, 2000, NATURE, V406, P62, DOI 10.1038/35017647; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hijmans RJ, 2012, R PACKAGE DISMO DISM; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hungate BA, 2012, NAT CLIM CHANGE, V2, P151, DOI 10.1038/nclimate1398; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; KAIMOWITZ D, 2005, INT HYDROL SER, P86; Knapen H, 2001, FORESTS FORTUNE ENV; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Kosoy N, 2007, ECOL ECON, V61, P446, DOI 10.1016/j.ecolecon.2006.03.016; Larson A.M., 2010, FORESTS PEOPLE COMMU; Law EA, 2012, NAT CLIM CHANGE, V2, P155, DOI [10.1038/NCLIMATE1376, 10.1038/nclimate1376]; Leadley P.W., 2010, CBD TECHNICAL SERIES, V50; LYNAM TJP, 2006, LIVELIHOODS LAND TYP; Meijaard E, 2013, INDONESIAS IN PRESS; Meijaard E., 2011, 66 CIFOR; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mulyoutami E, 2009, FOREST ECOL MANAG, V257, P2054, DOI 10.1016/j.foreco.2009.01.042; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pierce Colfer CJ, 1998, MANUSIA LINGKUNGAN H, V15, P3; Pramova E, 2012, WIRES CLIM CHANGE, V3, P581, DOI 10.1002/wcc.195; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Raymond CM, 2009, ECOL ECON, V68, P1301, DOI 10.1016/j.ecolecon.2008.12.006; Republic of Indonesia, 2012, GOVT REGULATION NUMB; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Ronnback P, 2007, ENVIRON CONSERV, V34, P313, DOI 10.1017/S0376892907004225; Sayer JA, 2012, INT FOREST REV, V14, P90, DOI 10.1505/146554812799973172; Sheil D, 2006, AMBIO, V35, P17, DOI 10.1579/0044-7447-35.1.17; Sheil D, 2002, CONSERV ECOL, V6; Sheil D, 2009, BIOSCIENCE, V59, P341, DOI 10.1525/bio.2009.59.4.12; Sheil Douglas, 2009, 51 CIFOR; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019; Smit H, 2013, PLOS ONE IN PRESS; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P1175, DOI 10.1007/s10531-009-9745-9; Spangenberg JH, 2010, ECOL COMPLEX, V7, P327, DOI 10.1016/j.ecocom.2010.04.007; Therneau T, 2012, RPART PACKAGE RECURS; Tomich TP, 2004, AGR ECOSYST ENVIRON, V104, P229, DOI 10.1016/j.agee.2004.01.017; Topp-Jorgensen E, 2005, BIODIVERS CONSERV, V14, P2653, DOI 10.1007/s10531-005-8399-5; Turner WR, 2012, BIOSCIENCE, V62, P85, DOI 10.1525/bio.2012.62.1.13; Vihervaara P, 2012, FOREST POLICY ECON, V14, P58, DOI 10.1016/j.forpol.2011.08.008; Wadley RL, 2004, HUM ECOL, V32, P313, DOI 10.1023/B:HUEC.0000028084.30742.d0; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717; Whitten T, 2004, HOTSPOTS REVISITED A; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Wollenberg E, 1998, METHODS DEV CONSERVA; World Bank, 2004, SUST FOR DEV STRAT; Wunder S, 2001, WORLD DEV, V29, P1817, DOI 10.1016/S0305-750X(01)00070-5; Zhang H, 1996, J CLIMATE, V9, P1497, DOI 10.1175/1520-0442(1996)009<1497:IOTDPI>2.0.CO;2	72	68	71	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73008	10.1371/journal.pone.0073008	http://dx.doi.org/10.1371/journal.pone.0073008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244QV	24039845	Green Published, gold			2022-12-25	WOS:000326405300043
J	Park, JE; Ao, L; Miller, Z; Kim, K; Wu, Y; Jang, ER; Lee, EY; Kim, KB; Lee, W				Park, Ji Eun; Ao, Lin; Miller, Zachary; Kim, Kyungbo; Wu, Ying; Jang, Eun Ryoung; Lee, Eun Young; Kim, Kyung Bo; Lee, Wooin			PSMB9 Codon 60 Polymorphisms Have No Impact on the Activity of the Immunoproteasome Catalytic Subunit B1i Expressed in Multiple Types of Solid Cancer	PLOS ONE			English	Article							ANTIGEN-PROCESSING MACHINERY; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; PROTEASOME INHIBITORS; LMP2 POLYMORPHISM; CELL CARCINOMA; DISEASE; ASSOCIATION; GENE; AMERINDIANS	The proteasome is a key regulator of cellular protein homeostasis and is a clinically validated anticancer target. The immunoproteasome, a subtype of proteasome expressed mainly in hematopoietic cells, was initially recognized for its role in antigen presentation during the immune response. Recently, the immunoproteasome has been implicated in several disease conditions including cancer and autoimmune disorders, but many of the factors contributing to these pathological processes remain unknown. In particular, the codon 60 polymorphism of the PSMB9 gene encoding the beta 1i immunoproteasome catalytic subunit has been investigated in the context of a variety of diseases. Despite this, previous studies have so far reported inconsistent findings regarding the impact of this polymorphism on proteasome activity. Thus, we set out to investigate the impact of the PSMB9 codon 60 polymorphism on the expression and activity of the beta 1i immunoproteasome subunit in a panel of human cancer cell lines. The beta 1i-selective fluorogenic substrate Acetyl-Pro-Ala-Leu-7-amino-4-methylcoumarin was used to specifically measure beta 1i catalytic activity. Our results indicate that the codon 60 Arg/His polymorphism does not significantly alter the expression and activity of beta 1i among the cell lines tested. Additionally, we also examined the expression of beta 1i in clinical samples from colon and pancreatic cancer patients. Our immunohistochemical analyses showed that similar to 70% of clinical colon cancer samples and similar to 53% of pancreatic cancer samples have detectable beta 1i expression. Taken together, our results indicate that the beta 1i subunit of the immunoproteasome is frequently expressed in colon and pancreatic cancers but that the codon 60 genetic variants of beta 1i display similar catalytic activities and are unlikely to contribute to the significant inter-cell-line and inter-individual variabilities in the immunoproteasome activity.	[Park, Ji Eun; Ao, Lin; Miller, Zachary; Kim, Kyungbo; Wu, Ying; Jang, Eun Ryoung; Kim, Kyung Bo; Lee, Wooin] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Lee, Eun Young] Univ Kentucky, Coll Med, Dept Pathol & Lab Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Lee, W (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA.	wooin.lee@uky.edu	Lee, Wooin/K-7789-2012	Lee, Wooin/0000-0001-7805-869X	National Cancer Institute [R15CA156601, R01CA128903]; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [R15CA156601, R01CA128903] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute grants, R15CA156601 and R01CA128903 and Kentucky Lung Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; DENG GY, 1995, AM J HUM GENET, V56, P528; Faucz FR, 2000, EUR J IMMUNOGENET, V27, P5; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; Goncharov S V, 2009, Fiziol Zh, V55, P3; Heward JM, 1999, CLIN ENDOCRINOL, V51, P115, DOI 10.1046/j.1365-2265.1999.00755.x; Ho YK, 2007, CHEM BIOL, V14, P419, DOI 10.1016/j.chembiol.2007.03.008; Imanishi Tatsuya, 2006, Kobe Journal of Medical Sciences, V52, P85; Jang ER, 2012, MOL BIOSYST, V8, P2295, DOI 10.1039/c2mb25125f; Kang JO, 2000, INT J ONCOL, V16, P1159; Kim KB, 2005, METHOD ENZYMOL, V399, P585, DOI 10.1016/S0076-6879(05)99039-3; Kuhn DJ, 2012, SEMIN HEMATOL, V49, P258, DOI 10.1053/j.seminhematol.2012.04.003; Lichter DI, 2012, BLOOD; Lin G, 2008, J BIOL CHEM, V283, P34423, DOI 10.1074/jbc.M805324200; Liu Q, 2009, SCAND J GASTROENTERO, V44, P960, DOI 10.1080/00365520902998679; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Maksymowych WP, 2000, J RHEUMATOL, V27, P183; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Meidenbauer N, 2004, CANCER RES, V64, P6319, DOI 10.1158/0008-5472.CAN-04-1341; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Miller Z, 2013, CURR PHARM IN PRESS; Mishto M, 2006, BIOL CHEM, V387, P417, DOI 10.1515/BC.2006.056; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8; Mishto M, 2002, EXP GERONTOL, V37, P301, DOI 10.1016/S0531-5565(01)00196-6; Mishto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009287; Murakami Y, 2001, MOL UROL, V5, P113, DOI 10.1089/10915360152559594; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Piccinini M, 2003, J NEUROIMMUNOL, V135, P135, DOI 10.1016/S0165-5728(02)00439-3; Ritz U, 2001, INT J ONCOL, V19, P1211; Singh AV, 2011, BRIT J HAEMATOL, V152, P155, DOI 10.1111/j.1365-2141.2010.08491.x; Vargas-Alarcon G, 2002, GENES IMMUN, V3, P373, DOI 10.1038/sj.gene.6363855; Vinasco J, 1998, ANN RHEUM DIS, V57, P33, DOI 10.1136/ard.57.1.33; Wehenkel M, 2012, BRIT J CANCER, V107, P53, DOI 10.1038/bjc.2012.243	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73732	10.1371/journal.pone.0073732	http://dx.doi.org/10.1371/journal.pone.0073732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040045	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300120
J	Pavlidou, M; Hanel, K; Mockel, L; Willbold, D				Pavlidou, Marina; Haenel, Karen; Moeckel, Luis; Willbold, Dieter			Nanodiscs Allow Phage Display Selection for Ligands to Non-Linear Epitopes on Membrane Proteins	PLOS ONE			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; PEPTIDE; BACTERIORHODOPSIN; RECEPTOR; LIBRARY; MIRROR; IDENTIFICATION; BINDING; SURFACE; SIZE	In this work, we exploited a method that uses polytopic membrane proteins as targets for phage display selections. Membrane proteins represent the largest class of drug targets and drug discovery is mostly based on the identification of ligands binding to target molecules. The screening of a phage display library for ligands against membrane proteins is typically hindered by the requirement of these proteins for a membrane environment, which is necessary to retain correct folding and epitope formation. Especially in proteins with multiple transmembrane domains, epitopes often are non-linear and consist of a combination of loops between transmembrane stretches of the proteins. Here, we have used bacteriorhodopsin (bR) as a model of polytopic membrane protein, assembled into nanoscale phospholipid bilayers, so called nanodiscs, to screen a phage display library for potential ligands. Nanodiscs provide a native-like environment to membrane proteins and thus selection of ligands can take place in a near physiological state. Screening a 12-mer phage display peptide library against bR nanodiscs led to the isolation of phage clones binding specifically to bR. We were further able to identify the binding site of selected phage clones proving that the clones bind to extramembranous, non-linear epitopes of bR. Thus, nanodiscs provide a suitable and general tool that allows screening of a phage display library against membrane proteins in a near native environment.	[Pavlidou, Marina; Haenel, Karen; Moeckel, Luis; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Pavlidou, Marina; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Hänel, Karen O/G-9431-2013; Möckel, Luis/AAA-7282-2022; Willbold, Dieter/A-6280-2013	Hänel, Karen O/0000-0001-8314-9668; Möckel, Luis/0000-0002-1338-8433; Willbold, Dieter/0000-0002-0065-7366	CLIB-Graduate Cluster Industrial Biotechnology	CLIB-Graduate Cluster Industrial Biotechnology	MP was supported by a fellowship from the CLIB-Graduate Cluster Industrial Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Borch J, 2008, ANAL CHEM, V80, P6245, DOI 10.1021/ac8000644; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; DENCHER NA, 1983, BIOCHEMISTRY-US, V22, P1323, DOI 10.1021/bi00275a002; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Engelhard M, 1996, EUR J BIOCHEM, V235, P526, DOI 10.1111/j.1432-1033.1996.00526.x; Gluck JM, 2011, ANAL BIOCHEM, V408, P46, DOI 10.1016/j.ab.2010.08.028; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Hoffmann S, 2010, MOL BIOSYST, V6, P126, DOI 10.1039/b910945e; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Labrijn AF, 2002, J IMMUNOL METHODS, V261, P37, DOI 10.1016/S0022-1759(01)00542-7; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Vrielink J, 2010, FEBS J, V277, P1653, DOI 10.1111/j.1742-4658.2010.07590.x; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang FY, 2006, BIOSCI BIOTECH BIOCH, V70, P2035, DOI 10.1271/bbb.50654; Wang JP, 2002, BIOPHYS J, V83, P1557, DOI 10.1016/S0006-3495(02)73925-8; Wiesehan K, 2003, CHEMBIOCHEM, V4, P811, DOI 10.1002/cbic.200300570; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Zhu XH, 2008, J HUAZHONG U SCI-MED, V28, P299, DOI 10.1007/s11596-008-0316-1	31	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72272	10.1371/journal.pone.0072272	http://dx.doi.org/10.1371/journal.pone.0072272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039747	Green Published, gold			2022-12-25	WOS:000326405300008
J	Zhang, YS; Xu, P; Huang, YL; Cheng, KW; Yao, DZ				Zhang, Yangsong; Xu, Peng; Huang, Yingling; Cheng, Kaiwen; Yao, Dezhong			SSVEP Response Is Related to Functional Brain Network Topology Entrained by the Flickering Stimulus	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; COMPUTER INTERFACE; FRONTAL-CORTEX; FREQUENCY; CONNECTIVITY; DYNAMICS; STABILITY; CHILDREN	Previous studies have shown that the brain network topology correlates with the cognitive function. However, few studies have investigated the relationship between functional brain networks that process sensory inputs and outputs. In this study, we focus on steady-state paradigms using a periodic visual stimulus, which are increasingly being used in both brain-computer interface (BCI) and cognitive neuroscience researches. Using the graph theoretical analysis, we investigated the relationship between the topology of functional networks entrained by periodic stimuli and steady state visually evoked potentials (SSVEP) using two frequencies and eleven subjects. First, the entire functional network (Network 0) of each frequency for each subject was constructed according to the coherence between electrode pairs. Next, Network 0 was divided into three sub-networks, in which the connection strengths were either significantly (positively for Network 1, negatively for Network 3) or non-significantly (Network 2) correlated with the SSVEP responses. Our results revealed that the SSVEP responses were positively correlated to the mean functional connectivity, clustering coefficient, and global and local efficiencies, while these responses were negatively correlated with the characteristic path length of Networks 0, 1 and 2. Furthermore, the strengths of these connections that significantly correlated with the SSVEP (both positively and negatively) were mainly found to be long-range connections between the parietal-occipital and frontal regions. These results indicate that larger SSVEP responses correspond with better functional network topology structures. This study may provide new insights for understanding brain mechanisms when using SSVEPs as frequency tags.	[Zhang, Yangsong; Xu, Peng; Huang, Yingling; Cheng, Kaiwen; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn		Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	973 project [2011CB707803]; 863 project [2012AA011601]; NSFC [31070881, 91232725]; 111 project; PCSIRT	973 project(National Basic Research Program of China); 863 project(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the 973 project 2011CB707803, the 863 project 2012AA011601, and NSFC No. 31070881 and No. 91232725, and in part by the 111 project and PCSIRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; FEDOTCHEV AI, 1990, INT J PSYCHOPHYSIOL, V9, P189, DOI 10.1016/0167-8760(90)90073-M; Hwang HJ, 2013, BRAIN RES, V1515, P66, DOI 10.1016/j.brainres.2013.03.050; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lazarev VV, 2001, BRAZ J MED BIOL RES, V34, P1573, DOI 10.1590/S0100-879X2001001200010; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; Murias M, 2007, CEREB CORTEX, V17, P1788, DOI 10.1093/cercor/bhl089; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Panicker RC, 2011, IEEE T BIO-MED ENG, V58, P1781, DOI 10.1109/TBME.2011.2116018; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Regan D., 1989, HUMAN BRAIN ELECTROP; Rubinov M, 2010, NEUROIMAGE, V52, P1059; Sporns O., 2010, NETWORKS BRAIN; Srinivasan R, 2006, BRAIN TOPOGR, V18, P167, DOI 10.1007/s10548-006-0267-4; Srinivasan R, 1998, IEEE T BIO-MED ENG, V45, P814, DOI 10.1109/10.686789; Srinivasan R, 2007, EXP BRAIN RES, V180, P677, DOI 10.1007/s00221-007-0886-3; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; TYLER CW, 1978, EXP BRAIN RES, V33, P535; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wilson JJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025026; Wu CH, 2011, J NEUROSCI METH, V196, P170, DOI 10.1016/j.jneumeth.2010.12.014; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Wu ZH, 2007, BRAIN TOPOGR, V20, P97, DOI 10.1007/s10548-007-0035-0; Wu ZH, 2010, J BIOL PHYS, V36, P261, DOI 10.1007/s10867-009-9181-9; Xu MP, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026001; Yan Z, 2011, NEUROSCI LETT, V499, P199, DOI 10.1016/j.neulet.2011.05.061; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhou G, 2012, NEUROSCIENCE, V202, P276, DOI 10.1016/j.neuroscience.2011.11.048	47	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72654	10.1371/journal.pone.0072654	http://dx.doi.org/10.1371/journal.pone.0072654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039789	gold, Green Published			2022-12-25	WOS:000326405300018
J	Dai, HY; Han, GF; Yan, YJ; Zhang, F; Liu, ZC; Li, XM; Li, WR; Ma, Y; Li, H; Liu, YX; Zhang, ZH				Dai, Hongyan; Han, Guofen; Yan, Yujiao; Zhang, Feng; Liu, Zhongchi; Li, Xiaoming; Li, Wenran; Ma, Yue; Li, He; Liu, Yuexue; Zhang, Zhihong			Transcript Assembly and Quantification by RNA-Seq Reveals Differentially Expressed Genes between Soft-Endocarp and Hard-Endocarp Hawthorns	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; MEDICAGO-SATIVA L.; FERULATE 5-HYDROXYLASE; LIGNIN BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CRATAEGUS-MONOGYNA; DOWN-REGULATION; POPLAR; FRUIT; GENOME	Hawthorn (Crataegus spp.) is an important pome with a long history as a fruit, an ornamental, and a source of medicine. Fruits of hawthorn are marked by hard stony endocarps, but a hawthorn germplasm with soft and thin endocarp was found in Liaoning province of China. To elucidate the molecular mechanism underlying the soft endocarp of hawthorn, we conducted a de novo assembly of the fruit transcriptome of Crataegus pinnatifida and compared gene expression profiles between the soft-endocarp and the hard-endocarp hawthorn varieties. De novo assembly yielded 52,673 putative unigenes, 20.4% of which are longer than 1,000 bp. Among the high-quality unique sequences, 35,979 (68.3%) had at least one significant match to an existing gene model. A total of 1,218 genes, represented 2.31% total putative unigenes, were differentially expressed between the soft-endocarp hawthorn and the hard-endocarp hawthorn. Among these differentially expressed genes, a number of lignin biosynthetic pathway genes were down-regulated while almost all the flavonoid biosynthetic pathway genes were strongly up-regulated, concomitant with the formation of soft endocarp. In addition, we have identified some MYB and NAC transcription factors that could potentially control lignin and flavonoid biosynthesis. The altered expression levels of the genes encoding lignin biosynthetic enzymes, MYB and NAC transcription factors were confirmed by quantitative RT-PCR. This is the first transcriptome analysis of Crataegus genus. The high quality ESTs generated in this study will aid future gene cloning from hawthorn. Our study provides important insights into the molecular mechanisms underlying soft endocarp formation in hawthorn.	[Dai, Hongyan; Han, Guofen; Li, Xiaoming; Li, Wenran; Ma, Yue; Li, He; Liu, Yuexue; Zhang, Zhihong] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China; [Yan, Yujiao; Zhang, Feng] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Peoples R China; [Liu, Zhongchi] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Shenyang Agricultural University; Shenyang Agricultural University; University System of Maryland; University of Maryland College Park	Zhang, ZH (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China.	zhangz@syau.edu.cn	Zhang, Zhihong/W-1011-2017; Liu, Zhongchi/E-6462-2010	Zhang, Zhihong/0000-0001-5935-1567; Liu, Zhongchi/0000-0001-9969-9381; Zhang, Feng/0000-0002-3200-5506	National Natural Science Foundation of China [31170635]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (Grant No. 31170635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba CM, 2000, PHYSIOL PLANTARUM, V109, P382, DOI 10.1034/j.1399-3054.2000.100403.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bujarska-Borkowska B., 2002, Dendrobiology, V47, P61; Chang L, 2007, J PHYTOPATHOL, V155, P431, DOI 10.1111/j.1439-0434.2007.01254.x; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COURTNEY SP, 1985, OIKOS, V44, P398, DOI 10.2307/3565780; Dai H, 2009, ANN APPL BIOL, V154, P175, DOI 10.1111/j.1744-7348.2008.00290.x; Dai H.Y., 2007, THESIS SHENYANG AGR; Dai HY, 2007, IN VITRO CELL DEV-PL, V43, P2, DOI 10.1007/s11627-006-9008-3; Dardick CD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-13; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Franke R, 2000, PLANT J, V22, P223, DOI 10.1046/j.1365-313x.2000.00727.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guitian P, 1998, PLANT ECOL, V137, P139, DOI 10.1023/A:1009712000104; Humphreys JM, 1999, P NATL ACAD SCI USA, V96, P10045, DOI 10.1073/pnas.96.18.10045; Kao ES, 2005, J AGR FOOD CHEM, V53, P430, DOI 10.1021/jf040231f; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; LaFayette PR, 1999, PLANT MOL BIOL, V40, P23, DOI 10.1023/A:1026437406859; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Marita JM, 1999, P NATL ACAD SCI USA, V96, P12328, DOI 10.1073/pnas.96.22.12328; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Meyer K, 1996, P NATL ACAD SCI USA, V93, P6869, DOI 10.1073/pnas.93.14.6869; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Morello JR, 2005, PLANT SCI, V168, P65, DOI 10.1016/j.plantsci.2004.07.013; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nas MN, 2012, PLANT GROWTH REGUL, V67, P57, DOI 10.1007/s10725-012-9662-x; Phipps J. B., 2003, HAWTHORNS MEDLARS; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Rigelsky JM, 2002, AM J HEALTH-SYST PH, V59, P417, DOI 10.1093/ajhp/59.5.417; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6; Zhao H.C., 1996, CHINA FRUIT PLANT MO; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	53	24	30	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72910	10.1371/journal.pone.0072910	http://dx.doi.org/10.1371/journal.pone.0072910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039819	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600043
J	Mayorga, ME; Reifsnider, OS; Neyens, DM; Gebregziabher, MG; Hunt, KJ				Mayorga, Maria E.; Reifsnider, Odette S.; Neyens, David M.; Gebregziabher, Mulugeta G.; Hunt, Kelly J.			Simulated Estimates of Pre-Pregnancy and Gestational Diabetes Mellitus in the US: 1980 to 2008	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; BIRTH-WEIGHT; PREGNANCY; WOMEN; PREVALENCE; COMPLICATIONS; OBESITY; RISK	Purpose: To simulate national estimates of prepregnancy and gestational diabetes mellitus (GDM) in non-Hispanic white (NHW) and non-Hispanic black (NHB) women. Methods: Prepregnancy diabetes and GDM were estimated as a function of age, race/ethnicity, and body mass index (BMI) using South Carolina live singleton births from 2004-2008. Diabetes risk was applied to a simulated population. Age, natality and BMI were assigned to women according to race-and age-specific US Census, Natality and National Health and Nutrition Examination Surveys (NHANES) data, respectively. Results: From 1980-2008, estimated GDM prevalence increased from 4.11% to 6.80% [2.68% (95% CI 2.58%-2.78%)] and from 3.96% to 6.43% [2.47% (95% CI 2.39%-2.55%)] in NHW and NHB women, respectively. In NHW women prepregnancy diabetes prevalence increased 0.90% (95% CI 0.85%-0.95%) from 0.95% in 1980 to 1.85% in 2008. In NHB women from 1980 through 2008 estimated prepregnancy diabetes prevalence increased 1.51% (95% CI 1.44%-1.57%), from 1.66% to 3.16%. Conclusions: Racial disparities in diabetes prevalence during pregnancy appear to stem from a higher prevalence of prepregnancy diabetes, but not GDM, in NHB than NHW.	[Mayorga, Maria E.] N Carolina State Univ, Dept Ind & Syst Engn, Raleigh, NC 27695 USA; [Reifsnider, Odette S.; Neyens, David M.] Clemson Univ, Dept Ind Engn, Clemson, SC USA; [Gebregziabher, Mulugeta G.; Hunt, Kelly J.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	University of North Carolina; North Carolina State University; Clemson University; Medical University of South Carolina	Mayorga, ME (corresponding author), N Carolina State Univ, Dept Ind & Syst Engn, Raleigh, NC 27695 USA.	memayorg@ncsu.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X; Mayorga, Maria/0000-0002-6399-2153	National Institute on Minority Health and Health Disparities [R01-MD004251]; Directorate For Engineering [1433602] Funding Source: National Science Foundation; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [R01MD004251] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Institute on Minority Health and Health Disparities (R01-MD004251). The funding agency did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Brandie M, 2011, INT J CLIN PHARM TH, V49, P217, DOI 10.5414/CPP49217; Caro JJ, 2010, VALUE HEALTH, V13, P1056, DOI 10.1111/j.1524-4733.2010.00775.x; Caro JJ, 2005, PHARMACOECONOMICS, V23, P323, DOI 10.2165/00019053-200523040-00003; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Engstrom JL, 2003, J MIDWIFERY WOM HEAL, V48, P338, DOI 10.1016/S1526-9523(03)00281-2; Erhardt W, 2012, CLIN DRUG INVEST, V32, P189, DOI 10.2165/11597060-000000000-00000; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gavin JR, 1999, DIABETES CARE, V22, pS5; Getahun D NC, 2008, AM J OBSTET GYNECOL, V198; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hunt KJ, 2012, DIABETOLOGIA, V55, P971, DOI 10.1007/s00125-011-2430-z; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Law A. M., 2000, SIMULATION MODELING; Law AM, 2000, SIMULATION MODELING, Vxxi; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lederman S A, 1998, Matern Child Health J, V2, P123; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Mainous AG, 2007, DIABETOLOGIA, V50, P934, DOI 10.1007/s00125-006-0528-5; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Mission JF, 2012, AM J OBSTET GYNECOL, V326, pe321; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; [National Center for Health Statistics Statistics NCfH], 2012, CRUDE BIRTH RATES FE; O'Sullivan J B, 2003, Obstet Gynecol, V102, P7; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; OSULLIVAN JB, 1966, OBSTET GYNECOL, V27, P683; Park S, 2011, MATERN CHILD HLTH J, V15, P851, DOI 10.1007/s10995-009-0544-4; PETTITT DJ, 1980, DIABETES CARE, V3, P458, DOI 10.2337/diacare.3.3.458; Pettitt DJ, 1998, DIABETES CARE, V21, pB138; PETTITT DJ, 1987, DIABETES CARE, V10, P76, DOI 10.2337/diacare.10.1.76; Pollock R F, 2011, J Med Econ, V14, P36, DOI 10.3111/13696998.2010.541045; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121; US Census Bureau, 1992, SINGLE YEARS OF AGE; [US Census Bureau Division P], 2004, DETAILED DATA FILES; US Census Bureau, 1980, 1980 CENSUS OF POPUL	47	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73437	10.1371/journal.pone.0073437	http://dx.doi.org/10.1371/journal.pone.0073437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039941	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600077
J	Meimandi-Parizi, A; Oryan, A; Moshiri, A				Meimandi-Parizi, Abdolhamid; Oryan, Ahmad; Moshiri, Ali			Tendon Tissue Engineering and Its Role on Healing of the Experimentally Induced Large Tendon Defect Model in Rabbits: A Comprehensive In Vivo Study	PLOS ONE			English	Article							DIGITAL FLEXOR TENDON; ACHILLES-TENDON; GROWTH-FACTORS; VENOUS THROMBOEMBOLISM; CELL COMPATIBILITY; CROSS-LINKING; LONG-TERM; RECONSTRUCTION; COLLAGEN; LIGAMENT	Healing of large tendon defects is challenging. We studied the role of collagen implant with or without polydioxanone (PDS) sheath on the healing of a large Achilles tendon defect model, in rabbits. Sixty rabbits were divided into three groups. A 2 cm gap was created in the left Achilles tendon of all rabbits. In the control lesions, no implant was used. The other two groups were reconstructed by collagen and collagen-PDS implants respectively. The animals were clinically examined at weekly intervals and their lesions were observed by ultrasonography. Blood samples were obtained from the animals and were assessed for hematological analysis and determination of serum PDGF level, at 60 days post injury (DPI). The animals were then euthanized and their lesions were assessed for gross and histopathology, scanning electron microscopy, biomechanical testing, dry matter and hydroxyproline content. Another 65 pilot animals were also studied grossly and histopathologically to define the host implant interaction and graft incorporation at serial time points. The treated animals gained significantly better clinical scoring compared to the controls. Treatment with collagen and collagen-PDS implants significantly increased the biomechanical properties of the lesions compared to the control tendons at 60 DPI (P<0.05). The tissue engineered implants also reduced peritendinous adhesion, muscle fibrosis and atrophy, and increased ultrasonographical echogenicity and homogenicity, maturation and differentiation of the collagen fibrils and fibers, tissue alignment and volume of the regenerated tissue compared to those of the control lesions (P<0.05). The implants were gradually absorbed and substituted by the new tendon. Implantation of the bioimplants had a significant role in initiating tendon healing and the implants were biocompatible, biodegradable and safe for application in tendon reconstructive surgery. The results of the present study may be valuable in clinical practice.	[Meimandi-Parizi, Abdolhamid; Moshiri, Ali] Shiraz Univ, Sch Vet Med, Dept Clin Sci, Div Surg, Shiraz, Iran; [Oryan, Ahmad] Shiraz Univ, Sch Vet Med, Dept Pathol, Shiraz, Iran	Shiraz University; Shiraz University	Meimandi-Parizi, A (corresponding author), Shiraz Univ, Sch Vet Med, Dept Clin Sci, Div Surg, Shiraz, Iran.	meimandi@shirazu.ac.ir	Moshiri, Ali/H-1851-2013; Oryan, Ahmad/J-6539-2014	Moshiri, Ali/0000-0003-3967-7468; Oryan, Ahmad/0000-0003-1697-2376; Oryan, Ahmad/0000-0001-8804-1832	Shiraz University Veterinary School; Iranian National Science Foundation [ISNF 87020247]	Shiraz University Veterinary School; Iranian National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by the Shiraz University Veterinary School and the Iranian National Science Foundation (grant ISNF 87020247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; AMIS AA, 1984, J BONE JOINT SURG BR, V66, P131, DOI 10.1302/0301-620X.66B1.6229543; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; BARTONE FF, 1976, INVEST UROL, V13, P390; Beals TC, 2010, J ORTHOP TRAUMA, V24, pE78, DOI 10.1097/BOT.0b013e3181c80a87; Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003; Bullocks JM, 2008, J PLAST RECONSTR AES, V61, P566, DOI 10.1016/j.bjps.2006.01.017; Cardwell RD, 2014, J TISSUE ENG REGEN M, V8, P937, DOI 10.1002/term.1589; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Czarkowska-Paczek B, 2006, J PHYSIOL PHARMACOL, V57, P189; DENNY HR, 1980, J SMALL ANIM PRACT, V21, P279, DOI 10.1111/j.1748-5827.1980.tb01248.x; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; DUFFY FJ, 1995, J HAND SURG-AM, V20A, P645, DOI 10.1016/S0363-5023(05)80284-9; Duthon VB, 2011, FOOT ANKLE INT, V32, P375, DOI 10.3113/FAI.2011.0375; Ettema HB, 2008, J THROMB HAEMOST, V6, P1093, DOI 10.1111/j.1538-7836.2008.02984.x; Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295; Foltran I, 2008, MACROMOL SYMP, V269, P111, DOI 10.1002/masy.200850914; Hee CK, 2012, TISSUE ENG PART B-RE, V18, P225, DOI [10.1089/ten.teb.2011.0603, 10.1089/ten.TEB.2011.0603]; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013; Lapidus LJ, 2007, J ORTHOP TRAUMA, V21, P52, DOI 10.1097/01.bot.0000250741.65003.14; LEITZEL K, 1991, CANCER RES, V51, P4149; Liu YW, 2012, LANGMUIR, V28, P17134, DOI 10.1021/la303490x; Longo UG, 2010, BRIT MED BULL, V94, P165, DOI 10.1093/bmb/ldp051; Maffulli N, 2012, J BONE JOINT SURG AM, V94A, P906, DOI 10.2106/JBJS.K.00869; Maheshwari AV, 2012, FOOT ANKLE INT, V33, P430, DOI 10.3113/FAI.2012.0430; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Moshiri A, 2011, J FOOT ANKLE SURG, V50, P654, DOI 10.1053/j.jfas.2011.05.002; Nishimoto H, 2012, INT ORTHOP, V36, P2379, DOI 10.1007/s00264-012-1660-0; Ooi CP, 2002, J BIOMED MATER RES, V63, P291, DOI 10.1002/jbm.10181; Oryan A, 2008, ANAT HISTOL EMBRYOL, V37, P134, DOI 10.1111/j.1439-0264.2007.00811.x; Oryan A, 2014, J TISSUE ENG REGEN M, V8, P421, DOI 10.1002/term.1534; Oryan A, 2011, J MUSCULOSKEL NEURON, V11, P185; Oryan A., 2012, HARD TISSUE, V1, P12, DOI [10.13172/2050-2303-1-2-292, DOI 10.13172/2050-2303-1-2-292]; Oryan A., 2012, HARD TISSUE, V1, P11, DOI [10.13172/2050-2303-1-2-291., DOI 10.13172/2050-2303-1-2-291]; Oryan A, 2012, CELLS TISSUES ORGANS, V196, P442, DOI 10.1159/000337860; Oryan Ahmad, 2012, Sports Med Arthrosc Rehabil Ther Technol, V4, P14, DOI 10.1186/1758-2555-4-14; Oryan A, 2012, J TISSUE VIABILITY, V21, P88, DOI 10.1016/j.jtv.2012.06.002; Oryan A, 2011, CONNECT TISSUE RES, V52, P329, DOI 10.3109/03008207.2010.531332; Oryan A, 2008, CONNECT TISSUE RES, V49, P351, DOI 10.1080/03008200802325169; Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259; Park YS, 2012, ORTHOPEDICS, V35, pE213, DOI 10.3928/01477447-20120123-13; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Peng YY, 2010, J BIOMED MATER RES A, V93A, P1235, DOI 10.1002/jbm.a.32616; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457; Ronel DN, 2004, MICROSURG, V24, P18, DOI 10.1002/micr.10191; Saeidi N, 2012, BIOTECHNOL BIOENG, V109, P2683, DOI 10.1002/bit.24533; Sato M, 2000, J Orthop Sci, V5, P256; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shearn JT, 2011, J MUSCULOSKEL NEURON, V11, P163; Siritientong T, 2011, AAPS PHARMSCITECH, V12, P771, DOI 10.1208/s12249-011-9641-y; Solchaga LA, 2013, CLIN DRUG INVEST, V33, P143, DOI 10.1007/s40261-013-0053-5; Stillaert FB, 2008, BIOMATERIALS, V29, P3953, DOI 10.1016/j.biomaterials.2008.06.005; Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104; Tsai SP, 2007, J APPL POLYM SCI, V105, P1774, DOI 10.1002/app.26157; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833; Veillette CJ, 1998, TRANSPLANTATION, V65, P486, DOI 10.1097/00007890-199802270-00006; Wray LS, 2009, TISSUE ENG PT A, V15, P1463, DOI 10.1089/ten.tea.2008.0239; Yang MW, 2013, J FOOT ANKLE SURG, V52, P103, DOI 10.1053/j.jfas.2012.06.019	62	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73016	10.1371/journal.pone.0073016	http://dx.doi.org/10.1371/journal.pone.0073016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039851	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600050
J	Gutierrez, M; Choi, MH; Tian, B; Xu, J; Rho, JK; Kim, MO; Cho, YH; Yoon, SC				Gutierrez, Merced; Choi, Mun Hwan; Tian, Baoxia; Xu, Ju; Rho, Jong Kook; Kim, Myeong Ok; Cho, You-Hee; Yoon, Sung Chul			Simultaneous Inhibition of Rhamnolipid and Polyhydroxyalkanoic Acid Synthesis and Biofilm Formation in Pseudomonas aeruginosa by 2-Bromoalkanoic Acids: Effect of Inhibitor Alkyl-Chain-Length	PLOS ONE			English	Article							DE-NOVO BIOSYNTHESIS; SWARMING MOTILITY; ESCHERICHIA-COLI; FLUORESCENS BM07; 2-BROMOOCTANOIC ACID; EXPRESSION; BIOSURFACTANTS; TRANSACYLASE; VIRULENCE; MULTIPLE	Pseudomonas aeruginosa, an opportunistic human pathogen is known to synthesize rhamnolipid and polyhydroxyalkanoic acid (PHA) of which the acyl-group precursors (e. g., (R)-3-hydroxydecanoic acid) are provided through RhlA and PhaG enzyme, respectively, which have 57% gene sequence homology. The inhibitory effect of three 2-bromo-fatty acids of 2-bromohexanoic acid (2-BrHA), 2-bromooctanoic acid (2-BrOA) and 2-bromodecanoic acid (2-BrDA) was compared to get an insight into the biochemical nature of their probable dual inhibition against the two enzymes. The 2-bromo-compounds were found to inhibit rhamnolipid and PHA synthesis simultaneously in alkyl-chain-length dependent manner at several millimolar concentrations. The separate and dual inhibition of the RhlA and PhaG pathway by the 2-bromo-compounds in the wild-type cells was verified by investigating their inhibitory effects on the rhamnolipid and PHA synthesis in P. aeruginosa Delta phaG and Delta rhlA mutants. Unexpectedly, the order of inhibition strength was found 2-BrHA (>= 90% at 2 mM). > 2-BrOA > 2-BrDA, equally for all of the rhamnolipids and PHA synthesis, swarming motility and biofilm formation. We suggest that the novel strongest inhibitor 2-BrHA could be potentially exploited to control the rhamnolipid-associated group behaviors of this pathogen as well as for its utilization as a lead compound in screening for antimicrobial agents based on new antimicrobial targets.	[Gutierrez, Merced; Tian, Baoxia; Xu, Ju; Rho, Jong Kook; Yoon, Sung Chul] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci, Nanobiomat Sci Lab, Jinju, South Korea; [Gutierrez, Merced; Choi, Mun Hwan; Tian, Baoxia; Kim, Myeong Ok; Yoon, Sung Chul] Gyeongsang Natl Univ, Natl Res Fdn Funded Pioneer Res Ctr Alzheimer Dis, Jinju, South Korea; [Kim, Myeong Ok] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci, Neurobiol Lab, Jinju, South Korea; [Cho, You-Hee] CHA Univ, Coll Pharm, Lab Antiinfect Agents & Phage Therapy, Gyeonggi Do, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Pochon Cha University	Yoon, SC (corresponding author), Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci, Nanobiomat Sci Lab, Jinju, South Korea.	scyoon@gnu.ac.kr	Cho, You-Hee/AAF-8582-2020; Kim, Myeong Ok/AAS-1488-2021; Yoon, Sung/L-5836-2019	Kim, Myeong Ok/0000-0003-4317-1072; Yoon, Sung Chul/0000-0002-8556-423X; Cho, You-Hee/0000-0001-7942-5893	NRF grant from the Ministry of Science, ICT & Future Planning/NRF [2009-0070747, 2012-0009522]; BK21 program	NRF grant from the Ministry of Science, ICT & Future Planning/NRF; BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This study was supported by grants (NRF grant #: 2009-0070747 and 2012-0009522) from the Ministry of Science, ICT & Future Planning/NRF. M. G., B. T., and J.X. were supported by a graduate scholarship through the BK21 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Cabrera-Valladares N, 2006, APPL MICROBIOL BIOT, V73, P187, DOI 10.1007/s00253-006-0468-5; Cady NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038492; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Choi MH, 2011, J BIOTECHNOL, V151, P30, DOI 10.1016/j.jbiotec.2010.10.072; Choi MH, 2010, BIORESOURCE TECHNOL, V101, P4540, DOI 10.1016/j.biortech.2010.01.082; Choi MH, 2009, BIOTECHNOL BIOENG, V102, P1209, DOI 10.1002/bit.22149; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Dusane DH, 2010, BIOTECHNOL GENET ENG, V27, P159, DOI 10.1080/02648725.2010.10648149; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Green PR, 2002, BIOMACROMOLECULES, V3, P208, DOI 10.1021/bm015620m; Gunther NW, 2005, APPL ENVIRON MICROB, V71, P2288, DOI 10.1128/AEM.71.5.2288-2293.2005; Hoffmann N, 2002, J BIOL CHEM, V277, P42926, DOI 10.1074/jbc.M207821200; Hori K, 2002, BIOTECHNOL BIOENG, V78, P699, DOI 10.1002/bit.10248; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kolodkin-Gal I, 2012, CELL, V149, P684, DOI 10.1016/j.cell.2012.02.055; Lang S., 1993, BIOSURFACTANTS PRODU, P251; Lee HJ, 2004, J MICROBIOL BIOTECHN, V14, P1256; Lee HJ, 2001, APPL ENVIRON MICROB, V67, P4963, DOI 10.1128/AEM.67.11.4963-4974.2001; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; Lequette Y, 2005, J BACTERIOL, V187, P37, DOI 10.1128/JB.187.1.37-44.2005; Maier RM, 2000, APPL MICROBIOL BIOT, V54, P625, DOI 10.1007/s002530000443; McClure CD, 1996, CURR MICROBIOL, V33, P109, DOI 10.1007/s002849900084; Noordman WH, 2002, APPL ENVIRON MICROB, V68, P4502, DOI 10.1128/AEM.68.9.4502-4508.2002; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pham TH, 2004, MICROBIOL-SGM, V150, P3405, DOI 10.1099/mic.0.27357-0; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rehm BHA, 2001, APPL ENVIRON MICROB, V67, P3102, DOI 10.1128/AEM.67.7.3102-3109.2001; Schooling S.R., 2004, BIOFILMS, V1, P91, DOI 10.1017/; SIEGMUND I, 1991, BIOTECHNOL TECH, V5, P265, DOI 10.1007/BF02438660; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Soberon-Chavez G, 2005, J IND MICROBIOL BIOT, V32, P675, DOI 10.1007/s10295-005-0243-0; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Wild M, 1997, FEMS MICROBIOL LETT, V153, P279, DOI 10.1016/S0378-1097(97)00251-6; Zhu K, 2008, J BACTERIOL, V190, P3147, DOI 10.1128/JB.00080-08	45	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73986	10.1371/journal.pone.0073986	http://dx.doi.org/10.1371/journal.pone.0073986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023921	gold, Green Published, Green Submitted			2022-12-25	WOS:000324515600127
J	Valentine, M; Song, K; Maresh, GA; Mack, H; Huaman, MC; Polacino, P; Ho, O; Cristillo, A; Chung, HK; Hu, SL; Pincus, SH				Valentine, Michael; Song, Kejing; Maresh, Grace A.; Mack, Heather; Huaman, Maria Cecilia; Polacino, Patricia; Ho, On; Cristillo, Anthony; Chung, Hye Kyung; Hu, Shiu-Lok; Pincus, Seth H.			Expression of the Memory Marker CD45RO on Helper T Cells in Macaques	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; UCHL1; ANTI-CD45RO; SUBSETS; PERSISTENCE; GENERATION; REACTIVITY; INFECTION; ANTIGEN; BLOOD	Background: In humans it has been reported that a major site of the latent reservoir of HIV is within CD4+ T cells expressing the memory marker CD45RO, defined by the mAb UCHL1. There are conflicting reports regarding the expression of this antigen in macaques, the most relevant animal species for studying HIV pathogenesis and testing new therapies. There is now a major effort to eradicate HIV reservoirs and cure the infection. One approach is to eliminate subsets of cells housing the latent reservoir, using UCHL1 to target these cells. So that such studies may be performed in macaques, it is essential to determine expression of CD45RO. Methods: We have used immunofluorescence and flow cytometry to study cell surface expression of CD45RO on lymphocytes from PBMC, lymphoid, and GI organs of rhesus, pigtailed, and cynomolgus macaques. Both direct and indirect immunofluorescence experiments were performed. Findings: CD45RO is expressed on a subset of CD4+ lymphocytes of all pigtailed, a fraction of rhesus, and neither of the cynomolgus macaques studied. The binding of UCHL1 to macaque cells was of lower avidity than to human cells. This could be overcome by forming UCHL1 multimers. Directly conjugating fluors to UCHL1 can inhibit UCHL1 binding to macaque cells. Patterns of UCHL1 expression differ somewhat in macaques and humans, and from that of other memory markers often used in macaques. Conclusions: CD45RO, defined with mAb UCHL1, is well expressed on CD4+ cells in pigtailed macaques. Using tissues recovered from latently infected pigtailed macaques we are determining whether UCHL1, or other memory markers, can define the cellular locus of the reservoir. The low avidity of this interaction could limit the utility of UCHL1, in its conventional form, to eliminate cells in vivo and test this approach in macaque models of HIV infection.	[Valentine, Michael; Song, Kejing; Maresh, Grace A.; Pincus, Seth H.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Valentine, Michael; Pincus, Seth H.] LSU Hlth Sci Ctr, Dept Microbiol, New Orleans, LA USA; [Valentine, Michael; Pincus, Seth H.] LSU Hlth Sci Ctr, Dept Immunol, New Orleans, LA USA; [Valentine, Michael; Pincus, Seth H.] LSU Hlth Sci Ctr, Dept Parasitol, New Orleans, LA USA; [Pincus, Seth H.] LSU Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Mack, Heather; Polacino, Patricia; Ho, On; Hu, Shiu-Lok] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Huaman, Maria Cecilia; Cristillo, Anthony; Chung, Hye Kyung] Adv BioSci Labs Inc, Rockville, MD USA	Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Washington; University of Washington Seattle	Pincus, SH (corresponding author), Childrens Hosp, Res Inst Children, New Orleans, LA USA.	spincus@chnola-research.org			Children's Hospital, New Orleans; Bill and Melinda Gates Foundation; Louisiana Vaccine Center; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	Children's Hospital, New Orleans; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Louisiana Vaccine Center; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by Children's Hospital, New Orleans, the Bill and Melinda Gates Foundation, the Louisiana Vaccine Center, and by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBAR AN, 1988, J IMMUNOL, V140, P2171; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2012, GLYCOBIOLOGY, V22, P529, DOI 10.1093/glycob/cwr178; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Craig RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046778; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Deere JD, 2011, CURR OPIN HIV AIDS, V6, P57, DOI 10.1097/COH.0b013e32834086ce; Descours B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-O43; Durand CM, 2012, TRENDS IMMUNOL, V33, P554, DOI 10.1016/j.it.2012.07.001; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; FIRPO PP, 1992, AIDS RES HUM RETROV, V8, P357, DOI 10.1089/aid.1992.8.357; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Li B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-8; LI J, 1992, IMMUNOLOGY, V75, P305; Liu JY, 2012, J VIROL, V86, P7829, DOI 10.1128/JVI.00512-12; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; McCoig C, 1999, P NATL ACAD SCI USA, V96, P11482, DOI 10.1073/pnas.96.20.11482; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; MIYAWAKI T, 1990, J EXP MED, V171, P1833, DOI 10.1084/jem.171.5.1833; O'Gorman MRG, 1999, CYTOMETRY, V38, P78, DOI 10.1002/(SICI)1097-0320(19990415)38:2<78::AID-CYTO6>3.3.CO;2-5; Pincus SH, 2012, VACCINE, V30, P4849, DOI 10.1016/j.vaccine.2012.05.006; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; PULIDO R, 1994, J EXP MED, V179, P1035, DOI 10.1084/jem.179.3.1035; RICHARDS SJ, 1990, CLIN EXP IMMUNOL, V81, P149; Saavedra-Lozano J, 2004, P NATL ACAD SCI USA, V101, P2494, DOI 10.1073/pnas.0308381100; Saavedra-Lozano J, 2002, J INFECT DIS, V185, P306, DOI 10.1086/338565; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sigal A, 2012, CELL HOST MICROBE, V12, P132, DOI 10.1016/j.chom.2012.07.005; SMITH SH, 1986, IMMUNOLOGY, V58, P63; Song KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062417; TERRY LA, 1988, IMMUNOLOGY, V64, P331; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Wang X, 2008, DEV COMP IMMUNOL, V32, P859, DOI 10.1016/j.dci.2007.12.009; ZOLA H, 1992, CELL IMMUNOL, V145, P175, DOI 10.1016/0008-8749(92)90321-F	40	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73969	10.1371/journal.pone.0073969	http://dx.doi.org/10.1371/journal.pone.0073969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023920	gold, Green Submitted, Green Published			2022-12-25	WOS:000324515600126
J	Warncke, K; Krasmann, M; Puff, R; Dunstheimer, D; Ziegler, AG; Beyerlein, A				Warncke, Katharina; Krasmann, Miriam; Puff, Ramona; Dunstheimer, Desiree; Ziegler, Anette-Gabriele; Beyerlein, Andreas			Does Diabetes Appear in Distinct Phenotypes in Young People? Results of the Diabetes Mellitus Incidence Cohort Registry (DiMelli)	PLOS ONE			English	Article							ANTIBODY STANDARDIZATION PROGRAM; CHILDHOOD; TYPE-1; CHILDREN; ADOLESCENTS; ASSAYS; AUTOANTIBODIES; GERMANY; TIME; RISK	Introduction: The diabetes mellitus Incidence Cohort Registry (DiMelli) aims to characterize diabetes phenotypes by immunologic, metabolic, and genetic markers. We classified patients into three groups according to islet autoantibody status and examined whether patients with multiple diabetes-associated autoantibodies, one autoantibody, or without autoantibodies differed with respect to clinical, metabolic, and genetic parameters, including an insulin sensitivity (IS) score based on waist, HbA1c, and triglycerides. We also assessed whether metabolic markers predicted the immune status. Materials and Methods: As of June 2012, 630 patients in Bavaria, Germany, aged <20 years diagnosed with any type of diabetes within the preceding 6 months were registered in DiMelli. We compared the clinical and laboratory parameters between islet autoantibody status defined patient groups. Parameters showing the strongest associations were included in principal component analysis. Receiver operating characteristic curves were used to assess the ability of the IS Score to predict islet autoantibody status. Results: Patients with multiple islet autoantibodies, one autoantibody, or without autoantibodies were significantly different in terms of BMI percentile, weight loss before diagnosis, fasting C-peptide (all, P<0.001), and IS Score (P=0.034). However, principal component analysis revealed no distinct patterns according to autoantibody status. At the optimal IS Score cut-off for predicting islet autoantibody positivity (single compared to none), the specificity was 52.0% and the sensitivity was 86.8%. With respect to prediction of multiple autoantibodies (compared to none), specificity and sensitivity were slightly lower and in combination inferior to those obtained using the BMI percentile and fasting C-peptide. Discussion: The DiMelli study indicated that patients with and without islet autoantibodies differed with respect to metabolic and genetic markers but there was considerable overlap of phenotypes, and autoantibody status could not be predicted by these parameters. Thus, our results suggest that refined diabetes classification may require both immune and metabolic phenotyping.	[Warncke, Katharina; Krasmann, Miriam; Puff, Ramona; Ziegler, Anette-Gabriele; Beyerlein, Andreas] Tech Univ Munich, Helmholtz Zentrum Munchen, Diabet Res Inst, Neuherberg, Germany; [Warncke, Katharina; Krasmann, Miriam; Puff, Ramona; Ziegler, Anette-Gabriele; Beyerlein, Andreas] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Neuherberg, Germany; [Warncke, Katharina; Ziegler, Anette-Gabriele] Forschergrp Diabet eV, Neuherberg, Germany; [Warncke, Katharina] Tech Univ Munich, Klinikum Rechts Isar, Dept Pediat, D-80290 Munich, Germany; [Dunstheimer, Desiree] Klinikum Augsburg, Dept Pediat 1, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Klinikum Augsburg	Ziegler, AG (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Diabet Res Inst, Neuherberg, Germany.	anette-g.ziegler@helmholtz-muenchen.de	Ziegler, Anette-Gabriele/M-4614-2014; Beyerlein, Andreas/I-7504-2019	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Beyerlein, Andreas/0000-0001-6603-5036; Puff, Ramona/0000-0001-9752-0122; Warncke, Katharina/0000-0003-1758-7656	Competence Network Diabetes Mellitus; Federal Ministry of Education and Research [FKZ 01GI0805]; German Center for Diabetes Research (DZD)	Competence Network Diabetes Mellitus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD)	DiMelli was supported by the Competence Network Diabetes Mellitus, Federal Ministry of Education and Research (FKZ 01GI0805; from 2008 to 2012, and has been supported by the German Center for Diabetes Research (DZD) since 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Badaru A, 2012, CURR DIABETES REP, V12, P75, DOI 10.1007/s11892-011-0247-2; Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5&lt;649::AID-SIM371&gt;3.0.CO;2-H; Dabelea D, 2011, DIABETOLOGIA, V54, P78, DOI 10.1007/s00125-010-1911-9; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2011, DIABETES CARE, V34, P1628, DOI 10.2337/dc10-2324; Ehehalt S, 2010, DIABETES CARE, V33, P338, DOI 10.2337/dc09-1503; Gale EAM, 2006, DIABETOLOGIA, V49, P1989, DOI 10.1007/s00125-006-0348-7; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lampasona V, 2011, CLIN CHEM, V57, P1693, DOI 10.1373/clinchem.2011.170662; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Rosenbauer J, 2002, DIABETOLOGIA, V45, P457; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Schober E, 2005, EUR J PEDIATR, V164, P705, DOI 10.1007/s00431-005-1709-9; SOELDNER JS, 1965, DIABETES, V14, P771, DOI 10.2337/diab.14.12.771; *STUD TEDD GROUP, 2007, PEDIAT DIABETES, V8, P286, DOI DOI 10.1111/J.1399-5448.2007.00269.X.PUBMED:17850472; Thumer Leonore, 2010, Rev Diabet Stud, V7, P202, DOI 10.1900/RDS.2010.7.202; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Warncke K, 2010, DIABETES CARE, V33, P2010, DOI 10.2337/dc10-0404; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74339	10.1371/journal.pone.0074339	http://dx.doi.org/10.1371/journal.pone.0074339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023937	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600136
J	Chu, BCH; DeWolf, T; Vogel, HJ				Chu, Byron C. H.; DeWolf, Timothy; Vogel, Hans J.			Role of the Two Structural Domains from the Periplasmic Escherichia coli Histidine-binding Protein HisJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; NMR-SPECTROSCOPY; LIGAND-BINDING; CRYSTAL-STRUCTURE; TRANSPORT-SYSTEM; CONFORMATIONAL PLASTICITY; CASSETTE TRANSPORTERS; MULTIDIMENSIONAL NMR; MALTOSE TRANSPORTER; BACKBONE DYNAMICS	Escherichia coli HisJ is a type II periplasmic binding protein that functions to reversibly capture histidine and transfer it to its cognate inner membrane ABC permease. Here, we used NMR spectroscopy to determine the structure of apo-HisJ (26.5 kDa) in solution. HisJ is a bilobal protein in which domain 1 (D1) is made up of two noncontiguous subdomains, and domain 2 (D2) is expressed as the inner domain. To better understand the roles of D1 and D2, we have isolated and characterized each domain separately. Structurally, D1 closely resembles its homologous domain in apo- and holo-HisJ, whereas D2 is more similar to the holo-form. NMR relaxation experiments reveal that HisJ becomes more ordered upon ligand binding, whereas isolated D2 experiences a significant reduction in slower (millisecond to microsecond) motions compared with the homologous domain in apo-HisJ. NMR titrations reveal that D1 is able to bind histidine in a similar manner as full-length HisJ, albeit with lower affinity. Unexpectedly, isolated D1 and D2 do not interact with each other in the presence or absence of histidine, which indicates the importance of intact interdomain-connecting elements (i.e. hinge regions) for HisJ functioning. Our results shed light on the binding mechanism of type II periplasmic binding proteins where ligand is initially bound by D1, and D2 plays a supporting role in this dynamic process.	[Chu, Byron C. H.; DeWolf, Timothy; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca		DeWolf, Timothy/0000-0002-0510-3602	Canadian Institutes of Health Research (Novel Alternatives to Antibiotics Program); Alberta Innovates Health Solutions	Canadian Institutes of Health Research (Novel Alternatives to Antibiotics Program)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	This work was supported in part by an operating grant from the Canadian Institutes of Health Research (Novel Alternatives to Antibiotics Program).; Recipient of a scientist award from Alberta Innovates Health Solutions. To whom correspondence should be addressed: Biochemistry Research Group, Dept. of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada. Tel.: 403-220-6006; Fax: 403-289-9311; E-mail: vogel@ucalgary.ca.	AMES GFL, 1972, J BIOL CHEM, V247, P4309; AMES GFL, 1970, P NATL ACAD SCI USA, V66, P1096, DOI 10.1073/pnas.66.4.1096; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bermejo GA, 2010, BIOCHEMISTRY-US, V49, P1893, DOI 10.1021/bi902045p; Bermejo GA, 2009, J AM CHEM SOC, V131, P9532, DOI 10.1021/ja902436g; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN KD, 1970, J BACTERIOL, V104, P177, DOI 10.1128/JB.104.1.177-188.1970; Bucher D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002034; CEDEL TE, 1984, BIOPHYS CHEM, V19, P279, DOI 10.1016/0301-4622(84)87011-8; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Chu BCH, 2014, PROTEINS, V82, P386, DOI 10.1002/prot.24396; Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; Eckey V, 2010, J BACTERIOL, V192, P2150, DOI 10.1128/JB.00809-09; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Felder CB, 1999, AAPS PHARMSCI, V1; FERROLUZZIAMES G, 1976, P NATL ACAD SCI USA, V73, P1877, DOI 10.1073/pnas.73.6.1877; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Goddard T. D., 2003, SPARKY 3 VERSION 3 1; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Huang Hao, 2013, Methods Mol Biol, V963, P99, DOI 10.1007/978-1-62703-230-8_7; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Igarashi S, 2010, BIOMOL NMR ASSIGN, V4, P17, DOI 10.1007/s12104-009-9200-6; Jacso T, 2012, J BIOL CHEM, V287, P17040, DOI 10.1074/jbc.M112.340679; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; KANG CH, 1991, J BIOL CHEM, V266, P23893; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Krewulak K. D., 2004, PERIPLASMIC BINDING, P113; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LEVER JE, 1972, ANAL BIOCHEM, V50, P73, DOI 10.1016/0003-2697(72)90487-3; Liu CE, 1999, J BIOL CHEM, V274, P739, DOI 10.1074/jbc.274.2.739; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Mosteller F., 1977, DATA ANAL REGRESSION, P133; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NIKAIDO K, 1992, J BIOL CHEM, V267, P20706; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P4135; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Ortega G, 2012, J AM CHEM SOC, V134, P19869, DOI 10.1021/ja3092938; Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pistolesi Sara, 2011, Biomol Concepts, V2, P53, DOI 10.1515/bmc.2011.005; POST JFM, 1984, J MOL BIOL, V179, P729, DOI 10.1016/0022-2836(84)90164-5; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva DA, 2011, PROTEINS, V79, P2097, DOI 10.1002/prot.23030; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WOLF A, 1994, J BIOL CHEM, V269, P23051; WOLF A, 1995, J BIOL CHEM, V270, P16097, DOI 10.1074/jbc.270.27.16097; Wolf A, 1996, J BIOL CHEM, V271, P21243, DOI 10.1074/jbc.271.35.21243; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519; ZUKIN RS, 1986, BIOPHYS J, V49, P1229, DOI 10.1016/S0006-3495(86)83752-3; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	92	16	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31409	31422		10.1074/jbc.M113.490441	http://dx.doi.org/10.1074/jbc.M113.490441			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24036119	hybrid, Green Published			2022-12-25	WOS:000330596200001
J	Folch, B; Deziel, E; Doucet, N				Folch, Benjamin; Deziel, Eric; Doucet, Nicolas			Systematic Mutational Analysis of the Putative Hydrolase PqsE: Toward a Deeper Molecular Understanding of Virulence Acquisition in Pseudomonas aeruginosa	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; PROTEIN SECONDARY STRUCTURE; TO-CELL COMMUNICATION; BURKHOLDERIA-PSEUDOMALLEI; NOSOCOMIAL INFECTIONS; STABILITY CHANGES; CRYSTAL-STRUCTURE; ANALYSIS REVEALS; BINDING-SITES; SEQUENCE	Pseudomonas aeruginosa is an important opportunistic human pathogen that can establish bacterial communication by synchronizing the behavior of individual cells in a molecular phenomenon known as "quorum sensing''. Through an elusive mechanism involving gene products of the pqs operon, the PqsE enzyme is absolutely required for the synthesis of extracellular phenazines, including the toxic blue pigment pyocyanin, effectively allowing cells to achieve full-fledged virulence. Despite several functional and structural attempts at deciphering the role of this relevant enzymatic drug target, no molecular function has yet been ascribed to PqsE. In the present study, we report a series of alanine scanning experiments aimed at altering the biological function of PqsE, allowing us to uncover key amino acid positions involved in the molecular function of this enzyme. We use sequence analysis and structural overlays with members of homologous folds to pinpoint critical positions located in the vicinity of the ligand binding cleft and surrounding environment, revealing the importance of a unique C-terminal a-helical motif in the molecular function of PqsE. Our results suggest that the active site of the enzyme involves residues that extend further into the hydrophobic core of the protein, advocating for a lid-like movement of the two terminal helices. This information should help design virtual libraries of PqsE inhibitors, providing means to counter P. aeruginosa virulence acquisition and helping to reduce nosocomial infections.	[Folch, Benjamin; Deziel, Eric; Doucet, Nicolas] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Doucet, Nicolas] Univ Laval, PROTEO, Quebec Network Res Prot Funct Struct & Engn, Quebec City, PQ, Canada; [Doucet, Nicolas] McGill Univ, GRASP, Grp Rech Axe Struct Prot, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Laval University; McGill University	Doucet, N (corresponding author), Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada.	nicolas.doucet@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115	Natural Sciences and Engineering Research Council [RGPIN 402623-2011]; CIHR [MOP-97888]; FRQS Research Scholar Junior 1 Career Award; FRQNT Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); FRQS Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines'' (GRASP); Fondation Universitaire Armand-Frappier de l'INRS	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS Research Scholar Junior 1 Career Award; FRQNT Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); FRQS Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines'' (GRASP); Fondation Universitaire Armand-Frappier de l'INRS	This work was supported by Natural Sciences and Engineering Research Council Discovery grant RGPIN 402623-2011 (to N.D.), CIHR operating grant MOP-97888 (to E. D.), and a FRQS Research Scholar Junior 1 Career Award (to N.D.). N.D. also acknowledges support from the FRQNT Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO) and the FRQS Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines'' (GRASP). E. D. holds a Canada Research Chair in sociomicrobiology. B. F. is the recipient of a "Fondation Universitaire Armand-Frappier de l'INRS" postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Berthelot P, 2005, PATHOL BIOL, V53, P341, DOI 10.1016/j.patbio.2004.09.006; Bertrand X, 2001, INTENS CARE MED, V27, P1263, DOI 10.1007/s001340100979; Bjarnsholt T, 2007, ANAL BIOANAL CHEM, V387, P409, DOI 10.1007/s00216-006-0774-x; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de Seny D, 2002, BIOCHEM J, V363, P687, DOI 10.1042/0264-6021:3630687; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diggle SP, 2006, CHEM BIOL, V13, P701, DOI 10.1016/j.chembiol.2006.05.006; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gang RK, 1999, BURNS, V25, P611, DOI 10.1016/S0305-4179(99)00042-X; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klein T, 2012, ACS CHEM BIOL, V7, P1496, DOI 10.1021/cb300208g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu CB, 2012, CHEM BIOL, V19, P381, DOI 10.1016/j.chembiol.2012.01.015; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Melino S, 1998, TRENDS BIOCHEM SCI, V23, P381, DOI 10.1016/S0968-0004(98)01264-X; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rampioni G, 2010, ENVIRON MICROBIOL, V12, P1659, DOI 10.1111/j.1462-2920.2010.02214.x; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Shimada A, 2010, PROTEINS, V78, P2399, DOI 10.1002/prot.22749; Storz MP, 2012, J AM CHEM SOC, V134, P16143, DOI 10.1021/ja3072397; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yu S, 2009, THESIS M PLANCK I MO; Yu S, 2009, BIOCHEMISTRY-US, V48, P10298, DOI 10.1021/bi900123j	41	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73727	10.1371/journal.pone.0073727	http://dx.doi.org/10.1371/journal.pone.0073727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040042	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000327538600040
J	Tomio, K; Kawana, K; Taguchi, A; Isobe, Y; Iwamoto, R; Yamashita, A; Kojima, S; Mori, M; Nagamatsu, T; Arimoto, T; Oda, K; Osuga, Y; Taketani, Y; Kang, JX; Arai, H; Arita, M; Kozuma, S; Fujii, T				Tomio, Kensuke; Kawana, Kei; Taguchi, Ayumi; Isobe, Yosuke; Iwamoto, Ryo; Yamashita, Aki; Kojima, Satoko; Mori, Mayuyo; Nagamatsu, Takeshi; Arimoto, Takahide; Oda, Katsutoshi; Osuga, Yutaka; Taketani, Yuji; Kang, Jing X.; Arai, Hiroyuki; Arita, Makoto; Kozuma, Shiro; Fujii, Tomoyuki			Omega-3 Polyunsaturated Fatty Acids Suppress the Cystic Lesion Formation of Peritoneal Endometriosis in Transgenic Mouse Models	PLOS ONE			English	Article							MEDIATOR RESOLVIN E1; IRON OVERLOAD; MICE RICH; INFLAMMATION; FLUID; MACROPHAGES; EXPRESSION; WOMEN; OMEGA-3-FATTY-ACIDS; 12/15-LIPOXYGENASE	Omega-3 polyunsaturated fatty acids (omega-3 PUFAs) play a role in controlling pathological inflammatory reactions. Endometriosis is characterized by the presence of endometrial tissue on the peritoneum and an exaggerated inflammatory environment around ectopic tissues. Here peritoneal endometriosis was reproduced using a mouse model in which murine endometrial fragments were inoculated into the peritoneal cavity of mice. Fat-1 mice, in which omega-6 can be converted to omega-3 PUFAs, or wild type mice, in which it cannot, were used for the endometriosis model to address the actions of omega-3 PUFAs on the development of endometriotic lesions. The number and weight of cystic endometriotic lesions in fat-1 mice two weeks after inoculation were significantly less than half to those of controls. Mediator lipidomics revealed that cystic endometriotic lesions and peritoneal fluids were abundant in 12/15-hydroxyeicosapentaenoic acid (12/15-HEPE), derived from eicosapentaenoic acid (EPA), and their amount in fat-1 mice was significantly larger than that in controls. 12/15-Lipoxygenase (12/15-LOX)-knockout (KO) and control mice with or without EPA administration were assessed for the endometriosis model. EPA administration decreased the number of lesions in controls but not in 12/15-LOX-KO mice. The peritoneal fluids in EPA-fed 12/15-LOX-KO mice contained reduced levels of EPA metabolites such as 12/15-HEPE and EPA-derived resolvin E3 even after EPA administration. cDNA microarrays of endometriotic lesions revealed that Interleukin-6 (IL6) expression in fat-1 mice was significantly lower than that in controls. These results suggest that both endogenous and exogenous EPA-derived PUFAs protect against the development of endometriosis through their anti-inflammatory effects and, in particular, the 12/15-LOX-pathway products of EPA may be key mediators to suppress endometriosis.	[Tomio, Kensuke; Kawana, Kei; Taguchi, Ayumi; Yamashita, Aki; Kojima, Satoko; Mori, Mayuyo; Nagamatsu, Takeshi; Arimoto, Takahide; Oda, Katsutoshi; Osuga, Yutaka; Taketani, Yuji; Kozuma, Shiro; Fujii, Tomoyuki] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Isobe, Yosuke; Iwamoto, Ryo; Arai, Hiroyuki; Arita, Makoto] Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Tokyo 113, Japan; [Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA USA	University of Tokyo; University of Tokyo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kawana, K (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan.	kkawana-tky@umin.org; marita@mol.f.u-tokyo.ac.jp	Nagamatsu, Takeshi/AAH-1402-2019; Nagamatsu, Takeshi/AAC-5201-2021	Nagamatsu, Takeshi/0000-0003-1480-5785; Arita, Makoto/0000-0001-9902-0463	Tokyo IGAKUKAI; Japan Science and Technology agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan	Tokyo IGAKUKAI; Japan Science and Technology agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Tokyo IGAKUKAI (KK) (http://square.umin.ac.jp/igakukai/02toppage/toppage.html); Japan Science and Technology agency Precursory Research for Embryonic Science and Technology (PRESTO) (MA) (http://www.inflam.jst.go.jp/); and The Ministry of Education, Culture, Sports, Science, and Technology of Japan (MA) (http://www.lipid.med.kyushu-u.ac.jp/). All of them are numberless. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arici A, 2002, ANN NY ACAD SCI, V955, P101, DOI 10.1111/j.1749-6632.2002.tb02770.x; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Awwad JT, 1999, HUM REPROD, V14, P3107, DOI 10.1093/humrep/14.12.3107; BUYALOS RP, 1992, FERTIL STERIL, V58, P302; COVENS AL, 1988, FERTIL STERIL, V49, P698; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Gazvani MR, 2001, FERTIL STERIL, V76, P717, DOI 10.1016/S0015-0282(01)01991-4; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gonzalez-Ramos R, 2010, FERTIL STERIL, V94, P1985, DOI 10.1016/j.fertnstert.2010.01.013; Hirata T, 2005, HUM REPROD, V20, P2092, DOI 10.1093/humrep/dei012; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Iwabe T, 2000, J CLIN ENDOCR METAB, V85, P824, DOI 10.1210/jc.85.2.824; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kure I, 2010, J PHARMACOL EXP THER, V332, P541, DOI 10.1124/jpet.109.159046; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Lousse JC, 2009, FERTIL STERIL, V91, P1668, DOI 10.1016/j.fertnstert.2008.02.103; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Montagna P, 2008, FERTIL STERIL, V90, P156, DOI 10.1016/j.fertnstert.2006.11.200; Nasu K, 2007, AM J PHYSIOL-ENDOC M, V293, pE16, DOI 10.1152/ajpendo.00135.2006; Netsu S, 2008, FERTIL STERIL, V90, P1496, DOI 10.1016/j.fertnstert.2007.08.014; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; Osuga Y, 2011, AM J REPROD IMMUNOL, V65, P1, DOI 10.1111/j.1600-0897.2010.00887.x; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seki H, 2010, THESCIENTIFICWORLDJO, V10, P818, DOI 10.1100/tsw.2010.72; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Story L, 2004, ILAR J, V45, P132, DOI 10.1093/ilar.45.2.132; TAKETANI Y, 1992, AM J OBSTET GYNECOL, V167, P265, DOI 10.1016/S0002-9378(11)91672-X; Tirado-Gonzalez I, 2010, J REPROD IMMUNOL, V86, P141, DOI 10.1016/j.jri.2010.05.001; Van Langendonckt A, 2002, FERTIL STERIL, V78, P712, DOI 10.1016/S0015-0282(02)03346-0; VERNON MW, 1985, FERTIL STERIL, V44, P684	39	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73085	10.1371/journal.pone.0073085	http://dx.doi.org/10.1371/journal.pone.0073085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24039864	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600017
J	Abdel-Daim, MM; Abuzead, SMM; Halawa, SM				Abdel-Daim, Mohamed M.; Abuzead, Said M. M.; Halawa, Safaa M.			Protective Role of Spirulina platensis against Acute Deltamethrin-Induced Toxicity in Rats	PLOS ONE			English	Article							OXIDATIVE-STRESS; INDUCED NEPHROTOXICITY; C-PHYCOCYANIN; FREE-RADICALS; LIVER; LEAD; METABOLISM; HEPATOTOXICITY; PYRETHROIDS; PESTICIDE	Deltamethrin is a broad-spectrum synthetic pyrethroid insecticide and acaricide widely used for agricultural and veterinary purposes. However, its human and animal exposure leads to hepatonephrotoxicity. Therefore, the present study was undertaken to examine the hepatonephroprotective and antioxidant potential of Spirulina platensis against deltamethrin toxicity in male Wistar albino rats. Deltamethrin treated animals revealed a significant increase in serum biochemical parameters as well as hepatic and renal lipid peroxidation but caused an inhibition in antioxidant biomarkers. Spirulina normalized the elevated serum levels of AST, ALT, APL, uric acid, urea and creatinine. Furthermore, it reduced deltamethrin-induced lipid peroxidation and oxidative stress in a dose dependent manner. Therefore, it could be concluded that spirulina administration able to minimize the toxic effects of deltamethrin by its free radical-scavenging and potent antioxidant activity.	[Abdel-Daim, Mohamed M.] Suez Canal Univ, Fac Vet Med, Dept Pharmacol, Ismailia, Egypt; [Abuzead, Said M. M.] Suez Canal Univ, Fac Vet Med, Dept Physiol, Ismailia, Egypt; [Halawa, Safaa M.] Benha Univ, Fac Agr, Dept Plant Protect, Banha, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Benha University	Abdel-Daim, MM (corresponding author), Suez Canal Univ, Fac Vet Med, Dept Pharmacol, Ismailia, Egypt.	abdeldaim.m@vet.suez.edu.eg	Abdel-Daim, Mohamed M./B-2545-2013	Abdel-Daim, Mohamed M./0000-0002-4341-2713				AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amin KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-45; Anand SS, 2006, TOXICOL APPL PHARM, V212, P156, DOI 10.1016/j.taap.2005.07.021; Avdagic N, 2008, BOSNIAN J BASIC MED, V8, P331, DOI 10.17305/bjbms.2008.2892; Azab S, 2013, MED CHEM RE IN PRESS; BABSON SR, 1973, CLIN CHIM ACTA, V44, P193, DOI 10.1016/0009-8981(73)90381-1; Banji D, 2013, FOOD CHEM, V140, P321, DOI 10.1016/j.foodchem.2013.02.076; Basha Osama M, 2008, Egypt J Immunol, V15, P161; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Chandra N, 2013, B ENVIRON CONTAM TOX, V90, P673, DOI 10.1007/s00128-013-0981-z; Chargui I, 2012, BIOMED ENVIRON SCI, V25, P672, DOI 10.3967/0895-3988.2012.06.009; CHINN K, 1986, J PHYSIOL-LONDON, V380, P191, DOI 10.1113/jphysiol.1986.sp016280; COLE LM, 1982, J AGR FOOD CHEM, V30, P631, DOI 10.1021/jf00112a003; COULOMBE JJ, 1963, CLIN CHEM, V9, P102; Du YZ, 2010, TOXICOL APPL PHARM, V247, P53, DOI 10.1016/j.taap.2010.05.016; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; El-Gerbed MS, 2012, TOXICOL IND IN PRESS; El-Maghraby S, 2007, BIOMED ENVIRON SCI, V20, P212; El-Sayed YS, 2007, ENVIRON TOXICOL PHAR, V24, P212, DOI 10.1016/j.etap.2007.05.006; FARBER JL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432207; Farooq SM, 2004, CLIN CHIM ACTA, V348, P199, DOI 10.1016/j.cccn.2004.05.016; Farooq SM, 2004, CHEM-BIOL INTERACT, V149, P1, DOI 10.1016/j.cbi.2004.05.006; FORSHAW PJ, 1983, EUR J PHARMACOL, V91, P207, DOI 10.1016/0014-2999(83)90466-1; Gargouri M, 2012, FOOD CHEM TOXICOL, V50, P2303, DOI 10.1016/j.fct.2012.04.003; HOELLINGER H, 1987, DRUG CHEM TOXICOL, V10, P291, DOI 10.3109/01480548709042988; Hogg N, 1998, SEMIN REPROD ENDOCR, V16, P241, DOI 10.1055/s-2007-1016284; HUSAIN R, 1994, PHARMACOL TOXICOL, V74, P211, DOI 10.1111/j.1600-0773.1994.tb01100.x; Ismail MF, 2009, INT J BIOL SCI, V5, P377; Issam C, 2009, J TOXICOL SCI, V34, P663, DOI 10.2131/jts.34.663; Kaplowitz N, 1996, Prog Liver Dis, V14, P131; Karadeniz A, 2008, PHYTOTHER RES, V22, P1506, DOI 10.1002/ptr.2522; Karadeniz A, 2009, ECOTOX ENVIRON SAFE, V72, P231, DOI 10.1016/j.ecoenv.2008.02.021; Khan M, 2006, J APPL TOXICOL, V26, P444, DOI 10.1002/jat.1159; Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607; Koracevic D, 2001, J CLIN PATHOL, V54, P356, DOI 10.1136/jcp.54.5.356; KOWALCZYKBRONISZ SH, 1990, ARCH IMMUNOL THER EX, V38, P229; Mohan IK, 2006, CANCER CHEMOTH PHARM, V58, P802, DOI 10.1007/s00280-006-0231-8; LARSEN K, 1972, CLIN CHIM ACTA, V38, P475, DOI 10.1016/0009-8981(72)90146-5; Li HY, 2011, TOXICOL IND HEALTH, V27, P579, DOI 10.1177/0748233710393400; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2010, BRIT J NUTR, V103, P1573, DOI 10.1017/S0007114509993758; LUKOWICZRATAJCZAK J, 1992, ENVIRON RES, V59, P467, DOI 10.1016/S0013-9351(05)80049-0; Mehlhorn H, 2011, PARASITOL RES, V108, P963, DOI 10.1007/s00436-010-2141-2; MICHELANGELI F, 1990, BIOCHIM BIOPHYS ACTA, V1028, P49, DOI 10.1016/0005-2736(90)90264-O; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Oda SS, 2012, EXP TOXICOL PATHOL, V64, P813, DOI 10.1016/j.etp.2011.03.001; Paniagua-Castro N, 2011, J MED FOOD, V14, P398, DOI 10.1089/jmf.2010.0070; Ponce-Canchihuaman JC, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-35; Reddy CM, 2000, BIOCHEM BIOPH RES CO, V277, P599, DOI 10.1006/bbrc.2000.3725; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; RICHMOND W, 1973, CLIN CHEM, V19, P1350; Schmidt M, 1975, Fortschr Med, V93, P1461; Simsek N, 2009, J HAZARD MATER, V164, P1304, DOI 10.1016/j.jhazmat.2008.09.041; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D; SZEPVOLGYI J, 1988, TOXICOLOGY, V53, P107, DOI 10.1016/0300-483X(88)90240-5; TIETZ NW, 1983, CLIN CHEM, V29, P751; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Upasani CD, 2003, PHYTOTHER RES, V17, P330, DOI 10.1002/ptr.1135; Vadiraja BB, 1998, BIOCHEM BIOPH RES CO, V249, P428, DOI 10.1006/bbrc.1998.9149; WHITEHEAD TP, 1991, CLIN CHEM, V37, P879	62	161	166	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e72991	10.1371/journal.pone.0072991	http://dx.doi.org/10.1371/journal.pone.0072991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039839	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300041
J	Chisti, MJ; Salam, MA; Ashraf, H; Faruque, ASG; Bardhan, PK; Hossain, MI; Shahid, ASMSB; Shahunja, KM; Das, SK; Imran, G; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Hossain, Md Iqbal; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Imran, Gazi; Ahmed, Tahmeed			Clinical Risk Factors of Death From Pneumonia in Children with Severe Acute Malnutrition in an Urban Critical Care Ward of Bangladesh	PLOS ONE			English	Article							DIARRHEA TREATMENT CENTER; MALNOURISHED CHILDREN; PREDICTORS; MORTALITY; INFANTS; MECHANISMS; HYPOXEMIA; DIAGNOSIS; ETIOLOGY; FEATURES	Background: Risks of death are high when children with pneumonia also have severe acute malnutrition (SAM) as a comorbidity. However, there is limited published information on risk factors of death from pneumonia in SAM children. We evaluated clinically identifiable factors associated with death in under-five children who were hospitalized for the management of pneumonia and SAM. Methods: For this unmatched case-control design, SAM children of either sex, aged 0-59 months, admitted to the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) during April 2011 to July 2012 with radiological pneumonia were studied. The SAM children with pneumonia who had fatal outcome constituted the cases (n = 35), and randomly selected SAM children with pneumonia who survived constituted controls (n = 105). Results: The median (inter-quartile range) age (months) was comparable among the cases and the controls [8.0 (4.9, 11.0) vs. 9.7 (5.0, 18.0); p = 0.210)]. In logistic regression analysis, after adjusting for potential confounders, such as vomiting, abnormal mental status, and systolic hypotension (<70 mm of Hg) in absence of dehydration, fatal cases of severely malnourished under-five children with pneumonia were more often hypoxemic (OR = 23.15, 95% CI = 4.38-122.42), had clinical dehydration (some/severe) (OR = 9.48, 95% CI = 2.42-37.19), abdominal distension at admission (OR = 4.41, 95% CI = 1.12-16.52), and received blood transfusion (OR = 5.50, 95% CI = 1.21-24.99) for the management of crystalloid resistant systolic hypotension. Conclusion and Significance: We identified hypoxemia, clinical dehydration, and abdominal distension as the independent predictors of death in SAM children with pneumonia. SAM children with pneumonia who required blood transfusion for the management of crystalloid resistant systolic hypotension were also at risk for death. Thus, early identification and prompt management of these simple clinically recognizable predictors of death and discourage the use of blood transfusion for the management of crystalloid resistant systolic hypotension may help reduce deaths in such population.	[Chisti, Mohammod Jobayer; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Hossain, Md Iqbal; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Ahmed, Tahmeed] Icddr B, CNFS, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Ashraf, Hasan; Bardhan, Pradip Kumar; Hossain, Md Iqbal] Icddr B, Dhaka Hosp, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Icddr B, Res Adm, Dhaka, Bangladesh; [Imran, Gazi] Dhaka Shishu Children Hosp, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Icddr B, CNFS, Dhaka, Bangladesh.	chisti@icddrb.org	Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Shahunja, K M/AAR-6229-2020	Shahunja, K M/0000-0002-9345-206X	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Adegbola RA, 2000, ANN TROP MED PARASIT, V94, P197, DOI 10.1080/00034980050006366; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; [Anonymous], PEDIAT ADV LIFE SUPP; Bachou Hanifa, 2006, BMC Pediatr, V6, P7, DOI 10.1186/1471-2431-6-7; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BROOKS SEH, 1994, W INDIAN MED J, V43, P52; Carcillo Joseph A, 2005, Pediatr Crit Care Med, V6, pS157, DOI 10.1097/01.PCC.0000161574.36857.CA; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2010, ANN TROP PAEDIATR, V30, P311, DOI 10.1179/146532810X12858955921230; Chisti MJ, 2009, ANN TROP PAEDIATR, V29, P45, DOI 10.1179/146532809X402024; Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051376; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Chisti MJ, 2009, ACTA PAEDIATR, V98, P873, DOI 10.1111/j.1651-2227.2008.01196.x; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Eisenhut M, 2007, MED HYPOTHESES, V68, P361, DOI 10.1016/j.mehy.2006.07.012; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; Gauvin F, 2012, PAED CHILD HEALT-CAN, V17, P235, DOI 10.1093/pch/17.5.235; Holder AL, 2013, CRIT CARE, V17, DOI 10.1186/cc12533; Liu L, 2012, LANCET; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Muriova K, 2010, Vnitr Lek, V56, P220; Nair H, 2013, LANCET; PARKS DA, 1985, ARCH INTERN MED, V145, P1278, DOI 10.1001/archinte.145.7.1278; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Rudiger A, 2013, CURR VASC PHARMACOL, V11, P187; Smyth A, 1998, ANN TROP PAEDIATR, V18, P31, DOI 10.1080/02724936.1998.11747923; West JB., 2008, WESTS RESP PHYSL ESS, V9th; WHO, 2006, POCK BOOK HOSP CAR C, P173; World Health Organization, 1999, MAN SEV MALN MAN PHY	37	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73728	10.1371/journal.pone.0073728	http://dx.doi.org/10.1371/journal.pone.0073728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040043	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300118
J	Holt, JS; Welles, SR; Silvera, K; Heap, IM; Heredia, SM; Martinez-Berdeja, A; Palenscar, KT; Sweet, LC; Ellstrand, NC				Holt, Jodie S.; Welles, Shana R.; Silvera, Katia; Heap, Ian M.; Heredia, Sylvia M.; Martinez-Berdeja, Alejandra; Palenscar, Kai T.; Sweet, Lynn C.; Ellstrand, Norman C.			Taxonomic and Life History Bias in Herbicide Resistant Weeds: Implications for Deployment of Resistant Crops	PLOS ONE			English	Article							GLYPHOSATE; EVOLUTION; MANAGEMENT	Evolved herbicide resistance (EHR) is an important agronomic problem and consequently a food security problem, as it jeopardizes herbicide effectiveness and increases the difficulty and cost of weed management. EHR in weeds was first reported in 1970 and the number of cases has accelerated dramatically over the last two decades. Despite 40 years of research on EHR, why some weeds evolve resistance and others do not is poorly understood. Here we ask whether weed species that have EHR are different from weeds in general. Comparing taxonomic and life history traits of weeds with EHR to a control group (''the world's worst weeds''), we found weeds with EHR significantly over-represented in certain plant families and having certain life history biases. In particular, resistance is overrepresented in Amaranthaceae, Brassicaceae and Poaceae relative to all weeds, and annuality is ca. 1.5 times as frequent in weeds with EHR as in the control group. Also, for perennial EHR weeds, vegetative reproduction is only 60% as frequent as in the control group. We found the same trends for subsets of weeds with EHR to acetolactate synthase (ALS), photosystem II (PSII), and 5-enolpyruvylshikimate-3phosphate (EPSP) synthase-inhibitor herbicides and with multiple resistance. As herbicide resistant crops (transgenic or not) are increasingly deployed in developing countries, the problems of EHR could increase in those countries as it has in the USA if the selecting herbicides are heavily applied and appropriate management strategies are not employed. Given our analysis, we make some predictions about additional species that might evolve resistance.	[Holt, Jodie S.; Welles, Shana R.; Heredia, Sylvia M.; Martinez-Berdeja, Alejandra; Palenscar, Kai T.; Sweet, Lynn C.; Ellstrand, Norman C.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Silvera, Katia] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Heap, Ian M.] Int Survey Herbicide Resistant Weeds, Corvallis, OR USA	University of California System; University of California Riverside; Smithsonian Institution; Smithsonian Tropical Research Institute	Welles, SR (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	shana.welles@email.ucr.edu	Sweet, Lynn/A-1896-2012; Sweet, Lynn/P-4924-2019	Sweet, Lynn/0000-0003-0886-4973	John Simon Guggenheim Memorial Fellowship; NSF OPUS [DEB-1020799];  [NSFDGE-0813967]	John Simon Guggenheim Memorial Fellowship; NSF OPUS; 	Support for NCE was provided by a John Simon Guggenheim Memorial Fellowship and NSF OPUS grant #DEB-1020799. Support for SRW is supported under grant NSFDGE-0813967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, PESTICIDE RESISTANCE; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Gresse lJ., 1982, HERBICIDE RESISTANCE, P81; GRESSEL J, 1978, J THEOR BIOL, V75, P349, DOI 10.1016/0022-5193(78)90340-5; Hall Linda M., 1994, P243; Harper JL, 1956, 3RD P BRIT WEED CONT, P179; Heap I, 2001, HERBICIDE RESISTANCE AND WORLD GRAINS, P1; Heap I., 2013, INT SURVEY HERBICIDE; Hickman J. C., 1993, JEPSON MANUAL HIGHER; HIRSCHBERG J, 1984, Z NATURFORSCH C, V39, P412; Holm L., 1997, NATURAL HIST DISTRIB; Holm L. G., 1977, WORLDS WORST WEEDS D; HOLT JS, 1992, WEED TECHNOL, V6, P615, DOI 10.1017/S0890037X00035910; Jasieniuk M, 1996, WEED SCI, V44, P176, DOI 10.1017/S0043174500093747; Kanazin V, 1996, P NATL ACAD SCI USA, V93, P11746, DOI 10.1073/pnas.93.21.11746; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Maddison WP, 2017, MESQUITE MODULAR SYS; MAXWELL BD, 1990, WEED TECHNOL, V4, P2, DOI 10.1017/S0890037X0002488X; Mortensen DA, 2012, BIOSCIENCE, V62, P75, DOI 10.1525/bio.2012.62.1.12; National Research Council Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability, 2010, IMP GEN ENG CROPS FA; Powles SB, 1998, WEED SCI, V46, P604, DOI 10.1017/S0043174500091165; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; R Core Team, 2012, R LANG ENV STAT COMP; Radosevich SR, 2007, ECOLOGY OF WEEDS AND INVASIVE PLANTS: RELATIONSHIP TO AGRICULTURE AND NATURAL RESOURCE MANAGEMENT, 3RD EDITION, P1, DOI 10.1002/9780470168943; RYAN GF, 1970, WEED SCI, V18, P614, DOI 10.1017/S0043174500034330; Shaner DL, 2000, PEST MANAG SCI, V56, P320, DOI 10.1002/(SICI)1526-4998(200004)56:4<320::AID-PS125>3.3.CO;2-2; Stace C.A., 2010, STACE, V3rd Edn; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; USDA ARS National Genetic Resources Program, 2011, GERMPL RES INF NETW; Yang ZF, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10201; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001	32	18	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e71916	10.1371/journal.pone.0071916	http://dx.doi.org/10.1371/journal.pone.0071916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039727	Green Published, gold			2022-12-25	WOS:000326405300004
J	Yao, ZT; Zou, CW; Zhou, H; Wang, JZ; Lu, LD; Li, Y; Chen, BS				Yao, Ziting; Zou, Chengwu; Zhou, Hui; Wang, Jinzi; Lu, Lidan; Li, Yang; Chen, Baoshan			Delta(1)-Pyrroline-5-Carboxylate/Glutamate Biogenesis Is Required for Fungal Virulence and Sporulation	PLOS ONE			English	Article							CHESTNUT BLIGHT FUNGUS; RICE BLAST FUNGUS; CRYPHONECTRIA-PARASITICA; SACCHAROMYCES-CEREVISIAE; PROLINE DEHYDROGENASE; VEGETATIVE INCOMPATIBILITY; INTRACELLULAR PROLINE; ENDOTHIA-PARASITICA; NITROGEN STARVATION; FUNCTIONAL-ANALYSIS	Proline dehydrogenase (Prodh) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5Cdh) are two key enzymes in the cellular biogenesis of glutamate. Recombinant Prodh and P5Cdh proteins of the chestnut blight fungus Cryphonectria parasitica were investigated and showed activity in in vitro assays. Additionally, the C. parasitica Prodh and P5Cdh genes were able to complement the Saccharomyces cerevisiae put1 and put2 null mutants, respectively, to allow these proline auxotrophic yeast mutants to grow on media with proline as the sole source of nitrogen. Deletion of the Prodh gene in C. parasitica resulted in hypovirulence and a lower level of sporulation, whereas deletion of P5Cdh resulted in hypovirulence though no effect on sporulation; both Delta prodh and Delta p5cdh mutants were unable to grow on minimal medium with proline as the sole nitrogen source. In a wild-type strain, the intracellular level of proline and the activity of Prodh and P5Cdh increased after supplementation of exogenous proline, though the intracellular Delta(1)-pyrroline-5-carboxylate (P5C) content remained unchanged. Prodh and P5Cdh were both transcriptionally down-regulated in cells infected with hypovirus. The disruption of other genes with products involved in the conversion of arginine to ornithine, ornithine and glutamate to P5C, and P5C to proline in the cytosol did not appear to affect virulence; however, asexual sporulation was reduced in the Delta pro1 and Delta pro2 mutants. Taken together, our results showed that Prodh, P5Cdh and related mitochondrial functions are essential for virulence and that proline/glutamate pathway components may represent down-stream targets of hypovirus regulation in C. parasitica.	[Yao, Ziting; Zou, Chengwu; Zhou, Hui; Wang, Jinzi; Lu, Lidan; Li, Yang; Chen, Baoshan] Guangxi Univ, Coll Life Sci & Technol, Key Lab Minist Educ Microbial & Plant Genet Engn, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China	Guangxi University	Chen, BS (corresponding author), Guangxi Univ, Coll Life Sci & Technol, Key Lab Minist Educ Microbial & Plant Genet Engn, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	chenyaoj@gxu.edu.cn	Zou, Chengwu/GXW-2438-2022		Natural Science Foundation of China [30130020]; Guangxi Natural Science Foundation [GNS0229001]; Plans for Creative Training of Post-Graduates in Guangxi University [2010-01]; Innovation Project of Guangxi Graduate Education [T31057]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Plans for Creative Training of Post-Graduates in Guangxi University; Innovation Project of Guangxi Graduate Education	This work was supported in part by grants from the Natural Science Foundation of China (30130020) and Guangxi Natural Science Foundation (GNS0229001) to BC, and the Plans for Creative Training of Post-Graduates in Guangxi University (2010-01) and Innovation Project of Guangxi Graduate Education (T31057) to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2004, EUKARYOT CELL, V3, P1227, DOI 10.1128/EC.3.5.1227-1232.2004; ANAGNOSTAKIS SL, 1982, GENETICS, V102, P25; BRANDRISS MC, 1979, J BACTERIOL, V140, P498, DOI 10.1128/JB.140.2.498-503.1979; BRANDRISS MC, 1992, J BACTERIOL, V174, P5176, DOI 10.1128/JB.174.15.5176-.1992; Chen CB, 2006, APPL ENVIRON MICROB, V72, P4001, DOI 10.1128/AEM.02428-05; Chen C, 2010, J BIOL CHEM, V285, P26685, DOI 10.1074/jbc.M110.117804; Chen MM, 2011, MOL PLANT PATHOL, V12, P239, DOI 10.1111/j.1364-3703.2010.00665.x; Choi ES, 2005, MICROBIOL-SGM, V151, P1349, DOI 10.1099/mic.0.27796-0; CHOI GH, 1992, SCIENCE, V257, P800, DOI 10.1126/science.1496400; CHOI GH, 1992, EMBO J, V11, P473, DOI 10.1002/j.1460-2075.1992.tb05077.x; CHOI GH, 1995, P NATL ACAD SCI USA, V92, P305, DOI 10.1073/pnas.92.1.305; Choi GH, 2012, GENETICS, V190, P113, DOI 10.1534/genetics.111.133983; Chung HJ, 2008, MOL PLANT MICROBE IN, V21, P1582, DOI 10.1094/MPMI-21-12-1582; Chung HJ, 2006, FUNGAL GENET BIOL, V43, P326, DOI 10.1016/j.fgb.2005.12.009; Churchill ACL, 1990, CURR GENET; Cortesi P, 1998, APPL ENVIRON MICROB, V64, P2988; CRAVEN MG, 1993, J VIROL, V67, P6513, DOI 10.1128/JVI.67.11.6513-6521.1993; Dawe AL, 2009, MICROBIOL-SGM, V155, P3913, DOI 10.1099/mic.0.029033-0; desEtages SAG, 1996, GENETICS, V142, P1069; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; do Rio MCS, 2008, CURR MICROBIOL, V56, P363, DOI 10.1007/s00284-007-9091-7; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Donofrio NM, 2006, FUNGAL GENET BIOL, V43, P605, DOI 10.1016/j.fgb.2006.03.005; Funck D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-70; Gao K, 2012, FUNGAL GENET BIOL; Gao SJ, 1996, P NATL ACAD SCI USA, V93, P14122, DOI 10.1073/pnas.93.24.14122; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Jacob-Wilk D, 2012, FUNGAL BIOL-UK, V116, P363, DOI 10.1016/j.funbio.2011.12.006; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kasahara S, 1997, MOL PLANT MICROBE IN, V10, P984, DOI 10.1094/MPMI.1997.10.8.984; Kawakami R, 2012, APPL MICROBIOL BIOT, V93, P83, DOI 10.1007/s00253-011-3682-8; KIM DH, 1995, MOL PLANT MICROBE IN, V8, P259, DOI 10.1094/MPMI-8-0259; Kim JM, 2012, CAN J MICROBIOL, V58, P863, DOI [10.1139/W2012-065, 10.1139/w2012-065]; Kirkland BH, 2005, J MED ENTOMOL, V42, P346, DOI 10.1603/0022-2585(2005)042[0346:OAAAFA]2.0.CO;2; Kiyosue T, 1996, PLANT CELL, V8, P1323, DOI 10.1105/tpc.8.8.1323; Lan XW, 2008, CURR GENET, V53, P59, DOI 10.1007/s00294-007-0162-x; Liao SH, 2012, FEMS MICROBIOL LETT, V336, P64, DOI 10.1111/j.1574-6968.2012.02657.x; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Martin O, 2003, APPL ENVIRON MICROB, V69, P1623, DOI 10.1128/AEM.69.3.1623-1628.2003; Matsuura K, 2005, J BIOSCI BIOENG, V100, P538, DOI 10.1263/jbb.100.538; Messenguy F, 2000, J BACTERIOL, V182, P3158, DOI 10.1128/JB.182.11.3158-3164.2000; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; MONTEIROVITORELLO CB, 1995, P NATL ACAD SCI USA, V92, P5935, DOI 10.1073/pnas.92.13.5935; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Nanjo T, 2003, PLANT CELL PHYSIOL, V44, P541, DOI 10.1093/pcp/pcg066; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Park JA, 2012, MOL PLANT PATHOL, V13, P240, DOI 10.1111/j.1364-3703.2011.00742.x; Park SM, 2004, MOL MICROBIOL, V51, P1267, DOI 10.1111/j.1365-2958.2004.03919.x; Parsley TB, 2003, CURR GENET, V43, P24, DOI 10.1007/s00294-003-0367-6; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; POWELL WA, 1987, J BACTERIOL, V169, P5324, DOI 10.1128/jb.169.11.5324-5326.1987; PUHALLA JE, 1971, PHYTOPATHOLOGY, V61, P169, DOI 10.1094/Phyto-61-169; Rostagno L, 2010, PHYTOPATHOLOGY, V100, P1100, DOI 10.1094/PHYTO-02-10-0044; SCARPULLA RC, 1978, J BIOL CHEM, V253, P5997; Segers GC, 2004, EUKARYOT CELL, V3, P1454, DOI 10.1128/EC.3.6.1454-1463.2004; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Takagi H, 2000, FEMS MICROBIOL LETT, V184, P103, DOI 10.1016/S0378-1097(00)00023-9; Talbot NJ, 1997, PHYSIOL MOL PLANT P, V50, P179, DOI 10.1006/pmpp.1997.0081; TOMENCHOK DM, 1987, J BACTERIOL, V169, P5364, DOI 10.1128/jb.169.12.5364-5372.1987; Wang FangZhen, 2012, Genomics and Applied Biology, V31, P45; Wang JZ, 2013, J PROTEOMICS, V78, P221, DOI 10.1016/j.jprot.2012.08.013; WANG SS, 1986, MOL CELL BIOL, V6, P2638, DOI 10.1128/MCB.6.7.2638; WANG SS, 1987, MOL CELL BIOL, V7, P4431, DOI 10.1128/MCB.7.12.4431; Yan BQ, 2007, BIOCHEM GENET, V45, P487, DOI 10.1007/s10528-007-9090-1; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299	71	8	11	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73483	10.1371/journal.pone.0073483	http://dx.doi.org/10.1371/journal.pone.0073483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24039956	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300079
J	Fewer, DP; Jokela, J; Paukku, E; Osterholm, J; Wahlsten, M; Permi, P; Aitio, O; Rouhiainen, L; Gomez-Saez, GV; Sivonen, K				Fewer, David P.; Jokela, Jouni; Paukku, Eeva; Osterholm, Julia; Wahlsten, Matti; Permi, Perttu; Aitio, Olli; Rouhiainen, Leo; Gomez-Saez, Gonzalo V.; Sivonen, Kaarina			New Structural Variants of Aeruginosin Produced by the Toxic Bloom Forming Cyanobacterium Nodularia spumigena	PLOS ONE			English	Article							GENE-CLUSTER; BALTIC SEA; BIOCHEMICAL-CHARACTERIZATION; BIOSYNTHESIS; INHIBITOR; PEPTIDES; DIVERSITY; EVOLUTION; THROMBIN; DOMAINS	Nodularia spumigena is a filamentous diazotrophic cyanobacterium that forms blooms in brackish water bodies. This cyanobacterium produces linear and cyclic peptide protease inhibitors which are thought to be part of a chemical defense against grazers. Here we show that N. spumigena produces structurally novel members of the aeruginosin family of serine protease inhibitors. Extensive chemical analyses including NMR demonstrated that the aeruginosins are comprised of an N-terminal short fatty acid chain, L-Tyr, L-Choi and L-argininal and in some cases pentose sugar. The genome of N. spumigena CCY9414 contains a compact 18-kb aeruginosin gene cluster encoding a peptide synthetase with a reductive release mechanism which offloads the aeruginosins as reactive peptide aldehydes. Analysis of the aeruginosin and spumigin gene clusters revealed two different strategies for the incorporation of N-terminal protecting carboxylic acids. These results demonstrate that strains of N. spumigena produce aeruginosins and spumigins, two families of structurally similar linear peptide aldehydes using separate peptide synthetases. The aeruginosins were chemically diverse and we found 11 structural variants in 16 strains from the Baltic Sea and Australia. Our findings broaden the known structural diversity of the aeruginosin peptide family to include peptides with rare N-terminal short chain (C-2-C-10) fatty acid moieties.	[Fewer, David P.; Jokela, Jouni; Paukku, Eeva; Osterholm, Julia; Wahlsten, Matti; Rouhiainen, Leo; Gomez-Saez, Gonzalo V.; Sivonen, Kaarina] Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland; [Permi, Perttu; Aitio, Olli] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland	University of Helsinki; University of Helsinki	Sivonen, K (corresponding author), Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi	Gomez-Saez, Gonzalo/K-3481-2013; Fewer, David P/A-8704-2008	Fewer, David P/0000-0003-3978-4845; Jokela, Jouni/0000-0001-5096-3575; Sivonen, Kaarina/0000-0002-2904-0458; Wahlsten, Matti/0000-0002-4107-1695; Gomez-Saez, Gonzalo V./0000-0002-6308-5764	Academy of Finland [258827]; research Center of Excellency from the Academy of Finland [118637]	Academy of Finland(Academy of Finland); research Center of Excellency from the Academy of Finland	This work was funded by a research Center of Excellency (118637) and Academy project grant (258827) both from the Academy of Finland to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas ARJ, 2012, J NAT PROD, V75, P1546, DOI 10.1021/np300282a; Bister B, 2004, J NAT PROD, V67, P1755, DOI 10.1021/np049828f; Cadel-Six S, 2008, MOL BIOL EVOL, V25, P2031, DOI 10.1093/molbev/msn150; Davis TW, 2012, HARMFUL ALGAE, V15, P26, DOI 10.1016/j.hal.2011.11.002; Ersmark K, 2008, ANGEW CHEM INT EDIT, V47, P1202, DOI 10.1002/anie.200605219; Fewer DP, 2009, MOL MICROBIOL, V73, P924, DOI 10.1111/j.1365-2958.2009.06816.x; Fujii K, 1997, TETRAHEDRON LETT, V38, P5525, DOI 10.1016/S0040-4039(97)01192-1; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; Hoffmann D, 2003, GENE, V311, P171, DOI 10.1016/S0378-1119(03)00587-0; Ishida K, 2007, CHEM BIOL, V14, P565, DOI 10.1016/j.chembiol.2007.04.006; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Jonasson S, 2008, FEMS MICROBIOL ECOL, V65, P31, DOI 10.1111/j.1574-6941.2008.00499.x; Konz D, 1999, J BACTERIOL, V181, P133, DOI 10.1128/JB.181.1.133-140.1999; Lehtimaki J, 2000, INT J SYST EVOL MICR, V50, P1043, DOI 10.1099/00207713-50-3-1043; Lyra C, 2005, INT J SYST EVOL MICR, V55, P555, DOI 10.1099/ijs.0.63288-0; Mazur-Marzec H, 2013, MAR DRUGS, V11, P1, DOI 10.3390/md11010001; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004; MURAKAMI M, 1994, TETRAHEDRON LETT, V35, P3129, DOI 10.1016/S0040-4039(00)76848-1; Nishizawa T, 2011, J BIOCHEM, V149, P475, DOI 10.1093/jb/mvq150; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rohrlack T, 2004, APPL ENVIRON MICROB, V70, P5047, DOI 10.1128/AEM.70.8.5047-5050.2004; Rouhiainen L, 2010, CHEM BIOL, V17, P265, DOI 10.1016/j.chembiol.2010.01.017; Schindler CS, 2008, ANGEW CHEM INT EDIT, V47, P8852, DOI 10.1002/anie.200803655; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Simola O, 2012, VET PATHOL, V49, P755, DOI 10.1177/0300985811415703; SIVONEN K, 1989, APPL ENVIRON MICROB, V55, P1990, DOI 10.1128/AEM.55.8.1990-1995.1989; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stal LJ, 2003, CONT SHELF RES, V23, P1695, DOI 10.1016/j.csr.2003.06.001; Voss B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060224; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x	31	31	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73618	10.1371/journal.pone.0073618	http://dx.doi.org/10.1371/journal.pone.0073618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040002	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500051
J	Pittet, V; Phister, TG; Ziola, B				Pittet, Vanessa; Phister, Trevor G.; Ziola, Barry			Transcriptome Sequence and Plasmid Copy Number Analysis of the Brewery Isolate Pediococcus claussenii ATCC BAA-344(T) during Growth in Beer	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LACTOBACILLUS-BREVIS; RNA-SEQ; ESCHERICHIA-COLI; ETHANOL TOLERANCE; TRANS-ISOHUMULONE; QUANTITATIVE PCR; GENE-EXPRESSION; BIOGENIC-AMINES; PREDICT GROWTH	Growth of specific lactic acid bacteria in beer leads to spoiled product and economic loss for the brewing industry. Microbial growth is typically inhibited by the combined stresses found in beer (e. g., ethanol, hops, low pH, minimal nutrients); however, certain bacteria have adapted to grow in this harsh environment. Considering little is known about the mechanisms used by bacteria to grow in and spoil beer, transcriptome sequencing was performed on a variant of the beer-spoilage organism Pediococcus claussenii ATCC BAA-344(T) (Pc344-358). Illumina sequencing was used to compare the transcript levels in Pc344-358 growing mid-exponentially in beer to those in nutrient-rich MRS broth. Various operons demonstrated high gene expression in beer, several of which are involved in nutrient acquisition and overcoming the inhibitory effects of hop compounds. As well, genes functioning in cell membrane modification and biosynthesis demonstrated significantly higher transcript levels in Pc344-358 growing in beer. Three plasmids had the majority of their genes showing increased transcript levels in beer, whereas the two cryptic plasmids showed slightly decreased gene expression. Follow-up analysis of plasmid copy number in both growth environments revealed similar trends, where more copies of the three non-cryptic plasmids were found in Pc344-358 growing in beer. Transcriptome sequencing also enabled the addition of several genes to the P. claussenii ATCC BAA-344(T) genome annotation, some of which are putatively transcribed as non-coding RNAs. The sequencing results not only provide the first transcriptome description of a beer-spoilage organism while growing in beer, but they also highlight several targets for future exploration, including genes that may have a role in the general stress response of lactic acid bacteria.	[Pittet, Vanessa; Ziola, Barry] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada; [Phister, Trevor G.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of Saskatchewan; University of North Carolina; North Carolina State University	Pittet, V (corresponding author), Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada.	v.pittet@usask.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); American Society of Brewing Chemists Foundation; MillerCoors Brewing Company; Golden CO; United States Department of Agriculture CREES National Research Initiative [2007-35504-18249]; NSERC [24067]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Society of Brewing Chemists Foundation; MillerCoors Brewing Company; Golden CO; United States Department of Agriculture CREES National Research Initiative; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	VP was the holder of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the recipient of the MillerCoors, Anheuser-Busch InBev, and Brian Williams Graduate Scholarships from the American Society of Brewing Chemists Foundation. VP also held a NSERC Michael Smith Foreign Study Supplement, which funded the study period at North Carolina State University with TP. This research was supported by MillerCoors Brewing Company, Golden CO, the United States Department of Agriculture CREES National Research Initiative (project number 2007-35504-18249), and NSERC Discovery Grant (24067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyoun P, GENOMICRANGES REPRES; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Behr J, 2006, APPL ENVIRON MICROB, V72, P6483, DOI 10.1128/AEM.00668-06; Behr J, 2010, APPL ENVIRON MICROB, V76, P142, DOI 10.1128/AEM.01693-09; Behr J, 2009, J AGR FOOD CHEM, V57, P6074, DOI 10.1021/jf900847y; Bergsveinson J, 2012, APPL MICROBIOL BIOT, V96, P461, DOI 10.1007/s00253-012-4334-3; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Brantl S, 2002, PLASMID, V48, P165, DOI 10.1016/S0147-619X(02)00108-7; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Dobson CM, 2002, INT J SYST EVOL MICR, V52, P2003, DOI 10.1099/00207713-52-6-2003; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Haakensen M, 2009, INT J FOOD MICROBIOL, V130, P56, DOI 10.1016/j.ijfoodmicro.2009.01.001; Haakensen MC, 2007, J AM SOC BREW CHEM, V65, P157, DOI 10.1094/j.ASBCJ-2007-0611-01; Haakensen M, 2008, J AM SOC BREW CHEM, V66, P63, DOI 10.1094/ASBCJ-2008-0314-01; Haakensen M, 2009, J AM SOC BREW CHEM, V67, P170, DOI 10.1094/ASBCJ-2009-0601-01; Halasz A, 1999, Z LEBENSM UNTERS F A, V208, P418, DOI 10.1007/s002170050440; Hayashi N, 2001, APPL MICROBIOL BIOT, V55, P596, DOI 10.1007/s002530100600; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Iijima K, 2007, J I BREWING, V113, P96, DOI 10.1002/j.2050-0416.2007.tb00262.x; INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305; Isabella VM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-51; Kalac P, 2003, J I BREWING, V109, P123, DOI 10.1002/j.2050-0416.2003.tb00141.x; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Krol JE, 2011, APPL ENVIRON MICROB, V77, P5079, DOI 10.1128/AEM.00090-11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loret S, 2005, FOOD CHEM, V89, P519, DOI 10.1016/j.foodchem.2004.03.010; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Pittet V, 2012, J BACTERIOL, V194, P1271, DOI 10.1128/JB.06759-11; Pittet V, 2011, J AM SOC BREW CHEM, V69, P57, DOI 10.1094/ASBCJ-2011-0124-01; Sami M, 1997, J FERMENT BIOENG, V84, P1, DOI 10.1016/S0922-338X(97)82778-X; SCHMALRECK AF, 1975, CAN J MICROBIOL, V21, P205, DOI 10.1139/m75-029; SIMPSON WJ, 1994, J AM SOC BREW CHEM, V52, P9; SIMPSON WJ, 1993, J GEN MICROBIOL, V139, P1041, DOI 10.1099/00221287-139-5-1041; Stillman TJ, 2005, MOL MICROBIOL, V57, P1101, DOI 10.1111/j.1365-2958.2005.04757.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki K, 2006, LETT APPL MICROBIOL, V42, P392, DOI 10.1111/j.1472-765X.2006.01860.x; Suzuki K, 2005, APPL ENVIRON MICROB, V71, P5089, DOI 10.1128/AEM.71.9.5089-5097.2005; Suzuki K, 2005, J AM SOC BREW CHEM, V63, P11, DOI 10.1094/ASBC-J-63-0011; TEUBER M, 1973, ARCH MIKROBIOL, V94, P159, DOI 10.1007/BF00416690; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	53	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73627	10.1371/journal.pone.0073627	http://dx.doi.org/10.1371/journal.pone.0073627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040005	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500052
J	Reddy, S; Taylor, M; Zhao, MJ; Cherubin, P; Geden, S; Ray, S; Francis, D; Teter, K				Reddy, Srikar; Taylor, Michael; Zhao, Mojun; Cherubin, Patrick; Geden, Sandra; Ray, Supriyo; Francis, David; Teter, Ken			Grape Extracts Inhibit Multiple Events in the Cell Biology of Cholera Intoxication	PLOS ONE			English	Article							TOXIN A1 SUBUNIT; INTESTINAL EPITHELIAL-CELLS; NATURAL POLYPHENOLS; PLANT POLYPHENOLS; CULTURED-CELLS; INTERNALIZATION; DEGRADATION; TRANSPORT; REDUCTION; BINDING	Vibrio cholerae produces cholera toxin (CT), an AB(5) protein toxin that is primarily responsible for the profuse watery diarrhea of cholera. CT is secreted into the extracellular milieu, but the toxin attacks its Gs alpha target within the cytosol of a host cell. Thus, CT must cross a cellular membrane barrier in order to function. This event only occurs after the toxin travels by retrograde vesicular transport from the cell surface to the endoplasmic reticulum (ER). The catalytic A1 polypeptide then dissociates from the rest of the toxin and assumes an unfolded conformation that facilitates its transfer to the cytosol by a process involving the quality control system of ER-associated degradation. Productive intoxication is blocked by alterations to the vesicular transport of CT and/or the ER-to-cytosol translocation of CTA1. Various plant compounds have been reported to inhibit the cytopathic activity of CT, so in this work we evaluated the potential anti-CT properties of grape extract. Two grape extracts currently sold as nutritional supplements inhibited CT and Escherichia coli heat-labile toxin activity against cultured cells and intestinal loops. CT intoxication was blocked even when the extracts were added an hour after the initial toxin exposure. A specific subset of host-toxin interactions involving both the catalytic CTA1 subunit and the cell-binding CTB pentamer were affected. The extracts blocked toxin binding to the cell surface, prevented unfolding of the isolated CTA1 subunit, inhibited CTA1 translocation to the cytosol, and disrupted the catalytic activity of CTA1. Grape extract could thus potentially serve as a novel therapeutic to prevent or possibly treat cholera.	[Reddy, Srikar; Taylor, Michael; Cherubin, Patrick; Geden, Sandra; Ray, Supriyo; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Reddy, Srikar] Lake Highland Preparatory Sch, Orlando, FL USA; [Zhao, Mojun; Francis, David] S Dakota State Univ, Dept Vet & Biomed Sci, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA	State University System of Florida; University of Central Florida; South Dakota State University	Teter, K (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	kteter@mail.ucf.edu	Ray, Supriyo/L-1020-2019	Teter, Ken/0000-0003-4176-9361; Cherubin, Patrick/0000-0002-3567-836X				APTER FM, 1993, INFECT IMMUN, V61, P5271, DOI 10.1128/IAI.61.12.5271-5278.1993; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Brijesh S, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-47; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Choi O, 2007, MICROB PATHOGENESIS, V42, P215, DOI 10.1016/j.micpath.2007.01.007; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Dell'Aica I, 2004, EMBO REP, V5, P418, DOI 10.1038/sj.embor.7400118; FISHMAN PH, 1982, J CELL BIOL, V93, P860, DOI 10.1083/jcb.93.3.860; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Kammerer D, 2004, J AGR FOOD CHEM, V52, P4360, DOI 10.1021/jf049613b; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2011, INFECT IMMUN, V79, P4739, DOI 10.1128/IAI.05503-11; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Monagas M, 2006, ANAL CHIM ACTA, V563, P401, DOI 10.1016/j.aca.2005.10.065; Morinaga N, 2005, J BIOL CHEM, V280, P23303, DOI 10.1074/JBC.M502093200; Morinaga N, 2001, J BIOL CHEM, V276, P22838, DOI 10.1074/jbc.M101184200; Morinaga N, 2010, TOXICON, V56, P29, DOI 10.1016/j.toxicon.2010.03.009; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oi H, 2002, P NATL ACAD SCI USA, V99, P3042, DOI 10.1073/pnas.052709499; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Podlipnik C, 2009, ACTA CHIM SLOV, V56, P156; Quinones B, 2009, APPL ENVIRON MICROB, V75, P1410, DOI 10.1128/AEM.02230-08; Ray S, 2012, J BIOL CHEM, V287, P30395, DOI 10.1074/jbc.M112.385575; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Saito T, 2002, MICROBIOL IMMUNOL, V46, P249, DOI 10.1111/j.1348-0421.2002.tb02693.x; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Shi John, 2003, Journal of Medicinal Food, V6, P291, DOI 10.1089/109662003772519831; Shogomori H, 2001, J NEUROCHEM, V78, P991, DOI 10.1046/j.1471-4159.2001.00489.x; Sivaprakasapillai B, 2009, METABOLISM, V58, P1743, DOI 10.1016/j.metabol.2009.05.030; SOMAN G, 1986, BIOCHEMISTRY-US, V25, P4113, DOI 10.1021/bi00362a019; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Sugita-Konishi Y, 1999, BBA-GEN SUBJECTS, V1472, P42, DOI 10.1016/S0304-4165(99)00102-6; SWAISGOOD HE, 1993, J DAIRY SCI, V76, P3054, DOI 10.3168/jds.S0022-0302(93)77645-6; Taylor M, 2012, JOVE-J VIS EXP, DOI 10.3791/3686; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor ME, 2011, APPL MATH SCI, V116, P1, DOI 10.1007/978-1-4419-7052-7_1; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vinson Joe A., 2001, J Med Food, V4, P17, DOI 10.1089/10966200152053677; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Winkeler A, 2003, FEBS LETT, V554, P439, DOI 10.1016/S0014-5793(03)01217-1; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yahiro K, 2005, HELICOBACTER, V10, P231, DOI 10.1111/j.1523-5378.2005.00315.x; Yoshino N, 2009, VACCINE, V27, P4808, DOI 10.1016/j.vaccine.2009.05.081	58	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73390	10.1371/journal.pone.0073390	http://dx.doi.org/10.1371/journal.pone.0073390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039929	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600069
J	Scheepers, E; Wendel-Vos, W; van Kempen, E; Int Panis, L; Maas, J; Stipdonk, H; Moerman, M; den Hertog, F; Staatsen, B; van Wesemael, P; Schuit, J				Scheepers, Eline; Wendel-Vos, Wanda; van Kempen, Elise; Int Panis, Luc; Maas, Jolanda; Stipdonk, Henk; Moerman, Menno; den Hertog, Frank; Staatsen, Brigit; van Wesemael, Pieter; Schuit, Jantine			Personal and Environmental Characteristics Associated with Choice of Active Transport Modes versus Car Use for Different Trip Purposes of Trips up to 7.5 Kilometers in The Netherlands	PLOS ONE			English	Article							HOUSEHOLD TRAVEL SURVEYS; HEALTH; WALKING; IMPACT; BENEFITS; POLICIES; BICYCLE; SAFETY; RISK	Introduction: This explorative study examines personal and neighbourhood characteristics associated with short-distance trips made by car, bicycle or walking in order to identify target groups for future interventions. Methods: Data were derived from 'Mobility Research Netherlands (2004-2009; MON)', a dataset including information regarding trips made by household members (n = +/- 53,000 respondents annually). Using postal codes of household addresses, MON data were enriched with data on neighbourhood typologies. Multilevel logistic modelling was used to calculate odds ratio (OR) of active transport versus car use associated with four different trip purposes (shopping (reference), commuting, taking or bringing persons or sports). A total of 277,292 short distance trips made by 102,885 persons were included in analyses. Results: Compared to women shopping, women less often take active transport to sports clubs (OR = 0.88) and men less often take active transport for shopping (OR = 0.92), or for bringing or taking persons (OR = 0.76). Those aged 25-34 years (OR = 0.83) and 35-44 years (OR = 0.96) were more likely to use active transport for taking or bringing persons than persons belonging to the other age groups (relative to trips made for shopping by those 65 years or over). A higher use of active transport modes by persons with an university or college degree was found and particularly persons living in urban-centre neighbourhoods were likely to use active transport modes. Conclusion: In developing policies promoting a mode shift special attention should be given to the following groups: a) men making short distance trips for taking or bringing persons, b) women making short distance trips to sport facilities, c) persons belonging to the age groups of 25-44 years of age, d) Persons with a primary school or lower general secondary education degree and persons with a high school or secondary school degree and e) persons living in rural or urban-green neighbourhoods.	[Scheepers, Eline; Schuit, Jantine] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Scheepers, Eline; Wendel-Vos, Wanda; Schuit, Jantine] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands; [van Kempen, Elise; Staatsen, Brigit] Natl Inst Publ Hlth & Environm, Ctr Sustainabil Environm & Hlth, NL-3720 BA Bilthoven, Netherlands; [Int Panis, Luc] Hasselt Univ, Transportat Res Inst IMOB, Diepenbeek, Belgium; [Int Panis, Luc] Vlaamse Instelling Technol Onderzoek, Flemish Inst Technol Res, B-2400 Mol, Belgium; [Maas, Jolanda] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Stipdonk, Henk] SWOV Inst Rd Safety Res, Leidschendam, Netherlands; [Moerman, Menno] Inbo Amsterdam, Amsterdam, Netherlands; [den Hertog, Frank] Natl Inst Publ Hlth & Environm, Ctr Hlth & Soc, NL-3720 BA Bilthoven, Netherlands; [van Wesemael, Pieter] Tech Univ Eindhoven, Dept Architectural Design & Engn, NL-5600 MB Eindhoven, Netherlands	Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Hasselt University; VITO; Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment; Eindhoven University of Technology	Scheepers, E (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	eline.scheepers@rivm.nl	Schuit, Albertine J/I-3148-2018; Panis, Luc Int/C-8717-2009	Panis, Luc Int/0000-0002-2558-4351; Schuit, Jantine/0000-0002-7499-1391				ABF Research, ABF NEIGHB TYP; Cervero R, 2003, AM J PUBLIC HEALTH, V93, P1478, DOI 10.2105/AJPH.93.9.1478; de Geus B, 2008, HEALTH EDUC RES, V23, P697, DOI 10.1093/her/cym055; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; de Vries H, 2003, HEALTH EDUC RES, V18, P649, DOI 10.1093/her/cyg033; Engbers LH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-89; Global Advocacy for Physical Activity (GAPA) the Advocacy Council of the International Society for Physical Activity and Health (ISPAH), 2011, NCD PREV INV WORK PH; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Handy S, 2005, ACCESS, V26, P16; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Lindsay G, 2011, AUST NZ J PUBL HEAL, V35, P54, DOI 10.1111/j.1753-6405.2010.00621.x; Maas J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-206; Merom D, 2010, AM J PREV MED, V39, P113, DOI 10.1016/j.amepre.2010.04.007; Ministerie van Verkeer en Waterstaat, 2010, MOB RES NETH 2009; Pucher J, 2006, TRANSPORT POLICY, V13, P265, DOI 10.1016/j.tranpol.2005.11.001; Richards R, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-52; Rietveld P, 2004, TRANSPORT RES A-POL, V38, P531, DOI 10.1016/j.tra.2004.05.003; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Stahl T, 2001, SOC SCI MED, V52, P1, DOI 10.1016/S0277-9536(00)00116-7; Statistics Netherlands, 2010, BIRTH DIFF CHAR; Steg L, 2005, TRANSPORT RES A-POL, V39, P147, DOI 10.1016/j.tra.2004.07.001; Stipdonk H, 2012, TRAFFIC INJ PREV, V13, P412, DOI 10.1080/15389588.2012.660661; Stopher PR, 2007, TRANSPORT RES A-POL, V41, P367, DOI 10.1016/j.tra.2006.09.005; Transportation Research Board and Institute of Medicine, 2005, 282 TRS; Van Kempen E, 2010, 6300530012010 RIVM; Vandenbulcke G, 2011, TRANSPORT RES A-POL, V45, P118, DOI 10.1016/j.tra.2010.11.004; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2012, PHYS IN GLOB PUBL HL	33	38	38	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73105	10.1371/journal.pone.0073105	http://dx.doi.org/10.1371/journal.pone.0073105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24039866	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600053
J	Witzel, K; Hanschen, FS; Schreiner, M; Krumbein, A; Ruppel, S; Grosch, R				Witzel, Katja; Hanschen, Franziska S.; Schreiner, Monika; Krumbein, Angelika; Ruppel, Silke; Grosch, Rita			Verticillium Suppression Is Associated with the Glucosinolate Composition of Arabidopsis thaliana Leaves	PLOS ONE			English	Article							ALLYL ISOTHIOCYANATE PRODUCTION; AMPLIFIED POLYMORPHIC DNA; RAPE BRASSICA-NAPUS; WINTER OILSEED RAPE; DISEASE RESISTANCE; IN-VITRO; TRANSCRIPTIONAL RESPONSES; SECONDARY METABOLITES; FUNGICIDAL ACTIVITY; MASS-SPECTROMETRY	The soil-borne fungal pathogen Verticillium longisporum is able to penetrate the root of a number of plant species and spread systemically via the xylem. Fumigation of Verticillium contaminated soil with Brassica green manure is used as an environmentally friendly method for crop protection. Here we present a study focused on the potential role of glucosinolates and their breakdown products of the model plant Arabidopsis thaliana in suppressing growth of V. longisporum. For this purpose we analysed the glucosinolate composition of the leaves and roots of a set of 19 key accessions of A. thaliana. The effect of volatile glucosinolate hydrolysis products on the in vitro growth of the pathogen was tested by exposing the fungus to hydrated lyophilized plant tissue. Volatiles released from leaf tissue were more effective than from root tissue in suppressing mycelial growth of V. longisporum. The accessions varied in their efficacy, with the most effective suppressing mycelial growth by 90%. An analysis of glucosinolate profiles and their enzymatic degradation products revealed a correlation between fungal growth inhibition and the concentration of alkenyl glucosinolates, particularly 2-propenyl (2Prop) glucosinolate, respectively its hydrolysis products. Exposure of the fungus to purified 2Prop glucosinolate revealed that its suppressive activity was correlated with its concentration. Spiking of 2Prop glucosinolate to leaf material of one of the least effective A. thaliana accessions led to fungal growth suppression. It is suggested that much of the inhibitory effect observed for the tested accessions can be explained by the accumulation of 2Prop glucosinolate.	[Witzel, Katja; Ruppel, Silke] Leibniz Inst Vegetable & Ornamental Crops, Dept Plant Nutr, Grossbeeren, Germany; [Hanschen, Franziska S.; Schreiner, Monika; Krumbein, Angelika] Leibniz Inst Vegetable & Ornamental Crops, Dept Plant Qual, Grossbeeren, Germany; [Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops, Dept Plant Hlth, Grossbeeren, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Witzel, K (corresponding author), Leibniz Inst Vegetable & Ornamental Crops, Dept Plant Nutr, Grossbeeren, Germany.	witzel@igzev.de	Grosch, Rita/HHM-5490-2022; Hanschen, Franziska/AAO-2855-2020	Grosch, Rita/0000-0002-7179-5715; Schreiner, Monika/0000-0002-5629-4429; Hanschen, Franziska/0000-0003-0949-6228	Leibniz association (PAKT project 'Chemical Communication in the Rhizosphere')	Leibniz association (PAKT project 'Chemical Communication in the Rhizosphere')	KW was financed by the Leibniz association (PAKT project 'Chemical Communication in the Rhizosphere'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires A, 2011, SCI HORTIC-AMSTERDAM, V129, P503, DOI 10.1016/j.scienta.2011.04.009; Aires A, 2009, AM J POTATO RES, V86, P327, DOI 10.1007/s12230-009-9086-y; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Down GJ, 2004, AGROINDUSTRIA, V3, P293; Dunker S, 2008, J PHYTOPATHOL, V156, P698, DOI 10.1111/j.1439-0434.2008.01429.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fayzalla E. A., 2009, Journal of Applied Sciences, V9, P2272, DOI 10.3923/jas.2009.2272.2279; Floerl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031435; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; GEBHARDT C, 1989, THEOR APPL GENET, V78, P65, DOI 10.1007/BF00299755; Giamoustaris A, 1997, PLANT PATHOL, V46, P271, DOI 10.1046/j.1365-3059.1997.d01-222.x; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Haffner E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-235; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hill MK, 1999, PLANT MOL BIOL, V40, P289, DOI 10.1023/A:1006146419544; Hu P, 2011, APPL SOIL ECOL, V49, P68, DOI 10.1016/j.apsoil.2011.06.014; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kirkegaard JA, 1996, PLANT PATHOL, V45, P593, DOI 10.1046/j.1365-3059.1996.d01-143.x; KIRKEGAARD JA, 1998, PLANT SOIL, V201, P71; Kissen R, 2009, J BIOL CHEM, V284, P12057, DOI 10.1074/jbc.M807500200; KJAER A, 1963, ACTA CHEM SCAND, V17, P2143; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; KOIKE ST, 1994, PLANT DIS, V78, P1116, DOI 10.1094/PD-78-1116; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Krumbein A., 2005, Journal of Applied Botany and Food Quality, V79, P168; Kuchernig JC, 2011, PHYTOCHEMISTRY, V72, P1699, DOI 10.1016/j.phytochem.2011.06.013; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Larkin RP, 2007, CROP PROT, V26, P1067, DOI 10.1016/j.cropro.2006.10.004; Li KN, 1999, MYCOL RES, V103, P1361, DOI 10.1017/S0953756299008357; Lord JS, 2011, J AGR FOOD CHEM, V59, P7882, DOI 10.1021/jf200925k; Manici LM, 1997, J AGR FOOD CHEM, V45, P2768, DOI 10.1021/jf9608635; Mayton HS, 1996, PHYTOPATHOLOGY, V86, P267, DOI 10.1094/Phyto-86-267; McFadden HG, 2001, PHYSIOL MOL PLANT P, V58, P119, DOI 10.1006/pmpp.2001.0320; MORRA MJ, 2004, AGROINDUSTRIA, V3, P251; Njoroge SMC, 2011, PHYTOPATHOLOGY, V101, P523, DOI 10.1094/PHYTO-08-10-0219; Olivier C, 1999, J CHEM ECOL, V25, P2687, DOI 10.1023/A:1020895306588; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rahmanpour S, 2009, PLANT PATHOL, V58, P479, DOI 10.1111/j.1365-3059.2008.02015.x; Rohloff J, 2005, PHYTOCHEMISTRY, V66, P1941, DOI 10.1016/j.phytochem.2005.06.021; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarsby J, 2012, PHYTOCHEMISTRY, V77, P110, DOI 10.1016/j.phytochem.2012.01.026; Sellam A, 2007, MOL PLANT PATHOL, V8, P195, DOI 10.1111/J.1364-3703.2007.00387.X; Smolinska U, 1999, J PHYTOPATHOL, V147, P119, DOI 10.1046/j.1439-0434.1999.147002119.x; Smolinska U, 2003, PLANT DIS, V87, P407, DOI 10.1094/PDIS.2003.87.4.407; SPENCER GF, 1980, J SCI FOOD AGR, V31, P359, DOI 10.1002/jsfa.2740310406; Steventon LA, 2002, MYCOL RES, V106, P570, DOI 10.1017/S0953756202005865; Steventon LA, 2001, J PHYTOPATHOL, V149, P395, DOI 10.1046/j.1439-0434.2001.00643.x; Szczyglowska M, 2011, INT J MOL SCI, V12, P7760, DOI 10.3390/ijms12117760; Textor S, 2009, PHYTOCHEM REV, V8, P149, DOI 10.1007/s11101-008-9117-1; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; TINKER NA, 1993, THEOR APPL GENET, V85, P976, DOI 10.1007/BF00215037; Tischner R, 2010, PHYSIOL MOL PLANT P, V74, P419, DOI 10.1016/j.pmpp.2010.06.004; Uppal AK, 2008, BIOL CONTROL, V44, P90, DOI 10.1016/j.biocontrol.2007.10.020; van Esse HP, 2009, MOL PLANT MICROBE IN, V22, P245, DOI 10.1094/MPMI-22-3-0245; van Os G. J., 2004, AGROINDUSTRIA, V3, P295; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Veronese P, 2003, PLANT J, V35, P574, DOI 10.1046/j.1365-313X.2003.01830.x; Vig AP, 2009, LWT-FOOD SCI TECHNOL, V42, P1561, DOI 10.1016/j.lwt.2009.05.023; Villeneuve F, 2004, AGROINDUSTRIA, V3, P395; Walker JC, 1937, AM J BOT, V24, P536, DOI 10.2307/2437076; Wang FX, 2011, PROTEOMICS, V11, P4296, DOI 10.1002/pmic.201100062; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Xu L, 2011, J PHYTOPATHOL, V159, P606, DOI 10.1111/j.1439-0434.2011.01813.x; Yang B, 2010, GENET RESOUR CROP EV, V57, P1079, DOI 10.1007/s10722-010-9549-5; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zhang Y, 2011, PLANT CELL REP, V30, P2085, DOI 10.1007/s00299-011-1115-x; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao FA, 2012, PLANT SCI, V185, P176, DOI 10.1016/j.plantsci.2011.10.007; Zhou L, 2006, PLANT PATHOL, V55, P137, DOI 10.1111/j.1365-3059.2005.01311.x; Zimmermann NS, 2007, MOL NUTR FOOD RES, V51, P1537, DOI 10.1002/mnfr.200700103	81	30	30	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e71877	10.1371/journal.pone.0071877	http://dx.doi.org/10.1371/journal.pone.0071877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039726	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600014
J	Xie, XJ; Gao, S; Gu, WH; Pan, GH; Wang, GC				Xie, Xiujun; Gao, Shan; Gu, Wenhui; Pan, Guanghua; Wang, Guangce			Desiccation Induces Accumulations of Antheraxanthin and Zeaxanthin in Intertidal Macro-Alga Ulva pertusa (Chlorophyta)	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; XANTHOPHYLL CYCLE; PHOTOPROTECTION; LIGHT; VIOLAXANTHIN; FLUORESCENCE; DROUGHT; PHOTOINHIBITION; CHLOROPLASTS	For plants and algae, exposure to high light levels is deleterious to their photosynthetic machineries. It also can accelerate water evaporation and thus potentially lead to drought stress. Most photosynthetic organisms protect themselves against high light caused photodamages by xanthophyll cycle-dependent thermal energy dissipation. It is generally accepted that high light activates xanthophyll cycle. However, the relationship between xanthophyll cycle and drought stress remains ambiguous. Herein, Ulva pertusa (Chlorophyta), a representative perennial intertidal macro-algae species with high drought-tolerant capabilities and simple structures, was used to investigate the operation of xanthophyll cycle during desiccation in air. The results indicate that desiccation under dim light induced accumulation of antheraxanthin (Ax) and zeaxanthin (Zx) at the expense of violaxanthin (Vx). This accumulation could be arrested by dithiothreitol completely and by uncoupler (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) partially, implying the participation of Vx de-epoxidase in conversion of Vx to Ax and Zx. Treatment with inhibitors of electron transport along thylakoid membrane, e. g. DCMU, PG and DBMIB, did not significantly arrest desiccation-induced accumulation of Ax and Zx. We propose that for U. pertusa, besides excess light, desiccation itself could also induce accumulation of Ax and Zx. This accumulation could proceed without electron transport along thylakoid membrane, and is possibly resulting from the reduction of thylakoid lumen volume during desiccation. Considering the pleiotropic effects of Ax and Zx, accumulated Ax and Zx may function in protecting thylakoid membrane and enhancing thermal quenching during emersion in air.	[Xie, Xiujun; Pan, Guanghua] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin Key Lab Marine Resources & Chem, Tianjin, Peoples R China; [Gao, Shan; Gu, Wenhui; Wang, Guangce] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Gao, Shan; Gu, Wenhui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, GC (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	gcwang@qdio.ac.cn		Gu, Wenhui/0000-0001-9326-001X; Xie, Xiujun/0000-0002-0672-9199	National Natural Science Foundation of China [30830015, 40806063, 30970302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30830015, 40806063, and 30970302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WW, 1992, PLANTA, V186, P390, DOI 10.1007/BF00195320; Aguilera J, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P58; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Contreras-Porcia L, 2011, J EXP BOT, V62, P1815, DOI 10.1093/jxb/erq364; Cournac L, 2000, J BIOL CHEM, V275, P17256, DOI 10.1074/jbc.M908732199; Cruz JA, 2001, PLANT PHYSIOL, V127, P1167, DOI 10.1104/pp.127.3.1167; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Fernandez-Marin B, 2011, PLANTA, V234, P579, DOI 10.1007/s00425-011-1420-1; Gao S, 2012, J EXP BOT, V63, P4349, DOI 10.1093/jxb/ers082; Gao S, 2011, PLANT CELL PHYSIOL, V52, P885, DOI 10.1093/pcp/pcr038; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; HENLEY WJ, 1992, OECOLOGIA, V89, P516, DOI 10.1007/BF00317158; Huang W, 2012, PLANTA, V235, P819, DOI 10.1007/s00425-011-1544-3; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; Li ZR, 2012, PLANT PHYSIOL, V158, P313, DOI 10.1104/pp.111.181230; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lin AP, 2009, PLANTA, V229, P803, DOI 10.1007/s00425-008-0874-2; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Medrano H, 2002, FUNCT PLANT BIOL, V29, P1197, DOI 10.1071/FP02016; Morales F, 2006, ADV PHOTO RESPIRAT, V21, P65; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; NEUBAUER C, 1992, PLANT PHYSIOL, V99, P1354, DOI 10.1104/pp.99.4.1354; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; PFUNDEL EE, 1994, PLANT PHYSIOL, V106, P1647, DOI 10.1104/pp.106.4.1647; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; SMITH CM, 1986, PLANT PHYSIOL, V80, P843, DOI 10.1104/pp.80.4.843; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; TING CS, 1993, PLANT PHYSIOL, V101, P1323, DOI 10.1104/pp.101.4.1323; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e72929	10.1371/journal.pone.0072929	http://dx.doi.org/10.1371/journal.pone.0072929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24039824	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600044
J	Sanders, MB; Bean, TP; Hutchinson, TH; Le Quesne, WJF				Sanders, Matthew Burton; Bean, Tim P.; Hutchinson, Thomas H.; Le Quesne, Will J. F.			Juvenile King Scallop, Pecten maximus, Is Potentially Tolerant to Low Levels of Ocean Acidification When Food Is Unrestricted	PLOS ONE			English	Article							EARLY-LIFE STAGES; MYTILUS-EDULIS; CRASSOSTREA-GIGAS; RNA/DNA RATIO; PHYSIOLOGICAL ENERGETICS; SEASONAL-VARIATIONS; ENERGY-METABOLISM; SHELL FORMATION; NUCLEIC-ACID; TERM GROWTH	The decline in ocean water pH and changes in carbonate saturation states through anthropogenically mediated increases in atmospheric CO2 levels may pose a hazard to marine organisms. This may be particularly acute for those species reliant on calcareous structures like shells and exoskeletons. This is of particular concern in the case of valuable commercially exploited species such as the king scallop, Pecten maximus. In this study we investigated the effects on oxygen consumption, clearance rates and cellular turnover in juvenile P. maximus following 3 months laboratory exposure to four pCO(2) treatments (290, 380, 750 and 1140 mu atm). None of the exposure levels were found to have significant effect on the clearance rates, respiration rates, condition index or cellular turnover (RNA: DNA) of individuals. While it is clear that some life stages of marine bivalves appear susceptible to future levels of ocean acidification, particularly under food limiting conditions, the results from this study suggest that where food is in abundance, bivalves like juvenile P. maximus may display a tolerance to limited changes in seawater chemistry.	[Sanders, Matthew Burton; Bean, Tim P.; Hutchinson, Thomas H.] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England; [Le Quesne, Will J. F.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science; Centre for Environment Fisheries & Aquaculture Science	Sanders, MB (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England.	matthew.sanders@cefas.co.uk	Bean, Tim/H-6792-2014	Bean, Tim/0000-0002-2544-9918; Sanders, Matthew/0000-0003-2450-381X; Hutchinson, Tom/0000-0001-8823-5442	Centre for Environment, Fisheries and Aquaculture Science (Cefas) [DP282]	Centre for Environment, Fisheries and Aquaculture Science (Cefas)	This work was financed by the Centre for Environment, Fisheries and Aquaculture Science (Cefas) under programme DP282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2013, BIOGEOSCIENCES DISCU, V10, P3281, DOI [10.5194/bgd-10-3281-2013, DOI 10.5194/BGD-10-3281-2013]; [Anonymous], 2007, LME4 LINEAR MIXED EF; ATKINSON DE, 1987, AM J PHYSIOL, V252, pF947, DOI 10.1152/ajprenal.1987.252.6.F947; Audet D, 2003, CAN J FISH AQUAT SCI, V60, P269, DOI 10.1139/F03-020; Baayen RH, 2010, LANGUAGER LIB R; BARRON MG, 1984, CAN J FISH AQUAT SCI, V41, P141, DOI 10.1139/f84-014; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; BAYNE BL, 1978, OECOLOGIA, V37, P137, DOI 10.1007/BF00344987; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; BENINGER PG, 1984, J EXP MAR BIOL ECOL, V79, P19, DOI 10.1016/0022-0981(84)90028-5; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Bignell JP, 2008, AQUAT BIOL, V2, P1, DOI 10.3354/ab00031; Blackford JC, 2007, J MARINE SYST, V64, P229, DOI 10.1016/j.jmarsys.2006.03.016; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Caldarone EM, 2003, MAR ECOL PROG SER, V262, P229, DOI 10.3354/meps262229; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chauvaud L, 1998, J EXP MAR BIOL ECOL, V227, P83, DOI 10.1016/S0022-0981(97)00263-3; Chicharo LMZ, 1995, SCI MAR, V59, P95; Chicharo MA, 2008, INT J MOL SCI, V9, P1453, DOI 10.3390/ijms9081453; CLEMMESEN C, 1994, MAR BIOL, V118, P377, DOI 10.1007/BF00350294; CLEMMESEN C, 1993, MAR ECOL PROG SER, V100, P177, DOI 10.3354/meps100177; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; HAINES TA, 1973, J FISH RES BOARD CAN, V30, P195, DOI 10.1139/f73-035; Heilmayer O, 2003, MAR BIOL, V143, P477, DOI 10.1007/s00227-003-1079-7; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Huning A, 2013, MAR BIOL, V160, P1845, DOI 10.1007/s00227-012-1930-9; Fernandez-Reiriz MJ, 2012, MAR ECOL PROG SER, V454, P65, DOI 10.3354/meps09660; Fernandez-Reiriz MJ, 2011, MAR ECOL PROG SER, V433, P97, DOI 10.3354/meps09062; Kirkwood DS, 1996, ICES TECHNIQUES MARI; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Laing I, 2004, AQUACULTURE, V240, P369, DOI 10.1016/j.aquaculture.2004.02.002; Laing I, 2002, SCALLOP CULTIVATION; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Le Quesne WJF, 2012, FISH FISH, V13, P333, DOI 10.1111/j.1467-2979.2011.00423.x; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Liu WG, 2012, CHIN J OCEANOL LIMN, V30, P206, DOI 10.1007/s00343-012-1067-1; Lodeiros CJM, 1996, MAR BIOL, V126, P245, DOI 10.1007/BF00347449; MacDonald Bruce A., 2006, Developments in Aquaculture and Fisheries Science, V35, P417; Marine Management Organisation, 2012, UK SEAF STAT 2011; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Melzner F, 2009, COMP BIOCHEM PHYS A, V153A, pS80, DOI 10.1016/j.cbpa.2009.04.056; Mercaldo-Allen R, 2006, J EXP MAR BIOL ECOL, V329, P187, DOI 10.1016/j.jembe.2005.08.015; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Michaelidis B, 2005, PHYSIOL BIOCHEM ZOOL, V78, P373, DOI 10.1086/430223; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Navarro JM, 2013, CHEMOSPHERE, V90, P1242, DOI 10.1016/j.chemosphere.2012.09.063; Norkko J, 2006, J EXP MAR BIOL ECOL, V337, P38, DOI 10.1016/j.jembe.2006.06.003; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; PORTNER HO, 1987, J EXP BIOL, V131, P69; R Core Team, 2016, R FDN STAT COMP; Range P, 2011, J EXP MAR BIOL ECOL, V396, P177, DOI 10.1016/j.jembe.2010.10.020; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI DOI 10.2777/58454; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roberts DA, 2013, GLOBAL CHANGE BIOL, V19, P340, DOI 10.1111/gcb.12048; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schalkhausser B, 2013, MAR BIOL, V160, P1995, DOI 10.1007/s00227-012-2057-8; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Tong ESP, 2010, CHEMOSPHERE, V80, P20, DOI 10.1016/j.chemosphere.2010.03.045; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3]; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Waldbusser GG, 2010, MAR ECOL PROG SER, V417, P171, DOI 10.3354/meps08809; WIDDOWS J, 1989, PHYSIOL ZOOL, V62, P764, DOI 10.1086/physzool.62.3.30157926; Widdows J., 2006, COPENHAGEN, V40, P1; WRIGHT DA, 1985, MAR ECOL PROG SER, V25, P199, DOI 10.3354/meps025199; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016; Zhang ML, 2011, J SHELLFISH RES, V30, P267, DOI 10.2983/035.030.0211	95	34	35	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e74118	10.1371/journal.pone.0074118	http://dx.doi.org/10.1371/journal.pone.0074118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023928	Green Submitted, Green Published, gold			2022-12-25	WOS:000324515600131
J	Dellinger, MT; Meadows, SM; Wynne, K; Cleaver, O; Brekken, RA				Dellinger, Michael T.; Meadows, Stryder M.; Wynne, Katherine; Cleaver, Ondine; Brekken, Rolf A.			Vascular Endothelial Growth Factor Receptor-2 Promotes the Development of the Lymphatic Vasculature	PLOS ONE			English	Article							LYMPHEDEMA-DISTICHIASIS; HEREDITARY LYMPHEDEMA; TRANSCRIPTION FACTOR; VESSEL GROWTH; LYMPHANGIOGENESIS; MUTATIONS; ANGIOGENESIS; EXPRESSION; MICE; MOUSE	Vascular endothelial growth factor receptor 2 (VEGFR2) is highly expressed by lymphatic endothelial cells and has been shown to stimulate lymphangiogenesis in adult mice. However, the role VEGFR2 serves in the development of the lymphatic vascular system has not been defined. Here we use the Cre-lox system to show that the proper development of the lymphatic vasculature requires VEGFR2 expression by lymphatic endothelium. We show that Lyve-1(wt/Cre); Vegfr2(flox/flox) mice possess significantly fewer dermal lymphatic vessels than Vegfr2(flox/flox) mice. Although Lyve-1(wt/Cre); Vegfr2(flox/flox) mice exhibit lymphatic hypoplasia, the lymphatic network is functional and contains all of the key features of a normal lymphatic network (initial lymphatic vessels and valved collecting vessels surrounded by smooth muscle cells (SMCs)). We also show that Lyve-1(Cre) mice display robust Cre activity in macrophages and in blood vessels in the yolk sac, liver and lung. This activity dramatically impairs the development of blood vessels in these tissues in Lyve-1(wt/Cre); Vegfr2(flox/flox) embryos, most of which die after embryonic day14.5. Lastly, we show that inactivation of Vegfr2 in the myeloid lineage does not affect the development of the lymphatic vasculature. Therefore, the abnormal lymphatic phenotype of Lyve-1(wt/Cre); Vegfr2(flox/flox) mice is due to the deletion of Vegfr2 in the lymphatic vasculature not macrophages. Together, this work demonstrates that VEGFR2 directly promotes the expansion of the lymphatic network and further defines the molecular mechanisms controlling the development of the lymphatic vascular system.	[Dellinger, Michael T.; Wynne, Katherine; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Meadows, Stryder M.; Cleaver, Ondine] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dellinger, MT (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA.	michael.dellinger@utsouthwestern.edu			National Institutes of Health [R01CA118240, T32-HL098040]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113498, T32HL098040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health (R01CA118240; RAB), Effie Marie Cain Scholarship (RAB), and by a Department of Defense Postdoctoral Fellowship for Breast Cancer Research (MTD). MTD was also supported by a National Institutes of Health Training Grant (T32-HL098040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; [Anonymous], CIRC RES, V112, P956; Au AC, 2010, AM J HUM GENET, V87, P436, DOI 10.1016/j.ajhg.2010.08.008; Bjorndahl MA, 2005, CANCER RES, V65, P9261, DOI 10.1158/0008-5472.CAN-04-2345; Brice G, 2013, CLIN GENET; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Dellinger MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028947; Dunworth WP, 2008, PEPTIDES, V29, P2243, DOI 10.1016/j.peptides.2008.09.009; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kulkarni RM, 2009, MECH DEVELOP, V126, P350, DOI 10.1016/j.mod.2009.02.003; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Witte MH, 1998, LYMPHOLOGY, V31, P145; Witte MH, 2001, MICROSC RES TECHNIQ, V55, P122, DOI 10.1002/jemt.1163; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Zheng W, 2011, BLOOD	50	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e74686	10.1371/journal.pone.0074686	http://dx.doi.org/10.1371/journal.pone.0074686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023956	Green Published, Green Submitted, gold			2022-12-25	WOS:000324238400100
J	Serra, D; Paixao, J; Nunes, C; Dinis, TCP; Almeida, LM				Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.			Cyanidin-3-Glucoside Suppresses Cytokine-Induced Inflammatory Response in Human Intestinal Cells: Comparison with 5-Aminosalicylic Acid	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; BOWEL-DISEASE; DIETARY ANTHOCYANINS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; EXPRESSION	The potential use of polyphenols in the prevention and treatment of chronic inflammatory diseases has been extensively investigated although the mechanisms involved in cellular signaling need to be further elucidated. Cyanidin-3-glucoside is a typical anthocyanin of many pigmented fruits and vegetables widespread in the human diet. In the present study, the protection afforded by cyanidin-3-glucoside against cytokine-triggered inflammatory response was evaluated in the human intestinal HT-29 cell line, in comparison with 5-aminosalicylic acid, a well-established anti-inflammatory drug, used in inflammatory bowel disease. For this purpose, some key inflammatory mediators and inflammatory enzymes were examined. Our data showed that cyanidin-3-glucoside reduced cytokine-induced inflammation in intestinal cells, in terms of NO, PGE(2) and IL-8 production and of iNOS and COX-2 expressions, at a much lower concentration than 5-aminosalicylic acid, suggesting a higher anti-inflammatory efficiency. Interestingly, cyanidin-3-glucoside and 5-aminosalicylic acid neither prevented IkB-alpha degradation nor the activation of NF-kB, but significantly reduced cytokine-induced levels of activated STAT1 accumulated in the cell nucleus. In addition, we established that phosphorylated p38 MAPK was not involved in the protective effect of cyanidin-3-glucoside or 5-aminosalicylic acid. Taking into account the high concentrations of dietary anthocyanins potentially reached in the gastrointestinal tract, cyanidin-3-glucoside may be envisaged as a promising nutraceutical giving complementary benefits in the context of inflammatory bowel disease.	[Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Dinis, TCP (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	tcpdinis@ci.uc.pt	Nunes, Carla/AAM-3056-2021; Serra, Francois Jose/A-8789-2011; Nunes, Carla/L-3456-2017; Serra, Diana/M-4062-2017	Nunes, Carla/0000-0002-7452-1592; Serra, Francois Jose/0000-0003-3895-4742; Nunes, Carla/0000-0002-7452-1592; Serra, Diana/0000-0002-5965-0281; Almeida, Leonor Martins/0000-0002-7769-4712; Becher, Veronica/0000-0002-5425-8563; Felix Paixao, Joana Isabel/0000-0002-2050-405X; Dinis, Teresa/0000-0001-6350-5741; Dopazo, Hernan/0000-0001-6125-2357	FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/SAU-OSM/102907/2008, PEst-C/SAU/LA0001/2013-2014]; FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade); FCT [SFRH/BD/7541/2010]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the grants PTDC/SAU-OSM/102907/2008 and PEst-C/SAU/LA0001/2013-2014, funded by FCT (Fundacao para a Ciencia e a Tecnologia) and FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade). Diana Serra is a recipient of the grant SFRH/BD/7541/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Aura AM, 2005, EUR J NUTR, V44, P133, DOI 10.1007/s00394-004-0502-2; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; CROTTY B, 1992, BRIT J CLIN PHARMACO, V34, P189, DOI 10.1111/j.1365-2125.1992.tb04124.x; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Kay CD, 2009, MOL NUTR FOOD RES, V53, pS92, DOI 10.1002/mnfr.200800461; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kolios G, 2006, EUR J CLIN INVEST, V36, P720, DOI 10.1111/j.1365-2362.2006.01710.x; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; KOLIOS G, 1995, BRIT J PHARMACOL, V116, P2866, DOI 10.1111/j.1476-5381.1995.tb15938.x; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050363; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mauray A, 2010, GENES NUTR, V5, P343, DOI 10.1007/s12263-010-0171-0; McCune LM, 2011, CRIT REV FOOD SCI, V51, P1, DOI 10.1080/10408390903001719; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Miguel M. G., 2011, Journal of Applied Pharmaceutical Science, V1, P7; Min SW, 2010, INT IMMUNOPHARMACOL, V10, P959, DOI 10.1016/j.intimp.2010.05.009; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Paixao J, 2012, CHEM-BIOL INTERACT, V199, P192, DOI 10.1016/j.cbi.2012.08.013; Paixao J, 2011, APOPTOSIS, V16, P976, DOI 10.1007/s10495-011-0632-y; Paul S, 2009, CANCER PREV RES, V2, P650, DOI 10.1158/1940-6207.CAPR-08-0224; Piberger H, 2011, MOL NUTR FOOD RES, V55, P1724, DOI 10.1002/mnfr.201100380; Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Salerno L, 2002, CURR PHARM DESIGN, V8, P177, DOI 10.2174/1381612023396375; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Stein RB, 2000, DRUG SAFETY, V23, P429, DOI 10.2165/00002018-200023050-00006; Surh YJ, 2001, J KOREAN MED SCI, V16, pS38, DOI 10.3346/jkms.2001.16.S.S38; Tedeschi E, 2004, MOL PHARMACOL, V65, P111, DOI 10.1124/mol.65.1.111; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	50	82	86	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73001	10.1371/journal.pone.0073001	http://dx.doi.org/10.1371/journal.pone.0073001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	23798991	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500030
J	Serra, FCO; Becher, V; Dopazo, H				Serra, Francois; Becher, Veronica; Dopazo, Hernan			Neutral Theory Predicts the Relative Abundance and Diversity of Genetic Elements in a Broad Array of Eukaryotic Genomes	PLOS ONE			English	Article								It is universally true in ecological communities, terrestrial or aquatic, temperate or tropical, that some species are very abundant, others are moderately common, and the majority are rare. Likewise, eukaryotic genomes also contain classes or "species'' of genetic elements that vary greatly in abundance: DNA transposons, retrotransposons, satellite sequences, simple repeats and their less abundant functional sequences such as RNA or genes. Are the patterns of relative species abundance and diversity similar among ecological communities and genomes? Previous dynamical models of genomic diversity have focused on the selective forces shaping the abundance and diversity of transposable elements (TEs). However, ideally, models of genome dynamics should consider not only TEs, but also the diversity of all genetic classes or ``species'' populating eukaryotic genomes. Here, in an analysis of the diversity and abundance of genetic elements in >500 eukaryotic chromosomes, we show that the patterns are consistent with a neutral hypothesis of genome assembly in virtually all chromosomes tested. The distributions of relative abundance of genetic elements are quite precisely predicted by the dynamics of an ecological model for which the principle of functional equivalence is the main assumption. We hypothesize that at large temporal scales an overarching neutral or nearly neutral process governs the evolution of abundance and diversity of genetic elements in eukaryotic genomes.	[Serra, Francois] Ctr Invest Principe Felipe, Evolutionary Genom Lab, Bioinformat & Genom Dept, Valencia, Spain; [Becher, Veronica] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Comp, Buenos Aires, Argentina; [Dopazo, Hernan] Banco Nacl Datos Genet, Inst Genom Humana, Buenos Aires, Argentina; [Dopazo, Hernan] Univ Buenos Aires, Dept Ecol Genet Evoluc, Fac Ciencias Exactas & Nat, Buenos Aires, Argentina; [Serra, Francois] Ctr Nacl Anal Genom CNAG, Struct Genom Team, Barcelona, Spain		Dopazo, H (corresponding author), Banco Nacl Datos Genet, Inst Genom Humana, Buenos Aires, Argentina.; Dopazo, H (corresponding author), Univ Buenos Aires, Dept Ecol Genet Evoluc, Fac Ciencias Exactas & Nat, Buenos Aires, Argentina.	hdopazo@bndg.gob.ar	Nunes, Carla/AAM-3056-2021; Serra, Francois Jose/A-8789-2011; Nunes, Carla/L-3456-2017; Serra, Diana/M-4062-2017	Nunes, Carla/0000-0002-7452-1592; Serra, Francois Jose/0000-0003-3895-4742; Nunes, Carla/0000-0002-7452-1592; Serra, Diana/0000-0002-5965-0281; Almeida, Leonor Martins/0000-0002-7769-4712; Becher, Veronica/0000-0002-5425-8563; Felix Paixao, Joana Isabel/0000-0002-2050-405X; Dinis, Teresa/0000-0001-6350-5741; Dopazo, Hernan/0000-0001-6125-2357	El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio' n (MINCy-TMICINN) [AR2009-0009]; MINCyT [BFU2009-13409-C02-01];  [BSC-2009]	El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio' n (MINCy-TMICINN); MINCyT; 	This work was supported by El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio ' n (MINCy-TMICINN)(AR2009-0009) to BV and HD, by MINCyT (BFU2009-13409-C02-01) to HD, and by BSC-2009 to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bartolome C, 2002, MOL BIOL EVOL, V19, P926, DOI 10.1093/oxfordjournals.molbev.a004150; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blythe RA, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07018; Brookfield JFY, 2005, NAT REV GENET, V6, P128, DOI 10.1038/nrg1524; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fousse L, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1236463.1236468; Granlund T., 2008, GNU MULTIPLE PRECISI; Hankin RKS, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i12; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2008, OIKOS, V117, P1308, DOI 10.1111/j.0030-1299.2008.16724.x; Jabot F, 2011, AM NAT, V178, pE37, DOI 10.1086/660829; Jones E., 2001, SCIPY OPEN SOURCE SC; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Leonardo TE, 2002, GENET RES, V80, P155, DOI 10.1017/S0016672302009710; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Magurran A.E, 2004, MEASURING BIOL DIVER; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Ohta T, 2011, GENOME BIOL EVOL, V3, P1034, DOI 10.1093/gbe/evr012; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Venner S, 2009, TRENDS GENET, V25, P317, DOI 10.1016/j.tig.2009.05.003; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wright S, 1931, GENETICS, V16, P0097	39	82	86	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6					1	9	e63915	10.1371/journal.pone.0063915	http://dx.doi.org/10.1371/journal.pone.0063915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VL6AY	23798991	Green Published, gold, Green Submitted			2022-12-25	WOS:000891778000001
J	Yan, LM; Kang, M; Qin, ZQ; Zhang, WY; Li, YM; Ou, HS				Yan, Limei; Kang, Min; Qin, Zhengqi; Zhang, Wenyu; Li, Yumei; Ou, Hesheng			An Intronic miRNA Regulates Expression of the Human Endothelial Nitric Oxide Synthase Gene and Proliferation of Endothelial Cells by a Mechanism Related to the Transcription Factor SP-1	PLOS ONE			English	Article							MICRORNAS; POLYMORPHISM; MIR-17-92; REPAIR	Objective: This study was to investigate the molecular mechanisms underlying the 27nt-miRNA-mediated regulation of expression of the endothelial nitric oxide synthase (eNOS) gene. Methods: Cell lines overexpressing 27nt-miRNA or its mutant were established by transfecting the miRNA expression vector into the endothelial cells. eNOS mRNA and protein expression were examined by RT-PCR and Western Blotting, respectively. Luciferase activity reporter system was used to study the target of 27nt-miRNA. Results: The results showed that overexpression of 27nt-miRNA significantly inhibited eNOS mRNA level and protein expression, and reduced the eNOS transcriptional efficiency. Such inhibitory effects of 27nt-miRNA were attenuated by the sequence mutations in 27nt-miRNA. Interestingly, the transcription factor SP-1 expression was reduced by 27nt-miRNA. Meanwhile, overxpression of SP-1 protein partially restored eNOS expression, and rescued the 27nt-miRNA-mediated reduction of endothelial cell proliferation. Moreover, certain sites in the SP-1 mRNA were found to be the direct target of 27nt-miRNA by a luciferase reporter system. Conclusions: These results demonstrate that the 27nt-miRNA suppresses eNOS gene expression and SP-1 expression in vascular endothelial cells. The 27nt-miRNA directly target to SP-1 mRNA, thereby contributing to proliferation of endothelial cells.	[Yan, Limei; Qin, Zhengqi] Univ South China, Biochem Res Ctr, Hengyang, Hunan, Peoples R China; [Kang, Min] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Zhang, Wenyu; Li, Yumei; Ou, Hesheng] Guangxi Med Univ, Coll Pharm, Nanning, Guangxi, Peoples R China	University of South China; Guangxi Medical University; Guangxi Medical University	Ou, HS (corresponding author), Guangxi Med Univ, Coll Pharm, Nanning, Guangxi, Peoples R China.	hsou01@126.com			National Natural Science Foundation of China [30670834, 30871186]; Research Foundation of the Education Department of Hunan Province, China [06A060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Education Department of Hunan Province, China	This work was supported by National Natural Science Foundation of China (Projects No. 30670834, and No. 30871186), and Research Foundation of the Education Department of Hunan Province, China (project No. 06A060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Bai X, 2010, VASC PHARMACOL, V52, P224, DOI 10.1016/j.vph.2010.02.001; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BREUSS JM, 2012, CELL ADHES MIGR, V17, P6; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chen K, 2012, BIOCHEM BIOPH RES CO, V427, P138, DOI 10.1016/j.bbrc.2012.09.026; Clement JQ, 1999, RNA, V5, P206, DOI 10.1017/S1355838299981190; Ding ZF, 2012, EXP BIOL MED, V237, P1093, DOI 10.1258/ebm.2012.012082; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr908; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; KAPPELMANN M, 2012, ONCOGENE; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Kim IJ, 2007, THROMB RES, V119, P579, DOI 10.1016/j.thromres.2006.06.005; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; LI Y, 2012, CURR MOL MED; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Ou HS, 2005, ARTERIOSCL THROM VAS, V25, P2509, DOI 10.1161/01.ATV.0000189306.99112.4c; Rittig K, 2008, HORM METAB RES, V40, P13, DOI 10.1055/s-2007-1004527; Romania P, 2008, BRIT J HAEMATOL, V143, P570, DOI 10.1111/j.1365-2141.2008.07382.x; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sinici I, 2010, J INVEST MED, V58, P23, DOI 10.2310/JIM.0b013e3181c6197f; Spoto B, 2007, AM J HYPERTENS, V20, P758, DOI 10.1016/j.amjhyper.2007.02.009; Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wattanapitayakul SK, 2001, TRENDS PHARMACOL SCI, V22, P361, DOI 10.1016/S0165-6147(00)01692-8; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yan LM, 2011, MOL CELL BIOCHEM, V357, P9, DOI 10.1007/s11010-011-0870-x; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zhang XL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-56; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	41	69	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70658	10.1371/journal.pone.0070658	http://dx.doi.org/10.1371/journal.pone.0070658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940615	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000109
J	Yan, L; Zhang, JD; Wang, B; Lv, YJ; Jiang, H; Liu, GL; Qiao, Y; Ren, M; Guo, XF				Yan, Lei; Zhang, Ji Dong; Wang, Bo; Lv, Yi Jing; Jiang, Hong; Liu, Gui Lin; Qiao, Yun; Ren, Ming; Guo, Xue Feng			Quercetin Inhibits Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats and Inhibits Angiotensin II-Induced H9C2 Cells Hypertrophy by Enhancing PPAR-gamma Expression and Suppressing AP-1 Activity	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INDUCED CARDIAC-HYPERTROPHY; NF-KAPPA-B; IN-VIVO; GENE-EXPRESSION; MUSCLE; GROWTH; CARDIOMYOBLASTS; MACROPHAGES; DYSFUNCTION	Background: Quercetin is the most abundant flavonoid in fruit and vegetables and is believed to attenuate cardiovascular disease. We hypothesized that quercetin inhibits cardiac hypertrophy by blocking AP-1 (c-fos, c-jun) and activating PPAR-gamma signaling pathways. Methodology/Principal Findings: The aim of this study was to identify the mechanism underlying quercetin-mediated attenuation of cardiac hypertrophy. Quercetin therapy reduced blood pressure and markedly reduced the ratio of left ventricular to body weight (LVW/BW) (P<0.05, vs. spontaneously hypertensive rats (SHRs)). In vitro, quercetin also significantly attenuated Ang II-induced H9C2 cells hypertrophy, as indicated by its concentration dependent inhibitory effects on [H-3] leucine incorporation into H9C2 cells (64% reduction) and by the reduced hypertrophic surface area in H9C2 cells compared with the Ang II group (P<0.01, vs. Ang II group). Concurrently, we found that PPAR-gamma activity was significantly increased in the quercetin-treated group both in vivo and in vitro when analyzed using immunofluorescent or immunohistochemical assays (P<0.05, vs. SHRs or P<0.01, vs. the Ang II group). Conversely, in vivo, AP-1 (c-fos, s-jun) activation was suppressed in the quercetin-treated group, as was the downstream hypertrophy gene, including mRNA levels of ANP and BNP (P<0.05, vs. SHRs). Additionally, both western blotting and real time-PCR demonstrated that PPAR-gamma protein and mRNA were increased in the myocardium and AP-1 protein and mRNA were significantly decreased in the quercetin-treated group (P<0.05, vs. SHRs). Furthermore, western blotting and real time-PCR analyses also showed that transfection with PPAR-gamma siRNA significantly increased AP-1 signaling and reversed the effects of quercetin inhibition on mRNA expression levels of genes such as ANP and BNP in hypertrophic H9C2 cells. Conclusions: Our data indicate that quercetin may inhibit cardiac hypertrophy by enhancing PPAR-gamma expression and by suppressing the AP-1 signaling pathway.	[Yan, Lei; Zhang, Ji Dong; Wang, Bo; Lv, Yi Jing; Qiao, Yun; Ren, Ming] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China; [Jiang, Hong] Shandong Univ, Qilu Hosp, Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; [Jiang, Hong] Chinese Minist Hlth, Jinan, Shandong, Peoples R China; [Liu, Gui Lin] Shandong Univ Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Guo, Xue Feng] Shandong Univ Tradit Chinese Med, Hosp 2, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine	Zhang, JD (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China.	drzhangjidong@hotmail.com			National Natural Science Foundation of China [30873324, 81100103]; Natural Science Foundation of Shandong Province [ZR2011HQ020]; Postdoctoral special foundation for innovative projects of Shandong Province [201103049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Postdoctoral special foundation for innovative projects of Shandong Province	This study was supported by the National Natural Science Foundation of China (30873324, 81100103); the Natural Science Foundation of Shandong Province (ZR2011HQ020); the Postdoctoral special foundation for innovative projects of Shandong Province (201103049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni C, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/837104; Asakawa M, 2002, CIRCULATION, V105, P1240, DOI 10.1161/hc1002.105225; Benson S, 2000, AM J HYPERTENS, V13, P74, DOI 10.1016/S0895-7061(99)00148-X; Calderone A, 2001, J APPL PHYSIOL, V91, P771, DOI 10.1152/jappl.2001.91.2.771; Chen X, 2010, PHARMACOGN MAG, V6, P135, DOI 10.4103/0973-1296.62900; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Duarte J, 2001, BRIT J PHARMACOL, V133, P117, DOI 10.1038/sj.bjp.0704064; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Ha H, 2005, EXP MOL MED, V37, P169, DOI 10.1038/emm.2005.23; Han JJ, 2009, J VET MED SCI, V71, P737, DOI 10.1292/jvms.71.737; Izumi Y, 2000, HYPERTENSION, V36, P511, DOI 10.1161/01.HYP.36.4.511; Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025; Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023; Kwon H, 2009, J CELL MOL MED, V13, P1549, DOI 10.1111/j.1582-4934.2009.00391.x; Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majalahti T, 2007, MOL CELL ENDOCRINOL, V273, P59, DOI 10.1016/j.mce.2007.05.003; Matsumura T, 2011, ARTERIOSCL THROM VAS, V31, P1268, DOI 10.1161/ATVBAHA.110.222067; Mehrabi MR, 2002, BIOMED PHARMACOTHER, V56, P407, DOI 10.1016/S0753-3322(02)00251-2; Nelson MT, 2002, NATURE, V416, P273, DOI 10.1038/416273a; Omura T, 2002, HYPERTENSION, V39, P81, DOI 10.1161/hy0102.100783; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Panicker SR, 2010, PHARMACOL RES, V62, P328, DOI 10.1016/j.phrs.2010.06.003; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; TAMARGO J, 1995, J CARDIOVASC PHARM, V26, P295, DOI 10.1097/00005344-199508000-00016; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; Tokola H, 2001, CAN J PHYSIOL PHARM, V79, P646, DOI 10.1139/cjpp-79-8-646; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Yamamoto K, 2009, HYPERTENSION, V54, P1353, DOI 10.1161/HYPERTENSIONAHA.109.138750; Yano P, 1998, CIRC RES, V83, P752, DOI 10.1161/01.RES.83.7.752; Yoshizumi M, 2002, BIOCHEM BIOPH RES CO, V293, P1458, DOI 10.1016/S0006-291X(02)00407-2; Zhang M, 2011, ADV EXP MED BIOL, V701, P283, DOI 10.1007/978-1-4419-7756-4_38; Zhou SS, 2012, EXP CELL RES, V318, P1480, DOI 10.1016/j.yexcr.2012.03.030	37	69	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72548	10.1371/journal.pone.0072548	http://dx.doi.org/10.1371/journal.pone.0072548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	23940615	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600009
J	Chang, CL; Mills, GD; Karalus, NC; Jennings, LC; Laing, R; Murdoch, DR; Chambers, ST; Vettise, D; Tuffery, CM; Hancox, RJ				Chang, Catherina L.; Mills, Graham D.; Karalus, Noel C.; Jennings, Lance C.; Laing, Richard; Murdoch, David R.; Chambers, Stephen T.; Vettise, Dominic; Tuffery, Christine M.; Hancox, Robert J.			Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ACUTE PULMONARY-EMBOLISM; HOSPITALIZED-PATIENTS; RISK STRATIFICATION; PROGNOSTIC VALUE; PREDICTION RULE; TERM MORTALITY; DISEASE; MARKER; COMPLICATIONS	Background: Cardiac dysfunction is common in acute respiratory diseases and may influence prognosis. We hypothesised that blood levels of N-terminal B-type natriuretic peptide (NT-proBNP) and high-sensitivity Troponin T would predict mortality in adults with community-acquired pneumonia. Methods and Findings: A prospective cohort of 474 consecutive patients admitted with community-acquired pneumonia to two New Zealand hospitals over one year. Blood taken on admission was available for 453 patients and was analysed for NT-proBNP and Troponin T. Elevated levels of NT-proBNP (>220 pmol/L) were present in 148 (33%) and 86 (19%) of these patients respectively. Among the 26 patients who died within 30 days of admission, 23 (89%) had a raised NT-proBNP and 14 (53%) had a raised Troponin T level on admission compared to 125 (29%) and 72 (17%) of the 427 who survived (p values<0.001). Both NT-proBNP and Troponin T predicted 30-day mortality in age-adjusted analysis but after mutual adjustment for the other cardiac biomarker and the Pneumonia Severity Index, a raised N-terminal pro-brain natriuretic peptide remained a predictor of 30-day mortality (OR = 5.3, 95% CI 1.4-19.8, p = 0.013) but Troponin T did not (OR = 1.3, 95% CI 0.5-3.2, p = 0.630). The areas under the receiver-operating curves to predict 30-day mortality were similar for NT-proBNP (0.88) and the Pneumonia Severity Index (0.87). Conclusions: Elevated N-terminal B-type natriuretic peptide is a strong predictor of mortality from community-acquired pneumonia independent of clinical prognostic indicators. The pathophysiological basis for this is unknown but suggests that cardiac involvement may be an under-recognised determinant of outcome in pneumonia and may require a different approach to treatment. In the meantime, measurement of B-type natriuretic peptides may help to assess prognosis.	[Chang, Catherina L.; Mills, Graham D.; Karalus, Noel C.; Vettise, Dominic; Tuffery, Christine M.; Hancox, Robert J.] Waikato Hosp, Dept Resp Med, Hamilton, New Zealand; [Mills, Graham D.] Waikato Hosp, Dept Gen Med, Hamilton, New Zealand; [Jennings, Lance C.; Murdoch, David R.] Canterbury Hlth Labs, Christchurch, New Zealand; [Jennings, Lance C.; Murdoch, David R.; Chambers, Stephen T.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Laing, Richard] Canterbury Dist Hlth Board, Canterbury Resp Serv, Christchurch, New Zealand; [Hancox, Robert J.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	Waikato Hospital; Waikato Hospital; Canterbury Health Laboratories; University of Otago; University of Otago	Hancox, RJ (corresponding author), Waikato Hosp, Dept Resp Med, Hamilton, New Zealand.	bob.hancox@otago.ac.nz	Murdoch, David/A-2012-2009	Lee, Gon-Ann/0000-0001-8433-8268; Chambers, Stephen/0000-0002-0698-3285	Health Research Council of New Zealand [00/349]; Waikato Respiratory Research Fund; NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); Waikato Respiratory Research Fund; NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland	The pneumonia cohort was funded by the Health Research Council of New Zealand, grant 00/349 (http://www.hrc.govt.nz/). Analysis of the cardiac biomarkers for this report was funded internally by the Waikato Respiratory Research Fund. Dominic Vettise was supported by a NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Chang CL, 2011, THORAX, V66, P764, DOI 10.1136/thx.2010.155333; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Goritsas C, 2010, EUR J EMERG MED, V17, P293, DOI 10.1097/MEJ.0b013e328332354b; Ilva TJ, 2010, J EMERG MED, V38, P1, DOI 10.1016/j.jemermed.2007.09.060; Ishii J, 2000, CLIN CHIM ACTA, V301, P19, DOI 10.1016/S0009-8981(00)00312-0; Jeong KY, 2011, EMERG MED J, V28, P122, DOI 10.1136/emj.2009.089383; Jimenez D, 2009, CHEST, V136, P974, DOI 10.1378/chest.09-0608; Kucher N, 2003, CIRCULATION, V107, P2545, DOI 10.1161/01.CIR.0000074039.45523.BE; Laing R, 2001, NEW ZEAL MED J, V114, P488; Leuchte HH, 2006, AM J RESP CRIT CARE, V173, P744, DOI 10.1164/rccm.200510-1545OC; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mandal P, 2011, QJM-INT J MED, V104, P489, DOI 10.1093/qjmed/hcq247; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moammar MQ, 2010, HEART LUNG CIRC, V19, P90, DOI 10.1016/j.hlc.2009.08.009; Nagaya N, 2000, CIRCULATION, V102, P865; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Tulevski II, 2001, THROMB HAEMOSTASIS, V86, P1193, DOI 10.1055/s-0037-1616050; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; WOODHEAD MA, 1987, LANCET, V1, P671	30	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62612	10.1371/journal.pone.0062612	http://dx.doi.org/10.1371/journal.pone.0062612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667500	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700051
J	Wang, MH; Li, JX; Lim, GE; Johnson, JD				Wang, Minghu; Li, Jiaxu; Lim, Gareth E.; Johnson, James D.			Is Dynamic Autocrine Insulin Signaling Possible? A Mathematical Model Predicts Picomolar Concentrations of Extracellular Monomeric Insulin within Human Pancreatic Islets	PLOS ONE			English	Article							BETA-CELL MASS; INJECTED SOLUBLE INSULIN; SUBCUTANEOUS INJECTION; PHARMACOKINETIC MODEL; ENDOGENOUS INSULIN; GLUCOSE; RECEPTOR; SECRETION; APOPTOSIS; ANALOGS	Insulin signaling is essential for beta-cell survival and proliferation in vivo. Insulin also has potent mitogenic and anti-apoptotic actions on cultured beta-cells, with maximum effect in the high picomolar range and diminishing effect at high nanomolar doses. In order to understand whether these effects of insulin are constitutive or can be subjected to physiological modulation, it is essential to estimate the extracellular concentration of monomeric insulin within an intact islet. Unfortunately, the in vivo concentration of insulin monomers within the islet cannot be measured directly with current technology. Here, we present the first mathematical model designed to estimate the levels of monomeric insulin within the islet extracellular space. Insulin is released as insoluble crystals that exhibit a delayed dissociation into hexamers, dimers, and eventually monomers, which only then can act as signaling ligands. The rates at which different forms of insulin dissolve in vivo have been estimated from studies of peripheral insulin injection sites. We used this and other information to formulate a mathematical model to estimate the local insulin concentration within a single islet as a function of glucose. Model parameters were estimated from existing literature. Components of the model were validated using experimental data, if available. Model analysis predicted that the majority of monomeric insulin in the islet is that which has been returned from the periphery, and the concentration of intra-islet monomeric insulin varies from similar to 50-300 pM when glucose is in the physiological range. Thus, our results suggest that the local concentration of monomeric insulin within the islet is in the picomolar 'sweet spot' range of insulin doses that activate the insulin receptor and have the most potent effects on beta-cells in vitro. Together with experimental data, these estimations support the concept that autocrine/ paracrine insulin signalling within the islet is dynamic, rather than constitutive and saturated.	[Wang, Minghu; Li, Jiaxu] Univ Louisville, Dept Math, Louisville, KY 40292 USA; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of Louisville; University of British Columbia; University of British Columbia	Li, JX (corresponding author), Univ Louisville, Dept Math, Louisville, KY 40292 USA.	jiaxu.li@louisville.edu; jimjohn@mail.ubc.ca	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	DOE (Department of Energy's) [DE-EM000197]; National Institutes of Health/National Institute of Dental and Craniofacial Research grant [R01-DE019243]; National Institutes of Health/National Institute of Environmental Health Sciences [P30-ES014443]; Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research; Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	DOE (Department of Energy's); National Institutes of Health/National Institute of Dental and Craniofacial Research grant; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Minghu Wang and Jiaxu Li were supported in part by DOE (Department of Energy's) grant DE-EM000197. Jiaxu Li is also supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grant R01-DE019243, and National Institutes of Health/National Institute of Environmental Health Sciences grant P30-ES014443. James D. Johnson and Gareth E. Lim were supported by the Canadian Institutes for Health Research, the Juvenile Diabetes Research Foundation, the Michael Smith Foundation for Health Research, and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Engelborghs K, 2001, J MATH BIOL, V42, P361, DOI 10.1007/s002850000072; Evert M, 2004, CANCER RES, V64, P8093, DOI 10.1158/0008-5472.CAN-04-2040; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; HORUK R, 1979, NATURE, V279, P439, DOI 10.1038/279439a0; HORUK R, 1980, NATURE, V286, P822, DOI 10.1038/286822a0; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Johnson JD, 2008, CELL CYCLE, V7, P1343, DOI 10.4161/cc.7.10.5865; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Li JX, 2012, MATH BIOSCI, V235, P128, DOI 10.1016/j.mbs.2011.11.005; Li JX, 2009, DISCRETE CONT DYN-B, V12, P401, DOI 10.3934/dcdsb.2009.12.401; Li J, 2009, MATH BIOSCI ENG, V6, P41, DOI 10.3934/mbe.2009.6.41; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim GE, 2013, DIABETOLOGIA; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; MILES KA, 1995, BRIT J RADIOL, V68, P471, DOI 10.1259/0007-1285-68-809-471; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; MOSEKILDE E, 1989, J PHARMACOKINET BIOP, V17, P67, DOI 10.1007/BF01059088; Nyman LR, 2008, J CLIN INVEST; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Smith H.L., 1995, MATH SURVEYS MONOGR; Soeborg T, 2009, EUR J PHARM SCI, V36, P78, DOI 10.1016/j.ejps.2008.10.018; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801; Tarin C, 2005, IEEE T BIO-MED ENG, V52, P1994, DOI 10.1109/TBME.2005.857681; TRAJANOSKI Z, 1993, BIOMED TECH, V38, P224, DOI 10.1515/bmte.1993.38.9.224; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Ueki K, 2003, DIABETES, V52, pA42; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h	58	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64860	10.1371/journal.pone.0064860	http://dx.doi.org/10.1371/journal.pone.0064860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798995	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300004
J	Wang, MJ; Yuan, DJ; Gao, WH; Li, Y; Tan, JF; Zhang, XL				Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong			A Comparative Genome Analysis of PME and PMEI Families Reveals the Evolution of Pectin Metabolism in Plant Cell Walls	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; METHYLESTERASE; GENE; SEQUENCE; DUPLICATION; POLYPLOIDY; INHIBITORS; KNOWLEDGE; DISPLAY	Pectins are fundamental polysaccharides in the plant primary cell wall. Pectins are synthesized and secreted to cell walls as highly methyl-esterified polymers and then demethyl-esterified by pectin methylesterases (PMEs), which are spatially regulated by pectin methylesterase inhibitors (PMEIs). Although PME and PMEI genes are pivotal in plant cell wall formation, few studies have focused on the evolutionary patterns of the PME and PMEI gene families. In this study, the gene origin, evolution, and expression diversity of these two families were systematically analyzed using 11 representative species, including algae, bryophytes, lycophytes and flowering land plants. The results show that 1) for the two subfamilies (PME and proPME) of PME, the origin of the PME subfamily is consistent with the appearance of pectins in early charophyte cell walls, 2) Whole genome duplication (WGD) and tandem duplication contribute to the expansion of proPME and PMEI families in land plants, 3) Evidence of selection pressure shows that the proPME and PMEI families have rapidly evolved, particularly the PMEI family in vascular plants, and 4) Comparative expression profile analysis of the two families indicates that the eudicot Arabidopsis and monocot rice have different expression patterns. In addition, the gene structure and sequence analyses show that the origin of the PMEI domain may be derived from the neofunctionalization of the pro domain after WGD. This study will advance the evolutionary understanding of the PME and PMEI families and plant cell wall development.	[Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yuan, DJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	robert@mail.hzau.edu.cn; xlzhang@mail.hzau.edu.cn	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	National Natural Science Foundation of China [31230056]; National Basic Research Program [2010CB126001]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was financially supported by the National Natural Science Foundation of China (NO. 31230056) and National Basic Research Program (2010CB126001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cao Jun, 2012, PLoS One, V7, pe46944, DOI 10.1371/journal.pone.0046944; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; de Freitas ST, 2012, PLANT J, V71, P824, DOI 10.1111/j.1365-313X.2012.05034.x; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Wang CM, 2012, PLANT PHYSIOL, V158, P1523, DOI 10.1104/pp.111.192203; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu ZL, 2009, PLANT PHYSIOL, V151, P1943, DOI 10.1104/pp.109.142984; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	66	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72082	10.1371/journal.pone.0072082	http://dx.doi.org/10.1371/journal.pone.0072082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23798995	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300177
